data_2jqv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jqv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.196 0.522 . . . . 74.23 109.915 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -107.81 150.53 26.89 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.673 -0.694 . . . . 72.12 111.925 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -124.52 124.65 42.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.075 -1.454 . . . . 74.14 107.075 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 7.6 p -130.61 123.5 55.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 120.539 -0.464 . . . . 53.4 111.991 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -77.81 120.09 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.974 -0.75 . . . . 74.23 108.974 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.97 148.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.136 0.493 . . . . 64.44 110.217 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.33 106.58 9.61 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.85 -0.796 . . . . 71.43 108.85 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 -69.04 1.44 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 114.285 0.474 . . . . 74.34 114.285 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -44.75 -72.31 0.06 Allowed 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.198 1.555 . . . . 73.14 115.198 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.415 ' HB ' HD13 ' A' ' 67' ' ' ILE . 4.2 mp -105.67 66.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 109.167 -0.679 . . . . 71.5 109.167 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.8 mt -114.6 16.35 17.58 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.472 -1.307 . . . . 61.12 107.472 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.36 146.75 43.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.423 -1.262 . . . . 73.4 110.956 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.38 -42.83 51.74 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.806 3.004 . . . . 70.24 114.165 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.48 -47.65 78.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 120.627 0.251 . . . . 73.22 111.233 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 26' ' ' ILE . 93.9 t -65.09 -45.16 95.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 CA-C-N 115.861 -0.608 . . . . 73.14 111.64 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.38 -37.3 80.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.118 0.485 . . . . 37.82 110.629 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.92 -33.49 68.31 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.768 -0.651 . . . . 63.31 111.522 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 22' ' ' VAL . 17.9 m -82.47 -28.58 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.969 -0.692 . . . . 73.42 111.254 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.5 tt -72.3 -47.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 119.736 -0.786 . . . . 73.41 111.829 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.532 HD21 ' CE2' ' A' ' 78' ' ' PHE . 77.7 mt -95.62 -55.56 2.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.834 -1.146 . . . . 60.04 112.072 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.1 t70 150.39 -33.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.534 -1.654 . . . . 73.41 106.534 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -134.78 159.86 40.0 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.786 -1.552 . . . . 73.12 108.028 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.0 m -76.01 119.04 19.41 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.205 0.526 . . . . 71.33 110.144 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.2 152.98 21.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.723 -0.843 . . . . 72.4 108.723 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -95.75 120.74 36.54 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.302 0.572 . . . . 54.34 112.322 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.3 p -93.46 145.24 24.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 115.144 -0.934 . . . . 63.34 109.114 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.2 t -124.08 134.71 25.63 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 106.82 -1.548 . . . . 73.3 106.82 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 33.1 Cg_endo -65.4 126.5 16.35 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.137 1.892 . . . . 74.44 111.73 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.97 155.26 39.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.516 -0.765 . . . . 63.2 110.558 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.75 129.08 75.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.55 0.691 . . . . 70.35 111.385 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.401 ' HA ' HG11 ' A' ' 93' ' ' VAL . 27.2 tp -91.58 95.36 9.89 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.332 -0.849 . . . . 73.33 111.804 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -73.55 131.96 42.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.123 -0.695 . . . . 75.12 109.123 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.11 -10.56 20.39 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 119.213 -1.47 . . . . 65.32 113.064 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.01 158.71 34.62 Favored 'General case' 0 CA--C 1.473 -1.993 0 N-CA-C 110.242 -0.281 . . . . 65.04 110.242 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -126.19 131.5 51.98 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.767 -1.197 . . . . 73.12 107.767 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.42 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -91.36 137.23 32.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.568 0.699 . . . . 73.43 112.665 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.33 -1.359 . . . . 73.23 107.33 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -88.12 -45.21 10.33 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.862 0.319 . . . . 73.3 111.862 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' PRO 0.261 7.5 mp 57.23 77.34 0.27 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 114.912 1.449 . . . . 70.14 114.912 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -78.58 105.25 9.74 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.79 -1.096 . . . . 72.34 110.626 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.88 -31.57 3.04 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 110.882 -0.887 . . . . 37.82 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.427 HD21 ' CZ2' ' A' ' 109' ' ' TRP . 4.2 mp -96.86 156.16 36.8 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 108.025 -1.102 . . . . 71.24 108.025 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.27 87.87 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 123.133 2.555 . . . . 62.43 113.955 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.615 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.595 34.6 p90 33.42 54.83 1.34 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 119.556 3.169 . . . . 75.31 119.556 -176.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 5.7 Cg_endo -103.63 169.49 0.21 Allowed 'Trans proline' 0 CA--C 1.555 1.542 1 C-N-CA 125.637 4.225 . . . . 73.14 110.298 174.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p -155.97 -178.43 7.3 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.245 2.218 . . . . 64.23 107.122 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.431 HG13 HG13 ' A' ' 108' ' ' VAL . 44.4 pt -126.64 124.24 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.625 -1.25 . . . . 65.22 107.625 164.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 m -146.71 172.71 3.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.856 -1.164 . . . . 71.14 107.856 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.6 m 71.04 129.94 0.03 OUTLIER 'General case' 0 C--O 1.24 0.577 0 O-C-N 124.909 1.38 . . . . 73.34 111.495 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -80.31 75.05 7.14 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.04 -1.467 . . . . 74.41 107.04 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.61 161.9 20.98 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 113.066 -1.879 . . . . 73.41 109.708 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.9 m -82.79 -4.29 57.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.667 0.27 . . . . 71.25 111.332 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.68 -171.17 47.4 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 121.505 -0.379 . . . . 70.31 112.433 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -144.69 154.78 43.13 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 120.82 0.343 . . . . 75.3 110.609 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.7 t -116.92 122.16 69.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.775 -0.648 . . . . 71.12 109.3 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -96.04 123.41 39.63 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.374 -0.531 . . . . 75.04 109.672 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.91 -143.8 3.76 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.894 -1.282 . . . . 71.12 109.894 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 35' ' ' PRO . 48.6 mtpt -140.76 150.68 43.69 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.762 0.781 . . . . 73.44 109.632 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.5 m -104.45 133.99 47.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 115.629 -0.714 . . . . 62.24 109.773 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.415 HD13 ' HB ' ' A' ' 17' ' ' ILE . 45.4 mt -87.23 111.54 21.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.8 -1.926 . . . . 72.2 105.8 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -103.91 162.03 13.47 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.296 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.67 72.03 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 116.147 -0.479 . . . . 73.42 111.966 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -94.97 122.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 109.939 -0.393 . . . . 72.01 109.939 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.0 t -73.74 163.22 28.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.325 -0.991 . . . . 74.15 108.325 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.9 -26.0 68.58 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.973 0.416 . . . . 64.13 110.575 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 -43.91 32.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.42 -0.585 . . . . 75.11 109.42 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.455 ' HB3' HD23 ' A' ' 27' ' ' LEU . 53.9 mt-10 -63.73 -43.2 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 71.45 110.599 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.15 -36.62 77.97 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.723 0.809 . . . . 73.31 110.077 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' HG22 ' A' ' 80' ' ' VAL . 58.4 t30 -60.92 -28.71 69.13 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.348 -0.842 . . . . 52.15 111.18 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.515 ' ND2' HG13 ' A' ' 26' ' ' ILE . 3.1 t30 -70.74 -30.17 66.61 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 119.791 -0.763 . . . . 64.24 109.484 -173.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 27' ' ' LEU . 92.6 m-85 -70.53 -32.59 70.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 64.01 109.484 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.13 -39.99 62.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.186 -0.915 . . . . 63.34 109.67 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 76' ' ' ASN . 65.5 t -74.62 -44.15 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.118 -0.946 . . . . 72.35 112.031 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.35 120.76 51.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.412 -0.358 . . . . 70.14 111.527 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 75.87 -26.78 0.19 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.934 1.294 . . . . 74.42 113.7 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 51.16 3.89 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.289 -0.724 . . . . 60.31 111.289 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.65 -43.11 49.29 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.073 0.549 . . . . 62.23 112.285 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.607 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 4.2 t70 -118.03 25.87 10.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.88 1.324 . . . . 72.51 107.552 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 89.5 m-85 -114.75 151.36 33.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.072 -1.422 . . . . 74.33 109.68 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.74 149.23 49.72 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.522 -0.547 . . . . 75.02 109.522 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -85.8 125.4 33.23 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.922 0.712 . . . . 71.13 112.922 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.25 155.79 41.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.965 -1.016 . . . . 70.32 109.218 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.5 m -96.98 124.14 40.87 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.384 -0.599 . . . . 74.21 109.384 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.96 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 107.904 -1.147 . . . . 74.21 107.904 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -112.52 131.63 55.5 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.747 -1.181 . . . . 74.55 108.26 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 38' ' ' LEU . 24.1 m -125.67 163.68 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 73.41 109.458 -174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.503 HG23 ' HG2' ' A' ' 101' ' ' LYS . 70.4 t -102.48 117.27 47.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.839 -0.619 . . . . 54.24 109.338 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -66.72 94.58 0.31 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.863 -1.162 . . . . 74.41 107.863 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.484 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -54.34 -35.57 62.86 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 125.496 1.518 . . . . 74.31 109.567 -177.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -52.6 -30.89 33.54 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.763 -1.108 . . . . 63.45 112.592 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -136.08 4.61 2.99 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.617 0.722 . . . . 53.22 110.968 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m 59.88 25.58 14.72 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.119 0.968 . . . . 74.44 112.742 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.83 160.61 14.33 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.656 -0.868 . . . . 72.41 108.656 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.503 ' HG2' HG23 ' A' ' 94' ' ' VAL . 39.8 mtmt -102.35 129.69 48.88 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.49 -0.559 . . . . 74.44 109.49 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.74 144.38 37.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.092 0.472 . . . . 53.31 110.431 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -93.94 126.35 39.09 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.524 -0.917 . . . . 75.23 108.524 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.081 0.467 . . . . 71.22 111.28 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 46.7 mt-10 -100.53 153.36 19.44 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.636 -1.246 . . . . 73.51 107.636 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -151.01 173.63 14.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 86' ' ' TYR . 92.5 m-85 -113.55 118.68 35.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 121.122 0.487 . . . . 73.51 110.29 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 54' ' ' ILE . 27.4 m -109.79 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.472 -0.936 . . . . 74.02 108.472 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.607 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 46.4 t-105 -93.33 129.17 39.53 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.223 -1.028 . . . . 74.31 108.223 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 85' ' ' ASP . 34.8 m -71.47 -20.07 20.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 N-CA-C 112.51 0.559 . . . . 71.41 112.51 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.546 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 25.4 t-20 -80.48 11.8 3.46 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.744 0.783 . . . . 75.13 109.942 176.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 19.6 ptpt -51.29 -15.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.747 2.019 . . . . 70.15 114.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.46 -52.07 18.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.957 0.903 . . . . 65.11 111.218 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -108.05 127.54 27.42 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 109.432 -0.581 . . . . 75.25 109.432 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.87 103.61 0.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 70.14 111.056 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -100.9 133.09 45.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.503 -0.771 . . . . 73.44 109.653 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.466 0.357 0 O-C-N 123.987 0.805 . . . . 72.13 110.078 -178.21 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.421 ' O ' HG23 ' A' ' 129' ' ' VAL . 36.9 tt0 . . . . . 0 N--CA 1.427 -1.594 0 N-CA-C 108.4 -0.963 . . . . 75.2 108.4 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -61.99 -44.17 97.3 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.424 -0.51 . . . . 71.33 109.871 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -56.27 -48.93 75.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.662 -0.699 . . . . 74.35 111.177 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.563 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 32.0 m -70.43 -40.59 77.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.154 -0.618 . . . . 74.43 112.37 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 125' ' ' GLU . 95.2 t -68.16 -44.81 84.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.548 -0.461 . . . . 63.4 111.767 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.514 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.6 p80 -67.39 -33.77 75.9 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 118.401 -1.319 . . . . 61.51 109.737 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 135' ' ' VAL . . . -64.54 -47.27 79.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.977 -0.556 . . . . 73.15 110.863 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 48.1 mt-10 -60.28 -41.52 93.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.954 0.406 . . . . 73.41 110.389 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.25 -48.05 81.67 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.179 -0.919 . . . . 72.31 111.897 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.514 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 56.4 m-85 -67.94 -45.43 74.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.581 -0.448 . . . . 74.23 111.572 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 131' ' ' ALA . 94.5 t -57.37 -48.26 83.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 116.391 -0.368 . . . . 70.43 111.68 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -58.55 -48.88 79.43 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 120.439 -0.504 . . . . 63.0 109.928 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -45.2 81.27 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.527 -0.76 . . . . 75.53 112.343 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.52 -43.05 73.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.872 -0.731 . . . . 64.21 112.067 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.49 -46.74 88.76 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.992 0.425 . . . . 62.22 111.207 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.95 -32.05 66.93 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.909 -0.587 . . . . 62.4 112.316 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -72.86 -32.07 65.18 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.41 -0.959 . . . . 75.24 108.41 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.56 -37.17 79.69 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.464 -0.789 . . . . 73.24 110.166 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.59 -46.44 89.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.1 0.476 . . . . 74.41 110.283 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -65.39 -43.73 89.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.871 -0.604 . . . . 74.14 110.8 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.6 -22.21 65.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.698 0.761 . . . . 74.23 111.09 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 0.7 OUTLIER -78.45 -26.66 46.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.447 -0.797 . . . . 72.22 109.193 177.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.01 82.14 0.22 Allowed Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.349 0.66 . . . . 73.0 109.72 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.25 -37.26 2.68 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.216 1.944 . . . . 61.33 112.031 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -96.47 3.44 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.562 -0.744 . . . . 73.34 110.572 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 109.636 -1.386 . . . . 75.32 109.636 -173.368 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 p . . . . . 0 N--CA 1.439 -0.986 0 CA-C-O 121.747 0.784 . . . . 63.21 110.351 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.95 156.2 19.04 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 114.647 -1.16 . . . . 73.33 111.059 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.489 ' CB ' HG13 ' A' ' 104' ' ' VAL . 3.3 m-20 -125.31 131.92 52.96 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.96 -1.496 . . . . 64.03 106.96 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.414 HG13 ' HB ' ' A' ' 13' ' ' VAL . 49.1 t -119.5 120.33 63.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 120.336 -0.546 . . . . 53.34 110.694 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -91.5 96.73 10.65 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 104.861 -2.274 . . . . 71.12 104.861 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.414 ' HB ' HG13 ' A' ' 11' ' ' VAL . 10.3 p -119.1 121.93 67.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 118.329 -1.348 . . . . 71.05 111.576 -173.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -92.35 66.86 4.77 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 106.025 -1.843 . . . . 72.33 106.025 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.38 -169.82 13.9 Favored Glycine 0 N--CA 1.42 -2.392 0 CA-C-N 113.537 -1.665 . . . . 70.43 109.381 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -88.0 85.11 6.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-O 121.606 0.717 . . . . 65.23 112.749 -174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.46 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 8.0 mm -144.43 -84.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 104.846 -2.279 . . . . 74.14 104.846 169.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.442 ' H ' ' HB ' ' A' ' 17' ' ' ILE . 80.6 mt 50.89 -42.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 128.086 2.554 . . . . 73.31 117.368 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.89 140.29 22.55 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.199 -0.667 . . . . 72.41 109.199 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -48.57 -28.65 12.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.586 3.524 . . . . 72.34 114.861 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.48 97.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.929 0.395 . . . . 73.54 111.08 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.626 ' O ' HG22 ' A' ' 25' ' ' VAL . 35.9 t -77.07 -30.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.882 -0.784 . . . . 65.05 108.882 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.64 -28.96 70.27 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.934 -0.765 . . . . 71.33 108.934 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.09 -8.7 57.59 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.434 -0.803 . . . . 37.77 111.767 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 22' ' ' VAL . 14.4 m -99.25 -23.07 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 119.619 -0.833 . . . . 71.52 110.773 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.432 HD11 ' C ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -85.85 -47.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 116.251 -0.431 . . . . 72.2 110.588 176.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' A' ' 31' ' ' ALA . 97.7 mt -89.66 -21.3 22.83 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 116.57 -0.286 . . . . 75.01 110.796 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 37.2 t70 68.72 10.7 8.04 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.289 1.519 . . . . 70.22 108.882 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -136.11 141.83 44.22 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 104.928 -2.249 . . . . 75.22 104.928 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -77.74 136.83 38.21 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.485 -0.886 . . . . 71.44 109.887 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -121.0 154.86 35.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.689 -0.485 . . . . 50.15 109.689 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -89.89 117.98 29.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.473 -0.566 . . . . 72.52 109.473 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.6 m -104.96 142.67 34.36 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.459 -2.052 . . . . 75.25 105.459 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.56 149.84 70.44 Favored Pre-proline 0 C--N 1.296 -1.75 0 O-C-N 122.088 -0.383 . . . . 74.02 110.133 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.53 133.47 37.24 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.605 2.203 . . . . 71.5 111.522 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.79 156.51 41.94 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.942 -0.572 . . . . 73.22 109.868 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.0 p -122.59 128.04 75.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-O 121.496 0.665 . . . . 73.23 111.045 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.446 ' HA ' HG11 ' A' ' 93' ' ' VAL . 22.4 tp -87.91 111.07 21.04 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.196 -0.911 . . . . 75.2 110.103 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -87.06 122.21 30.57 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.473 -0.785 . . . . 64.14 110.187 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.45 7.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.374 -1.393 . . . . 71.31 112.866 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.427 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 57.0 m-85 -117.78 161.11 20.24 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 109.288 -0.634 . . . . 73.12 109.288 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -133.41 131.98 40.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.25 -1.389 . . . . 72.0 107.25 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.458 ' C ' ' HD3' ' A' ' 43' ' ' ARG . 1.2 tmt_? -88.56 120.56 30.06 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 109.292 -0.633 . . . . 71.31 109.292 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -95.99 159.82 14.77 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.987 -1.486 . . . . 75.53 106.987 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.475 ' C ' ' HD3' ' A' ' 45' ' ' LYS . 7.7 tmtm? -82.78 -41.76 18.76 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 112.156 0.428 . . . . 70.53 112.156 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 49' ' ' LEU . 7.9 mp 62.75 158.27 0.07 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.529 1.307 . . . . 73.13 114.529 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.41 -51.25 1.28 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.799 -0.815 . . . . 75.5 108.799 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.29 74.63 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.661 -1.154 . . . . 71.4 111.678 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.474 ' HB2' HD21 ' A' ' 46' ' ' LEU . 3.0 mm? -107.63 167.34 9.5 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.409 -0.96 . . . . 71.35 108.409 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -62.68 -157.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.52 0 C-N-CA 123.01 2.473 . . . . 63.11 112.905 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.521 ' N ' ' HD2' ' A' ' 52' ' ' PRO 0.349 12.8 p90 -57.49 -31.34 9.92 Favored Pre-proline 0 CA--C 1.568 1.665 0 N-CA-C 116.557 2.058 . . . . 72.13 116.557 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 51' ' ' TYR . 3.3 Cg_exo -39.74 168.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.59 3.317 0 C-N-CA 123.631 2.887 . . . . 71.52 112.746 163.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 p -139.29 -175.87 4.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.199 -1.563 . . . . 75.33 110.963 11.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 45.1 pt -123.77 141.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.116 -1.068 . . . . 73.33 108.116 172.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 m -148.18 158.77 7.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.951 -0.759 . . . . 62.11 108.951 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 m -80.5 88.91 5.62 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.739 0.78 . . . . 75.02 109.839 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.5 t -144.1 -66.02 0.35 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.574 -1.639 . . . . 74.22 106.574 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.63 125.68 30.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.387 -1.709 . . . . 73.13 106.387 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -84.41 15.46 3.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.846 0.684 . . . . 64.13 112.846 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.84 -147.73 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 114.617 0.607 . . . . 53.44 114.617 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -139.82 154.09 47.25 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 120.167 -0.613 . . . . 75.32 111.184 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.55 123.23 70.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.474 -0.785 . . . . 61.24 109.861 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -94.13 123.9 37.8 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.855 -0.424 . . . . 63.03 109.855 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.32 -149.03 5.19 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.16 -0.776 . . . . 63.22 111.16 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -138.3 156.55 47.55 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.904 -0.776 . . . . 73.32 108.904 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 33' ' ' THR . 29.8 m -125.8 129.62 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 120.782 0.325 . . . . 74.24 111.053 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 17' ' ' ILE . 6.2 mt -90.15 116.77 32.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.163 -1.421 . . . . 61.42 107.163 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.2 p -100.89 161.15 13.79 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.936 -0.306 . . . . 75.01 110.717 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.13 33.39 23.58 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.135 -0.555 . . . . 73.05 112.805 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.59 122.32 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 O-C-N 122.473 -0.428 . . . . 73.21 110.642 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.407 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 65.8 m -79.23 158.64 27.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.794 -0.762 . . . . 65.12 109.951 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -52.17 -34.93 47.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.171 0.804 . . . . 53.13 113.171 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -37.64 37.56 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.306 0.574 . . . . 73.24 110.654 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 13.3 mm-40 -68.16 -30.53 69.67 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.229 -0.896 . . . . 74.15 109.43 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 105' ' ' GLU . 4.2 tt -59.37 -35.09 73.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.397 -1.274 . . . . 74.23 109.538 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' HG22 ' A' ' 80' ' ' VAL . 3.4 t-20 -60.37 -28.16 67.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 72.34 110.96 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -31.63 70.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.439 -0.949 . . . . 72.24 108.439 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -67.78 -35.3 78.42 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 116.421 -0.354 . . . . 73.24 110.38 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -69.59 -35.94 75.77 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.726 0.774 . . . . 74.44 109.478 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 76' ' ' ASN . 80.5 t -72.64 -24.59 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 CA-C-N 115.154 -0.93 . . . . 74.34 112.792 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.454 ' HB ' ' OH ' ' A' ' 107' ' ' TYR . 47.9 mm -44.4 -74.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 113.15 0.796 . . . . 73.11 113.15 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -141.77 19.55 2.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.249 0.547 . . . . 75.14 110.847 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.46 62.89 4.0 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.927 -0.654 . . . . 71.44 113.183 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.38 -42.88 18.08 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.908 -0.404 . . . . 73.13 109.908 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.506 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.8 m-20 -114.49 17.19 17.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.251 1.024 . . . . 75.35 109.718 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.98 156.58 26.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.497 -1.298 . . . . 75.5 107.497 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HB3' HG13 ' A' ' 110' ' ' VAL . 14.3 pt-20 -126.17 142.29 51.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.829 -0.804 . . . . 74.11 108.829 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 tmm_? -88.09 118.07 27.41 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.579 -0.737 . . . . 73.34 109.824 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 m -126.27 160.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.359 0.664 . . . . 73.41 111.834 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.3 m -89.18 129.61 35.74 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 123.628 0.58 . . . . 63.54 109.552 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.87 172.16 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.362 -1.347 . . . . 72.35 107.362 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -123.6 129.85 51.78 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.319 -0.952 . . . . 74.34 109.167 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.446 HG11 ' HA ' ' A' ' 38' ' ' LEU . 16.2 m -127.03 168.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.073 0.464 . . . . 74.45 110.72 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.48 HG23 ' HG2' ' A' ' 101' ' ' LYS . 68.0 t -114.07 122.43 68.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.819 -0.628 . . . . 74.44 110.931 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 75.0 ttt180 -70.98 102.12 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.926 -1.138 . . . . 74.55 107.926 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.412 ' HE2' ' O ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -45.37 -60.0 2.38 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 126.818 2.047 . . . . 72.34 111.511 -171.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.1 -32.64 62.16 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.804 1.039 . . . . 71.54 113.804 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -110.47 -8.78 14.63 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.292 0.849 . . . . 62.22 113.292 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.41 25.69 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.966 0.907 . . . . 74.41 110.384 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -98.83 160.19 14.43 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.864 -0.791 . . . . 72.43 108.864 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HG2' HG23 ' A' ' 94' ' ' VAL . 88.2 mttt -105.05 137.31 42.99 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.582 -0.525 . . . . 74.14 109.582 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.13 140.62 43.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.714 -0.476 . . . . 71.11 109.714 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -90.8 127.74 36.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.241 -1.392 . . . . 71.12 107.241 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.489 HG13 ' CB ' ' A' ' 10' ' ' ASN . 28.2 m -133.98 171.95 17.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.024 0.44 . . . . 75.01 112.121 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.491 ' HG3' HD11 ' A' ' 75' ' ' LEU . 31.2 mm-40 -104.24 153.97 20.35 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.255 -1.387 . . . . 74.04 107.255 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -156.0 177.79 11.01 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.247 0.476 . . . . 74.15 110.166 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.454 ' OH ' ' HB ' ' A' ' 81' ' ' ILE . 3.9 m-85 -103.55 119.78 39.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 122.914 0.485 . . . . 74.45 109.85 177.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -119.55 159.99 20.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.873 -1.528 . . . . 73.32 106.873 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.703 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 54.0 t-105 -83.96 134.27 34.66 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.669 -0.863 . . . . 75.33 108.669 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 85' ' ' ASP . 29.5 m -72.21 -20.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 118.981 0.809 . . . . 73.14 112.419 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.703 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 26.0 t-20 -92.0 15.5 13.11 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 125.323 1.449 . . . . 54.54 108.992 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 45.5 pttt -47.75 -15.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 127.242 2.217 . . . . 71.44 116.356 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.41 -20.39 60.07 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 119.112 -1.035 . . . . 61.42 111.442 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -97.46 124.48 48.64 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 107.544 -1.28 . . . . 74.05 107.544 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.25 102.24 1.5 Allowed 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 121.403 1.402 . . . . 73.44 111.011 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.79 112.02 17.78 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.895 -1.15 . . . . 72.22 107.895 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.47 0.544 0 O-C-N 124.639 1.212 . . . . 73.42 110.97 -175.098 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--O 1.239 0.516 0 CA-C-O 120.769 0.319 . . . . 63.04 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -51.6 -57.18 9.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.29 -0.868 . . . . 73.44 111.406 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.3 -34.18 65.59 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.044 -0.662 . . . . 73.34 111.81 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.75 -47.63 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.535 0.568 . . . . 74.11 112.535 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.16 -33.9 63.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.549 0.69 . . . . 75.33 109.905 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.471 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 55.6 t-80 -69.88 -45.71 67.06 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.961 -1.018 . . . . 65.44 109.844 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.47 ' O ' HG21 ' A' ' 135' ' ' VAL . . . -61.26 -52.97 62.5 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.98 -0.554 . . . . 52.11 111.022 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.03 -45.67 71.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 123.414 0.446 . . . . 72.11 111.51 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -61.51 -53.96 49.5 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.018 -0.992 . . . . 73.11 111.886 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 96.7 m-85 -74.95 -31.5 61.51 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 113.79 1.033 . . . . 75.43 113.79 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 131' ' ' ALA . 79.4 t -63.8 -45.94 95.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 121.139 -0.225 . . . . 54.13 111.295 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 12.5 pt-20 -67.77 -36.71 80.97 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.401 -0.919 . . . . 71.11 110.937 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.7 m -60.82 -47.21 87.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.937 -0.574 . . . . 73.13 109.46 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.546 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 87.1 t80 -59.16 -48.05 83.06 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.831 -0.622 . . . . 74.12 110.028 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 97.4 mtt180 -61.58 -42.89 99.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.181 -0.463 . . . . 74.42 112.148 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.4 mmtp -65.17 -42.37 93.73 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 121.019 -0.272 . . . . 75.25 110.537 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.523 ' HA ' ' HE3' ' A' ' 141' ' ' MET . 14.7 mmt -63.83 -31.86 73.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.199 -0.455 . . . . 72.14 111.728 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 90.6 mt -67.71 -45.53 74.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.858 -0.423 . . . . 70.03 109.858 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.1 mt-10 -60.79 -47.07 88.01 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 109.579 -0.526 . . . . 73.24 109.579 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -59.97 -38.98 84.11 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.216 1.007 . . . . 74.34 111.494 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.5 -45.61 13.41 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.056 -0.52 . . . . 72.05 112.262 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.71 -26.33 25.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.224 0.453 . . . . 63.21 112.224 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -123.25 124.17 26.46 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-O 120.731 0.301 . . . . 63.04 111.149 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.38 -19.41 67.17 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.656 2.237 . . . . 62.23 111.664 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -93.8 3.81 54.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.079 -0.51 . . . . 63.45 110.613 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.983 0 N-CA-C 108.912 -1.675 . . . . 74.22 108.912 174.724 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.434 -1.262 0 CA-C-O 121.53 0.681 . . . . 74.45 111.619 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -108.9 156.26 19.89 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.655 -0.702 . . . . 65.34 110.411 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.44 ' HB2' HG13 ' A' ' 104' ' ' VAL . 84.1 m-20 -132.16 126.41 33.56 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.164 -1.421 . . . . 73.4 107.164 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 46.3 t -117.78 120.62 65.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 121.18 -0.208 . . . . 38.08 110.85 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -84.67 112.76 20.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.476 -0.935 . . . . 75.53 108.476 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.2 t -113.55 142.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.76 -0.83 . . . . 73.31 108.76 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -81.24 -53.98 5.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.708 -0.223 . . . . 70.32 111.426 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.95 79.64 0.13 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 118.531 -1.795 . . . . 75.31 114.974 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 p -162.6 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.38 0.61 . . . . 74.34 110.902 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.461 HG13 HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -91.16 70.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 CA-C-O 123.69 1.709 . . . . 71.42 107.605 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 65' ' ' LYS . 80.7 mt -114.12 -11.7 12.64 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-N 113.372 -1.74 . . . . 65.42 106.96 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -85.68 125.97 67.58 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 113.469 -1.696 . . . . 73.33 110.168 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.12 -38.24 80.57 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.805 2.336 . . . . 75.0 111.669 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.84 -44.97 91.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.918 0.39 . . . . 38.08 111.07 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.52 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -70.16 -34.42 58.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 121.258 0.551 . . . . 51.34 109.795 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.32 -35.71 79.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.223 0.535 . . . . 71.44 109.557 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.84 -13.07 61.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.581 -0.736 . . . . 63.25 111.94 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 22' ' ' VAL . 12.0 m -98.58 -26.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 119.602 -0.839 . . . . 74.44 110.45 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.498 HD12 ' CD1' ' A' ' 78' ' ' PHE . 6.0 tt -84.41 -41.63 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.015 0.436 . . . . 65.44 112.095 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.493 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 86.1 mt -99.62 -21.16 15.99 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.299 -0.409 . . . . 71.33 111.173 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.4 t70 75.84 -5.0 2.26 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.624 1.202 . . . . 64.02 108.925 -171.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 27' ' ' LEU . 84.9 mtt180 -105.94 138.11 42.69 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 113.754 -1.566 . . . . 65.31 107.665 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -79.62 111.15 15.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 106.403 -1.703 . . . . 75.13 106.403 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -89.52 157.06 18.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.388 0.613 . . . . 73.04 111.726 -174.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.63 114.61 27.77 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.959 -1.019 . . . . 74.23 111.323 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 1.7 p -102.62 143.07 32.77 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.519 -0.764 . . . . 63.04 109.775 174.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 m -136.16 143.26 43.13 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 109.155 -0.683 . . . . 62.23 109.155 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.2 132.79 54.05 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.272 1.981 . . . . 64.15 110.671 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.12 36.51 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 109.014 -0.735 . . . . 62.21 109.014 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.23 127.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-O 121.743 0.782 . . . . 72.43 111.988 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.3 tp -90.24 102.36 15.08 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.723 -1.126 . . . . 63.34 109.943 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 61' ' ' LYS . 9.9 p-80 -76.28 125.26 28.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.302 -0.863 . . . . 72.13 109.771 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 117.42 -21.04 10.93 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 118.869 -1.634 . . . . 74.22 114.207 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -106.65 157.31 17.8 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 117.888 0.844 . . . . 73.15 111.482 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -124.92 124.26 41.67 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.403 -0.962 . . . . 72.04 108.403 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -90.86 147.19 23.34 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.763 0.316 . . . . 71.11 110.976 177.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.54 -169.99 1.96 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.527 0.566 . . . . 72.43 112.527 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HZ3' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -109.27 -36.83 5.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.592 -0.276 . . . . 75.25 110.878 178.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 3.8 mm? 64.06 -178.02 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.045 0.538 . . . . 62.51 111.991 -174.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 28.04 6.58 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 113.035 0.754 . . . . 71.52 113.035 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.44 15.0 0.17 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.731 -1.223 . . . . 71.31 113.339 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.411 ' C ' ' HG3' ' A' ' 52' ' ' PRO . 3.6 mm? -95.49 160.17 31.08 Favored Pre-proline 0 C--N 1.311 -1.075 0 O-C-N 122.291 -0.534 . . . . 74.14 110.834 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -90.35 119.56 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.01 2.474 . . . . 74.14 112.504 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.476 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.341 21.6 p90 39.78 60.66 6.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 113.835 1.05 . . . . 73.44 113.835 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 89.3 Cg_endo -115.52 144.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.153 3.235 . . . . 74.25 116.764 -170.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 82.2 m -153.46 -178.84 7.26 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 130.123 3.369 . . . . 74.22 101.916 -13.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 HG13 ' A' ' 108' ' ' VAL . 43.0 pt -123.35 122.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.988 -1.085 . . . . 74.3 110.94 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.33 177.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.704 -1.134 . . . . 75.05 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.8 p 50.96 102.43 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.619 1.568 . . . . 71.54 112.261 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 23.2 t -73.82 83.89 1.66 Allowed 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.799 -0.76 . . . . 73.22 111.617 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.0 -167.3 1.61 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.137 -0.938 . . . . 44.52 109.808 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.3 m -89.45 5.57 44.72 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.567 -0.901 . . . . 61.01 108.567 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.43 165.31 53.81 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.202 -0.908 . . . . 64.23 111.563 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HD2' ' HB3' ' A' ' 39' ' ' HIS . 27.9 mtmm -138.06 146.73 43.33 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.329 -0.619 . . . . 72.54 109.329 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -110.08 122.89 65.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.183 -0.673 . . . . 73.23 109.183 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.38 125.43 46.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.288 -1.004 . . . . 61.43 108.288 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.46 -141.24 3.17 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.501 -1.04 . . . . 52.31 110.501 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.418 ' HB2' HD23 ' A' ' 18' ' ' LEU . 38.9 mtmt -136.82 138.79 41.2 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 113.291 0.849 . . . . 74.51 113.291 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.428 HG11 HG22 ' A' ' 93' ' ' VAL . 31.5 m -104.7 133.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 114.689 -1.141 . . . . 54.01 110.054 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.441 HD11 HD13 ' A' ' 17' ' ' ILE . 14.5 mt -88.42 111.64 22.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 105.638 -1.986 . . . . 73.21 105.638 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -97.49 161.53 13.73 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.236 -0.586 . . . . 74.12 111.536 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.05 60.12 Favored Glycine 0 CA--C 1.522 0.52 0 O-C-N 123.285 0.366 . . . . 54.35 113.635 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.62 131.98 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 110.25 -0.278 . . . . 70.23 110.25 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.439 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 24.2 m -78.37 158.96 28.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.124 -0.631 . . . . 75.45 109.775 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -55.81 -45.44 78.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.612 -0.722 . . . . 70.12 111.342 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.51 -36.09 76.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.735 -0.666 . . . . 51.5 111.232 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.493 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 54.1 mt-10 -73.72 -35.7 65.13 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.722 -0.672 . . . . 75.21 111.09 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.502 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.5 tt -60.21 -35.41 75.37 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.706 -0.85 . . . . 65.05 108.706 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -55.5 -27.75 50.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.784 -1.098 . . . . 73.44 112.141 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.501 ' O ' HG21 ' A' ' 81' ' ' ILE . 5.4 t30 -74.33 -31.86 62.61 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 119.391 -0.924 . . . . 74.23 109.503 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.498 ' CD1' HD12 ' A' ' 26' ' ' ILE . 73.6 m-85 -71.81 -42.03 67.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.229 -1.397 . . . . 74.12 107.229 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.427 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 9.4 t70 -55.96 -52.63 63.47 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.261 -1.336 . . . . 72.22 110.291 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.02 -33.14 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 113.294 0.85 . . . . 75.42 113.294 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.501 HG21 ' O ' ' A' ' 77' ' ' ASN . 17.0 tt -101.21 -34.24 3.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 C-N-CA 118.464 -1.294 . . . . 73.14 113.996 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -79.26 -19.0 51.69 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.929 -0.708 . . . . 74.52 110.841 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.81 60.37 3.89 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.992 -0.623 . . . . 70.32 112.427 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -81.81 -44.59 16.73 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.853 -0.795 . . . . 74.44 108.853 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -141.05 21.55 2.27 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.873 -1.528 . . . . 71.44 106.873 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -122.7 153.74 39.01 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.731 -1.577 . . . . 75.43 107.401 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HB3' HG23 ' A' ' 110' ' ' VAL . 9.9 pt-20 -126.33 153.8 44.37 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 120.195 -0.602 . . . . 74.4 111.086 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.427 ' HD3' ' OD2' ' A' ' 79' ' ' ASP . 58.3 ttt180 -82.84 121.29 26.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.773 -1.103 . . . . 73.43 111.427 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.73 159.11 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.583 -0.735 . . . . 70.33 109.607 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.57 131.2 39.06 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.564 -0.902 . . . . 70.1 108.564 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.79 165.48 26.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.431 -1.322 . . . . 73.53 107.431 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -117.92 128.74 55.11 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.56 -1.256 . . . . 71.35 109.097 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.428 HG22 HG11 ' A' ' 66' ' ' VAL . 18.3 m -125.98 168.71 18.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.879 -0.415 . . . . 65.42 109.879 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.497 HG23 ' HG2' ' A' ' 101' ' ' LYS . 73.5 t -109.96 118.01 55.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 115.957 -0.565 . . . . 72.0 110.786 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -73.04 105.22 4.41 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.137 -1.06 . . . . 72.31 108.137 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.87 62.31 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 124.423 1.089 . . . . 75.44 110.032 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.98 -33.92 71.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.493 -0.776 . . . . 74.23 112.334 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -128.73 0.65 5.45 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 120.627 -0.429 . . . . 71.13 111.66 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 62.28 26.78 16.04 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.471 0.708 . . . . 43.22 110.615 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.9 160.52 14.54 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.557 -0.747 . . . . 72.24 109.727 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.497 ' HG2' HG23 ' A' ' 94' ' ' VAL . 38.7 mtmt -102.4 135.69 43.55 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.536 -0.913 . . . . 54.21 108.536 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.1 m -133.87 139.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.249 0.547 . . . . 71.14 109.892 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.62 122.06 30.84 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.648 -1.612 . . . . 61.25 106.648 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 10' ' ' ASN . 17.8 m -131.52 175.13 11.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.083 0.468 . . . . 75.31 111.137 -171.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.82 146.99 27.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.771 -1.196 . . . . 73.21 107.771 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.0 t -149.5 174.32 12.62 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.279 -1.008 . . . . 73.32 108.279 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 92.6 m-85 -118.75 118.72 32.35 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.276 0.56 . . . . 73.01 109.739 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 54' ' ' ILE . 33.7 m -108.98 175.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.184 -1.043 . . . . 63.4 108.184 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.529 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 23.0 t-105 -74.69 132.49 41.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.929 -1.508 . . . . 74.41 106.929 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.8 p -69.62 -20.78 24.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.918 0.866 . . . . 75.14 110.61 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 7.9 t30 -88.92 15.12 8.98 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.719 1.208 . . . . 74.31 109.17 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 61.3 pttt -48.94 -15.66 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.069 1.748 . . . . 75.13 115.123 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -72.84 -22.95 60.71 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.012 -0.675 . . . . 65.41 110.404 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -113.84 122.94 33.81 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.486 -0.561 . . . . 63.21 109.486 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.63 115.36 4.05 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.679 2.252 . . . . 74.54 109.591 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.683 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 30.7 ttm180 -129.61 124.26 33.3 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.741 -0.837 . . . . 72.5 108.741 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.683 ' SD ' ' HG2' ' A' ' 116' ' ' ARG . 1.3 mpt? . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.353 1.061 . . . . 74.04 112.263 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.515 0.674 . . . . 75.55 111.599 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -81.37 -35.64 30.57 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.185 -0.916 . . . . 74.13 110.1 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -51.85 -48.92 63.78 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.88 0.738 . . . . 74.21 111.49 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.7 -34.47 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.356 -0.838 . . . . 71.41 112.835 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.46 -44.3 17.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.224 -0.658 . . . . 65.43 109.224 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -55.49 -37.67 68.13 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.033 0.933 . . . . 74.34 111.73 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.74 72.05 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.855 -0.338 . . . . 53.15 111.256 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.464 ' HA ' HG11 ' A' ' 135' ' ' VAL . 7.4 mm-40 -72.3 -35.03 68.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.597 0.713 . . . . 63.34 111.028 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.529 ' HB3' ' HZ3' ' A' ' 133' ' ' LYS . 4.3 mmmp? -68.32 -22.08 64.72 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.466 -0.788 . . . . 74.45 112.276 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -98.15 -31.85 11.9 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.051 -0.659 . . . . 75.25 112.015 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 132' ' ' GLU . 11.4 p -66.07 -33.81 66.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 C-N-CA 120.04 -0.664 . . . . 61.23 109.64 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 11.4 pt-20 -60.15 -38.79 84.2 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.432 -0.349 . . . . 65.32 110.22 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 74.0 m -56.38 -46.4 80.09 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 123.538 0.524 . . . . 75.32 111.038 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' HA ' ' HG2' ' A' ' 141' ' ' MET . 95.6 m-85 -67.43 -32.2 72.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.231 -0.441 . . . . 72.53 111.265 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.637 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 53.5 mtp180 -70.38 -38.88 74.79 Favored 'General case' 0 C--O 1.184 -2.391 0 C-N-CA 119.474 -0.89 . . . . 70.02 111.087 171.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 75.2 mmtt -56.24 -47.23 78.9 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.807 -0.442 . . . . 71.04 109.807 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.648 ' HA ' ' CE3' ' A' ' 144' ' ' TRP . 27.0 ptm -66.22 -30.75 71.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.074 -0.512 . . . . 75.01 110.511 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -44.71 74.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.551 -1.277 . . . . 74.35 107.551 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 7.2 mm-40 -60.93 -29.64 69.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.912 0.885 . . . . 74.35 110.747 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.648 ' CE3' ' HA ' ' A' ' 141' ' ' MET . 26.1 m0 -75.3 -44.19 46.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.627 -0.508 . . . . 75.05 109.627 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.29 -47.85 72.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.384 -0.825 . . . . 63.41 112.248 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.11 -19.41 24.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.281 0.562 . . . . 74.35 110.351 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 143' ' ' GLU 0.345 7.9 p30 46.19 72.41 1.25 Allowed Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 116.96 2.208 . . . . 74.25 116.96 176.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.22 -27.11 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.14 1.893 . . . . 74.34 112.092 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.23 -25.53 22.83 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.108 0.48 . . . . 62.2 110.711 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.947 0 N-CA-C 110.52 -1.032 . . . . 72.32 110.52 -177.115 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.4 p . . . . . 0 N--CA 1.421 -1.923 0 CA-C-O 120.97 0.414 . . . . 65.02 111.111 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -87.56 153.07 21.69 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.555 -0.748 . . . . 74.41 110.23 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 84.5 m-20 -133.64 131.34 39.45 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.065 -1.828 . . . . 53.43 106.065 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 28.4 t -116.3 119.37 61.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 120.326 -0.55 . . . . 71.41 110.788 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -89.21 109.26 20.16 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.961 -1.496 . . . . 71.45 106.961 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.527 ' O ' HD13 ' A' ' 18' ' ' LEU . 12.4 p -136.29 154.98 33.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 119.741 -0.784 . . . . 54.12 109.994 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -125.11 93.27 3.83 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.094 -0.706 . . . . 73.01 109.094 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.88 -176.46 16.16 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.76 -1.109 . . . . 72.34 111.217 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m 67.5 -73.59 0.08 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 115.137 1.532 . . . . 61.35 115.137 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.454 ' CG1' HD13 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -119.06 14.71 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.046 0.758 . . . . 70.35 113.046 -172.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 13' ' ' VAL . 74.7 mt -74.89 -6.72 50.71 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.195 0.522 . . . . 74.52 111.033 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 115.11 60.47 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 107.436 -1.32 . . . . 62.03 107.436 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -42.24 -44.09 7.72 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.326 3.35 . . . . 71.04 114.659 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.12 94.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.169 0.509 . . . . 72.35 111.494 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 25' ' ' VAL . 46.6 t -71.58 -38.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.965 -0.561 . . . . 74.33 110.248 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.73 74.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.465 0.65 . . . . 64.03 110.05 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -74.84 -16.48 60.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.648 -0.705 . . . . 75.34 111.903 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.3 m -93.54 -33.51 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.493 -0.883 . . . . 65.04 111.233 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.618 HD12 ' CD1' ' A' ' 78' ' ' PHE . 9.2 tt -72.46 -47.04 53.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 CA-C-O 120.587 0.232 . . . . 74.11 111.119 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 31' ' ' ALA . 90.7 mt -85.71 -11.98 52.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 121.221 -0.191 . . . . 71.3 110.877 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.53 8.91 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.287 1.042 . . . . 74.33 110.296 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 97.5 mtt180 -145.12 178.66 7.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.162 -0.926 . . . . 75.24 109.321 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.6 p -76.66 111.2 11.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.523 0.678 . . . . 74.32 110.922 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.55 -0.75 . . . . 55.31 110.321 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -100.17 109.69 21.96 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.571 -0.529 . . . . 73.31 109.571 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.8 p -114.09 142.58 46.03 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 109.096 -0.705 . . . . 74.24 109.096 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.428 HG22 ' HE ' ' A' ' 95' ' ' ARG . 19.3 m -142.22 141.45 21.36 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 107.896 -1.15 . . . . 64.13 107.896 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 3.2 Cg_endo -59.76 135.78 66.05 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 121.47 1.447 . . . . 73.32 110.456 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -148.88 157.87 43.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.691 -0.686 . . . . 52.1 110.461 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.538 ' CG1' ' HD3' ' A' ' 61' ' ' LYS . 22.0 t -115.63 124.21 71.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 115.353 -0.839 . . . . 63.0 111.443 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.42 ' HA ' HG11 ' A' ' 93' ' ' VAL . 22.6 tp -97.6 86.67 3.88 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.211 0.529 . . . . 75.13 111.015 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 25.0 p-80 -62.34 132.47 52.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.027 -0.988 . . . . 74.44 109.46 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.38 -23.93 11.9 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.349 -0.929 . . . . 71.41 112.425 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 48.2 m-85 -109.81 160.46 16.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 112.481 0.548 . . . . 74.2 112.481 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -131.61 126.84 35.77 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.26 -1.385 . . . . 73.32 107.26 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 24.7 ptt180 -89.68 136.71 32.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.102 -1.039 . . . . 72.4 111.376 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.39 -177.56 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.946 -1.025 . . . . 75.12 109.58 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 45' ' ' LYS 0.252 0.0 OUTLIER -138.43 91.83 2.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.73 1.252 . . . . 75.1 112.199 178.497 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mm? -92.54 125.73 37.31 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.415 -0.812 . . . . 61.24 109.937 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -9.01 23.39 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.574 -0.739 . . . . 75.44 110.508 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.72 -14.82 39.07 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.409 -0.814 . . . . 71.35 111.191 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.412 HD13 ' CZ2' ' A' ' 109' ' ' TRP . 94.8 mt -118.46 163.57 24.75 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 109.448 -0.575 . . . . 73.01 109.448 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.409 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 Cg_endo -79.25 99.65 1.26 Allowed 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 123.074 2.516 . . . . 64.01 114.708 -173.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.625 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.5 p90 43.91 37.86 0.32 Allowed Pre-proline 0 CA--C 1.594 2.668 0 N-CA-C 116.614 2.079 . . . . 75.04 116.614 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 9.3 Cg_endo -97.77 167.18 0.8 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 123.384 2.723 . . . . 74.02 111.775 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 16.3 p -155.97 -169.52 3.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.582 2.353 . . . . 73.42 107.302 -4.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 36.5 pt -125.88 123.35 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 109.99 -0.374 . . . . 74.33 109.99 167.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 56' ' ' SER . 59.1 t -146.21 118.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.841 -0.8 . . . . 73.43 108.841 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 26.8 t 174.57 164.43 0.23 Allowed 'General case' 0 C--O 1.241 0.658 0 O-C-N 123.533 0.52 . . . . 71.32 110.23 175.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -137.19 7.85 2.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.227 -1.397 . . . . 74.3 107.227 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 59' ' ' SER . 13.3 t70 -82.94 -166.94 1.47 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.198 -1.365 . . . . 73.34 109.774 -174.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.429 ' H ' ' CG ' ' A' ' 58' ' ' ASP . 61.8 m -93.86 14.69 18.67 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.838 0.455 . . . . 43.11 111.657 -176.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.79 168.26 54.78 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 109.557 -1.417 . . . . 64.43 109.557 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.538 ' HD3' ' CG1' ' A' ' 37' ' ' VAL . 7.8 ptpp? -146.21 152.1 38.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.894 0.847 . . . . 72.14 111.117 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -115.51 133.41 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.402 -0.592 . . . . 64.05 109.402 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -99.9 137.64 38.08 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.3 -1.0 . . . . 62.13 108.3 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -166.1 -147.61 5.25 Favored Glycine 0 C--N 1.301 -1.373 0 N-CA-C 110.471 -1.052 . . . . 64.24 110.471 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -133.8 143.02 48.13 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.065 0.432 . . . . 60.11 111.844 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.1 m -108.68 133.18 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.157 -0.928 . . . . 60.23 110.946 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 23.7 mt -90.31 114.99 28.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.142 -1.799 . . . . 73.15 106.142 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.2 p -103.92 161.36 14.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.026 -0.67 . . . . 74.3 111.89 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.89 22.46 68.94 Favored Glycine 0 CA--C 1.506 -0.528 0 CA-C-N 115.728 -0.669 . . . . 53.43 113.082 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.02 121.83 37.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.893 -0.41 . . . . 72.04 109.893 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.419 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 18.0 m -73.18 158.62 34.9 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.378 -0.971 . . . . 64.24 108.378 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.39 -40.31 71.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.154 0.502 . . . . 71.43 111.64 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.64 78.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.927 -0.579 . . . . 74.44 110.838 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 48.0 mm-40 -72.31 -34.39 68.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.184 0.516 . . . . 70.54 110.212 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.63 -36.64 76.76 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.368 -0.833 . . . . 74.41 108.859 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.682 ' O ' HG22 ' A' ' 80' ' ' VAL . 28.2 t-20 -58.92 -29.41 67.07 Favored 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 114.628 -1.169 . . . . 70.1 111.467 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -68.3 -35.25 77.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.822 -0.807 . . . . 51.12 108.822 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.618 ' CD1' HD12 ' A' ' 26' ' ' ILE . 94.2 m-85 -74.16 -37.27 64.06 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.536 -0.756 . . . . 74.3 108.964 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.99 -34.19 77.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.201 -1.363 . . . . 73.03 110.995 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 76' ' ' ASN . 60.8 t -75.26 -42.96 43.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.71 -0.677 . . . . 71.13 111.709 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.8 tt -74.85 -61.14 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 114.675 1.361 . . . . 71.35 114.675 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -115.65 171.57 7.66 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.99 -0.444 . . . . 54.35 109.845 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 55.67 2.26 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.648 -0.787 . . . . 70.41 112.83 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.27 -42.31 46.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.759 0.281 . . . . 72.52 111.759 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.517 ' O ' HG22 ' A' ' 110' ' ' VAL . 1.9 t70 -108.16 26.43 10.42 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.325 -1.361 . . . . 73.01 107.325 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 51.6 m-85 -114.1 155.51 25.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.608 -1.178 . . . . 74.14 109.692 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HB3' HG13 ' A' ' 110' ' ' VAL . 15.7 pt-20 -126.66 158.6 35.94 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.3 0.375 . . . . 73.4 110.321 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -88.86 113.73 24.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.82 -0.627 . . . . 63.55 110.426 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.47 150.33 34.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.974 -0.38 . . . . 72.3 109.974 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.9 m -94.86 123.1 38.13 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.026 -0.731 . . . . 72.11 109.026 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' A' ' 38' ' ' LEU . 33.7 m -127.38 158.76 38.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.11 -1.07 . . . . 72.14 108.11 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -113.52 132.23 55.77 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.907 -1.117 . . . . 72.05 108.615 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.445 HG22 HG11 ' A' ' 66' ' ' VAL . 20.1 m -126.41 168.27 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 121.304 0.573 . . . . 74.35 110.331 -176.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.456 HG23 ' HG2' ' A' ' 101' ' ' LYS . 67.5 t -110.04 117.13 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.325 -0.852 . . . . 63.3 110.299 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.428 ' HE ' HG22 ' A' ' 34' ' ' VAL . 38.3 ttm180 -65.43 98.58 0.36 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.546 -0.909 . . . . 74.3 108.546 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.424 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 1.2 tmt? -53.84 -34.76 60.28 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 126.259 1.824 . . . . 74.12 110.908 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.02 -41.31 87.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.587 -0.733 . . . . 72.43 112.232 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -118.84 -3.95 10.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 120.315 -0.554 . . . . 75.32 112.355 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 67.44 24.98 8.66 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.73 0.812 . . . . 54.34 111.495 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.412 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 13.5 pt-20 -104.61 159.71 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.246 -0.65 . . . . 70.21 109.246 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.456 ' HG2' HG23 ' A' ' 94' ' ' VAL . 44.0 mtmt -102.48 135.08 44.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.699 -0.852 . . . . 62.03 108.699 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.62 138.47 44.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.03 0.443 . . . . 75.44 110.237 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.89 126.22 34.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.971 -1.122 . . . . 75.01 107.971 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.421 HG13 ' CB ' ' A' ' 10' ' ' ASN . 16.3 m -133.23 174.68 12.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 120.733 0.301 . . . . 74.15 110.256 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.97 150.27 28.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.558 -1.275 . . . . 72.02 107.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 t -145.94 175.18 10.63 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.421 -0.585 . . . . 61.24 109.421 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.68 118.35 36.43 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.052 -1.092 . . . . 72.51 108.052 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 54' ' ' ILE . 12.7 p -112.35 148.65 15.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.288 -1.375 . . . . 63.11 107.288 176.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 41.6 t-105 -73.08 125.93 28.82 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.693 -1.225 . . . . 72.22 107.693 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 85' ' ' ASP . 24.8 m -62.6 -22.46 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.947 0.721 . . . . 74.55 112.947 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.526 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 63.1 t30 -81.39 12.7 3.43 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.765 0.793 . . . . 73.32 110.09 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 -14.83 0.16 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.005 1.854 . . . . 64.43 116.005 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.07 -17.5 52.53 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.408 -0.517 . . . . 74.44 112.075 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.63 126.89 67.57 Favored Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 119.37 -0.932 . . . . 74.33 110.355 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.0 -6.11 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.719 2.946 . . . . 54.44 115.373 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -125.69 113.78 17.79 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.581 0.705 . . . . 75.11 110.846 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 122.19 0.995 . . . . 73.54 108.735 -177.327 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 129' ' ' VAL . 33.1 tt0 . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 108.499 -0.926 . . . . 64.35 108.499 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -60.23 -42.72 95.83 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.825 -0.625 . . . . 74.02 110.481 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.583 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 99.8 mtt180 -56.87 -48.58 77.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.272 -0.64 . . . . 64.42 109.272 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.613 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 79.2 t -59.21 -47.08 91.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.93 -1.032 . . . . 74.11 111.023 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 125' ' ' GLU . 98.6 t -67.35 -44.36 87.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.709 -0.223 . . . . 64.33 111.537 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.583 ' CE1' ' HA ' ' A' ' 127' ' ' ARG 0.253 3.7 p-80 -72.16 -30.41 64.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 118.612 -1.235 . . . . 74.51 111.827 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.33 77.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.979 -0.378 . . . . 43.45 109.979 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 42.6 mt-10 -63.31 -37.98 89.36 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.728 -0.669 . . . . 71.15 109.969 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.26 -38.26 88.6 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.069 -0.969 . . . . 74.43 110.479 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.423 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 86.8 m-85 -73.09 -52.16 15.32 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.842 -0.617 . . . . 74.32 111.098 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.55 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.1 p -59.89 -39.02 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 112.134 0.42 . . . . 72.53 112.134 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 48.6 mt-10 -59.07 -43.5 91.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 117.678 0.217 . . . . 60.21 111.048 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.6 m -58.36 -48.53 80.29 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.986 -0.552 . . . . 74.12 110.045 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 83.3 m-85 -61.73 -43.93 97.9 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.374 -0.376 . . . . 74.4 111.543 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 81.9 mtp180 -59.8 -44.83 93.79 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 123.047 0.217 . . . . 74.01 111.051 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 67.9 mttm -61.57 -47.34 85.95 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.314 0.384 . . . . 73.15 110.535 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.1 -34.99 78.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.12 110.964 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 91.3 mt -69.19 -38.88 78.88 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 116.291 -0.413 . . . . 73.41 110.628 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 32.3 mm-40 -59.35 -36.36 75.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.714 0.292 . . . . 74.41 110.362 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -68.22 -40.68 82.02 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.218 0.821 . . . . 64.54 113.218 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -74.32 -25.83 59.79 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.586 0.707 . . . . 74.13 110.606 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -78.91 -30.58 44.9 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.719 1.207 . . . . 74.43 112.161 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.36 99.82 45.39 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 120.249 -0.581 . . . . 64.4 112.457 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.28 -35.62 72.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.506 2.138 . . . . 74.55 110.103 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.27 -8.72 58.38 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.893 -1.049 . . . . 75.22 111.156 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.41 0 N-CA-C 111.252 -0.739 . . . . 73.01 111.252 179.88 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 106.686 -1.598 . . . . 74.2 106.686 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -87.88 155.56 19.81 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.553 0.692 . . . . 71.35 112.186 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -135.82 123.74 22.71 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.901 -1.518 . . . . 75.3 106.901 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.421 HG13 HG22 ' A' ' 13' ' ' VAL . 51.3 t -120.31 122.95 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 120.959 -0.297 . . . . 63.54 110.71 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -90.95 99.15 12.23 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.122 -0.695 . . . . 72.54 109.122 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.421 HG22 HG13 ' A' ' 11' ' ' VAL . 72.9 t -139.15 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.228 -0.286 . . . . 71.41 110.228 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.12 -73.89 0.23 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.932 -1.136 . . . . 74.12 107.932 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 45.38 -123.83 6.25 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 123.739 0.649 . . . . 63.14 113.344 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -139.07 9.36 2.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.743 -0.836 . . . . 74.13 108.743 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.9 mt -74.94 -8.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.972 -1.013 . . . . 70.23 110.31 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.27 -24.39 63.2 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-N 115.241 -0.89 . . . . 74.0 110.826 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.76 124.86 48.85 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.1 -0.955 . . . . 75.3 108.953 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.29 -35.43 11.41 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.603 3.535 . . . . 72.43 114.491 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -42.74 82.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.923 0.392 . . . . 72.3 111.224 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.6 -35.43 56.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.322 -0.399 . . . . 73.2 110.597 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.11 70.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.235 0.54 . . . . 60.43 109.844 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.61 71.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.663 -0.699 . . . . 73.34 110.854 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 m -71.02 -29.19 35.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.143 -0.623 . . . . 72.13 111.604 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.637 HG13 ' ND2' ' A' ' 77' ' ' ASN . 4.7 tt -79.46 -46.96 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 112.532 0.568 . . . . 64.32 112.532 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.587 HD21 ' CE2' ' A' ' 78' ' ' PHE . 36.8 mt -91.1 -14.55 31.02 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.188 -0.605 . . . . 60.5 112.227 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 t70 69.49 14.63 8.35 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.433 1.587 . . . . 63.23 108.35 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -147.36 135.43 21.4 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.643 -1.984 . . . . 74.3 105.643 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.0 m -76.95 111.12 12.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.5 -0.48 . . . . 65.31 110.295 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -93.74 143.73 26.06 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.607 -0.886 . . . . 38.62 108.607 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.4 126.04 42.4 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.122 -0.49 . . . . 64.13 110.303 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 14.7 p -93.71 144.05 25.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.969 -0.382 . . . . 62.14 109.969 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.22 139.41 35.59 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 108.829 -0.804 . . . . 73.24 108.829 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.92 129.53 35.46 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.754 2.303 . . . . 60.33 111.807 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.529 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.57 157.41 43.24 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.594 -0.73 . . . . 74.35 110.097 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.551 HG21 ' CG ' ' A' ' 61' ' ' LYS . 11.5 p -126.28 132.74 70.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-O 121.158 0.504 . . . . 74.43 110.429 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 93' ' ' VAL . 22.3 tp -91.68 112.33 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.71 -0.677 . . . . 73.3 111.745 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -88.68 112.21 22.86 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.473 -0.785 . . . . 61.15 109.494 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.09 -40.42 1.4 Allowed Glycine 0 C--N 1.305 -1.149 0 C-N-CA 120.653 -0.784 . . . . 64.55 112.695 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.456 ' O ' HG21 ' A' ' 62' ' ' VAL . 41.7 m-85 -108.96 166.41 10.85 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 122.782 -0.246 . . . . 72.05 111.346 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -137.08 134.58 36.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.008 -1.108 . . . . 63.32 108.008 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 25.7 ptt180 -88.87 125.84 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 73.03 111.1 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -98.23 145.92 26.14 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.097 -0.956 . . . . 74.24 110.691 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -91.39 100.13 12.97 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-O 121.729 0.776 . . . . 75.31 110.942 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.416 HD11 HD22 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -119.96 121.55 39.23 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.591 -1.186 . . . . 71.41 111.032 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -85.87 -5.63 59.21 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 113.233 0.827 . . . . 64.42 113.233 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.15 -25.66 65.86 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.398 -0.906 . . . . 71.0 111.751 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 52' ' ' PRO . 3.6 mm? -119.56 156.46 53.44 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-O 120.772 0.32 . . . . 64.24 111.607 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.73 146.86 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.87 2.38 . . . . 72.11 111.063 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.617 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 37.3 p90 44.47 41.91 0.82 Allowed Pre-proline 0 N--CA 1.506 2.33 0 N-CA-C 115.39 1.626 . . . . 75.23 115.39 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 78.4 Cg_endo -110.54 156.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.242 2.628 . . . . 74.34 114.806 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.609 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 89.0 m -153.76 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 131.368 3.867 . . . . 72.43 103.33 -15.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 25.5 pt -121.82 136.84 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-N 119.553 1.069 . . . . 63.45 110.914 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 112' ' ' LYS . 43.1 t -127.0 -80.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 115.026 -0.988 . . . . 72.33 112.589 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.4 p -177.17 156.21 1.23 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.809 -0.441 . . . . 75.25 109.809 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.1 m -165.08 173.63 11.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.138 0.975 . . . . 60.02 109.639 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.1 -65.68 0.58 Allowed 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 123.859 0.724 . . . . 72.34 110.01 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 p -105.98 -36.34 7.0 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 119.74 -0.784 . . . . 74.41 109.535 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.93 117.79 0.0 OUTLIER Glycine 0 C--N 1.361 1.971 0 C-N-CA 125.474 1.511 . . . . 74.32 116.817 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.551 ' CG ' HG21 ' A' ' 37' ' ' VAL . 21.9 ttpp -141.63 139.4 33.04 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.793 -1.563 . . . . 63.11 112.621 173.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 41' ' ' TYR . 54.4 t -123.86 123.72 67.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 C-N-CA 123.715 0.806 . . . . 71.35 111.252 -173.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -96.11 128.62 43.17 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.475 -0.49 . . . . 62.12 110.301 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.97 -142.58 3.44 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.85 -1.3 . . . . 38.62 109.85 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -140.44 146.72 38.65 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.779 -1.193 . . . . 72.43 107.779 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 33' ' ' THR . 26.8 m -104.49 135.44 42.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.043 0.449 . . . . 75.24 110.305 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.6 mt -85.72 110.61 19.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 104.479 -2.415 . . . . 74.51 104.479 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.6 p -101.23 161.94 13.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 111.766 0.284 . . . . 71.23 111.766 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.16 73.62 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.91 -0.586 . . . . 73.12 112.693 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.71 124.23 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 109.046 -0.724 . . . . 75.04 109.046 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.414 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 30.9 m -73.71 157.45 36.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.19 -0.67 . . . . 74.12 109.19 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.01 -46.08 68.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.771 0.428 . . . . 73.45 111.003 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -68.72 -36.96 79.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.299 0.571 . . . . 63.13 110.826 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -68.56 -34.57 76.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.414 -0.812 . . . . 74.22 111.685 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.45 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.6 tt -61.55 -37.9 85.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.302 -1.37 . . . . 65.55 107.302 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' O ' HG22 ' A' ' 80' ' ' VAL . 13.9 m120 -54.75 -26.73 36.07 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.851 1.056 . . . . 73.04 113.851 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.637 ' ND2' HG13 ' A' ' 26' ' ' ILE . 2.7 t30 -67.32 -34.41 77.3 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.76 -1.176 . . . . 72.21 108.595 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.587 ' CE2' HD21 ' A' ' 27' ' ' LEU . 86.5 m-85 -69.24 -34.2 74.45 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.913 -1.143 . . . . 73.1 107.913 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.99 -31.32 70.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.469 -1.242 . . . . 73.23 110.226 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 76' ' ' ASN . 90.7 t -72.8 -36.6 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.715 -0.675 . . . . 74.31 109.58 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 77' ' ' ASN . 48.2 mm -59.71 -40.95 83.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 N-CA-C 106.804 -1.554 . . . . 72.45 106.804 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 73.06 -81.76 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.775 -1.557 . . . . 64.24 114.861 167.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.71 104.2 1.01 Allowed Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 108.636 -1.786 . . . . 74.43 108.636 -172.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.34 -40.52 96.64 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.189 0.519 . . . . 60.43 111.722 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.421 ' O ' HG22 ' A' ' 110' ' ' VAL . 10.9 m-20 -97.73 8.53 44.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.746 -0.661 . . . . 73.14 109.807 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 96.9 m-85 -115.94 154.78 29.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.958 -0.564 . . . . 62.03 110.021 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -136.05 141.93 44.34 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.406 -0.59 . . . . 65.03 109.406 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.557 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 0.4 OUTLIER -88.52 109.56 20.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.415 0.626 . . . . 75.22 111.317 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.65 160.7 24.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.749 -1.114 . . . . 53.4 110.966 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -91.12 131.37 36.73 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.696 -0.853 . . . . 55.41 108.696 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.93 172.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.496 -1.298 . . . . 54.32 107.496 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -125.37 127.59 46.83 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.873 -1.131 . . . . 72.43 109.523 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 38' ' ' LEU . 18.2 m -126.72 168.24 20.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.316 0.579 . . . . 72.44 110.314 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.498 HG23 ' HG2' ' A' ' 101' ' ' LYS . 54.7 t -113.5 121.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.757 -0.831 . . . . 73.42 108.757 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.36 103.93 2.13 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 106.8 -1.555 . . . . 72.53 106.8 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.529 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 9.8 tmm? -61.62 -32.89 73.05 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.91 -1.144 . . . . 72.22 107.91 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.68 -44.96 81.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.936 -1.029 . . . . 73.24 112.336 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -111.42 -2.69 15.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.105 0.478 . . . . 71.1 110.956 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.5 24.28 14.0 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.942 1.297 . . . . 70.04 110.993 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -105.12 160.53 14.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.985 -0.376 . . . . 65.45 109.985 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HG2' HG23 ' A' ' 94' ' ' VAL . 55.4 mtpt -101.02 132.39 46.46 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.006 -0.739 . . . . 72.33 109.006 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.55 137.82 43.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.302 0.572 . . . . 73.13 110.838 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -87.77 119.34 28.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.835 -1.543 . . . . 74.05 106.835 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.0 m -127.31 175.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 120.949 0.404 . . . . 73.13 111.066 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.99 150.32 34.03 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.863 -0.421 . . . . 74.14 109.863 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -151.84 174.46 13.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.367 -0.605 . . . . 74.51 109.367 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.557 ' CE2' ' HB2' ' A' ' 88' ' ' ARG . 52.1 m-85 -114.39 118.12 32.96 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.466 -0.939 . . . . 71.24 108.466 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 30.6 m -109.87 172.5 2.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.946 -0.57 . . . . 72.14 110.373 -177.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.515 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 31.5 t-105 -86.39 121.71 29.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.101 -0.703 . . . . 74.24 109.101 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.4 m -72.06 -19.7 19.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-O 121.391 0.615 . . . . 73.04 112.291 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.451 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.6 t-20 -88.68 14.81 9.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.369 1.081 . . . . 71.21 109.333 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 40.1 ttmt -49.78 -24.92 2.63 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 127.459 2.303 . . . . 73.44 114.589 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -80.93 -21.67 40.29 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.776 1.028 . . . . 63.14 113.776 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -103.46 137.0 19.13 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 107.06 -1.459 . . . . 74.45 107.06 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.67 120.98 8.98 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.856 2.37 . . . . 74.15 114.468 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -124.6 113.52 18.15 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 109.047 -0.723 . . . . 74.51 109.047 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.089 0 O-C-N 124.326 1.016 . . . . 72.45 112.37 176.697 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.225 -0.19 0 N-CA-C 108.882 -0.784 . . . . 64.24 108.882 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -50.35 -46.86 56.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.61 0.764 . . . . 72.33 109.022 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -63.16 -49.22 75.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.825 -0.625 . . . . 74.31 111.874 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -38.77 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.328 0.492 . . . . 74.31 112.328 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.02 -43.93 81.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.972 -0.381 . . . . 64.2 109.972 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.539 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 56.4 t-80 -57.13 -38.55 73.63 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.909 -0.404 . . . . 74.21 109.909 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.78 -46.89 70.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.57 -0.287 . . . . 63.5 111.406 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 44.8 mt-10 -68.08 -40.03 82.79 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 111.943 0.349 . . . . 73.43 111.943 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.68 -31.9 73.17 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.152 0.797 . . . . 72.24 113.152 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.539 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 57.9 m-85 -83.91 -44.27 14.43 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.589 -0.844 . . . . 73.14 111.315 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 132' ' ' GLU . 14.7 p -63.92 -36.75 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 120.54 -0.464 . . . . 74.12 111.226 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -62.21 -36.35 81.68 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 120.18 -0.608 . . . . 75.41 110.425 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.8 m -63.39 -46.06 88.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.507 -0.315 . . . . 71.45 110.282 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -63.13 -37.13 85.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.778 0.323 . . . . 73.22 111.26 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.05 -44.54 68.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.45 -0.341 . . . . 75.25 111.316 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 32.3 mmmt -62.26 -44.05 97.44 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.715 0.293 . . . . 72.25 111.402 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.57 -31.88 72.26 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.368 -0.533 . . . . 73.4 110.715 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 tp -66.16 -50.56 63.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.391 -0.368 . . . . 55.23 110.384 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.436 ' O ' ' HA2' ' A' ' 150' ' ' GLY . 10.4 pt-20 -62.16 -44.17 97.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 121.055 -0.258 . . . . 70.11 111.263 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -65.61 -40.68 92.9 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 112.258 0.466 . . . . 73.24 112.258 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.3 -36.75 53.81 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.102 0.477 . . . . 73.51 111.98 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -79.82 -21.29 44.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.353 0.501 . . . . 72.11 112.353 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.69 142.55 45.92 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 119.815 -0.754 . . . . 63.24 109.598 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.66 -37.29 94.97 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.866 2.377 . . . . 72.13 112.253 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.74 -9.41 54.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.449 0.642 . . . . 63.33 109.475 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 143' ' ' GLU . . . . . . . . 0 N--CA 1.41 -3.079 0 N-CA-C 108.934 -1.666 . . . . 38.62 108.934 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.444 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 58.8 m . . . . . 0 N--CA 1.414 -2.27 0 CA-C-O 121.516 0.675 . . . . 74.12 111.141 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -130.42 157.4 42.7 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.029 -0.987 . . . . 73.33 109.298 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.9 m-20 -127.44 124.6 38.83 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 37.99 107.933 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 59.6 t -120.9 120.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 121.027 -0.269 . . . . 71.32 111.685 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -84.38 111.36 19.37 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.949 -1.5 . . . . 75.25 106.949 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.6 p -123.25 137.63 55.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.732 -0.787 . . . . 63.23 111.105 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -100.04 97.85 8.66 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.943 -1.132 . . . . 74.42 107.943 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.8 -142.0 22.24 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.012 -0.835 . . . . 50.14 111.012 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.9 t 65.49 -79.03 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.261 1.024 . . . . 74.45 113.416 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -117.95 12.98 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 75.3 111.763 -175.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.425 HD11 ' HE3' ' A' ' 65' ' ' LYS . 80.3 mt -68.18 -18.65 64.66 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 74.53 109.416 174.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.78 116.86 63.02 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 107.648 -1.242 . . . . 63.2 107.648 172.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.69 -39.72 18.35 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.302 3.334 . . . . 65.22 114.634 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.17 94.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.991 0.424 . . . . 74.33 111.688 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.3 t -72.46 -36.56 54.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.714 -0.676 . . . . 74.23 109.606 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 17' ' ' ILE . . . -62.53 -37.11 84.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.405 0.622 . . . . 37.99 109.88 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.92 -19.05 62.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.556 -0.747 . . . . 74.45 112.059 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.3 m -91.17 -30.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 119.511 -0.876 . . . . 74.12 110.975 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.524 HG12 ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -78.63 -47.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-O 120.696 0.284 . . . . 63.22 110.356 178.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 29' ' ' ARG . 95.5 mt -92.96 -10.41 36.48 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 112.106 0.41 . . . . 74.11 112.106 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 19.5 t70 76.61 -14.05 0.86 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.513 1.149 . . . . 73.51 110.279 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 27' ' ' LEU . 27.8 ptt180 -133.73 168.03 19.46 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.405 -1.27 . . . . 75.13 108.153 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.2 m -76.25 135.22 39.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.611 -0.885 . . . . 72.52 108.611 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.1 135.58 41.17 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 116.43 -0.35 . . . . 61.22 110.979 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.06 109.07 19.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.122 -1.436 . . . . 72.44 107.122 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.1 p -117.9 143.89 45.93 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 115.723 -0.672 . . . . 62.3 110.718 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.9 146.17 60.2 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 107.771 -1.196 . . . . 73.41 107.771 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -71.18 137.05 30.6 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 121.359 1.372 . . . . 71.14 111.302 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.32 156.05 41.48 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.315 -0.857 . . . . 74.01 108.921 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.19 126.39 75.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.897 -0.721 . . . . 71.33 111.005 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HA ' HG11 ' A' ' 93' ' ' VAL . 25.3 tp -92.43 89.2 6.68 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.35 -0.841 . . . . 70.14 111.204 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 27.6 p80 -66.09 131.37 46.04 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.973 -1.012 . . . . 75.44 108.824 171.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 119.32 -13.54 11.08 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 118.969 -1.586 . . . . 64.31 112.842 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -127.33 157.76 39.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 112.686 0.624 . . . . 74.54 112.686 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -116.54 138.5 51.36 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.549 -1.278 . . . . 74.41 107.549 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HA ' HG23 ' A' ' 54' ' ' ILE . 19.1 ptp180 -86.55 127.21 34.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.297 -0.631 . . . . 73.33 109.297 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.445 ' HD2' ' O ' ' A' ' 117' ' ' MET . 88.1 m-85 -108.82 112.27 24.44 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.03 -0.532 . . . . 72.4 111.689 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -86.4 116.8 24.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.38 -0.827 . . . . 73.31 111.533 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.453 ' CD2' ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.5 147.84 50.43 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.391 -1.277 . . . . 72.14 109.399 174.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -115.84 -12.44 11.44 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.268 0.556 . . . . 71.2 110.162 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 -26.2 71.63 Favored Glycine 0 N--CA 1.41 -3.088 0 C-N-CA 120.086 -1.054 . . . . 62.04 110.903 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 2.1 mm? -115.9 166.57 12.01 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 105.475 -2.046 . . . . 73.53 105.475 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 37.1 Cg_endo -66.6 -155.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.227 0 C-N-CA 122.326 2.018 . . . . 74.01 114.297 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.435 ' CD1' ' HD3' ' A' ' 52' ' ' PRO . 18.9 p90 -48.35 -26.42 0.71 Allowed Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 119.452 3.13 . . . . 61.25 119.452 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HD3' ' CD1' ' A' ' 51' ' ' TYR . 84.3 Cg_exo -49.32 165.69 0.22 Allowed 'Trans proline' 0 CA--C 1.584 2.989 0 CA-C-N 122.141 1.8 . . . . 70.14 111.999 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 52' ' ' PRO . 22.0 p -152.3 -178.99 7.15 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.508 1.523 . . . . 75.42 110.717 5.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.468 HG23 ' HA ' ' A' ' 43' ' ' ARG . 43.1 pt -135.31 132.44 52.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.36 -0.978 . . . . 74.43 108.36 170.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -154.2 -175.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.777 -0.823 . . . . 43.42 108.777 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m 82.05 -177.61 0.05 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.923 1.289 . . . . 72.43 114.443 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -71.9 -178.97 2.51 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.732 0.813 . . . . 65.45 112.746 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.453 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 3.5 p30 -82.13 28.92 0.42 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.689 1.196 . . . . 74.15 113.038 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 m -76.78 -8.28 57.0 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.129 0.418 . . . . 74.04 112.129 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.98 -172.81 19.74 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.149 -1.024 . . . . 61.02 112.076 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.447 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 18.6 ptpt -143.46 147.45 34.58 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.607 -0.516 . . . . 72.12 109.607 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -111.36 123.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.392 -0.596 . . . . 63.24 109.392 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -98.75 124.25 43.49 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.006 -0.739 . . . . 73.43 109.006 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.98 -139.03 2.67 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.761 -0.733 . . . . 75.33 111.921 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.425 ' HE3' HD11 ' A' ' 18' ' ' LEU . 39.2 mtmt -137.39 140.73 41.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.06 0.457 . . . . 44.54 112.082 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.7 m -107.21 133.93 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.149 -0.932 . . . . 74.35 109.653 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 48.7 mt -87.93 123.72 40.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.507 -1.664 . . . . 65.23 106.507 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.6 p -103.8 161.21 14.13 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.2 -0.6 . . . . 73.33 110.514 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 8' ' ' SER . . . 69.06 28.5 72.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.039 -0.6 . . . . 74.11 113.382 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.74 121.49 36.44 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 117.223 0.512 . . . . 54.05 109.651 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.9 m -77.37 164.22 25.7 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.997 -0.742 . . . . 54.31 108.997 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.83 -32.18 72.49 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.153 0.433 . . . . 72.24 111.289 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.36 64.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.389 0.614 . . . . 72.01 110.331 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.08 -44.22 39.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 75.14 110.326 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.66 -37.56 87.81 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.775 -1.194 . . . . 54.55 107.775 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' HG22 ' A' ' 80' ' ' VAL . 27.5 t-20 -54.69 -31.49 58.0 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.471 -1.241 . . . . 73.22 111.547 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.524 ' OD1' HG12 ' A' ' 26' ' ' ILE . 20.8 t-20 -75.1 -31.18 61.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 74.2 109.588 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -65.99 -35.56 80.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.39 0.614 . . . . 74.3 109.567 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.76 -33.71 72.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.307 -0.861 . . . . 72.24 110.283 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 76' ' ' ASN . 71.0 t -74.83 -25.44 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.498 -0.774 . . . . 75.45 111.784 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.7 mt -53.4 139.28 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 109.701 -0.481 . . . . 71.23 109.701 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.75 109.75 0.55 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.735 0.778 . . . . 72.51 112.174 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.26 55.83 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.003 0 N-CA-C 109.001 -1.64 . . . . 62.31 109.001 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -64.05 -19.28 65.1 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.302 0.572 . . . . 72.43 110.702 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.511 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 17.9 m-20 -91.0 10.16 27.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.419 . . . . 73.22 111.022 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.27 160.28 26.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 119.917 -0.713 . . . . 74.03 109.455 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -131.22 142.9 50.23 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 109.397 -0.594 . . . . 71.14 109.397 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -83.48 120.18 25.59 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.965 -0.754 . . . . 72.41 108.965 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.33 160.15 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 116.104 -0.498 . . . . 73.32 111.43 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -95.43 126.7 40.9 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 115.69 -0.686 . . . . 72.25 109.474 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.404 ' HB ' HD11 ' A' ' 38' ' ' LEU . 28.8 m -129.66 168.31 23.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.042 -1.096 . . . . 75.24 108.042 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -123.22 128.53 50.14 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.812 -1.155 . . . . 73.32 108.521 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 38' ' ' LEU . 19.8 m -126.18 169.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.176 0.512 . . . . 71.34 110.465 -173.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 101' ' ' LYS . 76.7 t -103.81 128.63 56.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.74 -0.664 . . . . 72.45 110.183 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -64.93 3.97 0.49 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 126.77 2.028 . . . . 73.2 113.119 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.524 ' SD ' ' HE3' ' A' ' 133' ' ' LYS . 12.5 tmm? 58.56 -72.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.704 2.002 . . . . 72.43 113.277 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.03 -29.34 67.2 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.301 1.041 . . . . 63.13 113.296 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -110.64 -5.18 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.372 -0.531 . . . . 63.41 110.68 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 m 62.82 4.94 1.59 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.801 0.841 . . . . 73.43 112.863 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.95 160.84 27.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.827 -0.805 . . . . 74.32 108.827 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 6.8 mptt -106.76 146.45 30.84 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.446 -0.946 . . . . 62.23 108.446 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.33 139.51 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.145 0.498 . . . . 61.12 110.336 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -87.4 129.77 34.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.148 -1.056 . . . . 62.41 108.148 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.45 173.16 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 122.325 0.25 . . . . 75.41 110.981 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -100.87 153.78 19.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.027 -1.101 . . . . 74.44 108.027 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -152.69 176.89 11.27 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-N 118.341 0.519 . . . . 64.41 110.881 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.31 117.88 35.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.734 0.813 . . . . 73.32 108.84 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.23 156.95 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 109.187 -0.671 . . . . 72.11 109.187 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.511 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 42.8 t-105 -98.86 120.12 38.77 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.645 0.378 . . . . 72.22 110.519 -171.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 85' ' ' ASP . 8.3 m -73.1 -23.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.312 0.486 . . . . 74.53 112.312 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.403 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 64.5 t30 -80.31 12.82 2.7 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.018 0.913 . . . . 73.35 110.99 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.85 -15.33 58.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.566 1.321 . . . . 74.42 114.566 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.41 -42.95 92.0 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.29 0.478 . . . . 71.31 112.29 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -85.59 138.19 35.95 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 107.747 -1.205 . . . . 74.52 107.747 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -40.7 116.85 0.43 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 124.288 3.326 . . . . 71.4 114.537 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.531 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 1.1 mmp_? -106.3 165.09 11.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 65.52 109.219 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.445 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 12.7 tpt . . . . . 0 C--O 1.204 -1.299 0 N-CA-C 109.29 -0.633 . . . . 74.51 109.29 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.51 ' O ' HG22 ' A' ' 128' ' ' VAL . 9.1 tp10 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 107.581 -1.266 . . . . 72.11 107.581 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -56.73 -36.98 70.35 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.375 -0.829 . . . . 75.41 110.914 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.438 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.269 4.0 ppt_? -63.16 -33.63 75.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.43 0.9 . . . . 75.24 113.43 -178.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 125' ' ' GLU . 29.9 m -77.38 -25.22 14.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 119.287 -0.965 . . . . 74.44 110.246 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.86 -44.78 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.493 -0.558 . . . . 65.21 109.493 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' A' ' 127' ' ' ARG . 2.4 p-80 -75.21 -28.95 60.17 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 119.124 -1.03 . . . . 71.35 111.038 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.65 36.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.144 -0.48 . . . . 45.22 111.161 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 128' ' ' VAL . 10.0 mm-40 -61.67 -26.16 67.85 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.202 0.525 . . . . 71.54 110.835 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.524 ' HE3' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.05 -59.64 2.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.935 -1.135 . . . . 74.44 107.935 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -69.46 -31.58 69.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 114.354 1.242 . . . . 73.23 114.354 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.514 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.7 p -58.35 -38.48 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.25 0.477 . . . . 71.42 110.2 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.11 -46.0 82.83 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.691 -0.485 . . . . 63.54 109.691 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.0 m -57.12 -46.37 82.69 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.609 -0.723 . . . . 74.52 110.821 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.46 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 40.8 m-85 -60.26 -49.0 79.34 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 121.235 -0.186 . . . . 72.43 110.65 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 99.1 mtt180 -57.68 -44.84 86.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.042 0.213 . . . . 71.34 110.863 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.51 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -60.98 -52.54 64.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.347 -0.388 . . . . 61.43 110.688 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.58 72.51 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.657 0.614 . . . . 63.35 112.657 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 94.3 mt -72.48 -42.77 64.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.246 0.462 . . . . 65.0 112.246 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.6 -35.16 75.05 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 119.492 -0.883 . . . . 73.12 110.369 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.687 ' O ' ' HA3' ' A' ' 150' ' ' GLY . 1.3 m-90 -63.86 -28.98 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.337 0.589 . . . . 74.45 111.042 171.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -78.37 -44.46 24.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.135 0.493 . . . . 53.43 110.857 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.37 -31.52 42.94 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.912 0.708 . . . . 75.22 112.912 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -95.26 143.87 26.85 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 111.806 0.298 . . . . 55.03 111.806 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.82 -16.37 55.02 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.482 2.788 . . . . 75.31 112.009 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.24 -13.32 60.43 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.768 0.794 . . . . 74.31 108.98 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 144' ' ' TRP . . . . . . . . 0 N--CA 1.399 -3.829 0 CA-C-N 114.658 -1.155 . . . . 53.31 112.455 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.424 -1.737 0 CA-C-O 121.689 0.757 . . . . 74.52 112.616 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -109.25 147.43 32.61 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.859 -1.064 . . . . 72.13 109.705 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.5 m-20 -132.4 122.5 25.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.269 -1.382 . . . . 55.22 107.269 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.58 125.09 73.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.937 -0.305 . . . . 65.02 111.061 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -80.86 112.83 18.61 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.206 -1.035 . . . . 75.43 108.206 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.15 151.81 24.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.256 -0.646 . . . . 74.34 109.256 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -131.3 -22.83 2.46 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 120.519 -0.472 . . . . 73.14 111.126 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.497 ' HA3' ' CD2' ' A' ' 51' ' ' TYR . . . -114.05 108.82 2.1 Favored Glycine 0 C--O 1.248 1.005 0 C-N-CA 120.303 -0.951 . . . . 65.31 112.428 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 22.6 t 69.56 -177.25 0.21 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.921 1.288 . . . . 64.35 110.489 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.521 HD11 ' CE1' ' A' ' 78' ' ' PHE . 12.4 pt 47.12 18.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 126.761 2.024 . . . . 74.12 114.476 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 16' ' ' SER . 85.1 mt -93.04 -1.37 56.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.438 0.637 . . . . 71.01 110.942 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -103.53 132.34 21.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.009 -0.996 . . . . 74.42 108.879 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -42.85 -45.22 8.97 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 124.247 3.298 . . . . 74.54 113.756 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.32 -37.6 85.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 72.4 111.474 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 25' ' ' VAL . 44.9 t -75.72 -39.47 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.202 0.525 . . . . 72.54 109.981 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.84 66.53 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.966 -0.753 . . . . 71.24 108.966 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.74 -31.49 57.15 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.677 -0.692 . . . . 65.54 111.588 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 22' ' ' VAL . 28.1 m -76.48 -30.41 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 119.584 -0.847 . . . . 72.2 111.619 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.445 HG13 ' ND2' ' A' ' 77' ' ' ASN . 3.3 tt -74.36 -42.29 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 63.34 111.925 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.749 HD21 ' CE2' ' A' ' 78' ' ' PHE . 75.2 mt -93.76 -22.25 18.81 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.706 0.632 . . . . 63.31 112.706 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 71.64 17.49 5.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.937 0.875 . . . . 72.42 109.92 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 ttm-85 -141.27 147.57 38.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.728 -1.953 . . . . 73.45 105.728 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.5 m -76.24 111.01 11.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.923 -0.769 . . . . 72.33 108.923 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.524 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -95.38 145.68 24.95 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.105 -0.498 . . . . 63.22 109.91 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.48 118.51 36.83 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.577 -0.738 . . . . 73.01 112.419 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 5.1 p -95.27 143.04 26.98 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.73 -0.668 . . . . 74.45 109.626 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.2 137.49 26.84 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 108.92 -0.77 . . . . 74.52 108.92 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 127.22 22.64 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.749 2.3 . . . . 72.34 112.083 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.58 37.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.516 -0.765 . . . . 50.03 109.022 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.478 HG22 ' CE ' ' A' ' 61' ' ' LYS . 11.4 p -118.14 130.05 73.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.722 0.772 . . . . 74.31 112.042 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.6 tp -87.95 106.77 18.34 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 122.123 0.963 . . . . 64.41 109.586 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.464 ' CD2' HG22 ' A' ' 94' ' ' VAL . 14.3 p80 -92.22 127.9 37.87 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.264 -1.335 . . . . 72.51 109.807 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.65 -5.93 29.59 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.023 -1.084 . . . . 51.54 112.044 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -117.86 144.86 45.04 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.709 0.29 . . . . 72.51 110.669 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 7.3 t60 -115.5 135.12 54.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.172 -0.677 . . . . 62.4 109.172 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.56 ' NH2' ' HA ' ' A' ' 125' ' ' GLU . 55.6 mtm180 -87.33 114.89 24.35 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.565 -0.902 . . . . 64.15 108.565 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.39 137.28 34.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.117 -0.697 . . . . 75.43 109.117 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.25 110.41 22.4 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.887 -1.153 . . . . 73.25 107.887 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . 0.308 0.0 OUTLIER -124.75 160.98 27.4 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.764 -1.107 . . . . 75.35 112.394 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -99.02 -22.84 15.52 Favored 'General case' 0 N--CA 1.398 -3.039 0 CA-C-N 113.406 -1.725 . . . . 71.03 110.999 -169.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.09 -25.51 61.76 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.895 -0.669 . . . . 53.34 113.06 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -122.7 146.89 49.19 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 109.397 -0.594 . . . . 71.22 109.397 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.49 -34.88 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.336 2.024 . . . . 64.14 111.724 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.53 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 37.9 p90 -123.38 177.63 1.62 Allowed Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 116.735 -1.602 . . . . 73.25 106.772 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.34 0.0 OUTLIER 34.5 169.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.608 0 C-N-CA 123.625 2.883 . . . . 73.34 119.172 -163.145 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.524 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 14.7 p -122.73 172.88 8.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.218 -1.551 . . . . 74.42 113.588 10.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 41.1 pt -130.71 149.92 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.831 -1.077 . . . . 61.4 109.911 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.421 HG11 ' HG3' ' A' ' 112' ' ' LYS . 12.7 m -148.12 164.27 5.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.355 -1.72 . . . . 75.33 106.355 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -80.04 123.27 27.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 114.064 1.135 . . . . 72.52 114.064 -170.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 p -147.67 120.08 8.46 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.486 -1.672 . . . . 73.13 106.486 172.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.23 -11.56 22.24 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 117.433 2.383 . . . . 63.44 117.433 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.5 m -98.08 1.1 47.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.489 -0.885 . . . . 75.15 111.382 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.5 159.09 15.59 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.182 -1.009 . . . . 51.21 114.044 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.478 ' CE ' HG22 ' A' ' 37' ' ' VAL . 48.9 mtpt -140.39 147.27 39.51 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 123.879 0.872 . . . . 75.41 109.827 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.74 122.05 63.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.534 -1.284 . . . . 75.53 107.534 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -111.35 115.99 30.21 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.582 -0.447 . . . . 62.54 111.287 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.9 -131.4 1.73 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.742 -0.543 . . . . 64.34 111.742 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HB2' HD23 ' A' ' 18' ' ' LEU . 94.1 mttt -141.12 154.4 45.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.423 -0.584 . . . . 72.03 109.423 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.7 m -109.6 133.58 54.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.626 -0.509 . . . . 74.41 109.626 173.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.442 HD13 HG13 ' A' ' 17' ' ' ILE . 47.4 mt -88.02 112.43 23.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.536 -1.654 . . . . 73.53 106.536 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.7 p -106.68 160.66 15.29 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.119 0.414 . . . . 74.24 112.119 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.74 24.98 59.27 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.713 -0.676 . . . . 43.25 113.84 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 127.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 O-C-N 122.642 -0.328 . . . . 64.1 110.337 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 m -78.85 160.45 27.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.213 -1.032 . . . . 72.34 108.213 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.39 -37.36 75.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.297 0.499 . . . . 72.24 111.768 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.08 78.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.434 0.635 . . . . 61.31 110.854 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.505 ' HB3' HD23 ' A' ' 27' ' ' LEU . 37.8 mt-10 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.731 -0.668 . . . . 62.41 109.232 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.76 -31.68 69.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.769 0.828 . . . . 73.31 109.808 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -56.95 -28.6 62.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 71.12 112.126 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.445 ' ND2' HG13 ' A' ' 26' ' ' ILE . 2.9 t30 -76.0 -31.77 59.09 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 119.043 -1.063 . . . . 75.41 109.436 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.749 ' CE2' HD21 ' A' ' 27' ' ' LEU . 41.2 m-85 -70.33 -28.96 65.57 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.638 0.732 . . . . 75.0 109.21 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.544 ' HA ' ' OH ' ' A' ' 107' ' ' TYR . 18.5 t70 -67.11 -43.21 83.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.827 -1.079 . . . . 74.43 111.693 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.04 -30.48 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 N-CA-C 112.708 0.633 . . . . 74.22 112.708 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.2 tt -82.48 111.16 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 112.905 0.705 . . . . 64.54 112.905 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 58.33 35.07 24.59 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.138 0.975 . . . . 74.33 110.486 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.55 25.49 9.65 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.647 -0.787 . . . . 53.05 111.485 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.61 -36.03 24.2 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.878 0.371 . . . . 73.3 111.669 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.563 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 12.8 m-20 -117.62 19.24 13.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.88 0.848 . . . . 71.02 109.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -130.62 161.36 31.74 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.791 -1.095 . . . . 72.34 108.666 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -130.06 147.18 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.781 -0.822 . . . . 75.14 108.781 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.504 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 40.0 ttp-105 -92.86 108.51 20.05 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.24 0.543 . . . . 63.43 111.36 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.4 m -111.18 159.38 11.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.749 -0.66 . . . . 75.32 110.416 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -91.33 133.43 35.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.575 -0.898 . . . . 75.44 108.575 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 30.2 m -133.75 168.81 23.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.803 -1.184 . . . . 73.11 107.803 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.429 ' HB2' ' CE ' ' A' ' 103' ' ' LYS . 42.8 tt0 -114.2 129.93 56.62 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.515 -0.874 . . . . 74.22 110.192 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.12 163.02 28.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.166 -0.679 . . . . 72.3 109.166 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.483 HG23 ' HG3' ' A' ' 101' ' ' LYS . 77.8 t -102.05 113.86 39.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 109.352 -0.61 . . . . 73.55 109.352 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -69.45 90.21 0.53 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.19 -2.522 . . . . 74.14 104.19 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -55.65 -45.81 77.58 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 125.079 1.351 . . . . 72.4 113.99 -162.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.74 -27.38 68.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.076 0.465 . . . . 70.2 111.304 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -101.47 -9.48 21.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.068 -0.515 . . . . 72.33 110.51 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.5 t 64.42 15.87 9.82 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.634 1.174 . . . . 72.21 112.106 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -96.07 161.26 14.05 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 122.647 0.379 . . . . 74.35 110.421 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -108.89 128.49 54.97 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.946 -0.761 . . . . 64.21 108.946 -175.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.5 148.51 28.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.988 0.423 . . . . 64.05 111.9 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' CE ' ' HB2' ' A' ' 92' ' ' GLU . 27.3 mmtp -90.84 118.12 29.99 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.556 0.742 . . . . 64.32 111.077 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.44 170.56 17.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.244 -0.889 . . . . 73.04 108.877 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.78 150.16 23.08 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.979 -0.378 . . . . 74.3 109.979 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.1 t -156.0 173.85 16.19 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.618 -0.882 . . . . 72.41 108.618 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.544 ' OH ' ' HA ' ' A' ' 79' ' ' ASP . 95.4 m-85 -110.11 122.82 48.5 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.296 0.569 . . . . 64.13 111.691 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.15 159.72 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 115.318 -0.856 . . . . 65.2 110.04 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 53' ' ' CYS . 26.1 t-105 -79.38 112.67 16.85 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.912 0.863 . . . . 74.41 111.963 -173.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 85' ' ' ASP . 43.1 t -72.33 -32.09 41.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.08 -1.418 . . . . 64.54 112.35 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.468 ' HB2' ' CZ2' ' A' ' 109' ' ' TRP . 86.1 m-20 -88.43 14.34 9.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 123.013 0.525 . . . . 55.2 112.074 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.503 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 0.4 OUTLIER -49.84 -36.81 28.13 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.512 1.525 . . . . 65.34 111.766 -177.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.362 15.7 m-20 -73.98 71.46 1.57 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 115.934 1.827 . . . . 71.03 115.934 -171.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -129.0 141.82 43.05 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 104.413 -2.44 . . . . 75.3 104.413 170.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.36 -25.55 57.66 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.216 2.611 . . . . 63.13 114.616 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -116.81 113.05 21.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.251 -0.98 . . . . 74.4 111.624 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.503 ' SD ' ' HA ' ' A' ' 112' ' ' LYS . 68.8 mtp . . . . . 0 CA--C 1.496 -1.111 0 C-N-CA 124.184 0.994 . . . . 74.01 111.131 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.56 ' HA ' ' NH2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.237 0.405 0 CA-C-O 120.707 0.289 . . . . 75.12 111.651 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -86.04 -36.91 19.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.11 0.481 . . . . 74.4 109.799 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -51.59 -47.07 63.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.608 1.163 . . . . 75.11 111.878 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 34.2 m -62.5 -33.15 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.376 0.51 . . . . 74.34 112.376 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.32 -37.14 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.7 0.762 . . . . 63.42 109.527 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.454 ' CE1' ' HE1' ' A' ' 134' ' ' PHE . 17.5 t-80 -66.83 -35.63 80.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.576 -0.738 . . . . 72.44 109.571 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.478 ' O ' HG21 ' A' ' 135' ' ' VAL . . . -65.47 -34.78 79.07 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 123.457 0.473 . . . . 71.11 110.643 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 43.4 mt-10 -59.4 -39.06 82.2 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.801 0.334 . . . . 73.13 110.577 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.1 tpmt? -57.56 -45.87 84.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.545 -0.752 . . . . 74.14 109.076 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.454 ' HE1' ' CE1' ' A' ' 130' ' ' HIS . 78.9 m-85 -62.6 -45.34 93.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.444 -0.798 . . . . 65.51 110.932 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 80.2 t -54.67 -49.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 O-C-N 123.55 0.531 . . . . 75.42 110.291 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.02 -41.3 91.88 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 123.197 0.311 . . . . 70.02 110.458 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -58.57 -47.31 84.69 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.856 -0.611 . . . . 61.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.416 ' O ' HD13 ' A' ' 142' ' ' LEU . 37.8 m-85 -63.62 -44.22 94.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.114 -0.494 . . . . 75.04 110.564 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 31.4 mtm180 -56.5 -49.92 73.31 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.882 -0.327 . . . . 74.43 110.147 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.13 -44.33 96.87 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.46 0.475 . . . . 64.52 111.684 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.86 -34.7 78.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.861 0.362 . . . . 63.44 110.997 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 10.8 mp -72.63 -31.82 65.43 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 120.622 -0.431 . . . . 72.33 111.403 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 46.5 mt-10 -59.79 -34.23 72.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.876 -0.416 . . . . 72.53 109.876 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -72.74 -44.77 61.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.199 -0.455 . . . . 73.13 111.817 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -73.81 -36.1 64.96 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.169 0.803 . . . . 74.33 113.169 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 142' ' ' LEU . 23.0 pttp -84.87 -6.38 59.34 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.937 -0.477 . . . . 72.11 111.458 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -74.67 144.7 80.78 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.492 -0.929 . . . . 73.54 108.492 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -43.0 -31.94 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.238 3.292 . . . . 71.24 115.018 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -71.85 -20.55 61.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.038 0.447 . . . . 75.12 110.871 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.868 0 CA-C-N 115.448 -0.796 . . . . 61.05 114.844 174.515 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.239 0.5 0 N-CA-C 109.267 -0.642 . . . . 44.32 109.267 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.405 ' C ' HD21 ' A' ' 10' ' ' ASN . 78.7 m80 -125.16 143.13 51.09 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 109.375 -0.602 . . . . 74.41 109.375 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 0.9 OUTLIER -128.95 123.85 33.57 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.307 -1.738 . . . . 70.31 106.307 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 t -111.82 120.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 119.777 -0.769 . . . . 72.23 109.393 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -81.97 113.89 20.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.755 -0.831 . . . . 74.42 108.755 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.16 159.25 41.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.345 0.593 . . . . 72.22 110.151 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -148.62 109.73 4.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 106.021 -1.844 . . . . 71.41 106.021 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 163.6 -92.21 0.11 Allowed Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.74 -0.944 . . . . 71.12 110.74 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.509 ' O ' HG13 ' A' ' 22' ' ' VAL . 49.5 m -149.6 78.95 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.19 1.182 . . . . 74.13 114.19 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 67' ' ' ILE . 63.8 mt -155.57 8.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 104.713 -2.329 . . . . 75.33 104.713 168.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.07 -17.21 25.34 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.372 -1.285 . . . . 74.13 109.676 -173.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.71 129.54 37.91 Favored Pre-proline 0 N--CA 1.403 -2.783 0 CA-C-N 114.676 -1.147 . . . . 45.41 108.635 172.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.71 -36.82 10.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.09 3.193 . . . . 73.12 113.034 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -55.46 -45.94 76.86 Favored 'General case' 0 C--O 1.224 -0.237 0 O-C-N 123.522 0.514 . . . . 73.42 112.008 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 16' ' ' SER . 92.3 t -77.3 -44.37 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.508 0.194 . . . . 74.52 111.446 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.48 -30.98 71.66 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.37 -0.532 . . . . 74.33 110.702 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.12 -40.62 74.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.062 -0.517 . . . . 74.35 111.268 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 21' ' ' ALA . 16.9 m -71.15 -31.16 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.294 -0.562 . . . . 74.23 111.687 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.532 HD12 ' CD1' ' A' ' 78' ' ' PHE . 6.1 tt -77.95 -38.57 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.275 0.56 . . . . 70.41 112.135 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 31' ' ' ALA . 95.6 mt -100.28 -10.75 20.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 113.93 1.085 . . . . 62.15 113.93 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 68.12 19.16 9.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.995 0.902 . . . . 71.04 109.432 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -162.28 142.68 10.05 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.338 -2.097 . . . . 73.3 105.338 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.2 m -77.06 119.24 20.5 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 120.948 0.404 . . . . 62.5 110.335 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -90.88 152.8 20.6 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.661 -0.496 . . . . 72.41 109.661 176.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.32 125.18 41.74 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.988 -0.551 . . . . 72.02 110.404 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 5.5 p -100.16 142.61 31.4 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 115.675 -0.693 . . . . 53.44 109.508 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.19 134.61 25.59 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.384 -1.339 . . . . 61.01 107.384 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.5 Cg_endo -61.8 130.38 31.04 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 121.932 1.755 . . . . 62.03 111.369 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.544 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.83 156.17 41.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.774 -1.103 . . . . 74.41 109.753 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.3 p -121.66 127.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.651 0.738 . . . . 73.13 111.546 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.424 ' HA ' HG11 ' A' ' 93' ' ' VAL . 23.3 tp -91.87 95.34 9.78 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.215 -0.902 . . . . 51.1 110.9 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 23.7 p80 -70.67 123.14 21.18 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.76 -1.109 . . . . 70.55 110.096 173.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 120.52 -13.59 10.1 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.878 -1.153 . . . . 73.22 113.8 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -123.62 166.06 16.12 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.326 0.861 . . . . 75.02 113.326 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -134.39 128.24 33.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.448 -1.686 . . . . 72.32 106.448 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -87.46 135.19 33.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.889 0.852 . . . . 73.04 112.722 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -107.53 106.98 17.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.305 -1.739 . . . . 73.51 106.305 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -47.79 -51.94 20.62 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.593 2.072 . . . . 74.31 116.593 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mp 53.43 95.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.746 1.387 . . . . 71.1 114.746 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.306 0.0 OUTLIER -82.67 -11.73 58.14 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.888 1.07 . . . . 72.22 113.888 174.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.99 -43.4 10.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.849 -0.691 . . . . 54.42 111.929 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.2 152.36 39.37 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.038 -0.727 . . . . 74.45 109.038 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.6 112.0 3.37 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 122.867 2.378 . . . . 70.03 114.382 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.574 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.513 35.2 p90 35.79 59.91 2.93 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 119.044 2.979 . . . . 71.13 119.044 -178.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 10.4 Cg_endo -106.02 172.25 0.12 Allowed 'Trans proline' 0 CA--C 1.547 1.136 1 C-N-CA 126.504 4.803 . . . . 72.33 110.132 175.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.562 ' SG ' ' HB2' ' A' ' 109' ' ' TRP . 43.3 t -158.13 175.24 14.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.577 3.151 . . . . 70.23 103.751 -11.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 pt -135.65 138.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 119.407 1.003 . . . . 71.32 111.307 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' HB ' ' H ' ' A' ' 56' ' ' SER . 5.5 m -154.37 -160.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.984 1.313 . . . . 71.42 108.88 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.423 ' H ' ' HB ' ' A' ' 55' ' ' VAL . 47.5 m 83.73 -39.87 0.08 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.226 1.41 . . . . 75.35 113.305 176.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 50.0 m 56.65 31.0 18.44 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.969 0.89 . . . . 73.33 109.402 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.09 175.77 7.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.194 -1.366 . . . . 74.31 110.159 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -79.74 -0.58 34.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.783 0.325 . . . . 72.43 111.073 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.94 -172.16 21.75 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 116.168 -0.469 . . . . 74.12 112.43 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 17.7 ptmt -154.44 143.01 20.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.308 -0.525 . . . . 73.23 109.785 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.7 t -105.11 123.38 59.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.685 -0.857 . . . . 62.35 108.685 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -102.96 115.82 31.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.018 -0.673 . . . . 63.03 109.241 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -150.65 -136.75 2.58 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 111.708 -0.557 . . . . 53.3 111.708 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 35' ' ' PRO . 52.4 mtmt -139.28 147.22 41.37 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.551 0.691 . . . . 75.12 112.775 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.8 m -104.4 133.11 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.838 -1.074 . . . . 63.35 108.887 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 5.8 mt -87.49 111.0 21.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.953 -2.24 . . . . 72.42 104.953 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -97.72 167.26 11.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.633 -0.427 . . . . 75.12 111.888 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.7 39.38 93.68 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.645 -0.707 . . . . 73.0 113.274 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.1 t -103.97 122.04 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.125 -1.065 . . . . 63.35 108.125 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 m -78.6 158.57 28.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.064 -1.088 . . . . 63.11 108.064 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.89 -35.56 69.09 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.44 0.563 . . . . 70.34 110.949 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.81 91.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 73.35 110.714 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.424 ' HB3' HD23 ' A' ' 27' ' ' LEU . 47.9 mt-10 -69.03 -32.67 72.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.678 0.791 . . . . 74.31 110.536 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.449 HD23 HH11 ' A' ' 88' ' ' ARG . 1.3 tt -64.16 -28.29 69.66 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.466 -0.938 . . . . 72.34 108.466 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -56.54 -27.76 58.41 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 112.729 0.64 . . . . 75.04 112.729 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.417 ' O ' HG12 ' A' ' 80' ' ' VAL . 45.0 t-20 -72.56 -37.45 68.23 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 119.559 -0.856 . . . . 60.25 109.292 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CD1' HD12 ' A' ' 26' ' ' ILE . 90.8 m-85 -70.43 -30.19 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.628 -0.879 . . . . 72.22 108.628 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.77 -41.07 62.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 65.04 112.446 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 77' ' ' ASN . 9.4 p -67.09 -21.61 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.023 0.44 . . . . 71.42 110.255 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.27 116.37 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.526 -1.287 . . . . 74.11 107.526 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.455 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -71.36 119.44 15.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.197 1.184 . . . . 72.22 114.197 -171.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.651 ' HA3' ' CE1' ' A' ' 86' ' ' TYR . . . -150.7 86.43 0.15 Allowed Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 107.709 -2.156 . . . . 75.33 107.709 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -65.58 -38.35 89.25 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.838 0.855 . . . . 63.53 111.307 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.577 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 10.2 m-20 -91.4 8.62 35.36 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.108 -0.951 . . . . 75.4 112.103 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.651 ' CE1' ' HA3' ' A' ' 83' ' ' GLY 0.266 0.3 OUTLIER -125.04 157.95 34.95 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 119.443 -0.903 . . . . 73.52 112.237 172.488 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 11.8 pt-20 -127.61 158.37 37.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.501 0.191 . . . . 75.34 110.614 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.449 HH11 HD23 ' A' ' 75' ' ' LEU . 61.9 ttp180 -93.77 110.96 22.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.047 0.451 . . . . 75.12 110.679 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.9 159.49 28.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.257 -0.429 . . . . 64.25 111.145 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.416 ' CG2' ' HG2' ' A' ' 103' ' ' LYS . 99.2 m -99.08 124.16 43.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.916 -0.584 . . . . 64.42 109.596 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.6 m -125.37 155.65 34.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.872 1.269 . . . . 73.44 108.165 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 31.0 tt0 -105.1 127.44 52.89 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.784 -0.767 . . . . 75.34 110.395 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 38' ' ' LEU . 19.0 m -126.43 167.9 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 115.424 -0.807 . . . . 74.22 108.993 -175.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.444 HG23 ' HG2' ' A' ' 101' ' ' LYS . 62.2 t -107.1 123.06 62.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 173.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -73.66 84.14 1.59 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.768 -1.197 . . . . 73.22 107.768 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.544 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 25.3 ttt -39.59 -51.75 2.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 128.02 2.528 . . . . 75.33 114.035 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.42 -36.39 78.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.071 0.397 . . . . 72.14 112.071 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.75 -9.43 23.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.98 0.419 . . . . 74.22 110.922 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.86 20.76 12.36 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.035 1.334 . . . . 73.01 111.853 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -105.13 161.16 14.49 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 120.878 0.371 . . . . 72.23 110.369 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HG2' HG23 ' A' ' 94' ' ' VAL . 89.4 mttt -100.09 131.28 46.14 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.232 -0.655 . . . . 65.31 109.232 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.82 140.99 37.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.89 -0.411 . . . . 71.31 109.89 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HD3' ' HB2' ' A' ' 92' ' ' GLU . 31.2 ttpt -104.07 117.96 35.52 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 119.449 -0.9 . . . . 74.55 110.224 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 10' ' ' ASN . 19.8 m -123.82 176.26 5.52 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 CA-C-N 115.076 -0.965 . . . . 74.25 112.181 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -99.46 150.62 21.99 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 122.782 0.433 . . . . 72.21 110.026 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -159.43 175.01 13.83 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.689 -0.856 . . . . 65.24 108.689 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 97.6 m-85 -114.38 119.13 35.89 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.086 0.47 . . . . 75.11 111.837 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.49 142.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.713 -0.676 . . . . 61.1 109.908 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.577 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 25.1 t-105 -72.16 113.88 9.67 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.515 0.726 . . . . 74.23 110.119 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 m -72.38 -23.23 21.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 122.047 0.927 . . . . 65.32 110.055 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.463 ' OD1' ' HG3' ' A' ' 116' ' ' ARG . 28.6 t-20 -83.08 5.24 23.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.409 -1.269 . . . . 54.21 112.173 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -59.62 -15.06 16.22 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.437 1.273 . . . . 70.15 114.437 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -59.38 -28.57 67.0 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.992 1.108 . . . . 70.02 113.992 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -106.06 167.09 10.13 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.196 -1.409 . . . . 65.0 107.196 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.14 98.03 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 N-CA-C 108.371 -1.434 . . . . 74.4 108.371 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.463 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 40.4 mmt180 -133.15 128.62 36.47 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.707 -0.679 . . . . 65.33 110.236 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.476 ' N ' ' HE1' ' A' ' 117' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.513 0 O-C-N 124.537 1.148 . . . . 70.33 114.044 171.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 42.7 mt-10 . . . . . 0 C--O 1.224 -0.256 0 CA-C-O 120.35 0.119 . . . . 74.01 111.159 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -67.72 -34.09 76.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 73.12 110.643 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -58.31 -39.15 78.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.538 -0.912 . . . . 72.15 108.538 174.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 98.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.556 -1.202 . . . . 36.53 110.385 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 125' ' ' GLU . 97.6 t -67.61 -45.19 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.782 -0.451 . . . . 70.22 109.782 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.458 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 23.7 t60 -60.84 -34.26 74.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.771 -0.649 . . . . 74.41 109.701 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.36 -52.46 39.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.025 -0.534 . . . . 71.43 110.622 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 42.5 mt-10 -63.69 -40.96 98.1 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.487 0.492 . . . . 63.03 112.14 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.513 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -60.22 -47.62 85.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.987 -0.551 . . . . 74.14 111.499 -177.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.458 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 78.9 m-85 -76.99 -34.57 57.51 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.929 0.714 . . . . 71.24 112.929 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.548 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 12.5 p -67.34 -40.95 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.628 -0.829 . . . . 60.32 111.168 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.4 pt-20 -64.76 -34.56 78.63 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 120.11 -0.636 . . . . 73.5 110.747 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.2 m -66.13 -38.34 87.91 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.96 -0.564 . . . . 71.43 109.541 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.416 ' O ' ' HG3' ' A' ' 141' ' ' MET . 87.6 t80 -66.64 -44.71 81.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.606 -0.724 . . . . 63.45 109.674 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.6 mtp180 -55.06 -46.85 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 61.33 109.956 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 13.8 mmmm -61.97 -44.17 97.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.606 -0.725 . . . . 64.44 111.816 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 3.0 ppp? -70.28 -33.05 71.11 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 120.631 -0.427 . . . . 74.1 109.97 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.96 -42.07 97.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.785 -0.643 . . . . 73.54 109.279 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 148' ' ' PRO . 13.7 mm-40 -61.19 -39.14 89.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.036 -0.529 . . . . 74.53 110.551 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 43.7 t90 -75.32 -29.99 60.19 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.572 -0.451 . . . . 72.01 111.009 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.63 -31.89 36.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.241 0.544 . . . . 74.05 110.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.74 -32.42 46.7 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.945 -0.57 . . . . 72.43 110.89 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 54.8 67.96 2.93 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.506 0.723 . . . . 63.1 111.908 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 143' ' ' GLU . 91.3 Cg_endo -105.82 -15.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.981 2.454 . . . . 53.34 115.047 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -94.01 13.59 22.42 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.992 0.738 . . . . 74.31 112.992 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.123 0 C-N-CA 120.149 -1.024 . . . . 64.04 112.018 179.156 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 N--CA 1.435 -1.222 0 CA-C-O 121.683 0.754 . . . . 74.22 112.278 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -106.91 155.7 19.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.518 -1.29 . . . . 72.25 107.518 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -136.24 133.51 37.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.947 -1.501 . . . . 72.44 106.947 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 t -118.96 120.82 65.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 120.693 -0.403 . . . . 71.35 110.551 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.34 113.49 21.69 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.536 -0.913 . . . . 72.03 108.536 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 m -121.65 160.23 23.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.91 -0.586 . . . . 52.52 110.792 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -132.55 118.45 19.24 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.402 -0.817 . . . . 74.31 109.186 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.406 ' H ' HD13 ' A' ' 18' ' ' LEU . . . 102.08 -71.2 0.34 Allowed Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.889 -0.596 . . . . 70.13 113.168 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -92.17 155.6 17.9 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 111.556 0.206 . . . . 71.55 111.556 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 67' ' ' ILE . 25.1 mt 72.73 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 125.003 1.321 . . . . 64.32 111.166 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 15' ' ' GLY . 56.4 mt -66.09 -28.19 68.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.137 0.494 . . . . 61.3 110.11 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.22 129.24 44.23 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 115.24 -0.891 . . . . 71.33 108.965 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.65 -33.52 31.81 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.804 3.003 . . . . 72.3 112.993 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.4 80.81 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 120.85 0.357 . . . . 72.52 111.173 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.491 ' O ' HG22 ' A' ' 25' ' ' VAL . 60.6 t -73.73 -36.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.483 0.659 . . . . 64.52 109.647 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . . . -67.45 -31.5 71.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.913 -0.773 . . . . 72.12 108.913 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.34 -3.88 39.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.133 -0.94 . . . . 74.25 111.903 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 22' ' ' VAL . 19.6 m -105.75 -34.4 3.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.528 -0.869 . . . . 72.24 110.476 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 78' ' ' PHE . 5.1 tt -70.03 -41.03 79.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 121.023 0.439 . . . . 71.25 111.067 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 31' ' ' ALA . 81.7 mt -100.37 -17.65 17.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.614 -0.434 . . . . 70.42 110.7 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 34.2 t70 73.08 -2.77 2.62 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.9 1.334 . . . . 65.02 110.017 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 27' ' ' LEU . 39.2 ttm105 -121.2 144.85 48.37 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.608 -1.997 . . . . 74.54 105.608 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.1 m -77.8 111.14 13.31 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.107 -0.637 . . . . 74.13 111.416 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -93.51 143.75 26.0 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.011 -1.107 . . . . 65.1 108.011 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -98.05 125.42 43.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.867 0.692 . . . . 63.25 112.867 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.6 p -94.47 145.13 25.0 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.189 -0.914 . . . . 75.02 109.612 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.2 137.38 29.65 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 108.26 -1.015 . . . . 63.32 108.26 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 127.51 23.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.965 1.777 . . . . 71.53 111.363 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.78 154.96 39.3 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 116.21 -0.45 . . . . 55.43 110.3 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.24 127.48 75.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.389 0.614 . . . . 74.03 111.157 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.405 HD11 ' HB ' ' A' ' 91' ' ' VAL . 19.2 tp -88.04 119.69 28.66 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.66 -0.7 . . . . 64.1 109.768 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.469 -0.787 . . . . 74.11 110.918 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.02 59.63 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 119.516 -1.326 . . . . 72.42 113.441 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.445 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 64.3 m-85 -121.51 151.99 39.68 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 117.212 0.506 . . . . 72.43 110.752 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 12.4 t-160 -122.86 138.26 54.71 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.994 -0.548 . . . . 74.43 109.993 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.494 HH21 ' HB2' ' A' ' 125' ' ' GLU . 32.0 ptt180 -86.03 109.75 19.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.165 0.983 . . . . 64.22 108.985 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.454 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 3.1 m-85 -74.62 154.72 38.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.701 -1.136 . . . . 73.42 112.781 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -87.69 -7.61 57.19 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.606 1.335 . . . . 74.33 114.606 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.433 HD22 ' H ' ' A' ' 46' ' ' LEU . 1.2 pt? -72.29 73.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.601 0.963 . . . . 73.44 113.601 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HA ' ' CG ' ' A' ' 52' ' ' PRO . 54.6 pttt -72.83 1.19 9.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.816 1.414 . . . . 74.41 114.816 -175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.66 -20.25 79.79 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 109.358 -1.497 . . . . 54.21 109.358 172.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.9 157.57 51.47 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 109.285 -0.635 . . . . 73.33 109.285 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.28 106.27 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.672 2.248 . . . . 73.12 114.368 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 45.84 69.54 2.54 Favored Pre-proline 0 N--CA 1.496 1.827 0 C-N-CA 124.469 1.108 . . . . 75.51 111.342 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 68.8 Cg_endo -110.88 153.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 124.108 3.205 . . . . 71.32 117.235 -167.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.484 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 72.9 m -155.15 163.03 40.78 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 130.012 3.325 . . . . 74.22 102.295 -17.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 43.7 pt -123.59 138.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 117.806 -1.557 . . . . 72.42 112.619 170.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 44' ' ' TYR . 71.9 t -135.84 153.26 32.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.014 -1.847 . . . . 71.21 106.014 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 t -65.84 136.17 55.81 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 122.148 0.975 . . . . 72.4 112.295 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.6 t -156.42 104.53 2.21 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 103.717 -2.697 . . . . 73.51 103.717 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.77 -37.51 73.8 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 114.111 1.152 . . . . 71.13 114.111 -169.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -86.63 -0.06 55.46 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.306 -0.557 . . . . 71.14 111.985 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.79 146.76 16.18 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.761 -0.733 . . . . 71.21 111.549 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -140.44 152.74 45.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.139 -0.689 . . . . 72.25 109.139 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 41' ' ' TYR . 46.4 t -114.96 122.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.623 -0.51 . . . . 61.43 109.623 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -96.96 121.23 38.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.238 -0.652 . . . . 45.41 109.238 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.39 -143.44 3.7 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.003 -0.839 . . . . 54.13 111.003 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -140.53 142.88 35.17 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.74 -0.837 . . . . 65.4 108.74 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.37 134.05 46.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 120.915 0.388 . . . . 63.01 110.722 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 17' ' ' ILE . 11.4 mt -86.44 110.27 19.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 104.67 -2.345 . . . . 74.45 104.67 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -101.58 162.72 12.7 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.27 0.47 . . . . 73.12 112.27 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.36 47.45 70.81 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.646 -0.706 . . . . 50.33 112.123 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.4 122.77 59.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.024 -0.732 . . . . 71.3 109.024 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 m -77.82 158.71 29.39 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.316 -0.954 . . . . 71.14 108.857 175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -54.57 -35.94 63.84 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 112.172 0.434 . . . . 73.43 112.172 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.22 79.72 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.482 0.658 . . . . 70.31 110.587 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -77.25 -37.23 53.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.331 -0.849 . . . . 62.43 109.921 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -33.47 71.04 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.986 -1.006 . . . . 73.3 109.697 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.06 -34.71 66.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.671 -1.149 . . . . 72.01 111.494 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.47 ' ND2' HG13 ' A' ' 26' ' ' ILE . 53.1 t30 -76.13 -29.77 57.93 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.113 -1.035 . . . . 64.42 109.856 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.686 ' O ' HG23 ' A' ' 81' ' ' ILE . 97.1 m-85 -66.06 -28.59 68.95 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.6 -0.727 . . . . 73.32 110.906 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.22 -31.63 71.26 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.591 -0.892 . . . . 73.34 108.591 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.21 -22.69 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 114.887 -1.051 . . . . 75.31 111.847 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 78' ' ' PHE . 11.7 tt -74.05 2.31 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 CA-C-O 121.842 0.829 . . . . 64.14 110.239 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.371 31.1 mm-40 88.63 126.95 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 117.539 2.422 . . . . 64.1 117.539 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.74 53.72 0.34 Allowed Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 106.883 -2.487 . . . . 64.44 106.883 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.59 -42.56 99.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.021 0.928 . . . . 64.13 113.011 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 110' ' ' VAL . 7.3 m-20 -100.12 16.3 24.57 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.756 0.789 . . . . 61.34 109.701 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.442 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 77.4 m-85 -121.17 159.2 26.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.428 -0.806 . . . . 72.43 109.032 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.458 ' HB3' HG13 ' A' ' 110' ' ' VAL . 12.5 pt-20 -127.88 157.91 39.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.417 -0.216 . . . . 63.23 110.417 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -85.15 113.05 21.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.18 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.31 159.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.447 -0.342 . . . . 74.3 110.485 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.7 m -106.41 122.47 46.34 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 108.902 -0.777 . . . . 73.34 108.902 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.3 m -128.01 161.9 35.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.946 -1.131 . . . . 74.04 107.946 -175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.494 ' HG3' ' CE ' ' A' ' 103' ' ' LYS . 1.2 mp0 -108.76 138.87 44.39 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.069 -1.452 . . . . 70.34 108.352 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.456 HG22 HG11 ' A' ' 66' ' ' VAL . 26.2 m -126.51 161.1 33.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.983 -0.747 . . . . 44.13 108.983 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.526 HG23 ' HG3' ' A' ' 101' ' ' LYS . 75.5 t -104.79 116.85 49.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.693 -0.685 . . . . 74.54 110.083 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.411 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 15.5 ttm180 -68.13 110.79 4.14 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.948 -1.871 . . . . 61.2 105.948 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.32 -54.1 49.45 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 114.848 1.425 . . . . 73.41 114.848 -164.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.53 -12.8 61.21 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.235 1.198 . . . . 74.01 114.235 -172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.1 -6.19 9.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.185 0.517 . . . . 73.53 110.705 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.2 m 61.46 25.93 15.78 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.148 0.579 . . . . 74.53 111.288 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 12.9 pt-20 -93.91 158.71 15.51 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 109.429 -0.582 . . . . 74.24 109.429 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.526 ' HG3' HG23 ' A' ' 94' ' ' VAL . 8.1 mptt -109.99 132.63 53.98 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.084 -0.71 . . . . 63.44 109.084 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.87 146.57 25.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.74 -0.467 . . . . 74.24 109.74 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.494 ' CE ' ' HG3' ' A' ' 92' ' ' GLU . 14.1 tppt? -91.6 132.77 36.08 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.622 -0.881 . . . . 74.44 108.622 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.0 m -139.56 173.33 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.733 0.301 . . . . 74.41 110.847 -177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.79 148.78 24.88 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.598 -0.89 . . . . 74.22 108.598 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 t -153.39 175.18 13.42 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 109.16 -0.682 . . . . 71.53 109.16 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -107.19 118.61 37.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.67 -1.233 . . . . 74.12 107.67 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.32 162.6 10.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.196 -1.039 . . . . 75.15 108.196 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.551 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 33.6 t-105 -77.8 127.59 32.65 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.724 -0.843 . . . . 74.34 108.724 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 85' ' ' ASP . 26.9 m -69.81 -23.57 25.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 O-C-N 121.757 -0.589 . . . . 74.14 111.579 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.551 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -91.75 14.35 15.59 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.717 -0.674 . . . . 53.21 109.703 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.5 ptpp? -49.68 -18.81 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.352 1.461 . . . . 73.33 113.822 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.35 -39.53 76.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.921 -0.4 . . . . 73.31 109.921 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -114.2 124.07 31.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 N-CA-C 109.69 -0.485 . . . . 74.12 109.69 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.83 116.51 4.62 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.167 1.911 . . . . 53.23 109.565 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -86.98 113.66 22.94 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.31 -0.996 . . . . 65.13 108.31 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.488 1.427 0 C-N-CA 124.465 1.106 . . . . 72.42 113.0 -179.054 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HB2' HH21 ' A' ' 43' ' ' ARG . 39.9 tt0 . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.672 -0.492 . . . . 61.4 109.672 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -52.52 -46.63 66.79 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.802 -0.814 . . . . 74.22 108.802 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -60.5 -48.88 79.84 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.104 -0.953 . . . . 61.42 111.702 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.7 m -73.91 -31.6 31.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 N-CA-C 112.682 0.623 . . . . 72.32 112.682 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 125' ' ' GLU . 84.4 t -67.48 -40.28 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.023 -0.732 . . . . 71.53 109.023 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.545 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 46.0 t60 -65.86 -42.88 89.88 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.644 -0.707 . . . . 74.41 109.189 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -62.59 -52.69 62.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.615 -0.266 . . . . 73.43 111.367 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 13.6 mm-40 -62.46 -31.69 72.45 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.378 -0.374 . . . . 73.32 111.407 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.497 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 3.4 tmtm? -59.64 -40.5 87.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.698 0.761 . . . . 75.52 109.645 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.545 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 82.7 m-85 -82.31 -36.13 27.28 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.593 -0.692 . . . . 61.25 110.857 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 131' ' ' ALA . 99.3 t -62.49 -44.8 99.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.445 -0.343 . . . . 72.53 111.254 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 11.2 pt-20 -60.27 -37.46 80.52 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 110.18 -0.304 . . . . 72.34 110.18 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -64.42 -44.43 91.24 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.734 -0.469 . . . . 73.4 109.734 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.08 -46.21 90.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.68 -0.489 . . . . 64.34 109.68 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.62 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 98.2 mtt180 -63.84 -49.26 73.51 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.566 -0.743 . . . . 74.41 112.681 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -60.4 -47.03 87.86 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.905 0.128 . . . . 74.44 110.82 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -63.38 -32.73 74.24 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.948 0.404 . . . . 63.21 110.053 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' ARG . 65.0 tp -62.62 -47.15 85.02 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.717 -0.674 . . . . 63.31 109.195 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.0 mt-10 -60.88 -46.99 88.44 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.427 0.454 . . . . 71.45 110.279 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -66.3 -36.9 84.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.768 0.655 . . . . 65.53 112.768 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.04 -28.23 29.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.047 0.451 . . . . 70.12 111.427 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 12.3 tmtt? -79.64 -32.28 41.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.447 -0.342 . . . . 74.22 110.194 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -69.88 118.75 66.24 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.258 -0.428 . . . . 74.53 111.06 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.13 -14.72 45.64 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.796 2.997 . . . . 72.22 113.188 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -70.77 -25.16 62.77 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.997 0.427 . . . . 75.41 111.301 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.883 0 N-CA-C 115.578 0.991 . . . . 51.33 115.578 172.764 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.424 -1.77 0 CA-C-O 121.49 0.662 . . . . 72.43 111.082 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -106.34 156.15 18.8 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 124.63 1.172 . . . . 75.2 109.25 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.461 HD21 HG23 ' A' ' 68' ' ' THR . 14.1 m120 -134.62 122.77 22.77 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.713 -1.958 . . . . 64.32 105.713 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.05 122.61 68.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.86 -0.736 . . . . 72.4 111.565 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -83.84 108.36 16.81 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.419 -1.326 . . . . 75.22 107.419 175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.5 147.76 26.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.886 -0.725 . . . . 75.44 110.716 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.422 ' HA ' HD13 ' A' ' 18' ' ' LEU . 50.0 t80 -127.34 96.76 4.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.465 -2.05 . . . . 74.43 105.465 170.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.0 -145.84 11.05 Favored Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.069 -1.539 . . . . 63.11 114.453 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 m -43.8 -61.51 1.4 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 127.396 2.278 . . . . 74.44 116.926 -170.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.464 HG13 ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -89.06 17.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 114.16 1.17 . . . . 75.04 114.16 -167.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 14' ' ' TYR . 54.7 mt -73.38 -17.27 61.3 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 120.12 -0.632 . . . . 65.23 111.13 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.97 125.96 80.8 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.501 -0.772 . . . . 62.35 109.4 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -46.62 -38.08 21.42 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 124.258 3.305 . . . . 74.24 114.785 -174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -60.15 -64.46 0.94 Allowed 'General case' 0 C--O 1.217 -0.649 0 O-C-N 123.126 0.266 . . . . 71.24 110.379 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.537 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 41.9 t -55.88 -32.68 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 124.13 0.972 . . . . 73.13 111.19 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HA ' HG23 ' A' ' 26' ' ' ILE . . . -65.42 -33.55 76.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.027 0.442 . . . . 54.45 111.394 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -80.94 -30.78 35.19 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 122.126 0.965 . . . . 75.03 108.648 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 22' ' ' VAL . 26.9 t -65.58 -33.85 66.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 125.26 1.424 . . . . 65.12 111.377 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.672 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tt -87.33 -42.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.733 0.642 . . . . 62.32 112.733 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 31' ' ' ALA . 87.8 mt -85.18 -30.15 24.16 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 112.188 0.44 . . . . 74.32 112.188 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 t70 81.78 1.75 1.47 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.245 1.418 . . . . 74.24 109.19 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 52.1 mtt180 -126.08 163.63 22.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.115 -1.439 . . . . 73.42 107.115 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -76.63 115.02 16.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.003 -0.74 . . . . 72.0 109.003 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -80.27 136.02 36.35 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.62 -0.718 . . . . 70.22 111.911 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.72 110.2 22.61 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.809 -0.757 . . . . 60.22 109.496 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.479 ' CG2' HG12 ' A' ' 67' ' ' ILE . 4.2 p -110.16 143.81 39.72 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.663 -0.699 . . . . 64.14 110.21 174.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -133.48 140.57 37.37 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 107.361 -1.348 . . . . 64.4 107.361 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.574 ' O ' ' HB3' ' A' ' 96' ' ' MET . 19.2 Cg_endo -60.62 137.18 71.82 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.68 1.586 . . . . 74.11 109.512 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.36 42.72 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.261 -0.644 . . . . 72.13 109.261 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.89 125.69 70.11 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 121.861 0.838 . . . . 73.35 111.543 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.8 tp -89.71 113.39 24.89 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 114.731 -1.122 . . . . 61.03 109.743 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -85.32 136.22 33.57 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.712 -0.847 . . . . 71.44 108.712 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 106.6 -23.38 28.33 Favored Glycine 0 C--O 1.203 -1.785 0 C-N-CA 118.965 -1.588 . . . . 63.24 112.666 174.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.437 ' O ' HG21 ' A' ' 62' ' ' VAL . 16.8 m-85 -101.59 143.37 31.65 Favored 'General case' 0 CA--C 1.456 -2.669 0 C-N-CA 119.718 -0.793 . . . . 73.12 110.928 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 3.7 t60 -112.31 135.08 53.43 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 115.285 -0.871 . . . . 75.21 109.26 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -87.2 112.22 21.77 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.7 -0.682 . . . . 71.01 109.792 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -105.76 126.58 52.33 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.757 -1.572 . . . . 70.41 106.757 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.549 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -85.12 -11.82 54.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.697 0.761 . . . . 73.15 109.612 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.628 HD11 ' SD ' ' A' ' 117' ' ' MET 0.282 2.6 mm? 72.79 -99.4 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 125.108 1.363 . . . . 73.42 112.723 -177.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt 171.49 -37.52 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.191 0.996 . . . . 72.32 110.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.51 4.26 3.67 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.069 -1.062 . . . . 64.23 112.718 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.36 134.01 30.43 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 119.038 -1.065 . . . . 71.35 111.797 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.787 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 73.6 Cg_endo -74.69 103.36 1.7 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.462 2.775 . . . . 72.53 114.466 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.52 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.455 38.5 p90 71.23 1.49 0.0 OUTLIER Pre-proline 0 CA--C 1.608 3.196 0 N-CA-C 121.025 3.713 . . . . 72.51 121.025 176.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.787 ' HD3' ' C ' ' A' ' 50' ' ' PRO . 1.7 Cg_endo -88.41 169.45 5.93 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.862 2.375 . . . . 72.52 108.502 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 15.2 p -156.42 -176.32 5.91 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 127.568 2.347 . . . . 74.01 108.535 -3.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 46.0 pt -134.9 130.59 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 74.21 108.113 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.19 -175.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.133 -1.432 . . . . 75.12 107.133 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.2 m 69.83 -173.09 0.18 Allowed 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.323 1.014 . . . . 71.2 111.431 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 56.8 m -148.69 34.28 0.77 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.466 -0.568 . . . . 74.41 109.466 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -75.15 -166.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.73 -0.668 . . . . 74.04 111.905 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 m -75.49 -9.75 58.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.86 0.689 . . . . 75.53 112.86 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.85 160.0 45.47 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.018 -0.611 . . . . 64.5 112.846 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -136.67 159.33 42.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.544 -0.91 . . . . 62.43 108.544 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 41' ' ' TYR . 49.1 t -126.25 128.02 71.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 110.088 -0.338 . . . . 74.42 110.088 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.79 122.06 42.2 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.746 -0.464 . . . . 70.32 109.746 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.51 -146.84 4.41 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 111.349 -0.7 . . . . 55.11 111.349 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -138.96 139.96 38.11 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.79 -0.819 . . . . 72.43 108.79 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -104.23 132.24 51.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 119.782 -0.767 . . . . 73.01 109.954 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.479 HG12 ' CG2' ' A' ' 33' ' ' THR . 36.0 mt -90.15 117.48 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.302 -1.37 . . . . 64.02 107.302 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.461 HG23 HD21 ' A' ' 10' ' ' ASN . 81.2 p -103.04 162.07 13.25 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.155 0.428 . . . . 64.41 112.155 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.04 33.6 74.73 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.619 -0.719 . . . . 53.14 113.671 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.57 122.28 39.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 122.506 -0.408 . . . . 74.21 110.198 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -75.04 159.11 32.12 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.579 -0.896 . . . . 74.45 108.579 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.21 -42.35 81.13 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.363 0.602 . . . . 71.21 112.075 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.58 72.01 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.339 -0.846 . . . . 52.44 110.857 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -76.26 -32.99 59.15 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.586 -0.734 . . . . 74.41 109.172 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.59 -40.68 95.67 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.97 -1.014 . . . . 75.45 109.847 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.618 ' O ' HG22 ' A' ' 80' ' ' VAL . 27.2 t-20 -55.88 -30.49 61.61 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.801 -1.091 . . . . 64.14 111.644 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.672 ' ND2' HG13 ' A' ' 26' ' ' ILE . 64.6 t30 -69.5 -31.47 69.75 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 120.768 -0.373 . . . . 72.44 110.671 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.59 ' CD1' HD12 ' A' ' 26' ' ' ILE . 81.2 m-85 -72.06 -42.13 66.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.516 -0.92 . . . . 75.45 108.516 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.18 -35.2 78.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.114 -1.403 . . . . 71.44 110.291 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 76' ' ' ASN . 60.9 t -74.98 -23.84 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 112.859 0.688 . . . . 72.22 112.859 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 77' ' ' ASN . 46.2 mm -75.76 -84.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 119.308 -0.957 . . . . 75.44 112.42 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.07 10.88 32.0 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 121.657 -0.652 . . . . 72.01 112.548 178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.55 32.01 2.65 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.52 -0.848 . . . . 63.31 112.847 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -83.16 -39.99 20.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.961 0.41 . . . . 74.44 111.361 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.17 14.97 20.66 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.148 0.975 . . . . 62.12 108.635 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -123.81 156.85 35.36 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.423 -1.325 . . . . 70.5 107.423 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HB3' HG23 ' A' ' 110' ' ' VAL . 14.0 pt-20 -126.71 155.2 43.06 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.737 -0.838 . . . . 74.12 108.737 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 106' ' ' THR . 49.0 mtm105 -94.84 107.69 19.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.481 0.548 . . . . 73.11 112.481 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.35 158.15 11.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.75 -0.659 . . . . 63.24 109.3 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.1 m -94.98 126.11 40.1 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.104 -0.702 . . . . 72.32 109.104 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.11 158.31 43.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.802 -1.184 . . . . 74.13 107.802 -177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -113.96 129.74 56.58 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.454 -1.298 . . . . 72.14 108.605 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.24 166.1 23.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.444 -0.576 . . . . 61.52 109.444 -174.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.498 HG13 ' H ' ' A' ' 96' ' ' MET . 73.0 t -99.76 124.79 53.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.598 -0.889 . . . . 74.33 108.598 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -68.24 5.12 1.04 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 125.558 1.543 . . . . 73.21 112.462 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 0.9 OUTLIER 51.5 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 127.004 2.122 . . . . 64.14 115.166 174.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.8 -43.09 80.57 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.779 0.832 . . . . 54.25 110.751 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.01 -8.84 24.76 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.448 -1.315 . . . . 72.31 107.448 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.7 m 62.63 12.36 5.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.742 1.217 . . . . 75.42 113.888 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.81 161.95 15.05 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.4 -0.592 . . . . 61.31 109.4 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HG2' HG23 ' A' ' 94' ' ' VAL . 89.3 mttt -96.89 129.68 44.3 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.701 -0.852 . . . . 63.43 108.701 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.14 130.04 69.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 121.256 0.55 . . . . 74.01 110.93 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -86.95 119.75 27.49 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.076 -1.083 . . . . 73.13 108.076 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.47 174.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.122 -0.49 . . . . 61.21 110.589 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.14 153.7 19.36 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.442 -0.948 . . . . 53.01 108.442 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 14.7 t -146.58 173.43 12.33 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.634 -0.876 . . . . 61.34 108.634 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -107.91 118.19 36.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.174 0.511 . . . . 75.23 110.02 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 HG13 ' A' ' 54' ' ' ILE . 27.3 m -110.23 168.74 4.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.417 -0.957 . . . . 43.14 108.417 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 111' ' ' ASN . 32.1 t-105 -83.14 119.62 24.75 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.997 -0.742 . . . . 75.11 108.997 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 87' ' ' GLU . 2.2 p -68.65 -20.44 25.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.396 -0.82 . . . . 61.43 111.48 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 18.1 m120 -84.95 13.52 5.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.173 1.389 . . . . 42.51 111.425 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -51.49 -27.66 11.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.541 1.136 . . . . 61.43 113.04 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -78.09 -15.46 58.86 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 120.865 0.364 . . . . 64.21 111.373 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.51 138.57 26.75 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 107.089 -1.449 . . . . 64.52 107.089 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -40.15 108.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.683 2.922 . . . . 75.43 112.664 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -95.47 162.47 13.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.039 -0.528 . . . . 75.21 110.471 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.628 ' SD ' HD11 ' A' ' 46' ' ' LEU . 1.3 mpt? . . . . . 0 CA--C 1.496 -1.107 0 N-CA-C 105.692 -1.966 . . . . 73.4 105.692 171.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 109.091 -0.707 . . . . 65.41 109.091 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -62.59 -48.28 80.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.665 -0.698 . . . . 74.54 110.108 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -59.06 -47.91 83.52 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 116.005 -0.543 . . . . 71.22 111.991 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.8 m -69.29 -40.44 80.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.461 -0.495 . . . . 70.1 112.29 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.04 -28.33 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.588 -0.445 . . . . 74.23 110.535 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.474 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 14.2 t60 -55.66 -47.05 77.34 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.905 -0.776 . . . . 73.12 108.905 174.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.91 98.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.66 -0.7 . . . . 74.11 110.919 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -67.37 -40.83 85.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.116 -0.493 . . . . 52.21 111.407 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.612 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -67.07 -53.5 30.38 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 108.383 -0.969 . . . . 65.31 108.383 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 77.2 m-85 -63.17 -31.44 72.59 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.904 1.446 . . . . 73.02 114.904 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.27 -34.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 119.117 -1.033 . . . . 54.11 109.508 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.4 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 1.6 tm-20 -69.34 -34.67 74.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.227 1.011 . . . . 73.23 109.028 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.3 m -57.62 -44.02 85.21 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.332 -0.618 . . . . 65.32 109.332 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.465 ' O ' ' HG3' ' A' ' 141' ' ' MET . 79.4 t80 -66.19 -36.31 82.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.764 -0.653 . . . . 72.44 109.266 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 81.2 mtp180 -60.94 -52.52 64.67 Favored 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.155 -0.475 . . . . 53.4 109.795 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.4 ' HG2' ' OE2' ' A' ' 136' ' ' GLU . 46.3 mmtm -56.03 -39.23 71.65 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.224 0.824 . . . . 73.32 113.224 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 3.3 ppp? -67.47 -31.79 72.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.968 -0.693 . . . . 71.43 110.001 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.2 tp -76.54 -41.71 45.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.527 -0.76 . . . . 75.14 109.622 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 12.4 mm-40 -59.54 -46.84 87.7 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.605 -0.517 . . . . 73.41 109.605 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -64.92 -36.63 85.0 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.285 -0.871 . . . . 74.33 112.027 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -82.17 -38.64 24.36 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.989 0.424 . . . . 75.42 111.438 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -79.48 -31.61 42.39 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.65 0.262 . . . . 65.55 110.508 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -124.7 82.85 59.41 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-O 120.863 0.363 . . . . 54.44 110.213 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.76 -24.18 18.44 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.81 2.34 . . . . 74.33 112.563 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -96.84 -15.97 21.0 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.372 0.606 . . . . 75.43 109.957 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.705 0 CA-C-N 115.407 -0.815 . . . . 74.35 113.384 -178.518 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.442 -0.868 0 CA-C-O 121.959 0.885 . . . . 73.12 111.939 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.494 ' CG ' HD13 ' A' ' 75' ' ' LEU . 75.5 m80 -126.89 155.42 43.03 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 115.222 -0.899 . . . . 73.54 110.171 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.1 m-20 -127.5 129.5 47.51 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.789 -1.56 . . . . 71.14 106.789 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.69 128.06 59.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.436 0.532 . . . . 74.53 112.436 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -82.01 108.24 15.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.044 -1.465 . . . . 75.25 107.044 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.29 123.16 68.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.422 0.63 . . . . 72.14 110.635 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -96.69 107.21 19.62 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.383 -1.34 . . . . 64.01 107.383 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 18' ' ' LEU . . . 75.59 -138.02 22.55 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.782 -0.927 . . . . 50.2 110.782 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.8 m 60.43 -80.77 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.159 1.17 . . . . 74.04 114.159 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 67' ' ' ILE . 32.6 pt -120.03 18.13 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 112.391 0.515 . . . . 74.44 112.391 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 64.1 mt -60.33 -21.91 62.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.429 0.633 . . . . 45.41 109.834 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.88 118.31 71.61 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.347 -1.353 . . . . 70.12 107.347 170.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -48.37 -36.46 30.39 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.961 3.107 . . . . 75.31 113.836 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.93 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 37.5 111.849 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.586 ' O ' HG22 ' A' ' 25' ' ' VAL . 13.0 t -77.86 -32.61 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.515 0.674 . . . . 64.02 109.797 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.18 -33.34 74.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.62 0.724 . . . . 72.12 109.118 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -75.46 -16.13 60.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.252 -0.886 . . . . 72.53 111.65 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 22' ' ' VAL . 13.1 m -89.01 -30.03 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 118.89 -1.124 . . . . 71.13 110.44 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.52 HG21 HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -81.57 -48.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 121.023 -0.271 . . . . 73.25 110.919 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.78 -16.59 25.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 120.808 0.337 . . . . 62.12 111.299 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 72.01 6.59 5.63 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.904 1.335 . . . . 72.22 109.999 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -141.97 169.28 17.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.32 -1.363 . . . . 63.44 107.32 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -76.43 128.46 34.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.891 -0.781 . . . . 74.35 108.891 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.25 137.81 41.46 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.711 0.291 . . . . 61.13 110.325 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -98.33 109.91 22.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.943 -1.132 . . . . 54.34 107.943 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.0 p -115.14 146.18 41.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.513 -0.767 . . . . 71.41 111.466 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.71 145.73 50.55 Favored Pre-proline 0 C--N 1.286 -2.162 0 N-CA-C 106.724 -1.584 . . . . 75.52 106.724 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.91 140.84 51.66 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.12 1.213 . . . . 74.14 110.243 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.68 156.44 41.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.051 -0.522 . . . . 53.41 109.808 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.93 123.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 121.628 0.728 . . . . 73.41 111.452 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HA ' HG11 ' A' ' 93' ' ' VAL . 23.1 tp -87.64 93.23 9.37 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.316 -0.856 . . . . 73.42 110.219 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -68.64 134.85 50.51 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.485 -1.234 . . . . 72.01 107.771 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 115.74 -29.85 6.96 Favored Glycine 0 C--N 1.29 -2.015 0 C-N-CA 118.618 -1.753 . . . . 71.01 112.35 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.509 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 58.9 m-85 -109.56 166.55 10.81 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 112.014 0.376 . . . . 71.12 112.014 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.503 ' NE2' ' HB2' ' A' ' 56' ' ' SER . 0.1 OUTLIER -155.14 139.29 16.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.756 -0.656 . . . . 71.21 111.707 -177.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.81 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 67.0 ttt180 -87.48 138.99 31.0 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.441 1.088 . . . . 74.54 112.792 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.62 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 6.8 m-85 -104.69 158.77 16.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.677 -1.147 . . . . 74.52 109.575 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' H ' ' HD3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.78 -44.92 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.795 1.035 . . . . 72.44 113.795 -174.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.585 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 3.1 mm? 60.63 -179.34 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.991 0.517 . . . . 51.12 111.678 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.07 -71.45 0.68 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.088 0.47 . . . . 70.54 109.86 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.57 20.12 50.08 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.325 -0.941 . . . . 72.33 114.209 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.9 151.03 37.9 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.749 -0.834 . . . . 74.42 108.749 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.4 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 123.015 2.476 . . . . 61.11 114.823 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -134.09 73.39 70.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 122.004 0.907 . . . . 73.22 112.507 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.679 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 20.7 Cg_endo -108.45 167.48 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.995 3.797 . . . . 54.21 112.501 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.81 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 20.2 p -156.18 162.4 40.2 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 127.882 2.473 . . . . 71.21 106.145 -8.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 41.7 pt -123.33 121.46 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.354 0 CA-C-N 119.57 1.077 . . . . 74.03 110.265 170.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.577 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 33.7 m -149.59 -173.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.312 -0.858 . . . . 73.44 110.423 -173.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.503 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 37.7 m 69.44 -161.18 0.17 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 124.626 1.204 . . . . 73.24 111.553 174.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -105.65 -172.66 2.13 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 120.911 0.386 . . . . 60.33 111.252 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.502 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 8.8 m-20 -68.02 36.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.413 1.885 . . . . 70.44 115.764 -169.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -79.53 -11.48 59.89 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.188 -0.945 . . . . 71.21 112.536 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.13 -169.99 15.68 Favored Glycine 0 CA--C 1.488 -1.63 0 C-N-CA 119.928 -1.13 . . . . 40.12 112.569 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -145.32 152.61 40.18 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.708 -1.219 . . . . 72.24 107.708 176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.401 HG23 ' CG2' ' A' ' 54' ' ' ILE . 48.7 t -122.2 123.18 68.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 110.177 -0.305 . . . . 75.23 110.177 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -95.41 129.37 42.59 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.373 -0.931 . . . . 64.31 109.967 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.1 -142.32 3.48 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 111.019 -0.833 . . . . 70.22 111.019 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -138.79 136.85 36.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.008 0.523 . . . . 70.31 111.524 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.45 133.67 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.697 -0.683 . . . . 70.41 109.842 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.552 ' CD1' HD12 ' A' ' 17' ' ' ILE . 32.6 mt -88.62 131.06 37.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.443 -1.688 . . . . 64.44 106.443 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -110.73 160.97 16.23 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.927 -0.709 . . . . 70.24 110.477 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.34 36.77 63.17 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.077 -0.582 . . . . 65.4 112.797 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -95.65 122.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.427 -0.455 . . . . 73.03 109.863 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.471 ' OG ' ' HG2' ' A' ' 74' ' ' GLU . 80.3 p -76.91 173.18 12.04 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 121.494 -0.754 . . . . 70.23 109.497 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.44 -29.56 70.25 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.87 0.367 . . . . 72.15 110.298 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.42 -41.27 40.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 71.25 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.471 ' HG2' ' OG ' ' A' ' 71' ' ' SER . 9.5 mm-40 -69.34 -36.49 76.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 75.53 110.194 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.494 HD13 ' CG ' ' A' ' 9' ' ' HIS . 2.3 tt -63.34 -37.86 88.91 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.28 -1.007 . . . . 64.22 108.28 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.48 ' O ' HG22 ' A' ' 80' ' ' VAL . 51.8 t30 -54.83 -31.19 59.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.636 -1.166 . . . . 72.4 111.567 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.491 ' O ' HG13 ' A' ' 81' ' ' ILE . 23.3 t-20 -75.21 -32.42 61.17 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.519 -0.873 . . . . 73.32 109.826 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -64.52 -36.17 83.32 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.068 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.57 -33.03 73.37 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.632 -0.713 . . . . 73.04 110.253 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 76' ' ' ASN . 99.6 t -69.16 -37.64 76.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.846 -0.615 . . . . 74.23 110.435 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.6 mt -57.79 -68.49 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 116.135 -0.484 . . . . 63.14 111.095 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 21.0 mm-40 -110.54 103.4 12.0 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.482 0.658 . . . . 74.24 112.591 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.64 11.79 0.85 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 115.045 -0.979 . . . . 72.33 111.695 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -75.17 -44.12 48.47 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.725 -0.472 . . . . 65.44 109.725 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.594 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 3.9 t70 -136.97 14.17 3.09 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.665 1.222 . . . . 73.32 107.786 175.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 21.1 m-85 -113.82 145.46 41.4 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.396 -1.275 . . . . 75.52 109.462 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.72 151.89 47.55 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.612 -0.884 . . . . 75.33 108.612 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -91.14 125.37 35.9 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.718 0.294 . . . . 74.32 111.038 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.66 159.6 34.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 116.013 -0.54 . . . . 72.31 110.559 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.28 129.8 39.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.638 -1.245 . . . . 73.44 107.638 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.65 169.13 20.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 108.628 -0.878 . . . . 63.41 108.628 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -118.72 124.55 47.59 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.28 -1.378 . . . . 74.11 107.28 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 38' ' ' LEU . 17.4 m -127.33 168.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.37 0.605 . . . . 75.24 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.571 HG23 ' HG3' ' A' ' 101' ' ' LYS . 69.5 t -102.41 117.58 47.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.739 -0.664 . . . . 73.34 109.474 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -74.69 88.26 2.21 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.5 -1.667 . . . . 62.31 106.5 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -50.26 -35.91 29.02 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.168 1.787 . . . . 71.12 112.701 -170.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.86 -31.4 39.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.908 0.755 . . . . 74.11 111.811 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -127.83 -1.29 5.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 120.282 -0.567 . . . . 61.02 110.746 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.5 t 69.13 16.71 8.56 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.802 0.841 . . . . 74.42 111.517 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.3 160.01 15.72 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 109.341 -0.614 . . . . 61.25 109.341 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.571 ' HG3' HG23 ' A' ' 94' ' ' VAL . 8.4 mptt -101.63 134.02 45.41 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 108.787 -0.82 . . . . 73.54 108.787 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.91 140.99 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.279 0.561 . . . . 64.34 111.047 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.84 125.52 34.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.628 -1.249 . . . . 63.23 107.628 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.29 176.09 8.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 C-N-CA 122.608 0.363 . . . . 72.42 111.171 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -99.59 153.55 18.97 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.355 -0.98 . . . . 73.05 108.355 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -159.56 177.07 11.29 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 117.951 0.341 . . . . 70.21 110.164 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 82' ' ' GLU . 81.6 m-85 -105.57 121.36 43.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.268 -1.012 . . . . 70.42 108.268 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.68 165.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 109.053 -0.721 . . . . 74.32 109.053 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.641 ' CD1' ' HB2' ' A' ' 111' ' ' ASN . 61.8 t-105 -97.4 129.65 44.61 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 107.682 -1.229 . . . . 75.34 107.682 -169.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.0 -20.21 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.569 . . . . 74.2 112.298 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.641 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 26.5 m-80 -77.77 15.6 0.82 Allowed 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 124.1 0.96 . . . . 74.41 110.837 171.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 19.3 ptpt -49.28 -21.0 0.73 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.711 1.204 . . . . 74.45 113.484 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -124.02 94.28 4.17 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 104.005 -2.591 . . . . 71.12 104.005 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.4 p-10 -120.5 158.83 50.36 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 113.888 -1.505 . . . . 73.05 111.767 -172.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -106.65 12.05 0.16 Allowed 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.806 2.337 . . . . 75.33 111.881 170.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -134.26 133.15 40.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.359 0.874 . . . . 71.01 113.359 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' A' ' 46' ' ' LEU . 57.6 mtt . . . . . 0 N--CA 1.497 1.892 0 C-N-CA 123.738 0.815 . . . . 74.03 111.306 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.543 ' O ' HG22 ' A' ' 129' ' ' VAL . 43.1 tt0 . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 109.734 -0.469 . . . . 75.44 109.734 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -55.91 -28.5 57.06 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.231 0.538 . . . . 73.33 110.012 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -58.0 -47.47 82.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.1 -0.5 . . . . 65.05 110.835 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 125' ' ' GLU . 20.0 m -81.86 -22.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.337 0.589 . . . . 72.43 110.133 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 125' ' ' GLU . 99.3 t -68.05 -34.4 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.697 -0.683 . . . . 63.24 109.835 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -55.54 -34.51 64.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.123 -0.489 . . . . 73.53 111.837 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.94 -55.11 9.08 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 121.02 -0.272 . . . . 73.32 111.178 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.491 ' HA ' HG13 ' A' ' 135' ' ' VAL . 9.5 pt-20 -66.84 -37.9 85.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 113.133 0.79 . . . . 55.32 113.133 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -59.29 -47.12 86.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.424 -0.353 . . . . 73.11 111.147 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -81.72 -37.58 27.08 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 112.573 0.583 . . . . 71.22 112.573 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.558 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 15.0 p -62.75 -41.64 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 119.625 -0.83 . . . . 71.55 111.226 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 29.4 mm-40 -58.81 -44.14 90.75 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 123.018 0.199 . . . . 74.52 110.919 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.9 m -54.1 -48.64 70.49 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 123.661 0.6 . . . . 74.13 110.761 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.33 -36.87 85.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.747 0.308 . . . . 75.43 111.288 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.7 mtp180 -66.68 -43.6 84.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 73.2 110.494 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.1 -40.6 71.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.932 -0.576 . . . . 71.13 111.725 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.4 mtm -66.82 -31.41 72.01 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.602 -0.439 . . . . 70.23 110.819 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.05 -43.94 97.75 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.654 -0.869 . . . . 62.4 108.654 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -62.41 -30.21 71.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.639 . . . . 70.41 111.004 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -75.39 -38.92 59.68 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.839 -0.619 . . . . 74.2 112.477 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -77.75 -43.31 31.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.796 0.331 . . . . 72.14 111.677 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.523 ' C ' ' HD3' ' A' ' 148' ' ' PRO . 88.0 tttt -79.23 -17.03 55.58 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.292 -0.413 . . . . 74.14 111.438 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.58 ' N ' ' HD3' ' A' ' 148' ' ' PRO . 3.5 t-20 75.7 16.59 0.0 OUTLIER Pre-proline 0 CA--C 1.609 3.224 0 N-CA-C 115.394 1.627 . . . . 73.24 115.394 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.58 ' HD3' ' N ' ' A' ' 147' ' ' ASN . 6.9 Cg_exo -73.85 -16.57 23.29 Favored 'Trans proline' 0 C--N 1.4 3.247 0 CA-C-N 122.795 2.034 . . . . 55.13 110.958 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.81 -22.71 59.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.528 -0.76 . . . . 74.13 110.212 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.137 0 C-N-CA 120.774 -0.727 . . . . 61.32 112.051 179.081 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.425 -1.717 0 N-CA-C 107.502 -1.295 . . . . 75.31 107.502 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -87.54 156.1 19.68 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.445 -0.798 . . . . 71.24 112.976 -173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -133.63 125.03 27.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.624 -1.625 . . . . 71.41 107.241 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 49.7 t -119.25 120.51 63.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.68 -0.408 . . . . 75.41 110.548 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.73 121.25 23.78 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.283 -1.747 . . . . 72.22 106.283 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.0 p -113.2 138.81 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 C-N-CA 118.858 -1.137 . . . . 73.14 112.206 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.4 -36.68 68.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.969 -1.468 . . . . 74.03 110.471 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.45 -175.13 46.81 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.794 -0.922 . . . . 61.15 110.794 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m 69.88 -65.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.304 1.041 . . . . 62.14 113.561 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 67' ' ' ILE . 45.9 mt -68.81 -8.75 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.677 0.751 . . . . 72.43 110.223 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.06 -29.12 69.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.852 -0.796 . . . . 61.44 108.852 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.36 114.22 58.62 Favored Pre-proline 0 N--CA 1.418 -2.033 0 N-CA-C 107.86 -1.163 . . . . 74.4 107.86 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.47 -28.39 8.64 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 124.808 3.672 . . . . 74.33 115.739 -174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -71.07 -29.78 65.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 72.41 110.955 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 25' ' ' VAL . 63.0 t -76.72 -36.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.4 -0.593 . . . . 62.53 109.4 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' HG23 ' A' ' 26' ' ' ILE . . . -65.99 -33.62 76.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.819 -0.808 . . . . 63.12 108.819 175.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.13 -17.72 61.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.256 -0.884 . . . . 74.21 111.894 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 22' ' ' VAL . 21.4 m -91.54 -25.4 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.191 -1.004 . . . . 74.42 110.831 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.465 HD12 ' CD1' ' A' ' 78' ' ' PHE . 11.2 tt -87.03 -45.3 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 120.054 -0.658 . . . . 64.41 112.123 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.535 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 89.7 mt -89.08 -18.4 27.33 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.996 -0.44 . . . . 64.41 110.434 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.0 t70 71.28 10.8 6.74 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.929 1.347 . . . . 71.13 108.526 -171.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -143.45 145.15 32.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.673 -1.603 . . . . 73.13 106.673 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.7 m -80.23 116.98 20.62 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 120.682 0.277 . . . . 63.25 110.291 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.535 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . . . -95.65 156.46 16.31 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.646 -0.501 . . . . 61.14 109.646 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.26 125.43 44.88 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.977 -0.556 . . . . 73.44 110.317 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -94.45 143.29 26.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.887 -0.783 . . . . 63.2 108.887 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.96 138.7 33.68 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.129 -0.693 . . . . 74.24 109.129 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.82 129.81 37.01 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.322 2.681 . . . . 65.31 113.063 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.52 157.08 42.6 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.467 -0.788 . . . . 70.3 110.218 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.1 126.77 72.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.518 0.675 . . . . 62.54 111.71 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.435 ' HA ' HG11 ' A' ' 93' ' ' VAL . 21.7 tp -89.69 95.35 10.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.339 -0.846 . . . . 74.53 112.188 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -70.33 128.54 36.56 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.058 -0.974 . . . . 75.14 111.568 174.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.28 -19.72 11.61 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 120.291 -0.957 . . . . 74.42 112.34 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 61.5 m-85 -114.79 158.76 21.45 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 113.015 0.746 . . . . 74.23 113.015 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.416 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 3.3 t-160 -128.02 124.4 37.06 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.53 -1.285 . . . . 75.23 107.53 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.416 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 10.6 ptm180 -91.88 144.39 25.53 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.838 -0.43 . . . . 72.13 109.838 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.78 176.54 5.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.949 0.404 . . . . 74.32 111.126 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -91.76 100.28 13.01 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.285 0.564 . . . . 74.41 109.702 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.68 118.61 32.0 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.631 0.729 . . . . 73.15 110.544 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -93.7 -43.96 8.39 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.775 -1.102 . . . . 74.35 108.713 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.14 -25.99 32.38 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.719 -1.128 . . . . 63.22 113.149 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 7.2 mp -92.27 132.71 31.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.415 -0.462 . . . . 65.43 110.868 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 57.4 Cg_endo -85.12 -20.8 3.3 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.466 2.777 . . . . 73.54 112.859 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.518 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 51.9 p90 -139.49 175.85 2.97 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 104.668 -2.345 . . . . 74.02 104.668 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.329 0.0 OUTLIER 31.43 169.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.595 3.55 0 C-N-CA 124.002 3.135 . . . . 71.41 119.795 -162.701 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 24.6 p -131.52 160.85 34.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.563 -1.336 . . . . 73.13 113.069 9.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 22.1 pt -122.92 137.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.92 -1.491 . . . . 73.33 107.863 174.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.36 151.78 34.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 106.141 -1.8 . . . . 54.12 106.141 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m -65.6 140.95 58.57 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.242 1.201 . . . . 65.44 114.242 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m -155.99 102.86 2.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.222 -2.14 . . . . 65.13 105.222 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.23 -31.83 65.91 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.258 0.836 . . . . 65.31 113.258 -172.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -87.52 -0.81 57.36 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.682 0.253 . . . . 72.3 111.682 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.86 168.11 12.96 Favored Glycine 0 C--O 1.238 0.372 0 C-N-CA 120.371 -0.919 . . . . 63.31 113.134 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -150.05 154.68 38.55 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 110.049 -0.352 . . . . 73.42 110.049 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.0 123.4 69.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.801 -0.444 . . . . 74.11 109.801 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -96.63 128.49 43.62 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.791 -0.763 . . . . 74.35 109.512 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.07 -141.03 3.07 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 109.887 -1.285 . . . . 54.33 109.887 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -141.1 150.71 43.23 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.873 -0.788 . . . . 63.31 108.873 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' THR . 28.7 m -104.11 134.16 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.123 -0.49 . . . . 64.33 110.094 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 17' ' ' ILE . 8.8 mt -87.19 115.78 28.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.744 -2.317 . . . . 74.44 104.744 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -109.63 160.49 16.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.838 -0.745 . . . . 75.33 112.421 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.37 41.47 11.57 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 115.806 -0.634 . . . . 43.53 112.702 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.6 t -106.68 122.16 60.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 108.862 -0.792 . . . . 74.21 108.862 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.2 t -79.3 174.23 11.78 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.019 -1.072 . . . . 73.34 109.409 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.45 -25.62 67.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.065 -0.346 . . . . 75.24 110.065 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.72 -53.34 18.93 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.852 -0.613 . . . . 73.03 110.371 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.19 -30.62 69.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.353 0.501 . . . . 73.53 112.353 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 75' ' ' LEU . 3.4 tm? -57.27 -31.69 65.86 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.335 0.588 . . . . 74.42 110.659 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.558 ' O ' HG22 ' A' ' 80' ' ' VAL . 15.0 m120 -60.07 -28.28 67.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.364 -0.835 . . . . 72.14 112.078 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.17 -38.02 69.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.591 -0.892 . . . . 55.14 108.591 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.465 ' CD1' HD12 ' A' ' 26' ' ' ILE . 97.3 m-85 -67.9 -32.7 73.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.616 -0.72 . . . . 74.12 109.338 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.426 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 29.0 t70 -67.93 -30.8 70.21 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.191 -0.913 . . . . 63.2 110.538 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 76' ' ' ASN . 58.2 t -72.83 -22.32 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-O 121.259 0.552 . . . . 73.41 110.864 177.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.4 mm -70.19 -24.42 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.32 0.581 . . . . 75.13 110.803 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -94.85 -171.72 2.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.767 -0.827 . . . . 74.41 108.767 176.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.49 -64.25 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 118.358 -1.877 . . . . 71.1 114.642 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -57.33 -46.25 83.45 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 117.521 0.66 . . . . 64.35 111.99 -173.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 110' ' ' VAL . 17.4 m-20 -154.8 12.38 0.38 Allowed 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.499 0.666 . . . . 70.43 109.222 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -116.06 147.6 41.1 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.641 -1.614 . . . . 75.11 106.641 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' OE2' ' HA ' ' A' ' 110' ' ' VAL . 11.4 pt-20 -133.5 138.72 46.26 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.432 -0.507 . . . . 73.13 111.7 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.409 ' HB2' ' HG2' ' A' ' 82' ' ' GLU . 2.2 tmm_? -88.65 114.01 24.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.771 -0.649 . . . . 75.13 109.502 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.07 160.28 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.492 -0.776 . . . . 64.44 111.54 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 m -90.09 130.01 36.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.229 -0.656 . . . . 60.23 109.229 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.16 172.28 16.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 124.703 1.201 . . . . 75.3 108.043 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -121.07 127.78 51.99 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.875 -1.13 . . . . 73.21 110.032 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' A' ' 38' ' ' LEU . 18.5 m -126.9 166.59 23.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.452 0.644 . . . . 61.24 110.519 -175.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.52 HG23 ' HG2' ' A' ' 101' ' ' LYS . 73.0 t -105.56 113.58 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 107.807 -1.182 . . . . 72.33 107.807 172.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -78.51 89.55 4.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 108.539 -0.911 . . . . 72.52 108.539 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -48.28 -36.83 14.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.285 2.234 . . . . 64.45 112.012 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -45.15 -48.26 12.28 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.239 0.962 . . . . 74.34 111.908 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -108.38 -3.83 17.93 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.308 -0.245 . . . . 73.35 111.219 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 m 66.13 28.65 10.17 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.898 0.879 . . . . 73.14 110.836 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -102.8 161.26 13.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.326 -0.852 . . . . 72.13 109.76 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.52 ' HG2' HG23 ' A' ' 94' ' ' VAL . 48.0 mtmt -98.0 133.85 41.91 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.063 -1.088 . . . . 71.34 108.063 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.22 139.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.439 0.638 . . . . 72.44 110.564 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.23 126.57 35.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.725 -1.213 . . . . 64.31 107.725 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.3 m -137.27 175.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.508 0.323 . . . . 72.44 110.419 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 44.4 mt-10 -105.2 153.28 21.76 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.979 -0.378 . . . . 75.24 109.979 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -156.01 176.79 12.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.694 0.283 . . . . 73.24 110.326 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -105.98 119.36 39.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 73.43 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.3 -178.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 109.165 -0.68 . . . . 72.3 109.165 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.546 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 64.8 t-105 -100.62 137.09 39.48 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.586 -1.264 . . . . 65.04 107.586 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 85' ' ' ASP . 30.6 m -66.8 -20.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 113.636 0.976 . . . . 74.1 113.636 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -90.51 13.96 14.38 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.099 0.952 . . . . 74.12 109.027 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 60.3 pttt -49.62 -17.39 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.712 2.005 . . . . 73.24 115.17 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.08 -22.38 65.84 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.212 0.529 . . . . 74.23 110.439 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -118.0 140.69 28.18 Favored Pre-proline 0 CA--C 1.513 -0.458 0 N-CA-C 109.628 -0.508 . . . . 72.25 109.628 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.86 104.86 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.112 1.875 . . . . 74.31 110.346 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 116' ' ' ARG . 2.8 mmp_? -99.06 142.7 30.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.512 -0.313 . . . . 74.24 110.876 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.698 1.199 . . . . 70.31 109.307 -178.496 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 129' ' ' VAL . 46.9 mt-10 . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 112.389 0.514 . . . . 74.42 112.389 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.465 ' HA ' HG13 ' A' ' 129' ' ' VAL . 72.6 t-105 -59.86 -22.7 62.65 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-O 120.775 0.321 . . . . 73.33 110.254 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.61 -45.82 91.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.116 0.484 . . . . 52.41 110.38 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.41 -43.41 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 113.084 0.772 . . . . 61.43 113.084 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 126' ' ' TRP . 7.7 p -75.38 -18.89 15.94 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.22 0 N-CA-C 111.946 0.351 . . . . 72.24 111.946 -174.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 126' ' ' TRP . 9.4 t60 -48.45 -45.53 36.69 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 122.49 0.316 . . . . 74.14 110.6 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.26 -44.5 75.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.451 -0.34 . . . . 65.42 110.666 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.44 -44.14 97.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 74.4 110.821 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER -61.58 -55.51 30.05 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.556 -0.747 . . . . 74.34 110.74 -177.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.419 ' O ' ' HD1' ' A' ' 138' ' ' PHE . 81.1 m-85 -65.46 -32.66 74.39 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.808 1.41 . . . . 74.01 114.808 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 9.1 p -63.59 -42.19 95.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 118.913 -1.115 . . . . 62.41 109.331 176.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.07 -37.6 69.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.18 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 97.1 m -49.62 -51.41 37.76 Favored 'General case' 0 C--O 1.214 -0.816 0 O-C-N 123.518 0.511 . . . . 73.32 110.407 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.658 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 90.5 m-85 -70.54 -39.34 74.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.434 0.531 . . . . 74.54 112.434 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -63.44 -48.86 76.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.039 -0.264 . . . . 64.21 110.775 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.24 -35.66 80.99 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.876 -0.416 . . . . 72.34 109.876 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 46.9 tpp -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.956 -0.566 . . . . 70.22 109.57 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 80.4 mt -66.49 -41.65 88.63 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.987 -0.375 . . . . 71.31 109.987 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 34.3 mt-10 -65.98 -34.91 79.19 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.529 0.681 . . . . 72.52 110.024 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -75.42 -33.56 60.94 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.52 -0.764 . . . . 73.4 110.315 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -47.12 16.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.729 -0.669 . . . . 75.11 112.365 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.73 -32.25 41.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.456 -0.498 . . . . 74.33 109.724 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 52.3 t30 58.4 84.23 0.21 Allowed Pre-proline 0 C--N 1.315 -0.917 0 C-N-CA 125.221 1.408 . . . . 72.14 114.434 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -93.43 -16.25 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.288 1.992 . . . . 75.25 112.245 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.67 -20.0 22.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.954 0.353 . . . . 74.23 111.954 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.059 0 C-N-CA 120.154 -1.022 . . . . 38.25 111.967 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 C--O 1.248 0.977 0 N-CA-C 114.271 1.211 . . . . 64.44 114.271 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.409 ' C ' HD21 ' A' ' 10' ' ' ASN . 76.5 m80 -107.89 142.35 38.1 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.781 -1.1 . . . . 73.22 109.097 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.409 HD21 ' C ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -124.36 130.95 53.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.876 -1.157 . . . . 75.21 107.876 178.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 27.7 t -124.59 120.32 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 110.172 -0.307 . . . . 74.14 110.172 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.511 ' HB3' HG22 ' A' ' 106' ' ' THR . 41.5 t80 -83.02 117.71 23.01 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.449 -0.945 . . . . 73.13 108.449 174.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.76 150.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.669 -0.696 . . . . 60.32 109.709 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -127.36 -10.08 5.77 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.522 -0.547 . . . . 75.11 109.522 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.07 -128.4 1.08 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 115.348 0.899 . . . . 74.21 115.348 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -62.83 -42.65 99.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.706 1.373 . . . . 72.2 114.706 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.467 HG22 HD11 ' A' ' 67' ' ' ILE . 30.4 mt -60.59 -21.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.427 0.899 . . . . 72.41 113.427 -171.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mp -66.14 -20.58 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.961 0.41 . . . . 61.4 111.117 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.19 116.16 65.73 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 108.509 -0.923 . . . . 74.21 108.509 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -40.11 -38.78 2.23 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 125.096 3.864 . . . . 62.21 115.456 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -57.82 -47.27 83.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.924 0.392 . . . . 73.52 111.065 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.6 t -67.03 -43.56 88.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.723 -0.671 . . . . 62.12 110.48 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . . . -62.59 -37.12 84.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.805 -0.634 . . . . 71.33 109.988 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -72.67 -29.57 63.52 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.81 -0.632 . . . . 64.52 111.867 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 21' ' ' ALA . 23.0 m -81.45 -25.06 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.554 -0.859 . . . . 62.41 111.424 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.465 HD11 ' C ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -82.93 -47.92 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 120.274 -0.571 . . . . 72.21 111.04 178.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 92.2 mt -92.96 -12.69 30.15 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.206 0.447 . . . . 71.23 112.206 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 t70 76.36 -6.57 1.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.37 1.081 . . . . 74.14 109.381 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.7 ptt180 -133.99 163.76 28.82 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 125.646 1.578 . . . . 72.4 106.747 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.8 m -76.72 127.81 33.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.237 -0.653 . . . . 64.31 109.237 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 23' ' ' ALA . . . -75.72 144.93 41.26 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 120.887 0.375 . . . . 65.12 111.489 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.77 108.89 20.9 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.817 -0.809 . . . . 65.1 108.817 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.1 p -111.71 143.7 42.19 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 115.144 -0.934 . . . . 54.03 109.934 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.29 138.89 33.83 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 108.503 -0.925 . . . . 74.1 108.503 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.71 134.76 62.77 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.636 2.224 . . . . 75.23 111.653 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.31 156.21 41.11 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.597 -0.729 . . . . 74.51 109.738 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.42 126.58 75.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.593 0.711 . . . . 75.25 111.58 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.6 tp -93.67 96.19 9.66 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.918 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -71.62 131.78 43.68 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.569 -0.901 . . . . 53.31 108.569 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 116.56 -22.87 10.66 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 117.854 -2.117 . . . . 73.21 113.151 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 156.17 24.47 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 120.939 0.399 . . . . 72.23 111.224 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -127.24 140.51 52.17 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.619 -0.719 . . . . 53.14 109.125 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -85.72 137.21 32.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.601 0.76 . . . . 65.44 109.809 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.33 145.78 49.22 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.858 -1.534 . . . . 72.43 106.858 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 25.1 pttm -90.43 -46.6 8.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.018 0.747 . . . . 64.45 113.018 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.443 ' HG ' HD22 ' A' ' 49' ' ' LEU . 2.7 mm? 60.77 179.99 0.1 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.98 0.912 . . . . 73.0 111.947 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.9 -43.22 0.81 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.372 0.606 . . . . 74.13 109.859 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.27 -13.44 76.73 Favored Glycine 0 N--CA 1.422 -2.234 0 CA-C-N 115.368 -0.833 . . . . 74.1 113.213 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.481 ' CB ' ' HG3' ' A' ' 52' ' ' PRO . 7.1 mp -89.73 163.29 33.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 122.69 -0.3 . . . . 71.25 110.604 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.18 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.881 2.387 . . . . 75.34 114.096 -173.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.86 75.87 75.03 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 122.61 1.195 . . . . 75.33 109.266 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CB ' ' SG ' ' A' ' 53' ' ' CYS 0.301 43.9 Cg_endo -113.2 165.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 125.071 3.847 . . . . 75.53 114.743 -171.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 69.6 m -156.06 175.87 13.4 Favored 'General case' 0 N--CA 1.505 2.288 1 C-N-CA 132.137 4.175 . . . . 73.03 104.82 -18.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 pt -123.94 143.31 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 120.199 -0.6 . . . . 64.04 110.505 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -131.56 146.22 33.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 m -59.49 113.43 2.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.562 0.745 . . . . 75.22 111.34 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -157.54 98.01 1.64 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.751 -1.203 . . . . 53.15 107.751 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.46 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 11.4 m-20 -62.4 -16.87 57.32 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.606 1.336 . . . . 75.24 114.606 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -75.35 -17.77 60.16 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.224 0.535 . . . . 73.32 109.953 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.51 164.1 12.11 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.808 -0.633 . . . . 62.42 112.451 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -143.77 152.09 40.81 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.027 -1.471 . . . . 71.2 107.027 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.2 123.1 71.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.328 -0.619 . . . . 75.44 109.328 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.23 126.67 46.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.369 -0.604 . . . . 61.11 109.369 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.9 -138.42 2.55 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 110.485 -1.046 . . . . 44.44 110.485 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 97.4 mttt -138.49 147.43 43.19 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 117.502 0.651 . . . . 64.43 110.785 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 31.2 m -105.41 133.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.829 -0.623 . . . . 63.33 109.833 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 17' ' ' ILE . 6.4 mt -87.14 110.63 20.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 104.189 -2.523 . . . . 64.32 104.189 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 p -104.42 167.21 9.89 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 116.424 -0.353 . . . . 74.13 111.025 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.07 38.29 95.86 Favored Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.603 0.564 . . . . 72.43 112.935 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.96 122.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.61 -0.885 . . . . 72.34 108.61 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.2 t -72.69 163.34 28.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.151 -0.685 . . . . 64.34 109.151 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.87 -38.42 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.206 -0.294 . . . . 71.15 110.206 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.4 71.84 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.936 0.874 . . . . 64.43 110.221 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.445 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.1 mm-40 -76.46 -38.24 55.71 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.811 -1.086 . . . . 65.03 110.022 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.478 HD23 HH12 ' A' ' 88' ' ' ARG . 3.1 tm? -65.21 -38.37 90.25 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.571 -0.74 . . . . 72.52 109.709 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 80' ' ' VAL . 94.9 m-20 -57.53 -27.58 62.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.026 -0.988 . . . . 64.43 112.725 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -75.38 -30.87 60.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.011 -1.076 . . . . 72.51 109.741 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -67.1 -30.34 70.34 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.698 -0.853 . . . . 74.11 108.698 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.84 -31.63 68.4 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.02 -0.991 . . . . 75.31 110.087 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 76' ' ' ASN . 94.7 t -65.65 -35.25 74.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.649 -0.705 . . . . 75.45 109.626 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -58.62 -54.87 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.162 -0.681 . . . . 73.42 109.162 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 66.86 166.15 0.22 Allowed 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 123.672 0.789 . . . . 72.23 112.642 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.83 20.3 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.654 -0.979 . . . . 37.67 110.654 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.89 -43.51 71.63 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.6 0.593 . . . . 72.13 112.6 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.667 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 15.5 t70 -143.73 34.18 1.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.498 -1.667 . . . . 63.22 106.498 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 55.7 m-85 -115.42 150.38 36.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.013 -1.449 . . . . 75.34 108.468 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.68 158.33 44.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.599 -0.519 . . . . 72.21 109.599 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 106' ' ' THR . 37.4 mtt180 -84.22 124.65 31.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 112.776 0.658 . . . . 75.43 112.776 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.7 150.05 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 CA-C-N 115.298 -0.864 . . . . 71.15 108.722 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.1 m -94.42 122.78 37.34 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.449 -0.945 . . . . 72.24 108.449 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.81 163.12 23.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 106.56 -1.645 . . . . 70.21 106.56 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -115.23 132.05 56.73 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 117.872 -1.531 . . . . 55.15 109.42 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -126.35 169.5 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 109.133 -0.691 . . . . 73.44 109.133 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.494 HG23 ' HG3' ' A' ' 101' ' ' LYS . 58.8 t -106.1 117.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.209 -0.663 . . . . 62.42 109.209 173.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -72.45 90.04 1.29 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.194 -1.41 . . . . 64.24 107.194 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.62 -36.83 57.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.145 1.378 . . . . 54.13 111.714 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -51.41 -27.75 10.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.484 0.714 . . . . 73.25 112.713 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -134.11 9.44 3.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 74.35 109.679 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m 56.76 17.55 3.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.106 0.962 . . . . 72.24 113.489 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -92.58 160.78 14.87 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.618 -0.512 . . . . 61.42 109.618 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 8.3 mptt -100.52 132.68 45.78 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 108.129 -1.063 . . . . 73.43 108.129 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.09 138.48 30.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.249 0.547 . . . . 72.51 110.874 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.39 122.55 32.71 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.417 -0.957 . . . . 63.34 108.417 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 12' ' ' PHE . 23.3 m -131.22 169.39 21.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.628 0.251 . . . . 73.34 111.22 -172.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.94 148.55 26.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.926 -0.398 . . . . 74.02 109.926 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 66.0 p -141.15 173.72 11.21 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 123.197 0.311 . . . . 71.21 111.623 -176.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.4 118.19 36.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.759 -1.571 . . . . 74.21 106.759 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 13.2 p -113.43 159.89 13.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.702 -0.851 . . . . 73.52 108.702 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.667 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 52.1 t-105 -83.14 118.49 23.61 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.844 -1.539 . . . . 71.14 106.844 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.9 m -62.73 -19.64 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.641 0.608 . . . . 63.4 112.641 -174.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 7.9 t30 -85.79 12.14 9.69 Favored 'General case' 0 C--O 1.199 -1.578 0 C-N-CA 123.996 0.918 . . . . 70.03 109.853 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.48 -15.12 0.22 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.798 2.148 . . . . 72.51 116.798 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.24 -14.4 55.57 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.521 -0.472 . . . . 73.03 110.759 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -115.36 124.58 29.91 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 123.727 0.811 . . . . 73.31 109.148 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -90.15 128.5 1.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.588 2.192 . . . . 61.11 113.255 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -131.07 118.01 19.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.887 -0.597 . . . . 72.01 110.176 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 51.6 ttm . . . . . 0 N--CA 1.479 1.017 0 O-C-N 124.238 0.961 . . . . 75.03 111.515 178.39 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.487 ' O ' HG23 ' A' ' 128' ' ' VAL . 11.3 tp10 . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.509 0.671 . . . . 71.24 109.223 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -58.23 -33.44 69.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 72.52 111.52 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -57.51 -36.08 71.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.043 -0.526 . . . . 74.03 112.227 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 125' ' ' GLU . 15.9 m -84.24 -29.96 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 119.96 -0.696 . . . . 74.32 110.534 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.54 -42.36 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.731 -0.668 . . . . 74.42 109.462 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.501 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.8 t60 -54.51 -38.37 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.675 -0.693 . . . . 74.33 110.733 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.51 50.83 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.55 -0.295 . . . . 74.21 111.159 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 40.8 mt-10 -69.47 -30.93 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.482 -0.487 . . . . 65.44 112.117 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -68.39 -50.67 51.33 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.06 -0.718 . . . . 70.35 109.06 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.501 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 69.3 m-85 -67.39 -31.21 71.27 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.473 1.286 . . . . 74.22 114.473 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.94 -42.03 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 119.052 -1.059 . . . . 75.42 111.477 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -70.06 -42.57 72.66 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.882 -0.327 . . . . 73.14 110.859 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.521 ' O ' ' HG3' ' A' ' 141' ' ' MET . 98.5 m -60.92 -42.01 97.3 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.417 -0.356 . . . . 75.32 110.753 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -57.6 -50.11 74.2 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.032 -0.358 . . . . 70.41 110.032 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 88.2 mtt180 -60.59 -46.54 89.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.556 . . . . 74.13 111.028 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.69 -33.03 74.93 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.592 0.59 . . . . 74.43 112.592 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 137' ' ' THR . 91.7 mtp -65.03 -36.27 83.83 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.88 -0.328 . . . . 71.33 110.578 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.4 -35.8 73.68 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 111.716 0.265 . . . . 72.15 111.716 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 23.9 mm-40 -62.86 -45.05 94.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 63.02 109.539 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -71.27 -29.36 64.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.249 -0.887 . . . . 73.2 110.783 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -71.99 -34.43 68.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.305 0.574 . . . . 65.51 109.769 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.97 -32.2 45.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.868 -0.605 . . . . 75.43 110.644 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -149.5 112.64 3.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 116.362 -0.381 . . . . 74.22 110.143 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.4 -23.55 76.99 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.805 2.336 . . . . 73.13 111.789 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -93.51 9.12 37.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.844 -0.616 . . . . 75.33 110.238 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 CA-C-N 115.84 -0.618 . . . . 53.12 112.649 -178.824 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.424 -1.769 0 CA-C-O 121.638 0.732 . . . . 71.32 110.498 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -89.5 153.31 20.9 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.844 -1.071 . . . . 65.13 111.402 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 36.7 m-80 -135.0 122.34 21.71 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.002 -1.851 . . . . 74.24 106.002 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 38.9 t -115.62 122.58 69.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 121.107 -0.237 . . . . 74.32 111.045 -173.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -87.48 108.22 18.92 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.857 -1.164 . . . . 74.41 107.857 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.83 149.18 33.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 120.974 0.416 . . . . 71.13 110.072 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.82 105.07 10.37 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.928 -1.138 . . . . 63.42 107.928 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' H ' ' CD1' ' A' ' 18' ' ' LEU . . . 87.44 -163.17 33.86 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.337 -0.705 . . . . 52.51 111.337 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t 70.0 -62.02 0.44 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.538 1.135 . . . . 75.03 113.785 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.451 HD12 ' C ' ' A' ' 17' ' ' ILE . 2.7 pp -129.84 9.17 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.157 0.799 . . . . 74.33 113.157 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.415 HD23 ' HB2' ' A' ' 65' ' ' LYS . 48.0 mt -64.42 -13.98 54.22 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.291 0.848 . . . . 74.45 113.291 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.56 124.51 83.77 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.112 -1.07 . . . . 70.51 108.112 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.79 -41.64 31.39 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.71 2.94 . . . . 73.21 114.047 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -65.61 -32.71 74.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 52.23 110.806 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.2 -43.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.06 -0.518 . . . . 74.33 110.14 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.68 70.73 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.395 0.616 . . . . 64.14 109.555 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.96 75.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.51 -0.768 . . . . 62.51 111.652 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 21' ' ' ALA . 18.1 m -72.69 -31.46 37.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 120.277 -0.569 . . . . 73.3 112.075 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.617 HD12 ' CD1' ' A' ' 78' ' ' PHE . 7.8 tt -73.57 -36.77 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.925 0.393 . . . . 63.31 111.799 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 74' ' ' GLU . 92.0 mt -100.25 -10.75 21.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 113.767 1.025 . . . . 72.35 113.767 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.3 18.25 10.24 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.972 1.368 . . . . 72.03 108.665 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -160.45 140.74 11.5 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 105.539 -2.023 . . . . 75.5 105.539 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -76.53 118.51 19.27 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.551 -0.86 . . . . 74.41 108.808 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.427 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -93.04 147.98 22.39 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 116.188 -0.46 . . . . 74.45 109.877 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -88.67 114.16 25.0 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.299 -0.864 . . . . 75.2 111.181 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.445 ' HB ' ' HE3' ' A' ' 65' ' ' LYS . 4.2 p -100.79 143.43 30.95 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.533 -0.758 . . . . 71.25 109.527 174.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.52 140.03 37.43 Favored Pre-proline 0 C--N 1.277 -2.552 0 N-CA-C 109.219 -0.66 . . . . 51.22 109.219 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.29 132.14 26.81 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.869 1.713 . . . . 75.51 110.671 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -145.58 156.1 43.47 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.23 -0.895 . . . . 72.11 109.029 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.47 128.24 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 CA-C-O 121.681 0.753 . . . . 74.41 110.979 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.445 ' HA ' HG11 ' A' ' 93' ' ' VAL . 23.1 tp -87.43 108.91 19.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.096 -0.957 . . . . 75.41 109.631 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -83.78 125.48 31.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.912 -1.04 . . . . 74.1 109.053 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 117.34 -13.74 13.65 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 118.277 -1.916 . . . . 52.33 113.611 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.484 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 39.1 m-85 -124.96 159.61 30.82 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 110.034 -0.358 . . . . 74.31 110.034 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 11.3 t-80 -130.16 137.26 50.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 120.014 -0.674 . . . . 75.34 109.679 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 44' ' ' TYR . 3.2 tmm_? -88.9 129.51 35.59 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.157 -1.053 . . . . 64.1 108.157 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.451 ' CE1' HG21 ' A' ' 55' ' ' VAL . 46.9 m-85 -95.5 152.88 18.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.642 -0.708 . . . . 71.23 110.979 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 6.1 tmtm? -84.91 -30.27 24.5 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.766 -0.827 . . . . 75.25 108.766 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.39 -166.26 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.438 0.695 . . . . 73.05 111.03 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.83 -42.93 2.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.335 -0.987 . . . . 73.32 108.335 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.81 -8.67 53.99 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.485 -0.864 . . . . 74.31 113.755 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.83 126.32 29.32 Favored Pre-proline 0 C--N 1.321 -0.648 0 O-C-N 122.521 -0.399 . . . . 71.0 110.475 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -83.49 -44.93 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.94 2.427 . . . . 75.32 112.267 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.9 p90 -113.67 172.11 3.83 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 105.59 -2.004 . . . . 65.33 105.59 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.308 0.0 OUTLIER 30.36 168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.593 3.466 0 C-N-CA 124.376 3.384 . . . . 63.44 118.713 -161.236 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 10.5 p -122.58 -175.29 3.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 119.623 -1.923 . . . . 71.11 112.513 8.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 30.1 pt -123.64 132.34 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.822 -1.081 . . . . 74.22 108.788 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 27.4 m -150.46 116.48 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.191 0 O-C-N 123.203 0.314 . . . . 73.22 111.521 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.6 t 55.91 -158.59 0.23 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.182 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.9 m 71.88 80.2 0.15 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.541 1.536 . . . . 70.23 111.23 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.512 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 p-10 -73.49 -10.26 59.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.613 0.72 . . . . 61.54 110.094 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.9 t -83.85 -6.16 59.36 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.0 -1.0 . . . . 73.34 109.097 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.69 164.74 13.36 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.864 -0.684 . . . . 62.53 112.246 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -142.15 147.17 36.22 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.029 -1.471 . . . . 72.4 107.029 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 41' ' ' TYR . 58.1 t -121.04 122.95 68.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 110.104 -0.332 . . . . 72.23 110.104 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -92.4 118.11 30.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.454 -0.943 . . . . 73.13 108.454 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.21 -152.96 5.74 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.048 -1.221 . . . . 72.4 110.048 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HE3' ' HB ' ' A' ' 33' ' ' THR . 30.3 mtpp -137.4 138.82 40.25 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.315 -0.624 . . . . 73.34 109.315 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.3 m -103.95 133.68 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.766 -0.652 . . . . 54.32 109.602 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 4.5 mt -87.4 119.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 105.292 -2.114 . . . . 71.25 105.292 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.4 p -106.43 160.48 15.36 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.277 -0.969 . . . . 75.13 111.5 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.89 39.84 85.1 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.902 -0.59 . . . . 70.11 112.46 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -103.83 123.57 57.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 N-CA-C 110.26 -0.274 . . . . 74.32 110.26 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.5 t -73.85 162.42 29.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.582 -0.895 . . . . 64.44 108.582 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.48 -39.3 79.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.015 0.436 . . . . 75.23 109.889 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.52 -32.47 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 40.01 109.84 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.518 ' HB3' HD23 ' A' ' 27' ' ' LEU . 52.8 mt-10 -76.98 -40.23 47.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.27 -0.877 . . . . 63.41 111.508 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.441 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.1 tt -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.036 -1.098 . . . . 72.52 108.036 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.583 ' O ' HG22 ' A' ' 80' ' ' VAL . 31.0 t-20 -53.83 -31.55 49.75 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.922 -1.49 . . . . 74.43 110.933 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -31.69 67.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 120.622 -0.431 . . . . 72.25 109.974 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.617 ' CD1' HD12 ' A' ' 26' ' ' ILE . 90.2 m-85 -72.35 -40.36 67.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.598 -0.89 . . . . 64.43 108.598 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.88 -29.42 70.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.571 -1.195 . . . . 70.14 111.98 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 76' ' ' ASN . 95.5 t -52.63 -22.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 124.036 0.934 . . . . 73.14 112.295 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.96 -29.88 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 N-CA-C 109.661 -0.496 . . . . 74.23 109.661 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 55.53 96.74 0.02 OUTLIER 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.663 1.585 . . . . 73.35 113.836 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.14 107.77 3.46 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 108.704 -1.759 . . . . 43.52 108.704 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.98 -35.42 76.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.323 0.562 . . . . 64.11 112.316 -175.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 109' ' ' TRP . 15.1 m-20 -101.59 17.96 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.055 0.455 . . . . 73.41 110.453 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -115.19 141.98 47.29 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.89 -0.411 . . . . 74.02 109.89 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -131.67 143.84 50.58 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.759 -0.83 . . . . 64.34 108.759 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 106' ' ' THR . 55.4 mtm180 -82.92 113.1 20.29 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.591 -0.444 . . . . 44.15 112.169 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.5 m -116.34 153.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.399 -0.819 . . . . 71.34 110.322 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.2 m -90.46 123.44 34.17 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.853 -0.795 . . . . 72.55 108.853 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.34 171.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.548 -1.278 . . . . 62.3 107.548 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -125.23 123.56 39.8 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.948 -1.501 . . . . 72.44 106.948 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 38' ' ' LEU . 13.7 m -126.81 163.07 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 121.504 0.669 . . . . 73.3 109.976 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.465 HG23 ' HG2' ' A' ' 101' ' ' LYS . 53.7 t -107.69 118.42 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.73 -0.668 . . . . 53.5 109.904 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.04 98.83 0.46 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.965 -1.494 . . . . 64.11 106.965 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.499 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -60.48 -36.27 77.89 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 125.03 1.332 . . . . 73.01 110.283 -170.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.7 -41.85 70.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.573 -0.74 . . . . 73.23 112.212 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.14 -1.55 12.97 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.415 0.626 . . . . 73.52 110.952 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 t 64.42 23.12 12.9 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.993 0.917 . . . . 72.31 111.451 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -96.59 161.39 13.92 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.88 -0.415 . . . . 73.31 109.88 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' HG2' HG23 ' A' ' 94' ' ' VAL . 48.0 mtpt -105.03 130.84 53.14 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.718 -0.475 . . . . 74.14 109.718 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.42 130.92 54.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.722 0.772 . . . . 65.22 111.277 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -87.52 120.29 28.67 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.022 -1.473 . . . . 71.13 107.022 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 10' ' ' ASN . 27.2 m -133.83 172.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.755 0.312 . . . . 60.2 111.17 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.4 152.57 23.43 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.774 -0.454 . . . . 64.53 109.774 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.0 t -151.91 174.64 13.36 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.658 -0.867 . . . . 61.05 108.658 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.1 118.42 36.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.204 -1.036 . . . . 73.31 108.204 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.42 153.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.836 -0.801 . . . . 71.23 108.836 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.593 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 63.7 t-105 -81.9 121.4 26.43 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.395 -1.335 . . . . 72.32 107.395 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.76 -20.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.402 0.89 . . . . 72.43 113.402 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.566 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 28.5 t-20 -80.57 11.35 3.81 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-O 121.702 0.763 . . . . 73.35 109.962 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -50.7 -25.67 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.918 1.287 . . . . 74.03 114.064 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.19 -6.78 57.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.081 0.467 . . . . 75.22 111.669 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.624 ' OD1' ' HB2' ' A' ' 116' ' ' ARG . 12.6 t70 -102.23 128.38 28.55 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 106.062 -1.829 . . . . 70.43 106.062 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.31 46.06 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.229 2.62 . . . . 70.22 111.978 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.624 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 14.2 ttm180 -95.29 115.39 27.37 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.246 -0.888 . . . . 73.33 111.872 -172.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 125.069 1.348 . . . . 74.23 114.546 175.685 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.223 -0.306 0 N-CA-C 109.162 -0.681 . . . . 71.42 109.162 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -56.09 -41.95 75.98 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.781 -0.645 . . . . 73.25 110.976 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -60.27 -41.26 92.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.725 -0.67 . . . . 74.3 111.224 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -82.95 -41.63 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.638 -0.425 . . . . 73.32 111.916 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.0 p -68.82 -40.11 80.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 112.767 0.654 . . . . 74.34 112.767 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -65.17 -35.25 80.49 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 118.882 -1.127 . . . . 74.4 110.645 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -64.3 -55.1 23.63 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.434 0.459 . . . . 62.43 111.03 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -23.42 64.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.168 0.433 . . . . 65.44 112.168 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.507 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.4 tpmt? -67.24 -45.3 77.13 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.78 -0.822 . . . . 73.33 108.78 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -67.47 -33.18 74.6 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.836 -0.345 . . . . 73.02 111.276 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.593 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 98.1 t -53.68 -53.19 27.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.11 -0.7 . . . . 73.02 109.11 173.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.95 -42.42 89.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.671 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.7 m -54.96 -50.51 68.74 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.775 0.672 . . . . 71.34 110.463 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -68.35 -29.85 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.162 0.43 . . . . 75.21 112.162 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -68.23 -44.73 75.08 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.463 0.649 . . . . 75.3 109.729 177.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -71.23 -42.09 69.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 75.44 110.378 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.49 ' HA ' ' HE1' ' A' ' 141' ' ' MET . 3.2 mmt -62.53 -31.45 72.22 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-N 116.344 -0.389 . . . . 74.31 110.844 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.46 -50.05 74.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.58 0.752 . . . . 73.43 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.44 -34.37 75.85 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.165 -0.614 . . . . 72.4 111.631 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -75.18 -27.18 59.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.183 0.516 . . . . 73.3 112.035 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -72.88 -37.3 67.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.483 0.713 . . . . 75.32 109.318 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 146' ' ' LYS . 11.3 tmtt? -78.95 -33.0 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.315 -0.624 . . . . 74.22 109.315 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -137.9 95.05 11.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 120.927 0.394 . . . . 73.23 110.628 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.03 -16.61 9.83 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.615 2.21 . . . . 75.05 111.175 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.22 -23.26 61.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.369 -0.832 . . . . 75.04 111.292 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.609 0 C-N-CA 120.454 -0.879 . . . . 65.52 112.506 -179.723 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 106.571 -1.64 . . . . 74.32 106.571 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.519 ' HD1' ' HG ' ' A' ' 75' ' ' LEU . 8.4 m170 -104.23 156.0 18.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.049 -0.523 . . . . 74.13 110.581 -172.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.456 ' HB2' HG13 ' A' ' 104' ' ' VAL . 25.2 m-80 -134.93 133.42 39.55 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.466 -1.679 . . . . 71.43 106.466 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.79 121.02 66.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.563 -0.455 . . . . 72.2 111.213 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.423 ' HB2' HG22 ' A' ' 104' ' ' VAL . 59.3 t80 -89.75 98.83 11.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.302 -0.629 . . . . 75.34 109.302 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.48 129.98 31.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.832 -0.803 . . . . 63.23 108.832 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.544 ' CD1' ' HA2' ' A' ' 64' ' ' GLY . 48.2 t80 -105.89 86.17 2.34 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.544 -0.863 . . . . 65.42 110.127 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.76 147.18 4.48 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.652 -1.158 . . . . 75.44 112.367 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t 70.67 -69.34 0.18 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.489 1.515 . . . . 73.41 113.718 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 67' ' ' ILE . 28.3 mt -75.96 3.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.027 0.918 . . . . 73.43 110.407 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -67.99 -23.04 64.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.568 -0.742 . . . . 74.45 109.159 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.63 119.94 74.52 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 108.565 -0.902 . . . . 71.21 108.565 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -48.55 -35.96 30.41 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.67 2.913 . . . . 75.14 112.54 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.441 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -60.37 -40.29 90.27 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.455 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 25' ' ' VAL . 70.9 t -70.46 -39.71 76.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.356 0.598 . . . . 74.3 110.056 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' HG23 ' A' ' 26' ' ' ILE . . . -66.43 -35.32 80.01 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.378 -0.601 . . . . 73.01 109.378 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.646 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -74.28 -10.14 59.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 72.34 112.038 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 21' ' ' ALA . 21.1 m -100.04 -31.68 3.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.346 -0.942 . . . . 72.33 110.513 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.544 HD12 ' CD2' ' A' ' 78' ' ' PHE . 9.9 tt -79.08 -42.96 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.153 0.501 . . . . 75.11 111.582 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.97 -21.38 18.65 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.156 -0.34 . . . . 74.24 110.319 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.646 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 28.2 t70 67.59 15.98 9.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 123.598 1.666 . . . . 74.55 107.723 -170.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -133.31 131.56 40.3 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.457 -2.053 . . . . 74.33 105.457 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -76.74 111.43 12.24 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.996 -1.082 . . . . 70.4 109.196 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.87 143.09 28.09 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.647 -0.706 . . . . 72.35 109.264 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.78 129.06 45.86 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.852 -0.796 . . . . 74.21 108.852 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.7 p -93.34 141.83 28.0 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 119.487 -0.885 . . . . 74.04 108.878 175.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.72 140.02 34.62 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.703 -0.851 . . . . 71.34 108.703 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.73 128.94 28.64 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.778 2.319 . . . . 64.13 111.969 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.24 154.45 37.95 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.902 -0.59 . . . . 38.3 109.518 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.85 131.92 71.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 C-N-CA 120.752 -0.379 . . . . 74.13 110.384 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HA ' HG11 ' A' ' 93' ' ' VAL . 20.9 tp -94.32 129.98 40.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.022 -0.535 . . . . 75.03 110.531 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -94.59 129.97 41.22 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.446 -0.343 . . . . 63.54 111.232 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 58' ' ' ASP . . . 105.4 -1.43 40.01 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 119.52 -1.324 . . . . 74.1 113.771 173.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 56.9 m-85 -126.59 160.76 29.73 Favored 'General case' 0 N--CA 1.414 -2.252 0 O-C-N 122.313 -0.522 . . . . 72.04 112.074 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -134.17 130.97 38.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.387 -1.338 . . . . 74.03 107.387 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.83 124.98 34.7 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.06 0.457 . . . . 74.1 111.208 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HE2' ' O ' ' A' ' 55' ' ' VAL . 93.6 m-85 -106.67 145.17 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.897 -1.149 . . . . 73.14 107.897 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 4.3 mmmp? -109.92 125.02 52.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 112.355 0.502 . . . . 73.43 112.355 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -131.83 141.67 49.49 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.189 -1.041 . . . . 71.34 108.189 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -90.65 -30.04 17.38 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.818 -0.808 . . . . 52.34 108.818 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -31.76 76.98 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.806 -1.088 . . . . 71.43 112.222 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.98 158.45 41.76 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 108.407 -0.96 . . . . 63.5 108.407 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.94 -76.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.849 2.366 . . . . 71.01 114.216 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.62 76.26 69.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.964 -1.124 . . . . 75.24 107.964 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.576 ' HA ' ' SG ' ' A' ' 53' ' ' CYS 0.257 51.9 Cg_endo -115.52 162.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 123.432 2.754 . . . . 72.31 116.19 -171.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 52' ' ' PRO . 1.7 m -158.01 158.21 34.43 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.205 3.402 . . . . 71.54 107.152 -19.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 108' ' ' VAL . 33.2 pt -124.09 128.33 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.638 -0.825 . . . . 72.33 111.888 174.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 24.2 m -154.58 145.75 13.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 124.342 1.057 . . . . 74.3 108.458 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 p 168.14 -57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.194 0.934 . . . . 72.04 110.671 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 m 69.8 13.6 8.06 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.363 1.078 . . . . 74.34 108.337 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.655 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 26.6 t70 -83.28 -178.05 6.95 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 113.938 -1.483 . . . . 71.24 109.715 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.0 m -80.42 -6.88 58.77 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.684 0.278 . . . . 70.44 110.889 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.42 156.17 31.1 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.887 -0.597 . . . . 74.03 111.971 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -129.03 152.91 48.12 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.895 -0.409 . . . . 71.3 109.895 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 122.53 67.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.295 -1.002 . . . . 72.33 108.295 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -97.77 115.64 28.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.426 -0.583 . . . . 73.14 109.426 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.544 ' HA2' ' CD1' ' A' ' 14' ' ' TYR . . . -146.44 -147.4 4.57 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.953 -0.641 . . . . 75.24 111.993 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 47.9 mtpt -139.68 146.21 39.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.213 -1.032 . . . . 71.31 108.213 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' THR . 35.2 m -104.72 135.14 43.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.165 -0.471 . . . . 64.54 110.883 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 17' ' ' ILE . 6.4 mt -86.27 111.8 21.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.762 -2.31 . . . . 74.1 104.762 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -99.44 161.64 13.5 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.495 -0.482 . . . . 71.21 111.694 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.41 35.32 37.6 Favored Glycine 0 C--O 1.245 0.789 0 CA-C-N 115.752 -0.658 . . . . 64.2 112.927 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t -97.37 124.82 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.02 -0.734 . . . . 63.44 109.02 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.0 m -77.95 157.92 29.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.553 -0.906 . . . . 74.41 108.553 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.502 ' HA ' ' CE1' ' A' ' 9' ' ' HIS . 7.3 p-10 -56.45 -42.74 78.64 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.211 0.529 . . . . 72.41 112.191 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.47 70.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.017 -0.992 . . . . 71.33 110.801 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.58 -30.02 62.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.516 -0.766 . . . . 60.3 110.793 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.519 ' HG ' ' HD1' ' A' ' 9' ' ' HIS . 3.0 tm? -58.21 -35.08 71.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.278 -0.873 . . . . 72.04 109.369 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.564 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -59.46 -27.53 66.17 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.357 -0.838 . . . . 63.12 111.919 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.481 ' OD1' HG13 ' A' ' 26' ' ' ILE . 1.9 t-20 -68.08 -31.61 71.35 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.219 -0.659 . . . . 74.25 109.219 -176.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.544 ' CD2' HD12 ' A' ' 26' ' ' ILE . 80.1 m-85 -74.46 -32.28 62.54 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 121.68 0.752 . . . . 75.22 109.007 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.83 -31.26 63.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.159 -0.928 . . . . 63.23 110.241 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 76' ' ' ASN . 98.1 t -66.65 -22.67 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 115.64 -0.709 . . . . 70.34 110.848 175.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.8 mm -58.96 143.22 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.915 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.41 113.71 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.742 1.617 . . . . 72.23 113.266 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.77 85.35 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.561 -0.828 . . . . 42.3 113.266 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -82.55 -33.17 28.22 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.632 -0.334 . . . . 65.14 111.576 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.542 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.5 m-20 -97.75 2.43 49.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.609 0.966 . . . . 74.45 113.609 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.326 1.6 p90 -122.18 142.31 50.55 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.14 -1.024 . . . . 75.12 111.114 171.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -125.03 159.45 31.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.159 -170.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -88.85 128.62 35.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.805 -0.443 . . . . 71.24 109.805 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.35 159.78 40.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 122.634 0.374 . . . . 75.43 110.504 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.7 m -93.67 129.43 39.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.986 -0.746 . . . . 71.31 108.986 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.48 157.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.918 -1.141 . . . . 72.54 107.918 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.482 ' HG3' ' CD ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -105.18 135.65 46.15 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.276 -0.97 . . . . 54.01 108.762 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.423 HG11 ' HA ' ' A' ' 38' ' ' LEU . 21.8 m -127.36 161.94 33.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.704 -0.85 . . . . 71.4 108.704 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.452 HG23 ' HG2' ' A' ' 101' ' ' LYS . 71.6 t -102.44 120.1 51.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 109.005 -0.739 . . . . 65.41 109.005 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -71.91 93.12 1.31 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.476 -1.676 . . . . 75.41 106.476 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -47.84 -49.54 28.91 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 127.262 2.225 . . . . 72.13 115.049 -167.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.88 -23.12 58.34 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.166 -0.614 . . . . 65.22 111.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -97.83 -10.89 23.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.3 -0.409 . . . . 62.34 110.864 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 m 59.26 19.49 7.61 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.464 1.106 . . . . 73.45 112.336 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -105.19 160.78 14.81 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.938 -0.393 . . . . 75.3 109.938 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.452 ' HG2' HG23 ' A' ' 94' ' ' VAL . 44.3 mtmt -100.31 143.21 30.76 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.618 -0.882 . . . . 73.21 108.618 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.75 162.23 15.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.301 -0.629 . . . . 63.12 109.301 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' CD ' ' HG3' ' A' ' 92' ' ' GLU . 3.6 tppp? -110.69 123.83 50.78 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.101 -1.074 . . . . 74.44 108.101 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 10' ' ' ASN . 21.2 m -130.97 174.37 13.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.837 0.351 . . . . 73.42 110.564 -174.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -112.11 146.91 37.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.077 -0.712 . . . . 74.33 109.077 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.4 t -149.26 174.03 12.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.085 -1.08 . . . . 75.42 108.085 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -113.43 119.55 38.0 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.61 0.719 . . . . 73.31 110.542 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 54' ' ' ILE . 14.0 p -114.0 143.79 22.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.975 -1.011 . . . . 73.31 109.747 -175.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.672 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 61.0 t-105 -70.01 127.86 34.31 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.57 -0.9 . . . . 75.41 108.57 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 85' ' ' ASP . 31.6 m -72.02 -19.82 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.519 0.676 . . . . 72.14 112.559 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.672 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -86.83 15.64 5.62 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 125.216 1.406 . . . . 71.31 109.29 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 0.8 OUTLIER -48.27 -22.96 0.76 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.23 1.812 . . . . 72.43 113.85 -176.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -101.71 68.51 1.16 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.551 -0.859 . . . . 73.32 110.984 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -128.56 144.38 51.93 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 114.798 -1.092 . . . . 74.14 108.331 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.35 -33.2 84.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 53.44 113.642 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.541 ' O ' ' HD2' ' A' ' 116' ' ' ARG 0.265 0.0 OUTLIER -133.26 114.22 13.53 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.112 1.153 . . . . 64.13 114.112 -178.463 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.441 ' HE2' ' HA ' ' A' ' 117' ' ' MET . 1.7 mmt . . . . . 0 CA--C 1.495 -1.146 0 CA-C-N 115.83 -0.623 . . . . 71.21 110.342 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 108.571 -0.9 . . . . 74.11 108.571 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -86.96 -23.84 24.94 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.467 -0.788 . . . . 74.31 109.546 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -59.49 -45.7 90.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 62.24 110.391 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.6 m -64.18 -19.75 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 116.362 -0.381 . . . . 75.42 111.956 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.3 -22.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.13 0.491 . . . . 63.21 110.552 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.474 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 5.2 p-80 -115.79 -33.12 5.25 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.695 -0.802 . . . . 74.33 112.952 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.544 ' O ' HG21 ' A' ' 135' ' ' VAL . . . -59.4 -55.73 31.0 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.811 0.671 . . . . 71.4 112.811 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.49 -34.07 77.37 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.694 -0.402 . . . . 74.43 111.855 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.473 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 1.1 tmtp? -61.55 -50.31 73.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.107 -0.701 . . . . 73.14 109.107 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 84.3 m-85 -69.37 -31.99 70.74 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.052 0.39 . . . . 73.11 112.052 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 131' ' ' ALA . 97.7 t -60.01 -38.66 77.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.061 -0.348 . . . . 70.04 110.061 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -57.39 -48.13 79.87 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.698 -0.482 . . . . 71.54 109.698 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 141' ' ' MET . 34.8 m -57.51 -46.67 83.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.335 -0.848 . . . . 75.4 110.412 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.401 ' O ' HD21 ' A' ' 142' ' ' LEU . 74.1 m-85 -61.47 -48.51 80.79 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.809 -0.356 . . . . 73.05 111.569 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -54.61 -47.51 73.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.703 0.287 . . . . 64.12 110.822 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -66.9 -42.96 84.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.684 -0.689 . . . . 72.22 111.909 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 137' ' ' THR . 60.5 mtm -66.52 -42.95 86.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.718 -0.393 . . . . 73.45 111.248 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.555 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 4.6 mm? -59.22 -49.96 75.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.246 0.832 . . . . 72.3 113.246 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.29 0.567 . . . . 75.22 111.698 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -75.91 -36.57 59.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.171 -0.922 . . . . 75.15 110.836 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -83.42 -35.57 24.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.299 0.851 . . . . 75.41 113.299 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -79.62 -7.24 58.41 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.863 -0.735 . . . . 73.43 112.308 -177.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -143.29 86.41 9.05 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-O 121.027 0.441 . . . . 75.01 111.398 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.4 -22.75 28.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.864 2.376 . . . . 74.33 110.496 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -76.84 -12.65 60.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.529 -0.76 . . . . 74.22 109.985 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.529 0 CA-C-N 115.387 -0.824 . . . . 71.43 111.181 178.104 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 108.722 -0.844 . . . . 61.24 108.722 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -91.6 148.52 22.22 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.455 -0.793 . . . . 75.32 109.508 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 83.1 m-20 -129.06 122.72 30.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.949 -1.13 . . . . 73.33 107.949 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 29.3 t -117.72 120.36 64.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.554 -0.459 . . . . 75.34 111.422 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -83.78 110.83 18.65 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.465 -1.309 . . . . 70.13 107.465 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.444 HG12 HD13 ' A' ' 17' ' ' ILE . 7.9 p -136.17 158.07 38.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.244 -0.582 . . . . 70.03 110.066 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.88 22.02 6.83 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-O 121.074 0.464 . . . . 72.22 110.988 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 51' ' ' TYR . . . -136.29 -133.7 3.23 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 118.128 -1.987 . . . . 61.02 117.072 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.6 m -40.46 -47.68 2.65 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.821 2.156 . . . . 71.22 116.821 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD13 HG12 ' A' ' 13' ' ' VAL . 2.4 pp -84.71 1.48 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 114.583 1.327 . . . . 74.42 114.583 -171.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.8 mp -68.54 -11.2 59.59 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.511 0.56 . . . . 73.22 112.511 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.9 119.05 75.45 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 107.121 -1.437 . . . . 52.41 107.121 170.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -47.52 -37.29 25.96 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.751 2.967 . . . . 74.34 114.036 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.98 -35.03 79.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.407 -0.361 . . . . 71.24 111.293 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 25' ' ' VAL . 45.3 t -76.92 -40.59 31.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.252 -0.431 . . . . 71.05 110.219 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.84 -33.81 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.676 . . . . 71.4 109.602 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.61 -11.33 59.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.452 -0.794 . . . . 75.11 112.46 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.5 m -102.12 -26.86 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.869 -0.732 . . . . 74.34 110.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.485 HD12 ' CD1' ' A' ' 78' ' ' PHE . 9.5 tt -77.05 -36.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.344 0.592 . . . . 75.02 110.607 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 31' ' ' ALA . 90.1 mt -95.93 -14.7 22.89 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.045 -0.525 . . . . 71.53 110.242 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 68.44 -1.22 1.96 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.461 1.124 . . . . 74.04 109.927 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 94.8 mtt180 -133.53 176.85 8.17 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.466 -1.679 . . . . 75.01 106.466 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -77.01 144.09 38.92 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.078 0.466 . . . . 74.23 111.251 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -116.27 134.97 54.31 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 109.046 -0.724 . . . . 72.34 109.046 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -99.42 109.71 22.27 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.903 -1.519 . . . . 74.24 109.174 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 3.0 p -105.93 142.12 36.18 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 120.272 -0.571 . . . . 75.44 109.933 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.15 137.64 31.43 Favored Pre-proline 0 C--N 1.284 -2.27 0 N-CA-C 108.766 -0.827 . . . . 73.42 108.766 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 96' ' ' MET . 6.4 Cg_endo -57.47 117.72 4.47 Favored 'Trans proline' 0 CA--C 1.504 -0.99 0 C-N-CA 122.254 1.969 . . . . 73.21 109.719 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.86 155.2 50.68 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.972 -0.751 . . . . 73.43 108.972 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.476 ' CG2' ' HE2' ' A' ' 61' ' ' LYS . 12.6 p -125.86 127.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.745 0.783 . . . . 71.24 111.695 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.448 ' HA ' HG11 ' A' ' 93' ' ' VAL . 20.8 tp -87.59 96.29 10.36 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.017 -0.992 . . . . 74.21 112.398 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -72.56 126.35 29.65 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.36 -0.836 . . . . 62.33 110.263 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.84 -7.84 17.05 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 119.635 -1.269 . . . . 70.53 113.14 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.496 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 33.8 m-85 -126.7 145.11 50.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 112.642 0.608 . . . . 74.32 112.642 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 22.3 t-160 -105.34 127.09 52.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.363 -0.835 . . . . 75.45 108.765 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -87.93 137.59 32.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.162 -0.681 . . . . 71.33 109.162 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -98.81 177.93 5.12 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 115.85 -0.614 . . . . 74.45 109.918 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 -28.59 6.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 114.005 1.113 . . . . 55.11 114.005 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 52' ' ' PRO . 4.1 mm? 57.88 -169.92 0.11 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.503 0.502 . . . . 71.21 111.576 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 23.29 5.19 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.731 -0.788 . . . . 64.14 112.886 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.64 7.18 0.08 OUTLIER Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.284 -0.96 . . . . 70.13 113.112 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.77 161.11 36.92 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 117.163 0.482 . . . . 71.43 110.413 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 2.7 Cg_exo -74.41 96.18 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.114 2.543 . . . . 72.23 114.598 -175.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.613 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.6 p90 44.2 35.11 0.2 Allowed Pre-proline 0 N--CA 1.515 2.815 0 N-CA-C 116.52 2.045 . . . . 72.42 116.52 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.891 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 72.6 Cg_endo -108.5 166.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.274 2.65 . . . . 74.13 113.516 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.891 ' SG ' ' HB2' ' A' ' 52' ' ' PRO . 33.5 m -134.29 -179.25 5.46 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 103.94 -2.615 . . . . 64.2 103.94 -4.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 40.2 pt -123.99 121.03 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 119.609 1.095 . . . . 75.4 112.179 174.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -154.12 133.04 3.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.743 -0.662 . . . . 73.35 111.454 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t 64.72 -175.99 0.17 Allowed 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.504 1.122 . . . . 75.52 113.426 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 42' ' ' HIS . 20.6 t 78.67 112.52 0.07 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.59 1.956 . . . . 72.24 112.932 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.17 -27.16 32.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.432 0.635 . . . . 75.34 109.944 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.5 m -82.97 -9.2 59.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.771 -0.649 . . . . 72.43 110.421 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.26 153.65 21.48 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.742 -0.663 . . . . 61.34 112.354 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.476 ' HE2' ' CG2' ' A' ' 37' ' ' VAL . 21.0 ptmt -154.17 145.7 23.18 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.293 -1.003 . . . . 55.31 108.293 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 HG23 ' CG2' ' A' ' 54' ' ' ILE . 62.1 t -114.27 123.76 70.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 112.044 0.387 . . . . 64.45 112.044 -173.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -88.1 120.6 29.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.536 -0.302 . . . . 74.24 110.242 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.34 -147.23 4.57 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.7 143.58 39.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.465 0.633 . . . . 74.15 110.121 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.68 133.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 109.336 -0.616 . . . . 75.31 109.336 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 4.6 mt -89.47 117.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 106.445 -1.687 . . . . 74.34 106.445 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -104.1 160.42 14.86 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.022 -1.071 . . . . 62.12 109.225 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.57 30.0 41.79 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.224 -0.988 . . . . 53.24 113.656 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.55 124.29 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.29 0.545 . . . . 75.03 110.013 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.478 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.9 m -75.48 158.29 32.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.791 -0.818 . . . . 70.34 108.791 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.17 -39.79 79.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.071 0.397 . . . . 74.02 112.071 -175.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.84 64.73 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.09 0.471 . . . . 51.2 110.732 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 50.7 mm-40 -73.64 -30.94 63.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.568 -0.742 . . . . 74.21 110.34 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.78 -37.05 73.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.178 0.991 . . . . 75.1 111.32 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 39.1 m-80 -57.37 -27.58 62.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.309 0.644 . . . . 74.02 111.657 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -69.08 -31.7 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.241 -0.652 . . . . 62.41 109.241 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.485 ' CD1' HD12 ' A' ' 26' ' ' ILE . 95.8 m-85 -70.97 -29.25 65.19 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 120.415 -0.514 . . . . 74.41 109.764 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 3.1 m-20 -60.96 -41.19 95.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.586 0.708 . . . . 74.25 109.439 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.24 -34.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.012 -0.995 . . . . 74.35 110.394 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -62.01 -50.75 78.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.233 -0.44 . . . . 64.11 111.152 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.06 141.83 12.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 120.933 0.397 . . . . 73.05 110.665 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.68 28.71 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.277 -0.874 . . . . 75.01 111.191 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -76.42 -43.06 41.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 120.187 -0.605 . . . . 51.41 110.551 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.483 ' O ' HG22 ' A' ' 110' ' ' VAL . 8.1 m-20 -125.93 13.15 7.89 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.091 0.948 . . . . 61.25 108.534 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -115.9 149.44 38.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.334 -1.358 . . . . 72.3 107.334 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 16.4 pt-20 -130.76 155.88 45.91 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.586 0.232 . . . . 74.1 110.531 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 106' ' ' THR . 45.5 ttm180 -91.1 126.66 36.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.865 0.364 . . . . 71.24 111.511 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.16 159.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.444 -0.947 . . . . 71.4 108.444 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 m -96.17 123.01 39.63 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.223 -0.658 . . . . 61.11 109.223 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 38' ' ' LEU . 26.8 m -125.96 157.76 35.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 123.826 0.85 . . . . 71.11 109.727 -175.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 29.3 tt0 -105.24 125.18 50.69 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.207 -0.597 . . . . 61.4 109.52 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 38' ' ' LEU . 15.1 m -126.13 168.41 19.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.964 -0.754 . . . . 63.33 108.964 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.44 HG13 ' H ' ' A' ' 96' ' ' MET . 68.6 t -104.25 128.12 57.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.341 -0.985 . . . . 73.51 108.341 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -68.53 -15.44 63.54 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.951 0.782 . . . . 73.43 110.215 -174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 0.6 OUTLIER 70.61 -54.86 0.64 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.131 1.773 . . . . 73.12 113.882 172.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -48.63 -45.65 38.7 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 70.43 111.432 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.87 9.95 16.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 123.345 0.658 . . . . 64.24 110.508 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.7 m 62.83 10.06 4.05 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.81 1.041 . . . . 74.54 113.81 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 161.11 21.85 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.569 -0.452 . . . . 44.0 110.361 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -101.91 134.05 45.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.654 -0.869 . . . . 74.11 108.654 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.01 139.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.727 -0.842 . . . . 71.32 108.727 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 92' ' ' GLU . 28.3 ttpt -107.48 116.65 32.33 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.865 0.84 . . . . 74.25 110.597 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.21 177.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.0 -1.454 . . . . 73.31 110.696 -168.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.32 144.09 28.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.804 -0.443 . . . . 71.22 109.804 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 10.5 t -144.72 175.22 10.33 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.233 -0.654 . . . . 74.32 109.233 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 78.3 m-85 -110.43 119.48 39.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.273 0.358 . . . . 74.14 110.272 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 54' ' ' ILE . 34.8 m -109.84 -173.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.918 -0.771 . . . . 60.44 108.918 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.502 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 61.1 t-105 -99.13 122.71 42.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.018 -0.734 . . . . 75.13 109.018 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 85' ' ' ASP . 26.8 m -65.61 -35.89 76.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 CA-C-O 121.363 0.601 . . . . 74.44 111.401 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.491 ' ND2' ' HB3' ' A' ' 114' ' ' ASP . 5.0 t30 -88.18 15.75 7.12 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.979 1.312 . . . . 71.22 109.506 -173.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.7 ptpp? -47.43 -14.87 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 126.859 2.064 . . . . 72.35 115.048 -171.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -90.4 6.8 41.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.828 0.347 . . . . 72.23 111.825 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.491 ' HB3' ' ND2' ' A' ' 111' ' ' ASN . 3.1 p30 -85.65 160.07 54.04 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.911 -1.144 . . . . 75.1 107.911 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.18 99.47 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.053 1.836 . . . . 63.21 110.827 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.556 ' HD3' ' H ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.65 -0.704 . . . . 74.03 111.366 -176.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 C--N 1.304 -1.378 0 CA-C-N 114.486 -1.234 . . . . 74.42 111.707 -174.738 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 128' ' ' VAL . 8.5 tp10 . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 107.128 -1.434 . . . . 64.03 107.128 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -57.74 -28.67 64.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.902 -1.045 . . . . 74.45 111.364 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -57.74 -49.08 77.77 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.234 0.457 . . . . 73.31 112.234 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 125' ' ' GLU . 18.8 m -72.24 -27.68 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.329 -0.548 . . . . 73.52 110.232 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 125' ' ' GLU . 88.6 t -68.44 -28.29 39.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.246 -0.888 . . . . 64.4 110.954 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -99.4 -28.58 13.21 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.869 -1.132 . . . . 73.23 110.843 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.54 82.45 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.786 -0.643 . . . . 71.42 112.3 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.646 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.47 -24.0 66.35 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 113.132 0.79 . . . . 62.42 113.132 -177.06 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.543 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 6.4 tmtt? -76.22 -55.78 5.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 109.604 -0.517 . . . . 64.12 109.604 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -63.86 -32.11 73.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.836 0.68 . . . . 65.43 112.836 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.61 -37.3 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 119.813 -0.755 . . . . 74.43 110.228 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 7.3 mm-40 -62.87 -39.72 95.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.849 -0.426 . . . . 71.32 109.849 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.505 -0.77 . . . . 74.33 110.7 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.403 ' HA ' ' HG2' ' A' ' 141' ' ' MET . 19.1 m-85 -67.72 -36.67 81.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.685 -0.487 . . . . 74.43 109.685 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -64.53 -51.59 62.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.973 -0.558 . . . . 73.4 110.929 176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -63.54 -34.54 78.01 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 112.672 0.619 . . . . 73.04 112.672 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 24.1 ptm -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.521 -0.872 . . . . 73.2 109.717 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 tp -77.36 -50.12 13.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 74.35 111.248 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.25 0.0 OUTLIER -68.47 -24.61 64.72 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.266 0.469 . . . . 62.54 112.266 -178.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -75.41 -43.81 47.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.81 -0.632 . . . . 74.43 110.817 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -69.05 -35.1 76.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.522 0.677 . . . . 74.33 110.01 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 41.1 ttmt -92.52 8.18 39.94 Favored 'General case' 0 CA--C 1.565 1.525 0 CA-C-N 115.498 -0.774 . . . . 72.14 110.554 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 28.0 t-20 -46.71 118.52 5.06 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 123.804 0.842 . . . . 73.51 112.909 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 19.9 Cg_exo -63.18 -24.26 72.75 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.492 2.795 . . . . 74.1 113.577 -176.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.35 -13.77 59.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.462 0.649 . . . . 70.31 110.176 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.905 0 CA-C-N 115.793 -0.639 . . . . 52.12 113.58 176.386 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.1 p . . . . . 0 N--CA 1.409 -2.487 0 N-CA-C 106.864 -1.532 . . . . 61.54 106.864 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.422 ' HD2' ' OE1' ' A' ' 105' ' ' GLU . 78.8 m80 -90.7 143.46 26.71 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.107 0.479 . . . . 71.32 111.739 -175.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.7 m-20 -128.31 122.36 31.43 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.454 -1.313 . . . . 74.24 107.454 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 22.5 t -116.23 121.28 67.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 121.053 -0.259 . . . . 71.33 110.56 -175.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -81.44 112.15 18.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 107.97 -1.122 . . . . 74.1 107.97 174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG22 ' HB ' ' A' ' 17' ' ' ILE . 24.1 m -113.49 140.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.531 0.681 . . . . 75.24 112.458 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -131.87 121.79 24.63 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.557 -1.275 . . . . 75.53 107.557 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.3 -58.91 4.17 Favored Glycine 0 C--N 1.302 -1.315 0 C-N-CA 120.895 -0.669 . . . . 72.44 111.441 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.1 m -78.25 145.82 35.23 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.97 -0.381 . . . . 74.43 109.97 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.468 HG22 ' CD1' ' A' ' 67' ' ' ILE . 9.3 mm 70.23 -104.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.8 1.24 . . . . 71.32 108.586 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.259 77.4 mt 49.1 -36.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.651 2.38 . . . . 64.33 117.092 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.19 132.15 29.9 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 109.393 -0.595 . . . . 72.22 109.393 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.4 -40.3 28.71 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.9 3.067 . . . . 61.43 113.543 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -60.16 -47.94 83.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.982 0.42 . . . . 71.42 110.967 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.67 -39.73 85.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.406 0.622 . . . . 73.34 110.402 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . . . -66.88 -34.94 78.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.81 -0.632 . . . . 64.42 110.947 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -75.62 -26.46 57.81 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.177 -0.465 . . . . 74.14 111.654 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 21' ' ' ALA . 20.9 m -85.34 -23.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.432 -0.507 . . . . 74.24 111.595 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.457 HD12 ' CD1' ' A' ' 78' ' ' PHE . 10.5 tt -82.46 -40.97 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.138 -0.625 . . . . 74.24 111.067 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 31' ' ' ALA . 82.8 mt -83.68 -18.17 38.94 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.293 -0.412 . . . . 74.42 111.27 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 64.18 25.91 13.74 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 106.739 -1.578 . . . . 62.12 106.739 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.4 ttt180 -162.83 166.59 23.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.678 -1.601 . . . . 73.53 106.68 -174.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -75.39 136.44 40.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 118.098 0.408 . . . . 74.11 110.426 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 23' ' ' ALA . . . -101.73 141.32 34.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 115.964 -0.562 . . . . 54.12 112.015 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -100.11 110.23 22.51 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.733 -0.667 . . . . 64.24 109.516 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.7 p -115.98 143.42 45.48 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.255 -0.43 . . . . 75.0 110.824 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.41 139.96 35.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.01 -0.737 . . . . 61.01 109.01 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.53 134.12 58.98 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.403 2.069 . . . . 64.23 112.028 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.464 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.88 157.03 42.78 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.377 -0.828 . . . . 70.33 110.246 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.12 127.89 72.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.537 0.684 . . . . 72.35 111.41 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.435 ' HA ' HG11 ' A' ' 93' ' ' VAL . 28.4 tp -91.39 95.93 10.25 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.405 -0.816 . . . . 75.3 111.809 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 9.9 p-80 -71.94 127.31 32.17 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.318 -0.855 . . . . 74.54 109.148 170.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.95 -17.48 7.63 Favored Glycine 0 C--N 1.292 -1.9 0 C-N-CA 119.69 -1.243 . . . . 51.23 112.651 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -124.93 160.26 29.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.091 0.774 . . . . 72.23 113.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.02 132.85 42.33 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.744 -1.116 . . . . 60.44 109.672 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.48 151.48 20.17 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.623 0.971 . . . . 74.43 113.623 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.15 169.86 14.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.846 -1.07 . . . . 75.33 109.539 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -138.46 86.83 2.18 Favored 'General case' 0 CA--C 1.485 -1.524 0 O-C-N 124.055 0.847 . . . . 73.03 111.447 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HG ' ' HD2' ' A' ' 52' ' ' PRO 0.35 0.3 OUTLIER -89.84 97.9 11.46 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.179 -1.008 . . . . 71.51 111.301 174.331 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -66.16 -23.22 66.43 Favored 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.52 1.528 . . . . 75.04 110.792 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.83 -12.91 63.01 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 115.435 -0.802 . . . . 52.14 111.782 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.2 mt -126.26 170.13 10.31 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 125.438 1.495 . . . . 70.14 107.432 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.89 50.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.519 2.978 0 C-N-CA 124.138 3.226 . . . . 73.44 114.981 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.561 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.487 7.8 p90 48.47 63.69 9.91 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 118.94 2.941 . . . . 72.13 118.94 178.169 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 3.2 Cg_endo -95.98 169.12 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.578 4.185 . . . . 54.23 109.261 172.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.0 p -157.41 -167.3 2.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.508 2.723 . . . . 73.35 108.499 -3.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.9 pt -123.74 131.07 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 107.13 -1.433 . . . . 74.13 107.13 162.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.471 HG22 ' SD ' ' A' ' 117' ' ' MET . 31.1 m -145.21 166.77 10.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 116.478 -0.328 . . . . 74.44 111.227 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t 63.6 138.7 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.797 1.639 . . . . 73.02 113.922 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -80.79 75.47 7.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.333 1.063 . . . . 75.53 110.711 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.65 168.25 16.49 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.254 -1.339 . . . . 75.4 110.044 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.8 m -91.69 4.8 51.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.151 0.501 . . . . 73.2 110.942 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.13 -167.84 43.74 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.334 -0.706 . . . . 73.2 111.334 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 39' ' ' HIS . 8.8 ptpp? -153.77 151.57 29.73 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.37 -0.532 . . . . 73.24 112.193 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.4 128.66 71.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 C-N-CA 124.095 0.958 . . . . 73.2 109.109 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -100.97 132.53 46.34 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.526 -0.87 . . . . 65.34 110.594 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.92 -138.08 2.44 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.93 -0.868 . . . . 52.34 110.93 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -142.68 145.23 33.2 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.12 0.568 . . . . 71.21 110.708 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.28 129.79 56.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.673 -0.491 . . . . 73.4 109.673 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.468 ' CD1' HG22 ' A' ' 17' ' ' ILE . 18.1 mt -89.46 110.91 22.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 106.834 -1.543 . . . . 63.21 106.834 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.2 p -99.25 161.84 13.39 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 116.054 -0.521 . . . . 64.04 111.464 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.57 74.25 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.329 -0.462 . . . . 73.04 113.189 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.29 128.93 38.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.652 -0.87 . . . . 72.43 108.652 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -85.3 160.95 19.71 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.823 -0.806 . . . . 64.3 108.823 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -52.36 -37.89 57.34 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.475 0.71 . . . . 72.42 111.846 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.83 63.13 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.924 -0.58 . . . . 37.57 111.464 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.57 -32.07 72.58 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.929 -0.309 . . . . 72.34 111.149 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.11 -33.85 69.56 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.742 -0.663 . . . . 74.02 110.469 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.43 ' O ' HG22 ' A' ' 80' ' ' VAL . 22.1 t-20 -63.58 -28.65 70.08 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.61 -0.723 . . . . 63.13 110.692 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' HG13 ' A' ' 26' ' ' ILE . 4.9 t30 -74.91 -31.88 61.66 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.817 -0.808 . . . . 63.22 108.817 -175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CD1' HD12 ' A' ' 26' ' ' ILE . 96.4 m-85 -64.8 -36.5 84.53 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 115.461 -0.79 . . . . 74.35 110.476 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.21 -31.55 71.15 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.541 0.686 . . . . 73.32 110.116 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 76' ' ' ASN . 55.6 t -75.64 -44.34 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 115.64 -0.709 . . . . 72.21 112.344 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 11.3 tt -72.13 117.72 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.306 0.574 . . . . 63.14 112.24 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.19 3.09 0.49 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.714 1.206 . . . . 75.4 113.978 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.37 53.56 1.54 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 111.358 -0.697 . . . . 53.33 111.358 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -82.37 -40.71 20.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.838 0.351 . . . . 73.43 110.825 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.598 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 5.6 t70 -119.88 28.87 7.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.667 1.222 . . . . 54.14 107.806 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.482 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 70.6 m-85 -113.76 161.16 17.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.48 -1.236 . . . . 75.25 109.707 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -130.48 141.91 50.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.936 -1.135 . . . . 75.45 107.936 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -81.88 121.47 26.5 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.191 -0.458 . . . . 74.51 110.996 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.33 159.64 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.71 -0.677 . . . . 75.54 110.205 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.1 m -97.8 124.56 42.24 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.945 -0.761 . . . . 70.04 108.945 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.13 169.95 13.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.582 -0.896 . . . . 72.5 108.582 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -124.79 120.93 33.13 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.651 -0.87 . . . . 75.32 108.651 -173.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' A' ' 38' ' ' LEU . 21.0 m -126.0 168.78 18.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-O 121.383 0.611 . . . . 73.14 110.886 -170.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.469 HG23 ' HG2' ' A' ' 101' ' ' LYS . 71.3 t -110.52 118.81 58.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.481 -0.782 . . . . 64.25 109.464 175.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -74.33 95.1 2.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 109.246 -0.65 . . . . 74.42 109.246 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.464 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -48.1 -33.64 8.51 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 126.57 1.948 . . . . 75.04 110.596 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.76 -38.71 70.2 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.458 -0.792 . . . . 64.1 112.013 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -115.61 -10.62 11.83 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.341 0.591 . . . . 72.04 109.748 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.6 t 67.71 22.5 8.93 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.07 0.948 . . . . 62.43 110.074 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -97.17 160.38 14.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.922 -0.581 . . . . 75.22 109.458 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.499 ' HZ1' ' HB3' ' A' ' 101' ' ' LYS . 5.9 mtpm? -101.85 135.78 42.82 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.613 -0.884 . . . . 75.32 108.613 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.86 145.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.064 0.459 . . . . 75.3 110.345 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -91.94 124.15 35.84 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.238 -1.023 . . . . 74.32 108.238 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.69 175.59 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.815 0.446 . . . . 73.41 110.691 -175.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.422 ' OE1' ' HD2' ' A' ' 9' ' ' HIS . 45.3 mt-10 -106.8 153.5 22.37 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.972 -0.455 . . . . 74.13 111.057 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 t -154.87 177.9 10.76 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 110.273 -0.269 . . . . 72.02 110.273 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -104.76 119.8 39.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.08 0.952 . . . . 64.4 108.673 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.75 151.88 20.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.553 -0.459 . . . . 73.51 109.913 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.598 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 35.6 t-105 -79.36 127.05 31.61 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.084 -0.709 . . . . 75.31 109.084 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.7 m -72.64 -28.3 27.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.115 0.483 . . . . 63.22 112.236 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -79.3 13.21 1.99 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.678 0.791 . . . . 70.24 111.282 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -51.65 -14.86 0.38 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.014 1.857 . . . . 52.32 116.014 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -72.87 9.96 1.01 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.124 0.488 . . . . 65.13 112.135 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.41 131.82 49.15 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 108.064 -1.087 . . . . 70.41 108.064 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 -15.98 28.48 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.317 2.678 . . . . 74.23 116.457 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -130.6 113.97 14.87 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 117.673 -1.611 . . . . 72.32 114.259 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.471 ' SD ' HG22 ' A' ' 55' ' ' VAL . 66.2 mtt . . . . . 0 C--N 1.306 -1.283 0 CA-C-N 114.745 -1.116 . . . . 63.53 109.064 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.7 mt-10 . . . . . 0 C--O 1.217 -0.619 0 N-CA-C 111.791 0.293 . . . . 73.15 111.791 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -60.95 -24.46 66.08 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.909 0.385 . . . . 74.3 111.301 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -58.43 -43.19 88.63 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.281 -0.637 . . . . 74.13 109.281 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 125' ' ' GLU . 17.9 m -84.37 -31.68 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 119.993 -0.683 . . . . 65.2 110.946 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 125' ' ' GLU . 52.2 t -68.18 -39.31 81.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 116.794 -0.185 . . . . 73.12 111.066 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.405 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 1.4 p-80 -67.47 -32.34 73.12 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.413 -0.915 . . . . 73.24 110.254 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.73 83.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 54.43 110.024 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.5 -25.77 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.259 -0.882 . . . . 71.04 112.249 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -76.68 -57.37 3.89 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.231 -1.396 . . . . 71.14 107.231 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 92.0 m-85 -61.79 -33.5 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.503 1.297 . . . . 75.45 114.503 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.8 p -58.1 -41.94 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.33 -0.548 . . . . 63.45 110.66 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 24.0 mm-40 -66.12 -39.35 89.83 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.172 -0.467 . . . . 54.31 110.494 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.7 m -59.32 -49.6 77.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 72.42 110.475 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -57.77 -41.61 82.38 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 121.134 -0.226 . . . . 64.33 111.247 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 82.5 mtp180 -63.27 -47.92 80.32 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.572 0.545 . . . . 71.33 111.193 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 73.1 mmtt -65.35 -42.97 92.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.747 0.308 . . . . 74.4 110.881 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.455 ' HA ' ' HE3' ' A' ' 141' ' ' MET . 2.6 mmt -61.79 -35.82 79.3 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.052 -0.722 . . . . 65.25 109.052 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.77 -39.09 90.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.537 -0.912 . . . . 74.03 108.537 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -64.06 -47.84 78.6 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.555 -0.293 . . . . 74.04 110.798 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -69.95 -28.66 65.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.611 0.967 . . . . 74.12 113.611 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -82.0 -47.76 12.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.972 0.36 . . . . 62.44 111.972 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.0 -26.94 30.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.227 0.455 . . . . 73.41 112.227 -175.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -136.03 78.16 47.78 Favored Pre-proline 0 C--N 1.313 -1.007 0 C-N-CA 120.605 -0.438 . . . . 71.22 111.885 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.71 -29.71 35.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.99 1.793 . . . . 73.3 109.875 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -87.56 0.11 56.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.308 -0.86 . . . . 74.43 109.763 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.968 0 N-CA-C 109.984 -1.246 . . . . 64.23 109.984 176.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 N--CA 1.433 -1.29 0 CA-C-O 121.772 0.796 . . . . 53.25 112.253 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -107.97 156.35 19.32 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.75 -1.113 . . . . 73.32 111.034 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.3 m-20 -125.14 122.91 38.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.144 -1.428 . . . . 75.11 107.144 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 19.5 t -119.78 124.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 120.753 -0.379 . . . . 74.42 110.976 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -84.02 113.91 21.34 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.825 -0.806 . . . . 74.32 108.825 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -125.17 160.54 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.518 0.675 . . . . 73.33 111.973 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -145.71 -55.67 0.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.815 -1.55 . . . . 71.51 106.815 175.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.5 63.27 0.6 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.513 -1.035 . . . . 75.2 110.513 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 m -153.97 -79.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.192 . . . . 71.4 111.033 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.529 HD13 ' CG2' ' A' ' 26' ' ' ILE . 33.2 pt -145.78 86.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 122.173 0.987 . . . . 74.43 111.312 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.447 HD23 ' HB2' ' A' ' 65' ' ' LYS . 77.7 mt -99.63 -5.19 29.39 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.474 -0.766 . . . . 74.32 109.223 175.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.78 130.81 24.6 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.258 -0.883 . . . . 65.23 111.046 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.62 -42.56 18.77 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.174 3.249 . . . . 71.14 114.417 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.38 83.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.744 0.276 . . . . 44.55 111.744 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.7 p -77.26 -30.87 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.288 0.566 . . . . 73.21 111.044 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.397 0.618 . . . . 71.14 109.377 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -74.85 -5.69 44.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.644 -0.707 . . . . 62.22 112.197 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.1 m -105.98 -15.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.805 -0.758 . . . . 72.3 111.223 177.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.529 ' CG2' HD13 ' A' ' 17' ' ' ILE . 10.0 tt -92.72 -42.47 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 121.468 0.651 . . . . 74.44 110.333 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 95.3 mt -87.08 -27.24 23.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.882 -0.599 . . . . 75.34 110.002 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 73.17 3.3 4.61 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.479 1.133 . . . . 75.04 108.122 -170.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.9 mmt180 -126.07 154.81 42.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.195 -2.15 . . . . 72.32 105.195 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -96.96 110.41 22.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.677 -1.209 . . . . 72.12 108.75 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 156.29 17.67 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.882 -0.599 . . . . 74.54 110.532 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.66 125.54 41.2 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.516 0.674 . . . . 63.04 112.816 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 p -100.44 143.94 30.03 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.582 -1.19 . . . . 73.41 109.532 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.7 141.66 38.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.304 -0.999 . . . . 74.4 108.304 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 2.1 Cg_endo -65.44 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.001 1.801 . . . . 75.44 111.637 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.17 156.36 41.46 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.691 -0.686 . . . . 75.42 110.444 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -122.44 127.84 75.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-O 121.399 0.619 . . . . 73.03 111.378 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 23.7 tp -90.49 97.86 11.43 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.206 -0.906 . . . . 72.34 109.429 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.444 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 6.3 p80 -70.63 132.3 45.23 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.014 -0.994 . . . . 71.43 110.018 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.61 38.57 Favored Glycine 0 C--O 1.215 -1.044 0 C-N-CA 118.844 -1.646 . . . . 74.22 113.993 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -101.99 143.35 31.95 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 113.768 1.025 . . . . 73.31 113.768 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.549 ' HB2' ' CB ' ' A' ' 58' ' ' ASP . 2.9 t-160 -104.63 122.55 45.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.386 -1.279 . . . . 62.14 108.379 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -89.53 115.86 27.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.189 -1.041 . . . . 71.41 108.189 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.407 ' HD2' ' O ' ' A' ' 117' ' ' MET . 26.3 m-85 -81.3 141.86 33.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.6 -0.518 . . . . 64.44 109.6 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.631 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -97.54 124.54 41.82 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.37 0.605 . . . . 75.34 111.291 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.77 133.1 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.835 -0.62 . . . . 62.33 110.079 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.89 -41.08 7.38 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 108.08 -1.082 . . . . 54.0 108.08 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.56 -21.15 77.62 Favored Glycine 0 N--CA 1.425 -2.096 0 CA-C-N 114.234 -1.348 . . . . 53.04 112.156 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.67 151.34 41.04 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 108.83 -0.804 . . . . 74.41 108.83 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.52 -61.76 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.832 2.355 . . . . 74.43 115.62 -172.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.681 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 4.1 p90 -132.62 16.33 0.05 OUTLIER Pre-proline 0 CA--C 1.585 2.299 0 N-CA-C 117.208 2.299 . . . . 75.24 117.208 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.705 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 1.0 OUTLIER -89.24 164.29 5.62 Favored 'Trans proline' 0 C--N 1.369 1.609 0 CA-C-N 122.129 1.796 . . . . 74.13 112.005 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 20.6 p -155.0 167.44 30.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.484 1.914 . . . . 74.03 108.034 -6.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 131.37 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.775 -0.77 . . . . 51.21 109.537 170.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 112' ' ' LYS . 8.1 p -157.52 170.51 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 108.572 -0.899 . . . . 73.01 108.572 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.4 ' H ' HG23 ' A' ' 55' ' ' VAL . 25.6 m 77.67 145.45 0.09 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.47 1.106 . . . . 75.51 112.83 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.1 t -88.73 76.23 8.07 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.225 -1.398 . . . . 75.24 107.225 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.549 ' CB ' ' HB2' ' A' ' 42' ' ' HIS . 17.9 t70 -84.22 175.24 9.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.26 -1.791 . . . . 74.44 109.325 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 m -83.75 -16.58 44.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.498 . . . . 73.4 109.706 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.62 170.24 53.94 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 115.391 -0.822 . . . . 45.34 113.602 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 42.3 mtmt -137.82 146.75 43.89 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.399 -1.334 . . . . 71.44 107.399 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.86 123.42 61.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.528 -0.545 . . . . 73.35 109.528 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -95.93 124.86 40.12 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.517 -0.549 . . . . 64.43 109.517 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.99 -141.89 3.26 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.101 -0.8 . . . . 37.77 111.101 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 48.9 mtmt -140.17 147.43 40.12 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 120.874 0.368 . . . . 75.42 111.622 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.1 m -104.87 133.71 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 115.454 -0.794 . . . . 75.45 109.551 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 17' ' ' ILE . 18.3 mt -88.37 130.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 106.023 -1.843 . . . . 70.3 106.023 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.3 p -115.01 161.32 18.49 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.732 -0.787 . . . . 62.25 111.415 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 33.66 67.67 Favored Glycine 0 N--CA 1.439 -1.114 0 O-C-N 123.543 0.527 . . . . 75.11 113.211 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -90.39 122.37 41.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.964 0.382 . . . . 70.3 110.633 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.8 m -76.62 158.7 30.88 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.458 -0.571 . . . . 75.1 109.458 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.79 -42.93 65.49 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.461 0.541 . . . . 72.42 112.461 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.2 -40.71 77.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.29 0.567 . . . . 73.5 110.141 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.37 -37.26 80.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.709 -1.132 . . . . 71.11 109.099 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.95 -33.5 74.4 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.404 1.082 . . . . 70.02 110.155 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -62.86 -27.14 69.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.158 -0.928 . . . . 70.34 113.16 179.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -32.89 71.4 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.191 -1.04 . . . . 64.31 108.191 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.463 ' CE1' HD12 ' A' ' 17' ' ' ILE . 83.4 m-85 -70.98 -28.59 64.56 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.29 0.566 . . . . 75.03 109.532 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.508 ' HA ' HH12 ' A' ' 88' ' ' ARG . 28.6 t70 -70.94 -36.13 72.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.614 -0.721 . . . . 60.41 109.848 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 76' ' ' ASN . 72.4 t -66.6 -22.51 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.229 -0.896 . . . . 75.31 111.511 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.4 103.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.337 0.589 . . . . 75.32 110.488 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.389 0.1 OUTLIER 64.39 -58.39 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.937 2.495 . . . . 73.42 112.631 -174.001 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.51 1.66 16.98 Favored Glycine 0 C--O 1.234 0.132 0 C-N-CA 123.191 0.424 . . . . 75.03 113.638 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -83.92 -44.17 14.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.649 0.24 . . . . 75.54 111.649 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.51 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 2.1 t70 -136.94 16.12 3.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 118.626 -1.23 . . . . 73.3 111.532 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.705 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 30.6 m-85 -112.56 151.88 29.51 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.224 -0.591 . . . . 63.42 110.723 175.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -131.56 159.65 37.57 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.172 -0.922 . . . . 73.14 109.292 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.508 HH12 ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -90.11 113.74 25.53 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.332 -0.395 . . . . 74.44 109.954 -178.236 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.62 159.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.662 0.267 . . . . 63.1 110.859 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.3 m -102.57 129.78 49.24 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.066 -0.716 . . . . 73.25 109.066 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.07 168.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.345 -1.354 . . . . 64.01 107.345 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -120.35 131.97 55.08 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.473 -1.291 . . . . 62.51 108.662 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.99 168.13 19.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.243 0.544 . . . . 44.41 109.617 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.504 HG23 ' HG2' ' A' ' 101' ' ' LYS . 69.3 t -109.78 120.1 60.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 115.658 -0.701 . . . . 64.14 109.962 177.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.418 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 77.3 ttt180 -67.41 97.23 0.55 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.799 -1.556 . . . . 75.42 106.799 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.5 ttt -48.74 -45.82 40.14 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 127.088 2.155 . . . . 64.13 113.664 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.4 -34.15 75.51 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.586 0.587 . . . . 74.13 112.586 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -103.48 -9.29 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.306 0.574 . . . . 65.43 111.272 -175.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m 64.8 25.58 12.92 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.793 0.837 . . . . 63.33 111.653 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -102.58 161.69 13.52 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.561 -0.903 . . . . 72.54 108.561 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.504 ' HG2' HG23 ' A' ' 94' ' ' VAL . 44.3 mtmt -104.6 135.85 45.24 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.953 -0.758 . . . . 63.21 108.953 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.52 135.86 48.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-O 121.139 0.495 . . . . 71.31 109.855 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -87.16 126.41 34.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.143 -1.428 . . . . 71.21 107.143 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.58 169.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.977 0.417 . . . . 73.11 111.123 -174.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.4 149.39 24.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.384 -0.371 . . . . 65.21 110.138 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 t -153.01 176.86 11.42 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.776 -0.453 . . . . 71.35 109.776 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.46 ' HD2' ' CE1' ' A' ' 86' ' ' TYR . 15.1 p90 -107.35 120.01 40.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 125.08 1.352 . . . . 75.13 110.407 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.401 ' O ' ' HD1' ' A' ' 86' ' ' TYR . 27.1 m -114.77 171.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 O-C-N 122.096 -0.377 . . . . 50.43 110.077 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.51 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 23.7 t-105 -97.7 121.2 39.34 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.483 -0.562 . . . . 75.43 109.483 -168.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 112' ' ' LYS . 33.5 m -73.12 -23.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 112.425 0.528 . . . . 74.54 112.425 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -76.42 11.81 1.45 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.352 0.596 . . . . 71.22 109.959 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.482 ' HB3' HG21 ' A' ' 55' ' ' VAL . 10.5 ptpp? -59.31 -20.07 51.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.298 1.039 . . . . 72.22 112.686 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.33 -24.67 50.78 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.253 0.549 . . . . 43.32 110.481 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.1 145.9 41.65 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.188 -1.782 . . . . 62.43 106.188 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -31.28 125.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 124.192 3.262 . . . . 75.11 112.687 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.82 114.33 13.16 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.477 0.656 . . . . 72.24 109.973 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.407 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 28.0 ttt . . . . . 0 N--CA 1.437 -1.125 0 N-CA-C 114.47 1.285 . . . . 73.35 114.47 -171.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 129' ' ' VAL . 16.5 tp10 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 108.738 -0.838 . . . . 73.43 108.738 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -55.3 -49.73 71.38 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-N 115.436 -0.802 . . . . 74.41 110.852 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -64.7 -40.07 94.74 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.752 -0.658 . . . . 73.13 112.225 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 m -70.78 -32.41 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.918 -0.713 . . . . 74.43 111.734 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.566 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 88.3 t -67.93 -45.23 84.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 109.009 -0.737 . . . . 74.41 109.009 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -70.52 -39.55 74.02 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.184 -0.606 . . . . 74.24 111.67 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.21 -54.7 42.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.662 0.245 . . . . 70.55 111.662 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 42.5 mt-10 -62.01 -38.16 87.59 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.078 0.466 . . . . 74.24 111.83 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -69.59 -43.68 72.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.555 -0.748 . . . . 64.41 111.965 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -72.24 -40.53 67.65 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.266 0.839 . . . . 72.24 113.266 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 34.5 m -60.09 -34.2 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 118.952 -0.546 . . . . 65.4 112.421 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 45.7 mt-10 -55.91 -51.82 66.28 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.204 -1.035 . . . . 74.04 108.204 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.3 m -58.63 -50.43 73.86 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.084 -1.416 . . . . 52.55 110.76 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -59.97 -50.48 73.57 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 112.166 0.432 . . . . 75.14 112.166 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 41.0 mtp180 -63.25 -53.41 53.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.669 0.618 . . . . 71.31 112.669 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -66.23 -31.73 72.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 112.096 0.406 . . . . 64.41 112.096 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.51 ' HA ' ' HE3' ' A' ' 141' ' ' MET . 4.5 mmt -76.17 -35.56 59.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 119.998 -0.681 . . . . 71.1 109.651 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.8 tp -63.94 -36.67 84.73 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 122.741 0.417 . . . . 63.43 110.599 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.253 -0.43 . . . . 75.23 111.358 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -76.24 -35.38 59.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.815 -0.63 . . . . 72.35 111.017 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.98 -39.6 61.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 75.03 112.135 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -99.62 9.36 43.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.32 0.581 . . . . 74.11 109.942 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -38.89 117.36 1.04 Allowed Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.592 1.557 . . . . 54.35 112.734 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.53 -19.59 52.94 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 123.907 3.071 . . . . 71.12 113.245 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -74.98 -7.09 52.63 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.206 -0.452 . . . . 54.22 111.551 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.565 0 C-N-CA 121.066 -0.588 . . . . 64.45 113.474 175.504 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.422 -1.847 0 CA-C-O 121.804 0.811 . . . . 71.25 112.296 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -130.3 157.67 41.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.692 -1.14 . . . . 75.52 109.891 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.452 ' HB2' HG13 ' A' ' 104' ' ' VAL . 32.7 m-80 -121.87 127.82 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.765 -0.828 . . . . 75.14 108.765 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.42 120.95 64.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 110.126 -0.324 . . . . 72.13 110.126 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.61 118.83 24.09 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 122.59 0.356 . . . . 72.21 110.275 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.35 160.61 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.314 -0.625 . . . . 73.4 109.314 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -131.15 17.21 5.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.846 0.831 . . . . 74.54 109.998 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.38 159.38 30.07 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 119.897 -1.144 . . . . 73.3 112.603 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m 67.11 -74.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.218 1.407 . . . . 73.51 113.946 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 67' ' ' ILE . 26.1 mt -70.25 -5.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.641 0.777 . . . . 73.31 111.757 -171.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -65.87 -30.12 70.68 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.163 -0.681 . . . . 75.13 109.163 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.07 132.21 25.05 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 115.155 -0.93 . . . . 75.42 110.446 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.54 -44.53 4.44 Favored 'Trans proline' 0 C--N 1.359 1.103 1 C-N-CA 125.362 4.041 . . . . 71.45 115.375 -175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.68 -42.52 79.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.888 0.699 . . . . 37.88 112.888 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -76.18 -35.85 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.279 0.561 . . . . 75.34 110.292 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.74 -32.85 74.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.451 0.643 . . . . 73.44 109.728 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -73.63 -20.82 60.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.607 -0.724 . . . . 65.14 111.837 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.6 m -87.71 -23.89 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.381 -0.928 . . . . 74.35 111.195 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' ND2' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -87.01 -46.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 116.508 -0.314 . . . . 62.13 110.904 178.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 31' ' ' ALA . 82.1 mt -93.86 -14.6 25.91 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.793 -0.363 . . . . 74.23 111.958 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.0 t70 73.56 6.86 5.07 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.494 1.14 . . . . 72.41 109.191 -175.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.2 mtp180 -144.22 163.81 32.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.22 1.408 . . . . 74.22 107.727 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.6 p -76.69 122.64 24.98 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.21 -0.293 . . . . 74.33 110.21 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.421 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -87.44 156.91 19.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 120.642 0.258 . . . . 54.34 111.052 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -99.93 109.86 22.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.176 -0.609 . . . . 74.1 110.843 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -99.92 142.09 31.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.171 -1.048 . . . . 71.31 108.171 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.76 147.54 57.36 Favored Pre-proline 0 C--N 1.289 -2.047 0 N-CA-C 108.751 -0.833 . . . . 74.21 108.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -59.51 135.73 66.65 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.573 2.182 . . . . 64.42 112.219 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.81 156.46 41.31 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.137 -0.69 . . . . 60.1 109.137 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.405 HG22 ' HE2' ' A' ' 61' ' ' LYS . 12.2 p -123.75 126.53 72.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 118.704 -1.198 . . . . 74.41 111.676 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.412 ' HA ' HG11 ' A' ' 93' ' ' VAL . 25.1 tp -92.17 90.88 7.51 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.729 0.776 . . . . 74.23 110.864 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.9 p80 -73.08 124.91 26.48 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 114.556 -1.202 . . . . 72.13 109.395 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.45 -16.8 8.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.369 -0.919 . . . . 63.04 112.699 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.408 ' O ' HG21 ' A' ' 62' ' ' VAL . 38.4 m-85 -122.27 155.04 36.74 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 110.108 -0.33 . . . . 72.43 110.108 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.443 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 5.4 t60 -129.27 135.95 49.44 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 37.2 ttp180 -88.16 127.18 35.43 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.128 -1.434 . . . . 74.32 107.128 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -100.65 123.05 44.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 106.188 -1.782 . . . . 74.31 106.188 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HD2' ' C ' ' A' ' 45' ' ' LYS . 2.5 tmmm? -76.3 94.03 3.52 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-O 122.014 0.911 . . . . 74.43 109.591 -173.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 10.5 mp -81.07 98.76 8.14 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.057 -1.429 . . . . 75.2 112.709 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.76 84.36 7.37 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 123.139 1.447 . . . . 72.14 109.276 172.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.91 -53.84 0.13 Allowed Glycine 0 N--CA 1.405 -3.427 0 CA-C-N 113.679 -1.601 . . . . 74.23 110.016 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -93.45 166.99 14.87 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.563 -0.532 . . . . 74.23 109.563 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.91 135.08 1.54 Allowed 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 122.599 2.199 . . . . 64.54 112.73 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.636 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 38.9 p90 44.97 47.26 3.59 Favored Pre-proline 0 N--CA 1.513 2.676 0 N-CA-C 115.383 1.623 . . . . 75.15 115.383 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 51' ' ' TYR 0.265 37.7 Cg_endo -114.93 157.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.231 3.287 . . . . 74.33 114.68 -175.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 91.9 m -153.76 166.55 32.5 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 131.684 3.994 . . . . 65.14 104.3 -13.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.1 pt -123.19 145.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 119.978 1.263 . . . . 63.13 112.102 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -144.82 150.07 16.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 106.763 -1.569 . . . . 64.32 106.763 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 p -94.44 94.34 8.18 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 121.452 0.644 . . . . 64.34 110.283 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -134.82 -57.43 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.823 -1.547 . . . . 64.44 106.823 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -82.23 139.1 34.44 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.839 -1.073 . . . . 64.54 108.622 174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -78.77 15.09 1.13 Allowed 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.57 0.952 . . . . 62.2 113.57 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.24 -172.06 5.44 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 121.514 0.508 . . . . 64.33 113.461 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.415 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 19.8 ptmt -139.42 140.06 37.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.472 -0.566 . . . . 74.13 109.472 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 41' ' ' TYR . 93.6 t -108.82 124.07 65.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 123.189 0.596 . . . . 74.21 109.575 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -90.27 144.62 25.68 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.475 -1.306 . . . . 74.44 107.475 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.63 -150.38 6.62 Favored Glycine 0 C--N 1.279 -2.619 0 N-CA-C 110.012 -1.235 . . . . 74.24 110.012 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -135.36 145.35 47.29 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.633 -0.827 . . . . 73.35 109.939 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.4 m -103.69 134.56 44.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.517 -0.765 . . . . 65.22 109.435 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 17' ' ' ILE . 11.0 mt -86.5 110.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 104.486 -2.413 . . . . 73.33 104.486 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.444 HG23 ' OD1' ' A' ' 10' ' ' ASN . 75.0 p -98.05 162.07 13.41 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.915 -0.584 . . . . 73.14 111.149 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 34.4 70.47 Favored Glycine 0 N--CA 1.436 -1.304 0 O-C-N 123.604 0.565 . . . . 54.55 112.866 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.43 121.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 120.55 -0.46 . . . . 54.22 109.936 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.681 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 42.7 m -81.64 158.61 24.25 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.642 -0.873 . . . . 70.42 108.642 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.6 -40.13 62.37 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.798 1.036 . . . . 73.31 113.798 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.64 -32.88 64.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.632 0.73 . . . . 73.11 110.656 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.681 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 3.8 mp0 -73.43 -31.41 63.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.031 -0.986 . . . . 73.24 110.251 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.91 -36.48 83.5 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.607 -1.257 . . . . 73.31 107.607 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.67 -28.11 53.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.416 -1.266 . . . . 74.34 111.913 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.448 ' ND2' HG12 ' A' ' 26' ' ' ILE . 64.2 t30 -75.29 -30.5 60.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.558 -0.857 . . . . 64.14 109.855 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -65.72 -34.28 77.82 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.446 0.641 . . . . 72.23 109.822 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.77 -38.43 90.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.838 -1.073 . . . . 64.35 110.526 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.5 -43.6 48.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.532 -0.758 . . . . 75.44 111.307 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -68.0 -64.06 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.829 1.048 . . . . 65.12 113.829 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.16 69.47 1.02 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.633 0.73 . . . . 73.4 110.931 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.36 15.44 2.29 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.055 -0.975 . . . . 64.2 111.776 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -82.59 -42.53 18.15 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.87 0.322 . . . . 73.04 111.87 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.01 14.0 6.27 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.602 -1.259 . . . . 44.42 107.602 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -128.28 157.02 42.09 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.172 -1.418 . . . . 74.41 107.172 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' HG23 ' A' ' 110' ' ' VAL . 11.7 pt-20 -129.35 146.68 51.18 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.229 -0.656 . . . . 54.43 109.229 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -83.75 117.09 23.02 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.502 -0.555 . . . . 71.23 109.502 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.07 159.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-O 120.84 0.352 . . . . 55.32 110.982 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.6 m -91.09 129.91 37.04 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 108.314 -0.995 . . . . 63.24 108.314 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.57 168.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.543 -1.28 . . . . 63.03 107.543 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.504 ' HB2' ' HZ3' ' A' ' 103' ' ' LYS . 21.1 tt0 -121.3 128.62 52.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.687 -1.205 . . . . 74.11 109.783 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 38' ' ' LEU . 17.0 m -127.19 168.37 20.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.831 -0.622 . . . . 62.33 109.66 -176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.442 HG23 ' HG3' ' A' ' 101' ' ' LYS . 75.0 t -103.44 112.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.214 -1.032 . . . . 44.35 108.214 172.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -80.51 99.66 8.16 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.738 -1.208 . . . . 73.54 107.738 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.496 ' SD ' ' HG3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.06 -18.08 59.52 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.959 1.304 . . . . 54.51 110.085 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -46.78 -37.33 8.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.602 0.761 . . . . 72.41 111.101 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -137.39 10.13 2.96 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 108.277 -1.009 . . . . 74.13 108.277 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t 60.01 26.41 15.71 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.966 0.889 . . . . 65.41 110.079 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -93.16 160.7 14.73 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.397 -0.82 . . . . 73.21 109.425 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.578 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 7.1 mptt -104.31 128.79 52.16 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 106.935 -1.506 . . . . 74.03 106.935 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.74 142.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.389 0.614 . . . . 73.53 111.803 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.504 ' HZ3' ' HB2' ' A' ' 92' ' ' GLU . 14.6 tppt? -89.38 125.81 35.29 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.287 -1.746 . . . . 73.33 106.287 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.452 HG13 ' HB2' ' A' ' 10' ' ' ASN . 18.5 m -133.2 174.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 120.587 0.232 . . . . 65.53 110.985 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -100.63 153.29 19.53 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.101 -1.074 . . . . 72.35 108.101 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -155.62 174.72 14.88 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.029 -0.73 . . . . 71.03 109.029 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -106.95 119.19 38.7 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.974 -1.121 . . . . 72.34 107.974 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.36 163.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 109.531 -0.544 . . . . 73.52 109.531 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -70.1 121.92 18.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.792 -0.818 . . . . 72.53 108.792 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.0 p -68.1 -20.58 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.231 0.538 . . . . 70.42 111.438 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 114' ' ' ASP . 8.2 t30 -89.13 12.13 16.63 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.648 -0.705 . . . . 71.4 110.422 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -51.81 -19.73 1.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.997 1.851 . . . . 74.44 115.997 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.33 -20.89 36.45 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.881 0.848 . . . . 65.31 109.854 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.5 ' HB3' ' ND2' ' A' ' 111' ' ' ASN . 14.5 t70 -91.66 139.09 24.87 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 107.844 -1.169 . . . . 74.04 107.844 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -71.85 78.56 1.73 Allowed 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 121.972 1.781 . . . . 75.21 111.984 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -134.53 114.57 12.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 116.084 -0.507 . . . . 72.23 110.171 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.468 0.471 0 O-C-N 124.405 1.066 . . . . 64.21 112.86 -178.899 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.42 ' O ' HG21 ' A' ' 129' ' ' VAL . 10.4 tp10 . . . . . 0 N--CA 1.432 -1.337 0 N-CA-C 109.073 -0.714 . . . . 63.05 109.073 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -71.44 -30.58 66.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.042 -1.463 . . . . 75.2 110.711 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -57.46 -46.17 83.93 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.847 -0.615 . . . . 75.2 109.547 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.31 -38.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.494 -0.482 . . . . 75.13 110.987 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 125' ' ' GLU . 92.2 t -67.63 -32.39 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 111.928 0.344 . . . . 71.24 111.928 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -83.06 -37.99 23.13 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 117.82 -1.552 . . . . 72.0 111.079 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.68 76.87 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.632 0.253 . . . . 53.14 111.363 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 22.8 mm-40 -64.35 -37.86 88.99 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 116.156 -0.474 . . . . 62.15 110.639 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -56.03 -42.53 76.65 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 116.245 -0.434 . . . . 53.43 111.133 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -76.45 -44.1 37.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 112.756 0.65 . . . . 73.53 112.756 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 132' ' ' GLU . 14.4 p -59.89 -37.28 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.024 -0.67 . . . . 74.42 111.226 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.595 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 91.9 mt-10 -58.34 -43.68 88.41 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.993 -0.743 . . . . 73.24 108.993 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.9 m -60.84 -50.19 74.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.19 -0.914 . . . . 70.51 110.535 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -63.86 -34.68 78.48 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 111.879 0.326 . . . . 73.24 111.879 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 76.4 mtp180 -63.84 -52.6 59.35 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.67 0.271 . . . . 72.12 110.352 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.496 ' HG3' ' SD ' ' A' ' 96' ' ' MET . 31.3 mmmt -60.95 -44.56 97.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.915 0.709 . . . . 74.45 112.915 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.46 ' HA ' ' HE3' ' A' ' 141' ' ' MET . 1.9 mmt -63.08 -41.34 99.39 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.77 -0.372 . . . . 75.12 110.445 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.27 -46.31 84.25 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.286 -0.415 . . . . 71.14 110.72 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.39 -34.38 77.83 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.173 -0.611 . . . . 73.52 112.013 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -68.86 -29.49 67.8 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.437 0.532 . . . . 73.25 112.437 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.94 -47.03 13.22 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.02 0.438 . . . . 74.05 111.181 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -79.75 -31.89 41.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 73.23 111.73 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -117.79 117.15 35.96 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.939 0.399 . . . . 71.03 111.889 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 -28.72 63.1 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.599 2.199 . . . . 73.44 110.522 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -73.15 -5.21 37.69 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.008 -0.996 . . . . 75.44 112.261 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.495 0 N-CA-C 110.405 -1.078 . . . . 37.88 110.405 176.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.326 0.584 . . . . 71.14 109.96 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.483 ' CG ' HD11 ' A' ' 75' ' ' LEU . 69.6 m80 -93.38 156.59 16.69 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.815 -0.629 . . . . 72.44 111.694 -173.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 91.4 m-20 -129.0 133.53 47.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.533 -1.284 . . . . 65.03 107.533 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.5 121.54 63.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.762 -0.375 . . . . 74.2 110.416 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -81.9 111.5 18.16 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.053 -1.091 . . . . 75.51 108.053 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.485 ' O ' HD21 ' A' ' 18' ' ' LEU . 95.8 t -120.19 142.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-O 121.488 0.661 . . . . 73.22 110.831 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -99.47 115.44 29.31 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.166 -1.05 . . . . 74.31 108.166 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.19 -68.09 2.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 116.096 1.199 . . . . 45.11 116.096 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.3 t -40.12 -81.26 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.669 2.1 . . . . 73.41 116.669 -167.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.457 ' HB ' HD13 ' A' ' 67' ' ' ILE . 3.1 mp -93.92 27.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 122.074 0.94 . . . . 63.51 109.552 -173.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' HB3' ' HE3' ' A' ' 65' ' ' LYS . 18.9 mt -74.52 -15.89 60.85 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.406 -0.809 . . . . 73.44 111.654 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.26 134.1 19.87 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 114.872 -1.058 . . . . 71.13 109.975 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.69 -31.6 41.75 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.753 2.968 . . . . 74.2 114.011 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.29 80.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.982 0.42 . . . . 72.13 111.332 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.582 ' O ' HG22 ' A' ' 25' ' ' VAL . 47.8 t -77.36 -34.32 20.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.151 -0.685 . . . . 70.43 109.151 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.31 75.66 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.87 -0.789 . . . . 71.02 108.87 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -71.08 -12.11 61.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.519 -0.764 . . . . 52.41 111.602 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 22' ' ' VAL . 10.6 m -97.94 -35.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 119.665 -0.814 . . . . 74.13 110.513 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.482 HG12 ' ND2' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -80.47 -48.44 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 120.782 0.325 . . . . 73.13 110.909 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 81.0 mt -90.12 -18.01 26.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.365 -0.606 . . . . 72.35 109.365 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.596 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 33.3 t70 70.64 8.76 6.69 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.896 1.332 . . . . 70.2 109.283 -175.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -142.0 143.7 33.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 113.757 -1.565 . . . . 73.53 107.721 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -76.45 117.05 17.72 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.545 0.212 . . . . 74.24 111.512 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . . . -105.72 158.8 16.47 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 116.074 -0.512 . . . . 74.11 110.018 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.94 131.81 46.64 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.694 -0.685 . . . . 72.21 111.965 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.3 p -103.46 143.81 32.22 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.312 -0.858 . . . . 71.42 110.272 174.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.4 144.94 51.07 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.394 -0.595 . . . . 71.34 109.394 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -68.24 133.77 29.5 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.035 1.823 . . . . 65.3 112.875 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.08 156.61 41.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.156 -0.929 . . . . 65.32 109.397 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.14 129.99 74.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.459 0.647 . . . . 73.13 110.86 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.402 ' HA ' HG11 ' A' ' 93' ' ' VAL . 20.9 tp -88.29 117.3 27.1 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.416 -0.811 . . . . 74.34 109.75 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -94.08 128.84 40.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.059 -0.519 . . . . 70.11 110.507 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.67 -4.54 27.72 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.029 -1.081 . . . . 51.02 112.561 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.482 ' O ' HG21 ' A' ' 62' ' ' VAL . 63.8 m-85 -124.82 147.42 48.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.242 0.46 . . . . 74.31 112.242 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -117.83 130.06 56.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.56 -1.274 . . . . 75.04 107.56 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -87.85 140.42 29.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.794 0.438 . . . . 72.22 110.804 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -112.22 150.64 30.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.774 -0.37 . . . . 70.22 111.235 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.46 100.66 13.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.66 0.743 . . . . 72.52 111.91 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -140.67 72.97 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 122.025 0.917 . . . . 53.32 109.915 172.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -83.14 8.78 12.11 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 113.968 1.099 . . . . 72.03 113.968 -175.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.41 -19.19 74.57 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.971 -2.052 . . . . 64.44 107.971 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.43 ' HG ' ' OH ' ' A' ' 86' ' ' TYR . 3.4 mm? -98.11 168.53 9.81 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 105.498 -2.038 . . . . 71.32 105.498 172.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -42.47 -65.79 0.18 Allowed 'Trans proline' 0 C--N 1.365 1.431 0 C-N-CA 122.271 1.981 . . . . 61.44 113.891 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.486 ' H ' ' HD2' ' A' ' 52' ' ' PRO . 33.7 m-85 -164.62 -36.44 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 125.366 1.466 . . . . 74.42 113.959 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 51' ' ' TYR . 63.3 Cg_exo -48.96 166.69 0.15 Allowed 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.33 2.02 . . . . 65.14 112.504 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.6 p -135.69 -171.7 2.91 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.445 1.098 . . . . 72.43 112.61 10.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 17.6 pt -131.02 150.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 114.076 -1.42 . . . . 63.22 110.109 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 151.71 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.448 -1.686 . . . . 71.22 106.448 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.0 t -71.34 145.5 49.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.384 0.611 . . . . 73.54 112.073 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -155.05 163.52 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.462 -1.31 . . . . 74.42 107.462 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.04 -56.6 4.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.274 0.559 . . . . 75.41 110.887 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 m -91.96 12.18 22.63 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.823 -0.626 . . . . 71.33 111.954 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.52 131.49 10.81 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 120.468 -0.872 . . . . 54.55 111.666 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -136.87 140.15 42.16 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.394 -0.965 . . . . 63.23 108.394 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 41' ' ' TYR . 57.3 t -114.36 122.84 69.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.837 -0.431 . . . . 72.42 109.837 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.7 126.51 37.82 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.528 -0.545 . . . . 62.12 109.528 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.93 -148.56 5.18 Favored Glycine 0 N--CA 1.42 -2.404 0 C-N-CA 120.23 -0.986 . . . . 72.33 111.747 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.505 ' HE3' ' HB3' ' A' ' 18' ' ' LEU . 44.3 mtmt -139.23 145.77 39.65 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.923 0.489 . . . . 74.32 110.53 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.44 134.3 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.415 -0.811 . . . . 64.33 109.827 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.457 HD13 ' HB ' ' A' ' 17' ' ' ILE . 15.3 mt -86.94 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 105.193 -2.151 . . . . 73.5 105.193 178.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 161.61 13.48 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.718 -0.393 . . . . 75.14 112.03 -173.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.55 37.2 77.79 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.799 -0.637 . . . . 37.8 112.901 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.43 121.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.653 -0.419 . . . . 74.5 109.97 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.7 m -73.99 158.8 33.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.052 -0.722 . . . . 65.21 109.052 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -52.92 -44.08 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.186 0.439 . . . . 73.5 112.186 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.47 78.49 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.539 0.685 . . . . 62.34 110.143 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.9 mm-40 -76.26 -38.69 55.88 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.775 -1.102 . . . . 71.33 110.217 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.488 ' O ' HD22 ' A' ' 75' ' ' LEU . 3.6 tt -61.57 -37.51 84.13 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.695 -1.224 . . . . 71.1 107.695 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.639 ' O ' HG22 ' A' ' 80' ' ' VAL . 28.5 t-20 -54.71 -28.8 50.54 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 114.272 -1.331 . . . . 74.03 112.239 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.482 ' ND2' HG12 ' A' ' 26' ' ' ILE . 6.3 t30 -73.74 -30.88 63.07 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 118.957 -1.097 . . . . 70.51 109.633 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.583 ' O ' HG23 ' A' ' 81' ' ' ILE . 68.0 m-85 -73.23 -31.12 63.94 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 107.912 -1.144 . . . . 72.43 107.912 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.34 -37.56 63.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.424 -0.807 . . . . 65.42 110.274 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 76' ' ' ASN . 58.3 t -76.41 -27.38 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 N-CA-C 113.475 0.917 . . . . 63.2 113.475 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 78' ' ' PHE . 13.7 tt -59.25 165.15 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 O-C-N 122.053 -0.404 . . . . 72.42 110.339 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -53.97 95.51 0.01 OUTLIER 'General case' 0 C--O 1.242 0.691 0 N-CA-C 114.296 1.221 . . . . 75.4 114.296 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.66 60.21 0.64 Allowed Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 107.848 -2.101 . . . . 63.22 107.848 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -57.95 -41.28 82.49 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.739 0.816 . . . . 65.04 112.43 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.516 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 8.2 t70 -128.44 24.25 5.86 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.932 -1.507 . . . . 74.11 106.932 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 52' ' ' PRO . 73.8 m-85 -119.2 150.71 39.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.453 -1.249 . . . . 72.3 108.695 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.85 144.44 51.31 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.781 -0.451 . . . . 71.54 109.781 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -93.17 114.93 27.56 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.906 -0.775 . . . . 75.04 108.906 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -128.69 161.05 38.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.663 0.785 . . . . 65.25 111.755 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.2 m -90.82 130.72 36.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.136 -1.061 . . . . 71.31 108.136 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.69 159.82 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.407 0.683 . . . . 72.41 109.158 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.68 123.87 46.38 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.3 -0.56 . . . . 63.11 110.545 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 38' ' ' LEU . 23.6 m -125.61 160.72 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 109.469 -0.567 . . . . 70.12 109.469 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 68.8 t -104.36 113.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.03 -0.986 . . . . 71.24 109.12 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -73.38 103.57 4.09 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 108.663 -0.866 . . . . 64.02 108.663 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -29.86 48.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.809 1.644 . . . . 71.12 110.437 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.29 -40.07 64.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.509 0.724 . . . . 73.33 111.729 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -123.95 -3.08 8.16 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.321 0.581 . . . . 72.43 111.025 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.94 26.19 14.11 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.014 0.926 . . . . 61.44 110.013 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 12.9 pt-20 -95.5 160.6 14.44 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.652 -0.704 . . . . 64.42 109.399 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 101' ' ' LYS . 0.8 OUTLIER -108.64 130.19 55.33 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.938 -1.134 . . . . 75.43 107.938 -178.473 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.77 144.27 21.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 109.702 -0.481 . . . . 54.34 109.702 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -87.62 127.09 35.28 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.683 0.754 . . . . 72.4 112.652 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.1 m -128.33 175.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 113.668 -1.605 . . . . 74.32 109.037 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -99.4 153.36 19.05 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.064 -0.717 . . . . 74.43 109.064 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 t -159.12 175.25 13.7 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.436 -0.579 . . . . 64.54 109.436 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -107.56 119.34 39.14 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.963 -0.754 . . . . 71.52 108.963 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.413 HG13 HG13 ' A' ' 54' ' ' ILE . 31.9 m -114.17 178.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 120.71 -0.396 . . . . 73.25 110.154 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.532 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 44.9 t-105 -101.54 124.84 47.86 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 -173.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.6 m -72.66 -26.71 24.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-O 121.28 0.562 . . . . 71.54 111.3 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.532 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 28.4 t-20 -80.01 12.51 2.73 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.732 0.813 . . . . 54.41 110.078 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.8 ptpp? -51.81 -24.67 6.36 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.362 1.065 . . . . 74.43 112.764 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -90.39 -3.15 57.9 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.143 0.497 . . . . 73.33 112.017 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.41 153.45 39.07 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.485 -0.325 . . . . 64.35 110.275 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.78 110.67 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.632 2.221 . . . . 73.41 111.248 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -133.55 166.77 21.79 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.922 -1.51 . . . . 73.24 106.922 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.342 -0.984 . . . . 60.22 108.342 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 121.113 0.482 . . . . 71.22 110.22 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -66.53 -37.44 85.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.053 -0.521 . . . . 75.2 109.712 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -56.45 -48.37 77.19 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 123.045 0.538 . . . . 75.25 110.311 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.5 m -69.37 -30.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.471 -0.491 . . . . 65.23 112.285 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -75.28 -44.47 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.421 -0.585 . . . . 74.11 109.421 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.47 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 26.3 t-80 -61.37 -40.79 95.6 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.07 -1.085 . . . . 74.31 108.07 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.89 97.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.703 -0.681 . . . . 42.43 111.652 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -67.81 -26.7 66.21 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 112.095 0.406 . . . . 73.22 112.095 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.541 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 8.8 tmtt? -70.71 -55.99 7.41 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.582 -0.896 . . . . 73.52 108.582 176.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 94.1 m-85 -66.29 -32.04 73.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.006 1.113 . . . . 74.32 114.006 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.9 p -62.37 -38.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.017 -0.673 . . . . 71.32 110.648 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -72.16 -32.41 66.83 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 119.593 -0.843 . . . . 71.3 111.277 179.221 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 80.1 m -61.92 -46.24 90.19 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.841 -0.618 . . . . 73.44 110.287 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -61.41 -34.7 75.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 121.073 -0.251 . . . . 72.43 111.123 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 99.3 mtt180 -70.13 -49.23 52.81 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.106 -0.497 . . . . 74.04 110.681 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 33.4 mmtp -58.51 -43.13 88.98 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.719 -0.474 . . . . 75.03 109.719 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.9 mtm -67.59 -31.17 71.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.693 -0.685 . . . . 63.35 111.295 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.56 -40.47 73.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.68 -0.489 . . . . 75.43 109.68 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 9.5 mm-40 -63.0 -34.16 76.96 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.982 0.896 . . . . 64.51 109.363 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -71.87 -44.36 63.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.509 -1.223 . . . . 75.22 108.956 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.49 -37.78 83.35 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 51.22 111.242 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -78.74 -11.71 59.99 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.06 0.763 . . . . 64.43 113.06 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -115.91 131.7 23.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 C-N-CA 120.101 -0.64 . . . . 73.11 112.168 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.61 -14.99 45.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.391 2.728 . . . . 73.23 111.324 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -75.39 -20.63 58.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.265 -0.88 . . . . 64.43 110.121 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.652 0 N-CA-C 108.942 -1.663 . . . . 73.35 108.942 176.156 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.18 -0.674 . . . . 70.41 109.18 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.6 m -78.35 100.95 6.98 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.972 -0.751 . . . . 64.23 108.972 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -151.92 133.27 14.53 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.805 -0.442 . . . . 73.14 109.805 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.3 p -77.17 142.89 39.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.612 0.244 . . . . 73.03 110.451 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -100.6 170.21 6.92 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 116.563 -0.29 . . . . 61.22 110.743 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.85 -177.22 0.31 Allowed 'Trans proline' 0 C--O 1.258 1.486 0 C-N-CA 122.699 2.266 . . . . 72.33 111.682 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 68.34 77.96 0.23 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.933 0.873 . . . . 74.23 109.659 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.1 m -80.72 144.25 32.34 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.736 -1.12 . . . . 74.23 109.915 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -107.81 150.53 26.89 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.673 -0.694 . . . . 72.12 111.925 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -124.52 124.65 42.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.075 -1.454 . . . . 74.14 107.075 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 7.6 p -130.61 123.5 55.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 120.539 -0.464 . . . . 53.4 111.991 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -77.81 120.09 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.974 -0.75 . . . . 74.23 108.974 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.97 148.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.136 0.493 . . . . 64.44 110.217 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.33 106.58 9.61 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.85 -0.796 . . . . 71.43 108.85 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 -69.04 1.44 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 114.285 0.474 . . . . 74.34 114.285 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -44.75 -72.31 0.06 Allowed 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.198 1.555 . . . . 73.14 115.198 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.415 ' HB ' HD13 ' A' ' 67' ' ' ILE . 4.2 mp -105.67 66.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 109.167 -0.679 . . . . 71.5 109.167 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.8 mt -114.6 16.35 17.58 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.472 -1.307 . . . . 61.12 107.472 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.36 146.75 43.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.423 -1.262 . . . . 73.4 110.956 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.38 -42.83 51.74 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.806 3.004 . . . . 70.24 114.165 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.48 -47.65 78.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 120.627 0.251 . . . . 73.22 111.233 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 26' ' ' ILE . 93.9 t -65.09 -45.16 95.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 CA-C-N 115.861 -0.608 . . . . 73.14 111.64 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.38 -37.3 80.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.118 0.485 . . . . 37.82 110.629 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.92 -33.49 68.31 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.768 -0.651 . . . . 63.31 111.522 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 22' ' ' VAL . 17.9 m -82.47 -28.58 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.969 -0.692 . . . . 73.42 111.254 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.5 tt -72.3 -47.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 119.736 -0.786 . . . . 73.41 111.829 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.532 HD21 ' CE2' ' A' ' 78' ' ' PHE . 77.7 mt -95.62 -55.56 2.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.834 -1.146 . . . . 60.04 112.072 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.1 t70 150.39 -33.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.534 -1.654 . . . . 73.41 106.534 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -134.78 159.86 40.0 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.786 -1.552 . . . . 73.12 108.028 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.0 m -76.01 119.04 19.41 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.205 0.526 . . . . 71.33 110.144 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.2 152.98 21.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.723 -0.843 . . . . 72.4 108.723 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -95.75 120.74 36.54 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.302 0.572 . . . . 54.34 112.322 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.3 p -93.46 145.24 24.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 115.144 -0.934 . . . . 63.34 109.114 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.2 t -124.08 134.71 25.63 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 106.82 -1.548 . . . . 73.3 106.82 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 33.1 Cg_endo -65.4 126.5 16.35 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.137 1.892 . . . . 74.44 111.73 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.97 155.26 39.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.516 -0.765 . . . . 63.2 110.558 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.75 129.08 75.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.55 0.691 . . . . 70.35 111.385 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.401 ' HA ' HG11 ' A' ' 93' ' ' VAL . 27.2 tp -91.58 95.36 9.89 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.332 -0.849 . . . . 73.33 111.804 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -73.55 131.96 42.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.123 -0.695 . . . . 75.12 109.123 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.11 -10.56 20.39 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 119.213 -1.47 . . . . 65.32 113.064 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.01 158.71 34.62 Favored 'General case' 0 CA--C 1.473 -1.993 0 N-CA-C 110.242 -0.281 . . . . 65.04 110.242 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.44 ' NE2' ' HB2' ' A' ' 120' ' ' GLU . 3.6 t60 -126.19 131.5 51.98 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.767 -1.197 . . . . 73.12 107.767 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.42 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -91.36 137.23 32.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.568 0.699 . . . . 73.43 112.665 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.33 -1.359 . . . . 73.23 107.33 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -88.12 -45.21 10.33 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.862 0.319 . . . . 73.3 111.862 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' PRO 0.261 7.5 mp 57.23 77.34 0.27 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 114.912 1.449 . . . . 70.14 114.912 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -78.58 105.25 9.74 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.79 -1.096 . . . . 72.34 110.626 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.88 -31.57 3.04 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 110.882 -0.887 . . . . 37.82 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.427 HD21 ' CZ2' ' A' ' 109' ' ' TRP . 4.2 mp -96.86 156.16 36.8 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 108.025 -1.102 . . . . 71.24 108.025 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.27 87.87 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 123.133 2.555 . . . . 62.43 113.955 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.615 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.595 34.6 p90 33.42 54.83 1.34 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 119.556 3.169 . . . . 75.31 119.556 -176.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 5.7 Cg_endo -103.63 169.49 0.21 Allowed 'Trans proline' 0 CA--C 1.555 1.542 1 C-N-CA 125.637 4.225 . . . . 73.14 110.298 174.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p -155.97 -178.43 7.3 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.245 2.218 . . . . 64.23 107.122 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.431 HG13 HG13 ' A' ' 108' ' ' VAL . 44.4 pt -126.64 124.24 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.625 -1.25 . . . . 65.22 107.625 164.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 m -146.71 172.71 3.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.856 -1.164 . . . . 71.14 107.856 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.6 m 71.04 129.94 0.03 OUTLIER 'General case' 0 C--O 1.24 0.577 0 O-C-N 124.909 1.38 . . . . 73.34 111.495 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -80.31 75.05 7.14 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.04 -1.467 . . . . 74.41 107.04 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.61 161.9 20.98 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 113.066 -1.879 . . . . 73.41 109.708 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.9 m -82.79 -4.29 57.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.667 0.27 . . . . 71.25 111.332 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.68 -171.17 47.4 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 121.505 -0.379 . . . . 70.31 112.433 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -144.69 154.78 43.13 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 120.82 0.343 . . . . 75.3 110.609 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.7 t -116.92 122.16 69.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.775 -0.648 . . . . 71.12 109.3 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -96.04 123.41 39.63 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.374 -0.531 . . . . 75.04 109.672 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.91 -143.8 3.76 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.894 -1.282 . . . . 71.12 109.894 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 35' ' ' PRO . 48.6 mtpt -140.76 150.68 43.69 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.762 0.781 . . . . 73.44 109.632 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.5 m -104.45 133.99 47.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 115.629 -0.714 . . . . 62.24 109.773 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.415 HD13 ' HB ' ' A' ' 17' ' ' ILE . 45.4 mt -87.23 111.54 21.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.8 -1.926 . . . . 72.2 105.8 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -103.91 162.03 13.47 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.296 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.67 72.03 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 116.147 -0.479 . . . . 73.42 111.966 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -94.97 122.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 109.939 -0.393 . . . . 72.01 109.939 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.0 t -73.74 163.22 28.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.325 -0.991 . . . . 74.15 108.325 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.9 -26.0 68.58 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.973 0.416 . . . . 64.13 110.575 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 -43.91 32.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.42 -0.585 . . . . 75.11 109.42 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.455 ' HB3' HD23 ' A' ' 27' ' ' LEU . 53.9 mt-10 -63.73 -43.2 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 71.45 110.599 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.15 -36.62 77.97 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.723 0.809 . . . . 73.31 110.077 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' HG22 ' A' ' 80' ' ' VAL . 58.4 t30 -60.92 -28.71 69.13 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.348 -0.842 . . . . 52.15 111.18 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.515 ' ND2' HG13 ' A' ' 26' ' ' ILE . 3.1 t30 -70.74 -30.17 66.61 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 119.791 -0.763 . . . . 64.24 109.484 -173.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 27' ' ' LEU . 92.6 m-85 -70.53 -32.59 70.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 64.01 109.484 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.13 -39.99 62.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.186 -0.915 . . . . 63.34 109.67 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 76' ' ' ASN . 65.5 t -74.62 -44.15 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.118 -0.946 . . . . 72.35 112.031 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.35 120.76 51.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.412 -0.358 . . . . 70.14 111.527 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 75.87 -26.78 0.19 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.934 1.294 . . . . 74.42 113.7 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 51.16 3.89 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.289 -0.724 . . . . 60.31 111.289 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.65 -43.11 49.29 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.073 0.549 . . . . 62.23 112.285 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.607 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 4.2 t70 -118.03 25.87 10.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.88 1.324 . . . . 72.51 107.552 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 89.5 m-85 -114.75 151.36 33.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.072 -1.422 . . . . 74.33 109.68 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.74 149.23 49.72 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.522 -0.547 . . . . 75.02 109.522 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -85.8 125.4 33.23 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.922 0.712 . . . . 71.13 112.922 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.25 155.79 41.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.965 -1.016 . . . . 70.32 109.218 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.5 m -96.98 124.14 40.87 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.384 -0.599 . . . . 74.21 109.384 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.96 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 107.904 -1.147 . . . . 74.21 107.904 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -112.52 131.63 55.5 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.747 -1.181 . . . . 74.55 108.26 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 38' ' ' LEU . 24.1 m -125.67 163.68 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 73.41 109.458 -174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.503 HG23 ' HG2' ' A' ' 101' ' ' LYS . 70.4 t -102.48 117.27 47.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.839 -0.619 . . . . 54.24 109.338 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -66.72 94.58 0.31 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.863 -1.162 . . . . 74.41 107.863 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.484 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -54.34 -35.57 62.86 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 125.496 1.518 . . . . 74.31 109.567 -177.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -52.6 -30.89 33.54 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.763 -1.108 . . . . 63.45 112.592 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -136.08 4.61 2.99 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.617 0.722 . . . . 53.22 110.968 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m 59.88 25.58 14.72 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.119 0.968 . . . . 74.44 112.742 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.83 160.61 14.33 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.656 -0.868 . . . . 72.41 108.656 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.503 ' HG2' HG23 ' A' ' 94' ' ' VAL . 39.8 mtmt -102.35 129.69 48.88 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.49 -0.559 . . . . 74.44 109.49 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.74 144.38 37.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.092 0.472 . . . . 53.31 110.431 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -93.94 126.35 39.09 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.524 -0.917 . . . . 75.23 108.524 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.081 0.467 . . . . 71.22 111.28 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 46.7 mt-10 -100.53 153.36 19.44 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.636 -1.246 . . . . 73.51 107.636 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -151.01 173.63 14.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 86' ' ' TYR . 92.5 m-85 -113.55 118.68 35.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 121.122 0.487 . . . . 73.51 110.29 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 54' ' ' ILE . 27.4 m -109.79 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.472 -0.936 . . . . 74.02 108.472 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.607 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 46.4 t-105 -93.33 129.17 39.53 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.223 -1.028 . . . . 74.31 108.223 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 85' ' ' ASP . 34.8 m -71.47 -20.07 20.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 N-CA-C 112.51 0.559 . . . . 71.41 112.51 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.546 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 25.4 t-20 -80.48 11.8 3.46 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.744 0.783 . . . . 75.13 109.942 176.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 19.6 ptpt -51.29 -15.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.747 2.019 . . . . 70.15 114.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.46 -52.07 18.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.957 0.903 . . . . 65.11 111.218 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -108.05 127.54 27.42 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 109.432 -0.581 . . . . 75.25 109.432 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.87 103.61 0.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 70.14 111.056 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -100.9 133.09 45.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.503 -0.771 . . . . 73.44 109.653 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 58.9 44.43 16.63 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.987 0.805 . . . . 72.13 110.078 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -57.63 -21.33 38.98 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.358 0.873 . . . . 73.11 113.358 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.21 129.36 9.34 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.313 -1.115 . . . . 73.14 110.313 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.44 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 67.6 tt0 -85.68 132.5 34.14 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.784 -0.821 . . . . 74.13 108.784 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -76.06 -172.97 2.18 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.818 -1.083 . . . . 74.45 111.298 -172.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -80.4 119.65 23.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.565 0.698 . . . . 74.41 110.184 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 50.2 m-85 -66.25 -34.98 79.24 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.479 -1.237 . . . . 73.54 108.93 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.77 -32.02 72.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.065 -0.971 . . . . 70.31 110.796 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.421 ' O ' HG23 ' A' ' 129' ' ' VAL . 36.9 tt0 -71.21 -40.59 71.05 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.4 -0.963 . . . . 75.2 108.4 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -61.99 -44.17 97.3 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.424 -0.51 . . . . 71.33 109.871 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 83.1 mtp180 -56.27 -48.93 75.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.662 -0.699 . . . . 74.35 111.177 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.563 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 32.0 m -70.43 -40.59 77.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.154 -0.618 . . . . 74.43 112.37 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 125' ' ' GLU . 95.2 t -68.16 -44.81 84.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.548 -0.461 . . . . 63.4 111.767 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.514 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.6 p80 -67.39 -33.77 75.9 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 118.401 -1.319 . . . . 61.51 109.737 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 135' ' ' VAL . . . -64.54 -47.27 79.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.977 -0.556 . . . . 73.15 110.863 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 48.1 mt-10 -60.28 -41.52 93.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.954 0.406 . . . . 73.41 110.389 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.25 -48.05 81.67 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.179 -0.919 . . . . 72.31 111.897 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.514 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 56.4 m-85 -67.94 -45.43 74.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.581 -0.448 . . . . 74.23 111.572 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 131' ' ' ALA . 94.5 t -57.37 -48.26 83.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 116.391 -0.368 . . . . 70.43 111.68 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -58.55 -48.88 79.43 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 120.439 -0.504 . . . . 63.0 109.928 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -45.2 81.27 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.527 -0.76 . . . . 75.53 112.343 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.52 -43.05 73.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.872 -0.731 . . . . 64.21 112.067 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.49 -46.74 88.76 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.992 0.425 . . . . 62.22 111.207 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.95 -32.05 66.93 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.909 -0.587 . . . . 62.4 112.316 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -72.86 -32.07 65.18 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.41 -0.959 . . . . 75.24 108.41 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.56 -37.17 79.69 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.464 -0.789 . . . . 73.24 110.166 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.59 -46.44 89.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.1 0.476 . . . . 74.41 110.283 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -65.39 -43.73 89.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.871 -0.604 . . . . 74.14 110.8 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.6 -22.21 65.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.698 0.761 . . . . 74.23 111.09 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 0.7 OUTLIER -78.45 -26.66 46.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.447 -0.797 . . . . 72.22 109.193 177.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.01 82.14 0.22 Allowed Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.349 0.66 . . . . 73.0 109.72 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.25 -37.26 2.68 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.216 1.944 . . . . 61.33 112.031 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -96.47 3.44 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.562 -0.744 . . . . 73.34 110.572 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 67.96 34.15 81.23 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 109.636 -1.386 . . . . 75.32 109.636 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -81.57 121.79 26.76 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.756 -0.722 . . . . 51.43 109.41 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.2 m -102.79 164.58 11.55 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.908 -0.405 . . . . 74.54 109.908 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 26.3 mmt -56.85 -43.44 81.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.272 0.841 . . . . 71.4 113.272 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -79.98 -25.01 40.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.46 0.648 . . . . 75.34 110.827 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.25 -45.8 45.58 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.899 -0.778 . . . . 60.51 108.899 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.97 -27.7 69.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.836 . . . . 51.32 112.412 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.7 p -92.79 128.66 44.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.422 -0.511 . . . . 70.34 110.708 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -77.25 78.07 1.48 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.062 -0.815 . . . . 64.43 111.062 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.0 t -76.66 152.35 35.83 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.655 -0.498 . . . . 75.34 109.655 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.62 141.61 46.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.543 -0.54 . . . . 61.41 109.543 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.0 mt -100.15 -16.71 17.71 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.128 0.489 . . . . 72.43 109.726 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 70.0 m 61.61 78.38 0.29 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.914 -1.039 . . . . 72.01 111.005 -174.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.4 t -77.32 131.91 38.34 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 114.093 -1.412 . . . . 64.54 109.232 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.45 108.82 2.86 Favored Glycine 0 N--CA 1.422 -2.282 0 N-CA-C 110.636 -0.986 . . . . 60.5 110.636 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--N 1.292 -1.898 0 CA-C-O 118.344 -0.836 . . . . 63.53 109.177 -179.561 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 109.031 -0.729 . . . . 72.22 109.031 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.1 m -79.69 -31.18 41.25 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.683 -0.407 . . . . 74.13 111.096 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.2 t -163.07 178.87 7.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.953 -1.129 . . . . 74.02 107.953 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -83.88 143.64 29.75 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.854 -1.165 . . . . 75.24 107.854 174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 12.1 t70 -64.65 125.05 87.95 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.538 -0.541 . . . . 75.51 109.538 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.1 -12.99 31.03 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.119 2.546 . . . . 72.42 114.197 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -140.34 38.98 1.9 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.257 -1.016 . . . . 73.31 108.257 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 42.3 p -52.23 124.09 12.29 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.161 -1.381 . . . . 63.21 110.351 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.95 156.2 19.04 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 114.647 -1.16 . . . . 73.33 111.059 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.489 ' CB ' HG13 ' A' ' 104' ' ' VAL . 3.3 m-20 -125.31 131.92 52.96 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.96 -1.496 . . . . 64.03 106.96 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.414 HG13 ' HB ' ' A' ' 13' ' ' VAL . 49.1 t -119.5 120.33 63.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 120.336 -0.546 . . . . 53.34 110.694 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -91.5 96.73 10.65 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 104.861 -2.274 . . . . 71.12 104.861 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.414 ' HB ' HG13 ' A' ' 11' ' ' VAL . 10.3 p -119.1 121.93 67.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 118.329 -1.348 . . . . 71.05 111.576 -173.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -92.35 66.86 4.77 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 106.025 -1.843 . . . . 72.33 106.025 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.38 -169.82 13.9 Favored Glycine 0 N--CA 1.42 -2.392 0 CA-C-N 113.537 -1.665 . . . . 70.43 109.381 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -88.0 85.11 6.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-O 121.606 0.717 . . . . 65.23 112.749 -174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.46 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 8.0 mm -144.43 -84.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 104.846 -2.279 . . . . 74.14 104.846 169.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.442 ' H ' ' HB ' ' A' ' 17' ' ' ILE . 80.6 mt 50.89 -42.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 128.086 2.554 . . . . 73.31 117.368 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.89 140.29 22.55 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.199 -0.667 . . . . 72.41 109.199 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -48.57 -28.65 12.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.586 3.524 . . . . 72.34 114.861 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.48 97.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.929 0.395 . . . . 73.54 111.08 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.626 ' O ' HG22 ' A' ' 25' ' ' VAL . 35.9 t -77.07 -30.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.882 -0.784 . . . . 65.05 108.882 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.64 -28.96 70.27 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.934 -0.765 . . . . 71.33 108.934 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.09 -8.7 57.59 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.434 -0.803 . . . . 37.77 111.767 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 22' ' ' VAL . 14.4 m -99.25 -23.07 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 119.619 -0.833 . . . . 71.52 110.773 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.432 HD11 ' C ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -85.85 -47.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 116.251 -0.431 . . . . 72.2 110.588 176.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' A' ' 31' ' ' ALA . 97.7 mt -89.66 -21.3 22.83 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 116.57 -0.286 . . . . 75.01 110.796 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 37.2 t70 68.72 10.7 8.04 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.289 1.519 . . . . 70.22 108.882 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -136.11 141.83 44.22 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 104.928 -2.249 . . . . 75.22 104.928 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -77.74 136.83 38.21 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.485 -0.886 . . . . 71.44 109.887 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -121.0 154.86 35.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.689 -0.485 . . . . 50.15 109.689 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -89.89 117.98 29.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.473 -0.566 . . . . 72.52 109.473 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.6 m -104.96 142.67 34.36 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.459 -2.052 . . . . 75.25 105.459 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.56 149.84 70.44 Favored Pre-proline 0 C--N 1.296 -1.75 0 O-C-N 122.088 -0.383 . . . . 74.02 110.133 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.53 133.47 37.24 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.605 2.203 . . . . 71.5 111.522 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.79 156.51 41.94 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.942 -0.572 . . . . 73.22 109.868 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.0 p -122.59 128.04 75.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-O 121.496 0.665 . . . . 73.23 111.045 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.446 ' HA ' HG11 ' A' ' 93' ' ' VAL . 22.4 tp -87.91 111.07 21.04 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.196 -0.911 . . . . 75.2 110.103 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -87.06 122.21 30.57 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.473 -0.785 . . . . 64.14 110.187 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.45 7.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.374 -1.393 . . . . 71.31 112.866 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.427 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 57.0 m-85 -117.78 161.11 20.24 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 109.288 -0.634 . . . . 73.12 109.288 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -133.41 131.98 40.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.25 -1.389 . . . . 72.0 107.25 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.688 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 1.2 tmt_? -88.56 120.56 30.06 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 109.292 -0.633 . . . . 71.31 109.292 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -95.99 159.82 14.77 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.987 -1.486 . . . . 75.53 106.987 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.475 ' C ' ' HD3' ' A' ' 45' ' ' LYS . 7.7 tmtm? -82.78 -41.76 18.76 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 112.156 0.428 . . . . 70.53 112.156 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 49' ' ' LEU . 7.9 mp 62.75 158.27 0.07 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.529 1.307 . . . . 73.13 114.529 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.41 -51.25 1.28 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.799 -0.815 . . . . 75.5 108.799 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.29 74.63 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.661 -1.154 . . . . 71.4 111.678 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.474 ' HB2' HD21 ' A' ' 46' ' ' LEU . 3.0 mm? -107.63 167.34 9.5 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.409 -0.96 . . . . 71.35 108.409 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -62.68 -157.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.52 0 C-N-CA 123.01 2.473 . . . . 63.11 112.905 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.521 ' N ' ' HD2' ' A' ' 52' ' ' PRO 0.349 12.8 p90 -57.49 -31.34 9.92 Favored Pre-proline 0 CA--C 1.568 1.665 0 N-CA-C 116.557 2.058 . . . . 72.13 116.557 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 51' ' ' TYR . 3.3 Cg_exo -39.74 168.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.59 3.317 0 C-N-CA 123.631 2.887 . . . . 71.52 112.746 163.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 p -139.29 -175.87 4.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.199 -1.563 . . . . 75.33 110.963 11.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 45.1 pt -123.77 141.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.116 -1.068 . . . . 73.33 108.116 172.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 m -148.18 158.77 7.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.951 -0.759 . . . . 62.11 108.951 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 m -80.5 88.91 5.62 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.739 0.78 . . . . 75.02 109.839 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.5 t -144.1 -66.02 0.35 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.574 -1.639 . . . . 74.22 106.574 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.63 125.68 30.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.387 -1.709 . . . . 73.13 106.387 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -84.41 15.46 3.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.846 0.684 . . . . 64.13 112.846 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.84 -147.73 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 114.617 0.607 . . . . 53.44 114.617 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -139.82 154.09 47.25 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 120.167 -0.613 . . . . 75.32 111.184 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.55 123.23 70.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.474 -0.785 . . . . 61.24 109.861 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -94.13 123.9 37.8 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.855 -0.424 . . . . 63.03 109.855 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.32 -149.03 5.19 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.16 -0.776 . . . . 63.22 111.16 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -138.3 156.55 47.55 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.904 -0.776 . . . . 73.32 108.904 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 33' ' ' THR . 29.8 m -125.8 129.62 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 120.782 0.325 . . . . 74.24 111.053 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 17' ' ' ILE . 6.2 mt -90.15 116.77 32.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.163 -1.421 . . . . 61.42 107.163 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.2 p -100.89 161.15 13.79 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.936 -0.306 . . . . 75.01 110.717 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.13 33.39 23.58 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.135 -0.555 . . . . 73.05 112.805 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.59 122.32 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 O-C-N 122.473 -0.428 . . . . 73.21 110.642 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.407 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 65.8 m -79.23 158.64 27.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.794 -0.762 . . . . 65.12 109.951 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -52.17 -34.93 47.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.171 0.804 . . . . 53.13 113.171 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -37.64 37.56 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.306 0.574 . . . . 73.24 110.654 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 13.3 mm-40 -68.16 -30.53 69.67 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.229 -0.896 . . . . 74.15 109.43 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 105' ' ' GLU . 4.2 tt -59.37 -35.09 73.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.397 -1.274 . . . . 74.23 109.538 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' HG22 ' A' ' 80' ' ' VAL . 3.4 t-20 -60.37 -28.16 67.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 72.34 110.96 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -31.63 70.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.439 -0.949 . . . . 72.24 108.439 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -67.78 -35.3 78.42 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 116.421 -0.354 . . . . 73.24 110.38 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -69.59 -35.94 75.77 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.726 0.774 . . . . 74.44 109.478 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 76' ' ' ASN . 80.5 t -72.64 -24.59 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 CA-C-N 115.154 -0.93 . . . . 74.34 112.792 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.454 ' HB ' ' OH ' ' A' ' 107' ' ' TYR . 47.9 mm -44.4 -74.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 113.15 0.796 . . . . 73.11 113.15 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -141.77 19.55 2.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.249 0.547 . . . . 75.14 110.847 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.46 62.89 4.0 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.927 -0.654 . . . . 71.44 113.183 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.38 -42.88 18.08 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.908 -0.404 . . . . 73.13 109.908 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.506 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.8 m-20 -114.49 17.19 17.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.251 1.024 . . . . 75.35 109.718 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.98 156.58 26.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.497 -1.298 . . . . 75.5 107.497 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HB3' HG13 ' A' ' 110' ' ' VAL . 14.3 pt-20 -126.17 142.29 51.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.829 -0.804 . . . . 74.11 108.829 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 tmm_? -88.09 118.07 27.41 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.579 -0.737 . . . . 73.34 109.824 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 m -126.27 160.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.359 0.664 . . . . 73.41 111.834 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.3 m -89.18 129.61 35.74 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 123.628 0.58 . . . . 63.54 109.552 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.87 172.16 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.362 -1.347 . . . . 72.35 107.362 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -123.6 129.85 51.78 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.319 -0.952 . . . . 74.34 109.167 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.446 HG11 ' HA ' ' A' ' 38' ' ' LEU . 16.2 m -127.03 168.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.073 0.464 . . . . 74.45 110.72 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.48 HG23 ' HG2' ' A' ' 101' ' ' LYS . 68.0 t -114.07 122.43 68.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.819 -0.628 . . . . 74.44 110.931 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 75.0 ttt180 -70.98 102.12 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.926 -1.138 . . . . 74.55 107.926 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.412 ' HE2' ' O ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -45.37 -60.0 2.38 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 126.818 2.047 . . . . 72.34 111.511 -171.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.1 -32.64 62.16 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.804 1.039 . . . . 71.54 113.804 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -110.47 -8.78 14.63 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.292 0.849 . . . . 62.22 113.292 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.41 25.69 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.966 0.907 . . . . 74.41 110.384 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -98.83 160.19 14.43 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.864 -0.791 . . . . 72.43 108.864 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HG2' HG23 ' A' ' 94' ' ' VAL . 88.2 mttt -105.05 137.31 42.99 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.582 -0.525 . . . . 74.14 109.582 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.13 140.62 43.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.714 -0.476 . . . . 71.11 109.714 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -90.8 127.74 36.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.241 -1.392 . . . . 71.12 107.241 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.489 HG13 ' CB ' ' A' ' 10' ' ' ASN . 28.2 m -133.98 171.95 17.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.024 0.44 . . . . 75.01 112.121 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.491 ' HG3' HD11 ' A' ' 75' ' ' LEU . 31.2 mm-40 -104.24 153.97 20.35 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.255 -1.387 . . . . 74.04 107.255 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -156.0 177.79 11.01 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.247 0.476 . . . . 74.15 110.166 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.454 ' OH ' ' HB ' ' A' ' 81' ' ' ILE . 3.9 m-85 -103.55 119.78 39.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 122.914 0.485 . . . . 74.45 109.85 177.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -119.55 159.99 20.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.873 -1.528 . . . . 73.32 106.873 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.703 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 54.0 t-105 -83.96 134.27 34.66 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.669 -0.863 . . . . 75.33 108.669 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 85' ' ' ASP . 29.5 m -72.21 -20.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 118.981 0.809 . . . . 73.14 112.419 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.703 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 26.0 t-20 -92.0 15.5 13.11 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 125.323 1.449 . . . . 54.54 108.992 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 45.5 pttt -47.75 -15.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 127.242 2.217 . . . . 71.44 116.356 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.41 -20.39 60.07 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 119.112 -1.035 . . . . 61.42 111.442 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -97.46 124.48 48.64 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 107.544 -1.28 . . . . 74.05 107.544 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.25 102.24 1.5 Allowed 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 121.403 1.402 . . . . 73.44 111.011 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.79 112.02 17.78 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.895 -1.15 . . . . 72.22 107.895 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 23.7 mmt 67.81 148.05 0.05 Allowed 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.639 1.212 . . . . 73.42 110.97 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -116.68 -20.88 9.35 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.962 -0.695 . . . . 75.31 111.199 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -134.26 164.38 24.54 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.748 -0.941 . . . . 64.54 110.748 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.688 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -144.75 149.91 36.35 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 115.128 1.529 . . . . 72.4 115.128 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -158.73 86.97 0.86 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.646 -1.615 . . . . 74.23 109.836 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.467 ' CB ' HH12 ' A' ' 43' ' ' ARG . 9.8 t70 -100.25 124.09 45.28 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.621 -0.718 . . . . 73.23 109.805 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -68.45 -42.98 78.03 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.687 0.995 . . . . 74.12 113.687 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 128' ' ' VAL 0.268 0.0 OUTLIER -74.3 -39.19 63.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 119.686 -0.805 . . . . 75.23 111.949 -175.156 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.76 -37.76 71.51 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.589 -0.732 . . . . 63.04 110.352 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -51.6 -57.18 9.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.29 -0.868 . . . . 73.44 111.406 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.3 -34.18 65.59 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.044 -0.662 . . . . 73.34 111.81 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 124' ' ' GLU . 70.8 t -62.75 -47.63 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.535 0.568 . . . . 74.11 112.535 -177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.16 -33.9 63.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.549 0.69 . . . . 75.33 109.905 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.471 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 55.6 t-80 -69.88 -45.71 67.06 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.961 -1.018 . . . . 65.44 109.844 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.47 ' O ' HG21 ' A' ' 135' ' ' VAL . . . -61.26 -52.97 62.5 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.98 -0.554 . . . . 52.11 111.022 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.03 -45.67 71.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 123.414 0.446 . . . . 72.11 111.51 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -61.51 -53.96 49.5 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.018 -0.992 . . . . 73.11 111.886 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 96.7 m-85 -74.95 -31.5 61.51 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 113.79 1.033 . . . . 75.43 113.79 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 131' ' ' ALA . 79.4 t -63.8 -45.94 95.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 121.139 -0.225 . . . . 54.13 111.295 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 12.5 pt-20 -67.77 -36.71 80.97 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.401 -0.919 . . . . 71.11 110.937 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.7 m -60.82 -47.21 87.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.937 -0.574 . . . . 73.13 109.46 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.546 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 87.1 t80 -59.16 -48.05 83.06 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.831 -0.622 . . . . 74.12 110.028 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 97.4 mtt180 -61.58 -42.89 99.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.181 -0.463 . . . . 74.42 112.148 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.4 mmtp -65.17 -42.37 93.73 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 121.019 -0.272 . . . . 75.25 110.537 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.523 ' HA ' ' HE3' ' A' ' 141' ' ' MET . 14.7 mmt -63.83 -31.86 73.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.199 -0.455 . . . . 72.14 111.728 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 90.6 mt -67.71 -45.53 74.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.858 -0.423 . . . . 70.03 109.858 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.1 mt-10 -60.79 -47.07 88.01 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 109.579 -0.526 . . . . 73.24 109.579 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -59.97 -38.98 84.11 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.216 1.007 . . . . 74.34 111.494 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.5 -45.61 13.41 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.056 -0.52 . . . . 72.05 112.262 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.71 -26.33 25.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.224 0.453 . . . . 63.21 112.224 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -123.25 124.17 26.46 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-O 120.731 0.301 . . . . 63.04 111.149 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.38 -19.41 67.17 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.656 2.237 . . . . 62.23 111.664 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -93.8 3.81 54.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.079 -0.51 . . . . 63.45 110.613 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.75 -32.98 74.78 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 108.912 -1.675 . . . . 74.22 108.912 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -94.92 145.37 24.96 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 105.774 -1.935 . . . . 53.24 105.774 170.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.6 m -74.25 155.65 38.05 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.271 -0.972 . . . . 71.33 110.337 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.437 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.3 mpt? -61.32 -39.84 92.02 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.822 0.849 . . . . 70.03 111.975 -172.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.66 -41.97 82.94 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 122.003 0.906 . . . . 71.14 110.497 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.83 -29.85 62.36 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.597 -1.183 . . . . 71.2 108.414 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.61 -27.28 69.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.786 -0.643 . . . . 65.23 110.219 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 153' ' ' MET . 48.3 t -84.32 -56.31 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.756 -0.831 . . . . 75.11 108.756 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 82.48 -44.72 3.25 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 121.156 -0.545 . . . . 63.12 112.869 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.8 m -71.73 -27.86 63.29 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.022 0.529 . . . . 74.2 111.032 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.9 mt -123.19 113.15 18.56 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.427 -0.583 . . . . 75.32 109.427 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tt -134.42 138.27 44.68 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.066 -1.087 . . . . 75.43 108.066 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.7 t -74.34 97.41 3.02 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.594 0.712 . . . . 72.23 110.163 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.8 t -171.27 124.64 0.61 Allowed 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 106.38 -1.711 . . . . 51.33 106.38 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -104.73 7.88 46.09 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.396 -0.906 . . . . 65.41 113.488 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.317 -0.841 0 CA-C-O 118.359 -0.829 . . . . 62.04 109.789 177.547 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.1 p . . . . . 0 C--O 1.241 0.65 0 N-CA-C 109.612 -0.514 . . . . 63.53 109.612 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 m -84.65 114.26 21.88 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.399 -1.334 . . . . 61.53 107.399 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -132.32 137.17 47.33 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.476 -0.329 . . . . 71.22 110.233 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.6 m 61.2 89.38 0.08 Allowed 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.987 0.915 . . . . 73.23 112.665 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 72' ' ' ASP . 12.4 m-20 -78.9 137.47 57.67 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 115.836 -0.62 . . . . 74.35 109.784 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.39 160.8 33.7 Favored 'Trans proline' 0 C--O 1.252 1.201 0 C-N-CA 122.206 1.937 . . . . 72.03 109.886 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 62.58 84.65 0.14 Allowed 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.861 0.839 . . . . 74.02 109.736 -172.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.7 p -64.23 149.07 48.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.673 -1.149 . . . . 74.45 111.619 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -108.9 156.26 19.89 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.655 -0.702 . . . . 65.34 110.411 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.44 ' HB2' HG13 ' A' ' 104' ' ' VAL . 84.1 m-20 -132.16 126.41 33.56 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.164 -1.421 . . . . 73.4 107.164 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 46.3 t -117.78 120.62 65.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 121.18 -0.208 . . . . 38.08 110.85 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -84.67 112.76 20.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.476 -0.935 . . . . 75.53 108.476 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.2 t -113.55 142.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.76 -0.83 . . . . 73.31 108.76 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -81.24 -53.98 5.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.708 -0.223 . . . . 70.32 111.426 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.95 79.64 0.13 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 118.531 -1.795 . . . . 75.31 114.974 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 p -162.6 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.38 0.61 . . . . 74.34 110.902 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.461 HG13 HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -91.16 70.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 CA-C-O 123.69 1.709 . . . . 71.42 107.605 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 65' ' ' LYS . 80.7 mt -114.12 -11.7 12.64 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-N 113.372 -1.74 . . . . 65.42 106.96 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -85.68 125.97 67.58 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 113.469 -1.696 . . . . 73.33 110.168 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.12 -38.24 80.57 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.805 2.336 . . . . 75.0 111.669 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.84 -44.97 91.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.918 0.39 . . . . 38.08 111.07 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.52 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -70.16 -34.42 58.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 121.258 0.551 . . . . 51.34 109.795 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.32 -35.71 79.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.223 0.535 . . . . 71.44 109.557 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.84 -13.07 61.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.581 -0.736 . . . . 63.25 111.94 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 22' ' ' VAL . 12.0 m -98.58 -26.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 119.602 -0.839 . . . . 74.44 110.45 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.498 HD12 ' CD1' ' A' ' 78' ' ' PHE . 6.0 tt -84.41 -41.63 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.015 0.436 . . . . 65.44 112.095 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.493 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 86.1 mt -99.62 -21.16 15.99 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.299 -0.409 . . . . 71.33 111.173 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.4 t70 75.84 -5.0 2.26 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.624 1.202 . . . . 64.02 108.925 -171.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 27' ' ' LEU . 84.9 mtt180 -105.94 138.11 42.69 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 113.754 -1.566 . . . . 65.31 107.665 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -79.62 111.15 15.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 106.403 -1.703 . . . . 75.13 106.403 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -89.52 157.06 18.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.388 0.613 . . . . 73.04 111.726 -174.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.63 114.61 27.77 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.959 -1.019 . . . . 74.23 111.323 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 1.7 p -102.62 143.07 32.77 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.519 -0.764 . . . . 63.04 109.775 174.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 m -136.16 143.26 43.13 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 109.155 -0.683 . . . . 62.23 109.155 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.2 132.79 54.05 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.272 1.981 . . . . 64.15 110.671 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.12 36.51 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 109.014 -0.735 . . . . 62.21 109.014 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.23 127.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-O 121.743 0.782 . . . . 72.43 111.988 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.3 tp -90.24 102.36 15.08 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.723 -1.126 . . . . 63.34 109.943 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 61' ' ' LYS . 9.9 p-80 -76.28 125.26 28.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.302 -0.863 . . . . 72.13 109.771 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 117.42 -21.04 10.93 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 118.869 -1.634 . . . . 74.22 114.207 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -106.65 157.31 17.8 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 117.888 0.844 . . . . 73.15 111.482 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -124.92 124.26 41.67 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.403 -0.962 . . . . 72.04 108.403 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -90.86 147.19 23.34 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.763 0.316 . . . . 71.11 110.976 177.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.54 -169.99 1.96 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.527 0.566 . . . . 72.43 112.527 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HZ3' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -109.27 -36.83 5.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.592 -0.276 . . . . 75.25 110.878 178.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 3.8 mm? 64.06 -178.02 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.045 0.538 . . . . 62.51 111.991 -174.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 28.04 6.58 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 113.035 0.754 . . . . 71.52 113.035 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.44 15.0 0.17 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.731 -1.223 . . . . 71.31 113.339 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.411 ' C ' ' HG3' ' A' ' 52' ' ' PRO . 3.6 mm? -95.49 160.17 31.08 Favored Pre-proline 0 C--N 1.311 -1.075 0 O-C-N 122.291 -0.534 . . . . 74.14 110.834 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -90.35 119.56 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.01 2.474 . . . . 74.14 112.504 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.476 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.341 21.6 p90 39.78 60.66 6.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 113.835 1.05 . . . . 73.44 113.835 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 89.3 Cg_endo -115.52 144.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.153 3.235 . . . . 74.25 116.764 -170.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 82.2 m -153.46 -178.84 7.26 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 130.123 3.369 . . . . 74.22 101.916 -13.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 HG13 ' A' ' 108' ' ' VAL . 43.0 pt -123.35 122.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.988 -1.085 . . . . 74.3 110.94 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.33 177.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.704 -1.134 . . . . 75.05 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.8 p 50.96 102.43 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.619 1.568 . . . . 71.54 112.261 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 23.2 t -73.82 83.89 1.66 Allowed 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.799 -0.76 . . . . 73.22 111.617 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.0 -167.3 1.61 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.137 -0.938 . . . . 44.52 109.808 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.3 m -89.45 5.57 44.72 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.567 -0.901 . . . . 61.01 108.567 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.43 165.31 53.81 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.202 -0.908 . . . . 64.23 111.563 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HD2' ' HB3' ' A' ' 39' ' ' HIS . 27.9 mtmm -138.06 146.73 43.33 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.329 -0.619 . . . . 72.54 109.329 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -110.08 122.89 65.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.183 -0.673 . . . . 73.23 109.183 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.38 125.43 46.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.288 -1.004 . . . . 61.43 108.288 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.46 -141.24 3.17 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.501 -1.04 . . . . 52.31 110.501 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.418 ' HB2' HD23 ' A' ' 18' ' ' LEU . 38.9 mtmt -136.82 138.79 41.2 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 113.291 0.849 . . . . 74.51 113.291 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.428 HG11 HG22 ' A' ' 93' ' ' VAL . 31.5 m -104.7 133.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 114.689 -1.141 . . . . 54.01 110.054 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.441 HD11 HD13 ' A' ' 17' ' ' ILE . 14.5 mt -88.42 111.64 22.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 105.638 -1.986 . . . . 73.21 105.638 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -97.49 161.53 13.73 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.236 -0.586 . . . . 74.12 111.536 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.05 60.12 Favored Glycine 0 CA--C 1.522 0.52 0 O-C-N 123.285 0.366 . . . . 54.35 113.635 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.62 131.98 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 110.25 -0.278 . . . . 70.23 110.25 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.46 ' HB3' ' H ' ' A' ' 5' ' ' ASP . 24.2 m -78.37 158.96 28.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.124 -0.631 . . . . 75.45 109.775 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' H ' ' HB2' ' A' ' 5' ' ' ASP . 19.0 t70 -55.81 -45.44 78.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.612 -0.722 . . . . 70.12 111.342 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.51 -36.09 76.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.735 -0.666 . . . . 51.5 111.232 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.493 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 54.1 mt-10 -73.72 -35.7 65.13 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.722 -0.672 . . . . 75.21 111.09 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.502 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.5 tt -60.21 -35.41 75.37 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.706 -0.85 . . . . 65.05 108.706 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -55.5 -27.75 50.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.784 -1.098 . . . . 73.44 112.141 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.501 ' O ' HG21 ' A' ' 81' ' ' ILE . 5.4 t30 -74.33 -31.86 62.61 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 119.391 -0.924 . . . . 74.23 109.503 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.498 ' CD1' HD12 ' A' ' 26' ' ' ILE . 73.6 m-85 -71.81 -42.03 67.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.229 -1.397 . . . . 74.12 107.229 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.427 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 9.4 t70 -55.96 -52.63 63.47 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.261 -1.336 . . . . 72.22 110.291 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.02 -33.14 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 113.294 0.85 . . . . 75.42 113.294 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.501 HG21 ' O ' ' A' ' 77' ' ' ASN . 17.0 tt -101.21 -34.24 3.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 C-N-CA 118.464 -1.294 . . . . 73.14 113.996 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -79.26 -19.0 51.69 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.929 -0.708 . . . . 74.52 110.841 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.81 60.37 3.89 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.992 -0.623 . . . . 70.32 112.427 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -81.81 -44.59 16.73 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.853 -0.795 . . . . 74.44 108.853 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -141.05 21.55 2.27 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.873 -1.528 . . . . 71.44 106.873 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -122.7 153.74 39.01 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.731 -1.577 . . . . 75.43 107.401 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HB3' HG23 ' A' ' 110' ' ' VAL . 9.9 pt-20 -126.33 153.8 44.37 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 120.195 -0.602 . . . . 74.4 111.086 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.427 ' HD3' ' OD2' ' A' ' 79' ' ' ASP . 58.3 ttt180 -82.84 121.29 26.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.773 -1.103 . . . . 73.43 111.427 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.73 159.11 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.583 -0.735 . . . . 70.33 109.607 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.57 131.2 39.06 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.564 -0.902 . . . . 70.1 108.564 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.79 165.48 26.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.431 -1.322 . . . . 73.53 107.431 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -117.92 128.74 55.11 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.56 -1.256 . . . . 71.35 109.097 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.428 HG22 HG11 ' A' ' 66' ' ' VAL . 18.3 m -125.98 168.71 18.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.879 -0.415 . . . . 65.42 109.879 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.497 HG23 ' HG2' ' A' ' 101' ' ' LYS . 73.5 t -109.96 118.01 55.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 115.957 -0.565 . . . . 72.0 110.786 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -73.04 105.22 4.41 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.137 -1.06 . . . . 72.31 108.137 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.87 62.31 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 124.423 1.089 . . . . 75.44 110.032 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.98 -33.92 71.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.493 -0.776 . . . . 74.23 112.334 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -128.73 0.65 5.45 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 120.627 -0.429 . . . . 71.13 111.66 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 62.28 26.78 16.04 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.471 0.708 . . . . 43.22 110.615 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.9 160.52 14.54 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.557 -0.747 . . . . 72.24 109.727 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.497 ' HG2' HG23 ' A' ' 94' ' ' VAL . 38.7 mtmt -102.4 135.69 43.55 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.536 -0.913 . . . . 54.21 108.536 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.1 m -133.87 139.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.249 0.547 . . . . 71.14 109.892 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.62 122.06 30.84 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.648 -1.612 . . . . 61.25 106.648 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 10' ' ' ASN . 17.8 m -131.52 175.13 11.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.083 0.468 . . . . 75.31 111.137 -171.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.82 146.99 27.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.771 -1.196 . . . . 73.21 107.771 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.0 t -149.5 174.32 12.62 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.279 -1.008 . . . . 73.32 108.279 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 92.6 m-85 -118.75 118.72 32.35 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.276 0.56 . . . . 73.01 109.739 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 54' ' ' ILE . 33.7 m -108.98 175.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.184 -1.043 . . . . 63.4 108.184 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.529 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 23.0 t-105 -74.69 132.49 41.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.929 -1.508 . . . . 74.41 106.929 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.8 p -69.62 -20.78 24.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.918 0.866 . . . . 75.14 110.61 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 7.9 t30 -88.92 15.12 8.98 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.719 1.208 . . . . 74.31 109.17 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 61.3 pttt -48.94 -15.66 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.069 1.748 . . . . 75.13 115.123 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -72.84 -22.95 60.71 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.012 -0.675 . . . . 65.41 110.404 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -113.84 122.94 33.81 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.486 -0.561 . . . . 63.21 109.486 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.63 115.36 4.05 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.679 2.252 . . . . 74.54 109.591 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.683 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 30.7 ttm180 -129.61 124.26 33.3 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.741 -0.837 . . . . 72.5 108.741 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.683 ' SD ' ' HG2' ' A' ' 116' ' ' ARG . 1.3 mpt? 74.07 129.47 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.353 1.061 . . . . 74.04 112.263 -174.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -108.23 -11.33 15.25 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.671 -0.695 . . . . 72.23 110.132 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 45' ' ' LYS . . . -79.56 137.11 18.43 Favored Glycine 0 N--CA 1.431 -1.665 0 CA-C-N 115.277 -0.874 . . . . 73.03 112.539 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.53 -179.86 4.35 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.869 -0.789 . . . . 73.32 108.869 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 79.82 109.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.173 0.921 . . . . 74.13 112.381 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 126' ' ' TRP . 7.5 t70 -127.27 143.02 51.32 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.83 -1.915 . . . . 74.34 105.83 173.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 126' ' ' TRP . 53.8 p90 -67.54 -47.69 69.14 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.548 1.314 . . . . 74.33 114.548 -174.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.89 -33.78 59.96 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.803 -0.759 . . . . 74.23 112.328 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -77.13 -2.33 33.75 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.515 0.674 . . . . 75.55 111.599 174.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.573 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 28.0 t90 -81.37 -35.64 30.57 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.185 -0.916 . . . . 74.13 110.1 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -51.85 -48.92 63.78 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.88 0.738 . . . . 74.21 111.49 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.7 -34.47 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.356 -0.838 . . . . 71.41 112.835 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.46 -44.3 17.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.224 -0.658 . . . . 65.43 109.224 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -55.49 -37.67 68.13 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.033 0.933 . . . . 74.34 111.73 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.74 72.05 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.855 -0.338 . . . . 53.15 111.256 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.464 ' HA ' HG11 ' A' ' 135' ' ' VAL . 7.4 mm-40 -72.3 -35.03 68.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.597 0.713 . . . . 63.34 111.028 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.529 ' HB3' ' HZ3' ' A' ' 133' ' ' LYS . 4.3 mmmp? -68.32 -22.08 64.72 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.466 -0.788 . . . . 74.45 112.276 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 163' ' ' SER . 5.2 m-85 -98.15 -31.85 11.9 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.051 -0.659 . . . . 75.25 112.015 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 132' ' ' GLU . 11.4 p -66.07 -33.81 66.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 C-N-CA 120.04 -0.664 . . . . 61.23 109.64 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 11.4 pt-20 -60.15 -38.79 84.2 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.432 -0.349 . . . . 65.32 110.22 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 162' ' ' SER . 74.0 m -56.38 -46.4 80.09 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 123.538 0.524 . . . . 75.32 111.038 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' HA ' ' HG2' ' A' ' 141' ' ' MET . 95.6 m-85 -67.43 -32.2 72.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.231 -0.441 . . . . 72.53 111.265 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.637 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 53.5 mtp180 -70.38 -38.88 74.79 Favored 'General case' 0 C--O 1.184 -2.391 0 C-N-CA 119.474 -0.89 . . . . 70.02 111.087 171.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 75.2 mmtt -56.24 -47.23 78.9 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.807 -0.442 . . . . 71.04 109.807 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.648 ' HA ' ' CE3' ' A' ' 144' ' ' TRP . 27.0 ptm -66.22 -30.75 71.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.074 -0.512 . . . . 75.01 110.511 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -44.71 74.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.551 -1.277 . . . . 74.35 107.551 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 7.2 mm-40 -60.93 -29.64 69.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.912 0.885 . . . . 74.35 110.747 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.648 ' CE3' ' HA ' ' A' ' 141' ' ' MET . 26.1 m0 -75.3 -44.19 46.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.627 -0.508 . . . . 75.05 109.627 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.29 -47.85 72.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.384 -0.825 . . . . 63.41 112.248 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.11 -19.41 24.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.281 0.562 . . . . 74.35 110.351 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 143' ' ' GLU 0.345 7.9 p30 46.19 72.41 1.25 Allowed Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 116.96 2.208 . . . . 74.25 116.96 176.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.22 -27.11 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.14 1.893 . . . . 74.34 112.092 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.23 -25.53 22.83 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.108 0.48 . . . . 62.2 110.711 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 90.39 12.81 60.84 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.52 -1.032 . . . . 72.32 110.52 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.63 144.94 24.83 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 109.68 -0.489 . . . . 73.14 109.68 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.1 m -105.72 171.32 7.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.435 -0.58 . . . . 74.24 109.435 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -65.41 -36.16 83.12 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.619 0.97 . . . . 72.12 113.619 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.68 -19.03 58.18 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.28 0.562 . . . . 72.32 110.753 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.9 -40.75 91.8 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.129 -1.063 . . . . 75.23 108.129 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.83 61.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.353 -0.84 . . . . 71.44 111.812 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 87.2 t -57.27 108.79 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.464 0.65 . . . . 73.32 110.743 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.25 -103.8 0.24 Allowed Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 109.277 -1.529 . . . . 72.32 109.277 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 56.6 p -89.52 75.75 7.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.39 0.614 . . . . 53.32 110.144 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 37.3 tp 179.29 150.83 0.32 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 104.977 -2.231 . . . . 70.25 104.977 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 48.7 tp -136.64 151.11 48.95 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.96 -0.756 . . . . 54.11 108.96 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 137' ' ' THR . 19.8 m -57.28 -37.33 72.23 Favored 'General case' 0 C--O 1.222 -0.385 0 O-C-N 123.6 0.563 . . . . 75.01 109.759 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 60.5 p 64.83 144.37 0.03 OUTLIER 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.425 1.49 . . . . 73.4 114.873 175.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.41 -155.16 25.97 Favored Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 108.223 -1.951 . . . . 74.33 108.223 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--N 1.282 -2.328 0 N-CA-C 109.106 -0.701 . . . . 62.13 109.106 176.33 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 109.498 -0.556 . . . . 63.32 109.498 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.9 m -132.96 92.91 3.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.552 -1.277 . . . . 73.43 107.552 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.1 m -111.1 95.89 5.81 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.717 0.77 . . . . 64.33 111.534 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 m -134.83 156.38 49.0 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.636 -1.246 . . . . 72.02 107.636 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -71.56 137.55 83.35 Favored Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 107.422 -1.325 . . . . 73.31 107.422 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.15 82.42 1.32 Allowed 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 121.782 1.654 . . . . 55.11 112.313 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.11 93.01 8.06 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 104.896 -2.261 . . . . 71.34 104.896 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.4 p -71.2 128.38 35.73 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 115.038 -0.983 . . . . 65.02 111.111 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -87.56 153.07 21.69 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.555 -0.748 . . . . 74.41 110.23 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 84.5 m-20 -133.64 131.34 39.45 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.065 -1.828 . . . . 53.43 106.065 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 28.4 t -116.3 119.37 61.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 120.326 -0.55 . . . . 71.41 110.788 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -89.21 109.26 20.16 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.961 -1.496 . . . . 71.45 106.961 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.527 ' O ' HD13 ' A' ' 18' ' ' LEU . 12.4 p -136.29 154.98 33.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 119.741 -0.784 . . . . 54.12 109.994 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -125.11 93.27 3.83 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.094 -0.706 . . . . 73.01 109.094 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.88 -176.46 16.16 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.76 -1.109 . . . . 72.34 111.217 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m 67.5 -73.59 0.08 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 115.137 1.532 . . . . 61.35 115.137 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.454 ' CG1' HD13 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -119.06 14.71 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.046 0.758 . . . . 70.35 113.046 -172.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 13' ' ' VAL . 74.7 mt -74.89 -6.72 50.71 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.195 0.522 . . . . 74.52 111.033 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 115.11 60.47 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 107.436 -1.32 . . . . 62.03 107.436 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -42.24 -44.09 7.72 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.326 3.35 . . . . 71.04 114.659 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.12 94.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.169 0.509 . . . . 72.35 111.494 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 25' ' ' VAL . 46.6 t -71.58 -38.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.965 -0.561 . . . . 74.33 110.248 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.73 74.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.465 0.65 . . . . 64.03 110.05 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -74.84 -16.48 60.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.648 -0.705 . . . . 75.34 111.903 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.3 m -93.54 -33.51 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.493 -0.883 . . . . 65.04 111.233 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.618 HD12 ' CD1' ' A' ' 78' ' ' PHE . 9.2 tt -72.46 -47.04 53.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 CA-C-O 120.587 0.232 . . . . 74.11 111.119 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 31' ' ' ALA . 90.7 mt -85.71 -11.98 52.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 121.221 -0.191 . . . . 71.3 110.877 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.53 8.91 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.287 1.042 . . . . 74.33 110.296 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 97.5 mtt180 -145.12 178.66 7.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.162 -0.926 . . . . 75.24 109.321 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.6 p -76.66 111.2 11.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.523 0.678 . . . . 74.32 110.922 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.55 -0.75 . . . . 55.31 110.321 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -100.17 109.69 21.96 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.571 -0.529 . . . . 73.31 109.571 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.8 p -114.09 142.58 46.03 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 109.096 -0.705 . . . . 74.24 109.096 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.428 HG22 ' HE ' ' A' ' 95' ' ' ARG . 19.3 m -142.22 141.45 21.36 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 107.896 -1.15 . . . . 64.13 107.896 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 3.2 Cg_endo -59.76 135.78 66.05 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 121.47 1.447 . . . . 73.32 110.456 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -148.88 157.87 43.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.691 -0.686 . . . . 52.1 110.461 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.538 ' CG1' ' HD3' ' A' ' 61' ' ' LYS . 22.0 t -115.63 124.21 71.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 115.353 -0.839 . . . . 63.0 111.443 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.42 ' HA ' HG11 ' A' ' 93' ' ' VAL . 22.6 tp -97.6 86.67 3.88 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.211 0.529 . . . . 75.13 111.015 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 25.0 p-80 -62.34 132.47 52.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.027 -0.988 . . . . 74.44 109.46 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.38 -23.93 11.9 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.349 -0.929 . . . . 71.41 112.425 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 48.2 m-85 -109.81 160.46 16.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 112.481 0.548 . . . . 74.2 112.481 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -131.61 126.84 35.77 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.26 -1.385 . . . . 73.32 107.26 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 24.7 ptt180 -89.68 136.71 32.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.102 -1.039 . . . . 72.4 111.376 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.39 -177.56 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.946 -1.025 . . . . 75.12 109.58 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 45' ' ' LYS 0.252 0.0 OUTLIER -138.43 91.83 2.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.73 1.252 . . . . 75.1 112.199 178.497 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mm? -92.54 125.73 37.31 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.415 -0.812 . . . . 61.24 109.937 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -9.01 23.39 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.574 -0.739 . . . . 75.44 110.508 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.72 -14.82 39.07 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.409 -0.814 . . . . 71.35 111.191 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD13 ' CZ2' ' A' ' 109' ' ' TRP . 94.8 mt -118.46 163.57 24.75 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 109.448 -0.575 . . . . 73.01 109.448 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 Cg_endo -79.25 99.65 1.26 Allowed 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 123.074 2.516 . . . . 64.01 114.708 -173.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.625 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.5 p90 43.91 37.86 0.32 Allowed Pre-proline 0 CA--C 1.594 2.668 0 N-CA-C 116.614 2.079 . . . . 75.04 116.614 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 9.3 Cg_endo -97.77 167.18 0.8 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 123.384 2.723 . . . . 74.02 111.775 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 16.3 p -155.97 -169.52 3.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.582 2.353 . . . . 73.42 107.302 -4.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 36.5 pt -125.88 123.35 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 109.99 -0.374 . . . . 74.33 109.99 167.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 56' ' ' SER . 59.1 t -146.21 118.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.841 -0.8 . . . . 73.43 108.841 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 26.8 t 174.57 164.43 0.23 Allowed 'General case' 0 C--O 1.241 0.658 0 O-C-N 123.533 0.52 . . . . 71.32 110.23 175.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -137.19 7.85 2.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.227 -1.397 . . . . 74.3 107.227 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 59' ' ' SER . 13.3 t70 -82.94 -166.94 1.47 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.198 -1.365 . . . . 73.34 109.774 -174.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.429 ' H ' ' CG ' ' A' ' 58' ' ' ASP . 61.8 m -93.86 14.69 18.67 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.838 0.455 . . . . 43.11 111.657 -176.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.79 168.26 54.78 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 109.557 -1.417 . . . . 64.43 109.557 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.538 ' HD3' ' CG1' ' A' ' 37' ' ' VAL . 7.8 ptpp? -146.21 152.1 38.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.894 0.847 . . . . 72.14 111.117 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -115.51 133.41 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.402 -0.592 . . . . 64.05 109.402 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -99.9 137.64 38.08 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.3 -1.0 . . . . 62.13 108.3 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -166.1 -147.61 5.25 Favored Glycine 0 C--N 1.301 -1.373 0 N-CA-C 110.471 -1.052 . . . . 64.24 110.471 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -133.8 143.02 48.13 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.065 0.432 . . . . 60.11 111.844 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.1 m -108.68 133.18 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.157 -0.928 . . . . 60.23 110.946 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 23.7 mt -90.31 114.99 28.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.142 -1.799 . . . . 73.15 106.142 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.2 p -103.92 161.36 14.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.026 -0.67 . . . . 74.3 111.89 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.89 22.46 68.94 Favored Glycine 0 CA--C 1.506 -0.528 0 CA-C-N 115.728 -0.669 . . . . 53.43 113.082 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.02 121.83 37.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.893 -0.41 . . . . 72.04 109.893 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.419 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 18.0 m -73.18 158.62 34.9 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.378 -0.971 . . . . 64.24 108.378 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.39 -40.31 71.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.154 0.502 . . . . 71.43 111.64 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.64 78.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.927 -0.579 . . . . 74.44 110.838 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 48.0 mm-40 -72.31 -34.39 68.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.184 0.516 . . . . 70.54 110.212 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.63 -36.64 76.76 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.368 -0.833 . . . . 74.41 108.859 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.682 ' O ' HG22 ' A' ' 80' ' ' VAL . 28.2 t-20 -58.92 -29.41 67.07 Favored 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 114.628 -1.169 . . . . 70.1 111.467 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -68.3 -35.25 77.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.822 -0.807 . . . . 51.12 108.822 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.618 ' CD1' HD12 ' A' ' 26' ' ' ILE . 94.2 m-85 -74.16 -37.27 64.06 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.536 -0.756 . . . . 74.3 108.964 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.99 -34.19 77.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.201 -1.363 . . . . 73.03 110.995 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 76' ' ' ASN . 60.8 t -75.26 -42.96 43.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.71 -0.677 . . . . 71.13 111.709 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.8 tt -74.85 -61.14 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 114.675 1.361 . . . . 71.35 114.675 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -115.65 171.57 7.66 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.99 -0.444 . . . . 54.35 109.845 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 55.67 2.26 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.648 -0.787 . . . . 70.41 112.83 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.27 -42.31 46.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.759 0.281 . . . . 72.52 111.759 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.517 ' O ' HG22 ' A' ' 110' ' ' VAL . 1.9 t70 -108.16 26.43 10.42 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.325 -1.361 . . . . 73.01 107.325 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 51.6 m-85 -114.1 155.51 25.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.608 -1.178 . . . . 74.14 109.692 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HB3' HG13 ' A' ' 110' ' ' VAL . 15.7 pt-20 -126.66 158.6 35.94 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.3 0.375 . . . . 73.4 110.321 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -88.86 113.73 24.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.82 -0.627 . . . . 63.55 110.426 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.47 150.33 34.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.974 -0.38 . . . . 72.3 109.974 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.9 m -94.86 123.1 38.13 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.026 -0.731 . . . . 72.11 109.026 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' A' ' 38' ' ' LEU . 33.7 m -127.38 158.76 38.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.11 -1.07 . . . . 72.14 108.11 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -113.52 132.23 55.77 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.907 -1.117 . . . . 72.05 108.615 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.445 HG22 HG11 ' A' ' 66' ' ' VAL . 20.1 m -126.41 168.27 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 121.304 0.573 . . . . 74.35 110.331 -176.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.456 HG23 ' HG2' ' A' ' 101' ' ' LYS . 67.5 t -110.04 117.13 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.325 -0.852 . . . . 63.3 110.299 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.428 ' HE ' HG22 ' A' ' 34' ' ' VAL . 38.3 ttm180 -65.43 98.58 0.36 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.546 -0.909 . . . . 74.3 108.546 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.424 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 1.2 tmt? -53.84 -34.76 60.28 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 126.259 1.824 . . . . 74.12 110.908 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.02 -41.31 87.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.587 -0.733 . . . . 72.43 112.232 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -118.84 -3.95 10.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 120.315 -0.554 . . . . 75.32 112.355 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 67.44 24.98 8.66 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.73 0.812 . . . . 54.34 111.495 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.412 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 13.5 pt-20 -104.61 159.71 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.246 -0.65 . . . . 70.21 109.246 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.456 ' HG2' HG23 ' A' ' 94' ' ' VAL . 44.0 mtmt -102.48 135.08 44.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.699 -0.852 . . . . 62.03 108.699 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.62 138.47 44.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.03 0.443 . . . . 75.44 110.237 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.89 126.22 34.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.971 -1.122 . . . . 75.01 107.971 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.421 HG13 ' CB ' ' A' ' 10' ' ' ASN . 16.3 m -133.23 174.68 12.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 120.733 0.301 . . . . 74.15 110.256 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.97 150.27 28.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.558 -1.275 . . . . 72.02 107.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 t -145.94 175.18 10.63 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.421 -0.585 . . . . 61.24 109.421 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.68 118.35 36.43 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.052 -1.092 . . . . 72.51 108.052 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 54' ' ' ILE . 12.7 p -112.35 148.65 15.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.288 -1.375 . . . . 63.11 107.288 176.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 41.6 t-105 -73.08 125.93 28.82 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.693 -1.225 . . . . 72.22 107.693 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 85' ' ' ASP . 24.8 m -62.6 -22.46 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.947 0.721 . . . . 74.55 112.947 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.526 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 63.1 t30 -81.39 12.7 3.43 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.765 0.793 . . . . 73.32 110.09 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 -14.83 0.16 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.005 1.854 . . . . 64.43 116.005 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.07 -17.5 52.53 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.408 -0.517 . . . . 74.44 112.075 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.63 126.89 67.57 Favored Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 119.37 -0.932 . . . . 74.33 110.355 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.0 -6.11 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.719 2.946 . . . . 54.44 115.373 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -125.69 113.78 17.79 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.581 0.705 . . . . 75.11 110.846 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 39.3 ttm -153.14 27.81 0.52 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.19 0.995 . . . . 73.54 108.735 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -72.72 -19.09 61.46 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 114.73 -1.123 . . . . 75.35 111.243 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.81 -139.07 23.9 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.5 -0.773 . . . . 52.33 112.811 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -113.23 -178.13 3.3 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 122.652 0.381 . . . . 64.45 111.447 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 76.0 m95 85.83 -159.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.416 1.886 . . . . 75.14 108.786 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.03 137.46 39.36 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.855 -0.338 . . . . 75.51 111.307 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -68.33 -40.48 81.59 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.954 -0.566 . . . . 74.22 111.98 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.7 tt0 -73.03 -35.81 66.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 120.948 0.404 . . . . 74.22 110.094 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 129' ' ' VAL . 33.1 tt0 -56.35 -43.56 79.22 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.499 -0.926 . . . . 64.35 108.499 173.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -60.23 -42.72 95.83 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.825 -0.625 . . . . 74.02 110.481 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.583 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 99.8 mtt180 -56.87 -48.58 77.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.272 -0.64 . . . . 64.42 109.272 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.613 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 79.2 t -59.21 -47.08 91.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.93 -1.032 . . . . 74.11 111.023 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 125' ' ' GLU . 98.6 t -67.35 -44.36 87.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.709 -0.223 . . . . 64.33 111.537 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.583 ' CE1' ' HA ' ' A' ' 127' ' ' ARG 0.253 3.7 p-80 -72.16 -30.41 64.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 118.612 -1.235 . . . . 74.51 111.827 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.33 77.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.979 -0.378 . . . . 43.45 109.979 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 42.6 mt-10 -63.31 -37.98 89.36 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.728 -0.669 . . . . 71.15 109.969 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.26 -38.26 88.6 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.069 -0.969 . . . . 74.43 110.479 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.423 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 86.8 m-85 -73.09 -52.16 15.32 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.842 -0.617 . . . . 74.32 111.098 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.55 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.1 p -59.89 -39.02 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 112.134 0.42 . . . . 72.53 112.134 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 48.6 mt-10 -59.07 -43.5 91.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 117.678 0.217 . . . . 60.21 111.048 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.6 m -58.36 -48.53 80.29 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.986 -0.552 . . . . 74.12 110.045 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 83.3 m-85 -61.73 -43.93 97.9 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.374 -0.376 . . . . 74.4 111.543 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 81.9 mtp180 -59.8 -44.83 93.79 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 123.047 0.217 . . . . 74.01 111.051 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 67.9 mttm -61.57 -47.34 85.95 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.314 0.384 . . . . 73.15 110.535 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.1 -34.99 78.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.12 110.964 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 91.3 mt -69.19 -38.88 78.88 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 116.291 -0.413 . . . . 73.41 110.628 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 32.3 mm-40 -59.35 -36.36 75.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.714 0.292 . . . . 74.41 110.362 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -68.22 -40.68 82.02 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.218 0.821 . . . . 64.54 113.218 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -74.32 -25.83 59.79 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.586 0.707 . . . . 74.13 110.606 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -78.91 -30.58 44.9 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.719 1.207 . . . . 74.43 112.161 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.36 99.82 45.39 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 120.249 -0.581 . . . . 64.4 112.457 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.28 -35.62 72.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.506 2.138 . . . . 74.55 110.103 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.27 -8.72 58.38 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.893 -1.049 . . . . 75.22 111.156 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.22 72.4 Favored Glycine 0 CA--C 1.507 -0.41 0 N-CA-C 111.252 -0.739 . . . . 73.01 111.252 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -94.04 149.3 21.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.438 -1.69 . . . . 72.04 106.438 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.466 ' H ' ' HB2' ' A' ' 155' ' ' GLU . 89.4 p -81.64 178.32 8.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.81 -0.811 . . . . 74.12 108.81 175.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -60.41 -30.83 69.86 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.193 0.521 . . . . 73.53 110.658 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -91.94 -23.69 19.5 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 116.015 -0.539 . . . . 73.51 110.814 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.466 ' HB2' ' H ' ' A' ' 152' ' ' SER . 23.5 mm-40 -74.82 -42.27 58.34 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.983 0.421 . . . . 64.01 111.397 174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.35 -34.83 48.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.077 -0.51 . . . . 65.44 109.933 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.9 t 58.16 114.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.785 1.234 . . . . 74.23 111.972 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.14 32.15 6.89 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 120.38 -0.914 . . . . 37.29 111.973 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.4 m -84.38 137.58 33.33 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.261 -1.014 . . . . 70.15 108.261 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.3 tp -96.7 130.11 43.99 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.601 -0.518 . . . . 73.2 109.601 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.7 tp -158.98 157.52 31.45 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.672 -1.232 . . . . 71.54 107.672 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 m -76.77 84.12 3.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.377 0.608 . . . . 71.33 110.34 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 54.7 m -157.18 90.57 1.13 Allowed 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 124.499 1.12 . . . . 72.31 108.273 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 174.8 73.08 0.05 OUTLIER Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 110.431 -1.068 . . . . 64.31 110.431 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 108.855 -0.795 . . . . 72.5 108.855 179.505 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 120.589 0.233 . . . . 63.42 110.791 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.9 p -84.44 105.79 15.54 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 121.234 0.54 . . . . 74.31 110.774 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 m -68.62 -26.44 65.35 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.254 -0.885 . . . . 75.42 112.532 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 m -127.29 83.87 2.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.29 0.567 . . . . 74.24 110.757 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 11.6 t70 -93.79 -61.74 0.18 Allowed Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.873 -0.603 . . . . 44.54 112.574 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 5' ' ' ASP . 5.7 Cg_exo -80.98 -43.56 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.215 1.277 . . . . 72.23 112.679 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -142.01 -173.9 3.94 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 123.565 0.746 . . . . 74.0 109.218 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m -127.77 151.89 48.44 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.686 -1.598 . . . . 74.2 106.686 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -87.88 155.56 19.81 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.553 0.692 . . . . 71.35 112.186 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -135.82 123.74 22.71 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.901 -1.518 . . . . 75.3 106.901 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.421 HG13 HG22 ' A' ' 13' ' ' VAL . 51.3 t -120.31 122.95 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 120.959 -0.297 . . . . 63.54 110.71 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -90.95 99.15 12.23 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.122 -0.695 . . . . 72.54 109.122 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.421 HG22 HG13 ' A' ' 11' ' ' VAL . 72.9 t -139.15 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.228 -0.286 . . . . 71.41 110.228 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.12 -73.89 0.23 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.932 -1.136 . . . . 74.12 107.932 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 45.38 -123.83 6.25 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 123.739 0.649 . . . . 63.14 113.344 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -139.07 9.36 2.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.743 -0.836 . . . . 74.13 108.743 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.9 mt -74.94 -8.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.972 -1.013 . . . . 70.23 110.31 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.27 -24.39 63.2 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-N 115.241 -0.89 . . . . 74.0 110.826 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.76 124.86 48.85 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.1 -0.955 . . . . 75.3 108.953 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.29 -35.43 11.41 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.603 3.535 . . . . 72.43 114.491 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -42.74 82.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.923 0.392 . . . . 72.3 111.224 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.6 -35.43 56.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.322 -0.399 . . . . 73.2 110.597 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.11 70.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.235 0.54 . . . . 60.43 109.844 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.61 71.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.663 -0.699 . . . . 73.34 110.854 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 m -71.02 -29.19 35.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.143 -0.623 . . . . 72.13 111.604 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.637 HG13 ' ND2' ' A' ' 77' ' ' ASN . 4.7 tt -79.46 -46.96 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 112.532 0.568 . . . . 64.32 112.532 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.587 HD21 ' CE2' ' A' ' 78' ' ' PHE . 36.8 mt -91.1 -14.55 31.02 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.188 -0.605 . . . . 60.5 112.227 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 t70 69.49 14.63 8.35 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.433 1.587 . . . . 63.23 108.35 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -147.36 135.43 21.4 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.643 -1.984 . . . . 74.3 105.643 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.0 m -76.95 111.12 12.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.5 -0.48 . . . . 65.31 110.295 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -93.74 143.73 26.06 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.607 -0.886 . . . . 38.62 108.607 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.4 126.04 42.4 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.122 -0.49 . . . . 64.13 110.303 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 14.7 p -93.71 144.05 25.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.969 -0.382 . . . . 62.14 109.969 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.22 139.41 35.59 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 108.829 -0.804 . . . . 73.24 108.829 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.92 129.53 35.46 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.754 2.303 . . . . 60.33 111.807 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.529 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.57 157.41 43.24 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.594 -0.73 . . . . 74.35 110.097 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.551 HG21 ' CG ' ' A' ' 61' ' ' LYS . 11.5 p -126.28 132.74 70.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-O 121.158 0.504 . . . . 74.43 110.429 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 93' ' ' VAL . 22.3 tp -91.68 112.33 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.71 -0.677 . . . . 73.3 111.745 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -88.68 112.21 22.86 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.473 -0.785 . . . . 61.15 109.494 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.09 -40.42 1.4 Allowed Glycine 0 C--N 1.305 -1.149 0 C-N-CA 120.653 -0.784 . . . . 64.55 112.695 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.456 ' O ' HG21 ' A' ' 62' ' ' VAL . 41.7 m-85 -108.96 166.41 10.85 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 122.782 -0.246 . . . . 72.05 111.346 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -137.08 134.58 36.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.008 -1.108 . . . . 63.32 108.008 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 25.7 ptt180 -88.87 125.84 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 73.03 111.1 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -98.23 145.92 26.14 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.097 -0.956 . . . . 74.24 110.691 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -91.39 100.13 12.97 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-O 121.729 0.776 . . . . 75.31 110.942 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.416 HD11 HD22 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -119.96 121.55 39.23 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.591 -1.186 . . . . 71.41 111.032 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -85.87 -5.63 59.21 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 113.233 0.827 . . . . 64.42 113.233 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.15 -25.66 65.86 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.398 -0.906 . . . . 71.0 111.751 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 52' ' ' PRO . 3.6 mm? -119.56 156.46 53.44 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-O 120.772 0.32 . . . . 64.24 111.607 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.73 146.86 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.87 2.38 . . . . 72.11 111.063 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.617 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 37.3 p90 44.47 41.91 0.82 Allowed Pre-proline 0 N--CA 1.506 2.33 0 N-CA-C 115.39 1.626 . . . . 75.23 115.39 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 78.4 Cg_endo -110.54 156.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.242 2.628 . . . . 74.34 114.806 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.609 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 89.0 m -153.76 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 131.368 3.867 . . . . 72.43 103.33 -15.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 25.5 pt -121.82 136.84 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-N 119.553 1.069 . . . . 63.45 110.914 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 112' ' ' LYS . 43.1 t -127.0 -80.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 115.026 -0.988 . . . . 72.33 112.589 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.4 p -177.17 156.21 1.23 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.809 -0.441 . . . . 75.25 109.809 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.1 m -165.08 173.63 11.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.138 0.975 . . . . 60.02 109.639 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.1 -65.68 0.58 Allowed 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 123.859 0.724 . . . . 72.34 110.01 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 p -105.98 -36.34 7.0 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 119.74 -0.784 . . . . 74.41 109.535 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.93 117.79 0.0 OUTLIER Glycine 0 C--N 1.361 1.971 0 C-N-CA 125.474 1.511 . . . . 74.32 116.817 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.551 ' CG ' HG21 ' A' ' 37' ' ' VAL . 21.9 ttpp -141.63 139.4 33.04 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.793 -1.563 . . . . 63.11 112.621 173.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 41' ' ' TYR . 54.4 t -123.86 123.72 67.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 C-N-CA 123.715 0.806 . . . . 71.35 111.252 -173.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -96.11 128.62 43.17 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.475 -0.49 . . . . 62.12 110.301 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.97 -142.58 3.44 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.85 -1.3 . . . . 38.62 109.85 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -140.44 146.72 38.65 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.779 -1.193 . . . . 72.43 107.779 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 33' ' ' THR . 26.8 m -104.49 135.44 42.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.043 0.449 . . . . 75.24 110.305 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.6 mt -85.72 110.61 19.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 104.479 -2.415 . . . . 74.51 104.479 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.6 p -101.23 161.94 13.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 111.766 0.284 . . . . 71.23 111.766 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.16 73.62 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.91 -0.586 . . . . 73.12 112.693 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.71 124.23 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 109.046 -0.724 . . . . 75.04 109.046 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.414 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 30.9 m -73.71 157.45 36.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.19 -0.67 . . . . 74.12 109.19 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.01 -46.08 68.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.771 0.428 . . . . 73.45 111.003 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -68.72 -36.96 79.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.299 0.571 . . . . 63.13 110.826 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -68.56 -34.57 76.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.414 -0.812 . . . . 74.22 111.685 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.45 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.6 tt -61.55 -37.9 85.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.302 -1.37 . . . . 65.55 107.302 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' O ' HG22 ' A' ' 80' ' ' VAL . 13.9 m120 -54.75 -26.73 36.07 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.851 1.056 . . . . 73.04 113.851 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.637 ' ND2' HG13 ' A' ' 26' ' ' ILE . 2.7 t30 -67.32 -34.41 77.3 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.76 -1.176 . . . . 72.21 108.595 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.587 ' CE2' HD21 ' A' ' 27' ' ' LEU . 86.5 m-85 -69.24 -34.2 74.45 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.913 -1.143 . . . . 73.1 107.913 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.99 -31.32 70.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.469 -1.242 . . . . 73.23 110.226 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 76' ' ' ASN . 90.7 t -72.8 -36.6 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.715 -0.675 . . . . 74.31 109.58 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 77' ' ' ASN . 48.2 mm -59.71 -40.95 83.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 N-CA-C 106.804 -1.554 . . . . 72.45 106.804 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 73.06 -81.76 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.775 -1.557 . . . . 64.24 114.861 167.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.71 104.2 1.01 Allowed Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 108.636 -1.786 . . . . 74.43 108.636 -172.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.34 -40.52 96.64 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.189 0.519 . . . . 60.43 111.722 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.421 ' O ' HG22 ' A' ' 110' ' ' VAL . 10.9 m-20 -97.73 8.53 44.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.746 -0.661 . . . . 73.14 109.807 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 96.9 m-85 -115.94 154.78 29.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.958 -0.564 . . . . 62.03 110.021 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -136.05 141.93 44.34 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.406 -0.59 . . . . 65.03 109.406 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.557 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 0.4 OUTLIER -88.52 109.56 20.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.415 0.626 . . . . 75.22 111.317 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.65 160.7 24.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.749 -1.114 . . . . 53.4 110.966 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -91.12 131.37 36.73 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.696 -0.853 . . . . 55.41 108.696 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.93 172.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.496 -1.298 . . . . 54.32 107.496 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -125.37 127.59 46.83 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.873 -1.131 . . . . 72.43 109.523 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 38' ' ' LEU . 18.2 m -126.72 168.24 20.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.316 0.579 . . . . 72.44 110.314 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.498 HG23 ' HG2' ' A' ' 101' ' ' LYS . 54.7 t -113.5 121.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.757 -0.831 . . . . 73.42 108.757 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.36 103.93 2.13 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 106.8 -1.555 . . . . 72.53 106.8 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.529 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 9.8 tmm? -61.62 -32.89 73.05 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.91 -1.144 . . . . 72.22 107.91 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.68 -44.96 81.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.936 -1.029 . . . . 73.24 112.336 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -111.42 -2.69 15.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.105 0.478 . . . . 71.1 110.956 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.5 24.28 14.0 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.942 1.297 . . . . 70.04 110.993 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -105.12 160.53 14.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.985 -0.376 . . . . 65.45 109.985 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HG2' HG23 ' A' ' 94' ' ' VAL . 55.4 mtpt -101.02 132.39 46.46 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.006 -0.739 . . . . 72.33 109.006 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.55 137.82 43.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.302 0.572 . . . . 73.13 110.838 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -87.77 119.34 28.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.835 -1.543 . . . . 74.05 106.835 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.0 m -127.31 175.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 120.949 0.404 . . . . 73.13 111.066 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.99 150.32 34.03 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.863 -0.421 . . . . 74.14 109.863 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -151.84 174.46 13.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.367 -0.605 . . . . 74.51 109.367 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.557 ' CE2' ' HB2' ' A' ' 88' ' ' ARG . 52.1 m-85 -114.39 118.12 32.96 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.466 -0.939 . . . . 71.24 108.466 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 30.6 m -109.87 172.5 2.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.946 -0.57 . . . . 72.14 110.373 -177.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.515 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 31.5 t-105 -86.39 121.71 29.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.101 -0.703 . . . . 74.24 109.101 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.4 m -72.06 -19.7 19.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-O 121.391 0.615 . . . . 73.04 112.291 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.451 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.6 t-20 -88.68 14.81 9.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.369 1.081 . . . . 71.21 109.333 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 40.1 ttmt -49.78 -24.92 2.63 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 127.459 2.303 . . . . 73.44 114.589 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -80.93 -21.67 40.29 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.776 1.028 . . . . 63.14 113.776 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -103.46 137.0 19.13 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 107.06 -1.459 . . . . 74.45 107.06 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.67 120.98 8.98 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.856 2.37 . . . . 74.15 114.468 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -124.6 113.52 18.15 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 109.047 -0.723 . . . . 74.51 109.047 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 51.88 28.43 5.08 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.326 1.016 . . . . 72.45 112.37 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -77.8 -48.29 16.88 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.746 -0.661 . . . . 70.01 110.244 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -104.26 13.42 51.76 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 120.064 -1.065 . . . . 61.13 112.293 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -143.54 130.75 20.79 Favored 'General case' 0 N--CA 1.427 -1.601 0 C-N-CA 120.473 -0.491 . . . . 75.02 110.554 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.0 t90 174.97 159.0 0.18 Allowed 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 126.274 1.829 . . . . 73.44 106.765 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.62 113.27 20.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.623 0.249 . . . . 55.13 110.437 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.499 ' O ' ' HB3' ' A' ' 126' ' ' TRP . 97.4 m-85 -68.46 -26.11 65.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.71 0.767 . . . . 74.05 109.614 175.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.9 -38.68 91.79 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.272 -0.877 . . . . 65.24 109.521 173.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.55 -34.7 67.7 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.882 -0.784 . . . . 64.24 108.882 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.499 ' HB3' ' O ' ' A' ' 123' ' ' PHE . 1.8 t90 -50.35 -46.86 56.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.61 0.764 . . . . 72.33 109.022 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 90.4 mtt180 -63.16 -49.22 75.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.825 -0.625 . . . . 74.31 111.874 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -38.77 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.328 0.492 . . . . 74.31 112.328 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.02 -43.93 81.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.972 -0.381 . . . . 64.2 109.972 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.539 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 56.4 t-80 -57.13 -38.55 73.63 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.909 -0.404 . . . . 74.21 109.909 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.78 -46.89 70.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.57 -0.287 . . . . 63.5 111.406 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 44.8 mt-10 -68.08 -40.03 82.79 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 111.943 0.349 . . . . 73.43 111.943 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.68 -31.9 73.17 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.152 0.797 . . . . 72.24 113.152 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.539 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 57.9 m-85 -83.91 -44.27 14.43 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.589 -0.844 . . . . 73.14 111.315 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 132' ' ' GLU . 14.7 p -63.92 -36.75 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 120.54 -0.464 . . . . 74.12 111.226 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -62.21 -36.35 81.68 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 120.18 -0.608 . . . . 75.41 110.425 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.8 m -63.39 -46.06 88.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.507 -0.315 . . . . 71.45 110.282 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -63.13 -37.13 85.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.778 0.323 . . . . 73.22 111.26 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.05 -44.54 68.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.45 -0.341 . . . . 75.25 111.316 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 32.3 mmmt -62.26 -44.05 97.44 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.715 0.293 . . . . 72.25 111.402 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.57 -31.88 72.26 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.368 -0.533 . . . . 73.4 110.715 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 tp -66.16 -50.56 63.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.391 -0.368 . . . . 55.23 110.384 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.436 ' O ' ' HA2' ' A' ' 150' ' ' GLY . 10.4 pt-20 -62.16 -44.17 97.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 121.055 -0.258 . . . . 70.11 111.263 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -65.61 -40.68 92.9 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 112.258 0.466 . . . . 73.24 112.258 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.3 -36.75 53.81 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.102 0.477 . . . . 73.51 111.98 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -79.82 -21.29 44.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.353 0.501 . . . . 72.11 112.353 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.69 142.55 45.92 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 119.815 -0.754 . . . . 63.24 109.598 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.66 -37.29 94.97 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.866 2.377 . . . . 72.13 112.253 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.74 -9.41 54.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.449 0.642 . . . . 63.33 109.475 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 143' ' ' GLU . . . 75.45 -100.14 1.27 Allowed Glycine 0 N--CA 1.41 -3.079 0 N-CA-C 108.934 -1.666 . . . . 38.62 108.934 -173.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 143' ' ' GLU . 31.5 ttpt -99.42 130.7 45.71 Favored 'General case' 0 C--N 1.268 -2.953 0 N-CA-C 108.957 -0.757 . . . . 72.02 108.957 174.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.6 m -67.63 161.37 25.92 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 123.278 0.361 . . . . 61.14 111.71 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.497 ' O ' HG21 ' A' ' 157' ' ' VAL . 27.2 ptt? -57.28 -44.55 84.09 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.6 1.333 . . . . 73.42 114.6 -171.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -81.26 -34.31 32.16 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 108.828 -0.804 . . . . 74.15 108.828 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.45 -37.19 86.65 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.429 -1.259 . . . . 74.4 110.091 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.26 -25.82 63.54 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.547 -0.751 . . . . 73.45 110.783 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 153' ' ' MET . 60.8 t -81.41 103.9 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 108.106 -1.072 . . . . 72.24 108.106 176.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 128.81 61.75 0.11 Allowed Glycine 0 N--CA 1.415 -2.711 0 N-CA-C 109.689 -1.364 . . . . 54.43 109.689 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.4 m -86.28 -26.31 25.03 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.408 -0.96 . . . . 74.24 108.408 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 mp 65.88 119.55 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 125.11 1.364 . . . . 73.21 113.387 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 163' ' ' SER . 39.6 tp -81.89 -41.4 21.0 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.242 -1.762 . . . . 74.24 106.242 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t 58.57 23.55 10.98 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 125.324 1.45 . . . . 65.21 110.371 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.427 ' HB2' ' HG ' ' A' ' 161' ' ' LEU . 19.9 m -124.54 85.82 2.47 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.447 -0.797 . . . . 74.31 110.387 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.71 12.49 6.21 Favored Glycine 0 CA--C 1.506 -0.496 0 N-CA-C 111.18 -0.768 . . . . 52.25 111.18 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 . . . . . 0 C--O 1.254 1.299 0 N-CA-C 108.519 -0.919 . . . . 71.22 108.519 -179.569 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.883 -0.414 . . . . 64.02 109.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 t -88.25 97.16 10.86 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.021 -0.733 . . . . 72.54 109.021 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 m 64.89 95.94 0.05 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.208 -0.905 . . . . 75.52 110.221 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.6 m -65.59 105.91 1.33 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 116.26 -0.427 . . . . 72.03 110.32 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.9 t70 69.25 103.07 0.03 OUTLIER Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.865 1.266 . . . . 72.15 109.502 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.48 37.43 0.68 Allowed 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 123.441 2.761 . . . . 62.01 112.242 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 63.57 90.82 0.08 Allowed 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 124.353 1.061 . . . . 71.42 110.683 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.444 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 58.8 m -110.62 171.46 7.45 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 121.516 0.675 . . . . 74.12 111.141 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -130.42 157.4 42.7 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.029 -0.987 . . . . 73.33 109.298 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.9 m-20 -127.44 124.6 38.83 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 37.99 107.933 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 59.6 t -120.9 120.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 121.027 -0.269 . . . . 71.32 111.685 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -84.38 111.36 19.37 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.949 -1.5 . . . . 75.25 106.949 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.6 p -123.25 137.63 55.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.732 -0.787 . . . . 63.23 111.105 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -100.04 97.85 8.66 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.943 -1.132 . . . . 74.42 107.943 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.8 -142.0 22.24 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.012 -0.835 . . . . 50.14 111.012 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.9 t 65.49 -79.03 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.261 1.024 . . . . 74.45 113.416 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -117.95 12.98 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 75.3 111.763 -175.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.425 HD11 ' HE3' ' A' ' 65' ' ' LYS . 80.3 mt -68.18 -18.65 64.66 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 74.53 109.416 174.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.78 116.86 63.02 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 107.648 -1.242 . . . . 63.2 107.648 172.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.69 -39.72 18.35 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.302 3.334 . . . . 65.22 114.634 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.17 94.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.991 0.424 . . . . 74.33 111.688 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.3 t -72.46 -36.56 54.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.714 -0.676 . . . . 74.23 109.606 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 17' ' ' ILE . . . -62.53 -37.11 84.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.405 0.622 . . . . 37.99 109.88 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.92 -19.05 62.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.556 -0.747 . . . . 74.45 112.059 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.3 m -91.17 -30.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 119.511 -0.876 . . . . 74.12 110.975 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.524 HG12 ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -78.63 -47.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-O 120.696 0.284 . . . . 63.22 110.356 178.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 29' ' ' ARG . 95.5 mt -92.96 -10.41 36.48 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 112.106 0.41 . . . . 74.11 112.106 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 19.5 t70 76.61 -14.05 0.86 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.513 1.149 . . . . 73.51 110.279 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 27' ' ' LEU . 27.8 ptt180 -133.73 168.03 19.46 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.405 -1.27 . . . . 75.13 108.153 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.2 m -76.25 135.22 39.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.611 -0.885 . . . . 72.52 108.611 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.1 135.58 41.17 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 116.43 -0.35 . . . . 61.22 110.979 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.06 109.07 19.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.122 -1.436 . . . . 72.44 107.122 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.1 p -117.9 143.89 45.93 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 115.723 -0.672 . . . . 62.3 110.718 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.9 146.17 60.2 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 107.771 -1.196 . . . . 73.41 107.771 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -71.18 137.05 30.6 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 121.359 1.372 . . . . 71.14 111.302 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.32 156.05 41.48 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.315 -0.857 . . . . 74.01 108.921 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.19 126.39 75.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.897 -0.721 . . . . 71.33 111.005 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HA ' HG11 ' A' ' 93' ' ' VAL . 25.3 tp -92.43 89.2 6.68 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.35 -0.841 . . . . 70.14 111.204 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 27.6 p80 -66.09 131.37 46.04 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.973 -1.012 . . . . 75.44 108.824 171.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 119.32 -13.54 11.08 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 118.969 -1.586 . . . . 64.31 112.842 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -127.33 157.76 39.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 112.686 0.624 . . . . 74.54 112.686 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -116.54 138.5 51.36 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.549 -1.278 . . . . 74.41 107.549 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HA ' HG23 ' A' ' 54' ' ' ILE . 19.1 ptp180 -86.55 127.21 34.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.297 -0.631 . . . . 73.33 109.297 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.445 ' HD2' ' O ' ' A' ' 117' ' ' MET . 88.1 m-85 -108.82 112.27 24.44 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.03 -0.532 . . . . 72.4 111.689 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -86.4 116.8 24.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.38 -0.827 . . . . 73.31 111.533 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.453 ' CD2' ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.5 147.84 50.43 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.391 -1.277 . . . . 72.14 109.399 174.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -115.84 -12.44 11.44 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.268 0.556 . . . . 71.2 110.162 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 -26.2 71.63 Favored Glycine 0 N--CA 1.41 -3.088 0 C-N-CA 120.086 -1.054 . . . . 62.04 110.903 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 2.1 mm? -115.9 166.57 12.01 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 105.475 -2.046 . . . . 73.53 105.475 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 37.1 Cg_endo -66.6 -155.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.227 0 C-N-CA 122.326 2.018 . . . . 74.01 114.297 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.435 ' CD1' ' HD3' ' A' ' 52' ' ' PRO . 18.9 p90 -48.35 -26.42 0.71 Allowed Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 119.452 3.13 . . . . 61.25 119.452 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HD3' ' CD1' ' A' ' 51' ' ' TYR . 84.3 Cg_exo -49.32 165.69 0.22 Allowed 'Trans proline' 0 CA--C 1.584 2.989 0 CA-C-N 122.141 1.8 . . . . 70.14 111.999 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 52' ' ' PRO . 22.0 p -152.3 -178.99 7.15 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.508 1.523 . . . . 75.42 110.717 5.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.468 HG23 ' HA ' ' A' ' 43' ' ' ARG . 43.1 pt -135.31 132.44 52.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.36 -0.978 . . . . 74.43 108.36 170.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -154.2 -175.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.777 -0.823 . . . . 43.42 108.777 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m 82.05 -177.61 0.05 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.923 1.289 . . . . 72.43 114.443 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -71.9 -178.97 2.51 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.732 0.813 . . . . 65.45 112.746 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.453 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 3.5 p30 -82.13 28.92 0.42 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.689 1.196 . . . . 74.15 113.038 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 m -76.78 -8.28 57.0 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.129 0.418 . . . . 74.04 112.129 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.98 -172.81 19.74 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.149 -1.024 . . . . 61.02 112.076 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 18.6 ptpt -143.46 147.45 34.58 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.607 -0.516 . . . . 72.12 109.607 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -111.36 123.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.392 -0.596 . . . . 63.24 109.392 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -98.75 124.25 43.49 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.006 -0.739 . . . . 73.43 109.006 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.98 -139.03 2.67 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.761 -0.733 . . . . 75.33 111.921 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.425 ' HE3' HD11 ' A' ' 18' ' ' LEU . 39.2 mtmt -137.39 140.73 41.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.06 0.457 . . . . 44.54 112.082 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.7 m -107.21 133.93 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.149 -0.932 . . . . 74.35 109.653 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 48.7 mt -87.93 123.72 40.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.507 -1.664 . . . . 65.23 106.507 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.6 p -103.8 161.21 14.13 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.2 -0.6 . . . . 73.33 110.514 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 8' ' ' SER . . . 69.06 28.5 72.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.039 -0.6 . . . . 74.11 113.382 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.74 121.49 36.44 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 117.223 0.512 . . . . 54.05 109.651 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.9 m -77.37 164.22 25.7 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.997 -0.742 . . . . 54.31 108.997 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.83 -32.18 72.49 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.153 0.433 . . . . 72.24 111.289 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.36 64.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.389 0.614 . . . . 72.01 110.331 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.08 -44.22 39.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 75.14 110.326 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.66 -37.56 87.81 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.775 -1.194 . . . . 54.55 107.775 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' HG22 ' A' ' 80' ' ' VAL . 27.5 t-20 -54.69 -31.49 58.0 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.471 -1.241 . . . . 73.22 111.547 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.524 ' OD1' HG12 ' A' ' 26' ' ' ILE . 20.8 t-20 -75.1 -31.18 61.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 74.2 109.588 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -65.99 -35.56 80.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.39 0.614 . . . . 74.3 109.567 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.76 -33.71 72.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.307 -0.861 . . . . 72.24 110.283 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 76' ' ' ASN . 71.0 t -74.83 -25.44 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.498 -0.774 . . . . 75.45 111.784 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.7 mt -53.4 139.28 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 109.701 -0.481 . . . . 71.23 109.701 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.75 109.75 0.55 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.735 0.778 . . . . 72.51 112.174 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.26 55.83 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.003 0 N-CA-C 109.001 -1.64 . . . . 62.31 109.001 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -64.05 -19.28 65.1 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.302 0.572 . . . . 72.43 110.702 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.511 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 17.9 m-20 -91.0 10.16 27.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.419 . . . . 73.22 111.022 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.27 160.28 26.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 119.917 -0.713 . . . . 74.03 109.455 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -131.22 142.9 50.23 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 109.397 -0.594 . . . . 71.14 109.397 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -83.48 120.18 25.59 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.965 -0.754 . . . . 72.41 108.965 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.33 160.15 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 116.104 -0.498 . . . . 73.32 111.43 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -95.43 126.7 40.9 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 115.69 -0.686 . . . . 72.25 109.474 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.404 ' HB ' HD11 ' A' ' 38' ' ' LEU . 28.8 m -129.66 168.31 23.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.042 -1.096 . . . . 75.24 108.042 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -123.22 128.53 50.14 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.812 -1.155 . . . . 73.32 108.521 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 38' ' ' LEU . 19.8 m -126.18 169.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.176 0.512 . . . . 71.34 110.465 -173.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 101' ' ' LYS . 76.7 t -103.81 128.63 56.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.74 -0.664 . . . . 72.45 110.183 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -64.93 3.97 0.49 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 126.77 2.028 . . . . 73.2 113.119 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.524 ' SD ' ' HE3' ' A' ' 133' ' ' LYS . 12.5 tmm? 58.56 -72.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.704 2.002 . . . . 72.43 113.277 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.03 -29.34 67.2 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.301 1.041 . . . . 63.13 113.296 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -110.64 -5.18 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.372 -0.531 . . . . 63.41 110.68 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 m 62.82 4.94 1.59 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.801 0.841 . . . . 73.43 112.863 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.95 160.84 27.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.827 -0.805 . . . . 74.32 108.827 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 6.8 mptt -106.76 146.45 30.84 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.446 -0.946 . . . . 62.23 108.446 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.33 139.51 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.145 0.498 . . . . 61.12 110.336 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -87.4 129.77 34.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.148 -1.056 . . . . 62.41 108.148 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.45 173.16 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 122.325 0.25 . . . . 75.41 110.981 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -100.87 153.78 19.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.027 -1.101 . . . . 74.44 108.027 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -152.69 176.89 11.27 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-N 118.341 0.519 . . . . 64.41 110.881 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.31 117.88 35.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.734 0.813 . . . . 73.32 108.84 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.23 156.95 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 109.187 -0.671 . . . . 72.11 109.187 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.511 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 42.8 t-105 -98.86 120.12 38.77 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.645 0.378 . . . . 72.22 110.519 -171.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 85' ' ' ASP . 8.3 m -73.1 -23.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.312 0.486 . . . . 74.53 112.312 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.403 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 64.5 t30 -80.31 12.82 2.7 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.018 0.913 . . . . 73.35 110.99 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.85 -15.33 58.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.566 1.321 . . . . 74.42 114.566 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.41 -42.95 92.0 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.29 0.478 . . . . 71.31 112.29 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -85.59 138.19 35.95 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 107.747 -1.205 . . . . 74.52 107.747 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -40.7 116.85 0.43 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 124.288 3.326 . . . . 71.4 114.537 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.531 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 1.1 mmp_? -106.3 165.09 11.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 65.52 109.219 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.445 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 12.7 tpt -58.81 130.73 48.33 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.29 -0.633 . . . . 74.51 109.29 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -59.53 -23.46 62.85 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.436 0.636 . . . . 75.03 111.742 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.402 ' H ' ' HG3' ' A' ' 117' ' ' MET . . . 85.36 107.15 0.68 Allowed Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 115.366 -0.834 . . . . 64.05 112.348 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -98.89 132.63 44.08 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.102 -0.703 . . . . 72.5 109.102 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -144.56 155.31 43.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.07 -2.196 . . . . 74.45 105.07 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -81.21 121.32 26.0 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.473 -0.891 . . . . 63.41 113.072 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -68.45 -26.97 65.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.643 -1.162 . . . . 75.24 111.226 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 41.7 tt0 -74.65 -20.07 60.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.531 0.681 . . . . 72.23 109.522 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.51 ' O ' HG22 ' A' ' 128' ' ' VAL . 9.1 tp10 -76.26 -40.93 50.64 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.581 -1.266 . . . . 72.11 107.581 173.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -56.73 -36.98 70.35 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.375 -0.829 . . . . 75.41 110.914 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 124' ' ' GLU 0.269 4.0 ppt_? -63.16 -33.63 75.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.43 0.9 . . . . 75.24 113.43 -178.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 125' ' ' GLU . 29.9 m -77.38 -25.22 14.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 119.287 -0.965 . . . . 74.44 110.246 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.86 -44.78 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.493 -0.558 . . . . 65.21 109.493 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' A' ' 127' ' ' ARG . 2.4 p-80 -75.21 -28.95 60.17 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 119.124 -1.03 . . . . 71.35 111.038 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.65 36.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.144 -0.48 . . . . 45.22 111.161 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 128' ' ' VAL . 10.0 mm-40 -61.67 -26.16 67.85 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.202 0.525 . . . . 71.54 110.835 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.524 ' HE3' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.05 -59.64 2.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.935 -1.135 . . . . 74.44 107.935 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -69.46 -31.58 69.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 114.354 1.242 . . . . 73.23 114.354 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.514 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.7 p -58.35 -38.48 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.25 0.477 . . . . 71.42 110.2 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.11 -46.0 82.83 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.691 -0.485 . . . . 63.54 109.691 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.0 m -57.12 -46.37 82.69 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.609 -0.723 . . . . 74.52 110.821 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.46 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 40.8 m-85 -60.26 -49.0 79.34 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 121.235 -0.186 . . . . 72.43 110.65 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 99.1 mtt180 -57.68 -44.84 86.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.042 0.213 . . . . 71.34 110.863 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.51 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -60.98 -52.54 64.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.347 -0.388 . . . . 61.43 110.688 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.58 72.51 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.657 0.614 . . . . 63.35 112.657 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 94.3 mt -72.48 -42.77 64.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.246 0.462 . . . . 65.0 112.246 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.6 -35.16 75.05 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 119.492 -0.883 . . . . 73.12 110.369 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.687 ' O ' ' HA3' ' A' ' 150' ' ' GLY . 1.3 m-90 -63.86 -28.98 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.337 0.589 . . . . 74.45 111.042 171.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -78.37 -44.46 24.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.135 0.493 . . . . 53.43 110.857 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.37 -31.52 42.94 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.912 0.708 . . . . 75.22 112.912 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -95.26 143.87 26.85 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 111.806 0.298 . . . . 55.03 111.806 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.82 -16.37 55.02 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.482 2.788 . . . . 75.31 112.009 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.24 -13.32 60.43 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.768 0.794 . . . . 74.31 108.98 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 144' ' ' TRP . . . -69.74 111.75 4.03 Favored Glycine 0 N--CA 1.399 -3.829 0 CA-C-N 114.658 -1.155 . . . . 53.31 112.455 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.38 140.12 57.19 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.605 -0.798 . . . . 74.2 109.646 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.2 m -67.41 157.4 34.22 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.537 -0.756 . . . . 64.54 111.406 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.43 -43.46 98.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.93 -0.577 . . . . 61.25 112.465 -176.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -72.76 -25.14 61.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.241 0.543 . . . . 71.15 110.969 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -75.7 -33.81 60.36 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.707 -0.679 . . . . 71.54 110.933 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.61 -30.36 62.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.841 . . . . 61.44 111.121 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.4 m -91.01 145.39 7.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.934 0.397 . . . . 65.43 110.719 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.01 -4.6 20.83 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.86 -0.896 . . . . 62.54 110.86 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.8 t -113.94 108.1 16.58 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.891 -0.781 . . . . 73.25 108.891 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.81 150.45 23.47 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.683 -1.228 . . . . 74.3 107.683 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.0 tp -87.5 119.4 27.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.752 -0.462 . . . . 63.51 109.752 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.0 p -73.66 97.88 2.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.665 0.745 . . . . 71.11 109.739 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.8 m -146.16 131.69 18.75 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.278 -0.874 . . . . 61.14 108.996 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 110.5 -84.96 0.38 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 108.281 -1.928 . . . . 73.32 108.281 -173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.246 0.87 0 C-N-CA 123.535 0.734 . . . . 73.11 109.28 175.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.0 p . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 109.684 -0.487 . . . . 70.53 109.684 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.5 t -83.18 132.86 35.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 121.193 0.52 . . . . 73.51 109.961 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -140.93 113.25 7.98 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.491 -0.559 . . . . 73.5 109.491 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.8 t -147.77 147.42 29.84 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.396 -0.594 . . . . 74.15 109.396 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -87.78 150.14 47.48 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.401 -0.592 . . . . 45.52 109.401 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.99 -36.65 97.93 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.232 1.955 . . . . 74.54 109.607 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -72.88 92.46 1.61 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.066 -1.457 . . . . 74.12 107.066 173.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 p -136.65 159.62 41.26 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 121.689 0.757 . . . . 74.52 112.616 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -109.25 147.43 32.61 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.859 -1.064 . . . . 72.13 109.705 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.5 m-20 -132.4 122.5 25.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.269 -1.382 . . . . 55.22 107.269 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.58 125.09 73.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.937 -0.305 . . . . 65.02 111.061 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -80.86 112.83 18.61 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.206 -1.035 . . . . 75.43 108.206 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.15 151.81 24.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.256 -0.646 . . . . 74.34 109.256 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -131.3 -22.83 2.46 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 120.519 -0.472 . . . . 73.14 111.126 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.497 ' HA3' ' CD2' ' A' ' 51' ' ' TYR . . . -114.05 108.82 2.1 Favored Glycine 0 C--O 1.248 1.005 0 C-N-CA 120.303 -0.951 . . . . 65.31 112.428 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 22.6 t 69.56 -177.25 0.21 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.921 1.288 . . . . 64.35 110.489 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.521 HD11 ' CE1' ' A' ' 78' ' ' PHE . 12.4 pt 47.12 18.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 126.761 2.024 . . . . 74.12 114.476 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 16' ' ' SER . 85.1 mt -93.04 -1.37 56.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.438 0.637 . . . . 71.01 110.942 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -103.53 132.34 21.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.009 -0.996 . . . . 74.42 108.879 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -42.85 -45.22 8.97 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 124.247 3.298 . . . . 74.54 113.756 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.32 -37.6 85.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 72.4 111.474 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 25' ' ' VAL . 44.9 t -75.72 -39.47 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.202 0.525 . . . . 72.54 109.981 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.84 66.53 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.966 -0.753 . . . . 71.24 108.966 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.74 -31.49 57.15 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.677 -0.692 . . . . 65.54 111.588 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 22' ' ' VAL . 28.1 m -76.48 -30.41 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 119.584 -0.847 . . . . 72.2 111.619 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.445 HG13 ' ND2' ' A' ' 77' ' ' ASN . 3.3 tt -74.36 -42.29 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 63.34 111.925 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.749 HD21 ' CE2' ' A' ' 78' ' ' PHE . 75.2 mt -93.76 -22.25 18.81 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.706 0.632 . . . . 63.31 112.706 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 71.64 17.49 5.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.937 0.875 . . . . 72.42 109.92 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 ttm-85 -141.27 147.57 38.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.728 -1.953 . . . . 73.45 105.728 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.5 m -76.24 111.01 11.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.923 -0.769 . . . . 72.33 108.923 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.524 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -95.38 145.68 24.95 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.105 -0.498 . . . . 63.22 109.91 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.48 118.51 36.83 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.577 -0.738 . . . . 73.01 112.419 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 5.1 p -95.27 143.04 26.98 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.73 -0.668 . . . . 74.45 109.626 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.2 137.49 26.84 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 108.92 -0.77 . . . . 74.52 108.92 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 127.22 22.64 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.749 2.3 . . . . 72.34 112.083 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.58 37.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.516 -0.765 . . . . 50.03 109.022 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.478 HG22 ' CE ' ' A' ' 61' ' ' LYS . 11.4 p -118.14 130.05 73.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.722 0.772 . . . . 74.31 112.042 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.6 tp -87.95 106.77 18.34 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 122.123 0.963 . . . . 64.41 109.586 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.464 ' CD2' HG22 ' A' ' 94' ' ' VAL . 14.3 p80 -92.22 127.9 37.87 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.264 -1.335 . . . . 72.51 109.807 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.65 -5.93 29.59 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.023 -1.084 . . . . 51.54 112.044 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -117.86 144.86 45.04 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.709 0.29 . . . . 72.51 110.669 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 7.3 t60 -115.5 135.12 54.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.172 -0.677 . . . . 62.4 109.172 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.56 ' NH2' ' HA ' ' A' ' 125' ' ' GLU . 55.6 mtm180 -87.33 114.89 24.35 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.565 -0.902 . . . . 64.15 108.565 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.39 137.28 34.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.117 -0.697 . . . . 75.43 109.117 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.25 110.41 22.4 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.887 -1.153 . . . . 73.25 107.887 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . 0.308 0.0 OUTLIER -124.75 160.98 27.4 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.764 -1.107 . . . . 75.35 112.394 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -99.02 -22.84 15.52 Favored 'General case' 0 N--CA 1.398 -3.039 0 CA-C-N 113.406 -1.725 . . . . 71.03 110.999 -169.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.09 -25.51 61.76 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.895 -0.669 . . . . 53.34 113.06 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -122.7 146.89 49.19 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 109.397 -0.594 . . . . 71.22 109.397 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.49 -34.88 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.336 2.024 . . . . 64.14 111.724 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.53 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 37.9 p90 -123.38 177.63 1.62 Allowed Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 116.735 -1.602 . . . . 73.25 106.772 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.34 0.0 OUTLIER 34.5 169.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.608 0 C-N-CA 123.625 2.883 . . . . 73.34 119.172 -163.145 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.524 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 14.7 p -122.73 172.88 8.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.218 -1.551 . . . . 74.42 113.588 10.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 41.1 pt -130.71 149.92 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.831 -1.077 . . . . 61.4 109.911 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG11 ' HG3' ' A' ' 112' ' ' LYS . 12.7 m -148.12 164.27 5.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.355 -1.72 . . . . 75.33 106.355 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -80.04 123.27 27.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 114.064 1.135 . . . . 72.52 114.064 -170.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 p -147.67 120.08 8.46 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.486 -1.672 . . . . 73.13 106.486 172.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.23 -11.56 22.24 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 117.433 2.383 . . . . 63.44 117.433 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.5 m -98.08 1.1 47.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.489 -0.885 . . . . 75.15 111.382 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.5 159.09 15.59 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.182 -1.009 . . . . 51.21 114.044 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' CE ' HG22 ' A' ' 37' ' ' VAL . 48.9 mtpt -140.39 147.27 39.51 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 123.879 0.872 . . . . 75.41 109.827 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.74 122.05 63.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.534 -1.284 . . . . 75.53 107.534 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -111.35 115.99 30.21 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.582 -0.447 . . . . 62.54 111.287 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.9 -131.4 1.73 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.742 -0.543 . . . . 64.34 111.742 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HB2' HD23 ' A' ' 18' ' ' LEU . 94.1 mttt -141.12 154.4 45.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.423 -0.584 . . . . 72.03 109.423 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.7 m -109.6 133.58 54.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.626 -0.509 . . . . 74.41 109.626 173.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.442 HD13 HG13 ' A' ' 17' ' ' ILE . 47.4 mt -88.02 112.43 23.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.536 -1.654 . . . . 73.53 106.536 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.7 p -106.68 160.66 15.29 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.119 0.414 . . . . 74.24 112.119 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.74 24.98 59.27 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.713 -0.676 . . . . 43.25 113.84 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 127.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 O-C-N 122.642 -0.328 . . . . 64.1 110.337 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 m -78.85 160.45 27.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.213 -1.032 . . . . 72.34 108.213 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.39 -37.36 75.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.297 0.499 . . . . 72.24 111.768 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.08 78.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.434 0.635 . . . . 61.31 110.854 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.505 ' HB3' HD23 ' A' ' 27' ' ' LEU . 37.8 mt-10 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.731 -0.668 . . . . 62.41 109.232 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.76 -31.68 69.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.769 0.828 . . . . 73.31 109.808 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -56.95 -28.6 62.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 71.12 112.126 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.445 ' ND2' HG13 ' A' ' 26' ' ' ILE . 2.9 t30 -76.0 -31.77 59.09 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 119.043 -1.063 . . . . 75.41 109.436 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.749 ' CE2' HD21 ' A' ' 27' ' ' LEU . 41.2 m-85 -70.33 -28.96 65.57 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.638 0.732 . . . . 75.0 109.21 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.544 ' HA ' ' OH ' ' A' ' 107' ' ' TYR . 18.5 t70 -67.11 -43.21 83.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.827 -1.079 . . . . 74.43 111.693 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.04 -30.48 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 N-CA-C 112.708 0.633 . . . . 74.22 112.708 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.2 tt -82.48 111.16 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 112.905 0.705 . . . . 64.54 112.905 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 58.33 35.07 24.59 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.138 0.975 . . . . 74.33 110.486 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.55 25.49 9.65 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.647 -0.787 . . . . 53.05 111.485 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.61 -36.03 24.2 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.878 0.371 . . . . 73.3 111.669 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.563 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 12.8 m-20 -117.62 19.24 13.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.88 0.848 . . . . 71.02 109.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -130.62 161.36 31.74 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.791 -1.095 . . . . 72.34 108.666 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -130.06 147.18 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.781 -0.822 . . . . 75.14 108.781 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.504 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 40.0 ttp-105 -92.86 108.51 20.05 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.24 0.543 . . . . 63.43 111.36 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.4 m -111.18 159.38 11.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.749 -0.66 . . . . 75.32 110.416 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -91.33 133.43 35.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.575 -0.898 . . . . 75.44 108.575 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 30.2 m -133.75 168.81 23.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.803 -1.184 . . . . 73.11 107.803 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.429 ' HB2' ' CE ' ' A' ' 103' ' ' LYS . 42.8 tt0 -114.2 129.93 56.62 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.515 -0.874 . . . . 74.22 110.192 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.12 163.02 28.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.166 -0.679 . . . . 72.3 109.166 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.483 HG23 ' HG3' ' A' ' 101' ' ' LYS . 77.8 t -102.05 113.86 39.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 109.352 -0.61 . . . . 73.55 109.352 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -69.45 90.21 0.53 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.19 -2.522 . . . . 74.14 104.19 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -55.65 -45.81 77.58 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 125.079 1.351 . . . . 72.4 113.99 -162.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.74 -27.38 68.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.076 0.465 . . . . 70.2 111.304 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -101.47 -9.48 21.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.068 -0.515 . . . . 72.33 110.51 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.5 t 64.42 15.87 9.82 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.634 1.174 . . . . 72.21 112.106 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -96.07 161.26 14.05 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 122.647 0.379 . . . . 74.35 110.421 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -108.89 128.49 54.97 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.946 -0.761 . . . . 64.21 108.946 -175.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.5 148.51 28.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.988 0.423 . . . . 64.05 111.9 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' CE ' ' HB2' ' A' ' 92' ' ' GLU . 27.3 mmtp -90.84 118.12 29.99 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.556 0.742 . . . . 64.32 111.077 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.44 170.56 17.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.244 -0.889 . . . . 73.04 108.877 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.78 150.16 23.08 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.979 -0.378 . . . . 74.3 109.979 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.1 t -156.0 173.85 16.19 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.618 -0.882 . . . . 72.41 108.618 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.544 ' OH ' ' HA ' ' A' ' 79' ' ' ASP . 95.4 m-85 -110.11 122.82 48.5 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.296 0.569 . . . . 64.13 111.691 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.15 159.72 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 115.318 -0.856 . . . . 65.2 110.04 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 53' ' ' CYS . 26.1 t-105 -79.38 112.67 16.85 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.912 0.863 . . . . 74.41 111.963 -173.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 85' ' ' ASP . 43.1 t -72.33 -32.09 41.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.08 -1.418 . . . . 64.54 112.35 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.468 ' HB2' ' CZ2' ' A' ' 109' ' ' TRP . 86.1 m-20 -88.43 14.34 9.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 123.013 0.525 . . . . 55.2 112.074 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.503 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 0.4 OUTLIER -49.84 -36.81 28.13 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.512 1.525 . . . . 65.34 111.766 -177.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.362 15.7 m-20 -73.98 71.46 1.57 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 115.934 1.827 . . . . 71.03 115.934 -171.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -129.0 141.82 43.05 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 104.413 -2.44 . . . . 75.3 104.413 170.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.36 -25.55 57.66 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.216 2.611 . . . . 63.13 114.616 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -116.81 113.05 21.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.251 -0.98 . . . . 74.4 111.624 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.503 ' SD ' ' HA ' ' A' ' 112' ' ' LYS . 68.8 mtp -161.08 100.28 1.23 Allowed 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 124.184 0.994 . . . . 74.01 111.131 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -149.18 -46.38 0.14 Allowed 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.769 -1.567 . . . . 73.24 106.769 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.47 -127.04 8.16 Favored Glycine 0 N--CA 1.407 -3.236 0 CA-C-N 114.101 -1.409 . . . . 73.12 111.767 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -145.89 141.18 27.57 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.7 -0.852 . . . . 64.33 108.7 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -82.58 100.9 10.42 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 118.306 -1.358 . . . . 55.51 109.298 167.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -81.65 148.64 28.93 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.695 -1.224 . . . . 75.25 107.695 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.41 -38.01 65.73 Favored 'General case' 0 N--CA 1.435 -1.203 0 O-C-N 123.54 0.525 . . . . 74.12 111.356 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.55 -37.82 65.45 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 120.586 -0.446 . . . . 61.21 110.438 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.56 ' HA ' ' NH2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -61.18 -30.88 70.68 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.31 -0.405 . . . . 75.12 111.651 176.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -86.04 -36.91 19.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.11 0.481 . . . . 74.4 109.799 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -51.59 -47.07 63.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.608 1.163 . . . . 75.11 111.878 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 34.2 m -62.5 -33.15 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.376 0.51 . . . . 74.34 112.376 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.32 -37.14 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.7 0.762 . . . . 63.42 109.527 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.454 ' CE1' ' HE1' ' A' ' 134' ' ' PHE . 17.5 t-80 -66.83 -35.63 80.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.576 -0.738 . . . . 72.44 109.571 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.478 ' O ' HG21 ' A' ' 135' ' ' VAL . . . -65.47 -34.78 79.07 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 123.457 0.473 . . . . 71.11 110.643 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 43.4 mt-10 -59.4 -39.06 82.2 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.801 0.334 . . . . 73.13 110.577 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.1 tpmt? -57.56 -45.87 84.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.545 -0.752 . . . . 74.14 109.076 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.454 ' HE1' ' CE1' ' A' ' 130' ' ' HIS . 78.9 m-85 -62.6 -45.34 93.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.444 -0.798 . . . . 65.51 110.932 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 80.2 t -54.67 -49.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 O-C-N 123.55 0.531 . . . . 75.42 110.291 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.02 -41.3 91.88 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 123.197 0.311 . . . . 70.02 110.458 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -58.57 -47.31 84.69 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.856 -0.611 . . . . 61.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.416 ' O ' HD13 ' A' ' 142' ' ' LEU . 37.8 m-85 -63.62 -44.22 94.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.114 -0.494 . . . . 75.04 110.564 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 31.4 mtm180 -56.5 -49.92 73.31 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.882 -0.327 . . . . 74.43 110.147 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.13 -44.33 96.87 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.46 0.475 . . . . 64.52 111.684 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.86 -34.7 78.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.861 0.362 . . . . 63.44 110.997 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 10.8 mp -72.63 -31.82 65.43 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 120.622 -0.431 . . . . 72.33 111.403 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 46.5 mt-10 -59.79 -34.23 72.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.876 -0.416 . . . . 72.53 109.876 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -72.74 -44.77 61.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.199 -0.455 . . . . 73.13 111.817 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -73.81 -36.1 64.96 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.169 0.803 . . . . 74.33 113.169 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 142' ' ' LEU . 23.0 pttp -84.87 -6.38 59.34 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.937 -0.477 . . . . 72.11 111.458 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -74.67 144.7 80.78 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.492 -0.929 . . . . 73.54 108.492 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -43.0 -31.94 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.238 3.292 . . . . 71.24 115.018 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -71.85 -20.55 61.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.038 0.447 . . . . 75.12 110.871 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 57.67 42.22 94.15 Favored Glycine 0 CA--C 1.5 -0.868 0 CA-C-N 115.448 -0.796 . . . . 61.05 114.844 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.49 121.26 26.05 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.749 -0.781 . . . . 74.45 109.535 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.3 m -94.51 172.93 7.88 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.865 -0.607 . . . . 71.55 109.63 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -66.53 -35.91 81.4 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 111.919 0.34 . . . . 61.55 111.919 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.82 -28.51 68.42 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.819 0.818 . . . . 74.05 109.859 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -75.81 -45.49 35.72 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.838 -1.073 . . . . 73.44 110.748 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.03 65.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.27 -0.877 . . . . 65.43 112.074 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.72 -56.22 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 112.912 0.708 . . . . 70.15 112.912 -176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 160.9 154.04 7.23 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.85 -0.9 . . . . 53.23 110.85 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.9 p -69.03 116.0 8.97 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.862 0.331 . . . . 71.42 110.305 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.0 tt -72.56 -53.16 12.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.079 -0.712 . . . . 72.31 109.079 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.37 -31.69 26.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.42 -0.354 . . . . 72.44 110.897 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 t 73.4 -69.81 0.18 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.301 1.04 . . . . 71.01 109.33 -176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.1 m 53.14 88.45 0.03 OUTLIER 'General case' 0 C--O 1.238 0.45 0 N-CA-C 114.795 1.406 . . . . 74.12 114.795 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.23 -78.05 1.1 Allowed Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 109.64 -1.384 . . . . 72.31 109.64 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 C--N 1.311 -1.097 0 N-CA-C 108.254 -1.017 . . . . 65.42 108.254 176.622 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.438 -1.062 0 N-CA-C 109.168 -0.678 . . . . 64.34 109.168 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 t -74.31 136.9 42.59 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.783 -0.821 . . . . 73.34 108.783 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.0 p -153.16 160.19 42.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.594 -0.521 . . . . 64.13 109.594 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.0 m -94.73 -22.96 17.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.357 -0.608 . . . . 73.24 109.357 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 57.82 98.26 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 124.61 1.164 . . . . 55.21 113.9 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.17 -26.97 35.76 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.849 1.699 . . . . 64.44 109.918 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 58.05 70.57 0.64 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 124.343 1.027 . . . . 73.35 108.858 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.3 m 61.79 -173.73 0.14 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.162 -0.927 . . . . 44.32 109.267 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.405 ' C ' HD21 ' A' ' 10' ' ' ASN . 78.7 m80 -125.16 143.13 51.09 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 109.375 -0.602 . . . . 74.41 109.375 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 0.9 OUTLIER -128.95 123.85 33.57 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.307 -1.738 . . . . 70.31 106.307 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 t -111.82 120.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 119.777 -0.769 . . . . 72.23 109.393 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -81.97 113.89 20.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.755 -0.831 . . . . 74.42 108.755 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.16 159.25 41.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.345 0.593 . . . . 72.22 110.151 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -148.62 109.73 4.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 106.021 -1.844 . . . . 71.41 106.021 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 163.6 -92.21 0.11 Allowed Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.74 -0.944 . . . . 71.12 110.74 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.509 ' O ' HG13 ' A' ' 22' ' ' VAL . 49.5 m -149.6 78.95 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.19 1.182 . . . . 74.13 114.19 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 67' ' ' ILE . 63.8 mt -155.57 8.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 104.713 -2.329 . . . . 75.33 104.713 168.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.07 -17.21 25.34 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.372 -1.285 . . . . 74.13 109.676 -173.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.71 129.54 37.91 Favored Pre-proline 0 N--CA 1.403 -2.783 0 CA-C-N 114.676 -1.147 . . . . 45.41 108.635 172.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.71 -36.82 10.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.09 3.193 . . . . 73.12 113.034 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -55.46 -45.94 76.86 Favored 'General case' 0 C--O 1.224 -0.237 0 O-C-N 123.522 0.514 . . . . 73.42 112.008 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 16' ' ' SER . 92.3 t -77.3 -44.37 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.508 0.194 . . . . 74.52 111.446 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.48 -30.98 71.66 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.37 -0.532 . . . . 74.33 110.702 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.12 -40.62 74.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.062 -0.517 . . . . 74.35 111.268 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 21' ' ' ALA . 16.9 m -71.15 -31.16 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.294 -0.562 . . . . 74.23 111.687 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.532 HD12 ' CD1' ' A' ' 78' ' ' PHE . 6.1 tt -77.95 -38.57 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.275 0.56 . . . . 70.41 112.135 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 31' ' ' ALA . 95.6 mt -100.28 -10.75 20.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 113.93 1.085 . . . . 62.15 113.93 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 68.12 19.16 9.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.995 0.902 . . . . 71.04 109.432 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -162.28 142.68 10.05 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.338 -2.097 . . . . 73.3 105.338 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.2 m -77.06 119.24 20.5 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 120.948 0.404 . . . . 62.5 110.335 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -90.88 152.8 20.6 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.661 -0.496 . . . . 72.41 109.661 176.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.32 125.18 41.74 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.988 -0.551 . . . . 72.02 110.404 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 5.5 p -100.16 142.61 31.4 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 115.675 -0.693 . . . . 53.44 109.508 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.19 134.61 25.59 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.384 -1.339 . . . . 61.01 107.384 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.5 Cg_endo -61.8 130.38 31.04 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 121.932 1.755 . . . . 62.03 111.369 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.544 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.83 156.17 41.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.774 -1.103 . . . . 74.41 109.753 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.3 p -121.66 127.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.651 0.738 . . . . 73.13 111.546 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.424 ' HA ' HG11 ' A' ' 93' ' ' VAL . 23.3 tp -91.87 95.34 9.78 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.215 -0.902 . . . . 51.1 110.9 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 23.7 p80 -70.67 123.14 21.18 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.76 -1.109 . . . . 70.55 110.096 173.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 120.52 -13.59 10.1 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.878 -1.153 . . . . 73.22 113.8 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -123.62 166.06 16.12 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.326 0.861 . . . . 75.02 113.326 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -134.39 128.24 33.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.448 -1.686 . . . . 72.32 106.448 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -87.46 135.19 33.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.889 0.852 . . . . 73.04 112.722 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -107.53 106.98 17.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.305 -1.739 . . . . 73.51 106.305 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.639 ' HG3' ' OE2' ' A' ' 120' ' ' GLU . 24.1 tptp -47.79 -51.94 20.62 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.593 2.072 . . . . 74.31 116.593 -173.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mp 53.43 95.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.746 1.387 . . . . 71.1 114.746 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.306 0.0 OUTLIER -82.67 -11.73 58.14 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.888 1.07 . . . . 72.22 113.888 174.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.99 -43.4 10.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.849 -0.691 . . . . 54.42 111.929 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.2 152.36 39.37 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.038 -0.727 . . . . 74.45 109.038 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.6 112.0 3.37 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 122.867 2.378 . . . . 70.03 114.382 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.574 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.513 35.2 p90 35.79 59.91 2.93 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 119.044 2.979 . . . . 71.13 119.044 -178.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 10.4 Cg_endo -106.02 172.25 0.12 Allowed 'Trans proline' 0 CA--C 1.547 1.136 1 C-N-CA 126.504 4.803 . . . . 72.33 110.132 175.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.562 ' SG ' ' HB2' ' A' ' 109' ' ' TRP . 43.3 t -158.13 175.24 14.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.577 3.151 . . . . 70.23 103.751 -11.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 pt -135.65 138.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 119.407 1.003 . . . . 71.32 111.307 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.423 ' HB ' ' H ' ' A' ' 56' ' ' SER . 5.5 m -154.37 -160.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.984 1.313 . . . . 71.42 108.88 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.423 ' H ' ' HB ' ' A' ' 55' ' ' VAL . 47.5 m 83.73 -39.87 0.08 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.226 1.41 . . . . 75.35 113.305 176.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 50.0 m 56.65 31.0 18.44 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.969 0.89 . . . . 73.33 109.402 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.09 175.77 7.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.194 -1.366 . . . . 74.31 110.159 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -79.74 -0.58 34.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.783 0.325 . . . . 72.43 111.073 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.94 -172.16 21.75 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 116.168 -0.469 . . . . 74.12 112.43 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 17.7 ptmt -154.44 143.01 20.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.308 -0.525 . . . . 73.23 109.785 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.7 t -105.11 123.38 59.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.685 -0.857 . . . . 62.35 108.685 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -102.96 115.82 31.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.018 -0.673 . . . . 63.03 109.241 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -150.65 -136.75 2.58 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 111.708 -0.557 . . . . 53.3 111.708 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 35' ' ' PRO . 52.4 mtmt -139.28 147.22 41.37 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.551 0.691 . . . . 75.12 112.775 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.8 m -104.4 133.11 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.838 -1.074 . . . . 63.35 108.887 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 5.8 mt -87.49 111.0 21.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.953 -2.24 . . . . 72.42 104.953 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -97.72 167.26 11.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.633 -0.427 . . . . 75.12 111.888 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.7 39.38 93.68 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.645 -0.707 . . . . 73.0 113.274 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.1 t -103.97 122.04 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.125 -1.065 . . . . 63.35 108.125 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 m -78.6 158.57 28.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.064 -1.088 . . . . 63.11 108.064 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.89 -35.56 69.09 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.44 0.563 . . . . 70.34 110.949 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.81 91.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 73.35 110.714 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.424 ' HB3' HD23 ' A' ' 27' ' ' LEU . 47.9 mt-10 -69.03 -32.67 72.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.678 0.791 . . . . 74.31 110.536 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.449 HD23 HH11 ' A' ' 88' ' ' ARG . 1.3 tt -64.16 -28.29 69.66 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.466 -0.938 . . . . 72.34 108.466 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -56.54 -27.76 58.41 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 112.729 0.64 . . . . 75.04 112.729 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.417 ' O ' HG12 ' A' ' 80' ' ' VAL . 45.0 t-20 -72.56 -37.45 68.23 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 119.559 -0.856 . . . . 60.25 109.292 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CD1' HD12 ' A' ' 26' ' ' ILE . 90.8 m-85 -70.43 -30.19 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.628 -0.879 . . . . 72.22 108.628 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.77 -41.07 62.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 65.04 112.446 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 77' ' ' ASN . 9.4 p -67.09 -21.61 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.023 0.44 . . . . 71.42 110.255 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.27 116.37 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.526 -1.287 . . . . 74.11 107.526 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.455 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -71.36 119.44 15.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.197 1.184 . . . . 72.22 114.197 -171.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.651 ' HA3' ' CE1' ' A' ' 86' ' ' TYR . . . -150.7 86.43 0.15 Allowed Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 107.709 -2.156 . . . . 75.33 107.709 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -65.58 -38.35 89.25 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.838 0.855 . . . . 63.53 111.307 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.577 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 10.2 m-20 -91.4 8.62 35.36 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.108 -0.951 . . . . 75.4 112.103 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.651 ' CE1' ' HA3' ' A' ' 83' ' ' GLY 0.266 0.3 OUTLIER -125.04 157.95 34.95 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 119.443 -0.903 . . . . 73.52 112.237 172.488 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 11.8 pt-20 -127.61 158.37 37.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.501 0.191 . . . . 75.34 110.614 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.449 HH11 HD23 ' A' ' 75' ' ' LEU . 61.9 ttp180 -93.77 110.96 22.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.047 0.451 . . . . 75.12 110.679 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.9 159.49 28.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.257 -0.429 . . . . 64.25 111.145 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.416 ' CG2' ' HG2' ' A' ' 103' ' ' LYS . 99.2 m -99.08 124.16 43.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.916 -0.584 . . . . 64.42 109.596 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.6 m -125.37 155.65 34.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.872 1.269 . . . . 73.44 108.165 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 31.0 tt0 -105.1 127.44 52.89 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.784 -0.767 . . . . 75.34 110.395 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 38' ' ' LEU . 19.0 m -126.43 167.9 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 115.424 -0.807 . . . . 74.22 108.993 -175.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.444 HG23 ' HG2' ' A' ' 101' ' ' LYS . 62.2 t -107.1 123.06 62.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 173.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -73.66 84.14 1.59 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.768 -1.197 . . . . 73.22 107.768 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.544 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 25.3 ttt -39.59 -51.75 2.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 128.02 2.528 . . . . 75.33 114.035 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.42 -36.39 78.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.071 0.397 . . . . 72.14 112.071 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.75 -9.43 23.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.98 0.419 . . . . 74.22 110.922 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.86 20.76 12.36 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.035 1.334 . . . . 73.01 111.853 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -105.13 161.16 14.49 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 120.878 0.371 . . . . 72.23 110.369 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HG2' HG23 ' A' ' 94' ' ' VAL . 89.4 mttt -100.09 131.28 46.14 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.232 -0.655 . . . . 65.31 109.232 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.82 140.99 37.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.89 -0.411 . . . . 71.31 109.89 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HD3' ' HB2' ' A' ' 92' ' ' GLU . 31.2 ttpt -104.07 117.96 35.52 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 119.449 -0.9 . . . . 74.55 110.224 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 10' ' ' ASN . 19.8 m -123.82 176.26 5.52 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 CA-C-N 115.076 -0.965 . . . . 74.25 112.181 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -99.46 150.62 21.99 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 122.782 0.433 . . . . 72.21 110.026 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -159.43 175.01 13.83 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.689 -0.856 . . . . 65.24 108.689 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 97.6 m-85 -114.38 119.13 35.89 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.086 0.47 . . . . 75.11 111.837 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.49 142.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.713 -0.676 . . . . 61.1 109.908 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.577 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 25.1 t-105 -72.16 113.88 9.67 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.515 0.726 . . . . 74.23 110.119 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 m -72.38 -23.23 21.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 122.047 0.927 . . . . 65.32 110.055 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.463 ' OD1' ' HG3' ' A' ' 116' ' ' ARG . 28.6 t-20 -83.08 5.24 23.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.409 -1.269 . . . . 54.21 112.173 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -59.62 -15.06 16.22 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.437 1.273 . . . . 70.15 114.437 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -59.38 -28.57 67.0 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.992 1.108 . . . . 70.02 113.992 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -106.06 167.09 10.13 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.196 -1.409 . . . . 65.0 107.196 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.14 98.03 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 N-CA-C 108.371 -1.434 . . . . 74.4 108.371 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.463 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 40.4 mmt180 -133.15 128.62 36.47 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.707 -0.679 . . . . 65.33 110.236 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.476 ' N ' ' HE1' ' A' ' 117' ' ' MET . 0.0 OUTLIER 71.82 130.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.537 1.148 . . . . 70.33 114.044 171.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -104.58 -44.22 4.95 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.408 -0.96 . . . . 73.15 108.408 175.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.07 176.37 27.05 Favored Glycine 0 C--O 1.244 0.748 0 CA-C-N 115.848 -0.615 . . . . 54.0 113.354 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.639 ' OE2' ' HG3' ' A' ' 45' ' ' LYS . 1.5 mp0 -94.26 131.04 40.27 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 119.596 -0.841 . . . . 75.51 109.223 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 -165.38 5.12 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 124.519 1.128 . . . . 72.12 109.3 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 124' ' ' GLU . 17.9 t70 -82.4 142.09 32.25 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 106.792 -1.559 . . . . 70.31 106.792 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -63.57 -38.32 90.67 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 111.795 0.294 . . . . 75.12 111.795 -174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.454 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 38.9 tt0 -66.19 -45.85 79.38 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.781 -0.451 . . . . 74.52 109.781 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 42.7 mt-10 -66.5 -35.64 80.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.185 -0.461 . . . . 74.01 111.159 176.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -67.72 -34.09 76.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 73.12 110.643 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -58.31 -39.15 78.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.538 -0.912 . . . . 72.15 108.538 174.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 98.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.556 -1.202 . . . . 36.53 110.385 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 125' ' ' GLU . 97.6 t -67.61 -45.19 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.782 -0.451 . . . . 70.22 109.782 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.458 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 23.7 t60 -60.84 -34.26 74.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.771 -0.649 . . . . 74.41 109.701 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.36 -52.46 39.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.025 -0.534 . . . . 71.43 110.622 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 42.5 mt-10 -63.69 -40.96 98.1 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.487 0.492 . . . . 63.03 112.14 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.513 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -60.22 -47.62 85.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.987 -0.551 . . . . 74.14 111.499 -177.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.458 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 78.9 m-85 -76.99 -34.57 57.51 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.929 0.714 . . . . 71.24 112.929 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.548 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 12.5 p -67.34 -40.95 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.628 -0.829 . . . . 60.32 111.168 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.4 pt-20 -64.76 -34.56 78.63 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 120.11 -0.636 . . . . 73.5 110.747 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.2 m -66.13 -38.34 87.91 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.96 -0.564 . . . . 71.43 109.541 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.416 ' O ' ' HG3' ' A' ' 141' ' ' MET . 87.6 t80 -66.64 -44.71 81.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.606 -0.724 . . . . 63.45 109.674 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.6 mtp180 -55.06 -46.85 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 61.33 109.956 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 13.8 mmmm -61.97 -44.17 97.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.606 -0.725 . . . . 64.44 111.816 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 3.0 ppp? -70.28 -33.05 71.11 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 120.631 -0.427 . . . . 74.1 109.97 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.96 -42.07 97.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.785 -0.643 . . . . 73.54 109.279 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 148' ' ' PRO . 13.7 mm-40 -61.19 -39.14 89.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.036 -0.529 . . . . 74.53 110.551 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.41 ' HE1' ' HB2' ' A' ' 156' ' ' ALA . 43.7 t90 -75.32 -29.99 60.19 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.572 -0.451 . . . . 72.01 111.009 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.63 -31.89 36.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.241 0.544 . . . . 74.05 110.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.74 -32.42 46.7 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.945 -0.57 . . . . 72.43 110.89 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.608 ' HB3' ' O ' ' A' ' 151' ' ' LYS . 40.9 m-80 54.8 67.96 2.93 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.506 0.723 . . . . 63.1 111.908 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 143' ' ' GLU . 91.3 Cg_endo -105.82 -15.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.981 2.454 . . . . 53.34 115.047 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -94.01 13.59 22.42 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.992 0.738 . . . . 74.31 112.992 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.35 -20.38 16.15 Favored Glycine 0 CA--C 1.496 -1.123 0 C-N-CA 120.149 -1.024 . . . . 64.04 112.018 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.608 ' O ' ' HB3' ' A' ' 147' ' ' ASN . 97.3 mttt -78.26 143.77 36.76 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.753 -0.462 . . . . 72.41 109.753 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.3 m -117.87 156.65 28.04 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 106.874 -1.528 . . . . 74.45 106.874 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.401 ' O ' HG13 ' A' ' 157' ' ' VAL . 26.1 ptt? -56.67 -43.37 80.35 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.582 0.956 . . . . 71.21 113.582 -173.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -66.58 -35.88 81.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.11 0.957 . . . . 74.02 109.976 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -76.36 -39.07 54.82 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.658 -1.156 . . . . 74.41 110.924 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.41 ' HB2' ' HE1' ' A' ' 144' ' ' TRP . . . -74.18 -25.07 59.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.456 -1.247 . . . . 53.33 112.794 -175.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 153' ' ' MET . 28.7 m -73.63 137.48 23.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 C-N-CA 119.488 -0.885 . . . . 73.31 111.216 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.55 98.67 0.21 Allowed Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 115.798 -0.637 . . . . 71.34 112.318 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.2 m -114.65 172.81 6.81 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 120.837 0.351 . . . . 74.31 110.055 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.6 tp -122.95 142.53 50.72 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.776 -1.564 . . . . 74.33 106.776 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.1 mp 77.18 108.7 0.08 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.168 0.918 . . . . 72.23 110.919 -174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 42.8 t -73.98 -18.75 60.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.419 -0.81 . . . . 73.42 110.436 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.6 p 53.18 79.68 0.12 Allowed 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.611 1.165 . . . . 74.4 113.654 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -113.68 -84.48 1.29 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.551 -1.02 . . . . 62.55 110.551 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 107.438 -1.319 . . . . 64.23 107.438 178.092 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.445 -0.725 0 N-CA-C 109.883 -0.414 . . . . 75.42 109.883 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.6 m -96.22 108.9 21.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.562 -0.533 . . . . 75.32 109.562 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 t -143.08 -44.46 0.3 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.437 -0.949 . . . . 45.51 108.437 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 t -106.34 157.51 17.55 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.653 -1.61 . . . . 61.31 106.653 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -112.46 143.39 28.82 Favored Pre-proline 0 C--N 1.31 -1.111 0 C-N-CA 120.379 -0.528 . . . . 72.14 111.191 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -73.97 -33.94 5.64 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.181 1.92 . . . . 70.11 108.715 168.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -164.68 121.88 1.61 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 106.682 -1.599 . . . . 72.54 106.682 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.5 p -85.3 142.67 29.19 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.683 0.754 . . . . 74.22 112.278 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -106.91 155.7 19.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.518 -1.29 . . . . 72.25 107.518 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -136.24 133.51 37.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.947 -1.501 . . . . 72.44 106.947 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 t -118.96 120.82 65.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 120.693 -0.403 . . . . 71.35 110.551 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.34 113.49 21.69 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.536 -0.913 . . . . 72.03 108.536 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 m -121.65 160.23 23.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.91 -0.586 . . . . 52.52 110.792 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -132.55 118.45 19.24 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.402 -0.817 . . . . 74.31 109.186 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.406 ' H ' HD13 ' A' ' 18' ' ' LEU . . . 102.08 -71.2 0.34 Allowed Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.889 -0.596 . . . . 70.13 113.168 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -92.17 155.6 17.9 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 111.556 0.206 . . . . 71.55 111.556 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 67' ' ' ILE . 25.1 mt 72.73 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 125.003 1.321 . . . . 64.32 111.166 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 15' ' ' GLY . 56.4 mt -66.09 -28.19 68.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.137 0.494 . . . . 61.3 110.11 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.22 129.24 44.23 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 115.24 -0.891 . . . . 71.33 108.965 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.65 -33.52 31.81 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.804 3.003 . . . . 72.3 112.993 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.4 80.81 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 120.85 0.357 . . . . 72.52 111.173 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.491 ' O ' HG22 ' A' ' 25' ' ' VAL . 60.6 t -73.73 -36.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.483 0.659 . . . . 64.52 109.647 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . . . -67.45 -31.5 71.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.913 -0.773 . . . . 72.12 108.913 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.34 -3.88 39.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.133 -0.94 . . . . 74.25 111.903 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 22' ' ' VAL . 19.6 m -105.75 -34.4 3.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.528 -0.869 . . . . 72.24 110.476 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 78' ' ' PHE . 5.1 tt -70.03 -41.03 79.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 121.023 0.439 . . . . 71.25 111.067 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 31' ' ' ALA . 81.7 mt -100.37 -17.65 17.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.614 -0.434 . . . . 70.42 110.7 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 34.2 t70 73.08 -2.77 2.62 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.9 1.334 . . . . 65.02 110.017 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 27' ' ' LEU . 39.2 ttm105 -121.2 144.85 48.37 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.608 -1.997 . . . . 74.54 105.608 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.1 m -77.8 111.14 13.31 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.107 -0.637 . . . . 74.13 111.416 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -93.51 143.75 26.0 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.011 -1.107 . . . . 65.1 108.011 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -98.05 125.42 43.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.867 0.692 . . . . 63.25 112.867 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.6 p -94.47 145.13 25.0 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.189 -0.914 . . . . 75.02 109.612 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.2 137.38 29.65 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 108.26 -1.015 . . . . 63.32 108.26 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 127.51 23.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.965 1.777 . . . . 71.53 111.363 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.78 154.96 39.3 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 116.21 -0.45 . . . . 55.43 110.3 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.24 127.48 75.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.389 0.614 . . . . 74.03 111.157 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.405 HD11 ' HB ' ' A' ' 91' ' ' VAL . 19.2 tp -88.04 119.69 28.66 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.66 -0.7 . . . . 64.1 109.768 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.469 -0.787 . . . . 74.11 110.918 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.02 59.63 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 119.516 -1.326 . . . . 72.42 113.441 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.445 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 64.3 m-85 -121.51 151.99 39.68 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 117.212 0.506 . . . . 72.43 110.752 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 12.4 t-160 -122.86 138.26 54.71 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.994 -0.548 . . . . 74.43 109.993 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.494 HH21 ' HB2' ' A' ' 125' ' ' GLU . 32.0 ptt180 -86.03 109.75 19.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.165 0.983 . . . . 64.22 108.985 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.65 ' CE2' ' HA ' ' A' ' 118' ' ' TYR . 3.1 m-85 -74.62 154.72 38.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.701 -1.136 . . . . 73.42 112.781 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -87.69 -7.61 57.19 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.606 1.335 . . . . 74.33 114.606 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.433 HD22 ' H ' ' A' ' 46' ' ' LEU . 1.2 pt? -72.29 73.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.601 0.963 . . . . 73.44 113.601 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HA ' ' CG ' ' A' ' 52' ' ' PRO . 54.6 pttt -72.83 1.19 9.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.816 1.414 . . . . 74.41 114.816 -175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.66 -20.25 79.79 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 109.358 -1.497 . . . . 54.21 109.358 172.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.9 157.57 51.47 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 109.285 -0.635 . . . . 73.33 109.285 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.28 106.27 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.672 2.248 . . . . 73.12 114.368 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 45.84 69.54 2.54 Favored Pre-proline 0 N--CA 1.496 1.827 0 C-N-CA 124.469 1.108 . . . . 75.51 111.342 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 68.8 Cg_endo -110.88 153.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 124.108 3.205 . . . . 71.32 117.235 -167.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.484 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 72.9 m -155.15 163.03 40.78 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 130.012 3.325 . . . . 74.22 102.295 -17.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 43.7 pt -123.59 138.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 117.806 -1.557 . . . . 72.42 112.619 170.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 44' ' ' TYR . 71.9 t -135.84 153.26 32.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.014 -1.847 . . . . 71.21 106.014 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 t -65.84 136.17 55.81 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 122.148 0.975 . . . . 72.4 112.295 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.6 t -156.42 104.53 2.21 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 103.717 -2.697 . . . . 73.51 103.717 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.77 -37.51 73.8 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 114.111 1.152 . . . . 71.13 114.111 -169.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -86.63 -0.06 55.46 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.306 -0.557 . . . . 71.14 111.985 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.79 146.76 16.18 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.761 -0.733 . . . . 71.21 111.549 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -140.44 152.74 45.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.139 -0.689 . . . . 72.25 109.139 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 41' ' ' TYR . 46.4 t -114.96 122.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.623 -0.51 . . . . 61.43 109.623 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -96.96 121.23 38.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.238 -0.652 . . . . 45.41 109.238 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.39 -143.44 3.7 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.003 -0.839 . . . . 54.13 111.003 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -140.53 142.88 35.17 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.74 -0.837 . . . . 65.4 108.74 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.37 134.05 46.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 120.915 0.388 . . . . 63.01 110.722 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 17' ' ' ILE . 11.4 mt -86.44 110.27 19.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 104.67 -2.345 . . . . 74.45 104.67 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -101.58 162.72 12.7 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.27 0.47 . . . . 73.12 112.27 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.36 47.45 70.81 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.646 -0.706 . . . . 50.33 112.123 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.4 122.77 59.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.024 -0.732 . . . . 71.3 109.024 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 m -77.82 158.71 29.39 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.316 -0.954 . . . . 71.14 108.857 175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -54.57 -35.94 63.84 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 112.172 0.434 . . . . 73.43 112.172 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.22 79.72 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.482 0.658 . . . . 70.31 110.587 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -77.25 -37.23 53.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.331 -0.849 . . . . 62.43 109.921 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -33.47 71.04 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.986 -1.006 . . . . 73.3 109.697 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.06 -34.71 66.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.671 -1.149 . . . . 72.01 111.494 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.47 ' ND2' HG13 ' A' ' 26' ' ' ILE . 53.1 t30 -76.13 -29.77 57.93 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.113 -1.035 . . . . 64.42 109.856 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.686 ' O ' HG23 ' A' ' 81' ' ' ILE . 97.1 m-85 -66.06 -28.59 68.95 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.6 -0.727 . . . . 73.32 110.906 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.22 -31.63 71.26 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.591 -0.892 . . . . 73.34 108.591 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.21 -22.69 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 114.887 -1.051 . . . . 75.31 111.847 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 78' ' ' PHE . 11.7 tt -74.05 2.31 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 CA-C-O 121.842 0.829 . . . . 64.14 110.239 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.371 31.1 mm-40 88.63 126.95 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 117.539 2.422 . . . . 64.1 117.539 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.74 53.72 0.34 Allowed Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 106.883 -2.487 . . . . 64.44 106.883 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.59 -42.56 99.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.021 0.928 . . . . 64.13 113.011 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 110' ' ' VAL . 7.3 m-20 -100.12 16.3 24.57 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.756 0.789 . . . . 61.34 109.701 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.442 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 77.4 m-85 -121.17 159.2 26.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.428 -0.806 . . . . 72.43 109.032 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.458 ' HB3' HG13 ' A' ' 110' ' ' VAL . 12.5 pt-20 -127.88 157.91 39.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.417 -0.216 . . . . 63.23 110.417 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -85.15 113.05 21.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.18 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.31 159.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.447 -0.342 . . . . 74.3 110.485 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.7 m -106.41 122.47 46.34 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 108.902 -0.777 . . . . 73.34 108.902 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.3 m -128.01 161.9 35.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.946 -1.131 . . . . 74.04 107.946 -175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.494 ' HG3' ' CE ' ' A' ' 103' ' ' LYS . 1.2 mp0 -108.76 138.87 44.39 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.069 -1.452 . . . . 70.34 108.352 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.456 HG22 HG11 ' A' ' 66' ' ' VAL . 26.2 m -126.51 161.1 33.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.983 -0.747 . . . . 44.13 108.983 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.526 HG23 ' HG3' ' A' ' 101' ' ' LYS . 75.5 t -104.79 116.85 49.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.693 -0.685 . . . . 74.54 110.083 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 15.5 ttm180 -68.13 110.79 4.14 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.948 -1.871 . . . . 61.2 105.948 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.32 -54.1 49.45 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 114.848 1.425 . . . . 73.41 114.848 -164.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.53 -12.8 61.21 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.235 1.198 . . . . 74.01 114.235 -172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.1 -6.19 9.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.185 0.517 . . . . 73.53 110.705 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.2 m 61.46 25.93 15.78 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.148 0.579 . . . . 74.53 111.288 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 12.9 pt-20 -93.91 158.71 15.51 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 109.429 -0.582 . . . . 74.24 109.429 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.526 ' HG3' HG23 ' A' ' 94' ' ' VAL . 8.1 mptt -109.99 132.63 53.98 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.084 -0.71 . . . . 63.44 109.084 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.87 146.57 25.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.74 -0.467 . . . . 74.24 109.74 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.494 ' CE ' ' HG3' ' A' ' 92' ' ' GLU . 14.1 tppt? -91.6 132.77 36.08 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.622 -0.881 . . . . 74.44 108.622 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.0 m -139.56 173.33 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.733 0.301 . . . . 74.41 110.847 -177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.79 148.78 24.88 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.598 -0.89 . . . . 74.22 108.598 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 t -153.39 175.18 13.42 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 109.16 -0.682 . . . . 71.53 109.16 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -107.19 118.61 37.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.67 -1.233 . . . . 74.12 107.67 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.32 162.6 10.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.196 -1.039 . . . . 75.15 108.196 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.551 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 33.6 t-105 -77.8 127.59 32.65 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.724 -0.843 . . . . 74.34 108.724 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 85' ' ' ASP . 26.9 m -69.81 -23.57 25.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 O-C-N 121.757 -0.589 . . . . 74.14 111.579 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.551 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -91.75 14.35 15.59 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.717 -0.674 . . . . 53.21 109.703 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.5 ptpp? -49.68 -18.81 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.352 1.461 . . . . 73.33 113.822 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.35 -39.53 76.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.921 -0.4 . . . . 73.31 109.921 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -114.2 124.07 31.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 N-CA-C 109.69 -0.485 . . . . 74.12 109.69 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.83 116.51 4.62 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.167 1.911 . . . . 53.23 109.565 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -86.98 113.66 22.94 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.31 -0.996 . . . . 65.13 108.31 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 69.89 -47.49 0.61 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.465 1.106 . . . . 72.42 113.0 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.65 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 69.1 t80 76.45 -61.72 0.44 Allowed 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 125.642 1.577 . . . . 72.51 107.908 -172.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 37.27 102.75 0.01 OUTLIER Glycine 0 C--N 1.339 0.702 0 O-C-N 125.761 1.913 . . . . 61.53 117.189 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.55 132.43 33.91 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 106.333 -1.728 . . . . 73.14 106.333 174.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -121.89 -29.76 4.23 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 113.362 0.875 . . . . 75.33 113.362 -170.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 124' ' ' GLU . 30.5 t70 -97.68 130.32 44.68 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.897 -0.721 . . . . 75.22 110.742 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -68.83 -30.52 69.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.407 -0.36 . . . . 75.25 111.916 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 39.8 tt0 -70.56 -39.59 73.84 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.738 -1.208 . . . . 72.01 107.738 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HB2' HH21 ' A' ' 43' ' ' ARG . 39.9 tt0 -58.13 -51.04 71.37 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.689 -1.141 . . . . 61.4 109.672 173.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -52.52 -46.63 66.79 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.802 -0.814 . . . . 74.22 108.802 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -60.5 -48.88 79.84 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.104 -0.953 . . . . 61.42 111.702 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.7 m -73.91 -31.6 31.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 N-CA-C 112.682 0.623 . . . . 72.32 112.682 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 125' ' ' GLU . 84.4 t -67.48 -40.28 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.023 -0.732 . . . . 71.53 109.023 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.545 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 46.0 t60 -65.86 -42.88 89.88 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.644 -0.707 . . . . 74.41 109.189 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -62.59 -52.69 62.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.615 -0.266 . . . . 73.43 111.367 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 13.6 mm-40 -62.46 -31.69 72.45 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.378 -0.374 . . . . 73.32 111.407 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.497 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 3.4 tmtm? -59.64 -40.5 87.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.698 0.761 . . . . 75.52 109.645 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.545 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 82.7 m-85 -82.31 -36.13 27.28 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.593 -0.692 . . . . 61.25 110.857 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 131' ' ' ALA . 99.3 t -62.49 -44.8 99.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.445 -0.343 . . . . 72.53 111.254 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 11.2 pt-20 -60.27 -37.46 80.52 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 110.18 -0.304 . . . . 72.34 110.18 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -64.42 -44.43 91.24 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.734 -0.469 . . . . 73.4 109.734 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.08 -46.21 90.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.68 -0.489 . . . . 64.34 109.68 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.62 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 98.2 mtt180 -63.84 -49.26 73.51 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.566 -0.743 . . . . 74.41 112.681 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -60.4 -47.03 87.86 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.905 0.128 . . . . 74.44 110.82 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -63.38 -32.73 74.24 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.948 0.404 . . . . 63.21 110.053 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' ARG . 65.0 tp -62.62 -47.15 85.02 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.717 -0.674 . . . . 63.31 109.195 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.0 mt-10 -60.88 -46.99 88.44 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.427 0.454 . . . . 71.45 110.279 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -66.3 -36.9 84.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.768 0.655 . . . . 65.53 112.768 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.04 -28.23 29.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.047 0.451 . . . . 70.12 111.427 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 12.3 tmtt? -79.64 -32.28 41.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.447 -0.342 . . . . 74.22 110.194 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -69.88 118.75 66.24 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.258 -0.428 . . . . 74.53 111.06 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.13 -14.72 45.64 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.796 2.997 . . . . 72.22 113.188 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -70.77 -25.16 62.77 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.997 0.427 . . . . 75.41 111.301 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.73 32.06 38.28 Favored Glycine 0 C--O 1.218 -0.883 0 N-CA-C 115.578 0.991 . . . . 51.33 115.578 172.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -79.66 127.64 32.42 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 118.138 0.969 . . . . 64.02 110.12 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.4 m -88.04 178.31 6.69 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.323 -0.399 . . . . 55.51 110.675 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.451 ' O ' HG12 ' A' ' 157' ' ' VAL . 26.9 ttt -64.24 -43.63 94.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.808 0.337 . . . . 72.53 110.664 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.68 -24.21 67.52 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.941 -0.572 . . . . 73.12 111.486 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -75.84 -44.51 40.57 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.46 0.647 . . . . 53.31 110.042 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.35 -25.08 62.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.267 -0.879 . . . . 73.1 112.996 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 153' ' ' MET . 14.7 p -128.09 141.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 120.43 -0.508 . . . . 63.33 110.062 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.23 93.91 1.0 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.713 -0.756 . . . . 64.52 111.221 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.3 t -94.15 146.07 24.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.889 -0.782 . . . . 74.5 108.889 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.74 108.78 15.56 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.934 -0.395 . . . . 73.41 109.934 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.4 tt -172.65 -46.91 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.328 -0.99 . . . . 70.13 108.328 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.7 t 68.45 78.93 0.22 Allowed 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.061 -0.972 . . . . 71.04 109.809 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.8 t -93.02 132.11 37.4 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.859 -1.064 . . . . 72.31 110.834 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.94 -134.36 2.02 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 109.365 -1.494 . . . . 75.1 109.365 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--N 1.295 -1.774 0 N-CA-C 108.793 -0.817 . . . . 71.54 108.793 177.904 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 109.316 -0.624 . . . . 71.42 109.316 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.2 p -127.88 147.94 50.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.292 -1.003 . . . . 73.45 108.292 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.0 t -84.75 82.64 8.34 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.844 -1.169 . . . . 72.14 107.844 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -178.68 -164.89 0.08 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.192 -2.521 . . . . 70.55 104.192 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 51.9 m-20 -84.37 120.76 74.81 Favored Pre-proline 0 C--N 1.313 -1.01 0 C-N-CA 119.523 -0.871 . . . . 70.42 110.819 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 5' ' ' ASP . 8.2 Cg_exo -74.91 -41.08 0.74 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.435 2.09 . . . . 51.0 112.652 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.22 -16.01 39.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.179 0.514 . . . . 61.02 110.774 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.4 m -121.03 173.67 7.12 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 121.49 0.662 . . . . 72.43 111.082 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -106.34 156.15 18.8 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 124.63 1.172 . . . . 75.2 109.25 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.461 HD21 HG23 ' A' ' 68' ' ' THR . 14.1 m120 -134.62 122.77 22.77 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.713 -1.958 . . . . 64.32 105.713 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.05 122.61 68.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.86 -0.736 . . . . 72.4 111.565 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -83.84 108.36 16.81 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.419 -1.326 . . . . 75.22 107.419 175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.5 147.76 26.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.886 -0.725 . . . . 75.44 110.716 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' HA ' HD13 ' A' ' 18' ' ' LEU . 50.0 t80 -127.34 96.76 4.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.465 -2.05 . . . . 74.43 105.465 170.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.0 -145.84 11.05 Favored Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.069 -1.539 . . . . 63.11 114.453 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 m -43.8 -61.51 1.4 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 127.396 2.278 . . . . 74.44 116.926 -170.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.464 HG13 ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -89.06 17.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 114.16 1.17 . . . . 75.04 114.16 -167.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 14' ' ' TYR . 54.7 mt -73.38 -17.27 61.3 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 120.12 -0.632 . . . . 65.23 111.13 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.97 125.96 80.8 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.501 -0.772 . . . . 62.35 109.4 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -46.62 -38.08 21.42 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 124.258 3.305 . . . . 74.24 114.785 -174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -60.15 -64.46 0.94 Allowed 'General case' 0 C--O 1.217 -0.649 0 O-C-N 123.126 0.266 . . . . 71.24 110.379 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.537 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 41.9 t -55.88 -32.68 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 124.13 0.972 . . . . 73.13 111.19 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HA ' HG23 ' A' ' 26' ' ' ILE . . . -65.42 -33.55 76.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.027 0.442 . . . . 54.45 111.394 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -80.94 -30.78 35.19 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 122.126 0.965 . . . . 75.03 108.648 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 22' ' ' VAL . 26.9 t -65.58 -33.85 66.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 125.26 1.424 . . . . 65.12 111.377 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.672 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tt -87.33 -42.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.733 0.642 . . . . 62.32 112.733 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 31' ' ' ALA . 87.8 mt -85.18 -30.15 24.16 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 112.188 0.44 . . . . 74.32 112.188 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 t70 81.78 1.75 1.47 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.245 1.418 . . . . 74.24 109.19 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 52.1 mtt180 -126.08 163.63 22.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.115 -1.439 . . . . 73.42 107.115 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -76.63 115.02 16.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.003 -0.74 . . . . 72.0 109.003 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -80.27 136.02 36.35 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.62 -0.718 . . . . 70.22 111.911 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.72 110.2 22.61 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.809 -0.757 . . . . 60.22 109.496 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.479 ' CG2' HG12 ' A' ' 67' ' ' ILE . 4.2 p -110.16 143.81 39.72 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.663 -0.699 . . . . 64.14 110.21 174.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -133.48 140.57 37.37 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 107.361 -1.348 . . . . 64.4 107.361 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.574 ' O ' ' HB3' ' A' ' 96' ' ' MET . 19.2 Cg_endo -60.62 137.18 71.82 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.68 1.586 . . . . 74.11 109.512 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.36 42.72 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.261 -0.644 . . . . 72.13 109.261 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.89 125.69 70.11 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 121.861 0.838 . . . . 73.35 111.543 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.8 tp -89.71 113.39 24.89 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 114.731 -1.122 . . . . 61.03 109.743 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -85.32 136.22 33.57 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.712 -0.847 . . . . 71.44 108.712 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 106.6 -23.38 28.33 Favored Glycine 0 C--O 1.203 -1.785 0 C-N-CA 118.965 -1.588 . . . . 63.24 112.666 174.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.437 ' O ' HG21 ' A' ' 62' ' ' VAL . 16.8 m-85 -101.59 143.37 31.65 Favored 'General case' 0 CA--C 1.456 -2.669 0 C-N-CA 119.718 -0.793 . . . . 73.12 110.928 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 3.7 t60 -112.31 135.08 53.43 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 115.285 -0.871 . . . . 75.21 109.26 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -87.2 112.22 21.77 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.7 -0.682 . . . . 71.01 109.792 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -105.76 126.58 52.33 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.757 -1.572 . . . . 70.41 106.757 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.549 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -85.12 -11.82 54.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.697 0.761 . . . . 73.15 109.612 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.628 HD11 ' SD ' ' A' ' 117' ' ' MET 0.282 2.6 mm? 72.79 -99.4 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 125.108 1.363 . . . . 73.42 112.723 -177.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt 171.49 -37.52 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.191 0.996 . . . . 72.32 110.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.51 4.26 3.67 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.069 -1.062 . . . . 64.23 112.718 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.36 134.01 30.43 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 119.038 -1.065 . . . . 71.35 111.797 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.787 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 73.6 Cg_endo -74.69 103.36 1.7 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.462 2.775 . . . . 72.53 114.466 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.52 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.455 38.5 p90 71.23 1.49 0.0 OUTLIER Pre-proline 0 CA--C 1.608 3.196 0 N-CA-C 121.025 3.713 . . . . 72.51 121.025 176.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.787 ' HD3' ' C ' ' A' ' 50' ' ' PRO . 1.7 Cg_endo -88.41 169.45 5.93 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.862 2.375 . . . . 72.52 108.502 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 15.2 p -156.42 -176.32 5.91 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 127.568 2.347 . . . . 74.01 108.535 -3.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 46.0 pt -134.9 130.59 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 74.21 108.113 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.19 -175.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.133 -1.432 . . . . 75.12 107.133 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.2 m 69.83 -173.09 0.18 Allowed 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.323 1.014 . . . . 71.2 111.431 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 56.8 m -148.69 34.28 0.77 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.466 -0.568 . . . . 74.41 109.466 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -75.15 -166.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.73 -0.668 . . . . 74.04 111.905 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 m -75.49 -9.75 58.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.86 0.689 . . . . 75.53 112.86 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.85 160.0 45.47 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.018 -0.611 . . . . 64.5 112.846 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -136.67 159.33 42.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.544 -0.91 . . . . 62.43 108.544 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 41' ' ' TYR . 49.1 t -126.25 128.02 71.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 110.088 -0.338 . . . . 74.42 110.088 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.79 122.06 42.2 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.746 -0.464 . . . . 70.32 109.746 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.51 -146.84 4.41 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 111.349 -0.7 . . . . 55.11 111.349 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -138.96 139.96 38.11 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.79 -0.819 . . . . 72.43 108.79 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -104.23 132.24 51.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 119.782 -0.767 . . . . 73.01 109.954 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.479 HG12 ' CG2' ' A' ' 33' ' ' THR . 36.0 mt -90.15 117.48 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.302 -1.37 . . . . 64.02 107.302 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.461 HG23 HD21 ' A' ' 10' ' ' ASN . 81.2 p -103.04 162.07 13.25 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.155 0.428 . . . . 64.41 112.155 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.04 33.6 74.73 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.619 -0.719 . . . . 53.14 113.671 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.57 122.28 39.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 122.506 -0.408 . . . . 74.21 110.198 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -75.04 159.11 32.12 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.579 -0.896 . . . . 74.45 108.579 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.21 -42.35 81.13 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.363 0.602 . . . . 71.21 112.075 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.58 72.01 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.339 -0.846 . . . . 52.44 110.857 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -76.26 -32.99 59.15 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.586 -0.734 . . . . 74.41 109.172 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.59 -40.68 95.67 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.97 -1.014 . . . . 75.45 109.847 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.618 ' O ' HG22 ' A' ' 80' ' ' VAL . 27.2 t-20 -55.88 -30.49 61.61 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.801 -1.091 . . . . 64.14 111.644 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.672 ' ND2' HG13 ' A' ' 26' ' ' ILE . 64.6 t30 -69.5 -31.47 69.75 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 120.768 -0.373 . . . . 72.44 110.671 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.59 ' CD1' HD12 ' A' ' 26' ' ' ILE . 81.2 m-85 -72.06 -42.13 66.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.516 -0.92 . . . . 75.45 108.516 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.18 -35.2 78.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.114 -1.403 . . . . 71.44 110.291 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 76' ' ' ASN . 60.9 t -74.98 -23.84 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 112.859 0.688 . . . . 72.22 112.859 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 77' ' ' ASN . 46.2 mm -75.76 -84.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 119.308 -0.957 . . . . 75.44 112.42 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.07 10.88 32.0 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 121.657 -0.652 . . . . 72.01 112.548 178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.55 32.01 2.65 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.52 -0.848 . . . . 63.31 112.847 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -83.16 -39.99 20.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.961 0.41 . . . . 74.44 111.361 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.17 14.97 20.66 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.148 0.975 . . . . 62.12 108.635 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -123.81 156.85 35.36 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.423 -1.325 . . . . 70.5 107.423 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HB3' HG23 ' A' ' 110' ' ' VAL . 14.0 pt-20 -126.71 155.2 43.06 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.737 -0.838 . . . . 74.12 108.737 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 106' ' ' THR . 49.0 mtm105 -94.84 107.69 19.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.481 0.548 . . . . 73.11 112.481 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.35 158.15 11.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.75 -0.659 . . . . 63.24 109.3 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.1 m -94.98 126.11 40.1 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.104 -0.702 . . . . 72.32 109.104 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.11 158.31 43.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.802 -1.184 . . . . 74.13 107.802 -177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -113.96 129.74 56.58 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.454 -1.298 . . . . 72.14 108.605 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.24 166.1 23.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.444 -0.576 . . . . 61.52 109.444 -174.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.498 HG13 ' H ' ' A' ' 96' ' ' MET . 73.0 t -99.76 124.79 53.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.598 -0.889 . . . . 74.33 108.598 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -68.24 5.12 1.04 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 125.558 1.543 . . . . 73.21 112.462 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 0.9 OUTLIER 51.5 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 127.004 2.122 . . . . 64.14 115.166 174.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.8 -43.09 80.57 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.779 0.832 . . . . 54.25 110.751 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.01 -8.84 24.76 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.448 -1.315 . . . . 72.31 107.448 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.7 m 62.63 12.36 5.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.742 1.217 . . . . 75.42 113.888 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.81 161.95 15.05 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.4 -0.592 . . . . 61.31 109.4 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HG2' HG23 ' A' ' 94' ' ' VAL . 89.3 mttt -96.89 129.68 44.3 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.701 -0.852 . . . . 63.43 108.701 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.14 130.04 69.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 121.256 0.55 . . . . 74.01 110.93 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -86.95 119.75 27.49 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.076 -1.083 . . . . 73.13 108.076 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.47 174.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.122 -0.49 . . . . 61.21 110.589 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.14 153.7 19.36 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.442 -0.948 . . . . 53.01 108.442 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 14.7 t -146.58 173.43 12.33 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.634 -0.876 . . . . 61.34 108.634 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -107.91 118.19 36.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.174 0.511 . . . . 75.23 110.02 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 HG13 ' A' ' 54' ' ' ILE . 27.3 m -110.23 168.74 4.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.417 -0.957 . . . . 43.14 108.417 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 111' ' ' ASN . 32.1 t-105 -83.14 119.62 24.75 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.997 -0.742 . . . . 75.11 108.997 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 87' ' ' GLU . 2.2 p -68.65 -20.44 25.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.396 -0.82 . . . . 61.43 111.48 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 18.1 m120 -84.95 13.52 5.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.173 1.389 . . . . 42.51 111.425 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -51.49 -27.66 11.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.541 1.136 . . . . 61.43 113.04 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -78.09 -15.46 58.86 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 120.865 0.364 . . . . 64.21 111.373 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.51 138.57 26.75 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 107.089 -1.449 . . . . 64.52 107.089 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -40.15 108.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.683 2.922 . . . . 75.43 112.664 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -95.47 162.47 13.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.039 -0.528 . . . . 75.21 110.471 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.628 ' SD ' HD11 ' A' ' 46' ' ' LEU . 1.3 mpt? -73.58 95.91 2.36 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 105.692 -1.966 . . . . 73.4 105.692 171.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -92.67 -32.19 14.83 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 116.043 -0.526 . . . . 75.23 110.76 -171.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.536 ' HA3' ' CD1' ' A' ' 126' ' ' TRP . . . -148.49 43.27 0.81 Allowed Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 119.345 -1.407 . . . . 63.1 113.336 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.9 165.75 15.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.622 -0.831 . . . . 72.33 109.926 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 78.3 m95 74.8 -39.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.752 1.221 . . . . 74.41 112.769 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -125.35 112.49 16.4 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.284 -0.636 . . . . 71.45 109.284 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -69.74 -40.82 75.96 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.527 -0.76 . . . . 74.23 113.037 -176.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -32.95 65.31 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.373 -0.531 . . . . 74.42 110.963 -173.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.58 -39.82 88.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.091 -0.707 . . . . 65.41 109.091 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CD1' ' HA3' ' A' ' 119' ' ' GLY . 29.0 t90 -62.59 -48.28 80.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.665 -0.698 . . . . 74.54 110.108 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -59.06 -47.91 83.52 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 116.005 -0.543 . . . . 71.22 111.991 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.8 m -69.29 -40.44 80.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.461 -0.495 . . . . 70.1 112.29 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.04 -28.33 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.588 -0.445 . . . . 74.23 110.535 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.474 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 14.2 t60 -55.66 -47.05 77.34 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.905 -0.776 . . . . 73.12 108.905 174.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.91 98.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.66 -0.7 . . . . 74.11 110.919 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -67.37 -40.83 85.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.116 -0.493 . . . . 52.21 111.407 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.612 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -67.07 -53.5 30.38 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 108.383 -0.969 . . . . 65.31 108.383 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 77.2 m-85 -63.17 -31.44 72.59 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.904 1.446 . . . . 73.02 114.904 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.27 -34.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 119.117 -1.033 . . . . 54.11 109.508 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.4 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 1.6 tm-20 -69.34 -34.67 74.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.227 1.011 . . . . 73.23 109.028 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.3 m -57.62 -44.02 85.21 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.332 -0.618 . . . . 65.32 109.332 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.465 ' O ' ' HG3' ' A' ' 141' ' ' MET . 79.4 t80 -66.19 -36.31 82.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.764 -0.653 . . . . 72.44 109.266 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 81.2 mtp180 -60.94 -52.52 64.67 Favored 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.155 -0.475 . . . . 53.4 109.795 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.536 ' HE3' ' OE1' ' A' ' 155' ' ' GLU . 46.3 mmtm -56.03 -39.23 71.65 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.224 0.824 . . . . 73.32 113.224 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 3.3 ppp? -67.47 -31.79 72.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.968 -0.693 . . . . 71.43 110.001 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.2 tp -76.54 -41.71 45.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.527 -0.76 . . . . 75.14 109.622 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 12.4 mm-40 -59.54 -46.84 87.7 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.605 -0.517 . . . . 73.41 109.605 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -64.92 -36.63 85.0 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.285 -0.871 . . . . 74.33 112.027 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -82.17 -38.64 24.36 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.989 0.424 . . . . 75.42 111.438 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -79.48 -31.61 42.39 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.65 0.262 . . . . 65.55 110.508 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -124.7 82.85 59.41 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-O 120.863 0.363 . . . . 54.44 110.213 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.76 -24.18 18.44 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.81 2.34 . . . . 74.33 112.563 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -96.84 -15.97 21.0 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.372 0.606 . . . . 75.43 109.957 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.36 -3.69 78.18 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.407 -0.815 . . . . 74.35 113.384 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.592 ' O ' ' HD2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -75.27 132.03 40.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.219 0.533 . . . . 75.22 111.91 178.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.6 m -101.11 177.94 4.8 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.147 -0.478 . . . . 72.5 111.991 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 66.9 mtt -56.56 -36.61 69.51 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.718 1.007 . . . . 45.54 113.718 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -99.63 -18.9 17.09 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.12 -1.067 . . . . 74.13 108.12 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.536 ' OE1' ' HE3' ' A' ' 140' ' ' LYS . 23.1 mm-40 -73.85 -52.32 13.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.275 0.559 . . . . 71.22 109.667 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.84 -25.53 37.66 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.322 -0.854 . . . . 70.42 109.807 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.7 t 65.54 92.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 113.973 -1.467 . . . . 74.1 111.368 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -128.27 -94.33 0.8 Allowed Glycine 0 C--N 1.297 -1.632 0 CA-C-N 114.627 -1.17 . . . . 74.43 110.413 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.6 p -76.66 96.88 4.28 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.213 -0.662 . . . . 60.43 109.213 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.4 tp -155.46 158.8 39.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.124 -1.806 . . . . 74.44 106.124 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.04 90.75 7.5 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.277 -0.569 . . . . 70.45 112.012 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.8 p -77.79 124.1 27.54 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.033 -1.099 . . . . 52.22 108.033 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 46.7 p -148.98 167.85 24.68 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.089 0.471 . . . . 62.34 111.694 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -149.81 -173.15 19.96 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 109.755 -1.338 . . . . 64.33 109.755 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 C--N 1.294 -1.811 0 N-CA-C 109.854 -0.424 . . . . 73.32 109.854 179.137 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 109.544 -0.539 . . . . 74.32 109.544 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p 44.87 -90.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.343 1.238 . . . . 72.11 114.343 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 p -138.43 117.61 12.66 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 115.897 -0.592 . . . . 74.31 109.537 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.5 p -77.16 101.3 6.1 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.397 -0.964 . . . . 72.35 108.397 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -57.72 108.79 1.39 Allowed Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 123.716 0.635 . . . . 73.12 109.662 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -89.21 -3.94 5.97 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.607 2.204 . . . . 64.42 112.251 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -162.9 -173.93 3.69 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 106.466 -1.679 . . . . 74.21 106.466 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m 68.45 179.78 0.23 Allowed 'General case' 0 C--N 1.31 -1.11 0 O-C-N 124.6 1.188 . . . . 73.12 111.939 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.494 ' CG ' HD13 ' A' ' 75' ' ' LEU . 75.5 m80 -126.89 155.42 43.03 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 115.222 -0.899 . . . . 73.54 110.171 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.1 m-20 -127.5 129.5 47.51 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.789 -1.56 . . . . 71.14 106.789 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.69 128.06 59.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.436 0.532 . . . . 74.53 112.436 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -82.01 108.24 15.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.044 -1.465 . . . . 75.25 107.044 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.29 123.16 68.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.422 0.63 . . . . 72.14 110.635 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -96.69 107.21 19.62 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.383 -1.34 . . . . 64.01 107.383 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 18' ' ' LEU . . . 75.59 -138.02 22.55 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.782 -0.927 . . . . 50.2 110.782 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.8 m 60.43 -80.77 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.159 1.17 . . . . 74.04 114.159 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 67' ' ' ILE . 32.6 pt -120.03 18.13 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 112.391 0.515 . . . . 74.44 112.391 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 64.1 mt -60.33 -21.91 62.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.429 0.633 . . . . 45.41 109.834 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.88 118.31 71.61 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.347 -1.353 . . . . 70.12 107.347 170.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -48.37 -36.46 30.39 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.961 3.107 . . . . 75.31 113.836 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.93 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 37.5 111.849 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.586 ' O ' HG22 ' A' ' 25' ' ' VAL . 13.0 t -77.86 -32.61 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.515 0.674 . . . . 64.02 109.797 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.18 -33.34 74.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.62 0.724 . . . . 72.12 109.118 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -75.46 -16.13 60.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.252 -0.886 . . . . 72.53 111.65 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 22' ' ' VAL . 13.1 m -89.01 -30.03 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 118.89 -1.124 . . . . 71.13 110.44 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.52 HG21 HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -81.57 -48.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 121.023 -0.271 . . . . 73.25 110.919 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.78 -16.59 25.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 120.808 0.337 . . . . 62.12 111.299 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 72.01 6.59 5.63 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.904 1.335 . . . . 72.22 109.999 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -141.97 169.28 17.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.32 -1.363 . . . . 63.44 107.32 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -76.43 128.46 34.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.891 -0.781 . . . . 74.35 108.891 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.25 137.81 41.46 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.711 0.291 . . . . 61.13 110.325 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -98.33 109.91 22.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.943 -1.132 . . . . 54.34 107.943 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.0 p -115.14 146.18 41.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.513 -0.767 . . . . 71.41 111.466 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.71 145.73 50.55 Favored Pre-proline 0 C--N 1.286 -2.162 0 N-CA-C 106.724 -1.584 . . . . 75.52 106.724 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.91 140.84 51.66 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.12 1.213 . . . . 74.14 110.243 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.68 156.44 41.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.051 -0.522 . . . . 53.41 109.808 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.93 123.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 121.628 0.728 . . . . 73.41 111.452 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HA ' HG11 ' A' ' 93' ' ' VAL . 23.1 tp -87.64 93.23 9.37 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.316 -0.856 . . . . 73.42 110.219 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -68.64 134.85 50.51 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.485 -1.234 . . . . 72.01 107.771 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 115.74 -29.85 6.96 Favored Glycine 0 C--N 1.29 -2.015 0 C-N-CA 118.618 -1.753 . . . . 71.01 112.35 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.509 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 58.9 m-85 -109.56 166.55 10.81 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 112.014 0.376 . . . . 71.12 112.014 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.503 ' NE2' ' HB2' ' A' ' 56' ' ' SER . 0.1 OUTLIER -155.14 139.29 16.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.756 -0.656 . . . . 71.21 111.707 -177.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.81 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 67.0 ttt180 -87.48 138.99 31.0 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.441 1.088 . . . . 74.54 112.792 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.62 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 6.8 m-85 -104.69 158.77 16.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.677 -1.147 . . . . 74.52 109.575 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' H ' ' HD3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.78 -44.92 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.795 1.035 . . . . 72.44 113.795 -174.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.585 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 3.1 mm? 60.63 -179.34 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.991 0.517 . . . . 51.12 111.678 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.07 -71.45 0.68 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.088 0.47 . . . . 70.54 109.86 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.57 20.12 50.08 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.325 -0.941 . . . . 72.33 114.209 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.9 151.03 37.9 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.749 -0.834 . . . . 74.42 108.749 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.4 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 123.015 2.476 . . . . 61.11 114.823 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -134.09 73.39 70.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 122.004 0.907 . . . . 73.22 112.507 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.679 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 20.7 Cg_endo -108.45 167.48 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.995 3.797 . . . . 54.21 112.501 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.81 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 20.2 p -156.18 162.4 40.2 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 127.882 2.473 . . . . 71.21 106.145 -8.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 41.7 pt -123.33 121.46 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.354 0 CA-C-N 119.57 1.077 . . . . 74.03 110.265 170.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.577 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 33.7 m -149.59 -173.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.312 -0.858 . . . . 73.44 110.423 -173.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.503 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 37.7 m 69.44 -161.18 0.17 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 124.626 1.204 . . . . 73.24 111.553 174.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -105.65 -172.66 2.13 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 120.911 0.386 . . . . 60.33 111.252 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.502 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 8.8 m-20 -68.02 36.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.413 1.885 . . . . 70.44 115.764 -169.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -79.53 -11.48 59.89 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.188 -0.945 . . . . 71.21 112.536 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.13 -169.99 15.68 Favored Glycine 0 CA--C 1.488 -1.63 0 C-N-CA 119.928 -1.13 . . . . 40.12 112.569 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -145.32 152.61 40.18 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.708 -1.219 . . . . 72.24 107.708 176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.401 HG23 ' CG2' ' A' ' 54' ' ' ILE . 48.7 t -122.2 123.18 68.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 110.177 -0.305 . . . . 75.23 110.177 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -95.41 129.37 42.59 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.373 -0.931 . . . . 64.31 109.967 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.1 -142.32 3.48 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 111.019 -0.833 . . . . 70.22 111.019 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -138.79 136.85 36.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.008 0.523 . . . . 70.31 111.524 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.45 133.67 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.697 -0.683 . . . . 70.41 109.842 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.552 ' CD1' HD12 ' A' ' 17' ' ' ILE . 32.6 mt -88.62 131.06 37.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.443 -1.688 . . . . 64.44 106.443 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -110.73 160.97 16.23 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.927 -0.709 . . . . 70.24 110.477 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.34 36.77 63.17 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.077 -0.582 . . . . 65.4 112.797 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -95.65 122.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.427 -0.455 . . . . 73.03 109.863 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.471 ' OG ' ' HG2' ' A' ' 74' ' ' GLU . 80.3 p -76.91 173.18 12.04 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 121.494 -0.754 . . . . 70.23 109.497 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.44 -29.56 70.25 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.87 0.367 . . . . 72.15 110.298 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.42 -41.27 40.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 71.25 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.471 ' HG2' ' OG ' ' A' ' 71' ' ' SER . 9.5 mm-40 -69.34 -36.49 76.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 75.53 110.194 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.494 HD13 ' CG ' ' A' ' 9' ' ' HIS . 2.3 tt -63.34 -37.86 88.91 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.28 -1.007 . . . . 64.22 108.28 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.48 ' O ' HG22 ' A' ' 80' ' ' VAL . 51.8 t30 -54.83 -31.19 59.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.636 -1.166 . . . . 72.4 111.567 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.491 ' O ' HG13 ' A' ' 81' ' ' ILE . 23.3 t-20 -75.21 -32.42 61.17 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.519 -0.873 . . . . 73.32 109.826 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -64.52 -36.17 83.32 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.068 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.57 -33.03 73.37 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.632 -0.713 . . . . 73.04 110.253 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 76' ' ' ASN . 99.6 t -69.16 -37.64 76.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.846 -0.615 . . . . 74.23 110.435 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.6 mt -57.79 -68.49 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 116.135 -0.484 . . . . 63.14 111.095 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 21.0 mm-40 -110.54 103.4 12.0 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.482 0.658 . . . . 74.24 112.591 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.64 11.79 0.85 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 115.045 -0.979 . . . . 72.33 111.695 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -75.17 -44.12 48.47 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.725 -0.472 . . . . 65.44 109.725 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.594 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 3.9 t70 -136.97 14.17 3.09 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.665 1.222 . . . . 73.32 107.786 175.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 21.1 m-85 -113.82 145.46 41.4 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.396 -1.275 . . . . 75.52 109.462 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.72 151.89 47.55 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.612 -0.884 . . . . 75.33 108.612 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -91.14 125.37 35.9 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.718 0.294 . . . . 74.32 111.038 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.66 159.6 34.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 116.013 -0.54 . . . . 72.31 110.559 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.28 129.8 39.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.638 -1.245 . . . . 73.44 107.638 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.65 169.13 20.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 108.628 -0.878 . . . . 63.41 108.628 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -118.72 124.55 47.59 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.28 -1.378 . . . . 74.11 107.28 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 38' ' ' LEU . 17.4 m -127.33 168.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.37 0.605 . . . . 75.24 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.571 HG23 ' HG3' ' A' ' 101' ' ' LYS . 69.5 t -102.41 117.58 47.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.739 -0.664 . . . . 73.34 109.474 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -74.69 88.26 2.21 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.5 -1.667 . . . . 62.31 106.5 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -50.26 -35.91 29.02 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.168 1.787 . . . . 71.12 112.701 -170.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.86 -31.4 39.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.908 0.755 . . . . 74.11 111.811 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -127.83 -1.29 5.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 120.282 -0.567 . . . . 61.02 110.746 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.5 t 69.13 16.71 8.56 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.802 0.841 . . . . 74.42 111.517 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.3 160.01 15.72 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 109.341 -0.614 . . . . 61.25 109.341 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.571 ' HG3' HG23 ' A' ' 94' ' ' VAL . 8.4 mptt -101.63 134.02 45.41 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 108.787 -0.82 . . . . 73.54 108.787 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.91 140.99 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.279 0.561 . . . . 64.34 111.047 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.84 125.52 34.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.628 -1.249 . . . . 63.23 107.628 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.29 176.09 8.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 C-N-CA 122.608 0.363 . . . . 72.42 111.171 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -99.59 153.55 18.97 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.355 -0.98 . . . . 73.05 108.355 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -159.56 177.07 11.29 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 117.951 0.341 . . . . 70.21 110.164 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 82' ' ' GLU . 81.6 m-85 -105.57 121.36 43.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.268 -1.012 . . . . 70.42 108.268 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.68 165.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 109.053 -0.721 . . . . 74.32 109.053 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.641 ' CD1' ' HB2' ' A' ' 111' ' ' ASN . 61.8 t-105 -97.4 129.65 44.61 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 107.682 -1.229 . . . . 75.34 107.682 -169.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.0 -20.21 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.569 . . . . 74.2 112.298 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.641 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 26.5 m-80 -77.77 15.6 0.82 Allowed 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 124.1 0.96 . . . . 74.41 110.837 171.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 19.3 ptpt -49.28 -21.0 0.73 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.711 1.204 . . . . 74.45 113.484 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.462 ' O ' HD21 ' A' ' 160' ' ' LEU . 4.7 t70 -124.02 94.28 4.17 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 104.005 -2.591 . . . . 71.12 104.005 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.4 p-10 -120.5 158.83 50.36 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 113.888 -1.505 . . . . 73.05 111.767 -172.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -106.65 12.05 0.16 Allowed 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.806 2.337 . . . . 75.33 111.881 170.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -134.26 133.15 40.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.359 0.874 . . . . 71.01 113.359 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' A' ' 46' ' ' LEU . 57.6 mtt 60.96 28.62 18.4 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.738 0.815 . . . . 74.03 111.306 174.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -70.74 27.95 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 115.267 1.581 . . . . 74.31 115.267 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 126' ' ' TRP . . . -138.65 137.79 8.97 Favored Glycine 0 C--N 1.279 -2.617 0 C-N-CA 121.113 -0.565 . . . . 61.33 112.816 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.79 -178.86 6.15 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.152 0.581 . . . . 72.35 110.68 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -67.57 -34.58 77.33 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.231 0.456 . . . . 75.21 112.231 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.71 112.03 19.19 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.419 0.628 . . . . 64.55 111.349 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -68.2 -32.05 72.0 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.997 -1.002 . . . . 71.42 111.576 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.99 -40.82 98.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.414 0.626 . . . . 74.23 109.956 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.543 ' O ' HG22 ' A' ' 129' ' ' VAL . 43.1 tt0 -78.12 -41.76 34.03 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.944 -1.026 . . . . 75.44 109.734 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.421 ' CE2' ' HA3' ' A' ' 119' ' ' GLY . 9.6 t90 -55.91 -28.5 57.06 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.231 0.538 . . . . 73.33 110.012 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -58.0 -47.47 82.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.1 -0.5 . . . . 65.05 110.835 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 125' ' ' GLU . 20.0 m -81.86 -22.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.337 0.589 . . . . 72.43 110.133 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 125' ' ' GLU . 99.3 t -68.05 -34.4 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.697 -0.683 . . . . 63.24 109.835 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -55.54 -34.51 64.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.123 -0.489 . . . . 73.53 111.837 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.94 -55.11 9.08 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 121.02 -0.272 . . . . 73.32 111.178 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.491 ' HA ' HG13 ' A' ' 135' ' ' VAL . 9.5 pt-20 -66.84 -37.9 85.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 113.133 0.79 . . . . 55.32 113.133 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -59.29 -47.12 86.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.424 -0.353 . . . . 73.11 111.147 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -81.72 -37.58 27.08 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 112.573 0.583 . . . . 71.22 112.573 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.558 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 15.0 p -62.75 -41.64 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 119.625 -0.83 . . . . 71.55 111.226 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 29.4 mm-40 -58.81 -44.14 90.75 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 123.018 0.199 . . . . 74.52 110.919 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.9 m -54.1 -48.64 70.49 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 123.661 0.6 . . . . 74.13 110.761 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.33 -36.87 85.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.747 0.308 . . . . 75.43 111.288 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.7 mtp180 -66.68 -43.6 84.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 73.2 110.494 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.1 -40.6 71.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.932 -0.576 . . . . 71.13 111.725 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.4 mtm -66.82 -31.41 72.01 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.602 -0.439 . . . . 70.23 110.819 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.05 -43.94 97.75 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.654 -0.869 . . . . 62.4 108.654 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -62.41 -30.21 71.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.639 . . . . 70.41 111.004 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.627 ' CG ' ' HB3' ' A' ' 156' ' ' ALA . 46.5 m0 -75.39 -38.92 59.68 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.839 -0.619 . . . . 74.2 112.477 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -77.75 -43.31 31.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.796 0.331 . . . . 72.14 111.677 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.523 ' C ' ' HD3' ' A' ' 148' ' ' PRO . 88.0 tttt -79.23 -17.03 55.58 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.292 -0.413 . . . . 74.14 111.438 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.58 ' N ' ' HD3' ' A' ' 148' ' ' PRO . 3.5 t-20 75.7 16.59 0.0 OUTLIER Pre-proline 0 CA--C 1.609 3.224 0 N-CA-C 115.394 1.627 . . . . 73.24 115.394 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.58 ' HD3' ' N ' ' A' ' 147' ' ' ASN . 6.9 Cg_exo -73.85 -16.57 23.29 Favored 'Trans proline' 0 C--N 1.4 3.247 0 CA-C-N 122.795 2.034 . . . . 55.13 110.958 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.81 -22.71 59.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.528 -0.76 . . . . 74.13 110.212 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.89 -47.46 1.04 Allowed Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.774 -0.727 . . . . 61.32 112.051 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -70.34 135.0 48.46 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 109.618 -0.512 . . . . 73.21 109.618 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 21.7 m -69.29 167.14 17.0 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.092 -0.707 . . . . 75.12 109.092 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.559 ' O ' HG21 ' A' ' 157' ' ' VAL . 27.9 ttt -54.1 -43.85 70.76 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.295 1.22 . . . . 37.5 114.295 -172.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.06 -30.67 55.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.125 -0.63 . . . . 63.1 110.915 -177.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.84 -32.99 70.2 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.094 0.949 . . . . 71.21 108.99 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.627 ' HB3' ' CG ' ' A' ' 144' ' ' TRP . . . -77.96 -24.72 48.04 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.987 -1.461 . . . . 70.32 112.375 -177.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 153' ' ' MET . 99.2 t -53.23 109.48 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.409 0.624 . . . . 74.12 112.108 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -117.61 -170.83 15.29 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.957 -1.657 . . . . 37.5 108.957 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.3 m -86.71 88.99 7.79 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 118.046 0.923 . . . . 73.51 111.479 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.462 HD21 ' O ' ' A' ' 113' ' ' ASP . 67.1 mt -154.21 -58.55 0.12 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.568 0.747 . . . . 71.44 111.465 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.1 tp -74.42 -8.1 55.16 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.047 -0.524 . . . . 64.15 111.38 -176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 56.6 m 68.09 78.05 0.24 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.25 1.02 . . . . 72.12 110.86 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 30.2 t -171.86 -175.06 1.44 Allowed 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.404 -1.702 . . . . 65.23 106.404 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -177.12 -47.56 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.719 0 N-CA-C 110.706 -0.958 . . . . 53.02 110.706 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 C--N 1.301 -1.524 0 CA-C-N 115.226 -0.487 . . . . 71.22 109.74 178.182 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.239 0.54 0 N-CA-C 109.187 -0.672 . . . . 73.22 109.187 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.3 m -137.46 96.67 3.3 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.346 -1.724 . . . . 63.52 106.346 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.5 m -134.21 151.87 51.54 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.23 -0.441 . . . . 63.22 111.56 -174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.8 t 67.94 14.39 9.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.296 1.038 . . . . 55.33 110.003 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 54.8 84.24 0.21 Allowed Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 124.922 1.289 . . . . 75.21 112.763 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.84 118.89 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.11 1.873 . . . . 64.41 108.325 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -137.57 127.56 25.79 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 120.996 0.427 . . . . 71.14 111.234 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.5 m -66.26 119.68 11.94 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.502 -1.295 . . . . 75.31 107.502 173.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -87.54 156.1 19.68 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.445 -0.798 . . . . 71.24 112.976 -173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -133.63 125.03 27.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.624 -1.625 . . . . 71.41 107.241 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 49.7 t -119.25 120.51 63.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.68 -0.408 . . . . 75.41 110.548 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.73 121.25 23.78 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.283 -1.747 . . . . 72.22 106.283 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.0 p -113.2 138.81 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 C-N-CA 118.858 -1.137 . . . . 73.14 112.206 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.4 -36.68 68.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.969 -1.468 . . . . 74.03 110.471 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.45 -175.13 46.81 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.794 -0.922 . . . . 61.15 110.794 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m 69.88 -65.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.304 1.041 . . . . 62.14 113.561 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 67' ' ' ILE . 45.9 mt -68.81 -8.75 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.677 0.751 . . . . 72.43 110.223 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.06 -29.12 69.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.852 -0.796 . . . . 61.44 108.852 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.36 114.22 58.62 Favored Pre-proline 0 N--CA 1.418 -2.033 0 N-CA-C 107.86 -1.163 . . . . 74.4 107.86 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.47 -28.39 8.64 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 124.808 3.672 . . . . 74.33 115.739 -174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -71.07 -29.78 65.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 72.41 110.955 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 25' ' ' VAL . 63.0 t -76.72 -36.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.4 -0.593 . . . . 62.53 109.4 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' HG23 ' A' ' 26' ' ' ILE . . . -65.99 -33.62 76.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.819 -0.808 . . . . 63.12 108.819 175.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.13 -17.72 61.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.256 -0.884 . . . . 74.21 111.894 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 22' ' ' VAL . 21.4 m -91.54 -25.4 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.191 -1.004 . . . . 74.42 110.831 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.465 HD12 ' CD1' ' A' ' 78' ' ' PHE . 11.2 tt -87.03 -45.3 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 120.054 -0.658 . . . . 64.41 112.123 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.535 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 89.7 mt -89.08 -18.4 27.33 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.996 -0.44 . . . . 64.41 110.434 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.0 t70 71.28 10.8 6.74 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.929 1.347 . . . . 71.13 108.526 -171.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -143.45 145.15 32.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.673 -1.603 . . . . 73.13 106.673 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.7 m -80.23 116.98 20.62 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 120.682 0.277 . . . . 63.25 110.291 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.535 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . . . -95.65 156.46 16.31 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.646 -0.501 . . . . 61.14 109.646 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.26 125.43 44.88 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.977 -0.556 . . . . 73.44 110.317 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -94.45 143.29 26.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.887 -0.783 . . . . 63.2 108.887 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.96 138.7 33.68 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.129 -0.693 . . . . 74.24 109.129 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.82 129.81 37.01 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.322 2.681 . . . . 65.31 113.063 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.52 157.08 42.6 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.467 -0.788 . . . . 70.3 110.218 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.1 126.77 72.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.518 0.675 . . . . 62.54 111.71 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.435 ' HA ' HG11 ' A' ' 93' ' ' VAL . 21.7 tp -89.69 95.35 10.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.339 -0.846 . . . . 74.53 112.188 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -70.33 128.54 36.56 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.058 -0.974 . . . . 75.14 111.568 174.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.28 -19.72 11.61 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 120.291 -0.957 . . . . 74.42 112.34 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 61.5 m-85 -114.79 158.76 21.45 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 113.015 0.746 . . . . 74.23 113.015 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.416 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 3.3 t-160 -128.02 124.4 37.06 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.53 -1.285 . . . . 75.23 107.53 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.416 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 10.6 ptm180 -91.88 144.39 25.53 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.838 -0.43 . . . . 72.13 109.838 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.78 176.54 5.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.949 0.404 . . . . 74.32 111.126 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -91.76 100.28 13.01 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.285 0.564 . . . . 74.41 109.702 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.68 118.61 32.0 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.631 0.729 . . . . 73.15 110.544 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -93.7 -43.96 8.39 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.775 -1.102 . . . . 74.35 108.713 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.14 -25.99 32.38 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.719 -1.128 . . . . 63.22 113.149 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 7.2 mp -92.27 132.71 31.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.415 -0.462 . . . . 65.43 110.868 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 57.4 Cg_endo -85.12 -20.8 3.3 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.466 2.777 . . . . 73.54 112.859 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.518 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 51.9 p90 -139.49 175.85 2.97 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 104.668 -2.345 . . . . 74.02 104.668 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.329 0.0 OUTLIER 31.43 169.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.595 3.55 0 C-N-CA 124.002 3.135 . . . . 71.41 119.795 -162.701 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 24.6 p -131.52 160.85 34.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.563 -1.336 . . . . 73.13 113.069 9.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 22.1 pt -122.92 137.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.92 -1.491 . . . . 73.33 107.863 174.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.36 151.78 34.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 106.141 -1.8 . . . . 54.12 106.141 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m -65.6 140.95 58.57 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.242 1.201 . . . . 65.44 114.242 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m -155.99 102.86 2.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.222 -2.14 . . . . 65.13 105.222 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.23 -31.83 65.91 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.258 0.836 . . . . 65.31 113.258 -172.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -87.52 -0.81 57.36 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.682 0.253 . . . . 72.3 111.682 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.86 168.11 12.96 Favored Glycine 0 C--O 1.238 0.372 0 C-N-CA 120.371 -0.919 . . . . 63.31 113.134 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -150.05 154.68 38.55 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 110.049 -0.352 . . . . 73.42 110.049 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.0 123.4 69.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.801 -0.444 . . . . 74.11 109.801 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -96.63 128.49 43.62 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.791 -0.763 . . . . 74.35 109.512 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.07 -141.03 3.07 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 109.887 -1.285 . . . . 54.33 109.887 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -141.1 150.71 43.23 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.873 -0.788 . . . . 63.31 108.873 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' THR . 28.7 m -104.11 134.16 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.123 -0.49 . . . . 64.33 110.094 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 17' ' ' ILE . 8.8 mt -87.19 115.78 28.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.744 -2.317 . . . . 74.44 104.744 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -109.63 160.49 16.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.838 -0.745 . . . . 75.33 112.421 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.37 41.47 11.57 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 115.806 -0.634 . . . . 43.53 112.702 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.6 t -106.68 122.16 60.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 108.862 -0.792 . . . . 74.21 108.862 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.2 t -79.3 174.23 11.78 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.019 -1.072 . . . . 73.34 109.409 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.45 -25.62 67.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.065 -0.346 . . . . 75.24 110.065 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.72 -53.34 18.93 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.852 -0.613 . . . . 73.03 110.371 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.19 -30.62 69.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.353 0.501 . . . . 73.53 112.353 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 75' ' ' LEU . 3.4 tm? -57.27 -31.69 65.86 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.335 0.588 . . . . 74.42 110.659 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.558 ' O ' HG22 ' A' ' 80' ' ' VAL . 15.0 m120 -60.07 -28.28 67.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.364 -0.835 . . . . 72.14 112.078 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.17 -38.02 69.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.591 -0.892 . . . . 55.14 108.591 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.465 ' CD1' HD12 ' A' ' 26' ' ' ILE . 97.3 m-85 -67.9 -32.7 73.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.616 -0.72 . . . . 74.12 109.338 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.426 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 29.0 t70 -67.93 -30.8 70.21 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.191 -0.913 . . . . 63.2 110.538 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 76' ' ' ASN . 58.2 t -72.83 -22.32 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-O 121.259 0.552 . . . . 73.41 110.864 177.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.4 mm -70.19 -24.42 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.32 0.581 . . . . 75.13 110.803 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -94.85 -171.72 2.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.767 -0.827 . . . . 74.41 108.767 176.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.49 -64.25 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 118.358 -1.877 . . . . 71.1 114.642 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -57.33 -46.25 83.45 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 117.521 0.66 . . . . 64.35 111.99 -173.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 110' ' ' VAL . 17.4 m-20 -154.8 12.38 0.38 Allowed 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.499 0.666 . . . . 70.43 109.222 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -116.06 147.6 41.1 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.641 -1.614 . . . . 75.11 106.641 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' OE2' ' HA ' ' A' ' 110' ' ' VAL . 11.4 pt-20 -133.5 138.72 46.26 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.432 -0.507 . . . . 73.13 111.7 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.409 ' HB2' ' HG2' ' A' ' 82' ' ' GLU . 2.2 tmm_? -88.65 114.01 24.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.771 -0.649 . . . . 75.13 109.502 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.07 160.28 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.492 -0.776 . . . . 64.44 111.54 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 m -90.09 130.01 36.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.229 -0.656 . . . . 60.23 109.229 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.16 172.28 16.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 124.703 1.201 . . . . 75.3 108.043 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -121.07 127.78 51.99 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.875 -1.13 . . . . 73.21 110.032 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' A' ' 38' ' ' LEU . 18.5 m -126.9 166.59 23.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.452 0.644 . . . . 61.24 110.519 -175.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.52 HG23 ' HG2' ' A' ' 101' ' ' LYS . 73.0 t -105.56 113.58 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 107.807 -1.182 . . . . 72.33 107.807 172.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -78.51 89.55 4.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 108.539 -0.911 . . . . 72.52 108.539 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -48.28 -36.83 14.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.285 2.234 . . . . 64.45 112.012 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -45.15 -48.26 12.28 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.239 0.962 . . . . 74.34 111.908 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -108.38 -3.83 17.93 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.308 -0.245 . . . . 73.35 111.219 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 m 66.13 28.65 10.17 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.898 0.879 . . . . 73.14 110.836 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -102.8 161.26 13.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.326 -0.852 . . . . 72.13 109.76 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.52 ' HG2' HG23 ' A' ' 94' ' ' VAL . 48.0 mtmt -98.0 133.85 41.91 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.063 -1.088 . . . . 71.34 108.063 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.22 139.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.439 0.638 . . . . 72.44 110.564 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.23 126.57 35.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.725 -1.213 . . . . 64.31 107.725 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.3 m -137.27 175.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.508 0.323 . . . . 72.44 110.419 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 44.4 mt-10 -105.2 153.28 21.76 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.979 -0.378 . . . . 75.24 109.979 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -156.01 176.79 12.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.694 0.283 . . . . 73.24 110.326 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -105.98 119.36 39.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 73.43 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.3 -178.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 109.165 -0.68 . . . . 72.3 109.165 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.546 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 64.8 t-105 -100.62 137.09 39.48 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.586 -1.264 . . . . 65.04 107.586 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 85' ' ' ASP . 30.6 m -66.8 -20.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 113.636 0.976 . . . . 74.1 113.636 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -90.51 13.96 14.38 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.099 0.952 . . . . 74.12 109.027 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 60.3 pttt -49.62 -17.39 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.712 2.005 . . . . 73.24 115.17 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.08 -22.38 65.84 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.212 0.529 . . . . 74.23 110.439 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -118.0 140.69 28.18 Favored Pre-proline 0 CA--C 1.513 -0.458 0 N-CA-C 109.628 -0.508 . . . . 72.25 109.628 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.86 104.86 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.112 1.875 . . . . 74.31 110.346 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 116' ' ' ARG . 2.8 mmp_? -99.06 142.7 30.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.512 -0.313 . . . . 74.24 110.876 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 tpt 68.15 17.5 9.4 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.698 1.199 . . . . 70.31 109.307 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -83.58 81.25 8.82 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.777 -1.194 . . . . 75.42 107.777 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.21 -33.53 0.02 OUTLIER Glycine 0 C--N 1.278 -2.684 0 CA-C-N 113.48 -1.691 . . . . 61.43 110.013 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -93.37 140.01 30.04 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.402 -1.333 . . . . 51.24 107.402 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -76.69 154.27 34.35 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.798 -0.361 . . . . 74.11 111.098 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.86 148.71 27.57 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.943 -0.571 . . . . 74.24 112.322 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -55.47 -41.22 72.66 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.206 1.002 . . . . 73.45 111.347 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -73.06 -43.47 61.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.484 -0.561 . . . . 74.11 109.484 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 129' ' ' VAL . 46.9 mt-10 -65.81 -8.69 22.98 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.634 -0.712 . . . . 74.42 112.389 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.465 ' HA ' HG13 ' A' ' 129' ' ' VAL . 72.6 t-105 -59.86 -22.7 62.65 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-O 120.775 0.321 . . . . 73.33 110.254 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.61 -45.82 91.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.116 0.484 . . . . 52.41 110.38 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.41 -43.41 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 113.084 0.772 . . . . 61.43 113.084 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 126' ' ' TRP . 7.7 p -75.38 -18.89 15.94 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.22 0 N-CA-C 111.946 0.351 . . . . 72.24 111.946 -174.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 126' ' ' TRP . 9.4 t60 -48.45 -45.53 36.69 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 122.49 0.316 . . . . 74.14 110.6 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.26 -44.5 75.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.451 -0.34 . . . . 65.42 110.666 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.44 -44.14 97.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 74.4 110.821 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER -61.58 -55.51 30.05 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.556 -0.747 . . . . 74.34 110.74 -177.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.419 ' O ' ' HD1' ' A' ' 138' ' ' PHE . 81.1 m-85 -65.46 -32.66 74.39 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.808 1.41 . . . . 74.01 114.808 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 9.1 p -63.59 -42.19 95.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 118.913 -1.115 . . . . 62.41 109.331 176.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.07 -37.6 69.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.18 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 97.1 m -49.62 -51.41 37.76 Favored 'General case' 0 C--O 1.214 -0.816 0 O-C-N 123.518 0.511 . . . . 73.32 110.407 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.658 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 90.5 m-85 -70.54 -39.34 74.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.434 0.531 . . . . 74.54 112.434 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -63.44 -48.86 76.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.039 -0.264 . . . . 64.21 110.775 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.24 -35.66 80.99 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.876 -0.416 . . . . 72.34 109.876 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 46.9 tpp -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.956 -0.566 . . . . 70.22 109.57 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 80.4 mt -66.49 -41.65 88.63 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.987 -0.375 . . . . 71.31 109.987 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 34.3 mt-10 -65.98 -34.91 79.19 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.529 0.681 . . . . 72.52 110.024 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.401 ' CZ2' ' HB3' ' A' ' 153' ' ' MET . 32.5 t90 -75.42 -33.56 60.94 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.52 -0.764 . . . . 73.4 110.315 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -47.12 16.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.729 -0.669 . . . . 75.11 112.365 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.73 -32.25 41.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.456 -0.498 . . . . 74.33 109.724 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 52.3 t30 58.4 84.23 0.21 Allowed Pre-proline 0 C--N 1.315 -0.917 0 C-N-CA 125.221 1.408 . . . . 72.14 114.434 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -93.43 -16.25 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.288 1.992 . . . . 75.25 112.245 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.67 -20.0 22.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.954 0.353 . . . . 74.23 111.954 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.96 31.37 9.28 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.154 -1.022 . . . . 38.25 111.967 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.43 144.97 25.64 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.556 -0.535 . . . . 51.42 109.556 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.8 m -86.12 155.6 20.71 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 106.154 -1.795 . . . . 71.12 106.154 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.401 ' HB3' ' CZ2' ' A' ' 144' ' ' TRP . 1.3 mpt? -67.82 -45.18 75.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.511 0.56 . . . . 73.42 112.511 -173.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.79 -26.07 61.39 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.066 0.46 . . . . 75.31 110.833 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -70.79 -48.11 55.93 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.327 0.584 . . . . 64.01 109.97 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.67 69.91 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.474 -0.785 . . . . 65.24 112.232 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 160' ' ' LEU . 34.3 m -94.94 -32.26 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 119.905 -0.718 . . . . 71.52 112.635 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 104.74 -108.22 3.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.747 -0.739 . . . . 53.42 111.376 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.7 p -115.06 20.41 15.03 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.927 0.87 . . . . 71.32 110.136 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 45.7 tp -92.92 -19.19 21.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.066 -0.97 . . . . 75.13 111.378 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.5 mp 66.84 -66.96 0.17 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.46 1.104 . . . . 54.31 111.627 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.9 t -172.73 -49.72 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.21 -2.145 . . . . 61.41 105.21 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.3 t 55.23 85.59 0.06 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.329 -1.305 . . . . 72.34 112.154 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.4 46.46 0.02 OUTLIER Glycine 0 C--N 1.305 -1.154 0 N-CA-C 110.252 -1.139 . . . . 61.13 110.252 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 108.416 -0.957 . . . . 73.41 108.416 -178.26 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 C--O 1.241 0.624 0 N-CA-C 109.324 -0.621 . . . . 64.31 109.324 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.2 m -79.92 123.51 27.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.585 -1.265 . . . . 61.22 107.585 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -68.39 110.62 4.21 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.352 0.596 . . . . 74.12 111.724 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 p -85.46 124.87 32.54 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.781 -0.822 . . . . 65.5 108.781 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -133.48 103.48 12.4 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 109.559 -0.534 . . . . 71.53 109.559 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.56 -74.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.04 1.826 . . . . 60.33 111.193 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -121.2 -77.63 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.302 -1.74 . . . . 70.54 106.302 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 m 49.08 -169.82 0.02 OUTLIER 'General case' 0 C--O 1.248 0.977 0 O-C-N 124.873 1.358 . . . . 64.44 114.271 171.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.409 ' C ' HD21 ' A' ' 10' ' ' ASN . 76.5 m80 -107.89 142.35 38.1 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.781 -1.1 . . . . 73.22 109.097 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.409 HD21 ' C ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -124.36 130.95 53.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.876 -1.157 . . . . 75.21 107.876 178.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 27.7 t -124.59 120.32 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 110.172 -0.307 . . . . 74.14 110.172 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.511 ' HB3' HG22 ' A' ' 106' ' ' THR . 41.5 t80 -83.02 117.71 23.01 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.449 -0.945 . . . . 73.13 108.449 174.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.76 150.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.669 -0.696 . . . . 60.32 109.709 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -127.36 -10.08 5.77 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.522 -0.547 . . . . 75.11 109.522 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.07 -128.4 1.08 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 115.348 0.899 . . . . 74.21 115.348 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -62.83 -42.65 99.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.706 1.373 . . . . 72.2 114.706 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.467 HG22 HD11 ' A' ' 67' ' ' ILE . 30.4 mt -60.59 -21.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.427 0.899 . . . . 72.41 113.427 -171.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mp -66.14 -20.58 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.961 0.41 . . . . 61.4 111.117 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.19 116.16 65.73 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 108.509 -0.923 . . . . 74.21 108.509 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -40.11 -38.78 2.23 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 125.096 3.864 . . . . 62.21 115.456 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -57.82 -47.27 83.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.924 0.392 . . . . 73.52 111.065 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.6 t -67.03 -43.56 88.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.723 -0.671 . . . . 62.12 110.48 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . . . -62.59 -37.12 84.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.805 -0.634 . . . . 71.33 109.988 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -72.67 -29.57 63.52 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.81 -0.632 . . . . 64.52 111.867 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 21' ' ' ALA . 23.0 m -81.45 -25.06 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.554 -0.859 . . . . 62.41 111.424 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.465 HD11 ' C ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -82.93 -47.92 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 120.274 -0.571 . . . . 72.21 111.04 178.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 92.2 mt -92.96 -12.69 30.15 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.206 0.447 . . . . 71.23 112.206 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 t70 76.36 -6.57 1.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.37 1.081 . . . . 74.14 109.381 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.7 ptt180 -133.99 163.76 28.82 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 125.646 1.578 . . . . 72.4 106.747 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.8 m -76.72 127.81 33.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.237 -0.653 . . . . 64.31 109.237 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 23' ' ' ALA . . . -75.72 144.93 41.26 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 120.887 0.375 . . . . 65.12 111.489 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.77 108.89 20.9 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.817 -0.809 . . . . 65.1 108.817 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.1 p -111.71 143.7 42.19 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 115.144 -0.934 . . . . 54.03 109.934 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.29 138.89 33.83 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 108.503 -0.925 . . . . 74.1 108.503 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.71 134.76 62.77 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.636 2.224 . . . . 75.23 111.653 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.31 156.21 41.11 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.597 -0.729 . . . . 74.51 109.738 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.42 126.58 75.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.593 0.711 . . . . 75.25 111.58 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.6 tp -93.67 96.19 9.66 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.918 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -71.62 131.78 43.68 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.569 -0.901 . . . . 53.31 108.569 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 116.56 -22.87 10.66 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 117.854 -2.117 . . . . 73.21 113.151 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 156.17 24.47 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 120.939 0.399 . . . . 72.23 111.224 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -127.24 140.51 52.17 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.619 -0.719 . . . . 53.14 109.125 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -85.72 137.21 32.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.601 0.76 . . . . 65.44 109.809 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 91.4 m-85 -124.33 145.78 49.22 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.858 -1.534 . . . . 72.43 106.858 174.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 25.1 pttm -90.43 -46.6 8.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.018 0.747 . . . . 64.45 113.018 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.443 ' HG ' HD22 ' A' ' 49' ' ' LEU . 2.7 mm? 60.77 179.99 0.1 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.98 0.912 . . . . 73.0 111.947 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.9 -43.22 0.81 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.372 0.606 . . . . 74.13 109.859 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.27 -13.44 76.73 Favored Glycine 0 N--CA 1.422 -2.234 0 CA-C-N 115.368 -0.833 . . . . 74.1 113.213 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.481 ' CB ' ' HG3' ' A' ' 52' ' ' PRO . 7.1 mp -89.73 163.29 33.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 122.69 -0.3 . . . . 71.25 110.604 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.18 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.881 2.387 . . . . 75.34 114.096 -173.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.86 75.87 75.03 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 122.61 1.195 . . . . 75.33 109.266 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CB ' ' SG ' ' A' ' 53' ' ' CYS 0.301 43.9 Cg_endo -113.2 165.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 125.071 3.847 . . . . 75.53 114.743 -171.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 69.6 m -156.06 175.87 13.4 Favored 'General case' 0 N--CA 1.505 2.288 1 C-N-CA 132.137 4.175 . . . . 73.03 104.82 -18.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 pt -123.94 143.31 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 120.199 -0.6 . . . . 64.04 110.505 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -131.56 146.22 33.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 m -59.49 113.43 2.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.562 0.745 . . . . 75.22 111.34 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -157.54 98.01 1.64 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.751 -1.203 . . . . 53.15 107.751 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.46 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 11.4 m-20 -62.4 -16.87 57.32 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.606 1.336 . . . . 75.24 114.606 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -75.35 -17.77 60.16 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.224 0.535 . . . . 73.32 109.953 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.51 164.1 12.11 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.808 -0.633 . . . . 62.42 112.451 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -143.77 152.09 40.81 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.027 -1.471 . . . . 71.2 107.027 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.2 123.1 71.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.328 -0.619 . . . . 75.44 109.328 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.23 126.67 46.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.369 -0.604 . . . . 61.11 109.369 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.9 -138.42 2.55 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 110.485 -1.046 . . . . 44.44 110.485 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 97.4 mttt -138.49 147.43 43.19 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 117.502 0.651 . . . . 64.43 110.785 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 31.2 m -105.41 133.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.829 -0.623 . . . . 63.33 109.833 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 17' ' ' ILE . 6.4 mt -87.14 110.63 20.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 104.189 -2.523 . . . . 64.32 104.189 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 p -104.42 167.21 9.89 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 116.424 -0.353 . . . . 74.13 111.025 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.07 38.29 95.86 Favored Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.603 0.564 . . . . 72.43 112.935 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.96 122.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.61 -0.885 . . . . 72.34 108.61 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.2 t -72.69 163.34 28.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.151 -0.685 . . . . 64.34 109.151 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.87 -38.42 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.206 -0.294 . . . . 71.15 110.206 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.4 71.84 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.936 0.874 . . . . 64.43 110.221 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.445 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.1 mm-40 -76.46 -38.24 55.71 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.811 -1.086 . . . . 65.03 110.022 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.478 HD23 HH12 ' A' ' 88' ' ' ARG . 3.1 tm? -65.21 -38.37 90.25 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.571 -0.74 . . . . 72.52 109.709 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 80' ' ' VAL . 94.9 m-20 -57.53 -27.58 62.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.026 -0.988 . . . . 64.43 112.725 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -75.38 -30.87 60.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.011 -1.076 . . . . 72.51 109.741 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -67.1 -30.34 70.34 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.698 -0.853 . . . . 74.11 108.698 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.84 -31.63 68.4 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.02 -0.991 . . . . 75.31 110.087 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 76' ' ' ASN . 94.7 t -65.65 -35.25 74.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.649 -0.705 . . . . 75.45 109.626 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -58.62 -54.87 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.162 -0.681 . . . . 73.42 109.162 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 66.86 166.15 0.22 Allowed 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 123.672 0.789 . . . . 72.23 112.642 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.83 20.3 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.654 -0.979 . . . . 37.67 110.654 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.89 -43.51 71.63 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.6 0.593 . . . . 72.13 112.6 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.667 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 15.5 t70 -143.73 34.18 1.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.498 -1.667 . . . . 63.22 106.498 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 55.7 m-85 -115.42 150.38 36.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.013 -1.449 . . . . 75.34 108.468 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.68 158.33 44.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.599 -0.519 . . . . 72.21 109.599 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 106' ' ' THR . 37.4 mtt180 -84.22 124.65 31.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 112.776 0.658 . . . . 75.43 112.776 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.7 150.05 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 CA-C-N 115.298 -0.864 . . . . 71.15 108.722 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.1 m -94.42 122.78 37.34 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.449 -0.945 . . . . 72.24 108.449 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.81 163.12 23.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 106.56 -1.645 . . . . 70.21 106.56 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -115.23 132.05 56.73 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 117.872 -1.531 . . . . 55.15 109.42 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -126.35 169.5 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 109.133 -0.691 . . . . 73.44 109.133 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG23 ' HG3' ' A' ' 101' ' ' LYS . 58.8 t -106.1 117.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.209 -0.663 . . . . 62.42 109.209 173.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -72.45 90.04 1.29 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.194 -1.41 . . . . 64.24 107.194 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.62 -36.83 57.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.145 1.378 . . . . 54.13 111.714 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -51.41 -27.75 10.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.484 0.714 . . . . 73.25 112.713 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -134.11 9.44 3.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 74.35 109.679 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m 56.76 17.55 3.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.106 0.962 . . . . 72.24 113.489 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -92.58 160.78 14.87 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.618 -0.512 . . . . 61.42 109.618 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 8.3 mptt -100.52 132.68 45.78 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 108.129 -1.063 . . . . 73.43 108.129 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.09 138.48 30.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.249 0.547 . . . . 72.51 110.874 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.39 122.55 32.71 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.417 -0.957 . . . . 63.34 108.417 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 12' ' ' PHE . 23.3 m -131.22 169.39 21.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.628 0.251 . . . . 73.34 111.22 -172.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.94 148.55 26.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.926 -0.398 . . . . 74.02 109.926 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 66.0 p -141.15 173.72 11.21 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 123.197 0.311 . . . . 71.21 111.623 -176.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.4 118.19 36.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.759 -1.571 . . . . 74.21 106.759 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 13.2 p -113.43 159.89 13.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.702 -0.851 . . . . 73.52 108.702 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.667 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 52.1 t-105 -83.14 118.49 23.61 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.844 -1.539 . . . . 71.14 106.844 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.9 m -62.73 -19.64 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.641 0.608 . . . . 63.4 112.641 -174.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 7.9 t30 -85.79 12.14 9.69 Favored 'General case' 0 C--O 1.199 -1.578 0 C-N-CA 123.996 0.918 . . . . 70.03 109.853 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.48 -15.12 0.22 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.798 2.148 . . . . 72.51 116.798 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.24 -14.4 55.57 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.521 -0.472 . . . . 73.03 110.759 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -115.36 124.58 29.91 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 123.727 0.811 . . . . 73.31 109.148 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -90.15 128.5 1.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.588 2.192 . . . . 61.11 113.255 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -131.07 118.01 19.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.887 -0.597 . . . . 72.01 110.176 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.477 ' HG2' ' H ' ' A' ' 119' ' ' GLY . 51.6 ttm 70.36 152.17 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 124.238 0.961 . . . . 75.03 111.515 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -77.37 -33.79 55.19 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.868 -0.79 . . . . 71.51 108.868 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.477 ' H ' ' HG2' ' A' ' 117' ' ' MET . . . 66.65 56.27 13.9 Favored Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 114.277 -1.329 . . . . 64.21 115.536 173.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -87.61 131.59 34.37 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.015 -0.674 . . . . 61.2 109.273 177.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -167.2 -32.81 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.788 -0.642 . . . . 72.11 110.959 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.45 142.81 33.93 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.697 -0.853 . . . . 74.42 108.697 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.627 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 62.9 t80 -58.99 -37.37 76.71 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.673 0.619 . . . . 71.34 112.673 -173.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.23 -33.39 74.32 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.686 0.755 . . . . 70.5 109.419 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.487 ' O ' HG23 ' A' ' 128' ' ' VAL . 11.3 tp10 -76.18 -42.85 45.08 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.138 -0.937 . . . . 71.24 109.223 177.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -58.23 -33.44 69.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 72.52 111.52 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 63.5 mtp180 -57.51 -36.08 71.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.043 -0.526 . . . . 74.03 112.227 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 125' ' ' GLU . 15.9 m -84.24 -29.96 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 119.96 -0.696 . . . . 74.32 110.534 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.54 -42.36 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.731 -0.668 . . . . 74.42 109.462 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.501 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.8 t60 -54.51 -38.37 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.675 -0.693 . . . . 74.33 110.733 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.51 50.83 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.55 -0.295 . . . . 74.21 111.159 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 40.8 mt-10 -69.47 -30.93 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.482 -0.487 . . . . 65.44 112.117 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -68.39 -50.67 51.33 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.06 -0.718 . . . . 70.35 109.06 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.501 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 69.3 m-85 -67.39 -31.21 71.27 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.473 1.286 . . . . 74.22 114.473 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.94 -42.03 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 119.052 -1.059 . . . . 75.42 111.477 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -70.06 -42.57 72.66 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.882 -0.327 . . . . 73.14 110.859 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.521 ' O ' ' HG3' ' A' ' 141' ' ' MET . 98.5 m -60.92 -42.01 97.3 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.417 -0.356 . . . . 75.32 110.753 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -57.6 -50.11 74.2 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.032 -0.358 . . . . 70.41 110.032 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 88.2 mtt180 -60.59 -46.54 89.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.556 . . . . 74.13 111.028 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.69 -33.03 74.93 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.592 0.59 . . . . 74.43 112.592 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 137' ' ' THR . 91.7 mtp -65.03 -36.27 83.83 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.88 -0.328 . . . . 71.33 110.578 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.4 -35.8 73.68 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 111.716 0.265 . . . . 72.15 111.716 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 23.9 mm-40 -62.86 -45.05 94.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 63.02 109.539 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -71.27 -29.36 64.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.249 -0.887 . . . . 73.2 110.783 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -71.99 -34.43 68.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.305 0.574 . . . . 65.51 109.769 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.97 -32.2 45.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.868 -0.605 . . . . 75.43 110.644 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -149.5 112.64 3.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 116.362 -0.381 . . . . 74.22 110.143 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.4 -23.55 76.99 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.805 2.336 . . . . 73.13 111.789 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -93.51 9.12 37.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.844 -0.616 . . . . 75.33 110.238 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.68 -30.17 72.79 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.84 -0.618 . . . . 53.12 112.649 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.01 121.8 34.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.704 -0.398 . . . . 55.03 111.111 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.5 m -90.64 157.94 17.2 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.013 -1.477 . . . . 62.15 107.013 173.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -66.71 -43.33 84.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 118.132 0.424 . . . . 72.43 111.054 -175.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.53 ' O ' HG22 ' A' ' 157' ' ' VAL . 63.4 mm-40 -68.67 -32.7 72.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.587 0.708 . . . . 75.32 110.917 176.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.59 -37.46 56.43 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 114.207 1.188 . . . . 70.11 114.207 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.94 -46.18 25.1 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.586 -0.445 . . . . 53.43 110.474 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 154' ' ' GLU . 58.1 t 24.57 79.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 125.094 1.496 . . . . 61.33 112.897 -169.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -96.53 -105.85 2.26 Favored Glycine 0 C--N 1.286 -2.244 0 N-CA-C 110.007 -1.237 . . . . 60.3 110.007 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 25.5 m -82.92 94.02 7.63 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 109.329 -0.619 . . . . 74.54 109.329 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 46.1 tp -100.18 111.49 23.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.34 -1.356 . . . . 73.15 107.34 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.4 -40.02 9.71 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 115.452 -0.795 . . . . 75.51 111.338 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.2 m 65.05 83.04 0.17 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.694 -1.225 . . . . 73.42 107.694 -169.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.5 t -65.32 112.28 3.41 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.173 -1.376 . . . . 72.21 111.487 -173.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -124.16 49.51 0.9 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 108.68 -1.768 . . . . 65.05 108.68 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 CA--C 1.49 -1.334 0 CA-C-N 114.694 -0.753 . . . . 75.31 109.582 -177.689 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 p . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 109.595 -0.521 . . . . 73.31 109.595 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.6 p 58.53 -172.41 0.1 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.991 0.917 . . . . 73.44 111.48 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 m -80.66 104.54 11.25 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.87 -0.789 . . . . 71.0 108.87 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.4 p -73.73 -34.36 64.75 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.096 -0.502 . . . . 72.45 110.768 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.41 126.05 91.79 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.681 -0.859 . . . . 74.52 108.681 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.91 122.16 10.88 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.585 2.857 . . . . 64.32 113.659 -174.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -89.31 91.72 8.86 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.652 -0.704 . . . . 64.22 109.28 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.0 p -73.34 124.28 25.43 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.638 0.732 . . . . 71.32 110.498 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -89.5 153.31 20.9 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.844 -1.071 . . . . 65.13 111.402 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 36.7 m-80 -135.0 122.34 21.71 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.002 -1.851 . . . . 74.24 106.002 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 38.9 t -115.62 122.58 69.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 121.107 -0.237 . . . . 74.32 111.045 -173.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -87.48 108.22 18.92 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.857 -1.164 . . . . 74.41 107.857 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.83 149.18 33.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 120.974 0.416 . . . . 71.13 110.072 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.82 105.07 10.37 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.928 -1.138 . . . . 63.42 107.928 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' H ' ' CD1' ' A' ' 18' ' ' LEU . . . 87.44 -163.17 33.86 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.337 -0.705 . . . . 52.51 111.337 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t 70.0 -62.02 0.44 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.538 1.135 . . . . 75.03 113.785 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.451 HD12 ' C ' ' A' ' 17' ' ' ILE . 2.7 pp -129.84 9.17 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.157 0.799 . . . . 74.33 113.157 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.415 HD23 ' HB2' ' A' ' 65' ' ' LYS . 48.0 mt -64.42 -13.98 54.22 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.291 0.848 . . . . 74.45 113.291 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.56 124.51 83.77 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.112 -1.07 . . . . 70.51 108.112 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.79 -41.64 31.39 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.71 2.94 . . . . 73.21 114.047 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -65.61 -32.71 74.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 52.23 110.806 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.2 -43.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.06 -0.518 . . . . 74.33 110.14 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.68 70.73 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.395 0.616 . . . . 64.14 109.555 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.96 75.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.51 -0.768 . . . . 62.51 111.652 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 21' ' ' ALA . 18.1 m -72.69 -31.46 37.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 120.277 -0.569 . . . . 73.3 112.075 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.617 HD12 ' CD1' ' A' ' 78' ' ' PHE . 7.8 tt -73.57 -36.77 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.925 0.393 . . . . 63.31 111.799 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 74' ' ' GLU . 92.0 mt -100.25 -10.75 21.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 113.767 1.025 . . . . 72.35 113.767 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.3 18.25 10.24 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.972 1.368 . . . . 72.03 108.665 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -160.45 140.74 11.5 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 105.539 -2.023 . . . . 75.5 105.539 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -76.53 118.51 19.27 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.551 -0.86 . . . . 74.41 108.808 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.427 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -93.04 147.98 22.39 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 116.188 -0.46 . . . . 74.45 109.877 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -88.67 114.16 25.0 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.299 -0.864 . . . . 75.2 111.181 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.445 ' HB ' ' HE3' ' A' ' 65' ' ' LYS . 4.2 p -100.79 143.43 30.95 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.533 -0.758 . . . . 71.25 109.527 174.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.52 140.03 37.43 Favored Pre-proline 0 C--N 1.277 -2.552 0 N-CA-C 109.219 -0.66 . . . . 51.22 109.219 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.29 132.14 26.81 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.869 1.713 . . . . 75.51 110.671 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -145.58 156.1 43.47 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.23 -0.895 . . . . 72.11 109.029 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.47 128.24 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 CA-C-O 121.681 0.753 . . . . 74.41 110.979 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.445 ' HA ' HG11 ' A' ' 93' ' ' VAL . 23.1 tp -87.43 108.91 19.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.096 -0.957 . . . . 75.41 109.631 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -83.78 125.48 31.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.912 -1.04 . . . . 74.1 109.053 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 117.34 -13.74 13.65 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 118.277 -1.916 . . . . 52.33 113.611 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.484 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 39.1 m-85 -124.96 159.61 30.82 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 110.034 -0.358 . . . . 74.31 110.034 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 11.3 t-80 -130.16 137.26 50.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 120.014 -0.674 . . . . 75.34 109.679 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 44' ' ' TYR . 3.2 tmm_? -88.9 129.51 35.59 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.157 -1.053 . . . . 64.1 108.157 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.451 ' CE1' HG21 ' A' ' 55' ' ' VAL . 46.9 m-85 -95.5 152.88 18.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.642 -0.708 . . . . 71.23 110.979 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 6.1 tmtm? -84.91 -30.27 24.5 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.766 -0.827 . . . . 75.25 108.766 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.39 -166.26 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.438 0.695 . . . . 73.05 111.03 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.83 -42.93 2.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.335 -0.987 . . . . 73.32 108.335 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.81 -8.67 53.99 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.485 -0.864 . . . . 74.31 113.755 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.83 126.32 29.32 Favored Pre-proline 0 C--N 1.321 -0.648 0 O-C-N 122.521 -0.399 . . . . 71.0 110.475 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -83.49 -44.93 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.94 2.427 . . . . 75.32 112.267 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.9 p90 -113.67 172.11 3.83 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 105.59 -2.004 . . . . 65.33 105.59 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.308 0.0 OUTLIER 30.36 168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.593 3.466 0 C-N-CA 124.376 3.384 . . . . 63.44 118.713 -161.236 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 10.5 p -122.58 -175.29 3.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 119.623 -1.923 . . . . 71.11 112.513 8.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 30.1 pt -123.64 132.34 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.822 -1.081 . . . . 74.22 108.788 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 27.4 m -150.46 116.48 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.191 0 O-C-N 123.203 0.314 . . . . 73.22 111.521 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.6 t 55.91 -158.59 0.23 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.182 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.9 m 71.88 80.2 0.15 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.541 1.536 . . . . 70.23 111.23 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 p-10 -73.49 -10.26 59.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.613 0.72 . . . . 61.54 110.094 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.9 t -83.85 -6.16 59.36 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.0 -1.0 . . . . 73.34 109.097 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.69 164.74 13.36 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.864 -0.684 . . . . 62.53 112.246 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -142.15 147.17 36.22 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.029 -1.471 . . . . 72.4 107.029 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 41' ' ' TYR . 58.1 t -121.04 122.95 68.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 110.104 -0.332 . . . . 72.23 110.104 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -92.4 118.11 30.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.454 -0.943 . . . . 73.13 108.454 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.21 -152.96 5.74 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.048 -1.221 . . . . 72.4 110.048 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HE3' ' HB ' ' A' ' 33' ' ' THR . 30.3 mtpp -137.4 138.82 40.25 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.315 -0.624 . . . . 73.34 109.315 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.3 m -103.95 133.68 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.766 -0.652 . . . . 54.32 109.602 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 4.5 mt -87.4 119.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 105.292 -2.114 . . . . 71.25 105.292 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.4 p -106.43 160.48 15.36 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.277 -0.969 . . . . 75.13 111.5 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.89 39.84 85.1 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.902 -0.59 . . . . 70.11 112.46 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -103.83 123.57 57.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 N-CA-C 110.26 -0.274 . . . . 74.32 110.26 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.5 t -73.85 162.42 29.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.582 -0.895 . . . . 64.44 108.582 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.48 -39.3 79.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.015 0.436 . . . . 75.23 109.889 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.52 -32.47 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 40.01 109.84 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' HB3' HD23 ' A' ' 27' ' ' LEU . 52.8 mt-10 -76.98 -40.23 47.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.27 -0.877 . . . . 63.41 111.508 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.441 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.1 tt -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.036 -1.098 . . . . 72.52 108.036 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.583 ' O ' HG22 ' A' ' 80' ' ' VAL . 31.0 t-20 -53.83 -31.55 49.75 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.922 -1.49 . . . . 74.43 110.933 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -31.69 67.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 120.622 -0.431 . . . . 72.25 109.974 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.617 ' CD1' HD12 ' A' ' 26' ' ' ILE . 90.2 m-85 -72.35 -40.36 67.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.598 -0.89 . . . . 64.43 108.598 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.88 -29.42 70.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.571 -1.195 . . . . 70.14 111.98 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 76' ' ' ASN . 95.5 t -52.63 -22.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 124.036 0.934 . . . . 73.14 112.295 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.96 -29.88 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 N-CA-C 109.661 -0.496 . . . . 74.23 109.661 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 55.53 96.74 0.02 OUTLIER 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.663 1.585 . . . . 73.35 113.836 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.14 107.77 3.46 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 108.704 -1.759 . . . . 43.52 108.704 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.98 -35.42 76.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.323 0.562 . . . . 64.11 112.316 -175.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 109' ' ' TRP . 15.1 m-20 -101.59 17.96 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.055 0.455 . . . . 73.41 110.453 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -115.19 141.98 47.29 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.89 -0.411 . . . . 74.02 109.89 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -131.67 143.84 50.58 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.759 -0.83 . . . . 64.34 108.759 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 106' ' ' THR . 55.4 mtm180 -82.92 113.1 20.29 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.591 -0.444 . . . . 44.15 112.169 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.5 m -116.34 153.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.399 -0.819 . . . . 71.34 110.322 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.2 m -90.46 123.44 34.17 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.853 -0.795 . . . . 72.55 108.853 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.34 171.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.548 -1.278 . . . . 62.3 107.548 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -125.23 123.56 39.8 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.948 -1.501 . . . . 72.44 106.948 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 38' ' ' LEU . 13.7 m -126.81 163.07 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 121.504 0.669 . . . . 73.3 109.976 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.465 HG23 ' HG2' ' A' ' 101' ' ' LYS . 53.7 t -107.69 118.42 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.73 -0.668 . . . . 53.5 109.904 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.04 98.83 0.46 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.965 -1.494 . . . . 64.11 106.965 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.499 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -60.48 -36.27 77.89 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 125.03 1.332 . . . . 73.01 110.283 -170.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.7 -41.85 70.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.573 -0.74 . . . . 73.23 112.212 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.14 -1.55 12.97 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.415 0.626 . . . . 73.52 110.952 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 t 64.42 23.12 12.9 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.993 0.917 . . . . 72.31 111.451 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -96.59 161.39 13.92 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.88 -0.415 . . . . 73.31 109.88 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' HG2' HG23 ' A' ' 94' ' ' VAL . 48.0 mtpt -105.03 130.84 53.14 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.718 -0.475 . . . . 74.14 109.718 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.42 130.92 54.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.722 0.772 . . . . 65.22 111.277 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -87.52 120.29 28.67 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.022 -1.473 . . . . 71.13 107.022 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 10' ' ' ASN . 27.2 m -133.83 172.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.755 0.312 . . . . 60.2 111.17 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.4 152.57 23.43 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.774 -0.454 . . . . 64.53 109.774 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.0 t -151.91 174.64 13.36 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.658 -0.867 . . . . 61.05 108.658 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.1 118.42 36.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.204 -1.036 . . . . 73.31 108.204 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.42 153.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.836 -0.801 . . . . 71.23 108.836 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.593 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 63.7 t-105 -81.9 121.4 26.43 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.395 -1.335 . . . . 72.32 107.395 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.76 -20.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.402 0.89 . . . . 72.43 113.402 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.566 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 28.5 t-20 -80.57 11.35 3.81 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-O 121.702 0.763 . . . . 73.35 109.962 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -50.7 -25.67 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.918 1.287 . . . . 74.03 114.064 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.19 -6.78 57.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.081 0.467 . . . . 75.22 111.669 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.624 ' OD1' ' HB2' ' A' ' 116' ' ' ARG . 12.6 t70 -102.23 128.38 28.55 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 106.062 -1.829 . . . . 70.43 106.062 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.31 46.06 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.229 2.62 . . . . 70.22 111.978 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.624 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 14.2 ttm180 -95.29 115.39 27.37 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.246 -0.888 . . . . 73.33 111.872 -172.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.9 mtt 75.54 142.81 0.07 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.069 1.348 . . . . 74.23 114.546 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -149.1 -42.23 0.15 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.293 -1.321 . . . . 74.42 109.039 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.16 -155.83 52.42 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.141 -0.936 . . . . 65.11 114.447 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.85 151.7 48.33 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.883 -0.784 . . . . 64.45 108.883 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -156.91 -62.7 0.1 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.933 0.873 . . . . 75.13 108.846 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.448 ' HB3' ' CB ' ' A' ' 125' ' ' GLU . 13.3 t70 -121.76 144.2 48.93 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.194 -1.41 . . . . 42.34 107.194 174.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.587 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 81.5 m-85 -66.3 -46.16 77.89 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.274 0.472 . . . . 73.24 112.274 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 127' ' ' ARG . 8.1 tp10 -68.27 -41.24 81.36 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.927 -0.768 . . . . 72.21 108.927 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.448 ' CB ' ' HB3' ' A' ' 122' ' ' ASP . 7.4 tp10 -56.85 -46.75 81.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.888 -1.051 . . . . 71.42 109.162 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -56.09 -41.95 75.98 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.781 -0.645 . . . . 73.25 110.976 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 72.4 mtp180 -60.27 -41.26 92.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.725 -0.67 . . . . 74.3 111.224 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -82.95 -41.63 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.638 -0.425 . . . . 73.32 111.916 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.0 p -68.82 -40.11 80.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 112.767 0.654 . . . . 74.34 112.767 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -65.17 -35.25 80.49 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 118.882 -1.127 . . . . 74.4 110.645 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -64.3 -55.1 23.63 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.434 0.459 . . . . 62.43 111.03 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -23.42 64.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.168 0.433 . . . . 65.44 112.168 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.507 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.4 tpmt? -67.24 -45.3 77.13 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.78 -0.822 . . . . 73.33 108.78 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -67.47 -33.18 74.6 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.836 -0.345 . . . . 73.02 111.276 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.593 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 98.1 t -53.68 -53.19 27.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.11 -0.7 . . . . 73.02 109.11 173.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.95 -42.42 89.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.671 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.7 m -54.96 -50.51 68.74 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.775 0.672 . . . . 71.34 110.463 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -68.35 -29.85 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.162 0.43 . . . . 75.21 112.162 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -68.23 -44.73 75.08 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.463 0.649 . . . . 75.3 109.729 177.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -71.23 -42.09 69.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 75.44 110.378 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.49 ' HA ' ' HE1' ' A' ' 141' ' ' MET . 3.2 mmt -62.53 -31.45 72.22 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-N 116.344 -0.389 . . . . 74.31 110.844 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.46 -50.05 74.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.58 0.752 . . . . 73.43 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.44 -34.37 75.85 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.165 -0.614 . . . . 72.4 111.631 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -75.18 -27.18 59.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.183 0.516 . . . . 73.3 112.035 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -72.88 -37.3 67.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.483 0.713 . . . . 75.32 109.318 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 146' ' ' LYS . 11.3 tmtt? -78.95 -33.0 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.315 -0.624 . . . . 74.22 109.315 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -137.9 95.05 11.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 120.927 0.394 . . . . 73.23 110.628 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.03 -16.61 9.83 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.615 2.21 . . . . 75.05 111.175 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.22 -23.26 61.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.369 -0.832 . . . . 75.04 111.292 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.43 7.05 71.7 Favored Glycine 0 C--O 1.242 0.609 0 C-N-CA 120.454 -0.879 . . . . 65.52 112.506 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -93.79 136.84 33.66 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.429 -1.323 . . . . 70.14 107.429 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.443 ' HB2' ' OE1' ' A' ' 155' ' ' GLU . 49.7 m -79.07 164.64 24.15 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 112.491 0.552 . . . . 61.03 112.491 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 66.4 mtt -59.86 -44.2 94.27 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.192 0.812 . . . . 74.3 113.192 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.06 -28.66 64.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.439 0.638 . . . . 75.4 110.713 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 159' ' ' SER . 1.1 mp0 -75.44 -32.9 60.83 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.51 -0.768 . . . . 71.01 110.734 175.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.99 -27.9 63.06 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.837 -0.62 . . . . 70.04 111.316 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.22 133.36 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 120.047 -0.661 . . . . 52.51 109.525 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 89.87 -55.53 3.72 Favored Glycine 0 C--N 1.305 -1.147 0 N-CA-C 109.544 -1.422 . . . . 75.42 109.544 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 155' ' ' GLU . 48.4 t -103.31 96.11 6.54 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 107.618 -1.253 . . . . 64.31 107.618 174.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.7 166.39 3.31 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.014 -0.539 . . . . 64.12 111.88 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.75 70.76 6.33 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.24 -0.652 . . . . 54.21 109.24 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.4 m -75.57 97.45 3.75 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 115.088 -0.96 . . . . 71.21 109.743 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.3 t -127.12 176.72 7.16 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.812 -1.085 . . . . 71.53 108.2 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.02 103.72 0.24 Allowed Glycine 0 N--CA 1.424 -2.108 0 C-N-CA 120.25 -0.976 . . . . 72.2 112.494 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 C--N 1.306 -1.326 0 N-CA-C 109.061 -0.718 . . . . 38.01 109.061 175.219 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.434 -0.58 . . . . 73.53 109.434 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.6 m -117.81 128.65 55.06 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.723 -0.843 . . . . 73.12 108.723 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 p -58.2 113.67 2.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.143 0.497 . . . . 60.24 111.996 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.1 t -101.43 -29.08 12.22 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.799 -0.637 . . . . 73.11 109.763 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.56 151.91 41.58 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.545 -0.909 . . . . 64.24 108.545 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.37 -6.03 17.77 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.703 2.269 . . . . 65.22 113.511 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 8.2 mm-40 -96.46 -6.89 36.23 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 119.657 -0.817 . . . . 63.44 111.835 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m -96.71 108.34 20.96 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.571 -1.64 . . . . 74.32 106.571 169.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.519 ' HD1' ' HG ' ' A' ' 75' ' ' LEU . 8.4 m170 -104.23 156.0 18.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.049 -0.523 . . . . 74.13 110.581 -172.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.456 ' HB2' HG13 ' A' ' 104' ' ' VAL . 25.2 m-80 -134.93 133.42 39.55 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.466 -1.679 . . . . 71.43 106.466 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.79 121.02 66.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.563 -0.455 . . . . 72.2 111.213 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.423 ' HB2' HG22 ' A' ' 104' ' ' VAL . 59.3 t80 -89.75 98.83 11.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.302 -0.629 . . . . 75.34 109.302 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.48 129.98 31.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.832 -0.803 . . . . 63.23 108.832 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.544 ' CD1' ' HA2' ' A' ' 64' ' ' GLY . 48.2 t80 -105.89 86.17 2.34 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.544 -0.863 . . . . 65.42 110.127 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.76 147.18 4.48 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.652 -1.158 . . . . 75.44 112.367 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t 70.67 -69.34 0.18 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.489 1.515 . . . . 73.41 113.718 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 67' ' ' ILE . 28.3 mt -75.96 3.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.027 0.918 . . . . 73.43 110.407 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -67.99 -23.04 64.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.568 -0.742 . . . . 74.45 109.159 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.63 119.94 74.52 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 108.565 -0.902 . . . . 71.21 108.565 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -48.55 -35.96 30.41 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.67 2.913 . . . . 75.14 112.54 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.441 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -60.37 -40.29 90.27 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.455 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 25' ' ' VAL . 70.9 t -70.46 -39.71 76.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.356 0.598 . . . . 74.3 110.056 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' HG23 ' A' ' 26' ' ' ILE . . . -66.43 -35.32 80.01 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.378 -0.601 . . . . 73.01 109.378 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.646 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -74.28 -10.14 59.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 72.34 112.038 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 21' ' ' ALA . 21.1 m -100.04 -31.68 3.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.346 -0.942 . . . . 72.33 110.513 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.544 HD12 ' CD2' ' A' ' 78' ' ' PHE . 9.9 tt -79.08 -42.96 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.153 0.501 . . . . 75.11 111.582 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.97 -21.38 18.65 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.156 -0.34 . . . . 74.24 110.319 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.646 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 28.2 t70 67.59 15.98 9.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 123.598 1.666 . . . . 74.55 107.723 -170.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -133.31 131.56 40.3 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.457 -2.053 . . . . 74.33 105.457 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -76.74 111.43 12.24 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.996 -1.082 . . . . 70.4 109.196 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.87 143.09 28.09 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.647 -0.706 . . . . 72.35 109.264 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.78 129.06 45.86 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.852 -0.796 . . . . 74.21 108.852 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.7 p -93.34 141.83 28.0 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 119.487 -0.885 . . . . 74.04 108.878 175.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.72 140.02 34.62 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.703 -0.851 . . . . 71.34 108.703 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.73 128.94 28.64 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.778 2.319 . . . . 64.13 111.969 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.24 154.45 37.95 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.902 -0.59 . . . . 38.3 109.518 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.85 131.92 71.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 C-N-CA 120.752 -0.379 . . . . 74.13 110.384 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HA ' HG11 ' A' ' 93' ' ' VAL . 20.9 tp -94.32 129.98 40.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.022 -0.535 . . . . 75.03 110.531 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -94.59 129.97 41.22 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.446 -0.343 . . . . 63.54 111.232 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 58' ' ' ASP . . . 105.4 -1.43 40.01 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 119.52 -1.324 . . . . 74.1 113.771 173.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 56.9 m-85 -126.59 160.76 29.73 Favored 'General case' 0 N--CA 1.414 -2.252 0 O-C-N 122.313 -0.522 . . . . 72.04 112.074 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -134.17 130.97 38.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.387 -1.338 . . . . 74.03 107.387 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.83 124.98 34.7 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.06 0.457 . . . . 74.1 111.208 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HE2' ' O ' ' A' ' 55' ' ' VAL . 93.6 m-85 -106.67 145.17 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.897 -1.149 . . . . 73.14 107.897 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 4.3 mmmp? -109.92 125.02 52.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 112.355 0.502 . . . . 73.43 112.355 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -131.83 141.67 49.49 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.189 -1.041 . . . . 71.34 108.189 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -90.65 -30.04 17.38 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.818 -0.808 . . . . 52.34 108.818 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -31.76 76.98 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.806 -1.088 . . . . 71.43 112.222 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.98 158.45 41.76 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 108.407 -0.96 . . . . 63.5 108.407 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.94 -76.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.849 2.366 . . . . 71.01 114.216 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.62 76.26 69.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.964 -1.124 . . . . 75.24 107.964 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.576 ' HA ' ' SG ' ' A' ' 53' ' ' CYS 0.257 51.9 Cg_endo -115.52 162.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 123.432 2.754 . . . . 72.31 116.19 -171.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 52' ' ' PRO . 1.7 m -158.01 158.21 34.43 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.205 3.402 . . . . 71.54 107.152 -19.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 108' ' ' VAL . 33.2 pt -124.09 128.33 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.638 -0.825 . . . . 72.33 111.888 174.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 24.2 m -154.58 145.75 13.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 124.342 1.057 . . . . 74.3 108.458 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 p 168.14 -57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.194 0.934 . . . . 72.04 110.671 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 m 69.8 13.6 8.06 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.363 1.078 . . . . 74.34 108.337 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.655 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 26.6 t70 -83.28 -178.05 6.95 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 113.938 -1.483 . . . . 71.24 109.715 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.0 m -80.42 -6.88 58.77 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.684 0.278 . . . . 70.44 110.889 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.42 156.17 31.1 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.887 -0.597 . . . . 74.03 111.971 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -129.03 152.91 48.12 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.895 -0.409 . . . . 71.3 109.895 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 122.53 67.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.295 -1.002 . . . . 72.33 108.295 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -97.77 115.64 28.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.426 -0.583 . . . . 73.14 109.426 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.544 ' HA2' ' CD1' ' A' ' 14' ' ' TYR . . . -146.44 -147.4 4.57 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.953 -0.641 . . . . 75.24 111.993 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 47.9 mtpt -139.68 146.21 39.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.213 -1.032 . . . . 71.31 108.213 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' THR . 35.2 m -104.72 135.14 43.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.165 -0.471 . . . . 64.54 110.883 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 17' ' ' ILE . 6.4 mt -86.27 111.8 21.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.762 -2.31 . . . . 74.1 104.762 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -99.44 161.64 13.5 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.495 -0.482 . . . . 71.21 111.694 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.41 35.32 37.6 Favored Glycine 0 C--O 1.245 0.789 0 CA-C-N 115.752 -0.658 . . . . 64.2 112.927 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t -97.37 124.82 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.02 -0.734 . . . . 63.44 109.02 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.0 m -77.95 157.92 29.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.553 -0.906 . . . . 74.41 108.553 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.502 ' HA ' ' CE1' ' A' ' 9' ' ' HIS . 7.3 p-10 -56.45 -42.74 78.64 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.211 0.529 . . . . 72.41 112.191 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.47 70.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.017 -0.992 . . . . 71.33 110.801 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.58 -30.02 62.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.516 -0.766 . . . . 60.3 110.793 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.519 ' HG ' ' HD1' ' A' ' 9' ' ' HIS . 3.0 tm? -58.21 -35.08 71.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.278 -0.873 . . . . 72.04 109.369 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.564 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -59.46 -27.53 66.17 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.357 -0.838 . . . . 63.12 111.919 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.481 ' OD1' HG13 ' A' ' 26' ' ' ILE . 1.9 t-20 -68.08 -31.61 71.35 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.219 -0.659 . . . . 74.25 109.219 -176.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.544 ' CD2' HD12 ' A' ' 26' ' ' ILE . 80.1 m-85 -74.46 -32.28 62.54 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 121.68 0.752 . . . . 75.22 109.007 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.83 -31.26 63.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.159 -0.928 . . . . 63.23 110.241 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 76' ' ' ASN . 98.1 t -66.65 -22.67 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 115.64 -0.709 . . . . 70.34 110.848 175.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.8 mm -58.96 143.22 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.915 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.41 113.71 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.742 1.617 . . . . 72.23 113.266 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.77 85.35 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.561 -0.828 . . . . 42.3 113.266 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -82.55 -33.17 28.22 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.632 -0.334 . . . . 65.14 111.576 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.542 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.5 m-20 -97.75 2.43 49.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.609 0.966 . . . . 74.45 113.609 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.326 1.6 p90 -122.18 142.31 50.55 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.14 -1.024 . . . . 75.12 111.114 171.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -125.03 159.45 31.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.159 -170.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -88.85 128.62 35.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.805 -0.443 . . . . 71.24 109.805 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.35 159.78 40.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 122.634 0.374 . . . . 75.43 110.504 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.7 m -93.67 129.43 39.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.986 -0.746 . . . . 71.31 108.986 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.48 157.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.918 -1.141 . . . . 72.54 107.918 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.482 ' HG3' ' CD ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -105.18 135.65 46.15 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.276 -0.97 . . . . 54.01 108.762 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.423 HG11 ' HA ' ' A' ' 38' ' ' LEU . 21.8 m -127.36 161.94 33.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.704 -0.85 . . . . 71.4 108.704 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.452 HG23 ' HG2' ' A' ' 101' ' ' LYS . 71.6 t -102.44 120.1 51.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 109.005 -0.739 . . . . 65.41 109.005 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -71.91 93.12 1.31 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.476 -1.676 . . . . 75.41 106.476 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -47.84 -49.54 28.91 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 127.262 2.225 . . . . 72.13 115.049 -167.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.88 -23.12 58.34 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.166 -0.614 . . . . 65.22 111.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -97.83 -10.89 23.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.3 -0.409 . . . . 62.34 110.864 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 m 59.26 19.49 7.61 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.464 1.106 . . . . 73.45 112.336 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -105.19 160.78 14.81 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.938 -0.393 . . . . 75.3 109.938 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.452 ' HG2' HG23 ' A' ' 94' ' ' VAL . 44.3 mtmt -100.31 143.21 30.76 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.618 -0.882 . . . . 73.21 108.618 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.75 162.23 15.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.301 -0.629 . . . . 63.12 109.301 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.482 ' CD ' ' HG3' ' A' ' 92' ' ' GLU . 3.6 tppp? -110.69 123.83 50.78 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.101 -1.074 . . . . 74.44 108.101 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 10' ' ' ASN . 21.2 m -130.97 174.37 13.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.837 0.351 . . . . 73.42 110.564 -174.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -112.11 146.91 37.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.077 -0.712 . . . . 74.33 109.077 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.4 t -149.26 174.03 12.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.085 -1.08 . . . . 75.42 108.085 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -113.43 119.55 38.0 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.61 0.719 . . . . 73.31 110.542 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 54' ' ' ILE . 14.0 p -114.0 143.79 22.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.975 -1.011 . . . . 73.31 109.747 -175.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.672 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 61.0 t-105 -70.01 127.86 34.31 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.57 -0.9 . . . . 75.41 108.57 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 85' ' ' ASP . 31.6 m -72.02 -19.82 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.519 0.676 . . . . 72.14 112.559 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.672 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -86.83 15.64 5.62 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 125.216 1.406 . . . . 71.31 109.29 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 0.8 OUTLIER -48.27 -22.96 0.76 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.23 1.812 . . . . 72.43 113.85 -176.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -101.71 68.51 1.16 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.551 -0.859 . . . . 73.32 110.984 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -128.56 144.38 51.93 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 114.798 -1.092 . . . . 74.14 108.331 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.35 -33.2 84.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 53.44 113.642 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.541 ' O ' ' HD2' ' A' ' 116' ' ' ARG 0.265 0.0 OUTLIER -133.26 114.22 13.53 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.112 1.153 . . . . 64.13 114.112 -178.463 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.441 ' HE2' ' HA ' ' A' ' 117' ' ' MET . 1.7 mmt -118.83 -12.58 9.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 115.83 -0.623 . . . . 71.21 110.342 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -86.12 91.24 8.37 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.841 -0.744 . . . . 74.31 109.772 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.41 153.25 2.89 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 114.2 -1.363 . . . . 64.12 111.312 170.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -86.02 131.69 34.22 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.367 0.603 . . . . 53.2 112.19 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.4 ' HB3' ' H ' ' A' ' 122' ' ' ASP . 72.5 m95 -142.64 -154.01 0.5 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.085 -1.45 . . . . 75.33 107.085 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.655 ' OD1' ' HG2' ' A' ' 124' ' ' GLU . 12.1 t70 -127.71 148.66 50.41 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.448 -1.315 . . . . 75.14 107.448 177.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -58.75 -38.16 77.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.934 0.334 . . . . 74.14 111.622 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.655 ' HG2' ' OD1' ' A' ' 122' ' ' ASP . 12.7 pt-20 -73.66 -26.17 60.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.486 0.66 . . . . 72.22 110.109 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -72.67 -34.19 67.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.053 -0.976 . . . . 74.11 108.571 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -86.96 -23.84 24.94 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.467 -0.788 . . . . 74.31 109.546 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -59.49 -45.7 90.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 62.24 110.391 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.6 m -64.18 -19.75 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 116.362 -0.381 . . . . 75.42 111.956 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.3 -22.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.13 0.491 . . . . 63.21 110.552 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.474 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 5.2 p-80 -115.79 -33.12 5.25 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.695 -0.802 . . . . 74.33 112.952 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.544 ' O ' HG21 ' A' ' 135' ' ' VAL . . . -59.4 -55.73 31.0 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.811 0.671 . . . . 71.4 112.811 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.49 -34.07 77.37 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.694 -0.402 . . . . 74.43 111.855 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.473 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 1.1 tmtp? -61.55 -50.31 73.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.107 -0.701 . . . . 73.14 109.107 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 84.3 m-85 -69.37 -31.99 70.74 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.052 0.39 . . . . 73.11 112.052 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 131' ' ' ALA . 97.7 t -60.01 -38.66 77.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.061 -0.348 . . . . 70.04 110.061 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -57.39 -48.13 79.87 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.698 -0.482 . . . . 71.54 109.698 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 141' ' ' MET . 34.8 m -57.51 -46.67 83.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.335 -0.848 . . . . 75.4 110.412 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.401 ' O ' HD21 ' A' ' 142' ' ' LEU . 74.1 m-85 -61.47 -48.51 80.79 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.809 -0.356 . . . . 73.05 111.569 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -54.61 -47.51 73.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.703 0.287 . . . . 64.12 110.822 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -66.9 -42.96 84.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.684 -0.689 . . . . 72.22 111.909 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 137' ' ' THR . 60.5 mtm -66.52 -42.95 86.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.718 -0.393 . . . . 73.45 111.248 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.555 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 4.6 mm? -59.22 -49.96 75.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.246 0.832 . . . . 72.3 113.246 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.29 0.567 . . . . 75.22 111.698 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.509 ' NE1' ' HE2' ' A' ' 151' ' ' LYS . 27.6 t90 -75.91 -36.57 59.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.171 -0.922 . . . . 75.15 110.836 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -83.42 -35.57 24.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.299 0.851 . . . . 75.41 113.299 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -79.62 -7.24 58.41 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.863 -0.735 . . . . 73.43 112.308 -177.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -143.29 86.41 9.05 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-O 121.027 0.441 . . . . 75.01 111.398 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.4 -22.75 28.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.864 2.376 . . . . 74.33 110.496 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -76.84 -12.65 60.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.529 -0.76 . . . . 74.22 109.985 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -95.83 3.43 65.07 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 115.387 -0.824 . . . . 71.43 111.181 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.509 ' HE2' ' NE1' ' A' ' 144' ' ' TRP . 40.6 ttmt -82.96 137.17 34.28 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.447 -1.316 . . . . 74.5 107.447 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.5 m -62.96 156.51 24.28 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 123.587 0.555 . . . . 72.25 111.428 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.418 ' O ' HG23 ' A' ' 157' ' ' VAL . 65.5 mtt -66.0 -44.2 85.47 Favored 'General case' 0 C--O 1.209 -1.037 0 N-CA-C 113.465 0.913 . . . . 74.24 113.465 -171.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.06 -33.52 63.72 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.575 0.703 . . . . 75.23 111.044 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.14 -39.18 63.46 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.443 -0.799 . . . . 73.24 111.11 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.95 -25.88 60.19 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 116.125 -0.489 . . . . 63.12 112.092 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 153' ' ' MET 0.267 35.0 m -81.21 76.42 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 113.846 1.054 . . . . 62.31 113.846 -178.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -91.76 -23.38 28.3 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 108.635 -1.786 . . . . 55.42 108.635 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.6 p -153.1 89.01 1.34 Allowed 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 113.769 -1.215 . . . . 75.14 108.608 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 63.6 tp -90.11 -57.38 2.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.083 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.1 mp 63.11 173.81 0.15 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.84 0.856 . . . . 71.44 110.626 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.0 m -100.67 82.19 2.4 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.972 -1.492 . . . . 65.35 106.972 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.0 m -107.95 168.5 9.24 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.549 -0.751 . . . . 61.21 110.65 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.77 -63.1 4.5 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 109.906 -1.278 . . . . 38.3 109.906 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 . . . . . 0 C--N 1.303 -1.43 0 N-CA-C 107.861 -1.163 . . . . 63.55 107.861 176.567 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 C--O 1.239 0.544 0 N-CA-C 109.46 -0.57 . . . . 63.44 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 p -64.1 120.56 12.3 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.508 -0.923 . . . . 72.11 108.508 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -114.85 148.99 37.8 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 113.927 1.084 . . . . 72.13 113.927 -171.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 t -131.33 103.82 6.67 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 104.547 -2.39 . . . . 74.42 104.547 176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -85.11 119.78 72.82 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 121.08 -0.248 . . . . 64.41 111.25 -172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.65 -53.07 6.19 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.546 2.83 . . . . 70.41 113.746 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -99.79 69.38 1.58 Allowed 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.336 0.589 . . . . 62.32 112.159 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m -163.49 168.94 19.52 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 124.633 1.173 . . . . 61.24 108.722 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -91.6 148.52 22.22 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.455 -0.793 . . . . 75.32 109.508 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 83.1 m-20 -129.06 122.72 30.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.949 -1.13 . . . . 73.33 107.949 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 29.3 t -117.72 120.36 64.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.554 -0.459 . . . . 75.34 111.422 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -83.78 110.83 18.65 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.465 -1.309 . . . . 70.13 107.465 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.444 HG12 HD13 ' A' ' 17' ' ' ILE . 7.9 p -136.17 158.07 38.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.244 -0.582 . . . . 70.03 110.066 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.88 22.02 6.83 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-O 121.074 0.464 . . . . 72.22 110.988 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 51' ' ' TYR . . . -136.29 -133.7 3.23 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 118.128 -1.987 . . . . 61.02 117.072 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.6 m -40.46 -47.68 2.65 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.821 2.156 . . . . 71.22 116.821 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD13 HG12 ' A' ' 13' ' ' VAL . 2.4 pp -84.71 1.48 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 114.583 1.327 . . . . 74.42 114.583 -171.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.8 mp -68.54 -11.2 59.59 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.511 0.56 . . . . 73.22 112.511 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.9 119.05 75.45 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 107.121 -1.437 . . . . 52.41 107.121 170.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -47.52 -37.29 25.96 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.751 2.967 . . . . 74.34 114.036 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.98 -35.03 79.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.407 -0.361 . . . . 71.24 111.293 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 25' ' ' VAL . 45.3 t -76.92 -40.59 31.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.252 -0.431 . . . . 71.05 110.219 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.84 -33.81 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.676 . . . . 71.4 109.602 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.61 -11.33 59.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.452 -0.794 . . . . 75.11 112.46 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.5 m -102.12 -26.86 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.869 -0.732 . . . . 74.34 110.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.485 HD12 ' CD1' ' A' ' 78' ' ' PHE . 9.5 tt -77.05 -36.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.344 0.592 . . . . 75.02 110.607 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 31' ' ' ALA . 90.1 mt -95.93 -14.7 22.89 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.045 -0.525 . . . . 71.53 110.242 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 68.44 -1.22 1.96 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.461 1.124 . . . . 74.04 109.927 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 94.8 mtt180 -133.53 176.85 8.17 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.466 -1.679 . . . . 75.01 106.466 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -77.01 144.09 38.92 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.078 0.466 . . . . 74.23 111.251 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -116.27 134.97 54.31 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 109.046 -0.724 . . . . 72.34 109.046 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -99.42 109.71 22.27 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.903 -1.519 . . . . 74.24 109.174 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 3.0 p -105.93 142.12 36.18 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 120.272 -0.571 . . . . 75.44 109.933 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.15 137.64 31.43 Favored Pre-proline 0 C--N 1.284 -2.27 0 N-CA-C 108.766 -0.827 . . . . 73.42 108.766 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 96' ' ' MET . 6.4 Cg_endo -57.47 117.72 4.47 Favored 'Trans proline' 0 CA--C 1.504 -0.99 0 C-N-CA 122.254 1.969 . . . . 73.21 109.719 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.86 155.2 50.68 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.972 -0.751 . . . . 73.43 108.972 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.476 ' CG2' ' HE2' ' A' ' 61' ' ' LYS . 12.6 p -125.86 127.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.745 0.783 . . . . 71.24 111.695 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.448 ' HA ' HG11 ' A' ' 93' ' ' VAL . 20.8 tp -87.59 96.29 10.36 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.017 -0.992 . . . . 74.21 112.398 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -72.56 126.35 29.65 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.36 -0.836 . . . . 62.33 110.263 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.84 -7.84 17.05 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 119.635 -1.269 . . . . 70.53 113.14 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.496 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 33.8 m-85 -126.7 145.11 50.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 112.642 0.608 . . . . 74.32 112.642 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 22.3 t-160 -105.34 127.09 52.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.363 -0.835 . . . . 75.45 108.765 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -87.93 137.59 32.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.162 -0.681 . . . . 71.33 109.162 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -98.81 177.93 5.12 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 115.85 -0.614 . . . . 74.45 109.918 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 -28.59 6.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 114.005 1.113 . . . . 55.11 114.005 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 52' ' ' PRO . 4.1 mm? 57.88 -169.92 0.11 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.503 0.502 . . . . 71.21 111.576 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 23.29 5.19 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.731 -0.788 . . . . 64.14 112.886 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.64 7.18 0.08 OUTLIER Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.284 -0.96 . . . . 70.13 113.112 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.77 161.11 36.92 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 117.163 0.482 . . . . 71.43 110.413 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 2.7 Cg_exo -74.41 96.18 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.114 2.543 . . . . 72.23 114.598 -175.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.613 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.6 p90 44.2 35.11 0.2 Allowed Pre-proline 0 N--CA 1.515 2.815 0 N-CA-C 116.52 2.045 . . . . 72.42 116.52 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.891 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 72.6 Cg_endo -108.5 166.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.274 2.65 . . . . 74.13 113.516 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.891 ' SG ' ' HB2' ' A' ' 52' ' ' PRO . 33.5 m -134.29 -179.25 5.46 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 103.94 -2.615 . . . . 64.2 103.94 -4.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 40.2 pt -123.99 121.03 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 119.609 1.095 . . . . 75.4 112.179 174.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -154.12 133.04 3.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.743 -0.662 . . . . 73.35 111.454 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t 64.72 -175.99 0.17 Allowed 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.504 1.122 . . . . 75.52 113.426 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 42' ' ' HIS . 20.6 t 78.67 112.52 0.07 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.59 1.956 . . . . 72.24 112.932 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.17 -27.16 32.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.432 0.635 . . . . 75.34 109.944 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.5 m -82.97 -9.2 59.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.771 -0.649 . . . . 72.43 110.421 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.26 153.65 21.48 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.742 -0.663 . . . . 61.34 112.354 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.476 ' HE2' ' CG2' ' A' ' 37' ' ' VAL . 21.0 ptmt -154.17 145.7 23.18 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.293 -1.003 . . . . 55.31 108.293 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG23 ' CG2' ' A' ' 54' ' ' ILE . 62.1 t -114.27 123.76 70.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 112.044 0.387 . . . . 64.45 112.044 -173.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -88.1 120.6 29.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.536 -0.302 . . . . 74.24 110.242 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.34 -147.23 4.57 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.7 143.58 39.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.465 0.633 . . . . 74.15 110.121 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.68 133.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 109.336 -0.616 . . . . 75.31 109.336 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 4.6 mt -89.47 117.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 106.445 -1.687 . . . . 74.34 106.445 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -104.1 160.42 14.86 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.022 -1.071 . . . . 62.12 109.225 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.57 30.0 41.79 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.224 -0.988 . . . . 53.24 113.656 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.55 124.29 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.29 0.545 . . . . 75.03 110.013 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.478 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.9 m -75.48 158.29 32.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.791 -0.818 . . . . 70.34 108.791 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.17 -39.79 79.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.071 0.397 . . . . 74.02 112.071 -175.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.84 64.73 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.09 0.471 . . . . 51.2 110.732 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 50.7 mm-40 -73.64 -30.94 63.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.568 -0.742 . . . . 74.21 110.34 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.78 -37.05 73.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.178 0.991 . . . . 75.1 111.32 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 39.1 m-80 -57.37 -27.58 62.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.309 0.644 . . . . 74.02 111.657 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -69.08 -31.7 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.241 -0.652 . . . . 62.41 109.241 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.485 ' CD1' HD12 ' A' ' 26' ' ' ILE . 95.8 m-85 -70.97 -29.25 65.19 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 120.415 -0.514 . . . . 74.41 109.764 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 3.1 m-20 -60.96 -41.19 95.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.586 0.708 . . . . 74.25 109.439 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.24 -34.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.012 -0.995 . . . . 74.35 110.394 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -62.01 -50.75 78.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.233 -0.44 . . . . 64.11 111.152 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.06 141.83 12.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 120.933 0.397 . . . . 73.05 110.665 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.68 28.71 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.277 -0.874 . . . . 75.01 111.191 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -76.42 -43.06 41.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 120.187 -0.605 . . . . 51.41 110.551 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.483 ' O ' HG22 ' A' ' 110' ' ' VAL . 8.1 m-20 -125.93 13.15 7.89 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.091 0.948 . . . . 61.25 108.534 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -115.9 149.44 38.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.334 -1.358 . . . . 72.3 107.334 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 16.4 pt-20 -130.76 155.88 45.91 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.586 0.232 . . . . 74.1 110.531 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 106' ' ' THR . 45.5 ttm180 -91.1 126.66 36.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.865 0.364 . . . . 71.24 111.511 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.16 159.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.444 -0.947 . . . . 71.4 108.444 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 m -96.17 123.01 39.63 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.223 -0.658 . . . . 61.11 109.223 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 38' ' ' LEU . 26.8 m -125.96 157.76 35.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 123.826 0.85 . . . . 71.11 109.727 -175.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 29.3 tt0 -105.24 125.18 50.69 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.207 -0.597 . . . . 61.4 109.52 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 38' ' ' LEU . 15.1 m -126.13 168.41 19.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.964 -0.754 . . . . 63.33 108.964 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.44 HG13 ' H ' ' A' ' 96' ' ' MET . 68.6 t -104.25 128.12 57.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.341 -0.985 . . . . 73.51 108.341 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -68.53 -15.44 63.54 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.951 0.782 . . . . 73.43 110.215 -174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 0.6 OUTLIER 70.61 -54.86 0.64 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.131 1.773 . . . . 73.12 113.882 172.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -48.63 -45.65 38.7 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 70.43 111.432 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.87 9.95 16.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 123.345 0.658 . . . . 64.24 110.508 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.7 m 62.83 10.06 4.05 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.81 1.041 . . . . 74.54 113.81 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 161.11 21.85 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.569 -0.452 . . . . 44.0 110.361 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -101.91 134.05 45.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.654 -0.869 . . . . 74.11 108.654 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.01 139.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.727 -0.842 . . . . 71.32 108.727 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 92' ' ' GLU . 28.3 ttpt -107.48 116.65 32.33 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.865 0.84 . . . . 74.25 110.597 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.21 177.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.0 -1.454 . . . . 73.31 110.696 -168.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.32 144.09 28.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.804 -0.443 . . . . 71.22 109.804 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 10.5 t -144.72 175.22 10.33 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.233 -0.654 . . . . 74.32 109.233 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 78.3 m-85 -110.43 119.48 39.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.273 0.358 . . . . 74.14 110.272 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 54' ' ' ILE . 34.8 m -109.84 -173.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.918 -0.771 . . . . 60.44 108.918 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.502 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 61.1 t-105 -99.13 122.71 42.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.018 -0.734 . . . . 75.13 109.018 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 85' ' ' ASP . 26.8 m -65.61 -35.89 76.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 CA-C-O 121.363 0.601 . . . . 74.44 111.401 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.491 ' ND2' ' HB3' ' A' ' 114' ' ' ASP . 5.0 t30 -88.18 15.75 7.12 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.979 1.312 . . . . 71.22 109.506 -173.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.7 ptpp? -47.43 -14.87 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 126.859 2.064 . . . . 72.35 115.048 -171.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -90.4 6.8 41.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.828 0.347 . . . . 72.23 111.825 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.491 ' HB3' ' ND2' ' A' ' 111' ' ' ASN . 3.1 p30 -85.65 160.07 54.04 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.911 -1.144 . . . . 75.1 107.911 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.18 99.47 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.053 1.836 . . . . 63.21 110.827 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.556 ' HD3' ' H ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.65 -0.704 . . . . 74.03 111.366 -176.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.2 ttm -72.93 98.48 2.49 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.486 -1.234 . . . . 74.42 111.707 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -101.65 -48.22 4.38 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 119.918 -0.713 . . . . 74.42 109.814 175.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.43 -112.95 2.64 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.535 -1.426 . . . . 71.31 109.535 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -121.46 137.93 54.51 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 106.035 -1.839 . . . . 61.21 106.035 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -100.34 172.82 6.91 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.326 -1.731 . . . . 75.23 106.326 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.09 111.74 18.5 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.136 -1.026 . . . . 75.13 110.987 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -68.22 -33.04 73.68 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.758 -1.11 . . . . 64.15 110.142 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.24 -28.85 64.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.682 -0.69 . . . . 73.22 110.381 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 128' ' ' VAL . 8.5 tp10 -76.02 -37.45 58.39 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.128 -1.434 . . . . 64.03 107.128 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -57.74 -28.67 64.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.902 -1.045 . . . . 74.45 111.364 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -57.74 -49.08 77.77 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.234 0.457 . . . . 73.31 112.234 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 125' ' ' GLU . 18.8 m -72.24 -27.68 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.329 -0.548 . . . . 73.52 110.232 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 125' ' ' GLU . 88.6 t -68.44 -28.29 39.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.246 -0.888 . . . . 64.4 110.954 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -99.4 -28.58 13.21 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.869 -1.132 . . . . 73.23 110.843 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.54 82.45 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.786 -0.643 . . . . 71.42 112.3 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.646 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.47 -24.0 66.35 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 113.132 0.79 . . . . 62.42 113.132 -177.06 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.543 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 6.4 tmtt? -76.22 -55.78 5.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 109.604 -0.517 . . . . 64.12 109.604 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -63.86 -32.11 73.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.836 0.68 . . . . 65.43 112.836 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.61 -37.3 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 119.813 -0.755 . . . . 74.43 110.228 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 7.3 mm-40 -62.87 -39.72 95.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.849 -0.426 . . . . 71.32 109.849 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.505 -0.77 . . . . 74.33 110.7 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.403 ' HA ' ' HG2' ' A' ' 141' ' ' MET . 19.1 m-85 -67.72 -36.67 81.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.685 -0.487 . . . . 74.43 109.685 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -64.53 -51.59 62.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.973 -0.558 . . . . 73.4 110.929 176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -63.54 -34.54 78.01 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 112.672 0.619 . . . . 73.04 112.672 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 24.1 ptm -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.521 -0.872 . . . . 73.2 109.717 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 tp -77.36 -50.12 13.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 74.35 111.248 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.25 0.0 OUTLIER -68.47 -24.61 64.72 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.266 0.469 . . . . 62.54 112.266 -178.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -75.41 -43.81 47.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.81 -0.632 . . . . 74.43 110.817 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -69.05 -35.1 76.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.522 0.677 . . . . 74.33 110.01 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 41.1 ttmt -92.52 8.18 39.94 Favored 'General case' 0 CA--C 1.565 1.525 0 CA-C-N 115.498 -0.774 . . . . 72.14 110.554 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 28.0 t-20 -46.71 118.52 5.06 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 123.804 0.842 . . . . 73.51 112.909 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 19.9 Cg_exo -63.18 -24.26 72.75 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.492 2.795 . . . . 74.1 113.577 -176.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.35 -13.77 59.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.462 0.649 . . . . 70.31 110.176 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.04 24.38 55.17 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.793 -0.639 . . . . 52.12 113.58 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.07 122.33 29.94 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.818 0.673 . . . . 73.34 112.818 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 77.5 p -115.53 168.48 9.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.652 -1.24 . . . . 71.54 107.652 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 19.1 ptp -73.34 -25.7 60.73 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.968 -0.693 . . . . 74.12 109.93 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.33 -37.8 68.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.314 -0.857 . . . . 73.24 109.137 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HA ' ' OG ' ' A' ' 159' ' ' SER . 34.3 tt0 -75.07 -31.59 61.27 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.247 -0.888 . . . . 73.22 109.816 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.99 -34.98 78.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.199 -0.91 . . . . 73.3 110.195 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.03 -172.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.336 -0.616 . . . . 75.32 109.336 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -67.75 102.88 0.88 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.914 -0.875 . . . . 63.42 110.914 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 155' ' ' GLU . 16.2 m -75.05 155.37 37.3 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.181 0.592 . . . . 73.32 110.113 -178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.0 tp -88.13 128.65 35.43 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.592 -0.522 . . . . 71.2 109.592 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.19 126.51 42.43 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.423 -0.954 . . . . 74.41 108.423 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 p -66.07 93.26 0.19 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.826 0.822 . . . . 71.32 110.945 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.7 p -160.37 115.56 2.28 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.244 -0.889 . . . . 74.52 110.34 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.69 -38.47 5.23 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.432 -0.89 . . . . 42.4 111.602 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.306 -1.305 0 N-CA-C 108.567 -0.901 . . . . 73.0 108.567 -179.624 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.441 -0.898 0 N-CA-C 108.532 -0.914 . . . . 74.23 108.532 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.1 p -84.34 96.07 8.93 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.539 0.685 . . . . 73.14 110.692 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 p -102.15 92.5 4.78 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 115.882 -0.599 . . . . 61.33 110.662 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.0 m -84.05 -31.26 25.48 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.701 -1.222 . . . . 64.32 107.701 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.9 t70 68.13 129.2 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.288 1.435 . . . . 44.31 112.739 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.86 17.5 0.82 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.09 2.527 . . . . 73.34 114.821 -176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -56.58 -36.21 69.08 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.878 0.847 . . . . 60.42 109.509 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.1 p -135.38 130.49 35.0 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 106.864 -1.532 . . . . 61.54 106.864 173.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.422 ' HD2' ' OE1' ' A' ' 105' ' ' GLU . 78.8 m80 -90.7 143.46 26.71 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.107 0.479 . . . . 71.32 111.739 -175.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.7 m-20 -128.31 122.36 31.43 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.454 -1.313 . . . . 74.24 107.454 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 22.5 t -116.23 121.28 67.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 121.053 -0.259 . . . . 71.33 110.56 -175.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -81.44 112.15 18.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 107.97 -1.122 . . . . 74.1 107.97 174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.419 HG22 ' HB ' ' A' ' 17' ' ' ILE . 24.1 m -113.49 140.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.531 0.681 . . . . 75.24 112.458 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -131.87 121.79 24.63 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.557 -1.275 . . . . 75.53 107.557 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.3 -58.91 4.17 Favored Glycine 0 C--N 1.302 -1.315 0 C-N-CA 120.895 -0.669 . . . . 72.44 111.441 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.1 m -78.25 145.82 35.23 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.97 -0.381 . . . . 74.43 109.97 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.468 HG22 ' CD1' ' A' ' 67' ' ' ILE . 9.3 mm 70.23 -104.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.8 1.24 . . . . 71.32 108.586 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.259 77.4 mt 49.1 -36.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.651 2.38 . . . . 64.33 117.092 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.19 132.15 29.9 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 109.393 -0.595 . . . . 72.22 109.393 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.4 -40.3 28.71 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.9 3.067 . . . . 61.43 113.543 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -60.16 -47.94 83.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.982 0.42 . . . . 71.42 110.967 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.67 -39.73 85.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.406 0.622 . . . . 73.34 110.402 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . . . -66.88 -34.94 78.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.81 -0.632 . . . . 64.42 110.947 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -75.62 -26.46 57.81 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.177 -0.465 . . . . 74.14 111.654 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 21' ' ' ALA . 20.9 m -85.34 -23.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.432 -0.507 . . . . 74.24 111.595 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.457 HD12 ' CD1' ' A' ' 78' ' ' PHE . 10.5 tt -82.46 -40.97 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.138 -0.625 . . . . 74.24 111.067 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 31' ' ' ALA . 82.8 mt -83.68 -18.17 38.94 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.293 -0.412 . . . . 74.42 111.27 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 64.18 25.91 13.74 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 106.739 -1.578 . . . . 62.12 106.739 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.4 ttt180 -162.83 166.59 23.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.678 -1.601 . . . . 73.53 106.68 -174.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -75.39 136.44 40.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 118.098 0.408 . . . . 74.11 110.426 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 23' ' ' ALA . . . -101.73 141.32 34.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 115.964 -0.562 . . . . 54.12 112.015 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -100.11 110.23 22.51 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.733 -0.667 . . . . 64.24 109.516 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.7 p -115.98 143.42 45.48 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.255 -0.43 . . . . 75.0 110.824 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.41 139.96 35.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.01 -0.737 . . . . 61.01 109.01 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.53 134.12 58.98 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.403 2.069 . . . . 64.23 112.028 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.464 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.88 157.03 42.78 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.377 -0.828 . . . . 70.33 110.246 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.12 127.89 72.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.537 0.684 . . . . 72.35 111.41 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.435 ' HA ' HG11 ' A' ' 93' ' ' VAL . 28.4 tp -91.39 95.93 10.25 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.405 -0.816 . . . . 75.3 111.809 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 9.9 p-80 -71.94 127.31 32.17 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.318 -0.855 . . . . 74.54 109.148 170.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.95 -17.48 7.63 Favored Glycine 0 C--N 1.292 -1.9 0 C-N-CA 119.69 -1.243 . . . . 51.23 112.651 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -124.93 160.26 29.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.091 0.774 . . . . 72.23 113.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.02 132.85 42.33 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.744 -1.116 . . . . 60.44 109.672 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.48 151.48 20.17 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.623 0.971 . . . . 74.43 113.623 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.463 ' HA ' ' CH2' ' A' ' 121' ' ' TRP . 94.2 m-85 -130.15 169.86 14.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.846 -1.07 . . . . 75.33 109.539 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -138.46 86.83 2.18 Favored 'General case' 0 CA--C 1.485 -1.524 0 O-C-N 124.055 0.847 . . . . 73.03 111.447 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HG ' ' HD2' ' A' ' 52' ' ' PRO 0.35 0.3 OUTLIER -89.84 97.9 11.46 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.179 -1.008 . . . . 71.51 111.301 174.331 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -66.16 -23.22 66.43 Favored 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.52 1.528 . . . . 75.04 110.792 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.83 -12.91 63.01 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 115.435 -0.802 . . . . 52.14 111.782 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.2 mt -126.26 170.13 10.31 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 125.438 1.495 . . . . 70.14 107.432 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.89 50.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.519 2.978 0 C-N-CA 124.138 3.226 . . . . 73.44 114.981 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.561 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.487 7.8 p90 48.47 63.69 9.91 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 118.94 2.941 . . . . 72.13 118.94 178.169 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 3.2 Cg_endo -95.98 169.12 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.578 4.185 . . . . 54.23 109.261 172.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.0 p -157.41 -167.3 2.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.508 2.723 . . . . 73.35 108.499 -3.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.9 pt -123.74 131.07 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 107.13 -1.433 . . . . 74.13 107.13 162.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.471 HG22 ' SD ' ' A' ' 117' ' ' MET . 31.1 m -145.21 166.77 10.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 116.478 -0.328 . . . . 74.44 111.227 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t 63.6 138.7 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.797 1.639 . . . . 73.02 113.922 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -80.79 75.47 7.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.333 1.063 . . . . 75.53 110.711 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.65 168.25 16.49 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.254 -1.339 . . . . 75.4 110.044 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.8 m -91.69 4.8 51.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.151 0.501 . . . . 73.2 110.942 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.13 -167.84 43.74 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.334 -0.706 . . . . 73.2 111.334 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 39' ' ' HIS . 8.8 ptpp? -153.77 151.57 29.73 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.37 -0.532 . . . . 73.24 112.193 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.4 128.66 71.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 C-N-CA 124.095 0.958 . . . . 73.2 109.109 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -100.97 132.53 46.34 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.526 -0.87 . . . . 65.34 110.594 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.92 -138.08 2.44 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.93 -0.868 . . . . 52.34 110.93 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -142.68 145.23 33.2 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.12 0.568 . . . . 71.21 110.708 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.28 129.79 56.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.673 -0.491 . . . . 73.4 109.673 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.468 ' CD1' HG22 ' A' ' 17' ' ' ILE . 18.1 mt -89.46 110.91 22.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 106.834 -1.543 . . . . 63.21 106.834 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.2 p -99.25 161.84 13.39 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 116.054 -0.521 . . . . 64.04 111.464 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.57 74.25 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.329 -0.462 . . . . 73.04 113.189 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.29 128.93 38.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.652 -0.87 . . . . 72.43 108.652 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -85.3 160.95 19.71 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.823 -0.806 . . . . 64.3 108.823 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -52.36 -37.89 57.34 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.475 0.71 . . . . 72.42 111.846 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.83 63.13 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.924 -0.58 . . . . 37.57 111.464 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.57 -32.07 72.58 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.929 -0.309 . . . . 72.34 111.149 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.11 -33.85 69.56 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.742 -0.663 . . . . 74.02 110.469 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.43 ' O ' HG22 ' A' ' 80' ' ' VAL . 22.1 t-20 -63.58 -28.65 70.08 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.61 -0.723 . . . . 63.13 110.692 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' HG13 ' A' ' 26' ' ' ILE . 4.9 t30 -74.91 -31.88 61.66 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.817 -0.808 . . . . 63.22 108.817 -175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CD1' HD12 ' A' ' 26' ' ' ILE . 96.4 m-85 -64.8 -36.5 84.53 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 115.461 -0.79 . . . . 74.35 110.476 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.21 -31.55 71.15 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.541 0.686 . . . . 73.32 110.116 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 76' ' ' ASN . 55.6 t -75.64 -44.34 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 115.64 -0.709 . . . . 72.21 112.344 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 11.3 tt -72.13 117.72 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.306 0.574 . . . . 63.14 112.24 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.19 3.09 0.49 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.714 1.206 . . . . 75.4 113.978 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.37 53.56 1.54 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 111.358 -0.697 . . . . 53.33 111.358 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -82.37 -40.71 20.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.838 0.351 . . . . 73.43 110.825 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.598 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 5.6 t70 -119.88 28.87 7.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.667 1.222 . . . . 54.14 107.806 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.482 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 70.6 m-85 -113.76 161.16 17.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.48 -1.236 . . . . 75.25 109.707 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -130.48 141.91 50.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.936 -1.135 . . . . 75.45 107.936 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -81.88 121.47 26.5 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.191 -0.458 . . . . 74.51 110.996 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.33 159.64 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.71 -0.677 . . . . 75.54 110.205 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.1 m -97.8 124.56 42.24 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.945 -0.761 . . . . 70.04 108.945 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.13 169.95 13.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.582 -0.896 . . . . 72.5 108.582 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -124.79 120.93 33.13 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.651 -0.87 . . . . 75.32 108.651 -173.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' A' ' 38' ' ' LEU . 21.0 m -126.0 168.78 18.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-O 121.383 0.611 . . . . 73.14 110.886 -170.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.469 HG23 ' HG2' ' A' ' 101' ' ' LYS . 71.3 t -110.52 118.81 58.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.481 -0.782 . . . . 64.25 109.464 175.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -74.33 95.1 2.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 109.246 -0.65 . . . . 74.42 109.246 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.464 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -48.1 -33.64 8.51 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 126.57 1.948 . . . . 75.04 110.596 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.76 -38.71 70.2 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.458 -0.792 . . . . 64.1 112.013 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -115.61 -10.62 11.83 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.341 0.591 . . . . 72.04 109.748 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.6 t 67.71 22.5 8.93 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.07 0.948 . . . . 62.43 110.074 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -97.17 160.38 14.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.922 -0.581 . . . . 75.22 109.458 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.499 ' HZ1' ' HB3' ' A' ' 101' ' ' LYS . 5.9 mtpm? -101.85 135.78 42.82 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.613 -0.884 . . . . 75.32 108.613 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.86 145.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.064 0.459 . . . . 75.3 110.345 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -91.94 124.15 35.84 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.238 -1.023 . . . . 74.32 108.238 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.69 175.59 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.815 0.446 . . . . 73.41 110.691 -175.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.422 ' OE1' ' HD2' ' A' ' 9' ' ' HIS . 45.3 mt-10 -106.8 153.5 22.37 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.972 -0.455 . . . . 74.13 111.057 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 t -154.87 177.9 10.76 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 110.273 -0.269 . . . . 72.02 110.273 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -104.76 119.8 39.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.08 0.952 . . . . 64.4 108.673 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.75 151.88 20.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.553 -0.459 . . . . 73.51 109.913 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.598 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 35.6 t-105 -79.36 127.05 31.61 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.084 -0.709 . . . . 75.31 109.084 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.7 m -72.64 -28.3 27.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.115 0.483 . . . . 63.22 112.236 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -79.3 13.21 1.99 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.678 0.791 . . . . 70.24 111.282 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -51.65 -14.86 0.38 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.014 1.857 . . . . 52.32 116.014 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -72.87 9.96 1.01 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.124 0.488 . . . . 65.13 112.135 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.41 131.82 49.15 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 108.064 -1.087 . . . . 70.41 108.064 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 -15.98 28.48 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.317 2.678 . . . . 74.23 116.457 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -130.6 113.97 14.87 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 117.673 -1.611 . . . . 72.32 114.259 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.471 ' SD ' HG22 ' A' ' 55' ' ' VAL . 66.2 mtt -140.64 111.54 7.02 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.745 -1.116 . . . . 63.53 109.064 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.5 p90 176.01 -28.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.598 1.159 . . . . 75.44 109.668 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.99 36.04 3.73 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.976 -0.556 . . . . 75.51 111.719 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.443 ' HG3' ' HB3' ' A' ' 46' ' ' LEU . 1.2 mp0 -87.73 -179.69 6.33 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 123.809 0.844 . . . . 54.45 110.987 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.463 ' CH2' ' HA ' ' A' ' 44' ' ' TYR . 31.2 m-90 74.33 166.72 0.29 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.493 1.117 . . . . 75.54 111.201 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.86 147.63 28.2 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.629 -1.249 . . . . 73.11 107.629 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -57.97 -40.54 80.87 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.727 0.299 . . . . 74.42 111.193 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -74.5 -42.88 58.18 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.44 -0.578 . . . . 63.35 109.44 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.7 mt-10 -66.94 -41.34 87.16 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.954 -0.566 . . . . 73.15 111.791 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -60.95 -24.46 66.08 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.909 0.385 . . . . 74.3 111.301 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -58.43 -43.19 88.63 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.281 -0.637 . . . . 74.13 109.281 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 125' ' ' GLU . 17.9 m -84.37 -31.68 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 119.993 -0.683 . . . . 65.2 110.946 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 125' ' ' GLU . 52.2 t -68.18 -39.31 81.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 116.794 -0.185 . . . . 73.12 111.066 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.405 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 1.4 p-80 -67.47 -32.34 73.12 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.413 -0.915 . . . . 73.24 110.254 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.73 83.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 54.43 110.024 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.5 -25.77 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.259 -0.882 . . . . 71.04 112.249 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -76.68 -57.37 3.89 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.231 -1.396 . . . . 71.14 107.231 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 92.0 m-85 -61.79 -33.5 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.503 1.297 . . . . 75.45 114.503 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.8 p -58.1 -41.94 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.33 -0.548 . . . . 63.45 110.66 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 24.0 mm-40 -66.12 -39.35 89.83 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.172 -0.467 . . . . 54.31 110.494 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.7 m -59.32 -49.6 77.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 72.42 110.475 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -57.77 -41.61 82.38 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 121.134 -0.226 . . . . 64.33 111.247 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 82.5 mtp180 -63.27 -47.92 80.32 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.572 0.545 . . . . 71.33 111.193 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 73.1 mmtt -65.35 -42.97 92.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.747 0.308 . . . . 74.4 110.881 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.455 ' HA ' ' HE3' ' A' ' 141' ' ' MET . 2.6 mmt -61.79 -35.82 79.3 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.052 -0.722 . . . . 65.25 109.052 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.77 -39.09 90.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.537 -0.912 . . . . 74.03 108.537 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -64.06 -47.84 78.6 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.555 -0.293 . . . . 74.04 110.798 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -69.95 -28.66 65.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.611 0.967 . . . . 74.12 113.611 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -82.0 -47.76 12.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.972 0.36 . . . . 62.44 111.972 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.0 -26.94 30.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.227 0.455 . . . . 73.41 112.227 -175.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -136.03 78.16 47.78 Favored Pre-proline 0 C--N 1.313 -1.007 0 C-N-CA 120.605 -0.438 . . . . 71.22 111.885 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.71 -29.71 35.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.99 1.793 . . . . 73.3 109.875 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -87.56 0.11 56.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.308 -0.86 . . . . 74.43 109.763 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -80.33 -23.89 60.06 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.984 -1.246 . . . . 64.23 109.984 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -80.07 151.08 30.08 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.981 -1.488 . . . . 74.02 106.981 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 45.4 m -62.44 156.74 21.88 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 112.169 0.433 . . . . 75.33 112.169 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 67.2 mtt -61.78 -45.09 95.38 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 114.949 1.463 . . . . 72.21 114.949 -169.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -65.18 -36.21 83.5 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.595 0.712 . . . . 74.23 109.97 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -73.45 -36.69 65.92 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.701 -1.136 . . . . 72.14 109.764 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.86 45.05 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.67 -0.696 . . . . 51.42 112.499 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.69 -12.95 9.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 113.11 0.781 . . . . 64.02 113.11 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -139.74 -138.69 3.66 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 119.857 -1.163 . . . . 37.57 111.876 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.0 m 72.77 163.75 0.28 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.718 1.207 . . . . 73.24 111.948 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.54 116.44 28.96 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.489 0.661 . . . . 72.33 109.439 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -174.32 139.1 0.58 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.036 -1.438 . . . . 74.22 108.357 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.1 m -81.71 79.48 8.26 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.679 0.752 . . . . 63.5 109.476 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.7 m -153.65 119.46 5.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.904 -1.044 . . . . 73.42 108.203 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 147.48 -60.7 0.46 Allowed Glycine 0 CA--C 1.492 -1.358 0 N-CA-C 110.062 -1.215 . . . . 60.04 110.062 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 109.434 -0.58 . . . . 64.1 109.434 176.839 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 109.345 -0.613 . . . . 73.42 109.345 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.413 HG21 ' H ' ' A' ' 4' ' ' SER . 37.2 m 76.77 146.32 0.09 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.998 0.919 . . . . 73.21 110.397 -177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 m -57.07 -29.84 63.8 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.448 0.699 . . . . 72.32 111.15 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.413 ' H ' HG21 ' A' ' 2' ' ' THR . 20.4 m -108.52 102.62 11.68 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.668 -0.696 . . . . 54.51 111.579 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 7' ' ' GLN . 15.7 t70 -81.92 150.49 65.53 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 106.913 -1.514 . . . . 70.3 106.913 172.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -57.49 35.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 124.839 3.693 . . . . 71.01 116.082 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -152.13 54.9 0.82 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 102.51 -3.144 . . . . 73.43 102.51 175.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 m -75.12 135.65 41.14 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.368 -1.287 . . . . 53.25 112.253 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -107.97 156.35 19.32 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.75 -1.113 . . . . 73.32 111.034 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.3 m-20 -125.14 122.91 38.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.144 -1.428 . . . . 75.11 107.144 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 19.5 t -119.78 124.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 120.753 -0.379 . . . . 74.42 110.976 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -84.02 113.91 21.34 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.825 -0.806 . . . . 74.32 108.825 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -125.17 160.54 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.518 0.675 . . . . 73.33 111.973 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -145.71 -55.67 0.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.815 -1.55 . . . . 71.51 106.815 175.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.5 63.27 0.6 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.513 -1.035 . . . . 75.2 110.513 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 m -153.97 -79.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.192 . . . . 71.4 111.033 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.529 HD13 ' CG2' ' A' ' 26' ' ' ILE . 33.2 pt -145.78 86.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 122.173 0.987 . . . . 74.43 111.312 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.447 HD23 ' HB2' ' A' ' 65' ' ' LYS . 77.7 mt -99.63 -5.19 29.39 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.474 -0.766 . . . . 74.32 109.223 175.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.78 130.81 24.6 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.258 -0.883 . . . . 65.23 111.046 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.62 -42.56 18.77 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.174 3.249 . . . . 71.14 114.417 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.38 83.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.744 0.276 . . . . 44.55 111.744 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.7 p -77.26 -30.87 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.288 0.566 . . . . 73.21 111.044 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.397 0.618 . . . . 71.14 109.377 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -74.85 -5.69 44.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.644 -0.707 . . . . 62.22 112.197 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.1 m -105.98 -15.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.805 -0.758 . . . . 72.3 111.223 177.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.529 ' CG2' HD13 ' A' ' 17' ' ' ILE . 10.0 tt -92.72 -42.47 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 121.468 0.651 . . . . 74.44 110.333 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 95.3 mt -87.08 -27.24 23.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.882 -0.599 . . . . 75.34 110.002 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 73.17 3.3 4.61 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.479 1.133 . . . . 75.04 108.122 -170.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.9 mmt180 -126.07 154.81 42.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.195 -2.15 . . . . 72.32 105.195 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -96.96 110.41 22.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.677 -1.209 . . . . 72.12 108.75 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 156.29 17.67 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.882 -0.599 . . . . 74.54 110.532 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.66 125.54 41.2 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.516 0.674 . . . . 63.04 112.816 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 p -100.44 143.94 30.03 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.582 -1.19 . . . . 73.41 109.532 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.7 141.66 38.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.304 -0.999 . . . . 74.4 108.304 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 2.1 Cg_endo -65.44 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.001 1.801 . . . . 75.44 111.637 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.17 156.36 41.46 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.691 -0.686 . . . . 75.42 110.444 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -122.44 127.84 75.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-O 121.399 0.619 . . . . 73.03 111.378 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 23.7 tp -90.49 97.86 11.43 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.206 -0.906 . . . . 72.34 109.429 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.444 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 6.3 p80 -70.63 132.3 45.23 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.014 -0.994 . . . . 71.43 110.018 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.61 38.57 Favored Glycine 0 C--O 1.215 -1.044 0 C-N-CA 118.844 -1.646 . . . . 74.22 113.993 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -101.99 143.35 31.95 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 113.768 1.025 . . . . 73.31 113.768 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.549 ' HB2' ' CB ' ' A' ' 58' ' ' ASP . 2.9 t-160 -104.63 122.55 45.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.386 -1.279 . . . . 62.14 108.379 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -89.53 115.86 27.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.189 -1.041 . . . . 71.41 108.189 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' HD2' ' O ' ' A' ' 117' ' ' MET . 26.3 m-85 -81.3 141.86 33.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.6 -0.518 . . . . 64.44 109.6 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.631 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -97.54 124.54 41.82 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.37 0.605 . . . . 75.34 111.291 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.77 133.1 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.835 -0.62 . . . . 62.33 110.079 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.89 -41.08 7.38 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 108.08 -1.082 . . . . 54.0 108.08 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.56 -21.15 77.62 Favored Glycine 0 N--CA 1.425 -2.096 0 CA-C-N 114.234 -1.348 . . . . 53.04 112.156 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.67 151.34 41.04 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 108.83 -0.804 . . . . 74.41 108.83 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.52 -61.76 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.832 2.355 . . . . 74.43 115.62 -172.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.681 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 4.1 p90 -132.62 16.33 0.05 OUTLIER Pre-proline 0 CA--C 1.585 2.299 0 N-CA-C 117.208 2.299 . . . . 75.24 117.208 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.705 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 1.0 OUTLIER -89.24 164.29 5.62 Favored 'Trans proline' 0 C--N 1.369 1.609 0 CA-C-N 122.129 1.796 . . . . 74.13 112.005 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 20.6 p -155.0 167.44 30.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.484 1.914 . . . . 74.03 108.034 -6.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 131.37 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.775 -0.77 . . . . 51.21 109.537 170.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 112' ' ' LYS . 8.1 p -157.52 170.51 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 108.572 -0.899 . . . . 73.01 108.572 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.4 ' H ' HG23 ' A' ' 55' ' ' VAL . 25.6 m 77.67 145.45 0.09 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.47 1.106 . . . . 75.51 112.83 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.1 t -88.73 76.23 8.07 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.225 -1.398 . . . . 75.24 107.225 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.549 ' CB ' ' HB2' ' A' ' 42' ' ' HIS . 17.9 t70 -84.22 175.24 9.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.26 -1.791 . . . . 74.44 109.325 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 m -83.75 -16.58 44.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.498 . . . . 73.4 109.706 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.62 170.24 53.94 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 115.391 -0.822 . . . . 45.34 113.602 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 42.3 mtmt -137.82 146.75 43.89 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.399 -1.334 . . . . 71.44 107.399 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.86 123.42 61.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.528 -0.545 . . . . 73.35 109.528 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -95.93 124.86 40.12 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.517 -0.549 . . . . 64.43 109.517 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.99 -141.89 3.26 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.101 -0.8 . . . . 37.77 111.101 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 48.9 mtmt -140.17 147.43 40.12 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 120.874 0.368 . . . . 75.42 111.622 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.1 m -104.87 133.71 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 115.454 -0.794 . . . . 75.45 109.551 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 17' ' ' ILE . 18.3 mt -88.37 130.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 106.023 -1.843 . . . . 70.3 106.023 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.3 p -115.01 161.32 18.49 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.732 -0.787 . . . . 62.25 111.415 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 33.66 67.67 Favored Glycine 0 N--CA 1.439 -1.114 0 O-C-N 123.543 0.527 . . . . 75.11 113.211 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -90.39 122.37 41.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.964 0.382 . . . . 70.3 110.633 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.8 m -76.62 158.7 30.88 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.458 -0.571 . . . . 75.1 109.458 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.79 -42.93 65.49 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.461 0.541 . . . . 72.42 112.461 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.2 -40.71 77.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.29 0.567 . . . . 73.5 110.141 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.37 -37.26 80.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.709 -1.132 . . . . 71.11 109.099 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.95 -33.5 74.4 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.404 1.082 . . . . 70.02 110.155 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -62.86 -27.14 69.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.158 -0.928 . . . . 70.34 113.16 179.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -32.89 71.4 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.191 -1.04 . . . . 64.31 108.191 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.463 ' CE1' HD12 ' A' ' 17' ' ' ILE . 83.4 m-85 -70.98 -28.59 64.56 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.29 0.566 . . . . 75.03 109.532 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.508 ' HA ' HH12 ' A' ' 88' ' ' ARG . 28.6 t70 -70.94 -36.13 72.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.614 -0.721 . . . . 60.41 109.848 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 76' ' ' ASN . 72.4 t -66.6 -22.51 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.229 -0.896 . . . . 75.31 111.511 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.4 103.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.337 0.589 . . . . 75.32 110.488 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.389 0.1 OUTLIER 64.39 -58.39 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.937 2.495 . . . . 73.42 112.631 -174.001 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.51 1.66 16.98 Favored Glycine 0 C--O 1.234 0.132 0 C-N-CA 123.191 0.424 . . . . 75.03 113.638 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -83.92 -44.17 14.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.649 0.24 . . . . 75.54 111.649 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.51 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 2.1 t70 -136.94 16.12 3.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 118.626 -1.23 . . . . 73.3 111.532 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.705 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 30.6 m-85 -112.56 151.88 29.51 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.224 -0.591 . . . . 63.42 110.723 175.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -131.56 159.65 37.57 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.172 -0.922 . . . . 73.14 109.292 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.508 HH12 ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -90.11 113.74 25.53 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.332 -0.395 . . . . 74.44 109.954 -178.236 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.62 159.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.662 0.267 . . . . 63.1 110.859 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.3 m -102.57 129.78 49.24 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.066 -0.716 . . . . 73.25 109.066 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.07 168.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.345 -1.354 . . . . 64.01 107.345 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -120.35 131.97 55.08 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.473 -1.291 . . . . 62.51 108.662 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.99 168.13 19.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.243 0.544 . . . . 44.41 109.617 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.504 HG23 ' HG2' ' A' ' 101' ' ' LYS . 69.3 t -109.78 120.1 60.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 115.658 -0.701 . . . . 64.14 109.962 177.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.418 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 77.3 ttt180 -67.41 97.23 0.55 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.799 -1.556 . . . . 75.42 106.799 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.5 ttt -48.74 -45.82 40.14 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 127.088 2.155 . . . . 64.13 113.664 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.4 -34.15 75.51 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.586 0.587 . . . . 74.13 112.586 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -103.48 -9.29 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.306 0.574 . . . . 65.43 111.272 -175.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m 64.8 25.58 12.92 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.793 0.837 . . . . 63.33 111.653 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -102.58 161.69 13.52 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.561 -0.903 . . . . 72.54 108.561 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.504 ' HG2' HG23 ' A' ' 94' ' ' VAL . 44.3 mtmt -104.6 135.85 45.24 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.953 -0.758 . . . . 63.21 108.953 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.52 135.86 48.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-O 121.139 0.495 . . . . 71.31 109.855 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -87.16 126.41 34.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.143 -1.428 . . . . 71.21 107.143 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.58 169.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.977 0.417 . . . . 73.11 111.123 -174.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.4 149.39 24.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.384 -0.371 . . . . 65.21 110.138 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 t -153.01 176.86 11.42 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.776 -0.453 . . . . 71.35 109.776 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.46 ' HD2' ' CE1' ' A' ' 86' ' ' TYR . 15.1 p90 -107.35 120.01 40.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 125.08 1.352 . . . . 75.13 110.407 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.401 ' O ' ' HD1' ' A' ' 86' ' ' TYR . 27.1 m -114.77 171.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 O-C-N 122.096 -0.377 . . . . 50.43 110.077 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.51 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 23.7 t-105 -97.7 121.2 39.34 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.483 -0.562 . . . . 75.43 109.483 -168.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 112' ' ' LYS . 33.5 m -73.12 -23.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 112.425 0.528 . . . . 74.54 112.425 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -76.42 11.81 1.45 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.352 0.596 . . . . 71.22 109.959 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.482 ' HB3' HG21 ' A' ' 55' ' ' VAL . 10.5 ptpp? -59.31 -20.07 51.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.298 1.039 . . . . 72.22 112.686 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.33 -24.67 50.78 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.253 0.549 . . . . 43.32 110.481 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.1 145.9 41.65 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.188 -1.782 . . . . 62.43 106.188 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -31.28 125.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 124.192 3.262 . . . . 75.11 112.687 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.82 114.33 13.16 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.477 0.656 . . . . 72.24 109.973 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.407 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 28.0 ttt -84.92 93.42 8.54 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 114.47 1.285 . . . . 73.35 114.47 -171.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -113.96 -16.77 12.12 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.186 -1.783 . . . . 73.54 106.186 167.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.53 -103.59 0.33 Allowed Glycine 0 CA--C 1.481 -2.031 0 CA-C-N 113.578 -1.647 . . . . 62.22 111.638 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -144.28 132.35 21.64 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.527 -0.916 . . . . 74.02 108.527 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.1 167.84 19.02 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 104.645 -2.354 . . . . 74.53 104.645 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' A' ' 124' ' ' GLU . 9.0 m-20 -80.72 133.53 35.69 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 119.329 -0.948 . . . . 64.52 111.866 -174.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.408 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 90.1 t80 -61.3 -29.45 69.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.764 -1.107 . . . . 74.42 110.524 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.499 ' HG2' ' HB3' ' A' ' 122' ' ' ASP . 10.8 pt-20 -61.3 -38.22 86.03 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 120.997 0.427 . . . . 74.51 110.09 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 129' ' ' VAL . 16.5 tp10 -77.71 -44.28 28.37 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.738 -0.838 . . . . 73.43 108.738 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -55.3 -49.73 71.38 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-N 115.436 -0.802 . . . . 74.41 110.852 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 123' ' ' PHE . 16.7 ptm180 -64.7 -40.07 94.74 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.752 -0.658 . . . . 73.13 112.225 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 m -70.78 -32.41 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.918 -0.713 . . . . 74.43 111.734 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.566 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 88.3 t -67.93 -45.23 84.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 109.009 -0.737 . . . . 74.41 109.009 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -70.52 -39.55 74.02 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.184 -0.606 . . . . 74.24 111.67 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.21 -54.7 42.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.662 0.245 . . . . 70.55 111.662 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 42.5 mt-10 -62.01 -38.16 87.59 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.078 0.466 . . . . 74.24 111.83 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -69.59 -43.68 72.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.555 -0.748 . . . . 64.41 111.965 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -72.24 -40.53 67.65 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.266 0.839 . . . . 72.24 113.266 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 34.5 m -60.09 -34.2 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 118.952 -0.546 . . . . 65.4 112.421 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 45.7 mt-10 -55.91 -51.82 66.28 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.204 -1.035 . . . . 74.04 108.204 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.3 m -58.63 -50.43 73.86 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.084 -1.416 . . . . 52.55 110.76 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -59.97 -50.48 73.57 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 112.166 0.432 . . . . 75.14 112.166 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 41.0 mtp180 -63.25 -53.41 53.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.669 0.618 . . . . 71.31 112.669 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -66.23 -31.73 72.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 112.096 0.406 . . . . 64.41 112.096 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.51 ' HA ' ' HE3' ' A' ' 141' ' ' MET . 4.5 mmt -76.17 -35.56 59.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 119.998 -0.681 . . . . 71.1 109.651 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.8 tp -63.94 -36.67 84.73 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 122.741 0.417 . . . . 63.43 110.599 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.253 -0.43 . . . . 75.23 111.358 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -76.24 -35.38 59.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.815 -0.63 . . . . 72.35 111.017 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.98 -39.6 61.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 75.03 112.135 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -99.62 9.36 43.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.32 0.581 . . . . 74.11 109.942 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -38.89 117.36 1.04 Allowed Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.592 1.557 . . . . 54.35 112.734 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.53 -19.59 52.94 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 123.907 3.071 . . . . 71.12 113.245 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -74.98 -7.09 52.63 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.206 -0.452 . . . . 54.22 111.551 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.53 -7.63 79.7 Favored Glycine 0 CA--C 1.505 -0.565 0 C-N-CA 121.066 -0.588 . . . . 64.45 113.474 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.602 ' HG2' ' OE2' ' A' ' 155' ' ' GLU . 66.0 mttm -77.73 122.48 25.43 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.877 0.37 . . . . 65.53 111.744 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.8 m -97.44 172.61 7.65 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.252 -0.885 . . . . 52.04 109.388 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 20.6 ptp -56.78 -43.33 80.75 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.372 0.879 . . . . 74.1 113.372 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.86 -10.21 59.37 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.04 0.385 . . . . 70.21 112.04 -176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.602 ' OE2' ' HG2' ' A' ' 151' ' ' LYS . 39.4 tt0 -73.93 -33.07 63.8 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.984 -0.747 . . . . 74.42 108.984 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.12 -25.5 58.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.231 -0.895 . . . . 43.1 109.841 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.45 154.34 4.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.447 -0.946 . . . . 73.21 108.447 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.75 79.08 0.72 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.235 -0.746 . . . . 40.54 111.235 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.3 p -100.56 144.73 29.19 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 123.251 0.621 . . . . 73.12 110.923 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.5 tp -104.76 124.81 50.05 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.592 -0.892 . . . . 74.11 108.592 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.8 165.3 20.37 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.575 -0.898 . . . . 75.11 108.575 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -83.77 -66.27 0.91 Allowed 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.356 -1.35 . . . . 75.15 107.356 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.3 p 51.49 21.53 1.27 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.27 1.428 . . . . 63.43 114.678 175.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.34 -123.74 2.48 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.565 -1.014 . . . . 70.24 110.565 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.305 -1.326 0 N-CA-C 108.76 -0.83 . . . . 51.45 108.76 176.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 C--O 1.236 0.391 0 N-CA-C 108.555 -0.905 . . . . 62.14 108.555 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.2 p -115.7 -31.02 5.96 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.317 0.858 . . . . 71.23 113.317 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 m -83.39 115.16 21.91 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.354 0.501 . . . . 74.44 112.354 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.5 m 64.04 12.01 6.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.782 0.833 . . . . 70.11 113.098 177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.62 154.45 94.78 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 116.642 -0.253 . . . . 70.12 111.093 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.56 1.75 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.429 2.753 . . . . 45.42 114.35 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -77.94 88.13 4.12 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 108.087 -1.079 . . . . 70.04 108.087 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 p -88.13 145.27 26.02 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.804 0.811 . . . . 71.25 112.296 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -130.3 157.67 41.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.692 -1.14 . . . . 75.52 109.891 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.452 ' HB2' HG13 ' A' ' 104' ' ' VAL . 32.7 m-80 -121.87 127.82 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.765 -0.828 . . . . 75.14 108.765 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.42 120.95 64.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 110.126 -0.324 . . . . 72.13 110.126 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.61 118.83 24.09 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 122.59 0.356 . . . . 72.21 110.275 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.35 160.61 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.314 -0.625 . . . . 73.4 109.314 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -131.15 17.21 5.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.846 0.831 . . . . 74.54 109.998 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.38 159.38 30.07 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 119.897 -1.144 . . . . 73.3 112.603 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m 67.11 -74.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.218 1.407 . . . . 73.51 113.946 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 67' ' ' ILE . 26.1 mt -70.25 -5.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.641 0.777 . . . . 73.31 111.757 -171.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -65.87 -30.12 70.68 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.163 -0.681 . . . . 75.13 109.163 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.07 132.21 25.05 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 115.155 -0.93 . . . . 75.42 110.446 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.54 -44.53 4.44 Favored 'Trans proline' 0 C--N 1.359 1.103 1 C-N-CA 125.362 4.041 . . . . 71.45 115.375 -175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.68 -42.52 79.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.888 0.699 . . . . 37.88 112.888 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -76.18 -35.85 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.279 0.561 . . . . 75.34 110.292 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.74 -32.85 74.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.451 0.643 . . . . 73.44 109.728 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -73.63 -20.82 60.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.607 -0.724 . . . . 65.14 111.837 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.6 m -87.71 -23.89 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.381 -0.928 . . . . 74.35 111.195 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' ND2' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -87.01 -46.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 116.508 -0.314 . . . . 62.13 110.904 178.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 31' ' ' ALA . 82.1 mt -93.86 -14.6 25.91 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.793 -0.363 . . . . 74.23 111.958 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.0 t70 73.56 6.86 5.07 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.494 1.14 . . . . 72.41 109.191 -175.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.2 mtp180 -144.22 163.81 32.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.22 1.408 . . . . 74.22 107.727 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.6 p -76.69 122.64 24.98 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.21 -0.293 . . . . 74.33 110.21 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.421 ' HB3' HD12 ' A' ' 27' ' ' LEU . . . -87.44 156.91 19.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 120.642 0.258 . . . . 54.34 111.052 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -99.93 109.86 22.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.176 -0.609 . . . . 74.1 110.843 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -99.92 142.09 31.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.171 -1.048 . . . . 71.31 108.171 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.76 147.54 57.36 Favored Pre-proline 0 C--N 1.289 -2.047 0 N-CA-C 108.751 -0.833 . . . . 74.21 108.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -59.51 135.73 66.65 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.573 2.182 . . . . 64.42 112.219 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.81 156.46 41.31 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.137 -0.69 . . . . 60.1 109.137 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.405 HG22 ' HE2' ' A' ' 61' ' ' LYS . 12.2 p -123.75 126.53 72.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 118.704 -1.198 . . . . 74.41 111.676 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.412 ' HA ' HG11 ' A' ' 93' ' ' VAL . 25.1 tp -92.17 90.88 7.51 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.729 0.776 . . . . 74.23 110.864 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.9 p80 -73.08 124.91 26.48 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 114.556 -1.202 . . . . 72.13 109.395 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.45 -16.8 8.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.369 -0.919 . . . . 63.04 112.699 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.408 ' O ' HG21 ' A' ' 62' ' ' VAL . 38.4 m-85 -122.27 155.04 36.74 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 110.108 -0.33 . . . . 72.43 110.108 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.443 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 5.4 t60 -129.27 135.95 49.44 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 37.2 ttp180 -88.16 127.18 35.43 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.128 -1.434 . . . . 74.32 107.128 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -100.65 123.05 44.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 106.188 -1.782 . . . . 74.31 106.188 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HD2' ' C ' ' A' ' 45' ' ' LYS . 2.5 tmmm? -76.3 94.03 3.52 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-O 122.014 0.911 . . . . 74.43 109.591 -173.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 10.5 mp -81.07 98.76 8.14 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.057 -1.429 . . . . 75.2 112.709 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.76 84.36 7.37 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 123.139 1.447 . . . . 72.14 109.276 172.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.91 -53.84 0.13 Allowed Glycine 0 N--CA 1.405 -3.427 0 CA-C-N 113.679 -1.601 . . . . 74.23 110.016 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -93.45 166.99 14.87 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.563 -0.532 . . . . 74.23 109.563 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.91 135.08 1.54 Allowed 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 122.599 2.199 . . . . 64.54 112.73 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.636 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 38.9 p90 44.97 47.26 3.59 Favored Pre-proline 0 N--CA 1.513 2.676 0 N-CA-C 115.383 1.623 . . . . 75.15 115.383 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 51' ' ' TYR 0.265 37.7 Cg_endo -114.93 157.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.231 3.287 . . . . 74.33 114.68 -175.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 91.9 m -153.76 166.55 32.5 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 131.684 3.994 . . . . 65.14 104.3 -13.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.1 pt -123.19 145.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 119.978 1.263 . . . . 63.13 112.102 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -144.82 150.07 16.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 106.763 -1.569 . . . . 64.32 106.763 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 p -94.44 94.34 8.18 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 121.452 0.644 . . . . 64.34 110.283 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -134.82 -57.43 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.823 -1.547 . . . . 64.44 106.823 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -82.23 139.1 34.44 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.839 -1.073 . . . . 64.54 108.622 174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -78.77 15.09 1.13 Allowed 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.57 0.952 . . . . 62.2 113.57 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.24 -172.06 5.44 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 121.514 0.508 . . . . 64.33 113.461 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.415 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 19.8 ptmt -139.42 140.06 37.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.472 -0.566 . . . . 74.13 109.472 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 41' ' ' TYR . 93.6 t -108.82 124.07 65.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 123.189 0.596 . . . . 74.21 109.575 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -90.27 144.62 25.68 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.475 -1.306 . . . . 74.44 107.475 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.63 -150.38 6.62 Favored Glycine 0 C--N 1.279 -2.619 0 N-CA-C 110.012 -1.235 . . . . 74.24 110.012 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -135.36 145.35 47.29 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.633 -0.827 . . . . 73.35 109.939 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.4 m -103.69 134.56 44.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.517 -0.765 . . . . 65.22 109.435 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 17' ' ' ILE . 11.0 mt -86.5 110.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 104.486 -2.413 . . . . 73.33 104.486 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.444 HG23 ' OD1' ' A' ' 10' ' ' ASN . 75.0 p -98.05 162.07 13.41 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.915 -0.584 . . . . 73.14 111.149 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 34.4 70.47 Favored Glycine 0 N--CA 1.436 -1.304 0 O-C-N 123.604 0.565 . . . . 54.55 112.866 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.43 121.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 120.55 -0.46 . . . . 54.22 109.936 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.681 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 42.7 m -81.64 158.61 24.25 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.642 -0.873 . . . . 70.42 108.642 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.6 -40.13 62.37 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.798 1.036 . . . . 73.31 113.798 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.64 -32.88 64.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.632 0.73 . . . . 73.11 110.656 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.681 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 3.8 mp0 -73.43 -31.41 63.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.031 -0.986 . . . . 73.24 110.251 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.91 -36.48 83.5 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.607 -1.257 . . . . 73.31 107.607 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.67 -28.11 53.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.416 -1.266 . . . . 74.34 111.913 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.448 ' ND2' HG12 ' A' ' 26' ' ' ILE . 64.2 t30 -75.29 -30.5 60.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.558 -0.857 . . . . 64.14 109.855 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -65.72 -34.28 77.82 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.446 0.641 . . . . 72.23 109.822 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.77 -38.43 90.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.838 -1.073 . . . . 64.35 110.526 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.5 -43.6 48.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.532 -0.758 . . . . 75.44 111.307 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -68.0 -64.06 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.829 1.048 . . . . 65.12 113.829 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.16 69.47 1.02 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.633 0.73 . . . . 73.4 110.931 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.36 15.44 2.29 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.055 -0.975 . . . . 64.2 111.776 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -82.59 -42.53 18.15 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.87 0.322 . . . . 73.04 111.87 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.01 14.0 6.27 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.602 -1.259 . . . . 44.42 107.602 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -128.28 157.02 42.09 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.172 -1.418 . . . . 74.41 107.172 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' HG23 ' A' ' 110' ' ' VAL . 11.7 pt-20 -129.35 146.68 51.18 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.229 -0.656 . . . . 54.43 109.229 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -83.75 117.09 23.02 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.502 -0.555 . . . . 71.23 109.502 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.07 159.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-O 120.84 0.352 . . . . 55.32 110.982 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.6 m -91.09 129.91 37.04 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 108.314 -0.995 . . . . 63.24 108.314 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.57 168.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.543 -1.28 . . . . 63.03 107.543 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.504 ' HB2' ' HZ3' ' A' ' 103' ' ' LYS . 21.1 tt0 -121.3 128.62 52.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.687 -1.205 . . . . 74.11 109.783 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 38' ' ' LEU . 17.0 m -127.19 168.37 20.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.831 -0.622 . . . . 62.33 109.66 -176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.442 HG23 ' HG3' ' A' ' 101' ' ' LYS . 75.0 t -103.44 112.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.214 -1.032 . . . . 44.35 108.214 172.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -80.51 99.66 8.16 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.738 -1.208 . . . . 73.54 107.738 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.496 ' SD ' ' HG3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.06 -18.08 59.52 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.959 1.304 . . . . 54.51 110.085 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -46.78 -37.33 8.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.602 0.761 . . . . 72.41 111.101 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -137.39 10.13 2.96 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 108.277 -1.009 . . . . 74.13 108.277 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t 60.01 26.41 15.71 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.966 0.889 . . . . 65.41 110.079 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -93.16 160.7 14.73 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.397 -0.82 . . . . 73.21 109.425 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.578 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 7.1 mptt -104.31 128.79 52.16 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 106.935 -1.506 . . . . 74.03 106.935 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.74 142.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.389 0.614 . . . . 73.53 111.803 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.504 ' HZ3' ' HB2' ' A' ' 92' ' ' GLU . 14.6 tppt? -89.38 125.81 35.29 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.287 -1.746 . . . . 73.33 106.287 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.452 HG13 ' HB2' ' A' ' 10' ' ' ASN . 18.5 m -133.2 174.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 120.587 0.232 . . . . 65.53 110.985 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -100.63 153.29 19.53 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.101 -1.074 . . . . 72.35 108.101 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -155.62 174.72 14.88 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.029 -0.73 . . . . 71.03 109.029 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -106.95 119.19 38.7 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.974 -1.121 . . . . 72.34 107.974 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.36 163.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 109.531 -0.544 . . . . 73.52 109.531 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -70.1 121.92 18.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.792 -0.818 . . . . 72.53 108.792 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.0 p -68.1 -20.58 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.231 0.538 . . . . 70.42 111.438 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 114' ' ' ASP . 8.2 t30 -89.13 12.13 16.63 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.648 -0.705 . . . . 71.4 110.422 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -51.81 -19.73 1.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.997 1.851 . . . . 74.44 115.997 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.33 -20.89 36.45 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.881 0.848 . . . . 65.31 109.854 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.5 ' HB3' ' ND2' ' A' ' 111' ' ' ASN . 14.5 t70 -91.66 139.09 24.87 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 107.844 -1.169 . . . . 74.04 107.844 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -71.85 78.56 1.73 Allowed 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 121.972 1.781 . . . . 75.21 111.984 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -134.53 114.57 12.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 116.084 -0.507 . . . . 72.23 110.171 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 57.02 79.21 0.19 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.405 1.066 . . . . 64.21 112.86 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -142.31 4.6 1.6 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.807 -0.633 . . . . 74.05 110.648 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -105.08 -176.02 24.46 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.847 -0.692 . . . . 53.13 111.843 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -109.14 146.13 34.61 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.988 -0.745 . . . . 71.4 108.988 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -163.74 -5.08 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 O-C-N 123.409 0.443 . . . . 74.34 111.903 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 124' ' ' GLU . 34.6 t70 -127.83 114.65 17.5 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.407 1.262 . . . . 63.01 114.407 -170.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -68.22 -27.32 66.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.157 -0.929 . . . . 74.11 110.321 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.496 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 39.6 tt0 -70.31 -41.12 73.73 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 124.159 0.984 . . . . 73.24 109.761 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.42 ' O ' HG21 ' A' ' 129' ' ' VAL . 10.4 tp10 -56.12 -51.42 67.99 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.943 -1.026 . . . . 63.05 109.073 176.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -71.44 -30.58 66.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.042 -1.463 . . . . 75.2 110.711 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -57.46 -46.17 83.93 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.847 -0.615 . . . . 75.2 109.547 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.31 -38.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.494 -0.482 . . . . 75.13 110.987 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 125' ' ' GLU . 92.2 t -67.63 -32.39 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 111.928 0.344 . . . . 71.24 111.928 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -83.06 -37.99 23.13 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 117.82 -1.552 . . . . 72.0 111.079 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.68 76.87 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.632 0.253 . . . . 53.14 111.363 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 22.8 mm-40 -64.35 -37.86 88.99 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 116.156 -0.474 . . . . 62.15 110.639 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -56.03 -42.53 76.65 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 116.245 -0.434 . . . . 53.43 111.133 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -76.45 -44.1 37.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 112.756 0.65 . . . . 73.53 112.756 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 132' ' ' GLU . 14.4 p -59.89 -37.28 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.024 -0.67 . . . . 74.42 111.226 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.595 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 91.9 mt-10 -58.34 -43.68 88.41 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.993 -0.743 . . . . 73.24 108.993 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.9 m -60.84 -50.19 74.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.19 -0.914 . . . . 70.51 110.535 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -63.86 -34.68 78.48 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 111.879 0.326 . . . . 73.24 111.879 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 76.4 mtp180 -63.84 -52.6 59.35 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.67 0.271 . . . . 72.12 110.352 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.496 ' HG3' ' SD ' ' A' ' 96' ' ' MET . 31.3 mmmt -60.95 -44.56 97.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.915 0.709 . . . . 74.45 112.915 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.46 ' HA ' ' HE3' ' A' ' 141' ' ' MET . 1.9 mmt -63.08 -41.34 99.39 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.77 -0.372 . . . . 75.12 110.445 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.27 -46.31 84.25 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.286 -0.415 . . . . 71.14 110.72 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.39 -34.38 77.83 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.173 -0.611 . . . . 73.52 112.013 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -68.86 -29.49 67.8 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.437 0.532 . . . . 73.25 112.437 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.94 -47.03 13.22 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.02 0.438 . . . . 74.05 111.181 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -79.75 -31.89 41.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 73.23 111.73 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -117.79 117.15 35.96 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.939 0.399 . . . . 71.03 111.889 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 -28.72 63.1 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.599 2.199 . . . . 73.44 110.522 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -73.15 -5.21 37.69 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.008 -0.996 . . . . 75.44 112.261 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -70.45 -29.33 70.06 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.405 -1.078 . . . . 37.88 110.405 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.586 ' HE2' ' OE1' ' A' ' 155' ' ' GLU . 2.2 tpmt? -97.09 146.51 24.96 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.048 -1.834 . . . . 74.33 106.048 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.4 m -80.19 155.9 27.18 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.333 -1.347 . . . . 72.4 108.178 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 66.2 mtt -72.09 -44.37 63.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.421 0.526 . . . . 74.53 112.421 -175.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -71.17 -22.01 62.1 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.051 0.929 . . . . 71.04 109.628 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.586 ' OE1' ' HE2' ' A' ' 151' ' ' LYS . 43.5 tt0 -75.76 -40.37 55.44 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.685 -1.143 . . . . 73.04 111.181 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.98 -35.68 77.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.972 -0.558 . . . . 65.12 110.77 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -133.54 116.1 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 115.868 -0.605 . . . . 73.14 111.038 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.79 -34.36 31.23 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.764 -0.731 . . . . 62.4 112.664 -177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.4 p -146.78 128.74 15.46 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.571 0.7 . . . . 74.25 112.556 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.2 mt -128.93 160.39 32.83 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.293 -1.373 . . . . 71.15 107.293 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.405 ' O ' HD13 ' A' ' 161' ' ' LEU . 2.5 pp -142.24 140.28 32.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.782 0.66 . . . . 73.13 112.782 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 p -90.87 -35.74 14.6 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.531 0.681 . . . . 70.24 109.213 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 43.6 p 53.45 70.47 0.59 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.819 1.247 . . . . 74.22 114.291 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -113.89 -11.73 12.23 Favored Glycine 0 C--O 1.246 0.887 0 N-CA-C 109.635 -1.386 . . . . 51.52 109.635 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 N--CA 1.436 -1.155 0 C-N-CA 124.342 1.057 . . . . 62.55 108.317 178.859 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.283 -0.636 . . . . 75.42 109.283 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 83.8 m -136.87 109.98 7.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.514 -0.55 . . . . 73.24 109.514 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -111.09 140.14 45.89 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 116.57 -0.286 . . . . 73.21 110.654 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -87.1 88.74 7.77 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.395 -0.965 . . . . 72.43 108.395 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 5.7 m-20 -72.42 121.62 85.29 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.558 -0.747 . . . . 73.42 111.525 -178.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 5' ' ' ASP . 5.8 Cg_exo -77.9 12.56 1.94 Allowed 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 123.154 2.569 . . . . 72.53 113.16 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -76.71 108.2 9.56 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.65 -1.241 . . . . 75.12 107.65 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.2 p -56.66 123.51 15.15 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.326 0.584 . . . . 71.14 109.96 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.483 ' CG ' HD11 ' A' ' 75' ' ' LEU . 69.6 m80 -93.38 156.59 16.69 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.815 -0.629 . . . . 72.44 111.694 -173.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 91.4 m-20 -129.0 133.53 47.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.533 -1.284 . . . . 65.03 107.533 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.5 121.54 63.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.762 -0.375 . . . . 74.2 110.416 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -81.9 111.5 18.16 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.053 -1.091 . . . . 75.51 108.053 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.485 ' O ' HD21 ' A' ' 18' ' ' LEU . 95.8 t -120.19 142.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-O 121.488 0.661 . . . . 73.22 110.831 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -99.47 115.44 29.31 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.166 -1.05 . . . . 74.31 108.166 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.19 -68.09 2.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 116.096 1.199 . . . . 45.11 116.096 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.3 t -40.12 -81.26 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.669 2.1 . . . . 73.41 116.669 -167.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.457 ' HB ' HD13 ' A' ' 67' ' ' ILE . 3.1 mp -93.92 27.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 122.074 0.94 . . . . 63.51 109.552 -173.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.505 ' HB3' ' HE3' ' A' ' 65' ' ' LYS . 18.9 mt -74.52 -15.89 60.85 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.406 -0.809 . . . . 73.44 111.654 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.26 134.1 19.87 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 114.872 -1.058 . . . . 71.13 109.975 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.69 -31.6 41.75 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.753 2.968 . . . . 74.2 114.011 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.29 80.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.982 0.42 . . . . 72.13 111.332 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.582 ' O ' HG22 ' A' ' 25' ' ' VAL . 47.8 t -77.36 -34.32 20.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.151 -0.685 . . . . 70.43 109.151 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.31 75.66 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.87 -0.789 . . . . 71.02 108.87 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -71.08 -12.11 61.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.519 -0.764 . . . . 52.41 111.602 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 22' ' ' VAL . 10.6 m -97.94 -35.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 119.665 -0.814 . . . . 74.13 110.513 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.482 HG12 ' ND2' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -80.47 -48.44 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 120.782 0.325 . . . . 73.13 110.909 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 81.0 mt -90.12 -18.01 26.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.365 -0.606 . . . . 72.35 109.365 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.596 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 33.3 t70 70.64 8.76 6.69 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.896 1.332 . . . . 70.2 109.283 -175.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -142.0 143.7 33.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 113.757 -1.565 . . . . 73.53 107.721 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -76.45 117.05 17.72 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.545 0.212 . . . . 74.24 111.512 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . . . -105.72 158.8 16.47 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 116.074 -0.512 . . . . 74.11 110.018 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.94 131.81 46.64 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.694 -0.685 . . . . 72.21 111.965 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.3 p -103.46 143.81 32.22 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.312 -0.858 . . . . 71.42 110.272 174.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.4 144.94 51.07 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.394 -0.595 . . . . 71.34 109.394 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -68.24 133.77 29.5 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.035 1.823 . . . . 65.3 112.875 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.08 156.61 41.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.156 -0.929 . . . . 65.32 109.397 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.14 129.99 74.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.459 0.647 . . . . 73.13 110.86 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.402 ' HA ' HG11 ' A' ' 93' ' ' VAL . 20.9 tp -88.29 117.3 27.1 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.416 -0.811 . . . . 74.34 109.75 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -94.08 128.84 40.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.059 -0.519 . . . . 70.11 110.507 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.67 -4.54 27.72 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.029 -1.081 . . . . 51.02 112.561 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.482 ' O ' HG21 ' A' ' 62' ' ' VAL . 63.8 m-85 -124.82 147.42 48.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.242 0.46 . . . . 74.31 112.242 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -117.83 130.06 56.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.56 -1.274 . . . . 75.04 107.56 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -87.85 140.42 29.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.794 0.438 . . . . 72.22 110.804 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.617 ' CE1' ' HA ' ' A' ' 118' ' ' TYR . 87.5 m-85 -112.22 150.64 30.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.774 -0.37 . . . . 70.22 111.235 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.46 100.66 13.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.66 0.743 . . . . 72.52 111.91 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -140.67 72.97 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 122.025 0.917 . . . . 53.32 109.915 172.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -83.14 8.78 12.11 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 113.968 1.099 . . . . 72.03 113.968 -175.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.41 -19.19 74.57 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.971 -2.052 . . . . 64.44 107.971 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.43 ' HG ' ' OH ' ' A' ' 86' ' ' TYR . 3.4 mm? -98.11 168.53 9.81 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 105.498 -2.038 . . . . 71.32 105.498 172.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -42.47 -65.79 0.18 Allowed 'Trans proline' 0 C--N 1.365 1.431 0 C-N-CA 122.271 1.981 . . . . 61.44 113.891 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.486 ' H ' ' HD2' ' A' ' 52' ' ' PRO . 33.7 m-85 -164.62 -36.44 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 125.366 1.466 . . . . 74.42 113.959 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 51' ' ' TYR . 63.3 Cg_exo -48.96 166.69 0.15 Allowed 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.33 2.02 . . . . 65.14 112.504 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.6 p -135.69 -171.7 2.91 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.445 1.098 . . . . 72.43 112.61 10.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 17.6 pt -131.02 150.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 114.076 -1.42 . . . . 63.22 110.109 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 151.71 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.448 -1.686 . . . . 71.22 106.448 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.0 t -71.34 145.5 49.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.384 0.611 . . . . 73.54 112.073 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -155.05 163.52 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.462 -1.31 . . . . 74.42 107.462 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.04 -56.6 4.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.274 0.559 . . . . 75.41 110.887 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 m -91.96 12.18 22.63 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.823 -0.626 . . . . 71.33 111.954 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.52 131.49 10.81 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 120.468 -0.872 . . . . 54.55 111.666 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -136.87 140.15 42.16 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.394 -0.965 . . . . 63.23 108.394 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 41' ' ' TYR . 57.3 t -114.36 122.84 69.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.837 -0.431 . . . . 72.42 109.837 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.7 126.51 37.82 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.528 -0.545 . . . . 62.12 109.528 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.93 -148.56 5.18 Favored Glycine 0 N--CA 1.42 -2.404 0 C-N-CA 120.23 -0.986 . . . . 72.33 111.747 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.505 ' HE3' ' HB3' ' A' ' 18' ' ' LEU . 44.3 mtmt -139.23 145.77 39.65 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.923 0.489 . . . . 74.32 110.53 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.44 134.3 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.415 -0.811 . . . . 64.33 109.827 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.457 HD13 ' HB ' ' A' ' 17' ' ' ILE . 15.3 mt -86.94 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 105.193 -2.151 . . . . 73.5 105.193 178.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 161.61 13.48 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.718 -0.393 . . . . 75.14 112.03 -173.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.55 37.2 77.79 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.799 -0.637 . . . . 37.8 112.901 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.43 121.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.653 -0.419 . . . . 74.5 109.97 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.7 m -73.99 158.8 33.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.052 -0.722 . . . . 65.21 109.052 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -52.92 -44.08 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.186 0.439 . . . . 73.5 112.186 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.47 78.49 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.539 0.685 . . . . 62.34 110.143 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.9 mm-40 -76.26 -38.69 55.88 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.775 -1.102 . . . . 71.33 110.217 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.488 ' O ' HD22 ' A' ' 75' ' ' LEU . 3.6 tt -61.57 -37.51 84.13 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.695 -1.224 . . . . 71.1 107.695 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.639 ' O ' HG22 ' A' ' 80' ' ' VAL . 28.5 t-20 -54.71 -28.8 50.54 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 114.272 -1.331 . . . . 74.03 112.239 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.482 ' ND2' HG12 ' A' ' 26' ' ' ILE . 6.3 t30 -73.74 -30.88 63.07 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 118.957 -1.097 . . . . 70.51 109.633 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.583 ' O ' HG23 ' A' ' 81' ' ' ILE . 68.0 m-85 -73.23 -31.12 63.94 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 107.912 -1.144 . . . . 72.43 107.912 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.34 -37.56 63.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.424 -0.807 . . . . 65.42 110.274 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 76' ' ' ASN . 58.3 t -76.41 -27.38 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 N-CA-C 113.475 0.917 . . . . 63.2 113.475 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 78' ' ' PHE . 13.7 tt -59.25 165.15 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 O-C-N 122.053 -0.404 . . . . 72.42 110.339 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -53.97 95.51 0.01 OUTLIER 'General case' 0 C--O 1.242 0.691 0 N-CA-C 114.296 1.221 . . . . 75.4 114.296 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.66 60.21 0.64 Allowed Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 107.848 -2.101 . . . . 63.22 107.848 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -57.95 -41.28 82.49 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.739 0.816 . . . . 65.04 112.43 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.516 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 8.2 t70 -128.44 24.25 5.86 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.932 -1.507 . . . . 74.11 106.932 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 52' ' ' PRO . 73.8 m-85 -119.2 150.71 39.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.453 -1.249 . . . . 72.3 108.695 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.85 144.44 51.31 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.781 -0.451 . . . . 71.54 109.781 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -93.17 114.93 27.56 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.906 -0.775 . . . . 75.04 108.906 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -128.69 161.05 38.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.663 0.785 . . . . 65.25 111.755 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.2 m -90.82 130.72 36.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.136 -1.061 . . . . 71.31 108.136 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.69 159.82 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.407 0.683 . . . . 72.41 109.158 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.68 123.87 46.38 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.3 -0.56 . . . . 63.11 110.545 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 38' ' ' LEU . 23.6 m -125.61 160.72 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 109.469 -0.567 . . . . 70.12 109.469 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 68.8 t -104.36 113.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.03 -0.986 . . . . 71.24 109.12 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -73.38 103.57 4.09 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 108.663 -0.866 . . . . 64.02 108.663 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -29.86 48.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.809 1.644 . . . . 71.12 110.437 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.29 -40.07 64.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.509 0.724 . . . . 73.33 111.729 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -123.95 -3.08 8.16 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.321 0.581 . . . . 72.43 111.025 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.94 26.19 14.11 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.014 0.926 . . . . 61.44 110.013 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 12.9 pt-20 -95.5 160.6 14.44 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.652 -0.704 . . . . 64.42 109.399 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 101' ' ' LYS . 0.8 OUTLIER -108.64 130.19 55.33 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.938 -1.134 . . . . 75.43 107.938 -178.473 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.77 144.27 21.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 109.702 -0.481 . . . . 54.34 109.702 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -87.62 127.09 35.28 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.683 0.754 . . . . 72.4 112.652 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.1 m -128.33 175.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 113.668 -1.605 . . . . 74.32 109.037 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -99.4 153.36 19.05 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.064 -0.717 . . . . 74.43 109.064 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 t -159.12 175.25 13.7 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.436 -0.579 . . . . 64.54 109.436 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -107.56 119.34 39.14 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.963 -0.754 . . . . 71.52 108.963 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.413 HG13 HG13 ' A' ' 54' ' ' ILE . 31.9 m -114.17 178.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 120.71 -0.396 . . . . 73.25 110.154 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.532 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 44.9 t-105 -101.54 124.84 47.86 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 -173.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.6 m -72.66 -26.71 24.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-O 121.28 0.562 . . . . 71.54 111.3 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.532 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 28.4 t-20 -80.01 12.51 2.73 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.732 0.813 . . . . 54.41 110.078 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.8 ptpp? -51.81 -24.67 6.36 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.362 1.065 . . . . 74.43 112.764 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -90.39 -3.15 57.9 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.143 0.497 . . . . 73.33 112.017 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.41 153.45 39.07 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.485 -0.325 . . . . 64.35 110.275 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.78 110.67 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.632 2.221 . . . . 73.41 111.248 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -133.55 166.77 21.79 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.922 -1.51 . . . . 73.24 106.922 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.24 122.57 5.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.342 -0.984 . . . . 60.22 108.342 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.617 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 54.6 p90 -130.78 5.62 4.64 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 120.904 0.383 . . . . 73.22 111.414 -176.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.21 -155.3 10.8 Favored Glycine 0 C--N 1.299 -1.486 0 N-CA-C 115.537 0.975 . . . . 63.22 115.537 -173.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.16 176.32 6.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.376 -0.912 . . . . 74.44 111.478 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -96.61 -57.49 2.29 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.32 1.057 . . . . 72.31 109.26 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 125' ' ' GLU . 33.6 m-20 -124.48 118.73 27.29 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 113.428 -1.715 . . . . 62.04 108.508 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -65.44 -27.47 68.54 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 112.096 0.406 . . . . 62.44 112.096 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -68.51 -49.65 58.06 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.441 -0.577 . . . . 71.23 109.441 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 122' ' ' ASP . 41.4 tt0 -62.83 -44.83 95.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.202 -0.908 . . . . 71.22 110.22 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -66.53 -37.44 85.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.053 -0.521 . . . . 75.2 109.712 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -56.45 -48.37 77.19 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 123.045 0.538 . . . . 75.25 110.311 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.5 m -69.37 -30.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.471 -0.491 . . . . 65.23 112.285 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -75.28 -44.47 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.421 -0.585 . . . . 74.11 109.421 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.47 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 26.3 t-80 -61.37 -40.79 95.6 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.07 -1.085 . . . . 74.31 108.07 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.89 97.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.703 -0.681 . . . . 42.43 111.652 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -67.81 -26.7 66.21 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 112.095 0.406 . . . . 73.22 112.095 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.541 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 8.8 tmtt? -70.71 -55.99 7.41 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.582 -0.896 . . . . 73.52 108.582 176.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 94.1 m-85 -66.29 -32.04 73.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.006 1.113 . . . . 74.32 114.006 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.9 p -62.37 -38.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.017 -0.673 . . . . 71.32 110.648 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -72.16 -32.41 66.83 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 119.593 -0.843 . . . . 71.3 111.277 179.221 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 80.1 m -61.92 -46.24 90.19 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.841 -0.618 . . . . 73.44 110.287 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -61.41 -34.7 75.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 121.073 -0.251 . . . . 72.43 111.123 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 99.3 mtt180 -70.13 -49.23 52.81 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.106 -0.497 . . . . 74.04 110.681 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 33.4 mmtp -58.51 -43.13 88.98 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.719 -0.474 . . . . 75.03 109.719 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.9 mtm -67.59 -31.17 71.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.693 -0.685 . . . . 63.35 111.295 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.56 -40.47 73.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.68 -0.489 . . . . 75.43 109.68 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 9.5 mm-40 -63.0 -34.16 76.96 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.982 0.896 . . . . 64.51 109.363 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.414 ' HD1' ' HG2' ' A' ' 151' ' ' LYS . 3.3 t-105 -71.87 -44.36 63.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.509 -1.223 . . . . 75.22 108.956 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.49 -37.78 83.35 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 51.22 111.242 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -78.74 -11.71 59.99 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.06 0.763 . . . . 64.43 113.06 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -115.91 131.7 23.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 C-N-CA 120.101 -0.64 . . . . 73.11 112.168 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 151' ' ' LYS . 30.4 Cg_endo -63.61 -14.99 45.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.391 2.728 . . . . 73.23 111.324 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -75.39 -20.63 58.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.265 -0.88 . . . . 64.43 110.121 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -98.76 -63.46 0.85 Allowed Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 108.942 -1.663 . . . . 73.35 108.942 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 73.1 mmtt -97.61 124.0 41.72 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.502 -0.555 . . . . 71.32 109.502 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.4 m -66.75 157.11 33.63 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 109.755 -0.461 . . . . 73.54 109.755 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.494 ' O ' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -60.47 -42.27 95.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.884 0.698 . . . . 72.43 112.884 -174.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.39 -19.69 59.4 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 120.402 -0.519 . . . . 54.43 111.127 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -74.77 -47.6 30.13 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.437 0.637 . . . . 64.2 109.601 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.83 79.49 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.799 -1.091 . . . . 72.52 112.568 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 153' ' ' MET . 14.7 p -115.35 -20.24 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 119.382 -0.927 . . . . 51.25 112.65 -174.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 94.56 141.77 11.82 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.8 -1.32 . . . . 72.12 109.8 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.1 m -62.56 112.42 2.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.518 0.675 . . . . 74.51 111.43 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.16 165.18 27.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.006 -0.997 . . . . 75.43 108.891 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.6 mt -99.36 143.78 29.22 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.582 -1.636 . . . . 72.45 106.582 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -64.45 -56.16 16.07 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.5 m 56.77 -165.62 0.14 Allowed 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.829 0.705 . . . . 75.31 111.528 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.17 -37.67 3.69 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 110.321 -1.112 . . . . 52.24 110.321 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 108.106 -1.072 . . . . 74.25 108.106 176.867 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.196 0.522 . . . . 73.15 109.915 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -107.81 150.53 26.89 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.673 -0.694 . . . . 71.54 111.925 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -124.52 124.65 42.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.075 -1.454 . . . . 74.14 107.075 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 7.6 p -130.61 123.5 55.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 120.539 -0.464 . . . . 53.4 111.991 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -77.81 120.09 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.974 -0.75 . . . . 72.33 108.974 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.97 148.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.136 0.493 . . . . 64.44 110.217 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.33 106.58 9.61 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.85 -0.796 . . . . 71.43 108.85 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 -69.04 1.44 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 114.285 0.474 . . . . 74.34 114.285 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -44.75 -72.31 0.06 Allowed 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.198 1.555 . . . . 64.3 115.198 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.526 ' HB ' HD11 ' A' ' 67' ' ' ILE . 4.2 mp -105.67 66.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 109.167 -0.679 . . . . 61.34 109.167 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.8 mt -114.6 16.35 17.58 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.472 -1.307 . . . . 61.12 107.472 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.36 146.75 43.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.423 -1.262 . . . . 73.4 110.956 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.38 -42.83 51.74 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.806 3.004 . . . . 70.24 114.165 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.48 -47.65 78.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 120.627 0.251 . . . . 73.22 111.233 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 26' ' ' ILE . 93.9 t -65.09 -45.16 95.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 CA-C-N 115.861 -0.608 . . . . 73.14 111.64 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB1' ' H ' ' A' ' 31' ' ' ALA . . . -60.38 -37.3 80.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.118 0.485 . . . . 35.13 110.629 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.92 -33.49 68.31 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.768 -0.651 . . . . 63.31 111.522 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 22' ' ' VAL . 17.9 m -82.47 -28.58 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.969 -0.692 . . . . 73.42 111.254 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.5 tt -72.3 -47.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 119.736 -0.786 . . . . 72.41 111.829 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 74' ' ' GLU . 77.7 mt -95.62 -55.56 2.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.834 -1.146 . . . . 60.04 112.072 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.1 t70 150.39 -33.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.534 -1.654 . . . . 73.41 106.534 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -134.78 159.86 40.0 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.786 -1.552 . . . . 73.12 108.028 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.0 m -76.01 119.04 19.41 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.205 0.526 . . . . 71.33 110.144 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' H ' ' HB1' ' A' ' 23' ' ' ALA . . . -87.2 152.98 21.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.723 -0.843 . . . . 72.4 108.723 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -95.75 120.74 36.54 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.302 0.572 . . . . 54.34 112.322 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.3 p -93.46 145.24 24.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 115.144 -0.934 . . . . 63.34 109.114 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.2 t -124.08 134.71 25.63 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 106.82 -1.548 . . . . 73.3 106.82 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 33.1 Cg_endo -65.4 126.5 16.35 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.137 1.892 . . . . 74.44 111.73 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.54 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.97 155.26 39.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.516 -0.765 . . . . 63.2 110.558 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.425 HG21 ' HD3' ' A' ' 61' ' ' LYS . 7.1 p -121.75 129.08 75.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.55 0.691 . . . . 70.35 111.385 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.456 ' HB2' HG12 ' A' ' 93' ' ' VAL . 27.2 tp -91.58 95.36 9.89 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.332 -0.849 . . . . 64.43 111.804 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 17.6 p-80 -73.55 131.96 42.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.123 -0.695 . . . . 75.12 109.123 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.11 -10.56 20.39 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 119.213 -1.47 . . . . 65.32 113.064 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.01 158.71 34.62 Favored 'General case' 0 CA--C 1.473 -1.993 0 N-CA-C 110.242 -0.281 . . . . 65.04 110.242 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -126.19 131.5 51.98 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.767 -1.197 . . . . 73.12 107.767 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.428 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -91.36 137.23 32.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.568 0.699 . . . . 73.43 112.665 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.33 -1.359 . . . . 73.23 107.33 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -88.12 -45.21 10.33 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.862 0.319 . . . . 73.3 111.862 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.507 HD23 HD22 ' A' ' 49' ' ' LEU 0.261 7.5 mp 57.23 77.34 0.27 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 114.912 1.449 . . . . 70.14 114.912 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -78.58 105.25 9.74 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.79 -1.096 . . . . 51.54 110.626 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.88 -31.57 3.04 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 110.882 -0.887 . . . . 33.14 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD22 HD23 ' A' ' 46' ' ' LEU . 4.2 mp -96.86 156.16 36.8 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 108.025 -1.102 . . . . 71.24 108.025 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.27 87.87 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 123.133 2.555 . . . . 62.43 113.955 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.601 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.595 34.6 p90 33.42 54.83 1.34 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 119.556 3.169 . . . . 75.31 119.556 -176.337 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 5.7 Cg_endo -103.63 169.49 0.21 Allowed 'Trans proline' 0 CA--C 1.555 1.542 1 C-N-CA 125.637 4.225 . . . . 73.14 110.298 174.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p -155.97 -178.43 7.3 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.245 2.218 . . . . 64.23 107.122 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.464 HG13 HG12 ' A' ' 108' ' ' VAL . 44.4 pt -126.64 124.24 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.625 -1.25 . . . . 65.22 107.625 164.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 m -146.71 172.71 3.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.856 -1.164 . . . . 71.14 107.856 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.6 m 71.04 129.94 0.03 OUTLIER 'General case' 0 C--O 1.24 0.577 0 O-C-N 124.909 1.38 . . . . 73.34 111.495 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -80.31 75.05 7.14 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.04 -1.467 . . . . 74.41 107.04 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.61 161.9 20.98 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 113.066 -1.879 . . . . 73.41 109.708 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.9 m -82.79 -4.29 57.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.667 0.27 . . . . 71.25 111.332 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.68 -171.17 47.4 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 121.505 -0.379 . . . . 70.31 112.433 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HD3' HG21 ' A' ' 37' ' ' VAL . 9.4 ptpp? -144.69 154.78 43.13 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 120.82 0.343 . . . . 75.3 110.609 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG13 ' HG2' ' A' ' 43' ' ' ARG . 65.7 t -116.92 122.16 69.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.775 -0.648 . . . . 71.12 109.3 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -96.04 123.41 39.63 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.374 -0.531 . . . . 75.04 109.672 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.91 -143.8 3.76 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.894 -1.282 . . . . 71.12 109.894 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 48.6 mtpt -140.76 150.68 43.69 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.762 0.781 . . . . 53.14 109.632 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.5 m -104.45 133.99 47.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 115.629 -0.714 . . . . 62.24 109.773 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.526 HD11 ' HB ' ' A' ' 17' ' ' ILE . 45.4 mt -87.23 111.54 21.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.8 -1.926 . . . . 72.2 105.8 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -103.91 162.03 13.47 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.296 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.67 72.03 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 116.147 -0.479 . . . . 73.42 111.966 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -94.97 122.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 109.939 -0.393 . . . . 72.01 109.939 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.0 t -73.74 163.22 28.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.325 -0.991 . . . . 74.15 108.325 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.9 -26.0 68.58 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.973 0.416 . . . . 64.13 110.575 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 -43.91 32.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.42 -0.585 . . . . 75.11 109.42 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.631 ' HB3' HD22 ' A' ' 27' ' ' LEU . 53.9 mt-10 -63.73 -43.2 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 71.45 110.599 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.15 -36.62 77.97 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.723 0.809 . . . . 73.31 110.077 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' HG23 ' A' ' 80' ' ' VAL . 58.4 t30 -60.92 -28.71 69.13 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.348 -0.842 . . . . 52.15 111.18 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -70.74 -30.17 66.61 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 119.791 -0.763 . . . . 64.24 109.484 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.554 ' CE2' HD21 ' A' ' 27' ' ' LEU . 92.6 m-85 -70.53 -32.59 70.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 64.01 109.484 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.13 -39.99 62.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.186 -0.915 . . . . 63.34 109.67 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 76' ' ' ASN . 65.5 t -74.62 -44.15 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.118 -0.946 . . . . 72.35 112.031 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.35 120.76 51.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.412 -0.358 . . . . 70.14 111.527 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 75.87 -26.78 0.19 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.934 1.294 . . . . 74.42 113.7 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 51.16 3.89 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.289 -0.724 . . . . 60.31 111.289 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.65 -43.11 49.29 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.073 0.549 . . . . 62.23 112.285 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.628 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 4.2 t70 -118.03 25.87 10.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.88 1.324 . . . . 72.51 107.552 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 89.5 m-85 -114.75 151.36 33.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.072 -1.422 . . . . 74.33 109.68 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.74 149.23 49.72 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.522 -0.547 . . . . 75.02 109.522 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -85.8 125.4 33.23 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.922 0.712 . . . . 63.35 112.922 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.25 155.79 41.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.965 -1.016 . . . . 70.32 109.218 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.5 m -96.98 124.14 40.87 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.384 -0.599 . . . . 71.3 109.384 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.3 m -128.96 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 107.904 -1.147 . . . . 60.33 107.904 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -112.52 131.63 55.5 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.747 -1.181 . . . . 74.55 108.26 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 38' ' ' LEU . 24.1 m -125.67 163.68 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 73.41 109.458 -174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 101' ' ' LYS . 70.4 t -102.48 117.27 47.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.839 -0.619 . . . . 54.24 109.338 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -66.72 94.58 0.31 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.863 -1.162 . . . . 74.41 107.863 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.54 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -54.34 -35.57 62.86 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 125.496 1.518 . . . . 74.31 109.567 -177.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -52.6 -30.89 33.54 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.763 -1.108 . . . . 63.45 112.592 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -136.08 4.61 2.99 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.617 0.722 . . . . 53.22 110.968 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m 59.88 25.58 14.72 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.119 0.968 . . . . 74.44 112.742 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.83 160.61 14.33 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.656 -0.868 . . . . 72.41 108.656 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 94' ' ' VAL . 39.8 mtmt -102.35 129.69 48.88 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.49 -0.559 . . . . 74.44 109.49 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.74 144.38 37.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.092 0.472 . . . . 53.31 110.431 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -93.94 126.35 39.09 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.524 -0.917 . . . . 75.23 108.524 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.081 0.467 . . . . 64.01 111.28 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 46.7 mt-10 -100.53 153.36 19.44 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.636 -1.246 . . . . 73.51 107.636 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -151.01 173.63 14.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 86' ' ' TYR . 92.5 m-85 -113.55 118.68 35.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 121.122 0.487 . . . . 72.24 110.29 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG12 HG13 ' A' ' 54' ' ' ILE . 27.4 m -109.79 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.472 -0.936 . . . . 74.02 108.472 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.628 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 46.4 t-105 -93.33 129.17 39.53 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.223 -1.028 . . . . 64.33 108.223 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 85' ' ' ASP . 34.8 m -71.47 -20.07 20.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 N-CA-C 112.51 0.559 . . . . 71.41 112.51 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.556 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 25.4 t-20 -80.48 11.8 3.46 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.744 0.783 . . . . 75.13 109.942 176.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 19.6 ptpt -51.29 -15.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.747 2.019 . . . . 70.15 114.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.46 -52.07 18.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.957 0.903 . . . . 65.11 111.218 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -108.05 127.54 27.42 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 109.432 -0.581 . . . . 75.25 109.432 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.87 103.61 0.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 62.02 111.056 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -100.9 133.09 45.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.503 -0.771 . . . . 73.44 109.653 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.466 0.357 0 O-C-N 123.987 0.805 . . . . 72.13 110.078 -178.21 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 129' ' ' VAL . 36.9 tt0 . . . . . 0 N--CA 1.427 -1.594 0 N-CA-C 108.4 -0.963 . . . . 75.2 108.4 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -61.99 -44.17 97.3 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.424 -0.51 . . . . 70.45 109.871 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -56.27 -48.93 75.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.662 -0.699 . . . . 74.35 111.177 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.57 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 32.0 m -70.43 -40.59 77.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.154 -0.618 . . . . 40.22 112.37 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 125' ' ' GLU . 95.2 t -68.16 -44.81 84.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.548 -0.461 . . . . 63.4 111.767 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.514 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.6 p80 -67.39 -33.77 75.9 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 118.401 -1.319 . . . . 61.51 109.737 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -64.54 -47.27 79.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.977 -0.556 . . . . 73.15 110.863 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 48.1 mt-10 -60.28 -41.52 93.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.954 0.406 . . . . 73.41 110.389 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.25 -48.05 81.67 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.179 -0.919 . . . . 72.31 111.897 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.514 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 56.4 m-85 -67.94 -45.43 74.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.581 -0.448 . . . . 74.23 111.572 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 131' ' ' ALA . 94.5 t -57.37 -48.26 83.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 116.391 -0.368 . . . . 70.43 111.68 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -58.55 -48.88 79.43 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 120.439 -0.504 . . . . 63.0 109.928 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -45.2 81.27 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.527 -0.76 . . . . 75.53 112.343 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.52 -43.05 73.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.872 -0.731 . . . . 63.12 112.067 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 98.9 mtt180 -61.49 -46.74 88.76 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.992 0.425 . . . . 62.22 111.207 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.95 -32.05 66.93 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.909 -0.587 . . . . 62.4 112.316 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -72.86 -32.07 65.18 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.41 -0.959 . . . . 75.24 108.41 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.56 -37.17 79.69 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.464 -0.789 . . . . 73.24 110.166 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 8.6 mm-40 -61.59 -46.44 89.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.1 0.476 . . . . 74.41 110.283 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -65.39 -43.73 89.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.871 -0.604 . . . . 74.14 110.8 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.6 -22.21 65.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.698 0.761 . . . . 74.23 111.09 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 146' ' ' LYS . 0.7 OUTLIER -78.45 -26.66 46.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.447 -0.797 . . . . 72.22 109.193 177.523 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 64.01 82.14 0.22 Allowed Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.349 0.66 . . . . 73.0 109.72 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.25 -37.26 2.68 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.216 1.944 . . . . 61.33 112.031 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -96.47 3.44 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.562 -0.744 . . . . 73.34 110.572 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 109.636 -1.386 . . . . 75.32 109.636 -173.368 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 p . . . . . 0 N--CA 1.439 -0.986 0 CA-C-O 121.747 0.784 . . . . 63.21 110.351 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.95 156.2 19.04 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 114.647 -1.16 . . . . 73.33 111.059 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.557 ' HB2' HG12 ' A' ' 104' ' ' VAL . 3.3 m-20 -125.31 131.92 52.96 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.96 -1.496 . . . . 50.24 106.96 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 13' ' ' VAL . 49.1 t -119.5 120.33 63.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 120.336 -0.546 . . . . 51.35 110.694 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' HB2' HG21 ' A' ' 104' ' ' VAL . 43.4 t80 -91.5 96.73 10.65 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 104.861 -2.274 . . . . 71.12 104.861 173.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 11' ' ' VAL . 10.3 p -119.1 121.93 67.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 118.329 -1.348 . . . . 71.05 111.576 -173.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -92.35 66.86 4.77 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 106.025 -1.843 . . . . 64.45 106.025 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.38 -169.82 13.9 Favored Glycine 0 N--CA 1.42 -2.392 0 CA-C-N 113.537 -1.665 . . . . 70.43 109.381 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -88.0 85.11 6.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-O 121.606 0.717 . . . . 65.23 112.749 -174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 67' ' ' ILE . 8.0 mm -144.43 -84.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 104.846 -2.279 . . . . 74.14 104.846 169.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' H ' ' HB ' ' A' ' 17' ' ' ILE . 80.6 mt 50.89 -42.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 128.086 2.554 . . . . 73.31 117.368 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.89 140.29 22.55 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.199 -0.667 . . . . 72.41 109.199 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -48.57 -28.65 12.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.586 3.524 . . . . 62.45 114.861 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.48 97.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.929 0.395 . . . . 73.54 111.08 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 25' ' ' VAL . 35.9 t -77.07 -30.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.882 -0.784 . . . . 65.05 108.882 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.64 -28.96 70.27 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.934 -0.765 . . . . 71.33 108.934 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.09 -8.7 57.59 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.434 -0.803 . . . . 21.42 111.767 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 22' ' ' VAL . 14.4 m -99.25 -23.07 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 119.619 -0.833 . . . . 71.52 110.773 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.559 HG21 HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -85.85 -47.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 116.251 -0.431 . . . . 62.32 110.588 176.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 31' ' ' ALA . 97.7 mt -89.66 -21.3 22.83 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 116.57 -0.286 . . . . 73.51 110.796 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 37.2 t70 68.72 10.7 8.04 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.289 1.519 . . . . 70.22 108.882 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -136.11 141.83 44.22 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 104.928 -2.249 . . . . 75.22 104.928 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -77.74 136.83 38.21 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.485 -0.886 . . . . 60.1 109.887 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -121.0 154.86 35.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.689 -0.485 . . . . 42.32 109.689 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -89.89 117.98 29.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.473 -0.566 . . . . 62.02 109.473 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.6 m -104.96 142.67 34.36 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.459 -2.052 . . . . 75.25 105.459 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.56 149.84 70.44 Favored Pre-proline 0 C--N 1.296 -1.75 0 O-C-N 122.088 -0.383 . . . . 74.02 110.133 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.53 133.47 37.24 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.605 2.203 . . . . 71.5 111.522 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.79 156.51 41.94 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.942 -0.572 . . . . 73.22 109.868 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.0 p -122.59 128.04 75.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-O 121.496 0.665 . . . . 73.23 111.045 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.47 ' HA ' HG12 ' A' ' 93' ' ' VAL . 22.4 tp -87.91 111.07 21.04 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.196 -0.911 . . . . 75.2 110.103 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 13.9 p80 -87.06 122.21 30.57 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.473 -0.785 . . . . 64.14 110.187 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.45 7.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.374 -1.393 . . . . 71.31 112.866 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.444 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 57.0 m-85 -117.78 161.11 20.24 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 109.288 -0.634 . . . . 73.12 109.288 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -133.41 131.98 40.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.25 -1.389 . . . . 72.0 107.25 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.457 ' C ' ' HD3' ' A' ' 43' ' ' ARG . 1.2 tmt_? -88.56 120.56 30.06 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 109.292 -0.633 . . . . 71.31 109.292 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 39.0 m-85 -95.99 159.82 14.77 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.987 -1.486 . . . . 74.43 106.987 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' C ' ' HD3' ' A' ' 45' ' ' LYS . 7.7 tmtm? -82.78 -41.76 18.76 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 112.156 0.428 . . . . 70.53 112.156 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 49' ' ' LEU . 7.9 mp 62.75 158.27 0.07 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.529 1.307 . . . . 71.1 114.529 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.41 -51.25 1.28 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.799 -0.815 . . . . 75.5 108.799 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.29 74.63 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.661 -1.154 . . . . 71.4 111.678 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HB2' HD23 ' A' ' 46' ' ' LEU . 3.0 mm? -107.63 167.34 9.5 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.409 -0.96 . . . . 62.42 108.409 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 41.5 Cg_exo -62.68 -157.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.52 0 C-N-CA 123.01 2.473 . . . . 51.32 112.905 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' N ' ' HD2' ' A' ' 52' ' ' PRO 0.349 12.8 p90 -57.49 -31.34 9.92 Favored Pre-proline 0 CA--C 1.568 1.665 0 N-CA-C 116.557 2.058 . . . . 72.13 116.557 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 51' ' ' TYR . 3.3 Cg_exo -39.74 168.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.59 3.317 0 C-N-CA 123.631 2.887 . . . . 71.52 112.746 163.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 p -139.29 -175.87 4.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.199 -1.563 . . . . 72.4 110.963 11.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 45.1 pt -123.77 141.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.116 -1.068 . . . . 70.1 108.116 172.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.407 HG22 ' HE2' ' A' ' 44' ' ' TYR . 30.8 m -148.18 158.77 7.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.951 -0.759 . . . . 45.21 108.951 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 m -80.5 88.91 5.62 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.739 0.78 . . . . 62.42 109.839 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.5 t -144.1 -66.02 0.35 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.574 -1.639 . . . . 74.22 106.574 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.63 125.68 30.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.387 -1.709 . . . . 73.13 106.387 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -84.41 15.46 3.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.846 0.684 . . . . 64.13 112.846 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.84 -147.73 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 114.617 0.607 . . . . 53.44 114.617 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 27.0 mtmm -139.82 154.09 47.25 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 120.167 -0.613 . . . . 75.32 111.184 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 54' ' ' ILE . 45.2 t -114.55 123.23 70.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.474 -0.785 . . . . 61.24 109.861 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -94.13 123.9 37.8 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.855 -0.424 . . . . 63.03 109.855 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.32 -149.03 5.19 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.16 -0.776 . . . . 63.22 111.16 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -138.3 156.55 47.55 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.904 -0.776 . . . . 73.32 108.904 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . 29.8 m -125.8 129.62 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 120.782 0.325 . . . . 74.24 111.053 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.603 HD13 HG21 ' A' ' 17' ' ' ILE . 6.2 mt -90.15 116.77 32.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.163 -1.421 . . . . 61.42 107.163 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.2 p -100.89 161.15 13.79 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.936 -0.306 . . . . 75.01 110.717 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.13 33.39 23.58 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.135 -0.555 . . . . 73.05 112.805 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.59 122.32 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 O-C-N 122.473 -0.428 . . . . 64.1 110.642 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.483 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 65.8 m -79.23 158.64 27.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.794 -0.762 . . . . 65.12 109.951 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -52.17 -34.93 47.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.171 0.804 . . . . 53.13 113.171 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -37.64 37.56 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.306 0.574 . . . . 73.24 110.654 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 13.3 mm-40 -68.16 -30.53 69.67 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.229 -0.896 . . . . 74.15 109.43 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 ' HG3' ' A' ' 105' ' ' GLU . 4.2 tt -59.37 -35.09 73.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.397 -1.274 . . . . 74.23 109.538 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 80' ' ' VAL . 58.7 t30 -60.37 -28.16 67.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 72.34 110.96 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -31.63 70.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.439 -0.949 . . . . 72.24 108.439 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.411 ' CZ ' HD12 ' A' ' 26' ' ' ILE . 73.3 m-85 -67.78 -35.3 78.42 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 116.421 -0.354 . . . . 73.24 110.38 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -69.59 -35.94 75.77 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.726 0.774 . . . . 74.44 109.478 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 76' ' ' ASN . 80.5 t -72.64 -24.59 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 CA-C-N 115.154 -0.93 . . . . 74.34 112.792 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.467 ' HB ' ' OH ' ' A' ' 107' ' ' TYR . 47.9 mm -44.4 -74.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 113.15 0.796 . . . . 73.11 113.15 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -141.77 19.55 2.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.249 0.547 . . . . 75.14 110.847 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.46 62.89 4.0 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.927 -0.654 . . . . 71.44 113.183 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.38 -42.88 18.08 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.908 -0.404 . . . . 73.13 109.908 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.8 m-20 -114.49 17.19 17.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.251 1.024 . . . . 75.35 109.718 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.98 156.58 26.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.497 -1.298 . . . . 64.34 107.497 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HB3' HG12 ' A' ' 110' ' ' VAL . 14.3 pt-20 -126.17 142.29 51.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.829 -0.804 . . . . 74.11 108.829 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 tmm_? -88.09 118.07 27.41 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.579 -0.737 . . . . 73.34 109.824 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 m -126.27 160.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.359 0.664 . . . . 65.2 111.834 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.3 m -89.18 129.61 35.74 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 123.628 0.58 . . . . 63.54 109.552 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.87 172.16 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.362 -1.347 . . . . 65.34 107.362 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -123.6 129.85 51.78 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.319 -0.952 . . . . 74.34 109.167 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 38' ' ' LEU . 16.2 m -127.03 168.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.073 0.464 . . . . 73.32 110.72 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.534 HG22 ' HG2' ' A' ' 101' ' ' LYS . 68.0 t -114.07 122.43 68.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.819 -0.628 . . . . 74.44 110.931 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.48 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 75.0 ttt180 -70.98 102.12 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.926 -1.138 . . . . 74.55 107.926 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.37 -60.0 2.38 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 126.818 2.047 . . . . 72.34 111.511 -171.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.1 -32.64 62.16 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.804 1.039 . . . . 71.54 113.804 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -110.47 -8.78 14.63 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.292 0.849 . . . . 62.22 113.292 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.41 25.69 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.966 0.907 . . . . 74.41 110.384 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -98.83 160.19 14.43 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.864 -0.791 . . . . 72.43 108.864 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.534 ' HG2' HG22 ' A' ' 94' ' ' VAL . 88.2 mttt -105.05 137.31 42.99 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.582 -0.525 . . . . 74.14 109.582 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.13 140.62 43.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.714 -0.476 . . . . 55.25 109.714 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -90.8 127.74 36.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.241 -1.392 . . . . 71.12 107.241 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.557 HG12 ' HB2' ' A' ' 10' ' ' ASN . 28.2 m -133.98 171.95 17.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.024 0.44 . . . . 75.01 112.121 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.558 ' HG3' HD11 ' A' ' 75' ' ' LEU . 31.2 mm-40 -104.24 153.97 20.35 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.255 -1.387 . . . . 74.04 107.255 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -156.0 177.79 11.01 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.247 0.476 . . . . 74.15 110.166 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' A' ' 81' ' ' ILE . 3.9 m-85 -103.55 119.78 39.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 122.914 0.485 . . . . 74.45 109.85 177.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -119.55 159.99 20.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.873 -1.528 . . . . 73.32 106.873 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.715 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 54.0 t-105 -83.96 134.27 34.66 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.669 -0.863 . . . . 75.33 108.669 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 85' ' ' ASP . 29.5 m -72.21 -20.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 118.981 0.809 . . . . 54.44 112.419 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.715 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 26.0 t-20 -92.0 15.5 13.11 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 125.323 1.449 . . . . 54.54 108.992 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 45.5 pttt -47.75 -15.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 127.242 2.217 . . . . 71.44 116.356 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.41 -20.39 60.07 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 119.112 -1.035 . . . . 61.42 111.442 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -97.46 124.48 48.64 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 107.544 -1.28 . . . . 74.05 107.544 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.25 102.24 1.5 Allowed 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 121.403 1.402 . . . . 73.44 111.011 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.79 112.02 17.78 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.895 -1.15 . . . . 72.22 107.895 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.47 0.544 0 O-C-N 124.639 1.212 . . . . 73.42 110.97 -175.098 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--O 1.239 0.516 0 CA-C-O 120.769 0.319 . . . . 63.04 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -51.6 -57.18 9.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.29 -0.868 . . . . 73.44 111.406 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.3 -34.18 65.59 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.044 -0.662 . . . . 73.34 111.81 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.75 -47.63 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.535 0.568 . . . . 74.11 112.535 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.16 -33.9 63.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.549 0.69 . . . . 72.21 109.905 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.47 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 55.6 t-80 -69.88 -45.71 67.06 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.961 -1.018 . . . . 65.44 109.844 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -61.26 -52.97 62.5 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.98 -0.554 . . . . 52.11 111.022 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.03 -45.67 71.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 123.414 0.446 . . . . 72.11 111.51 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -61.51 -53.96 49.5 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.018 -0.992 . . . . 73.11 111.886 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.47 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 96.7 m-85 -74.95 -31.5 61.51 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 113.79 1.033 . . . . 71.44 113.79 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 131' ' ' ALA . 79.4 t -63.8 -45.94 95.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 121.139 -0.225 . . . . 54.13 111.295 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 12.5 pt-20 -67.77 -36.71 80.97 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.401 -0.919 . . . . 71.11 110.937 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.7 m -60.82 -47.21 87.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.937 -0.574 . . . . 73.13 109.46 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.554 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 87.1 t80 -59.16 -48.05 83.06 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.831 -0.622 . . . . 74.12 110.028 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 97.4 mtt180 -61.58 -42.89 99.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.181 -0.463 . . . . 74.1 112.148 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.4 mmtp -65.17 -42.37 93.73 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 121.019 -0.272 . . . . 75.25 110.537 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.7 mmt -63.83 -31.86 73.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.199 -0.455 . . . . 71.02 111.728 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 90.6 mt -67.71 -45.53 74.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.858 -0.423 . . . . 70.03 109.858 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.1 mt-10 -60.79 -47.07 88.01 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 109.579 -0.526 . . . . 73.24 109.579 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -59.97 -38.98 84.11 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.216 1.007 . . . . 72.34 111.494 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.5 -45.61 13.41 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.056 -0.52 . . . . 72.05 112.262 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.71 -26.33 25.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.224 0.453 . . . . 63.21 112.224 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -123.25 124.17 26.46 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-O 120.731 0.301 . . . . 63.04 111.149 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.38 -19.41 67.17 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.656 2.237 . . . . 62.23 111.664 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -93.8 3.81 54.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.079 -0.51 . . . . 63.45 110.613 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.983 0 N-CA-C 108.912 -1.675 . . . . 74.22 108.912 174.724 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.434 -1.262 0 CA-C-O 121.53 0.681 . . . . 74.45 111.619 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.407 ' CB ' HD12 ' A' ' 75' ' ' LEU . 80.6 m80 -108.9 156.26 19.89 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.655 -0.702 . . . . 65.34 110.411 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.552 ' HB2' HG12 ' A' ' 104' ' ' VAL . 84.1 m-20 -132.16 126.41 33.56 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.164 -1.421 . . . . 73.4 107.164 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.78 120.62 65.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 121.18 -0.208 . . . . 35.24 110.85 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -84.67 112.76 20.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.476 -0.935 . . . . 72.23 108.476 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.2 t -113.55 142.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.76 -0.83 . . . . 53.42 108.76 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -81.24 -53.98 5.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.708 -0.223 . . . . 70.32 111.426 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.95 79.64 0.13 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 118.531 -1.795 . . . . 75.31 114.974 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 p -162.6 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.38 0.61 . . . . 74.34 110.902 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -91.16 70.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 CA-C-O 123.69 1.709 . . . . 71.42 107.605 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 65' ' ' LYS . 80.7 mt -114.12 -11.7 12.64 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-N 113.372 -1.74 . . . . 65.42 106.96 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -85.68 125.97 67.58 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 113.469 -1.696 . . . . 73.33 110.168 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.12 -38.24 80.57 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.805 2.336 . . . . 75.0 111.669 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.84 -44.97 91.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.918 0.39 . . . . 34.23 111.07 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.533 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -70.16 -34.42 58.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 121.258 0.551 . . . . 51.34 109.795 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -62.32 -35.71 79.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.223 0.535 . . . . 71.44 109.557 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.84 -13.07 61.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.581 -0.736 . . . . 63.25 111.94 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 22' ' ' VAL . 12.0 m -98.58 -26.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 119.602 -0.839 . . . . 73.32 110.45 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.555 HG21 HG13 ' A' ' 17' ' ' ILE . 6.0 tt -84.41 -41.63 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.015 0.436 . . . . 65.44 112.095 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 86.1 mt -99.62 -21.16 15.99 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.299 -0.409 . . . . 63.22 111.173 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.4 t70 75.84 -5.0 2.26 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.624 1.202 . . . . 64.02 108.925 -171.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 27' ' ' LEU . 84.9 mtt180 -105.94 138.11 42.69 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 113.754 -1.566 . . . . 65.31 107.665 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -79.62 111.15 15.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 106.403 -1.703 . . . . 71.4 106.403 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -89.52 157.06 18.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.388 0.613 . . . . 73.04 111.726 -174.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.63 114.61 27.77 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.959 -1.019 . . . . 74.23 111.323 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 1.7 p -102.62 143.07 32.77 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.519 -0.764 . . . . 52.51 109.775 174.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 m -136.16 143.26 43.13 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 109.155 -0.683 . . . . 62.23 109.155 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.2 132.79 54.05 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.272 1.981 . . . . 64.15 110.671 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.12 36.51 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 109.014 -0.735 . . . . 62.21 109.014 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.23 127.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-O 121.743 0.782 . . . . 72.43 111.988 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 93' ' ' VAL . 22.3 tp -90.24 102.36 15.08 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.723 -1.126 . . . . 63.34 109.943 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 61' ' ' LYS . 9.9 p-80 -76.28 125.26 28.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.302 -0.863 . . . . 72.13 109.771 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 117.42 -21.04 10.93 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 118.869 -1.634 . . . . 74.22 114.207 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -106.65 157.31 17.8 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 117.888 0.844 . . . . 73.15 111.482 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -124.92 124.26 41.67 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.403 -0.962 . . . . 53.41 108.403 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -90.86 147.19 23.34 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.763 0.316 . . . . 71.11 110.976 177.063 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.54 -169.99 1.96 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.527 0.566 . . . . 72.43 112.527 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -36.83 5.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.592 -0.276 . . . . 75.25 110.878 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 3.8 mm? 64.06 -178.02 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.045 0.538 . . . . 62.51 111.991 -174.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 28.04 6.58 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 113.035 0.754 . . . . 71.52 113.035 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.44 15.0 0.17 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.731 -1.223 . . . . 71.31 113.339 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.418 ' C ' ' HG3' ' A' ' 52' ' ' PRO . 3.6 mm? -95.49 160.17 31.08 Favored Pre-proline 0 C--N 1.311 -1.075 0 O-C-N 122.291 -0.534 . . . . 74.14 110.834 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -90.35 119.56 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.01 2.474 . . . . 74.14 112.504 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.497 ' HA ' ' CG ' ' A' ' 125' ' ' GLU 0.341 21.6 p90 39.78 60.66 6.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 113.835 1.05 . . . . 73.44 113.835 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 89.3 Cg_endo -115.52 144.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.153 3.235 . . . . 74.25 116.764 -170.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 82.2 m -153.46 -178.84 7.26 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 130.123 3.369 . . . . 54.21 101.916 -13.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.535 HG13 HG12 ' A' ' 108' ' ' VAL . 43.0 pt -123.35 122.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.988 -1.085 . . . . 74.3 110.94 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.33 177.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.704 -1.134 . . . . 75.05 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.8 p 50.96 102.43 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.619 1.568 . . . . 71.54 112.261 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 23.2 t -73.82 83.89 1.66 Allowed 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.799 -0.76 . . . . 73.22 111.617 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.0 -167.3 1.61 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.137 -0.938 . . . . 44.52 109.808 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.3 m -89.45 5.57 44.72 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.567 -0.901 . . . . 61.01 108.567 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.43 165.31 53.81 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.202 -0.908 . . . . 64.23 111.563 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 39' ' ' HIS . 27.9 mtmm -138.06 146.73 43.33 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.329 -0.619 . . . . 72.54 109.329 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 54' ' ' ILE . 40.3 t -110.08 122.89 65.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.183 -0.673 . . . . 73.23 109.183 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.38 125.43 46.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.288 -1.004 . . . . 61.43 108.288 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.46 -141.24 3.17 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.501 -1.04 . . . . 52.31 110.501 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.502 ' HB2' HD22 ' A' ' 18' ' ' LEU . 38.9 mtmt -136.82 138.79 41.2 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 113.291 0.849 . . . . 74.51 113.291 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 93' ' ' VAL . 31.5 m -104.7 133.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 114.689 -1.141 . . . . 53.34 110.054 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.566 HD13 HD12 ' A' ' 17' ' ' ILE . 14.5 mt -88.42 111.64 22.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 105.638 -1.986 . . . . 64.4 105.638 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -97.49 161.53 13.73 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.236 -0.586 . . . . 62.41 111.536 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.05 60.12 Favored Glycine 0 CA--C 1.522 0.52 0 O-C-N 123.285 0.366 . . . . 54.35 113.635 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.62 131.98 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 110.25 -0.278 . . . . 70.23 110.25 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.478 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 24.2 m -78.37 158.96 28.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.124 -0.631 . . . . 75.45 109.775 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -55.81 -45.44 78.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.612 -0.722 . . . . 70.12 111.342 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.51 -36.09 76.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.735 -0.666 . . . . 51.5 111.232 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 54.1 mt-10 -73.72 -35.7 65.13 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.722 -0.672 . . . . 75.21 111.09 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.5 tt -60.21 -35.41 75.37 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.706 -0.85 . . . . 65.05 108.706 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -55.5 -27.75 50.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.784 -1.098 . . . . 73.44 112.141 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.507 ' O ' HG22 ' A' ' 81' ' ' ILE . 12.8 t-20 -74.33 -31.86 62.61 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 119.391 -0.924 . . . . 74.23 109.503 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.479 ' CD1' HD13 ' A' ' 26' ' ' ILE . 73.6 m-85 -71.81 -42.03 67.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.229 -1.397 . . . . 74.12 107.229 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.424 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 9.4 t70 -55.96 -52.63 63.47 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.261 -1.336 . . . . 72.22 110.291 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.02 -33.14 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 113.294 0.85 . . . . 61.23 113.294 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 77' ' ' ASN . 17.0 tt -101.21 -34.24 3.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 C-N-CA 118.464 -1.294 . . . . 73.14 113.996 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -79.26 -19.0 51.69 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.929 -0.708 . . . . 74.52 110.841 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.81 60.37 3.89 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.992 -0.623 . . . . 70.32 112.427 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -81.81 -44.59 16.73 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.853 -0.795 . . . . 74.44 108.853 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -141.05 21.55 2.27 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.873 -1.528 . . . . 71.44 106.873 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -122.7 153.74 39.01 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.731 -1.577 . . . . 75.43 107.401 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HB3' HG23 ' A' ' 110' ' ' VAL . 9.9 pt-20 -126.33 153.8 44.37 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 120.195 -0.602 . . . . 74.4 111.086 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.424 ' HD3' ' OD2' ' A' ' 79' ' ' ASP . 58.3 ttt180 -82.84 121.29 26.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.773 -1.103 . . . . 73.43 111.427 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.73 159.11 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.583 -0.735 . . . . 70.33 109.607 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.57 131.2 39.06 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.564 -0.902 . . . . 70.1 108.564 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.414 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.4 m -137.79 165.48 26.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.431 -1.322 . . . . 73.53 107.431 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -117.92 128.74 55.11 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.56 -1.256 . . . . 71.35 109.097 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 66' ' ' VAL . 18.3 m -125.98 168.71 18.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.879 -0.415 . . . . 65.22 109.879 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' A' ' 101' ' ' LYS . 73.5 t -109.96 118.01 55.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 115.957 -0.565 . . . . 72.0 110.786 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -73.04 105.22 4.41 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.137 -1.06 . . . . 72.31 108.137 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.87 62.31 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 124.423 1.089 . . . . 75.44 110.032 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.98 -33.92 71.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.493 -0.776 . . . . 74.23 112.334 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -128.73 0.65 5.45 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 120.627 -0.429 . . . . 71.13 111.66 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 62.28 26.78 16.04 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.471 0.708 . . . . 24.33 110.615 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.9 160.52 14.54 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.557 -0.747 . . . . 72.24 109.727 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.535 ' HG2' HG22 ' A' ' 94' ' ' VAL . 38.7 mtmt -102.4 135.69 43.55 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.536 -0.913 . . . . 45.53 108.536 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.1 m -133.87 139.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.249 0.547 . . . . 71.14 109.892 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.62 122.06 30.84 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.648 -1.612 . . . . 61.25 106.648 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 10' ' ' ASN . 17.8 m -131.52 175.13 11.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.083 0.468 . . . . 75.31 111.137 -171.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.82 146.99 27.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.771 -1.196 . . . . 73.21 107.771 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.0 t -149.5 174.32 12.62 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.279 -1.008 . . . . 60.03 108.279 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 92.6 m-85 -118.75 118.72 32.35 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.276 0.56 . . . . 73.01 109.739 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG12 HG13 ' A' ' 54' ' ' ILE . 33.7 m -108.98 175.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.184 -1.043 . . . . 63.4 108.184 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 23.0 t-105 -74.69 132.49 41.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.929 -1.508 . . . . 74.41 106.929 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.8 p -69.62 -20.78 24.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.918 0.866 . . . . 75.14 110.61 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.54 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 20.9 t-20 -88.92 15.12 8.98 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.719 1.208 . . . . 72.22 109.17 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 61.3 pttt -48.94 -15.66 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.069 1.748 . . . . 75.13 115.123 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -72.84 -22.95 60.71 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.012 -0.675 . . . . 65.41 110.404 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -113.84 122.94 33.81 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.486 -0.561 . . . . 63.21 109.486 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.63 115.36 4.05 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.679 2.252 . . . . 74.54 109.591 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.697 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 30.7 ttm180 -129.61 124.26 33.3 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.741 -0.837 . . . . 72.5 108.741 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.697 ' SD ' ' HG2' ' A' ' 116' ' ' ARG . 1.3 mpt? . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.353 1.061 . . . . 74.04 112.263 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.497 ' CG ' ' HA ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.515 0.674 . . . . 75.55 111.599 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -81.37 -35.64 30.57 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.185 -0.916 . . . . 74.13 110.1 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -51.85 -48.92 63.78 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.88 0.738 . . . . 71.51 111.49 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.7 -34.47 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.356 -0.838 . . . . 71.41 112.835 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.46 -44.3 17.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.224 -0.658 . . . . 43.12 109.224 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -55.49 -37.67 68.13 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.033 0.933 . . . . 74.34 111.73 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.74 72.05 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.855 -0.338 . . . . 53.15 111.256 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.555 ' HA ' HG12 ' A' ' 135' ' ' VAL . 7.4 mm-40 -72.3 -35.03 68.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.597 0.713 . . . . 63.34 111.028 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -68.32 -22.08 64.72 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.466 -0.788 . . . . 73.21 112.276 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -98.15 -31.85 11.9 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.051 -0.659 . . . . 75.25 112.015 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 132' ' ' GLU . 11.4 p -66.07 -33.81 66.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 C-N-CA 120.04 -0.664 . . . . 61.23 109.64 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 11.4 pt-20 -60.15 -38.79 84.2 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.432 -0.349 . . . . 65.32 110.22 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 74.0 m -56.38 -46.4 80.09 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 123.538 0.524 . . . . 72.54 111.038 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.483 ' HA ' ' HG2' ' A' ' 141' ' ' MET . 95.6 m-85 -67.43 -32.2 72.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.231 -0.441 . . . . 70.21 111.265 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.647 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 53.5 mtp180 -70.38 -38.88 74.79 Favored 'General case' 0 C--O 1.184 -2.391 0 C-N-CA 119.474 -0.89 . . . . 70.02 111.087 171.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 75.2 mmtt -56.24 -47.23 78.9 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.807 -0.442 . . . . 71.04 109.807 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.671 ' HA ' ' CE3' ' A' ' 144' ' ' TRP . 27.0 ptm -66.22 -30.75 71.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.074 -0.512 . . . . 75.01 110.511 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -44.71 74.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.551 -1.277 . . . . 74.35 107.551 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 7.2 mm-40 -60.93 -29.64 69.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.912 0.885 . . . . 74.35 110.747 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.671 ' CE3' ' HA ' ' A' ' 141' ' ' MET . 26.1 m0 -75.3 -44.19 46.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.627 -0.508 . . . . 74.5 109.627 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.29 -47.85 72.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.384 -0.825 . . . . 63.41 112.248 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.11 -19.41 24.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.281 0.562 . . . . 74.35 110.351 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 143' ' ' GLU 0.345 7.9 p30 46.19 72.41 1.25 Allowed Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 116.96 2.208 . . . . 74.25 116.96 176.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.22 -27.11 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.14 1.893 . . . . 74.34 112.092 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.23 -25.53 22.83 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.108 0.48 . . . . 62.2 110.711 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.947 0 N-CA-C 110.52 -1.032 . . . . 72.32 110.52 -177.115 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.4 p . . . . . 0 N--CA 1.421 -1.923 0 CA-C-O 120.97 0.414 . . . . 65.02 111.111 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -87.56 153.07 21.69 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.555 -0.748 . . . . 70.11 110.23 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 84.5 m-20 -133.64 131.34 39.45 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.065 -1.828 . . . . 53.43 106.065 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 28.4 t -116.3 119.37 61.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 120.326 -0.55 . . . . 62.45 110.788 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.418 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.1 t80 -89.21 109.26 20.16 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.961 -1.496 . . . . 61.14 106.961 173.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.539 HG11 HD11 ' A' ' 17' ' ' ILE . 12.4 p -136.29 154.98 33.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 119.741 -0.784 . . . . 54.12 109.994 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.439 ' HA ' HD11 ' A' ' 18' ' ' LEU . 51.0 t80 -125.11 93.27 3.83 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.094 -0.706 . . . . 64.11 109.094 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.88 -176.46 16.16 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.76 -1.109 . . . . 72.34 111.217 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m 67.5 -73.59 0.08 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 115.137 1.532 . . . . 42.33 115.137 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.539 HD11 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -119.06 14.71 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.046 0.758 . . . . 70.35 113.046 -172.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 13' ' ' VAL . 74.7 mt -74.89 -6.72 50.71 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.195 0.522 . . . . 74.52 111.033 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 115.11 60.47 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 107.436 -1.32 . . . . 62.03 107.436 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -42.24 -44.09 7.72 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.326 3.35 . . . . 71.04 114.659 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.12 94.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.169 0.509 . . . . 72.35 111.494 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 25' ' ' VAL . 46.6 t -71.58 -38.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.965 -0.561 . . . . 74.33 110.248 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.73 74.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.465 0.65 . . . . 64.03 110.05 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -74.84 -16.48 60.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.648 -0.705 . . . . 75.34 111.903 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.3 m -93.54 -33.51 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.493 -0.883 . . . . 65.04 111.233 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' ' 78' ' ' PHE . 9.2 tt -72.46 -47.04 53.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 CA-C-O 120.587 0.232 . . . . 74.11 111.119 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 31' ' ' ALA . 90.7 mt -85.71 -11.98 52.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 121.221 -0.191 . . . . 71.3 110.877 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.53 8.91 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.287 1.042 . . . . 74.33 110.296 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 97.5 mtt180 -145.12 178.66 7.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.162 -0.926 . . . . 75.24 109.321 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.6 p -76.66 111.2 11.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.523 0.678 . . . . 72.04 110.922 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.55 -0.75 . . . . 55.31 110.321 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -100.17 109.69 21.96 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.571 -0.529 . . . . 73.31 109.571 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.8 p -114.09 142.58 46.03 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 109.096 -0.705 . . . . 74.15 109.096 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -142.22 141.45 21.36 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 107.896 -1.15 . . . . 64.13 107.896 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 3.2 Cg_endo -59.76 135.78 66.05 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 121.47 1.447 . . . . 73.32 110.456 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -148.88 157.87 43.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.691 -0.686 . . . . 41.23 110.461 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.574 HG11 ' HD3' ' A' ' 61' ' ' LYS . 22.0 t -115.63 124.21 71.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 115.353 -0.839 . . . . 62.44 111.443 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.491 HD11 ' HB ' ' A' ' 91' ' ' VAL . 22.6 tp -97.6 86.67 3.88 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.211 0.529 . . . . 75.13 111.015 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 25.0 p-80 -62.34 132.47 52.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.027 -0.988 . . . . 74.44 109.46 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.38 -23.93 11.9 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.349 -0.929 . . . . 71.41 112.425 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.464 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 48.2 m-85 -109.81 160.46 16.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 112.481 0.548 . . . . 74.2 112.481 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -131.61 126.84 35.77 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.26 -1.385 . . . . 73.32 107.26 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 24.7 ptt180 -89.68 136.71 32.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.102 -1.039 . . . . 72.4 111.376 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.39 -177.56 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.946 -1.025 . . . . 75.12 109.58 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HD2' ' A' ' 45' ' ' LYS 0.252 0.0 OUTLIER -138.43 91.83 2.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.73 1.252 . . . . 75.1 112.199 178.497 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mm? -92.54 125.73 37.31 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.415 -0.812 . . . . 61.24 109.937 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -9.01 23.39 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.574 -0.739 . . . . 75.44 110.508 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.72 -14.82 39.07 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.409 -0.814 . . . . 71.35 111.191 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.441 HD12 ' HG ' ' A' ' 46' ' ' LEU . 94.8 mt -118.46 163.57 24.75 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 109.448 -0.575 . . . . 73.01 109.448 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -79.25 99.65 1.26 Allowed 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 123.074 2.516 . . . . 64.01 114.708 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.615 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.5 p90 43.91 37.86 0.32 Allowed Pre-proline 0 CA--C 1.594 2.668 0 N-CA-C 116.614 2.079 . . . . 75.04 116.614 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 9.3 Cg_endo -97.77 167.18 0.8 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 123.384 2.723 . . . . 74.02 111.775 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.475 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 16.3 p -155.97 -169.52 3.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.582 2.353 . . . . 71.23 107.302 -4.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 36.5 pt -125.88 123.35 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 109.99 -0.374 . . . . 74.33 109.99 167.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' SER . 59.1 t -146.21 118.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.841 -0.8 . . . . 61.55 108.841 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 26.8 t 174.57 164.43 0.23 Allowed 'General case' 0 C--O 1.241 0.658 0 O-C-N 123.533 0.52 . . . . 71.32 110.23 175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -137.19 7.85 2.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.227 -1.397 . . . . 74.3 107.227 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.94 -166.94 1.47 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.198 -1.365 . . . . 73.34 109.774 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.8 m -93.86 14.69 18.67 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.838 0.455 . . . . 43.11 111.657 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.79 168.26 54.78 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 109.557 -1.417 . . . . 64.43 109.557 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.574 ' HD3' HG11 ' A' ' 37' ' ' VAL . 7.8 ptpp? -146.21 152.1 38.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.894 0.847 . . . . 72.14 111.117 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.402 HG21 ' CG2' ' A' ' 54' ' ' ILE . 54.0 t -115.51 133.41 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.402 -0.592 . . . . 55.12 109.402 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -99.9 137.64 38.08 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.3 -1.0 . . . . 62.13 108.3 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -166.1 -147.61 5.25 Favored Glycine 0 C--N 1.301 -1.373 0 N-CA-C 110.471 -1.052 . . . . 64.24 110.471 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' HB2' HD22 ' A' ' 18' ' ' LEU . 44.8 mtmt -133.8 143.02 48.13 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.065 0.432 . . . . 60.11 111.844 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.1 m -108.68 133.18 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.157 -0.928 . . . . 60.23 110.946 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 23.7 mt -90.31 114.99 28.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.142 -1.799 . . . . 71.3 106.142 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.2 p -103.92 161.36 14.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.026 -0.67 . . . . 74.3 111.89 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.89 22.46 68.94 Favored Glycine 0 CA--C 1.506 -0.528 0 CA-C-N 115.728 -0.669 . . . . 53.43 113.082 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.02 121.83 37.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.893 -0.41 . . . . 72.04 109.893 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 18.0 m -73.18 158.62 34.9 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.378 -0.971 . . . . 64.24 108.378 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.39 -40.31 71.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.154 0.502 . . . . 71.43 111.64 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.64 78.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.927 -0.579 . . . . 74.44 110.838 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 48.0 mm-40 -72.31 -34.39 68.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.184 0.516 . . . . 70.54 110.212 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.63 -36.64 76.76 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.368 -0.833 . . . . 74.2 108.859 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.682 ' O ' HG23 ' A' ' 80' ' ' VAL . 28.2 t-20 -58.92 -29.41 67.07 Favored 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 114.628 -1.169 . . . . 70.1 111.467 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -68.3 -35.25 77.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.822 -0.807 . . . . 51.12 108.822 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 26' ' ' ILE . 94.2 m-85 -74.16 -37.27 64.06 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.536 -0.756 . . . . 65.34 108.964 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.99 -34.19 77.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.201 -1.363 . . . . 73.03 110.995 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 76' ' ' ASN . 60.8 t -75.26 -42.96 43.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.71 -0.677 . . . . 71.13 111.709 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.8 tt -74.85 -61.14 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 114.675 1.361 . . . . 64.21 114.675 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -115.65 171.57 7.66 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.99 -0.444 . . . . 54.35 109.845 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 55.67 2.26 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.648 -0.787 . . . . 70.41 112.83 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.27 -42.31 46.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.759 0.281 . . . . 72.52 111.759 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.602 ' HB3' ' CH2' ' A' ' 109' ' ' TRP . 1.9 t70 -108.16 26.43 10.42 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.325 -1.361 . . . . 73.01 107.325 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 51.6 m-85 -114.1 155.51 25.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.608 -1.178 . . . . 74.14 109.692 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.54 ' HB3' HG12 ' A' ' 110' ' ' VAL . 15.7 pt-20 -126.66 158.6 35.94 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.3 0.375 . . . . 73.4 110.321 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -88.86 113.73 24.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.82 -0.627 . . . . 63.55 110.426 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.47 150.33 34.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.974 -0.38 . . . . 72.3 109.974 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.9 m -94.86 123.1 38.13 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.026 -0.731 . . . . 72.11 109.026 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' A' ' 38' ' ' LEU . 33.7 m -127.38 158.76 38.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.11 -1.07 . . . . 72.14 108.11 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -113.52 132.23 55.77 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.907 -1.117 . . . . 72.05 108.615 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.515 HG21 HG11 ' A' ' 66' ' ' VAL . 20.1 m -126.41 168.27 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 121.304 0.573 . . . . 74.35 110.331 -176.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 101' ' ' LYS . 67.5 t -110.04 117.13 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.325 -0.852 . . . . 61.44 110.299 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 38.3 ttm180 -65.43 98.58 0.36 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.546 -0.909 . . . . 74.3 108.546 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.473 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 1.2 tmt? -53.84 -34.76 60.28 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 126.259 1.824 . . . . 74.12 110.908 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.02 -41.31 87.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.587 -0.733 . . . . 72.43 112.232 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -118.84 -3.95 10.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 120.315 -0.554 . . . . 75.32 112.355 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 67.44 24.98 8.66 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.73 0.812 . . . . 35.42 111.495 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.5 pt-20 -104.61 159.71 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.246 -0.65 . . . . 70.21 109.246 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.0 mtmt -102.48 135.08 44.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.699 -0.852 . . . . 62.03 108.699 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.62 138.47 44.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.03 0.443 . . . . 75.44 110.237 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.89 126.22 34.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.971 -1.122 . . . . 75.01 107.971 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 10' ' ' ASN . 16.3 m -133.23 174.68 12.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 120.733 0.301 . . . . 74.15 110.256 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.97 150.27 28.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.558 -1.275 . . . . 72.02 107.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 t -145.94 175.18 10.63 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.421 -0.585 . . . . 61.24 109.421 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.68 118.35 36.43 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.052 -1.092 . . . . 62.11 108.052 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 54' ' ' ILE . 12.7 p -112.35 148.65 15.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.288 -1.375 . . . . 62.33 107.288 176.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.602 ' CH2' ' HB3' ' A' ' 85' ' ' ASP . 41.6 t-105 -73.08 125.93 28.82 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.693 -1.225 . . . . 72.22 107.693 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 87' ' ' GLU . 24.8 m -62.6 -22.46 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.947 0.721 . . . . 62.13 112.947 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.539 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 63.1 t30 -81.39 12.7 3.43 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.765 0.793 . . . . 73.32 110.09 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 -14.83 0.16 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.005 1.854 . . . . 64.43 116.005 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.07 -17.5 52.53 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.408 -0.517 . . . . 74.44 112.075 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.63 126.89 67.57 Favored Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 119.37 -0.932 . . . . 74.33 110.355 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.0 -6.11 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.719 2.946 . . . . 54.44 115.373 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -125.69 113.78 17.79 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.581 0.705 . . . . 54.04 110.846 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 122.19 0.995 . . . . 71.5 108.735 -177.327 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 129' ' ' VAL . 33.1 tt0 . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 108.499 -0.926 . . . . 64.35 108.499 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -60.23 -42.72 95.83 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.825 -0.625 . . . . 72.4 110.481 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.591 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 99.8 mtt180 -56.87 -48.58 77.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.272 -0.64 . . . . 64.42 109.272 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.624 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 79.2 t -59.21 -47.08 91.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.93 -1.032 . . . . 74.11 111.023 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 125' ' ' GLU . 98.6 t -67.35 -44.36 87.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.709 -0.223 . . . . 61.21 111.537 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.591 ' CE1' ' HA ' ' A' ' 127' ' ' ARG 0.253 3.7 p-80 -72.16 -30.41 64.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 118.612 -1.235 . . . . 74.51 111.827 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.33 77.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.979 -0.378 . . . . 43.45 109.979 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 42.6 mt-10 -63.31 -37.98 89.36 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.728 -0.669 . . . . 71.15 109.969 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.26 -38.26 88.6 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.069 -0.969 . . . . 74.43 110.479 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 86.8 m-85 -73.09 -52.16 15.32 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.842 -0.617 . . . . 64.25 111.098 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.1 p -59.89 -39.02 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 112.134 0.42 . . . . 72.53 112.134 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 48.6 mt-10 -59.07 -43.5 91.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 117.678 0.217 . . . . 60.21 111.048 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.6 m -58.36 -48.53 80.29 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.986 -0.552 . . . . 63.4 110.045 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.48 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 83.3 m-85 -61.73 -43.93 97.9 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.374 -0.376 . . . . 73.31 111.543 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 81.9 mtp180 -59.8 -44.83 93.79 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 123.047 0.217 . . . . 74.01 111.051 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 67.9 mttm -61.57 -47.34 85.95 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.314 0.384 . . . . 73.15 110.535 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.1 -34.99 78.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.12 110.964 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 91.3 mt -69.19 -38.88 78.88 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 116.291 -0.413 . . . . 73.41 110.628 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 32.3 mm-40 -59.35 -36.36 75.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.714 0.292 . . . . 74.41 110.362 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -68.22 -40.68 82.02 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.218 0.821 . . . . 64.54 113.218 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -74.32 -25.83 59.79 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.586 0.707 . . . . 51.23 110.606 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -78.91 -30.58 44.9 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.719 1.207 . . . . 74.43 112.161 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.36 99.82 45.39 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 120.249 -0.581 . . . . 53.04 112.457 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.28 -35.62 72.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.506 2.138 . . . . 74.55 110.103 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.27 -8.72 58.38 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.893 -1.049 . . . . 75.22 111.156 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.41 0 N-CA-C 111.252 -0.739 . . . . 73.01 111.252 179.88 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 106.686 -1.598 . . . . 74.2 106.686 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -87.88 155.56 19.81 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.553 0.692 . . . . 71.35 112.186 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.467 ' HB2' HG12 ' A' ' 104' ' ' VAL . 42.4 m-80 -135.82 123.74 22.71 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.901 -1.518 . . . . 75.3 106.901 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.554 HG12 HG23 ' A' ' 13' ' ' VAL . 51.3 t -120.31 122.95 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 120.959 -0.297 . . . . 61.35 110.71 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -90.95 99.15 12.23 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.122 -0.695 . . . . 72.54 109.122 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.554 HG23 HG12 ' A' ' 11' ' ' VAL . 72.9 t -139.15 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.228 -0.286 . . . . 71.41 110.228 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.12 -73.89 0.23 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.932 -1.136 . . . . 74.12 107.932 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' HA2' ' CG ' ' A' ' 51' ' ' TYR . . . 45.38 -123.83 6.25 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 123.739 0.649 . . . . 63.14 113.344 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -139.07 9.36 2.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.743 -0.836 . . . . 74.13 108.743 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.523 HG21 HD13 ' A' ' 67' ' ' ILE . 40.9 mt -74.94 -8.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.972 -1.013 . . . . 65.34 110.31 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 65' ' ' LYS . 54.1 mt -59.27 -24.39 63.2 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-N 115.241 -0.89 . . . . 74.0 110.826 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.76 124.86 48.85 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.1 -0.955 . . . . 75.3 108.953 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.29 -35.43 11.41 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.603 3.535 . . . . 72.43 114.491 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -42.74 82.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.923 0.392 . . . . 72.3 111.224 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.6 -35.43 56.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.322 -0.399 . . . . 73.2 110.597 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.11 70.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.235 0.54 . . . . 60.43 109.844 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.61 71.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.663 -0.699 . . . . 73.34 110.854 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 m -71.02 -29.19 35.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.143 -0.623 . . . . 72.13 111.604 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.488 HD13 ' CE1' ' A' ' 78' ' ' PHE . 4.7 tt -79.46 -46.96 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 112.532 0.568 . . . . 64.32 112.532 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 74' ' ' GLU . 36.8 mt -91.1 -14.55 31.02 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.188 -0.605 . . . . 60.5 112.227 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 t70 69.49 14.63 8.35 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.433 1.587 . . . . 63.23 108.35 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -147.36 135.43 21.4 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.643 -1.984 . . . . 60.13 105.643 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.0 m -76.95 111.12 12.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.5 -0.48 . . . . 65.31 110.295 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.546 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -93.74 143.73 26.06 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.607 -0.886 . . . . 31.44 108.607 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.4 126.04 42.4 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.122 -0.49 . . . . 64.13 110.303 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 14.7 p -93.71 144.05 25.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.969 -0.382 . . . . 44.43 109.969 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.22 139.41 35.59 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 108.829 -0.804 . . . . 73.24 108.829 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.92 129.53 35.46 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.754 2.303 . . . . 60.33 111.807 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.57 157.41 43.24 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.594 -0.73 . . . . 74.35 110.097 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.551 HG22 ' CG ' ' A' ' 61' ' ' LYS . 11.5 p -126.28 132.74 70.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-O 121.158 0.504 . . . . 72.11 110.429 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.453 ' HA ' HG12 ' A' ' 93' ' ' VAL . 22.3 tp -91.68 112.33 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.71 -0.677 . . . . 73.3 111.745 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -88.68 112.21 22.86 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.473 -0.785 . . . . 61.15 109.494 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.09 -40.42 1.4 Allowed Glycine 0 C--N 1.305 -1.149 0 C-N-CA 120.653 -0.784 . . . . 64.55 112.695 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.466 ' O ' HG23 ' A' ' 62' ' ' VAL . 41.7 m-85 -108.96 166.41 10.85 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 122.782 -0.246 . . . . 72.05 111.346 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -137.08 134.58 36.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.008 -1.108 . . . . 60.22 108.008 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 25.7 ptt180 -88.87 125.84 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 73.03 111.1 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -98.23 145.92 26.14 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.097 -0.956 . . . . 74.24 110.691 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -91.39 100.13 12.97 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-O 121.729 0.776 . . . . 75.31 110.942 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -119.96 121.55 39.23 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.591 -1.186 . . . . 71.41 111.032 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -85.87 -5.63 59.21 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 113.233 0.827 . . . . 64.42 113.233 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.15 -25.66 65.86 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.398 -0.906 . . . . 71.0 111.751 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 46' ' ' LEU . 3.6 mm? -119.56 156.46 53.44 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-O 120.772 0.32 . . . . 64.24 111.607 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.73 146.86 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.87 2.38 . . . . 72.11 111.063 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.612 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 37.3 p90 44.47 41.91 0.82 Allowed Pre-proline 0 N--CA 1.506 2.33 0 N-CA-C 115.39 1.626 . . . . 73.0 115.39 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 78.4 Cg_endo -110.54 156.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.242 2.628 . . . . 74.34 114.806 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 89.0 m -153.76 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 131.368 3.867 . . . . 72.43 103.33 -15.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 25.5 pt -121.82 136.84 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-N 119.553 1.069 . . . . 63.45 110.914 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.45 HG13 ' HA ' ' A' ' 112' ' ' LYS . 43.1 t -127.0 -80.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 115.026 -0.988 . . . . 72.33 112.589 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.4 p -177.17 156.21 1.23 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.809 -0.441 . . . . 75.25 109.809 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.1 m -165.08 173.63 11.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.138 0.975 . . . . 60.02 109.639 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.1 -65.68 0.58 Allowed 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 123.859 0.724 . . . . 72.34 110.01 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 p -105.98 -36.34 7.0 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 119.74 -0.784 . . . . 74.41 109.535 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.93 117.79 0.0 OUTLIER Glycine 0 C--N 1.361 1.971 0 C-N-CA 125.474 1.511 . . . . 74.32 116.817 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.551 ' CG ' HG22 ' A' ' 37' ' ' VAL . 21.9 ttpp -141.63 139.4 33.04 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.793 -1.563 . . . . 63.11 112.621 173.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 41' ' ' TYR . 54.4 t -123.86 123.72 67.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 C-N-CA 123.715 0.806 . . . . 71.35 111.252 -173.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -96.11 128.62 43.17 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.475 -0.49 . . . . 54.24 110.301 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.97 -142.58 3.44 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.85 -1.3 . . . . 21.12 109.85 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 50.3 mtpt -140.44 146.72 38.65 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.779 -1.193 . . . . 72.43 107.779 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.484 HG11 HG21 ' A' ' 93' ' ' VAL . 26.8 m -104.49 135.44 42.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.043 0.449 . . . . 75.24 110.305 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.523 HD13 HG21 ' A' ' 17' ' ' ILE . 11.6 mt -85.72 110.61 19.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 104.479 -2.415 . . . . 74.51 104.479 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.6 p -101.23 161.94 13.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 111.766 0.284 . . . . 71.23 111.766 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.16 73.62 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.91 -0.586 . . . . 73.12 112.693 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.71 124.23 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 109.046 -0.724 . . . . 75.04 109.046 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 30.9 m -73.71 157.45 36.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.19 -0.67 . . . . 74.12 109.19 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.01 -46.08 68.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.771 0.428 . . . . 73.45 111.003 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -68.72 -36.96 79.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.299 0.571 . . . . 63.13 110.826 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.602 ' HB3' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -68.56 -34.57 76.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.414 -0.812 . . . . 74.22 111.685 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.457 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.6 tt -61.55 -37.9 85.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.302 -1.37 . . . . 65.55 107.302 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.554 ' O ' HG23 ' A' ' 80' ' ' VAL . 34.0 m-80 -54.75 -26.73 36.07 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.851 1.056 . . . . 73.04 113.851 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.465 ' OD1' HG13 ' A' ' 26' ' ' ILE . 8.8 t-20 -67.32 -34.41 77.3 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.76 -1.176 . . . . 72.21 108.595 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.599 ' CE2' HD21 ' A' ' 27' ' ' LEU . 86.5 m-85 -69.24 -34.2 74.45 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.913 -1.143 . . . . 73.1 107.913 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.99 -31.32 70.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.469 -1.242 . . . . 73.23 110.226 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 76' ' ' ASN . 90.7 t -72.8 -36.6 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.715 -0.675 . . . . 61.22 109.58 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 77' ' ' ASN . 48.2 mm -59.71 -40.95 83.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 N-CA-C 106.804 -1.554 . . . . 72.24 106.804 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 73.06 -81.76 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.775 -1.557 . . . . 64.24 114.861 167.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.71 104.2 1.01 Allowed Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 108.636 -1.786 . . . . 74.43 108.636 -172.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.34 -40.52 96.64 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.189 0.519 . . . . 60.43 111.722 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 110' ' ' VAL . 10.9 m-20 -97.73 8.53 44.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.746 -0.661 . . . . 73.14 109.807 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 96.9 m-85 -115.94 154.78 29.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.958 -0.564 . . . . 62.03 110.021 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -136.05 141.93 44.34 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.406 -0.59 . . . . 65.03 109.406 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 0.4 OUTLIER -88.52 109.56 20.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.415 0.626 . . . . 75.22 111.317 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.65 160.7 24.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.749 -1.114 . . . . 53.4 110.966 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -91.12 131.37 36.73 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.696 -0.853 . . . . 55.41 108.696 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.8 m -133.93 172.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.496 -1.298 . . . . 52.44 107.496 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -125.37 127.59 46.83 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.873 -1.131 . . . . 72.43 109.523 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.484 HG21 HG11 ' A' ' 66' ' ' VAL . 18.2 m -126.72 168.24 20.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.316 0.579 . . . . 72.44 110.314 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 101' ' ' LYS . 54.7 t -113.5 121.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.757 -0.831 . . . . 73.42 108.757 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.36 103.93 2.13 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 106.8 -1.555 . . . . 72.53 106.8 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.603 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 9.8 tmm? -61.62 -32.89 73.05 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.91 -1.144 . . . . 71.12 107.91 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.68 -44.96 81.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.936 -1.029 . . . . 73.24 112.336 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -111.42 -2.69 15.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.105 0.478 . . . . 71.1 110.956 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.5 24.28 14.0 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.942 1.297 . . . . 70.04 110.993 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -105.12 160.53 14.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.985 -0.376 . . . . 65.45 109.985 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.593 ' HG2' HG22 ' A' ' 94' ' ' VAL . 55.4 mtpt -101.02 132.39 46.46 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.006 -0.739 . . . . 72.33 109.006 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.55 137.82 43.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.302 0.572 . . . . 73.13 110.838 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -87.77 119.34 28.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.835 -1.543 . . . . 74.05 106.835 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 10' ' ' ASN . 21.0 m -127.31 175.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 120.949 0.404 . . . . 73.13 111.066 -172.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.99 150.32 34.03 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.863 -0.421 . . . . 74.14 109.863 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -151.84 174.46 13.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.367 -0.605 . . . . 74.51 109.367 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 88' ' ' ARG . 52.1 m-85 -114.39 118.12 32.96 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.466 -0.939 . . . . 71.24 108.466 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 30.6 m -109.87 172.5 2.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.946 -0.57 . . . . 72.14 110.373 -177.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.53 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 31.5 t-105 -86.39 121.71 29.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.101 -0.703 . . . . 71.21 109.101 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.4 m -72.06 -19.7 19.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-O 121.391 0.615 . . . . 71.41 112.291 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.469 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.6 t-20 -88.68 14.81 9.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.369 1.081 . . . . 62.3 109.333 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 40.1 ttmt -49.78 -24.92 2.63 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 127.459 2.303 . . . . 73.44 114.589 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -80.93 -21.67 40.29 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.776 1.028 . . . . 63.14 113.776 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -103.46 137.0 19.13 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 107.06 -1.459 . . . . 74.45 107.06 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.67 120.98 8.98 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.856 2.37 . . . . 74.15 114.468 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -124.6 113.52 18.15 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 109.047 -0.723 . . . . 74.51 109.047 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.089 0 O-C-N 124.326 1.016 . . . . 72.45 112.37 176.697 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.225 -0.19 0 N-CA-C 108.882 -0.784 . . . . 52.31 108.882 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -50.35 -46.86 56.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.61 0.764 . . . . 65.21 109.022 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -63.16 -49.22 75.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.825 -0.625 . . . . 74.31 111.874 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -38.77 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.328 0.492 . . . . 74.31 112.328 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.02 -43.93 81.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.972 -0.381 . . . . 64.2 109.972 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.542 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 56.4 t-80 -57.13 -38.55 73.63 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.909 -0.404 . . . . 74.21 109.909 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.78 -46.89 70.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.57 -0.287 . . . . 55.35 111.406 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 44.8 mt-10 -68.08 -40.03 82.79 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 111.943 0.349 . . . . 73.43 111.943 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.68 -31.9 73.17 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.152 0.797 . . . . 72.24 113.152 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.542 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 57.9 m-85 -83.91 -44.27 14.43 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.589 -0.844 . . . . 73.14 111.315 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 132' ' ' GLU . 14.7 p -63.92 -36.75 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 120.54 -0.464 . . . . 74.12 111.226 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -62.21 -36.35 81.68 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 120.18 -0.608 . . . . 75.41 110.425 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.8 m -63.39 -46.06 88.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.507 -0.315 . . . . 70.45 110.282 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -63.13 -37.13 85.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.778 0.323 . . . . 60.45 111.26 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.05 -44.54 68.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.45 -0.341 . . . . 75.25 111.316 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 32.3 mmmt -62.26 -44.05 97.44 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.715 0.293 . . . . 72.25 111.402 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.57 -31.88 72.26 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.368 -0.533 . . . . 73.4 110.715 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 tp -66.16 -50.56 63.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.391 -0.368 . . . . 55.23 110.384 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' ' HA2' ' A' ' 150' ' ' GLY . 10.4 pt-20 -62.16 -44.17 97.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 121.055 -0.258 . . . . 70.11 111.263 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.407 ' CZ2' ' HE3' ' A' ' 140' ' ' LYS . 23.5 m0 -65.61 -40.68 92.9 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 112.258 0.466 . . . . 73.24 112.258 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.3 -36.75 53.81 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.102 0.477 . . . . 73.51 111.98 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -79.82 -21.29 44.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.353 0.501 . . . . 72.11 112.353 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.69 142.55 45.92 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 119.815 -0.754 . . . . 63.24 109.598 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.66 -37.29 94.97 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.866 2.377 . . . . 72.13 112.253 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.74 -9.41 54.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.449 0.642 . . . . 63.33 109.475 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 143' ' ' GLU . . . . . . . . 0 N--CA 1.41 -3.079 0 N-CA-C 108.934 -1.666 . . . . 22.04 108.934 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.506 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 58.8 m . . . . . 0 N--CA 1.414 -2.27 0 CA-C-O 121.516 0.675 . . . . 74.12 111.141 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -130.42 157.4 42.7 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.029 -0.987 . . . . 73.33 109.298 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.9 m-20 -127.44 124.6 38.83 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 31.11 107.933 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 59.6 t -120.9 120.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 121.027 -0.269 . . . . 71.32 111.685 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' HB2' HG21 ' A' ' 104' ' ' VAL . 46.0 t80 -84.38 111.36 19.37 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.949 -1.5 . . . . 75.25 106.949 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 17' ' ' ILE . 8.6 p -123.25 137.63 55.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.732 -0.787 . . . . 63.23 111.105 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -100.04 97.85 8.66 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.943 -1.132 . . . . 74.42 107.943 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.454 ' H ' HD12 ' A' ' 18' ' ' LEU . . . 81.8 -142.0 22.24 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.012 -0.835 . . . . 50.14 111.012 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.9 t 65.49 -79.03 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.261 1.024 . . . . 74.45 113.416 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.581 HG22 HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -117.95 12.98 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 75.3 111.763 -175.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.469 HD13 ' HE3' ' A' ' 65' ' ' LYS . 80.3 mt -68.18 -18.65 64.66 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 73.4 109.416 174.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.78 116.86 63.02 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 107.648 -1.242 . . . . 63.2 107.648 172.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.69 -39.72 18.35 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.302 3.334 . . . . 65.22 114.634 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.17 94.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.991 0.424 . . . . 74.33 111.688 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 17' ' ' ILE . 22.3 t -72.46 -36.56 54.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.714 -0.676 . . . . 73.11 109.606 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' ILE . . . -62.53 -37.11 84.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.405 0.622 . . . . 31.42 109.88 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.92 -19.05 62.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.556 -0.747 . . . . 74.45 112.059 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.3 m -91.17 -30.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 119.511 -0.876 . . . . 74.12 110.975 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.553 HG12 ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -78.63 -47.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-O 120.696 0.284 . . . . 63.22 110.356 178.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.434 ' HG ' HG23 ' A' ' 26' ' ' ILE . 95.5 mt -92.96 -10.41 36.48 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 112.106 0.41 . . . . 74.11 112.106 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 19.5 t70 76.61 -14.05 0.86 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.513 1.149 . . . . 73.51 110.279 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 27' ' ' LEU . 27.8 ptt180 -133.73 168.03 19.46 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.405 -1.27 . . . . 75.13 108.153 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.2 m -76.25 135.22 39.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.611 -0.885 . . . . 72.52 108.611 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.414 ' HB1' HG23 ' A' ' 67' ' ' ILE . . . -75.1 135.58 41.17 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 116.43 -0.35 . . . . 61.22 110.979 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.06 109.07 19.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.122 -1.436 . . . . 72.44 107.122 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.1 p -117.9 143.89 45.93 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 115.723 -0.672 . . . . 62.3 110.718 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.9 146.17 60.2 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 107.771 -1.196 . . . . 73.41 107.771 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -71.18 137.05 30.6 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 121.359 1.372 . . . . 62.31 111.302 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.32 156.05 41.48 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.315 -0.857 . . . . 74.01 108.921 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.444 HG21 ' HD3' ' A' ' 61' ' ' LYS . 14.7 p -120.19 126.39 75.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.897 -0.721 . . . . 71.33 111.005 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.467 HD11 ' HB ' ' A' ' 91' ' ' VAL . 25.3 tp -92.43 89.2 6.68 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.35 -0.841 . . . . 53.55 111.204 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.45 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 27.6 p80 -66.09 131.37 46.04 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.973 -1.012 . . . . 75.44 108.824 171.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 119.32 -13.54 11.08 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 118.969 -1.586 . . . . 64.31 112.842 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 47.5 m-85 -127.33 157.76 39.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 112.686 0.624 . . . . 70.52 112.686 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -116.54 138.5 51.36 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.549 -1.278 . . . . 64.41 107.549 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.599 ' HA ' HG22 ' A' ' 54' ' ' ILE . 19.1 ptp180 -86.55 127.21 34.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.297 -0.631 . . . . 73.33 109.297 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.446 ' HD2' ' O ' ' A' ' 117' ' ' MET . 88.1 m-85 -108.82 112.27 24.44 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.03 -0.532 . . . . 71.31 111.689 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -86.4 116.8 24.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.38 -0.827 . . . . 73.31 111.533 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.5 147.84 50.43 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.391 -1.277 . . . . 72.14 109.399 174.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -115.84 -12.44 11.44 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.268 0.556 . . . . 71.2 110.162 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 -26.2 71.63 Favored Glycine 0 N--CA 1.41 -3.088 0 C-N-CA 120.086 -1.054 . . . . 62.04 110.903 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HB2' HD23 ' A' ' 46' ' ' LEU . 2.1 mm? -115.9 166.57 12.01 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 105.475 -2.046 . . . . 64.04 105.475 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 37.1 Cg_endo -66.6 -155.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.227 0 C-N-CA 122.326 2.018 . . . . 74.01 114.297 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CD1' ' HD3' ' A' ' 52' ' ' PRO . 18.9 p90 -48.35 -26.42 0.71 Allowed Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 119.452 3.13 . . . . 61.25 119.452 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HB3' ' HB3' ' A' ' 53' ' ' CYS . 84.3 Cg_exo -49.32 165.69 0.22 Allowed 'Trans proline' 0 CA--C 1.584 2.989 0 CA-C-N 122.141 1.8 . . . . 54.22 111.999 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 52' ' ' PRO . 22.0 p -152.3 -178.99 7.15 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.508 1.523 . . . . 75.42 110.717 5.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 43' ' ' ARG . 43.1 pt -135.31 132.44 52.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.36 -0.978 . . . . 74.43 108.36 170.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 112' ' ' LYS . 30.4 m -154.2 -175.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.777 -0.823 . . . . 43.42 108.777 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m 82.05 -177.61 0.05 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.923 1.289 . . . . 63.33 114.443 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -71.9 -178.97 2.51 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.732 0.813 . . . . 65.45 112.746 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.473 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 3.5 p30 -82.13 28.92 0.42 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.689 1.196 . . . . 44.33 113.038 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 m -76.78 -8.28 57.0 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.129 0.418 . . . . 74.04 112.129 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.98 -172.81 19.74 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.149 -1.024 . . . . 61.02 112.076 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 18.6 ptpt -143.46 147.45 34.58 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.607 -0.516 . . . . 63.51 109.607 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -111.36 123.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.392 -0.596 . . . . 63.24 109.392 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -98.75 124.25 43.49 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.006 -0.739 . . . . 73.43 109.006 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.98 -139.03 2.67 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.761 -0.733 . . . . 75.33 111.921 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.469 ' HE3' HD13 ' A' ' 18' ' ' LEU . 39.2 mtmt -137.39 140.73 41.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.06 0.457 . . . . 40.24 112.082 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.7 m -107.21 133.93 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.149 -0.932 . . . . 74.35 109.653 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 48.7 mt -87.93 123.72 40.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.507 -1.664 . . . . 65.23 106.507 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.6 p -103.8 161.21 14.13 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.2 -0.6 . . . . 73.33 110.514 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 8' ' ' SER . . . 69.06 28.5 72.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.039 -0.6 . . . . 74.11 113.382 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.74 121.49 36.44 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 117.223 0.512 . . . . 54.05 109.651 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.9 m -77.37 164.22 25.7 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.997 -0.742 . . . . 54.31 108.997 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.83 -32.18 72.49 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.153 0.433 . . . . 72.24 111.289 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.36 64.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.389 0.614 . . . . 72.01 110.331 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.08 -44.22 39.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 75.14 110.326 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.66 -37.56 87.81 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.775 -1.194 . . . . 54.55 107.775 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.555 ' O ' HG23 ' A' ' 80' ' ' VAL . 27.5 t-20 -54.69 -31.49 58.0 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.471 -1.241 . . . . 73.22 111.547 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.553 ' OD1' HG12 ' A' ' 26' ' ' ILE . 20.8 t-20 -75.1 -31.18 61.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 74.2 109.588 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -65.99 -35.56 80.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.39 0.614 . . . . 74.3 109.567 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.76 -33.71 72.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.307 -0.861 . . . . 61.23 110.283 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 76' ' ' ASN . 71.0 t -74.83 -25.44 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.498 -0.774 . . . . 75.45 111.784 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.7 mt -53.4 139.28 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 109.701 -0.481 . . . . 71.23 109.701 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.75 109.75 0.55 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.735 0.778 . . . . 72.51 112.174 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.26 55.83 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.003 0 N-CA-C 109.001 -1.64 . . . . 62.31 109.001 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -64.05 -19.28 65.1 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.302 0.572 . . . . 72.43 110.702 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.529 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 17.9 m-20 -91.0 10.16 27.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.419 . . . . 73.22 111.022 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.27 160.28 26.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 119.917 -0.713 . . . . 74.03 109.455 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -131.22 142.9 50.23 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 109.397 -0.594 . . . . 71.14 109.397 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -83.48 120.18 25.59 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.965 -0.754 . . . . 72.41 108.965 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.33 160.15 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 116.104 -0.498 . . . . 73.32 111.43 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -95.43 126.7 40.9 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 115.69 -0.686 . . . . 72.25 109.474 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' HB ' HD11 ' A' ' 38' ' ' LEU . 28.8 m -129.66 168.31 23.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.042 -1.096 . . . . 75.24 108.042 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -123.22 128.53 50.14 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.812 -1.155 . . . . 73.32 108.521 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' LEU . 19.8 m -126.18 169.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.176 0.512 . . . . 71.34 110.465 -173.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 96' ' ' MET . 76.7 t -103.81 128.63 56.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.74 -0.664 . . . . 72.45 110.183 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -64.93 3.97 0.49 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 126.77 2.028 . . . . 72.04 113.119 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.618 ' H ' HG12 ' A' ' 94' ' ' VAL . 12.5 tmm? 58.56 -72.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.704 2.002 . . . . 71.0 113.277 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.03 -29.34 67.2 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.301 1.041 . . . . 63.13 113.296 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -110.64 -5.18 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.372 -0.531 . . . . 63.41 110.68 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 m 62.82 4.94 1.59 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.801 0.841 . . . . 73.43 112.863 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.95 160.84 27.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.827 -0.805 . . . . 74.32 108.827 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 6.8 mptt -106.76 146.45 30.84 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.446 -0.946 . . . . 62.23 108.446 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.33 139.51 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.145 0.498 . . . . 61.12 110.336 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -87.4 129.77 34.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.148 -1.056 . . . . 62.41 108.148 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 12' ' ' PHE . 33.3 m -139.45 173.16 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 122.325 0.25 . . . . 63.14 110.981 -174.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -100.87 153.78 19.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.027 -1.101 . . . . 74.44 108.027 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -152.69 176.89 11.27 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-N 118.341 0.519 . . . . 64.41 110.881 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.31 117.88 35.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.734 0.813 . . . . 73.32 108.84 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.23 156.95 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 109.187 -0.671 . . . . 72.11 109.187 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 42.8 t-105 -98.86 120.12 38.77 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.645 0.378 . . . . 72.11 110.519 -171.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 85' ' ' ASP . 8.3 m -73.1 -23.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.312 0.486 . . . . 74.53 112.312 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.42 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 64.5 t30 -80.31 12.82 2.7 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.018 0.913 . . . . 73.35 110.99 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.444 ' HB3' HG11 ' A' ' 55' ' ' VAL . 20.9 ptmt -63.85 -15.33 58.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.566 1.321 . . . . 74.42 114.566 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.41 -42.95 92.0 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.29 0.478 . . . . 63.25 112.29 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -85.59 138.19 35.95 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 107.747 -1.205 . . . . 74.52 107.747 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -40.7 116.85 0.43 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 124.288 3.326 . . . . 71.4 114.537 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.596 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 1.1 mmp_? -106.3 165.09 11.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 65.52 109.219 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.446 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 12.7 tpt . . . . . 0 C--O 1.204 -1.299 0 N-CA-C 109.29 -0.633 . . . . 74.51 109.29 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.519 ' O ' HG22 ' A' ' 128' ' ' VAL . 9.1 tp10 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 107.581 -1.266 . . . . 72.11 107.581 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -56.73 -36.98 70.35 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.375 -0.829 . . . . 75.41 110.914 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 128' ' ' VAL 0.269 4.0 ppt_? -63.16 -33.63 75.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.43 0.9 . . . . 75.24 113.43 -178.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 125' ' ' GLU . 29.9 m -77.38 -25.22 14.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 119.287 -0.965 . . . . 74.44 110.246 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.86 -44.78 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.493 -0.558 . . . . 65.21 109.493 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -75.21 -28.95 60.17 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 119.124 -1.03 . . . . 53.34 111.038 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.65 36.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.144 -0.48 . . . . 45.22 111.161 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 128' ' ' VAL . 10.0 mm-40 -61.67 -26.16 67.85 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.202 0.525 . . . . 71.54 110.835 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.54 ' HE3' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.05 -59.64 2.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.935 -1.135 . . . . 74.44 107.935 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -69.46 -31.58 69.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 114.354 1.242 . . . . 61.42 114.354 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.7 p -58.35 -38.48 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.25 0.477 . . . . 71.42 110.2 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.11 -46.0 82.83 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.691 -0.485 . . . . 63.54 109.691 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.0 m -57.12 -46.37 82.69 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.609 -0.723 . . . . 74.5 110.821 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 40.8 m-85 -60.26 -49.0 79.34 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 121.235 -0.186 . . . . 72.43 110.65 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 99.1 mtt180 -57.68 -44.84 86.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.042 0.213 . . . . 71.34 110.863 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -60.98 -52.54 64.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.347 -0.388 . . . . 61.43 110.688 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.58 72.51 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.657 0.614 . . . . 63.35 112.657 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 94.3 mt -72.48 -42.77 64.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.246 0.462 . . . . 65.0 112.246 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.6 -35.16 75.05 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 119.492 -0.883 . . . . 73.12 110.369 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.699 ' O ' ' HA3' ' A' ' 150' ' ' GLY . 1.3 m-90 -63.86 -28.98 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.337 0.589 . . . . 74.45 111.042 171.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -78.37 -44.46 24.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.135 0.493 . . . . 53.43 110.857 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.37 -31.52 42.94 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.912 0.708 . . . . 75.22 112.912 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 4.1 m-20 -95.26 143.87 26.85 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 111.806 0.298 . . . . 55.03 111.806 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 24.6 Cg_exo -64.82 -16.37 55.02 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.482 2.788 . . . . 75.31 112.009 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.24 -13.32 60.43 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.768 0.794 . . . . 74.31 108.98 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 144' ' ' TRP . . . . . . . . 0 N--CA 1.399 -3.829 0 CA-C-N 114.658 -1.155 . . . . 53.31 112.455 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.424 -1.737 0 CA-C-O 121.689 0.757 . . . . 74.52 112.616 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -109.25 147.43 32.61 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.859 -1.064 . . . . 72.13 109.705 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.5 m-20 -132.4 122.5 25.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.269 -1.382 . . . . 52.41 107.269 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.58 125.09 73.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.937 -0.305 . . . . 65.02 111.061 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -80.86 112.83 18.61 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.206 -1.035 . . . . 75.43 108.206 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.15 151.81 24.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.256 -0.646 . . . . 74.34 109.256 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -131.3 -22.83 2.46 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 120.519 -0.472 . . . . 73.14 111.126 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.506 ' HA3' ' CD2' ' A' ' 51' ' ' TYR . . . -114.05 108.82 2.1 Favored Glycine 0 C--O 1.248 1.005 0 C-N-CA 120.303 -0.951 . . . . 65.31 112.428 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 22.6 t 69.56 -177.25 0.21 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.921 1.288 . . . . 60.41 110.489 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.602 HD12 ' CE1' ' A' ' 78' ' ' PHE . 12.4 pt 47.12 18.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 126.761 2.024 . . . . 74.12 114.476 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 16' ' ' SER . 85.1 mt -93.04 -1.37 56.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.438 0.637 . . . . 63.03 110.942 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -103.53 132.34 21.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.009 -0.996 . . . . 74.42 108.879 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -42.85 -45.22 8.97 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 124.247 3.298 . . . . 74.54 113.756 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.32 -37.6 85.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 72.4 111.474 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 17' ' ' ILE . 44.9 t -75.72 -39.47 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.202 0.525 . . . . 72.4 109.981 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -66.96 -25.84 66.53 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.966 -0.753 . . . . 71.24 108.966 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.74 -31.49 57.15 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.677 -0.692 . . . . 65.54 111.588 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 22' ' ' VAL . 28.1 m -76.48 -30.41 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 119.584 -0.847 . . . . 72.2 111.619 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.457 HG23 ' HG ' ' A' ' 27' ' ' LEU . 3.3 tt -74.36 -42.29 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 63.34 111.925 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.77 HD21 ' CE2' ' A' ' 78' ' ' PHE . 75.2 mt -93.76 -22.25 18.81 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.706 0.632 . . . . 63.31 112.706 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 71.64 17.49 5.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.937 0.875 . . . . 72.42 109.92 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 ttm-85 -141.27 147.57 38.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.728 -1.953 . . . . 73.45 105.728 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.5 m -76.24 111.01 11.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.923 -0.769 . . . . 65.25 108.923 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -95.38 145.68 24.95 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.105 -0.498 . . . . 63.22 109.91 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.48 118.51 36.83 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.577 -0.738 . . . . 73.01 112.419 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 5.1 p -95.27 143.04 26.98 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.73 -0.668 . . . . 60.14 109.626 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.2 137.49 26.84 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 108.92 -0.77 . . . . 74.52 108.92 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 127.22 22.64 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.749 2.3 . . . . 72.34 112.083 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.58 37.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.516 -0.765 . . . . 35.55 109.022 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.505 HG21 ' CE ' ' A' ' 61' ' ' LYS . 11.4 p -118.14 130.05 73.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.722 0.772 . . . . 71.4 112.042 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.449 HD11 ' HB ' ' A' ' 91' ' ' VAL . 21.6 tp -87.95 106.77 18.34 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 122.123 0.963 . . . . 62.45 109.586 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -92.22 127.9 37.87 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.264 -1.335 . . . . 72.51 109.807 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.65 -5.93 29.59 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.023 -1.084 . . . . 51.54 112.044 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -117.86 144.86 45.04 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.709 0.29 . . . . 63.31 110.669 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -115.5 135.12 54.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.172 -0.677 . . . . 62.4 109.172 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.575 ' NH2' ' HA ' ' A' ' 125' ' ' GLU . 55.6 mtm180 -87.33 114.89 24.35 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.565 -0.902 . . . . 64.15 108.565 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.39 137.28 34.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.117 -0.697 . . . . 75.43 109.117 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.25 110.41 22.4 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.887 -1.153 . . . . 73.25 107.887 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 49' ' ' LEU 0.308 0.0 OUTLIER -124.75 160.98 27.4 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.764 -1.107 . . . . 72.21 112.394 179.488 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -99.02 -22.84 15.52 Favored 'General case' 0 N--CA 1.398 -3.039 0 CA-C-N 113.406 -1.725 . . . . 71.03 110.999 -169.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.09 -25.51 61.76 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.895 -0.669 . . . . 53.34 113.06 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 46' ' ' LEU . 2.1 mm? -122.7 146.89 49.19 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 109.397 -0.594 . . . . 71.22 109.397 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.49 -34.88 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.336 2.024 . . . . 64.14 111.724 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.676 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 37.9 p90 -123.38 177.63 1.62 Allowed Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 116.735 -1.602 . . . . 73.25 106.772 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.676 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.34 0.0 OUTLIER 34.5 169.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.608 0 C-N-CA 123.625 2.883 . . . . 73.34 119.172 -163.145 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 14.7 p -122.73 172.88 8.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.218 -1.551 . . . . 74.42 113.588 10.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.526 HG21 HG21 ' A' ' 62' ' ' VAL . 41.1 pt -130.71 149.92 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.831 -1.077 . . . . 61.4 109.911 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.449 HG11 ' HG3' ' A' ' 112' ' ' LYS . 12.7 m -148.12 164.27 5.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.355 -1.72 . . . . 75.33 106.355 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -80.04 123.27 27.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 114.064 1.135 . . . . 62.21 114.064 -170.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 p -147.67 120.08 8.46 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.486 -1.672 . . . . 73.13 106.486 172.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.23 -11.56 22.24 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 117.433 2.383 . . . . 63.44 117.433 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.5 m -98.08 1.1 47.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.489 -0.885 . . . . 75.15 111.382 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.5 159.09 15.59 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.182 -1.009 . . . . 51.21 114.044 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.505 ' CE ' HG21 ' A' ' 37' ' ' VAL . 48.9 mtpt -140.39 147.27 39.51 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 123.879 0.872 . . . . 64.15 109.827 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.526 HG21 HG21 ' A' ' 54' ' ' ILE . 48.0 t -123.74 122.05 63.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.534 -1.284 . . . . 75.53 107.534 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -111.35 115.99 30.21 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.582 -0.447 . . . . 62.54 111.287 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.9 -131.4 1.73 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.742 -0.543 . . . . 64.34 111.742 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB2' HD22 ' A' ' 18' ' ' LEU . 94.1 mttt -141.12 154.4 45.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.423 -0.584 . . . . 72.03 109.423 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.7 m -109.6 133.58 54.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.626 -0.509 . . . . 74.41 109.626 173.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.424 HD11 HG13 ' A' ' 17' ' ' ILE . 47.4 mt -88.02 112.43 23.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.536 -1.654 . . . . 72.33 106.536 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.7 p -106.68 160.66 15.29 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.119 0.414 . . . . 74.24 112.119 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.74 24.98 59.27 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.713 -0.676 . . . . 43.25 113.84 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 127.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 O-C-N 122.642 -0.328 . . . . 64.1 110.337 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 m -78.85 160.45 27.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.213 -1.032 . . . . 72.34 108.213 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.39 -37.36 75.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.297 0.499 . . . . 72.24 111.768 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.08 78.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.434 0.635 . . . . 61.31 110.854 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.695 ' HB3' HD22 ' A' ' 27' ' ' LEU . 37.8 mt-10 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.731 -0.668 . . . . 62.41 109.232 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 75' ' ' LEU . 3.2 tm? -59.76 -31.68 69.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.769 0.828 . . . . 73.31 109.808 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -56.95 -28.6 62.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 71.12 112.126 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -76.0 -31.77 59.09 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 119.043 -1.063 . . . . 75.41 109.436 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.77 ' CE2' HD21 ' A' ' 27' ' ' LEU . 41.2 m-85 -70.33 -28.96 65.57 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.638 0.732 . . . . 75.0 109.21 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.541 ' HA ' ' OH ' ' A' ' 107' ' ' TYR . 18.5 t70 -67.11 -43.21 83.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.827 -1.079 . . . . 74.43 111.693 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.04 -30.48 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 N-CA-C 112.708 0.633 . . . . 74.22 112.708 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.2 tt -82.48 111.16 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 112.905 0.705 . . . . 64.54 112.905 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 58.33 35.07 24.59 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.138 0.975 . . . . 74.33 110.486 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.55 25.49 9.65 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.647 -0.787 . . . . 53.05 111.485 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.61 -36.03 24.2 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.878 0.371 . . . . 73.3 111.669 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 12.8 m-20 -117.62 19.24 13.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.88 0.848 . . . . 71.02 109.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -130.62 161.36 31.74 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.791 -1.095 . . . . 72.34 108.666 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -130.06 147.18 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.781 -0.822 . . . . 75.14 108.781 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 40.0 ttp-105 -92.86 108.51 20.05 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.24 0.543 . . . . 63.43 111.36 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.4 m -111.18 159.38 11.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.749 -0.66 . . . . 75.32 110.416 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -91.33 133.43 35.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.575 -0.898 . . . . 55.3 108.575 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 38' ' ' LEU . 30.2 m -133.75 168.81 23.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.803 -1.184 . . . . 73.11 107.803 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.457 ' HB2' ' HE3' ' A' ' 103' ' ' LYS . 42.8 tt0 -114.2 129.93 56.62 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.515 -0.874 . . . . 74.22 110.192 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 38' ' ' LEU . 20.6 m -126.12 163.02 28.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.166 -0.679 . . . . 72.3 109.166 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 101' ' ' LYS . 77.8 t -102.05 113.86 39.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 109.352 -0.61 . . . . 73.55 109.352 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -69.45 90.21 0.53 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.19 -2.522 . . . . 74.14 104.19 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -55.65 -45.81 77.58 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 125.079 1.351 . . . . 72.4 113.99 -162.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.74 -27.38 68.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.076 0.465 . . . . 70.2 111.304 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -101.47 -9.48 21.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.068 -0.515 . . . . 72.33 110.51 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.5 t 64.42 15.87 9.82 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.634 1.174 . . . . 53.1 112.106 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -96.07 161.26 14.05 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 122.647 0.379 . . . . 74.35 110.421 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -108.89 128.49 54.97 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.946 -0.761 . . . . 64.21 108.946 -175.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.5 148.51 28.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.988 0.423 . . . . 62.01 111.9 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 92' ' ' GLU . 27.3 mmtp -90.84 118.12 29.99 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.556 0.742 . . . . 64.32 111.077 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.44 170.56 17.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.244 -0.889 . . . . 73.04 108.877 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.78 150.16 23.08 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.979 -0.378 . . . . 74.3 109.979 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.1 t -156.0 173.85 16.19 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.618 -0.882 . . . . 60.11 108.618 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 79' ' ' ASP . 95.4 m-85 -110.11 122.82 48.5 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.296 0.569 . . . . 53.12 111.691 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.15 159.72 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 115.318 -0.856 . . . . 65.2 110.04 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 53' ' ' CYS . 26.1 t-105 -79.38 112.67 16.85 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.912 0.863 . . . . 74.41 111.963 -173.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 85' ' ' ASP . 43.1 t -72.33 -32.09 41.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.08 -1.418 . . . . 64.54 112.35 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.478 ' HB2' ' CZ2' ' A' ' 109' ' ' TRP . 86.1 m-20 -88.43 14.34 9.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 123.013 0.525 . . . . 55.2 112.074 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.531 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 0.4 OUTLIER -49.84 -36.81 28.13 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.512 1.525 . . . . 65.34 111.766 -177.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.362 15.7 m-20 -73.98 71.46 1.57 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 115.934 1.827 . . . . 71.03 115.934 -171.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -129.0 141.82 43.05 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 104.413 -2.44 . . . . 75.3 104.413 170.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.36 -25.55 57.66 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.216 2.611 . . . . 63.13 114.616 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -116.81 113.05 21.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.251 -0.98 . . . . 63.03 111.624 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HA ' ' A' ' 112' ' ' LYS . 68.8 mtp . . . . . 0 CA--C 1.496 -1.111 0 C-N-CA 124.184 0.994 . . . . 74.01 111.131 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.575 ' HA ' ' NH2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.237 0.405 0 CA-C-O 120.707 0.289 . . . . 75.12 111.651 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -86.04 -36.91 19.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.11 0.481 . . . . 71.41 109.799 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -51.59 -47.07 63.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.608 1.163 . . . . 75.11 111.878 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 34.2 m -62.5 -33.15 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.376 0.51 . . . . 74.34 112.376 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.32 -37.14 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.7 0.762 . . . . 63.42 109.527 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.409 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 76.2 t60 -66.83 -35.63 80.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.576 -0.738 . . . . 72.44 109.571 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -65.47 -34.78 79.07 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 123.457 0.473 . . . . 71.11 110.643 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 43.4 mt-10 -59.4 -39.06 82.2 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.801 0.334 . . . . 73.13 110.577 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.613 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.1 tpmt? -57.56 -45.87 84.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.545 -0.752 . . . . 73.25 109.076 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 78.9 m-85 -62.6 -45.34 93.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.444 -0.798 . . . . 62.11 110.932 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.561 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 80.2 t -54.67 -49.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 O-C-N 123.55 0.531 . . . . 74.34 110.291 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.02 -41.3 91.88 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 123.197 0.311 . . . . 64.05 110.458 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -58.57 -47.31 84.69 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.856 -0.611 . . . . 61.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.403 ' O ' HD13 ' A' ' 142' ' ' LEU . 37.8 m-85 -63.62 -44.22 94.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.114 -0.494 . . . . 75.04 110.564 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 31.4 mtm180 -56.5 -49.92 73.31 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.882 -0.327 . . . . 72.13 110.147 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.13 -44.33 96.87 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.46 0.475 . . . . 64.52 111.684 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.86 -34.7 78.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.861 0.362 . . . . 55.12 110.997 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.565 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 10.8 mp -72.63 -31.82 65.43 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 120.622 -0.431 . . . . 72.33 111.403 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 46.5 mt-10 -59.79 -34.23 72.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.876 -0.416 . . . . 72.45 109.876 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -72.74 -44.77 61.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.199 -0.455 . . . . 73.13 111.817 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -73.81 -36.1 64.96 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.169 0.803 . . . . 74.33 113.169 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 142' ' ' LEU . 23.0 pttp -84.87 -6.38 59.34 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.937 -0.477 . . . . 72.11 111.458 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -74.67 144.7 80.78 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.492 -0.929 . . . . 73.54 108.492 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -43.0 -31.94 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.238 3.292 . . . . 71.24 115.018 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -71.85 -20.55 61.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.038 0.447 . . . . 75.12 110.871 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.868 0 CA-C-N 115.448 -0.796 . . . . 61.05 114.844 174.515 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.239 0.5 0 N-CA-C 109.267 -0.642 . . . . 44.32 109.267 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.431 ' C ' HD22 ' A' ' 10' ' ' ASN . 82.0 m-70 -125.16 143.13 51.09 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 109.375 -0.602 . . . . 64.54 109.375 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -128.95 123.85 33.57 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.307 -1.738 . . . . 70.31 106.307 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 13' ' ' VAL . 20.7 t -111.82 120.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 119.777 -0.769 . . . . 72.23 109.393 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.472 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.0 t80 -81.97 113.89 20.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.755 -0.831 . . . . 74.11 108.755 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 11' ' ' VAL . 27.2 m -135.16 159.25 41.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.345 0.593 . . . . 72.22 110.151 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -148.62 109.73 4.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 106.021 -1.844 . . . . 71.41 106.021 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 163.6 -92.21 0.11 Allowed Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.74 -0.944 . . . . 71.12 110.74 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.518 ' O ' HG11 ' A' ' 22' ' ' VAL . 49.5 m -149.6 78.95 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.19 1.182 . . . . 74.13 114.19 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.641 HG21 HD13 ' A' ' 67' ' ' ILE . 63.8 mt -155.57 8.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 104.713 -2.329 . . . . 75.33 104.713 168.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 6.9 mp -92.07 -17.21 25.34 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.372 -1.285 . . . . 52.0 109.676 -173.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.71 129.54 37.91 Favored Pre-proline 0 N--CA 1.403 -2.783 0 CA-C-N 114.676 -1.147 . . . . 45.41 108.635 172.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.71 -36.82 10.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.09 3.193 . . . . 73.12 113.034 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -55.46 -45.94 76.86 Favored 'General case' 0 C--O 1.224 -0.237 0 O-C-N 123.522 0.514 . . . . 73.42 112.008 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 16' ' ' SER . 92.3 t -77.3 -44.37 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.508 0.194 . . . . 51.04 111.446 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.48 -30.98 71.66 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.37 -0.532 . . . . 74.33 110.702 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.12 -40.62 74.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.062 -0.517 . . . . 74.35 111.268 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 21' ' ' ALA . 16.9 m -71.15 -31.16 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.294 -0.562 . . . . 74.23 111.687 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.547 HD13 ' CD1' ' A' ' 78' ' ' PHE . 6.1 tt -77.95 -38.57 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.275 0.56 . . . . 70.41 112.135 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 31' ' ' ALA . 95.6 mt -100.28 -10.75 20.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 113.93 1.085 . . . . 62.15 113.93 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 68.12 19.16 9.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.995 0.902 . . . . 71.04 109.432 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -162.28 142.68 10.05 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.338 -2.097 . . . . 73.3 105.338 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.2 m -77.06 119.24 20.5 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 120.948 0.404 . . . . 62.5 110.335 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -90.88 152.8 20.6 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.661 -0.496 . . . . 72.41 109.661 176.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.32 125.18 41.74 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.988 -0.551 . . . . 72.02 110.404 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 5.5 p -100.16 142.61 31.4 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 115.675 -0.693 . . . . 53.44 109.508 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.19 134.61 25.59 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.384 -1.339 . . . . 61.01 107.384 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.586 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.5 Cg_endo -61.8 130.38 31.04 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 121.932 1.755 . . . . 62.03 111.369 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.83 156.17 41.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.774 -1.103 . . . . 74.41 109.753 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.438 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.3 p -121.66 127.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.651 0.738 . . . . 64.32 111.546 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD22 HG21 ' A' ' 91' ' ' VAL . 23.3 tp -91.87 95.34 9.78 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.215 -0.902 . . . . 44.12 110.9 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 23.7 p80 -70.67 123.14 21.18 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.76 -1.109 . . . . 54.02 110.096 173.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 120.52 -13.59 10.1 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.878 -1.153 . . . . 73.22 113.8 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.404 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 60.1 m-85 -123.62 166.06 16.12 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.326 0.861 . . . . 73.53 113.326 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -134.39 128.24 33.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.448 -1.686 . . . . 72.32 106.448 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -87.46 135.19 33.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.889 0.852 . . . . 62.21 112.722 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -107.53 106.98 17.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.305 -1.739 . . . . 71.44 106.305 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -47.79 -51.94 20.62 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.593 2.072 . . . . 74.31 116.593 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.405 HD21 ' HG2' ' A' ' 117' ' ' MET . 8.6 mp 53.43 95.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.746 1.387 . . . . 71.1 114.746 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 47' ' ' LYS 0.306 0.0 OUTLIER -82.67 -11.73 58.14 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.888 1.07 . . . . 72.22 113.888 174.524 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.99 -43.4 10.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.849 -0.691 . . . . 54.42 111.929 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.2 152.36 39.37 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.038 -0.727 . . . . 74.45 109.038 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.6 112.0 3.37 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 122.867 2.378 . . . . 70.03 114.382 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.554 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.513 35.2 p90 35.79 59.91 2.93 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 119.044 2.979 . . . . 71.13 119.044 -178.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 10.4 Cg_endo -106.02 172.25 0.12 Allowed 'Trans proline' 0 CA--C 1.547 1.136 1 C-N-CA 126.504 4.803 . . . . 72.33 110.132 175.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 109' ' ' TRP . 43.3 t -158.13 175.24 14.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.577 3.151 . . . . 70.23 103.751 -11.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.413 HG13 HG12 ' A' ' 108' ' ' VAL . 25.8 pt -135.65 138.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 119.407 1.003 . . . . 44.2 111.307 174.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 56' ' ' SER . 5.5 m -154.37 -160.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.984 1.313 . . . . 71.12 108.88 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.43 ' H ' ' HB ' ' A' ' 55' ' ' VAL . 47.5 m 83.73 -39.87 0.08 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.226 1.41 . . . . 75.35 113.305 176.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 50.0 m 56.65 31.0 18.44 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.969 0.89 . . . . 73.11 109.402 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.09 175.77 7.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.194 -1.366 . . . . 74.1 110.159 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -79.74 -0.58 34.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.783 0.325 . . . . 72.43 111.073 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.94 -172.16 21.75 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 116.168 -0.469 . . . . 74.12 112.43 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.438 ' HE2' HG21 ' A' ' 37' ' ' VAL . 17.7 ptmt -154.44 143.01 20.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.308 -0.525 . . . . 54.4 109.785 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.7 t -105.11 123.38 59.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.685 -0.857 . . . . 62.35 108.685 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -102.96 115.82 31.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.018 -0.673 . . . . 63.03 109.241 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -150.65 -136.75 2.58 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 111.708 -0.557 . . . . 53.3 111.708 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 35' ' ' PRO . 52.4 mtmt -139.28 147.22 41.37 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.551 0.691 . . . . 75.12 112.775 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.8 m -104.4 133.11 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.838 -1.074 . . . . 63.35 108.887 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.641 HD13 HG21 ' A' ' 17' ' ' ILE . 5.8 mt -87.49 111.0 21.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.953 -2.24 . . . . 72.42 104.953 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -97.72 167.26 11.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.633 -0.427 . . . . 75.12 111.888 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.7 39.38 93.68 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.645 -0.707 . . . . 73.0 113.274 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.1 t -103.97 122.04 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.125 -1.065 . . . . 62.42 108.125 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 m -78.6 158.57 28.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.064 -1.088 . . . . 63.11 108.064 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.89 -35.56 69.09 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.44 0.563 . . . . 64.54 110.949 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.81 91.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 73.35 110.714 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 27' ' ' LEU . 47.9 mt-10 -69.03 -32.67 72.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.678 0.791 . . . . 74.31 110.536 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.482 HD22 HH11 ' A' ' 88' ' ' ARG . 1.3 tt -64.16 -28.29 69.66 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.466 -0.938 . . . . 72.34 108.466 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 79' ' ' ASP . 29.0 m120 -56.54 -27.76 58.41 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 112.729 0.64 . . . . 75.04 112.729 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.426 ' HA ' HG12 ' A' ' 80' ' ' VAL . 45.0 t-20 -72.56 -37.45 68.23 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 119.559 -0.856 . . . . 60.25 109.292 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.547 ' CD1' HD13 ' A' ' 26' ' ' ILE . 90.8 m-85 -70.43 -30.19 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.628 -0.879 . . . . 64.32 108.628 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 76' ' ' ASN . 19.8 t70 -73.77 -41.07 62.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 65.04 112.446 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 77' ' ' ASN . 9.4 p -67.09 -21.61 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.023 0.44 . . . . 71.42 110.255 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 77' ' ' ASN . 69.9 mt -57.27 116.37 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.526 -1.287 . . . . 74.11 107.526 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -71.36 119.44 15.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.197 1.184 . . . . 70.53 114.197 -171.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.646 ' HA3' ' CE1' ' A' ' 86' ' ' TYR . . . -150.7 86.43 0.15 Allowed Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 107.709 -2.156 . . . . 75.33 107.709 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -65.58 -38.35 89.25 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.838 0.855 . . . . 63.53 111.307 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 10.2 m-20 -91.4 8.62 35.36 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.108 -0.951 . . . . 75.4 112.103 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.646 ' CE1' ' HA3' ' A' ' 83' ' ' GLY 0.266 0.3 OUTLIER -125.04 157.95 34.95 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 119.443 -0.903 . . . . 73.52 112.237 172.488 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 11.8 pt-20 -127.61 158.37 37.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.501 0.191 . . . . 72.14 110.614 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.482 HH11 HD22 ' A' ' 75' ' ' LEU . 61.9 ttp180 -93.77 110.96 22.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.047 0.451 . . . . 75.12 110.679 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.9 159.49 28.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.257 -0.429 . . . . 64.25 111.145 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.51 HG22 ' HG2' ' A' ' 103' ' ' LYS . 99.2 m -99.08 124.16 43.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.916 -0.584 . . . . 54.34 109.596 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.422 HG21 HD22 ' A' ' 38' ' ' LEU . 29.6 m -125.37 155.65 34.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.872 1.269 . . . . 73.44 108.165 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 31.0 tt0 -105.1 127.44 52.89 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.784 -0.767 . . . . 75.34 110.395 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 38' ' ' LEU . 19.0 m -126.43 167.9 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 115.424 -0.807 . . . . 74.22 108.993 -175.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 101' ' ' LYS . 62.2 t -107.1 123.06 62.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 173.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -73.66 84.14 1.59 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.768 -1.197 . . . . 73.22 107.768 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.613 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 25.3 ttt -39.59 -51.75 2.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 128.02 2.528 . . . . 75.33 114.035 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.42 -36.39 78.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.071 0.397 . . . . 72.14 112.071 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.75 -9.43 23.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.98 0.419 . . . . 72.54 110.922 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.86 20.76 12.36 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.035 1.334 . . . . 73.01 111.853 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -105.13 161.16 14.49 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 120.878 0.371 . . . . 72.23 110.369 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HG2' HG22 ' A' ' 94' ' ' VAL . 89.4 mttt -100.09 131.28 46.14 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.232 -0.655 . . . . 65.31 109.232 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.82 140.99 37.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.89 -0.411 . . . . 71.31 109.89 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 31.2 ttpt -104.07 117.96 35.52 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 119.449 -0.9 . . . . 74.55 110.224 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' A' ' 12' ' ' PHE . 19.8 m -123.82 176.26 5.52 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 CA-C-N 115.076 -0.965 . . . . 74.25 112.181 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -99.46 150.62 21.99 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 122.782 0.433 . . . . 72.21 110.026 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -159.43 175.01 13.83 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.689 -0.856 . . . . 65.24 108.689 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 97.6 m-85 -114.38 119.13 35.89 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.086 0.47 . . . . 73.01 111.837 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.413 HG12 HG13 ' A' ' 54' ' ' ILE . 27.1 m -109.49 142.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.713 -0.676 . . . . 61.1 109.908 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 25.1 t-105 -72.16 113.88 9.67 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.515 0.726 . . . . 74.23 110.119 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 m -72.38 -23.23 21.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 122.047 0.927 . . . . 65.32 110.055 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.469 ' OD1' ' HG3' ' A' ' 116' ' ' ARG . 28.6 t-20 -83.08 5.24 23.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.409 -1.269 . . . . 54.21 112.173 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -59.62 -15.06 16.22 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.437 1.273 . . . . 70.15 114.437 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -59.38 -28.57 67.0 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.992 1.108 . . . . 70.02 113.992 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.405 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . 24.5 m-20 -106.06 167.09 10.13 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.196 -1.409 . . . . 65.0 107.196 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.14 98.03 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 N-CA-C 108.371 -1.434 . . . . 74.4 108.371 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.469 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 40.4 mmt180 -133.15 128.62 36.47 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.707 -0.679 . . . . 65.33 110.236 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.405 ' HG2' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.513 0 O-C-N 124.537 1.148 . . . . 70.33 114.044 171.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.438 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 42.7 mt-10 . . . . . 0 C--O 1.224 -0.256 0 CA-C-O 120.35 0.119 . . . . 74.01 111.159 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -67.72 -34.09 76.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 73.12 110.643 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -58.31 -39.15 78.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.538 -0.912 . . . . 72.15 108.538 174.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 98.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.556 -1.202 . . . . 35.22 110.385 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 125' ' ' GLU . 97.6 t -67.61 -45.19 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.782 -0.451 . . . . 70.22 109.782 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.458 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 23.7 t60 -60.84 -34.26 74.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.771 -0.649 . . . . 74.41 109.701 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.36 -52.46 39.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.025 -0.534 . . . . 71.43 110.622 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.507 ' HA ' HG12 ' A' ' 135' ' ' VAL . 42.5 mt-10 -63.69 -40.96 98.1 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.487 0.492 . . . . 63.03 112.14 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.596 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -60.22 -47.62 85.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.987 -0.551 . . . . 74.14 111.499 -177.101 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.458 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 78.9 m-85 -76.99 -34.57 57.51 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.929 0.714 . . . . 71.24 112.929 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.55 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 12.5 p -67.34 -40.95 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.628 -0.829 . . . . 60.32 111.168 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.4 pt-20 -64.76 -34.56 78.63 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 120.11 -0.636 . . . . 73.5 110.747 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.2 m -66.13 -38.34 87.91 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.96 -0.564 . . . . 71.43 109.541 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.472 ' HA ' ' HG3' ' A' ' 141' ' ' MET . 87.6 t80 -66.64 -44.71 81.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.606 -0.724 . . . . 61.14 109.674 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.6 mtp180 -55.06 -46.85 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 61.33 109.956 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 13.8 mmmm -61.97 -44.17 97.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.606 -0.725 . . . . 64.44 111.816 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.472 ' HG3' ' HA ' ' A' ' 138' ' ' PHE . 3.0 ppp? -70.28 -33.05 71.11 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 120.631 -0.427 . . . . 72.12 109.97 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.96 -42.07 97.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.785 -0.643 . . . . 55.11 109.279 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 148' ' ' PRO . 13.7 mm-40 -61.19 -39.14 89.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.036 -0.529 . . . . 74.53 110.551 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 43.7 t90 -75.32 -29.99 60.19 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.572 -0.451 . . . . 72.01 111.009 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.63 -31.89 36.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.241 0.544 . . . . 74.05 110.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.74 -32.42 46.7 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.945 -0.57 . . . . 72.43 110.89 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 54.8 67.96 2.93 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.506 0.723 . . . . 63.1 111.908 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 143' ' ' GLU . 91.3 Cg_endo -105.82 -15.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.981 2.454 . . . . 53.34 115.047 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -94.01 13.59 22.42 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.992 0.738 . . . . 74.31 112.992 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.123 0 C-N-CA 120.149 -1.024 . . . . 64.04 112.018 179.156 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 N--CA 1.435 -1.222 0 CA-C-O 121.683 0.754 . . . . 74.22 112.278 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -106.91 155.7 19.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.518 -1.29 . . . . 72.25 107.518 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.421 ' HB2' HG12 ' A' ' 104' ' ' VAL . 91.3 m-20 -136.24 133.51 37.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.947 -1.501 . . . . 72.44 106.947 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 t -118.96 120.82 65.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 120.693 -0.403 . . . . 71.24 110.551 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 66' ' ' VAL . 62.2 t80 -85.34 113.49 21.69 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.536 -0.913 . . . . 72.03 108.536 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 m -121.65 160.23 23.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.91 -0.586 . . . . 52.52 110.792 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -132.55 118.45 19.24 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.402 -0.817 . . . . 74.31 109.186 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.501 ' H ' HD11 ' A' ' 18' ' ' LEU . . . 102.08 -71.2 0.34 Allowed Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.889 -0.596 . . . . 70.13 113.168 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -92.17 155.6 17.9 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 111.556 0.206 . . . . 71.55 111.556 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.596 HG21 HD13 ' A' ' 67' ' ' ILE . 25.1 mt 72.73 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 125.003 1.321 . . . . 64.32 111.166 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.501 HD11 ' H ' ' A' ' 15' ' ' GLY . 56.4 mt -66.09 -28.19 68.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.137 0.494 . . . . 44.4 110.11 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.22 129.24 44.23 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 115.24 -0.891 . . . . 71.33 108.965 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.65 -33.52 31.81 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.804 3.003 . . . . 72.3 112.993 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.4 80.81 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 120.85 0.357 . . . . 72.52 111.173 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 25' ' ' VAL . 60.6 t -73.73 -36.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.483 0.659 . . . . 64.52 109.647 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -67.45 -31.5 71.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.913 -0.773 . . . . 72.12 108.913 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.34 -3.88 39.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.133 -0.94 . . . . 74.25 111.903 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 22' ' ' VAL . 19.6 m -105.75 -34.4 3.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.528 -0.869 . . . . 72.24 110.476 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.547 HD13 ' CD1' ' A' ' 78' ' ' PHE . 5.1 tt -70.03 -41.03 79.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 121.023 0.439 . . . . 71.25 111.067 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 31' ' ' ALA . 81.7 mt -100.37 -17.65 17.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.614 -0.434 . . . . 70.42 110.7 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 34.2 t70 73.08 -2.77 2.62 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.9 1.334 . . . . 65.02 110.017 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.2 ttm105 -121.2 144.85 48.37 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.608 -1.997 . . . . 74.54 105.608 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.1 m -77.8 111.14 13.31 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.107 -0.637 . . . . 74.13 111.416 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . . . -93.51 143.75 26.0 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.011 -1.107 . . . . 65.1 108.011 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -98.05 125.42 43.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.867 0.692 . . . . 63.25 112.867 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.6 p -94.47 145.13 25.0 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.189 -0.914 . . . . 75.02 109.612 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.2 137.38 29.65 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 108.26 -1.015 . . . . 63.32 108.26 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 127.51 23.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.965 1.777 . . . . 71.53 111.363 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.78 154.96 39.3 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 116.21 -0.45 . . . . 55.43 110.3 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.24 127.48 75.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.389 0.614 . . . . 74.03 111.157 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.47 HD11 ' HB ' ' A' ' 91' ' ' VAL . 19.2 tp -88.04 119.69 28.66 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.66 -0.7 . . . . 64.1 109.768 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.469 -0.787 . . . . 70.41 110.918 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.02 59.63 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 119.516 -1.326 . . . . 72.42 113.441 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 64.3 m-85 -121.51 151.99 39.68 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 117.212 0.506 . . . . 72.31 110.752 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 12.4 t-160 -122.86 138.26 54.71 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.994 -0.548 . . . . 74.43 109.993 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.512 HH21 ' HB2' ' A' ' 125' ' ' GLU . 32.0 ptt180 -86.03 109.75 19.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.165 0.983 . . . . 64.22 108.985 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.459 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 3.1 m-85 -74.62 154.72 38.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.701 -1.136 . . . . 73.42 112.781 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -87.69 -7.61 57.19 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.606 1.335 . . . . 74.33 114.606 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.2 pt? -72.29 73.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.601 0.963 . . . . 73.44 113.601 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 52' ' ' PRO . 54.6 pttt -72.83 1.19 9.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.816 1.414 . . . . 74.41 114.816 -175.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.66 -20.25 79.79 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 109.358 -1.497 . . . . 54.21 109.358 172.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.9 157.57 51.47 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 109.285 -0.635 . . . . 73.33 109.285 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.28 106.27 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.672 2.248 . . . . 73.12 114.368 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 45.84 69.54 2.54 Favored Pre-proline 0 N--CA 1.496 1.827 0 C-N-CA 124.469 1.108 . . . . 75.51 111.342 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 68.8 Cg_endo -110.88 153.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 124.108 3.205 . . . . 71.32 117.235 -167.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.484 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 72.9 m -155.15 163.03 40.78 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 130.012 3.325 . . . . 74.22 102.295 -17.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 43.7 pt -123.59 138.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 117.806 -1.557 . . . . 72.2 112.619 170.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' CE1' ' A' ' 44' ' ' TYR . 71.9 t -135.84 153.26 32.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.014 -1.847 . . . . 71.21 106.014 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 t -65.84 136.17 55.81 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 122.148 0.975 . . . . 72.4 112.295 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.6 t -156.42 104.53 2.21 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 103.717 -2.697 . . . . 73.51 103.717 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.77 -37.51 73.8 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 114.111 1.152 . . . . 71.13 114.111 -169.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -86.63 -0.06 55.46 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.306 -0.557 . . . . 71.14 111.985 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.79 146.76 16.18 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.761 -0.733 . . . . 71.21 111.549 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -140.44 152.74 45.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.139 -0.689 . . . . 72.25 109.139 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 41' ' ' TYR . 46.4 t -114.96 122.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.623 -0.51 . . . . 42.32 109.623 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -96.96 121.23 38.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.238 -0.652 . . . . 45.41 109.238 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.39 -143.44 3.7 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.003 -0.839 . . . . 54.13 111.003 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.468 ' HB2' HD22 ' A' ' 18' ' ' LEU . 55.5 mtpt -140.53 142.88 35.17 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.74 -0.837 . . . . 65.4 108.74 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.544 HG11 HG21 ' A' ' 93' ' ' VAL . 30.7 m -104.37 134.05 46.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 120.915 0.388 . . . . 63.01 110.722 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 17' ' ' ILE . 11.4 mt -86.44 110.27 19.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 104.67 -2.345 . . . . 74.45 104.67 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -101.58 162.72 12.7 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.27 0.47 . . . . 73.12 112.27 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.36 47.45 70.81 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.646 -0.706 . . . . 50.33 112.123 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.4 122.77 59.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.024 -0.732 . . . . 71.3 109.024 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 m -77.82 158.71 29.39 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.316 -0.954 . . . . 41.54 108.857 175.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -54.57 -35.94 63.84 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 112.172 0.434 . . . . 73.43 112.172 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.22 79.72 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.482 0.658 . . . . 70.31 110.587 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HB3' HD22 ' A' ' 27' ' ' LEU . 6.3 mm-40 -77.25 -37.23 53.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.331 -0.849 . . . . 62.43 109.921 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -33.47 71.04 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.986 -1.006 . . . . 72.4 109.697 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.06 -34.71 66.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.671 -1.149 . . . . 53.34 111.494 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.461 ' ND2' HG13 ' A' ' 26' ' ' ILE . 53.1 t30 -76.13 -29.77 57.93 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.113 -1.035 . . . . 64.42 109.856 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.695 ' O ' HG22 ' A' ' 81' ' ' ILE . 97.1 m-85 -66.06 -28.59 68.95 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.6 -0.727 . . . . 73.32 110.906 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.22 -31.63 71.26 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.591 -0.892 . . . . 73.34 108.591 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.21 -22.69 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 114.887 -1.051 . . . . 75.31 111.847 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 78' ' ' PHE . 11.7 tt -74.05 2.31 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 CA-C-O 121.842 0.829 . . . . 64.14 110.239 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.371 31.1 mm-40 88.63 126.95 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 117.539 2.422 . . . . 64.1 117.539 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.74 53.72 0.34 Allowed Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 106.883 -2.487 . . . . 64.44 106.883 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.59 -42.56 99.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.021 0.928 . . . . 64.13 113.011 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 110' ' ' VAL . 7.3 m-20 -100.12 16.3 24.57 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.756 0.789 . . . . 61.34 109.701 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.17 159.2 26.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.428 -0.806 . . . . 72.43 109.032 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 110' ' ' VAL . 12.5 pt-20 -127.88 157.91 39.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.417 -0.216 . . . . 63.23 110.417 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -85.15 113.05 21.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.18 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.31 159.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.447 -0.342 . . . . 63.23 110.485 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.411 HG22 ' HD2' ' A' ' 103' ' ' LYS . 12.7 m -106.41 122.47 46.34 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 108.902 -0.777 . . . . 73.34 108.902 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.47 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.3 m -128.01 161.9 35.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.946 -1.131 . . . . 74.04 107.946 -175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.516 ' HG3' ' CE ' ' A' ' 103' ' ' LYS . 1.2 mp0 -108.76 138.87 44.39 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.069 -1.452 . . . . 70.34 108.352 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 66' ' ' VAL . 26.2 m -126.51 161.1 33.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.983 -0.747 . . . . 44.13 108.983 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.576 HG22 ' HG3' ' A' ' 101' ' ' LYS . 75.5 t -104.79 116.85 49.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.693 -0.685 . . . . 74.54 110.083 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 15.5 ttm180 -68.13 110.79 4.14 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.948 -1.871 . . . . 61.2 105.948 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.32 -54.1 49.45 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 114.848 1.425 . . . . 73.41 114.848 -164.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.53 -12.8 61.21 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.235 1.198 . . . . 71.01 114.235 -172.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.1 -6.19 9.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.185 0.517 . . . . 72.53 110.705 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.2 m 61.46 25.93 15.78 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.148 0.579 . . . . 74.53 111.288 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 12.9 pt-20 -93.91 158.71 15.51 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 109.429 -0.582 . . . . 74.24 109.429 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.1 mptt -109.99 132.63 53.98 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.084 -0.71 . . . . 63.44 109.084 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.87 146.57 25.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.74 -0.467 . . . . 74.24 109.74 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.516 ' CE ' ' HG3' ' A' ' 92' ' ' GLU . 14.1 tppt? -91.6 132.77 36.08 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.622 -0.881 . . . . 74.44 108.622 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 10' ' ' ASN . 23.0 m -139.56 173.33 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.733 0.301 . . . . 74.41 110.847 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.79 148.78 24.88 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.598 -0.89 . . . . 74.22 108.598 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 t -153.39 175.18 13.42 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 109.16 -0.682 . . . . 71.53 109.16 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -107.19 118.61 37.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.67 -1.233 . . . . 70.04 107.67 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.32 162.6 10.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.196 -1.039 . . . . 73.01 108.196 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.559 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 33.6 t-105 -77.8 127.59 32.65 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.724 -0.843 . . . . 74.34 108.724 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 85' ' ' ASP . 26.9 m -69.81 -23.57 25.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 O-C-N 121.757 -0.589 . . . . 74.14 111.579 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.559 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -91.75 14.35 15.59 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.717 -0.674 . . . . 53.21 109.703 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.5 ptpp? -49.68 -18.81 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.352 1.461 . . . . 73.33 113.822 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.35 -39.53 76.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.921 -0.4 . . . . 73.31 109.921 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -114.2 124.07 31.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 N-CA-C 109.69 -0.485 . . . . 74.12 109.69 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.83 116.51 4.62 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.167 1.911 . . . . 53.23 109.565 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -86.98 113.66 22.94 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.31 -0.996 . . . . 65.13 108.31 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.488 1.427 0 C-N-CA 124.465 1.106 . . . . 72.42 113.0 -179.054 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.512 ' HB2' HH21 ' A' ' 43' ' ' ARG . 39.9 tt0 . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.672 -0.492 . . . . 61.4 109.672 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -52.52 -46.63 66.79 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.802 -0.814 . . . . 74.22 108.802 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -60.5 -48.88 79.84 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.104 -0.953 . . . . 61.42 111.702 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 125' ' ' GLU . 24.7 m -73.91 -31.6 31.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 N-CA-C 112.682 0.623 . . . . 72.32 112.682 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 125' ' ' GLU . 84.4 t -67.48 -40.28 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.023 -0.732 . . . . 71.53 109.023 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.545 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 46.0 t60 -65.86 -42.88 89.88 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.644 -0.707 . . . . 72.32 109.189 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -62.59 -52.69 62.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.615 -0.266 . . . . 73.43 111.367 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 13.6 mm-40 -62.46 -31.69 72.45 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.378 -0.374 . . . . 73.32 111.407 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 3.4 tmtm? -59.64 -40.5 87.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.698 0.761 . . . . 75.52 109.645 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.545 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 82.7 m-85 -82.31 -36.13 27.28 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.593 -0.692 . . . . 53.52 110.857 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 131' ' ' ALA . 99.3 t -62.49 -44.8 99.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.445 -0.343 . . . . 72.53 111.254 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 11.2 pt-20 -60.27 -37.46 80.52 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 110.18 -0.304 . . . . 72.34 110.18 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -64.42 -44.43 91.24 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.734 -0.469 . . . . 73.4 109.734 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.08 -46.21 90.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.68 -0.489 . . . . 64.34 109.68 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.636 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 98.2 mtt180 -63.84 -49.26 73.51 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.566 -0.743 . . . . 74.41 112.681 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -60.4 -47.03 87.86 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.905 0.128 . . . . 74.44 110.82 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -63.38 -32.73 74.24 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.948 0.404 . . . . 63.21 110.053 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 139' ' ' ARG . 65.0 tp -62.62 -47.15 85.02 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.717 -0.674 . . . . 61.13 109.195 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.0 mt-10 -60.88 -46.99 88.44 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.427 0.454 . . . . 71.45 110.279 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -66.3 -36.9 84.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.768 0.655 . . . . 65.53 112.768 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.04 -28.23 29.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.047 0.451 . . . . 70.12 111.427 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 12.3 tmtt? -79.64 -32.28 41.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.447 -0.342 . . . . 74.22 110.194 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.4 HD21 ' HB3' ' A' ' 149' ' ' ASN . 30.8 t30 -69.88 118.75 66.24 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.258 -0.428 . . . . 71.43 111.06 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.13 -14.72 45.64 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.796 2.997 . . . . 72.22 113.188 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.4 ' HB3' HD21 ' A' ' 147' ' ' ASN . 27.7 t-20 -70.77 -25.16 62.77 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.997 0.427 . . . . 75.41 111.301 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.883 0 N-CA-C 115.578 0.991 . . . . 51.33 115.578 172.764 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.424 -1.77 0 CA-C-O 121.49 0.662 . . . . 72.43 111.082 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -106.34 156.15 18.8 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 124.63 1.172 . . . . 75.2 109.25 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.45 ' HB2' HG12 ' A' ' 104' ' ' VAL . 24.0 m-80 -134.62 122.77 22.77 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.713 -1.958 . . . . 64.32 105.713 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.05 122.61 68.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.86 -0.736 . . . . 72.4 111.565 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' HB2' HG21 ' A' ' 104' ' ' VAL . 52.0 t80 -83.84 108.36 16.81 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.419 -1.326 . . . . 61.34 107.419 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.5 147.76 26.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.886 -0.725 . . . . 75.44 110.716 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' HA ' HD11 ' A' ' 18' ' ' LEU . 50.0 t80 -127.34 96.76 4.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.465 -2.05 . . . . 74.43 105.465 170.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.0 -145.84 11.05 Favored Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.069 -1.539 . . . . 63.11 114.453 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 m -43.8 -61.51 1.4 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 127.396 2.278 . . . . 74.44 116.926 -170.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.508 HG13 ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -89.06 17.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 114.16 1.17 . . . . 75.04 114.16 -167.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 65' ' ' LYS . 54.7 mt -73.38 -17.27 61.3 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 120.12 -0.632 . . . . 65.23 111.13 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.97 125.96 80.8 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.501 -0.772 . . . . 62.35 109.4 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -46.62 -38.08 21.42 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 124.258 3.305 . . . . 74.24 114.785 -174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -60.15 -64.46 0.94 Allowed 'General case' 0 C--O 1.217 -0.649 0 O-C-N 123.126 0.266 . . . . 71.24 110.379 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 41.9 t -55.88 -32.68 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 124.13 0.972 . . . . 73.13 111.19 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -65.42 -33.55 76.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.027 0.442 . . . . 54.45 111.394 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -80.94 -30.78 35.19 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 122.126 0.965 . . . . 75.03 108.648 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 22' ' ' VAL . 26.9 t -65.58 -33.85 66.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 125.26 1.424 . . . . 65.12 111.377 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.684 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tt -87.33 -42.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.733 0.642 . . . . 62.32 112.733 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 31' ' ' ALA . 87.8 mt -85.18 -30.15 24.16 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 112.188 0.44 . . . . 74.32 112.188 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 t70 81.78 1.75 1.47 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.245 1.418 . . . . 74.24 109.19 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 52.1 mtt180 -126.08 163.63 22.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.115 -1.439 . . . . 73.42 107.115 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -76.63 115.02 16.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.003 -0.74 . . . . 72.0 109.003 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -80.27 136.02 36.35 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.62 -0.718 . . . . 70.22 111.911 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.72 110.2 22.61 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.809 -0.757 . . . . 60.22 109.496 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.507 ' CG2' HG12 ' A' ' 67' ' ' ILE . 4.2 p -110.16 143.81 39.72 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.663 -0.699 . . . . 64.14 110.21 174.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -133.48 140.57 37.37 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 107.361 -1.348 . . . . 64.4 107.361 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 96' ' ' MET . 19.2 Cg_endo -60.62 137.18 71.82 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.68 1.586 . . . . 74.11 109.512 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.36 42.72 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.261 -0.644 . . . . 72.13 109.261 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.89 125.69 70.11 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 121.861 0.838 . . . . 73.35 111.543 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD11 ' HB ' ' A' ' 91' ' ' VAL . 22.8 tp -89.71 113.39 24.89 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 114.731 -1.122 . . . . 61.03 109.743 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -85.32 136.22 33.57 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.712 -0.847 . . . . 71.44 108.712 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 106.6 -23.38 28.33 Favored Glycine 0 C--O 1.203 -1.785 0 C-N-CA 118.965 -1.588 . . . . 63.24 112.666 174.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 62' ' ' VAL . 16.8 m-85 -101.59 143.37 31.65 Favored 'General case' 0 CA--C 1.456 -2.669 0 C-N-CA 119.718 -0.793 . . . . 63.13 110.928 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 3.7 t60 -112.31 135.08 53.43 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 115.285 -0.871 . . . . 75.21 109.26 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -87.2 112.22 21.77 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.7 -0.682 . . . . 71.01 109.792 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -105.76 126.58 52.33 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.757 -1.572 . . . . 70.41 106.757 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.543 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -85.12 -11.82 54.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.697 0.761 . . . . 73.15 109.612 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.636 HD12 ' SD ' ' A' ' 117' ' ' MET 0.282 2.6 mm? 72.79 -99.4 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 125.108 1.363 . . . . 73.42 112.723 -177.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt 171.49 -37.52 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.191 0.996 . . . . 71.21 110.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.51 4.26 3.67 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.069 -1.062 . . . . 64.23 112.718 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 6.3 mp -91.36 134.01 30.43 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 119.038 -1.065 . . . . 71.35 111.797 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.793 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 73.6 Cg_endo -74.69 103.36 1.7 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.462 2.775 . . . . 72.53 114.466 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.455 38.5 p90 71.23 1.49 0.0 OUTLIER Pre-proline 0 CA--C 1.608 3.196 0 N-CA-C 121.025 3.713 . . . . 72.2 121.025 176.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.793 ' HD3' ' C ' ' A' ' 50' ' ' PRO . 1.7 Cg_endo -88.41 169.45 5.93 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.862 2.375 . . . . 72.52 108.502 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 15.2 p -156.42 -176.32 5.91 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 127.568 2.347 . . . . 74.01 108.535 -3.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.556 HG21 HG21 ' A' ' 62' ' ' VAL . 46.0 pt -134.9 130.59 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 62.23 108.113 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.19 -175.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.133 -1.432 . . . . 61.24 107.133 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.2 m 69.83 -173.09 0.18 Allowed 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.323 1.014 . . . . 71.2 111.431 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 56.8 m -148.69 34.28 0.77 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.466 -0.568 . . . . 74.41 109.466 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -75.15 -166.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.73 -0.668 . . . . 74.04 111.905 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 m -75.49 -9.75 58.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.86 0.689 . . . . 75.53 112.86 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.85 160.0 45.47 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.018 -0.611 . . . . 64.5 112.846 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -136.67 159.33 42.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.544 -0.91 . . . . 62.43 108.544 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.556 HG21 HG21 ' A' ' 54' ' ' ILE . 49.1 t -126.25 128.02 71.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 110.088 -0.338 . . . . 74.42 110.088 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.79 122.06 42.2 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.746 -0.464 . . . . 65.15 109.746 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.51 -146.84 4.41 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 111.349 -0.7 . . . . 55.11 111.349 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.551 ' HB2' HD22 ' A' ' 18' ' ' LEU . 61.6 mtpt -138.96 139.96 38.11 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.79 -0.819 . . . . 72.43 108.79 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -104.23 132.24 51.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 119.782 -0.767 . . . . 73.01 109.954 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.507 HG12 ' CG2' ' A' ' 33' ' ' THR . 36.0 mt -90.15 117.48 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.302 -1.37 . . . . 64.02 107.302 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.2 p -103.04 162.07 13.25 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.155 0.428 . . . . 52.41 112.155 -174.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.04 33.6 74.73 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.619 -0.719 . . . . 53.14 113.671 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.57 122.28 39.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 122.506 -0.408 . . . . 54.35 110.198 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -75.04 159.11 32.12 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.579 -0.896 . . . . 74.45 108.579 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.21 -42.35 81.13 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.363 0.602 . . . . 71.21 112.075 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.58 72.01 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.339 -0.846 . . . . 52.44 110.857 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -76.26 -32.99 59.15 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.586 -0.734 . . . . 74.41 109.172 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.59 -40.68 95.67 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.97 -1.014 . . . . 75.45 109.847 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.619 ' O ' HG23 ' A' ' 80' ' ' VAL . 27.2 t-20 -55.88 -30.49 61.61 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.801 -1.091 . . . . 64.14 111.644 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.684 ' ND2' HG13 ' A' ' 26' ' ' ILE . 64.6 t30 -69.5 -31.47 69.75 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 120.768 -0.373 . . . . 72.44 110.671 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.579 ' CD1' HD13 ' A' ' 26' ' ' ILE . 81.2 m-85 -72.06 -42.13 66.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.516 -0.92 . . . . 75.45 108.516 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.18 -35.2 78.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.114 -1.403 . . . . 71.44 110.291 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 76' ' ' ASN . 60.9 t -74.98 -23.84 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 112.859 0.688 . . . . 72.22 112.859 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 77' ' ' ASN . 46.2 mm -75.76 -84.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 119.308 -0.957 . . . . 75.44 112.42 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.07 10.88 32.0 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 121.657 -0.652 . . . . 72.01 112.548 178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.55 32.01 2.65 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.52 -0.848 . . . . 63.31 112.847 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -83.16 -39.99 20.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.961 0.41 . . . . 74.44 111.361 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.17 14.97 20.66 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.148 0.975 . . . . 62.12 108.635 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -123.81 156.85 35.36 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.423 -1.325 . . . . 63.55 107.423 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.431 ' HB3' HG23 ' A' ' 110' ' ' VAL . 14.0 pt-20 -126.71 155.2 43.06 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.737 -0.838 . . . . 74.12 108.737 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 106' ' ' THR . 49.0 mtm105 -94.84 107.69 19.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.481 0.548 . . . . 73.11 112.481 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.35 158.15 11.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.75 -0.659 . . . . 63.24 109.3 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.441 HG22 ' HD2' ' A' ' 103' ' ' LYS . 15.1 m -94.98 126.11 40.1 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.104 -0.702 . . . . 72.32 109.104 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.444 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.4 m -132.11 158.31 43.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.802 -1.184 . . . . 74.13 107.802 -177.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -113.96 129.74 56.58 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.454 -1.298 . . . . 72.14 108.605 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 38' ' ' LEU . 16.4 m -126.24 166.1 23.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.444 -0.576 . . . . 61.04 109.444 -174.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 96' ' ' MET . 73.0 t -99.76 124.79 53.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.598 -0.889 . . . . 74.33 108.598 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -68.24 5.12 1.04 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 125.558 1.543 . . . . 73.21 112.462 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.608 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.9 OUTLIER 51.5 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 127.004 2.122 . . . . 64.14 115.166 174.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.8 -43.09 80.57 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.779 0.832 . . . . 54.25 110.751 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.01 -8.84 24.76 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.448 -1.315 . . . . 64.12 107.448 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.7 m 62.63 12.36 5.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.742 1.217 . . . . 75.42 113.888 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.81 161.95 15.05 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.4 -0.592 . . . . 61.31 109.4 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 94' ' ' VAL . 89.3 mttt -96.89 129.68 44.3 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.701 -0.852 . . . . 63.43 108.701 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.14 130.04 69.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 121.256 0.55 . . . . 74.01 110.93 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HD2' HG22 ' A' ' 90' ' ' THR . 5.6 tppp? -86.95 119.75 27.49 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.076 -1.083 . . . . 73.13 108.076 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 10' ' ' ASN . 30.9 m -135.47 174.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.122 -0.49 . . . . 61.21 110.589 -173.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.14 153.7 19.36 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.442 -0.948 . . . . 53.01 108.442 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 14.7 t -146.58 173.43 12.33 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.634 -0.876 . . . . 61.34 108.634 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -107.91 118.19 36.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.174 0.511 . . . . 74.55 110.02 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 54' ' ' ILE . 27.3 m -110.23 168.74 4.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.417 -0.957 . . . . 43.14 108.417 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 53' ' ' CYS . 32.1 t-105 -83.14 119.62 24.75 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.997 -0.742 . . . . 75.11 108.997 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 87' ' ' GLU . 2.2 p -68.65 -20.44 25.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.396 -0.82 . . . . 51.31 111.48 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 18.1 m120 -84.95 13.52 5.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.173 1.389 . . . . 41.42 111.425 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -51.49 -27.66 11.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.541 1.136 . . . . 61.43 113.04 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -78.09 -15.46 58.86 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 120.865 0.364 . . . . 64.21 111.373 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.51 138.57 26.75 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 107.089 -1.449 . . . . 64.52 107.089 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -40.15 108.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.683 2.922 . . . . 75.43 112.664 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -95.47 162.47 13.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.039 -0.528 . . . . 75.21 110.471 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.636 ' SD ' HD12 ' A' ' 46' ' ' LEU . 1.3 mpt? . . . . . 0 CA--C 1.496 -1.107 0 N-CA-C 105.692 -1.966 . . . . 73.4 105.692 171.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 109.091 -0.707 . . . . 65.41 109.091 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -62.59 -48.28 80.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.665 -0.698 . . . . 74.54 110.108 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -59.06 -47.91 83.52 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 116.005 -0.543 . . . . 71.22 111.991 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.8 m -69.29 -40.44 80.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.461 -0.495 . . . . 70.1 112.29 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.04 -28.33 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.588 -0.445 . . . . 74.23 110.535 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.471 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 14.2 t60 -55.66 -47.05 77.34 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.905 -0.776 . . . . 73.12 108.905 174.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.91 98.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.66 -0.7 . . . . 74.11 110.919 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -67.37 -40.83 85.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.116 -0.493 . . . . 52.21 111.407 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.617 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -67.07 -53.5 30.38 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 108.383 -0.969 . . . . 65.31 108.383 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 77.2 m-85 -63.17 -31.44 72.59 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.904 1.446 . . . . 73.02 114.904 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.27 -34.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 119.117 -1.033 . . . . 52.52 109.508 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.414 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 1.6 tm-20 -69.34 -34.67 74.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.227 1.011 . . . . 73.23 109.028 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.3 m -57.62 -44.02 85.21 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.332 -0.618 . . . . 61.54 109.332 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.462 ' O ' ' HG3' ' A' ' 141' ' ' MET . 79.4 t80 -66.19 -36.31 82.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.764 -0.653 . . . . 70.43 109.266 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.566 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 81.2 mtp180 -60.94 -52.52 64.67 Favored 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.155 -0.475 . . . . 53.4 109.795 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.414 ' HG2' ' OE2' ' A' ' 136' ' ' GLU . 46.3 mmtm -56.03 -39.23 71.65 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.224 0.824 . . . . 73.32 113.224 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 3.3 ppp? -67.47 -31.79 72.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.968 -0.693 . . . . 71.43 110.001 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.2 tp -76.54 -41.71 45.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.527 -0.76 . . . . 75.14 109.622 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 12.4 mm-40 -59.54 -46.84 87.7 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.605 -0.517 . . . . 73.41 109.605 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -64.92 -36.63 85.0 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.285 -0.871 . . . . 74.33 112.027 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -82.17 -38.64 24.36 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.989 0.424 . . . . 75.42 111.438 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -79.48 -31.61 42.39 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.65 0.262 . . . . 65.55 110.508 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -124.7 82.85 59.41 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-O 120.863 0.363 . . . . 54.44 110.213 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.76 -24.18 18.44 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.81 2.34 . . . . 74.33 112.563 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -96.84 -15.97 21.0 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.372 0.606 . . . . 75.43 109.957 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.705 0 CA-C-N 115.407 -0.815 . . . . 74.35 113.384 -178.518 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.442 -0.868 0 CA-C-O 121.959 0.885 . . . . 73.12 111.939 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.505 ' CG ' HD12 ' A' ' 75' ' ' LEU . 75.5 m80 -126.89 155.42 43.03 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 115.222 -0.899 . . . . 73.54 110.171 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.1 m-20 -127.5 129.5 47.51 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.789 -1.56 . . . . 71.14 106.789 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.69 128.06 59.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.436 0.532 . . . . 74.53 112.436 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -82.01 108.24 15.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.044 -1.465 . . . . 75.25 107.044 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.29 123.16 68.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.422 0.63 . . . . 72.14 110.635 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -96.69 107.21 19.62 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.383 -1.34 . . . . 64.01 107.383 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' A' ' 18' ' ' LEU . . . 75.59 -138.02 22.55 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.782 -0.927 . . . . 50.2 110.782 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.8 m 60.43 -80.77 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.159 1.17 . . . . 74.04 114.159 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 67' ' ' ILE . 32.6 pt -120.03 18.13 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 112.391 0.515 . . . . 74.44 112.391 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 64.1 mt -60.33 -21.91 62.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.429 0.633 . . . . 45.41 109.834 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.88 118.31 71.61 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.347 -1.353 . . . . 63.15 107.347 170.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -48.37 -36.46 30.39 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.961 3.107 . . . . 75.31 113.836 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.93 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 35.03 111.849 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.591 ' O ' HG22 ' A' ' 25' ' ' VAL . 13.0 t -77.86 -32.61 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.515 0.674 . . . . 64.02 109.797 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.18 -33.34 74.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.62 0.724 . . . . 62.13 109.118 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -75.46 -16.13 60.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.252 -0.886 . . . . 72.53 111.65 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 22' ' ' VAL . 13.1 m -89.01 -30.03 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 118.89 -1.124 . . . . 71.13 110.44 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.524 HG21 HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -81.57 -48.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 121.023 -0.271 . . . . 73.25 110.919 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.78 -16.59 25.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 120.808 0.337 . . . . 62.12 111.299 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 72.01 6.59 5.63 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.904 1.335 . . . . 61.13 109.999 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -141.97 169.28 17.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.32 -1.363 . . . . 61.4 107.32 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -76.43 128.46 34.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.891 -0.781 . . . . 74.35 108.891 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.25 137.81 41.46 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.711 0.291 . . . . 61.13 110.325 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -98.33 109.91 22.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.943 -1.132 . . . . 54.34 107.943 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.0 p -115.14 146.18 41.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.513 -0.767 . . . . 63.3 111.466 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.71 145.73 50.55 Favored Pre-proline 0 C--N 1.286 -2.162 0 N-CA-C 106.724 -1.584 . . . . 75.52 106.724 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.91 140.84 51.66 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.12 1.213 . . . . 74.14 110.243 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.68 156.44 41.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.051 -0.522 . . . . 53.41 109.808 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 7.3 p -122.93 123.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 121.628 0.728 . . . . 73.41 111.452 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.44 ' HA ' HG12 ' A' ' 93' ' ' VAL . 23.1 tp -87.64 93.23 9.37 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.316 -0.856 . . . . 73.42 110.219 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.428 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 26.3 p80 -68.64 134.85 50.51 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.485 -1.234 . . . . 72.01 107.771 174.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 115.74 -29.85 6.96 Favored Glycine 0 C--N 1.29 -2.015 0 C-N-CA 118.618 -1.753 . . . . 71.01 112.35 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.543 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 58.9 m-85 -109.56 166.55 10.81 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 112.014 0.376 . . . . 71.12 112.014 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.522 ' NE2' ' HB2' ' A' ' 56' ' ' SER . 0.1 OUTLIER -155.14 139.29 16.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.756 -0.656 . . . . 71.21 111.707 -177.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.806 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 67.0 ttt180 -87.48 138.99 31.0 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.441 1.088 . . . . 74.54 112.792 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.628 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 6.8 m-85 -104.69 158.77 16.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.677 -1.147 . . . . 74.52 109.575 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.56 ' H ' ' HD3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.78 -44.92 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.795 1.035 . . . . 72.44 113.795 -174.505 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.57 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 3.1 mm? 60.63 -179.34 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.991 0.517 . . . . 51.12 111.678 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.07 -71.45 0.68 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.088 0.47 . . . . 44.43 109.86 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.57 20.12 50.08 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.325 -0.941 . . . . 72.33 114.209 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 52' ' ' PRO . 2.8 mm? -101.9 151.03 37.9 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.749 -0.834 . . . . 74.42 108.749 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.4 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 123.015 2.476 . . . . 61.11 114.823 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -134.09 73.39 70.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 122.004 0.907 . . . . 73.22 112.507 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.679 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 20.7 Cg_endo -108.45 167.48 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.995 3.797 . . . . 52.44 112.501 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.806 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 20.2 p -156.18 162.4 40.2 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 127.882 2.473 . . . . 71.21 106.145 -8.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 41.7 pt -123.33 121.46 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.354 0 CA-C-N 119.57 1.077 . . . . 74.03 110.265 170.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.581 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 33.7 m -149.59 -173.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.312 -0.858 . . . . 73.44 110.423 -173.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.522 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 37.7 m 69.44 -161.18 0.17 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 124.626 1.204 . . . . 73.24 111.553 174.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -105.65 -172.66 2.13 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 120.911 0.386 . . . . 60.33 111.252 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 8.8 m-20 -68.02 36.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.413 1.885 . . . . 70.44 115.764 -169.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -79.53 -11.48 59.89 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.188 -0.945 . . . . 71.21 112.536 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.13 -169.99 15.68 Favored Glycine 0 CA--C 1.488 -1.63 0 C-N-CA 119.928 -1.13 . . . . 40.12 112.569 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 33.0 mtmt -145.32 152.61 40.18 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.708 -1.219 . . . . 72.24 107.708 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.49 HG21 HG21 ' A' ' 54' ' ' ILE . 48.7 t -122.2 123.18 68.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 110.177 -0.305 . . . . 75.23 110.177 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 3.8 p-10 -95.41 129.37 42.59 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.373 -0.931 . . . . 64.31 109.967 177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.1 -142.32 3.48 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 111.019 -0.833 . . . . 70.22 111.019 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -138.79 136.85 36.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.008 0.523 . . . . 70.31 111.524 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.45 133.67 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.697 -0.683 . . . . 70.41 109.842 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.677 ' CD1' HD11 ' A' ' 17' ' ' ILE . 32.6 mt -88.62 131.06 37.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.443 -1.688 . . . . 64.44 106.443 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -110.73 160.97 16.23 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.927 -0.709 . . . . 70.24 110.477 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.34 36.77 63.17 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.077 -0.582 . . . . 65.4 112.797 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -95.65 122.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.427 -0.455 . . . . 73.03 109.863 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.486 ' OG ' ' HG2' ' A' ' 74' ' ' GLU . 80.3 p -76.91 173.18 12.04 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 121.494 -0.754 . . . . 70.23 109.497 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.44 -29.56 70.25 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.87 0.367 . . . . 72.15 110.298 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.42 -41.27 40.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 71.25 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.486 ' HG2' ' OG ' ' A' ' 71' ' ' SER . 9.5 mm-40 -69.34 -36.49 76.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 75.53 110.194 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.505 HD12 ' CG ' ' A' ' 9' ' ' HIS . 2.3 tt -63.34 -37.86 88.91 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.28 -1.007 . . . . 64.22 108.28 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 80' ' ' VAL . 51.8 t30 -54.83 -31.19 59.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.636 -1.166 . . . . 72.4 111.567 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.511 ' OD1' HG12 ' A' ' 26' ' ' ILE . 23.3 t-20 -75.21 -32.42 61.17 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.519 -0.873 . . . . 73.32 109.826 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HE1' HD13 ' A' ' 17' ' ' ILE . 57.7 m-85 -64.52 -36.17 83.32 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.068 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.57 -33.03 73.37 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.632 -0.713 . . . . 73.04 110.253 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 76' ' ' ASN . 99.6 t -69.16 -37.64 76.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.846 -0.615 . . . . 74.23 110.435 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.6 mt -57.79 -68.49 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 116.135 -0.484 . . . . 63.14 111.095 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 21.0 mm-40 -110.54 103.4 12.0 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.482 0.658 . . . . 74.24 112.591 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 86' ' ' TYR . . . -150.64 11.79 0.85 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 115.045 -0.979 . . . . 72.33 111.695 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -75.17 -44.12 48.47 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.725 -0.472 . . . . 63.4 109.725 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 3.9 t70 -136.97 14.17 3.09 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.665 1.222 . . . . 63.21 107.786 175.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 21.1 m-85 -113.82 145.46 41.4 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.396 -1.275 . . . . 75.52 109.462 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.72 151.89 47.55 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.612 -0.884 . . . . 75.33 108.612 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -91.14 125.37 35.9 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.718 0.294 . . . . 74.32 111.038 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.66 159.6 34.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 116.013 -0.54 . . . . 72.31 110.559 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.28 129.8 39.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.638 -1.245 . . . . 73.44 107.638 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.411 ' HB ' HD11 ' A' ' 38' ' ' LEU . 30.6 m -128.65 169.13 20.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 108.628 -0.878 . . . . 63.41 108.628 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -118.72 124.55 47.59 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.28 -1.378 . . . . 74.11 107.28 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 38' ' ' LEU . 17.4 m -127.33 168.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.37 0.605 . . . . 71.3 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 101' ' ' LYS . 69.5 t -102.41 117.58 47.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.739 -0.664 . . . . 73.34 109.474 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -74.69 88.26 2.21 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.5 -1.667 . . . . 62.31 106.5 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -50.26 -35.91 29.02 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.168 1.787 . . . . 71.12 112.701 -170.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.86 -31.4 39.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.908 0.755 . . . . 74.11 111.811 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -127.83 -1.29 5.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 120.282 -0.567 . . . . 61.02 110.746 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.5 t 69.13 16.71 8.56 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.802 0.841 . . . . 74.42 111.517 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.3 160.01 15.72 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 109.341 -0.614 . . . . 61.25 109.341 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.666 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.4 mptt -101.63 134.02 45.41 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 108.787 -0.82 . . . . 73.54 108.787 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.91 140.99 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.279 0.561 . . . . 64.34 111.047 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.84 125.52 34.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.628 -1.249 . . . . 63.23 107.628 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.29 176.09 8.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 C-N-CA 122.608 0.363 . . . . 70.53 111.171 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -99.59 153.55 18.97 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.355 -0.98 . . . . 73.05 108.355 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -159.56 177.07 11.29 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 117.951 0.341 . . . . 70.21 110.164 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 82' ' ' GLU . 81.6 m-85 -105.57 121.36 43.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.268 -1.012 . . . . 54.33 108.268 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.68 165.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 109.053 -0.721 . . . . 74.32 109.053 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.663 ' CD1' ' HB2' ' A' ' 111' ' ' ASN . 61.8 t-105 -97.4 129.65 44.61 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 107.682 -1.229 . . . . 73.33 107.682 -169.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.0 -20.21 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.569 . . . . 74.2 112.298 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.663 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 26.5 m-80 -77.77 15.6 0.82 Allowed 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 124.1 0.96 . . . . 72.23 110.837 171.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 19.3 ptpt -49.28 -21.0 0.73 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.711 1.204 . . . . 74.45 113.484 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -124.02 94.28 4.17 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 104.005 -2.591 . . . . 71.12 104.005 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.4 p-10 -120.5 158.83 50.36 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 113.888 -1.505 . . . . 73.05 111.767 -172.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -106.65 12.05 0.16 Allowed 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.806 2.337 . . . . 75.33 111.881 170.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -134.26 133.15 40.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.359 0.874 . . . . 71.01 113.359 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.57 ' SD ' ' HA ' ' A' ' 46' ' ' LEU . 57.6 mtt . . . . . 0 N--CA 1.497 1.892 0 C-N-CA 123.738 0.815 . . . . 74.03 111.306 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.1 tt0 . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 109.734 -0.469 . . . . 75.44 109.734 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -55.91 -28.5 57.06 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.231 0.538 . . . . 73.33 110.012 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -58.0 -47.47 82.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.1 -0.5 . . . . 55.31 110.835 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 125' ' ' GLU . 20.0 m -81.86 -22.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.337 0.589 . . . . 71.22 110.133 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 125' ' ' GLU . 99.3 t -68.05 -34.4 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.697 -0.683 . . . . 63.24 109.835 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -55.54 -34.51 64.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.123 -0.489 . . . . 73.53 111.837 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.94 -55.11 9.08 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 121.02 -0.272 . . . . 73.32 111.178 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.565 ' HA ' HG12 ' A' ' 135' ' ' VAL . 9.5 pt-20 -66.84 -37.9 85.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 113.133 0.79 . . . . 55.32 113.133 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.569 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -59.29 -47.12 86.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.424 -0.353 . . . . 73.11 111.147 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -81.72 -37.58 27.08 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 112.573 0.583 . . . . 62.45 112.573 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 132' ' ' GLU . 15.0 p -62.75 -41.64 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 119.625 -0.83 . . . . 52.22 111.226 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 29.4 mm-40 -58.81 -44.14 90.75 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 123.018 0.199 . . . . 74.52 110.919 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.9 m -54.1 -48.64 70.49 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 123.661 0.6 . . . . 73.51 110.761 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.33 -36.87 85.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.747 0.308 . . . . 74.54 111.288 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.7 mtp180 -66.68 -43.6 84.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 73.2 110.494 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.1 -40.6 71.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.932 -0.576 . . . . 71.13 111.725 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.4 mtm -66.82 -31.41 72.01 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.602 -0.439 . . . . 70.23 110.819 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.05 -43.94 97.75 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.654 -0.869 . . . . 62.4 108.654 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 149' ' ' ASN . 12.6 mm-40 -62.41 -30.21 71.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.639 . . . . 70.41 111.004 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -75.39 -38.92 59.68 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.839 -0.619 . . . . 74.2 112.477 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -77.75 -43.31 31.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.796 0.331 . . . . 72.14 111.677 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.521 ' C ' ' HD3' ' A' ' 148' ' ' PRO . 88.0 tttt -79.23 -17.03 55.58 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.292 -0.413 . . . . 74.14 111.438 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.583 ' N ' ' HD3' ' A' ' 148' ' ' PRO . 3.5 t-20 75.7 16.59 0.0 OUTLIER Pre-proline 0 CA--C 1.609 3.224 0 N-CA-C 115.394 1.627 . . . . 73.24 115.394 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 147' ' ' ASN . 6.9 Cg_exo -73.85 -16.57 23.29 Favored 'Trans proline' 0 C--N 1.4 3.247 0 CA-C-N 122.795 2.034 . . . . 55.13 110.958 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 143' ' ' GLU . 26.6 t-20 -73.81 -22.71 59.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.528 -0.76 . . . . 74.13 110.212 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.137 0 C-N-CA 120.774 -0.727 . . . . 61.32 112.051 179.081 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.425 -1.717 0 N-CA-C 107.502 -1.295 . . . . 44.3 107.502 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -87.54 156.1 19.68 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.445 -0.798 . . . . 71.2 112.976 -173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -133.63 125.03 27.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.624 -1.625 . . . . 71.41 107.241 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 49.7 t -119.25 120.51 63.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.68 -0.408 . . . . 75.41 110.548 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.73 121.25 23.78 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.283 -1.747 . . . . 70.41 106.283 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HB ' HD11 ' A' ' 67' ' ' ILE . 13.0 p -113.2 138.81 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 C-N-CA 118.858 -1.137 . . . . 73.14 112.206 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.4 -36.68 68.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.969 -1.468 . . . . 74.03 110.471 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 13' ' ' VAL . . . 179.45 -175.13 46.81 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.794 -0.922 . . . . 61.15 110.794 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m 69.88 -65.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.304 1.041 . . . . 62.14 113.561 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.628 HG21 HD13 ' A' ' 67' ' ' ILE . 45.9 mt -68.81 -8.75 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.677 0.751 . . . . 72.43 110.223 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.06 -29.12 69.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.852 -0.796 . . . . 61.44 108.852 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.36 114.22 58.62 Favored Pre-proline 0 N--CA 1.418 -2.033 0 N-CA-C 107.86 -1.163 . . . . 74.4 107.86 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.47 -28.39 8.64 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 124.808 3.672 . . . . 74.33 115.739 -174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -71.07 -29.78 65.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 63.51 110.955 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 25' ' ' VAL . 63.0 t -76.72 -36.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.4 -0.593 . . . . 62.53 109.4 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.62 76.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.819 -0.808 . . . . 63.12 108.819 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.13 -17.72 61.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.256 -0.884 . . . . 74.21 111.894 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 22' ' ' VAL . 21.4 m -91.54 -25.4 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.191 -1.004 . . . . 74.42 110.831 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.507 HD13 ' CD1' ' A' ' 78' ' ' PHE . 11.2 tt -87.03 -45.3 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 120.054 -0.658 . . . . 64.41 112.123 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 31' ' ' ALA . 89.7 mt -89.08 -18.4 27.33 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.996 -0.44 . . . . 64.41 110.434 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.0 t70 71.28 10.8 6.74 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.929 1.347 . . . . 71.13 108.526 -171.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -143.45 145.15 32.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.673 -1.603 . . . . 73.13 106.673 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.7 m -80.23 116.98 20.62 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 120.682 0.277 . . . . 63.25 110.291 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 27' ' ' LEU . . . -95.65 156.46 16.31 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.646 -0.501 . . . . 61.14 109.646 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.26 125.43 44.88 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.977 -0.556 . . . . 73.44 110.317 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -94.45 143.29 26.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.887 -0.783 . . . . 63.2 108.887 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.96 138.7 33.68 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.129 -0.693 . . . . 74.24 109.129 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.82 129.81 37.01 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.322 2.681 . . . . 65.31 113.063 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -150.52 157.08 42.6 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.467 -0.788 . . . . 70.3 110.218 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.1 126.77 72.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.518 0.675 . . . . 62.54 111.71 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.461 HD11 ' HB ' ' A' ' 91' ' ' VAL . 21.7 tp -89.69 95.35 10.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.339 -0.846 . . . . 74.53 112.188 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 7.0 p-80 -70.33 128.54 36.56 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.058 -0.974 . . . . 73.52 111.568 174.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.28 -19.72 11.61 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 120.291 -0.957 . . . . 74.42 112.34 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.491 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 61.5 m-85 -114.79 158.76 21.45 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 113.015 0.746 . . . . 74.23 113.015 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.423 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 3.3 t-160 -128.02 124.4 37.06 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.53 -1.285 . . . . 74.44 107.53 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.423 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 10.6 ptm180 -91.88 144.39 25.53 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.838 -0.43 . . . . 72.13 109.838 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.78 176.54 5.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.949 0.404 . . . . 74.32 111.126 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -91.76 100.28 13.01 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.285 0.564 . . . . 74.41 109.702 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.418 HD12 HD13 ' A' ' 49' ' ' LEU . 4.0 mm? -94.68 118.61 32.0 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.631 0.729 . . . . 73.15 110.544 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -93.7 -43.96 8.39 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.775 -1.102 . . . . 74.35 108.713 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.14 -25.99 32.38 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.719 -1.128 . . . . 63.22 113.149 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.418 HD13 HD12 ' A' ' 46' ' ' LEU . 7.2 mp -92.27 132.71 31.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.415 -0.462 . . . . 65.43 110.868 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 57.4 Cg_endo -85.12 -20.8 3.3 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.466 2.777 . . . . 73.54 112.859 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.652 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 51.9 p90 -139.49 175.85 2.97 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 104.668 -2.345 . . . . 74.02 104.668 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.329 0.0 OUTLIER 31.43 169.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.595 3.55 0 C-N-CA 124.002 3.135 . . . . 71.41 119.795 -162.701 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 24.6 p -131.52 160.85 34.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.563 -1.336 . . . . 71.21 113.069 9.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 22.1 pt -122.92 137.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.92 -1.491 . . . . 73.33 107.863 174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.36 151.78 34.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 106.141 -1.8 . . . . 53.21 106.141 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m -65.6 140.95 58.57 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.242 1.201 . . . . 65.44 114.242 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m -155.99 102.86 2.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.222 -2.14 . . . . 65.13 105.222 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.23 -31.83 65.91 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.258 0.836 . . . . 65.31 113.258 -172.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -87.52 -0.81 57.36 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.682 0.253 . . . . 72.3 111.682 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.86 168.11 12.96 Favored Glycine 0 C--O 1.238 0.372 0 C-N-CA 120.371 -0.919 . . . . 63.31 113.134 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 18.5 ptpt -150.05 154.68 38.55 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 110.049 -0.352 . . . . 73.42 110.049 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.0 123.4 69.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.801 -0.444 . . . . 74.11 109.801 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -96.63 128.49 43.62 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.791 -0.763 . . . . 74.35 109.512 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.07 -141.03 3.07 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 109.887 -1.285 . . . . 54.33 109.887 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 49.6 mtpt -141.1 150.71 43.23 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.873 -0.788 . . . . 63.31 108.873 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . 28.7 m -104.11 134.16 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.123 -0.49 . . . . 64.33 110.094 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.628 HD13 HG21 ' A' ' 17' ' ' ILE . 8.8 mt -87.19 115.78 28.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.744 -2.317 . . . . 65.31 104.744 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -109.63 160.49 16.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.838 -0.745 . . . . 75.33 112.421 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.37 41.47 11.57 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 115.806 -0.634 . . . . 43.53 112.702 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.6 t -106.68 122.16 60.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 108.862 -0.792 . . . . 74.21 108.862 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.2 t -79.3 174.23 11.78 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.019 -1.072 . . . . 64.35 109.409 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.45 -25.62 67.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.065 -0.346 . . . . 75.24 110.065 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.72 -53.34 18.93 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.852 -0.613 . . . . 71.34 110.371 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.19 -30.62 69.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.353 0.501 . . . . 73.53 112.353 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 75' ' ' LEU . 3.4 tm? -57.27 -31.69 65.86 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.335 0.588 . . . . 74.42 110.659 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.564 ' O ' HG23 ' A' ' 80' ' ' VAL . 88.9 m-20 -60.07 -28.28 67.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.364 -0.835 . . . . 72.14 112.078 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.17 -38.02 69.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.591 -0.892 . . . . 51.43 108.591 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CD1' HD13 ' A' ' 26' ' ' ILE . 97.3 m-85 -67.9 -32.7 73.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.616 -0.72 . . . . 74.12 109.338 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 29.0 t70 -67.93 -30.8 70.21 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.191 -0.913 . . . . 63.2 110.538 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 76' ' ' ASN . 58.2 t -72.83 -22.32 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-O 121.259 0.552 . . . . 73.41 110.864 177.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.4 mm -70.19 -24.42 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.32 0.581 . . . . 75.13 110.803 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HG2' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -94.85 -171.72 2.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.767 -0.827 . . . . 74.41 108.767 176.747 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.49 -64.25 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 118.358 -1.877 . . . . 71.1 114.642 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -57.33 -46.25 83.45 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 117.521 0.66 . . . . 64.35 111.99 -173.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.484 ' O ' HG22 ' A' ' 110' ' ' VAL . 17.4 m-20 -154.8 12.38 0.38 Allowed 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.499 0.666 . . . . 70.43 109.222 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -116.06 147.6 41.1 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.641 -1.614 . . . . 75.11 106.641 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.471 ' OE2' ' HA ' ' A' ' 110' ' ' VAL . 11.4 pt-20 -133.5 138.72 46.26 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.432 -0.507 . . . . 73.13 111.7 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HB2' ' HG2' ' A' ' 82' ' ' GLU . 2.2 tmm_? -88.65 114.01 24.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.771 -0.649 . . . . 75.13 109.502 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.07 160.28 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.492 -0.776 . . . . 64.44 111.54 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 m -90.09 130.01 36.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.229 -0.656 . . . . 60.23 109.229 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.6 m -133.16 172.28 16.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 124.703 1.201 . . . . 75.3 108.043 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -121.07 127.78 51.99 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.875 -1.13 . . . . 60.31 110.032 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 38' ' ' LEU . 18.5 m -126.9 166.59 23.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.452 0.644 . . . . 61.24 110.519 -175.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 101' ' ' LYS . 73.0 t -105.56 113.58 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 107.807 -1.182 . . . . 72.33 107.807 172.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -78.51 89.55 4.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 108.539 -0.911 . . . . 72.52 108.539 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.446 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -48.28 -36.83 14.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.285 2.234 . . . . 64.45 112.012 -174.048 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -45.15 -48.26 12.28 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.239 0.962 . . . . 74.34 111.908 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -108.38 -3.83 17.93 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.308 -0.245 . . . . 73.35 111.219 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 m 66.13 28.65 10.17 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.898 0.879 . . . . 73.14 110.836 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -102.8 161.26 13.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.326 -0.852 . . . . 72.13 109.76 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.602 ' HG2' HG22 ' A' ' 94' ' ' VAL . 48.0 mtmt -98.0 133.85 41.91 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.063 -1.088 . . . . 71.34 108.063 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.22 139.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.439 0.638 . . . . 72.44 110.564 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.23 126.57 35.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.725 -1.213 . . . . 64.31 107.725 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.3 m -137.27 175.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.508 0.323 . . . . 72.44 110.419 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 44.4 mt-10 -105.2 153.28 21.76 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.979 -0.378 . . . . 75.24 109.979 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -156.01 176.79 12.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.694 0.283 . . . . 73.24 110.326 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -105.98 119.36 39.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 73.43 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 54' ' ' ILE . 27.6 m -119.3 -178.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 109.165 -0.68 . . . . 72.3 109.165 175.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.521 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 64.8 t-105 -100.62 137.09 39.48 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.586 -1.264 . . . . 63.05 107.586 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 85' ' ' ASP . 30.6 m -66.8 -20.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 113.636 0.976 . . . . 74.1 113.636 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -90.51 13.96 14.38 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.099 0.952 . . . . 74.12 109.027 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 60.3 pttt -49.62 -17.39 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.712 2.005 . . . . 64.21 115.17 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.08 -22.38 65.84 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.212 0.529 . . . . 74.23 110.439 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -118.0 140.69 28.18 Favored Pre-proline 0 CA--C 1.513 -0.458 0 N-CA-C 109.628 -0.508 . . . . 72.25 109.628 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.86 104.86 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.112 1.875 . . . . 74.31 110.346 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 116' ' ' ARG . 2.8 mmp_? -99.06 142.7 30.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.512 -0.313 . . . . 74.24 110.876 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.698 1.199 . . . . 70.31 109.307 -178.496 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 129' ' ' VAL . 46.9 mt-10 . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 112.389 0.514 . . . . 74.42 112.389 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.526 ' HA ' HG12 ' A' ' 129' ' ' VAL . 72.6 t-105 -59.86 -22.7 62.65 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-O 120.775 0.321 . . . . 73.33 110.254 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.61 -45.82 91.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.116 0.484 . . . . 51.34 110.38 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.41 -43.41 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 113.084 0.772 . . . . 61.43 113.084 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 126' ' ' TRP . 7.7 p -75.38 -18.89 15.94 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.22 0 N-CA-C 111.946 0.351 . . . . 72.24 111.946 -174.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 126' ' ' TRP . 9.4 t60 -48.45 -45.53 36.69 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 122.49 0.316 . . . . 74.14 110.6 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.26 -44.5 75.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.451 -0.34 . . . . 65.42 110.666 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.44 -44.14 97.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 74.4 110.821 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER -61.58 -55.51 30.05 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.556 -0.747 . . . . 72.52 110.74 -177.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.418 ' O ' ' HD1' ' A' ' 138' ' ' PHE . 81.1 m-85 -65.46 -32.66 74.39 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.808 1.41 . . . . 74.01 114.808 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.543 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 9.1 p -63.59 -42.19 95.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 118.913 -1.115 . . . . 62.41 109.331 176.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.07 -37.6 69.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.18 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 141' ' ' MET . 97.1 m -49.62 -51.41 37.76 Favored 'General case' 0 C--O 1.214 -0.816 0 O-C-N 123.518 0.511 . . . . 73.32 110.407 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.67 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 90.5 m-85 -70.54 -39.34 74.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.434 0.531 . . . . 74.54 112.434 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -63.44 -48.86 76.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.039 -0.264 . . . . 64.03 110.775 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.24 -35.66 80.99 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.876 -0.416 . . . . 72.34 109.876 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 137' ' ' THR . 46.9 tpp -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.956 -0.566 . . . . 70.22 109.57 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 80.4 mt -66.49 -41.65 88.63 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.987 -0.375 . . . . 71.31 109.987 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 34.3 mt-10 -65.98 -34.91 79.19 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.529 0.681 . . . . 72.52 110.024 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -75.42 -33.56 60.94 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.52 -0.764 . . . . 73.4 110.315 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -47.12 16.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.729 -0.669 . . . . 75.11 112.365 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.73 -32.25 41.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.456 -0.498 . . . . 74.14 109.724 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' GLU . 52.3 t30 58.4 84.23 0.21 Allowed Pre-proline 0 C--N 1.315 -0.917 0 C-N-CA 125.221 1.408 . . . . 72.14 114.434 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -93.43 -16.25 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.288 1.992 . . . . 75.25 112.245 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.67 -20.0 22.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.954 0.353 . . . . 73.44 111.954 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.059 0 C-N-CA 120.154 -1.022 . . . . 14.22 111.967 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 C--O 1.248 0.977 0 N-CA-C 114.271 1.211 . . . . 64.41 114.271 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.44 ' C ' HD22 ' A' ' 10' ' ' ASN . 82.6 m-70 -107.89 142.35 38.1 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.781 -1.1 . . . . 73.22 109.097 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.44 HD22 ' C ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -124.36 130.95 53.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.876 -1.157 . . . . 75.21 107.876 178.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 27.7 t -124.59 120.32 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 110.172 -0.307 . . . . 74.14 110.172 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.617 ' HB3' HG22 ' A' ' 106' ' ' THR . 41.5 t80 -83.02 117.71 23.01 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.449 -0.945 . . . . 72.42 108.449 174.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 17' ' ' ILE . 7.5 p -136.76 150.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.669 -0.696 . . . . 54.21 109.709 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -127.36 -10.08 5.77 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.522 -0.547 . . . . 65.21 109.522 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.07 -128.4 1.08 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 115.348 0.899 . . . . 74.21 115.348 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -62.83 -42.65 99.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.706 1.373 . . . . 60.44 114.706 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.582 HG21 HD13 ' A' ' 67' ' ' ILE . 30.4 mt -60.59 -21.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.427 0.899 . . . . 72.41 113.427 -171.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' CD1' HG13 ' A' ' 13' ' ' VAL . 7.2 mp -66.14 -20.58 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.961 0.41 . . . . 61.4 111.117 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.19 116.16 65.73 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 108.509 -0.923 . . . . 74.21 108.509 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -40.11 -38.78 2.23 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 125.096 3.864 . . . . 62.21 115.456 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -57.82 -47.27 83.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.924 0.392 . . . . 73.52 111.065 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.6 t -67.03 -43.56 88.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.723 -0.671 . . . . 50.0 110.48 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB1' ' CB ' ' A' ' 31' ' ' ALA . . . -62.59 -37.12 84.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.805 -0.634 . . . . 71.33 109.988 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -72.67 -29.57 63.52 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.81 -0.632 . . . . 64.52 111.867 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 21' ' ' ALA . 23.0 m -81.45 -25.06 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.554 -0.859 . . . . 62.41 111.424 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.463 ' C ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -82.93 -47.92 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 120.274 -0.571 . . . . 72.21 111.04 178.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 92.2 mt -92.96 -12.69 30.15 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.206 0.447 . . . . 71.23 112.206 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 t70 76.36 -6.57 1.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.37 1.081 . . . . 73.42 109.381 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.7 ptt180 -133.99 163.76 28.82 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 125.646 1.578 . . . . 72.4 106.747 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.8 m -76.72 127.81 33.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.237 -0.653 . . . . 42.03 109.237 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' CB ' ' HB1' ' A' ' 23' ' ' ALA . . . -75.72 144.93 41.26 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 120.887 0.375 . . . . 65.12 111.489 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.77 108.89 20.9 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.817 -0.809 . . . . 53.23 108.817 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.1 p -111.71 143.7 42.19 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 115.144 -0.934 . . . . 53.54 109.934 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.29 138.89 33.83 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 108.503 -0.925 . . . . 74.1 108.503 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.71 134.76 62.77 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.636 2.224 . . . . 75.23 111.653 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.31 156.21 41.11 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.597 -0.729 . . . . 13.11 109.738 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.42 126.58 75.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.593 0.711 . . . . 75.25 111.58 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 93' ' ' VAL . 22.6 tp -93.67 96.19 9.66 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.918 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.464 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 19.7 p80 -71.62 131.78 43.68 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.569 -0.901 . . . . 53.31 108.569 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 116.56 -22.87 10.66 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 117.854 -2.117 . . . . 73.21 113.151 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 156.17 24.47 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 120.939 0.399 . . . . 72.23 111.224 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -127.24 140.51 52.17 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.619 -0.719 . . . . 44.31 109.125 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -85.72 137.21 32.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.601 0.76 . . . . 65.44 109.809 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.33 145.78 49.22 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.858 -1.534 . . . . 72.43 106.858 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 25.1 pttm -90.43 -46.6 8.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.018 0.747 . . . . 64.45 113.018 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.537 ' HG ' HD22 ' A' ' 49' ' ' LEU . 2.7 mm? 60.77 179.99 0.1 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.98 0.912 . . . . 73.0 111.947 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.9 -43.22 0.81 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.372 0.606 . . . . 52.23 109.859 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.27 -13.44 76.73 Favored Glycine 0 N--CA 1.422 -2.234 0 CA-C-N 115.368 -0.833 . . . . 74.1 113.213 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.537 HD22 ' HG ' ' A' ' 46' ' ' LEU . 7.1 mp -89.73 163.29 33.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 122.69 -0.3 . . . . 71.25 110.604 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.18 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.881 2.387 . . . . 75.34 114.096 -173.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.86 75.87 75.03 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 122.61 1.195 . . . . 75.33 109.266 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CB ' ' SG ' ' A' ' 53' ' ' CYS 0.301 43.9 Cg_endo -113.2 165.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 125.071 3.847 . . . . 74.13 114.743 -171.161 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 69.6 m -156.06 175.87 13.4 Favored 'General case' 0 N--CA 1.505 2.288 1 C-N-CA 132.137 4.175 . . . . 73.03 104.82 -18.044 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 pt -123.94 143.31 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 120.199 -0.6 . . . . 64.04 110.505 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -131.56 146.22 33.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 m -59.49 113.43 2.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.562 0.745 . . . . 75.22 111.34 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -157.54 98.01 1.64 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.751 -1.203 . . . . 45.22 107.751 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 11.4 m-20 -62.4 -16.87 57.32 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.606 1.336 . . . . 75.24 114.606 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -75.35 -17.77 60.16 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.224 0.535 . . . . 71.45 109.953 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.51 164.1 12.11 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.808 -0.633 . . . . 62.42 112.451 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 28.6 mtmm -143.77 152.09 40.81 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.027 -1.471 . . . . 71.2 107.027 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.2 123.1 71.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.328 -0.619 . . . . 75.44 109.328 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.23 126.67 46.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.369 -0.604 . . . . 61.11 109.369 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.9 -138.42 2.55 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 110.485 -1.046 . . . . 44.44 110.485 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 97.4 mttt -138.49 147.43 43.19 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 117.502 0.651 . . . . 64.43 110.785 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 31.2 m -105.41 133.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.829 -0.623 . . . . 63.33 109.833 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.582 HD13 HG21 ' A' ' 17' ' ' ILE . 6.4 mt -87.14 110.63 20.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 104.189 -2.523 . . . . 64.32 104.189 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 p -104.42 167.21 9.89 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 116.424 -0.353 . . . . 74.13 111.025 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.07 38.29 95.86 Favored Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.603 0.564 . . . . 72.43 112.935 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.96 122.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.61 -0.885 . . . . 72.34 108.61 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.45 ' HB3' ' HG2' ' A' ' 74' ' ' GLU . 32.2 t -72.69 163.34 28.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.151 -0.685 . . . . 64.34 109.151 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.87 -38.42 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.206 -0.294 . . . . 71.15 110.206 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.4 71.84 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.936 0.874 . . . . 64.43 110.221 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.1 mm-40 -76.46 -38.24 55.71 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.811 -1.086 . . . . 65.03 110.022 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.526 HD21 HH12 ' A' ' 88' ' ' ARG . 3.1 tm? -65.21 -38.37 90.25 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.571 -0.74 . . . . 72.52 109.709 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 80' ' ' VAL . 94.9 m-20 -57.53 -27.58 62.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.026 -0.988 . . . . 64.43 112.725 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -75.38 -30.87 60.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.011 -1.076 . . . . 72.5 109.741 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -67.1 -30.34 70.34 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.698 -0.853 . . . . 74.11 108.698 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.84 -31.63 68.4 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.02 -0.991 . . . . 75.31 110.087 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 76' ' ' ASN . 94.7 t -65.65 -35.25 74.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.649 -0.705 . . . . 75.45 109.626 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -58.62 -54.87 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.162 -0.681 . . . . 73.42 109.162 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 66.86 166.15 0.22 Allowed 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 123.672 0.789 . . . . 72.23 112.642 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.83 20.3 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.654 -0.979 . . . . 32.21 110.654 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.89 -43.51 71.63 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.6 0.593 . . . . 72.13 112.6 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.688 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 15.5 t70 -143.73 34.18 1.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.498 -1.667 . . . . 63.22 106.498 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 55.7 m-85 -115.42 150.38 36.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.013 -1.449 . . . . 75.34 108.468 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.68 158.33 44.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.599 -0.519 . . . . 72.21 109.599 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 106' ' ' THR . 37.4 mtt180 -84.22 124.65 31.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 112.776 0.658 . . . . 75.43 112.776 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.7 150.05 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 CA-C-N 115.298 -0.864 . . . . 65.24 108.722 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.1 m -94.42 122.78 37.34 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.449 -0.945 . . . . 72.24 108.449 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.421 HG21 HD22 ' A' ' 38' ' ' LEU . 20.1 m -123.81 163.12 23.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 106.56 -1.645 . . . . 70.21 106.56 -176.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -115.23 132.05 56.73 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 117.872 -1.531 . . . . 55.15 109.42 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' LEU . 18.7 m -126.35 169.5 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 109.133 -0.691 . . . . 73.44 109.133 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.537 HG22 ' HG3' ' A' ' 101' ' ' LYS . 58.8 t -106.1 117.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.209 -0.663 . . . . 62.42 109.209 173.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -72.45 90.04 1.29 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.194 -1.41 . . . . 64.13 107.194 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.62 -36.83 57.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.145 1.378 . . . . 54.13 111.714 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -51.41 -27.75 10.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.484 0.714 . . . . 73.25 112.713 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -134.11 9.44 3.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 63.01 109.679 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m 56.76 17.55 3.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.106 0.962 . . . . 61.0 113.489 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -92.58 160.78 14.87 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.618 -0.512 . . . . 61.42 109.618 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.537 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.3 mptt -100.52 132.68 45.78 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 108.129 -1.063 . . . . 73.43 108.129 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.09 138.48 30.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.249 0.547 . . . . 72.51 110.874 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.39 122.55 32.71 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.417 -0.957 . . . . 63.34 108.417 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.503 HG21 ' HB2' ' A' ' 12' ' ' PHE . 23.3 m -131.22 169.39 21.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.628 0.251 . . . . 73.34 111.22 -172.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.94 148.55 26.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.926 -0.398 . . . . 74.02 109.926 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 66.0 p -141.15 173.72 11.21 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 123.197 0.311 . . . . 62.11 111.623 -176.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.4 118.19 36.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.759 -1.571 . . . . 74.21 106.759 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 13.2 p -113.43 159.89 13.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.702 -0.851 . . . . 73.04 108.702 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.688 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 52.1 t-105 -83.14 118.49 23.61 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.844 -1.539 . . . . 71.01 106.844 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.9 m -62.73 -19.64 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.641 0.608 . . . . 63.4 112.641 -174.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.525 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 7.9 t30 -85.79 12.14 9.69 Favored 'General case' 0 C--O 1.199 -1.578 0 C-N-CA 123.996 0.918 . . . . 70.03 109.853 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.48 -15.12 0.22 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.798 2.148 . . . . 72.51 116.798 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.24 -14.4 55.57 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.521 -0.472 . . . . 73.03 110.759 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -115.36 124.58 29.91 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 123.727 0.811 . . . . 73.31 109.148 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -90.15 128.5 1.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.588 2.192 . . . . 61.11 113.255 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -131.07 118.01 19.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.887 -0.597 . . . . 70.25 110.176 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 51.6 ttm . . . . . 0 N--CA 1.479 1.017 0 O-C-N 124.238 0.961 . . . . 75.03 111.515 178.39 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.496 ' O ' HG22 ' A' ' 128' ' ' VAL . 11.3 tp10 . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.509 0.671 . . . . 71.24 109.223 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -58.23 -33.44 69.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 72.52 111.52 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -57.51 -36.08 71.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.043 -0.526 . . . . 74.03 112.227 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 125' ' ' GLU . 15.9 m -84.24 -29.96 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 119.96 -0.696 . . . . 74.32 110.534 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.54 -42.36 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.731 -0.668 . . . . 74.42 109.462 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.5 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.8 t60 -54.51 -38.37 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.675 -0.693 . . . . 64.34 110.733 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.51 50.83 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.55 -0.295 . . . . 74.21 111.159 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 40.8 mt-10 -69.47 -30.93 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.482 -0.487 . . . . 65.44 112.117 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -68.39 -50.67 51.33 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.06 -0.718 . . . . 70.35 109.06 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.5 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 69.3 m-85 -67.39 -31.21 71.27 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.473 1.286 . . . . 71.43 114.473 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.94 -42.03 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 119.052 -1.059 . . . . 75.42 111.477 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -70.06 -42.57 72.66 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.882 -0.327 . . . . 73.14 110.859 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 141' ' ' MET . 98.5 m -60.92 -42.01 97.3 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.417 -0.356 . . . . 75.32 110.753 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -57.6 -50.11 74.2 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.032 -0.358 . . . . 70.41 110.032 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 88.2 mtt180 -60.59 -46.54 89.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.556 . . . . 74.13 111.028 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.69 -33.03 74.93 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.592 0.59 . . . . 74.43 112.592 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 137' ' ' THR . 91.7 mtp -65.03 -36.27 83.83 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.88 -0.328 . . . . 71.33 110.578 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.4 -35.8 73.68 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 111.716 0.265 . . . . 72.15 111.716 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 23.9 mm-40 -62.86 -45.05 94.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 63.02 109.539 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -71.27 -29.36 64.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.249 -0.887 . . . . 73.2 110.783 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -71.99 -34.43 68.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.305 0.574 . . . . 65.51 109.769 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.97 -32.2 45.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.868 -0.605 . . . . 75.43 110.644 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -149.5 112.64 3.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 116.362 -0.381 . . . . 74.22 110.143 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.4 -23.55 76.99 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.805 2.336 . . . . 73.13 111.789 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -93.51 9.12 37.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.844 -0.616 . . . . 75.33 110.238 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 CA-C-N 115.84 -0.618 . . . . 53.12 112.649 -178.824 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.424 -1.769 0 CA-C-O 121.638 0.732 . . . . 71.32 110.498 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -89.5 153.31 20.9 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.844 -1.071 . . . . 65.13 111.402 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 36.7 m-80 -135.0 122.34 21.71 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.002 -1.851 . . . . 74.24 106.002 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 38.9 t -115.62 122.58 69.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 121.107 -0.237 . . . . 63.12 111.045 -173.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.49 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.7 t80 -87.48 108.22 18.92 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.857 -1.164 . . . . 71.43 107.857 175.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.83 149.18 33.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 120.974 0.416 . . . . 50.4 110.072 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.82 105.07 10.37 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.928 -1.138 . . . . 63.42 107.928 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.456 ' H ' ' CD1' ' A' ' 18' ' ' LEU . . . 87.44 -163.17 33.86 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.337 -0.705 . . . . 52.51 111.337 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t 70.0 -62.02 0.44 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.538 1.135 . . . . 75.03 113.785 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 67' ' ' ILE . 2.7 pp -129.84 9.17 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.157 0.799 . . . . 74.33 113.157 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 65' ' ' LYS . 48.0 mt -64.42 -13.98 54.22 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.291 0.848 . . . . 74.45 113.291 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.56 124.51 83.77 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.112 -1.07 . . . . 70.51 108.112 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.79 -41.64 31.39 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.71 2.94 . . . . 73.21 114.047 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.475 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -65.61 -32.71 74.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 52.23 110.806 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.2 -43.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.06 -0.518 . . . . 74.33 110.14 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.68 70.73 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.395 0.616 . . . . 53.41 109.555 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.96 75.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.51 -0.768 . . . . 62.51 111.652 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 21' ' ' ALA . 18.1 m -72.69 -31.46 37.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 120.277 -0.569 . . . . 73.3 112.075 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.589 HD13 ' CD1' ' A' ' 78' ' ' PHE . 7.8 tt -73.57 -36.77 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.925 0.393 . . . . 63.31 111.799 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 74' ' ' GLU . 92.0 mt -100.25 -10.75 21.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 113.767 1.025 . . . . 72.35 113.767 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.3 18.25 10.24 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.972 1.368 . . . . 72.03 108.665 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -160.45 140.74 11.5 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 105.539 -2.023 . . . . 75.5 105.539 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -76.53 118.51 19.27 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.551 -0.86 . . . . 73.23 108.808 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -93.04 147.98 22.39 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 116.188 -0.46 . . . . 63.44 109.877 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -88.67 114.16 25.0 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.299 -0.864 . . . . 75.2 111.181 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.431 ' HB ' ' HE3' ' A' ' 65' ' ' LYS . 4.2 p -100.79 143.43 30.95 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.533 -0.758 . . . . 71.25 109.527 174.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.52 140.03 37.43 Favored Pre-proline 0 C--N 1.277 -2.552 0 N-CA-C 109.219 -0.66 . . . . 51.22 109.219 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 39.7 Cg_endo -67.29 132.14 26.81 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.869 1.713 . . . . 75.51 110.671 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.551 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -145.58 156.1 43.47 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.23 -0.895 . . . . 72.11 109.029 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 11.3 p -120.47 128.24 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 CA-C-O 121.681 0.753 . . . . 74.41 110.979 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.463 ' HA ' HG12 ' A' ' 93' ' ' VAL . 23.1 tp -87.43 108.91 19.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.096 -0.957 . . . . 75.41 109.631 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -83.78 125.48 31.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.912 -1.04 . . . . 74.1 109.053 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 117.34 -13.74 13.65 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 118.277 -1.916 . . . . 52.33 113.611 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.516 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 39.1 m-85 -124.96 159.61 30.82 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 110.034 -0.358 . . . . 74.31 110.034 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 11.3 t-80 -130.16 137.26 50.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 120.014 -0.674 . . . . 75.34 109.679 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 44' ' ' TYR . 3.2 tmm_? -88.9 129.51 35.59 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.157 -1.053 . . . . 64.1 108.157 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.45 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 46.9 m-85 -95.5 152.88 18.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.642 -0.708 . . . . 71.23 110.979 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 6.1 tmtm? -84.91 -30.27 24.5 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.766 -0.827 . . . . 75.25 108.766 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.39 -166.26 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.438 0.695 . . . . 73.05 111.03 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.83 -42.93 2.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.335 -0.987 . . . . 73.32 108.335 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.81 -8.67 53.99 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.485 -0.864 . . . . 74.31 113.755 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.83 126.32 29.32 Favored Pre-proline 0 C--N 1.321 -0.648 0 O-C-N 122.521 -0.399 . . . . 55.41 110.475 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -83.49 -44.93 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.94 2.427 . . . . 75.32 112.267 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.677 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.9 p90 -113.67 172.11 3.83 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 105.59 -2.004 . . . . 65.33 105.59 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.308 0.0 OUTLIER 30.36 168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.593 3.466 0 C-N-CA 124.376 3.384 . . . . 63.44 118.713 -161.236 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 10.5 p -122.58 -175.29 3.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 119.623 -1.923 . . . . 71.11 112.513 8.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 30.1 pt -123.64 132.34 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.822 -1.081 . . . . 74.22 108.788 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 27.4 m -150.46 116.48 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.191 0 O-C-N 123.203 0.314 . . . . 73.22 111.521 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.6 t 55.91 -158.59 0.23 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.182 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.9 m 71.88 80.2 0.15 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.541 1.536 . . . . 70.23 111.23 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.584 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 p-10 -73.49 -10.26 59.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.613 0.72 . . . . 61.54 110.094 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.9 t -83.85 -6.16 59.36 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.0 -1.0 . . . . 73.34 109.097 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.69 164.74 13.36 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.864 -0.684 . . . . 62.53 112.246 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -142.15 147.17 36.22 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.029 -1.471 . . . . 72.4 107.029 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 41' ' ' TYR . 58.1 t -121.04 122.95 68.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 110.104 -0.332 . . . . 72.23 110.104 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -92.4 118.11 30.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.454 -0.943 . . . . 73.13 108.454 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -145.21 -152.96 5.74 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.048 -1.221 . . . . 72.4 110.048 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 18' ' ' LEU . 30.3 mtpp -137.4 138.82 40.25 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.315 -0.624 . . . . 73.34 109.315 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.3 m -103.95 133.68 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.766 -0.652 . . . . 54.32 109.602 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 17' ' ' ILE . 4.5 mt -87.4 119.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 105.292 -2.114 . . . . 62.13 105.292 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.4 p -106.43 160.48 15.36 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.277 -0.969 . . . . 75.13 111.5 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.89 39.84 85.1 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.902 -0.59 . . . . 70.11 112.46 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -103.83 123.57 57.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 N-CA-C 110.26 -0.274 . . . . 55.51 110.26 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.5 t -73.85 162.42 29.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.582 -0.895 . . . . 55.15 108.582 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.48 -39.3 79.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.015 0.436 . . . . 75.23 109.889 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.52 -32.47 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 40.01 109.84 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.667 ' HB3' HD22 ' A' ' 27' ' ' LEU . 52.8 mt-10 -76.98 -40.23 47.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.27 -0.877 . . . . 63.41 111.508 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.1 tt -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.036 -1.098 . . . . 72.52 108.036 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.591 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.0 t-20 -53.83 -31.55 49.75 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.922 -1.49 . . . . 74.43 110.933 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -31.69 67.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 120.622 -0.431 . . . . 72.25 109.974 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CD1' HD13 ' A' ' 26' ' ' ILE . 90.2 m-85 -72.35 -40.36 67.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.598 -0.89 . . . . 55.42 108.598 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.88 -29.42 70.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.571 -1.195 . . . . 70.14 111.98 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 76' ' ' ASN . 95.5 t -52.63 -22.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 124.036 0.934 . . . . 73.14 112.295 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.96 -29.88 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 N-CA-C 109.661 -0.496 . . . . 71.54 109.661 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 55.53 96.74 0.02 OUTLIER 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.663 1.585 . . . . 73.35 113.836 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.14 107.77 3.46 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 108.704 -1.759 . . . . 43.52 108.704 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.98 -35.42 76.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.323 0.562 . . . . 64.11 112.316 -175.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 109' ' ' TRP . 15.1 m-20 -101.59 17.96 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.055 0.455 . . . . 73.41 110.453 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -115.19 141.98 47.29 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.89 -0.411 . . . . 74.02 109.89 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -131.67 143.84 50.58 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.759 -0.83 . . . . 64.34 108.759 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 106' ' ' THR . 55.4 mtm180 -82.92 113.1 20.29 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.591 -0.444 . . . . 44.15 112.169 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.5 m -116.34 153.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.399 -0.819 . . . . 71.34 110.322 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.2 m -90.46 123.44 34.17 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.853 -0.795 . . . . 72.21 108.853 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.34 171.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.548 -1.278 . . . . 62.3 107.548 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -125.23 123.56 39.8 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.948 -1.501 . . . . 72.44 106.948 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 38' ' ' LEU . 13.7 m -126.81 163.07 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 121.504 0.669 . . . . 73.3 109.976 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 101' ' ' LYS . 53.7 t -107.69 118.42 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.73 -0.668 . . . . 53.5 109.904 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.43 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 40.9 ttm180 -66.04 98.83 0.46 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.965 -1.494 . . . . 64.11 106.965 175.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.551 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -60.48 -36.27 77.89 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 125.03 1.332 . . . . 73.01 110.283 -170.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.7 -41.85 70.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.573 -0.74 . . . . 73.23 112.212 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.14 -1.55 12.97 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.415 0.626 . . . . 73.52 110.952 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 t 64.42 23.12 12.9 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.993 0.917 . . . . 72.31 111.451 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.3 pt-20 -96.59 161.39 13.92 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.88 -0.415 . . . . 73.31 109.88 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.499 ' HG2' HG22 ' A' ' 94' ' ' VAL . 48.0 mtpt -105.03 130.84 53.14 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.718 -0.475 . . . . 74.14 109.718 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.42 130.92 54.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.722 0.772 . . . . 65.13 111.277 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -87.52 120.29 28.67 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.022 -1.473 . . . . 71.13 107.022 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.517 HG12 ' HB2' ' A' ' 10' ' ' ASN . 27.2 m -133.83 172.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.755 0.312 . . . . 60.2 111.17 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.4 152.57 23.43 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.774 -0.454 . . . . 64.53 109.774 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.0 t -151.91 174.64 13.36 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.658 -0.867 . . . . 61.05 108.658 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.1 118.42 36.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.204 -1.036 . . . . 61.53 108.204 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.42 153.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.836 -0.801 . . . . 71.23 108.836 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.603 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 63.7 t-105 -81.9 121.4 26.43 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.395 -1.335 . . . . 72.32 107.395 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.76 -20.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.402 0.89 . . . . 72.43 113.402 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.577 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 28.5 t-20 -80.57 11.35 3.81 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-O 121.702 0.763 . . . . 73.35 109.962 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -50.7 -25.67 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.918 1.287 . . . . 74.03 114.064 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.19 -6.78 57.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.081 0.467 . . . . 75.22 111.669 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.633 ' OD1' ' HB2' ' A' ' 116' ' ' ARG . 12.6 t70 -102.23 128.38 28.55 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 106.062 -1.829 . . . . 70.43 106.062 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.31 46.06 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.229 2.62 . . . . 70.22 111.978 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.633 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 14.2 ttm180 -95.29 115.39 27.37 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.246 -0.888 . . . . 73.33 111.872 -172.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 125.069 1.348 . . . . 74.23 114.546 175.685 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.223 -0.306 0 N-CA-C 109.162 -0.681 . . . . 71.42 109.162 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.42 ' HA ' HG12 ' A' ' 129' ' ' VAL . 75.3 t90 -56.09 -41.95 75.98 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.781 -0.645 . . . . 73.25 110.976 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -60.27 -41.26 92.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.725 -0.67 . . . . 74.3 111.224 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -82.95 -41.63 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.638 -0.425 . . . . 72.35 111.916 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 126' ' ' TRP . 13.0 p -68.82 -40.11 80.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 112.767 0.654 . . . . 74.34 112.767 -174.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -65.17 -35.25 80.49 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 118.882 -1.127 . . . . 74.4 110.645 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -64.3 -55.1 23.63 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.434 0.459 . . . . 62.43 111.03 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -23.42 64.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.168 0.433 . . . . 65.44 112.168 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.618 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.4 tpmt? -67.24 -45.3 77.13 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.78 -0.822 . . . . 73.33 108.78 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -67.47 -33.18 74.6 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.836 -0.345 . . . . 73.02 111.276 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 98.1 t -53.68 -53.19 27.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.11 -0.7 . . . . 73.02 109.11 173.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.95 -42.42 89.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.671 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.7 m -54.96 -50.51 68.74 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.775 0.672 . . . . 71.34 110.463 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -68.35 -29.85 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.162 0.43 . . . . 72.34 112.162 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -68.23 -44.73 75.08 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.463 0.649 . . . . 61.51 109.729 177.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -71.23 -42.09 69.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 75.44 110.378 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.2 mmt -62.53 -31.45 72.22 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-N 116.344 -0.389 . . . . 74.31 110.844 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.46 -50.05 74.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.58 0.752 . . . . 73.43 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.44 -34.37 75.85 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.165 -0.614 . . . . 72.4 111.631 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -75.18 -27.18 59.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.183 0.516 . . . . 73.3 112.035 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -72.88 -37.3 67.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.483 0.713 . . . . 75.32 109.318 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 146' ' ' LYS . 11.3 tmtt? -78.95 -33.0 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.315 -0.624 . . . . 74.22 109.315 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -137.9 95.05 11.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 120.927 0.394 . . . . 73.23 110.628 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.03 -16.61 9.83 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.615 2.21 . . . . 75.05 111.175 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.22 -23.26 61.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.369 -0.832 . . . . 75.04 111.292 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.609 0 C-N-CA 120.454 -0.879 . . . . 65.52 112.506 -179.723 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 106.571 -1.64 . . . . 74.32 106.571 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.638 ' HD1' ' HG ' ' A' ' 75' ' ' LEU . 8.4 m170 -104.23 156.0 18.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.049 -0.523 . . . . 74.13 110.581 -172.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.578 ' HB2' HG12 ' A' ' 104' ' ' VAL . 25.2 m-80 -134.93 133.42 39.55 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.466 -1.679 . . . . 71.43 106.466 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.408 ' HB ' HD12 ' A' ' 67' ' ' ILE . 47.6 t -114.79 121.02 66.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.563 -0.455 . . . . 72.2 111.213 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.535 ' HB2' HG21 ' A' ' 104' ' ' VAL . 59.3 t80 -89.75 98.83 11.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.302 -0.629 . . . . 75.34 109.302 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.48 129.98 31.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.832 -0.803 . . . . 63.23 108.832 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.562 ' CD1' ' HA2' ' A' ' 64' ' ' GLY . 48.2 t80 -105.89 86.17 2.34 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.544 -0.863 . . . . 65.42 110.127 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.76 147.18 4.48 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.652 -1.158 . . . . 75.44 112.367 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t 70.67 -69.34 0.18 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.489 1.515 . . . . 73.41 113.718 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.586 HG21 HD13 ' A' ' 67' ' ' ILE . 28.3 mt -75.96 3.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.027 0.918 . . . . 73.43 110.407 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -67.99 -23.04 64.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.568 -0.742 . . . . 74.45 109.159 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.63 119.94 74.52 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 108.565 -0.902 . . . . 71.21 108.565 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -48.55 -35.96 30.41 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.67 2.913 . . . . 53.14 112.54 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -60.37 -40.29 90.27 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.455 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 25' ' ' VAL . 70.9 t -70.46 -39.71 76.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.356 0.598 . . . . 74.3 110.056 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -66.43 -35.32 80.01 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.378 -0.601 . . . . 72.14 109.378 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -74.28 -10.14 59.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 72.34 112.038 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 21' ' ' ALA . 21.1 m -100.04 -31.68 3.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.346 -0.942 . . . . 72.33 110.513 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.553 HD13 ' CD2' ' A' ' 78' ' ' PHE . 9.9 tt -79.08 -42.96 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.153 0.501 . . . . 75.11 111.582 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 31' ' ' ALA . 95.8 mt -94.97 -21.38 18.65 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.156 -0.34 . . . . 74.24 110.319 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 28.2 t70 67.59 15.98 9.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 123.598 1.666 . . . . 52.31 107.723 -170.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -133.31 131.56 40.3 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.457 -2.053 . . . . 74.33 105.457 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -76.74 111.43 12.24 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.996 -1.082 . . . . 70.4 109.196 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -96.87 143.09 28.09 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.647 -0.706 . . . . 72.35 109.264 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.78 129.06 45.86 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.852 -0.796 . . . . 74.21 108.852 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 12.7 p -93.34 141.83 28.0 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 119.487 -0.885 . . . . 74.04 108.878 175.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.72 140.02 34.62 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.703 -0.851 . . . . 71.34 108.703 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.73 128.94 28.64 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.778 2.319 . . . . 64.13 111.969 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.24 154.45 37.95 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.902 -0.59 . . . . 35.13 109.518 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.85 131.92 71.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 C-N-CA 120.752 -0.379 . . . . 74.13 110.384 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.454 HD11 ' HB ' ' A' ' 91' ' ' VAL . 20.9 tp -94.32 129.98 40.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.022 -0.535 . . . . 75.03 110.531 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -94.59 129.97 41.22 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.446 -0.343 . . . . 63.54 111.232 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 58' ' ' ASP . . . 105.4 -1.43 40.01 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 119.52 -1.324 . . . . 74.1 113.771 173.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.499 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 56.9 m-85 -126.59 160.76 29.73 Favored 'General case' 0 N--CA 1.414 -2.252 0 O-C-N 122.313 -0.522 . . . . 64.23 112.074 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -134.17 130.97 38.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.387 -1.338 . . . . 74.03 107.387 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.83 124.98 34.7 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.06 0.457 . . . . 74.1 111.208 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HE2' ' O ' ' A' ' 55' ' ' VAL . 93.6 m-85 -106.67 145.17 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.897 -1.149 . . . . 62.01 107.897 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 4.3 mmmp? -109.92 125.02 52.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 112.355 0.502 . . . . 73.43 112.355 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.407 HD23 ' HB2' ' A' ' 52' ' ' PRO . 1.4 mm? -131.83 141.67 49.49 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.189 -1.041 . . . . 71.34 108.189 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -90.65 -30.04 17.38 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.818 -0.808 . . . . 52.34 108.818 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -31.76 76.98 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.806 -1.088 . . . . 71.43 112.222 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.43 ' HB2' ' HG3' ' A' ' 52' ' ' PRO . 6.4 mp -90.98 158.45 41.76 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 108.407 -0.96 . . . . 63.5 108.407 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.94 -76.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.849 2.366 . . . . 71.01 114.216 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.62 76.26 69.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.964 -1.124 . . . . 75.24 107.964 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HG3' ' HB2' ' A' ' 49' ' ' LEU 0.257 51.9 Cg_endo -115.52 162.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 123.432 2.754 . . . . 72.31 116.19 -171.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 m -158.01 158.21 34.43 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.205 3.402 . . . . 71.54 107.152 -19.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 108' ' ' VAL . 33.2 pt -124.09 128.33 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.638 -0.825 . . . . 72.33 111.888 174.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 24.2 m -154.58 145.75 13.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 124.342 1.057 . . . . 63.44 108.458 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 p 168.14 -57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.194 0.934 . . . . 72.04 110.671 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 m 69.8 13.6 8.06 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.363 1.078 . . . . 74.34 108.337 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.663 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 26.6 t70 -83.28 -178.05 6.95 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 113.938 -1.483 . . . . 71.24 109.715 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.0 m -80.42 -6.88 58.77 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.684 0.278 . . . . 70.44 110.889 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.42 156.17 31.1 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.887 -0.597 . . . . 74.03 111.971 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -129.03 152.91 48.12 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.895 -0.409 . . . . 71.3 109.895 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 122.53 67.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.295 -1.002 . . . . 72.33 108.295 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -97.77 115.64 28.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.426 -0.583 . . . . 73.14 109.426 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.562 ' HA2' ' CD1' ' A' ' 14' ' ' TYR . . . -146.44 -147.4 4.57 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.953 -0.641 . . . . 75.24 111.993 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 47.9 mtpt -139.68 146.21 39.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.213 -1.032 . . . . 71.31 108.213 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 33' ' ' THR . 35.2 m -104.72 135.14 43.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.165 -0.471 . . . . 64.54 110.883 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.586 HD13 HG21 ' A' ' 17' ' ' ILE . 6.4 mt -86.27 111.8 21.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.762 -2.31 . . . . 64.42 104.762 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -99.44 161.64 13.5 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.495 -0.482 . . . . 71.21 111.694 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.41 35.32 37.6 Favored Glycine 0 C--O 1.245 0.789 0 CA-C-N 115.752 -0.658 . . . . 64.2 112.927 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t -97.37 124.82 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.02 -0.734 . . . . 63.44 109.02 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.0 m -77.95 157.92 29.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.553 -0.906 . . . . 74.41 108.553 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HA ' ' CE1' ' A' ' 9' ' ' HIS . 7.3 p-10 -56.45 -42.74 78.64 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.211 0.529 . . . . 72.41 112.191 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.47 70.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.017 -0.992 . . . . 71.33 110.801 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.58 -30.02 62.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.516 -0.766 . . . . 60.3 110.793 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.638 ' HG ' ' HD1' ' A' ' 9' ' ' HIS . 3.0 tm? -58.21 -35.08 71.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.278 -0.873 . . . . 72.04 109.369 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.575 ' O ' HG23 ' A' ' 80' ' ' VAL . 5.4 m-20 -59.46 -27.53 66.17 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.357 -0.838 . . . . 63.12 111.919 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.485 ' OD1' HG13 ' A' ' 26' ' ' ILE . 1.9 t-20 -68.08 -31.61 71.35 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.219 -0.659 . . . . 74.25 109.219 -176.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 26' ' ' ILE . 80.1 m-85 -74.46 -32.28 62.54 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 121.68 0.752 . . . . 72.21 109.007 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.83 -31.26 63.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.159 -0.928 . . . . 63.23 110.241 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 76' ' ' ASN . 98.1 t -66.65 -22.67 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 115.64 -0.709 . . . . 70.34 110.848 175.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.8 mm -58.96 143.22 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.915 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.41 113.71 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.742 1.617 . . . . 72.23 113.266 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.77 85.35 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.561 -0.828 . . . . 42.3 113.266 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -82.55 -33.17 28.22 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.632 -0.334 . . . . 65.14 111.576 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.537 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.5 m-20 -97.75 2.43 49.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.609 0.966 . . . . 74.45 113.609 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.431 ' HD2' ' HB3' ' A' ' 107' ' ' TYR 0.326 1.6 p90 -122.18 142.31 50.55 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.14 -1.024 . . . . 75.12 111.114 171.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 15.5 pt-20 -125.03 159.45 31.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.159 -170.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.403 ' CD ' HD11 ' A' ' 75' ' ' LEU . 30.3 ttp-105 -88.85 128.62 35.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.805 -0.443 . . . . 63.44 109.805 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.35 159.78 40.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 122.634 0.374 . . . . 75.43 110.504 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.7 m -93.67 129.43 39.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.986 -0.746 . . . . 71.31 108.986 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.454 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.8 m -136.48 157.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.918 -1.141 . . . . 72.54 107.918 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.51 ' HG3' ' HD3' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -105.18 135.65 46.15 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.276 -0.97 . . . . 54.01 108.762 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 38' ' ' LEU . 21.8 m -127.36 161.94 33.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.704 -0.85 . . . . 65.34 108.704 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 101' ' ' LYS . 71.6 t -102.44 120.1 51.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 109.005 -0.739 . . . . 63.2 109.005 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -71.91 93.12 1.31 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.476 -1.676 . . . . 72.32 106.476 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -47.84 -49.54 28.91 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 127.262 2.225 . . . . 72.13 115.049 -167.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.88 -23.12 58.34 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.166 -0.614 . . . . 65.22 111.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -97.83 -10.89 23.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.3 -0.409 . . . . 62.34 110.864 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 m 59.26 19.49 7.61 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.464 1.106 . . . . 73.45 112.336 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -105.19 160.78 14.81 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.938 -0.393 . . . . 75.3 109.938 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.3 mtmt -100.31 143.21 30.76 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.618 -0.882 . . . . 73.21 108.618 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.75 162.23 15.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.301 -0.629 . . . . 51.33 109.301 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HD3' ' HG3' ' A' ' 92' ' ' GLU . 3.6 tppp? -110.69 123.83 50.78 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.101 -1.074 . . . . 74.44 108.101 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 10' ' ' ASN . 21.2 m -130.97 174.37 13.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.837 0.351 . . . . 73.42 110.564 -174.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -112.11 146.91 37.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.077 -0.712 . . . . 74.33 109.077 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.4 t -149.26 174.03 12.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.085 -1.08 . . . . 75.42 108.085 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.431 ' HB3' ' HD2' ' A' ' 86' ' ' TYR . 90.1 m-85 -113.43 119.55 38.0 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.61 0.719 . . . . 64.53 110.542 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 54' ' ' ILE . 14.0 p -114.0 143.79 22.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.975 -1.011 . . . . 70.31 109.747 -175.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.686 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 61.0 t-105 -70.01 127.86 34.31 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.57 -0.9 . . . . 75.41 108.57 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 85' ' ' ASP . 31.6 m -72.02 -19.82 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.519 0.676 . . . . 72.14 112.559 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.686 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -86.83 15.64 5.62 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 125.216 1.406 . . . . 71.31 109.29 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 0.8 OUTLIER -48.27 -22.96 0.76 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.23 1.812 . . . . 72.43 113.85 -176.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -101.71 68.51 1.16 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.551 -0.859 . . . . 73.32 110.984 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -128.56 144.38 51.93 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 114.798 -1.092 . . . . 74.14 108.331 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.35 -33.2 84.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 53.44 113.642 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.559 ' O ' ' HD2' ' A' ' 116' ' ' ARG 0.265 0.0 OUTLIER -133.26 114.22 13.53 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.112 1.153 . . . . 64.13 114.112 -178.463 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.436 ' HE2' ' HA ' ' A' ' 117' ' ' MET . 1.7 mmt . . . . . 0 CA--C 1.495 -1.146 0 CA-C-N 115.83 -0.623 . . . . 71.21 110.342 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 108.571 -0.9 . . . . 74.11 108.571 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -86.96 -23.84 24.94 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.467 -0.788 . . . . 74.31 109.546 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -59.49 -45.7 90.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 62.24 110.391 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.6 m -64.18 -19.75 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 116.362 -0.381 . . . . 73.13 111.956 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.3 -22.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.13 0.491 . . . . 63.21 110.552 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.474 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 5.2 p-80 -115.79 -33.12 5.25 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.695 -0.802 . . . . 74.33 112.952 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -59.4 -55.73 31.0 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.811 0.671 . . . . 55.22 112.811 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.49 -34.07 77.37 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.694 -0.402 . . . . 74.43 111.855 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.482 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 1.1 tmtp? -61.55 -50.31 73.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.107 -0.701 . . . . 73.14 109.107 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 84.3 m-85 -69.37 -31.99 70.74 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.052 0.39 . . . . 51.43 112.052 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 131' ' ' ALA . 97.7 t -60.01 -38.66 77.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.061 -0.348 . . . . 62.41 110.061 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 12.8 mm-40 -57.39 -48.13 79.87 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.698 -0.482 . . . . 71.54 109.698 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' A' ' 141' ' ' MET . 34.8 m -57.51 -46.67 83.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.335 -0.848 . . . . 75.4 110.412 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.402 ' O ' HD23 ' A' ' 142' ' ' LEU . 74.1 m-85 -61.47 -48.51 80.79 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.809 -0.356 . . . . 71.5 111.569 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -54.61 -47.51 73.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.703 0.287 . . . . 64.12 110.822 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 75.4 mmtt -66.9 -42.96 84.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.684 -0.689 . . . . 45.35 111.909 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 137' ' ' THR . 60.5 mtm -66.52 -42.95 86.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.718 -0.393 . . . . 73.45 111.248 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.557 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 4.6 mm? -59.22 -49.96 75.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.246 0.832 . . . . 62.43 113.246 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.29 0.567 . . . . 75.22 111.698 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -75.91 -36.57 59.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.171 -0.922 . . . . 72.03 110.836 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -83.42 -35.57 24.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.299 0.851 . . . . 75.41 113.299 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -79.62 -7.24 58.41 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.863 -0.735 . . . . 73.43 112.308 -177.514 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -143.29 86.41 9.05 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-O 121.027 0.441 . . . . 75.01 111.398 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.4 -22.75 28.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.864 2.376 . . . . 74.33 110.496 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -76.84 -12.65 60.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.529 -0.76 . . . . 72.23 109.985 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.529 0 CA-C-N 115.387 -0.824 . . . . 71.43 111.181 178.104 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 108.722 -0.844 . . . . 61.24 108.722 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -91.6 148.52 22.22 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.455 -0.793 . . . . 75.32 109.508 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 83.1 m-20 -129.06 122.72 30.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.949 -1.13 . . . . 65.32 107.949 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 29.3 t -117.72 120.36 64.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.554 -0.459 . . . . 75.34 111.422 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -83.78 110.83 18.65 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.465 -1.309 . . . . 70.13 107.465 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG11 HD11 ' A' ' 17' ' ' ILE . 7.9 p -136.17 158.07 38.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.244 -0.582 . . . . 70.03 110.066 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.88 22.02 6.83 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-O 121.074 0.464 . . . . 72.22 110.988 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.501 ' HA3' ' CZ ' ' A' ' 51' ' ' TYR . . . -136.29 -133.7 3.23 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 118.128 -1.987 . . . . 61.02 117.072 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.6 m -40.46 -47.68 2.65 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.821 2.156 . . . . 71.22 116.821 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 67' ' ' ILE . 2.4 pp -84.71 1.48 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 114.583 1.327 . . . . 74.42 114.583 -171.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD11 HG13 ' A' ' 13' ' ' VAL . 9.8 mp -68.54 -11.2 59.59 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.511 0.56 . . . . 64.11 112.511 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.9 119.05 75.45 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 107.121 -1.437 . . . . 52.41 107.121 170.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -47.52 -37.29 25.96 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.751 2.967 . . . . 74.34 114.036 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.98 -35.03 79.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.407 -0.361 . . . . 62.35 111.293 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 17' ' ' ILE . 45.3 t -76.92 -40.59 31.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.252 -0.431 . . . . 71.05 110.219 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -58.84 -33.81 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.676 . . . . 71.4 109.602 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.61 -11.33 59.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.452 -0.794 . . . . 75.11 112.46 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.5 m -102.12 -26.86 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.869 -0.732 . . . . 74.34 110.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 78' ' ' PHE . 9.5 tt -77.05 -36.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.344 0.592 . . . . 75.02 110.607 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 31' ' ' ALA . 90.1 mt -95.93 -14.7 22.89 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.045 -0.525 . . . . 71.53 110.242 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 68.44 -1.22 1.96 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.461 1.124 . . . . 74.04 109.927 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 94.8 mtt180 -133.53 176.85 8.17 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.466 -1.679 . . . . 64.11 106.466 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -77.01 144.09 38.92 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.078 0.466 . . . . 74.23 111.251 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.65 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -116.27 134.97 54.31 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 109.046 -0.724 . . . . 72.34 109.046 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -99.42 109.71 22.27 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.903 -1.519 . . . . 74.24 109.174 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 3.0 p -105.93 142.12 36.18 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 120.272 -0.571 . . . . 75.44 109.933 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.15 137.64 31.43 Favored Pre-proline 0 C--N 1.284 -2.27 0 N-CA-C 108.766 -0.827 . . . . 73.42 108.766 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 96' ' ' MET . 6.4 Cg_endo -57.47 117.72 4.47 Favored 'Trans proline' 0 CA--C 1.504 -0.99 0 C-N-CA 122.254 1.969 . . . . 73.21 109.719 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.86 155.2 50.68 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.972 -0.751 . . . . 63.53 108.972 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.593 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.6 p -125.86 127.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.745 0.783 . . . . 71.24 111.695 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.488 HD11 ' HB ' ' A' ' 91' ' ' VAL . 20.8 tp -87.59 96.29 10.36 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.017 -0.992 . . . . 74.21 112.398 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -72.56 126.35 29.65 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.36 -0.836 . . . . 62.33 110.263 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.84 -7.84 17.05 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 119.635 -1.269 . . . . 70.53 113.14 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 33.8 m-85 -126.7 145.11 50.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 112.642 0.608 . . . . 74.32 112.642 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 22.3 t-160 -105.34 127.09 52.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.363 -0.835 . . . . 64.31 108.765 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' HG22 ' A' ' 54' ' ' ILE . 2.4 ptm180 -87.93 137.59 32.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.162 -0.681 . . . . 71.33 109.162 175.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.4 ' HD2' ' O ' ' A' ' 117' ' ' MET . 22.2 m-85 -98.81 177.93 5.12 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 115.85 -0.614 . . . . 74.45 109.918 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -117.03 -28.59 6.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 114.005 1.113 . . . . 55.11 114.005 -177.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 52' ' ' PRO . 4.1 mm? 57.88 -169.92 0.11 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.503 0.502 . . . . 71.21 111.576 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 23.29 5.19 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.731 -0.788 . . . . 63.45 112.886 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.64 7.18 0.08 OUTLIER Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.284 -0.96 . . . . 70.13 113.112 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.77 161.11 36.92 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 117.163 0.482 . . . . 71.43 110.413 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.41 96.18 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.114 2.543 . . . . 72.23 114.598 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.605 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.6 p90 44.2 35.11 0.2 Allowed Pre-proline 0 N--CA 1.515 2.815 0 N-CA-C 116.52 2.045 . . . . 71.11 116.52 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.893 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 72.6 Cg_endo -108.5 166.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.274 2.65 . . . . 74.13 113.516 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.893 ' SG ' ' HB2' ' A' ' 52' ' ' PRO . 33.5 m -134.29 -179.25 5.46 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 103.94 -2.615 . . . . 61.1 103.94 -4.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 43' ' ' ARG . 40.2 pt -123.99 121.03 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 119.609 1.095 . . . . 75.4 112.179 174.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -154.12 133.04 3.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.743 -0.662 . . . . 73.35 111.454 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t 64.72 -175.99 0.17 Allowed 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.504 1.122 . . . . 75.52 113.426 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.595 ' HB3' ' HB2' ' A' ' 42' ' ' HIS . 20.6 t 78.67 112.52 0.07 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.59 1.956 . . . . 72.24 112.932 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.17 -27.16 32.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.432 0.635 . . . . 75.34 109.944 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.5 m -82.97 -9.2 59.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.771 -0.649 . . . . 65.02 110.421 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.26 153.65 21.48 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.742 -0.663 . . . . 61.34 112.354 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.593 ' HE2' HG21 ' A' ' 37' ' ' VAL . 21.0 ptmt -154.17 145.7 23.18 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.293 -1.003 . . . . 55.31 108.293 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 54' ' ' ILE . 62.1 t -114.27 123.76 70.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 112.044 0.387 . . . . 64.45 112.044 -173.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -88.1 120.6 29.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.536 -0.302 . . . . 74.24 110.242 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.34 -147.23 4.57 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.7 143.58 39.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.465 0.633 . . . . 74.15 110.121 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.68 133.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 109.336 -0.616 . . . . 75.31 109.336 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 4.6 mt -89.47 117.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 106.445 -1.687 . . . . 74.34 106.445 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -104.1 160.42 14.86 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.022 -1.071 . . . . 62.12 109.225 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.57 30.0 41.79 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.224 -0.988 . . . . 53.24 113.656 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.55 124.29 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.29 0.545 . . . . 75.03 110.013 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.563 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.9 m -75.48 158.29 32.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.791 -0.818 . . . . 70.34 108.791 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.17 -39.79 79.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.071 0.397 . . . . 74.02 112.071 -175.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.84 64.73 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.09 0.471 . . . . 51.2 110.732 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.563 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 50.7 mm-40 -73.64 -30.94 63.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.568 -0.742 . . . . 74.21 110.34 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.78 -37.05 73.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.178 0.991 . . . . 75.1 111.32 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 39.1 m-80 -57.37 -27.58 62.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.309 0.644 . . . . 74.02 111.657 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -69.08 -31.7 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.241 -0.652 . . . . 62.41 109.241 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD1' HD13 ' A' ' 26' ' ' ILE . 95.8 m-85 -70.97 -29.25 65.19 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 120.415 -0.514 . . . . 74.22 109.764 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 3.1 m-20 -60.96 -41.19 95.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.586 0.708 . . . . 74.25 109.439 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 76' ' ' ASN . 43.0 t -65.24 -34.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.012 -0.995 . . . . 74.35 110.394 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -62.01 -50.75 78.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.233 -0.44 . . . . 64.11 111.152 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.06 141.83 12.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 120.933 0.397 . . . . 73.05 110.665 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.68 28.71 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.277 -0.874 . . . . 75.01 111.191 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -76.42 -43.06 41.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 120.187 -0.605 . . . . 51.41 110.551 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 110' ' ' VAL . 8.1 m-20 -125.93 13.15 7.89 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.091 0.948 . . . . 61.25 108.534 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 50.5 m-85 -115.9 149.44 38.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.334 -1.358 . . . . 72.3 107.334 -177.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 16.4 pt-20 -130.76 155.88 45.91 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.586 0.232 . . . . 74.1 110.531 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 106' ' ' THR . 45.5 ttm180 -91.1 126.66 36.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.865 0.364 . . . . 71.24 111.511 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.16 159.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.444 -0.947 . . . . 71.4 108.444 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 m -96.17 123.01 39.63 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.223 -0.658 . . . . 52.2 109.223 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 38' ' ' LEU . 26.8 m -125.96 157.76 35.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 123.826 0.85 . . . . 71.11 109.727 -175.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 29.3 tt0 -105.24 125.18 50.69 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.207 -0.597 . . . . 61.4 109.52 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 38' ' ' LEU . 15.1 m -126.13 168.41 19.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.964 -0.754 . . . . 63.33 108.964 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 96' ' ' MET . 68.6 t -104.25 128.12 57.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.341 -0.985 . . . . 73.51 108.341 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -68.53 -15.44 63.54 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.951 0.782 . . . . 73.43 110.215 -174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.566 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER 70.61 -54.86 0.64 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.131 1.773 . . . . 73.12 113.882 172.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -48.63 -45.65 38.7 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 70.43 111.432 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -114.87 9.95 16.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 123.345 0.658 . . . . 64.24 110.508 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.7 m 62.83 10.06 4.05 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.81 1.041 . . . . 74.54 113.81 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 161.11 21.85 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.569 -0.452 . . . . 44.0 110.361 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HG2' HG22 ' A' ' 94' ' ' VAL . 88.2 mttt -101.91 134.05 45.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.654 -0.869 . . . . 74.11 108.654 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.01 139.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.727 -0.842 . . . . 71.32 108.727 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 28.3 ttpt -107.48 116.65 32.33 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.865 0.84 . . . . 74.25 110.597 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.21 177.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.0 -1.454 . . . . 73.31 110.696 -168.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.32 144.09 28.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.804 -0.443 . . . . 71.22 109.804 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 10.5 t -144.72 175.22 10.33 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.233 -0.654 . . . . 73.34 109.233 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 78.3 m-85 -110.43 119.48 39.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.273 0.358 . . . . 74.14 110.272 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 54' ' ' ILE . 34.8 m -109.84 -173.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.918 -0.771 . . . . 60.44 108.918 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.497 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 61.1 t-105 -99.13 122.71 42.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.018 -0.734 . . . . 74.41 109.018 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' A' ' 87' ' ' GLU . 26.8 m -65.61 -35.89 76.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 CA-C-O 121.363 0.601 . . . . 74.44 111.401 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 114' ' ' ASP . 5.0 t30 -88.18 15.75 7.12 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.979 1.312 . . . . 71.22 109.506 -173.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.7 ptpp? -47.43 -14.87 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 126.859 2.064 . . . . 72.35 115.048 -171.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -90.4 6.8 41.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.828 0.347 . . . . 72.23 111.825 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' HB3' ' ND2' ' A' ' 111' ' ' ASN . 3.1 p30 -85.65 160.07 54.04 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.911 -1.144 . . . . 75.1 107.911 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.18 99.47 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.053 1.836 . . . . 63.21 110.827 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.692 ' HD3' ' H ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.65 -0.704 . . . . 74.03 111.366 -176.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.4 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 49.2 ttm . . . . . 0 C--N 1.304 -1.378 0 CA-C-N 114.486 -1.234 . . . . 74.42 111.707 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 128' ' ' VAL . 8.5 tp10 . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 107.128 -1.434 . . . . 64.03 107.128 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -57.74 -28.67 64.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.902 -1.045 . . . . 74.45 111.364 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -57.74 -49.08 77.77 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.234 0.457 . . . . 73.31 112.234 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 125' ' ' GLU . 18.8 m -72.24 -27.68 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.329 -0.548 . . . . 73.52 110.232 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 125' ' ' GLU . 88.6 t -68.44 -28.29 39.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.246 -0.888 . . . . 54.31 110.954 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -99.4 -28.58 13.21 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.869 -1.132 . . . . 73.23 110.843 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.54 82.45 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.786 -0.643 . . . . 71.42 112.3 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.47 -24.0 66.35 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 113.132 0.79 . . . . 62.42 113.132 -177.06 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 6.4 tmtt? -76.22 -55.78 5.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 109.604 -0.517 . . . . 64.12 109.604 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -63.86 -32.11 73.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.836 0.68 . . . . 60.05 112.836 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.61 -37.3 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 119.813 -0.755 . . . . 74.43 110.228 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 7.3 mm-40 -62.87 -39.72 95.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.849 -0.426 . . . . 71.32 109.849 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.505 -0.77 . . . . 73.53 110.7 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -67.72 -36.67 81.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.685 -0.487 . . . . 63.32 109.685 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 98.4 mtt180 -64.53 -51.59 62.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.973 -0.558 . . . . 73.4 110.929 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 31.1 mmmt -63.54 -34.54 78.01 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 112.672 0.619 . . . . 73.04 112.672 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.1 ptm -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.521 -0.872 . . . . 73.2 109.717 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 tp -77.36 -50.12 13.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 74.35 111.248 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HG3' ' HA ' ' A' ' 140' ' ' LYS 0.25 0.0 OUTLIER -68.47 -24.61 64.72 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.266 0.469 . . . . 62.54 112.266 -178.287 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -75.41 -43.81 47.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.81 -0.632 . . . . 74.34 110.817 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -69.05 -35.1 76.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.522 0.677 . . . . 74.33 110.01 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 41.1 ttmt -92.52 8.18 39.94 Favored 'General case' 0 CA--C 1.565 1.525 0 CA-C-N 115.498 -0.774 . . . . 72.14 110.554 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 28.0 t-20 -46.71 118.52 5.06 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 123.804 0.842 . . . . 73.51 112.909 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 19.9 Cg_exo -63.18 -24.26 72.75 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.492 2.795 . . . . 74.1 113.577 -176.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.35 -13.77 59.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.462 0.649 . . . . 70.31 110.176 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.905 0 CA-C-N 115.793 -0.639 . . . . 52.12 113.58 176.386 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.1 p . . . . . 0 N--CA 1.409 -2.487 0 N-CA-C 106.864 -1.532 . . . . 61.54 106.864 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -90.7 143.46 26.71 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.107 0.479 . . . . 71.32 111.739 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.7 m-20 -128.31 122.36 31.43 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.454 -1.313 . . . . 74.24 107.454 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.23 121.28 67.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 121.053 -0.259 . . . . 71.33 110.56 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.4 ' HB2' HG21 ' A' ' 104' ' ' VAL . 64.3 t80 -81.44 112.15 18.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 107.97 -1.122 . . . . 74.1 107.97 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 17' ' ' ILE . 24.1 m -113.49 140.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.531 0.681 . . . . 75.24 112.458 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -131.87 121.79 24.63 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.557 -1.275 . . . . 75.53 107.557 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.3 -58.91 4.17 Favored Glycine 0 C--N 1.302 -1.315 0 C-N-CA 120.895 -0.669 . . . . 72.44 111.441 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.1 m -78.25 145.82 35.23 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.97 -0.381 . . . . 73.13 109.97 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.486 HG21 ' CD1' ' A' ' 67' ' ' ILE . 9.3 mm 70.23 -104.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.8 1.24 . . . . 71.32 108.586 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.259 77.4 mt 49.1 -36.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.651 2.38 . . . . 64.33 117.092 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.19 132.15 29.9 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 109.393 -0.595 . . . . 72.22 109.393 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.4 -40.3 28.71 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.9 3.067 . . . . 61.43 113.543 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -60.16 -47.94 83.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.982 0.42 . . . . 71.42 110.967 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.67 -39.73 85.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.406 0.622 . . . . 23.22 110.402 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 31' ' ' ALA . . . -66.88 -34.94 78.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.81 -0.632 . . . . 64.42 110.947 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -75.62 -26.46 57.81 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.654 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 21' ' ' ALA . 20.9 m -85.34 -23.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.432 -0.507 . . . . 74.24 111.595 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.451 HD13 ' CD1' ' A' ' 78' ' ' PHE . 10.5 tt -82.46 -40.97 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.138 -0.625 . . . . 74.24 111.067 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 31' ' ' ALA . 82.8 mt -83.68 -18.17 38.94 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.293 -0.412 . . . . 74.42 111.27 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 64.18 25.91 13.74 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 106.739 -1.578 . . . . 62.12 106.739 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.4 ttt180 -162.83 166.59 23.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.678 -1.601 . . . . 73.53 106.68 -174.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -75.39 136.44 40.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 118.098 0.408 . . . . 74.11 110.426 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -101.73 141.32 34.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 115.964 -0.562 . . . . 54.12 112.015 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -100.11 110.23 22.51 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.733 -0.667 . . . . 64.24 109.516 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.7 p -115.98 143.42 45.48 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.255 -0.43 . . . . 75.0 110.824 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.41 139.96 35.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.01 -0.737 . . . . 45.43 109.01 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.53 134.12 58.98 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.403 2.069 . . . . 64.23 112.028 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.514 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.88 157.03 42.78 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.377 -0.828 . . . . 64.21 110.246 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.12 127.89 72.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.537 0.684 . . . . 70.15 111.41 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HA ' HG12 ' A' ' 93' ' ' VAL . 28.4 tp -91.39 95.93 10.25 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.405 -0.816 . . . . 71.43 111.809 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 9.9 p-80 -71.94 127.31 32.17 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.318 -0.855 . . . . 74.54 109.148 170.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.95 -17.48 7.63 Favored Glycine 0 C--N 1.292 -1.9 0 C-N-CA 119.69 -1.243 . . . . 51.23 112.651 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -124.93 160.26 29.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.091 0.774 . . . . 72.23 113.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.02 132.85 42.33 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.744 -1.116 . . . . 60.44 109.672 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HB3' HG22 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -92.48 151.48 20.17 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.623 0.971 . . . . 74.43 113.623 -177.348 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.15 169.86 14.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.846 -1.07 . . . . 73.44 109.539 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 71.5 mmtt -138.46 86.83 2.18 Favored 'General case' 0 CA--C 1.485 -1.524 0 O-C-N 124.055 0.847 . . . . 73.03 111.447 173.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' HG ' ' HD2' ' A' ' 52' ' ' PRO 0.35 0.3 OUTLIER -89.84 97.9 11.46 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.179 -1.008 . . . . 71.51 111.301 174.331 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -66.16 -23.22 66.43 Favored 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.52 1.528 . . . . 75.04 110.792 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.83 -12.91 63.01 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 115.435 -0.802 . . . . 52.14 111.782 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.2 mt -126.26 170.13 10.31 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 125.438 1.495 . . . . 70.14 107.432 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.89 50.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.519 2.978 0 C-N-CA 124.138 3.226 . . . . 73.44 114.981 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.547 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.487 7.8 p90 48.47 63.69 9.91 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 118.94 2.941 . . . . 72.13 118.94 178.169 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 3.2 Cg_endo -95.98 169.12 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.578 4.185 . . . . 53.21 109.261 172.387 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 6.0 p -157.41 -167.3 2.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.508 2.723 . . . . 53.0 108.499 -3.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' A' ' 43' ' ' ARG . 47.9 pt -123.74 131.07 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 107.13 -1.433 . . . . 74.13 107.13 162.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.48 HG21 ' SD ' ' A' ' 117' ' ' MET . 31.1 m -145.21 166.77 10.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 116.478 -0.328 . . . . 74.44 111.227 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t 63.6 138.7 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.797 1.639 . . . . 73.02 113.922 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -80.79 75.47 7.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.333 1.063 . . . . 64.13 110.711 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.65 168.25 16.49 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.254 -1.339 . . . . 75.4 110.044 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.8 m -91.69 4.8 51.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.151 0.501 . . . . 73.2 110.942 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.13 -167.84 43.74 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.334 -0.706 . . . . 73.2 111.334 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 39' ' ' HIS . 8.8 ptpp? -153.77 151.57 29.73 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.37 -0.532 . . . . 73.24 112.193 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.4 128.66 71.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 C-N-CA 124.095 0.958 . . . . 73.2 109.109 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -100.97 132.53 46.34 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.526 -0.87 . . . . 65.34 110.594 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.92 -138.08 2.44 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.93 -0.868 . . . . 52.34 110.93 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -142.68 145.23 33.2 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.12 0.568 . . . . 71.21 110.708 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.28 129.79 56.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.673 -0.491 . . . . 73.4 109.673 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.486 ' CD1' HG21 ' A' ' 17' ' ' ILE . 18.1 mt -89.46 110.91 22.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 106.834 -1.543 . . . . 63.21 106.834 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.2 p -99.25 161.84 13.39 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 116.054 -0.521 . . . . 64.04 111.464 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.57 74.25 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.329 -0.462 . . . . 73.04 113.189 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.29 128.93 38.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.652 -0.87 . . . . 72.43 108.652 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -85.3 160.95 19.71 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.823 -0.806 . . . . 64.3 108.823 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -52.36 -37.89 57.34 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.475 0.71 . . . . 72.42 111.846 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.83 63.13 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.924 -0.58 . . . . 34.32 111.464 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.57 -32.07 72.58 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.929 -0.309 . . . . 72.34 111.149 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.11 -33.85 69.56 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.742 -0.663 . . . . 74.02 110.469 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 80' ' ' VAL . 22.1 t-20 -63.58 -28.65 70.08 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.61 -0.723 . . . . 63.13 110.692 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -74.91 -31.88 61.66 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.817 -0.808 . . . . 63.22 108.817 -175.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CD1' HD13 ' A' ' 26' ' ' ILE . 96.4 m-85 -64.8 -36.5 84.53 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 115.461 -0.79 . . . . 74.35 110.476 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.21 -31.55 71.15 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.541 0.686 . . . . 73.32 110.116 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 76' ' ' ASN . 55.6 t -75.64 -44.34 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 115.64 -0.709 . . . . 62.41 112.344 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 ' HA ' ' A' ' 78' ' ' PHE . 11.3 tt -72.13 117.72 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.306 0.574 . . . . 63.14 112.24 -175.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.19 3.09 0.49 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.714 1.206 . . . . 75.4 113.978 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.37 53.56 1.54 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 111.358 -0.697 . . . . 53.33 111.358 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -82.37 -40.71 20.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.838 0.351 . . . . 62.43 110.825 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.615 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 5.6 t70 -119.88 28.87 7.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.667 1.222 . . . . 54.14 107.806 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.446 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 70.6 m-85 -113.76 161.16 17.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.48 -1.236 . . . . 75.25 109.707 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -130.48 141.91 50.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.936 -1.135 . . . . 75.45 107.936 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -81.88 121.47 26.5 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.191 -0.458 . . . . 74.51 110.996 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.33 159.64 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.71 -0.677 . . . . 75.54 110.205 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.1 m -97.8 124.56 42.24 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.945 -0.761 . . . . 70.04 108.945 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.13 169.95 13.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.582 -0.896 . . . . 72.5 108.582 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -124.79 120.93 33.13 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.651 -0.87 . . . . 75.32 108.651 -173.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 38' ' ' LEU . 21.0 m -126.0 168.78 18.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-O 121.383 0.611 . . . . 72.31 110.886 -170.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.539 HG22 ' HG2' ' A' ' 101' ' ' LYS . 71.3 t -110.52 118.81 58.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.481 -0.782 . . . . 64.25 109.464 175.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -74.33 95.1 2.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 109.246 -0.65 . . . . 74.42 109.246 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.514 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -48.1 -33.64 8.51 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 126.57 1.948 . . . . 75.04 110.596 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.76 -38.71 70.2 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.458 -0.792 . . . . 64.1 112.013 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.61 -10.62 11.83 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.341 0.591 . . . . 72.04 109.748 -177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.6 t 67.71 22.5 8.93 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.07 0.948 . . . . 62.43 110.074 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -97.17 160.38 14.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.922 -0.581 . . . . 75.22 109.458 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HG2' HG22 ' A' ' 94' ' ' VAL . 5.9 mtpm? -101.85 135.78 42.82 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.613 -0.884 . . . . 52.42 108.613 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.86 145.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.064 0.459 . . . . 73.21 110.345 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -91.94 124.15 35.84 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.238 -1.023 . . . . 74.32 108.238 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 12' ' ' PHE . 32.6 m -136.69 175.59 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.815 0.446 . . . . 73.41 110.691 -175.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -106.8 153.5 22.37 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.972 -0.455 . . . . 74.13 111.057 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 t -154.87 177.9 10.76 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 110.273 -0.269 . . . . 70.43 110.273 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -104.76 119.8 39.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.08 0.952 . . . . 62.51 108.673 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.75 151.88 20.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.553 -0.459 . . . . 73.51 109.913 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.615 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 35.6 t-105 -79.36 127.05 31.61 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.084 -0.709 . . . . 75.31 109.084 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.7 m -72.64 -28.3 27.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.115 0.483 . . . . 63.22 112.236 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 62.5 t30 -79.3 13.21 1.99 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.678 0.791 . . . . 70.24 111.282 -176.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -51.65 -14.86 0.38 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.014 1.857 . . . . 52.32 116.014 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.412 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 9.4 m-20 -72.87 9.96 1.01 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.124 0.488 . . . . 65.13 112.135 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.41 131.82 49.15 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 108.064 -1.087 . . . . 70.41 108.064 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 -15.98 28.48 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.317 2.678 . . . . 74.23 116.457 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -130.6 113.97 14.87 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 117.673 -1.611 . . . . 72.32 114.259 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 55' ' ' VAL . 66.2 mtt . . . . . 0 C--N 1.306 -1.283 0 CA-C-N 114.745 -1.116 . . . . 63.53 109.064 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.7 mt-10 . . . . . 0 C--O 1.217 -0.619 0 N-CA-C 111.791 0.293 . . . . 73.15 111.791 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -60.95 -24.46 66.08 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.909 0.385 . . . . 74.3 111.301 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -58.43 -43.19 88.63 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.281 -0.637 . . . . 74.13 109.281 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 125' ' ' GLU . 17.9 m -84.37 -31.68 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 119.993 -0.683 . . . . 65.2 110.946 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 125' ' ' GLU . 52.2 t -68.18 -39.31 81.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 116.794 -0.185 . . . . 73.12 111.066 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.405 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 1.4 p-80 -67.47 -32.34 73.12 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.413 -0.915 . . . . 73.24 110.254 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.73 83.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 54.43 110.024 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.5 -25.77 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.259 -0.882 . . . . 71.04 112.249 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.532 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -76.68 -57.37 3.89 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.231 -1.396 . . . . 64.5 107.231 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 92.0 m-85 -61.79 -33.5 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.503 1.297 . . . . 63.31 114.503 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.461 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.8 p -58.1 -41.94 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.33 -0.548 . . . . 63.45 110.66 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 24.0 mm-40 -66.12 -39.35 89.83 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.172 -0.467 . . . . 54.31 110.494 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.7 m -59.32 -49.6 77.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 72.42 110.475 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -57.77 -41.61 82.38 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 121.134 -0.226 . . . . 64.33 111.247 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 82.5 mtp180 -63.27 -47.92 80.32 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.572 0.545 . . . . 71.33 111.193 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 73.1 mmtt -65.35 -42.97 92.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.747 0.308 . . . . 74.4 110.881 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.6 mmt -61.79 -35.82 79.3 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.052 -0.722 . . . . 65.25 109.052 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.77 -39.09 90.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.537 -0.912 . . . . 74.03 108.537 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -64.06 -47.84 78.6 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.555 -0.293 . . . . 74.04 110.798 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -69.95 -28.66 65.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.611 0.967 . . . . 70.13 113.611 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -82.0 -47.76 12.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.972 0.36 . . . . 51.22 111.972 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.0 -26.94 30.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.227 0.455 . . . . 73.41 112.227 -175.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -136.03 78.16 47.78 Favored Pre-proline 0 C--N 1.313 -1.007 0 C-N-CA 120.605 -0.438 . . . . 71.22 111.885 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.71 -29.71 35.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.99 1.793 . . . . 73.3 109.875 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -87.56 0.11 56.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.308 -0.86 . . . . 74.43 109.763 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.968 0 N-CA-C 109.984 -1.246 . . . . 64.23 109.984 176.936 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 N--CA 1.433 -1.29 0 CA-C-O 121.772 0.796 . . . . 53.25 112.253 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -107.97 156.35 19.32 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.75 -1.113 . . . . 73.32 111.034 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.3 m-20 -125.14 122.91 38.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.144 -1.428 . . . . 75.11 107.144 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 19.5 t -119.78 124.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 120.753 -0.379 . . . . 72.25 110.976 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.509 ' HB2' HG21 ' A' ' 104' ' ' VAL . 73.4 t80 -84.02 113.91 21.34 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.825 -0.806 . . . . 74.32 108.825 175.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -125.17 160.54 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.518 0.675 . . . . 73.33 111.973 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -145.71 -55.67 0.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.815 -1.55 . . . . 71.51 106.815 175.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.5 63.27 0.6 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.513 -1.035 . . . . 75.2 110.513 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 m -153.97 -79.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.192 . . . . 71.4 111.033 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 67' ' ' ILE . 33.2 pt -145.78 86.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 122.173 0.987 . . . . 51.44 111.312 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 65' ' ' LYS . 77.7 mt -99.63 -5.19 29.39 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.474 -0.766 . . . . 63.24 109.223 175.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.78 130.81 24.6 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.258 -0.883 . . . . 65.23 111.046 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.62 -42.56 18.77 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.174 3.249 . . . . 71.14 114.417 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.38 83.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.744 0.276 . . . . 44.55 111.744 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.7 p -77.26 -30.87 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.288 0.566 . . . . 65.34 111.044 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.397 0.618 . . . . 71.14 109.377 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -74.85 -5.69 44.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.644 -0.707 . . . . 62.22 112.197 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.1 m -105.98 -15.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.805 -0.758 . . . . 72.3 111.223 177.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.587 HG21 HD13 ' A' ' 17' ' ' ILE . 10.0 tt -92.72 -42.47 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 121.468 0.651 . . . . 74.44 110.333 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 95.3 mt -87.08 -27.24 23.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.882 -0.599 . . . . 75.34 110.002 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 73.17 3.3 4.61 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.479 1.133 . . . . 75.04 108.122 -170.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.9 mmt180 -126.07 154.81 42.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.195 -2.15 . . . . 72.32 105.195 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -96.96 110.41 22.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.677 -1.209 . . . . 71.22 108.75 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 156.29 17.67 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.882 -0.599 . . . . 74.54 110.532 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.66 125.54 41.2 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.516 0.674 . . . . 54.21 112.816 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 p -100.44 143.94 30.03 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.582 -1.19 . . . . 72.42 109.532 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.7 141.66 38.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.304 -0.999 . . . . 74.4 108.304 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.483 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 2.1 Cg_endo -65.44 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.001 1.801 . . . . 75.44 111.637 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -150.17 156.36 41.46 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.691 -0.686 . . . . 75.42 110.444 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -122.44 127.84 75.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-O 121.399 0.619 . . . . 73.03 111.378 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 93' ' ' VAL . 23.7 tp -90.49 97.86 11.43 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.206 -0.906 . . . . 72.34 109.429 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.532 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 6.3 p80 -70.63 132.3 45.23 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.014 -0.994 . . . . 71.43 110.018 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.61 38.57 Favored Glycine 0 C--O 1.215 -1.044 0 C-N-CA 118.844 -1.646 . . . . 74.22 113.993 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -101.99 143.35 31.95 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 113.768 1.025 . . . . 72.01 113.768 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.579 ' HB2' ' CB ' ' A' ' 58' ' ' ASP . 2.9 t-160 -104.63 122.55 45.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.386 -1.279 . . . . 53.25 108.379 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -89.53 115.86 27.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.189 -1.041 . . . . 71.41 108.189 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.401 ' HD2' ' O ' ' A' ' 117' ' ' MET . 26.3 m-85 -81.3 141.86 33.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.6 -0.518 . . . . 62.14 109.6 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -97.54 124.54 41.82 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.37 0.605 . . . . 75.34 111.291 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.77 133.1 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.835 -0.62 . . . . 62.33 110.079 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.89 -41.08 7.38 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 108.08 -1.082 . . . . 54.0 108.08 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.56 -21.15 77.62 Favored Glycine 0 N--CA 1.425 -2.096 0 CA-C-N 114.234 -1.348 . . . . 53.04 112.156 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 6.1 mp -107.67 151.34 41.04 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 108.83 -0.804 . . . . 74.41 108.83 177.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.52 -61.76 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.832 2.355 . . . . 74.43 115.62 -172.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.685 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 4.1 p90 -132.62 16.33 0.05 OUTLIER Pre-proline 0 CA--C 1.585 2.299 0 N-CA-C 117.208 2.299 . . . . 75.24 117.208 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -89.24 164.29 5.62 Favored 'Trans proline' 0 C--N 1.369 1.609 0 CA-C-N 122.129 1.796 . . . . 74.13 112.005 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 20.6 p -155.0 167.44 30.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.484 1.914 . . . . 74.03 108.034 -6.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 131.37 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.775 -0.77 . . . . 51.21 109.537 170.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 112' ' ' LYS . 8.1 p -157.52 170.51 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 108.572 -0.899 . . . . 73.01 108.572 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 55' ' ' VAL . 25.6 m 77.67 145.45 0.09 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.47 1.106 . . . . 53.52 112.83 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.1 t -88.73 76.23 8.07 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.225 -1.398 . . . . 75.24 107.225 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.579 ' CB ' ' HB2' ' A' ' 42' ' ' HIS . 17.9 t70 -84.22 175.24 9.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.26 -1.791 . . . . 74.44 109.325 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 m -83.75 -16.58 44.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.498 . . . . 73.4 109.706 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.62 170.24 53.94 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 115.391 -0.822 . . . . 45.34 113.602 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 42.3 mtmt -137.82 146.75 43.89 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.399 -1.334 . . . . 71.44 107.399 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.86 123.42 61.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.528 -0.545 . . . . 73.35 109.528 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -95.93 124.86 40.12 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.517 -0.549 . . . . 64.43 109.517 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.99 -141.89 3.26 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.101 -0.8 . . . . 34.22 111.101 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 48.9 mtmt -140.17 147.43 40.12 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 120.874 0.368 . . . . 75.42 111.622 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.1 m -104.87 133.71 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 115.454 -0.794 . . . . 75.45 109.551 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.749 HD13 HD11 ' A' ' 17' ' ' ILE . 18.3 mt -88.37 130.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 106.023 -1.843 . . . . 64.41 106.023 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.3 p -115.01 161.32 18.49 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.732 -0.787 . . . . 62.25 111.415 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 33.66 67.67 Favored Glycine 0 N--CA 1.439 -1.114 0 O-C-N 123.543 0.527 . . . . 75.11 113.211 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -90.39 122.37 41.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.964 0.382 . . . . 63.13 110.633 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.451 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 36.8 m -76.62 158.7 30.88 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.458 -0.571 . . . . 75.1 109.458 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.79 -42.93 65.49 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.461 0.541 . . . . 72.42 112.461 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.2 -40.71 77.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.29 0.567 . . . . 73.5 110.141 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 4.4 mm-40 -68.37 -37.26 80.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.709 -1.132 . . . . 64.33 109.099 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.95 -33.5 74.4 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.404 1.082 . . . . 70.02 110.155 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 80' ' ' VAL . 7.2 m-20 -62.86 -27.14 69.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.158 -0.928 . . . . 70.34 113.16 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -32.89 71.4 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.191 -1.04 . . . . 64.31 108.191 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -70.98 -28.59 64.56 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.29 0.566 . . . . 75.03 109.532 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.548 ' HA ' HH12 ' A' ' 88' ' ' ARG . 28.6 t70 -70.94 -36.13 72.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.614 -0.721 . . . . 60.41 109.848 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 76' ' ' ASN . 72.4 t -66.6 -22.51 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.229 -0.896 . . . . 75.31 111.511 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.4 103.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.337 0.589 . . . . 75.32 110.488 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.389 0.1 OUTLIER 64.39 -58.39 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.937 2.495 . . . . 73.42 112.631 -174.001 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.51 1.66 16.98 Favored Glycine 0 C--O 1.234 0.132 0 C-N-CA 123.191 0.424 . . . . 75.03 113.638 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -83.92 -44.17 14.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.649 0.24 . . . . 75.54 111.649 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.522 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 2.1 t70 -136.94 16.12 3.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 118.626 -1.23 . . . . 73.3 111.532 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.65 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 30.6 m-85 -112.56 151.88 29.51 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.224 -0.591 . . . . 63.42 110.723 175.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -131.56 159.65 37.57 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.172 -0.922 . . . . 73.14 109.292 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.548 HH12 ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -90.11 113.74 25.53 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.332 -0.395 . . . . 74.44 109.954 -178.236 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.62 159.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.662 0.267 . . . . 63.1 110.859 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.3 m -102.57 129.78 49.24 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.066 -0.716 . . . . 73.25 109.066 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.07 168.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.345 -1.354 . . . . 64.01 107.345 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -120.35 131.97 55.08 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.473 -1.291 . . . . 50.34 108.662 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.419 HG12 ' HB2' ' A' ' 38' ' ' LEU . 18.6 m -125.99 168.13 19.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.243 0.544 . . . . 44.41 109.617 -175.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 101' ' ' LYS . 69.3 t -109.78 120.1 60.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 115.658 -0.701 . . . . 64.14 109.962 177.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 77.3 ttt180 -67.41 97.23 0.55 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.799 -1.556 . . . . 75.42 106.799 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.454 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 25.5 ttt -48.74 -45.82 40.14 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 127.088 2.155 . . . . 53.54 113.664 -169.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.4 -34.15 75.51 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.586 0.587 . . . . 74.13 112.586 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -103.48 -9.29 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.306 0.574 . . . . 65.43 111.272 -175.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m 64.8 25.58 12.92 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.793 0.837 . . . . 63.33 111.653 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -102.58 161.69 13.52 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.561 -0.903 . . . . 72.54 108.561 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.555 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.3 mtmt -104.6 135.85 45.24 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.953 -0.758 . . . . 63.21 108.953 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.52 135.86 48.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-O 121.139 0.495 . . . . 63.1 109.855 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -87.16 126.41 34.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.143 -1.428 . . . . 71.21 107.143 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 12' ' ' PHE . 32.9 m -137.58 169.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.977 0.417 . . . . 73.11 111.123 -174.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.4 149.39 24.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.384 -0.371 . . . . 64.23 110.138 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 t -153.01 176.86 11.42 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.776 -0.453 . . . . 71.23 109.776 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.461 ' HD2' ' CE1' ' A' ' 86' ' ' TYR . 15.1 p90 -107.35 120.01 40.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 125.08 1.352 . . . . 75.13 110.407 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.77 171.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 O-C-N 122.096 -0.377 . . . . 50.3 110.077 175.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.522 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 23.7 t-105 -97.7 121.2 39.34 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.483 -0.562 . . . . 74.23 109.483 -168.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.427 ' HA ' ' HZ2' ' A' ' 112' ' ' LYS . 33.5 m -73.12 -23.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 112.425 0.528 . . . . 74.54 112.425 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.42 11.81 1.45 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.352 0.596 . . . . 71.22 109.959 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.581 ' HB3' HG21 ' A' ' 55' ' ' VAL . 10.5 ptpp? -59.31 -20.07 51.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.298 1.039 . . . . 72.22 112.686 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.33 -24.67 50.78 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.253 0.549 . . . . 43.32 110.481 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.1 145.9 41.65 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.188 -1.782 . . . . 62.43 106.188 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -31.28 125.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 124.192 3.262 . . . . 75.11 112.687 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.82 114.33 13.16 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.477 0.656 . . . . 72.24 109.973 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.401 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 28.0 ttt . . . . . 0 N--CA 1.437 -1.125 0 N-CA-C 114.47 1.285 . . . . 73.35 114.47 -171.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 129' ' ' VAL . 16.5 tp10 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 108.738 -0.838 . . . . 73.43 108.738 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -55.3 -49.73 71.38 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-N 115.436 -0.802 . . . . 74.41 110.852 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -64.7 -40.07 94.74 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.752 -0.658 . . . . 73.13 112.225 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 m -70.78 -32.41 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.918 -0.713 . . . . 74.43 111.734 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.573 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 88.3 t -67.93 -45.23 84.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 109.009 -0.737 . . . . 74.41 109.009 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -70.52 -39.55 74.02 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.184 -0.606 . . . . 74.24 111.67 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.21 -54.7 42.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.662 0.245 . . . . 62.33 111.662 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 42.5 mt-10 -62.01 -38.16 87.59 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.078 0.466 . . . . 74.24 111.83 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -69.59 -43.68 72.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.555 -0.748 . . . . 64.41 111.965 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -72.24 -40.53 67.65 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.266 0.839 . . . . 72.24 113.266 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.09 -34.2 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 118.952 -0.546 . . . . 64.35 112.421 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 45.7 mt-10 -55.91 -51.82 66.28 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.204 -1.035 . . . . 74.04 108.204 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.3 m -58.63 -50.43 73.86 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.084 -1.416 . . . . 52.55 110.76 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -59.97 -50.48 73.57 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 112.166 0.432 . . . . 75.14 112.166 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -63.25 -53.41 53.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.669 0.618 . . . . 71.31 112.669 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -66.23 -31.73 72.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 112.096 0.406 . . . . 64.41 112.096 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.5 mmt -76.17 -35.56 59.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 119.998 -0.681 . . . . 71.1 109.651 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.8 tp -63.94 -36.67 84.73 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 122.741 0.417 . . . . 63.43 110.599 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.253 -0.43 . . . . 75.23 111.358 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -76.24 -35.38 59.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.815 -0.63 . . . . 72.35 111.017 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.98 -39.6 61.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 75.03 112.135 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -99.62 9.36 43.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.32 0.581 . . . . 74.11 109.942 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 38.3 t30 -38.89 117.36 1.04 Allowed Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.592 1.557 . . . . 54.35 112.734 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 36.9 Cg_exo -59.53 -19.59 52.94 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 123.907 3.071 . . . . 71.12 113.245 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -74.98 -7.09 52.63 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.206 -0.452 . . . . 54.22 111.551 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.565 0 C-N-CA 121.066 -0.588 . . . . 64.45 113.474 175.504 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.422 -1.847 0 CA-C-O 121.804 0.811 . . . . 71.25 112.296 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -130.3 157.67 41.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.692 -1.14 . . . . 75.52 109.891 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.578 ' HB2' HG12 ' A' ' 104' ' ' VAL . 32.7 m-80 -121.87 127.82 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.765 -0.828 . . . . 75.14 108.765 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.42 120.95 64.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 110.126 -0.324 . . . . 72.13 110.126 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.61 118.83 24.09 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 122.59 0.356 . . . . 72.21 110.275 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.35 160.61 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.314 -0.625 . . . . 73.4 109.314 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -131.15 17.21 5.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.846 0.831 . . . . 74.54 109.998 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.38 159.38 30.07 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 119.897 -1.144 . . . . 73.3 112.603 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.417 ' HB3' HG11 ' A' ' 22' ' ' VAL . 18.3 m 67.11 -74.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.218 1.407 . . . . 73.51 113.946 175.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.585 HG21 HD13 ' A' ' 67' ' ' ILE . 26.1 mt -70.25 -5.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.641 0.777 . . . . 73.31 111.757 -171.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -65.87 -30.12 70.68 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.163 -0.681 . . . . 75.13 109.163 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.07 132.21 25.05 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 115.155 -0.93 . . . . 75.42 110.446 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.54 -44.53 4.44 Favored 'Trans proline' 0 C--N 1.359 1.103 1 C-N-CA 125.362 4.041 . . . . 71.45 115.375 -175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -56.68 -42.52 79.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.888 0.699 . . . . 31.13 112.888 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.506 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -76.18 -35.85 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.279 0.561 . . . . 75.34 110.292 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -66.74 -32.85 74.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.451 0.643 . . . . 73.44 109.728 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -73.63 -20.82 60.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.607 -0.724 . . . . 65.14 111.837 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.6 m -87.71 -23.89 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.381 -0.928 . . . . 74.35 111.195 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.434 ' C ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -87.01 -46.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 116.508 -0.314 . . . . 62.13 110.904 178.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.587 HD12 ' HB2' ' A' ' 31' ' ' ALA . 82.1 mt -93.86 -14.6 25.91 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.793 -0.363 . . . . 74.23 111.958 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.0 t70 73.56 6.86 5.07 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.494 1.14 . . . . 72.41 109.191 -175.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.2 mtp180 -144.22 163.81 32.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.22 1.408 . . . . 62.14 107.727 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.6 p -76.69 122.64 24.98 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.21 -0.293 . . . . 74.33 110.21 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.587 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -87.44 156.91 19.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 120.642 0.258 . . . . 54.34 111.052 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -99.93 109.86 22.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.176 -0.609 . . . . 74.1 110.843 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -99.92 142.09 31.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.171 -1.048 . . . . 71.31 108.171 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.76 147.54 57.36 Favored Pre-proline 0 C--N 1.289 -2.047 0 N-CA-C 108.751 -0.833 . . . . 74.21 108.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -59.51 135.73 66.65 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.573 2.182 . . . . 64.42 112.219 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.81 156.46 41.31 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.137 -0.69 . . . . 60.1 109.137 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.509 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.2 p -123.75 126.53 72.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 118.704 -1.198 . . . . 74.41 111.676 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 93' ' ' VAL . 25.1 tp -92.17 90.88 7.51 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.729 0.776 . . . . 74.23 110.864 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.9 p80 -73.08 124.91 26.48 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 114.556 -1.202 . . . . 72.13 109.395 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.45 -16.8 8.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.369 -0.919 . . . . 63.04 112.699 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 62' ' ' VAL . 38.4 m-85 -122.27 155.04 36.74 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 110.108 -0.33 . . . . 63.51 110.108 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.443 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 5.4 t60 -129.27 135.95 49.44 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 37.2 ttp180 -88.16 127.18 35.43 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.128 -1.434 . . . . 74.32 107.128 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -100.65 123.05 44.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 106.188 -1.782 . . . . 74.31 106.188 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -76.3 94.03 3.52 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-O 122.014 0.911 . . . . 74.43 109.591 -173.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 10.5 mp -81.07 98.76 8.14 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.057 -1.429 . . . . 75.2 112.709 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.551 ' O ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.76 84.36 7.37 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 123.139 1.447 . . . . 72.14 109.276 172.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.91 -53.84 0.13 Allowed Glycine 0 N--CA 1.405 -3.427 0 CA-C-N 113.679 -1.601 . . . . 74.23 110.016 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -93.45 166.99 14.87 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.563 -0.532 . . . . 72.32 109.563 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.91 135.08 1.54 Allowed 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 122.599 2.199 . . . . 64.23 112.73 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.617 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 38.9 p90 44.97 47.26 3.59 Favored Pre-proline 0 N--CA 1.513 2.676 0 N-CA-C 115.383 1.623 . . . . 71.23 115.383 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 51' ' ' TYR 0.265 37.7 Cg_endo -114.93 157.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.231 3.287 . . . . 74.33 114.68 -175.527 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 91.9 m -153.76 166.55 32.5 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 131.684 3.994 . . . . 65.14 104.3 -13.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.419 HG22 ' HA ' ' A' ' 43' ' ' ARG . 49.1 pt -123.19 145.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 119.978 1.263 . . . . 63.13 112.102 175.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -144.82 150.07 16.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 106.763 -1.569 . . . . 64.32 106.763 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 p -94.44 94.34 8.18 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 121.452 0.644 . . . . 64.34 110.283 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -134.82 -57.43 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.823 -1.547 . . . . 64.44 106.823 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -82.23 139.1 34.44 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.839 -1.073 . . . . 64.54 108.622 174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -78.77 15.09 1.13 Allowed 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.57 0.952 . . . . 62.2 113.57 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.24 -172.06 5.44 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 121.514 0.508 . . . . 64.33 113.461 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HE2' HG21 ' A' ' 37' ' ' VAL . 19.8 ptmt -139.42 140.06 37.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.472 -0.566 . . . . 74.13 109.472 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 41' ' ' TYR . 93.6 t -108.82 124.07 65.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 123.189 0.596 . . . . 73.04 109.575 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.417 HD21 ' CB ' ' A' ' 132' ' ' GLU . 3.4 p-10 -90.27 144.62 25.68 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.475 -1.306 . . . . 74.44 107.475 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.63 -150.38 6.62 Favored Glycine 0 C--N 1.279 -2.619 0 N-CA-C 110.012 -1.235 . . . . 74.24 110.012 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -135.36 145.35 47.29 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.633 -0.827 . . . . 73.35 109.939 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.4 m -103.69 134.56 44.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.517 -0.765 . . . . 65.22 109.435 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.585 HD13 HG21 ' A' ' 17' ' ' ILE . 11.0 mt -86.5 110.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 104.486 -2.413 . . . . 73.33 104.486 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.453 HG22 ' OD1' ' A' ' 10' ' ' ASN . 75.0 p -98.05 162.07 13.41 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.915 -0.584 . . . . 73.14 111.149 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 34.4 70.47 Favored Glycine 0 N--CA 1.436 -1.304 0 O-C-N 123.604 0.565 . . . . 54.55 112.866 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.43 121.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 120.55 -0.46 . . . . 54.22 109.936 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.702 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 42.7 m -81.64 158.61 24.25 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.642 -0.873 . . . . 70.42 108.642 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.6 -40.13 62.37 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.798 1.036 . . . . 73.14 113.798 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.64 -32.88 64.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.632 0.73 . . . . 73.11 110.656 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.702 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 3.8 mp0 -73.43 -31.41 63.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.031 -0.986 . . . . 73.24 110.251 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.91 -36.48 83.5 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.607 -1.257 . . . . 73.31 107.607 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.67 -28.11 53.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.416 -1.266 . . . . 74.34 111.913 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.43 ' ND2' HG12 ' A' ' 26' ' ' ILE . 64.2 t30 -75.29 -30.5 60.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.558 -0.857 . . . . 64.14 109.855 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 17' ' ' ILE . 64.7 m-85 -65.72 -34.28 77.82 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.446 0.641 . . . . 64.32 109.822 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.77 -38.43 90.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.838 -1.073 . . . . 64.35 110.526 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.5 -43.6 48.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.532 -0.758 . . . . 75.1 111.307 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -68.0 -64.06 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.829 1.048 . . . . 54.2 113.829 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.16 69.47 1.02 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.633 0.73 . . . . 73.4 110.931 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.36 15.44 2.29 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.055 -0.975 . . . . 64.2 111.776 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -82.59 -42.53 18.15 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.87 0.322 . . . . 73.04 111.87 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.01 14.0 6.27 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.602 -1.259 . . . . 44.42 107.602 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -128.28 157.02 42.09 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.172 -1.418 . . . . 74.41 107.172 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HB3' HG23 ' A' ' 110' ' ' VAL . 11.7 pt-20 -129.35 146.68 51.18 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.229 -0.656 . . . . 54.43 109.229 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -83.75 117.09 23.02 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.502 -0.555 . . . . 71.23 109.502 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.07 159.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-O 120.84 0.352 . . . . 55.32 110.982 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.6 m -91.09 129.91 37.04 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 108.314 -0.995 . . . . 63.24 108.314 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.57 168.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.543 -1.28 . . . . 63.03 107.543 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -121.3 128.62 52.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.687 -1.205 . . . . 74.11 109.783 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 38' ' ' LEU . 17.0 m -127.19 168.37 20.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.831 -0.622 . . . . 61.23 109.66 -176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 101' ' ' LYS . 75.0 t -103.44 112.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.214 -1.032 . . . . 44.35 108.214 172.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -80.51 99.66 8.16 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.738 -1.208 . . . . 73.54 107.738 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.503 ' SD ' ' HG3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.06 -18.08 59.52 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.959 1.304 . . . . 54.51 110.085 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -46.78 -37.33 8.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.602 0.761 . . . . 72.41 111.101 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.39 10.13 2.96 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 108.277 -1.009 . . . . 74.13 108.277 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t 60.01 26.41 15.71 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.966 0.889 . . . . 65.41 110.079 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -93.16 160.7 14.73 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.397 -0.82 . . . . 73.21 109.425 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 7.1 mptt -104.31 128.79 52.16 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 106.935 -1.506 . . . . 74.03 106.935 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.74 142.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.389 0.614 . . . . 52.13 111.803 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -89.38 125.81 35.29 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.287 -1.746 . . . . 73.33 106.287 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 10' ' ' ASN . 18.5 m -133.2 174.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 120.587 0.232 . . . . 65.53 110.985 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -100.63 153.29 19.53 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.101 -1.074 . . . . 65.23 108.101 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -155.62 174.72 14.88 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.029 -0.73 . . . . 71.03 109.029 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -106.95 119.19 38.7 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.974 -1.121 . . . . 72.34 107.974 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.4 HG12 HG13 ' A' ' 54' ' ' ILE . 35.7 m -113.36 163.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 109.531 -0.544 . . . . 73.52 109.531 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -70.1 121.92 18.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.792 -0.818 . . . . 52.21 108.792 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.0 p -68.1 -20.58 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.231 0.538 . . . . 70.42 111.438 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -89.13 12.13 16.63 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.648 -0.705 . . . . 71.4 110.422 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -51.81 -19.73 1.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.997 1.851 . . . . 74.44 115.997 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.33 -20.89 36.45 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.881 0.848 . . . . 65.31 109.854 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 14.5 t70 -91.66 139.09 24.87 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 107.844 -1.169 . . . . 74.04 107.844 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 8.8 Cg_exo -71.85 78.56 1.73 Allowed 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 121.972 1.781 . . . . 75.21 111.984 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -134.53 114.57 12.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 116.084 -0.507 . . . . 52.53 110.171 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.468 0.471 0 O-C-N 124.405 1.066 . . . . 64.21 112.86 -178.899 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 129' ' ' VAL . 10.4 tp10 . . . . . 0 N--CA 1.432 -1.337 0 N-CA-C 109.073 -0.714 . . . . 62.22 109.073 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -71.44 -30.58 66.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.042 -1.463 . . . . 75.2 110.711 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -57.46 -46.17 83.93 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.847 -0.615 . . . . 75.2 109.547 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.31 -38.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.494 -0.482 . . . . 75.13 110.987 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 125' ' ' GLU . 92.2 t -67.63 -32.39 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 111.928 0.344 . . . . 71.24 111.928 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -83.06 -37.99 23.13 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 117.82 -1.552 . . . . 72.0 111.079 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.68 76.87 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.632 0.253 . . . . 42.33 111.363 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 22.8 mm-40 -64.35 -37.86 88.99 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 116.156 -0.474 . . . . 62.15 110.639 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -56.03 -42.53 76.65 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 116.245 -0.434 . . . . 53.43 111.133 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -76.45 -44.1 37.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 112.756 0.65 . . . . 73.53 112.756 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 132' ' ' GLU . 14.4 p -59.89 -37.28 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.024 -0.67 . . . . 74.42 111.226 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.594 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 91.9 mt-10 -58.34 -43.68 88.41 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.993 -0.743 . . . . 73.24 108.993 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.9 m -60.84 -50.19 74.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.19 -0.914 . . . . 70.51 110.535 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -63.86 -34.68 78.48 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 111.879 0.326 . . . . 73.24 111.879 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 76.4 mtp180 -63.84 -52.6 59.35 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.67 0.271 . . . . 72.12 110.352 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.503 ' HG3' ' SD ' ' A' ' 96' ' ' MET . 31.3 mmmt -60.95 -44.56 97.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.915 0.709 . . . . 74.45 112.915 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.9 mmt -63.08 -41.34 99.39 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.77 -0.372 . . . . 75.12 110.445 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.27 -46.31 84.25 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.286 -0.415 . . . . 71.14 110.72 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.39 -34.38 77.83 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.173 -0.611 . . . . 73.52 112.013 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -68.86 -29.49 67.8 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.437 0.532 . . . . 73.25 112.437 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.94 -47.03 13.22 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.02 0.438 . . . . 74.05 111.181 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -79.75 -31.89 41.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 73.23 111.73 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -117.79 117.15 35.96 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.939 0.399 . . . . 64.12 111.889 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 -28.72 63.1 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.599 2.199 . . . . 61.24 110.522 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -73.15 -5.21 37.69 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.008 -0.996 . . . . 75.44 112.261 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.495 0 N-CA-C 110.405 -1.078 . . . . 33.34 110.405 176.951 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.326 0.584 . . . . 71.14 109.96 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.508 ' CG ' HD12 ' A' ' 75' ' ' LEU . 69.6 m80 -93.38 156.59 16.69 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.815 -0.629 . . . . 72.44 111.694 -173.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.496 ' HB2' HG12 ' A' ' 104' ' ' VAL . 91.4 m-20 -129.0 133.53 47.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.533 -1.284 . . . . 65.03 107.533 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.5 121.54 63.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.762 -0.375 . . . . 74.2 110.416 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.495 ' HB2' HG21 ' A' ' 104' ' ' VAL . 59.9 t80 -81.9 111.5 18.16 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.053 -1.091 . . . . 75.51 108.053 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 17' ' ' ILE . 95.8 t -120.19 142.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-O 121.488 0.661 . . . . 73.22 110.831 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -99.47 115.44 29.31 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.166 -1.05 . . . . 74.31 108.166 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.19 -68.09 2.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 116.096 1.199 . . . . 45.11 116.096 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.3 t -40.12 -81.26 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.669 2.1 . . . . 73.41 116.669 -167.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.588 ' HB ' HD11 ' A' ' 67' ' ' ILE . 3.1 mp -93.92 27.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 122.074 0.94 . . . . 63.51 109.552 -173.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 65' ' ' LYS . 18.9 mt -74.52 -15.89 60.85 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.406 -0.809 . . . . 73.44 111.654 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.26 134.1 19.87 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 114.872 -1.058 . . . . 71.13 109.975 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.69 -31.6 41.75 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.753 2.968 . . . . 74.2 114.011 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.29 80.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.982 0.42 . . . . 72.13 111.332 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.596 ' O ' HG22 ' A' ' 25' ' ' VAL . 47.8 t -77.36 -34.32 20.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.151 -0.685 . . . . 63.44 109.151 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.31 75.66 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.87 -0.789 . . . . 71.02 108.87 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -71.08 -12.11 61.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.519 -0.764 . . . . 50.35 111.602 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 22' ' ' VAL . 10.6 m -97.94 -35.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 119.665 -0.814 . . . . 74.13 110.513 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.438 ' C ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -80.47 -48.44 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 120.782 0.325 . . . . 73.13 110.909 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 81.0 mt -90.12 -18.01 26.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.365 -0.606 . . . . 51.11 109.365 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 33.3 t70 70.64 8.76 6.69 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.896 1.332 . . . . 70.2 109.283 -175.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -142.0 143.7 33.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 113.757 -1.565 . . . . 73.53 107.721 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -76.45 117.05 17.72 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.545 0.212 . . . . 55.14 111.512 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.423 ' HB2' ' CD1' ' A' ' 27' ' ' LEU . . . -105.72 158.8 16.47 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 116.074 -0.512 . . . . 72.45 110.018 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.94 131.81 46.64 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.694 -0.685 . . . . 72.21 111.965 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.3 p -103.46 143.81 32.22 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.312 -0.858 . . . . 71.42 110.272 174.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.4 144.94 51.07 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.394 -0.595 . . . . 71.34 109.394 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -68.24 133.77 29.5 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.035 1.823 . . . . 53.11 112.875 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.08 156.61 41.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.156 -0.929 . . . . 65.32 109.397 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.14 129.99 74.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.459 0.647 . . . . 73.13 110.86 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.4 ' HA ' HG12 ' A' ' 93' ' ' VAL . 20.9 tp -88.29 117.3 27.1 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.416 -0.811 . . . . 71.12 109.75 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -94.08 128.84 40.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.059 -0.519 . . . . 52.23 110.507 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 56' ' ' SER . . . 111.67 -4.54 27.72 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.029 -1.081 . . . . 51.02 112.561 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.494 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 63.8 m-85 -124.82 147.42 48.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.242 0.46 . . . . 74.31 112.242 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -117.83 130.06 56.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.56 -1.274 . . . . 72.4 107.56 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.467 ' HA ' HG22 ' A' ' 54' ' ' ILE . 19.4 ptt180 -87.85 140.42 29.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.794 0.438 . . . . 72.22 110.804 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -112.22 150.64 30.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.774 -0.37 . . . . 70.22 111.235 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.46 100.66 13.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.66 0.743 . . . . 72.52 111.91 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.67 72.97 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 122.025 0.917 . . . . 53.32 109.915 172.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -83.14 8.78 12.11 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 113.968 1.099 . . . . 72.03 113.968 -175.584 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.41 -19.19 74.57 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.971 -2.052 . . . . 64.44 107.971 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 3.4 mm? -98.11 168.53 9.81 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 105.498 -2.038 . . . . 71.32 105.498 172.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 99.8 Cg_exo -42.47 -65.79 0.18 Allowed 'Trans proline' 0 C--N 1.365 1.431 0 C-N-CA 122.271 1.981 . . . . 61.44 113.891 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.605 ' H ' ' HD2' ' A' ' 52' ' ' PRO . 33.7 m-85 -164.62 -36.44 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 125.366 1.466 . . . . 74.42 113.959 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' ' H ' ' A' ' 51' ' ' TYR . 63.3 Cg_exo -48.96 166.69 0.15 Allowed 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.33 2.02 . . . . 65.14 112.504 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.6 p -135.69 -171.7 2.91 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.445 1.098 . . . . 72.43 112.61 10.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 17.6 pt -131.02 150.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 114.076 -1.42 . . . . 61.42 110.109 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 151.71 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.448 -1.686 . . . . 65.11 106.448 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 33.0 t -71.34 145.5 49.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.384 0.611 . . . . 73.54 112.073 -174.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -155.05 163.52 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.462 -1.31 . . . . 74.42 107.462 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.04 -56.6 4.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.274 0.559 . . . . 75.41 110.887 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 m -91.96 12.18 22.63 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.823 -0.626 . . . . 71.33 111.954 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.52 131.49 10.81 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 120.468 -0.872 . . . . 54.55 111.666 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -136.87 140.15 42.16 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.394 -0.965 . . . . 63.23 108.394 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 41' ' ' TYR . 57.3 t -114.36 122.84 69.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.837 -0.431 . . . . 72.42 109.837 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.7 126.51 37.82 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.528 -0.545 . . . . 62.12 109.528 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.93 -148.56 5.18 Favored Glycine 0 N--CA 1.42 -2.404 0 C-N-CA 120.23 -0.986 . . . . 72.33 111.747 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.679 ' HB2' HD22 ' A' ' 18' ' ' LEU . 44.3 mtmt -139.23 145.77 39.65 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.923 0.489 . . . . 74.32 110.53 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.44 134.3 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.415 -0.811 . . . . 64.33 109.827 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.588 HD11 ' HB ' ' A' ' 17' ' ' ILE . 15.3 mt -86.94 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 105.193 -2.151 . . . . 70.2 105.193 178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 161.61 13.48 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.718 -0.393 . . . . 75.14 112.03 -173.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.55 37.2 77.79 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.799 -0.637 . . . . 20.24 112.901 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.43 121.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.653 -0.419 . . . . 74.5 109.97 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.401 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 46.7 m -73.99 158.8 33.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.052 -0.722 . . . . 65.21 109.052 177.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -52.92 -44.08 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.186 0.439 . . . . 73.5 112.186 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.47 78.49 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.539 0.685 . . . . 62.33 110.143 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.9 mm-40 -76.26 -38.69 55.88 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.775 -1.102 . . . . 63.23 110.217 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.508 HD12 ' CG ' ' A' ' 9' ' ' HIS . 3.6 tt -61.57 -37.51 84.13 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.695 -1.224 . . . . 71.1 107.695 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.618 ' O ' HG23 ' A' ' 80' ' ' VAL . 28.5 t-20 -54.71 -28.8 50.54 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 114.272 -1.331 . . . . 73.04 112.239 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.405 ' OD1' HG12 ' A' ' 26' ' ' ILE . 21.4 t-20 -73.74 -30.88 63.07 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 118.957 -1.097 . . . . 70.51 109.633 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.592 ' O ' HG22 ' A' ' 81' ' ' ILE . 68.0 m-85 -73.23 -31.12 63.94 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 107.912 -1.144 . . . . 72.43 107.912 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.34 -37.56 63.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.424 -0.807 . . . . 65.42 110.274 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 76' ' ' ASN . 58.3 t -76.41 -27.38 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 N-CA-C 113.475 0.917 . . . . 63.2 113.475 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 78' ' ' PHE . 13.7 tt -59.25 165.15 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 O-C-N 122.053 -0.404 . . . . 72.42 110.339 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -53.97 95.51 0.01 OUTLIER 'General case' 0 C--O 1.242 0.691 0 N-CA-C 114.296 1.221 . . . . 75.4 114.296 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.66 60.21 0.64 Allowed Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 107.848 -2.101 . . . . 63.22 107.848 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -57.95 -41.28 82.49 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.739 0.816 . . . . 65.04 112.43 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.518 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 8.2 t70 -128.44 24.25 5.86 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.932 -1.507 . . . . 74.11 106.932 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.491 ' CE2' ' HB2' ' A' ' 52' ' ' PRO . 73.8 m-85 -119.2 150.71 39.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.453 -1.249 . . . . 70.21 108.695 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.85 144.44 51.31 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.781 -0.451 . . . . 71.54 109.781 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -93.17 114.93 27.56 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.906 -0.775 . . . . 75.04 108.906 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -128.69 161.05 38.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.663 0.785 . . . . 65.25 111.755 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.2 m -90.82 130.72 36.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.136 -1.061 . . . . 53.12 108.136 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.69 159.82 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.407 0.683 . . . . 72.41 109.158 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.68 123.87 46.38 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.3 -0.56 . . . . 61.34 110.545 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 38' ' ' LEU . 23.6 m -125.61 160.72 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 109.469 -0.567 . . . . 70.12 109.469 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 68.8 t -104.36 113.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.03 -0.986 . . . . 71.24 109.12 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -73.38 103.57 4.09 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 108.663 -0.866 . . . . 52.43 108.663 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -29.86 48.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.809 1.644 . . . . 71.12 110.437 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.29 -40.07 64.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.509 0.724 . . . . 73.33 111.729 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -123.95 -3.08 8.16 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.321 0.581 . . . . 72.43 111.025 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.94 26.19 14.11 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.014 0.926 . . . . 61.44 110.013 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 12.9 pt-20 -95.5 160.6 14.44 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.652 -0.704 . . . . 63.51 109.399 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -108.64 130.19 55.33 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.938 -1.134 . . . . 75.43 107.938 -178.473 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.77 144.27 21.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 109.702 -0.481 . . . . 54.34 109.702 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -87.62 127.09 35.28 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.683 0.754 . . . . 72.4 112.652 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.496 HG12 ' HB2' ' A' ' 10' ' ' ASN . 23.1 m -128.33 175.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 113.668 -1.605 . . . . 74.32 109.037 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.457 ' HG3' HD11 ' A' ' 75' ' ' LEU . 10.7 mm-40 -99.4 153.36 19.05 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.064 -0.717 . . . . 74.43 109.064 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 t -159.12 175.25 13.7 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.436 -0.579 . . . . 64.54 109.436 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -107.56 119.34 39.14 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.963 -0.754 . . . . 71.52 108.963 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG12 HG13 ' A' ' 54' ' ' ILE . 31.9 m -114.17 178.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 120.71 -0.396 . . . . 73.25 110.154 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.535 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 44.9 t-105 -101.54 124.84 47.86 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 -173.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.6 m -72.66 -26.71 24.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-O 121.28 0.562 . . . . 71.54 111.3 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.535 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 28.4 t-20 -80.01 12.51 2.73 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.732 0.813 . . . . 54.41 110.078 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.8 ptpp? -51.81 -24.67 6.36 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.362 1.065 . . . . 74.43 112.764 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -90.39 -3.15 57.9 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.143 0.497 . . . . 73.33 112.017 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.41 153.45 39.07 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.485 -0.325 . . . . 64.35 110.275 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.78 110.67 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.632 2.221 . . . . 73.41 111.248 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -133.55 166.77 21.79 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.922 -1.51 . . . . 73.24 106.922 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.342 -0.984 . . . . 60.22 108.342 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 121.113 0.482 . . . . 71.22 110.22 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -66.53 -37.44 85.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.053 -0.521 . . . . 75.2 109.712 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -56.45 -48.37 77.19 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 123.045 0.538 . . . . 75.25 110.311 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.5 m -69.37 -30.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.471 -0.491 . . . . 62.44 112.285 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -75.28 -44.47 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.421 -0.585 . . . . 74.11 109.421 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.47 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 26.3 t-80 -61.37 -40.79 95.6 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.07 -1.085 . . . . 74.31 108.07 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.89 97.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.703 -0.681 . . . . 42.43 111.652 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.436 ' HA ' HG12 ' A' ' 135' ' ' VAL . 36.3 mm-40 -67.81 -26.7 66.21 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 112.095 0.406 . . . . 73.22 112.095 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 8.8 tmtt? -70.71 -55.99 7.41 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.582 -0.896 . . . . 73.52 108.582 176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 94.1 m-85 -66.29 -32.04 73.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.006 1.113 . . . . 74.32 114.006 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.9 p -62.37 -38.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.017 -0.673 . . . . 71.32 110.648 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -72.16 -32.41 66.83 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 119.593 -0.843 . . . . 71.3 111.277 179.221 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 80.1 m -61.92 -46.24 90.19 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.841 -0.618 . . . . 73.44 110.287 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -61.41 -34.7 75.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 121.073 -0.251 . . . . 65.1 111.123 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 99.3 mtt180 -70.13 -49.23 52.81 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.106 -0.497 . . . . 74.04 110.681 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 33.4 mmtp -58.51 -43.13 88.98 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.719 -0.474 . . . . 75.03 109.719 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.9 mtm -67.59 -31.17 71.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.693 -0.685 . . . . 63.35 111.295 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.56 -40.47 73.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.68 -0.489 . . . . 72.31 109.68 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 9.5 mm-40 -63.0 -34.16 76.96 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.982 0.896 . . . . 64.51 109.363 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -71.87 -44.36 63.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.509 -1.223 . . . . 75.22 108.956 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.49 -37.78 83.35 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 51.22 111.242 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -78.74 -11.71 59.99 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.06 0.763 . . . . 62.33 113.06 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -115.91 131.7 23.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 C-N-CA 120.101 -0.64 . . . . 73.11 112.168 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.61 -14.99 45.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.391 2.728 . . . . 73.23 111.324 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -75.39 -20.63 58.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.265 -0.88 . . . . 64.43 110.121 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.652 0 N-CA-C 108.942 -1.663 . . . . 73.35 108.942 176.156 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.18 -0.674 . . . . 70.41 109.18 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.6 m -78.35 100.95 6.98 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.972 -0.751 . . . . 64.23 108.972 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -151.92 133.27 14.53 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.805 -0.442 . . . . 73.14 109.805 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.3 p -77.17 142.89 39.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.612 0.244 . . . . 73.03 110.451 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -100.6 170.21 6.92 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 116.563 -0.29 . . . . 61.22 110.743 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.85 -177.22 0.31 Allowed 'Trans proline' 0 C--O 1.258 1.486 0 C-N-CA 122.699 2.266 . . . . 72.33 111.682 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 68.34 77.96 0.23 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.933 0.873 . . . . 74.23 109.659 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.1 m -80.72 144.25 32.34 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.736 -1.12 . . . . 73.15 109.915 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -107.81 150.53 26.89 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.673 -0.694 . . . . 71.54 111.925 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -124.52 124.65 42.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.075 -1.454 . . . . 74.14 107.075 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 7.6 p -130.61 123.5 55.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 120.539 -0.464 . . . . 53.4 111.991 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -77.81 120.09 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.974 -0.75 . . . . 72.33 108.974 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.97 148.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.136 0.493 . . . . 64.44 110.217 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.33 106.58 9.61 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.85 -0.796 . . . . 71.43 108.85 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 -69.04 1.44 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 114.285 0.474 . . . . 74.34 114.285 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -44.75 -72.31 0.06 Allowed 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.198 1.555 . . . . 64.3 115.198 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.526 ' HB ' HD11 ' A' ' 67' ' ' ILE . 4.2 mp -105.67 66.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 109.167 -0.679 . . . . 61.34 109.167 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.8 mt -114.6 16.35 17.58 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.472 -1.307 . . . . 61.12 107.472 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.36 146.75 43.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.423 -1.262 . . . . 73.4 110.956 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.38 -42.83 51.74 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.806 3.004 . . . . 70.24 114.165 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.48 -47.65 78.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 120.627 0.251 . . . . 73.22 111.233 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 26' ' ' ILE . 93.9 t -65.09 -45.16 95.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 CA-C-N 115.861 -0.608 . . . . 73.14 111.64 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB1' ' H ' ' A' ' 31' ' ' ALA . . . -60.38 -37.3 80.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.118 0.485 . . . . 35.13 110.629 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.92 -33.49 68.31 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.768 -0.651 . . . . 63.31 111.522 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 22' ' ' VAL . 17.9 m -82.47 -28.58 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.969 -0.692 . . . . 73.42 111.254 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.5 tt -72.3 -47.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 119.736 -0.786 . . . . 72.41 111.829 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 74' ' ' GLU . 77.7 mt -95.62 -55.56 2.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.834 -1.146 . . . . 60.04 112.072 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.1 t70 150.39 -33.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.534 -1.654 . . . . 73.41 106.534 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -134.78 159.86 40.0 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.786 -1.552 . . . . 73.12 108.028 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.0 m -76.01 119.04 19.41 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.205 0.526 . . . . 71.33 110.144 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' H ' ' HB1' ' A' ' 23' ' ' ALA . . . -87.2 152.98 21.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.723 -0.843 . . . . 72.4 108.723 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -95.75 120.74 36.54 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.302 0.572 . . . . 54.34 112.322 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.3 p -93.46 145.24 24.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 115.144 -0.934 . . . . 63.34 109.114 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.2 t -124.08 134.71 25.63 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 106.82 -1.548 . . . . 73.3 106.82 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 33.1 Cg_endo -65.4 126.5 16.35 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.137 1.892 . . . . 74.44 111.73 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.54 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.97 155.26 39.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.516 -0.765 . . . . 63.2 110.558 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.425 HG21 ' HD3' ' A' ' 61' ' ' LYS . 7.1 p -121.75 129.08 75.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.55 0.691 . . . . 70.35 111.385 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.456 ' HB2' HG12 ' A' ' 93' ' ' VAL . 27.2 tp -91.58 95.36 9.89 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.332 -0.849 . . . . 64.43 111.804 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 17.6 p-80 -73.55 131.96 42.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.123 -0.695 . . . . 75.12 109.123 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.11 -10.56 20.39 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 119.213 -1.47 . . . . 65.32 113.064 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.01 158.71 34.62 Favored 'General case' 0 CA--C 1.473 -1.993 0 N-CA-C 110.242 -0.281 . . . . 65.04 110.242 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.456 ' NE2' ' HB2' ' A' ' 120' ' ' GLU . 3.6 t60 -126.19 131.5 51.98 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.767 -1.197 . . . . 73.12 107.767 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.428 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -91.36 137.23 32.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.568 0.699 . . . . 73.43 112.665 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 118' ' ' TYR . 62.0 m-85 -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.33 -1.359 . . . . 73.23 107.33 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -88.12 -45.21 10.33 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.862 0.319 . . . . 73.3 111.862 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.507 HD23 HD22 ' A' ' 49' ' ' LEU 0.261 7.5 mp 57.23 77.34 0.27 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 114.912 1.449 . . . . 70.14 114.912 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -78.58 105.25 9.74 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.79 -1.096 . . . . 51.54 110.626 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.88 -31.57 3.04 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 110.882 -0.887 . . . . 33.14 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD22 HD23 ' A' ' 46' ' ' LEU . 4.2 mp -96.86 156.16 36.8 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 108.025 -1.102 . . . . 71.24 108.025 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.27 87.87 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 123.133 2.555 . . . . 62.43 113.955 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.601 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.595 34.6 p90 33.42 54.83 1.34 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 119.556 3.169 . . . . 75.31 119.556 -176.337 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 5.7 Cg_endo -103.63 169.49 0.21 Allowed 'Trans proline' 0 CA--C 1.555 1.542 1 C-N-CA 125.637 4.225 . . . . 73.14 110.298 174.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p -155.97 -178.43 7.3 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.245 2.218 . . . . 64.23 107.122 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.464 HG13 HG12 ' A' ' 108' ' ' VAL . 44.4 pt -126.64 124.24 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.625 -1.25 . . . . 65.22 107.625 164.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 m -146.71 172.71 3.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.856 -1.164 . . . . 71.14 107.856 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.6 m 71.04 129.94 0.03 OUTLIER 'General case' 0 C--O 1.24 0.577 0 O-C-N 124.909 1.38 . . . . 73.34 111.495 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -80.31 75.05 7.14 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.04 -1.467 . . . . 74.41 107.04 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.61 161.9 20.98 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 113.066 -1.879 . . . . 73.41 109.708 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.9 m -82.79 -4.29 57.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.667 0.27 . . . . 71.25 111.332 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.68 -171.17 47.4 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 121.505 -0.379 . . . . 70.31 112.433 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HD3' HG21 ' A' ' 37' ' ' VAL . 9.4 ptpp? -144.69 154.78 43.13 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 120.82 0.343 . . . . 75.3 110.609 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG13 ' HG2' ' A' ' 43' ' ' ARG . 65.7 t -116.92 122.16 69.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.775 -0.648 . . . . 71.12 109.3 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -96.04 123.41 39.63 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.374 -0.531 . . . . 75.04 109.672 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.91 -143.8 3.76 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.894 -1.282 . . . . 71.12 109.894 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 48.6 mtpt -140.76 150.68 43.69 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.762 0.781 . . . . 53.14 109.632 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.5 m -104.45 133.99 47.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 115.629 -0.714 . . . . 62.24 109.773 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.526 HD11 ' HB ' ' A' ' 17' ' ' ILE . 45.4 mt -87.23 111.54 21.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.8 -1.926 . . . . 72.2 105.8 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -103.91 162.03 13.47 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.296 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.67 72.03 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 116.147 -0.479 . . . . 73.42 111.966 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -94.97 122.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 109.939 -0.393 . . . . 72.01 109.939 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.0 t -73.74 163.22 28.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.325 -0.991 . . . . 74.15 108.325 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.9 -26.0 68.58 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.973 0.416 . . . . 64.13 110.575 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 -43.91 32.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.42 -0.585 . . . . 75.11 109.42 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.631 ' HB3' HD22 ' A' ' 27' ' ' LEU . 53.9 mt-10 -63.73 -43.2 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 71.45 110.599 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.15 -36.62 77.97 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.723 0.809 . . . . 73.31 110.077 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' HG23 ' A' ' 80' ' ' VAL . 58.4 t30 -60.92 -28.71 69.13 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.348 -0.842 . . . . 52.15 111.18 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -70.74 -30.17 66.61 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 119.791 -0.763 . . . . 64.24 109.484 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.554 ' CE2' HD21 ' A' ' 27' ' ' LEU . 92.6 m-85 -70.53 -32.59 70.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 64.01 109.484 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.13 -39.99 62.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.186 -0.915 . . . . 63.34 109.67 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 76' ' ' ASN . 65.5 t -74.62 -44.15 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.118 -0.946 . . . . 72.35 112.031 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.35 120.76 51.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.412 -0.358 . . . . 70.14 111.527 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 75.87 -26.78 0.19 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.934 1.294 . . . . 74.42 113.7 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 51.16 3.89 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.289 -0.724 . . . . 60.31 111.289 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.65 -43.11 49.29 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.073 0.549 . . . . 62.23 112.285 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.628 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 4.2 t70 -118.03 25.87 10.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.88 1.324 . . . . 72.51 107.552 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 89.5 m-85 -114.75 151.36 33.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.072 -1.422 . . . . 74.33 109.68 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.74 149.23 49.72 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.522 -0.547 . . . . 75.02 109.522 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -85.8 125.4 33.23 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.922 0.712 . . . . 63.35 112.922 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.25 155.79 41.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.965 -1.016 . . . . 70.32 109.218 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.5 m -96.98 124.14 40.87 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.384 -0.599 . . . . 71.3 109.384 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.3 m -128.96 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 107.904 -1.147 . . . . 60.33 107.904 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -112.52 131.63 55.5 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.747 -1.181 . . . . 74.55 108.26 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 38' ' ' LEU . 24.1 m -125.67 163.68 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 73.41 109.458 -174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 101' ' ' LYS . 70.4 t -102.48 117.27 47.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.839 -0.619 . . . . 54.24 109.338 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -66.72 94.58 0.31 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.863 -1.162 . . . . 74.41 107.863 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.54 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -54.34 -35.57 62.86 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 125.496 1.518 . . . . 74.31 109.567 -177.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -52.6 -30.89 33.54 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.763 -1.108 . . . . 63.45 112.592 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -136.08 4.61 2.99 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.617 0.722 . . . . 53.22 110.968 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m 59.88 25.58 14.72 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.119 0.968 . . . . 74.44 112.742 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.83 160.61 14.33 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.656 -0.868 . . . . 72.41 108.656 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 94' ' ' VAL . 39.8 mtmt -102.35 129.69 48.88 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.49 -0.559 . . . . 74.44 109.49 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.74 144.38 37.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.092 0.472 . . . . 53.31 110.431 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -93.94 126.35 39.09 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.524 -0.917 . . . . 75.23 108.524 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.081 0.467 . . . . 64.01 111.28 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 46.7 mt-10 -100.53 153.36 19.44 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.636 -1.246 . . . . 73.51 107.636 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -151.01 173.63 14.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 86' ' ' TYR . 92.5 m-85 -113.55 118.68 35.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 121.122 0.487 . . . . 72.24 110.29 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG12 HG13 ' A' ' 54' ' ' ILE . 27.4 m -109.79 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.472 -0.936 . . . . 74.02 108.472 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.628 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 46.4 t-105 -93.33 129.17 39.53 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.223 -1.028 . . . . 64.33 108.223 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 85' ' ' ASP . 34.8 m -71.47 -20.07 20.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 N-CA-C 112.51 0.559 . . . . 71.41 112.51 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.556 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 25.4 t-20 -80.48 11.8 3.46 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.744 0.783 . . . . 75.13 109.942 176.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 19.6 ptpt -51.29 -15.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.747 2.019 . . . . 70.15 114.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.46 -52.07 18.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.957 0.903 . . . . 65.11 111.218 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -108.05 127.54 27.42 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 109.432 -0.581 . . . . 75.25 109.432 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.87 103.61 0.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 62.02 111.056 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -100.9 133.09 45.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.503 -0.771 . . . . 73.44 109.653 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 58.9 44.43 16.63 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.987 0.805 . . . . 72.13 110.078 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.413 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 47.5 p90 -57.63 -21.33 38.98 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.358 0.873 . . . . 64.44 113.358 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.21 129.36 9.34 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.313 -1.115 . . . . 73.14 110.313 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 67.6 tt0 -85.68 132.5 34.14 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.784 -0.821 . . . . 74.13 108.784 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -76.06 -172.97 2.18 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.818 -1.083 . . . . 74.45 111.298 -172.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -80.4 119.65 23.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.565 0.698 . . . . 74.41 110.184 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.482 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 50.2 m-85 -66.25 -34.98 79.24 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.479 -1.237 . . . . 73.54 108.93 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.77 -32.02 72.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.065 -0.971 . . . . 70.31 110.796 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 129' ' ' VAL . 36.9 tt0 -71.21 -40.59 71.05 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.4 -0.963 . . . . 75.2 108.4 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -61.99 -44.17 97.3 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.424 -0.51 . . . . 70.45 109.871 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 83.1 mtp180 -56.27 -48.93 75.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.662 -0.699 . . . . 74.35 111.177 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.57 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 32.0 m -70.43 -40.59 77.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.154 -0.618 . . . . 40.22 112.37 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 125' ' ' GLU . 95.2 t -68.16 -44.81 84.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.548 -0.461 . . . . 63.4 111.767 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.514 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.6 p80 -67.39 -33.77 75.9 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 118.401 -1.319 . . . . 61.51 109.737 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -64.54 -47.27 79.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.977 -0.556 . . . . 73.15 110.863 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 48.1 mt-10 -60.28 -41.52 93.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.954 0.406 . . . . 73.41 110.389 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.25 -48.05 81.67 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.179 -0.919 . . . . 72.31 111.897 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.514 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 56.4 m-85 -67.94 -45.43 74.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.581 -0.448 . . . . 74.23 111.572 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 131' ' ' ALA . 94.5 t -57.37 -48.26 83.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 116.391 -0.368 . . . . 70.43 111.68 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -58.55 -48.88 79.43 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 120.439 -0.504 . . . . 63.0 109.928 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -45.2 81.27 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.527 -0.76 . . . . 75.53 112.343 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.52 -43.05 73.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.872 -0.731 . . . . 63.12 112.067 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 98.9 mtt180 -61.49 -46.74 88.76 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.992 0.425 . . . . 62.22 111.207 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.95 -32.05 66.93 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.909 -0.587 . . . . 62.4 112.316 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -72.86 -32.07 65.18 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.41 -0.959 . . . . 75.24 108.41 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.56 -37.17 79.69 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.464 -0.789 . . . . 73.24 110.166 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 8.6 mm-40 -61.59 -46.44 89.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.1 0.476 . . . . 74.41 110.283 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -65.39 -43.73 89.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.871 -0.604 . . . . 74.14 110.8 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.6 -22.21 65.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.698 0.761 . . . . 74.23 111.09 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 146' ' ' LYS . 0.7 OUTLIER -78.45 -26.66 46.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.447 -0.797 . . . . 72.22 109.193 177.523 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 64.01 82.14 0.22 Allowed Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.349 0.66 . . . . 73.0 109.72 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.25 -37.26 2.68 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.216 1.944 . . . . 61.33 112.031 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -96.47 3.44 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.562 -0.744 . . . . 73.34 110.572 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 67.96 34.15 81.23 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 109.636 -1.386 . . . . 75.32 109.636 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -81.57 121.79 26.76 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.756 -0.722 . . . . 51.11 109.41 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.2 m -102.79 164.58 11.55 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.908 -0.405 . . . . 74.54 109.908 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 26.3 mmt -56.85 -43.44 81.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.272 0.841 . . . . 71.4 113.272 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -79.98 -25.01 40.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.46 0.648 . . . . 74.34 110.827 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.25 -45.8 45.58 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.899 -0.778 . . . . 60.51 108.899 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.97 -27.7 69.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.836 . . . . 31.33 112.412 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.7 p -92.79 128.66 44.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.422 -0.511 . . . . 70.34 110.708 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -77.25 78.07 1.48 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.062 -0.815 . . . . 64.43 111.062 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.0 t -76.66 152.35 35.83 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.655 -0.498 . . . . 75.34 109.655 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.62 141.61 46.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.543 -0.54 . . . . 61.33 109.543 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.0 mt -100.15 -16.71 17.71 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.128 0.489 . . . . 72.43 109.726 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 70.0 m 61.61 78.38 0.29 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.914 -1.039 . . . . 72.01 111.005 -174.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.4 t -77.32 131.91 38.34 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 114.093 -1.412 . . . . 64.54 109.232 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.45 108.82 2.86 Favored Glycine 0 N--CA 1.422 -2.282 0 N-CA-C 110.636 -0.986 . . . . 60.5 110.636 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--N 1.292 -1.898 0 CA-C-O 118.344 -0.836 . . . . 63.53 109.177 -179.561 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 109.031 -0.729 . . . . 72.22 109.031 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.1 m -79.69 -31.18 41.25 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.683 -0.407 . . . . 71.14 111.096 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.2 t -163.07 178.87 7.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.953 -1.129 . . . . 74.02 107.953 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -83.88 143.64 29.75 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.854 -1.165 . . . . 75.24 107.854 174.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 12.1 t70 -64.65 125.05 87.95 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.538 -0.541 . . . . 75.51 109.538 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.1 -12.99 31.03 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.119 2.546 . . . . 72.42 114.197 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -140.34 38.98 1.9 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.257 -1.016 . . . . 73.31 108.257 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 42.3 p -52.23 124.09 12.29 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.161 -1.381 . . . . 63.21 110.351 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.95 156.2 19.04 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 114.647 -1.16 . . . . 73.33 111.059 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.557 ' HB2' HG12 ' A' ' 104' ' ' VAL . 3.3 m-20 -125.31 131.92 52.96 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.96 -1.496 . . . . 50.24 106.96 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 13' ' ' VAL . 49.1 t -119.5 120.33 63.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 120.336 -0.546 . . . . 51.35 110.694 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' HB2' HG21 ' A' ' 104' ' ' VAL . 43.4 t80 -91.5 96.73 10.65 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 104.861 -2.274 . . . . 71.12 104.861 173.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 11' ' ' VAL . 10.3 p -119.1 121.93 67.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 118.329 -1.348 . . . . 71.05 111.576 -173.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -92.35 66.86 4.77 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 106.025 -1.843 . . . . 64.45 106.025 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.38 -169.82 13.9 Favored Glycine 0 N--CA 1.42 -2.392 0 CA-C-N 113.537 -1.665 . . . . 70.43 109.381 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -88.0 85.11 6.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-O 121.606 0.717 . . . . 65.23 112.749 -174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 67' ' ' ILE . 8.0 mm -144.43 -84.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 104.846 -2.279 . . . . 74.14 104.846 169.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' H ' ' HB ' ' A' ' 17' ' ' ILE . 80.6 mt 50.89 -42.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 128.086 2.554 . . . . 73.31 117.368 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.89 140.29 22.55 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.199 -0.667 . . . . 72.41 109.199 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -48.57 -28.65 12.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.586 3.524 . . . . 62.45 114.861 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.48 97.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.929 0.395 . . . . 73.54 111.08 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 25' ' ' VAL . 35.9 t -77.07 -30.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.882 -0.784 . . . . 65.05 108.882 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.64 -28.96 70.27 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.934 -0.765 . . . . 71.33 108.934 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.09 -8.7 57.59 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.434 -0.803 . . . . 21.42 111.767 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 22' ' ' VAL . 14.4 m -99.25 -23.07 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 119.619 -0.833 . . . . 71.52 110.773 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.559 HG21 HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -85.85 -47.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 116.251 -0.431 . . . . 62.32 110.588 176.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 31' ' ' ALA . 97.7 mt -89.66 -21.3 22.83 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 116.57 -0.286 . . . . 73.51 110.796 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 37.2 t70 68.72 10.7 8.04 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.289 1.519 . . . . 70.22 108.882 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -136.11 141.83 44.22 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 104.928 -2.249 . . . . 75.22 104.928 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -77.74 136.83 38.21 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.485 -0.886 . . . . 60.1 109.887 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -121.0 154.86 35.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.689 -0.485 . . . . 42.32 109.689 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -89.89 117.98 29.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.473 -0.566 . . . . 62.02 109.473 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.6 m -104.96 142.67 34.36 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.459 -2.052 . . . . 75.25 105.459 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.56 149.84 70.44 Favored Pre-proline 0 C--N 1.296 -1.75 0 O-C-N 122.088 -0.383 . . . . 74.02 110.133 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.53 133.47 37.24 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.605 2.203 . . . . 71.5 111.522 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.79 156.51 41.94 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.942 -0.572 . . . . 73.22 109.868 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.0 p -122.59 128.04 75.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-O 121.496 0.665 . . . . 73.23 111.045 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.47 ' HA ' HG12 ' A' ' 93' ' ' VAL . 22.4 tp -87.91 111.07 21.04 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.196 -0.911 . . . . 75.2 110.103 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 13.9 p80 -87.06 122.21 30.57 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.473 -0.785 . . . . 64.14 110.187 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.45 7.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.374 -1.393 . . . . 71.31 112.866 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.444 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 57.0 m-85 -117.78 161.11 20.24 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 109.288 -0.634 . . . . 73.12 109.288 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -133.41 131.98 40.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.25 -1.389 . . . . 72.0 107.25 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.711 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 1.2 tmt_? -88.56 120.56 30.06 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 109.292 -0.633 . . . . 71.31 109.292 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 39.0 m-85 -95.99 159.82 14.77 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.987 -1.486 . . . . 74.43 106.987 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' C ' ' HD3' ' A' ' 45' ' ' LYS . 7.7 tmtm? -82.78 -41.76 18.76 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 112.156 0.428 . . . . 70.53 112.156 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 49' ' ' LEU . 7.9 mp 62.75 158.27 0.07 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.529 1.307 . . . . 71.1 114.529 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.41 -51.25 1.28 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.799 -0.815 . . . . 75.5 108.799 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.29 74.63 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.661 -1.154 . . . . 71.4 111.678 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HB2' HD23 ' A' ' 46' ' ' LEU . 3.0 mm? -107.63 167.34 9.5 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.409 -0.96 . . . . 62.42 108.409 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 41.5 Cg_exo -62.68 -157.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.52 0 C-N-CA 123.01 2.473 . . . . 51.32 112.905 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' N ' ' HD2' ' A' ' 52' ' ' PRO 0.349 12.8 p90 -57.49 -31.34 9.92 Favored Pre-proline 0 CA--C 1.568 1.665 0 N-CA-C 116.557 2.058 . . . . 72.13 116.557 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 51' ' ' TYR . 3.3 Cg_exo -39.74 168.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.59 3.317 0 C-N-CA 123.631 2.887 . . . . 71.52 112.746 163.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 p -139.29 -175.87 4.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.199 -1.563 . . . . 72.4 110.963 11.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 45.1 pt -123.77 141.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.116 -1.068 . . . . 70.1 108.116 172.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.407 HG22 ' HE2' ' A' ' 44' ' ' TYR . 30.8 m -148.18 158.77 7.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.951 -0.759 . . . . 45.21 108.951 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 m -80.5 88.91 5.62 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.739 0.78 . . . . 62.42 109.839 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.5 t -144.1 -66.02 0.35 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.574 -1.639 . . . . 74.22 106.574 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.63 125.68 30.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.387 -1.709 . . . . 73.13 106.387 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -84.41 15.46 3.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.846 0.684 . . . . 64.13 112.846 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.84 -147.73 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 114.617 0.607 . . . . 53.44 114.617 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 27.0 mtmm -139.82 154.09 47.25 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 120.167 -0.613 . . . . 75.32 111.184 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 54' ' ' ILE . 45.2 t -114.55 123.23 70.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.474 -0.785 . . . . 61.24 109.861 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -94.13 123.9 37.8 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.855 -0.424 . . . . 63.03 109.855 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.32 -149.03 5.19 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.16 -0.776 . . . . 63.22 111.16 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -138.3 156.55 47.55 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.904 -0.776 . . . . 73.32 108.904 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . 29.8 m -125.8 129.62 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 120.782 0.325 . . . . 74.24 111.053 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.603 HD13 HG21 ' A' ' 17' ' ' ILE . 6.2 mt -90.15 116.77 32.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.163 -1.421 . . . . 61.42 107.163 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.2 p -100.89 161.15 13.79 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.936 -0.306 . . . . 75.01 110.717 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.13 33.39 23.58 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.135 -0.555 . . . . 73.05 112.805 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.59 122.32 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 O-C-N 122.473 -0.428 . . . . 64.1 110.642 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.483 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 65.8 m -79.23 158.64 27.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.794 -0.762 . . . . 65.12 109.951 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -52.17 -34.93 47.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.171 0.804 . . . . 53.13 113.171 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -37.64 37.56 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.306 0.574 . . . . 73.24 110.654 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 13.3 mm-40 -68.16 -30.53 69.67 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.229 -0.896 . . . . 74.15 109.43 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 ' HG3' ' A' ' 105' ' ' GLU . 4.2 tt -59.37 -35.09 73.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.397 -1.274 . . . . 74.23 109.538 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 80' ' ' VAL . 58.7 t30 -60.37 -28.16 67.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 72.34 110.96 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -31.63 70.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.439 -0.949 . . . . 72.24 108.439 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.411 ' CZ ' HD12 ' A' ' 26' ' ' ILE . 73.3 m-85 -67.78 -35.3 78.42 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 116.421 -0.354 . . . . 73.24 110.38 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -69.59 -35.94 75.77 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.726 0.774 . . . . 74.44 109.478 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 76' ' ' ASN . 80.5 t -72.64 -24.59 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 CA-C-N 115.154 -0.93 . . . . 74.34 112.792 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.467 ' HB ' ' OH ' ' A' ' 107' ' ' TYR . 47.9 mm -44.4 -74.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 113.15 0.796 . . . . 73.11 113.15 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -141.77 19.55 2.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.249 0.547 . . . . 75.14 110.847 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.46 62.89 4.0 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.927 -0.654 . . . . 71.44 113.183 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.38 -42.88 18.08 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.908 -0.404 . . . . 73.13 109.908 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.8 m-20 -114.49 17.19 17.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.251 1.024 . . . . 75.35 109.718 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.98 156.58 26.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.497 -1.298 . . . . 64.34 107.497 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HB3' HG12 ' A' ' 110' ' ' VAL . 14.3 pt-20 -126.17 142.29 51.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.829 -0.804 . . . . 74.11 108.829 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 tmm_? -88.09 118.07 27.41 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.579 -0.737 . . . . 73.34 109.824 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 m -126.27 160.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.359 0.664 . . . . 65.2 111.834 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.3 m -89.18 129.61 35.74 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 123.628 0.58 . . . . 63.54 109.552 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.87 172.16 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.362 -1.347 . . . . 65.34 107.362 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -123.6 129.85 51.78 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.319 -0.952 . . . . 74.34 109.167 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 38' ' ' LEU . 16.2 m -127.03 168.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.073 0.464 . . . . 73.32 110.72 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.534 HG22 ' HG2' ' A' ' 101' ' ' LYS . 68.0 t -114.07 122.43 68.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.819 -0.628 . . . . 74.44 110.931 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.48 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 75.0 ttt180 -70.98 102.12 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.926 -1.138 . . . . 74.55 107.926 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.37 -60.0 2.38 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 126.818 2.047 . . . . 72.34 111.511 -171.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.1 -32.64 62.16 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.804 1.039 . . . . 71.54 113.804 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -110.47 -8.78 14.63 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.292 0.849 . . . . 62.22 113.292 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.41 25.69 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.966 0.907 . . . . 74.41 110.384 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -98.83 160.19 14.43 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.864 -0.791 . . . . 72.43 108.864 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.534 ' HG2' HG22 ' A' ' 94' ' ' VAL . 88.2 mttt -105.05 137.31 42.99 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.582 -0.525 . . . . 74.14 109.582 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.13 140.62 43.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.714 -0.476 . . . . 55.25 109.714 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -90.8 127.74 36.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.241 -1.392 . . . . 71.12 107.241 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.557 HG12 ' HB2' ' A' ' 10' ' ' ASN . 28.2 m -133.98 171.95 17.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.024 0.44 . . . . 75.01 112.121 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.558 ' HG3' HD11 ' A' ' 75' ' ' LEU . 31.2 mm-40 -104.24 153.97 20.35 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.255 -1.387 . . . . 74.04 107.255 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -156.0 177.79 11.01 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.247 0.476 . . . . 74.15 110.166 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' A' ' 81' ' ' ILE . 3.9 m-85 -103.55 119.78 39.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 122.914 0.485 . . . . 74.45 109.85 177.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -119.55 159.99 20.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.873 -1.528 . . . . 73.32 106.873 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.715 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 54.0 t-105 -83.96 134.27 34.66 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.669 -0.863 . . . . 75.33 108.669 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 85' ' ' ASP . 29.5 m -72.21 -20.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 118.981 0.809 . . . . 54.44 112.419 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.715 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 26.0 t-20 -92.0 15.5 13.11 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 125.323 1.449 . . . . 54.54 108.992 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 45.5 pttt -47.75 -15.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 127.242 2.217 . . . . 71.44 116.356 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.41 -20.39 60.07 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 119.112 -1.035 . . . . 61.42 111.442 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -97.46 124.48 48.64 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 107.544 -1.28 . . . . 74.05 107.544 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.25 102.24 1.5 Allowed 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 121.403 1.402 . . . . 73.44 111.011 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.79 112.02 17.78 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.895 -1.15 . . . . 72.22 107.895 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 23.7 mmt 67.81 148.05 0.05 Allowed 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.639 1.212 . . . . 73.42 110.97 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -116.68 -20.88 9.35 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.962 -0.695 . . . . 75.31 111.199 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -134.26 164.38 24.54 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.748 -0.941 . . . . 64.54 110.748 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.711 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -144.75 149.91 36.35 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 115.128 1.529 . . . . 64.44 115.128 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -158.73 86.97 0.86 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.646 -1.615 . . . . 74.23 109.836 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.49 ' CB ' HH12 ' A' ' 43' ' ' ARG . 9.8 t70 -100.25 124.09 45.28 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.621 -0.718 . . . . 73.23 109.805 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -68.45 -42.98 78.03 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.687 0.995 . . . . 74.12 113.687 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 128' ' ' VAL 0.268 0.0 OUTLIER -74.3 -39.19 63.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 119.686 -0.805 . . . . 75.23 111.949 -175.156 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.76 -37.76 71.51 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.589 -0.732 . . . . 63.04 110.352 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -51.6 -57.18 9.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.29 -0.868 . . . . 73.44 111.406 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.3 -34.18 65.59 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.044 -0.662 . . . . 73.34 111.81 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 124' ' ' GLU . 70.8 t -62.75 -47.63 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.535 0.568 . . . . 74.11 112.535 -177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.16 -33.9 63.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.549 0.69 . . . . 72.21 109.905 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.47 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 55.6 t-80 -69.88 -45.71 67.06 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.961 -1.018 . . . . 65.44 109.844 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -61.26 -52.97 62.5 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.98 -0.554 . . . . 52.11 111.022 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.03 -45.67 71.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 123.414 0.446 . . . . 72.11 111.51 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -61.51 -53.96 49.5 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.018 -0.992 . . . . 73.11 111.886 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.47 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 96.7 m-85 -74.95 -31.5 61.51 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 113.79 1.033 . . . . 71.44 113.79 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 131' ' ' ALA . 79.4 t -63.8 -45.94 95.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 121.139 -0.225 . . . . 54.13 111.295 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 12.5 pt-20 -67.77 -36.71 80.97 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.401 -0.919 . . . . 71.11 110.937 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.7 m -60.82 -47.21 87.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.937 -0.574 . . . . 73.13 109.46 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.554 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 87.1 t80 -59.16 -48.05 83.06 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.831 -0.622 . . . . 74.12 110.028 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 97.4 mtt180 -61.58 -42.89 99.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.181 -0.463 . . . . 74.1 112.148 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.4 mmtp -65.17 -42.37 93.73 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 121.019 -0.272 . . . . 75.25 110.537 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.7 mmt -63.83 -31.86 73.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.199 -0.455 . . . . 71.02 111.728 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 90.6 mt -67.71 -45.53 74.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.858 -0.423 . . . . 70.03 109.858 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.1 mt-10 -60.79 -47.07 88.01 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 109.579 -0.526 . . . . 73.24 109.579 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -59.97 -38.98 84.11 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.216 1.007 . . . . 72.34 111.494 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.5 -45.61 13.41 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.056 -0.52 . . . . 72.05 112.262 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.71 -26.33 25.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.224 0.453 . . . . 63.21 112.224 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -123.25 124.17 26.46 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-O 120.731 0.301 . . . . 63.04 111.149 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.38 -19.41 67.17 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.656 2.237 . . . . 62.23 111.664 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -93.8 3.81 54.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.079 -0.51 . . . . 63.45 110.613 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.75 -32.98 74.78 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 108.912 -1.675 . . . . 74.22 108.912 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -94.92 145.37 24.96 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 105.774 -1.935 . . . . 53.24 105.774 170.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.6 m -74.25 155.65 38.05 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.271 -0.972 . . . . 62.3 110.337 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.443 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.3 mpt? -61.32 -39.84 92.02 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.822 0.849 . . . . 70.03 111.975 -172.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 161' ' ' LEU . 38.8 tt0 -67.66 -41.97 82.94 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 122.003 0.906 . . . . 71.14 110.497 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.83 -29.85 62.36 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.597 -1.183 . . . . 71.2 108.414 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.61 -27.28 69.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.786 -0.643 . . . . 65.23 110.219 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 153' ' ' MET . 48.3 t -84.32 -56.31 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.756 -0.831 . . . . 75.11 108.756 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 82.48 -44.72 3.25 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 121.156 -0.545 . . . . 63.12 112.869 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.8 m -71.73 -27.86 63.29 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.022 0.529 . . . . 74.2 111.032 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.9 mt -123.19 113.15 18.56 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.427 -0.583 . . . . 75.32 109.427 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 154' ' ' GLU . 6.9 tt -134.42 138.27 44.68 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.066 -1.087 . . . . 73.31 108.066 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.7 t -74.34 97.41 3.02 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.594 0.712 . . . . 72.23 110.163 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.8 t -171.27 124.64 0.61 Allowed 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 106.38 -1.711 . . . . 51.33 106.38 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -104.73 7.88 46.09 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.396 -0.906 . . . . 65.41 113.488 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.317 -0.841 0 CA-C-O 118.359 -0.829 . . . . 62.04 109.789 177.547 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.1 p . . . . . 0 C--O 1.241 0.65 0 N-CA-C 109.612 -0.514 . . . . 63.53 109.612 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 m -84.65 114.26 21.88 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.399 -1.334 . . . . 61.53 107.399 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -132.32 137.17 47.33 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.476 -0.329 . . . . 71.22 110.233 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.6 m 61.2 89.38 0.08 Allowed 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.987 0.915 . . . . 73.23 112.665 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.531 ' H ' ' HB3' ' A' ' 71' ' ' SER . 12.4 m-20 -78.9 137.47 57.67 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 115.836 -0.62 . . . . 74.35 109.784 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.39 160.8 33.7 Favored 'Trans proline' 0 C--O 1.252 1.201 0 C-N-CA 122.206 1.937 . . . . 72.03 109.886 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 62.58 84.65 0.14 Allowed 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.861 0.839 . . . . 74.02 109.736 -172.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.7 p -64.23 149.07 48.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.673 -1.149 . . . . 74.45 111.619 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.407 ' CB ' HD12 ' A' ' 75' ' ' LEU . 80.6 m80 -108.9 156.26 19.89 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.655 -0.702 . . . . 65.34 110.411 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.552 ' HB2' HG12 ' A' ' 104' ' ' VAL . 84.1 m-20 -132.16 126.41 33.56 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.164 -1.421 . . . . 73.4 107.164 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.78 120.62 65.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 121.18 -0.208 . . . . 35.24 110.85 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -84.67 112.76 20.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.476 -0.935 . . . . 72.23 108.476 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.2 t -113.55 142.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.76 -0.83 . . . . 53.42 108.76 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -81.24 -53.98 5.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.708 -0.223 . . . . 70.32 111.426 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.95 79.64 0.13 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 118.531 -1.795 . . . . 75.31 114.974 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 p -162.6 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.38 0.61 . . . . 74.34 110.902 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -91.16 70.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 CA-C-O 123.69 1.709 . . . . 71.42 107.605 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 65' ' ' LYS . 80.7 mt -114.12 -11.7 12.64 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-N 113.372 -1.74 . . . . 65.42 106.96 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -85.68 125.97 67.58 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 113.469 -1.696 . . . . 73.33 110.168 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.12 -38.24 80.57 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.805 2.336 . . . . 75.0 111.669 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.84 -44.97 91.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.918 0.39 . . . . 34.23 111.07 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.533 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -70.16 -34.42 58.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 121.258 0.551 . . . . 51.34 109.795 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -62.32 -35.71 79.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.223 0.535 . . . . 71.44 109.557 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.84 -13.07 61.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.581 -0.736 . . . . 63.25 111.94 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 22' ' ' VAL . 12.0 m -98.58 -26.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 119.602 -0.839 . . . . 73.32 110.45 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.555 HG21 HG13 ' A' ' 17' ' ' ILE . 6.0 tt -84.41 -41.63 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.015 0.436 . . . . 65.44 112.095 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 86.1 mt -99.62 -21.16 15.99 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.299 -0.409 . . . . 63.22 111.173 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.4 t70 75.84 -5.0 2.26 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.624 1.202 . . . . 64.02 108.925 -171.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 27' ' ' LEU . 84.9 mtt180 -105.94 138.11 42.69 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 113.754 -1.566 . . . . 65.31 107.665 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -79.62 111.15 15.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 106.403 -1.703 . . . . 71.4 106.403 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -89.52 157.06 18.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.388 0.613 . . . . 73.04 111.726 -174.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.63 114.61 27.77 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.959 -1.019 . . . . 74.23 111.323 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 1.7 p -102.62 143.07 32.77 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.519 -0.764 . . . . 52.51 109.775 174.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 m -136.16 143.26 43.13 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 109.155 -0.683 . . . . 62.23 109.155 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.2 132.79 54.05 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.272 1.981 . . . . 64.15 110.671 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.12 36.51 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 109.014 -0.735 . . . . 62.21 109.014 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.23 127.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-O 121.743 0.782 . . . . 72.43 111.988 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 93' ' ' VAL . 22.3 tp -90.24 102.36 15.08 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.723 -1.126 . . . . 63.34 109.943 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 61' ' ' LYS . 9.9 p-80 -76.28 125.26 28.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.302 -0.863 . . . . 72.13 109.771 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 117.42 -21.04 10.93 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 118.869 -1.634 . . . . 74.22 114.207 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -106.65 157.31 17.8 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 117.888 0.844 . . . . 73.15 111.482 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -124.92 124.26 41.67 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.403 -0.962 . . . . 53.41 108.403 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -90.86 147.19 23.34 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.763 0.316 . . . . 71.11 110.976 177.063 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.54 -169.99 1.96 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.527 0.566 . . . . 72.43 112.527 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -109.27 -36.83 5.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.592 -0.276 . . . . 75.25 110.878 178.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 3.8 mm? 64.06 -178.02 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.045 0.538 . . . . 62.51 111.991 -174.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 28.04 6.58 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 113.035 0.754 . . . . 71.52 113.035 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.44 15.0 0.17 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.731 -1.223 . . . . 71.31 113.339 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.418 ' C ' ' HG3' ' A' ' 52' ' ' PRO . 3.6 mm? -95.49 160.17 31.08 Favored Pre-proline 0 C--N 1.311 -1.075 0 O-C-N 122.291 -0.534 . . . . 74.14 110.834 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -90.35 119.56 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.01 2.474 . . . . 74.14 112.504 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.497 ' HA ' ' CG ' ' A' ' 125' ' ' GLU 0.341 21.6 p90 39.78 60.66 6.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 113.835 1.05 . . . . 73.44 113.835 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 89.3 Cg_endo -115.52 144.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.153 3.235 . . . . 74.25 116.764 -170.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 82.2 m -153.46 -178.84 7.26 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 130.123 3.369 . . . . 54.21 101.916 -13.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.535 HG13 HG12 ' A' ' 108' ' ' VAL . 43.0 pt -123.35 122.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.988 -1.085 . . . . 74.3 110.94 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.33 177.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.704 -1.134 . . . . 75.05 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.8 p 50.96 102.43 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.619 1.568 . . . . 71.54 112.261 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 23.2 t -73.82 83.89 1.66 Allowed 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.799 -0.76 . . . . 73.22 111.617 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.0 -167.3 1.61 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.137 -0.938 . . . . 44.52 109.808 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.3 m -89.45 5.57 44.72 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.567 -0.901 . . . . 61.01 108.567 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.43 165.31 53.81 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.202 -0.908 . . . . 64.23 111.563 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 39' ' ' HIS . 27.9 mtmm -138.06 146.73 43.33 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.329 -0.619 . . . . 72.54 109.329 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 54' ' ' ILE . 40.3 t -110.08 122.89 65.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.183 -0.673 . . . . 73.23 109.183 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.38 125.43 46.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.288 -1.004 . . . . 61.43 108.288 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.46 -141.24 3.17 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.501 -1.04 . . . . 52.31 110.501 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.502 ' HB2' HD22 ' A' ' 18' ' ' LEU . 38.9 mtmt -136.82 138.79 41.2 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 113.291 0.849 . . . . 74.51 113.291 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 93' ' ' VAL . 31.5 m -104.7 133.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 114.689 -1.141 . . . . 53.34 110.054 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.566 HD13 HD12 ' A' ' 17' ' ' ILE . 14.5 mt -88.42 111.64 22.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 105.638 -1.986 . . . . 64.4 105.638 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -97.49 161.53 13.73 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.236 -0.586 . . . . 62.41 111.536 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.05 60.12 Favored Glycine 0 CA--C 1.522 0.52 0 O-C-N 123.285 0.366 . . . . 54.35 113.635 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.62 131.98 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 110.25 -0.278 . . . . 70.23 110.25 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 5' ' ' ASP . 24.2 m -78.37 158.96 28.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.124 -0.631 . . . . 75.45 109.775 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.493 ' H ' ' HB2' ' A' ' 5' ' ' ASP . 19.0 t70 -55.81 -45.44 78.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.612 -0.722 . . . . 70.12 111.342 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.51 -36.09 76.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.735 -0.666 . . . . 51.5 111.232 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 54.1 mt-10 -73.72 -35.7 65.13 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.722 -0.672 . . . . 75.21 111.09 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.5 tt -60.21 -35.41 75.37 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.706 -0.85 . . . . 65.05 108.706 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -55.5 -27.75 50.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.784 -1.098 . . . . 73.44 112.141 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.507 ' O ' HG22 ' A' ' 81' ' ' ILE . 12.8 t-20 -74.33 -31.86 62.61 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 119.391 -0.924 . . . . 74.23 109.503 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.479 ' CD1' HD13 ' A' ' 26' ' ' ILE . 73.6 m-85 -71.81 -42.03 67.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.229 -1.397 . . . . 74.12 107.229 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.424 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 9.4 t70 -55.96 -52.63 63.47 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.261 -1.336 . . . . 72.22 110.291 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.02 -33.14 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 113.294 0.85 . . . . 61.23 113.294 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 77' ' ' ASN . 17.0 tt -101.21 -34.24 3.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 C-N-CA 118.464 -1.294 . . . . 73.14 113.996 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -79.26 -19.0 51.69 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.929 -0.708 . . . . 74.52 110.841 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.81 60.37 3.89 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.992 -0.623 . . . . 70.32 112.427 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -81.81 -44.59 16.73 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.853 -0.795 . . . . 74.44 108.853 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -141.05 21.55 2.27 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.873 -1.528 . . . . 71.44 106.873 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -122.7 153.74 39.01 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.731 -1.577 . . . . 75.43 107.401 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HB3' HG23 ' A' ' 110' ' ' VAL . 9.9 pt-20 -126.33 153.8 44.37 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 120.195 -0.602 . . . . 74.4 111.086 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' HD3' ' OD2' ' A' ' 79' ' ' ASP . 58.3 ttt180 -82.84 121.29 26.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.773 -1.103 . . . . 73.43 111.427 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.73 159.11 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.583 -0.735 . . . . 70.33 109.607 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.57 131.2 39.06 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.564 -0.902 . . . . 70.1 108.564 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.414 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.4 m -137.79 165.48 26.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.431 -1.322 . . . . 73.53 107.431 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -117.92 128.74 55.11 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.56 -1.256 . . . . 71.35 109.097 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 66' ' ' VAL . 18.3 m -125.98 168.71 18.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.879 -0.415 . . . . 65.22 109.879 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' A' ' 101' ' ' LYS . 73.5 t -109.96 118.01 55.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 115.957 -0.565 . . . . 72.0 110.786 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -73.04 105.22 4.41 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.137 -1.06 . . . . 72.31 108.137 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.87 62.31 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 124.423 1.089 . . . . 75.44 110.032 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.98 -33.92 71.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.493 -0.776 . . . . 74.23 112.334 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -128.73 0.65 5.45 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 120.627 -0.429 . . . . 71.13 111.66 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 62.28 26.78 16.04 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.471 0.708 . . . . 24.33 110.615 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.9 160.52 14.54 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.557 -0.747 . . . . 72.24 109.727 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.535 ' HG2' HG22 ' A' ' 94' ' ' VAL . 38.7 mtmt -102.4 135.69 43.55 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.536 -0.913 . . . . 45.53 108.536 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.1 m -133.87 139.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.249 0.547 . . . . 71.14 109.892 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.62 122.06 30.84 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.648 -1.612 . . . . 61.25 106.648 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 10' ' ' ASN . 17.8 m -131.52 175.13 11.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.083 0.468 . . . . 75.31 111.137 -171.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.82 146.99 27.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.771 -1.196 . . . . 73.21 107.771 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.0 t -149.5 174.32 12.62 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.279 -1.008 . . . . 60.03 108.279 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 92.6 m-85 -118.75 118.72 32.35 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.276 0.56 . . . . 73.01 109.739 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG12 HG13 ' A' ' 54' ' ' ILE . 33.7 m -108.98 175.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.184 -1.043 . . . . 63.4 108.184 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 23.0 t-105 -74.69 132.49 41.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.929 -1.508 . . . . 74.41 106.929 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.8 p -69.62 -20.78 24.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.918 0.866 . . . . 75.14 110.61 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.54 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 20.9 t-20 -88.92 15.12 8.98 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.719 1.208 . . . . 72.22 109.17 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 61.3 pttt -48.94 -15.66 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.069 1.748 . . . . 75.13 115.123 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -72.84 -22.95 60.71 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.012 -0.675 . . . . 65.41 110.404 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -113.84 122.94 33.81 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.486 -0.561 . . . . 63.21 109.486 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.63 115.36 4.05 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.679 2.252 . . . . 74.54 109.591 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.697 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 30.7 ttm180 -129.61 124.26 33.3 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.741 -0.837 . . . . 72.5 108.741 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.697 ' SD ' ' HG2' ' A' ' 116' ' ' ARG . 1.3 mpt? 74.07 129.47 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.353 1.061 . . . . 74.04 112.263 -174.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -108.23 -11.33 15.25 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.671 -0.695 . . . . 72.23 110.132 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 45' ' ' LYS . . . -79.56 137.11 18.43 Favored Glycine 0 N--CA 1.431 -1.665 0 CA-C-N 115.277 -0.874 . . . . 73.03 112.539 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.53 -179.86 4.35 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.869 -0.789 . . . . 52.42 108.869 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 79.82 109.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.173 0.921 . . . . 74.13 112.381 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.603 ' O ' ' HB2' ' A' ' 126' ' ' TRP . 7.5 t70 -127.27 143.02 51.32 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.83 -1.915 . . . . 74.34 105.83 173.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.512 ' O ' ' HB3' ' A' ' 126' ' ' TRP . 53.8 p90 -67.54 -47.69 69.14 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.548 1.314 . . . . 71.32 114.548 -174.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.89 -33.78 59.96 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.803 -0.759 . . . . 64.44 112.328 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -77.13 -2.33 33.75 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.515 0.674 . . . . 75.55 111.599 174.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.603 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 28.0 t90 -81.37 -35.64 30.57 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.185 -0.916 . . . . 74.13 110.1 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -51.85 -48.92 63.78 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.88 0.738 . . . . 71.51 111.49 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.7 -34.47 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.356 -0.838 . . . . 71.41 112.835 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.46 -44.3 17.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.224 -0.658 . . . . 43.12 109.224 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -55.49 -37.67 68.13 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.033 0.933 . . . . 74.34 111.73 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.74 72.05 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.855 -0.338 . . . . 53.15 111.256 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.555 ' HA ' HG12 ' A' ' 135' ' ' VAL . 7.4 mm-40 -72.3 -35.03 68.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.597 0.713 . . . . 63.34 111.028 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -68.32 -22.08 64.72 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.466 -0.788 . . . . 73.21 112.276 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 163' ' ' SER . 5.2 m-85 -98.15 -31.85 11.9 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.051 -0.659 . . . . 75.25 112.015 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 132' ' ' GLU . 11.4 p -66.07 -33.81 66.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 C-N-CA 120.04 -0.664 . . . . 61.23 109.64 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 11.4 pt-20 -60.15 -38.79 84.2 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.432 -0.349 . . . . 65.32 110.22 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 162' ' ' SER . 74.0 m -56.38 -46.4 80.09 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 123.538 0.524 . . . . 72.54 111.038 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.483 ' HA ' ' HG2' ' A' ' 141' ' ' MET . 95.6 m-85 -67.43 -32.2 72.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.231 -0.441 . . . . 70.21 111.265 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.647 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 53.5 mtp180 -70.38 -38.88 74.79 Favored 'General case' 0 C--O 1.184 -2.391 0 C-N-CA 119.474 -0.89 . . . . 70.02 111.087 171.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 75.2 mmtt -56.24 -47.23 78.9 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.807 -0.442 . . . . 71.04 109.807 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.671 ' HA ' ' CE3' ' A' ' 144' ' ' TRP . 27.0 ptm -66.22 -30.75 71.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.074 -0.512 . . . . 75.01 110.511 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -44.71 74.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.551 -1.277 . . . . 74.35 107.551 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 7.2 mm-40 -60.93 -29.64 69.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.912 0.885 . . . . 74.35 110.747 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.671 ' CE3' ' HA ' ' A' ' 141' ' ' MET . 26.1 m0 -75.3 -44.19 46.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.627 -0.508 . . . . 74.5 109.627 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.29 -47.85 72.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.384 -0.825 . . . . 63.41 112.248 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.11 -19.41 24.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.281 0.562 . . . . 74.35 110.351 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 143' ' ' GLU 0.345 7.9 p30 46.19 72.41 1.25 Allowed Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 116.96 2.208 . . . . 74.25 116.96 176.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.22 -27.11 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.14 1.893 . . . . 74.34 112.092 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.23 -25.53 22.83 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.108 0.48 . . . . 62.2 110.711 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 90.39 12.81 60.84 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.52 -1.032 . . . . 72.32 110.52 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.63 144.94 24.83 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 109.68 -0.489 . . . . 73.14 109.68 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.1 m -105.72 171.32 7.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.435 -0.58 . . . . 42.12 109.435 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -65.41 -36.16 83.12 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.619 0.97 . . . . 61.04 113.619 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.68 -19.03 58.18 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.28 0.562 . . . . 72.32 110.753 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.9 -40.75 91.8 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.129 -1.063 . . . . 75.23 108.129 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.83 61.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.353 -0.84 . . . . 71.44 111.812 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 87.2 t -57.27 108.79 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.464 0.65 . . . . 73.32 110.743 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.25 -103.8 0.24 Allowed Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 109.277 -1.529 . . . . 72.32 109.277 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 56.6 p -89.52 75.75 7.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.39 0.614 . . . . 53.32 110.144 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 37.3 tp 179.29 150.83 0.32 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 104.977 -2.231 . . . . 70.25 104.977 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.475 ' HG ' ' H ' ' A' ' 163' ' ' SER . 48.7 tp -136.64 151.11 48.95 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.96 -0.756 . . . . 53.5 108.96 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.447 ' O ' HG21 ' A' ' 137' ' ' THR . 19.8 m -57.28 -37.33 72.23 Favored 'General case' 0 C--O 1.222 -0.385 0 O-C-N 123.6 0.563 . . . . 64.43 109.759 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.475 ' H ' ' HG ' ' A' ' 161' ' ' LEU . 60.5 p 64.83 144.37 0.03 OUTLIER 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.425 1.49 . . . . 73.4 114.873 175.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.41 -155.16 25.97 Favored Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 108.223 -1.951 . . . . 74.33 108.223 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--N 1.282 -2.328 0 N-CA-C 109.106 -0.701 . . . . 53.41 109.106 176.33 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 109.498 -0.556 . . . . 52.43 109.498 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.9 m -132.96 92.91 3.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.552 -1.277 . . . . 71.4 107.552 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.1 m -111.1 95.89 5.81 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.717 0.77 . . . . 64.33 111.534 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 m -134.83 156.38 49.0 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.636 -1.246 . . . . 72.02 107.636 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 7.2 p-10 -71.56 137.55 83.35 Favored Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 107.422 -1.325 . . . . 72.01 107.422 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 5' ' ' ASP . 3.8 Cg_exo -72.15 82.42 1.32 Allowed 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 121.782 1.654 . . . . 55.11 112.313 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.11 93.01 8.06 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 104.896 -2.261 . . . . 71.34 104.896 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.4 p -71.2 128.38 35.73 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 115.038 -0.983 . . . . 65.02 111.111 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -87.56 153.07 21.69 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.555 -0.748 . . . . 70.11 110.23 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 84.5 m-20 -133.64 131.34 39.45 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.065 -1.828 . . . . 53.43 106.065 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 28.4 t -116.3 119.37 61.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 120.326 -0.55 . . . . 62.45 110.788 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.418 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.1 t80 -89.21 109.26 20.16 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.961 -1.496 . . . . 61.14 106.961 173.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.539 HG11 HD11 ' A' ' 17' ' ' ILE . 12.4 p -136.29 154.98 33.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 119.741 -0.784 . . . . 54.12 109.994 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.439 ' HA ' HD11 ' A' ' 18' ' ' LEU . 51.0 t80 -125.11 93.27 3.83 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.094 -0.706 . . . . 64.11 109.094 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.88 -176.46 16.16 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.76 -1.109 . . . . 72.34 111.217 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m 67.5 -73.59 0.08 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 115.137 1.532 . . . . 42.33 115.137 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.539 HD11 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -119.06 14.71 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.046 0.758 . . . . 70.35 113.046 -172.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 13' ' ' VAL . 74.7 mt -74.89 -6.72 50.71 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.195 0.522 . . . . 74.52 111.033 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 115.11 60.47 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 107.436 -1.32 . . . . 62.03 107.436 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -42.24 -44.09 7.72 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.326 3.35 . . . . 71.04 114.659 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.12 94.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.169 0.509 . . . . 72.35 111.494 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 25' ' ' VAL . 46.6 t -71.58 -38.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.965 -0.561 . . . . 74.33 110.248 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.73 74.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.465 0.65 . . . . 64.03 110.05 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -74.84 -16.48 60.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.648 -0.705 . . . . 75.34 111.903 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.3 m -93.54 -33.51 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.493 -0.883 . . . . 65.04 111.233 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' ' 78' ' ' PHE . 9.2 tt -72.46 -47.04 53.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 CA-C-O 120.587 0.232 . . . . 74.11 111.119 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 31' ' ' ALA . 90.7 mt -85.71 -11.98 52.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 121.221 -0.191 . . . . 71.3 110.877 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.53 8.91 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.287 1.042 . . . . 74.33 110.296 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 97.5 mtt180 -145.12 178.66 7.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.162 -0.926 . . . . 75.24 109.321 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.6 p -76.66 111.2 11.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.523 0.678 . . . . 72.04 110.922 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.55 -0.75 . . . . 55.31 110.321 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -100.17 109.69 21.96 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.571 -0.529 . . . . 73.31 109.571 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.8 p -114.09 142.58 46.03 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 109.096 -0.705 . . . . 74.15 109.096 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -142.22 141.45 21.36 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 107.896 -1.15 . . . . 64.13 107.896 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 3.2 Cg_endo -59.76 135.78 66.05 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 121.47 1.447 . . . . 73.32 110.456 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -148.88 157.87 43.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.691 -0.686 . . . . 41.23 110.461 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.574 HG11 ' HD3' ' A' ' 61' ' ' LYS . 22.0 t -115.63 124.21 71.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 115.353 -0.839 . . . . 62.44 111.443 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.491 HD11 ' HB ' ' A' ' 91' ' ' VAL . 22.6 tp -97.6 86.67 3.88 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.211 0.529 . . . . 75.13 111.015 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 25.0 p-80 -62.34 132.47 52.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.027 -0.988 . . . . 74.44 109.46 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.38 -23.93 11.9 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.349 -0.929 . . . . 71.41 112.425 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.464 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 48.2 m-85 -109.81 160.46 16.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 112.481 0.548 . . . . 74.2 112.481 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -131.61 126.84 35.77 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.26 -1.385 . . . . 73.32 107.26 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 24.7 ptt180 -89.68 136.71 32.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.102 -1.039 . . . . 72.4 111.376 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.39 -177.56 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.946 -1.025 . . . . 75.12 109.58 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HD2' ' A' ' 45' ' ' LYS 0.252 0.0 OUTLIER -138.43 91.83 2.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.73 1.252 . . . . 75.1 112.199 178.497 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mm? -92.54 125.73 37.31 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.415 -0.812 . . . . 61.24 109.937 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -9.01 23.39 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.574 -0.739 . . . . 75.44 110.508 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.72 -14.82 39.07 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.409 -0.814 . . . . 71.35 111.191 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.441 HD12 ' HG ' ' A' ' 46' ' ' LEU . 94.8 mt -118.46 163.57 24.75 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 109.448 -0.575 . . . . 73.01 109.448 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -79.25 99.65 1.26 Allowed 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 123.074 2.516 . . . . 64.01 114.708 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.615 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.5 p90 43.91 37.86 0.32 Allowed Pre-proline 0 CA--C 1.594 2.668 0 N-CA-C 116.614 2.079 . . . . 75.04 116.614 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 9.3 Cg_endo -97.77 167.18 0.8 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 123.384 2.723 . . . . 74.02 111.775 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.475 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 16.3 p -155.97 -169.52 3.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.582 2.353 . . . . 71.23 107.302 -4.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 36.5 pt -125.88 123.35 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 109.99 -0.374 . . . . 74.33 109.99 167.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' SER . 59.1 t -146.21 118.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.841 -0.8 . . . . 61.55 108.841 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 26.8 t 174.57 164.43 0.23 Allowed 'General case' 0 C--O 1.241 0.658 0 O-C-N 123.533 0.52 . . . . 71.32 110.23 175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -137.19 7.85 2.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.227 -1.397 . . . . 74.3 107.227 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.94 -166.94 1.47 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.198 -1.365 . . . . 73.34 109.774 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.8 m -93.86 14.69 18.67 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.838 0.455 . . . . 43.11 111.657 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.79 168.26 54.78 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 109.557 -1.417 . . . . 64.43 109.557 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.574 ' HD3' HG11 ' A' ' 37' ' ' VAL . 7.8 ptpp? -146.21 152.1 38.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.894 0.847 . . . . 72.14 111.117 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.402 HG21 ' CG2' ' A' ' 54' ' ' ILE . 54.0 t -115.51 133.41 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.402 -0.592 . . . . 55.12 109.402 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -99.9 137.64 38.08 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.3 -1.0 . . . . 62.13 108.3 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -166.1 -147.61 5.25 Favored Glycine 0 C--N 1.301 -1.373 0 N-CA-C 110.471 -1.052 . . . . 64.24 110.471 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' HB2' HD22 ' A' ' 18' ' ' LEU . 44.8 mtmt -133.8 143.02 48.13 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.065 0.432 . . . . 60.11 111.844 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.1 m -108.68 133.18 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.157 -0.928 . . . . 60.23 110.946 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 23.7 mt -90.31 114.99 28.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.142 -1.799 . . . . 71.3 106.142 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.2 p -103.92 161.36 14.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.026 -0.67 . . . . 74.3 111.89 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.89 22.46 68.94 Favored Glycine 0 CA--C 1.506 -0.528 0 CA-C-N 115.728 -0.669 . . . . 53.43 113.082 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.02 121.83 37.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.893 -0.41 . . . . 72.04 109.893 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 18.0 m -73.18 158.62 34.9 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.378 -0.971 . . . . 64.24 108.378 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.39 -40.31 71.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.154 0.502 . . . . 71.43 111.64 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.64 78.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.927 -0.579 . . . . 74.44 110.838 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 48.0 mm-40 -72.31 -34.39 68.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.184 0.516 . . . . 70.54 110.212 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.63 -36.64 76.76 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.368 -0.833 . . . . 74.2 108.859 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.682 ' O ' HG23 ' A' ' 80' ' ' VAL . 28.2 t-20 -58.92 -29.41 67.07 Favored 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 114.628 -1.169 . . . . 70.1 111.467 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -68.3 -35.25 77.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.822 -0.807 . . . . 51.12 108.822 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 26' ' ' ILE . 94.2 m-85 -74.16 -37.27 64.06 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.536 -0.756 . . . . 65.34 108.964 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.99 -34.19 77.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.201 -1.363 . . . . 73.03 110.995 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 76' ' ' ASN . 60.8 t -75.26 -42.96 43.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.71 -0.677 . . . . 71.13 111.709 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.8 tt -74.85 -61.14 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 114.675 1.361 . . . . 64.21 114.675 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -115.65 171.57 7.66 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.99 -0.444 . . . . 54.35 109.845 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 55.67 2.26 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.648 -0.787 . . . . 70.41 112.83 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.27 -42.31 46.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.759 0.281 . . . . 72.52 111.759 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.602 ' HB3' ' CH2' ' A' ' 109' ' ' TRP . 1.9 t70 -108.16 26.43 10.42 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.325 -1.361 . . . . 73.01 107.325 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 51.6 m-85 -114.1 155.51 25.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.608 -1.178 . . . . 74.14 109.692 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.54 ' HB3' HG12 ' A' ' 110' ' ' VAL . 15.7 pt-20 -126.66 158.6 35.94 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.3 0.375 . . . . 73.4 110.321 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -88.86 113.73 24.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.82 -0.627 . . . . 63.55 110.426 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.47 150.33 34.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.974 -0.38 . . . . 72.3 109.974 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.9 m -94.86 123.1 38.13 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.026 -0.731 . . . . 72.11 109.026 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' A' ' 38' ' ' LEU . 33.7 m -127.38 158.76 38.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.11 -1.07 . . . . 72.14 108.11 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -113.52 132.23 55.77 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.907 -1.117 . . . . 72.05 108.615 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.515 HG21 HG11 ' A' ' 66' ' ' VAL . 20.1 m -126.41 168.27 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 121.304 0.573 . . . . 74.35 110.331 -176.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 101' ' ' LYS . 67.5 t -110.04 117.13 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.325 -0.852 . . . . 61.44 110.299 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 38.3 ttm180 -65.43 98.58 0.36 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.546 -0.909 . . . . 74.3 108.546 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.473 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 1.2 tmt? -53.84 -34.76 60.28 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 126.259 1.824 . . . . 74.12 110.908 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.02 -41.31 87.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.587 -0.733 . . . . 72.43 112.232 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -118.84 -3.95 10.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 120.315 -0.554 . . . . 75.32 112.355 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 67.44 24.98 8.66 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.73 0.812 . . . . 35.42 111.495 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.5 pt-20 -104.61 159.71 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.246 -0.65 . . . . 70.21 109.246 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.0 mtmt -102.48 135.08 44.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.699 -0.852 . . . . 62.03 108.699 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.62 138.47 44.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.03 0.443 . . . . 75.44 110.237 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.89 126.22 34.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.971 -1.122 . . . . 75.01 107.971 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 10' ' ' ASN . 16.3 m -133.23 174.68 12.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 120.733 0.301 . . . . 74.15 110.256 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.97 150.27 28.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.558 -1.275 . . . . 72.02 107.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 t -145.94 175.18 10.63 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.421 -0.585 . . . . 61.24 109.421 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.68 118.35 36.43 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.052 -1.092 . . . . 62.11 108.052 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 54' ' ' ILE . 12.7 p -112.35 148.65 15.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.288 -1.375 . . . . 62.33 107.288 176.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.602 ' CH2' ' HB3' ' A' ' 85' ' ' ASP . 41.6 t-105 -73.08 125.93 28.82 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.693 -1.225 . . . . 72.22 107.693 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 87' ' ' GLU . 24.8 m -62.6 -22.46 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.947 0.721 . . . . 62.13 112.947 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.539 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 63.1 t30 -81.39 12.7 3.43 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.765 0.793 . . . . 73.32 110.09 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 -14.83 0.16 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.005 1.854 . . . . 64.43 116.005 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.07 -17.5 52.53 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.408 -0.517 . . . . 74.44 112.075 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.63 126.89 67.57 Favored Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 119.37 -0.932 . . . . 74.33 110.355 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.0 -6.11 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.719 2.946 . . . . 54.44 115.373 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -125.69 113.78 17.79 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.581 0.705 . . . . 54.04 110.846 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 39.3 ttm -153.14 27.81 0.52 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.19 0.995 . . . . 71.5 108.735 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -72.72 -19.09 61.46 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 114.73 -1.123 . . . . 75.35 111.243 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.81 -139.07 23.9 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.5 -0.773 . . . . 52.33 112.811 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -113.23 -178.13 3.3 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 122.652 0.381 . . . . 64.45 111.447 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 76.0 m95 85.83 -159.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.416 1.886 . . . . 71.32 108.786 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.03 137.46 39.36 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.855 -0.338 . . . . 75.51 111.307 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -68.33 -40.48 81.59 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.954 -0.566 . . . . 74.22 111.98 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.7 tt0 -73.03 -35.81 66.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 120.948 0.404 . . . . 74.22 110.094 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 129' ' ' VAL . 33.1 tt0 -56.35 -43.56 79.22 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.499 -0.926 . . . . 64.35 108.499 173.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -60.23 -42.72 95.83 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.825 -0.625 . . . . 72.4 110.481 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.591 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 99.8 mtt180 -56.87 -48.58 77.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.272 -0.64 . . . . 64.42 109.272 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.624 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 79.2 t -59.21 -47.08 91.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.93 -1.032 . . . . 74.11 111.023 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 125' ' ' GLU . 98.6 t -67.35 -44.36 87.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.709 -0.223 . . . . 61.21 111.537 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.591 ' CE1' ' HA ' ' A' ' 127' ' ' ARG 0.253 3.7 p-80 -72.16 -30.41 64.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 118.612 -1.235 . . . . 74.51 111.827 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.33 77.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.979 -0.378 . . . . 43.45 109.979 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 42.6 mt-10 -63.31 -37.98 89.36 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.728 -0.669 . . . . 71.15 109.969 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.26 -38.26 88.6 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.069 -0.969 . . . . 74.43 110.479 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 86.8 m-85 -73.09 -52.16 15.32 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.842 -0.617 . . . . 64.25 111.098 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.1 p -59.89 -39.02 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 112.134 0.42 . . . . 72.53 112.134 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 48.6 mt-10 -59.07 -43.5 91.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 117.678 0.217 . . . . 60.21 111.048 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.6 m -58.36 -48.53 80.29 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.986 -0.552 . . . . 63.4 110.045 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.48 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 83.3 m-85 -61.73 -43.93 97.9 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.374 -0.376 . . . . 73.31 111.543 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 81.9 mtp180 -59.8 -44.83 93.79 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 123.047 0.217 . . . . 74.01 111.051 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 67.9 mttm -61.57 -47.34 85.95 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.314 0.384 . . . . 73.15 110.535 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.1 -34.99 78.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.12 110.964 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 91.3 mt -69.19 -38.88 78.88 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 116.291 -0.413 . . . . 73.41 110.628 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 32.3 mm-40 -59.35 -36.36 75.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.714 0.292 . . . . 74.41 110.362 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -68.22 -40.68 82.02 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.218 0.821 . . . . 64.54 113.218 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -74.32 -25.83 59.79 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.586 0.707 . . . . 51.23 110.606 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -78.91 -30.58 44.9 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.719 1.207 . . . . 74.43 112.161 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.36 99.82 45.39 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 120.249 -0.581 . . . . 53.04 112.457 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.28 -35.62 72.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.506 2.138 . . . . 74.55 110.103 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.27 -8.72 58.38 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.893 -1.049 . . . . 75.22 111.156 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.22 72.4 Favored Glycine 0 CA--C 1.507 -0.41 0 N-CA-C 111.252 -0.739 . . . . 73.01 111.252 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -94.04 149.3 21.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.438 -1.69 . . . . 72.04 106.438 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.495 ' H ' ' HB2' ' A' ' 155' ' ' GLU . 89.4 p -81.64 178.32 8.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.81 -0.811 . . . . 74.12 108.81 175.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -60.41 -30.83 69.86 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.193 0.521 . . . . 73.53 110.658 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -91.94 -23.69 19.5 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 116.015 -0.539 . . . . 70.34 110.814 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.495 ' HB2' ' H ' ' A' ' 152' ' ' SER . 23.5 mm-40 -74.82 -42.27 58.34 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.983 0.421 . . . . 64.01 111.397 174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.35 -34.83 48.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.077 -0.51 . . . . 65.44 109.933 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.9 t 58.16 114.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.785 1.234 . . . . 74.23 111.972 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.14 32.15 6.89 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 120.38 -0.914 . . . . 32.22 111.973 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.4 m -84.38 137.58 33.33 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.261 -1.014 . . . . 70.15 108.261 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.3 tp -96.7 130.11 43.99 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.601 -0.518 . . . . 73.01 109.601 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.7 tp -158.98 157.52 31.45 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.672 -1.232 . . . . 71.15 107.672 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 m -76.77 84.12 3.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.377 0.608 . . . . 71.33 110.34 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 54.7 m -157.18 90.57 1.13 Allowed 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 124.499 1.12 . . . . 72.31 108.273 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 174.8 73.08 0.05 OUTLIER Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 110.431 -1.068 . . . . 64.31 110.431 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 108.855 -0.795 . . . . 72.5 108.855 179.505 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 120.589 0.233 . . . . 63.42 110.791 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.9 p -84.44 105.79 15.54 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 121.234 0.54 . . . . 74.31 110.774 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 m -68.62 -26.44 65.35 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.254 -0.885 . . . . 75.42 112.532 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 m -127.29 83.87 2.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.29 0.567 . . . . 74.24 110.757 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 11.6 t70 -93.79 -61.74 0.18 Allowed Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.873 -0.603 . . . . 43.42 112.574 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 5' ' ' ASP . 5.7 Cg_exo -80.98 -43.56 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.215 1.277 . . . . 72.23 112.679 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -142.01 -173.9 3.94 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 123.565 0.746 . . . . 74.0 109.218 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m -127.77 151.89 48.44 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.686 -1.598 . . . . 74.2 106.686 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -87.88 155.56 19.81 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.553 0.692 . . . . 71.35 112.186 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.467 ' HB2' HG12 ' A' ' 104' ' ' VAL . 42.4 m-80 -135.82 123.74 22.71 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.901 -1.518 . . . . 75.3 106.901 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.554 HG12 HG23 ' A' ' 13' ' ' VAL . 51.3 t -120.31 122.95 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 120.959 -0.297 . . . . 61.35 110.71 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -90.95 99.15 12.23 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.122 -0.695 . . . . 72.54 109.122 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.554 HG23 HG12 ' A' ' 11' ' ' VAL . 72.9 t -139.15 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.228 -0.286 . . . . 71.41 110.228 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.12 -73.89 0.23 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.932 -1.136 . . . . 74.12 107.932 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' HA2' ' CG ' ' A' ' 51' ' ' TYR . . . 45.38 -123.83 6.25 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 123.739 0.649 . . . . 63.14 113.344 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -139.07 9.36 2.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.743 -0.836 . . . . 74.13 108.743 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.523 HG21 HD13 ' A' ' 67' ' ' ILE . 40.9 mt -74.94 -8.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.972 -1.013 . . . . 65.34 110.31 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 65' ' ' LYS . 54.1 mt -59.27 -24.39 63.2 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-N 115.241 -0.89 . . . . 74.0 110.826 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.76 124.86 48.85 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.1 -0.955 . . . . 75.3 108.953 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.29 -35.43 11.41 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.603 3.535 . . . . 72.43 114.491 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -42.74 82.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.923 0.392 . . . . 72.3 111.224 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.6 -35.43 56.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.322 -0.399 . . . . 73.2 110.597 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.11 70.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.235 0.54 . . . . 60.43 109.844 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.61 71.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.663 -0.699 . . . . 73.34 110.854 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 m -71.02 -29.19 35.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.143 -0.623 . . . . 72.13 111.604 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.488 HD13 ' CE1' ' A' ' 78' ' ' PHE . 4.7 tt -79.46 -46.96 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 112.532 0.568 . . . . 64.32 112.532 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 74' ' ' GLU . 36.8 mt -91.1 -14.55 31.02 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.188 -0.605 . . . . 60.5 112.227 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 t70 69.49 14.63 8.35 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.433 1.587 . . . . 63.23 108.35 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -147.36 135.43 21.4 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.643 -1.984 . . . . 60.13 105.643 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.0 m -76.95 111.12 12.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.5 -0.48 . . . . 65.31 110.295 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -93.74 143.73 26.06 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.607 -0.886 . . . . 31.44 108.607 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.4 126.04 42.4 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.122 -0.49 . . . . 64.13 110.303 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 14.7 p -93.71 144.05 25.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.969 -0.382 . . . . 44.43 109.969 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.22 139.41 35.59 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 108.829 -0.804 . . . . 73.24 108.829 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.92 129.53 35.46 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.754 2.303 . . . . 60.33 111.807 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.57 157.41 43.24 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.594 -0.73 . . . . 74.35 110.097 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.551 HG22 ' CG ' ' A' ' 61' ' ' LYS . 11.5 p -126.28 132.74 70.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-O 121.158 0.504 . . . . 72.11 110.429 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.453 ' HA ' HG12 ' A' ' 93' ' ' VAL . 22.3 tp -91.68 112.33 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.71 -0.677 . . . . 73.3 111.745 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -88.68 112.21 22.86 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.473 -0.785 . . . . 61.15 109.494 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.09 -40.42 1.4 Allowed Glycine 0 C--N 1.305 -1.149 0 C-N-CA 120.653 -0.784 . . . . 64.55 112.695 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.466 ' O ' HG23 ' A' ' 62' ' ' VAL . 41.7 m-85 -108.96 166.41 10.85 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 122.782 -0.246 . . . . 72.05 111.346 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -137.08 134.58 36.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.008 -1.108 . . . . 60.22 108.008 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 25.7 ptt180 -88.87 125.84 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 73.03 111.1 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CE2' ' HA ' ' A' ' 118' ' ' TYR . 91.6 m-85 -98.23 145.92 26.14 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.097 -0.956 . . . . 74.24 110.691 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -91.39 100.13 12.97 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-O 121.729 0.776 . . . . 75.31 110.942 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -119.96 121.55 39.23 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.591 -1.186 . . . . 71.41 111.032 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -85.87 -5.63 59.21 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 113.233 0.827 . . . . 64.42 113.233 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.15 -25.66 65.86 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.398 -0.906 . . . . 71.0 111.751 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 46' ' ' LEU . 3.6 mm? -119.56 156.46 53.44 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-O 120.772 0.32 . . . . 64.24 111.607 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.73 146.86 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.87 2.38 . . . . 72.11 111.063 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.612 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 37.3 p90 44.47 41.91 0.82 Allowed Pre-proline 0 N--CA 1.506 2.33 0 N-CA-C 115.39 1.626 . . . . 73.0 115.39 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 78.4 Cg_endo -110.54 156.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.242 2.628 . . . . 74.34 114.806 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 89.0 m -153.76 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 131.368 3.867 . . . . 72.43 103.33 -15.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 25.5 pt -121.82 136.84 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-N 119.553 1.069 . . . . 63.45 110.914 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.45 HG13 ' HA ' ' A' ' 112' ' ' LYS . 43.1 t -127.0 -80.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 115.026 -0.988 . . . . 72.33 112.589 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.4 p -177.17 156.21 1.23 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.809 -0.441 . . . . 75.25 109.809 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.1 m -165.08 173.63 11.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.138 0.975 . . . . 60.02 109.639 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.1 -65.68 0.58 Allowed 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 123.859 0.724 . . . . 72.34 110.01 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 p -105.98 -36.34 7.0 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 119.74 -0.784 . . . . 74.41 109.535 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.93 117.79 0.0 OUTLIER Glycine 0 C--N 1.361 1.971 0 C-N-CA 125.474 1.511 . . . . 74.32 116.817 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.551 ' CG ' HG22 ' A' ' 37' ' ' VAL . 21.9 ttpp -141.63 139.4 33.04 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.793 -1.563 . . . . 63.11 112.621 173.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 41' ' ' TYR . 54.4 t -123.86 123.72 67.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 C-N-CA 123.715 0.806 . . . . 71.35 111.252 -173.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -96.11 128.62 43.17 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.475 -0.49 . . . . 54.24 110.301 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.97 -142.58 3.44 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.85 -1.3 . . . . 21.12 109.85 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 50.3 mtpt -140.44 146.72 38.65 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.779 -1.193 . . . . 72.43 107.779 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.484 HG11 HG21 ' A' ' 93' ' ' VAL . 26.8 m -104.49 135.44 42.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.043 0.449 . . . . 75.24 110.305 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.523 HD13 HG21 ' A' ' 17' ' ' ILE . 11.6 mt -85.72 110.61 19.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 104.479 -2.415 . . . . 74.51 104.479 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.6 p -101.23 161.94 13.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 111.766 0.284 . . . . 71.23 111.766 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.16 73.62 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.91 -0.586 . . . . 73.12 112.693 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.71 124.23 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 109.046 -0.724 . . . . 75.04 109.046 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 30.9 m -73.71 157.45 36.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.19 -0.67 . . . . 74.12 109.19 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.01 -46.08 68.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.771 0.428 . . . . 73.45 111.003 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -68.72 -36.96 79.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.299 0.571 . . . . 63.13 110.826 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.602 ' HB3' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -68.56 -34.57 76.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.414 -0.812 . . . . 74.22 111.685 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.457 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.6 tt -61.55 -37.9 85.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.302 -1.37 . . . . 65.55 107.302 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.554 ' O ' HG23 ' A' ' 80' ' ' VAL . 34.0 m-80 -54.75 -26.73 36.07 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.851 1.056 . . . . 73.04 113.851 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.465 ' OD1' HG13 ' A' ' 26' ' ' ILE . 8.8 t-20 -67.32 -34.41 77.3 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.76 -1.176 . . . . 72.21 108.595 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.599 ' CE2' HD21 ' A' ' 27' ' ' LEU . 86.5 m-85 -69.24 -34.2 74.45 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.913 -1.143 . . . . 73.1 107.913 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.99 -31.32 70.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.469 -1.242 . . . . 73.23 110.226 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 76' ' ' ASN . 90.7 t -72.8 -36.6 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.715 -0.675 . . . . 61.22 109.58 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 77' ' ' ASN . 48.2 mm -59.71 -40.95 83.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 N-CA-C 106.804 -1.554 . . . . 72.24 106.804 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 73.06 -81.76 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.775 -1.557 . . . . 64.24 114.861 167.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.71 104.2 1.01 Allowed Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 108.636 -1.786 . . . . 74.43 108.636 -172.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.34 -40.52 96.64 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.189 0.519 . . . . 60.43 111.722 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 110' ' ' VAL . 10.9 m-20 -97.73 8.53 44.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.746 -0.661 . . . . 73.14 109.807 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 96.9 m-85 -115.94 154.78 29.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.958 -0.564 . . . . 62.03 110.021 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -136.05 141.93 44.34 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.406 -0.59 . . . . 65.03 109.406 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 0.4 OUTLIER -88.52 109.56 20.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.415 0.626 . . . . 75.22 111.317 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.65 160.7 24.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.749 -1.114 . . . . 53.4 110.966 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -91.12 131.37 36.73 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.696 -0.853 . . . . 55.41 108.696 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.8 m -133.93 172.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.496 -1.298 . . . . 52.44 107.496 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -125.37 127.59 46.83 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.873 -1.131 . . . . 72.43 109.523 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.484 HG21 HG11 ' A' ' 66' ' ' VAL . 18.2 m -126.72 168.24 20.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.316 0.579 . . . . 72.44 110.314 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 101' ' ' LYS . 54.7 t -113.5 121.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.757 -0.831 . . . . 73.42 108.757 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.36 103.93 2.13 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 106.8 -1.555 . . . . 72.53 106.8 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.603 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 9.8 tmm? -61.62 -32.89 73.05 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.91 -1.144 . . . . 71.12 107.91 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.68 -44.96 81.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.936 -1.029 . . . . 73.24 112.336 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -111.42 -2.69 15.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.105 0.478 . . . . 71.1 110.956 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.5 24.28 14.0 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.942 1.297 . . . . 70.04 110.993 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -105.12 160.53 14.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.985 -0.376 . . . . 65.45 109.985 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.593 ' HG2' HG22 ' A' ' 94' ' ' VAL . 55.4 mtpt -101.02 132.39 46.46 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.006 -0.739 . . . . 72.33 109.006 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.55 137.82 43.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.302 0.572 . . . . 73.13 110.838 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -87.77 119.34 28.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.835 -1.543 . . . . 74.05 106.835 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 10' ' ' ASN . 21.0 m -127.31 175.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 120.949 0.404 . . . . 73.13 111.066 -172.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.99 150.32 34.03 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.863 -0.421 . . . . 74.14 109.863 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -151.84 174.46 13.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.367 -0.605 . . . . 74.51 109.367 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 88' ' ' ARG . 52.1 m-85 -114.39 118.12 32.96 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.466 -0.939 . . . . 71.24 108.466 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 30.6 m -109.87 172.5 2.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.946 -0.57 . . . . 72.14 110.373 -177.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.53 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 31.5 t-105 -86.39 121.71 29.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.101 -0.703 . . . . 71.21 109.101 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.4 m -72.06 -19.7 19.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-O 121.391 0.615 . . . . 71.41 112.291 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.469 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.6 t-20 -88.68 14.81 9.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.369 1.081 . . . . 62.3 109.333 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 40.1 ttmt -49.78 -24.92 2.63 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 127.459 2.303 . . . . 73.44 114.589 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -80.93 -21.67 40.29 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.776 1.028 . . . . 63.14 113.776 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -103.46 137.0 19.13 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 107.06 -1.459 . . . . 74.45 107.06 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.67 120.98 8.98 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.856 2.37 . . . . 74.15 114.468 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -124.6 113.52 18.15 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 109.047 -0.723 . . . . 74.51 109.047 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 51.88 28.43 5.08 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.326 1.016 . . . . 72.45 112.37 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.409 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 51.7 t80 -77.8 -48.29 16.88 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.746 -0.661 . . . . 70.01 110.244 -177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -104.26 13.42 51.76 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 120.064 -1.065 . . . . 61.13 112.293 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -143.54 130.75 20.79 Favored 'General case' 0 N--CA 1.427 -1.601 0 C-N-CA 120.473 -0.491 . . . . 75.02 110.554 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.0 t90 174.97 159.0 0.18 Allowed 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 126.274 1.829 . . . . 73.44 106.765 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.62 113.27 20.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.623 0.249 . . . . 55.13 110.437 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 126' ' ' TRP . 97.4 m-85 -68.46 -26.11 65.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.71 0.767 . . . . 73.21 109.614 175.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.9 -38.68 91.79 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.272 -0.877 . . . . 65.24 109.521 173.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.55 -34.7 67.7 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.882 -0.784 . . . . 52.31 108.882 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.506 ' HB3' ' O ' ' A' ' 123' ' ' PHE . 1.8 t90 -50.35 -46.86 56.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.61 0.764 . . . . 65.21 109.022 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 90.4 mtt180 -63.16 -49.22 75.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.825 -0.625 . . . . 74.31 111.874 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -38.77 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.328 0.492 . . . . 74.31 112.328 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.02 -43.93 81.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.972 -0.381 . . . . 64.2 109.972 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.542 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 56.4 t-80 -57.13 -38.55 73.63 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.909 -0.404 . . . . 74.21 109.909 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.78 -46.89 70.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.57 -0.287 . . . . 55.35 111.406 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 44.8 mt-10 -68.08 -40.03 82.79 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 111.943 0.349 . . . . 73.43 111.943 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.68 -31.9 73.17 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.152 0.797 . . . . 72.24 113.152 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.542 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 57.9 m-85 -83.91 -44.27 14.43 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.589 -0.844 . . . . 73.14 111.315 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 132' ' ' GLU . 14.7 p -63.92 -36.75 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 120.54 -0.464 . . . . 74.12 111.226 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -62.21 -36.35 81.68 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 120.18 -0.608 . . . . 75.41 110.425 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.8 m -63.39 -46.06 88.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.507 -0.315 . . . . 70.45 110.282 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -63.13 -37.13 85.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.778 0.323 . . . . 60.45 111.26 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.05 -44.54 68.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.45 -0.341 . . . . 75.25 111.316 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 32.3 mmmt -62.26 -44.05 97.44 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.715 0.293 . . . . 72.25 111.402 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.57 -31.88 72.26 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.368 -0.533 . . . . 73.4 110.715 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 tp -66.16 -50.56 63.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.391 -0.368 . . . . 55.23 110.384 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' ' HA2' ' A' ' 150' ' ' GLY . 10.4 pt-20 -62.16 -44.17 97.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 121.055 -0.258 . . . . 70.11 111.263 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.407 ' CZ2' ' HE3' ' A' ' 140' ' ' LYS . 23.5 m0 -65.61 -40.68 92.9 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 112.258 0.466 . . . . 73.24 112.258 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.3 -36.75 53.81 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.102 0.477 . . . . 73.51 111.98 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -79.82 -21.29 44.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.353 0.501 . . . . 72.11 112.353 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.69 142.55 45.92 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 119.815 -0.754 . . . . 63.24 109.598 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.66 -37.29 94.97 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.866 2.377 . . . . 72.13 112.253 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.74 -9.41 54.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.449 0.642 . . . . 63.33 109.475 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 143' ' ' GLU . . . 75.45 -100.14 1.27 Allowed Glycine 0 N--CA 1.41 -3.079 0 N-CA-C 108.934 -1.666 . . . . 22.04 108.934 -173.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 156' ' ' ALA . 31.5 ttpt -99.42 130.7 45.71 Favored 'General case' 0 C--N 1.268 -2.953 0 N-CA-C 108.957 -0.757 . . . . 72.02 108.957 174.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.6 m -67.63 161.37 25.92 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 123.278 0.361 . . . . 61.14 111.71 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.5 ' O ' HG23 ' A' ' 157' ' ' VAL . 27.2 ptt? -57.28 -44.55 84.09 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.6 1.333 . . . . 73.42 114.6 -171.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -81.26 -34.31 32.16 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 108.828 -0.804 . . . . 74.15 108.828 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.45 -37.19 86.65 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.429 -1.259 . . . . 74.4 110.091 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.415 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . . . -70.26 -25.82 63.54 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.547 -0.751 . . . . 73.45 110.783 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 153' ' ' MET . 60.8 t -81.41 103.9 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 108.106 -1.072 . . . . 72.24 108.106 176.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 128.81 61.75 0.11 Allowed Glycine 0 N--CA 1.415 -2.711 0 N-CA-C 109.689 -1.364 . . . . 54.43 109.689 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.4 m -86.28 -26.31 25.03 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.408 -0.96 . . . . 74.24 108.408 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 mp 65.88 119.55 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 125.11 1.364 . . . . 73.21 113.387 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 163' ' ' SER . 39.6 tp -81.89 -41.4 21.0 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.242 -1.762 . . . . 74.24 106.242 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t 58.57 23.55 10.98 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 125.324 1.45 . . . . 65.21 110.371 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.417 ' HB2' ' HG ' ' A' ' 161' ' ' LEU . 19.9 m -124.54 85.82 2.47 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.447 -0.797 . . . . 74.31 110.387 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.71 12.49 6.21 Favored Glycine 0 CA--C 1.506 -0.496 0 N-CA-C 111.18 -0.768 . . . . 52.25 111.18 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 . . . . . 0 C--O 1.254 1.299 0 N-CA-C 108.519 -0.919 . . . . 53.55 108.519 -179.569 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.883 -0.414 . . . . 62.21 109.883 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 t -88.25 97.16 10.86 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.021 -0.733 . . . . 72.54 109.021 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 m 64.89 95.94 0.05 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.208 -0.905 . . . . 75.52 110.221 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.6 m -65.59 105.91 1.33 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 116.26 -0.427 . . . . 72.03 110.32 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.9 t70 69.25 103.07 0.03 OUTLIER Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.865 1.266 . . . . 72.15 109.502 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.48 37.43 0.68 Allowed 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 123.441 2.761 . . . . 62.01 112.242 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 63.57 90.82 0.08 Allowed 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 124.353 1.061 . . . . 71.42 110.683 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.506 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 58.8 m -110.62 171.46 7.45 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 121.516 0.675 . . . . 74.12 111.141 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -130.42 157.4 42.7 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.029 -0.987 . . . . 73.33 109.298 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.9 m-20 -127.44 124.6 38.83 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 31.11 107.933 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 59.6 t -120.9 120.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 121.027 -0.269 . . . . 71.32 111.685 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' HB2' HG21 ' A' ' 104' ' ' VAL . 46.0 t80 -84.38 111.36 19.37 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.949 -1.5 . . . . 75.25 106.949 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 17' ' ' ILE . 8.6 p -123.25 137.63 55.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.732 -0.787 . . . . 63.23 111.105 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -100.04 97.85 8.66 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.943 -1.132 . . . . 74.42 107.943 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.454 ' H ' HD12 ' A' ' 18' ' ' LEU . . . 81.8 -142.0 22.24 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.012 -0.835 . . . . 50.14 111.012 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.9 t 65.49 -79.03 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.261 1.024 . . . . 74.45 113.416 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.581 HG22 HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -117.95 12.98 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 75.3 111.763 -175.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.469 HD13 ' HE3' ' A' ' 65' ' ' LYS . 80.3 mt -68.18 -18.65 64.66 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 73.4 109.416 174.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.78 116.86 63.02 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 107.648 -1.242 . . . . 63.2 107.648 172.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.69 -39.72 18.35 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.302 3.334 . . . . 65.22 114.634 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.17 94.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.991 0.424 . . . . 74.33 111.688 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 17' ' ' ILE . 22.3 t -72.46 -36.56 54.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.714 -0.676 . . . . 73.11 109.606 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' ILE . . . -62.53 -37.11 84.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.405 0.622 . . . . 31.42 109.88 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.92 -19.05 62.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.556 -0.747 . . . . 74.45 112.059 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.3 m -91.17 -30.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 119.511 -0.876 . . . . 74.12 110.975 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.553 HG12 ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -78.63 -47.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-O 120.696 0.284 . . . . 63.22 110.356 178.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.434 ' HG ' HG23 ' A' ' 26' ' ' ILE . 95.5 mt -92.96 -10.41 36.48 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 112.106 0.41 . . . . 74.11 112.106 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 19.5 t70 76.61 -14.05 0.86 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.513 1.149 . . . . 73.51 110.279 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 27' ' ' LEU . 27.8 ptt180 -133.73 168.03 19.46 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.405 -1.27 . . . . 75.13 108.153 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.2 m -76.25 135.22 39.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.611 -0.885 . . . . 72.52 108.611 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.414 ' HB1' HG23 ' A' ' 67' ' ' ILE . . . -75.1 135.58 41.17 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 116.43 -0.35 . . . . 61.22 110.979 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.06 109.07 19.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.122 -1.436 . . . . 72.44 107.122 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.1 p -117.9 143.89 45.93 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 115.723 -0.672 . . . . 62.3 110.718 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.9 146.17 60.2 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 107.771 -1.196 . . . . 73.41 107.771 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -71.18 137.05 30.6 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 121.359 1.372 . . . . 62.31 111.302 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.32 156.05 41.48 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.315 -0.857 . . . . 74.01 108.921 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.444 HG21 ' HD3' ' A' ' 61' ' ' LYS . 14.7 p -120.19 126.39 75.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.897 -0.721 . . . . 71.33 111.005 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.467 HD11 ' HB ' ' A' ' 91' ' ' VAL . 25.3 tp -92.43 89.2 6.68 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.35 -0.841 . . . . 53.55 111.204 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.45 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 27.6 p80 -66.09 131.37 46.04 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.973 -1.012 . . . . 75.44 108.824 171.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 119.32 -13.54 11.08 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 118.969 -1.586 . . . . 64.31 112.842 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 47.5 m-85 -127.33 157.76 39.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 112.686 0.624 . . . . 70.52 112.686 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -116.54 138.5 51.36 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.549 -1.278 . . . . 64.41 107.549 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.599 ' HA ' HG22 ' A' ' 54' ' ' ILE . 19.1 ptp180 -86.55 127.21 34.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.297 -0.631 . . . . 73.33 109.297 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.446 ' HD2' ' O ' ' A' ' 117' ' ' MET . 88.1 m-85 -108.82 112.27 24.44 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.03 -0.532 . . . . 71.31 111.689 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -86.4 116.8 24.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.38 -0.827 . . . . 73.31 111.533 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.5 147.84 50.43 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.391 -1.277 . . . . 72.14 109.399 174.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -115.84 -12.44 11.44 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.268 0.556 . . . . 71.2 110.162 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 -26.2 71.63 Favored Glycine 0 N--CA 1.41 -3.088 0 C-N-CA 120.086 -1.054 . . . . 62.04 110.903 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HB2' HD23 ' A' ' 46' ' ' LEU . 2.1 mm? -115.9 166.57 12.01 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 105.475 -2.046 . . . . 64.04 105.475 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 37.1 Cg_endo -66.6 -155.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.227 0 C-N-CA 122.326 2.018 . . . . 74.01 114.297 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CD1' ' HD3' ' A' ' 52' ' ' PRO . 18.9 p90 -48.35 -26.42 0.71 Allowed Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 119.452 3.13 . . . . 61.25 119.452 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HB3' ' HB3' ' A' ' 53' ' ' CYS . 84.3 Cg_exo -49.32 165.69 0.22 Allowed 'Trans proline' 0 CA--C 1.584 2.989 0 CA-C-N 122.141 1.8 . . . . 54.22 111.999 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 52' ' ' PRO . 22.0 p -152.3 -178.99 7.15 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.508 1.523 . . . . 75.42 110.717 5.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 43' ' ' ARG . 43.1 pt -135.31 132.44 52.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.36 -0.978 . . . . 74.43 108.36 170.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 112' ' ' LYS . 30.4 m -154.2 -175.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.777 -0.823 . . . . 43.42 108.777 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m 82.05 -177.61 0.05 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.923 1.289 . . . . 63.33 114.443 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -71.9 -178.97 2.51 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.732 0.813 . . . . 65.45 112.746 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.473 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 3.5 p30 -82.13 28.92 0.42 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.689 1.196 . . . . 44.33 113.038 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 m -76.78 -8.28 57.0 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.129 0.418 . . . . 74.04 112.129 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.98 -172.81 19.74 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.149 -1.024 . . . . 61.02 112.076 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 18.6 ptpt -143.46 147.45 34.58 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.607 -0.516 . . . . 63.51 109.607 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -111.36 123.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.392 -0.596 . . . . 63.24 109.392 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -98.75 124.25 43.49 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.006 -0.739 . . . . 73.43 109.006 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.98 -139.03 2.67 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.761 -0.733 . . . . 75.33 111.921 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.469 ' HE3' HD13 ' A' ' 18' ' ' LEU . 39.2 mtmt -137.39 140.73 41.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.06 0.457 . . . . 40.24 112.082 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.7 m -107.21 133.93 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.149 -0.932 . . . . 74.35 109.653 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 48.7 mt -87.93 123.72 40.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.507 -1.664 . . . . 65.23 106.507 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.6 p -103.8 161.21 14.13 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.2 -0.6 . . . . 73.33 110.514 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 8' ' ' SER . . . 69.06 28.5 72.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.039 -0.6 . . . . 74.11 113.382 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.74 121.49 36.44 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 117.223 0.512 . . . . 54.05 109.651 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.9 m -77.37 164.22 25.7 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.997 -0.742 . . . . 54.31 108.997 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.83 -32.18 72.49 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.153 0.433 . . . . 72.24 111.289 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.36 64.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.389 0.614 . . . . 72.01 110.331 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.08 -44.22 39.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 75.14 110.326 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.66 -37.56 87.81 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.775 -1.194 . . . . 54.55 107.775 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.555 ' O ' HG23 ' A' ' 80' ' ' VAL . 27.5 t-20 -54.69 -31.49 58.0 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.471 -1.241 . . . . 73.22 111.547 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.553 ' OD1' HG12 ' A' ' 26' ' ' ILE . 20.8 t-20 -75.1 -31.18 61.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 74.2 109.588 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -65.99 -35.56 80.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.39 0.614 . . . . 74.3 109.567 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.76 -33.71 72.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.307 -0.861 . . . . 61.23 110.283 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 76' ' ' ASN . 71.0 t -74.83 -25.44 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.498 -0.774 . . . . 75.45 111.784 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.7 mt -53.4 139.28 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 109.701 -0.481 . . . . 71.23 109.701 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.75 109.75 0.55 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.735 0.778 . . . . 72.51 112.174 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.26 55.83 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.003 0 N-CA-C 109.001 -1.64 . . . . 62.31 109.001 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -64.05 -19.28 65.1 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.302 0.572 . . . . 72.43 110.702 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.529 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 17.9 m-20 -91.0 10.16 27.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.419 . . . . 73.22 111.022 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.27 160.28 26.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 119.917 -0.713 . . . . 74.03 109.455 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -131.22 142.9 50.23 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 109.397 -0.594 . . . . 71.14 109.397 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -83.48 120.18 25.59 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.965 -0.754 . . . . 72.41 108.965 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.33 160.15 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 116.104 -0.498 . . . . 73.32 111.43 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -95.43 126.7 40.9 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 115.69 -0.686 . . . . 72.25 109.474 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' HB ' HD11 ' A' ' 38' ' ' LEU . 28.8 m -129.66 168.31 23.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.042 -1.096 . . . . 75.24 108.042 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -123.22 128.53 50.14 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.812 -1.155 . . . . 73.32 108.521 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' LEU . 19.8 m -126.18 169.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.176 0.512 . . . . 71.34 110.465 -173.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 96' ' ' MET . 76.7 t -103.81 128.63 56.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.74 -0.664 . . . . 72.45 110.183 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -64.93 3.97 0.49 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 126.77 2.028 . . . . 72.04 113.119 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.618 ' H ' HG12 ' A' ' 94' ' ' VAL . 12.5 tmm? 58.56 -72.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.704 2.002 . . . . 71.0 113.277 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.03 -29.34 67.2 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.301 1.041 . . . . 63.13 113.296 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -110.64 -5.18 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.372 -0.531 . . . . 63.41 110.68 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 m 62.82 4.94 1.59 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.801 0.841 . . . . 73.43 112.863 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.95 160.84 27.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.827 -0.805 . . . . 74.32 108.827 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 6.8 mptt -106.76 146.45 30.84 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.446 -0.946 . . . . 62.23 108.446 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.33 139.51 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.145 0.498 . . . . 61.12 110.336 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -87.4 129.77 34.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.148 -1.056 . . . . 62.41 108.148 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 12' ' ' PHE . 33.3 m -139.45 173.16 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 122.325 0.25 . . . . 63.14 110.981 -174.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -100.87 153.78 19.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.027 -1.101 . . . . 74.44 108.027 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -152.69 176.89 11.27 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-N 118.341 0.519 . . . . 64.41 110.881 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.31 117.88 35.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.734 0.813 . . . . 73.32 108.84 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.23 156.95 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 109.187 -0.671 . . . . 72.11 109.187 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 42.8 t-105 -98.86 120.12 38.77 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.645 0.378 . . . . 72.11 110.519 -171.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 85' ' ' ASP . 8.3 m -73.1 -23.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.312 0.486 . . . . 74.53 112.312 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.42 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 64.5 t30 -80.31 12.82 2.7 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.018 0.913 . . . . 73.35 110.99 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.444 ' HB3' HG11 ' A' ' 55' ' ' VAL . 20.9 ptmt -63.85 -15.33 58.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.566 1.321 . . . . 74.42 114.566 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.41 -42.95 92.0 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.29 0.478 . . . . 63.25 112.29 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -85.59 138.19 35.95 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 107.747 -1.205 . . . . 74.52 107.747 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -40.7 116.85 0.43 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 124.288 3.326 . . . . 71.4 114.537 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.596 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 1.1 mmp_? -106.3 165.09 11.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 65.52 109.219 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.497 ' HG3' ' H ' ' A' ' 119' ' ' GLY . 12.7 tpt -58.81 130.73 48.33 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.29 -0.633 . . . . 74.51 109.29 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -59.53 -23.46 62.85 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.436 0.636 . . . . 75.03 111.742 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.497 ' H ' ' HG3' ' A' ' 117' ' ' MET . . . 85.36 107.15 0.68 Allowed Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 115.366 -0.834 . . . . 64.05 112.348 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -98.89 132.63 44.08 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.102 -0.703 . . . . 72.5 109.102 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -144.56 155.31 43.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.07 -2.196 . . . . 74.33 105.07 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -81.21 121.32 26.0 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.473 -0.891 . . . . 63.41 113.072 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -68.45 -26.97 65.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.643 -1.162 . . . . 75.24 111.226 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 41.7 tt0 -74.65 -20.07 60.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.531 0.681 . . . . 72.23 109.522 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.519 ' O ' HG22 ' A' ' 128' ' ' VAL . 9.1 tp10 -76.26 -40.93 50.64 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.581 -1.266 . . . . 72.11 107.581 173.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -56.73 -36.98 70.35 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.375 -0.829 . . . . 75.41 110.914 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 124' ' ' GLU 0.269 4.0 ppt_? -63.16 -33.63 75.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.43 0.9 . . . . 75.24 113.43 -178.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 125' ' ' GLU . 29.9 m -77.38 -25.22 14.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 119.287 -0.965 . . . . 74.44 110.246 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.86 -44.78 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.493 -0.558 . . . . 65.21 109.493 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -75.21 -28.95 60.17 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 119.124 -1.03 . . . . 53.34 111.038 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.65 36.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.144 -0.48 . . . . 45.22 111.161 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 128' ' ' VAL . 10.0 mm-40 -61.67 -26.16 67.85 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.202 0.525 . . . . 71.54 110.835 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.54 ' HE3' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.05 -59.64 2.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.935 -1.135 . . . . 74.44 107.935 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -69.46 -31.58 69.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 114.354 1.242 . . . . 61.42 114.354 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.7 p -58.35 -38.48 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.25 0.477 . . . . 71.42 110.2 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.11 -46.0 82.83 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.691 -0.485 . . . . 63.54 109.691 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.0 m -57.12 -46.37 82.69 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.609 -0.723 . . . . 74.5 110.821 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 40.8 m-85 -60.26 -49.0 79.34 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 121.235 -0.186 . . . . 72.43 110.65 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 99.1 mtt180 -57.68 -44.84 86.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.042 0.213 . . . . 71.34 110.863 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -60.98 -52.54 64.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.347 -0.388 . . . . 61.43 110.688 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.58 72.51 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.657 0.614 . . . . 63.35 112.657 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 94.3 mt -72.48 -42.77 64.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.246 0.462 . . . . 65.0 112.246 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.6 -35.16 75.05 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 119.492 -0.883 . . . . 73.12 110.369 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.699 ' O ' ' HA3' ' A' ' 150' ' ' GLY . 1.3 m-90 -63.86 -28.98 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.337 0.589 . . . . 74.45 111.042 171.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -78.37 -44.46 24.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.135 0.493 . . . . 53.43 110.857 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.37 -31.52 42.94 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.912 0.708 . . . . 75.22 112.912 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 4.1 m-20 -95.26 143.87 26.85 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 111.806 0.298 . . . . 55.03 111.806 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 24.6 Cg_exo -64.82 -16.37 55.02 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.482 2.788 . . . . 75.31 112.009 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.24 -13.32 60.43 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.768 0.794 . . . . 74.31 108.98 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 144' ' ' TRP . . . -69.74 111.75 4.03 Favored Glycine 0 N--CA 1.399 -3.829 0 CA-C-N 114.658 -1.155 . . . . 53.31 112.455 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.38 140.12 57.19 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.605 -0.798 . . . . 74.2 109.646 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.2 m -67.41 157.4 34.22 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.537 -0.756 . . . . 64.54 111.406 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.43 -43.46 98.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.93 -0.577 . . . . 61.25 112.465 -176.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -72.76 -25.14 61.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.241 0.543 . . . . 71.15 110.969 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -75.7 -33.81 60.36 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.707 -0.679 . . . . 71.54 110.933 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.61 -30.36 62.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.841 . . . . 61.44 111.121 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.4 m -91.01 145.39 7.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.934 0.397 . . . . 65.43 110.719 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.01 -4.6 20.83 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.86 -0.896 . . . . 62.54 110.86 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.8 t -113.94 108.1 16.58 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.891 -0.781 . . . . 73.25 108.891 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.81 150.45 23.47 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.683 -1.228 . . . . 74.3 107.683 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.0 tp -87.5 119.4 27.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.752 -0.462 . . . . 54.23 109.752 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.0 p -73.66 97.88 2.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.665 0.745 . . . . 71.11 109.739 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.8 m -146.16 131.69 18.75 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.278 -0.874 . . . . 61.14 108.996 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 110.5 -84.96 0.38 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 108.281 -1.928 . . . . 73.32 108.281 -173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.246 0.87 0 C-N-CA 123.535 0.734 . . . . 73.11 109.28 175.736 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.0 p . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 109.684 -0.487 . . . . 70.53 109.684 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.5 t -83.18 132.86 35.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 121.193 0.52 . . . . 73.51 109.961 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -140.93 113.25 7.98 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.491 -0.559 . . . . 73.5 109.491 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.8 t -147.77 147.42 29.84 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.396 -0.594 . . . . 74.15 109.396 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -87.78 150.14 47.48 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.401 -0.592 . . . . 45.52 109.401 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.99 -36.65 97.93 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.232 1.955 . . . . 65.41 109.607 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -72.88 92.46 1.61 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.066 -1.457 . . . . 74.12 107.066 173.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 p -136.65 159.62 41.26 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 121.689 0.757 . . . . 74.52 112.616 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -109.25 147.43 32.61 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.859 -1.064 . . . . 72.13 109.705 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.5 m-20 -132.4 122.5 25.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.269 -1.382 . . . . 52.41 107.269 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.58 125.09 73.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.937 -0.305 . . . . 65.02 111.061 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -80.86 112.83 18.61 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.206 -1.035 . . . . 75.43 108.206 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.15 151.81 24.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.256 -0.646 . . . . 74.34 109.256 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -131.3 -22.83 2.46 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 120.519 -0.472 . . . . 73.14 111.126 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' HA3' ' CD2' ' A' ' 51' ' ' TYR . . . -114.05 108.82 2.1 Favored Glycine 0 C--O 1.248 1.005 0 C-N-CA 120.303 -0.951 . . . . 65.31 112.428 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 22.6 t 69.56 -177.25 0.21 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.921 1.288 . . . . 60.41 110.489 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.602 HD12 ' CE1' ' A' ' 78' ' ' PHE . 12.4 pt 47.12 18.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 126.761 2.024 . . . . 74.12 114.476 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 16' ' ' SER . 85.1 mt -93.04 -1.37 56.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.438 0.637 . . . . 63.03 110.942 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -103.53 132.34 21.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.009 -0.996 . . . . 74.42 108.879 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -42.85 -45.22 8.97 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 124.247 3.298 . . . . 74.54 113.756 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.32 -37.6 85.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 72.4 111.474 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 17' ' ' ILE . 44.9 t -75.72 -39.47 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.202 0.525 . . . . 72.4 109.981 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -66.96 -25.84 66.53 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.966 -0.753 . . . . 71.24 108.966 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.74 -31.49 57.15 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.677 -0.692 . . . . 65.54 111.588 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 22' ' ' VAL . 28.1 m -76.48 -30.41 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 119.584 -0.847 . . . . 72.2 111.619 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.457 HG23 ' HG ' ' A' ' 27' ' ' LEU . 3.3 tt -74.36 -42.29 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 63.34 111.925 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.77 HD21 ' CE2' ' A' ' 78' ' ' PHE . 75.2 mt -93.76 -22.25 18.81 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.706 0.632 . . . . 63.31 112.706 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 71.64 17.49 5.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.937 0.875 . . . . 72.42 109.92 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 ttm-85 -141.27 147.57 38.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.728 -1.953 . . . . 73.45 105.728 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.5 m -76.24 111.01 11.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.923 -0.769 . . . . 65.25 108.923 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -95.38 145.68 24.95 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.105 -0.498 . . . . 63.22 109.91 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.48 118.51 36.83 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.577 -0.738 . . . . 73.01 112.419 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 5.1 p -95.27 143.04 26.98 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.73 -0.668 . . . . 60.14 109.626 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.2 137.49 26.84 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 108.92 -0.77 . . . . 74.52 108.92 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 127.22 22.64 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.749 2.3 . . . . 72.34 112.083 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.58 37.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.516 -0.765 . . . . 35.55 109.022 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.505 HG21 ' CE ' ' A' ' 61' ' ' LYS . 11.4 p -118.14 130.05 73.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.722 0.772 . . . . 71.4 112.042 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.449 HD11 ' HB ' ' A' ' 91' ' ' VAL . 21.6 tp -87.95 106.77 18.34 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 122.123 0.963 . . . . 62.45 109.586 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -92.22 127.9 37.87 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.264 -1.335 . . . . 72.51 109.807 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.65 -5.93 29.59 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.023 -1.084 . . . . 51.54 112.044 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -117.86 144.86 45.04 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.709 0.29 . . . . 63.31 110.669 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -115.5 135.12 54.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.172 -0.677 . . . . 62.4 109.172 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.575 ' NH2' ' HA ' ' A' ' 125' ' ' GLU . 55.6 mtm180 -87.33 114.89 24.35 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.565 -0.902 . . . . 64.15 108.565 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.39 137.28 34.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.117 -0.697 . . . . 75.43 109.117 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' HB3' ' H ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -95.25 110.41 22.4 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.887 -1.153 . . . . 73.25 107.887 -177.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 49' ' ' LEU 0.308 0.0 OUTLIER -124.75 160.98 27.4 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.764 -1.107 . . . . 72.21 112.394 179.488 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -99.02 -22.84 15.52 Favored 'General case' 0 N--CA 1.398 -3.039 0 CA-C-N 113.406 -1.725 . . . . 71.03 110.999 -169.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.09 -25.51 61.76 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.895 -0.669 . . . . 53.34 113.06 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 46' ' ' LEU . 2.1 mm? -122.7 146.89 49.19 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 109.397 -0.594 . . . . 71.22 109.397 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.49 -34.88 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.336 2.024 . . . . 64.14 111.724 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.676 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 37.9 p90 -123.38 177.63 1.62 Allowed Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 116.735 -1.602 . . . . 73.25 106.772 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.676 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.34 0.0 OUTLIER 34.5 169.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.608 0 C-N-CA 123.625 2.883 . . . . 73.34 119.172 -163.145 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 14.7 p -122.73 172.88 8.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.218 -1.551 . . . . 74.42 113.588 10.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.526 HG21 HG21 ' A' ' 62' ' ' VAL . 41.1 pt -130.71 149.92 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.831 -1.077 . . . . 61.4 109.911 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.449 HG11 ' HG3' ' A' ' 112' ' ' LYS . 12.7 m -148.12 164.27 5.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.355 -1.72 . . . . 75.33 106.355 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -80.04 123.27 27.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 114.064 1.135 . . . . 62.21 114.064 -170.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 p -147.67 120.08 8.46 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.486 -1.672 . . . . 73.13 106.486 172.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.23 -11.56 22.24 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 117.433 2.383 . . . . 63.44 117.433 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.5 m -98.08 1.1 47.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.489 -0.885 . . . . 75.15 111.382 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.5 159.09 15.59 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.182 -1.009 . . . . 51.21 114.044 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' CE ' HG21 ' A' ' 37' ' ' VAL . 48.9 mtpt -140.39 147.27 39.51 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 123.879 0.872 . . . . 64.15 109.827 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.526 HG21 HG21 ' A' ' 54' ' ' ILE . 48.0 t -123.74 122.05 63.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.534 -1.284 . . . . 75.53 107.534 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -111.35 115.99 30.21 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.582 -0.447 . . . . 62.54 111.287 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.9 -131.4 1.73 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.742 -0.543 . . . . 64.34 111.742 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB2' HD22 ' A' ' 18' ' ' LEU . 94.1 mttt -141.12 154.4 45.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.423 -0.584 . . . . 72.03 109.423 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.7 m -109.6 133.58 54.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.626 -0.509 . . . . 74.41 109.626 173.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.424 HD11 HG13 ' A' ' 17' ' ' ILE . 47.4 mt -88.02 112.43 23.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.536 -1.654 . . . . 72.33 106.536 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.7 p -106.68 160.66 15.29 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.119 0.414 . . . . 74.24 112.119 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.74 24.98 59.27 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.713 -0.676 . . . . 43.25 113.84 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 127.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 O-C-N 122.642 -0.328 . . . . 64.1 110.337 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 m -78.85 160.45 27.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.213 -1.032 . . . . 72.34 108.213 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.39 -37.36 75.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.297 0.499 . . . . 72.24 111.768 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.08 78.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.434 0.635 . . . . 61.31 110.854 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.695 ' HB3' HD22 ' A' ' 27' ' ' LEU . 37.8 mt-10 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.731 -0.668 . . . . 62.41 109.232 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 75' ' ' LEU . 3.2 tm? -59.76 -31.68 69.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.769 0.828 . . . . 73.31 109.808 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -56.95 -28.6 62.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 71.12 112.126 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -76.0 -31.77 59.09 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 119.043 -1.063 . . . . 75.41 109.436 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.77 ' CE2' HD21 ' A' ' 27' ' ' LEU . 41.2 m-85 -70.33 -28.96 65.57 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.638 0.732 . . . . 75.0 109.21 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.541 ' HA ' ' OH ' ' A' ' 107' ' ' TYR . 18.5 t70 -67.11 -43.21 83.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.827 -1.079 . . . . 74.43 111.693 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.04 -30.48 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 N-CA-C 112.708 0.633 . . . . 74.22 112.708 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.2 tt -82.48 111.16 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 112.905 0.705 . . . . 64.54 112.905 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 58.33 35.07 24.59 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.138 0.975 . . . . 74.33 110.486 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.55 25.49 9.65 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.647 -0.787 . . . . 53.05 111.485 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.61 -36.03 24.2 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.878 0.371 . . . . 73.3 111.669 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 12.8 m-20 -117.62 19.24 13.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.88 0.848 . . . . 71.02 109.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -130.62 161.36 31.74 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.791 -1.095 . . . . 72.34 108.666 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -130.06 147.18 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.781 -0.822 . . . . 75.14 108.781 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 40.0 ttp-105 -92.86 108.51 20.05 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.24 0.543 . . . . 63.43 111.36 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.4 m -111.18 159.38 11.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.749 -0.66 . . . . 75.32 110.416 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -91.33 133.43 35.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.575 -0.898 . . . . 55.3 108.575 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 38' ' ' LEU . 30.2 m -133.75 168.81 23.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.803 -1.184 . . . . 73.11 107.803 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.457 ' HB2' ' HE3' ' A' ' 103' ' ' LYS . 42.8 tt0 -114.2 129.93 56.62 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.515 -0.874 . . . . 74.22 110.192 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 38' ' ' LEU . 20.6 m -126.12 163.02 28.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.166 -0.679 . . . . 72.3 109.166 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 101' ' ' LYS . 77.8 t -102.05 113.86 39.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 109.352 -0.61 . . . . 73.55 109.352 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -69.45 90.21 0.53 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.19 -2.522 . . . . 74.14 104.19 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -55.65 -45.81 77.58 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 125.079 1.351 . . . . 72.4 113.99 -162.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.74 -27.38 68.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.076 0.465 . . . . 70.2 111.304 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -101.47 -9.48 21.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.068 -0.515 . . . . 72.33 110.51 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.5 t 64.42 15.87 9.82 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.634 1.174 . . . . 53.1 112.106 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -96.07 161.26 14.05 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 122.647 0.379 . . . . 74.35 110.421 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -108.89 128.49 54.97 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.946 -0.761 . . . . 64.21 108.946 -175.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.5 148.51 28.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.988 0.423 . . . . 62.01 111.9 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 92' ' ' GLU . 27.3 mmtp -90.84 118.12 29.99 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.556 0.742 . . . . 64.32 111.077 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.44 170.56 17.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.244 -0.889 . . . . 73.04 108.877 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.78 150.16 23.08 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.979 -0.378 . . . . 74.3 109.979 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.1 t -156.0 173.85 16.19 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.618 -0.882 . . . . 60.11 108.618 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 79' ' ' ASP . 95.4 m-85 -110.11 122.82 48.5 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.296 0.569 . . . . 53.12 111.691 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.15 159.72 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 115.318 -0.856 . . . . 65.2 110.04 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 53' ' ' CYS . 26.1 t-105 -79.38 112.67 16.85 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.912 0.863 . . . . 74.41 111.963 -173.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 85' ' ' ASP . 43.1 t -72.33 -32.09 41.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.08 -1.418 . . . . 64.54 112.35 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.478 ' HB2' ' CZ2' ' A' ' 109' ' ' TRP . 86.1 m-20 -88.43 14.34 9.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 123.013 0.525 . . . . 55.2 112.074 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.531 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 0.4 OUTLIER -49.84 -36.81 28.13 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.512 1.525 . . . . 65.34 111.766 -177.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.362 15.7 m-20 -73.98 71.46 1.57 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 115.934 1.827 . . . . 71.03 115.934 -171.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -129.0 141.82 43.05 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 104.413 -2.44 . . . . 75.3 104.413 170.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.36 -25.55 57.66 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.216 2.611 . . . . 63.13 114.616 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -116.81 113.05 21.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.251 -0.98 . . . . 63.03 111.624 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HA ' ' A' ' 112' ' ' LYS . 68.8 mtp -161.08 100.28 1.23 Allowed 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 124.184 0.994 . . . . 74.01 111.131 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -149.18 -46.38 0.14 Allowed 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.769 -1.567 . . . . 73.24 106.769 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.47 -127.04 8.16 Favored Glycine 0 N--CA 1.407 -3.236 0 CA-C-N 114.101 -1.409 . . . . 73.12 111.767 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.439 ' H ' ' HB3' ' A' ' 45' ' ' LYS . 38.5 tt0 -145.89 141.18 27.57 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.7 -0.852 . . . . 52.24 108.7 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -82.58 100.9 10.42 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 118.306 -1.358 . . . . 55.15 109.298 167.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -81.65 148.64 28.93 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.695 -1.224 . . . . 75.25 107.695 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.41 -38.01 65.73 Favored 'General case' 0 N--CA 1.435 -1.203 0 O-C-N 123.54 0.525 . . . . 74.12 111.356 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.55 -37.82 65.45 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 120.586 -0.446 . . . . 61.21 110.438 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.575 ' HA ' ' NH2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -61.18 -30.88 70.68 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.31 -0.405 . . . . 75.12 111.651 176.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -86.04 -36.91 19.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.11 0.481 . . . . 71.41 109.799 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -51.59 -47.07 63.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.608 1.163 . . . . 75.11 111.878 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 34.2 m -62.5 -33.15 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.376 0.51 . . . . 74.34 112.376 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.32 -37.14 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.7 0.762 . . . . 63.42 109.527 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.409 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 76.2 t60 -66.83 -35.63 80.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.576 -0.738 . . . . 72.44 109.571 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -65.47 -34.78 79.07 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 123.457 0.473 . . . . 71.11 110.643 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 43.4 mt-10 -59.4 -39.06 82.2 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.801 0.334 . . . . 73.13 110.577 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.613 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.1 tpmt? -57.56 -45.87 84.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.545 -0.752 . . . . 73.25 109.076 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 78.9 m-85 -62.6 -45.34 93.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.444 -0.798 . . . . 62.11 110.932 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.561 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 80.2 t -54.67 -49.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 O-C-N 123.55 0.531 . . . . 74.34 110.291 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.02 -41.3 91.88 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 123.197 0.311 . . . . 64.05 110.458 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -58.57 -47.31 84.69 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.856 -0.611 . . . . 61.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.403 ' O ' HD13 ' A' ' 142' ' ' LEU . 37.8 m-85 -63.62 -44.22 94.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.114 -0.494 . . . . 75.04 110.564 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 31.4 mtm180 -56.5 -49.92 73.31 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.882 -0.327 . . . . 72.13 110.147 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.13 -44.33 96.87 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.46 0.475 . . . . 64.52 111.684 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.86 -34.7 78.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.861 0.362 . . . . 55.12 110.997 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.565 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 10.8 mp -72.63 -31.82 65.43 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 120.622 -0.431 . . . . 72.33 111.403 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 46.5 mt-10 -59.79 -34.23 72.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.876 -0.416 . . . . 72.45 109.876 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -72.74 -44.77 61.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.199 -0.455 . . . . 73.13 111.817 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -73.81 -36.1 64.96 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.169 0.803 . . . . 74.33 113.169 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 142' ' ' LEU . 23.0 pttp -84.87 -6.38 59.34 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.937 -0.477 . . . . 72.11 111.458 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -74.67 144.7 80.78 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.492 -0.929 . . . . 73.54 108.492 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -43.0 -31.94 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.238 3.292 . . . . 71.24 115.018 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -71.85 -20.55 61.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.038 0.447 . . . . 75.12 110.871 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 57.67 42.22 94.15 Favored Glycine 0 CA--C 1.5 -0.868 0 CA-C-N 115.448 -0.796 . . . . 61.05 114.844 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.49 121.26 26.05 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.749 -0.781 . . . . 74.45 109.535 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.3 m -94.51 172.93 7.88 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.865 -0.607 . . . . 71.55 109.63 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -66.53 -35.91 81.4 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 111.919 0.34 . . . . 61.55 111.919 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.82 -28.51 68.42 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.819 0.818 . . . . 74.05 109.859 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -75.81 -45.49 35.72 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.838 -1.073 . . . . 73.44 110.748 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.03 65.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.27 -0.877 . . . . 65.43 112.074 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.72 -56.22 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 112.912 0.708 . . . . 70.15 112.912 -176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 160.9 154.04 7.23 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.85 -0.9 . . . . 53.23 110.85 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.9 p -69.03 116.0 8.97 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.862 0.331 . . . . 64.1 110.305 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.0 tt -72.56 -53.16 12.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.079 -0.712 . . . . 72.31 109.079 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.37 -31.69 26.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.42 -0.354 . . . . 72.44 110.897 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 t 73.4 -69.81 0.18 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.301 1.04 . . . . 71.01 109.33 -176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.1 m 53.14 88.45 0.03 OUTLIER 'General case' 0 C--O 1.238 0.45 0 N-CA-C 114.795 1.406 . . . . 74.12 114.795 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.23 -78.05 1.1 Allowed Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 109.64 -1.384 . . . . 72.31 109.64 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 C--N 1.311 -1.097 0 N-CA-C 108.254 -1.017 . . . . 65.42 108.254 176.622 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.438 -1.062 0 N-CA-C 109.168 -0.678 . . . . 42.42 109.168 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 t -74.31 136.9 42.59 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.783 -0.821 . . . . 61.33 108.783 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.0 p -153.16 160.19 42.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.594 -0.521 . . . . 64.13 109.594 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.0 m -94.73 -22.96 17.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.357 -0.608 . . . . 73.24 109.357 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 57.82 98.26 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 124.61 1.164 . . . . 55.21 113.9 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.17 -26.97 35.76 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.849 1.699 . . . . 64.44 109.918 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 58.05 70.57 0.64 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 124.343 1.027 . . . . 73.35 108.858 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.3 m 61.79 -173.73 0.14 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.162 -0.927 . . . . 44.32 109.267 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.431 ' C ' HD22 ' A' ' 10' ' ' ASN . 82.0 m-70 -125.16 143.13 51.09 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 109.375 -0.602 . . . . 64.54 109.375 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -128.95 123.85 33.57 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.307 -1.738 . . . . 70.31 106.307 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 13' ' ' VAL . 20.7 t -111.82 120.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 119.777 -0.769 . . . . 72.23 109.393 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.0 t80 -81.97 113.89 20.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.755 -0.831 . . . . 74.11 108.755 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 11' ' ' VAL . 27.2 m -135.16 159.25 41.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.345 0.593 . . . . 72.22 110.151 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -148.62 109.73 4.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 106.021 -1.844 . . . . 71.41 106.021 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 163.6 -92.21 0.11 Allowed Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.74 -0.944 . . . . 71.12 110.74 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.518 ' O ' HG11 ' A' ' 22' ' ' VAL . 49.5 m -149.6 78.95 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.19 1.182 . . . . 74.13 114.19 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.641 HG21 HD13 ' A' ' 67' ' ' ILE . 63.8 mt -155.57 8.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 104.713 -2.329 . . . . 75.33 104.713 168.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 6.9 mp -92.07 -17.21 25.34 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.372 -1.285 . . . . 52.0 109.676 -173.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.71 129.54 37.91 Favored Pre-proline 0 N--CA 1.403 -2.783 0 CA-C-N 114.676 -1.147 . . . . 45.41 108.635 172.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.71 -36.82 10.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.09 3.193 . . . . 73.12 113.034 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -55.46 -45.94 76.86 Favored 'General case' 0 C--O 1.224 -0.237 0 O-C-N 123.522 0.514 . . . . 73.42 112.008 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 16' ' ' SER . 92.3 t -77.3 -44.37 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.508 0.194 . . . . 51.04 111.446 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.48 -30.98 71.66 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.37 -0.532 . . . . 74.33 110.702 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.12 -40.62 74.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.062 -0.517 . . . . 74.35 111.268 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 21' ' ' ALA . 16.9 m -71.15 -31.16 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.294 -0.562 . . . . 74.23 111.687 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.547 HD13 ' CD1' ' A' ' 78' ' ' PHE . 6.1 tt -77.95 -38.57 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.275 0.56 . . . . 70.41 112.135 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 31' ' ' ALA . 95.6 mt -100.28 -10.75 20.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 113.93 1.085 . . . . 62.15 113.93 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 68.12 19.16 9.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.995 0.902 . . . . 71.04 109.432 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -162.28 142.68 10.05 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.338 -2.097 . . . . 73.3 105.338 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.2 m -77.06 119.24 20.5 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 120.948 0.404 . . . . 62.5 110.335 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -90.88 152.8 20.6 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.661 -0.496 . . . . 72.41 109.661 176.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.32 125.18 41.74 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.988 -0.551 . . . . 72.02 110.404 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 5.5 p -100.16 142.61 31.4 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 115.675 -0.693 . . . . 53.44 109.508 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.19 134.61 25.59 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.384 -1.339 . . . . 61.01 107.384 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.586 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.5 Cg_endo -61.8 130.38 31.04 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 121.932 1.755 . . . . 62.03 111.369 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.83 156.17 41.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.774 -1.103 . . . . 74.41 109.753 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.438 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.3 p -121.66 127.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.651 0.738 . . . . 64.32 111.546 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.422 HD22 HG21 ' A' ' 91' ' ' VAL . 23.3 tp -91.87 95.34 9.78 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.215 -0.902 . . . . 44.12 110.9 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 23.7 p80 -70.67 123.14 21.18 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.76 -1.109 . . . . 54.02 110.096 173.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 120.52 -13.59 10.1 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.878 -1.153 . . . . 73.22 113.8 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.404 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 60.1 m-85 -123.62 166.06 16.12 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.326 0.861 . . . . 73.53 113.326 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -134.39 128.24 33.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.448 -1.686 . . . . 72.32 106.448 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -87.46 135.19 33.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.889 0.852 . . . . 62.21 112.722 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -107.53 106.98 17.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.305 -1.739 . . . . 71.44 106.305 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.652 ' HG3' ' OE2' ' A' ' 120' ' ' GLU . 24.1 tptp -47.79 -51.94 20.62 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.593 2.072 . . . . 74.31 116.593 -173.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.405 HD21 ' HG2' ' A' ' 117' ' ' MET . 8.6 mp 53.43 95.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.746 1.387 . . . . 71.1 114.746 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 47' ' ' LYS 0.306 0.0 OUTLIER -82.67 -11.73 58.14 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.888 1.07 . . . . 72.22 113.888 174.524 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.99 -43.4 10.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.849 -0.691 . . . . 54.42 111.929 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.2 152.36 39.37 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.038 -0.727 . . . . 74.45 109.038 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.6 112.0 3.37 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 122.867 2.378 . . . . 70.03 114.382 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.554 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.513 35.2 p90 35.79 59.91 2.93 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 119.044 2.979 . . . . 71.13 119.044 -178.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 10.4 Cg_endo -106.02 172.25 0.12 Allowed 'Trans proline' 0 CA--C 1.547 1.136 1 C-N-CA 126.504 4.803 . . . . 72.33 110.132 175.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 109' ' ' TRP . 43.3 t -158.13 175.24 14.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.577 3.151 . . . . 70.23 103.751 -11.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.413 HG13 HG12 ' A' ' 108' ' ' VAL . 25.8 pt -135.65 138.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 119.407 1.003 . . . . 44.2 111.307 174.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 56' ' ' SER . 5.5 m -154.37 -160.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.984 1.313 . . . . 71.12 108.88 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.43 ' H ' ' HB ' ' A' ' 55' ' ' VAL . 47.5 m 83.73 -39.87 0.08 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.226 1.41 . . . . 75.35 113.305 176.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 50.0 m 56.65 31.0 18.44 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.969 0.89 . . . . 73.11 109.402 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.09 175.77 7.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.194 -1.366 . . . . 74.1 110.159 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -79.74 -0.58 34.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.783 0.325 . . . . 72.43 111.073 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.94 -172.16 21.75 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 116.168 -0.469 . . . . 74.12 112.43 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.438 ' HE2' HG21 ' A' ' 37' ' ' VAL . 17.7 ptmt -154.44 143.01 20.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.308 -0.525 . . . . 54.4 109.785 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.7 t -105.11 123.38 59.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.685 -0.857 . . . . 62.35 108.685 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -102.96 115.82 31.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.018 -0.673 . . . . 63.03 109.241 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -150.65 -136.75 2.58 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 111.708 -0.557 . . . . 53.3 111.708 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 35' ' ' PRO . 52.4 mtmt -139.28 147.22 41.37 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.551 0.691 . . . . 75.12 112.775 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.8 m -104.4 133.11 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.838 -1.074 . . . . 63.35 108.887 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.641 HD13 HG21 ' A' ' 17' ' ' ILE . 5.8 mt -87.49 111.0 21.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.953 -2.24 . . . . 72.42 104.953 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -97.72 167.26 11.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.633 -0.427 . . . . 75.12 111.888 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.7 39.38 93.68 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.645 -0.707 . . . . 73.0 113.274 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.1 t -103.97 122.04 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.125 -1.065 . . . . 62.42 108.125 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 m -78.6 158.57 28.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.064 -1.088 . . . . 63.11 108.064 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.89 -35.56 69.09 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.44 0.563 . . . . 64.54 110.949 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.81 91.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 73.35 110.714 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 27' ' ' LEU . 47.9 mt-10 -69.03 -32.67 72.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.678 0.791 . . . . 74.31 110.536 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.482 HD22 HH11 ' A' ' 88' ' ' ARG . 1.3 tt -64.16 -28.29 69.66 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.466 -0.938 . . . . 72.34 108.466 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 79' ' ' ASP . 29.0 m120 -56.54 -27.76 58.41 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 112.729 0.64 . . . . 75.04 112.729 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.426 ' HA ' HG12 ' A' ' 80' ' ' VAL . 45.0 t-20 -72.56 -37.45 68.23 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 119.559 -0.856 . . . . 60.25 109.292 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.547 ' CD1' HD13 ' A' ' 26' ' ' ILE . 90.8 m-85 -70.43 -30.19 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.628 -0.879 . . . . 64.32 108.628 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 76' ' ' ASN . 19.8 t70 -73.77 -41.07 62.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 65.04 112.446 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 77' ' ' ASN . 9.4 p -67.09 -21.61 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.023 0.44 . . . . 71.42 110.255 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 77' ' ' ASN . 69.9 mt -57.27 116.37 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.526 -1.287 . . . . 74.11 107.526 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -71.36 119.44 15.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.197 1.184 . . . . 70.53 114.197 -171.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.646 ' HA3' ' CE1' ' A' ' 86' ' ' TYR . . . -150.7 86.43 0.15 Allowed Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 107.709 -2.156 . . . . 75.33 107.709 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -65.58 -38.35 89.25 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.838 0.855 . . . . 63.53 111.307 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 10.2 m-20 -91.4 8.62 35.36 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.108 -0.951 . . . . 75.4 112.103 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.646 ' CE1' ' HA3' ' A' ' 83' ' ' GLY 0.266 0.3 OUTLIER -125.04 157.95 34.95 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 119.443 -0.903 . . . . 73.52 112.237 172.488 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 11.8 pt-20 -127.61 158.37 37.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.501 0.191 . . . . 72.14 110.614 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.482 HH11 HD22 ' A' ' 75' ' ' LEU . 61.9 ttp180 -93.77 110.96 22.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.047 0.451 . . . . 75.12 110.679 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.9 159.49 28.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.257 -0.429 . . . . 64.25 111.145 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.51 HG22 ' HG2' ' A' ' 103' ' ' LYS . 99.2 m -99.08 124.16 43.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.916 -0.584 . . . . 54.34 109.596 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.422 HG21 HD22 ' A' ' 38' ' ' LEU . 29.6 m -125.37 155.65 34.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.872 1.269 . . . . 73.44 108.165 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 31.0 tt0 -105.1 127.44 52.89 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.784 -0.767 . . . . 75.34 110.395 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 38' ' ' LEU . 19.0 m -126.43 167.9 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 115.424 -0.807 . . . . 74.22 108.993 -175.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 101' ' ' LYS . 62.2 t -107.1 123.06 62.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 173.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -73.66 84.14 1.59 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.768 -1.197 . . . . 73.22 107.768 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.613 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 25.3 ttt -39.59 -51.75 2.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 128.02 2.528 . . . . 75.33 114.035 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.42 -36.39 78.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.071 0.397 . . . . 72.14 112.071 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.75 -9.43 23.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.98 0.419 . . . . 72.54 110.922 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.86 20.76 12.36 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.035 1.334 . . . . 73.01 111.853 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -105.13 161.16 14.49 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 120.878 0.371 . . . . 72.23 110.369 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HG2' HG22 ' A' ' 94' ' ' VAL . 89.4 mttt -100.09 131.28 46.14 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.232 -0.655 . . . . 65.31 109.232 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.82 140.99 37.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.89 -0.411 . . . . 71.31 109.89 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 31.2 ttpt -104.07 117.96 35.52 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 119.449 -0.9 . . . . 74.55 110.224 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' A' ' 12' ' ' PHE . 19.8 m -123.82 176.26 5.52 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 CA-C-N 115.076 -0.965 . . . . 74.25 112.181 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -99.46 150.62 21.99 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 122.782 0.433 . . . . 72.21 110.026 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -159.43 175.01 13.83 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.689 -0.856 . . . . 65.24 108.689 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 97.6 m-85 -114.38 119.13 35.89 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.086 0.47 . . . . 73.01 111.837 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.413 HG12 HG13 ' A' ' 54' ' ' ILE . 27.1 m -109.49 142.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.713 -0.676 . . . . 61.1 109.908 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 25.1 t-105 -72.16 113.88 9.67 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.515 0.726 . . . . 74.23 110.119 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 m -72.38 -23.23 21.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 122.047 0.927 . . . . 65.32 110.055 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.469 ' OD1' ' HG3' ' A' ' 116' ' ' ARG . 28.6 t-20 -83.08 5.24 23.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.409 -1.269 . . . . 54.21 112.173 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -59.62 -15.06 16.22 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.437 1.273 . . . . 70.15 114.437 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -59.38 -28.57 67.0 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.992 1.108 . . . . 70.02 113.992 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . 24.5 m-20 -106.06 167.09 10.13 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.196 -1.409 . . . . 65.0 107.196 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.14 98.03 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 N-CA-C 108.371 -1.434 . . . . 74.4 108.371 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.469 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 40.4 mmt180 -133.15 128.62 36.47 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.707 -0.679 . . . . 65.33 110.236 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.405 ' HG2' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER 71.82 130.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.537 1.148 . . . . 70.33 114.044 171.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -104.58 -44.22 4.95 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.408 -0.96 . . . . 73.15 108.408 175.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.07 176.37 27.05 Favored Glycine 0 C--O 1.244 0.748 0 CA-C-N 115.848 -0.615 . . . . 54.0 113.354 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.652 ' OE2' ' HG3' ' A' ' 45' ' ' LYS . 1.5 mp0 -94.26 131.04 40.27 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 119.596 -0.841 . . . . 75.51 109.223 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.45 ' H ' ' H ' ' A' ' 122' ' ' ASP . 37.6 p-90 -165.38 5.12 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 124.519 1.128 . . . . 64.43 109.3 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 124' ' ' GLU . 17.9 t70 -82.4 142.09 32.25 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 106.792 -1.559 . . . . 70.31 106.792 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -63.57 -38.32 90.67 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 111.795 0.294 . . . . 75.12 111.795 -174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.465 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 38.9 tt0 -66.19 -45.85 79.38 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.781 -0.451 . . . . 74.52 109.781 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.438 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 42.7 mt-10 -66.5 -35.64 80.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.185 -0.461 . . . . 74.01 111.159 176.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -67.72 -34.09 76.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 73.12 110.643 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -58.31 -39.15 78.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.538 -0.912 . . . . 72.15 108.538 174.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 98.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.556 -1.202 . . . . 35.22 110.385 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 125' ' ' GLU . 97.6 t -67.61 -45.19 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.782 -0.451 . . . . 70.22 109.782 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.458 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 23.7 t60 -60.84 -34.26 74.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.771 -0.649 . . . . 74.41 109.701 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.36 -52.46 39.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.025 -0.534 . . . . 71.43 110.622 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.507 ' HA ' HG12 ' A' ' 135' ' ' VAL . 42.5 mt-10 -63.69 -40.96 98.1 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.487 0.492 . . . . 63.03 112.14 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.596 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -60.22 -47.62 85.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.987 -0.551 . . . . 74.14 111.499 -177.101 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.458 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 78.9 m-85 -76.99 -34.57 57.51 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.929 0.714 . . . . 71.24 112.929 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.55 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 12.5 p -67.34 -40.95 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.628 -0.829 . . . . 60.32 111.168 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.4 pt-20 -64.76 -34.56 78.63 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 120.11 -0.636 . . . . 73.5 110.747 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.2 m -66.13 -38.34 87.91 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.96 -0.564 . . . . 71.43 109.541 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.472 ' HA ' ' HG3' ' A' ' 141' ' ' MET . 87.6 t80 -66.64 -44.71 81.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.606 -0.724 . . . . 61.14 109.674 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.6 mtp180 -55.06 -46.85 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 61.33 109.956 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 13.8 mmmm -61.97 -44.17 97.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.606 -0.725 . . . . 64.44 111.816 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.472 ' HG3' ' HA ' ' A' ' 138' ' ' PHE . 3.0 ppp? -70.28 -33.05 71.11 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 120.631 -0.427 . . . . 72.12 109.97 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.96 -42.07 97.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.785 -0.643 . . . . 55.11 109.279 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 148' ' ' PRO . 13.7 mm-40 -61.19 -39.14 89.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.036 -0.529 . . . . 74.53 110.551 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.442 ' NE1' ' HB1' ' A' ' 156' ' ' ALA . 43.7 t90 -75.32 -29.99 60.19 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.572 -0.451 . . . . 72.01 111.009 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.63 -31.89 36.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.241 0.544 . . . . 74.05 110.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.74 -32.42 46.7 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.945 -0.57 . . . . 72.43 110.89 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.614 ' HB3' ' O ' ' A' ' 151' ' ' LYS . 40.9 m-80 54.8 67.96 2.93 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.506 0.723 . . . . 63.1 111.908 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 143' ' ' GLU . 91.3 Cg_endo -105.82 -15.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.981 2.454 . . . . 53.34 115.047 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -94.01 13.59 22.42 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.992 0.738 . . . . 74.31 112.992 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.35 -20.38 16.15 Favored Glycine 0 CA--C 1.496 -1.123 0 C-N-CA 120.149 -1.024 . . . . 64.04 112.018 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.614 ' O ' ' HB3' ' A' ' 147' ' ' ASN . 97.3 mttt -78.26 143.77 36.76 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.753 -0.462 . . . . 72.41 109.753 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.3 m -117.87 156.65 28.04 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 106.874 -1.528 . . . . 74.42 106.874 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 157' ' ' VAL . 26.1 ptt? -56.67 -43.37 80.35 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.582 0.956 . . . . 71.21 113.582 -173.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -66.58 -35.88 81.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.11 0.957 . . . . 74.02 109.976 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -76.36 -39.07 54.82 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.658 -1.156 . . . . 74.41 110.924 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.442 ' HB1' ' NE1' ' A' ' 144' ' ' TRP . . . -74.18 -25.07 59.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.456 -1.247 . . . . 53.33 112.794 -175.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 153' ' ' MET . 28.7 m -73.63 137.48 23.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 C-N-CA 119.488 -0.885 . . . . 73.31 111.216 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.55 98.67 0.21 Allowed Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 115.798 -0.637 . . . . 71.34 112.318 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.2 m -114.65 172.81 6.81 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 120.837 0.351 . . . . 74.31 110.055 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.461 ' HG ' HD12 ' A' ' 161' ' ' LEU . 43.6 tp -122.95 142.53 50.72 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.776 -1.564 . . . . 74.33 106.776 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.461 HD12 ' HG ' ' A' ' 160' ' ' LEU . 8.1 mp 77.18 108.7 0.08 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.168 0.918 . . . . 72.23 110.919 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 42.8 t -73.98 -18.75 60.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.419 -0.81 . . . . 73.42 110.436 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.6 p 53.18 79.68 0.12 Allowed 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.611 1.165 . . . . 74.4 113.654 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -113.68 -84.48 1.29 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.551 -1.02 . . . . 62.55 110.551 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 107.438 -1.319 . . . . 64.23 107.438 178.092 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.445 -0.725 0 N-CA-C 109.883 -0.414 . . . . 75.42 109.883 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.6 m -96.22 108.9 21.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.562 -0.533 . . . . 75.32 109.562 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 t -143.08 -44.46 0.3 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.437 -0.949 . . . . 34.42 108.437 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 t -106.34 157.51 17.55 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.653 -1.61 . . . . 61.31 106.653 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -112.46 143.39 28.82 Favored Pre-proline 0 C--N 1.31 -1.111 0 C-N-CA 120.379 -0.528 . . . . 72.14 111.191 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -73.97 -33.94 5.64 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.181 1.92 . . . . 70.11 108.715 168.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -164.68 121.88 1.61 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 106.682 -1.599 . . . . 72.54 106.682 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.5 p -85.3 142.67 29.19 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.683 0.754 . . . . 74.22 112.278 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -106.91 155.7 19.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.518 -1.29 . . . . 72.25 107.518 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.421 ' HB2' HG12 ' A' ' 104' ' ' VAL . 91.3 m-20 -136.24 133.51 37.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.947 -1.501 . . . . 72.44 106.947 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 t -118.96 120.82 65.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 120.693 -0.403 . . . . 71.24 110.551 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 66' ' ' VAL . 62.2 t80 -85.34 113.49 21.69 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.536 -0.913 . . . . 72.03 108.536 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 m -121.65 160.23 23.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.91 -0.586 . . . . 52.52 110.792 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -132.55 118.45 19.24 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.402 -0.817 . . . . 74.31 109.186 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.501 ' H ' HD11 ' A' ' 18' ' ' LEU . . . 102.08 -71.2 0.34 Allowed Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.889 -0.596 . . . . 70.13 113.168 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -92.17 155.6 17.9 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 111.556 0.206 . . . . 71.55 111.556 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.596 HG21 HD13 ' A' ' 67' ' ' ILE . 25.1 mt 72.73 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 125.003 1.321 . . . . 64.32 111.166 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.501 HD11 ' H ' ' A' ' 15' ' ' GLY . 56.4 mt -66.09 -28.19 68.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.137 0.494 . . . . 44.4 110.11 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.22 129.24 44.23 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 115.24 -0.891 . . . . 71.33 108.965 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.65 -33.52 31.81 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.804 3.003 . . . . 72.3 112.993 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.4 80.81 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 120.85 0.357 . . . . 72.52 111.173 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 25' ' ' VAL . 60.6 t -73.73 -36.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.483 0.659 . . . . 64.52 109.647 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -67.45 -31.5 71.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.913 -0.773 . . . . 72.12 108.913 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.34 -3.88 39.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.133 -0.94 . . . . 74.25 111.903 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 22' ' ' VAL . 19.6 m -105.75 -34.4 3.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.528 -0.869 . . . . 72.24 110.476 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.547 HD13 ' CD1' ' A' ' 78' ' ' PHE . 5.1 tt -70.03 -41.03 79.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 121.023 0.439 . . . . 71.25 111.067 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 31' ' ' ALA . 81.7 mt -100.37 -17.65 17.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.614 -0.434 . . . . 70.42 110.7 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 34.2 t70 73.08 -2.77 2.62 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.9 1.334 . . . . 65.02 110.017 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.2 ttm105 -121.2 144.85 48.37 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.608 -1.997 . . . . 74.54 105.608 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.1 m -77.8 111.14 13.31 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.107 -0.637 . . . . 74.13 111.416 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . . . -93.51 143.75 26.0 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.011 -1.107 . . . . 65.1 108.011 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -98.05 125.42 43.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.867 0.692 . . . . 63.25 112.867 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.6 p -94.47 145.13 25.0 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.189 -0.914 . . . . 75.02 109.612 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.2 137.38 29.65 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 108.26 -1.015 . . . . 63.32 108.26 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 127.51 23.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.965 1.777 . . . . 71.53 111.363 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.78 154.96 39.3 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 116.21 -0.45 . . . . 55.43 110.3 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.24 127.48 75.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.389 0.614 . . . . 74.03 111.157 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.47 HD11 ' HB ' ' A' ' 91' ' ' VAL . 19.2 tp -88.04 119.69 28.66 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.66 -0.7 . . . . 64.1 109.768 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.469 -0.787 . . . . 70.41 110.918 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.02 59.63 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 119.516 -1.326 . . . . 72.42 113.441 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 64.3 m-85 -121.51 151.99 39.68 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 117.212 0.506 . . . . 72.31 110.752 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 12.4 t-160 -122.86 138.26 54.71 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.994 -0.548 . . . . 74.43 109.993 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.512 HH21 ' HB2' ' A' ' 125' ' ' GLU . 32.0 ptt180 -86.03 109.75 19.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.165 0.983 . . . . 64.22 108.985 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 118' ' ' TYR . 3.1 m-85 -74.62 154.72 38.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.701 -1.136 . . . . 73.42 112.781 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -87.69 -7.61 57.19 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.606 1.335 . . . . 74.33 114.606 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.2 pt? -72.29 73.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.601 0.963 . . . . 73.44 113.601 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 52' ' ' PRO . 54.6 pttt -72.83 1.19 9.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.816 1.414 . . . . 74.41 114.816 -175.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.66 -20.25 79.79 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 109.358 -1.497 . . . . 54.21 109.358 172.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.9 157.57 51.47 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 109.285 -0.635 . . . . 73.33 109.285 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.28 106.27 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.672 2.248 . . . . 73.12 114.368 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 45.84 69.54 2.54 Favored Pre-proline 0 N--CA 1.496 1.827 0 C-N-CA 124.469 1.108 . . . . 75.51 111.342 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 68.8 Cg_endo -110.88 153.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 124.108 3.205 . . . . 71.32 117.235 -167.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.484 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 72.9 m -155.15 163.03 40.78 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 130.012 3.325 . . . . 74.22 102.295 -17.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 43.7 pt -123.59 138.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 117.806 -1.557 . . . . 72.2 112.619 170.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' CE1' ' A' ' 44' ' ' TYR . 71.9 t -135.84 153.26 32.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.014 -1.847 . . . . 71.21 106.014 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 t -65.84 136.17 55.81 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 122.148 0.975 . . . . 72.4 112.295 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.6 t -156.42 104.53 2.21 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 103.717 -2.697 . . . . 73.51 103.717 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.77 -37.51 73.8 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 114.111 1.152 . . . . 71.13 114.111 -169.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -86.63 -0.06 55.46 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.306 -0.557 . . . . 71.14 111.985 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.79 146.76 16.18 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.761 -0.733 . . . . 71.21 111.549 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -140.44 152.74 45.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.139 -0.689 . . . . 72.25 109.139 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 41' ' ' TYR . 46.4 t -114.96 122.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.623 -0.51 . . . . 42.32 109.623 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -96.96 121.23 38.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.238 -0.652 . . . . 45.41 109.238 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.39 -143.44 3.7 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.003 -0.839 . . . . 54.13 111.003 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.468 ' HB2' HD22 ' A' ' 18' ' ' LEU . 55.5 mtpt -140.53 142.88 35.17 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.74 -0.837 . . . . 65.4 108.74 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.544 HG11 HG21 ' A' ' 93' ' ' VAL . 30.7 m -104.37 134.05 46.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 120.915 0.388 . . . . 63.01 110.722 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 17' ' ' ILE . 11.4 mt -86.44 110.27 19.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 104.67 -2.345 . . . . 74.45 104.67 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -101.58 162.72 12.7 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.27 0.47 . . . . 73.12 112.27 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.36 47.45 70.81 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.646 -0.706 . . . . 50.33 112.123 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.4 122.77 59.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.024 -0.732 . . . . 71.3 109.024 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 m -77.82 158.71 29.39 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.316 -0.954 . . . . 41.54 108.857 175.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -54.57 -35.94 63.84 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 112.172 0.434 . . . . 73.43 112.172 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.22 79.72 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.482 0.658 . . . . 70.31 110.587 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HB3' HD22 ' A' ' 27' ' ' LEU . 6.3 mm-40 -77.25 -37.23 53.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.331 -0.849 . . . . 62.43 109.921 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -33.47 71.04 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.986 -1.006 . . . . 72.4 109.697 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.06 -34.71 66.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.671 -1.149 . . . . 53.34 111.494 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.461 ' ND2' HG13 ' A' ' 26' ' ' ILE . 53.1 t30 -76.13 -29.77 57.93 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.113 -1.035 . . . . 64.42 109.856 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.695 ' O ' HG22 ' A' ' 81' ' ' ILE . 97.1 m-85 -66.06 -28.59 68.95 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.6 -0.727 . . . . 73.32 110.906 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.22 -31.63 71.26 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.591 -0.892 . . . . 73.34 108.591 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.21 -22.69 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 114.887 -1.051 . . . . 75.31 111.847 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 78' ' ' PHE . 11.7 tt -74.05 2.31 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 CA-C-O 121.842 0.829 . . . . 64.14 110.239 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.371 31.1 mm-40 88.63 126.95 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 117.539 2.422 . . . . 64.1 117.539 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.74 53.72 0.34 Allowed Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 106.883 -2.487 . . . . 64.44 106.883 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.59 -42.56 99.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.021 0.928 . . . . 64.13 113.011 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 110' ' ' VAL . 7.3 m-20 -100.12 16.3 24.57 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.756 0.789 . . . . 61.34 109.701 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.17 159.2 26.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.428 -0.806 . . . . 72.43 109.032 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 110' ' ' VAL . 12.5 pt-20 -127.88 157.91 39.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.417 -0.216 . . . . 63.23 110.417 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -85.15 113.05 21.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.18 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.31 159.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.447 -0.342 . . . . 63.23 110.485 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.411 HG22 ' HD2' ' A' ' 103' ' ' LYS . 12.7 m -106.41 122.47 46.34 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 108.902 -0.777 . . . . 73.34 108.902 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.47 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.3 m -128.01 161.9 35.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.946 -1.131 . . . . 74.04 107.946 -175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.516 ' HG3' ' CE ' ' A' ' 103' ' ' LYS . 1.2 mp0 -108.76 138.87 44.39 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.069 -1.452 . . . . 70.34 108.352 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 66' ' ' VAL . 26.2 m -126.51 161.1 33.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.983 -0.747 . . . . 44.13 108.983 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.576 HG22 ' HG3' ' A' ' 101' ' ' LYS . 75.5 t -104.79 116.85 49.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.693 -0.685 . . . . 74.54 110.083 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 15.5 ttm180 -68.13 110.79 4.14 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.948 -1.871 . . . . 61.2 105.948 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.32 -54.1 49.45 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 114.848 1.425 . . . . 73.41 114.848 -164.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.53 -12.8 61.21 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.235 1.198 . . . . 71.01 114.235 -172.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.1 -6.19 9.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.185 0.517 . . . . 72.53 110.705 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.2 m 61.46 25.93 15.78 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.148 0.579 . . . . 74.53 111.288 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 12.9 pt-20 -93.91 158.71 15.51 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 109.429 -0.582 . . . . 74.24 109.429 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.1 mptt -109.99 132.63 53.98 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.084 -0.71 . . . . 63.44 109.084 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.87 146.57 25.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.74 -0.467 . . . . 74.24 109.74 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.516 ' CE ' ' HG3' ' A' ' 92' ' ' GLU . 14.1 tppt? -91.6 132.77 36.08 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.622 -0.881 . . . . 74.44 108.622 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 10' ' ' ASN . 23.0 m -139.56 173.33 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.733 0.301 . . . . 74.41 110.847 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.79 148.78 24.88 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.598 -0.89 . . . . 74.22 108.598 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 t -153.39 175.18 13.42 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 109.16 -0.682 . . . . 71.53 109.16 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -107.19 118.61 37.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.67 -1.233 . . . . 70.04 107.67 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.32 162.6 10.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.196 -1.039 . . . . 73.01 108.196 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.559 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 33.6 t-105 -77.8 127.59 32.65 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.724 -0.843 . . . . 74.34 108.724 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 85' ' ' ASP . 26.9 m -69.81 -23.57 25.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 O-C-N 121.757 -0.589 . . . . 74.14 111.579 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.559 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -91.75 14.35 15.59 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.717 -0.674 . . . . 53.21 109.703 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.5 ptpp? -49.68 -18.81 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.352 1.461 . . . . 73.33 113.822 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.35 -39.53 76.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.921 -0.4 . . . . 73.31 109.921 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -114.2 124.07 31.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 N-CA-C 109.69 -0.485 . . . . 74.12 109.69 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.83 116.51 4.62 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.167 1.911 . . . . 53.23 109.565 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -86.98 113.66 22.94 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.31 -0.996 . . . . 65.13 108.31 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 69.89 -47.49 0.61 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.465 1.106 . . . . 72.42 113.0 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.643 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 69.1 t80 76.45 -61.72 0.44 Allowed 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 125.642 1.577 . . . . 72.31 107.908 -172.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 37.27 102.75 0.01 OUTLIER Glycine 0 C--N 1.339 0.702 0 O-C-N 125.761 1.913 . . . . 61.53 117.189 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -86.55 132.43 33.91 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 106.333 -1.728 . . . . 73.14 106.333 174.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -121.89 -29.76 4.23 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 113.362 0.875 . . . . 75.33 113.362 -170.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.505 ' OD2' ' HB3' ' A' ' 124' ' ' GLU . 30.5 t70 -97.68 130.32 44.68 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.897 -0.721 . . . . 73.15 110.742 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -68.83 -30.52 69.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.407 -0.36 . . . . 75.25 111.916 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.505 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 39.8 tt0 -70.56 -39.59 73.84 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.738 -1.208 . . . . 72.01 107.738 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.512 ' HB2' HH21 ' A' ' 43' ' ' ARG . 39.9 tt0 -58.13 -51.04 71.37 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.689 -1.141 . . . . 61.4 109.672 173.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -52.52 -46.63 66.79 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.802 -0.814 . . . . 74.22 108.802 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -60.5 -48.88 79.84 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.104 -0.953 . . . . 61.42 111.702 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 125' ' ' GLU . 24.7 m -73.91 -31.6 31.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 N-CA-C 112.682 0.623 . . . . 72.32 112.682 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 125' ' ' GLU . 84.4 t -67.48 -40.28 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.023 -0.732 . . . . 71.53 109.023 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.545 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 46.0 t60 -65.86 -42.88 89.88 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.644 -0.707 . . . . 72.32 109.189 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -62.59 -52.69 62.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.615 -0.266 . . . . 73.43 111.367 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 13.6 mm-40 -62.46 -31.69 72.45 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.378 -0.374 . . . . 73.32 111.407 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 3.4 tmtm? -59.64 -40.5 87.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.698 0.761 . . . . 75.52 109.645 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.545 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 82.7 m-85 -82.31 -36.13 27.28 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.593 -0.692 . . . . 53.52 110.857 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 131' ' ' ALA . 99.3 t -62.49 -44.8 99.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.445 -0.343 . . . . 72.53 111.254 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 11.2 pt-20 -60.27 -37.46 80.52 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 110.18 -0.304 . . . . 72.34 110.18 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -64.42 -44.43 91.24 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.734 -0.469 . . . . 73.4 109.734 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.08 -46.21 90.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.68 -0.489 . . . . 64.34 109.68 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.636 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 98.2 mtt180 -63.84 -49.26 73.51 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.566 -0.743 . . . . 74.41 112.681 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -60.4 -47.03 87.86 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.905 0.128 . . . . 74.44 110.82 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -63.38 -32.73 74.24 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.948 0.404 . . . . 63.21 110.053 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 139' ' ' ARG . 65.0 tp -62.62 -47.15 85.02 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.717 -0.674 . . . . 61.13 109.195 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.0 mt-10 -60.88 -46.99 88.44 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.427 0.454 . . . . 71.45 110.279 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -66.3 -36.9 84.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.768 0.655 . . . . 65.53 112.768 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.04 -28.23 29.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.047 0.451 . . . . 70.12 111.427 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 12.3 tmtt? -79.64 -32.28 41.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.447 -0.342 . . . . 74.22 110.194 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.4 HD21 ' HB3' ' A' ' 149' ' ' ASN . 30.8 t30 -69.88 118.75 66.24 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.258 -0.428 . . . . 71.43 111.06 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.13 -14.72 45.64 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.796 2.997 . . . . 72.22 113.188 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.4 ' HB3' HD21 ' A' ' 147' ' ' ASN . 27.7 t-20 -70.77 -25.16 62.77 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.997 0.427 . . . . 75.41 111.301 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.73 32.06 38.28 Favored Glycine 0 C--O 1.218 -0.883 0 N-CA-C 115.578 0.991 . . . . 51.33 115.578 172.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -79.66 127.64 32.42 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 118.138 0.969 . . . . 62.52 110.12 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.4 m -88.04 178.31 6.69 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.323 -0.399 . . . . 52.53 110.675 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.457 ' O ' HG12 ' A' ' 157' ' ' VAL . 26.9 ttt -64.24 -43.63 94.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.808 0.337 . . . . 72.53 110.664 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.68 -24.21 67.52 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.941 -0.572 . . . . 73.12 111.486 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -75.84 -44.51 40.57 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.46 0.647 . . . . 53.31 110.042 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.35 -25.08 62.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.267 -0.879 . . . . 73.1 112.996 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 153' ' ' MET . 14.7 p -128.09 141.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 120.43 -0.508 . . . . 63.33 110.062 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.23 93.91 1.0 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.713 -0.756 . . . . 64.52 111.221 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.3 t -94.15 146.07 24.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.889 -0.782 . . . . 72.44 108.889 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.74 108.78 15.56 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.934 -0.395 . . . . 73.41 109.934 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.4 tt -172.65 -46.91 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.328 -0.99 . . . . 63.45 108.328 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.7 t 68.45 78.93 0.22 Allowed 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.061 -0.972 . . . . 71.04 109.809 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.8 t -93.02 132.11 37.4 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.859 -1.064 . . . . 72.31 110.834 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.94 -134.36 2.02 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 109.365 -1.494 . . . . 75.1 109.365 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--N 1.295 -1.774 0 N-CA-C 108.793 -0.817 . . . . 71.54 108.793 177.904 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 109.316 -0.624 . . . . 71.42 109.316 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.2 p -127.88 147.94 50.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.292 -1.003 . . . . 73.45 108.292 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.0 t -84.75 82.64 8.34 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.844 -1.169 . . . . 72.14 107.844 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -178.68 -164.89 0.08 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.192 -2.521 . . . . 70.55 104.192 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 51.9 m-20 -84.37 120.76 74.81 Favored Pre-proline 0 C--N 1.313 -1.01 0 C-N-CA 119.523 -0.871 . . . . 70.42 110.819 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 5' ' ' ASP . 8.2 Cg_exo -74.91 -41.08 0.74 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.435 2.09 . . . . 51.0 112.652 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.22 -16.01 39.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.179 0.514 . . . . 52.52 110.774 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.4 m -121.03 173.67 7.12 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 121.49 0.662 . . . . 72.43 111.082 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -106.34 156.15 18.8 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 124.63 1.172 . . . . 75.2 109.25 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.539 HD22 HG22 ' A' ' 68' ' ' THR . 14.1 m120 -134.62 122.77 22.77 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.713 -1.958 . . . . 64.32 105.713 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.05 122.61 68.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.86 -0.736 . . . . 72.4 111.565 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' HB2' HG21 ' A' ' 104' ' ' VAL . 52.0 t80 -83.84 108.36 16.81 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.419 -1.326 . . . . 61.34 107.419 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.5 147.76 26.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.886 -0.725 . . . . 75.44 110.716 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' HA ' HD11 ' A' ' 18' ' ' LEU . 50.0 t80 -127.34 96.76 4.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.465 -2.05 . . . . 74.43 105.465 170.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.0 -145.84 11.05 Favored Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.069 -1.539 . . . . 63.11 114.453 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 m -43.8 -61.51 1.4 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 127.396 2.278 . . . . 74.44 116.926 -170.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.508 HG13 ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -89.06 17.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 114.16 1.17 . . . . 75.04 114.16 -167.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 65' ' ' LYS . 54.7 mt -73.38 -17.27 61.3 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 120.12 -0.632 . . . . 65.23 111.13 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.97 125.96 80.8 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.501 -0.772 . . . . 62.35 109.4 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -46.62 -38.08 21.42 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 124.258 3.305 . . . . 74.24 114.785 -174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -60.15 -64.46 0.94 Allowed 'General case' 0 C--O 1.217 -0.649 0 O-C-N 123.126 0.266 . . . . 71.24 110.379 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 41.9 t -55.88 -32.68 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 124.13 0.972 . . . . 73.13 111.19 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -65.42 -33.55 76.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.027 0.442 . . . . 54.45 111.394 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -80.94 -30.78 35.19 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 122.126 0.965 . . . . 75.03 108.648 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 22' ' ' VAL . 26.9 t -65.58 -33.85 66.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 125.26 1.424 . . . . 65.12 111.377 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.684 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tt -87.33 -42.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.733 0.642 . . . . 62.32 112.733 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 31' ' ' ALA . 87.8 mt -85.18 -30.15 24.16 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 112.188 0.44 . . . . 74.32 112.188 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 t70 81.78 1.75 1.47 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.245 1.418 . . . . 74.24 109.19 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 52.1 mtt180 -126.08 163.63 22.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.115 -1.439 . . . . 73.42 107.115 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -76.63 115.02 16.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.003 -0.74 . . . . 72.0 109.003 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -80.27 136.02 36.35 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.62 -0.718 . . . . 70.22 111.911 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.72 110.2 22.61 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.809 -0.757 . . . . 60.22 109.496 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.507 ' CG2' HG12 ' A' ' 67' ' ' ILE . 4.2 p -110.16 143.81 39.72 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.663 -0.699 . . . . 64.14 110.21 174.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -133.48 140.57 37.37 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 107.361 -1.348 . . . . 64.4 107.361 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 96' ' ' MET . 19.2 Cg_endo -60.62 137.18 71.82 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.68 1.586 . . . . 74.11 109.512 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.36 42.72 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.261 -0.644 . . . . 72.13 109.261 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.89 125.69 70.11 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 121.861 0.838 . . . . 73.35 111.543 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD11 ' HB ' ' A' ' 91' ' ' VAL . 22.8 tp -89.71 113.39 24.89 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 114.731 -1.122 . . . . 61.03 109.743 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -85.32 136.22 33.57 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.712 -0.847 . . . . 71.44 108.712 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 106.6 -23.38 28.33 Favored Glycine 0 C--O 1.203 -1.785 0 C-N-CA 118.965 -1.588 . . . . 63.24 112.666 174.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 62' ' ' VAL . 16.8 m-85 -101.59 143.37 31.65 Favored 'General case' 0 CA--C 1.456 -2.669 0 C-N-CA 119.718 -0.793 . . . . 63.13 110.928 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 3.7 t60 -112.31 135.08 53.43 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 115.285 -0.871 . . . . 75.21 109.26 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -87.2 112.22 21.77 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.7 -0.682 . . . . 71.01 109.792 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -105.76 126.58 52.33 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.757 -1.572 . . . . 70.41 106.757 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.543 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -85.12 -11.82 54.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.697 0.761 . . . . 73.15 109.612 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.636 HD12 ' SD ' ' A' ' 117' ' ' MET 0.282 2.6 mm? 72.79 -99.4 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 125.108 1.363 . . . . 73.42 112.723 -177.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt 171.49 -37.52 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.191 0.996 . . . . 71.21 110.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.51 4.26 3.67 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.069 -1.062 . . . . 64.23 112.718 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 6.3 mp -91.36 134.01 30.43 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 119.038 -1.065 . . . . 71.35 111.797 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.793 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 73.6 Cg_endo -74.69 103.36 1.7 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.462 2.775 . . . . 72.53 114.466 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.455 38.5 p90 71.23 1.49 0.0 OUTLIER Pre-proline 0 CA--C 1.608 3.196 0 N-CA-C 121.025 3.713 . . . . 72.2 121.025 176.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.793 ' HD3' ' C ' ' A' ' 50' ' ' PRO . 1.7 Cg_endo -88.41 169.45 5.93 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.862 2.375 . . . . 72.52 108.502 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 15.2 p -156.42 -176.32 5.91 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 127.568 2.347 . . . . 74.01 108.535 -3.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.556 HG21 HG21 ' A' ' 62' ' ' VAL . 46.0 pt -134.9 130.59 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 62.23 108.113 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.19 -175.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.133 -1.432 . . . . 61.24 107.133 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.2 m 69.83 -173.09 0.18 Allowed 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.323 1.014 . . . . 71.2 111.431 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 56.8 m -148.69 34.28 0.77 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.466 -0.568 . . . . 74.41 109.466 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -75.15 -166.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.73 -0.668 . . . . 74.04 111.905 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 m -75.49 -9.75 58.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.86 0.689 . . . . 75.53 112.86 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.85 160.0 45.47 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.018 -0.611 . . . . 64.5 112.846 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -136.67 159.33 42.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.544 -0.91 . . . . 62.43 108.544 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.556 HG21 HG21 ' A' ' 54' ' ' ILE . 49.1 t -126.25 128.02 71.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 110.088 -0.338 . . . . 74.42 110.088 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.79 122.06 42.2 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.746 -0.464 . . . . 65.15 109.746 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.51 -146.84 4.41 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 111.349 -0.7 . . . . 55.11 111.349 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.551 ' HB2' HD22 ' A' ' 18' ' ' LEU . 61.6 mtpt -138.96 139.96 38.11 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.79 -0.819 . . . . 72.43 108.79 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -104.23 132.24 51.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 119.782 -0.767 . . . . 73.01 109.954 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.507 HG12 ' CG2' ' A' ' 33' ' ' THR . 36.0 mt -90.15 117.48 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.302 -1.37 . . . . 64.02 107.302 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.539 HG22 HD22 ' A' ' 10' ' ' ASN . 81.2 p -103.04 162.07 13.25 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.155 0.428 . . . . 52.41 112.155 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.04 33.6 74.73 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.619 -0.719 . . . . 53.14 113.671 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.57 122.28 39.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 122.506 -0.408 . . . . 54.35 110.198 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -75.04 159.11 32.12 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.579 -0.896 . . . . 74.45 108.579 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.21 -42.35 81.13 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.363 0.602 . . . . 71.21 112.075 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.58 72.01 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.339 -0.846 . . . . 52.44 110.857 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -76.26 -32.99 59.15 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.586 -0.734 . . . . 74.41 109.172 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.59 -40.68 95.67 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.97 -1.014 . . . . 75.45 109.847 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.619 ' O ' HG23 ' A' ' 80' ' ' VAL . 27.2 t-20 -55.88 -30.49 61.61 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.801 -1.091 . . . . 64.14 111.644 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.684 ' ND2' HG13 ' A' ' 26' ' ' ILE . 64.6 t30 -69.5 -31.47 69.75 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 120.768 -0.373 . . . . 72.44 110.671 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.579 ' CD1' HD13 ' A' ' 26' ' ' ILE . 81.2 m-85 -72.06 -42.13 66.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.516 -0.92 . . . . 75.45 108.516 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.18 -35.2 78.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.114 -1.403 . . . . 71.44 110.291 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 76' ' ' ASN . 60.9 t -74.98 -23.84 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 112.859 0.688 . . . . 72.22 112.859 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 77' ' ' ASN . 46.2 mm -75.76 -84.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 119.308 -0.957 . . . . 75.44 112.42 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.07 10.88 32.0 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 121.657 -0.652 . . . . 72.01 112.548 178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.55 32.01 2.65 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.52 -0.848 . . . . 63.31 112.847 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -83.16 -39.99 20.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.961 0.41 . . . . 74.44 111.361 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.17 14.97 20.66 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.148 0.975 . . . . 62.12 108.635 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -123.81 156.85 35.36 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.423 -1.325 . . . . 63.55 107.423 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.431 ' HB3' HG23 ' A' ' 110' ' ' VAL . 14.0 pt-20 -126.71 155.2 43.06 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.737 -0.838 . . . . 74.12 108.737 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 106' ' ' THR . 49.0 mtm105 -94.84 107.69 19.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.481 0.548 . . . . 73.11 112.481 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.35 158.15 11.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.75 -0.659 . . . . 63.24 109.3 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.441 HG22 ' HD2' ' A' ' 103' ' ' LYS . 15.1 m -94.98 126.11 40.1 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.104 -0.702 . . . . 72.32 109.104 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.444 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.4 m -132.11 158.31 43.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.802 -1.184 . . . . 74.13 107.802 -177.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -113.96 129.74 56.58 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.454 -1.298 . . . . 72.14 108.605 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 38' ' ' LEU . 16.4 m -126.24 166.1 23.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.444 -0.576 . . . . 61.04 109.444 -174.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 96' ' ' MET . 73.0 t -99.76 124.79 53.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.598 -0.889 . . . . 74.33 108.598 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -68.24 5.12 1.04 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 125.558 1.543 . . . . 73.21 112.462 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.608 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.9 OUTLIER 51.5 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 127.004 2.122 . . . . 64.14 115.166 174.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.8 -43.09 80.57 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.779 0.832 . . . . 54.25 110.751 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.01 -8.84 24.76 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.448 -1.315 . . . . 64.12 107.448 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.7 m 62.63 12.36 5.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.742 1.217 . . . . 75.42 113.888 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.81 161.95 15.05 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.4 -0.592 . . . . 61.31 109.4 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 94' ' ' VAL . 89.3 mttt -96.89 129.68 44.3 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.701 -0.852 . . . . 63.43 108.701 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.14 130.04 69.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 121.256 0.55 . . . . 74.01 110.93 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HD2' HG22 ' A' ' 90' ' ' THR . 5.6 tppp? -86.95 119.75 27.49 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.076 -1.083 . . . . 73.13 108.076 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 10' ' ' ASN . 30.9 m -135.47 174.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.122 -0.49 . . . . 61.21 110.589 -173.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.14 153.7 19.36 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.442 -0.948 . . . . 53.01 108.442 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 14.7 t -146.58 173.43 12.33 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.634 -0.876 . . . . 61.34 108.634 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -107.91 118.19 36.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.174 0.511 . . . . 74.55 110.02 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 54' ' ' ILE . 27.3 m -110.23 168.74 4.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.417 -0.957 . . . . 43.14 108.417 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 53' ' ' CYS . 32.1 t-105 -83.14 119.62 24.75 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.997 -0.742 . . . . 75.11 108.997 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 87' ' ' GLU . 2.2 p -68.65 -20.44 25.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.396 -0.82 . . . . 51.31 111.48 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 34.9 m-80 -84.95 13.52 5.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.173 1.389 . . . . 41.42 111.425 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -51.49 -27.66 11.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.541 1.136 . . . . 61.43 113.04 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -78.09 -15.46 58.86 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 120.865 0.364 . . . . 64.21 111.373 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.51 138.57 26.75 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 107.089 -1.449 . . . . 64.52 107.089 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -40.15 108.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.683 2.922 . . . . 75.43 112.664 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -95.47 162.47 13.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.039 -0.528 . . . . 75.21 110.471 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.636 ' SD ' HD12 ' A' ' 46' ' ' LEU . 1.3 mpt? -73.58 95.91 2.36 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 105.692 -1.966 . . . . 73.4 105.692 171.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -92.67 -32.19 14.83 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 116.043 -0.526 . . . . 75.23 110.76 -171.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.543 ' HA3' ' CD1' ' A' ' 126' ' ' TRP . . . -148.49 43.27 0.81 Allowed Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 119.345 -1.407 . . . . 63.1 113.336 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.9 165.75 15.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.622 -0.831 . . . . 72.33 109.926 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 78.3 m95 74.8 -39.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.752 1.221 . . . . 74.41 112.769 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -125.35 112.49 16.4 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.284 -0.636 . . . . 71.45 109.284 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -69.74 -40.82 75.96 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.527 -0.76 . . . . 74.23 113.037 -176.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -32.95 65.31 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.373 -0.531 . . . . 74.42 110.963 -173.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.58 -39.82 88.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.091 -0.707 . . . . 65.41 109.091 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.543 ' CD1' ' HA3' ' A' ' 119' ' ' GLY . 29.0 t90 -62.59 -48.28 80.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.665 -0.698 . . . . 74.54 110.108 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -59.06 -47.91 83.52 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 116.005 -0.543 . . . . 71.22 111.991 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.8 m -69.29 -40.44 80.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.461 -0.495 . . . . 70.1 112.29 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.04 -28.33 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.588 -0.445 . . . . 74.23 110.535 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.471 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 14.2 t60 -55.66 -47.05 77.34 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.905 -0.776 . . . . 73.12 108.905 174.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.91 98.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.66 -0.7 . . . . 74.11 110.919 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -67.37 -40.83 85.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.116 -0.493 . . . . 52.21 111.407 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.617 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -67.07 -53.5 30.38 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 108.383 -0.969 . . . . 65.31 108.383 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 77.2 m-85 -63.17 -31.44 72.59 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.904 1.446 . . . . 73.02 114.904 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.27 -34.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 119.117 -1.033 . . . . 52.52 109.508 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.414 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 1.6 tm-20 -69.34 -34.67 74.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.227 1.011 . . . . 73.23 109.028 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.3 m -57.62 -44.02 85.21 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.332 -0.618 . . . . 61.54 109.332 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.462 ' O ' ' HG3' ' A' ' 141' ' ' MET . 79.4 t80 -66.19 -36.31 82.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.764 -0.653 . . . . 70.43 109.266 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.566 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 81.2 mtp180 -60.94 -52.52 64.67 Favored 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.155 -0.475 . . . . 53.4 109.795 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.546 ' HE3' ' OE1' ' A' ' 155' ' ' GLU . 46.3 mmtm -56.03 -39.23 71.65 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.224 0.824 . . . . 73.32 113.224 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 3.3 ppp? -67.47 -31.79 72.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.968 -0.693 . . . . 71.43 110.001 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.2 tp -76.54 -41.71 45.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.527 -0.76 . . . . 75.14 109.622 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 12.4 mm-40 -59.54 -46.84 87.7 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.605 -0.517 . . . . 73.41 109.605 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -64.92 -36.63 85.0 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.285 -0.871 . . . . 74.33 112.027 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -82.17 -38.64 24.36 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.989 0.424 . . . . 75.42 111.438 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -79.48 -31.61 42.39 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.65 0.262 . . . . 65.55 110.508 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -124.7 82.85 59.41 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-O 120.863 0.363 . . . . 54.44 110.213 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.401 ' O ' ' HE3' ' A' ' 151' ' ' LYS . 13.9 Cg_exo -72.76 -24.18 18.44 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.81 2.34 . . . . 74.33 112.563 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -96.84 -15.97 21.0 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.372 0.606 . . . . 75.43 109.957 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.36 -3.69 78.18 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.407 -0.815 . . . . 74.35 113.384 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.603 ' O ' ' HD2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -75.27 132.03 40.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.219 0.533 . . . . 75.22 111.91 178.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.45 ' HB2' ' HG2' ' A' ' 155' ' ' GLU . 50.6 m -101.11 177.94 4.8 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.147 -0.478 . . . . 72.5 111.991 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 66.9 mtt -56.56 -36.61 69.51 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.718 1.007 . . . . 45.54 113.718 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -99.63 -18.9 17.09 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.12 -1.067 . . . . 74.13 108.12 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.546 ' OE1' ' HE3' ' A' ' 140' ' ' LYS . 23.1 mm-40 -73.85 -52.32 13.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.275 0.559 . . . . 71.22 109.667 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.84 -25.53 37.66 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.322 -0.854 . . . . 70.42 109.807 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.7 t 65.54 92.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 113.973 -1.467 . . . . 74.1 111.368 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -128.27 -94.33 0.8 Allowed Glycine 0 C--N 1.297 -1.632 0 CA-C-N 114.627 -1.17 . . . . 74.43 110.413 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.6 p -76.66 96.88 4.28 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.213 -0.662 . . . . 60.43 109.213 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.4 tp -155.46 158.8 39.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.124 -1.806 . . . . 74.44 106.124 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.04 90.75 7.5 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.277 -0.569 . . . . 63.15 112.012 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.8 p -77.79 124.1 27.54 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.033 -1.099 . . . . 51.41 108.033 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 46.7 p -148.98 167.85 24.68 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.089 0.471 . . . . 62.34 111.694 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -149.81 -173.15 19.96 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 109.755 -1.338 . . . . 64.33 109.755 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 C--N 1.294 -1.811 0 N-CA-C 109.854 -0.424 . . . . 73.32 109.854 179.137 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 109.544 -0.539 . . . . 74.32 109.544 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p 44.87 -90.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.343 1.238 . . . . 52.31 114.343 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 p -138.43 117.61 12.66 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 115.897 -0.592 . . . . 74.31 109.537 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.5 p -77.16 101.3 6.1 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.397 -0.964 . . . . 72.35 108.397 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -57.72 108.79 1.39 Allowed Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 123.716 0.635 . . . . 73.12 109.662 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -89.21 -3.94 5.97 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.607 2.204 . . . . 64.42 112.251 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -162.9 -173.93 3.69 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 106.466 -1.679 . . . . 74.21 106.466 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m 68.45 179.78 0.23 Allowed 'General case' 0 C--N 1.31 -1.11 0 O-C-N 124.6 1.188 . . . . 73.12 111.939 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.505 ' CG ' HD12 ' A' ' 75' ' ' LEU . 75.5 m80 -126.89 155.42 43.03 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 115.222 -0.899 . . . . 73.54 110.171 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.1 m-20 -127.5 129.5 47.51 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.789 -1.56 . . . . 71.14 106.789 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.69 128.06 59.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.436 0.532 . . . . 74.53 112.436 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -82.01 108.24 15.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.044 -1.465 . . . . 75.25 107.044 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.29 123.16 68.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.422 0.63 . . . . 72.14 110.635 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -96.69 107.21 19.62 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.383 -1.34 . . . . 64.01 107.383 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' A' ' 18' ' ' LEU . . . 75.59 -138.02 22.55 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.782 -0.927 . . . . 50.2 110.782 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.8 m 60.43 -80.77 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.159 1.17 . . . . 74.04 114.159 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 67' ' ' ILE . 32.6 pt -120.03 18.13 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 112.391 0.515 . . . . 74.44 112.391 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 64.1 mt -60.33 -21.91 62.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.429 0.633 . . . . 45.41 109.834 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.88 118.31 71.61 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.347 -1.353 . . . . 63.15 107.347 170.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -48.37 -36.46 30.39 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.961 3.107 . . . . 75.31 113.836 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.93 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 35.03 111.849 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.591 ' O ' HG22 ' A' ' 25' ' ' VAL . 13.0 t -77.86 -32.61 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.515 0.674 . . . . 64.02 109.797 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.18 -33.34 74.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.62 0.724 . . . . 62.13 109.118 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -75.46 -16.13 60.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.252 -0.886 . . . . 72.53 111.65 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 22' ' ' VAL . 13.1 m -89.01 -30.03 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 118.89 -1.124 . . . . 71.13 110.44 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.524 HG21 HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -81.57 -48.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 121.023 -0.271 . . . . 73.25 110.919 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.78 -16.59 25.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 120.808 0.337 . . . . 62.12 111.299 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 72.01 6.59 5.63 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.904 1.335 . . . . 61.13 109.999 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -141.97 169.28 17.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.32 -1.363 . . . . 61.4 107.32 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -76.43 128.46 34.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.891 -0.781 . . . . 74.35 108.891 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.25 137.81 41.46 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.711 0.291 . . . . 61.13 110.325 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -98.33 109.91 22.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.943 -1.132 . . . . 54.34 107.943 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.0 p -115.14 146.18 41.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.513 -0.767 . . . . 63.3 111.466 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.71 145.73 50.55 Favored Pre-proline 0 C--N 1.286 -2.162 0 N-CA-C 106.724 -1.584 . . . . 75.52 106.724 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.91 140.84 51.66 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.12 1.213 . . . . 74.14 110.243 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.68 156.44 41.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.051 -0.522 . . . . 53.41 109.808 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 7.3 p -122.93 123.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 121.628 0.728 . . . . 73.41 111.452 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.44 ' HA ' HG12 ' A' ' 93' ' ' VAL . 23.1 tp -87.64 93.23 9.37 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.316 -0.856 . . . . 73.42 110.219 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.428 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 26.3 p80 -68.64 134.85 50.51 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.485 -1.234 . . . . 72.01 107.771 174.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 115.74 -29.85 6.96 Favored Glycine 0 C--N 1.29 -2.015 0 C-N-CA 118.618 -1.753 . . . . 71.01 112.35 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.543 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 58.9 m-85 -109.56 166.55 10.81 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 112.014 0.376 . . . . 71.12 112.014 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.522 ' NE2' ' HB2' ' A' ' 56' ' ' SER . 0.1 OUTLIER -155.14 139.29 16.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.756 -0.656 . . . . 71.21 111.707 -177.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.806 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 67.0 ttt180 -87.48 138.99 31.0 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.441 1.088 . . . . 74.54 112.792 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.628 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 6.8 m-85 -104.69 158.77 16.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.677 -1.147 . . . . 74.52 109.575 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.56 ' H ' ' HD3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.78 -44.92 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.795 1.035 . . . . 72.44 113.795 -174.505 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.57 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 3.1 mm? 60.63 -179.34 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.991 0.517 . . . . 51.12 111.678 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.07 -71.45 0.68 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.088 0.47 . . . . 44.43 109.86 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.57 20.12 50.08 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.325 -0.941 . . . . 72.33 114.209 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 52' ' ' PRO . 2.8 mm? -101.9 151.03 37.9 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.749 -0.834 . . . . 74.42 108.749 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.4 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 123.015 2.476 . . . . 61.11 114.823 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -134.09 73.39 70.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 122.004 0.907 . . . . 73.22 112.507 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.679 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 20.7 Cg_endo -108.45 167.48 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.995 3.797 . . . . 52.44 112.501 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.806 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 20.2 p -156.18 162.4 40.2 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 127.882 2.473 . . . . 71.21 106.145 -8.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 41.7 pt -123.33 121.46 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.354 0 CA-C-N 119.57 1.077 . . . . 74.03 110.265 170.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.581 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 33.7 m -149.59 -173.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.312 -0.858 . . . . 73.44 110.423 -173.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.522 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 37.7 m 69.44 -161.18 0.17 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 124.626 1.204 . . . . 73.24 111.553 174.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -105.65 -172.66 2.13 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 120.911 0.386 . . . . 60.33 111.252 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 8.8 m-20 -68.02 36.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.413 1.885 . . . . 70.44 115.764 -169.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -79.53 -11.48 59.89 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.188 -0.945 . . . . 71.21 112.536 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.13 -169.99 15.68 Favored Glycine 0 CA--C 1.488 -1.63 0 C-N-CA 119.928 -1.13 . . . . 40.12 112.569 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 33.0 mtmt -145.32 152.61 40.18 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.708 -1.219 . . . . 72.24 107.708 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.49 HG21 HG21 ' A' ' 54' ' ' ILE . 48.7 t -122.2 123.18 68.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 110.177 -0.305 . . . . 75.23 110.177 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 3.8 p-10 -95.41 129.37 42.59 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.373 -0.931 . . . . 64.31 109.967 177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.1 -142.32 3.48 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 111.019 -0.833 . . . . 70.22 111.019 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -138.79 136.85 36.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.008 0.523 . . . . 70.31 111.524 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.45 133.67 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.697 -0.683 . . . . 70.41 109.842 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.677 ' CD1' HD11 ' A' ' 17' ' ' ILE . 32.6 mt -88.62 131.06 37.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.443 -1.688 . . . . 64.44 106.443 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -110.73 160.97 16.23 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.927 -0.709 . . . . 70.24 110.477 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.34 36.77 63.17 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.077 -0.582 . . . . 65.4 112.797 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -95.65 122.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.427 -0.455 . . . . 73.03 109.863 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.486 ' OG ' ' HG2' ' A' ' 74' ' ' GLU . 80.3 p -76.91 173.18 12.04 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 121.494 -0.754 . . . . 70.23 109.497 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.44 -29.56 70.25 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.87 0.367 . . . . 72.15 110.298 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.42 -41.27 40.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 71.25 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.486 ' HG2' ' OG ' ' A' ' 71' ' ' SER . 9.5 mm-40 -69.34 -36.49 76.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 75.53 110.194 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.505 HD12 ' CG ' ' A' ' 9' ' ' HIS . 2.3 tt -63.34 -37.86 88.91 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.28 -1.007 . . . . 64.22 108.28 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 80' ' ' VAL . 51.8 t30 -54.83 -31.19 59.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.636 -1.166 . . . . 72.4 111.567 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.511 ' OD1' HG12 ' A' ' 26' ' ' ILE . 23.3 t-20 -75.21 -32.42 61.17 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.519 -0.873 . . . . 73.32 109.826 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HE1' HD13 ' A' ' 17' ' ' ILE . 57.7 m-85 -64.52 -36.17 83.32 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.068 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.57 -33.03 73.37 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.632 -0.713 . . . . 73.04 110.253 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 76' ' ' ASN . 99.6 t -69.16 -37.64 76.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.846 -0.615 . . . . 74.23 110.435 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.6 mt -57.79 -68.49 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 116.135 -0.484 . . . . 63.14 111.095 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 21.0 mm-40 -110.54 103.4 12.0 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.482 0.658 . . . . 74.24 112.591 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 86' ' ' TYR . . . -150.64 11.79 0.85 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 115.045 -0.979 . . . . 72.33 111.695 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -75.17 -44.12 48.47 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.725 -0.472 . . . . 63.4 109.725 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 3.9 t70 -136.97 14.17 3.09 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.665 1.222 . . . . 63.21 107.786 175.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 21.1 m-85 -113.82 145.46 41.4 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.396 -1.275 . . . . 75.52 109.462 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.72 151.89 47.55 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.612 -0.884 . . . . 75.33 108.612 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -91.14 125.37 35.9 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.718 0.294 . . . . 74.32 111.038 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.66 159.6 34.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 116.013 -0.54 . . . . 72.31 110.559 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.28 129.8 39.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.638 -1.245 . . . . 73.44 107.638 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.411 ' HB ' HD11 ' A' ' 38' ' ' LEU . 30.6 m -128.65 169.13 20.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 108.628 -0.878 . . . . 63.41 108.628 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -118.72 124.55 47.59 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.28 -1.378 . . . . 74.11 107.28 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 38' ' ' LEU . 17.4 m -127.33 168.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.37 0.605 . . . . 71.3 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 101' ' ' LYS . 69.5 t -102.41 117.58 47.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.739 -0.664 . . . . 73.34 109.474 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -74.69 88.26 2.21 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.5 -1.667 . . . . 62.31 106.5 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -50.26 -35.91 29.02 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.168 1.787 . . . . 71.12 112.701 -170.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.86 -31.4 39.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.908 0.755 . . . . 74.11 111.811 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -127.83 -1.29 5.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 120.282 -0.567 . . . . 61.02 110.746 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.5 t 69.13 16.71 8.56 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.802 0.841 . . . . 74.42 111.517 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.3 160.01 15.72 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 109.341 -0.614 . . . . 61.25 109.341 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.666 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.4 mptt -101.63 134.02 45.41 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 108.787 -0.82 . . . . 73.54 108.787 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.91 140.99 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.279 0.561 . . . . 64.34 111.047 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.84 125.52 34.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.628 -1.249 . . . . 63.23 107.628 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.29 176.09 8.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 C-N-CA 122.608 0.363 . . . . 70.53 111.171 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -99.59 153.55 18.97 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.355 -0.98 . . . . 73.05 108.355 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -159.56 177.07 11.29 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 117.951 0.341 . . . . 70.21 110.164 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 82' ' ' GLU . 81.6 m-85 -105.57 121.36 43.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.268 -1.012 . . . . 54.33 108.268 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.68 165.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 109.053 -0.721 . . . . 74.32 109.053 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.663 ' CD1' ' HB2' ' A' ' 111' ' ' ASN . 61.8 t-105 -97.4 129.65 44.61 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 107.682 -1.229 . . . . 73.33 107.682 -169.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.0 -20.21 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.569 . . . . 74.2 112.298 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.663 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 26.5 m-80 -77.77 15.6 0.82 Allowed 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 124.1 0.96 . . . . 72.23 110.837 171.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 19.3 ptpt -49.28 -21.0 0.73 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.711 1.204 . . . . 74.45 113.484 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.485 ' O ' HD21 ' A' ' 160' ' ' LEU . 4.7 t70 -124.02 94.28 4.17 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 104.005 -2.591 . . . . 71.12 104.005 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.4 p-10 -120.5 158.83 50.36 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 113.888 -1.505 . . . . 73.05 111.767 -172.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -106.65 12.05 0.16 Allowed 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.806 2.337 . . . . 75.33 111.881 170.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -134.26 133.15 40.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.359 0.874 . . . . 71.01 113.359 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.57 ' SD ' ' HA ' ' A' ' 46' ' ' LEU . 57.6 mtt 60.96 28.62 18.4 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.738 0.815 . . . . 74.03 111.306 174.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -70.74 27.95 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 115.267 1.581 . . . . 74.31 115.267 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 126' ' ' TRP . . . -138.65 137.79 8.97 Favored Glycine 0 C--N 1.279 -2.617 0 C-N-CA 121.113 -0.565 . . . . 61.33 112.816 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.79 -178.86 6.15 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.152 0.581 . . . . 72.35 110.68 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -67.57 -34.58 77.33 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.231 0.456 . . . . 75.21 112.231 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.71 112.03 19.19 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.419 0.628 . . . . 64.55 111.349 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -68.2 -32.05 72.0 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.997 -1.002 . . . . 64.13 111.576 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.99 -40.82 98.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.414 0.626 . . . . 74.23 109.956 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.1 tt0 -78.12 -41.76 34.03 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.944 -1.026 . . . . 75.44 109.734 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.437 ' CE2' ' HA3' ' A' ' 119' ' ' GLY . 9.6 t90 -55.91 -28.5 57.06 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.231 0.538 . . . . 73.33 110.012 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -58.0 -47.47 82.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.1 -0.5 . . . . 55.31 110.835 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 125' ' ' GLU . 20.0 m -81.86 -22.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.337 0.589 . . . . 71.22 110.133 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 125' ' ' GLU . 99.3 t -68.05 -34.4 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.697 -0.683 . . . . 63.24 109.835 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -55.54 -34.51 64.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.123 -0.489 . . . . 73.53 111.837 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.94 -55.11 9.08 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 121.02 -0.272 . . . . 73.32 111.178 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.565 ' HA ' HG12 ' A' ' 135' ' ' VAL . 9.5 pt-20 -66.84 -37.9 85.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 113.133 0.79 . . . . 55.32 113.133 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.569 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -59.29 -47.12 86.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.424 -0.353 . . . . 73.11 111.147 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -81.72 -37.58 27.08 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 112.573 0.583 . . . . 62.45 112.573 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 132' ' ' GLU . 15.0 p -62.75 -41.64 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 119.625 -0.83 . . . . 52.22 111.226 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 29.4 mm-40 -58.81 -44.14 90.75 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 123.018 0.199 . . . . 74.52 110.919 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.9 m -54.1 -48.64 70.49 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 123.661 0.6 . . . . 73.51 110.761 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.33 -36.87 85.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.747 0.308 . . . . 74.54 111.288 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.7 mtp180 -66.68 -43.6 84.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 73.2 110.494 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.1 -40.6 71.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.932 -0.576 . . . . 71.13 111.725 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.4 mtm -66.82 -31.41 72.01 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.602 -0.439 . . . . 70.23 110.819 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.05 -43.94 97.75 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.654 -0.869 . . . . 62.4 108.654 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 149' ' ' ASN . 12.6 mm-40 -62.41 -30.21 71.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.639 . . . . 70.41 111.004 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.65 ' CG ' ' HB1' ' A' ' 156' ' ' ALA . 46.5 m0 -75.39 -38.92 59.68 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.839 -0.619 . . . . 74.2 112.477 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -77.75 -43.31 31.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.796 0.331 . . . . 72.14 111.677 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.521 ' C ' ' HD3' ' A' ' 148' ' ' PRO . 88.0 tttt -79.23 -17.03 55.58 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.292 -0.413 . . . . 74.14 111.438 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.583 ' N ' ' HD3' ' A' ' 148' ' ' PRO . 3.5 t-20 75.7 16.59 0.0 OUTLIER Pre-proline 0 CA--C 1.609 3.224 0 N-CA-C 115.394 1.627 . . . . 73.24 115.394 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 147' ' ' ASN . 6.9 Cg_exo -73.85 -16.57 23.29 Favored 'Trans proline' 0 C--N 1.4 3.247 0 CA-C-N 122.795 2.034 . . . . 55.13 110.958 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 143' ' ' GLU . 26.6 t-20 -73.81 -22.71 59.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.528 -0.76 . . . . 74.13 110.212 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.89 -47.46 1.04 Allowed Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.774 -0.727 . . . . 61.32 112.051 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -70.34 135.0 48.46 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 109.618 -0.512 . . . . 73.21 109.618 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 21.7 m -69.29 167.14 17.0 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.092 -0.707 . . . . 75.12 109.092 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.544 ' O ' HG23 ' A' ' 157' ' ' VAL . 27.9 ttt -54.1 -43.85 70.76 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.295 1.22 . . . . 34.4 114.295 -172.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 154' ' ' GLU . 0.1 OUTLIER -77.06 -30.67 55.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.125 -0.63 . . . . 63.1 110.915 -177.184 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.84 -32.99 70.2 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.094 0.949 . . . . 71.21 108.99 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.65 ' HB1' ' CG ' ' A' ' 144' ' ' TRP . . . -77.96 -24.72 48.04 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.987 -1.461 . . . . 70.32 112.375 -177.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 153' ' ' MET . 99.2 t -53.23 109.48 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.409 0.624 . . . . 74.12 112.108 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -117.61 -170.83 15.29 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.957 -1.657 . . . . 31.43 108.957 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.3 m -86.71 88.99 7.79 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 118.046 0.923 . . . . 72.35 111.479 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 113' ' ' ASP . 67.1 mt -154.21 -58.55 0.12 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.568 0.747 . . . . 71.44 111.465 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.1 tp -74.42 -8.1 55.16 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.047 -0.524 . . . . 64.15 111.38 -176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 56.6 m 68.09 78.05 0.24 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.25 1.02 . . . . 44.13 110.86 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 30.2 t -171.86 -175.06 1.44 Allowed 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.404 -1.702 . . . . 65.23 106.404 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -177.12 -47.56 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.719 0 N-CA-C 110.706 -0.958 . . . . 53.02 110.706 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 C--N 1.301 -1.524 0 CA-C-N 115.226 -0.487 . . . . 71.22 109.74 178.182 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.239 0.54 0 N-CA-C 109.187 -0.672 . . . . 73.22 109.187 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.3 m -137.46 96.67 3.3 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.346 -1.724 . . . . 63.31 106.346 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.5 m -134.21 151.87 51.54 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.23 -0.441 . . . . 63.22 111.56 -174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.8 t 67.94 14.39 9.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.296 1.038 . . . . 55.33 110.003 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 54.8 84.24 0.21 Allowed Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 124.922 1.289 . . . . 75.21 112.763 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.84 118.89 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.11 1.873 . . . . 64.41 108.325 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -137.57 127.56 25.79 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 120.996 0.427 . . . . 71.14 111.234 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.5 m -66.26 119.68 11.94 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.502 -1.295 . . . . 44.3 107.502 173.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -87.54 156.1 19.68 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.445 -0.798 . . . . 71.2 112.976 -173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -133.63 125.03 27.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.624 -1.625 . . . . 71.41 107.241 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 49.7 t -119.25 120.51 63.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.68 -0.408 . . . . 75.41 110.548 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.73 121.25 23.78 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.283 -1.747 . . . . 70.41 106.283 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HB ' HD11 ' A' ' 67' ' ' ILE . 13.0 p -113.2 138.81 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 C-N-CA 118.858 -1.137 . . . . 73.14 112.206 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.4 -36.68 68.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.969 -1.468 . . . . 74.03 110.471 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 13' ' ' VAL . . . 179.45 -175.13 46.81 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.794 -0.922 . . . . 61.15 110.794 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m 69.88 -65.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.304 1.041 . . . . 62.14 113.561 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.628 HG21 HD13 ' A' ' 67' ' ' ILE . 45.9 mt -68.81 -8.75 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.677 0.751 . . . . 72.43 110.223 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.06 -29.12 69.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.852 -0.796 . . . . 61.44 108.852 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.36 114.22 58.62 Favored Pre-proline 0 N--CA 1.418 -2.033 0 N-CA-C 107.86 -1.163 . . . . 74.4 107.86 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.47 -28.39 8.64 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 124.808 3.672 . . . . 74.33 115.739 -174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -71.07 -29.78 65.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 63.51 110.955 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 25' ' ' VAL . 63.0 t -76.72 -36.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.4 -0.593 . . . . 62.53 109.4 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.62 76.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.819 -0.808 . . . . 63.12 108.819 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.13 -17.72 61.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.256 -0.884 . . . . 74.21 111.894 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 22' ' ' VAL . 21.4 m -91.54 -25.4 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.191 -1.004 . . . . 74.42 110.831 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.507 HD13 ' CD1' ' A' ' 78' ' ' PHE . 11.2 tt -87.03 -45.3 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 120.054 -0.658 . . . . 64.41 112.123 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 31' ' ' ALA . 89.7 mt -89.08 -18.4 27.33 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.996 -0.44 . . . . 64.41 110.434 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.0 t70 71.28 10.8 6.74 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.929 1.347 . . . . 71.13 108.526 -171.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -143.45 145.15 32.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.673 -1.603 . . . . 73.13 106.673 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.7 m -80.23 116.98 20.62 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 120.682 0.277 . . . . 63.25 110.291 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 27' ' ' LEU . . . -95.65 156.46 16.31 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.646 -0.501 . . . . 61.14 109.646 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.26 125.43 44.88 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.977 -0.556 . . . . 73.44 110.317 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -94.45 143.29 26.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.887 -0.783 . . . . 63.2 108.887 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.96 138.7 33.68 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.129 -0.693 . . . . 74.24 109.129 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.82 129.81 37.01 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.322 2.681 . . . . 65.31 113.063 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -150.52 157.08 42.6 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.467 -0.788 . . . . 70.3 110.218 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.1 126.77 72.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.518 0.675 . . . . 62.54 111.71 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.461 HD11 ' HB ' ' A' ' 91' ' ' VAL . 21.7 tp -89.69 95.35 10.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.339 -0.846 . . . . 74.53 112.188 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 7.0 p-80 -70.33 128.54 36.56 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.058 -0.974 . . . . 73.52 111.568 174.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.28 -19.72 11.61 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 120.291 -0.957 . . . . 74.42 112.34 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.491 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 61.5 m-85 -114.79 158.76 21.45 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 113.015 0.746 . . . . 74.23 113.015 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.423 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 3.3 t-160 -128.02 124.4 37.06 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.53 -1.285 . . . . 74.44 107.53 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.423 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 10.6 ptm180 -91.88 144.39 25.53 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.838 -0.43 . . . . 72.13 109.838 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.78 176.54 5.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.949 0.404 . . . . 74.32 111.126 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -91.76 100.28 13.01 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.285 0.564 . . . . 74.41 109.702 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.418 HD12 HD13 ' A' ' 49' ' ' LEU . 4.0 mm? -94.68 118.61 32.0 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.631 0.729 . . . . 73.15 110.544 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -93.7 -43.96 8.39 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.775 -1.102 . . . . 74.35 108.713 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.14 -25.99 32.38 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.719 -1.128 . . . . 63.22 113.149 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.418 HD13 HD12 ' A' ' 46' ' ' LEU . 7.2 mp -92.27 132.71 31.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.415 -0.462 . . . . 65.43 110.868 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 57.4 Cg_endo -85.12 -20.8 3.3 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.466 2.777 . . . . 73.54 112.859 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.652 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 51.9 p90 -139.49 175.85 2.97 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 104.668 -2.345 . . . . 74.02 104.668 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.329 0.0 OUTLIER 31.43 169.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.595 3.55 0 C-N-CA 124.002 3.135 . . . . 71.41 119.795 -162.701 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 24.6 p -131.52 160.85 34.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.563 -1.336 . . . . 71.21 113.069 9.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 22.1 pt -122.92 137.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.92 -1.491 . . . . 73.33 107.863 174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.36 151.78 34.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 106.141 -1.8 . . . . 53.21 106.141 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m -65.6 140.95 58.57 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.242 1.201 . . . . 65.44 114.242 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m -155.99 102.86 2.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.222 -2.14 . . . . 65.13 105.222 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.23 -31.83 65.91 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.258 0.836 . . . . 65.31 113.258 -172.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -87.52 -0.81 57.36 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.682 0.253 . . . . 72.3 111.682 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.86 168.11 12.96 Favored Glycine 0 C--O 1.238 0.372 0 C-N-CA 120.371 -0.919 . . . . 63.31 113.134 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 18.5 ptpt -150.05 154.68 38.55 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 110.049 -0.352 . . . . 73.42 110.049 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.0 123.4 69.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.801 -0.444 . . . . 74.11 109.801 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -96.63 128.49 43.62 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.791 -0.763 . . . . 74.35 109.512 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.07 -141.03 3.07 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 109.887 -1.285 . . . . 54.33 109.887 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 49.6 mtpt -141.1 150.71 43.23 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.873 -0.788 . . . . 63.31 108.873 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . 28.7 m -104.11 134.16 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.123 -0.49 . . . . 64.33 110.094 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.628 HD13 HG21 ' A' ' 17' ' ' ILE . 8.8 mt -87.19 115.78 28.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.744 -2.317 . . . . 65.31 104.744 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -109.63 160.49 16.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.838 -0.745 . . . . 75.33 112.421 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.37 41.47 11.57 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 115.806 -0.634 . . . . 43.53 112.702 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.6 t -106.68 122.16 60.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 108.862 -0.792 . . . . 74.21 108.862 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.2 t -79.3 174.23 11.78 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.019 -1.072 . . . . 64.35 109.409 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.45 -25.62 67.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.065 -0.346 . . . . 75.24 110.065 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.72 -53.34 18.93 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.852 -0.613 . . . . 71.34 110.371 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.19 -30.62 69.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.353 0.501 . . . . 73.53 112.353 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 75' ' ' LEU . 3.4 tm? -57.27 -31.69 65.86 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.335 0.588 . . . . 74.42 110.659 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.564 ' O ' HG23 ' A' ' 80' ' ' VAL . 88.9 m-20 -60.07 -28.28 67.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.364 -0.835 . . . . 72.14 112.078 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.17 -38.02 69.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.591 -0.892 . . . . 51.43 108.591 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CD1' HD13 ' A' ' 26' ' ' ILE . 97.3 m-85 -67.9 -32.7 73.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.616 -0.72 . . . . 74.12 109.338 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 29.0 t70 -67.93 -30.8 70.21 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.191 -0.913 . . . . 63.2 110.538 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 76' ' ' ASN . 58.2 t -72.83 -22.32 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-O 121.259 0.552 . . . . 73.41 110.864 177.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.4 mm -70.19 -24.42 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.32 0.581 . . . . 75.13 110.803 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HG2' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -94.85 -171.72 2.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.767 -0.827 . . . . 74.41 108.767 176.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.49 -64.25 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 118.358 -1.877 . . . . 71.1 114.642 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -57.33 -46.25 83.45 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 117.521 0.66 . . . . 64.35 111.99 -173.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.484 ' O ' HG22 ' A' ' 110' ' ' VAL . 17.4 m-20 -154.8 12.38 0.38 Allowed 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.499 0.666 . . . . 70.43 109.222 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -116.06 147.6 41.1 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.641 -1.614 . . . . 75.11 106.641 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.471 ' OE2' ' HA ' ' A' ' 110' ' ' VAL . 11.4 pt-20 -133.5 138.72 46.26 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.432 -0.507 . . . . 73.13 111.7 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HB2' ' HG2' ' A' ' 82' ' ' GLU . 2.2 tmm_? -88.65 114.01 24.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.771 -0.649 . . . . 75.13 109.502 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.07 160.28 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.492 -0.776 . . . . 64.44 111.54 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 m -90.09 130.01 36.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.229 -0.656 . . . . 60.23 109.229 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.6 m -133.16 172.28 16.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 124.703 1.201 . . . . 75.3 108.043 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -121.07 127.78 51.99 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.875 -1.13 . . . . 60.31 110.032 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 38' ' ' LEU . 18.5 m -126.9 166.59 23.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.452 0.644 . . . . 61.24 110.519 -175.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 101' ' ' LYS . 73.0 t -105.56 113.58 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 107.807 -1.182 . . . . 72.33 107.807 172.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -78.51 89.55 4.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 108.539 -0.911 . . . . 72.52 108.539 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.446 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -48.28 -36.83 14.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.285 2.234 . . . . 64.45 112.012 -174.048 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -45.15 -48.26 12.28 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.239 0.962 . . . . 74.34 111.908 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -108.38 -3.83 17.93 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.308 -0.245 . . . . 73.35 111.219 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 m 66.13 28.65 10.17 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.898 0.879 . . . . 73.14 110.836 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -102.8 161.26 13.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.326 -0.852 . . . . 72.13 109.76 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.602 ' HG2' HG22 ' A' ' 94' ' ' VAL . 48.0 mtmt -98.0 133.85 41.91 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.063 -1.088 . . . . 71.34 108.063 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.22 139.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.439 0.638 . . . . 72.44 110.564 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.23 126.57 35.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.725 -1.213 . . . . 64.31 107.725 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.3 m -137.27 175.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.508 0.323 . . . . 72.44 110.419 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 44.4 mt-10 -105.2 153.28 21.76 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.979 -0.378 . . . . 75.24 109.979 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -156.01 176.79 12.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.694 0.283 . . . . 73.24 110.326 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -105.98 119.36 39.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 73.43 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 54' ' ' ILE . 27.6 m -119.3 -178.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 109.165 -0.68 . . . . 72.3 109.165 175.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.521 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 64.8 t-105 -100.62 137.09 39.48 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.586 -1.264 . . . . 63.05 107.586 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 85' ' ' ASP . 30.6 m -66.8 -20.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 113.636 0.976 . . . . 74.1 113.636 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -90.51 13.96 14.38 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.099 0.952 . . . . 74.12 109.027 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 60.3 pttt -49.62 -17.39 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.712 2.005 . . . . 64.21 115.17 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.08 -22.38 65.84 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.212 0.529 . . . . 74.23 110.439 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -118.0 140.69 28.18 Favored Pre-proline 0 CA--C 1.513 -0.458 0 N-CA-C 109.628 -0.508 . . . . 72.25 109.628 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.86 104.86 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.112 1.875 . . . . 74.31 110.346 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 116' ' ' ARG . 2.8 mmp_? -99.06 142.7 30.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.512 -0.313 . . . . 74.24 110.876 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 tpt 68.15 17.5 9.4 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.698 1.199 . . . . 70.31 109.307 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -83.58 81.25 8.82 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.777 -1.194 . . . . 75.42 107.777 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.21 -33.53 0.02 OUTLIER Glycine 0 C--N 1.278 -2.684 0 CA-C-N 113.48 -1.691 . . . . 61.43 110.013 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -93.37 140.01 30.04 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.402 -1.333 . . . . 51.24 107.402 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -76.69 154.27 34.35 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.798 -0.361 . . . . 74.11 111.098 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.86 148.71 27.57 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.943 -0.571 . . . . 74.24 112.322 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -55.47 -41.22 72.66 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.206 1.002 . . . . 73.45 111.347 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -73.06 -43.47 61.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.484 -0.561 . . . . 74.11 109.484 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 129' ' ' VAL . 46.9 mt-10 -65.81 -8.69 22.98 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.634 -0.712 . . . . 74.42 112.389 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.526 ' HA ' HG12 ' A' ' 129' ' ' VAL . 72.6 t-105 -59.86 -22.7 62.65 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-O 120.775 0.321 . . . . 73.33 110.254 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.61 -45.82 91.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.116 0.484 . . . . 51.34 110.38 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.41 -43.41 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 113.084 0.772 . . . . 61.43 113.084 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 126' ' ' TRP . 7.7 p -75.38 -18.89 15.94 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.22 0 N-CA-C 111.946 0.351 . . . . 72.24 111.946 -174.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 126' ' ' TRP . 9.4 t60 -48.45 -45.53 36.69 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 122.49 0.316 . . . . 74.14 110.6 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.26 -44.5 75.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.451 -0.34 . . . . 65.42 110.666 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.44 -44.14 97.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 74.4 110.821 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER -61.58 -55.51 30.05 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.556 -0.747 . . . . 72.52 110.74 -177.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.418 ' O ' ' HD1' ' A' ' 138' ' ' PHE . 81.1 m-85 -65.46 -32.66 74.39 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.808 1.41 . . . . 74.01 114.808 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.543 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 9.1 p -63.59 -42.19 95.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 118.913 -1.115 . . . . 62.41 109.331 176.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.07 -37.6 69.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.18 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 141' ' ' MET . 97.1 m -49.62 -51.41 37.76 Favored 'General case' 0 C--O 1.214 -0.816 0 O-C-N 123.518 0.511 . . . . 73.32 110.407 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.67 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 90.5 m-85 -70.54 -39.34 74.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.434 0.531 . . . . 74.54 112.434 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -63.44 -48.86 76.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.039 -0.264 . . . . 64.03 110.775 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.24 -35.66 80.99 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.876 -0.416 . . . . 72.34 109.876 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 137' ' ' THR . 46.9 tpp -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.956 -0.566 . . . . 70.22 109.57 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 80.4 mt -66.49 -41.65 88.63 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.987 -0.375 . . . . 71.31 109.987 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 34.3 mt-10 -65.98 -34.91 79.19 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.529 0.681 . . . . 72.52 110.024 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.413 ' CZ2' ' HB3' ' A' ' 153' ' ' MET . 32.5 t90 -75.42 -33.56 60.94 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.52 -0.764 . . . . 73.4 110.315 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -47.12 16.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.729 -0.669 . . . . 75.11 112.365 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.73 -32.25 41.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.456 -0.498 . . . . 74.14 109.724 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' GLU . 52.3 t30 58.4 84.23 0.21 Allowed Pre-proline 0 C--N 1.315 -0.917 0 C-N-CA 125.221 1.408 . . . . 72.14 114.434 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -93.43 -16.25 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.288 1.992 . . . . 75.25 112.245 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.67 -20.0 22.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.954 0.353 . . . . 73.44 111.954 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.96 31.37 9.28 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.154 -1.022 . . . . 14.22 111.967 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.43 144.97 25.64 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.556 -0.535 . . . . 44.52 109.556 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.8 m -86.12 155.6 20.71 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 106.154 -1.795 . . . . 71.12 106.154 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.413 ' HB3' ' CZ2' ' A' ' 144' ' ' TRP . 1.3 mpt? -67.82 -45.18 75.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.511 0.56 . . . . 73.42 112.511 -173.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.79 -26.07 61.39 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.066 0.46 . . . . 75.31 110.833 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -70.79 -48.11 55.93 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.327 0.584 . . . . 64.01 109.97 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.67 69.91 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.474 -0.785 . . . . 54.02 112.232 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 160' ' ' LEU . 34.3 m -94.94 -32.26 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 119.905 -0.718 . . . . 71.52 112.635 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 104.74 -108.22 3.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.747 -0.739 . . . . 53.42 111.376 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.7 p -115.06 20.41 15.03 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.927 0.87 . . . . 71.32 110.136 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 45.7 tp -92.92 -19.19 21.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.066 -0.97 . . . . 75.13 111.378 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.5 mp 66.84 -66.96 0.17 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.46 1.104 . . . . 54.31 111.627 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.9 t -172.73 -49.72 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.21 -2.145 . . . . 61.41 105.21 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.3 t 55.23 85.59 0.06 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.329 -1.305 . . . . 72.34 112.154 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.4 46.46 0.02 OUTLIER Glycine 0 C--N 1.305 -1.154 0 N-CA-C 110.252 -1.139 . . . . 61.13 110.252 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 108.416 -0.957 . . . . 51.32 108.416 -178.26 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 C--O 1.241 0.624 0 N-CA-C 109.324 -0.621 . . . . 60.31 109.324 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.2 m -79.92 123.51 27.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.585 -1.265 . . . . 61.22 107.585 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -68.39 110.62 4.21 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.352 0.596 . . . . 74.12 111.724 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 p -85.46 124.87 32.54 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.781 -0.822 . . . . 65.5 108.781 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -133.48 103.48 12.4 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 109.559 -0.534 . . . . 71.53 109.559 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.56 -74.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.04 1.826 . . . . 60.33 111.193 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -121.2 -77.63 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.302 -1.74 . . . . 70.54 106.302 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 m 49.08 -169.82 0.02 OUTLIER 'General case' 0 C--O 1.248 0.977 0 O-C-N 124.873 1.358 . . . . 64.41 114.271 171.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.44 ' C ' HD22 ' A' ' 10' ' ' ASN . 82.6 m-70 -107.89 142.35 38.1 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.781 -1.1 . . . . 73.22 109.097 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.44 HD22 ' C ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -124.36 130.95 53.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.876 -1.157 . . . . 75.21 107.876 178.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 27.7 t -124.59 120.32 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 110.172 -0.307 . . . . 74.14 110.172 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.617 ' HB3' HG22 ' A' ' 106' ' ' THR . 41.5 t80 -83.02 117.71 23.01 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.449 -0.945 . . . . 72.42 108.449 174.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 17' ' ' ILE . 7.5 p -136.76 150.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.669 -0.696 . . . . 54.21 109.709 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -127.36 -10.08 5.77 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.522 -0.547 . . . . 65.21 109.522 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.07 -128.4 1.08 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 115.348 0.899 . . . . 74.21 115.348 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -62.83 -42.65 99.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.706 1.373 . . . . 60.44 114.706 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.582 HG21 HD13 ' A' ' 67' ' ' ILE . 30.4 mt -60.59 -21.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.427 0.899 . . . . 72.41 113.427 -171.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' CD1' HG13 ' A' ' 13' ' ' VAL . 7.2 mp -66.14 -20.58 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.961 0.41 . . . . 61.4 111.117 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.19 116.16 65.73 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 108.509 -0.923 . . . . 74.21 108.509 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -40.11 -38.78 2.23 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 125.096 3.864 . . . . 62.21 115.456 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -57.82 -47.27 83.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.924 0.392 . . . . 73.52 111.065 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.6 t -67.03 -43.56 88.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.723 -0.671 . . . . 50.0 110.48 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB1' ' CB ' ' A' ' 31' ' ' ALA . . . -62.59 -37.12 84.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.805 -0.634 . . . . 71.33 109.988 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -72.67 -29.57 63.52 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.81 -0.632 . . . . 64.52 111.867 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 21' ' ' ALA . 23.0 m -81.45 -25.06 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.554 -0.859 . . . . 62.41 111.424 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.463 ' C ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -82.93 -47.92 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 120.274 -0.571 . . . . 72.21 111.04 178.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 92.2 mt -92.96 -12.69 30.15 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.206 0.447 . . . . 71.23 112.206 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 t70 76.36 -6.57 1.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.37 1.081 . . . . 73.42 109.381 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.7 ptt180 -133.99 163.76 28.82 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 125.646 1.578 . . . . 72.4 106.747 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.8 m -76.72 127.81 33.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.237 -0.653 . . . . 42.03 109.237 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' CB ' ' HB1' ' A' ' 23' ' ' ALA . . . -75.72 144.93 41.26 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 120.887 0.375 . . . . 65.12 111.489 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.77 108.89 20.9 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.817 -0.809 . . . . 53.23 108.817 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.1 p -111.71 143.7 42.19 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 115.144 -0.934 . . . . 53.54 109.934 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.29 138.89 33.83 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 108.503 -0.925 . . . . 74.1 108.503 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.71 134.76 62.77 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.636 2.224 . . . . 75.23 111.653 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.31 156.21 41.11 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.597 -0.729 . . . . 13.11 109.738 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.42 126.58 75.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.593 0.711 . . . . 75.25 111.58 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 93' ' ' VAL . 22.6 tp -93.67 96.19 9.66 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.918 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.464 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 19.7 p80 -71.62 131.78 43.68 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.569 -0.901 . . . . 53.31 108.569 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 116.56 -22.87 10.66 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 117.854 -2.117 . . . . 73.21 113.151 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 156.17 24.47 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 120.939 0.399 . . . . 72.23 111.224 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -127.24 140.51 52.17 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.619 -0.719 . . . . 44.31 109.125 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -85.72 137.21 32.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.601 0.76 . . . . 65.44 109.809 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.512 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 91.4 m-85 -124.33 145.78 49.22 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.858 -1.534 . . . . 72.43 106.858 174.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 25.1 pttm -90.43 -46.6 8.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.018 0.747 . . . . 64.45 113.018 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.537 ' HG ' HD22 ' A' ' 49' ' ' LEU . 2.7 mm? 60.77 179.99 0.1 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.98 0.912 . . . . 73.0 111.947 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.9 -43.22 0.81 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.372 0.606 . . . . 52.23 109.859 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.27 -13.44 76.73 Favored Glycine 0 N--CA 1.422 -2.234 0 CA-C-N 115.368 -0.833 . . . . 74.1 113.213 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.537 HD22 ' HG ' ' A' ' 46' ' ' LEU . 7.1 mp -89.73 163.29 33.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 122.69 -0.3 . . . . 71.25 110.604 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.18 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.881 2.387 . . . . 75.34 114.096 -173.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.86 75.87 75.03 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 122.61 1.195 . . . . 75.33 109.266 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CB ' ' SG ' ' A' ' 53' ' ' CYS 0.301 43.9 Cg_endo -113.2 165.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 125.071 3.847 . . . . 74.13 114.743 -171.161 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 69.6 m -156.06 175.87 13.4 Favored 'General case' 0 N--CA 1.505 2.288 1 C-N-CA 132.137 4.175 . . . . 73.03 104.82 -18.044 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 pt -123.94 143.31 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 120.199 -0.6 . . . . 64.04 110.505 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -131.56 146.22 33.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 m -59.49 113.43 2.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.562 0.745 . . . . 75.22 111.34 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -157.54 98.01 1.64 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.751 -1.203 . . . . 45.22 107.751 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 11.4 m-20 -62.4 -16.87 57.32 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.606 1.336 . . . . 75.24 114.606 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -75.35 -17.77 60.16 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.224 0.535 . . . . 71.45 109.953 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.51 164.1 12.11 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.808 -0.633 . . . . 62.42 112.451 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 28.6 mtmm -143.77 152.09 40.81 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.027 -1.471 . . . . 71.2 107.027 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.2 123.1 71.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.328 -0.619 . . . . 75.44 109.328 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.23 126.67 46.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.369 -0.604 . . . . 61.11 109.369 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.9 -138.42 2.55 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 110.485 -1.046 . . . . 44.44 110.485 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 97.4 mttt -138.49 147.43 43.19 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 117.502 0.651 . . . . 64.43 110.785 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 31.2 m -105.41 133.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.829 -0.623 . . . . 63.33 109.833 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.582 HD13 HG21 ' A' ' 17' ' ' ILE . 6.4 mt -87.14 110.63 20.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 104.189 -2.523 . . . . 64.32 104.189 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 p -104.42 167.21 9.89 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 116.424 -0.353 . . . . 74.13 111.025 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.07 38.29 95.86 Favored Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.603 0.564 . . . . 72.43 112.935 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.96 122.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.61 -0.885 . . . . 72.34 108.61 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.45 ' HB3' ' HG2' ' A' ' 74' ' ' GLU . 32.2 t -72.69 163.34 28.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.151 -0.685 . . . . 64.34 109.151 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.87 -38.42 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.206 -0.294 . . . . 71.15 110.206 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.4 71.84 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.936 0.874 . . . . 64.43 110.221 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.1 mm-40 -76.46 -38.24 55.71 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.811 -1.086 . . . . 65.03 110.022 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.526 HD21 HH12 ' A' ' 88' ' ' ARG . 3.1 tm? -65.21 -38.37 90.25 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.571 -0.74 . . . . 72.52 109.709 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 80' ' ' VAL . 94.9 m-20 -57.53 -27.58 62.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.026 -0.988 . . . . 64.43 112.725 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -75.38 -30.87 60.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.011 -1.076 . . . . 72.5 109.741 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -67.1 -30.34 70.34 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.698 -0.853 . . . . 74.11 108.698 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.84 -31.63 68.4 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.02 -0.991 . . . . 75.31 110.087 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 76' ' ' ASN . 94.7 t -65.65 -35.25 74.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.649 -0.705 . . . . 75.45 109.626 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -58.62 -54.87 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.162 -0.681 . . . . 73.42 109.162 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 66.86 166.15 0.22 Allowed 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 123.672 0.789 . . . . 72.23 112.642 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.83 20.3 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.654 -0.979 . . . . 32.21 110.654 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.89 -43.51 71.63 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.6 0.593 . . . . 72.13 112.6 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.688 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 15.5 t70 -143.73 34.18 1.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.498 -1.667 . . . . 63.22 106.498 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 55.7 m-85 -115.42 150.38 36.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.013 -1.449 . . . . 75.34 108.468 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.68 158.33 44.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.599 -0.519 . . . . 72.21 109.599 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 106' ' ' THR . 37.4 mtt180 -84.22 124.65 31.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 112.776 0.658 . . . . 75.43 112.776 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.7 150.05 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 CA-C-N 115.298 -0.864 . . . . 65.24 108.722 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.1 m -94.42 122.78 37.34 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.449 -0.945 . . . . 72.24 108.449 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.421 HG21 HD22 ' A' ' 38' ' ' LEU . 20.1 m -123.81 163.12 23.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 106.56 -1.645 . . . . 70.21 106.56 -176.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -115.23 132.05 56.73 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 117.872 -1.531 . . . . 55.15 109.42 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' LEU . 18.7 m -126.35 169.5 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 109.133 -0.691 . . . . 73.44 109.133 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.537 HG22 ' HG3' ' A' ' 101' ' ' LYS . 58.8 t -106.1 117.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.209 -0.663 . . . . 62.42 109.209 173.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -72.45 90.04 1.29 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.194 -1.41 . . . . 64.13 107.194 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.62 -36.83 57.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.145 1.378 . . . . 54.13 111.714 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -51.41 -27.75 10.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.484 0.714 . . . . 73.25 112.713 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -134.11 9.44 3.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 63.01 109.679 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m 56.76 17.55 3.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.106 0.962 . . . . 61.0 113.489 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -92.58 160.78 14.87 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.618 -0.512 . . . . 61.42 109.618 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.537 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.3 mptt -100.52 132.68 45.78 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 108.129 -1.063 . . . . 73.43 108.129 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.09 138.48 30.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.249 0.547 . . . . 72.51 110.874 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.39 122.55 32.71 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.417 -0.957 . . . . 63.34 108.417 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.503 HG21 ' HB2' ' A' ' 12' ' ' PHE . 23.3 m -131.22 169.39 21.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.628 0.251 . . . . 73.34 111.22 -172.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.94 148.55 26.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.926 -0.398 . . . . 74.02 109.926 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 66.0 p -141.15 173.72 11.21 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 123.197 0.311 . . . . 62.11 111.623 -176.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.4 118.19 36.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.759 -1.571 . . . . 74.21 106.759 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 13.2 p -113.43 159.89 13.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.702 -0.851 . . . . 73.04 108.702 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.688 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 52.1 t-105 -83.14 118.49 23.61 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.844 -1.539 . . . . 71.01 106.844 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.9 m -62.73 -19.64 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.641 0.608 . . . . 63.4 112.641 -174.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.525 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 7.9 t30 -85.79 12.14 9.69 Favored 'General case' 0 C--O 1.199 -1.578 0 C-N-CA 123.996 0.918 . . . . 70.03 109.853 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.48 -15.12 0.22 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.798 2.148 . . . . 72.51 116.798 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.24 -14.4 55.57 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.521 -0.472 . . . . 73.03 110.759 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -115.36 124.58 29.91 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 123.727 0.811 . . . . 73.31 109.148 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -90.15 128.5 1.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.588 2.192 . . . . 61.11 113.255 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -131.07 118.01 19.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.887 -0.597 . . . . 70.25 110.176 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.562 ' HG2' ' H ' ' A' ' 119' ' ' GLY . 51.6 ttm 70.36 152.17 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 124.238 0.961 . . . . 75.03 111.515 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -77.37 -33.79 55.19 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.868 -0.79 . . . . 71.51 108.868 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.562 ' H ' ' HG2' ' A' ' 117' ' ' MET . . . 66.65 56.27 13.9 Favored Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 114.277 -1.329 . . . . 64.21 115.536 173.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -87.61 131.59 34.37 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.015 -0.674 . . . . 61.2 109.273 177.019 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -167.2 -32.81 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.788 -0.642 . . . . 72.11 110.959 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.45 142.81 33.93 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.697 -0.853 . . . . 73.15 108.697 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.637 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 62.9 t80 -58.99 -37.37 76.71 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.673 0.619 . . . . 63.22 112.673 -173.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.23 -33.39 74.32 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.686 0.755 . . . . 70.5 109.419 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.496 ' O ' HG22 ' A' ' 128' ' ' VAL . 11.3 tp10 -76.18 -42.85 45.08 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.138 -0.937 . . . . 71.24 109.223 177.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -58.23 -33.44 69.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 72.52 111.52 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 63.5 mtp180 -57.51 -36.08 71.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.043 -0.526 . . . . 74.03 112.227 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 125' ' ' GLU . 15.9 m -84.24 -29.96 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 119.96 -0.696 . . . . 74.32 110.534 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.54 -42.36 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.731 -0.668 . . . . 74.42 109.462 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.5 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.8 t60 -54.51 -38.37 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.675 -0.693 . . . . 64.34 110.733 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.51 50.83 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.55 -0.295 . . . . 74.21 111.159 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 40.8 mt-10 -69.47 -30.93 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.482 -0.487 . . . . 65.44 112.117 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -68.39 -50.67 51.33 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.06 -0.718 . . . . 70.35 109.06 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.5 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 69.3 m-85 -67.39 -31.21 71.27 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.473 1.286 . . . . 71.43 114.473 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.94 -42.03 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 119.052 -1.059 . . . . 75.42 111.477 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -70.06 -42.57 72.66 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.882 -0.327 . . . . 73.14 110.859 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 141' ' ' MET . 98.5 m -60.92 -42.01 97.3 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.417 -0.356 . . . . 75.32 110.753 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -57.6 -50.11 74.2 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.032 -0.358 . . . . 70.41 110.032 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 88.2 mtt180 -60.59 -46.54 89.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.556 . . . . 74.13 111.028 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.69 -33.03 74.93 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.592 0.59 . . . . 74.43 112.592 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 137' ' ' THR . 91.7 mtp -65.03 -36.27 83.83 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.88 -0.328 . . . . 71.33 110.578 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.4 -35.8 73.68 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 111.716 0.265 . . . . 72.15 111.716 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 23.9 mm-40 -62.86 -45.05 94.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 63.02 109.539 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -71.27 -29.36 64.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.249 -0.887 . . . . 73.2 110.783 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -71.99 -34.43 68.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.305 0.574 . . . . 65.51 109.769 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.97 -32.2 45.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.868 -0.605 . . . . 75.43 110.644 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -149.5 112.64 3.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 116.362 -0.381 . . . . 74.22 110.143 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.4 -23.55 76.99 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.805 2.336 . . . . 73.13 111.789 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -93.51 9.12 37.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.844 -0.616 . . . . 75.33 110.238 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.68 -30.17 72.79 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.84 -0.618 . . . . 53.12 112.649 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.01 121.8 34.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.704 -0.398 . . . . 55.03 111.111 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.5 m -90.64 157.94 17.2 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.013 -1.477 . . . . 55.53 107.013 173.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -66.71 -43.33 84.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 118.132 0.424 . . . . 72.43 111.054 -175.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 157' ' ' VAL . 63.4 mm-40 -68.67 -32.7 72.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.587 0.708 . . . . 75.32 110.917 176.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.59 -37.46 56.43 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 114.207 1.188 . . . . 70.11 114.207 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.94 -46.18 25.1 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.586 -0.445 . . . . 53.43 110.474 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 154' ' ' GLU . 58.1 t 24.57 79.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 125.094 1.496 . . . . 61.33 112.897 -169.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -96.53 -105.85 2.26 Favored Glycine 0 C--N 1.286 -2.244 0 N-CA-C 110.007 -1.237 . . . . 60.3 110.007 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 25.5 m -82.92 94.02 7.63 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 109.329 -0.619 . . . . 74.54 109.329 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 46.1 tp -100.18 111.49 23.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.34 -1.356 . . . . 73.15 107.34 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.4 -40.02 9.71 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 115.452 -0.795 . . . . 75.51 111.338 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.2 m 65.05 83.04 0.17 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.694 -1.225 . . . . 73.42 107.694 -169.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.5 t -65.32 112.28 3.41 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.173 -1.376 . . . . 72.21 111.487 -173.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -124.16 49.51 0.9 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 108.68 -1.768 . . . . 65.05 108.68 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 CA--C 1.49 -1.334 0 CA-C-N 114.694 -0.753 . . . . 75.31 109.582 -177.689 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 p . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 109.595 -0.521 . . . . 72.4 109.595 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.6 p 58.53 -172.41 0.1 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.991 0.917 . . . . 73.44 111.48 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 m -80.66 104.54 11.25 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.87 -0.789 . . . . 71.0 108.87 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.4 p -73.73 -34.36 64.75 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.096 -0.502 . . . . 72.45 110.768 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.41 126.05 91.79 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.681 -0.859 . . . . 74.52 108.681 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.91 122.16 10.88 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.585 2.857 . . . . 64.32 113.659 -174.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -89.31 91.72 8.86 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.652 -0.704 . . . . 64.22 109.28 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.0 p -73.34 124.28 25.43 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.638 0.732 . . . . 71.32 110.498 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -89.5 153.31 20.9 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.844 -1.071 . . . . 65.13 111.402 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 36.7 m-80 -135.0 122.34 21.71 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.002 -1.851 . . . . 74.24 106.002 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 38.9 t -115.62 122.58 69.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 121.107 -0.237 . . . . 63.12 111.045 -173.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.49 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.7 t80 -87.48 108.22 18.92 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.857 -1.164 . . . . 71.43 107.857 175.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.83 149.18 33.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 120.974 0.416 . . . . 50.4 110.072 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.82 105.07 10.37 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.928 -1.138 . . . . 63.42 107.928 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.456 ' H ' ' CD1' ' A' ' 18' ' ' LEU . . . 87.44 -163.17 33.86 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.337 -0.705 . . . . 52.51 111.337 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t 70.0 -62.02 0.44 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.538 1.135 . . . . 75.03 113.785 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 67' ' ' ILE . 2.7 pp -129.84 9.17 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.157 0.799 . . . . 74.33 113.157 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 65' ' ' LYS . 48.0 mt -64.42 -13.98 54.22 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.291 0.848 . . . . 74.45 113.291 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.56 124.51 83.77 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.112 -1.07 . . . . 70.51 108.112 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.79 -41.64 31.39 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.71 2.94 . . . . 73.21 114.047 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.475 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -65.61 -32.71 74.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 52.23 110.806 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.2 -43.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.06 -0.518 . . . . 74.33 110.14 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.68 70.73 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.395 0.616 . . . . 53.41 109.555 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.96 75.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.51 -0.768 . . . . 62.51 111.652 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 21' ' ' ALA . 18.1 m -72.69 -31.46 37.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 120.277 -0.569 . . . . 73.3 112.075 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.589 HD13 ' CD1' ' A' ' 78' ' ' PHE . 7.8 tt -73.57 -36.77 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.925 0.393 . . . . 63.31 111.799 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 74' ' ' GLU . 92.0 mt -100.25 -10.75 21.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 113.767 1.025 . . . . 72.35 113.767 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.3 18.25 10.24 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.972 1.368 . . . . 72.03 108.665 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -160.45 140.74 11.5 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 105.539 -2.023 . . . . 75.5 105.539 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -76.53 118.51 19.27 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.551 -0.86 . . . . 73.23 108.808 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -93.04 147.98 22.39 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 116.188 -0.46 . . . . 63.44 109.877 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -88.67 114.16 25.0 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.299 -0.864 . . . . 75.2 111.181 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.431 ' HB ' ' HE3' ' A' ' 65' ' ' LYS . 4.2 p -100.79 143.43 30.95 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.533 -0.758 . . . . 71.25 109.527 174.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.52 140.03 37.43 Favored Pre-proline 0 C--N 1.277 -2.552 0 N-CA-C 109.219 -0.66 . . . . 51.22 109.219 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 39.7 Cg_endo -67.29 132.14 26.81 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.869 1.713 . . . . 75.51 110.671 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.551 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -145.58 156.1 43.47 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.23 -0.895 . . . . 72.11 109.029 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 11.3 p -120.47 128.24 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 CA-C-O 121.681 0.753 . . . . 74.41 110.979 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.463 ' HA ' HG12 ' A' ' 93' ' ' VAL . 23.1 tp -87.43 108.91 19.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.096 -0.957 . . . . 75.41 109.631 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -83.78 125.48 31.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.912 -1.04 . . . . 74.1 109.053 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 117.34 -13.74 13.65 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 118.277 -1.916 . . . . 52.33 113.611 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.516 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 39.1 m-85 -124.96 159.61 30.82 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 110.034 -0.358 . . . . 74.31 110.034 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 11.3 t-80 -130.16 137.26 50.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 120.014 -0.674 . . . . 75.34 109.679 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 44' ' ' TYR . 3.2 tmm_? -88.9 129.51 35.59 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.157 -1.053 . . . . 64.1 108.157 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.45 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 46.9 m-85 -95.5 152.88 18.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.642 -0.708 . . . . 71.23 110.979 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 6.1 tmtm? -84.91 -30.27 24.5 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.766 -0.827 . . . . 75.25 108.766 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.39 -166.26 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.438 0.695 . . . . 73.05 111.03 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.83 -42.93 2.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.335 -0.987 . . . . 73.32 108.335 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.81 -8.67 53.99 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.485 -0.864 . . . . 74.31 113.755 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.83 126.32 29.32 Favored Pre-proline 0 C--N 1.321 -0.648 0 O-C-N 122.521 -0.399 . . . . 55.41 110.475 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -83.49 -44.93 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.94 2.427 . . . . 75.32 112.267 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.677 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.9 p90 -113.67 172.11 3.83 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 105.59 -2.004 . . . . 65.33 105.59 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.308 0.0 OUTLIER 30.36 168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.593 3.466 0 C-N-CA 124.376 3.384 . . . . 63.44 118.713 -161.236 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 10.5 p -122.58 -175.29 3.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 119.623 -1.923 . . . . 71.11 112.513 8.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 30.1 pt -123.64 132.34 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.822 -1.081 . . . . 74.22 108.788 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 27.4 m -150.46 116.48 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.191 0 O-C-N 123.203 0.314 . . . . 73.22 111.521 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.6 t 55.91 -158.59 0.23 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.182 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.9 m 71.88 80.2 0.15 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.541 1.536 . . . . 70.23 111.23 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.584 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 p-10 -73.49 -10.26 59.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.613 0.72 . . . . 61.54 110.094 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.9 t -83.85 -6.16 59.36 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.0 -1.0 . . . . 73.34 109.097 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.69 164.74 13.36 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.864 -0.684 . . . . 62.53 112.246 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -142.15 147.17 36.22 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.029 -1.471 . . . . 72.4 107.029 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 41' ' ' TYR . 58.1 t -121.04 122.95 68.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 110.104 -0.332 . . . . 72.23 110.104 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -92.4 118.11 30.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.454 -0.943 . . . . 73.13 108.454 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -145.21 -152.96 5.74 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.048 -1.221 . . . . 72.4 110.048 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 18' ' ' LEU . 30.3 mtpp -137.4 138.82 40.25 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.315 -0.624 . . . . 73.34 109.315 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.3 m -103.95 133.68 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.766 -0.652 . . . . 54.32 109.602 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 17' ' ' ILE . 4.5 mt -87.4 119.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 105.292 -2.114 . . . . 62.13 105.292 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.4 p -106.43 160.48 15.36 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.277 -0.969 . . . . 75.13 111.5 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.89 39.84 85.1 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.902 -0.59 . . . . 70.11 112.46 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -103.83 123.57 57.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 N-CA-C 110.26 -0.274 . . . . 55.51 110.26 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.5 t -73.85 162.42 29.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.582 -0.895 . . . . 55.15 108.582 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.48 -39.3 79.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.015 0.436 . . . . 75.23 109.889 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.52 -32.47 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 40.01 109.84 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.667 ' HB3' HD22 ' A' ' 27' ' ' LEU . 52.8 mt-10 -76.98 -40.23 47.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.27 -0.877 . . . . 63.41 111.508 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.1 tt -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.036 -1.098 . . . . 72.52 108.036 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.591 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.0 t-20 -53.83 -31.55 49.75 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.922 -1.49 . . . . 74.43 110.933 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -31.69 67.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 120.622 -0.431 . . . . 72.25 109.974 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CD1' HD13 ' A' ' 26' ' ' ILE . 90.2 m-85 -72.35 -40.36 67.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.598 -0.89 . . . . 55.42 108.598 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.88 -29.42 70.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.571 -1.195 . . . . 70.14 111.98 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 76' ' ' ASN . 95.5 t -52.63 -22.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 124.036 0.934 . . . . 73.14 112.295 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.96 -29.88 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 N-CA-C 109.661 -0.496 . . . . 71.54 109.661 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 55.53 96.74 0.02 OUTLIER 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.663 1.585 . . . . 73.35 113.836 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.14 107.77 3.46 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 108.704 -1.759 . . . . 43.52 108.704 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.98 -35.42 76.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.323 0.562 . . . . 64.11 112.316 -175.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 109' ' ' TRP . 15.1 m-20 -101.59 17.96 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.055 0.455 . . . . 73.41 110.453 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -115.19 141.98 47.29 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.89 -0.411 . . . . 74.02 109.89 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -131.67 143.84 50.58 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.759 -0.83 . . . . 64.34 108.759 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 106' ' ' THR . 55.4 mtm180 -82.92 113.1 20.29 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.591 -0.444 . . . . 44.15 112.169 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.5 m -116.34 153.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.399 -0.819 . . . . 71.34 110.322 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.2 m -90.46 123.44 34.17 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.853 -0.795 . . . . 72.21 108.853 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.34 171.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.548 -1.278 . . . . 62.3 107.548 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -125.23 123.56 39.8 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.948 -1.501 . . . . 72.44 106.948 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 38' ' ' LEU . 13.7 m -126.81 163.07 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 121.504 0.669 . . . . 73.3 109.976 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 101' ' ' LYS . 53.7 t -107.69 118.42 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.73 -0.668 . . . . 53.5 109.904 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.43 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 40.9 ttm180 -66.04 98.83 0.46 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.965 -1.494 . . . . 64.11 106.965 175.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.551 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -60.48 -36.27 77.89 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 125.03 1.332 . . . . 73.01 110.283 -170.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.7 -41.85 70.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.573 -0.74 . . . . 73.23 112.212 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.14 -1.55 12.97 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.415 0.626 . . . . 73.52 110.952 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 t 64.42 23.12 12.9 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.993 0.917 . . . . 72.31 111.451 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.3 pt-20 -96.59 161.39 13.92 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.88 -0.415 . . . . 73.31 109.88 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.499 ' HG2' HG22 ' A' ' 94' ' ' VAL . 48.0 mtpt -105.03 130.84 53.14 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.718 -0.475 . . . . 74.14 109.718 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.42 130.92 54.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.722 0.772 . . . . 65.13 111.277 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -87.52 120.29 28.67 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.022 -1.473 . . . . 71.13 107.022 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.517 HG12 ' HB2' ' A' ' 10' ' ' ASN . 27.2 m -133.83 172.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.755 0.312 . . . . 60.2 111.17 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.4 152.57 23.43 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.774 -0.454 . . . . 64.53 109.774 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.0 t -151.91 174.64 13.36 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.658 -0.867 . . . . 61.05 108.658 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.1 118.42 36.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.204 -1.036 . . . . 61.53 108.204 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.42 153.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.836 -0.801 . . . . 71.23 108.836 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.603 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 63.7 t-105 -81.9 121.4 26.43 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.395 -1.335 . . . . 72.32 107.395 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.76 -20.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.402 0.89 . . . . 72.43 113.402 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.577 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 28.5 t-20 -80.57 11.35 3.81 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-O 121.702 0.763 . . . . 73.35 109.962 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -50.7 -25.67 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.918 1.287 . . . . 74.03 114.064 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.19 -6.78 57.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.081 0.467 . . . . 75.22 111.669 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.633 ' OD1' ' HB2' ' A' ' 116' ' ' ARG . 12.6 t70 -102.23 128.38 28.55 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 106.062 -1.829 . . . . 70.43 106.062 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.31 46.06 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.229 2.62 . . . . 70.22 111.978 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.633 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 14.2 ttm180 -95.29 115.39 27.37 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.246 -0.888 . . . . 73.33 111.872 -172.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.9 mtt 75.54 142.81 0.07 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.069 1.348 . . . . 74.23 114.546 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -149.1 -42.23 0.15 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.293 -1.321 . . . . 52.0 109.039 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.16 -155.83 52.42 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.141 -0.936 . . . . 65.11 114.447 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.85 151.7 48.33 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.883 -0.784 . . . . 64.45 108.883 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -156.91 -62.7 0.1 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.933 0.873 . . . . 75.13 108.846 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.463 ' HB3' ' CB ' ' A' ' 125' ' ' GLU . 13.3 t70 -121.76 144.2 48.93 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.194 -1.41 . . . . 42.34 107.194 174.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.591 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 81.5 m-85 -66.3 -46.16 77.89 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.274 0.472 . . . . 73.24 112.274 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.432 ' OE1' ' HD3' ' A' ' 127' ' ' ARG . 8.1 tp10 -68.27 -41.24 81.36 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.927 -0.768 . . . . 72.21 108.927 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.463 ' CB ' ' HB3' ' A' ' 122' ' ' ASP . 7.4 tp10 -56.85 -46.75 81.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.888 -1.051 . . . . 71.42 109.162 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.42 ' HA ' HG12 ' A' ' 129' ' ' VAL . 75.3 t90 -56.09 -41.95 75.98 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.781 -0.645 . . . . 73.25 110.976 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 72.4 mtp180 -60.27 -41.26 92.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.725 -0.67 . . . . 74.3 111.224 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -82.95 -41.63 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.638 -0.425 . . . . 72.35 111.916 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 126' ' ' TRP . 13.0 p -68.82 -40.11 80.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 112.767 0.654 . . . . 74.34 112.767 -174.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -65.17 -35.25 80.49 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 118.882 -1.127 . . . . 74.4 110.645 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -64.3 -55.1 23.63 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.434 0.459 . . . . 62.43 111.03 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -23.42 64.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.168 0.433 . . . . 65.44 112.168 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.618 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.4 tpmt? -67.24 -45.3 77.13 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.78 -0.822 . . . . 73.33 108.78 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -67.47 -33.18 74.6 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.836 -0.345 . . . . 73.02 111.276 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 98.1 t -53.68 -53.19 27.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.11 -0.7 . . . . 73.02 109.11 173.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.95 -42.42 89.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.671 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.7 m -54.96 -50.51 68.74 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.775 0.672 . . . . 71.34 110.463 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -68.35 -29.85 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.162 0.43 . . . . 72.34 112.162 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -68.23 -44.73 75.08 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.463 0.649 . . . . 61.51 109.729 177.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -71.23 -42.09 69.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 75.44 110.378 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.2 mmt -62.53 -31.45 72.22 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-N 116.344 -0.389 . . . . 74.31 110.844 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.46 -50.05 74.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.58 0.752 . . . . 73.43 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.44 -34.37 75.85 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.165 -0.614 . . . . 72.4 111.631 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -75.18 -27.18 59.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.183 0.516 . . . . 73.3 112.035 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -72.88 -37.3 67.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.483 0.713 . . . . 75.32 109.318 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 146' ' ' LYS . 11.3 tmtt? -78.95 -33.0 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.315 -0.624 . . . . 74.22 109.315 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -137.9 95.05 11.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 120.927 0.394 . . . . 73.23 110.628 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.03 -16.61 9.83 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.615 2.21 . . . . 75.05 111.175 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.22 -23.26 61.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.369 -0.832 . . . . 75.04 111.292 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.43 7.05 71.7 Favored Glycine 0 C--O 1.242 0.609 0 C-N-CA 120.454 -0.879 . . . . 65.52 112.506 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.402 ' HD3' HD23 ' A' ' 161' ' ' LEU . 82.7 tttt -93.79 136.84 33.66 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.429 -1.323 . . . . 70.14 107.429 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.455 ' HB2' ' OE1' ' A' ' 155' ' ' GLU . 49.7 m -79.07 164.64 24.15 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 112.491 0.552 . . . . 53.44 112.491 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 66.4 mtt -59.86 -44.2 94.27 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.192 0.812 . . . . 74.3 113.192 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.407 ' HA ' HG22 ' A' ' 157' ' ' VAL . 40.6 tt0 -71.06 -28.66 64.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.439 0.638 . . . . 54.31 110.713 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 159' ' ' SER . 1.1 mp0 -75.44 -32.9 60.83 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.51 -0.768 . . . . 71.01 110.734 175.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.99 -27.9 63.06 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.837 -0.62 . . . . 70.04 111.316 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 154' ' ' GLU . 27.4 m -88.22 133.36 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 120.047 -0.661 . . . . 51.34 109.525 175.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 89.87 -55.53 3.72 Favored Glycine 0 C--N 1.305 -1.147 0 N-CA-C 109.544 -1.422 . . . . 75.42 109.544 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 155' ' ' GLU . 48.4 t -103.31 96.11 6.54 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 107.618 -1.253 . . . . 64.31 107.618 174.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.7 166.39 3.31 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.014 -0.539 . . . . 64.12 111.88 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.402 HD23 ' HD3' ' A' ' 151' ' ' LYS . 93.0 mt -79.75 70.76 6.33 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.24 -0.652 . . . . 54.21 109.24 176.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.4 m -75.57 97.45 3.75 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 115.088 -0.96 . . . . 55.5 109.743 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.3 t -127.12 176.72 7.16 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.812 -1.085 . . . . 71.53 108.2 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.02 103.72 0.24 Allowed Glycine 0 N--CA 1.424 -2.108 0 C-N-CA 120.25 -0.976 . . . . 72.2 112.494 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 C--N 1.306 -1.326 0 N-CA-C 109.061 -0.718 . . . . 38.01 109.061 175.219 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.434 -0.58 . . . . 73.53 109.434 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.6 m -117.81 128.65 55.06 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.723 -0.843 . . . . 71.4 108.723 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 p -58.2 113.67 2.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.143 0.497 . . . . 44.45 111.996 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.1 t -101.43 -29.08 12.22 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.799 -0.637 . . . . 73.11 109.763 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.56 151.91 41.58 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.545 -0.909 . . . . 64.24 108.545 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.37 -6.03 17.77 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.703 2.269 . . . . 65.22 113.511 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.522 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 8.2 mm-40 -96.46 -6.89 36.23 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 119.657 -0.817 . . . . 63.3 111.835 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m -96.71 108.34 20.96 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.571 -1.64 . . . . 74.32 106.571 169.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.638 ' HD1' ' HG ' ' A' ' 75' ' ' LEU . 8.4 m170 -104.23 156.0 18.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.049 -0.523 . . . . 74.13 110.581 -172.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.578 ' HB2' HG12 ' A' ' 104' ' ' VAL . 25.2 m-80 -134.93 133.42 39.55 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.466 -1.679 . . . . 71.43 106.466 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.408 ' HB ' HD12 ' A' ' 67' ' ' ILE . 47.6 t -114.79 121.02 66.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.563 -0.455 . . . . 72.2 111.213 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.535 ' HB2' HG21 ' A' ' 104' ' ' VAL . 59.3 t80 -89.75 98.83 11.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.302 -0.629 . . . . 75.34 109.302 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.48 129.98 31.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.832 -0.803 . . . . 63.23 108.832 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.562 ' CD1' ' HA2' ' A' ' 64' ' ' GLY . 48.2 t80 -105.89 86.17 2.34 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.544 -0.863 . . . . 65.42 110.127 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.76 147.18 4.48 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.652 -1.158 . . . . 75.44 112.367 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t 70.67 -69.34 0.18 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.489 1.515 . . . . 73.41 113.718 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.586 HG21 HD13 ' A' ' 67' ' ' ILE . 28.3 mt -75.96 3.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.027 0.918 . . . . 73.43 110.407 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -67.99 -23.04 64.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.568 -0.742 . . . . 74.45 109.159 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.63 119.94 74.52 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 108.565 -0.902 . . . . 71.21 108.565 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -48.55 -35.96 30.41 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.67 2.913 . . . . 53.14 112.54 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -60.37 -40.29 90.27 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.455 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 25' ' ' VAL . 70.9 t -70.46 -39.71 76.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.356 0.598 . . . . 74.3 110.056 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -66.43 -35.32 80.01 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.378 -0.601 . . . . 72.14 109.378 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -74.28 -10.14 59.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 72.34 112.038 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 21' ' ' ALA . 21.1 m -100.04 -31.68 3.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.346 -0.942 . . . . 72.33 110.513 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.553 HD13 ' CD2' ' A' ' 78' ' ' PHE . 9.9 tt -79.08 -42.96 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.153 0.501 . . . . 75.11 111.582 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 31' ' ' ALA . 95.8 mt -94.97 -21.38 18.65 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.156 -0.34 . . . . 74.24 110.319 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 28.2 t70 67.59 15.98 9.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 123.598 1.666 . . . . 52.31 107.723 -170.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -133.31 131.56 40.3 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.457 -2.053 . . . . 74.33 105.457 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -76.74 111.43 12.24 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.996 -1.082 . . . . 70.4 109.196 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -96.87 143.09 28.09 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.647 -0.706 . . . . 72.35 109.264 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.78 129.06 45.86 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.852 -0.796 . . . . 74.21 108.852 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 12.7 p -93.34 141.83 28.0 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 119.487 -0.885 . . . . 74.04 108.878 175.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.72 140.02 34.62 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.703 -0.851 . . . . 71.34 108.703 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.73 128.94 28.64 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.778 2.319 . . . . 64.13 111.969 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.24 154.45 37.95 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.902 -0.59 . . . . 35.13 109.518 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.85 131.92 71.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 C-N-CA 120.752 -0.379 . . . . 74.13 110.384 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.454 HD11 ' HB ' ' A' ' 91' ' ' VAL . 20.9 tp -94.32 129.98 40.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.022 -0.535 . . . . 75.03 110.531 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -94.59 129.97 41.22 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.446 -0.343 . . . . 63.54 111.232 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 58' ' ' ASP . . . 105.4 -1.43 40.01 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 119.52 -1.324 . . . . 74.1 113.771 173.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.499 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 56.9 m-85 -126.59 160.76 29.73 Favored 'General case' 0 N--CA 1.414 -2.252 0 O-C-N 122.313 -0.522 . . . . 64.23 112.074 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -134.17 130.97 38.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.387 -1.338 . . . . 74.03 107.387 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.83 124.98 34.7 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.06 0.457 . . . . 74.1 111.208 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HE2' ' O ' ' A' ' 55' ' ' VAL . 93.6 m-85 -106.67 145.17 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.897 -1.149 . . . . 62.01 107.897 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 4.3 mmmp? -109.92 125.02 52.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 112.355 0.502 . . . . 73.43 112.355 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.407 HD23 ' HB2' ' A' ' 52' ' ' PRO . 1.4 mm? -131.83 141.67 49.49 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.189 -1.041 . . . . 71.34 108.189 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -90.65 -30.04 17.38 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.818 -0.808 . . . . 52.34 108.818 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -31.76 76.98 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.806 -1.088 . . . . 71.43 112.222 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.43 ' HB2' ' HG3' ' A' ' 52' ' ' PRO . 6.4 mp -90.98 158.45 41.76 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 108.407 -0.96 . . . . 63.5 108.407 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.94 -76.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.849 2.366 . . . . 71.01 114.216 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.62 76.26 69.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.964 -1.124 . . . . 75.24 107.964 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HG3' ' HB2' ' A' ' 49' ' ' LEU 0.257 51.9 Cg_endo -115.52 162.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 123.432 2.754 . . . . 72.31 116.19 -171.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 m -158.01 158.21 34.43 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.205 3.402 . . . . 71.54 107.152 -19.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 108' ' ' VAL . 33.2 pt -124.09 128.33 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.638 -0.825 . . . . 72.33 111.888 174.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 24.2 m -154.58 145.75 13.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 124.342 1.057 . . . . 63.44 108.458 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 p 168.14 -57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.194 0.934 . . . . 72.04 110.671 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 m 69.8 13.6 8.06 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.363 1.078 . . . . 74.34 108.337 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.663 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 26.6 t70 -83.28 -178.05 6.95 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 113.938 -1.483 . . . . 71.24 109.715 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.0 m -80.42 -6.88 58.77 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.684 0.278 . . . . 70.44 110.889 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.42 156.17 31.1 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.887 -0.597 . . . . 74.03 111.971 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -129.03 152.91 48.12 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.895 -0.409 . . . . 71.3 109.895 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 122.53 67.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.295 -1.002 . . . . 72.33 108.295 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -97.77 115.64 28.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.426 -0.583 . . . . 73.14 109.426 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.562 ' HA2' ' CD1' ' A' ' 14' ' ' TYR . . . -146.44 -147.4 4.57 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.953 -0.641 . . . . 75.24 111.993 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 47.9 mtpt -139.68 146.21 39.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.213 -1.032 . . . . 71.31 108.213 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 33' ' ' THR . 35.2 m -104.72 135.14 43.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.165 -0.471 . . . . 64.54 110.883 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.586 HD13 HG21 ' A' ' 17' ' ' ILE . 6.4 mt -86.27 111.8 21.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.762 -2.31 . . . . 64.42 104.762 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -99.44 161.64 13.5 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.495 -0.482 . . . . 71.21 111.694 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.41 35.32 37.6 Favored Glycine 0 C--O 1.245 0.789 0 CA-C-N 115.752 -0.658 . . . . 64.2 112.927 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t -97.37 124.82 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.02 -0.734 . . . . 63.44 109.02 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.0 m -77.95 157.92 29.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.553 -0.906 . . . . 74.41 108.553 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HA ' ' CE1' ' A' ' 9' ' ' HIS . 7.3 p-10 -56.45 -42.74 78.64 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.211 0.529 . . . . 72.41 112.191 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.47 70.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.017 -0.992 . . . . 71.33 110.801 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.58 -30.02 62.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.516 -0.766 . . . . 60.3 110.793 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.638 ' HG ' ' HD1' ' A' ' 9' ' ' HIS . 3.0 tm? -58.21 -35.08 71.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.278 -0.873 . . . . 72.04 109.369 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.575 ' O ' HG23 ' A' ' 80' ' ' VAL . 5.4 m-20 -59.46 -27.53 66.17 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.357 -0.838 . . . . 63.12 111.919 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.485 ' OD1' HG13 ' A' ' 26' ' ' ILE . 1.9 t-20 -68.08 -31.61 71.35 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.219 -0.659 . . . . 74.25 109.219 -176.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 26' ' ' ILE . 80.1 m-85 -74.46 -32.28 62.54 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 121.68 0.752 . . . . 72.21 109.007 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.83 -31.26 63.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.159 -0.928 . . . . 63.23 110.241 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 76' ' ' ASN . 98.1 t -66.65 -22.67 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 115.64 -0.709 . . . . 70.34 110.848 175.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.8 mm -58.96 143.22 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.915 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.41 113.71 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.742 1.617 . . . . 72.23 113.266 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.77 85.35 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.561 -0.828 . . . . 42.3 113.266 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -82.55 -33.17 28.22 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.632 -0.334 . . . . 65.14 111.576 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.537 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.5 m-20 -97.75 2.43 49.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.609 0.966 . . . . 74.45 113.609 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.431 ' HD2' ' HB3' ' A' ' 107' ' ' TYR 0.326 1.6 p90 -122.18 142.31 50.55 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.14 -1.024 . . . . 75.12 111.114 171.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 15.5 pt-20 -125.03 159.45 31.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.159 -170.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.403 ' CD ' HD11 ' A' ' 75' ' ' LEU . 30.3 ttp-105 -88.85 128.62 35.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.805 -0.443 . . . . 63.44 109.805 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.35 159.78 40.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 122.634 0.374 . . . . 75.43 110.504 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.7 m -93.67 129.43 39.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.986 -0.746 . . . . 71.31 108.986 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.454 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.8 m -136.48 157.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.918 -1.141 . . . . 72.54 107.918 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.51 ' HG3' ' HD3' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -105.18 135.65 46.15 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.276 -0.97 . . . . 54.01 108.762 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 38' ' ' LEU . 21.8 m -127.36 161.94 33.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.704 -0.85 . . . . 65.34 108.704 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 101' ' ' LYS . 71.6 t -102.44 120.1 51.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 109.005 -0.739 . . . . 63.2 109.005 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -71.91 93.12 1.31 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.476 -1.676 . . . . 72.32 106.476 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -47.84 -49.54 28.91 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 127.262 2.225 . . . . 72.13 115.049 -167.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.88 -23.12 58.34 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.166 -0.614 . . . . 65.22 111.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -97.83 -10.89 23.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.3 -0.409 . . . . 62.34 110.864 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 m 59.26 19.49 7.61 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.464 1.106 . . . . 73.45 112.336 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -105.19 160.78 14.81 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.938 -0.393 . . . . 75.3 109.938 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.3 mtmt -100.31 143.21 30.76 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.618 -0.882 . . . . 73.21 108.618 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.75 162.23 15.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.301 -0.629 . . . . 51.33 109.301 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HD3' ' HG3' ' A' ' 92' ' ' GLU . 3.6 tppp? -110.69 123.83 50.78 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.101 -1.074 . . . . 74.44 108.101 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 10' ' ' ASN . 21.2 m -130.97 174.37 13.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.837 0.351 . . . . 73.42 110.564 -174.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -112.11 146.91 37.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.077 -0.712 . . . . 74.33 109.077 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.4 t -149.26 174.03 12.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.085 -1.08 . . . . 75.42 108.085 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.431 ' HB3' ' HD2' ' A' ' 86' ' ' TYR . 90.1 m-85 -113.43 119.55 38.0 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.61 0.719 . . . . 64.53 110.542 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 54' ' ' ILE . 14.0 p -114.0 143.79 22.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.975 -1.011 . . . . 70.31 109.747 -175.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.686 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 61.0 t-105 -70.01 127.86 34.31 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.57 -0.9 . . . . 75.41 108.57 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 85' ' ' ASP . 31.6 m -72.02 -19.82 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.519 0.676 . . . . 72.14 112.559 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.686 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -86.83 15.64 5.62 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 125.216 1.406 . . . . 71.31 109.29 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 0.8 OUTLIER -48.27 -22.96 0.76 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.23 1.812 . . . . 72.43 113.85 -176.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -101.71 68.51 1.16 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.551 -0.859 . . . . 73.32 110.984 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -128.56 144.38 51.93 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 114.798 -1.092 . . . . 74.14 108.331 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.35 -33.2 84.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 53.44 113.642 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.559 ' O ' ' HD2' ' A' ' 116' ' ' ARG 0.265 0.0 OUTLIER -133.26 114.22 13.53 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.112 1.153 . . . . 64.13 114.112 -178.463 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.436 ' HE2' ' HA ' ' A' ' 117' ' ' MET . 1.7 mmt -118.83 -12.58 9.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 115.83 -0.623 . . . . 71.21 110.342 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -86.12 91.24 8.37 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.841 -0.744 . . . . 74.31 109.772 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.41 153.25 2.89 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 114.2 -1.363 . . . . 64.12 111.312 170.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -86.02 131.69 34.22 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.367 0.603 . . . . 53.2 112.19 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -142.64 -154.01 0.5 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.085 -1.45 . . . . 75.33 107.085 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.665 ' OD1' ' HG2' ' A' ' 124' ' ' GLU . 12.1 t70 -127.71 148.66 50.41 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.448 -1.315 . . . . 75.14 107.448 177.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -58.75 -38.16 77.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.934 0.334 . . . . 65.21 111.622 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.665 ' HG2' ' OD1' ' A' ' 122' ' ' ASP . 12.7 pt-20 -73.66 -26.17 60.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.486 0.66 . . . . 72.22 110.109 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -72.67 -34.19 67.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.053 -0.976 . . . . 74.11 108.571 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -86.96 -23.84 24.94 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.467 -0.788 . . . . 74.31 109.546 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -59.49 -45.7 90.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 62.24 110.391 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.6 m -64.18 -19.75 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 116.362 -0.381 . . . . 73.13 111.956 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.3 -22.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.13 0.491 . . . . 63.21 110.552 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.474 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 5.2 p-80 -115.79 -33.12 5.25 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.695 -0.802 . . . . 74.33 112.952 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -59.4 -55.73 31.0 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.811 0.671 . . . . 55.22 112.811 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.49 -34.07 77.37 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.694 -0.402 . . . . 74.43 111.855 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.482 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 1.1 tmtp? -61.55 -50.31 73.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.107 -0.701 . . . . 73.14 109.107 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 84.3 m-85 -69.37 -31.99 70.74 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.052 0.39 . . . . 51.43 112.052 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 131' ' ' ALA . 97.7 t -60.01 -38.66 77.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.061 -0.348 . . . . 62.41 110.061 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 12.8 mm-40 -57.39 -48.13 79.87 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.698 -0.482 . . . . 71.54 109.698 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' A' ' 141' ' ' MET . 34.8 m -57.51 -46.67 83.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.335 -0.848 . . . . 75.4 110.412 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.402 ' O ' HD23 ' A' ' 142' ' ' LEU . 74.1 m-85 -61.47 -48.51 80.79 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.809 -0.356 . . . . 71.5 111.569 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -54.61 -47.51 73.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.703 0.287 . . . . 64.12 110.822 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 75.4 mmtt -66.9 -42.96 84.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.684 -0.689 . . . . 45.35 111.909 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 137' ' ' THR . 60.5 mtm -66.52 -42.95 86.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.718 -0.393 . . . . 73.45 111.248 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.557 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 4.6 mm? -59.22 -49.96 75.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.246 0.832 . . . . 62.43 113.246 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.29 0.567 . . . . 75.22 111.698 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.52 ' NE1' ' HE2' ' A' ' 151' ' ' LYS . 27.6 t90 -75.91 -36.57 59.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.171 -0.922 . . . . 72.03 110.836 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -83.42 -35.57 24.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.299 0.851 . . . . 75.41 113.299 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -79.62 -7.24 58.41 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.863 -0.735 . . . . 73.43 112.308 -177.514 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -143.29 86.41 9.05 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-O 121.027 0.441 . . . . 75.01 111.398 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.4 -22.75 28.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.864 2.376 . . . . 74.33 110.496 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -76.84 -12.65 60.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.529 -0.76 . . . . 72.23 109.985 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -95.83 3.43 65.07 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 115.387 -0.824 . . . . 71.43 111.181 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.52 ' HE2' ' NE1' ' A' ' 144' ' ' TRP . 40.6 ttmt -82.96 137.17 34.28 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.447 -1.316 . . . . 74.5 107.447 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.5 m -62.96 156.51 24.28 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 123.587 0.555 . . . . 72.25 111.428 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 157' ' ' VAL . 65.5 mtt -66.0 -44.2 85.47 Favored 'General case' 0 C--O 1.209 -1.037 0 N-CA-C 113.465 0.913 . . . . 74.24 113.465 -171.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.06 -33.52 63.72 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.575 0.703 . . . . 75.23 111.044 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.14 -39.18 63.46 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.443 -0.799 . . . . 73.24 111.11 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.95 -25.88 60.19 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 116.125 -0.489 . . . . 63.12 112.092 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 153' ' ' MET 0.267 35.0 m -81.21 76.42 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 113.846 1.054 . . . . 62.31 113.846 -178.769 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -91.76 -23.38 28.3 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 108.635 -1.786 . . . . 55.42 108.635 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.6 p -153.1 89.01 1.34 Allowed 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 113.769 -1.215 . . . . 75.14 108.608 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 63.6 tp -90.11 -57.38 2.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.083 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.1 mp 63.11 173.81 0.15 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.84 0.856 . . . . 71.44 110.626 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.0 m -100.67 82.19 2.4 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.972 -1.492 . . . . 65.35 106.972 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.0 m -107.95 168.5 9.24 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.549 -0.751 . . . . 61.21 110.65 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.77 -63.1 4.5 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 109.906 -1.278 . . . . 21.11 109.906 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 . . . . . 0 C--N 1.303 -1.43 0 N-CA-C 107.861 -1.163 . . . . 63.55 107.861 176.567 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 C--O 1.239 0.544 0 N-CA-C 109.46 -0.57 . . . . 63.44 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 p -64.1 120.56 12.3 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.508 -0.923 . . . . 72.11 108.508 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -114.85 148.99 37.8 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 113.927 1.084 . . . . 72.13 113.927 -171.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 t -131.33 103.82 6.67 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 104.547 -2.39 . . . . 74.42 104.547 176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -85.11 119.78 72.82 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 121.08 -0.248 . . . . 64.41 111.25 -172.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.65 -53.07 6.19 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.546 2.83 . . . . 70.41 113.746 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -99.79 69.38 1.58 Allowed 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.336 0.589 . . . . 62.32 112.159 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m -163.49 168.94 19.52 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 124.633 1.173 . . . . 61.24 108.722 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -91.6 148.52 22.22 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.455 -0.793 . . . . 75.32 109.508 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 83.1 m-20 -129.06 122.72 30.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.949 -1.13 . . . . 65.32 107.949 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 29.3 t -117.72 120.36 64.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.554 -0.459 . . . . 75.34 111.422 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -83.78 110.83 18.65 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.465 -1.309 . . . . 70.13 107.465 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG11 HD11 ' A' ' 17' ' ' ILE . 7.9 p -136.17 158.07 38.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.244 -0.582 . . . . 70.03 110.066 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.88 22.02 6.83 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-O 121.074 0.464 . . . . 72.22 110.988 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.501 ' HA3' ' CZ ' ' A' ' 51' ' ' TYR . . . -136.29 -133.7 3.23 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 118.128 -1.987 . . . . 61.02 117.072 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.6 m -40.46 -47.68 2.65 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.821 2.156 . . . . 71.22 116.821 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 67' ' ' ILE . 2.4 pp -84.71 1.48 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 114.583 1.327 . . . . 74.42 114.583 -171.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD11 HG13 ' A' ' 13' ' ' VAL . 9.8 mp -68.54 -11.2 59.59 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.511 0.56 . . . . 64.11 112.511 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.9 119.05 75.45 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 107.121 -1.437 . . . . 52.41 107.121 170.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -47.52 -37.29 25.96 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.751 2.967 . . . . 74.34 114.036 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.98 -35.03 79.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.407 -0.361 . . . . 62.35 111.293 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 17' ' ' ILE . 45.3 t -76.92 -40.59 31.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.252 -0.431 . . . . 71.05 110.219 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -58.84 -33.81 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.676 . . . . 71.4 109.602 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.61 -11.33 59.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.452 -0.794 . . . . 75.11 112.46 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.5 m -102.12 -26.86 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.869 -0.732 . . . . 74.34 110.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 78' ' ' PHE . 9.5 tt -77.05 -36.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.344 0.592 . . . . 75.02 110.607 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 31' ' ' ALA . 90.1 mt -95.93 -14.7 22.89 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.045 -0.525 . . . . 71.53 110.242 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 68.44 -1.22 1.96 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.461 1.124 . . . . 74.04 109.927 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 94.8 mtt180 -133.53 176.85 8.17 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.466 -1.679 . . . . 64.11 106.466 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -77.01 144.09 38.92 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.078 0.466 . . . . 74.23 111.251 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.65 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -116.27 134.97 54.31 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 109.046 -0.724 . . . . 72.34 109.046 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -99.42 109.71 22.27 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.903 -1.519 . . . . 74.24 109.174 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 3.0 p -105.93 142.12 36.18 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 120.272 -0.571 . . . . 75.44 109.933 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.15 137.64 31.43 Favored Pre-proline 0 C--N 1.284 -2.27 0 N-CA-C 108.766 -0.827 . . . . 73.42 108.766 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 96' ' ' MET . 6.4 Cg_endo -57.47 117.72 4.47 Favored 'Trans proline' 0 CA--C 1.504 -0.99 0 C-N-CA 122.254 1.969 . . . . 73.21 109.719 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.86 155.2 50.68 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.972 -0.751 . . . . 63.53 108.972 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.593 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.6 p -125.86 127.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.745 0.783 . . . . 71.24 111.695 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.488 HD11 ' HB ' ' A' ' 91' ' ' VAL . 20.8 tp -87.59 96.29 10.36 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.017 -0.992 . . . . 74.21 112.398 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -72.56 126.35 29.65 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.36 -0.836 . . . . 62.33 110.263 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.84 -7.84 17.05 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 119.635 -1.269 . . . . 70.53 113.14 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 33.8 m-85 -126.7 145.11 50.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 112.642 0.608 . . . . 74.32 112.642 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 22.3 t-160 -105.34 127.09 52.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.363 -0.835 . . . . 64.31 108.765 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' HG22 ' A' ' 54' ' ' ILE . 2.4 ptm180 -87.93 137.59 32.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.162 -0.681 . . . . 71.33 109.162 175.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.4 ' HD2' ' O ' ' A' ' 117' ' ' MET . 22.2 m-85 -98.81 177.93 5.12 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 115.85 -0.614 . . . . 74.45 109.918 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -117.03 -28.59 6.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 114.005 1.113 . . . . 55.11 114.005 -177.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 52' ' ' PRO . 4.1 mm? 57.88 -169.92 0.11 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.503 0.502 . . . . 71.21 111.576 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 23.29 5.19 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.731 -0.788 . . . . 63.45 112.886 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.64 7.18 0.08 OUTLIER Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.284 -0.96 . . . . 70.13 113.112 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.77 161.11 36.92 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 117.163 0.482 . . . . 71.43 110.413 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.41 96.18 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.114 2.543 . . . . 72.23 114.598 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.605 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.6 p90 44.2 35.11 0.2 Allowed Pre-proline 0 N--CA 1.515 2.815 0 N-CA-C 116.52 2.045 . . . . 71.11 116.52 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.893 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 72.6 Cg_endo -108.5 166.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.274 2.65 . . . . 74.13 113.516 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.893 ' SG ' ' HB2' ' A' ' 52' ' ' PRO . 33.5 m -134.29 -179.25 5.46 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 103.94 -2.615 . . . . 61.1 103.94 -4.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 43' ' ' ARG . 40.2 pt -123.99 121.03 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 119.609 1.095 . . . . 75.4 112.179 174.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -154.12 133.04 3.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.743 -0.662 . . . . 73.35 111.454 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t 64.72 -175.99 0.17 Allowed 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.504 1.122 . . . . 75.52 113.426 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.595 ' HB3' ' HB2' ' A' ' 42' ' ' HIS . 20.6 t 78.67 112.52 0.07 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.59 1.956 . . . . 72.24 112.932 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.17 -27.16 32.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.432 0.635 . . . . 75.34 109.944 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.5 m -82.97 -9.2 59.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.771 -0.649 . . . . 65.02 110.421 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.26 153.65 21.48 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.742 -0.663 . . . . 61.34 112.354 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.593 ' HE2' HG21 ' A' ' 37' ' ' VAL . 21.0 ptmt -154.17 145.7 23.18 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.293 -1.003 . . . . 55.31 108.293 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 54' ' ' ILE . 62.1 t -114.27 123.76 70.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 112.044 0.387 . . . . 64.45 112.044 -173.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -88.1 120.6 29.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.536 -0.302 . . . . 74.24 110.242 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.34 -147.23 4.57 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.7 143.58 39.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.465 0.633 . . . . 74.15 110.121 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.68 133.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 109.336 -0.616 . . . . 75.31 109.336 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 4.6 mt -89.47 117.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 106.445 -1.687 . . . . 74.34 106.445 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -104.1 160.42 14.86 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.022 -1.071 . . . . 62.12 109.225 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.57 30.0 41.79 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.224 -0.988 . . . . 53.24 113.656 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.55 124.29 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.29 0.545 . . . . 75.03 110.013 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.563 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.9 m -75.48 158.29 32.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.791 -0.818 . . . . 70.34 108.791 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.17 -39.79 79.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.071 0.397 . . . . 74.02 112.071 -175.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.84 64.73 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.09 0.471 . . . . 51.2 110.732 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.563 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 50.7 mm-40 -73.64 -30.94 63.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.568 -0.742 . . . . 74.21 110.34 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.78 -37.05 73.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.178 0.991 . . . . 75.1 111.32 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 39.1 m-80 -57.37 -27.58 62.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.309 0.644 . . . . 74.02 111.657 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -69.08 -31.7 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.241 -0.652 . . . . 62.41 109.241 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD1' HD13 ' A' ' 26' ' ' ILE . 95.8 m-85 -70.97 -29.25 65.19 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 120.415 -0.514 . . . . 74.22 109.764 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 3.1 m-20 -60.96 -41.19 95.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.586 0.708 . . . . 74.25 109.439 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 76' ' ' ASN . 43.0 t -65.24 -34.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.012 -0.995 . . . . 74.35 110.394 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -62.01 -50.75 78.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.233 -0.44 . . . . 64.11 111.152 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.06 141.83 12.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 120.933 0.397 . . . . 73.05 110.665 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.68 28.71 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.277 -0.874 . . . . 75.01 111.191 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -76.42 -43.06 41.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 120.187 -0.605 . . . . 51.41 110.551 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 110' ' ' VAL . 8.1 m-20 -125.93 13.15 7.89 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.091 0.948 . . . . 61.25 108.534 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 50.5 m-85 -115.9 149.44 38.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.334 -1.358 . . . . 72.3 107.334 -177.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 16.4 pt-20 -130.76 155.88 45.91 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.586 0.232 . . . . 74.1 110.531 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 106' ' ' THR . 45.5 ttm180 -91.1 126.66 36.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.865 0.364 . . . . 71.24 111.511 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.16 159.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.444 -0.947 . . . . 71.4 108.444 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 m -96.17 123.01 39.63 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.223 -0.658 . . . . 52.2 109.223 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 38' ' ' LEU . 26.8 m -125.96 157.76 35.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 123.826 0.85 . . . . 71.11 109.727 -175.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 29.3 tt0 -105.24 125.18 50.69 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.207 -0.597 . . . . 61.4 109.52 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 38' ' ' LEU . 15.1 m -126.13 168.41 19.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.964 -0.754 . . . . 63.33 108.964 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 96' ' ' MET . 68.6 t -104.25 128.12 57.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.341 -0.985 . . . . 73.51 108.341 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -68.53 -15.44 63.54 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.951 0.782 . . . . 73.43 110.215 -174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.566 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER 70.61 -54.86 0.64 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.131 1.773 . . . . 73.12 113.882 172.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -48.63 -45.65 38.7 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 70.43 111.432 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -114.87 9.95 16.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 123.345 0.658 . . . . 64.24 110.508 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.7 m 62.83 10.06 4.05 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.81 1.041 . . . . 74.54 113.81 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 161.11 21.85 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.569 -0.452 . . . . 44.0 110.361 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HG2' HG22 ' A' ' 94' ' ' VAL . 88.2 mttt -101.91 134.05 45.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.654 -0.869 . . . . 74.11 108.654 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.01 139.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.727 -0.842 . . . . 71.32 108.727 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 28.3 ttpt -107.48 116.65 32.33 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.865 0.84 . . . . 74.25 110.597 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.21 177.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.0 -1.454 . . . . 73.31 110.696 -168.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.32 144.09 28.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.804 -0.443 . . . . 71.22 109.804 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 10.5 t -144.72 175.22 10.33 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.233 -0.654 . . . . 73.34 109.233 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 78.3 m-85 -110.43 119.48 39.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.273 0.358 . . . . 74.14 110.272 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 54' ' ' ILE . 34.8 m -109.84 -173.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.918 -0.771 . . . . 60.44 108.918 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.497 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 61.1 t-105 -99.13 122.71 42.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.018 -0.734 . . . . 74.41 109.018 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' A' ' 87' ' ' GLU . 26.8 m -65.61 -35.89 76.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 CA-C-O 121.363 0.601 . . . . 74.44 111.401 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 114' ' ' ASP . 5.0 t30 -88.18 15.75 7.12 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.979 1.312 . . . . 71.22 109.506 -173.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.7 ptpp? -47.43 -14.87 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 126.859 2.064 . . . . 72.35 115.048 -171.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -90.4 6.8 41.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.828 0.347 . . . . 72.23 111.825 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' HB3' ' ND2' ' A' ' 111' ' ' ASN . 3.1 p30 -85.65 160.07 54.04 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.911 -1.144 . . . . 75.1 107.911 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.18 99.47 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.053 1.836 . . . . 63.21 110.827 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.692 ' HD3' ' H ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.65 -0.704 . . . . 74.03 111.366 -176.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.4 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 49.2 ttm -72.93 98.48 2.49 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.486 -1.234 . . . . 74.42 111.707 -174.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -101.65 -48.22 4.38 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 119.918 -0.713 . . . . 71.51 109.814 175.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.43 -112.95 2.64 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.535 -1.426 . . . . 71.31 109.535 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -121.46 137.93 54.51 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 106.035 -1.839 . . . . 61.21 106.035 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -100.34 172.82 6.91 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.326 -1.731 . . . . 70.2 106.326 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.09 111.74 18.5 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.136 -1.026 . . . . 71.45 110.987 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -68.22 -33.04 73.68 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.758 -1.11 . . . . 61.53 110.142 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.24 -28.85 64.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.682 -0.69 . . . . 70.1 110.381 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 128' ' ' VAL . 8.5 tp10 -76.02 -37.45 58.39 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.128 -1.434 . . . . 64.03 107.128 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -57.74 -28.67 64.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.902 -1.045 . . . . 74.45 111.364 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -57.74 -49.08 77.77 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.234 0.457 . . . . 73.31 112.234 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 125' ' ' GLU . 18.8 m -72.24 -27.68 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.329 -0.548 . . . . 73.52 110.232 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 125' ' ' GLU . 88.6 t -68.44 -28.29 39.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.246 -0.888 . . . . 54.31 110.954 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -99.4 -28.58 13.21 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.869 -1.132 . . . . 73.23 110.843 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.54 82.45 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.786 -0.643 . . . . 71.42 112.3 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.47 -24.0 66.35 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 113.132 0.79 . . . . 62.42 113.132 -177.06 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 6.4 tmtt? -76.22 -55.78 5.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 109.604 -0.517 . . . . 64.12 109.604 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -63.86 -32.11 73.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.836 0.68 . . . . 60.05 112.836 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.61 -37.3 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 119.813 -0.755 . . . . 74.43 110.228 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 7.3 mm-40 -62.87 -39.72 95.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.849 -0.426 . . . . 71.32 109.849 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.505 -0.77 . . . . 73.53 110.7 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -67.72 -36.67 81.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.685 -0.487 . . . . 63.32 109.685 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 98.4 mtt180 -64.53 -51.59 62.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.973 -0.558 . . . . 73.4 110.929 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 31.1 mmmt -63.54 -34.54 78.01 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 112.672 0.619 . . . . 73.04 112.672 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.1 ptm -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.521 -0.872 . . . . 73.2 109.717 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 tp -77.36 -50.12 13.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 74.35 111.248 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HG3' ' HA ' ' A' ' 140' ' ' LYS 0.25 0.0 OUTLIER -68.47 -24.61 64.72 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.266 0.469 . . . . 62.54 112.266 -178.287 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -75.41 -43.81 47.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.81 -0.632 . . . . 74.34 110.817 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -69.05 -35.1 76.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.522 0.677 . . . . 74.33 110.01 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 41.1 ttmt -92.52 8.18 39.94 Favored 'General case' 0 CA--C 1.565 1.525 0 CA-C-N 115.498 -0.774 . . . . 72.14 110.554 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 28.0 t-20 -46.71 118.52 5.06 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 123.804 0.842 . . . . 73.51 112.909 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 19.9 Cg_exo -63.18 -24.26 72.75 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.492 2.795 . . . . 74.1 113.577 -176.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.35 -13.77 59.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.462 0.649 . . . . 70.31 110.176 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.04 24.38 55.17 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.793 -0.639 . . . . 52.12 113.58 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.07 122.33 29.94 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.818 0.673 . . . . 73.34 112.818 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 77.5 p -115.53 168.48 9.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.652 -1.24 . . . . 71.54 107.652 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 19.1 ptp -73.34 -25.7 60.73 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.968 -0.693 . . . . 74.12 109.93 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.33 -37.8 68.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.314 -0.857 . . . . 73.24 109.137 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.45 ' HA ' ' OG ' ' A' ' 159' ' ' SER . 34.3 tt0 -75.07 -31.59 61.27 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.247 -0.888 . . . . 63.2 109.816 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.99 -34.98 78.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.199 -0.91 . . . . 43.32 110.195 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.03 -172.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.336 -0.616 . . . . 75.32 109.336 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -67.75 102.88 0.88 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.914 -0.875 . . . . 63.42 110.914 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 155' ' ' GLU . 16.2 m -75.05 155.37 37.3 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.181 0.592 . . . . 73.32 110.113 -178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.0 tp -88.13 128.65 35.43 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.592 -0.522 . . . . 71.2 109.592 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.19 126.51 42.43 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.423 -0.954 . . . . 74.41 108.423 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 p -66.07 93.26 0.19 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.826 0.822 . . . . 71.32 110.945 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.7 p -160.37 115.56 2.28 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.244 -0.889 . . . . 74.41 110.34 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.69 -38.47 5.23 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.432 -0.89 . . . . 42.4 111.602 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.306 -1.305 0 N-CA-C 108.567 -0.901 . . . . 73.0 108.567 -179.624 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.441 -0.898 0 N-CA-C 108.532 -0.914 . . . . 74.23 108.532 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.1 p -84.34 96.07 8.93 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.539 0.685 . . . . 73.14 110.692 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 p -102.15 92.5 4.78 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 115.882 -0.599 . . . . 51.33 110.662 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.0 m -84.05 -31.26 25.48 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.701 -1.222 . . . . 63.24 107.701 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.9 t70 68.13 129.2 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.288 1.435 . . . . 44.31 112.739 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.86 17.5 0.82 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.09 2.527 . . . . 73.34 114.821 -176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -56.58 -36.21 69.08 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.878 0.847 . . . . 51.34 109.509 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.1 p -135.38 130.49 35.0 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 106.864 -1.532 . . . . 61.54 106.864 173.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -90.7 143.46 26.71 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.107 0.479 . . . . 71.32 111.739 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.7 m-20 -128.31 122.36 31.43 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.454 -1.313 . . . . 74.24 107.454 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.23 121.28 67.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 121.053 -0.259 . . . . 71.33 110.56 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.4 ' HB2' HG21 ' A' ' 104' ' ' VAL . 64.3 t80 -81.44 112.15 18.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 107.97 -1.122 . . . . 74.1 107.97 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 17' ' ' ILE . 24.1 m -113.49 140.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.531 0.681 . . . . 75.24 112.458 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -131.87 121.79 24.63 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.557 -1.275 . . . . 75.53 107.557 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.3 -58.91 4.17 Favored Glycine 0 C--N 1.302 -1.315 0 C-N-CA 120.895 -0.669 . . . . 72.44 111.441 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.1 m -78.25 145.82 35.23 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.97 -0.381 . . . . 73.13 109.97 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.486 HG21 ' CD1' ' A' ' 67' ' ' ILE . 9.3 mm 70.23 -104.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.8 1.24 . . . . 71.32 108.586 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.259 77.4 mt 49.1 -36.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.651 2.38 . . . . 64.33 117.092 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.19 132.15 29.9 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 109.393 -0.595 . . . . 72.22 109.393 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.4 -40.3 28.71 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.9 3.067 . . . . 61.43 113.543 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -60.16 -47.94 83.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.982 0.42 . . . . 71.42 110.967 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.67 -39.73 85.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.406 0.622 . . . . 23.22 110.402 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 31' ' ' ALA . . . -66.88 -34.94 78.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.81 -0.632 . . . . 64.42 110.947 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -75.62 -26.46 57.81 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.654 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 21' ' ' ALA . 20.9 m -85.34 -23.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.432 -0.507 . . . . 74.24 111.595 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.451 HD13 ' CD1' ' A' ' 78' ' ' PHE . 10.5 tt -82.46 -40.97 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.138 -0.625 . . . . 74.24 111.067 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 31' ' ' ALA . 82.8 mt -83.68 -18.17 38.94 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.293 -0.412 . . . . 74.42 111.27 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 64.18 25.91 13.74 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 106.739 -1.578 . . . . 62.12 106.739 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.4 ttt180 -162.83 166.59 23.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.678 -1.601 . . . . 73.53 106.68 -174.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -75.39 136.44 40.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 118.098 0.408 . . . . 74.11 110.426 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -101.73 141.32 34.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 115.964 -0.562 . . . . 54.12 112.015 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -100.11 110.23 22.51 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.733 -0.667 . . . . 64.24 109.516 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.7 p -115.98 143.42 45.48 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.255 -0.43 . . . . 75.0 110.824 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.41 139.96 35.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.01 -0.737 . . . . 45.43 109.01 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.53 134.12 58.98 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.403 2.069 . . . . 64.23 112.028 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.514 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.88 157.03 42.78 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.377 -0.828 . . . . 64.21 110.246 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.12 127.89 72.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.537 0.684 . . . . 70.15 111.41 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HA ' HG12 ' A' ' 93' ' ' VAL . 28.4 tp -91.39 95.93 10.25 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.405 -0.816 . . . . 71.43 111.809 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 9.9 p-80 -71.94 127.31 32.17 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.318 -0.855 . . . . 74.54 109.148 170.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.95 -17.48 7.63 Favored Glycine 0 C--N 1.292 -1.9 0 C-N-CA 119.69 -1.243 . . . . 51.23 112.651 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -124.93 160.26 29.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.091 0.774 . . . . 72.23 113.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.02 132.85 42.33 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.744 -1.116 . . . . 60.44 109.672 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HB3' HG22 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -92.48 151.48 20.17 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.623 0.971 . . . . 74.43 113.623 -177.348 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.476 ' HA ' ' CH2' ' A' ' 121' ' ' TRP . 94.2 m-85 -130.15 169.86 14.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.846 -1.07 . . . . 73.44 109.539 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 71.5 mmtt -138.46 86.83 2.18 Favored 'General case' 0 CA--C 1.485 -1.524 0 O-C-N 124.055 0.847 . . . . 73.03 111.447 173.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.524 ' HB3' ' HG3' ' A' ' 120' ' ' GLU 0.35 0.3 OUTLIER -89.84 97.9 11.46 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.179 -1.008 . . . . 71.51 111.301 174.331 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -66.16 -23.22 66.43 Favored 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.52 1.528 . . . . 75.04 110.792 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.83 -12.91 63.01 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 115.435 -0.802 . . . . 52.14 111.782 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.2 mt -126.26 170.13 10.31 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 125.438 1.495 . . . . 70.14 107.432 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.89 50.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.519 2.978 0 C-N-CA 124.138 3.226 . . . . 73.44 114.981 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.547 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.487 7.8 p90 48.47 63.69 9.91 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 118.94 2.941 . . . . 72.13 118.94 178.169 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 3.2 Cg_endo -95.98 169.12 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.578 4.185 . . . . 53.21 109.261 172.387 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 6.0 p -157.41 -167.3 2.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.508 2.723 . . . . 53.0 108.499 -3.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' A' ' 43' ' ' ARG . 47.9 pt -123.74 131.07 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 107.13 -1.433 . . . . 74.13 107.13 162.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.48 HG21 ' SD ' ' A' ' 117' ' ' MET . 31.1 m -145.21 166.77 10.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 116.478 -0.328 . . . . 74.44 111.227 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t 63.6 138.7 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.797 1.639 . . . . 73.02 113.922 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -80.79 75.47 7.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.333 1.063 . . . . 64.13 110.711 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.65 168.25 16.49 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.254 -1.339 . . . . 75.4 110.044 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.8 m -91.69 4.8 51.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.151 0.501 . . . . 73.2 110.942 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.13 -167.84 43.74 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.334 -0.706 . . . . 73.2 111.334 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 39' ' ' HIS . 8.8 ptpp? -153.77 151.57 29.73 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.37 -0.532 . . . . 73.24 112.193 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.4 128.66 71.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 C-N-CA 124.095 0.958 . . . . 73.2 109.109 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -100.97 132.53 46.34 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.526 -0.87 . . . . 65.34 110.594 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.92 -138.08 2.44 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.93 -0.868 . . . . 52.34 110.93 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -142.68 145.23 33.2 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.12 0.568 . . . . 71.21 110.708 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.28 129.79 56.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.673 -0.491 . . . . 73.4 109.673 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.486 ' CD1' HG21 ' A' ' 17' ' ' ILE . 18.1 mt -89.46 110.91 22.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 106.834 -1.543 . . . . 63.21 106.834 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.2 p -99.25 161.84 13.39 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 116.054 -0.521 . . . . 64.04 111.464 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.57 74.25 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.329 -0.462 . . . . 73.04 113.189 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.29 128.93 38.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.652 -0.87 . . . . 72.43 108.652 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -85.3 160.95 19.71 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.823 -0.806 . . . . 64.3 108.823 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -52.36 -37.89 57.34 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.475 0.71 . . . . 72.42 111.846 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.83 63.13 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.924 -0.58 . . . . 34.32 111.464 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.57 -32.07 72.58 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.929 -0.309 . . . . 72.34 111.149 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.11 -33.85 69.56 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.742 -0.663 . . . . 74.02 110.469 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 80' ' ' VAL . 22.1 t-20 -63.58 -28.65 70.08 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.61 -0.723 . . . . 63.13 110.692 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -74.91 -31.88 61.66 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.817 -0.808 . . . . 63.22 108.817 -175.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CD1' HD13 ' A' ' 26' ' ' ILE . 96.4 m-85 -64.8 -36.5 84.53 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 115.461 -0.79 . . . . 74.35 110.476 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.21 -31.55 71.15 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.541 0.686 . . . . 73.32 110.116 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 76' ' ' ASN . 55.6 t -75.64 -44.34 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 115.64 -0.709 . . . . 62.41 112.344 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 ' HA ' ' A' ' 78' ' ' PHE . 11.3 tt -72.13 117.72 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.306 0.574 . . . . 63.14 112.24 -175.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.19 3.09 0.49 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.714 1.206 . . . . 75.4 113.978 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.37 53.56 1.54 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 111.358 -0.697 . . . . 53.33 111.358 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -82.37 -40.71 20.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.838 0.351 . . . . 62.43 110.825 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.615 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 5.6 t70 -119.88 28.87 7.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.667 1.222 . . . . 54.14 107.806 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.446 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 70.6 m-85 -113.76 161.16 17.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.48 -1.236 . . . . 75.25 109.707 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -130.48 141.91 50.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.936 -1.135 . . . . 75.45 107.936 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -81.88 121.47 26.5 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.191 -0.458 . . . . 74.51 110.996 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.33 159.64 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.71 -0.677 . . . . 75.54 110.205 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.1 m -97.8 124.56 42.24 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.945 -0.761 . . . . 70.04 108.945 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.13 169.95 13.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.582 -0.896 . . . . 72.5 108.582 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -124.79 120.93 33.13 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.651 -0.87 . . . . 75.32 108.651 -173.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 38' ' ' LEU . 21.0 m -126.0 168.78 18.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-O 121.383 0.611 . . . . 72.31 110.886 -170.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.539 HG22 ' HG2' ' A' ' 101' ' ' LYS . 71.3 t -110.52 118.81 58.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.481 -0.782 . . . . 64.25 109.464 175.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -74.33 95.1 2.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 109.246 -0.65 . . . . 74.42 109.246 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.514 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -48.1 -33.64 8.51 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 126.57 1.948 . . . . 75.04 110.596 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.76 -38.71 70.2 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.458 -0.792 . . . . 64.1 112.013 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.61 -10.62 11.83 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.341 0.591 . . . . 72.04 109.748 -177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.6 t 67.71 22.5 8.93 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.07 0.948 . . . . 62.43 110.074 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -97.17 160.38 14.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.922 -0.581 . . . . 75.22 109.458 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HG2' HG22 ' A' ' 94' ' ' VAL . 5.9 mtpm? -101.85 135.78 42.82 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.613 -0.884 . . . . 52.42 108.613 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.86 145.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.064 0.459 . . . . 73.21 110.345 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -91.94 124.15 35.84 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.238 -1.023 . . . . 74.32 108.238 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 12' ' ' PHE . 32.6 m -136.69 175.59 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.815 0.446 . . . . 73.41 110.691 -175.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -106.8 153.5 22.37 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.972 -0.455 . . . . 74.13 111.057 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 t -154.87 177.9 10.76 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 110.273 -0.269 . . . . 70.43 110.273 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -104.76 119.8 39.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.08 0.952 . . . . 62.51 108.673 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.75 151.88 20.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.553 -0.459 . . . . 73.51 109.913 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.615 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 35.6 t-105 -79.36 127.05 31.61 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.084 -0.709 . . . . 75.31 109.084 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.7 m -72.64 -28.3 27.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.115 0.483 . . . . 63.22 112.236 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 62.5 t30 -79.3 13.21 1.99 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.678 0.791 . . . . 70.24 111.282 -176.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -51.65 -14.86 0.38 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.014 1.857 . . . . 52.32 116.014 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 9.4 m-20 -72.87 9.96 1.01 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.124 0.488 . . . . 65.13 112.135 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.41 131.82 49.15 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 108.064 -1.087 . . . . 70.41 108.064 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 -15.98 28.48 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.317 2.678 . . . . 74.23 116.457 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -130.6 113.97 14.87 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 117.673 -1.611 . . . . 72.32 114.259 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 55' ' ' VAL . 66.2 mtt -140.64 111.54 7.02 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.745 -1.116 . . . . 63.53 109.064 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.5 p90 176.01 -28.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.598 1.159 . . . . 75.44 109.668 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.99 36.04 3.73 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.976 -0.556 . . . . 75.51 111.719 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 46' ' ' LEU . 1.2 mp0 -87.73 -179.69 6.33 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 123.809 0.844 . . . . 54.45 110.987 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.476 ' CH2' ' HA ' ' A' ' 44' ' ' TYR . 31.2 m-90 74.33 166.72 0.29 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.493 1.117 . . . . 75.54 111.201 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.86 147.63 28.2 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.629 -1.249 . . . . 73.11 107.629 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -57.97 -40.54 80.87 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.727 0.299 . . . . 62.2 111.193 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -74.5 -42.88 58.18 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.44 -0.578 . . . . 61.34 109.44 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.7 mt-10 -66.94 -41.34 87.16 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.954 -0.566 . . . . 73.15 111.791 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -60.95 -24.46 66.08 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.909 0.385 . . . . 74.3 111.301 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -58.43 -43.19 88.63 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.281 -0.637 . . . . 74.13 109.281 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 125' ' ' GLU . 17.9 m -84.37 -31.68 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 119.993 -0.683 . . . . 65.2 110.946 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 125' ' ' GLU . 52.2 t -68.18 -39.31 81.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 116.794 -0.185 . . . . 73.12 111.066 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.405 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 1.4 p-80 -67.47 -32.34 73.12 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.413 -0.915 . . . . 73.24 110.254 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.73 83.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 54.43 110.024 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.5 -25.77 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.259 -0.882 . . . . 71.04 112.249 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.532 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -76.68 -57.37 3.89 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.231 -1.396 . . . . 64.5 107.231 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 92.0 m-85 -61.79 -33.5 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.503 1.297 . . . . 63.31 114.503 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.461 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.8 p -58.1 -41.94 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.33 -0.548 . . . . 63.45 110.66 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 24.0 mm-40 -66.12 -39.35 89.83 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.172 -0.467 . . . . 54.31 110.494 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.7 m -59.32 -49.6 77.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 72.42 110.475 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -57.77 -41.61 82.38 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 121.134 -0.226 . . . . 64.33 111.247 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 82.5 mtp180 -63.27 -47.92 80.32 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.572 0.545 . . . . 71.33 111.193 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 73.1 mmtt -65.35 -42.97 92.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.747 0.308 . . . . 74.4 110.881 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.6 mmt -61.79 -35.82 79.3 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.052 -0.722 . . . . 65.25 109.052 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.77 -39.09 90.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.537 -0.912 . . . . 74.03 108.537 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -64.06 -47.84 78.6 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.555 -0.293 . . . . 74.04 110.798 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -69.95 -28.66 65.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.611 0.967 . . . . 70.13 113.611 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -82.0 -47.76 12.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.972 0.36 . . . . 51.22 111.972 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.0 -26.94 30.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.227 0.455 . . . . 73.41 112.227 -175.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -136.03 78.16 47.78 Favored Pre-proline 0 C--N 1.313 -1.007 0 C-N-CA 120.605 -0.438 . . . . 71.22 111.885 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.71 -29.71 35.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.99 1.793 . . . . 73.3 109.875 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -87.56 0.11 56.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.308 -0.86 . . . . 74.43 109.763 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -80.33 -23.89 60.06 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.984 -1.246 . . . . 64.23 109.984 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -80.07 151.08 30.08 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.981 -1.488 . . . . 74.02 106.981 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 45.4 m -62.44 156.74 21.88 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 112.169 0.433 . . . . 75.33 112.169 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 67.2 mtt -61.78 -45.09 95.38 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 114.949 1.463 . . . . 72.21 114.949 -169.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -65.18 -36.21 83.5 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.595 0.712 . . . . 74.23 109.97 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -73.45 -36.69 65.92 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.701 -1.136 . . . . 72.14 109.764 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.86 45.05 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.67 -0.696 . . . . 50.42 112.499 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.69 -12.95 9.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 113.11 0.781 . . . . 64.02 113.11 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -139.74 -138.69 3.66 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 119.857 -1.163 . . . . 23.35 111.876 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.0 m 72.77 163.75 0.28 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.718 1.207 . . . . 73.24 111.948 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.54 116.44 28.96 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.489 0.661 . . . . 72.33 109.439 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -174.32 139.1 0.58 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.036 -1.438 . . . . 74.22 108.357 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.1 m -81.71 79.48 8.26 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.679 0.752 . . . . 63.5 109.476 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.7 m -153.65 119.46 5.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.904 -1.044 . . . . 71.5 108.203 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 147.48 -60.7 0.46 Allowed Glycine 0 CA--C 1.492 -1.358 0 N-CA-C 110.062 -1.215 . . . . 60.04 110.062 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 109.434 -0.58 . . . . 63.12 109.434 176.839 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 109.345 -0.613 . . . . 73.42 109.345 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 4' ' ' SER . 37.2 m 76.77 146.32 0.09 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.998 0.919 . . . . 73.21 110.397 -177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 m -57.07 -29.84 63.8 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.448 0.699 . . . . 72.32 111.15 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 2' ' ' THR . 20.4 m -108.52 102.62 11.68 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.668 -0.696 . . . . 54.51 111.579 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 7' ' ' GLN . 15.7 t70 -81.92 150.49 65.53 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 106.913 -1.514 . . . . 70.3 106.913 172.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -57.49 35.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 124.839 3.693 . . . . 71.01 116.082 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -152.13 54.9 0.82 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 102.51 -3.144 . . . . 73.43 102.51 175.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 m -75.12 135.65 41.14 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.368 -1.287 . . . . 53.25 112.253 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -107.97 156.35 19.32 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.75 -1.113 . . . . 73.32 111.034 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.3 m-20 -125.14 122.91 38.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.144 -1.428 . . . . 75.11 107.144 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 19.5 t -119.78 124.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 120.753 -0.379 . . . . 72.25 110.976 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.509 ' HB2' HG21 ' A' ' 104' ' ' VAL . 73.4 t80 -84.02 113.91 21.34 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.825 -0.806 . . . . 74.32 108.825 175.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -125.17 160.54 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.518 0.675 . . . . 73.33 111.973 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -145.71 -55.67 0.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.815 -1.55 . . . . 71.51 106.815 175.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.5 63.27 0.6 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.513 -1.035 . . . . 75.2 110.513 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 m -153.97 -79.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.192 . . . . 71.4 111.033 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 67' ' ' ILE . 33.2 pt -145.78 86.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 122.173 0.987 . . . . 51.44 111.312 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 65' ' ' LYS . 77.7 mt -99.63 -5.19 29.39 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.474 -0.766 . . . . 63.24 109.223 175.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.78 130.81 24.6 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.258 -0.883 . . . . 65.23 111.046 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.62 -42.56 18.77 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.174 3.249 . . . . 71.14 114.417 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.38 83.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.744 0.276 . . . . 44.55 111.744 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.7 p -77.26 -30.87 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.288 0.566 . . . . 65.34 111.044 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.397 0.618 . . . . 71.14 109.377 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -74.85 -5.69 44.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.644 -0.707 . . . . 62.22 112.197 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.1 m -105.98 -15.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.805 -0.758 . . . . 72.3 111.223 177.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.587 HG21 HD13 ' A' ' 17' ' ' ILE . 10.0 tt -92.72 -42.47 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 121.468 0.651 . . . . 74.44 110.333 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 95.3 mt -87.08 -27.24 23.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.882 -0.599 . . . . 75.34 110.002 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 73.17 3.3 4.61 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.479 1.133 . . . . 75.04 108.122 -170.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.9 mmt180 -126.07 154.81 42.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.195 -2.15 . . . . 72.32 105.195 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -96.96 110.41 22.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.677 -1.209 . . . . 71.22 108.75 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 156.29 17.67 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.882 -0.599 . . . . 74.54 110.532 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.66 125.54 41.2 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.516 0.674 . . . . 54.21 112.816 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 p -100.44 143.94 30.03 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.582 -1.19 . . . . 72.42 109.532 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.7 141.66 38.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.304 -0.999 . . . . 74.4 108.304 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.483 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 2.1 Cg_endo -65.44 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.001 1.801 . . . . 75.44 111.637 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -150.17 156.36 41.46 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.691 -0.686 . . . . 75.42 110.444 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -122.44 127.84 75.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-O 121.399 0.619 . . . . 73.03 111.378 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 93' ' ' VAL . 23.7 tp -90.49 97.86 11.43 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.206 -0.906 . . . . 72.34 109.429 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.532 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 6.3 p80 -70.63 132.3 45.23 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.014 -0.994 . . . . 71.43 110.018 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.61 38.57 Favored Glycine 0 C--O 1.215 -1.044 0 C-N-CA 118.844 -1.646 . . . . 74.22 113.993 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -101.99 143.35 31.95 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 113.768 1.025 . . . . 72.01 113.768 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.579 ' HB2' ' CB ' ' A' ' 58' ' ' ASP . 2.9 t-160 -104.63 122.55 45.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.386 -1.279 . . . . 53.25 108.379 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -89.53 115.86 27.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.189 -1.041 . . . . 71.41 108.189 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.401 ' HD2' ' O ' ' A' ' 117' ' ' MET . 26.3 m-85 -81.3 141.86 33.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.6 -0.518 . . . . 62.14 109.6 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -97.54 124.54 41.82 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.37 0.605 . . . . 75.34 111.291 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.77 133.1 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.835 -0.62 . . . . 62.33 110.079 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.89 -41.08 7.38 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 108.08 -1.082 . . . . 54.0 108.08 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.56 -21.15 77.62 Favored Glycine 0 N--CA 1.425 -2.096 0 CA-C-N 114.234 -1.348 . . . . 53.04 112.156 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 6.1 mp -107.67 151.34 41.04 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 108.83 -0.804 . . . . 74.41 108.83 177.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.52 -61.76 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.832 2.355 . . . . 74.43 115.62 -172.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.685 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 4.1 p90 -132.62 16.33 0.05 OUTLIER Pre-proline 0 CA--C 1.585 2.299 0 N-CA-C 117.208 2.299 . . . . 75.24 117.208 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -89.24 164.29 5.62 Favored 'Trans proline' 0 C--N 1.369 1.609 0 CA-C-N 122.129 1.796 . . . . 74.13 112.005 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 20.6 p -155.0 167.44 30.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.484 1.914 . . . . 74.03 108.034 -6.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 131.37 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.775 -0.77 . . . . 51.21 109.537 170.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 112' ' ' LYS . 8.1 p -157.52 170.51 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 108.572 -0.899 . . . . 73.01 108.572 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 55' ' ' VAL . 25.6 m 77.67 145.45 0.09 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.47 1.106 . . . . 53.52 112.83 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.1 t -88.73 76.23 8.07 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.225 -1.398 . . . . 75.24 107.225 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.579 ' CB ' ' HB2' ' A' ' 42' ' ' HIS . 17.9 t70 -84.22 175.24 9.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.26 -1.791 . . . . 74.44 109.325 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 m -83.75 -16.58 44.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.498 . . . . 73.4 109.706 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.62 170.24 53.94 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 115.391 -0.822 . . . . 45.34 113.602 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 42.3 mtmt -137.82 146.75 43.89 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.399 -1.334 . . . . 71.44 107.399 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.86 123.42 61.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.528 -0.545 . . . . 73.35 109.528 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -95.93 124.86 40.12 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.517 -0.549 . . . . 64.43 109.517 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.99 -141.89 3.26 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.101 -0.8 . . . . 34.22 111.101 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 48.9 mtmt -140.17 147.43 40.12 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 120.874 0.368 . . . . 75.42 111.622 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.1 m -104.87 133.71 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 115.454 -0.794 . . . . 75.45 109.551 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.749 HD13 HD11 ' A' ' 17' ' ' ILE . 18.3 mt -88.37 130.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 106.023 -1.843 . . . . 64.41 106.023 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.3 p -115.01 161.32 18.49 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.732 -0.787 . . . . 62.25 111.415 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 33.66 67.67 Favored Glycine 0 N--CA 1.439 -1.114 0 O-C-N 123.543 0.527 . . . . 75.11 113.211 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -90.39 122.37 41.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.964 0.382 . . . . 63.13 110.633 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.451 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 36.8 m -76.62 158.7 30.88 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.458 -0.571 . . . . 75.1 109.458 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.79 -42.93 65.49 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.461 0.541 . . . . 72.42 112.461 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.2 -40.71 77.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.29 0.567 . . . . 73.5 110.141 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 4.4 mm-40 -68.37 -37.26 80.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.709 -1.132 . . . . 64.33 109.099 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.95 -33.5 74.4 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.404 1.082 . . . . 70.02 110.155 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 80' ' ' VAL . 7.2 m-20 -62.86 -27.14 69.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.158 -0.928 . . . . 70.34 113.16 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -32.89 71.4 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.191 -1.04 . . . . 64.31 108.191 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -70.98 -28.59 64.56 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.29 0.566 . . . . 75.03 109.532 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.548 ' HA ' HH12 ' A' ' 88' ' ' ARG . 28.6 t70 -70.94 -36.13 72.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.614 -0.721 . . . . 60.41 109.848 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 76' ' ' ASN . 72.4 t -66.6 -22.51 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.229 -0.896 . . . . 75.31 111.511 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.4 103.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.337 0.589 . . . . 75.32 110.488 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.389 0.1 OUTLIER 64.39 -58.39 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.937 2.495 . . . . 73.42 112.631 -174.001 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.51 1.66 16.98 Favored Glycine 0 C--O 1.234 0.132 0 C-N-CA 123.191 0.424 . . . . 75.03 113.638 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -83.92 -44.17 14.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.649 0.24 . . . . 75.54 111.649 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.522 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 2.1 t70 -136.94 16.12 3.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 118.626 -1.23 . . . . 73.3 111.532 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.65 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 30.6 m-85 -112.56 151.88 29.51 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.224 -0.591 . . . . 63.42 110.723 175.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -131.56 159.65 37.57 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.172 -0.922 . . . . 73.14 109.292 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.548 HH12 ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -90.11 113.74 25.53 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.332 -0.395 . . . . 74.44 109.954 -178.236 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.62 159.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.662 0.267 . . . . 63.1 110.859 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.3 m -102.57 129.78 49.24 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.066 -0.716 . . . . 73.25 109.066 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.07 168.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.345 -1.354 . . . . 64.01 107.345 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -120.35 131.97 55.08 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.473 -1.291 . . . . 50.34 108.662 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.419 HG12 ' HB2' ' A' ' 38' ' ' LEU . 18.6 m -125.99 168.13 19.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.243 0.544 . . . . 44.41 109.617 -175.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 101' ' ' LYS . 69.3 t -109.78 120.1 60.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 115.658 -0.701 . . . . 64.14 109.962 177.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 77.3 ttt180 -67.41 97.23 0.55 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.799 -1.556 . . . . 75.42 106.799 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.454 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 25.5 ttt -48.74 -45.82 40.14 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 127.088 2.155 . . . . 53.54 113.664 -169.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.4 -34.15 75.51 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.586 0.587 . . . . 74.13 112.586 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -103.48 -9.29 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.306 0.574 . . . . 65.43 111.272 -175.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m 64.8 25.58 12.92 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.793 0.837 . . . . 63.33 111.653 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -102.58 161.69 13.52 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.561 -0.903 . . . . 72.54 108.561 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.555 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.3 mtmt -104.6 135.85 45.24 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.953 -0.758 . . . . 63.21 108.953 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.52 135.86 48.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-O 121.139 0.495 . . . . 63.1 109.855 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -87.16 126.41 34.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.143 -1.428 . . . . 71.21 107.143 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 12' ' ' PHE . 32.9 m -137.58 169.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.977 0.417 . . . . 73.11 111.123 -174.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.4 149.39 24.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.384 -0.371 . . . . 64.23 110.138 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 t -153.01 176.86 11.42 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.776 -0.453 . . . . 71.23 109.776 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.461 ' HD2' ' CE1' ' A' ' 86' ' ' TYR . 15.1 p90 -107.35 120.01 40.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 125.08 1.352 . . . . 75.13 110.407 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.77 171.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 O-C-N 122.096 -0.377 . . . . 50.3 110.077 175.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.522 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 23.7 t-105 -97.7 121.2 39.34 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.483 -0.562 . . . . 74.23 109.483 -168.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.427 ' HA ' ' HZ2' ' A' ' 112' ' ' LYS . 33.5 m -73.12 -23.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 112.425 0.528 . . . . 74.54 112.425 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.42 11.81 1.45 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.352 0.596 . . . . 71.22 109.959 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.581 ' HB3' HG21 ' A' ' 55' ' ' VAL . 10.5 ptpp? -59.31 -20.07 51.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.298 1.039 . . . . 72.22 112.686 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.33 -24.67 50.78 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.253 0.549 . . . . 43.32 110.481 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.1 145.9 41.65 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.188 -1.782 . . . . 62.43 106.188 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -31.28 125.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 124.192 3.262 . . . . 75.11 112.687 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.82 114.33 13.16 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.477 0.656 . . . . 72.24 109.973 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.401 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 28.0 ttt -84.92 93.42 8.54 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 114.47 1.285 . . . . 73.35 114.47 -171.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -113.96 -16.77 12.12 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.186 -1.783 . . . . 73.54 106.186 167.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.53 -103.59 0.33 Allowed Glycine 0 CA--C 1.481 -2.031 0 CA-C-N 113.578 -1.647 . . . . 62.22 111.638 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -144.28 132.35 21.64 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.527 -0.916 . . . . 74.02 108.527 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.408 ' HE3' ' HA ' ' A' ' 121' ' ' TRP . 0.0 OUTLIER -132.1 167.84 19.02 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 104.645 -2.354 . . . . 74.53 104.645 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.592 ' HB3' ' HG2' ' A' ' 124' ' ' GLU . 9.0 m-20 -80.72 133.53 35.69 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 119.329 -0.948 . . . . 64.52 111.866 -174.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.402 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 90.1 t80 -61.3 -29.45 69.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.764 -1.107 . . . . 74.35 110.524 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.592 ' HG2' ' HB3' ' A' ' 122' ' ' ASP . 10.8 pt-20 -61.3 -38.22 86.03 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 120.997 0.427 . . . . 74.51 110.09 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 129' ' ' VAL . 16.5 tp10 -77.71 -44.28 28.37 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.738 -0.838 . . . . 73.43 108.738 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -55.3 -49.73 71.38 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-N 115.436 -0.802 . . . . 74.41 110.852 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 123' ' ' PHE . 16.7 ptm180 -64.7 -40.07 94.74 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.752 -0.658 . . . . 73.13 112.225 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 m -70.78 -32.41 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.918 -0.713 . . . . 74.43 111.734 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.573 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 88.3 t -67.93 -45.23 84.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 109.009 -0.737 . . . . 74.41 109.009 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -70.52 -39.55 74.02 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.184 -0.606 . . . . 74.24 111.67 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.21 -54.7 42.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.662 0.245 . . . . 62.33 111.662 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 42.5 mt-10 -62.01 -38.16 87.59 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.078 0.466 . . . . 74.24 111.83 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -69.59 -43.68 72.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.555 -0.748 . . . . 64.41 111.965 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -72.24 -40.53 67.65 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.266 0.839 . . . . 72.24 113.266 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.09 -34.2 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 118.952 -0.546 . . . . 64.35 112.421 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 45.7 mt-10 -55.91 -51.82 66.28 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.204 -1.035 . . . . 74.04 108.204 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.3 m -58.63 -50.43 73.86 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.084 -1.416 . . . . 52.55 110.76 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -59.97 -50.48 73.57 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 112.166 0.432 . . . . 75.14 112.166 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -63.25 -53.41 53.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.669 0.618 . . . . 71.31 112.669 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -66.23 -31.73 72.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 112.096 0.406 . . . . 64.41 112.096 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.5 mmt -76.17 -35.56 59.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 119.998 -0.681 . . . . 71.1 109.651 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.8 tp -63.94 -36.67 84.73 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 122.741 0.417 . . . . 63.43 110.599 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.253 -0.43 . . . . 75.23 111.358 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -76.24 -35.38 59.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.815 -0.63 . . . . 72.35 111.017 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.98 -39.6 61.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 75.03 112.135 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -99.62 9.36 43.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.32 0.581 . . . . 74.11 109.942 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 38.3 t30 -38.89 117.36 1.04 Allowed Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.592 1.557 . . . . 54.35 112.734 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 36.9 Cg_exo -59.53 -19.59 52.94 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 123.907 3.071 . . . . 71.12 113.245 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -74.98 -7.09 52.63 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.206 -0.452 . . . . 54.22 111.551 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.53 -7.63 79.7 Favored Glycine 0 CA--C 1.505 -0.565 0 C-N-CA 121.066 -0.588 . . . . 64.45 113.474 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.61 ' HG2' ' OE2' ' A' ' 155' ' ' GLU . 66.0 mttm -77.73 122.48 25.43 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.877 0.37 . . . . 42.05 111.744 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.8 m -97.44 172.61 7.65 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.252 -0.885 . . . . 45.31 109.388 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 20.6 ptp -56.78 -43.33 80.75 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.372 0.879 . . . . 74.1 113.372 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.86 -10.21 59.37 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.04 0.385 . . . . 70.21 112.04 -176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.61 ' OE2' ' HG2' ' A' ' 151' ' ' LYS . 39.4 tt0 -73.93 -33.07 63.8 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.984 -0.747 . . . . 74.42 108.984 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.12 -25.5 58.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.231 -0.895 . . . . 43.1 109.841 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.45 154.34 4.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.447 -0.946 . . . . 73.21 108.447 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.75 79.08 0.72 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.235 -0.746 . . . . 40.54 111.235 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.3 p -100.56 144.73 29.19 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 123.251 0.621 . . . . 64.04 110.923 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.5 tp -104.76 124.81 50.05 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.592 -0.892 . . . . 74.11 108.592 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.8 165.3 20.37 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.575 -0.898 . . . . 75.11 108.575 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -83.77 -66.27 0.91 Allowed 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.356 -1.35 . . . . 75.15 107.356 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.3 p 51.49 21.53 1.27 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.27 1.428 . . . . 63.43 114.678 175.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.34 -123.74 2.48 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.565 -1.014 . . . . 70.24 110.565 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.305 -1.326 0 N-CA-C 108.76 -0.83 . . . . 51.45 108.76 176.959 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 C--O 1.236 0.391 0 N-CA-C 108.555 -0.905 . . . . 62.14 108.555 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.2 p -115.7 -31.02 5.96 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.317 0.858 . . . . 71.23 113.317 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 29.9 m -83.39 115.16 21.91 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.354 0.501 . . . . 74.44 112.354 -174.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.5 m 64.04 12.01 6.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.782 0.833 . . . . 70.11 113.098 177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.62 154.45 94.78 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 116.642 -0.253 . . . . 70.12 111.093 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.56 1.75 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.429 2.753 . . . . 45.42 114.35 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -77.94 88.13 4.12 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 108.087 -1.079 . . . . 70.04 108.087 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 p -88.13 145.27 26.02 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.804 0.811 . . . . 71.25 112.296 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -130.3 157.67 41.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.692 -1.14 . . . . 75.52 109.891 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.578 ' HB2' HG12 ' A' ' 104' ' ' VAL . 32.7 m-80 -121.87 127.82 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.765 -0.828 . . . . 75.14 108.765 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.42 120.95 64.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 110.126 -0.324 . . . . 72.13 110.126 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.61 118.83 24.09 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 122.59 0.356 . . . . 72.21 110.275 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.35 160.61 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.314 -0.625 . . . . 73.4 109.314 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -131.15 17.21 5.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.846 0.831 . . . . 74.54 109.998 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.38 159.38 30.07 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 119.897 -1.144 . . . . 73.3 112.603 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.417 ' HB3' HG11 ' A' ' 22' ' ' VAL . 18.3 m 67.11 -74.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.218 1.407 . . . . 73.51 113.946 175.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.585 HG21 HD13 ' A' ' 67' ' ' ILE . 26.1 mt -70.25 -5.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.641 0.777 . . . . 73.31 111.757 -171.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -65.87 -30.12 70.68 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.163 -0.681 . . . . 75.13 109.163 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.07 132.21 25.05 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 115.155 -0.93 . . . . 75.42 110.446 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.54 -44.53 4.44 Favored 'Trans proline' 0 C--N 1.359 1.103 1 C-N-CA 125.362 4.041 . . . . 71.45 115.375 -175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -56.68 -42.52 79.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.888 0.699 . . . . 31.13 112.888 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.506 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -76.18 -35.85 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.279 0.561 . . . . 75.34 110.292 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -66.74 -32.85 74.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.451 0.643 . . . . 73.44 109.728 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -73.63 -20.82 60.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.607 -0.724 . . . . 65.14 111.837 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.6 m -87.71 -23.89 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.381 -0.928 . . . . 74.35 111.195 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.434 ' C ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -87.01 -46.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 116.508 -0.314 . . . . 62.13 110.904 178.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.587 HD12 ' HB2' ' A' ' 31' ' ' ALA . 82.1 mt -93.86 -14.6 25.91 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.793 -0.363 . . . . 74.23 111.958 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.0 t70 73.56 6.86 5.07 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.494 1.14 . . . . 72.41 109.191 -175.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.2 mtp180 -144.22 163.81 32.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.22 1.408 . . . . 62.14 107.727 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.6 p -76.69 122.64 24.98 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.21 -0.293 . . . . 74.33 110.21 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.587 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -87.44 156.91 19.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 120.642 0.258 . . . . 54.34 111.052 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -99.93 109.86 22.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.176 -0.609 . . . . 74.1 110.843 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -99.92 142.09 31.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.171 -1.048 . . . . 71.31 108.171 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.76 147.54 57.36 Favored Pre-proline 0 C--N 1.289 -2.047 0 N-CA-C 108.751 -0.833 . . . . 74.21 108.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -59.51 135.73 66.65 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.573 2.182 . . . . 64.42 112.219 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.81 156.46 41.31 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.137 -0.69 . . . . 60.1 109.137 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.509 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.2 p -123.75 126.53 72.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 118.704 -1.198 . . . . 74.41 111.676 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 93' ' ' VAL . 25.1 tp -92.17 90.88 7.51 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.729 0.776 . . . . 74.23 110.864 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.9 p80 -73.08 124.91 26.48 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 114.556 -1.202 . . . . 72.13 109.395 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.45 -16.8 8.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.369 -0.919 . . . . 63.04 112.699 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 62' ' ' VAL . 38.4 m-85 -122.27 155.04 36.74 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 110.108 -0.33 . . . . 63.51 110.108 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.443 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 5.4 t60 -129.27 135.95 49.44 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 37.2 ttp180 -88.16 127.18 35.43 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.128 -1.434 . . . . 74.32 107.128 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -100.65 123.05 44.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 106.188 -1.782 . . . . 74.31 106.188 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -76.3 94.03 3.52 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-O 122.014 0.911 . . . . 74.43 109.591 -173.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 10.5 mp -81.07 98.76 8.14 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.057 -1.429 . . . . 75.2 112.709 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.551 ' O ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.76 84.36 7.37 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 123.139 1.447 . . . . 72.14 109.276 172.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.91 -53.84 0.13 Allowed Glycine 0 N--CA 1.405 -3.427 0 CA-C-N 113.679 -1.601 . . . . 74.23 110.016 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -93.45 166.99 14.87 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.563 -0.532 . . . . 72.32 109.563 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.91 135.08 1.54 Allowed 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 122.599 2.199 . . . . 64.23 112.73 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.617 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 38.9 p90 44.97 47.26 3.59 Favored Pre-proline 0 N--CA 1.513 2.676 0 N-CA-C 115.383 1.623 . . . . 71.23 115.383 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 51' ' ' TYR 0.265 37.7 Cg_endo -114.93 157.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.231 3.287 . . . . 74.33 114.68 -175.527 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 91.9 m -153.76 166.55 32.5 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 131.684 3.994 . . . . 65.14 104.3 -13.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.419 HG22 ' HA ' ' A' ' 43' ' ' ARG . 49.1 pt -123.19 145.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 119.978 1.263 . . . . 63.13 112.102 175.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -144.82 150.07 16.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 106.763 -1.569 . . . . 64.32 106.763 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 p -94.44 94.34 8.18 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 121.452 0.644 . . . . 64.34 110.283 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -134.82 -57.43 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.823 -1.547 . . . . 64.44 106.823 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -82.23 139.1 34.44 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.839 -1.073 . . . . 64.54 108.622 174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -78.77 15.09 1.13 Allowed 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.57 0.952 . . . . 62.2 113.57 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.24 -172.06 5.44 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 121.514 0.508 . . . . 64.33 113.461 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HE2' HG21 ' A' ' 37' ' ' VAL . 19.8 ptmt -139.42 140.06 37.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.472 -0.566 . . . . 74.13 109.472 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 41' ' ' TYR . 93.6 t -108.82 124.07 65.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 123.189 0.596 . . . . 73.04 109.575 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.417 HD21 ' CB ' ' A' ' 132' ' ' GLU . 3.4 p-10 -90.27 144.62 25.68 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.475 -1.306 . . . . 74.44 107.475 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.63 -150.38 6.62 Favored Glycine 0 C--N 1.279 -2.619 0 N-CA-C 110.012 -1.235 . . . . 74.24 110.012 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -135.36 145.35 47.29 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.633 -0.827 . . . . 73.35 109.939 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.4 m -103.69 134.56 44.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.517 -0.765 . . . . 65.22 109.435 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.585 HD13 HG21 ' A' ' 17' ' ' ILE . 11.0 mt -86.5 110.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 104.486 -2.413 . . . . 73.33 104.486 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.453 HG22 ' OD1' ' A' ' 10' ' ' ASN . 75.0 p -98.05 162.07 13.41 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.915 -0.584 . . . . 73.14 111.149 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 34.4 70.47 Favored Glycine 0 N--CA 1.436 -1.304 0 O-C-N 123.604 0.565 . . . . 54.55 112.866 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.43 121.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 120.55 -0.46 . . . . 54.22 109.936 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.702 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 42.7 m -81.64 158.61 24.25 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.642 -0.873 . . . . 70.42 108.642 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.6 -40.13 62.37 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.798 1.036 . . . . 73.14 113.798 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 3' ' ' SER . . . -73.64 -32.88 64.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.632 0.73 . . . . 73.11 110.656 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.702 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 3.8 mp0 -73.43 -31.41 63.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.031 -0.986 . . . . 73.24 110.251 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.91 -36.48 83.5 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.607 -1.257 . . . . 73.31 107.607 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.67 -28.11 53.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.416 -1.266 . . . . 74.34 111.913 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.43 ' ND2' HG12 ' A' ' 26' ' ' ILE . 64.2 t30 -75.29 -30.5 60.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.558 -0.857 . . . . 64.14 109.855 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 17' ' ' ILE . 64.7 m-85 -65.72 -34.28 77.82 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.446 0.641 . . . . 64.32 109.822 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.77 -38.43 90.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.838 -1.073 . . . . 64.35 110.526 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.5 -43.6 48.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.532 -0.758 . . . . 75.1 111.307 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -68.0 -64.06 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.829 1.048 . . . . 54.2 113.829 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.16 69.47 1.02 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.633 0.73 . . . . 73.4 110.931 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.36 15.44 2.29 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.055 -0.975 . . . . 64.2 111.776 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -82.59 -42.53 18.15 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.87 0.322 . . . . 73.04 111.87 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.01 14.0 6.27 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.602 -1.259 . . . . 44.42 107.602 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -128.28 157.02 42.09 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.172 -1.418 . . . . 74.41 107.172 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HB3' HG23 ' A' ' 110' ' ' VAL . 11.7 pt-20 -129.35 146.68 51.18 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.229 -0.656 . . . . 54.43 109.229 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -83.75 117.09 23.02 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.502 -0.555 . . . . 71.23 109.502 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.07 159.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-O 120.84 0.352 . . . . 55.32 110.982 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.6 m -91.09 129.91 37.04 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 108.314 -0.995 . . . . 63.24 108.314 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.57 168.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.543 -1.28 . . . . 63.03 107.543 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -121.3 128.62 52.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.687 -1.205 . . . . 74.11 109.783 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 38' ' ' LEU . 17.0 m -127.19 168.37 20.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.831 -0.622 . . . . 61.23 109.66 -176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 101' ' ' LYS . 75.0 t -103.44 112.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.214 -1.032 . . . . 44.35 108.214 172.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -80.51 99.66 8.16 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.738 -1.208 . . . . 73.54 107.738 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.503 ' SD ' ' HG3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.06 -18.08 59.52 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.959 1.304 . . . . 54.51 110.085 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -46.78 -37.33 8.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.602 0.761 . . . . 72.41 111.101 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -137.39 10.13 2.96 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 108.277 -1.009 . . . . 74.13 108.277 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t 60.01 26.41 15.71 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.966 0.889 . . . . 65.41 110.079 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -93.16 160.7 14.73 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.397 -0.82 . . . . 73.21 109.425 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 7.1 mptt -104.31 128.79 52.16 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 106.935 -1.506 . . . . 74.03 106.935 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.74 142.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.389 0.614 . . . . 52.13 111.803 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -89.38 125.81 35.29 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.287 -1.746 . . . . 73.33 106.287 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 10' ' ' ASN . 18.5 m -133.2 174.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 120.587 0.232 . . . . 65.53 110.985 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -100.63 153.29 19.53 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.101 -1.074 . . . . 65.23 108.101 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -155.62 174.72 14.88 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.029 -0.73 . . . . 71.03 109.029 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -106.95 119.19 38.7 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.974 -1.121 . . . . 72.34 107.974 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.4 HG12 HG13 ' A' ' 54' ' ' ILE . 35.7 m -113.36 163.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 109.531 -0.544 . . . . 73.52 109.531 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -70.1 121.92 18.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.792 -0.818 . . . . 52.21 108.792 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.0 p -68.1 -20.58 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.231 0.538 . . . . 70.42 111.438 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -89.13 12.13 16.63 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.648 -0.705 . . . . 71.4 110.422 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -51.81 -19.73 1.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.997 1.851 . . . . 74.44 115.997 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.33 -20.89 36.45 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.881 0.848 . . . . 65.31 109.854 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 14.5 t70 -91.66 139.09 24.87 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 107.844 -1.169 . . . . 74.04 107.844 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 8.8 Cg_exo -71.85 78.56 1.73 Allowed 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 121.972 1.781 . . . . 75.21 111.984 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -134.53 114.57 12.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 116.084 -0.507 . . . . 52.53 110.171 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 57.02 79.21 0.19 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.405 1.066 . . . . 64.21 112.86 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -142.31 4.6 1.6 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.807 -0.633 . . . . 74.05 110.648 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -105.08 -176.02 24.46 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.847 -0.692 . . . . 53.13 111.843 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -109.14 146.13 34.61 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.988 -0.745 . . . . 71.4 108.988 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -163.74 -5.08 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 O-C-N 123.409 0.443 . . . . 74.34 111.903 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 124' ' ' GLU . 34.6 t70 -127.83 114.65 17.5 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.407 1.262 . . . . 63.01 114.407 -170.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -68.22 -27.32 66.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.157 -0.929 . . . . 74.11 110.321 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.499 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 39.6 tt0 -70.31 -41.12 73.73 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 124.159 0.984 . . . . 73.24 109.761 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 129' ' ' VAL . 10.4 tp10 -56.12 -51.42 67.99 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.943 -1.026 . . . . 62.22 109.073 176.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -71.44 -30.58 66.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.042 -1.463 . . . . 75.2 110.711 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -57.46 -46.17 83.93 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.847 -0.615 . . . . 75.2 109.547 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.31 -38.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.494 -0.482 . . . . 75.13 110.987 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 125' ' ' GLU . 92.2 t -67.63 -32.39 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 111.928 0.344 . . . . 71.24 111.928 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -83.06 -37.99 23.13 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 117.82 -1.552 . . . . 72.0 111.079 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.68 76.87 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.632 0.253 . . . . 42.33 111.363 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 22.8 mm-40 -64.35 -37.86 88.99 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 116.156 -0.474 . . . . 62.15 110.639 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -56.03 -42.53 76.65 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 116.245 -0.434 . . . . 53.43 111.133 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -76.45 -44.1 37.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 112.756 0.65 . . . . 73.53 112.756 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 132' ' ' GLU . 14.4 p -59.89 -37.28 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.024 -0.67 . . . . 74.42 111.226 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.594 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 91.9 mt-10 -58.34 -43.68 88.41 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.993 -0.743 . . . . 73.24 108.993 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.9 m -60.84 -50.19 74.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.19 -0.914 . . . . 70.51 110.535 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -63.86 -34.68 78.48 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 111.879 0.326 . . . . 73.24 111.879 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 76.4 mtp180 -63.84 -52.6 59.35 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.67 0.271 . . . . 72.12 110.352 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.503 ' HG3' ' SD ' ' A' ' 96' ' ' MET . 31.3 mmmt -60.95 -44.56 97.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.915 0.709 . . . . 74.45 112.915 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.9 mmt -63.08 -41.34 99.39 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.77 -0.372 . . . . 75.12 110.445 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.27 -46.31 84.25 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.286 -0.415 . . . . 71.14 110.72 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.39 -34.38 77.83 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.173 -0.611 . . . . 73.52 112.013 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -68.86 -29.49 67.8 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.437 0.532 . . . . 73.25 112.437 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.94 -47.03 13.22 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.02 0.438 . . . . 74.05 111.181 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -79.75 -31.89 41.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 73.23 111.73 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -117.79 117.15 35.96 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.939 0.399 . . . . 64.12 111.889 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 -28.72 63.1 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.599 2.199 . . . . 61.24 110.522 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -73.15 -5.21 37.69 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.008 -0.996 . . . . 75.44 112.261 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -70.45 -29.33 70.06 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.405 -1.078 . . . . 33.34 110.405 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.597 ' HE2' ' OE1' ' A' ' 155' ' ' GLU . 2.2 tpmt? -97.09 146.51 24.96 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.048 -1.834 . . . . 74.33 106.048 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.4 m -80.19 155.9 27.18 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.333 -1.347 . . . . 72.4 108.178 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 66.2 mtt -72.09 -44.37 63.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.421 0.526 . . . . 74.53 112.421 -175.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -71.17 -22.01 62.1 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.051 0.929 . . . . 71.04 109.628 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.597 ' OE1' ' HE2' ' A' ' 151' ' ' LYS . 43.5 tt0 -75.76 -40.37 55.44 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.685 -1.143 . . . . 73.04 111.181 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.405 ' HB2' ' HG2' ' A' ' 151' ' ' LYS . . . -68.98 -35.68 77.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.972 -0.558 . . . . 65.12 110.77 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -133.54 116.1 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 115.868 -0.605 . . . . 73.14 111.038 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.79 -34.36 31.23 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.764 -0.731 . . . . 62.4 112.664 -177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.4 p -146.78 128.74 15.46 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.571 0.7 . . . . 72.13 112.556 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.2 mt -128.93 160.39 32.83 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.293 -1.373 . . . . 71.15 107.293 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.24 140.28 32.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.782 0.66 . . . . 73.13 112.782 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 p -90.87 -35.74 14.6 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.531 0.681 . . . . 70.24 109.213 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 43.6 p 53.45 70.47 0.59 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.819 1.247 . . . . 65.21 114.291 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -113.89 -11.73 12.23 Favored Glycine 0 C--O 1.246 0.887 0 N-CA-C 109.635 -1.386 . . . . 51.52 109.635 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 N--CA 1.436 -1.155 0 C-N-CA 124.342 1.057 . . . . 62.55 108.317 178.859 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.283 -0.636 . . . . 63.23 109.283 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 83.8 m -136.87 109.98 7.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.514 -0.55 . . . . 71.22 109.514 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -111.09 140.14 45.89 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 116.57 -0.286 . . . . 73.21 110.654 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -87.1 88.74 7.77 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.395 -0.965 . . . . 72.43 108.395 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.484 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 5.7 m-20 -72.42 121.62 85.29 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.558 -0.747 . . . . 73.42 111.525 -178.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 5' ' ' ASP . 5.8 Cg_exo -77.9 12.56 1.94 Allowed 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 123.154 2.569 . . . . 72.53 113.16 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -76.71 108.2 9.56 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.65 -1.241 . . . . 75.12 107.65 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.2 p -56.66 123.51 15.15 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.326 0.584 . . . . 71.14 109.96 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.508 ' CG ' HD12 ' A' ' 75' ' ' LEU . 69.6 m80 -93.38 156.59 16.69 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.815 -0.629 . . . . 72.44 111.694 -173.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.496 ' HB2' HG12 ' A' ' 104' ' ' VAL . 91.4 m-20 -129.0 133.53 47.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.533 -1.284 . . . . 65.03 107.533 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.5 121.54 63.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.762 -0.375 . . . . 74.2 110.416 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.495 ' HB2' HG21 ' A' ' 104' ' ' VAL . 59.9 t80 -81.9 111.5 18.16 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.053 -1.091 . . . . 75.51 108.053 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 17' ' ' ILE . 95.8 t -120.19 142.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-O 121.488 0.661 . . . . 73.22 110.831 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -99.47 115.44 29.31 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.166 -1.05 . . . . 74.31 108.166 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.19 -68.09 2.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 116.096 1.199 . . . . 45.11 116.096 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.3 t -40.12 -81.26 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.669 2.1 . . . . 73.41 116.669 -167.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.588 ' HB ' HD11 ' A' ' 67' ' ' ILE . 3.1 mp -93.92 27.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 122.074 0.94 . . . . 63.51 109.552 -173.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 65' ' ' LYS . 18.9 mt -74.52 -15.89 60.85 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.406 -0.809 . . . . 73.44 111.654 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.26 134.1 19.87 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 114.872 -1.058 . . . . 71.13 109.975 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.69 -31.6 41.75 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.753 2.968 . . . . 74.2 114.011 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.29 80.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.982 0.42 . . . . 72.13 111.332 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.596 ' O ' HG22 ' A' ' 25' ' ' VAL . 47.8 t -77.36 -34.32 20.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.151 -0.685 . . . . 63.44 109.151 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.31 75.66 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.87 -0.789 . . . . 71.02 108.87 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -71.08 -12.11 61.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.519 -0.764 . . . . 50.35 111.602 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 22' ' ' VAL . 10.6 m -97.94 -35.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 119.665 -0.814 . . . . 74.13 110.513 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.438 ' C ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -80.47 -48.44 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 120.782 0.325 . . . . 73.13 110.909 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 81.0 mt -90.12 -18.01 26.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.365 -0.606 . . . . 51.11 109.365 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 33.3 t70 70.64 8.76 6.69 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.896 1.332 . . . . 70.2 109.283 -175.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -142.0 143.7 33.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 113.757 -1.565 . . . . 73.53 107.721 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -76.45 117.05 17.72 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.545 0.212 . . . . 55.14 111.512 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.423 ' HB2' ' CD1' ' A' ' 27' ' ' LEU . . . -105.72 158.8 16.47 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 116.074 -0.512 . . . . 72.45 110.018 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.94 131.81 46.64 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.694 -0.685 . . . . 72.21 111.965 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.3 p -103.46 143.81 32.22 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.312 -0.858 . . . . 71.42 110.272 174.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.4 144.94 51.07 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.394 -0.595 . . . . 71.34 109.394 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -68.24 133.77 29.5 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.035 1.823 . . . . 53.11 112.875 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.08 156.61 41.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.156 -0.929 . . . . 65.32 109.397 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.14 129.99 74.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.459 0.647 . . . . 73.13 110.86 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.4 ' HA ' HG12 ' A' ' 93' ' ' VAL . 20.9 tp -88.29 117.3 27.1 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.416 -0.811 . . . . 71.12 109.75 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -94.08 128.84 40.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.059 -0.519 . . . . 52.23 110.507 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 56' ' ' SER . . . 111.67 -4.54 27.72 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.029 -1.081 . . . . 51.02 112.561 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.494 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 63.8 m-85 -124.82 147.42 48.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.242 0.46 . . . . 74.31 112.242 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -117.83 130.06 56.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.56 -1.274 . . . . 72.4 107.56 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.467 ' HA ' HG22 ' A' ' 54' ' ' ILE . 19.4 ptt180 -87.85 140.42 29.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.794 0.438 . . . . 72.22 110.804 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.648 ' CE1' ' HA ' ' A' ' 118' ' ' TYR . 87.5 m-85 -112.22 150.64 30.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.774 -0.37 . . . . 70.22 111.235 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.46 100.66 13.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.66 0.743 . . . . 72.52 111.91 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.67 72.97 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 122.025 0.917 . . . . 53.32 109.915 172.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -83.14 8.78 12.11 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 113.968 1.099 . . . . 72.03 113.968 -175.584 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.41 -19.19 74.57 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.971 -2.052 . . . . 64.44 107.971 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 3.4 mm? -98.11 168.53 9.81 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 105.498 -2.038 . . . . 71.32 105.498 172.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 99.8 Cg_exo -42.47 -65.79 0.18 Allowed 'Trans proline' 0 C--N 1.365 1.431 0 C-N-CA 122.271 1.981 . . . . 61.44 113.891 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.605 ' H ' ' HD2' ' A' ' 52' ' ' PRO . 33.7 m-85 -164.62 -36.44 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 125.366 1.466 . . . . 74.42 113.959 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' ' H ' ' A' ' 51' ' ' TYR . 63.3 Cg_exo -48.96 166.69 0.15 Allowed 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.33 2.02 . . . . 65.14 112.504 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.6 p -135.69 -171.7 2.91 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.445 1.098 . . . . 72.43 112.61 10.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 17.6 pt -131.02 150.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 114.076 -1.42 . . . . 61.42 110.109 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 151.71 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.448 -1.686 . . . . 65.11 106.448 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 33.0 t -71.34 145.5 49.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.384 0.611 . . . . 73.54 112.073 -174.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -155.05 163.52 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.462 -1.31 . . . . 74.42 107.462 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.04 -56.6 4.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.274 0.559 . . . . 75.41 110.887 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 m -91.96 12.18 22.63 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.823 -0.626 . . . . 71.33 111.954 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.52 131.49 10.81 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 120.468 -0.872 . . . . 54.55 111.666 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -136.87 140.15 42.16 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.394 -0.965 . . . . 63.23 108.394 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 41' ' ' TYR . 57.3 t -114.36 122.84 69.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.837 -0.431 . . . . 72.42 109.837 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.7 126.51 37.82 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.528 -0.545 . . . . 62.12 109.528 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.93 -148.56 5.18 Favored Glycine 0 N--CA 1.42 -2.404 0 C-N-CA 120.23 -0.986 . . . . 72.33 111.747 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.679 ' HB2' HD22 ' A' ' 18' ' ' LEU . 44.3 mtmt -139.23 145.77 39.65 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.923 0.489 . . . . 74.32 110.53 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.44 134.3 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.415 -0.811 . . . . 64.33 109.827 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.588 HD11 ' HB ' ' A' ' 17' ' ' ILE . 15.3 mt -86.94 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 105.193 -2.151 . . . . 70.2 105.193 178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 161.61 13.48 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.718 -0.393 . . . . 75.14 112.03 -173.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.55 37.2 77.79 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.799 -0.637 . . . . 20.24 112.901 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.43 121.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.653 -0.419 . . . . 74.5 109.97 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.401 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 46.7 m -73.99 158.8 33.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.052 -0.722 . . . . 65.21 109.052 177.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -52.92 -44.08 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.186 0.439 . . . . 73.5 112.186 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.47 78.49 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.539 0.685 . . . . 62.33 110.143 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.9 mm-40 -76.26 -38.69 55.88 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.775 -1.102 . . . . 63.23 110.217 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.508 HD12 ' CG ' ' A' ' 9' ' ' HIS . 3.6 tt -61.57 -37.51 84.13 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.695 -1.224 . . . . 71.1 107.695 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.618 ' O ' HG23 ' A' ' 80' ' ' VAL . 28.5 t-20 -54.71 -28.8 50.54 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 114.272 -1.331 . . . . 73.04 112.239 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.405 ' OD1' HG12 ' A' ' 26' ' ' ILE . 21.4 t-20 -73.74 -30.88 63.07 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 118.957 -1.097 . . . . 70.51 109.633 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.592 ' O ' HG22 ' A' ' 81' ' ' ILE . 68.0 m-85 -73.23 -31.12 63.94 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 107.912 -1.144 . . . . 72.43 107.912 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.34 -37.56 63.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.424 -0.807 . . . . 65.42 110.274 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 76' ' ' ASN . 58.3 t -76.41 -27.38 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 N-CA-C 113.475 0.917 . . . . 63.2 113.475 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 78' ' ' PHE . 13.7 tt -59.25 165.15 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 O-C-N 122.053 -0.404 . . . . 72.42 110.339 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -53.97 95.51 0.01 OUTLIER 'General case' 0 C--O 1.242 0.691 0 N-CA-C 114.296 1.221 . . . . 75.4 114.296 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.66 60.21 0.64 Allowed Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 107.848 -2.101 . . . . 63.22 107.848 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -57.95 -41.28 82.49 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.739 0.816 . . . . 65.04 112.43 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.518 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 8.2 t70 -128.44 24.25 5.86 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.932 -1.507 . . . . 74.11 106.932 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.491 ' CE2' ' HB2' ' A' ' 52' ' ' PRO . 73.8 m-85 -119.2 150.71 39.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.453 -1.249 . . . . 70.21 108.695 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.85 144.44 51.31 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.781 -0.451 . . . . 71.54 109.781 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -93.17 114.93 27.56 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.906 -0.775 . . . . 75.04 108.906 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -128.69 161.05 38.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.663 0.785 . . . . 65.25 111.755 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.2 m -90.82 130.72 36.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.136 -1.061 . . . . 53.12 108.136 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.69 159.82 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.407 0.683 . . . . 72.41 109.158 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.68 123.87 46.38 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.3 -0.56 . . . . 61.34 110.545 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 38' ' ' LEU . 23.6 m -125.61 160.72 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 109.469 -0.567 . . . . 70.12 109.469 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 68.8 t -104.36 113.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.03 -0.986 . . . . 71.24 109.12 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -73.38 103.57 4.09 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 108.663 -0.866 . . . . 52.43 108.663 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -29.86 48.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.809 1.644 . . . . 71.12 110.437 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.29 -40.07 64.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.509 0.724 . . . . 73.33 111.729 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -123.95 -3.08 8.16 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.321 0.581 . . . . 72.43 111.025 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.94 26.19 14.11 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.014 0.926 . . . . 61.44 110.013 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 12.9 pt-20 -95.5 160.6 14.44 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.652 -0.704 . . . . 63.51 109.399 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -108.64 130.19 55.33 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.938 -1.134 . . . . 75.43 107.938 -178.473 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.77 144.27 21.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 109.702 -0.481 . . . . 54.34 109.702 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -87.62 127.09 35.28 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.683 0.754 . . . . 72.4 112.652 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.496 HG12 ' HB2' ' A' ' 10' ' ' ASN . 23.1 m -128.33 175.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 113.668 -1.605 . . . . 74.32 109.037 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.457 ' HG3' HD11 ' A' ' 75' ' ' LEU . 10.7 mm-40 -99.4 153.36 19.05 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.064 -0.717 . . . . 74.43 109.064 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 t -159.12 175.25 13.7 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.436 -0.579 . . . . 64.54 109.436 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -107.56 119.34 39.14 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.963 -0.754 . . . . 71.52 108.963 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG12 HG13 ' A' ' 54' ' ' ILE . 31.9 m -114.17 178.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 120.71 -0.396 . . . . 73.25 110.154 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.535 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 44.9 t-105 -101.54 124.84 47.86 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 -173.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.6 m -72.66 -26.71 24.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-O 121.28 0.562 . . . . 71.54 111.3 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.535 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 28.4 t-20 -80.01 12.51 2.73 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.732 0.813 . . . . 54.41 110.078 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.8 ptpp? -51.81 -24.67 6.36 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.362 1.065 . . . . 74.43 112.764 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -90.39 -3.15 57.9 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.143 0.497 . . . . 73.33 112.017 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.41 153.45 39.07 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.485 -0.325 . . . . 64.35 110.275 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.78 110.67 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.632 2.221 . . . . 73.41 111.248 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -133.55 166.77 21.79 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.922 -1.51 . . . . 73.24 106.922 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.24 122.57 5.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.342 -0.984 . . . . 60.22 108.342 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.648 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 54.6 p90 -130.78 5.62 4.64 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 120.904 0.383 . . . . 71.2 111.414 -176.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.21 -155.3 10.8 Favored Glycine 0 C--N 1.299 -1.486 0 N-CA-C 115.537 0.975 . . . . 63.22 115.537 -173.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -93.16 176.32 6.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.376 -0.912 . . . . 74.44 111.478 -177.195 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -96.61 -57.49 2.29 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.32 1.057 . . . . 72.31 109.26 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 125' ' ' GLU . 33.6 m-20 -124.48 118.73 27.29 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 113.428 -1.715 . . . . 62.04 108.508 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -65.44 -27.47 68.54 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 112.096 0.406 . . . . 62.44 112.096 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -68.51 -49.65 58.06 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.441 -0.577 . . . . 71.23 109.441 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 122' ' ' ASP . 41.4 tt0 -62.83 -44.83 95.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.202 -0.908 . . . . 71.22 110.22 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -66.53 -37.44 85.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.053 -0.521 . . . . 75.2 109.712 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -56.45 -48.37 77.19 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 123.045 0.538 . . . . 75.25 110.311 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.5 m -69.37 -30.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.471 -0.491 . . . . 62.44 112.285 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -75.28 -44.47 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.421 -0.585 . . . . 74.11 109.421 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.47 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 26.3 t-80 -61.37 -40.79 95.6 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.07 -1.085 . . . . 74.31 108.07 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.89 97.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.703 -0.681 . . . . 42.43 111.652 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.436 ' HA ' HG12 ' A' ' 135' ' ' VAL . 36.3 mm-40 -67.81 -26.7 66.21 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 112.095 0.406 . . . . 73.22 112.095 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 8.8 tmtt? -70.71 -55.99 7.41 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.582 -0.896 . . . . 73.52 108.582 176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 94.1 m-85 -66.29 -32.04 73.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.006 1.113 . . . . 74.32 114.006 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.9 p -62.37 -38.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.017 -0.673 . . . . 71.32 110.648 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -72.16 -32.41 66.83 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 119.593 -0.843 . . . . 71.3 111.277 179.221 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 80.1 m -61.92 -46.24 90.19 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.841 -0.618 . . . . 73.44 110.287 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -61.41 -34.7 75.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 121.073 -0.251 . . . . 65.1 111.123 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 99.3 mtt180 -70.13 -49.23 52.81 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.106 -0.497 . . . . 74.04 110.681 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 33.4 mmtp -58.51 -43.13 88.98 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.719 -0.474 . . . . 75.03 109.719 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.9 mtm -67.59 -31.17 71.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.693 -0.685 . . . . 63.35 111.295 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.56 -40.47 73.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.68 -0.489 . . . . 72.31 109.68 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 9.5 mm-40 -63.0 -34.16 76.96 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.982 0.896 . . . . 64.51 109.363 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.502 ' HD1' ' HG2' ' A' ' 151' ' ' LYS . 3.3 t-105 -71.87 -44.36 63.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.509 -1.223 . . . . 75.22 108.956 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.49 -37.78 83.35 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 51.22 111.242 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -78.74 -11.71 59.99 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.06 0.763 . . . . 62.33 113.06 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -115.91 131.7 23.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 C-N-CA 120.101 -0.64 . . . . 73.11 112.168 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 151' ' ' LYS . 30.4 Cg_endo -63.61 -14.99 45.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.391 2.728 . . . . 73.23 111.324 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -75.39 -20.63 58.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.265 -0.88 . . . . 64.43 110.121 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -98.76 -63.46 0.85 Allowed Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 108.942 -1.663 . . . . 73.35 108.942 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 73.1 mmtt -97.61 124.0 41.72 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.502 -0.555 . . . . 71.32 109.502 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.4 m -66.75 157.11 33.63 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 109.755 -0.461 . . . . 73.54 109.755 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -60.47 -42.27 95.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.884 0.698 . . . . 72.43 112.884 -174.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.39 -19.69 59.4 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 120.402 -0.519 . . . . 54.43 111.127 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -74.77 -47.6 30.13 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.437 0.637 . . . . 64.2 109.601 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.83 79.49 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.799 -1.091 . . . . 72.52 112.568 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 153' ' ' MET . 14.7 p -115.35 -20.24 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 119.382 -0.927 . . . . 51.25 112.65 -174.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 94.56 141.77 11.82 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.8 -1.32 . . . . 72.12 109.8 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.1 m -62.56 112.42 2.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.518 0.675 . . . . 74.51 111.43 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.16 165.18 27.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.006 -0.997 . . . . 45.34 108.891 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.6 mt -99.36 143.78 29.22 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.582 -1.636 . . . . 72.45 106.582 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -64.45 -56.16 16.07 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.5 m 56.77 -165.62 0.14 Allowed 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.829 0.705 . . . . 75.31 111.528 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.17 -37.67 3.69 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 110.321 -1.112 . . . . 52.24 110.321 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 108.106 -1.072 . . . . 74.25 108.106 176.867 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.196 0.522 . . . . 73.15 109.915 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -107.81 150.53 26.89 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.673 -0.694 . . . . 71.54 111.925 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -124.52 124.65 42.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.075 -1.454 . . . . 74.14 107.075 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 7.6 p -130.61 123.5 55.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 120.539 -0.464 . . . . 53.4 111.991 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -77.81 120.09 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.974 -0.75 . . . . 72.33 108.974 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.97 148.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.136 0.493 . . . . 64.44 110.217 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.33 106.58 9.61 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.85 -0.796 . . . . 71.43 108.85 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 -69.04 1.44 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 114.285 0.474 . . . . 74.34 114.285 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -44.75 -72.31 0.06 Allowed 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.198 1.555 . . . . 64.3 115.198 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.526 ' HB ' HD11 ' A' ' 67' ' ' ILE . 4.2 mp -105.67 66.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 109.167 -0.679 . . . . 61.34 109.167 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.8 mt -114.6 16.35 17.58 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.472 -1.307 . . . . 61.12 107.472 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.36 146.75 43.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.423 -1.262 . . . . 73.4 110.956 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.38 -42.83 51.74 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.806 3.004 . . . . 70.24 114.165 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.48 -47.65 78.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 120.627 0.251 . . . . 73.22 111.233 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 26' ' ' ILE . 93.9 t -65.09 -45.16 95.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 CA-C-N 115.861 -0.608 . . . . 73.14 111.64 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB1' ' H ' ' A' ' 31' ' ' ALA . . . -60.38 -37.3 80.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.118 0.485 . . . . 35.13 110.629 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.92 -33.49 68.31 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.768 -0.651 . . . . 63.31 111.522 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 22' ' ' VAL . 17.9 m -82.47 -28.58 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.969 -0.692 . . . . 73.42 111.254 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.5 tt -72.3 -47.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 119.736 -0.786 . . . . 72.41 111.829 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 74' ' ' GLU . 77.7 mt -95.62 -55.56 2.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.834 -1.146 . . . . 60.04 112.072 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.1 t70 150.39 -33.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.534 -1.654 . . . . 73.41 106.534 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -134.78 159.86 40.0 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.786 -1.552 . . . . 73.12 108.028 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.0 m -76.01 119.04 19.41 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.205 0.526 . . . . 71.33 110.144 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' H ' ' HB1' ' A' ' 23' ' ' ALA . . . -87.2 152.98 21.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.723 -0.843 . . . . 72.4 108.723 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -95.75 120.74 36.54 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.302 0.572 . . . . 54.34 112.322 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.3 p -93.46 145.24 24.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 115.144 -0.934 . . . . 63.34 109.114 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.2 t -124.08 134.71 25.63 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 106.82 -1.548 . . . . 73.3 106.82 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 33.1 Cg_endo -65.4 126.5 16.35 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.137 1.892 . . . . 74.44 111.73 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.54 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.97 155.26 39.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.516 -0.765 . . . . 63.2 110.558 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.425 HG21 ' HD3' ' A' ' 61' ' ' LYS . 7.1 p -121.75 129.08 75.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.55 0.691 . . . . 70.35 111.385 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.456 ' HB2' HG12 ' A' ' 93' ' ' VAL . 27.2 tp -91.58 95.36 9.89 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.332 -0.849 . . . . 64.43 111.804 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 17.6 p-80 -73.55 131.96 42.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.123 -0.695 . . . . 75.12 109.123 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.11 -10.56 20.39 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 119.213 -1.47 . . . . 65.32 113.064 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.01 158.71 34.62 Favored 'General case' 0 CA--C 1.473 -1.993 0 N-CA-C 110.242 -0.281 . . . . 65.04 110.242 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -126.19 131.5 51.98 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.767 -1.197 . . . . 73.12 107.767 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.428 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -91.36 137.23 32.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.568 0.699 . . . . 73.43 112.665 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.33 -1.359 . . . . 73.23 107.33 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -88.12 -45.21 10.33 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.862 0.319 . . . . 73.3 111.862 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.507 HD23 HD22 ' A' ' 49' ' ' LEU 0.261 7.5 mp 57.23 77.34 0.27 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 114.912 1.449 . . . . 70.14 114.912 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -78.58 105.25 9.74 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.79 -1.096 . . . . 51.54 110.626 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.88 -31.57 3.04 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 110.882 -0.887 . . . . 33.14 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD22 HD23 ' A' ' 46' ' ' LEU . 4.2 mp -96.86 156.16 36.8 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 108.025 -1.102 . . . . 71.24 108.025 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.27 87.87 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 123.133 2.555 . . . . 62.43 113.955 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.601 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.595 34.6 p90 33.42 54.83 1.34 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 119.556 3.169 . . . . 75.31 119.556 -176.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 5.7 Cg_endo -103.63 169.49 0.21 Allowed 'Trans proline' 0 CA--C 1.555 1.542 1 C-N-CA 125.637 4.225 . . . . 73.14 110.298 174.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p -155.97 -178.43 7.3 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.245 2.218 . . . . 64.23 107.122 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.464 HG13 HG12 ' A' ' 108' ' ' VAL . 44.4 pt -126.64 124.24 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.625 -1.25 . . . . 65.22 107.625 164.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 m -146.71 172.71 3.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.856 -1.164 . . . . 71.14 107.856 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.6 m 71.04 129.94 0.03 OUTLIER 'General case' 0 C--O 1.24 0.577 0 O-C-N 124.909 1.38 . . . . 73.34 111.495 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -80.31 75.05 7.14 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.04 -1.467 . . . . 74.41 107.04 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.61 161.9 20.98 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 113.066 -1.879 . . . . 73.41 109.708 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.9 m -82.79 -4.29 57.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.667 0.27 . . . . 71.25 111.332 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.68 -171.17 47.4 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 121.505 -0.379 . . . . 70.31 112.433 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HD3' HG21 ' A' ' 37' ' ' VAL . 9.4 ptpp? -144.69 154.78 43.13 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 120.82 0.343 . . . . 75.3 110.609 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG13 ' HG2' ' A' ' 43' ' ' ARG . 65.7 t -116.92 122.16 69.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.775 -0.648 . . . . 71.12 109.3 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -96.04 123.41 39.63 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.374 -0.531 . . . . 75.04 109.672 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.91 -143.8 3.76 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.894 -1.282 . . . . 71.12 109.894 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 48.6 mtpt -140.76 150.68 43.69 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.762 0.781 . . . . 53.14 109.632 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.5 m -104.45 133.99 47.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 115.629 -0.714 . . . . 62.24 109.773 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.526 HD11 ' HB ' ' A' ' 17' ' ' ILE . 45.4 mt -87.23 111.54 21.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.8 -1.926 . . . . 72.2 105.8 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -103.91 162.03 13.47 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.296 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.67 72.03 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 116.147 -0.479 . . . . 73.42 111.966 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -94.97 122.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 109.939 -0.393 . . . . 72.01 109.939 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.0 t -73.74 163.22 28.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.325 -0.991 . . . . 74.15 108.325 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.9 -26.0 68.58 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.973 0.416 . . . . 64.13 110.575 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 -43.91 32.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.42 -0.585 . . . . 75.11 109.42 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.631 ' HB3' HD22 ' A' ' 27' ' ' LEU . 53.9 mt-10 -63.73 -43.2 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 71.45 110.599 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.15 -36.62 77.97 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.723 0.809 . . . . 73.31 110.077 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' HG23 ' A' ' 80' ' ' VAL . 58.4 t30 -60.92 -28.71 69.13 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.348 -0.842 . . . . 52.15 111.18 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.511 ' ND2' HG13 ' A' ' 26' ' ' ILE . 3.1 t30 -70.74 -30.17 66.61 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 119.791 -0.763 . . . . 64.24 109.484 -173.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.554 ' CE2' HD21 ' A' ' 27' ' ' LEU . 92.6 m-85 -70.53 -32.59 70.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 64.01 109.484 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.13 -39.99 62.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.186 -0.915 . . . . 63.34 109.67 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 76' ' ' ASN . 65.5 t -74.62 -44.15 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.118 -0.946 . . . . 72.35 112.031 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.35 120.76 51.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.412 -0.358 . . . . 70.14 111.527 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 75.87 -26.78 0.19 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.934 1.294 . . . . 74.42 113.7 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 51.16 3.89 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.289 -0.724 . . . . 60.31 111.289 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.65 -43.11 49.29 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.073 0.549 . . . . 62.23 112.285 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.628 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 4.2 t70 -118.03 25.87 10.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.88 1.324 . . . . 72.51 107.552 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 89.5 m-85 -114.75 151.36 33.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.072 -1.422 . . . . 74.33 109.68 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.74 149.23 49.72 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.522 -0.547 . . . . 75.02 109.522 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -85.8 125.4 33.23 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.922 0.712 . . . . 63.35 112.922 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.25 155.79 41.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.965 -1.016 . . . . 70.32 109.218 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.5 m -96.98 124.14 40.87 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.384 -0.599 . . . . 71.3 109.384 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.3 m -128.96 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 107.904 -1.147 . . . . 60.33 107.904 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -112.52 131.63 55.5 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.747 -1.181 . . . . 74.55 108.26 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 38' ' ' LEU . 24.1 m -125.67 163.68 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 73.41 109.458 -174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 101' ' ' LYS . 70.4 t -102.48 117.27 47.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.839 -0.619 . . . . 54.24 109.338 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -66.72 94.58 0.31 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.863 -1.162 . . . . 74.41 107.863 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.54 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -54.34 -35.57 62.86 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 125.496 1.518 . . . . 74.31 109.567 -177.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -52.6 -30.89 33.54 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.763 -1.108 . . . . 63.45 112.592 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -136.08 4.61 2.99 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.617 0.722 . . . . 53.22 110.968 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m 59.88 25.58 14.72 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.119 0.968 . . . . 74.44 112.742 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.83 160.61 14.33 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.656 -0.868 . . . . 72.41 108.656 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 94' ' ' VAL . 39.8 mtmt -102.35 129.69 48.88 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.49 -0.559 . . . . 74.44 109.49 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.74 144.38 37.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.092 0.472 . . . . 53.31 110.431 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -93.94 126.35 39.09 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.524 -0.917 . . . . 75.23 108.524 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.081 0.467 . . . . 64.01 111.28 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 46.7 mt-10 -100.53 153.36 19.44 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.636 -1.246 . . . . 73.51 107.636 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -151.01 173.63 14.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 86' ' ' TYR . 92.5 m-85 -113.55 118.68 35.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 121.122 0.487 . . . . 72.24 110.29 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG12 HG13 ' A' ' 54' ' ' ILE . 27.4 m -109.79 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.472 -0.936 . . . . 74.02 108.472 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.628 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 46.4 t-105 -93.33 129.17 39.53 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.223 -1.028 . . . . 64.33 108.223 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 85' ' ' ASP . 34.8 m -71.47 -20.07 20.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 N-CA-C 112.51 0.559 . . . . 71.41 112.51 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.556 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 25.4 t-20 -80.48 11.8 3.46 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.744 0.783 . . . . 75.13 109.942 176.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 19.6 ptpt -51.29 -15.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.747 2.019 . . . . 70.15 114.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.46 -52.07 18.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.957 0.903 . . . . 65.11 111.218 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -108.05 127.54 27.42 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 109.432 -0.581 . . . . 75.25 109.432 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.87 103.61 0.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 62.02 111.056 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -100.9 133.09 45.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.503 -0.771 . . . . 73.44 109.653 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.466 0.357 0 O-C-N 123.987 0.805 . . . . 72.13 110.078 -178.21 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 129' ' ' VAL . 36.9 tt0 . . . . . 0 N--CA 1.427 -1.594 0 N-CA-C 108.4 -0.963 . . . . 75.2 108.4 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -61.99 -44.17 97.3 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.424 -0.51 . . . . 70.45 109.871 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -56.27 -48.93 75.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.662 -0.699 . . . . 74.35 111.177 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.57 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 32.0 m -70.43 -40.59 77.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.154 -0.618 . . . . 40.22 112.37 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 125' ' ' GLU . 95.2 t -68.16 -44.81 84.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.548 -0.461 . . . . 63.4 111.767 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.514 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.6 p80 -67.39 -33.77 75.9 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 118.401 -1.319 . . . . 61.51 109.737 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -64.54 -47.27 79.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.977 -0.556 . . . . 73.15 110.863 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 48.1 mt-10 -60.28 -41.52 93.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.954 0.406 . . . . 73.41 110.389 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.25 -48.05 81.67 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.179 -0.919 . . . . 72.31 111.897 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.514 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 56.4 m-85 -67.94 -45.43 74.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.581 -0.448 . . . . 74.23 111.572 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 131' ' ' ALA . 94.5 t -57.37 -48.26 83.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 116.391 -0.368 . . . . 70.43 111.68 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -58.55 -48.88 79.43 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 120.439 -0.504 . . . . 63.0 109.928 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -45.2 81.27 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.527 -0.76 . . . . 75.53 112.343 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.52 -43.05 73.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.872 -0.731 . . . . 63.12 112.067 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 98.9 mtt180 -61.49 -46.74 88.76 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.992 0.425 . . . . 62.22 111.207 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.95 -32.05 66.93 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.909 -0.587 . . . . 62.4 112.316 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -72.86 -32.07 65.18 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.41 -0.959 . . . . 75.24 108.41 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.56 -37.17 79.69 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.464 -0.789 . . . . 73.24 110.166 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 8.6 mm-40 -61.59 -46.44 89.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.1 0.476 . . . . 74.41 110.283 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -65.39 -43.73 89.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.871 -0.604 . . . . 74.14 110.8 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.6 -22.21 65.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.698 0.761 . . . . 74.23 111.09 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 146' ' ' LYS . 0.7 OUTLIER -78.45 -26.66 46.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.447 -0.797 . . . . 72.22 109.193 177.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.01 82.14 0.22 Allowed Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.349 0.66 . . . . 73.0 109.72 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.25 -37.26 2.68 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.216 1.944 . . . . 61.33 112.031 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -96.47 3.44 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.562 -0.744 . . . . 73.34 110.572 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 109.636 -1.386 . . . . 75.32 109.636 -173.368 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 p . . . . . 0 N--CA 1.439 -0.986 0 CA-C-O 121.747 0.784 . . . . 63.21 110.351 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.95 156.2 19.04 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 114.647 -1.16 . . . . 73.33 111.059 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.557 ' HB2' HG12 ' A' ' 104' ' ' VAL . 3.3 m-20 -125.31 131.92 52.96 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.96 -1.496 . . . . 50.24 106.96 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 13' ' ' VAL . 49.1 t -119.5 120.33 63.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 120.336 -0.546 . . . . 51.35 110.694 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' HB2' HG21 ' A' ' 104' ' ' VAL . 43.4 t80 -91.5 96.73 10.65 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 104.861 -2.274 . . . . 71.12 104.861 173.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 11' ' ' VAL . 10.3 p -119.1 121.93 67.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 118.329 -1.348 . . . . 71.05 111.576 -173.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -92.35 66.86 4.77 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 106.025 -1.843 . . . . 64.45 106.025 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.38 -169.82 13.9 Favored Glycine 0 N--CA 1.42 -2.392 0 CA-C-N 113.537 -1.665 . . . . 70.43 109.381 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -88.0 85.11 6.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-O 121.606 0.717 . . . . 65.23 112.749 -174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 67' ' ' ILE . 8.0 mm -144.43 -84.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 104.846 -2.279 . . . . 74.14 104.846 169.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' H ' ' HB ' ' A' ' 17' ' ' ILE . 80.6 mt 50.89 -42.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 128.086 2.554 . . . . 73.31 117.368 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.89 140.29 22.55 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.199 -0.667 . . . . 72.41 109.199 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -48.57 -28.65 12.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.586 3.524 . . . . 62.45 114.861 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.48 97.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.929 0.395 . . . . 73.54 111.08 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 25' ' ' VAL . 35.9 t -77.07 -30.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.882 -0.784 . . . . 65.05 108.882 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.64 -28.96 70.27 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.934 -0.765 . . . . 71.33 108.934 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.09 -8.7 57.59 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.434 -0.803 . . . . 21.42 111.767 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 22' ' ' VAL . 14.4 m -99.25 -23.07 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 119.619 -0.833 . . . . 71.52 110.773 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.559 HG21 HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -85.85 -47.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 116.251 -0.431 . . . . 62.32 110.588 176.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 31' ' ' ALA . 97.7 mt -89.66 -21.3 22.83 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 116.57 -0.286 . . . . 73.51 110.796 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 37.2 t70 68.72 10.7 8.04 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.289 1.519 . . . . 70.22 108.882 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -136.11 141.83 44.22 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 104.928 -2.249 . . . . 75.22 104.928 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -77.74 136.83 38.21 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.485 -0.886 . . . . 60.1 109.887 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -121.0 154.86 35.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.689 -0.485 . . . . 42.32 109.689 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -89.89 117.98 29.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.473 -0.566 . . . . 62.02 109.473 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.6 m -104.96 142.67 34.36 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.459 -2.052 . . . . 75.25 105.459 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.56 149.84 70.44 Favored Pre-proline 0 C--N 1.296 -1.75 0 O-C-N 122.088 -0.383 . . . . 74.02 110.133 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.53 133.47 37.24 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.605 2.203 . . . . 71.5 111.522 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.79 156.51 41.94 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.942 -0.572 . . . . 73.22 109.868 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.0 p -122.59 128.04 75.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-O 121.496 0.665 . . . . 73.23 111.045 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.47 ' HA ' HG12 ' A' ' 93' ' ' VAL . 22.4 tp -87.91 111.07 21.04 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.196 -0.911 . . . . 75.2 110.103 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 13.9 p80 -87.06 122.21 30.57 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.473 -0.785 . . . . 64.14 110.187 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.45 7.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.374 -1.393 . . . . 71.31 112.866 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.444 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 57.0 m-85 -117.78 161.11 20.24 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 109.288 -0.634 . . . . 73.12 109.288 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -133.41 131.98 40.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.25 -1.389 . . . . 72.0 107.25 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.457 ' C ' ' HD3' ' A' ' 43' ' ' ARG . 1.2 tmt_? -88.56 120.56 30.06 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 109.292 -0.633 . . . . 71.31 109.292 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 39.0 m-85 -95.99 159.82 14.77 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.987 -1.486 . . . . 74.43 106.987 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' C ' ' HD3' ' A' ' 45' ' ' LYS . 7.7 tmtm? -82.78 -41.76 18.76 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 112.156 0.428 . . . . 70.53 112.156 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 49' ' ' LEU . 7.9 mp 62.75 158.27 0.07 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.529 1.307 . . . . 71.1 114.529 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.41 -51.25 1.28 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.799 -0.815 . . . . 75.5 108.799 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.29 74.63 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.661 -1.154 . . . . 71.4 111.678 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HB2' HD23 ' A' ' 46' ' ' LEU . 3.0 mm? -107.63 167.34 9.5 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.409 -0.96 . . . . 62.42 108.409 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 41.5 Cg_exo -62.68 -157.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.52 0 C-N-CA 123.01 2.473 . . . . 51.32 112.905 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' N ' ' HD2' ' A' ' 52' ' ' PRO 0.349 12.8 p90 -57.49 -31.34 9.92 Favored Pre-proline 0 CA--C 1.568 1.665 0 N-CA-C 116.557 2.058 . . . . 72.13 116.557 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 51' ' ' TYR . 3.3 Cg_exo -39.74 168.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.59 3.317 0 C-N-CA 123.631 2.887 . . . . 71.52 112.746 163.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 p -139.29 -175.87 4.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.199 -1.563 . . . . 72.4 110.963 11.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 45.1 pt -123.77 141.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.116 -1.068 . . . . 70.1 108.116 172.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.407 HG22 ' HE2' ' A' ' 44' ' ' TYR . 30.8 m -148.18 158.77 7.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.951 -0.759 . . . . 45.21 108.951 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 m -80.5 88.91 5.62 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.739 0.78 . . . . 62.42 109.839 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.5 t -144.1 -66.02 0.35 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.574 -1.639 . . . . 74.22 106.574 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.63 125.68 30.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.387 -1.709 . . . . 73.13 106.387 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -84.41 15.46 3.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.846 0.684 . . . . 64.13 112.846 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.84 -147.73 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 114.617 0.607 . . . . 53.44 114.617 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 27.0 mtmm -139.82 154.09 47.25 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 120.167 -0.613 . . . . 75.32 111.184 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 54' ' ' ILE . 45.2 t -114.55 123.23 70.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.474 -0.785 . . . . 61.24 109.861 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -94.13 123.9 37.8 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.855 -0.424 . . . . 63.03 109.855 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.32 -149.03 5.19 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.16 -0.776 . . . . 63.22 111.16 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -138.3 156.55 47.55 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.904 -0.776 . . . . 73.32 108.904 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . 29.8 m -125.8 129.62 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 120.782 0.325 . . . . 74.24 111.053 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.603 HD13 HG21 ' A' ' 17' ' ' ILE . 6.2 mt -90.15 116.77 32.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.163 -1.421 . . . . 61.42 107.163 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.2 p -100.89 161.15 13.79 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.936 -0.306 . . . . 75.01 110.717 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.13 33.39 23.58 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.135 -0.555 . . . . 73.05 112.805 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.59 122.32 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 O-C-N 122.473 -0.428 . . . . 64.1 110.642 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.483 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 65.8 m -79.23 158.64 27.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.794 -0.762 . . . . 65.12 109.951 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -52.17 -34.93 47.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.171 0.804 . . . . 53.13 113.171 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -37.64 37.56 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.306 0.574 . . . . 73.24 110.654 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 13.3 mm-40 -68.16 -30.53 69.67 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.229 -0.896 . . . . 74.15 109.43 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 ' HG3' ' A' ' 105' ' ' GLU . 4.2 tt -59.37 -35.09 73.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.397 -1.274 . . . . 74.23 109.538 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 80' ' ' VAL . 3.4 t-20 -60.37 -28.16 67.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 72.34 110.96 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -31.63 70.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.439 -0.949 . . . . 72.24 108.439 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.411 ' CZ ' HD12 ' A' ' 26' ' ' ILE . 73.3 m-85 -67.78 -35.3 78.42 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 116.421 -0.354 . . . . 73.24 110.38 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -69.59 -35.94 75.77 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.726 0.774 . . . . 74.44 109.478 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 76' ' ' ASN . 80.5 t -72.64 -24.59 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 CA-C-N 115.154 -0.93 . . . . 74.34 112.792 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.467 ' HB ' ' OH ' ' A' ' 107' ' ' TYR . 47.9 mm -44.4 -74.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 113.15 0.796 . . . . 73.11 113.15 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -141.77 19.55 2.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.249 0.547 . . . . 75.14 110.847 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.46 62.89 4.0 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.927 -0.654 . . . . 71.44 113.183 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.38 -42.88 18.08 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.908 -0.404 . . . . 73.13 109.908 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.8 m-20 -114.49 17.19 17.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.251 1.024 . . . . 75.35 109.718 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.98 156.58 26.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.497 -1.298 . . . . 64.34 107.497 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HB3' HG12 ' A' ' 110' ' ' VAL . 14.3 pt-20 -126.17 142.29 51.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.829 -0.804 . . . . 74.11 108.829 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 tmm_? -88.09 118.07 27.41 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.579 -0.737 . . . . 73.34 109.824 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 m -126.27 160.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.359 0.664 . . . . 65.2 111.834 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.3 m -89.18 129.61 35.74 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 123.628 0.58 . . . . 63.54 109.552 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.87 172.16 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.362 -1.347 . . . . 65.34 107.362 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -123.6 129.85 51.78 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.319 -0.952 . . . . 74.34 109.167 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 38' ' ' LEU . 16.2 m -127.03 168.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.073 0.464 . . . . 73.32 110.72 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.534 HG22 ' HG2' ' A' ' 101' ' ' LYS . 68.0 t -114.07 122.43 68.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.819 -0.628 . . . . 74.44 110.931 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.48 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 75.0 ttt180 -70.98 102.12 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.926 -1.138 . . . . 74.55 107.926 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.37 -60.0 2.38 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 126.818 2.047 . . . . 72.34 111.511 -171.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.1 -32.64 62.16 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.804 1.039 . . . . 71.54 113.804 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -110.47 -8.78 14.63 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.292 0.849 . . . . 62.22 113.292 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.41 25.69 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.966 0.907 . . . . 74.41 110.384 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -98.83 160.19 14.43 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.864 -0.791 . . . . 72.43 108.864 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.534 ' HG2' HG22 ' A' ' 94' ' ' VAL . 88.2 mttt -105.05 137.31 42.99 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.582 -0.525 . . . . 74.14 109.582 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.13 140.62 43.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.714 -0.476 . . . . 55.25 109.714 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -90.8 127.74 36.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.241 -1.392 . . . . 71.12 107.241 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.557 HG12 ' HB2' ' A' ' 10' ' ' ASN . 28.2 m -133.98 171.95 17.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.024 0.44 . . . . 75.01 112.121 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.558 ' HG3' HD11 ' A' ' 75' ' ' LEU . 31.2 mm-40 -104.24 153.97 20.35 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.255 -1.387 . . . . 74.04 107.255 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -156.0 177.79 11.01 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.247 0.476 . . . . 74.15 110.166 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' A' ' 81' ' ' ILE . 3.9 m-85 -103.55 119.78 39.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 122.914 0.485 . . . . 74.45 109.85 177.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -119.55 159.99 20.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.873 -1.528 . . . . 73.32 106.873 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.715 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 54.0 t-105 -83.96 134.27 34.66 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.669 -0.863 . . . . 75.33 108.669 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 85' ' ' ASP . 29.5 m -72.21 -20.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 118.981 0.809 . . . . 54.44 112.419 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.715 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 26.0 t-20 -92.0 15.5 13.11 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 125.323 1.449 . . . . 54.54 108.992 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 45.5 pttt -47.75 -15.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 127.242 2.217 . . . . 71.44 116.356 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.41 -20.39 60.07 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 119.112 -1.035 . . . . 61.42 111.442 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -97.46 124.48 48.64 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 107.544 -1.28 . . . . 74.05 107.544 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.25 102.24 1.5 Allowed 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 121.403 1.402 . . . . 73.44 111.011 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.79 112.02 17.78 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.895 -1.15 . . . . 72.22 107.895 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.47 0.544 0 O-C-N 124.639 1.212 . . . . 73.42 110.97 -175.098 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--O 1.239 0.516 0 CA-C-O 120.769 0.319 . . . . 63.04 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -51.6 -57.18 9.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.29 -0.868 . . . . 73.44 111.406 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.3 -34.18 65.59 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.044 -0.662 . . . . 73.34 111.81 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.75 -47.63 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.535 0.568 . . . . 74.11 112.535 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.16 -33.9 63.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.549 0.69 . . . . 72.21 109.905 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.47 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 55.6 t-80 -69.88 -45.71 67.06 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.961 -1.018 . . . . 65.44 109.844 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -61.26 -52.97 62.5 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.98 -0.554 . . . . 52.11 111.022 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.03 -45.67 71.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 123.414 0.446 . . . . 72.11 111.51 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -61.51 -53.96 49.5 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.018 -0.992 . . . . 73.11 111.886 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.47 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 96.7 m-85 -74.95 -31.5 61.51 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 113.79 1.033 . . . . 71.44 113.79 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 131' ' ' ALA . 79.4 t -63.8 -45.94 95.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 121.139 -0.225 . . . . 54.13 111.295 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 12.5 pt-20 -67.77 -36.71 80.97 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.401 -0.919 . . . . 71.11 110.937 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.7 m -60.82 -47.21 87.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.937 -0.574 . . . . 73.13 109.46 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.554 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 87.1 t80 -59.16 -48.05 83.06 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.831 -0.622 . . . . 74.12 110.028 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 97.4 mtt180 -61.58 -42.89 99.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.181 -0.463 . . . . 74.1 112.148 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.4 mmtp -65.17 -42.37 93.73 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 121.019 -0.272 . . . . 75.25 110.537 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.7 mmt -63.83 -31.86 73.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.199 -0.455 . . . . 71.02 111.728 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 90.6 mt -67.71 -45.53 74.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.858 -0.423 . . . . 70.03 109.858 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.1 mt-10 -60.79 -47.07 88.01 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 109.579 -0.526 . . . . 73.24 109.579 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -59.97 -38.98 84.11 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.216 1.007 . . . . 72.34 111.494 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.5 -45.61 13.41 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.056 -0.52 . . . . 72.05 112.262 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.71 -26.33 25.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.224 0.453 . . . . 63.21 112.224 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -123.25 124.17 26.46 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-O 120.731 0.301 . . . . 63.04 111.149 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.38 -19.41 67.17 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.656 2.237 . . . . 62.23 111.664 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -93.8 3.81 54.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.079 -0.51 . . . . 63.45 110.613 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.983 0 N-CA-C 108.912 -1.675 . . . . 74.22 108.912 174.724 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.434 -1.262 0 CA-C-O 121.53 0.681 . . . . 74.45 111.619 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.407 ' CB ' HD12 ' A' ' 75' ' ' LEU . 80.6 m80 -108.9 156.26 19.89 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.655 -0.702 . . . . 65.34 110.411 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.552 ' HB2' HG12 ' A' ' 104' ' ' VAL . 84.1 m-20 -132.16 126.41 33.56 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.164 -1.421 . . . . 73.4 107.164 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.78 120.62 65.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 121.18 -0.208 . . . . 35.24 110.85 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -84.67 112.76 20.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.476 -0.935 . . . . 72.23 108.476 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.2 t -113.55 142.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.76 -0.83 . . . . 53.42 108.76 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -81.24 -53.98 5.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.708 -0.223 . . . . 70.32 111.426 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.95 79.64 0.13 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 118.531 -1.795 . . . . 75.31 114.974 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 p -162.6 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.38 0.61 . . . . 74.34 110.902 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -91.16 70.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 CA-C-O 123.69 1.709 . . . . 71.42 107.605 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 65' ' ' LYS . 80.7 mt -114.12 -11.7 12.64 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-N 113.372 -1.74 . . . . 65.42 106.96 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -85.68 125.97 67.58 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 113.469 -1.696 . . . . 73.33 110.168 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.12 -38.24 80.57 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.805 2.336 . . . . 75.0 111.669 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.84 -44.97 91.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.918 0.39 . . . . 34.23 111.07 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.533 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -70.16 -34.42 58.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 121.258 0.551 . . . . 51.34 109.795 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -62.32 -35.71 79.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.223 0.535 . . . . 71.44 109.557 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.84 -13.07 61.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.581 -0.736 . . . . 63.25 111.94 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 22' ' ' VAL . 12.0 m -98.58 -26.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 119.602 -0.839 . . . . 73.32 110.45 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.555 HG21 HG13 ' A' ' 17' ' ' ILE . 6.0 tt -84.41 -41.63 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.015 0.436 . . . . 65.44 112.095 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 86.1 mt -99.62 -21.16 15.99 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.299 -0.409 . . . . 63.22 111.173 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.4 t70 75.84 -5.0 2.26 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.624 1.202 . . . . 64.02 108.925 -171.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 27' ' ' LEU . 84.9 mtt180 -105.94 138.11 42.69 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 113.754 -1.566 . . . . 65.31 107.665 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -79.62 111.15 15.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 106.403 -1.703 . . . . 71.4 106.403 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -89.52 157.06 18.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.388 0.613 . . . . 73.04 111.726 -174.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.63 114.61 27.77 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.959 -1.019 . . . . 74.23 111.323 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 1.7 p -102.62 143.07 32.77 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.519 -0.764 . . . . 52.51 109.775 174.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 m -136.16 143.26 43.13 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 109.155 -0.683 . . . . 62.23 109.155 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.2 132.79 54.05 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.272 1.981 . . . . 64.15 110.671 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.12 36.51 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 109.014 -0.735 . . . . 62.21 109.014 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.23 127.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-O 121.743 0.782 . . . . 72.43 111.988 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 93' ' ' VAL . 22.3 tp -90.24 102.36 15.08 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.723 -1.126 . . . . 63.34 109.943 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 61' ' ' LYS . 9.9 p-80 -76.28 125.26 28.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.302 -0.863 . . . . 72.13 109.771 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 117.42 -21.04 10.93 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 118.869 -1.634 . . . . 74.22 114.207 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -106.65 157.31 17.8 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 117.888 0.844 . . . . 73.15 111.482 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -124.92 124.26 41.67 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.403 -0.962 . . . . 53.41 108.403 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -90.86 147.19 23.34 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.763 0.316 . . . . 71.11 110.976 177.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.54 -169.99 1.96 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.527 0.566 . . . . 72.43 112.527 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -36.83 5.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.592 -0.276 . . . . 75.25 110.878 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 3.8 mm? 64.06 -178.02 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.045 0.538 . . . . 62.51 111.991 -174.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 28.04 6.58 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 113.035 0.754 . . . . 71.52 113.035 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.44 15.0 0.17 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.731 -1.223 . . . . 71.31 113.339 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.418 ' C ' ' HG3' ' A' ' 52' ' ' PRO . 3.6 mm? -95.49 160.17 31.08 Favored Pre-proline 0 C--N 1.311 -1.075 0 O-C-N 122.291 -0.534 . . . . 74.14 110.834 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -90.35 119.56 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.01 2.474 . . . . 74.14 112.504 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.497 ' HA ' ' CG ' ' A' ' 125' ' ' GLU 0.341 21.6 p90 39.78 60.66 6.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 113.835 1.05 . . . . 73.44 113.835 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 89.3 Cg_endo -115.52 144.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.153 3.235 . . . . 74.25 116.764 -170.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 82.2 m -153.46 -178.84 7.26 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 130.123 3.369 . . . . 54.21 101.916 -13.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.535 HG13 HG12 ' A' ' 108' ' ' VAL . 43.0 pt -123.35 122.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.988 -1.085 . . . . 74.3 110.94 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.33 177.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.704 -1.134 . . . . 75.05 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.8 p 50.96 102.43 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.619 1.568 . . . . 71.54 112.261 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 23.2 t -73.82 83.89 1.66 Allowed 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.799 -0.76 . . . . 73.22 111.617 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.0 -167.3 1.61 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.137 -0.938 . . . . 44.52 109.808 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.3 m -89.45 5.57 44.72 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.567 -0.901 . . . . 61.01 108.567 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.43 165.31 53.81 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.202 -0.908 . . . . 64.23 111.563 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 39' ' ' HIS . 27.9 mtmm -138.06 146.73 43.33 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.329 -0.619 . . . . 72.54 109.329 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 54' ' ' ILE . 40.3 t -110.08 122.89 65.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.183 -0.673 . . . . 73.23 109.183 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.38 125.43 46.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.288 -1.004 . . . . 61.43 108.288 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.46 -141.24 3.17 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.501 -1.04 . . . . 52.31 110.501 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.502 ' HB2' HD22 ' A' ' 18' ' ' LEU . 38.9 mtmt -136.82 138.79 41.2 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 113.291 0.849 . . . . 74.51 113.291 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 93' ' ' VAL . 31.5 m -104.7 133.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 114.689 -1.141 . . . . 53.34 110.054 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.566 HD13 HD12 ' A' ' 17' ' ' ILE . 14.5 mt -88.42 111.64 22.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 105.638 -1.986 . . . . 64.4 105.638 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -97.49 161.53 13.73 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.236 -0.586 . . . . 62.41 111.536 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.05 60.12 Favored Glycine 0 CA--C 1.522 0.52 0 O-C-N 123.285 0.366 . . . . 54.35 113.635 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.62 131.98 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 110.25 -0.278 . . . . 70.23 110.25 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.478 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 24.2 m -78.37 158.96 28.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.124 -0.631 . . . . 75.45 109.775 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -55.81 -45.44 78.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.612 -0.722 . . . . 70.12 111.342 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.51 -36.09 76.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.735 -0.666 . . . . 51.5 111.232 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 54.1 mt-10 -73.72 -35.7 65.13 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.722 -0.672 . . . . 75.21 111.09 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.5 tt -60.21 -35.41 75.37 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.706 -0.85 . . . . 65.05 108.706 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -55.5 -27.75 50.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.784 -1.098 . . . . 73.44 112.141 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.507 ' O ' HG22 ' A' ' 81' ' ' ILE . 5.4 t30 -74.33 -31.86 62.61 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 119.391 -0.924 . . . . 74.23 109.503 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.479 ' CD1' HD13 ' A' ' 26' ' ' ILE . 73.6 m-85 -71.81 -42.03 67.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.229 -1.397 . . . . 74.12 107.229 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.424 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 9.4 t70 -55.96 -52.63 63.47 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.261 -1.336 . . . . 72.22 110.291 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.02 -33.14 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 113.294 0.85 . . . . 61.23 113.294 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 77' ' ' ASN . 17.0 tt -101.21 -34.24 3.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 C-N-CA 118.464 -1.294 . . . . 73.14 113.996 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -79.26 -19.0 51.69 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.929 -0.708 . . . . 74.52 110.841 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.81 60.37 3.89 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.992 -0.623 . . . . 70.32 112.427 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -81.81 -44.59 16.73 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.853 -0.795 . . . . 74.44 108.853 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -141.05 21.55 2.27 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.873 -1.528 . . . . 71.44 106.873 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -122.7 153.74 39.01 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.731 -1.577 . . . . 75.43 107.401 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HB3' HG23 ' A' ' 110' ' ' VAL . 9.9 pt-20 -126.33 153.8 44.37 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 120.195 -0.602 . . . . 74.4 111.086 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.424 ' HD3' ' OD2' ' A' ' 79' ' ' ASP . 58.3 ttt180 -82.84 121.29 26.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.773 -1.103 . . . . 73.43 111.427 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.73 159.11 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.583 -0.735 . . . . 70.33 109.607 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.57 131.2 39.06 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.564 -0.902 . . . . 70.1 108.564 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.414 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.4 m -137.79 165.48 26.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.431 -1.322 . . . . 73.53 107.431 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -117.92 128.74 55.11 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.56 -1.256 . . . . 71.35 109.097 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 66' ' ' VAL . 18.3 m -125.98 168.71 18.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.879 -0.415 . . . . 65.22 109.879 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' A' ' 101' ' ' LYS . 73.5 t -109.96 118.01 55.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 115.957 -0.565 . . . . 72.0 110.786 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -73.04 105.22 4.41 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.137 -1.06 . . . . 72.31 108.137 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.87 62.31 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 124.423 1.089 . . . . 75.44 110.032 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.98 -33.92 71.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.493 -0.776 . . . . 74.23 112.334 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -128.73 0.65 5.45 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 120.627 -0.429 . . . . 71.13 111.66 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 62.28 26.78 16.04 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.471 0.708 . . . . 24.33 110.615 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.9 160.52 14.54 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.557 -0.747 . . . . 72.24 109.727 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.535 ' HG2' HG22 ' A' ' 94' ' ' VAL . 38.7 mtmt -102.4 135.69 43.55 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.536 -0.913 . . . . 45.53 108.536 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.1 m -133.87 139.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.249 0.547 . . . . 71.14 109.892 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.62 122.06 30.84 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.648 -1.612 . . . . 61.25 106.648 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 10' ' ' ASN . 17.8 m -131.52 175.13 11.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.083 0.468 . . . . 75.31 111.137 -171.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.82 146.99 27.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.771 -1.196 . . . . 73.21 107.771 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.0 t -149.5 174.32 12.62 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.279 -1.008 . . . . 60.03 108.279 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 92.6 m-85 -118.75 118.72 32.35 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.276 0.56 . . . . 73.01 109.739 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG12 HG13 ' A' ' 54' ' ' ILE . 33.7 m -108.98 175.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.184 -1.043 . . . . 63.4 108.184 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 23.0 t-105 -74.69 132.49 41.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.929 -1.508 . . . . 74.41 106.929 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.8 p -69.62 -20.78 24.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.918 0.866 . . . . 75.14 110.61 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.54 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 7.9 t30 -88.92 15.12 8.98 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.719 1.208 . . . . 72.22 109.17 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 61.3 pttt -48.94 -15.66 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.069 1.748 . . . . 75.13 115.123 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -72.84 -22.95 60.71 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.012 -0.675 . . . . 65.41 110.404 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -113.84 122.94 33.81 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.486 -0.561 . . . . 63.21 109.486 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.63 115.36 4.05 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.679 2.252 . . . . 74.54 109.591 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.697 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 30.7 ttm180 -129.61 124.26 33.3 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.741 -0.837 . . . . 72.5 108.741 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.697 ' SD ' ' HG2' ' A' ' 116' ' ' ARG . 1.3 mpt? . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.353 1.061 . . . . 74.04 112.263 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.497 ' CG ' ' HA ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.515 0.674 . . . . 75.55 111.599 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -81.37 -35.64 30.57 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.185 -0.916 . . . . 74.13 110.1 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -51.85 -48.92 63.78 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.88 0.738 . . . . 71.51 111.49 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.7 -34.47 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.356 -0.838 . . . . 71.41 112.835 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.46 -44.3 17.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.224 -0.658 . . . . 43.12 109.224 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -55.49 -37.67 68.13 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.033 0.933 . . . . 74.34 111.73 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.74 72.05 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.855 -0.338 . . . . 53.15 111.256 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.555 ' HA ' HG12 ' A' ' 135' ' ' VAL . 7.4 mm-40 -72.3 -35.03 68.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.597 0.713 . . . . 63.34 111.028 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -68.32 -22.08 64.72 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.466 -0.788 . . . . 73.21 112.276 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -98.15 -31.85 11.9 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.051 -0.659 . . . . 75.25 112.015 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 132' ' ' GLU . 11.4 p -66.07 -33.81 66.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 C-N-CA 120.04 -0.664 . . . . 61.23 109.64 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 11.4 pt-20 -60.15 -38.79 84.2 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.432 -0.349 . . . . 65.32 110.22 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 74.0 m -56.38 -46.4 80.09 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 123.538 0.524 . . . . 72.54 111.038 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.483 ' HA ' ' HG2' ' A' ' 141' ' ' MET . 95.6 m-85 -67.43 -32.2 72.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.231 -0.441 . . . . 70.21 111.265 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.647 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 53.5 mtp180 -70.38 -38.88 74.79 Favored 'General case' 0 C--O 1.184 -2.391 0 C-N-CA 119.474 -0.89 . . . . 70.02 111.087 171.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 75.2 mmtt -56.24 -47.23 78.9 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.807 -0.442 . . . . 71.04 109.807 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.671 ' HA ' ' CE3' ' A' ' 144' ' ' TRP . 27.0 ptm -66.22 -30.75 71.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.074 -0.512 . . . . 75.01 110.511 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -44.71 74.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.551 -1.277 . . . . 74.35 107.551 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 7.2 mm-40 -60.93 -29.64 69.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.912 0.885 . . . . 74.35 110.747 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.671 ' CE3' ' HA ' ' A' ' 141' ' ' MET . 26.1 m0 -75.3 -44.19 46.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.627 -0.508 . . . . 74.5 109.627 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.29 -47.85 72.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.384 -0.825 . . . . 63.41 112.248 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.11 -19.41 24.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.281 0.562 . . . . 74.35 110.351 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 143' ' ' GLU 0.345 7.9 p30 46.19 72.41 1.25 Allowed Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 116.96 2.208 . . . . 74.25 116.96 176.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.22 -27.11 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.14 1.893 . . . . 74.34 112.092 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.23 -25.53 22.83 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.108 0.48 . . . . 62.2 110.711 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.947 0 N-CA-C 110.52 -1.032 . . . . 72.32 110.52 -177.115 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.4 p . . . . . 0 N--CA 1.421 -1.923 0 CA-C-O 120.97 0.414 . . . . 65.02 111.111 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -87.56 153.07 21.69 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.555 -0.748 . . . . 70.11 110.23 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 84.5 m-20 -133.64 131.34 39.45 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.065 -1.828 . . . . 53.43 106.065 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 28.4 t -116.3 119.37 61.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 120.326 -0.55 . . . . 62.45 110.788 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.418 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.1 t80 -89.21 109.26 20.16 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.961 -1.496 . . . . 61.14 106.961 173.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.539 HG11 HD11 ' A' ' 17' ' ' ILE . 12.4 p -136.29 154.98 33.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 119.741 -0.784 . . . . 54.12 109.994 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.439 ' HA ' HD11 ' A' ' 18' ' ' LEU . 51.0 t80 -125.11 93.27 3.83 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.094 -0.706 . . . . 64.11 109.094 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.88 -176.46 16.16 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.76 -1.109 . . . . 72.34 111.217 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m 67.5 -73.59 0.08 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 115.137 1.532 . . . . 42.33 115.137 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.539 HD11 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -119.06 14.71 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.046 0.758 . . . . 70.35 113.046 -172.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 13' ' ' VAL . 74.7 mt -74.89 -6.72 50.71 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.195 0.522 . . . . 74.52 111.033 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 115.11 60.47 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 107.436 -1.32 . . . . 62.03 107.436 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -42.24 -44.09 7.72 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.326 3.35 . . . . 71.04 114.659 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.12 94.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.169 0.509 . . . . 72.35 111.494 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 25' ' ' VAL . 46.6 t -71.58 -38.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.965 -0.561 . . . . 74.33 110.248 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.73 74.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.465 0.65 . . . . 64.03 110.05 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -74.84 -16.48 60.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.648 -0.705 . . . . 75.34 111.903 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.3 m -93.54 -33.51 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.493 -0.883 . . . . 65.04 111.233 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' ' 78' ' ' PHE . 9.2 tt -72.46 -47.04 53.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 CA-C-O 120.587 0.232 . . . . 74.11 111.119 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 31' ' ' ALA . 90.7 mt -85.71 -11.98 52.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 121.221 -0.191 . . . . 71.3 110.877 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.53 8.91 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.287 1.042 . . . . 74.33 110.296 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 97.5 mtt180 -145.12 178.66 7.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.162 -0.926 . . . . 75.24 109.321 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.6 p -76.66 111.2 11.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.523 0.678 . . . . 72.04 110.922 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.55 -0.75 . . . . 55.31 110.321 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -100.17 109.69 21.96 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.571 -0.529 . . . . 73.31 109.571 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.8 p -114.09 142.58 46.03 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 109.096 -0.705 . . . . 74.15 109.096 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -142.22 141.45 21.36 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 107.896 -1.15 . . . . 64.13 107.896 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 3.2 Cg_endo -59.76 135.78 66.05 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 121.47 1.447 . . . . 73.32 110.456 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -148.88 157.87 43.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.691 -0.686 . . . . 41.23 110.461 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.574 HG11 ' HD3' ' A' ' 61' ' ' LYS . 22.0 t -115.63 124.21 71.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 115.353 -0.839 . . . . 62.44 111.443 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.491 HD11 ' HB ' ' A' ' 91' ' ' VAL . 22.6 tp -97.6 86.67 3.88 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.211 0.529 . . . . 75.13 111.015 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 25.0 p-80 -62.34 132.47 52.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.027 -0.988 . . . . 74.44 109.46 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.38 -23.93 11.9 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.349 -0.929 . . . . 71.41 112.425 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.464 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 48.2 m-85 -109.81 160.46 16.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 112.481 0.548 . . . . 74.2 112.481 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -131.61 126.84 35.77 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.26 -1.385 . . . . 73.32 107.26 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 24.7 ptt180 -89.68 136.71 32.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.102 -1.039 . . . . 72.4 111.376 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.39 -177.56 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.946 -1.025 . . . . 75.12 109.58 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HD2' ' A' ' 45' ' ' LYS 0.252 0.0 OUTLIER -138.43 91.83 2.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.73 1.252 . . . . 75.1 112.199 178.497 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mm? -92.54 125.73 37.31 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.415 -0.812 . . . . 61.24 109.937 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -9.01 23.39 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.574 -0.739 . . . . 75.44 110.508 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.72 -14.82 39.07 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.409 -0.814 . . . . 71.35 111.191 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.441 HD12 ' HG ' ' A' ' 46' ' ' LEU . 94.8 mt -118.46 163.57 24.75 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 109.448 -0.575 . . . . 73.01 109.448 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -79.25 99.65 1.26 Allowed 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 123.074 2.516 . . . . 64.01 114.708 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.615 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.5 p90 43.91 37.86 0.32 Allowed Pre-proline 0 CA--C 1.594 2.668 0 N-CA-C 116.614 2.079 . . . . 75.04 116.614 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 9.3 Cg_endo -97.77 167.18 0.8 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 123.384 2.723 . . . . 74.02 111.775 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.475 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 16.3 p -155.97 -169.52 3.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.582 2.353 . . . . 71.23 107.302 -4.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 36.5 pt -125.88 123.35 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 109.99 -0.374 . . . . 74.33 109.99 167.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' SER . 59.1 t -146.21 118.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.841 -0.8 . . . . 61.55 108.841 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 26.8 t 174.57 164.43 0.23 Allowed 'General case' 0 C--O 1.241 0.658 0 O-C-N 123.533 0.52 . . . . 71.32 110.23 175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -137.19 7.85 2.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.227 -1.397 . . . . 74.3 107.227 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.94 -166.94 1.47 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.198 -1.365 . . . . 73.34 109.774 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.8 m -93.86 14.69 18.67 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.838 0.455 . . . . 43.11 111.657 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.79 168.26 54.78 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 109.557 -1.417 . . . . 64.43 109.557 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.574 ' HD3' HG11 ' A' ' 37' ' ' VAL . 7.8 ptpp? -146.21 152.1 38.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.894 0.847 . . . . 72.14 111.117 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.402 HG21 ' CG2' ' A' ' 54' ' ' ILE . 54.0 t -115.51 133.41 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.402 -0.592 . . . . 55.12 109.402 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -99.9 137.64 38.08 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.3 -1.0 . . . . 62.13 108.3 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -166.1 -147.61 5.25 Favored Glycine 0 C--N 1.301 -1.373 0 N-CA-C 110.471 -1.052 . . . . 64.24 110.471 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' HB2' HD22 ' A' ' 18' ' ' LEU . 44.8 mtmt -133.8 143.02 48.13 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.065 0.432 . . . . 60.11 111.844 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.1 m -108.68 133.18 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.157 -0.928 . . . . 60.23 110.946 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 23.7 mt -90.31 114.99 28.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.142 -1.799 . . . . 71.3 106.142 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.2 p -103.92 161.36 14.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.026 -0.67 . . . . 74.3 111.89 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.89 22.46 68.94 Favored Glycine 0 CA--C 1.506 -0.528 0 CA-C-N 115.728 -0.669 . . . . 53.43 113.082 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.02 121.83 37.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.893 -0.41 . . . . 72.04 109.893 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 18.0 m -73.18 158.62 34.9 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.378 -0.971 . . . . 64.24 108.378 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.39 -40.31 71.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.154 0.502 . . . . 71.43 111.64 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.64 78.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.927 -0.579 . . . . 74.44 110.838 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 48.0 mm-40 -72.31 -34.39 68.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.184 0.516 . . . . 70.54 110.212 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.63 -36.64 76.76 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.368 -0.833 . . . . 74.2 108.859 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.682 ' O ' HG23 ' A' ' 80' ' ' VAL . 28.2 t-20 -58.92 -29.41 67.07 Favored 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 114.628 -1.169 . . . . 70.1 111.467 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -68.3 -35.25 77.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.822 -0.807 . . . . 51.12 108.822 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 26' ' ' ILE . 94.2 m-85 -74.16 -37.27 64.06 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.536 -0.756 . . . . 65.34 108.964 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.99 -34.19 77.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.201 -1.363 . . . . 73.03 110.995 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 76' ' ' ASN . 60.8 t -75.26 -42.96 43.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.71 -0.677 . . . . 71.13 111.709 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.8 tt -74.85 -61.14 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 114.675 1.361 . . . . 64.21 114.675 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -115.65 171.57 7.66 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.99 -0.444 . . . . 54.35 109.845 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 55.67 2.26 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.648 -0.787 . . . . 70.41 112.83 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.27 -42.31 46.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.759 0.281 . . . . 72.52 111.759 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.602 ' HB3' ' CH2' ' A' ' 109' ' ' TRP . 1.9 t70 -108.16 26.43 10.42 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.325 -1.361 . . . . 73.01 107.325 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 51.6 m-85 -114.1 155.51 25.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.608 -1.178 . . . . 74.14 109.692 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.54 ' HB3' HG12 ' A' ' 110' ' ' VAL . 15.7 pt-20 -126.66 158.6 35.94 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.3 0.375 . . . . 73.4 110.321 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -88.86 113.73 24.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.82 -0.627 . . . . 63.55 110.426 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.47 150.33 34.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.974 -0.38 . . . . 72.3 109.974 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.9 m -94.86 123.1 38.13 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.026 -0.731 . . . . 72.11 109.026 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' A' ' 38' ' ' LEU . 33.7 m -127.38 158.76 38.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.11 -1.07 . . . . 72.14 108.11 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -113.52 132.23 55.77 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.907 -1.117 . . . . 72.05 108.615 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.515 HG21 HG11 ' A' ' 66' ' ' VAL . 20.1 m -126.41 168.27 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 121.304 0.573 . . . . 74.35 110.331 -176.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 101' ' ' LYS . 67.5 t -110.04 117.13 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.325 -0.852 . . . . 61.44 110.299 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 38.3 ttm180 -65.43 98.58 0.36 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.546 -0.909 . . . . 74.3 108.546 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.473 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 1.2 tmt? -53.84 -34.76 60.28 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 126.259 1.824 . . . . 74.12 110.908 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.02 -41.31 87.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.587 -0.733 . . . . 72.43 112.232 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -118.84 -3.95 10.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 120.315 -0.554 . . . . 75.32 112.355 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 67.44 24.98 8.66 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.73 0.812 . . . . 35.42 111.495 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.5 pt-20 -104.61 159.71 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.246 -0.65 . . . . 70.21 109.246 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.0 mtmt -102.48 135.08 44.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.699 -0.852 . . . . 62.03 108.699 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.62 138.47 44.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.03 0.443 . . . . 75.44 110.237 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.89 126.22 34.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.971 -1.122 . . . . 75.01 107.971 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 10' ' ' ASN . 16.3 m -133.23 174.68 12.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 120.733 0.301 . . . . 74.15 110.256 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.97 150.27 28.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.558 -1.275 . . . . 72.02 107.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 t -145.94 175.18 10.63 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.421 -0.585 . . . . 61.24 109.421 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.68 118.35 36.43 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.052 -1.092 . . . . 62.11 108.052 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 54' ' ' ILE . 12.7 p -112.35 148.65 15.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.288 -1.375 . . . . 62.33 107.288 176.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.602 ' CH2' ' HB3' ' A' ' 85' ' ' ASP . 41.6 t-105 -73.08 125.93 28.82 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.693 -1.225 . . . . 72.22 107.693 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 87' ' ' GLU . 24.8 m -62.6 -22.46 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.947 0.721 . . . . 62.13 112.947 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.539 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 63.1 t30 -81.39 12.7 3.43 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.765 0.793 . . . . 73.32 110.09 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 -14.83 0.16 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.005 1.854 . . . . 64.43 116.005 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.07 -17.5 52.53 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.408 -0.517 . . . . 74.44 112.075 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.63 126.89 67.57 Favored Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 119.37 -0.932 . . . . 74.33 110.355 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.0 -6.11 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.719 2.946 . . . . 54.44 115.373 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -125.69 113.78 17.79 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.581 0.705 . . . . 54.04 110.846 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 122.19 0.995 . . . . 71.5 108.735 -177.327 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 129' ' ' VAL . 33.1 tt0 . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 108.499 -0.926 . . . . 64.35 108.499 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -60.23 -42.72 95.83 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.825 -0.625 . . . . 72.4 110.481 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.591 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 99.8 mtt180 -56.87 -48.58 77.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.272 -0.64 . . . . 64.42 109.272 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.624 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 79.2 t -59.21 -47.08 91.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.93 -1.032 . . . . 74.11 111.023 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 125' ' ' GLU . 98.6 t -67.35 -44.36 87.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.709 -0.223 . . . . 61.21 111.537 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.591 ' CE1' ' HA ' ' A' ' 127' ' ' ARG 0.253 3.7 p-80 -72.16 -30.41 64.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 118.612 -1.235 . . . . 74.51 111.827 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.33 77.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.979 -0.378 . . . . 43.45 109.979 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 42.6 mt-10 -63.31 -37.98 89.36 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.728 -0.669 . . . . 71.15 109.969 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.26 -38.26 88.6 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.069 -0.969 . . . . 74.43 110.479 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 86.8 m-85 -73.09 -52.16 15.32 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.842 -0.617 . . . . 64.25 111.098 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.1 p -59.89 -39.02 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 112.134 0.42 . . . . 72.53 112.134 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 48.6 mt-10 -59.07 -43.5 91.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 117.678 0.217 . . . . 60.21 111.048 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.6 m -58.36 -48.53 80.29 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.986 -0.552 . . . . 63.4 110.045 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.48 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 83.3 m-85 -61.73 -43.93 97.9 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.374 -0.376 . . . . 73.31 111.543 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 81.9 mtp180 -59.8 -44.83 93.79 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 123.047 0.217 . . . . 74.01 111.051 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 67.9 mttm -61.57 -47.34 85.95 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.314 0.384 . . . . 73.15 110.535 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.1 -34.99 78.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.12 110.964 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 91.3 mt -69.19 -38.88 78.88 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 116.291 -0.413 . . . . 73.41 110.628 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 32.3 mm-40 -59.35 -36.36 75.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.714 0.292 . . . . 74.41 110.362 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -68.22 -40.68 82.02 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.218 0.821 . . . . 64.54 113.218 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -74.32 -25.83 59.79 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.586 0.707 . . . . 51.23 110.606 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -78.91 -30.58 44.9 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.719 1.207 . . . . 74.43 112.161 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.36 99.82 45.39 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 120.249 -0.581 . . . . 53.04 112.457 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.28 -35.62 72.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.506 2.138 . . . . 74.55 110.103 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.27 -8.72 58.38 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.893 -1.049 . . . . 75.22 111.156 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.41 0 N-CA-C 111.252 -0.739 . . . . 73.01 111.252 179.88 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 106.686 -1.598 . . . . 74.2 106.686 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -87.88 155.56 19.81 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.553 0.692 . . . . 71.35 112.186 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.467 ' HB2' HG12 ' A' ' 104' ' ' VAL . 42.4 m-80 -135.82 123.74 22.71 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.901 -1.518 . . . . 75.3 106.901 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.554 HG12 HG23 ' A' ' 13' ' ' VAL . 51.3 t -120.31 122.95 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 120.959 -0.297 . . . . 61.35 110.71 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -90.95 99.15 12.23 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.122 -0.695 . . . . 72.54 109.122 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.554 HG23 HG12 ' A' ' 11' ' ' VAL . 72.9 t -139.15 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.228 -0.286 . . . . 71.41 110.228 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.12 -73.89 0.23 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.932 -1.136 . . . . 74.12 107.932 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' HA2' ' CG ' ' A' ' 51' ' ' TYR . . . 45.38 -123.83 6.25 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 123.739 0.649 . . . . 63.14 113.344 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -139.07 9.36 2.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.743 -0.836 . . . . 74.13 108.743 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.523 HG21 HD13 ' A' ' 67' ' ' ILE . 40.9 mt -74.94 -8.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.972 -1.013 . . . . 65.34 110.31 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 65' ' ' LYS . 54.1 mt -59.27 -24.39 63.2 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-N 115.241 -0.89 . . . . 74.0 110.826 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.76 124.86 48.85 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.1 -0.955 . . . . 75.3 108.953 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.29 -35.43 11.41 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.603 3.535 . . . . 72.43 114.491 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -42.74 82.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.923 0.392 . . . . 72.3 111.224 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.6 -35.43 56.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.322 -0.399 . . . . 73.2 110.597 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.11 70.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.235 0.54 . . . . 60.43 109.844 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.61 71.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.663 -0.699 . . . . 73.34 110.854 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 m -71.02 -29.19 35.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.143 -0.623 . . . . 72.13 111.604 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.619 HG13 ' ND2' ' A' ' 77' ' ' ASN . 4.7 tt -79.46 -46.96 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 112.532 0.568 . . . . 64.32 112.532 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 74' ' ' GLU . 36.8 mt -91.1 -14.55 31.02 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.188 -0.605 . . . . 60.5 112.227 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 t70 69.49 14.63 8.35 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.433 1.587 . . . . 63.23 108.35 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -147.36 135.43 21.4 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.643 -1.984 . . . . 60.13 105.643 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.0 m -76.95 111.12 12.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.5 -0.48 . . . . 65.31 110.295 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.546 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -93.74 143.73 26.06 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.607 -0.886 . . . . 31.44 108.607 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.4 126.04 42.4 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.122 -0.49 . . . . 64.13 110.303 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 14.7 p -93.71 144.05 25.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.969 -0.382 . . . . 44.43 109.969 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.22 139.41 35.59 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 108.829 -0.804 . . . . 73.24 108.829 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.92 129.53 35.46 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.754 2.303 . . . . 60.33 111.807 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.57 157.41 43.24 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.594 -0.73 . . . . 74.35 110.097 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.551 HG22 ' CG ' ' A' ' 61' ' ' LYS . 11.5 p -126.28 132.74 70.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-O 121.158 0.504 . . . . 72.11 110.429 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.453 ' HA ' HG12 ' A' ' 93' ' ' VAL . 22.3 tp -91.68 112.33 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.71 -0.677 . . . . 73.3 111.745 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -88.68 112.21 22.86 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.473 -0.785 . . . . 61.15 109.494 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.09 -40.42 1.4 Allowed Glycine 0 C--N 1.305 -1.149 0 C-N-CA 120.653 -0.784 . . . . 64.55 112.695 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.466 ' O ' HG23 ' A' ' 62' ' ' VAL . 41.7 m-85 -108.96 166.41 10.85 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 122.782 -0.246 . . . . 72.05 111.346 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -137.08 134.58 36.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.008 -1.108 . . . . 60.22 108.008 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 25.7 ptt180 -88.87 125.84 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 73.03 111.1 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -98.23 145.92 26.14 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.097 -0.956 . . . . 74.24 110.691 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -91.39 100.13 12.97 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-O 121.729 0.776 . . . . 75.31 110.942 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -119.96 121.55 39.23 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.591 -1.186 . . . . 71.41 111.032 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -85.87 -5.63 59.21 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 113.233 0.827 . . . . 64.42 113.233 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.15 -25.66 65.86 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.398 -0.906 . . . . 71.0 111.751 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 46' ' ' LEU . 3.6 mm? -119.56 156.46 53.44 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-O 120.772 0.32 . . . . 64.24 111.607 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.73 146.86 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.87 2.38 . . . . 72.11 111.063 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.612 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 37.3 p90 44.47 41.91 0.82 Allowed Pre-proline 0 N--CA 1.506 2.33 0 N-CA-C 115.39 1.626 . . . . 73.0 115.39 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 78.4 Cg_endo -110.54 156.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.242 2.628 . . . . 74.34 114.806 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 89.0 m -153.76 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 131.368 3.867 . . . . 72.43 103.33 -15.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 25.5 pt -121.82 136.84 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-N 119.553 1.069 . . . . 63.45 110.914 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.45 HG13 ' HA ' ' A' ' 112' ' ' LYS . 43.1 t -127.0 -80.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 115.026 -0.988 . . . . 72.33 112.589 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.4 p -177.17 156.21 1.23 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.809 -0.441 . . . . 75.25 109.809 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.1 m -165.08 173.63 11.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.138 0.975 . . . . 60.02 109.639 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.1 -65.68 0.58 Allowed 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 123.859 0.724 . . . . 72.34 110.01 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 p -105.98 -36.34 7.0 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 119.74 -0.784 . . . . 74.41 109.535 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.93 117.79 0.0 OUTLIER Glycine 0 C--N 1.361 1.971 0 C-N-CA 125.474 1.511 . . . . 74.32 116.817 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.551 ' CG ' HG22 ' A' ' 37' ' ' VAL . 21.9 ttpp -141.63 139.4 33.04 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.793 -1.563 . . . . 63.11 112.621 173.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 41' ' ' TYR . 54.4 t -123.86 123.72 67.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 C-N-CA 123.715 0.806 . . . . 71.35 111.252 -173.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -96.11 128.62 43.17 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.475 -0.49 . . . . 54.24 110.301 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.97 -142.58 3.44 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.85 -1.3 . . . . 21.12 109.85 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 50.3 mtpt -140.44 146.72 38.65 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.779 -1.193 . . . . 72.43 107.779 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.484 HG11 HG21 ' A' ' 93' ' ' VAL . 26.8 m -104.49 135.44 42.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.043 0.449 . . . . 75.24 110.305 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.523 HD13 HG21 ' A' ' 17' ' ' ILE . 11.6 mt -85.72 110.61 19.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 104.479 -2.415 . . . . 74.51 104.479 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.6 p -101.23 161.94 13.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 111.766 0.284 . . . . 71.23 111.766 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.16 73.62 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.91 -0.586 . . . . 73.12 112.693 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.71 124.23 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 109.046 -0.724 . . . . 75.04 109.046 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 30.9 m -73.71 157.45 36.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.19 -0.67 . . . . 74.12 109.19 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.01 -46.08 68.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.771 0.428 . . . . 73.45 111.003 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -68.72 -36.96 79.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.299 0.571 . . . . 63.13 110.826 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.602 ' HB3' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -68.56 -34.57 76.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.414 -0.812 . . . . 74.22 111.685 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.457 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.6 tt -61.55 -37.9 85.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.302 -1.37 . . . . 65.55 107.302 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.554 ' O ' HG23 ' A' ' 80' ' ' VAL . 13.9 m120 -54.75 -26.73 36.07 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.851 1.056 . . . . 73.04 113.851 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.619 ' ND2' HG13 ' A' ' 26' ' ' ILE . 2.7 t30 -67.32 -34.41 77.3 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.76 -1.176 . . . . 72.21 108.595 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.599 ' CE2' HD21 ' A' ' 27' ' ' LEU . 86.5 m-85 -69.24 -34.2 74.45 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.913 -1.143 . . . . 73.1 107.913 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.99 -31.32 70.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.469 -1.242 . . . . 73.23 110.226 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 76' ' ' ASN . 90.7 t -72.8 -36.6 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.715 -0.675 . . . . 61.22 109.58 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 77' ' ' ASN . 48.2 mm -59.71 -40.95 83.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 N-CA-C 106.804 -1.554 . . . . 72.24 106.804 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 73.06 -81.76 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.775 -1.557 . . . . 64.24 114.861 167.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.71 104.2 1.01 Allowed Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 108.636 -1.786 . . . . 74.43 108.636 -172.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.34 -40.52 96.64 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.189 0.519 . . . . 60.43 111.722 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 110' ' ' VAL . 10.9 m-20 -97.73 8.53 44.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.746 -0.661 . . . . 73.14 109.807 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 96.9 m-85 -115.94 154.78 29.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.958 -0.564 . . . . 62.03 110.021 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -136.05 141.93 44.34 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.406 -0.59 . . . . 65.03 109.406 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 0.4 OUTLIER -88.52 109.56 20.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.415 0.626 . . . . 75.22 111.317 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.65 160.7 24.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.749 -1.114 . . . . 53.4 110.966 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -91.12 131.37 36.73 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.696 -0.853 . . . . 55.41 108.696 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.8 m -133.93 172.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.496 -1.298 . . . . 52.44 107.496 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -125.37 127.59 46.83 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.873 -1.131 . . . . 72.43 109.523 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.484 HG21 HG11 ' A' ' 66' ' ' VAL . 18.2 m -126.72 168.24 20.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.316 0.579 . . . . 72.44 110.314 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 101' ' ' LYS . 54.7 t -113.5 121.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.757 -0.831 . . . . 73.42 108.757 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.36 103.93 2.13 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 106.8 -1.555 . . . . 72.53 106.8 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.603 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 9.8 tmm? -61.62 -32.89 73.05 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.91 -1.144 . . . . 71.12 107.91 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.68 -44.96 81.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.936 -1.029 . . . . 73.24 112.336 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -111.42 -2.69 15.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.105 0.478 . . . . 71.1 110.956 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.5 24.28 14.0 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.942 1.297 . . . . 70.04 110.993 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -105.12 160.53 14.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.985 -0.376 . . . . 65.45 109.985 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.593 ' HG2' HG22 ' A' ' 94' ' ' VAL . 55.4 mtpt -101.02 132.39 46.46 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.006 -0.739 . . . . 72.33 109.006 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.55 137.82 43.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.302 0.572 . . . . 73.13 110.838 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -87.77 119.34 28.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.835 -1.543 . . . . 74.05 106.835 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 10' ' ' ASN . 21.0 m -127.31 175.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 120.949 0.404 . . . . 73.13 111.066 -172.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.99 150.32 34.03 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.863 -0.421 . . . . 74.14 109.863 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -151.84 174.46 13.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.367 -0.605 . . . . 74.51 109.367 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 88' ' ' ARG . 52.1 m-85 -114.39 118.12 32.96 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.466 -0.939 . . . . 71.24 108.466 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 30.6 m -109.87 172.5 2.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.946 -0.57 . . . . 72.14 110.373 -177.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.53 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 31.5 t-105 -86.39 121.71 29.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.101 -0.703 . . . . 71.21 109.101 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.4 m -72.06 -19.7 19.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-O 121.391 0.615 . . . . 71.41 112.291 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.469 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.6 t-20 -88.68 14.81 9.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.369 1.081 . . . . 62.3 109.333 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 40.1 ttmt -49.78 -24.92 2.63 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 127.459 2.303 . . . . 73.44 114.589 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -80.93 -21.67 40.29 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.776 1.028 . . . . 63.14 113.776 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -103.46 137.0 19.13 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 107.06 -1.459 . . . . 74.45 107.06 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.67 120.98 8.98 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.856 2.37 . . . . 74.15 114.468 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -124.6 113.52 18.15 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 109.047 -0.723 . . . . 74.51 109.047 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.089 0 O-C-N 124.326 1.016 . . . . 72.45 112.37 176.697 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.225 -0.19 0 N-CA-C 108.882 -0.784 . . . . 52.31 108.882 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -50.35 -46.86 56.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.61 0.764 . . . . 65.21 109.022 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -63.16 -49.22 75.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.825 -0.625 . . . . 74.31 111.874 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -38.77 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.328 0.492 . . . . 74.31 112.328 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.02 -43.93 81.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.972 -0.381 . . . . 64.2 109.972 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.542 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 56.4 t-80 -57.13 -38.55 73.63 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.909 -0.404 . . . . 74.21 109.909 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.78 -46.89 70.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.57 -0.287 . . . . 55.35 111.406 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 44.8 mt-10 -68.08 -40.03 82.79 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 111.943 0.349 . . . . 73.43 111.943 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.68 -31.9 73.17 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.152 0.797 . . . . 72.24 113.152 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.542 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 57.9 m-85 -83.91 -44.27 14.43 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.589 -0.844 . . . . 73.14 111.315 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 132' ' ' GLU . 14.7 p -63.92 -36.75 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 120.54 -0.464 . . . . 74.12 111.226 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -62.21 -36.35 81.68 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 120.18 -0.608 . . . . 75.41 110.425 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.8 m -63.39 -46.06 88.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.507 -0.315 . . . . 70.45 110.282 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -63.13 -37.13 85.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.778 0.323 . . . . 60.45 111.26 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.05 -44.54 68.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.45 -0.341 . . . . 75.25 111.316 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 32.3 mmmt -62.26 -44.05 97.44 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.715 0.293 . . . . 72.25 111.402 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.57 -31.88 72.26 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.368 -0.533 . . . . 73.4 110.715 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 tp -66.16 -50.56 63.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.391 -0.368 . . . . 55.23 110.384 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' ' HA2' ' A' ' 150' ' ' GLY . 10.4 pt-20 -62.16 -44.17 97.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 121.055 -0.258 . . . . 70.11 111.263 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.407 ' CZ2' ' HE3' ' A' ' 140' ' ' LYS . 23.5 m0 -65.61 -40.68 92.9 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 112.258 0.466 . . . . 73.24 112.258 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.3 -36.75 53.81 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.102 0.477 . . . . 73.51 111.98 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -79.82 -21.29 44.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.353 0.501 . . . . 72.11 112.353 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.69 142.55 45.92 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 119.815 -0.754 . . . . 63.24 109.598 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.66 -37.29 94.97 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.866 2.377 . . . . 72.13 112.253 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.74 -9.41 54.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.449 0.642 . . . . 63.33 109.475 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 143' ' ' GLU . . . . . . . . 0 N--CA 1.41 -3.079 0 N-CA-C 108.934 -1.666 . . . . 22.04 108.934 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.506 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 58.8 m . . . . . 0 N--CA 1.414 -2.27 0 CA-C-O 121.516 0.675 . . . . 74.12 111.141 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -130.42 157.4 42.7 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.029 -0.987 . . . . 73.33 109.298 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.9 m-20 -127.44 124.6 38.83 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 31.11 107.933 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 59.6 t -120.9 120.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 121.027 -0.269 . . . . 71.32 111.685 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' HB2' HG21 ' A' ' 104' ' ' VAL . 46.0 t80 -84.38 111.36 19.37 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.949 -1.5 . . . . 75.25 106.949 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 17' ' ' ILE . 8.6 p -123.25 137.63 55.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.732 -0.787 . . . . 63.23 111.105 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -100.04 97.85 8.66 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.943 -1.132 . . . . 74.42 107.943 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.454 ' H ' HD12 ' A' ' 18' ' ' LEU . . . 81.8 -142.0 22.24 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.012 -0.835 . . . . 50.14 111.012 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.9 t 65.49 -79.03 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.261 1.024 . . . . 74.45 113.416 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.581 HG22 HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -117.95 12.98 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 75.3 111.763 -175.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.469 HD13 ' HE3' ' A' ' 65' ' ' LYS . 80.3 mt -68.18 -18.65 64.66 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 73.4 109.416 174.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.78 116.86 63.02 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 107.648 -1.242 . . . . 63.2 107.648 172.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.69 -39.72 18.35 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.302 3.334 . . . . 65.22 114.634 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.17 94.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.991 0.424 . . . . 74.33 111.688 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 17' ' ' ILE . 22.3 t -72.46 -36.56 54.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.714 -0.676 . . . . 73.11 109.606 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' ILE . . . -62.53 -37.11 84.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.405 0.622 . . . . 31.42 109.88 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.92 -19.05 62.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.556 -0.747 . . . . 74.45 112.059 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.3 m -91.17 -30.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 119.511 -0.876 . . . . 74.12 110.975 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.553 HG12 ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -78.63 -47.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-O 120.696 0.284 . . . . 63.22 110.356 178.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.434 ' HG ' HG23 ' A' ' 26' ' ' ILE . 95.5 mt -92.96 -10.41 36.48 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 112.106 0.41 . . . . 74.11 112.106 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 19.5 t70 76.61 -14.05 0.86 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.513 1.149 . . . . 73.51 110.279 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 27' ' ' LEU . 27.8 ptt180 -133.73 168.03 19.46 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.405 -1.27 . . . . 75.13 108.153 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.2 m -76.25 135.22 39.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.611 -0.885 . . . . 72.52 108.611 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.414 ' HB1' HG23 ' A' ' 67' ' ' ILE . . . -75.1 135.58 41.17 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 116.43 -0.35 . . . . 61.22 110.979 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.06 109.07 19.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.122 -1.436 . . . . 72.44 107.122 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.1 p -117.9 143.89 45.93 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 115.723 -0.672 . . . . 62.3 110.718 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.9 146.17 60.2 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 107.771 -1.196 . . . . 73.41 107.771 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -71.18 137.05 30.6 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 121.359 1.372 . . . . 62.31 111.302 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.32 156.05 41.48 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.315 -0.857 . . . . 74.01 108.921 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.444 HG21 ' HD3' ' A' ' 61' ' ' LYS . 14.7 p -120.19 126.39 75.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.897 -0.721 . . . . 71.33 111.005 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.467 HD11 ' HB ' ' A' ' 91' ' ' VAL . 25.3 tp -92.43 89.2 6.68 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.35 -0.841 . . . . 53.55 111.204 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.45 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 27.6 p80 -66.09 131.37 46.04 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.973 -1.012 . . . . 75.44 108.824 171.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 119.32 -13.54 11.08 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 118.969 -1.586 . . . . 64.31 112.842 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 47.5 m-85 -127.33 157.76 39.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 112.686 0.624 . . . . 70.52 112.686 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -116.54 138.5 51.36 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.549 -1.278 . . . . 64.41 107.549 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.599 ' HA ' HG22 ' A' ' 54' ' ' ILE . 19.1 ptp180 -86.55 127.21 34.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.297 -0.631 . . . . 73.33 109.297 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.446 ' HD2' ' O ' ' A' ' 117' ' ' MET . 88.1 m-85 -108.82 112.27 24.44 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.03 -0.532 . . . . 71.31 111.689 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -86.4 116.8 24.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.38 -0.827 . . . . 73.31 111.533 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.5 147.84 50.43 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.391 -1.277 . . . . 72.14 109.399 174.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -115.84 -12.44 11.44 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.268 0.556 . . . . 71.2 110.162 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 -26.2 71.63 Favored Glycine 0 N--CA 1.41 -3.088 0 C-N-CA 120.086 -1.054 . . . . 62.04 110.903 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HB2' HD23 ' A' ' 46' ' ' LEU . 2.1 mm? -115.9 166.57 12.01 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 105.475 -2.046 . . . . 64.04 105.475 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 37.1 Cg_endo -66.6 -155.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.227 0 C-N-CA 122.326 2.018 . . . . 74.01 114.297 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CD1' ' HD3' ' A' ' 52' ' ' PRO . 18.9 p90 -48.35 -26.42 0.71 Allowed Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 119.452 3.13 . . . . 61.25 119.452 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HB3' ' HB3' ' A' ' 53' ' ' CYS . 84.3 Cg_exo -49.32 165.69 0.22 Allowed 'Trans proline' 0 CA--C 1.584 2.989 0 CA-C-N 122.141 1.8 . . . . 54.22 111.999 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 52' ' ' PRO . 22.0 p -152.3 -178.99 7.15 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.508 1.523 . . . . 75.42 110.717 5.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 43' ' ' ARG . 43.1 pt -135.31 132.44 52.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.36 -0.978 . . . . 74.43 108.36 170.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 112' ' ' LYS . 30.4 m -154.2 -175.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.777 -0.823 . . . . 43.42 108.777 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m 82.05 -177.61 0.05 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.923 1.289 . . . . 63.33 114.443 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -71.9 -178.97 2.51 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.732 0.813 . . . . 65.45 112.746 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.473 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 3.5 p30 -82.13 28.92 0.42 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.689 1.196 . . . . 44.33 113.038 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 m -76.78 -8.28 57.0 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.129 0.418 . . . . 74.04 112.129 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.98 -172.81 19.74 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.149 -1.024 . . . . 61.02 112.076 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 18.6 ptpt -143.46 147.45 34.58 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.607 -0.516 . . . . 63.51 109.607 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -111.36 123.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.392 -0.596 . . . . 63.24 109.392 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -98.75 124.25 43.49 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.006 -0.739 . . . . 73.43 109.006 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.98 -139.03 2.67 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.761 -0.733 . . . . 75.33 111.921 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.469 ' HE3' HD13 ' A' ' 18' ' ' LEU . 39.2 mtmt -137.39 140.73 41.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.06 0.457 . . . . 40.24 112.082 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.7 m -107.21 133.93 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.149 -0.932 . . . . 74.35 109.653 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 48.7 mt -87.93 123.72 40.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.507 -1.664 . . . . 65.23 106.507 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.6 p -103.8 161.21 14.13 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.2 -0.6 . . . . 73.33 110.514 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 8' ' ' SER . . . 69.06 28.5 72.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.039 -0.6 . . . . 74.11 113.382 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.74 121.49 36.44 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 117.223 0.512 . . . . 54.05 109.651 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.9 m -77.37 164.22 25.7 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.997 -0.742 . . . . 54.31 108.997 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.83 -32.18 72.49 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.153 0.433 . . . . 72.24 111.289 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.36 64.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.389 0.614 . . . . 72.01 110.331 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.08 -44.22 39.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 75.14 110.326 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.66 -37.56 87.81 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.775 -1.194 . . . . 54.55 107.775 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.555 ' O ' HG23 ' A' ' 80' ' ' VAL . 27.5 t-20 -54.69 -31.49 58.0 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.471 -1.241 . . . . 73.22 111.547 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.553 ' OD1' HG12 ' A' ' 26' ' ' ILE . 20.8 t-20 -75.1 -31.18 61.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 74.2 109.588 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -65.99 -35.56 80.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.39 0.614 . . . . 74.3 109.567 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.76 -33.71 72.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.307 -0.861 . . . . 61.23 110.283 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 76' ' ' ASN . 71.0 t -74.83 -25.44 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.498 -0.774 . . . . 75.45 111.784 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.7 mt -53.4 139.28 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 109.701 -0.481 . . . . 71.23 109.701 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.75 109.75 0.55 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.735 0.778 . . . . 72.51 112.174 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.26 55.83 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.003 0 N-CA-C 109.001 -1.64 . . . . 62.31 109.001 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -64.05 -19.28 65.1 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.302 0.572 . . . . 72.43 110.702 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.529 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 17.9 m-20 -91.0 10.16 27.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.419 . . . . 73.22 111.022 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.27 160.28 26.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 119.917 -0.713 . . . . 74.03 109.455 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -131.22 142.9 50.23 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 109.397 -0.594 . . . . 71.14 109.397 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -83.48 120.18 25.59 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.965 -0.754 . . . . 72.41 108.965 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.33 160.15 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 116.104 -0.498 . . . . 73.32 111.43 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -95.43 126.7 40.9 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 115.69 -0.686 . . . . 72.25 109.474 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' HB ' HD11 ' A' ' 38' ' ' LEU . 28.8 m -129.66 168.31 23.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.042 -1.096 . . . . 75.24 108.042 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -123.22 128.53 50.14 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.812 -1.155 . . . . 73.32 108.521 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' LEU . 19.8 m -126.18 169.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.176 0.512 . . . . 71.34 110.465 -173.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 96' ' ' MET . 76.7 t -103.81 128.63 56.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.74 -0.664 . . . . 72.45 110.183 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -64.93 3.97 0.49 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 126.77 2.028 . . . . 72.04 113.119 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.618 ' H ' HG12 ' A' ' 94' ' ' VAL . 12.5 tmm? 58.56 -72.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.704 2.002 . . . . 71.0 113.277 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.03 -29.34 67.2 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.301 1.041 . . . . 63.13 113.296 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -110.64 -5.18 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.372 -0.531 . . . . 63.41 110.68 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 m 62.82 4.94 1.59 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.801 0.841 . . . . 73.43 112.863 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.95 160.84 27.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.827 -0.805 . . . . 74.32 108.827 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 6.8 mptt -106.76 146.45 30.84 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.446 -0.946 . . . . 62.23 108.446 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.33 139.51 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.145 0.498 . . . . 61.12 110.336 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -87.4 129.77 34.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.148 -1.056 . . . . 62.41 108.148 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 12' ' ' PHE . 33.3 m -139.45 173.16 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 122.325 0.25 . . . . 63.14 110.981 -174.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -100.87 153.78 19.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.027 -1.101 . . . . 74.44 108.027 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -152.69 176.89 11.27 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-N 118.341 0.519 . . . . 64.41 110.881 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.31 117.88 35.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.734 0.813 . . . . 73.32 108.84 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.23 156.95 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 109.187 -0.671 . . . . 72.11 109.187 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 42.8 t-105 -98.86 120.12 38.77 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.645 0.378 . . . . 72.11 110.519 -171.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 85' ' ' ASP . 8.3 m -73.1 -23.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.312 0.486 . . . . 74.53 112.312 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.42 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 64.5 t30 -80.31 12.82 2.7 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.018 0.913 . . . . 73.35 110.99 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.444 ' HB3' HG11 ' A' ' 55' ' ' VAL . 20.9 ptmt -63.85 -15.33 58.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.566 1.321 . . . . 74.42 114.566 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.41 -42.95 92.0 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.29 0.478 . . . . 63.25 112.29 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -85.59 138.19 35.95 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 107.747 -1.205 . . . . 74.52 107.747 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -40.7 116.85 0.43 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 124.288 3.326 . . . . 71.4 114.537 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.596 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 1.1 mmp_? -106.3 165.09 11.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 65.52 109.219 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.446 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 12.7 tpt . . . . . 0 C--O 1.204 -1.299 0 N-CA-C 109.29 -0.633 . . . . 74.51 109.29 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.519 ' O ' HG22 ' A' ' 128' ' ' VAL . 9.1 tp10 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 107.581 -1.266 . . . . 72.11 107.581 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -56.73 -36.98 70.35 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.375 -0.829 . . . . 75.41 110.914 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.269 4.0 ppt_? -63.16 -33.63 75.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.43 0.9 . . . . 75.24 113.43 -178.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 125' ' ' GLU . 29.9 m -77.38 -25.22 14.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 119.287 -0.965 . . . . 74.44 110.246 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.86 -44.78 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.493 -0.558 . . . . 65.21 109.493 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 127' ' ' ARG . 2.4 p-80 -75.21 -28.95 60.17 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 119.124 -1.03 . . . . 53.34 111.038 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.65 36.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.144 -0.48 . . . . 45.22 111.161 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 128' ' ' VAL . 10.0 mm-40 -61.67 -26.16 67.85 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.202 0.525 . . . . 71.54 110.835 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.54 ' HE3' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.05 -59.64 2.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.935 -1.135 . . . . 74.44 107.935 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -69.46 -31.58 69.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 114.354 1.242 . . . . 61.42 114.354 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.7 p -58.35 -38.48 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.25 0.477 . . . . 71.42 110.2 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.11 -46.0 82.83 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.691 -0.485 . . . . 63.54 109.691 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.0 m -57.12 -46.37 82.69 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.609 -0.723 . . . . 74.5 110.821 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 40.8 m-85 -60.26 -49.0 79.34 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 121.235 -0.186 . . . . 72.43 110.65 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 99.1 mtt180 -57.68 -44.84 86.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.042 0.213 . . . . 71.34 110.863 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -60.98 -52.54 64.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.347 -0.388 . . . . 61.43 110.688 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.58 72.51 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.657 0.614 . . . . 63.35 112.657 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 94.3 mt -72.48 -42.77 64.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.246 0.462 . . . . 65.0 112.246 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.6 -35.16 75.05 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 119.492 -0.883 . . . . 73.12 110.369 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.699 ' O ' ' HA3' ' A' ' 150' ' ' GLY . 1.3 m-90 -63.86 -28.98 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.337 0.589 . . . . 74.45 111.042 171.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -78.37 -44.46 24.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.135 0.493 . . . . 53.43 110.857 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.37 -31.52 42.94 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.912 0.708 . . . . 75.22 112.912 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 4.1 m-20 -95.26 143.87 26.85 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 111.806 0.298 . . . . 55.03 111.806 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 24.6 Cg_exo -64.82 -16.37 55.02 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.482 2.788 . . . . 75.31 112.009 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.24 -13.32 60.43 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.768 0.794 . . . . 74.31 108.98 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 144' ' ' TRP . . . . . . . . 0 N--CA 1.399 -3.829 0 CA-C-N 114.658 -1.155 . . . . 53.31 112.455 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.424 -1.737 0 CA-C-O 121.689 0.757 . . . . 74.52 112.616 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -109.25 147.43 32.61 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.859 -1.064 . . . . 72.13 109.705 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.5 m-20 -132.4 122.5 25.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.269 -1.382 . . . . 52.41 107.269 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.58 125.09 73.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.937 -0.305 . . . . 65.02 111.061 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -80.86 112.83 18.61 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.206 -1.035 . . . . 75.43 108.206 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.15 151.81 24.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.256 -0.646 . . . . 74.34 109.256 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -131.3 -22.83 2.46 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 120.519 -0.472 . . . . 73.14 111.126 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.506 ' HA3' ' CD2' ' A' ' 51' ' ' TYR . . . -114.05 108.82 2.1 Favored Glycine 0 C--O 1.248 1.005 0 C-N-CA 120.303 -0.951 . . . . 65.31 112.428 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 22.6 t 69.56 -177.25 0.21 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.921 1.288 . . . . 60.41 110.489 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.602 HD12 ' CE1' ' A' ' 78' ' ' PHE . 12.4 pt 47.12 18.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 126.761 2.024 . . . . 74.12 114.476 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 16' ' ' SER . 85.1 mt -93.04 -1.37 56.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.438 0.637 . . . . 63.03 110.942 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -103.53 132.34 21.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.009 -0.996 . . . . 74.42 108.879 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -42.85 -45.22 8.97 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 124.247 3.298 . . . . 74.54 113.756 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.32 -37.6 85.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 72.4 111.474 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 17' ' ' ILE . 44.9 t -75.72 -39.47 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.202 0.525 . . . . 72.4 109.981 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -66.96 -25.84 66.53 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.966 -0.753 . . . . 71.24 108.966 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.74 -31.49 57.15 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.677 -0.692 . . . . 65.54 111.588 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 22' ' ' VAL . 28.1 m -76.48 -30.41 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 119.584 -0.847 . . . . 72.2 111.619 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.457 HG23 ' HG ' ' A' ' 27' ' ' LEU . 3.3 tt -74.36 -42.29 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 63.34 111.925 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.77 HD21 ' CE2' ' A' ' 78' ' ' PHE . 75.2 mt -93.76 -22.25 18.81 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.706 0.632 . . . . 63.31 112.706 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 71.64 17.49 5.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.937 0.875 . . . . 72.42 109.92 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 ttm-85 -141.27 147.57 38.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.728 -1.953 . . . . 73.45 105.728 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.5 m -76.24 111.01 11.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.923 -0.769 . . . . 65.25 108.923 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -95.38 145.68 24.95 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.105 -0.498 . . . . 63.22 109.91 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.48 118.51 36.83 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.577 -0.738 . . . . 73.01 112.419 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 5.1 p -95.27 143.04 26.98 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.73 -0.668 . . . . 60.14 109.626 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.2 137.49 26.84 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 108.92 -0.77 . . . . 74.52 108.92 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 127.22 22.64 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.749 2.3 . . . . 72.34 112.083 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.58 37.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.516 -0.765 . . . . 35.55 109.022 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.505 HG21 ' CE ' ' A' ' 61' ' ' LYS . 11.4 p -118.14 130.05 73.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.722 0.772 . . . . 71.4 112.042 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.449 HD11 ' HB ' ' A' ' 91' ' ' VAL . 21.6 tp -87.95 106.77 18.34 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 122.123 0.963 . . . . 62.45 109.586 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.476 ' CD2' HG23 ' A' ' 94' ' ' VAL . 14.3 p80 -92.22 127.9 37.87 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.264 -1.335 . . . . 72.51 109.807 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.65 -5.93 29.59 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.023 -1.084 . . . . 51.54 112.044 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -117.86 144.86 45.04 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.709 0.29 . . . . 63.31 110.669 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -115.5 135.12 54.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.172 -0.677 . . . . 62.4 109.172 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.575 ' NH2' ' HA ' ' A' ' 125' ' ' GLU . 55.6 mtm180 -87.33 114.89 24.35 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.565 -0.902 . . . . 64.15 108.565 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.39 137.28 34.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.117 -0.697 . . . . 75.43 109.117 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.25 110.41 22.4 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.887 -1.153 . . . . 73.25 107.887 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 49' ' ' LEU 0.308 0.0 OUTLIER -124.75 160.98 27.4 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.764 -1.107 . . . . 72.21 112.394 179.488 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -99.02 -22.84 15.52 Favored 'General case' 0 N--CA 1.398 -3.039 0 CA-C-N 113.406 -1.725 . . . . 71.03 110.999 -169.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.09 -25.51 61.76 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.895 -0.669 . . . . 53.34 113.06 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 46' ' ' LEU . 2.1 mm? -122.7 146.89 49.19 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 109.397 -0.594 . . . . 71.22 109.397 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.49 -34.88 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.336 2.024 . . . . 64.14 111.724 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.676 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 37.9 p90 -123.38 177.63 1.62 Allowed Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 116.735 -1.602 . . . . 73.25 106.772 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.676 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.34 0.0 OUTLIER 34.5 169.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.608 0 C-N-CA 123.625 2.883 . . . . 73.34 119.172 -163.145 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 14.7 p -122.73 172.88 8.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.218 -1.551 . . . . 74.42 113.588 10.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.526 HG21 HG21 ' A' ' 62' ' ' VAL . 41.1 pt -130.71 149.92 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.831 -1.077 . . . . 61.4 109.911 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.449 HG11 ' HG3' ' A' ' 112' ' ' LYS . 12.7 m -148.12 164.27 5.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.355 -1.72 . . . . 75.33 106.355 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -80.04 123.27 27.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 114.064 1.135 . . . . 62.21 114.064 -170.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 p -147.67 120.08 8.46 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.486 -1.672 . . . . 73.13 106.486 172.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.23 -11.56 22.24 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 117.433 2.383 . . . . 63.44 117.433 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.5 m -98.08 1.1 47.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.489 -0.885 . . . . 75.15 111.382 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.5 159.09 15.59 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.182 -1.009 . . . . 51.21 114.044 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.505 ' CE ' HG21 ' A' ' 37' ' ' VAL . 48.9 mtpt -140.39 147.27 39.51 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 123.879 0.872 . . . . 64.15 109.827 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.526 HG21 HG21 ' A' ' 54' ' ' ILE . 48.0 t -123.74 122.05 63.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.534 -1.284 . . . . 75.53 107.534 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -111.35 115.99 30.21 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.582 -0.447 . . . . 62.54 111.287 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.9 -131.4 1.73 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.742 -0.543 . . . . 64.34 111.742 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB2' HD22 ' A' ' 18' ' ' LEU . 94.1 mttt -141.12 154.4 45.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.423 -0.584 . . . . 72.03 109.423 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.7 m -109.6 133.58 54.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.626 -0.509 . . . . 74.41 109.626 173.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.424 HD11 HG13 ' A' ' 17' ' ' ILE . 47.4 mt -88.02 112.43 23.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.536 -1.654 . . . . 72.33 106.536 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.7 p -106.68 160.66 15.29 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.119 0.414 . . . . 74.24 112.119 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.74 24.98 59.27 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.713 -0.676 . . . . 43.25 113.84 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 127.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 O-C-N 122.642 -0.328 . . . . 64.1 110.337 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 m -78.85 160.45 27.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.213 -1.032 . . . . 72.34 108.213 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.39 -37.36 75.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.297 0.499 . . . . 72.24 111.768 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.08 78.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.434 0.635 . . . . 61.31 110.854 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.695 ' HB3' HD22 ' A' ' 27' ' ' LEU . 37.8 mt-10 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.731 -0.668 . . . . 62.41 109.232 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 75' ' ' LEU . 3.2 tm? -59.76 -31.68 69.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.769 0.828 . . . . 73.31 109.808 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -56.95 -28.6 62.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 71.12 112.126 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.45 ' ND2' HG13 ' A' ' 26' ' ' ILE . 2.9 t30 -76.0 -31.77 59.09 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 119.043 -1.063 . . . . 75.41 109.436 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.77 ' CE2' HD21 ' A' ' 27' ' ' LEU . 41.2 m-85 -70.33 -28.96 65.57 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.638 0.732 . . . . 75.0 109.21 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.541 ' HA ' ' OH ' ' A' ' 107' ' ' TYR . 18.5 t70 -67.11 -43.21 83.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.827 -1.079 . . . . 74.43 111.693 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.04 -30.48 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 N-CA-C 112.708 0.633 . . . . 74.22 112.708 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.2 tt -82.48 111.16 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 112.905 0.705 . . . . 64.54 112.905 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 58.33 35.07 24.59 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.138 0.975 . . . . 74.33 110.486 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.55 25.49 9.65 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.647 -0.787 . . . . 53.05 111.485 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.61 -36.03 24.2 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.878 0.371 . . . . 73.3 111.669 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 12.8 m-20 -117.62 19.24 13.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.88 0.848 . . . . 71.02 109.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -130.62 161.36 31.74 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.791 -1.095 . . . . 72.34 108.666 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -130.06 147.18 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.781 -0.822 . . . . 75.14 108.781 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 40.0 ttp-105 -92.86 108.51 20.05 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.24 0.543 . . . . 63.43 111.36 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.4 m -111.18 159.38 11.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.749 -0.66 . . . . 75.32 110.416 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -91.33 133.43 35.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.575 -0.898 . . . . 55.3 108.575 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 38' ' ' LEU . 30.2 m -133.75 168.81 23.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.803 -1.184 . . . . 73.11 107.803 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.457 ' HB2' ' HE3' ' A' ' 103' ' ' LYS . 42.8 tt0 -114.2 129.93 56.62 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.515 -0.874 . . . . 74.22 110.192 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 38' ' ' LEU . 20.6 m -126.12 163.02 28.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.166 -0.679 . . . . 72.3 109.166 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 101' ' ' LYS . 77.8 t -102.05 113.86 39.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 109.352 -0.61 . . . . 73.55 109.352 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -69.45 90.21 0.53 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.19 -2.522 . . . . 74.14 104.19 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -55.65 -45.81 77.58 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 125.079 1.351 . . . . 72.4 113.99 -162.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.74 -27.38 68.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.076 0.465 . . . . 70.2 111.304 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -101.47 -9.48 21.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.068 -0.515 . . . . 72.33 110.51 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.5 t 64.42 15.87 9.82 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.634 1.174 . . . . 53.1 112.106 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -96.07 161.26 14.05 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 122.647 0.379 . . . . 74.35 110.421 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -108.89 128.49 54.97 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.946 -0.761 . . . . 64.21 108.946 -175.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.5 148.51 28.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.988 0.423 . . . . 62.01 111.9 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 92' ' ' GLU . 27.3 mmtp -90.84 118.12 29.99 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.556 0.742 . . . . 64.32 111.077 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.44 170.56 17.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.244 -0.889 . . . . 73.04 108.877 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.78 150.16 23.08 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.979 -0.378 . . . . 74.3 109.979 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.1 t -156.0 173.85 16.19 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.618 -0.882 . . . . 60.11 108.618 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 79' ' ' ASP . 95.4 m-85 -110.11 122.82 48.5 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.296 0.569 . . . . 53.12 111.691 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.15 159.72 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 115.318 -0.856 . . . . 65.2 110.04 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 53' ' ' CYS . 26.1 t-105 -79.38 112.67 16.85 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.912 0.863 . . . . 74.41 111.963 -173.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 85' ' ' ASP . 43.1 t -72.33 -32.09 41.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.08 -1.418 . . . . 64.54 112.35 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.478 ' HB2' ' CZ2' ' A' ' 109' ' ' TRP . 86.1 m-20 -88.43 14.34 9.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 123.013 0.525 . . . . 55.2 112.074 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.531 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 0.4 OUTLIER -49.84 -36.81 28.13 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.512 1.525 . . . . 65.34 111.766 -177.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.362 15.7 m-20 -73.98 71.46 1.57 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 115.934 1.827 . . . . 71.03 115.934 -171.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -129.0 141.82 43.05 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 104.413 -2.44 . . . . 75.3 104.413 170.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.36 -25.55 57.66 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.216 2.611 . . . . 63.13 114.616 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -116.81 113.05 21.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.251 -0.98 . . . . 63.03 111.624 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HA ' ' A' ' 112' ' ' LYS . 68.8 mtp . . . . . 0 CA--C 1.496 -1.111 0 C-N-CA 124.184 0.994 . . . . 74.01 111.131 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.575 ' HA ' ' NH2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.237 0.405 0 CA-C-O 120.707 0.289 . . . . 75.12 111.651 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -86.04 -36.91 19.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.11 0.481 . . . . 71.41 109.799 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -51.59 -47.07 63.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.608 1.163 . . . . 75.11 111.878 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 34.2 m -62.5 -33.15 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.376 0.51 . . . . 74.34 112.376 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.32 -37.14 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.7 0.762 . . . . 63.42 109.527 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.456 ' CE1' ' HE1' ' A' ' 134' ' ' PHE . 17.5 t-80 -66.83 -35.63 80.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.576 -0.738 . . . . 72.44 109.571 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -65.47 -34.78 79.07 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 123.457 0.473 . . . . 71.11 110.643 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 43.4 mt-10 -59.4 -39.06 82.2 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.801 0.334 . . . . 73.13 110.577 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.613 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.1 tpmt? -57.56 -45.87 84.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.545 -0.752 . . . . 73.25 109.076 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.456 ' HE1' ' CE1' ' A' ' 130' ' ' HIS . 78.9 m-85 -62.6 -45.34 93.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.444 -0.798 . . . . 62.11 110.932 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.561 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 80.2 t -54.67 -49.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 O-C-N 123.55 0.531 . . . . 74.34 110.291 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.02 -41.3 91.88 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 123.197 0.311 . . . . 64.05 110.458 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -58.57 -47.31 84.69 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.856 -0.611 . . . . 61.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.403 ' O ' HD13 ' A' ' 142' ' ' LEU . 37.8 m-85 -63.62 -44.22 94.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.114 -0.494 . . . . 75.04 110.564 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 31.4 mtm180 -56.5 -49.92 73.31 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.882 -0.327 . . . . 72.13 110.147 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.13 -44.33 96.87 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.46 0.475 . . . . 64.52 111.684 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.86 -34.7 78.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.861 0.362 . . . . 55.12 110.997 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.565 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 10.8 mp -72.63 -31.82 65.43 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 120.622 -0.431 . . . . 72.33 111.403 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 46.5 mt-10 -59.79 -34.23 72.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.876 -0.416 . . . . 72.45 109.876 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -72.74 -44.77 61.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.199 -0.455 . . . . 73.13 111.817 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -73.81 -36.1 64.96 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.169 0.803 . . . . 74.33 113.169 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 142' ' ' LEU . 23.0 pttp -84.87 -6.38 59.34 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.937 -0.477 . . . . 72.11 111.458 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -74.67 144.7 80.78 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.492 -0.929 . . . . 73.54 108.492 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -43.0 -31.94 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.238 3.292 . . . . 71.24 115.018 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -71.85 -20.55 61.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.038 0.447 . . . . 75.12 110.871 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.868 0 CA-C-N 115.448 -0.796 . . . . 61.05 114.844 174.515 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.239 0.5 0 N-CA-C 109.267 -0.642 . . . . 44.32 109.267 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.431 ' C ' HD22 ' A' ' 10' ' ' ASN . 78.7 m80 -125.16 143.13 51.09 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 109.375 -0.602 . . . . 64.54 109.375 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -128.95 123.85 33.57 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.307 -1.738 . . . . 70.31 106.307 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 13' ' ' VAL . 20.7 t -111.82 120.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 119.777 -0.769 . . . . 72.23 109.393 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.472 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.0 t80 -81.97 113.89 20.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.755 -0.831 . . . . 74.11 108.755 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 11' ' ' VAL . 27.2 m -135.16 159.25 41.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.345 0.593 . . . . 72.22 110.151 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -148.62 109.73 4.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 106.021 -1.844 . . . . 71.41 106.021 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 163.6 -92.21 0.11 Allowed Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.74 -0.944 . . . . 71.12 110.74 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.518 ' O ' HG11 ' A' ' 22' ' ' VAL . 49.5 m -149.6 78.95 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.19 1.182 . . . . 74.13 114.19 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.641 HG21 HD13 ' A' ' 67' ' ' ILE . 63.8 mt -155.57 8.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 104.713 -2.329 . . . . 75.33 104.713 168.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 6.9 mp -92.07 -17.21 25.34 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.372 -1.285 . . . . 52.0 109.676 -173.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.71 129.54 37.91 Favored Pre-proline 0 N--CA 1.403 -2.783 0 CA-C-N 114.676 -1.147 . . . . 45.41 108.635 172.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.71 -36.82 10.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.09 3.193 . . . . 73.12 113.034 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -55.46 -45.94 76.86 Favored 'General case' 0 C--O 1.224 -0.237 0 O-C-N 123.522 0.514 . . . . 73.42 112.008 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 16' ' ' SER . 92.3 t -77.3 -44.37 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.508 0.194 . . . . 51.04 111.446 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.48 -30.98 71.66 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.37 -0.532 . . . . 74.33 110.702 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.12 -40.62 74.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.062 -0.517 . . . . 74.35 111.268 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 21' ' ' ALA . 16.9 m -71.15 -31.16 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.294 -0.562 . . . . 74.23 111.687 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.547 HD13 ' CD1' ' A' ' 78' ' ' PHE . 6.1 tt -77.95 -38.57 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.275 0.56 . . . . 70.41 112.135 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 31' ' ' ALA . 95.6 mt -100.28 -10.75 20.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 113.93 1.085 . . . . 62.15 113.93 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 68.12 19.16 9.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.995 0.902 . . . . 71.04 109.432 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -162.28 142.68 10.05 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.338 -2.097 . . . . 73.3 105.338 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.2 m -77.06 119.24 20.5 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 120.948 0.404 . . . . 62.5 110.335 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -90.88 152.8 20.6 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.661 -0.496 . . . . 72.41 109.661 176.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.32 125.18 41.74 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.988 -0.551 . . . . 72.02 110.404 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 5.5 p -100.16 142.61 31.4 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 115.675 -0.693 . . . . 53.44 109.508 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.19 134.61 25.59 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.384 -1.339 . . . . 61.01 107.384 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.586 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.5 Cg_endo -61.8 130.38 31.04 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 121.932 1.755 . . . . 62.03 111.369 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.83 156.17 41.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.774 -1.103 . . . . 74.41 109.753 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.438 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.3 p -121.66 127.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.651 0.738 . . . . 64.32 111.546 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD22 HG21 ' A' ' 91' ' ' VAL . 23.3 tp -91.87 95.34 9.78 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.215 -0.902 . . . . 44.12 110.9 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 23.7 p80 -70.67 123.14 21.18 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.76 -1.109 . . . . 54.02 110.096 173.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 120.52 -13.59 10.1 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.878 -1.153 . . . . 73.22 113.8 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.404 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 60.1 m-85 -123.62 166.06 16.12 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.326 0.861 . . . . 73.53 113.326 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -134.39 128.24 33.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.448 -1.686 . . . . 72.32 106.448 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -87.46 135.19 33.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.889 0.852 . . . . 62.21 112.722 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -107.53 106.98 17.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.305 -1.739 . . . . 71.44 106.305 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -47.79 -51.94 20.62 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.593 2.072 . . . . 74.31 116.593 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.405 HD21 ' HG2' ' A' ' 117' ' ' MET . 8.6 mp 53.43 95.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.746 1.387 . . . . 71.1 114.746 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 47' ' ' LYS 0.306 0.0 OUTLIER -82.67 -11.73 58.14 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.888 1.07 . . . . 72.22 113.888 174.524 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.99 -43.4 10.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.849 -0.691 . . . . 54.42 111.929 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.2 152.36 39.37 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.038 -0.727 . . . . 74.45 109.038 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.6 112.0 3.37 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 122.867 2.378 . . . . 70.03 114.382 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.554 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.513 35.2 p90 35.79 59.91 2.93 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 119.044 2.979 . . . . 71.13 119.044 -178.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 10.4 Cg_endo -106.02 172.25 0.12 Allowed 'Trans proline' 0 CA--C 1.547 1.136 1 C-N-CA 126.504 4.803 . . . . 72.33 110.132 175.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 109' ' ' TRP . 43.3 t -158.13 175.24 14.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.577 3.151 . . . . 70.23 103.751 -11.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.413 HG13 HG12 ' A' ' 108' ' ' VAL . 25.8 pt -135.65 138.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 119.407 1.003 . . . . 44.2 111.307 174.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 56' ' ' SER . 5.5 m -154.37 -160.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.984 1.313 . . . . 71.12 108.88 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.43 ' H ' ' HB ' ' A' ' 55' ' ' VAL . 47.5 m 83.73 -39.87 0.08 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.226 1.41 . . . . 75.35 113.305 176.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 50.0 m 56.65 31.0 18.44 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.969 0.89 . . . . 73.11 109.402 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.09 175.77 7.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.194 -1.366 . . . . 74.1 110.159 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -79.74 -0.58 34.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.783 0.325 . . . . 72.43 111.073 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.94 -172.16 21.75 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 116.168 -0.469 . . . . 74.12 112.43 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.438 ' HE2' HG21 ' A' ' 37' ' ' VAL . 17.7 ptmt -154.44 143.01 20.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.308 -0.525 . . . . 54.4 109.785 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.7 t -105.11 123.38 59.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.685 -0.857 . . . . 62.35 108.685 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -102.96 115.82 31.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.018 -0.673 . . . . 63.03 109.241 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -150.65 -136.75 2.58 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 111.708 -0.557 . . . . 53.3 111.708 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 35' ' ' PRO . 52.4 mtmt -139.28 147.22 41.37 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.551 0.691 . . . . 75.12 112.775 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.8 m -104.4 133.11 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.838 -1.074 . . . . 63.35 108.887 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.641 HD13 HG21 ' A' ' 17' ' ' ILE . 5.8 mt -87.49 111.0 21.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.953 -2.24 . . . . 72.42 104.953 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -97.72 167.26 11.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.633 -0.427 . . . . 75.12 111.888 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.7 39.38 93.68 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.645 -0.707 . . . . 73.0 113.274 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.1 t -103.97 122.04 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.125 -1.065 . . . . 62.42 108.125 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 m -78.6 158.57 28.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.064 -1.088 . . . . 63.11 108.064 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.89 -35.56 69.09 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.44 0.563 . . . . 64.54 110.949 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HA ' HD22 ' A' ' 76' ' ' ASN . . . -63.98 -44.81 91.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 73.35 110.714 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 27' ' ' LEU . 47.9 mt-10 -69.03 -32.67 72.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.678 0.791 . . . . 74.31 110.536 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.482 HD22 HH11 ' A' ' 88' ' ' ARG . 1.3 tt -64.16 -28.29 69.66 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.466 -0.938 . . . . 72.34 108.466 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' A' ' 73' ' ' ALA . 58.9 m-80 -56.54 -27.76 58.41 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 112.729 0.64 . . . . 75.04 112.729 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.426 ' HA ' HG12 ' A' ' 80' ' ' VAL . 45.0 t-20 -72.56 -37.45 68.23 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 119.559 -0.856 . . . . 60.25 109.292 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.547 ' CD1' HD13 ' A' ' 26' ' ' ILE . 90.8 m-85 -70.43 -30.19 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.628 -0.879 . . . . 64.32 108.628 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 76' ' ' ASN . 19.8 t70 -73.77 -41.07 62.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 65.04 112.446 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 77' ' ' ASN . 9.4 p -67.09 -21.61 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.023 0.44 . . . . 71.42 110.255 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 77' ' ' ASN . 69.9 mt -57.27 116.37 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.526 -1.287 . . . . 74.11 107.526 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -71.36 119.44 15.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.197 1.184 . . . . 70.53 114.197 -171.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.646 ' HA3' ' CE1' ' A' ' 86' ' ' TYR . . . -150.7 86.43 0.15 Allowed Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 107.709 -2.156 . . . . 75.33 107.709 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -65.58 -38.35 89.25 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.838 0.855 . . . . 63.53 111.307 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 10.2 m-20 -91.4 8.62 35.36 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.108 -0.951 . . . . 75.4 112.103 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.646 ' CE1' ' HA3' ' A' ' 83' ' ' GLY 0.266 0.3 OUTLIER -125.04 157.95 34.95 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 119.443 -0.903 . . . . 73.52 112.237 172.488 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 11.8 pt-20 -127.61 158.37 37.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.501 0.191 . . . . 72.14 110.614 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.482 HH11 HD22 ' A' ' 75' ' ' LEU . 61.9 ttp180 -93.77 110.96 22.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.047 0.451 . . . . 75.12 110.679 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.9 159.49 28.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.257 -0.429 . . . . 64.25 111.145 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.51 HG22 ' HG2' ' A' ' 103' ' ' LYS . 99.2 m -99.08 124.16 43.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.916 -0.584 . . . . 54.34 109.596 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.422 HG21 HD22 ' A' ' 38' ' ' LEU . 29.6 m -125.37 155.65 34.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.872 1.269 . . . . 73.44 108.165 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 31.0 tt0 -105.1 127.44 52.89 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.784 -0.767 . . . . 75.34 110.395 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 38' ' ' LEU . 19.0 m -126.43 167.9 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 115.424 -0.807 . . . . 74.22 108.993 -175.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 101' ' ' LYS . 62.2 t -107.1 123.06 62.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 173.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -73.66 84.14 1.59 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.768 -1.197 . . . . 73.22 107.768 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.613 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 25.3 ttt -39.59 -51.75 2.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 128.02 2.528 . . . . 75.33 114.035 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.42 -36.39 78.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.071 0.397 . . . . 72.14 112.071 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.75 -9.43 23.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.98 0.419 . . . . 72.54 110.922 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.86 20.76 12.36 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.035 1.334 . . . . 73.01 111.853 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -105.13 161.16 14.49 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 120.878 0.371 . . . . 72.23 110.369 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HG2' HG22 ' A' ' 94' ' ' VAL . 89.4 mttt -100.09 131.28 46.14 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.232 -0.655 . . . . 65.31 109.232 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.82 140.99 37.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.89 -0.411 . . . . 71.31 109.89 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 31.2 ttpt -104.07 117.96 35.52 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 119.449 -0.9 . . . . 74.55 110.224 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' A' ' 12' ' ' PHE . 19.8 m -123.82 176.26 5.52 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 CA-C-N 115.076 -0.965 . . . . 74.25 112.181 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -99.46 150.62 21.99 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 122.782 0.433 . . . . 72.21 110.026 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -159.43 175.01 13.83 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.689 -0.856 . . . . 65.24 108.689 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 97.6 m-85 -114.38 119.13 35.89 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.086 0.47 . . . . 73.01 111.837 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.413 HG12 HG13 ' A' ' 54' ' ' ILE . 27.1 m -109.49 142.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.713 -0.676 . . . . 61.1 109.908 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 25.1 t-105 -72.16 113.88 9.67 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.515 0.726 . . . . 74.23 110.119 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 m -72.38 -23.23 21.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 122.047 0.927 . . . . 65.32 110.055 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.469 ' OD1' ' HG3' ' A' ' 116' ' ' ARG . 28.6 t-20 -83.08 5.24 23.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.409 -1.269 . . . . 54.21 112.173 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -59.62 -15.06 16.22 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.437 1.273 . . . . 70.15 114.437 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -59.38 -28.57 67.0 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.992 1.108 . . . . 70.02 113.992 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.405 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . 24.5 m-20 -106.06 167.09 10.13 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.196 -1.409 . . . . 65.0 107.196 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.14 98.03 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 N-CA-C 108.371 -1.434 . . . . 74.4 108.371 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.469 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 40.4 mmt180 -133.15 128.62 36.47 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.707 -0.679 . . . . 65.33 110.236 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.405 ' HG2' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.513 0 O-C-N 124.537 1.148 . . . . 70.33 114.044 171.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.438 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 42.7 mt-10 . . . . . 0 C--O 1.224 -0.256 0 CA-C-O 120.35 0.119 . . . . 74.01 111.159 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -67.72 -34.09 76.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 73.12 110.643 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -58.31 -39.15 78.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.538 -0.912 . . . . 72.15 108.538 174.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 98.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.556 -1.202 . . . . 35.22 110.385 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 125' ' ' GLU . 97.6 t -67.61 -45.19 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.782 -0.451 . . . . 70.22 109.782 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.458 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 23.7 t60 -60.84 -34.26 74.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.771 -0.649 . . . . 74.41 109.701 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.36 -52.46 39.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.025 -0.534 . . . . 71.43 110.622 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.507 ' HA ' HG12 ' A' ' 135' ' ' VAL . 42.5 mt-10 -63.69 -40.96 98.1 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.487 0.492 . . . . 63.03 112.14 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.596 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -60.22 -47.62 85.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.987 -0.551 . . . . 74.14 111.499 -177.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.458 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 78.9 m-85 -76.99 -34.57 57.51 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.929 0.714 . . . . 71.24 112.929 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.55 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 12.5 p -67.34 -40.95 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.628 -0.829 . . . . 60.32 111.168 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.4 pt-20 -64.76 -34.56 78.63 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 120.11 -0.636 . . . . 73.5 110.747 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.2 m -66.13 -38.34 87.91 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.96 -0.564 . . . . 71.43 109.541 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.472 ' HA ' ' HG3' ' A' ' 141' ' ' MET . 87.6 t80 -66.64 -44.71 81.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.606 -0.724 . . . . 61.14 109.674 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.6 mtp180 -55.06 -46.85 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 61.33 109.956 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 13.8 mmmm -61.97 -44.17 97.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.606 -0.725 . . . . 64.44 111.816 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.472 ' HG3' ' HA ' ' A' ' 138' ' ' PHE . 3.0 ppp? -70.28 -33.05 71.11 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 120.631 -0.427 . . . . 72.12 109.97 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.96 -42.07 97.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.785 -0.643 . . . . 55.11 109.279 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 148' ' ' PRO . 13.7 mm-40 -61.19 -39.14 89.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.036 -0.529 . . . . 74.53 110.551 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 43.7 t90 -75.32 -29.99 60.19 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.572 -0.451 . . . . 72.01 111.009 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.63 -31.89 36.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.241 0.544 . . . . 74.05 110.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.74 -32.42 46.7 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.945 -0.57 . . . . 72.43 110.89 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 54.8 67.96 2.93 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.506 0.723 . . . . 63.1 111.908 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 143' ' ' GLU . 91.3 Cg_endo -105.82 -15.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.981 2.454 . . . . 53.34 115.047 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -94.01 13.59 22.42 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.992 0.738 . . . . 74.31 112.992 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.123 0 C-N-CA 120.149 -1.024 . . . . 64.04 112.018 179.156 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 N--CA 1.435 -1.222 0 CA-C-O 121.683 0.754 . . . . 74.22 112.278 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -106.91 155.7 19.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.518 -1.29 . . . . 72.25 107.518 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.421 ' HB2' HG12 ' A' ' 104' ' ' VAL . 91.3 m-20 -136.24 133.51 37.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.947 -1.501 . . . . 72.44 106.947 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 t -118.96 120.82 65.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 120.693 -0.403 . . . . 71.24 110.551 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 66' ' ' VAL . 62.2 t80 -85.34 113.49 21.69 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.536 -0.913 . . . . 72.03 108.536 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 m -121.65 160.23 23.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.91 -0.586 . . . . 52.52 110.792 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -132.55 118.45 19.24 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.402 -0.817 . . . . 74.31 109.186 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.501 ' H ' HD11 ' A' ' 18' ' ' LEU . . . 102.08 -71.2 0.34 Allowed Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.889 -0.596 . . . . 70.13 113.168 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -92.17 155.6 17.9 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 111.556 0.206 . . . . 71.55 111.556 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.596 HG21 HD13 ' A' ' 67' ' ' ILE . 25.1 mt 72.73 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 125.003 1.321 . . . . 64.32 111.166 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.501 HD11 ' H ' ' A' ' 15' ' ' GLY . 56.4 mt -66.09 -28.19 68.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.137 0.494 . . . . 44.4 110.11 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.22 129.24 44.23 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 115.24 -0.891 . . . . 71.33 108.965 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.65 -33.52 31.81 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.804 3.003 . . . . 72.3 112.993 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.4 80.81 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 120.85 0.357 . . . . 72.52 111.173 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 25' ' ' VAL . 60.6 t -73.73 -36.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.483 0.659 . . . . 64.52 109.647 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -67.45 -31.5 71.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.913 -0.773 . . . . 72.12 108.913 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.34 -3.88 39.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.133 -0.94 . . . . 74.25 111.903 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 22' ' ' VAL . 19.6 m -105.75 -34.4 3.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.528 -0.869 . . . . 72.24 110.476 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.547 HD13 ' CD1' ' A' ' 78' ' ' PHE . 5.1 tt -70.03 -41.03 79.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 121.023 0.439 . . . . 71.25 111.067 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 31' ' ' ALA . 81.7 mt -100.37 -17.65 17.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.614 -0.434 . . . . 70.42 110.7 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 34.2 t70 73.08 -2.77 2.62 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.9 1.334 . . . . 65.02 110.017 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.2 ttm105 -121.2 144.85 48.37 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.608 -1.997 . . . . 74.54 105.608 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.1 m -77.8 111.14 13.31 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.107 -0.637 . . . . 74.13 111.416 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . . . -93.51 143.75 26.0 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.011 -1.107 . . . . 65.1 108.011 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -98.05 125.42 43.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.867 0.692 . . . . 63.25 112.867 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.6 p -94.47 145.13 25.0 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.189 -0.914 . . . . 75.02 109.612 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.2 137.38 29.65 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 108.26 -1.015 . . . . 63.32 108.26 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 127.51 23.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.965 1.777 . . . . 71.53 111.363 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.78 154.96 39.3 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 116.21 -0.45 . . . . 55.43 110.3 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.24 127.48 75.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.389 0.614 . . . . 74.03 111.157 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.47 HD11 ' HB ' ' A' ' 91' ' ' VAL . 19.2 tp -88.04 119.69 28.66 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.66 -0.7 . . . . 64.1 109.768 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.469 -0.787 . . . . 70.41 110.918 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.02 59.63 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 119.516 -1.326 . . . . 72.42 113.441 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 64.3 m-85 -121.51 151.99 39.68 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 117.212 0.506 . . . . 72.31 110.752 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 12.4 t-160 -122.86 138.26 54.71 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.994 -0.548 . . . . 74.43 109.993 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.512 HH21 ' HB2' ' A' ' 125' ' ' GLU . 32.0 ptt180 -86.03 109.75 19.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.165 0.983 . . . . 64.22 108.985 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.459 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 3.1 m-85 -74.62 154.72 38.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.701 -1.136 . . . . 73.42 112.781 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -87.69 -7.61 57.19 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.606 1.335 . . . . 74.33 114.606 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.2 pt? -72.29 73.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.601 0.963 . . . . 73.44 113.601 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 52' ' ' PRO . 54.6 pttt -72.83 1.19 9.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.816 1.414 . . . . 74.41 114.816 -175.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.66 -20.25 79.79 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 109.358 -1.497 . . . . 54.21 109.358 172.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.9 157.57 51.47 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 109.285 -0.635 . . . . 73.33 109.285 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.28 106.27 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.672 2.248 . . . . 73.12 114.368 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 45.84 69.54 2.54 Favored Pre-proline 0 N--CA 1.496 1.827 0 C-N-CA 124.469 1.108 . . . . 75.51 111.342 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 68.8 Cg_endo -110.88 153.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 124.108 3.205 . . . . 71.32 117.235 -167.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.484 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 72.9 m -155.15 163.03 40.78 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 130.012 3.325 . . . . 74.22 102.295 -17.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 43.7 pt -123.59 138.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 117.806 -1.557 . . . . 72.2 112.619 170.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' CE1' ' A' ' 44' ' ' TYR . 71.9 t -135.84 153.26 32.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.014 -1.847 . . . . 71.21 106.014 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 t -65.84 136.17 55.81 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 122.148 0.975 . . . . 72.4 112.295 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.6 t -156.42 104.53 2.21 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 103.717 -2.697 . . . . 73.51 103.717 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.77 -37.51 73.8 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 114.111 1.152 . . . . 71.13 114.111 -169.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -86.63 -0.06 55.46 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.306 -0.557 . . . . 71.14 111.985 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.79 146.76 16.18 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.761 -0.733 . . . . 71.21 111.549 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -140.44 152.74 45.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.139 -0.689 . . . . 72.25 109.139 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 41' ' ' TYR . 46.4 t -114.96 122.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.623 -0.51 . . . . 42.32 109.623 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -96.96 121.23 38.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.238 -0.652 . . . . 45.41 109.238 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.39 -143.44 3.7 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.003 -0.839 . . . . 54.13 111.003 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.468 ' HB2' HD22 ' A' ' 18' ' ' LEU . 55.5 mtpt -140.53 142.88 35.17 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.74 -0.837 . . . . 65.4 108.74 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.544 HG11 HG21 ' A' ' 93' ' ' VAL . 30.7 m -104.37 134.05 46.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 120.915 0.388 . . . . 63.01 110.722 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 17' ' ' ILE . 11.4 mt -86.44 110.27 19.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 104.67 -2.345 . . . . 74.45 104.67 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -101.58 162.72 12.7 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.27 0.47 . . . . 73.12 112.27 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.36 47.45 70.81 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.646 -0.706 . . . . 50.33 112.123 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.4 122.77 59.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.024 -0.732 . . . . 71.3 109.024 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 m -77.82 158.71 29.39 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.316 -0.954 . . . . 41.54 108.857 175.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -54.57 -35.94 63.84 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 112.172 0.434 . . . . 73.43 112.172 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.22 79.72 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.482 0.658 . . . . 70.31 110.587 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HB3' HD22 ' A' ' 27' ' ' LEU . 6.3 mm-40 -77.25 -37.23 53.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.331 -0.849 . . . . 62.43 109.921 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -33.47 71.04 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.986 -1.006 . . . . 72.4 109.697 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.06 -34.71 66.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.671 -1.149 . . . . 53.34 111.494 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.461 ' ND2' HG13 ' A' ' 26' ' ' ILE . 53.1 t30 -76.13 -29.77 57.93 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.113 -1.035 . . . . 64.42 109.856 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.695 ' O ' HG22 ' A' ' 81' ' ' ILE . 97.1 m-85 -66.06 -28.59 68.95 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.6 -0.727 . . . . 73.32 110.906 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.22 -31.63 71.26 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.591 -0.892 . . . . 73.34 108.591 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.21 -22.69 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 114.887 -1.051 . . . . 75.31 111.847 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 78' ' ' PHE . 11.7 tt -74.05 2.31 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 CA-C-O 121.842 0.829 . . . . 64.14 110.239 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.371 31.1 mm-40 88.63 126.95 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 117.539 2.422 . . . . 64.1 117.539 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.74 53.72 0.34 Allowed Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 106.883 -2.487 . . . . 64.44 106.883 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.59 -42.56 99.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.021 0.928 . . . . 64.13 113.011 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 110' ' ' VAL . 7.3 m-20 -100.12 16.3 24.57 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.756 0.789 . . . . 61.34 109.701 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.17 159.2 26.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.428 -0.806 . . . . 72.43 109.032 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 110' ' ' VAL . 12.5 pt-20 -127.88 157.91 39.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.417 -0.216 . . . . 63.23 110.417 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -85.15 113.05 21.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.18 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.31 159.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.447 -0.342 . . . . 63.23 110.485 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.411 HG22 ' HD2' ' A' ' 103' ' ' LYS . 12.7 m -106.41 122.47 46.34 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 108.902 -0.777 . . . . 73.34 108.902 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.47 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.3 m -128.01 161.9 35.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.946 -1.131 . . . . 74.04 107.946 -175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.516 ' HG3' ' CE ' ' A' ' 103' ' ' LYS . 1.2 mp0 -108.76 138.87 44.39 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.069 -1.452 . . . . 70.34 108.352 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 66' ' ' VAL . 26.2 m -126.51 161.1 33.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.983 -0.747 . . . . 44.13 108.983 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.576 HG22 ' HG3' ' A' ' 101' ' ' LYS . 75.5 t -104.79 116.85 49.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.693 -0.685 . . . . 74.54 110.083 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 15.5 ttm180 -68.13 110.79 4.14 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.948 -1.871 . . . . 61.2 105.948 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.32 -54.1 49.45 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 114.848 1.425 . . . . 73.41 114.848 -164.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.53 -12.8 61.21 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.235 1.198 . . . . 71.01 114.235 -172.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.1 -6.19 9.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.185 0.517 . . . . 72.53 110.705 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.2 m 61.46 25.93 15.78 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.148 0.579 . . . . 74.53 111.288 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 12.9 pt-20 -93.91 158.71 15.51 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 109.429 -0.582 . . . . 74.24 109.429 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.1 mptt -109.99 132.63 53.98 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.084 -0.71 . . . . 63.44 109.084 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.87 146.57 25.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.74 -0.467 . . . . 74.24 109.74 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.516 ' CE ' ' HG3' ' A' ' 92' ' ' GLU . 14.1 tppt? -91.6 132.77 36.08 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.622 -0.881 . . . . 74.44 108.622 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 10' ' ' ASN . 23.0 m -139.56 173.33 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.733 0.301 . . . . 74.41 110.847 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.79 148.78 24.88 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.598 -0.89 . . . . 74.22 108.598 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 t -153.39 175.18 13.42 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 109.16 -0.682 . . . . 71.53 109.16 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -107.19 118.61 37.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.67 -1.233 . . . . 70.04 107.67 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.32 162.6 10.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.196 -1.039 . . . . 73.01 108.196 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.559 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 33.6 t-105 -77.8 127.59 32.65 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.724 -0.843 . . . . 74.34 108.724 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 85' ' ' ASP . 26.9 m -69.81 -23.57 25.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 O-C-N 121.757 -0.589 . . . . 74.14 111.579 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.559 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -91.75 14.35 15.59 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.717 -0.674 . . . . 53.21 109.703 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.5 ptpp? -49.68 -18.81 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.352 1.461 . . . . 73.33 113.822 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.35 -39.53 76.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.921 -0.4 . . . . 73.31 109.921 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -114.2 124.07 31.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 N-CA-C 109.69 -0.485 . . . . 74.12 109.69 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.83 116.51 4.62 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.167 1.911 . . . . 53.23 109.565 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -86.98 113.66 22.94 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.31 -0.996 . . . . 65.13 108.31 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.488 1.427 0 C-N-CA 124.465 1.106 . . . . 72.42 113.0 -179.054 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.512 ' HB2' HH21 ' A' ' 43' ' ' ARG . 39.9 tt0 . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.672 -0.492 . . . . 61.4 109.672 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -52.52 -46.63 66.79 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.802 -0.814 . . . . 74.22 108.802 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -60.5 -48.88 79.84 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.104 -0.953 . . . . 61.42 111.702 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 125' ' ' GLU . 24.7 m -73.91 -31.6 31.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 N-CA-C 112.682 0.623 . . . . 72.32 112.682 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 125' ' ' GLU . 84.4 t -67.48 -40.28 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.023 -0.732 . . . . 71.53 109.023 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.545 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 46.0 t60 -65.86 -42.88 89.88 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.644 -0.707 . . . . 72.32 109.189 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -62.59 -52.69 62.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.615 -0.266 . . . . 73.43 111.367 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 13.6 mm-40 -62.46 -31.69 72.45 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.378 -0.374 . . . . 73.32 111.407 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 3.4 tmtm? -59.64 -40.5 87.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.698 0.761 . . . . 75.52 109.645 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.545 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 82.7 m-85 -82.31 -36.13 27.28 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.593 -0.692 . . . . 53.52 110.857 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 131' ' ' ALA . 99.3 t -62.49 -44.8 99.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.445 -0.343 . . . . 72.53 111.254 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 11.2 pt-20 -60.27 -37.46 80.52 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 110.18 -0.304 . . . . 72.34 110.18 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -64.42 -44.43 91.24 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.734 -0.469 . . . . 73.4 109.734 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.08 -46.21 90.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.68 -0.489 . . . . 64.34 109.68 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.636 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 98.2 mtt180 -63.84 -49.26 73.51 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.566 -0.743 . . . . 74.41 112.681 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -60.4 -47.03 87.86 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.905 0.128 . . . . 74.44 110.82 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -63.38 -32.73 74.24 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.948 0.404 . . . . 63.21 110.053 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 139' ' ' ARG . 65.0 tp -62.62 -47.15 85.02 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.717 -0.674 . . . . 61.13 109.195 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.0 mt-10 -60.88 -46.99 88.44 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.427 0.454 . . . . 71.45 110.279 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -66.3 -36.9 84.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.768 0.655 . . . . 65.53 112.768 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.04 -28.23 29.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.047 0.451 . . . . 70.12 111.427 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 12.3 tmtt? -79.64 -32.28 41.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.447 -0.342 . . . . 74.22 110.194 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.4 HD21 ' HB3' ' A' ' 149' ' ' ASN . 30.8 t30 -69.88 118.75 66.24 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.258 -0.428 . . . . 71.43 111.06 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.13 -14.72 45.64 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.796 2.997 . . . . 72.22 113.188 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.4 ' HB3' HD21 ' A' ' 147' ' ' ASN . 27.7 t-20 -70.77 -25.16 62.77 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.997 0.427 . . . . 75.41 111.301 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.883 0 N-CA-C 115.578 0.991 . . . . 51.33 115.578 172.764 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.424 -1.77 0 CA-C-O 121.49 0.662 . . . . 72.43 111.082 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -106.34 156.15 18.8 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 124.63 1.172 . . . . 75.2 109.25 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.539 HD22 HG22 ' A' ' 68' ' ' THR . 14.1 m120 -134.62 122.77 22.77 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.713 -1.958 . . . . 64.32 105.713 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.05 122.61 68.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.86 -0.736 . . . . 72.4 111.565 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' HB2' HG21 ' A' ' 104' ' ' VAL . 52.0 t80 -83.84 108.36 16.81 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.419 -1.326 . . . . 61.34 107.419 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.5 147.76 26.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.886 -0.725 . . . . 75.44 110.716 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' HA ' HD11 ' A' ' 18' ' ' LEU . 50.0 t80 -127.34 96.76 4.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.465 -2.05 . . . . 74.43 105.465 170.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.0 -145.84 11.05 Favored Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.069 -1.539 . . . . 63.11 114.453 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 m -43.8 -61.51 1.4 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 127.396 2.278 . . . . 74.44 116.926 -170.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.508 HG13 ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -89.06 17.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 114.16 1.17 . . . . 75.04 114.16 -167.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 65' ' ' LYS . 54.7 mt -73.38 -17.27 61.3 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 120.12 -0.632 . . . . 65.23 111.13 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.97 125.96 80.8 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.501 -0.772 . . . . 62.35 109.4 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -46.62 -38.08 21.42 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 124.258 3.305 . . . . 74.24 114.785 -174.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -60.15 -64.46 0.94 Allowed 'General case' 0 C--O 1.217 -0.649 0 O-C-N 123.126 0.266 . . . . 71.24 110.379 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 41.9 t -55.88 -32.68 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 124.13 0.972 . . . . 73.13 111.19 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -65.42 -33.55 76.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.027 0.442 . . . . 54.45 111.394 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -80.94 -30.78 35.19 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 122.126 0.965 . . . . 75.03 108.648 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 22' ' ' VAL . 26.9 t -65.58 -33.85 66.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 125.26 1.424 . . . . 65.12 111.377 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.684 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tt -87.33 -42.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.733 0.642 . . . . 62.32 112.733 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 31' ' ' ALA . 87.8 mt -85.18 -30.15 24.16 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 112.188 0.44 . . . . 74.32 112.188 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 t70 81.78 1.75 1.47 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.245 1.418 . . . . 74.24 109.19 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 52.1 mtt180 -126.08 163.63 22.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.115 -1.439 . . . . 73.42 107.115 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -76.63 115.02 16.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.003 -0.74 . . . . 72.0 109.003 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -80.27 136.02 36.35 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.62 -0.718 . . . . 70.22 111.911 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.72 110.2 22.61 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.809 -0.757 . . . . 60.22 109.496 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.507 ' CG2' HG12 ' A' ' 67' ' ' ILE . 4.2 p -110.16 143.81 39.72 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.663 -0.699 . . . . 64.14 110.21 174.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -133.48 140.57 37.37 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 107.361 -1.348 . . . . 64.4 107.361 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 96' ' ' MET . 19.2 Cg_endo -60.62 137.18 71.82 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.68 1.586 . . . . 74.11 109.512 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.36 42.72 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.261 -0.644 . . . . 72.13 109.261 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.89 125.69 70.11 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 121.861 0.838 . . . . 73.35 111.543 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD11 ' HB ' ' A' ' 91' ' ' VAL . 22.8 tp -89.71 113.39 24.89 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 114.731 -1.122 . . . . 61.03 109.743 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -85.32 136.22 33.57 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.712 -0.847 . . . . 71.44 108.712 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 106.6 -23.38 28.33 Favored Glycine 0 C--O 1.203 -1.785 0 C-N-CA 118.965 -1.588 . . . . 63.24 112.666 174.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 62' ' ' VAL . 16.8 m-85 -101.59 143.37 31.65 Favored 'General case' 0 CA--C 1.456 -2.669 0 C-N-CA 119.718 -0.793 . . . . 63.13 110.928 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 3.7 t60 -112.31 135.08 53.43 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 115.285 -0.871 . . . . 75.21 109.26 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -87.2 112.22 21.77 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.7 -0.682 . . . . 71.01 109.792 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -105.76 126.58 52.33 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.757 -1.572 . . . . 70.41 106.757 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.543 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -85.12 -11.82 54.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.697 0.761 . . . . 73.15 109.612 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.636 HD12 ' SD ' ' A' ' 117' ' ' MET 0.282 2.6 mm? 72.79 -99.4 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 125.108 1.363 . . . . 73.42 112.723 -177.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt 171.49 -37.52 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.191 0.996 . . . . 71.21 110.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.51 4.26 3.67 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.069 -1.062 . . . . 64.23 112.718 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 6.3 mp -91.36 134.01 30.43 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 119.038 -1.065 . . . . 71.35 111.797 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.793 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 73.6 Cg_endo -74.69 103.36 1.7 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.462 2.775 . . . . 72.53 114.466 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.455 38.5 p90 71.23 1.49 0.0 OUTLIER Pre-proline 0 CA--C 1.608 3.196 0 N-CA-C 121.025 3.713 . . . . 72.2 121.025 176.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.793 ' HD3' ' C ' ' A' ' 50' ' ' PRO . 1.7 Cg_endo -88.41 169.45 5.93 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.862 2.375 . . . . 72.52 108.502 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 15.2 p -156.42 -176.32 5.91 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 127.568 2.347 . . . . 74.01 108.535 -3.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.556 HG21 HG21 ' A' ' 62' ' ' VAL . 46.0 pt -134.9 130.59 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 62.23 108.113 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.19 -175.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.133 -1.432 . . . . 61.24 107.133 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.2 m 69.83 -173.09 0.18 Allowed 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.323 1.014 . . . . 71.2 111.431 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 56.8 m -148.69 34.28 0.77 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.466 -0.568 . . . . 74.41 109.466 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -75.15 -166.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.73 -0.668 . . . . 74.04 111.905 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 m -75.49 -9.75 58.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.86 0.689 . . . . 75.53 112.86 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.85 160.0 45.47 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.018 -0.611 . . . . 64.5 112.846 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -136.67 159.33 42.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.544 -0.91 . . . . 62.43 108.544 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.556 HG21 HG21 ' A' ' 54' ' ' ILE . 49.1 t -126.25 128.02 71.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 110.088 -0.338 . . . . 74.42 110.088 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.79 122.06 42.2 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.746 -0.464 . . . . 65.15 109.746 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.51 -146.84 4.41 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 111.349 -0.7 . . . . 55.11 111.349 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.551 ' HB2' HD22 ' A' ' 18' ' ' LEU . 61.6 mtpt -138.96 139.96 38.11 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.79 -0.819 . . . . 72.43 108.79 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -104.23 132.24 51.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 119.782 -0.767 . . . . 73.01 109.954 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.507 HG12 ' CG2' ' A' ' 33' ' ' THR . 36.0 mt -90.15 117.48 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.302 -1.37 . . . . 64.02 107.302 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.539 HG22 HD22 ' A' ' 10' ' ' ASN . 81.2 p -103.04 162.07 13.25 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.155 0.428 . . . . 52.41 112.155 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.04 33.6 74.73 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.619 -0.719 . . . . 53.14 113.671 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.57 122.28 39.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 122.506 -0.408 . . . . 54.35 110.198 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -75.04 159.11 32.12 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.579 -0.896 . . . . 74.45 108.579 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.21 -42.35 81.13 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.363 0.602 . . . . 71.21 112.075 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.58 72.01 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.339 -0.846 . . . . 52.44 110.857 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -76.26 -32.99 59.15 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.586 -0.734 . . . . 74.41 109.172 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.59 -40.68 95.67 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.97 -1.014 . . . . 75.45 109.847 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.619 ' O ' HG23 ' A' ' 80' ' ' VAL . 27.2 t-20 -55.88 -30.49 61.61 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.801 -1.091 . . . . 64.14 111.644 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.684 ' ND2' HG13 ' A' ' 26' ' ' ILE . 64.6 t30 -69.5 -31.47 69.75 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 120.768 -0.373 . . . . 72.44 110.671 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.579 ' CD1' HD13 ' A' ' 26' ' ' ILE . 81.2 m-85 -72.06 -42.13 66.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.516 -0.92 . . . . 75.45 108.516 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.18 -35.2 78.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.114 -1.403 . . . . 71.44 110.291 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 76' ' ' ASN . 60.9 t -74.98 -23.84 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 112.859 0.688 . . . . 72.22 112.859 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 77' ' ' ASN . 46.2 mm -75.76 -84.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 119.308 -0.957 . . . . 75.44 112.42 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.07 10.88 32.0 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 121.657 -0.652 . . . . 72.01 112.548 178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.55 32.01 2.65 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.52 -0.848 . . . . 63.31 112.847 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -83.16 -39.99 20.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.961 0.41 . . . . 74.44 111.361 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.17 14.97 20.66 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.148 0.975 . . . . 62.12 108.635 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -123.81 156.85 35.36 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.423 -1.325 . . . . 63.55 107.423 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.431 ' HB3' HG23 ' A' ' 110' ' ' VAL . 14.0 pt-20 -126.71 155.2 43.06 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.737 -0.838 . . . . 74.12 108.737 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 106' ' ' THR . 49.0 mtm105 -94.84 107.69 19.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.481 0.548 . . . . 73.11 112.481 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.35 158.15 11.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.75 -0.659 . . . . 63.24 109.3 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.441 HG22 ' HD2' ' A' ' 103' ' ' LYS . 15.1 m -94.98 126.11 40.1 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.104 -0.702 . . . . 72.32 109.104 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.444 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.4 m -132.11 158.31 43.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.802 -1.184 . . . . 74.13 107.802 -177.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -113.96 129.74 56.58 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.454 -1.298 . . . . 72.14 108.605 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 38' ' ' LEU . 16.4 m -126.24 166.1 23.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.444 -0.576 . . . . 61.04 109.444 -174.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 96' ' ' MET . 73.0 t -99.76 124.79 53.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.598 -0.889 . . . . 74.33 108.598 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -68.24 5.12 1.04 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 125.558 1.543 . . . . 73.21 112.462 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.608 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.9 OUTLIER 51.5 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 127.004 2.122 . . . . 64.14 115.166 174.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.8 -43.09 80.57 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.779 0.832 . . . . 54.25 110.751 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.01 -8.84 24.76 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.448 -1.315 . . . . 64.12 107.448 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.7 m 62.63 12.36 5.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.742 1.217 . . . . 75.42 113.888 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.81 161.95 15.05 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.4 -0.592 . . . . 61.31 109.4 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 94' ' ' VAL . 89.3 mttt -96.89 129.68 44.3 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.701 -0.852 . . . . 63.43 108.701 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.14 130.04 69.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 121.256 0.55 . . . . 74.01 110.93 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HD2' HG22 ' A' ' 90' ' ' THR . 5.6 tppp? -86.95 119.75 27.49 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.076 -1.083 . . . . 73.13 108.076 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 10' ' ' ASN . 30.9 m -135.47 174.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.122 -0.49 . . . . 61.21 110.589 -173.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.14 153.7 19.36 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.442 -0.948 . . . . 53.01 108.442 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 14.7 t -146.58 173.43 12.33 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.634 -0.876 . . . . 61.34 108.634 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -107.91 118.19 36.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.174 0.511 . . . . 74.55 110.02 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 54' ' ' ILE . 27.3 m -110.23 168.74 4.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.417 -0.957 . . . . 43.14 108.417 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 53' ' ' CYS . 32.1 t-105 -83.14 119.62 24.75 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.997 -0.742 . . . . 75.11 108.997 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 87' ' ' GLU . 2.2 p -68.65 -20.44 25.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.396 -0.82 . . . . 51.31 111.48 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 18.1 m120 -84.95 13.52 5.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.173 1.389 . . . . 41.42 111.425 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -51.49 -27.66 11.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.541 1.136 . . . . 61.43 113.04 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -78.09 -15.46 58.86 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 120.865 0.364 . . . . 64.21 111.373 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.51 138.57 26.75 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 107.089 -1.449 . . . . 64.52 107.089 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -40.15 108.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.683 2.922 . . . . 75.43 112.664 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -95.47 162.47 13.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.039 -0.528 . . . . 75.21 110.471 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.636 ' SD ' HD12 ' A' ' 46' ' ' LEU . 1.3 mpt? . . . . . 0 CA--C 1.496 -1.107 0 N-CA-C 105.692 -1.966 . . . . 73.4 105.692 171.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 109.091 -0.707 . . . . 65.41 109.091 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -62.59 -48.28 80.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.665 -0.698 . . . . 74.54 110.108 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -59.06 -47.91 83.52 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 116.005 -0.543 . . . . 71.22 111.991 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.8 m -69.29 -40.44 80.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.461 -0.495 . . . . 70.1 112.29 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.04 -28.33 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.588 -0.445 . . . . 74.23 110.535 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.471 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 14.2 t60 -55.66 -47.05 77.34 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.905 -0.776 . . . . 73.12 108.905 174.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.91 98.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.66 -0.7 . . . . 74.11 110.919 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -67.37 -40.83 85.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.116 -0.493 . . . . 52.21 111.407 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.617 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -67.07 -53.5 30.38 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 108.383 -0.969 . . . . 65.31 108.383 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 77.2 m-85 -63.17 -31.44 72.59 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.904 1.446 . . . . 73.02 114.904 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.27 -34.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 119.117 -1.033 . . . . 52.52 109.508 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.414 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 1.6 tm-20 -69.34 -34.67 74.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.227 1.011 . . . . 73.23 109.028 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.3 m -57.62 -44.02 85.21 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.332 -0.618 . . . . 61.54 109.332 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.462 ' O ' ' HG3' ' A' ' 141' ' ' MET . 79.4 t80 -66.19 -36.31 82.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.764 -0.653 . . . . 70.43 109.266 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.566 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 81.2 mtp180 -60.94 -52.52 64.67 Favored 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.155 -0.475 . . . . 53.4 109.795 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.414 ' HG2' ' OE2' ' A' ' 136' ' ' GLU . 46.3 mmtm -56.03 -39.23 71.65 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.224 0.824 . . . . 73.32 113.224 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 3.3 ppp? -67.47 -31.79 72.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.968 -0.693 . . . . 71.43 110.001 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.2 tp -76.54 -41.71 45.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.527 -0.76 . . . . 75.14 109.622 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 12.4 mm-40 -59.54 -46.84 87.7 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.605 -0.517 . . . . 73.41 109.605 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -64.92 -36.63 85.0 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.285 -0.871 . . . . 74.33 112.027 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -82.17 -38.64 24.36 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.989 0.424 . . . . 75.42 111.438 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -79.48 -31.61 42.39 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.65 0.262 . . . . 65.55 110.508 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -124.7 82.85 59.41 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-O 120.863 0.363 . . . . 54.44 110.213 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.76 -24.18 18.44 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.81 2.34 . . . . 74.33 112.563 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -96.84 -15.97 21.0 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.372 0.606 . . . . 75.43 109.957 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.705 0 CA-C-N 115.407 -0.815 . . . . 74.35 113.384 -178.518 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.442 -0.868 0 CA-C-O 121.959 0.885 . . . . 73.12 111.939 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.505 ' CG ' HD12 ' A' ' 75' ' ' LEU . 75.5 m80 -126.89 155.42 43.03 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 115.222 -0.899 . . . . 73.54 110.171 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.1 m-20 -127.5 129.5 47.51 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.789 -1.56 . . . . 71.14 106.789 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.69 128.06 59.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.436 0.532 . . . . 74.53 112.436 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -82.01 108.24 15.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.044 -1.465 . . . . 75.25 107.044 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.29 123.16 68.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.422 0.63 . . . . 72.14 110.635 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -96.69 107.21 19.62 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.383 -1.34 . . . . 64.01 107.383 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' A' ' 18' ' ' LEU . . . 75.59 -138.02 22.55 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.782 -0.927 . . . . 50.2 110.782 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.8 m 60.43 -80.77 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.159 1.17 . . . . 74.04 114.159 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 67' ' ' ILE . 32.6 pt -120.03 18.13 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 112.391 0.515 . . . . 74.44 112.391 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 64.1 mt -60.33 -21.91 62.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.429 0.633 . . . . 45.41 109.834 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.88 118.31 71.61 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.347 -1.353 . . . . 63.15 107.347 170.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -48.37 -36.46 30.39 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.961 3.107 . . . . 75.31 113.836 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.93 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 35.03 111.849 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.591 ' O ' HG22 ' A' ' 25' ' ' VAL . 13.0 t -77.86 -32.61 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.515 0.674 . . . . 64.02 109.797 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.18 -33.34 74.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.62 0.724 . . . . 62.13 109.118 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -75.46 -16.13 60.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.252 -0.886 . . . . 72.53 111.65 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 22' ' ' VAL . 13.1 m -89.01 -30.03 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 118.89 -1.124 . . . . 71.13 110.44 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.524 HG21 HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -81.57 -48.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 121.023 -0.271 . . . . 73.25 110.919 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.78 -16.59 25.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 120.808 0.337 . . . . 62.12 111.299 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 72.01 6.59 5.63 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.904 1.335 . . . . 61.13 109.999 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -141.97 169.28 17.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.32 -1.363 . . . . 61.4 107.32 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -76.43 128.46 34.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.891 -0.781 . . . . 74.35 108.891 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.25 137.81 41.46 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.711 0.291 . . . . 61.13 110.325 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -98.33 109.91 22.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.943 -1.132 . . . . 54.34 107.943 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.0 p -115.14 146.18 41.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.513 -0.767 . . . . 63.3 111.466 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.71 145.73 50.55 Favored Pre-proline 0 C--N 1.286 -2.162 0 N-CA-C 106.724 -1.584 . . . . 75.52 106.724 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.91 140.84 51.66 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.12 1.213 . . . . 74.14 110.243 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.68 156.44 41.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.051 -0.522 . . . . 53.41 109.808 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 7.3 p -122.93 123.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 121.628 0.728 . . . . 73.41 111.452 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.44 ' HA ' HG12 ' A' ' 93' ' ' VAL . 23.1 tp -87.64 93.23 9.37 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.316 -0.856 . . . . 73.42 110.219 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.428 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 26.3 p80 -68.64 134.85 50.51 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.485 -1.234 . . . . 72.01 107.771 174.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 115.74 -29.85 6.96 Favored Glycine 0 C--N 1.29 -2.015 0 C-N-CA 118.618 -1.753 . . . . 71.01 112.35 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.543 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 58.9 m-85 -109.56 166.55 10.81 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 112.014 0.376 . . . . 71.12 112.014 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.522 ' NE2' ' HB2' ' A' ' 56' ' ' SER . 0.1 OUTLIER -155.14 139.29 16.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.756 -0.656 . . . . 71.21 111.707 -177.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.806 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 67.0 ttt180 -87.48 138.99 31.0 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.441 1.088 . . . . 74.54 112.792 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.628 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 6.8 m-85 -104.69 158.77 16.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.677 -1.147 . . . . 74.52 109.575 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.56 ' H ' ' HD3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.78 -44.92 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.795 1.035 . . . . 72.44 113.795 -174.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.57 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 3.1 mm? 60.63 -179.34 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.991 0.517 . . . . 51.12 111.678 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.07 -71.45 0.68 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.088 0.47 . . . . 44.43 109.86 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.57 20.12 50.08 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.325 -0.941 . . . . 72.33 114.209 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 52' ' ' PRO . 2.8 mm? -101.9 151.03 37.9 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.749 -0.834 . . . . 74.42 108.749 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.4 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 123.015 2.476 . . . . 61.11 114.823 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -134.09 73.39 70.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 122.004 0.907 . . . . 73.22 112.507 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.679 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 20.7 Cg_endo -108.45 167.48 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.995 3.797 . . . . 52.44 112.501 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.806 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 20.2 p -156.18 162.4 40.2 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 127.882 2.473 . . . . 71.21 106.145 -8.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 41.7 pt -123.33 121.46 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.354 0 CA-C-N 119.57 1.077 . . . . 74.03 110.265 170.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.581 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 33.7 m -149.59 -173.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.312 -0.858 . . . . 73.44 110.423 -173.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.522 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 37.7 m 69.44 -161.18 0.17 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 124.626 1.204 . . . . 73.24 111.553 174.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -105.65 -172.66 2.13 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 120.911 0.386 . . . . 60.33 111.252 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 8.8 m-20 -68.02 36.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.413 1.885 . . . . 70.44 115.764 -169.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -79.53 -11.48 59.89 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.188 -0.945 . . . . 71.21 112.536 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.13 -169.99 15.68 Favored Glycine 0 CA--C 1.488 -1.63 0 C-N-CA 119.928 -1.13 . . . . 40.12 112.569 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 33.0 mtmt -145.32 152.61 40.18 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.708 -1.219 . . . . 72.24 107.708 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.49 HG21 HG21 ' A' ' 54' ' ' ILE . 48.7 t -122.2 123.18 68.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 110.177 -0.305 . . . . 75.23 110.177 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 3.8 p-10 -95.41 129.37 42.59 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.373 -0.931 . . . . 64.31 109.967 177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.1 -142.32 3.48 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 111.019 -0.833 . . . . 70.22 111.019 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -138.79 136.85 36.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.008 0.523 . . . . 70.31 111.524 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.45 133.67 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.697 -0.683 . . . . 70.41 109.842 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.677 ' CD1' HD11 ' A' ' 17' ' ' ILE . 32.6 mt -88.62 131.06 37.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.443 -1.688 . . . . 64.44 106.443 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -110.73 160.97 16.23 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.927 -0.709 . . . . 70.24 110.477 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.34 36.77 63.17 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.077 -0.582 . . . . 65.4 112.797 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -95.65 122.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.427 -0.455 . . . . 73.03 109.863 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.486 ' OG ' ' HG2' ' A' ' 74' ' ' GLU . 80.3 p -76.91 173.18 12.04 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 121.494 -0.754 . . . . 70.23 109.497 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.44 -29.56 70.25 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.87 0.367 . . . . 72.15 110.298 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.42 -41.27 40.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 71.25 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.486 ' HG2' ' OG ' ' A' ' 71' ' ' SER . 9.5 mm-40 -69.34 -36.49 76.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 75.53 110.194 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.505 HD12 ' CG ' ' A' ' 9' ' ' HIS . 2.3 tt -63.34 -37.86 88.91 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.28 -1.007 . . . . 64.22 108.28 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 80' ' ' VAL . 51.8 t30 -54.83 -31.19 59.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.636 -1.166 . . . . 72.4 111.567 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.511 ' OD1' HG12 ' A' ' 26' ' ' ILE . 23.3 t-20 -75.21 -32.42 61.17 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.519 -0.873 . . . . 73.32 109.826 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HE1' HD13 ' A' ' 17' ' ' ILE . 57.7 m-85 -64.52 -36.17 83.32 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.068 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.57 -33.03 73.37 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.632 -0.713 . . . . 73.04 110.253 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 76' ' ' ASN . 99.6 t -69.16 -37.64 76.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.846 -0.615 . . . . 74.23 110.435 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.6 mt -57.79 -68.49 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 116.135 -0.484 . . . . 63.14 111.095 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 21.0 mm-40 -110.54 103.4 12.0 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.482 0.658 . . . . 74.24 112.591 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 86' ' ' TYR . . . -150.64 11.79 0.85 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 115.045 -0.979 . . . . 72.33 111.695 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -75.17 -44.12 48.47 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.725 -0.472 . . . . 63.4 109.725 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 3.9 t70 -136.97 14.17 3.09 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.665 1.222 . . . . 63.21 107.786 175.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 21.1 m-85 -113.82 145.46 41.4 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.396 -1.275 . . . . 75.52 109.462 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.72 151.89 47.55 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.612 -0.884 . . . . 75.33 108.612 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -91.14 125.37 35.9 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.718 0.294 . . . . 74.32 111.038 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.66 159.6 34.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 116.013 -0.54 . . . . 72.31 110.559 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.28 129.8 39.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.638 -1.245 . . . . 73.44 107.638 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.411 ' HB ' HD11 ' A' ' 38' ' ' LEU . 30.6 m -128.65 169.13 20.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 108.628 -0.878 . . . . 63.41 108.628 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -118.72 124.55 47.59 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.28 -1.378 . . . . 74.11 107.28 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 38' ' ' LEU . 17.4 m -127.33 168.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.37 0.605 . . . . 71.3 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 101' ' ' LYS . 69.5 t -102.41 117.58 47.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.739 -0.664 . . . . 73.34 109.474 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -74.69 88.26 2.21 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.5 -1.667 . . . . 62.31 106.5 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -50.26 -35.91 29.02 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.168 1.787 . . . . 71.12 112.701 -170.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.86 -31.4 39.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.908 0.755 . . . . 74.11 111.811 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -127.83 -1.29 5.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 120.282 -0.567 . . . . 61.02 110.746 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.5 t 69.13 16.71 8.56 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.802 0.841 . . . . 74.42 111.517 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.3 160.01 15.72 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 109.341 -0.614 . . . . 61.25 109.341 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.666 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.4 mptt -101.63 134.02 45.41 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 108.787 -0.82 . . . . 73.54 108.787 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.91 140.99 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.279 0.561 . . . . 64.34 111.047 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.84 125.52 34.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.628 -1.249 . . . . 63.23 107.628 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.29 176.09 8.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 C-N-CA 122.608 0.363 . . . . 70.53 111.171 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -99.59 153.55 18.97 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.355 -0.98 . . . . 73.05 108.355 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -159.56 177.07 11.29 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 117.951 0.341 . . . . 70.21 110.164 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 82' ' ' GLU . 81.6 m-85 -105.57 121.36 43.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.268 -1.012 . . . . 54.33 108.268 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.68 165.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 109.053 -0.721 . . . . 74.32 109.053 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.663 ' CD1' ' HB2' ' A' ' 111' ' ' ASN . 61.8 t-105 -97.4 129.65 44.61 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 107.682 -1.229 . . . . 73.33 107.682 -169.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.0 -20.21 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.569 . . . . 74.2 112.298 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.663 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 26.5 m-80 -77.77 15.6 0.82 Allowed 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 124.1 0.96 . . . . 72.23 110.837 171.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 19.3 ptpt -49.28 -21.0 0.73 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.711 1.204 . . . . 74.45 113.484 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -124.02 94.28 4.17 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 104.005 -2.591 . . . . 71.12 104.005 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.4 p-10 -120.5 158.83 50.36 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 113.888 -1.505 . . . . 73.05 111.767 -172.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -106.65 12.05 0.16 Allowed 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.806 2.337 . . . . 75.33 111.881 170.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -134.26 133.15 40.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.359 0.874 . . . . 71.01 113.359 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.57 ' SD ' ' HA ' ' A' ' 46' ' ' LEU . 57.6 mtt . . . . . 0 N--CA 1.497 1.892 0 C-N-CA 123.738 0.815 . . . . 74.03 111.306 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.1 tt0 . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 109.734 -0.469 . . . . 75.44 109.734 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -55.91 -28.5 57.06 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.231 0.538 . . . . 73.33 110.012 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -58.0 -47.47 82.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.1 -0.5 . . . . 55.31 110.835 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 125' ' ' GLU . 20.0 m -81.86 -22.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.337 0.589 . . . . 71.22 110.133 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 125' ' ' GLU . 99.3 t -68.05 -34.4 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.697 -0.683 . . . . 63.24 109.835 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -55.54 -34.51 64.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.123 -0.489 . . . . 73.53 111.837 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.94 -55.11 9.08 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 121.02 -0.272 . . . . 73.32 111.178 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.565 ' HA ' HG12 ' A' ' 135' ' ' VAL . 9.5 pt-20 -66.84 -37.9 85.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 113.133 0.79 . . . . 55.32 113.133 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.569 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -59.29 -47.12 86.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.424 -0.353 . . . . 73.11 111.147 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -81.72 -37.58 27.08 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 112.573 0.583 . . . . 62.45 112.573 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 132' ' ' GLU . 15.0 p -62.75 -41.64 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 119.625 -0.83 . . . . 52.22 111.226 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 29.4 mm-40 -58.81 -44.14 90.75 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 123.018 0.199 . . . . 74.52 110.919 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.9 m -54.1 -48.64 70.49 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 123.661 0.6 . . . . 73.51 110.761 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.33 -36.87 85.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.747 0.308 . . . . 74.54 111.288 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.7 mtp180 -66.68 -43.6 84.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 73.2 110.494 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.1 -40.6 71.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.932 -0.576 . . . . 71.13 111.725 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.4 mtm -66.82 -31.41 72.01 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.602 -0.439 . . . . 70.23 110.819 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.05 -43.94 97.75 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.654 -0.869 . . . . 62.4 108.654 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 149' ' ' ASN . 12.6 mm-40 -62.41 -30.21 71.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.639 . . . . 70.41 111.004 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -75.39 -38.92 59.68 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.839 -0.619 . . . . 74.2 112.477 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -77.75 -43.31 31.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.796 0.331 . . . . 72.14 111.677 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.521 ' C ' ' HD3' ' A' ' 148' ' ' PRO . 88.0 tttt -79.23 -17.03 55.58 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.292 -0.413 . . . . 74.14 111.438 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.583 ' N ' ' HD3' ' A' ' 148' ' ' PRO . 3.5 t-20 75.7 16.59 0.0 OUTLIER Pre-proline 0 CA--C 1.609 3.224 0 N-CA-C 115.394 1.627 . . . . 73.24 115.394 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 147' ' ' ASN . 6.9 Cg_exo -73.85 -16.57 23.29 Favored 'Trans proline' 0 C--N 1.4 3.247 0 CA-C-N 122.795 2.034 . . . . 55.13 110.958 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 143' ' ' GLU . 26.6 t-20 -73.81 -22.71 59.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.528 -0.76 . . . . 74.13 110.212 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.137 0 C-N-CA 120.774 -0.727 . . . . 61.32 112.051 179.081 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.425 -1.717 0 N-CA-C 107.502 -1.295 . . . . 44.3 107.502 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -87.54 156.1 19.68 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.445 -0.798 . . . . 71.2 112.976 -173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -133.63 125.03 27.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.624 -1.625 . . . . 71.41 107.241 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 49.7 t -119.25 120.51 63.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.68 -0.408 . . . . 75.41 110.548 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.73 121.25 23.78 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.283 -1.747 . . . . 70.41 106.283 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HB ' HD11 ' A' ' 67' ' ' ILE . 13.0 p -113.2 138.81 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 C-N-CA 118.858 -1.137 . . . . 73.14 112.206 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.4 -36.68 68.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.969 -1.468 . . . . 74.03 110.471 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 13' ' ' VAL . . . 179.45 -175.13 46.81 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.794 -0.922 . . . . 61.15 110.794 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m 69.88 -65.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.304 1.041 . . . . 62.14 113.561 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.628 HG21 HD13 ' A' ' 67' ' ' ILE . 45.9 mt -68.81 -8.75 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.677 0.751 . . . . 72.43 110.223 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.06 -29.12 69.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.852 -0.796 . . . . 61.44 108.852 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.36 114.22 58.62 Favored Pre-proline 0 N--CA 1.418 -2.033 0 N-CA-C 107.86 -1.163 . . . . 74.4 107.86 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.47 -28.39 8.64 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 124.808 3.672 . . . . 74.33 115.739 -174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -71.07 -29.78 65.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 63.51 110.955 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 25' ' ' VAL . 63.0 t -76.72 -36.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.4 -0.593 . . . . 62.53 109.4 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.62 76.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.819 -0.808 . . . . 63.12 108.819 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.13 -17.72 61.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.256 -0.884 . . . . 74.21 111.894 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 22' ' ' VAL . 21.4 m -91.54 -25.4 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.191 -1.004 . . . . 74.42 110.831 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.507 HD13 ' CD1' ' A' ' 78' ' ' PHE . 11.2 tt -87.03 -45.3 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 120.054 -0.658 . . . . 64.41 112.123 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 31' ' ' ALA . 89.7 mt -89.08 -18.4 27.33 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.996 -0.44 . . . . 64.41 110.434 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.0 t70 71.28 10.8 6.74 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.929 1.347 . . . . 71.13 108.526 -171.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -143.45 145.15 32.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.673 -1.603 . . . . 73.13 106.673 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.7 m -80.23 116.98 20.62 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 120.682 0.277 . . . . 63.25 110.291 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 27' ' ' LEU . . . -95.65 156.46 16.31 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.646 -0.501 . . . . 61.14 109.646 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.26 125.43 44.88 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.977 -0.556 . . . . 73.44 110.317 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -94.45 143.29 26.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.887 -0.783 . . . . 63.2 108.887 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.96 138.7 33.68 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.129 -0.693 . . . . 74.24 109.129 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.82 129.81 37.01 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.322 2.681 . . . . 65.31 113.063 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -150.52 157.08 42.6 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.467 -0.788 . . . . 70.3 110.218 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.1 126.77 72.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.518 0.675 . . . . 62.54 111.71 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.461 HD11 ' HB ' ' A' ' 91' ' ' VAL . 21.7 tp -89.69 95.35 10.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.339 -0.846 . . . . 74.53 112.188 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 7.0 p-80 -70.33 128.54 36.56 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.058 -0.974 . . . . 73.52 111.568 174.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.28 -19.72 11.61 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 120.291 -0.957 . . . . 74.42 112.34 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.491 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 61.5 m-85 -114.79 158.76 21.45 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 113.015 0.746 . . . . 74.23 113.015 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.423 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 3.3 t-160 -128.02 124.4 37.06 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.53 -1.285 . . . . 74.44 107.53 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.423 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 10.6 ptm180 -91.88 144.39 25.53 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.838 -0.43 . . . . 72.13 109.838 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.78 176.54 5.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.949 0.404 . . . . 74.32 111.126 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -91.76 100.28 13.01 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.285 0.564 . . . . 74.41 109.702 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.418 HD12 HD13 ' A' ' 49' ' ' LEU . 4.0 mm? -94.68 118.61 32.0 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.631 0.729 . . . . 73.15 110.544 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -93.7 -43.96 8.39 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.775 -1.102 . . . . 74.35 108.713 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.14 -25.99 32.38 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.719 -1.128 . . . . 63.22 113.149 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.418 HD13 HD12 ' A' ' 46' ' ' LEU . 7.2 mp -92.27 132.71 31.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.415 -0.462 . . . . 65.43 110.868 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 57.4 Cg_endo -85.12 -20.8 3.3 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.466 2.777 . . . . 73.54 112.859 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.652 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 51.9 p90 -139.49 175.85 2.97 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 104.668 -2.345 . . . . 74.02 104.668 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.329 0.0 OUTLIER 31.43 169.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.595 3.55 0 C-N-CA 124.002 3.135 . . . . 71.41 119.795 -162.701 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 24.6 p -131.52 160.85 34.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.563 -1.336 . . . . 71.21 113.069 9.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 22.1 pt -122.92 137.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.92 -1.491 . . . . 73.33 107.863 174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.36 151.78 34.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 106.141 -1.8 . . . . 53.21 106.141 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m -65.6 140.95 58.57 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.242 1.201 . . . . 65.44 114.242 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m -155.99 102.86 2.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.222 -2.14 . . . . 65.13 105.222 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.23 -31.83 65.91 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.258 0.836 . . . . 65.31 113.258 -172.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -87.52 -0.81 57.36 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.682 0.253 . . . . 72.3 111.682 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.86 168.11 12.96 Favored Glycine 0 C--O 1.238 0.372 0 C-N-CA 120.371 -0.919 . . . . 63.31 113.134 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 18.5 ptpt -150.05 154.68 38.55 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 110.049 -0.352 . . . . 73.42 110.049 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.0 123.4 69.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.801 -0.444 . . . . 74.11 109.801 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -96.63 128.49 43.62 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.791 -0.763 . . . . 74.35 109.512 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.07 -141.03 3.07 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 109.887 -1.285 . . . . 54.33 109.887 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 49.6 mtpt -141.1 150.71 43.23 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.873 -0.788 . . . . 63.31 108.873 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . 28.7 m -104.11 134.16 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.123 -0.49 . . . . 64.33 110.094 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.628 HD13 HG21 ' A' ' 17' ' ' ILE . 8.8 mt -87.19 115.78 28.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.744 -2.317 . . . . 65.31 104.744 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -109.63 160.49 16.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.838 -0.745 . . . . 75.33 112.421 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.37 41.47 11.57 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 115.806 -0.634 . . . . 43.53 112.702 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.6 t -106.68 122.16 60.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 108.862 -0.792 . . . . 74.21 108.862 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.2 t -79.3 174.23 11.78 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.019 -1.072 . . . . 64.35 109.409 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.45 -25.62 67.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.065 -0.346 . . . . 75.24 110.065 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.72 -53.34 18.93 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.852 -0.613 . . . . 71.34 110.371 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.19 -30.62 69.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.353 0.501 . . . . 73.53 112.353 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 75' ' ' LEU . 3.4 tm? -57.27 -31.69 65.86 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.335 0.588 . . . . 74.42 110.659 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.564 ' O ' HG23 ' A' ' 80' ' ' VAL . 15.0 m120 -60.07 -28.28 67.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.364 -0.835 . . . . 72.14 112.078 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.17 -38.02 69.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.591 -0.892 . . . . 51.43 108.591 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CD1' HD13 ' A' ' 26' ' ' ILE . 97.3 m-85 -67.9 -32.7 73.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.616 -0.72 . . . . 74.12 109.338 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 29.0 t70 -67.93 -30.8 70.21 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.191 -0.913 . . . . 63.2 110.538 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 76' ' ' ASN . 58.2 t -72.83 -22.32 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-O 121.259 0.552 . . . . 73.41 110.864 177.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.4 mm -70.19 -24.42 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.32 0.581 . . . . 75.13 110.803 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HG2' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -94.85 -171.72 2.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.767 -0.827 . . . . 74.41 108.767 176.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.49 -64.25 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 118.358 -1.877 . . . . 71.1 114.642 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -57.33 -46.25 83.45 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 117.521 0.66 . . . . 64.35 111.99 -173.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.484 ' O ' HG22 ' A' ' 110' ' ' VAL . 17.4 m-20 -154.8 12.38 0.38 Allowed 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.499 0.666 . . . . 70.43 109.222 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -116.06 147.6 41.1 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.641 -1.614 . . . . 75.11 106.641 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.471 ' OE2' ' HA ' ' A' ' 110' ' ' VAL . 11.4 pt-20 -133.5 138.72 46.26 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.432 -0.507 . . . . 73.13 111.7 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HB2' ' HG2' ' A' ' 82' ' ' GLU . 2.2 tmm_? -88.65 114.01 24.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.771 -0.649 . . . . 75.13 109.502 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.07 160.28 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.492 -0.776 . . . . 64.44 111.54 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 m -90.09 130.01 36.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.229 -0.656 . . . . 60.23 109.229 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.6 m -133.16 172.28 16.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 124.703 1.201 . . . . 75.3 108.043 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -121.07 127.78 51.99 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.875 -1.13 . . . . 60.31 110.032 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 38' ' ' LEU . 18.5 m -126.9 166.59 23.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.452 0.644 . . . . 61.24 110.519 -175.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 101' ' ' LYS . 73.0 t -105.56 113.58 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 107.807 -1.182 . . . . 72.33 107.807 172.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -78.51 89.55 4.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 108.539 -0.911 . . . . 72.52 108.539 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.446 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -48.28 -36.83 14.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.285 2.234 . . . . 64.45 112.012 -174.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -45.15 -48.26 12.28 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.239 0.962 . . . . 74.34 111.908 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -108.38 -3.83 17.93 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.308 -0.245 . . . . 73.35 111.219 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 m 66.13 28.65 10.17 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.898 0.879 . . . . 73.14 110.836 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -102.8 161.26 13.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.326 -0.852 . . . . 72.13 109.76 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.602 ' HG2' HG22 ' A' ' 94' ' ' VAL . 48.0 mtmt -98.0 133.85 41.91 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.063 -1.088 . . . . 71.34 108.063 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.22 139.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.439 0.638 . . . . 72.44 110.564 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.23 126.57 35.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.725 -1.213 . . . . 64.31 107.725 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.3 m -137.27 175.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.508 0.323 . . . . 72.44 110.419 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 44.4 mt-10 -105.2 153.28 21.76 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.979 -0.378 . . . . 75.24 109.979 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -156.01 176.79 12.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.694 0.283 . . . . 73.24 110.326 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -105.98 119.36 39.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 73.43 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 54' ' ' ILE . 27.6 m -119.3 -178.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 109.165 -0.68 . . . . 72.3 109.165 175.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.521 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 64.8 t-105 -100.62 137.09 39.48 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.586 -1.264 . . . . 63.05 107.586 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 85' ' ' ASP . 30.6 m -66.8 -20.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 113.636 0.976 . . . . 74.1 113.636 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -90.51 13.96 14.38 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.099 0.952 . . . . 74.12 109.027 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 60.3 pttt -49.62 -17.39 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.712 2.005 . . . . 64.21 115.17 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.08 -22.38 65.84 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.212 0.529 . . . . 74.23 110.439 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -118.0 140.69 28.18 Favored Pre-proline 0 CA--C 1.513 -0.458 0 N-CA-C 109.628 -0.508 . . . . 72.25 109.628 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.86 104.86 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.112 1.875 . . . . 74.31 110.346 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 116' ' ' ARG . 2.8 mmp_? -99.06 142.7 30.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.512 -0.313 . . . . 74.24 110.876 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.698 1.199 . . . . 70.31 109.307 -178.496 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 129' ' ' VAL . 46.9 mt-10 . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 112.389 0.514 . . . . 74.42 112.389 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.526 ' HA ' HG12 ' A' ' 129' ' ' VAL . 72.6 t-105 -59.86 -22.7 62.65 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-O 120.775 0.321 . . . . 73.33 110.254 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.61 -45.82 91.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.116 0.484 . . . . 51.34 110.38 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.41 -43.41 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 113.084 0.772 . . . . 61.43 113.084 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 126' ' ' TRP . 7.7 p -75.38 -18.89 15.94 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.22 0 N-CA-C 111.946 0.351 . . . . 72.24 111.946 -174.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 126' ' ' TRP . 9.4 t60 -48.45 -45.53 36.69 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 122.49 0.316 . . . . 74.14 110.6 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.26 -44.5 75.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.451 -0.34 . . . . 65.42 110.666 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.44 -44.14 97.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 74.4 110.821 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER -61.58 -55.51 30.05 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.556 -0.747 . . . . 72.52 110.74 -177.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.418 ' O ' ' HD1' ' A' ' 138' ' ' PHE . 81.1 m-85 -65.46 -32.66 74.39 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.808 1.41 . . . . 74.01 114.808 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.543 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 9.1 p -63.59 -42.19 95.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 118.913 -1.115 . . . . 62.41 109.331 176.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.07 -37.6 69.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.18 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 141' ' ' MET . 97.1 m -49.62 -51.41 37.76 Favored 'General case' 0 C--O 1.214 -0.816 0 O-C-N 123.518 0.511 . . . . 73.32 110.407 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.67 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 90.5 m-85 -70.54 -39.34 74.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.434 0.531 . . . . 74.54 112.434 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -63.44 -48.86 76.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.039 -0.264 . . . . 64.03 110.775 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.24 -35.66 80.99 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.876 -0.416 . . . . 72.34 109.876 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 137' ' ' THR . 46.9 tpp -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.956 -0.566 . . . . 70.22 109.57 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 80.4 mt -66.49 -41.65 88.63 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.987 -0.375 . . . . 71.31 109.987 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 34.3 mt-10 -65.98 -34.91 79.19 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.529 0.681 . . . . 72.52 110.024 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -75.42 -33.56 60.94 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.52 -0.764 . . . . 73.4 110.315 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -47.12 16.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.729 -0.669 . . . . 75.11 112.365 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.73 -32.25 41.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.456 -0.498 . . . . 74.14 109.724 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' GLU . 52.3 t30 58.4 84.23 0.21 Allowed Pre-proline 0 C--N 1.315 -0.917 0 C-N-CA 125.221 1.408 . . . . 72.14 114.434 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -93.43 -16.25 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.288 1.992 . . . . 75.25 112.245 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.67 -20.0 22.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.954 0.353 . . . . 73.44 111.954 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.059 0 C-N-CA 120.154 -1.022 . . . . 14.22 111.967 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 C--O 1.248 0.977 0 N-CA-C 114.271 1.211 . . . . 64.41 114.271 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.44 ' C ' HD22 ' A' ' 10' ' ' ASN . 76.5 m80 -107.89 142.35 38.1 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.781 -1.1 . . . . 73.22 109.097 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.44 HD22 ' C ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -124.36 130.95 53.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.876 -1.157 . . . . 75.21 107.876 178.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 27.7 t -124.59 120.32 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 110.172 -0.307 . . . . 74.14 110.172 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.617 ' HB3' HG22 ' A' ' 106' ' ' THR . 41.5 t80 -83.02 117.71 23.01 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.449 -0.945 . . . . 72.42 108.449 174.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 17' ' ' ILE . 7.5 p -136.76 150.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.669 -0.696 . . . . 54.21 109.709 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -127.36 -10.08 5.77 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.522 -0.547 . . . . 65.21 109.522 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.07 -128.4 1.08 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 115.348 0.899 . . . . 74.21 115.348 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -62.83 -42.65 99.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.706 1.373 . . . . 60.44 114.706 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.582 HG21 HD13 ' A' ' 67' ' ' ILE . 30.4 mt -60.59 -21.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.427 0.899 . . . . 72.41 113.427 -171.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' CD1' HG13 ' A' ' 13' ' ' VAL . 7.2 mp -66.14 -20.58 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.961 0.41 . . . . 61.4 111.117 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.19 116.16 65.73 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 108.509 -0.923 . . . . 74.21 108.509 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -40.11 -38.78 2.23 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 125.096 3.864 . . . . 62.21 115.456 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -57.82 -47.27 83.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.924 0.392 . . . . 73.52 111.065 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.6 t -67.03 -43.56 88.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.723 -0.671 . . . . 50.0 110.48 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB1' ' CB ' ' A' ' 31' ' ' ALA . . . -62.59 -37.12 84.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.805 -0.634 . . . . 71.33 109.988 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -72.67 -29.57 63.52 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.81 -0.632 . . . . 64.52 111.867 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 21' ' ' ALA . 23.0 m -81.45 -25.06 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.554 -0.859 . . . . 62.41 111.424 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.463 ' C ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -82.93 -47.92 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 120.274 -0.571 . . . . 72.21 111.04 178.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 92.2 mt -92.96 -12.69 30.15 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.206 0.447 . . . . 71.23 112.206 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 t70 76.36 -6.57 1.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.37 1.081 . . . . 73.42 109.381 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.7 ptt180 -133.99 163.76 28.82 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 125.646 1.578 . . . . 72.4 106.747 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.8 m -76.72 127.81 33.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.237 -0.653 . . . . 42.03 109.237 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' CB ' ' HB1' ' A' ' 23' ' ' ALA . . . -75.72 144.93 41.26 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 120.887 0.375 . . . . 65.12 111.489 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.77 108.89 20.9 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.817 -0.809 . . . . 53.23 108.817 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.1 p -111.71 143.7 42.19 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 115.144 -0.934 . . . . 53.54 109.934 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.29 138.89 33.83 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 108.503 -0.925 . . . . 74.1 108.503 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.71 134.76 62.77 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.636 2.224 . . . . 75.23 111.653 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.31 156.21 41.11 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.597 -0.729 . . . . 13.11 109.738 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.42 126.58 75.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.593 0.711 . . . . 75.25 111.58 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 93' ' ' VAL . 22.6 tp -93.67 96.19 9.66 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.918 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.464 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 19.7 p80 -71.62 131.78 43.68 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.569 -0.901 . . . . 53.31 108.569 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 116.56 -22.87 10.66 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 117.854 -2.117 . . . . 73.21 113.151 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 156.17 24.47 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 120.939 0.399 . . . . 72.23 111.224 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -127.24 140.51 52.17 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.619 -0.719 . . . . 44.31 109.125 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -85.72 137.21 32.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.601 0.76 . . . . 65.44 109.809 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.33 145.78 49.22 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.858 -1.534 . . . . 72.43 106.858 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 25.1 pttm -90.43 -46.6 8.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.018 0.747 . . . . 64.45 113.018 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.537 ' HG ' HD22 ' A' ' 49' ' ' LEU . 2.7 mm? 60.77 179.99 0.1 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.98 0.912 . . . . 73.0 111.947 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.9 -43.22 0.81 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.372 0.606 . . . . 52.23 109.859 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.27 -13.44 76.73 Favored Glycine 0 N--CA 1.422 -2.234 0 CA-C-N 115.368 -0.833 . . . . 74.1 113.213 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.537 HD22 ' HG ' ' A' ' 46' ' ' LEU . 7.1 mp -89.73 163.29 33.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 122.69 -0.3 . . . . 71.25 110.604 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.18 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.881 2.387 . . . . 75.34 114.096 -173.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.86 75.87 75.03 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 122.61 1.195 . . . . 75.33 109.266 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CB ' ' SG ' ' A' ' 53' ' ' CYS 0.301 43.9 Cg_endo -113.2 165.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 125.071 3.847 . . . . 74.13 114.743 -171.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 69.6 m -156.06 175.87 13.4 Favored 'General case' 0 N--CA 1.505 2.288 1 C-N-CA 132.137 4.175 . . . . 73.03 104.82 -18.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 pt -123.94 143.31 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 120.199 -0.6 . . . . 64.04 110.505 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -131.56 146.22 33.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 m -59.49 113.43 2.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.562 0.745 . . . . 75.22 111.34 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -157.54 98.01 1.64 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.751 -1.203 . . . . 45.22 107.751 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 11.4 m-20 -62.4 -16.87 57.32 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.606 1.336 . . . . 75.24 114.606 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -75.35 -17.77 60.16 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.224 0.535 . . . . 71.45 109.953 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.51 164.1 12.11 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.808 -0.633 . . . . 62.42 112.451 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 28.6 mtmm -143.77 152.09 40.81 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.027 -1.471 . . . . 71.2 107.027 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.2 123.1 71.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.328 -0.619 . . . . 75.44 109.328 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.23 126.67 46.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.369 -0.604 . . . . 61.11 109.369 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.9 -138.42 2.55 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 110.485 -1.046 . . . . 44.44 110.485 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 97.4 mttt -138.49 147.43 43.19 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 117.502 0.651 . . . . 64.43 110.785 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 31.2 m -105.41 133.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.829 -0.623 . . . . 63.33 109.833 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.582 HD13 HG21 ' A' ' 17' ' ' ILE . 6.4 mt -87.14 110.63 20.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 104.189 -2.523 . . . . 64.32 104.189 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 p -104.42 167.21 9.89 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 116.424 -0.353 . . . . 74.13 111.025 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.07 38.29 95.86 Favored Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.603 0.564 . . . . 72.43 112.935 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.96 122.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.61 -0.885 . . . . 72.34 108.61 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.45 ' HB3' ' HG2' ' A' ' 74' ' ' GLU . 32.2 t -72.69 163.34 28.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.151 -0.685 . . . . 64.34 109.151 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.87 -38.42 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.206 -0.294 . . . . 71.15 110.206 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.4 71.84 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.936 0.874 . . . . 64.43 110.221 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.1 mm-40 -76.46 -38.24 55.71 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.811 -1.086 . . . . 65.03 110.022 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.526 HD21 HH12 ' A' ' 88' ' ' ARG . 3.1 tm? -65.21 -38.37 90.25 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.571 -0.74 . . . . 72.52 109.709 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 80' ' ' VAL . 94.9 m-20 -57.53 -27.58 62.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.026 -0.988 . . . . 64.43 112.725 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -75.38 -30.87 60.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.011 -1.076 . . . . 72.5 109.741 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -67.1 -30.34 70.34 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.698 -0.853 . . . . 74.11 108.698 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.84 -31.63 68.4 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.02 -0.991 . . . . 75.31 110.087 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 76' ' ' ASN . 94.7 t -65.65 -35.25 74.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.649 -0.705 . . . . 75.45 109.626 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -58.62 -54.87 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.162 -0.681 . . . . 73.42 109.162 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 66.86 166.15 0.22 Allowed 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 123.672 0.789 . . . . 72.23 112.642 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.83 20.3 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.654 -0.979 . . . . 32.21 110.654 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.89 -43.51 71.63 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.6 0.593 . . . . 72.13 112.6 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.688 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 15.5 t70 -143.73 34.18 1.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.498 -1.667 . . . . 63.22 106.498 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 55.7 m-85 -115.42 150.38 36.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.013 -1.449 . . . . 75.34 108.468 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.68 158.33 44.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.599 -0.519 . . . . 72.21 109.599 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 106' ' ' THR . 37.4 mtt180 -84.22 124.65 31.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 112.776 0.658 . . . . 75.43 112.776 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.7 150.05 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 CA-C-N 115.298 -0.864 . . . . 65.24 108.722 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.1 m -94.42 122.78 37.34 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.449 -0.945 . . . . 72.24 108.449 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.421 HG21 HD22 ' A' ' 38' ' ' LEU . 20.1 m -123.81 163.12 23.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 106.56 -1.645 . . . . 70.21 106.56 -176.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -115.23 132.05 56.73 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 117.872 -1.531 . . . . 55.15 109.42 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' LEU . 18.7 m -126.35 169.5 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 109.133 -0.691 . . . . 73.44 109.133 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.537 HG22 ' HG3' ' A' ' 101' ' ' LYS . 58.8 t -106.1 117.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.209 -0.663 . . . . 62.42 109.209 173.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -72.45 90.04 1.29 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.194 -1.41 . . . . 64.13 107.194 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.62 -36.83 57.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.145 1.378 . . . . 54.13 111.714 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -51.41 -27.75 10.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.484 0.714 . . . . 73.25 112.713 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -134.11 9.44 3.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 63.01 109.679 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m 56.76 17.55 3.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.106 0.962 . . . . 61.0 113.489 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -92.58 160.78 14.87 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.618 -0.512 . . . . 61.42 109.618 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.537 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.3 mptt -100.52 132.68 45.78 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 108.129 -1.063 . . . . 73.43 108.129 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.09 138.48 30.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.249 0.547 . . . . 72.51 110.874 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.39 122.55 32.71 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.417 -0.957 . . . . 63.34 108.417 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.503 HG21 ' HB2' ' A' ' 12' ' ' PHE . 23.3 m -131.22 169.39 21.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.628 0.251 . . . . 73.34 111.22 -172.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.94 148.55 26.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.926 -0.398 . . . . 74.02 109.926 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 66.0 p -141.15 173.72 11.21 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 123.197 0.311 . . . . 62.11 111.623 -176.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.4 118.19 36.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.759 -1.571 . . . . 74.21 106.759 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 13.2 p -113.43 159.89 13.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.702 -0.851 . . . . 73.04 108.702 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.688 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 52.1 t-105 -83.14 118.49 23.61 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.844 -1.539 . . . . 71.01 106.844 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.9 m -62.73 -19.64 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.641 0.608 . . . . 63.4 112.641 -174.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.525 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 7.9 t30 -85.79 12.14 9.69 Favored 'General case' 0 C--O 1.199 -1.578 0 C-N-CA 123.996 0.918 . . . . 70.03 109.853 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.48 -15.12 0.22 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.798 2.148 . . . . 72.51 116.798 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.24 -14.4 55.57 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.521 -0.472 . . . . 73.03 110.759 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -115.36 124.58 29.91 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 123.727 0.811 . . . . 73.31 109.148 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -90.15 128.5 1.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.588 2.192 . . . . 61.11 113.255 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -131.07 118.01 19.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.887 -0.597 . . . . 70.25 110.176 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 51.6 ttm . . . . . 0 N--CA 1.479 1.017 0 O-C-N 124.238 0.961 . . . . 75.03 111.515 178.39 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.496 ' O ' HG22 ' A' ' 128' ' ' VAL . 11.3 tp10 . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.509 0.671 . . . . 71.24 109.223 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -58.23 -33.44 69.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 72.52 111.52 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -57.51 -36.08 71.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.043 -0.526 . . . . 74.03 112.227 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 125' ' ' GLU . 15.9 m -84.24 -29.96 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 119.96 -0.696 . . . . 74.32 110.534 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.54 -42.36 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.731 -0.668 . . . . 74.42 109.462 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.5 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.8 t60 -54.51 -38.37 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.675 -0.693 . . . . 64.34 110.733 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.51 50.83 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.55 -0.295 . . . . 74.21 111.159 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 40.8 mt-10 -69.47 -30.93 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.482 -0.487 . . . . 65.44 112.117 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -68.39 -50.67 51.33 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.06 -0.718 . . . . 70.35 109.06 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.5 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 69.3 m-85 -67.39 -31.21 71.27 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.473 1.286 . . . . 71.43 114.473 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.94 -42.03 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 119.052 -1.059 . . . . 75.42 111.477 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -70.06 -42.57 72.66 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.882 -0.327 . . . . 73.14 110.859 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 141' ' ' MET . 98.5 m -60.92 -42.01 97.3 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.417 -0.356 . . . . 75.32 110.753 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -57.6 -50.11 74.2 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.032 -0.358 . . . . 70.41 110.032 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 88.2 mtt180 -60.59 -46.54 89.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.556 . . . . 74.13 111.028 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.69 -33.03 74.93 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.592 0.59 . . . . 74.43 112.592 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 137' ' ' THR . 91.7 mtp -65.03 -36.27 83.83 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.88 -0.328 . . . . 71.33 110.578 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.4 -35.8 73.68 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 111.716 0.265 . . . . 72.15 111.716 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 23.9 mm-40 -62.86 -45.05 94.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 63.02 109.539 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -71.27 -29.36 64.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.249 -0.887 . . . . 73.2 110.783 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -71.99 -34.43 68.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.305 0.574 . . . . 65.51 109.769 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.97 -32.2 45.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.868 -0.605 . . . . 75.43 110.644 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -149.5 112.64 3.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 116.362 -0.381 . . . . 74.22 110.143 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.4 -23.55 76.99 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.805 2.336 . . . . 73.13 111.789 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -93.51 9.12 37.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.844 -0.616 . . . . 75.33 110.238 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 CA-C-N 115.84 -0.618 . . . . 53.12 112.649 -178.824 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.424 -1.769 0 CA-C-O 121.638 0.732 . . . . 71.32 110.498 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -89.5 153.31 20.9 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.844 -1.071 . . . . 65.13 111.402 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 36.7 m-80 -135.0 122.34 21.71 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.002 -1.851 . . . . 74.24 106.002 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 38.9 t -115.62 122.58 69.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 121.107 -0.237 . . . . 63.12 111.045 -173.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.49 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.7 t80 -87.48 108.22 18.92 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.857 -1.164 . . . . 71.43 107.857 175.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.83 149.18 33.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 120.974 0.416 . . . . 50.4 110.072 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.82 105.07 10.37 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.928 -1.138 . . . . 63.42 107.928 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.456 ' H ' ' CD1' ' A' ' 18' ' ' LEU . . . 87.44 -163.17 33.86 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.337 -0.705 . . . . 52.51 111.337 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t 70.0 -62.02 0.44 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.538 1.135 . . . . 75.03 113.785 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 67' ' ' ILE . 2.7 pp -129.84 9.17 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.157 0.799 . . . . 74.33 113.157 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 65' ' ' LYS . 48.0 mt -64.42 -13.98 54.22 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.291 0.848 . . . . 74.45 113.291 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.56 124.51 83.77 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.112 -1.07 . . . . 70.51 108.112 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.79 -41.64 31.39 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.71 2.94 . . . . 73.21 114.047 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.475 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -65.61 -32.71 74.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 52.23 110.806 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.2 -43.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.06 -0.518 . . . . 74.33 110.14 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.68 70.73 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.395 0.616 . . . . 53.41 109.555 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.96 75.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.51 -0.768 . . . . 62.51 111.652 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 21' ' ' ALA . 18.1 m -72.69 -31.46 37.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 120.277 -0.569 . . . . 73.3 112.075 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.589 HD13 ' CD1' ' A' ' 78' ' ' PHE . 7.8 tt -73.57 -36.77 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.925 0.393 . . . . 63.31 111.799 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 74' ' ' GLU . 92.0 mt -100.25 -10.75 21.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 113.767 1.025 . . . . 72.35 113.767 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.3 18.25 10.24 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.972 1.368 . . . . 72.03 108.665 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -160.45 140.74 11.5 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 105.539 -2.023 . . . . 75.5 105.539 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -76.53 118.51 19.27 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.551 -0.86 . . . . 73.23 108.808 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -93.04 147.98 22.39 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 116.188 -0.46 . . . . 63.44 109.877 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -88.67 114.16 25.0 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.299 -0.864 . . . . 75.2 111.181 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.431 ' HB ' ' HE3' ' A' ' 65' ' ' LYS . 4.2 p -100.79 143.43 30.95 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.533 -0.758 . . . . 71.25 109.527 174.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.52 140.03 37.43 Favored Pre-proline 0 C--N 1.277 -2.552 0 N-CA-C 109.219 -0.66 . . . . 51.22 109.219 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 39.7 Cg_endo -67.29 132.14 26.81 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.869 1.713 . . . . 75.51 110.671 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.551 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -145.58 156.1 43.47 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.23 -0.895 . . . . 72.11 109.029 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 11.3 p -120.47 128.24 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 CA-C-O 121.681 0.753 . . . . 74.41 110.979 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.463 ' HA ' HG12 ' A' ' 93' ' ' VAL . 23.1 tp -87.43 108.91 19.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.096 -0.957 . . . . 75.41 109.631 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -83.78 125.48 31.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.912 -1.04 . . . . 74.1 109.053 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 117.34 -13.74 13.65 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 118.277 -1.916 . . . . 52.33 113.611 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.516 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 39.1 m-85 -124.96 159.61 30.82 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 110.034 -0.358 . . . . 74.31 110.034 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 11.3 t-80 -130.16 137.26 50.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 120.014 -0.674 . . . . 75.34 109.679 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 44' ' ' TYR . 3.2 tmm_? -88.9 129.51 35.59 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.157 -1.053 . . . . 64.1 108.157 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.45 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 46.9 m-85 -95.5 152.88 18.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.642 -0.708 . . . . 71.23 110.979 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 6.1 tmtm? -84.91 -30.27 24.5 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.766 -0.827 . . . . 75.25 108.766 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.39 -166.26 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.438 0.695 . . . . 73.05 111.03 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.83 -42.93 2.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.335 -0.987 . . . . 73.32 108.335 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.81 -8.67 53.99 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.485 -0.864 . . . . 74.31 113.755 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.83 126.32 29.32 Favored Pre-proline 0 C--N 1.321 -0.648 0 O-C-N 122.521 -0.399 . . . . 55.41 110.475 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -83.49 -44.93 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.94 2.427 . . . . 75.32 112.267 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.677 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.9 p90 -113.67 172.11 3.83 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 105.59 -2.004 . . . . 65.33 105.59 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.308 0.0 OUTLIER 30.36 168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.593 3.466 0 C-N-CA 124.376 3.384 . . . . 63.44 118.713 -161.236 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 10.5 p -122.58 -175.29 3.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 119.623 -1.923 . . . . 71.11 112.513 8.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 30.1 pt -123.64 132.34 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.822 -1.081 . . . . 74.22 108.788 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 27.4 m -150.46 116.48 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.191 0 O-C-N 123.203 0.314 . . . . 73.22 111.521 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.6 t 55.91 -158.59 0.23 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.182 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.9 m 71.88 80.2 0.15 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.541 1.536 . . . . 70.23 111.23 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.584 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 p-10 -73.49 -10.26 59.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.613 0.72 . . . . 61.54 110.094 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.9 t -83.85 -6.16 59.36 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.0 -1.0 . . . . 73.34 109.097 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.69 164.74 13.36 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.864 -0.684 . . . . 62.53 112.246 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -142.15 147.17 36.22 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.029 -1.471 . . . . 72.4 107.029 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 41' ' ' TYR . 58.1 t -121.04 122.95 68.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 110.104 -0.332 . . . . 72.23 110.104 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -92.4 118.11 30.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.454 -0.943 . . . . 73.13 108.454 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -145.21 -152.96 5.74 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.048 -1.221 . . . . 72.4 110.048 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 18' ' ' LEU . 30.3 mtpp -137.4 138.82 40.25 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.315 -0.624 . . . . 73.34 109.315 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.3 m -103.95 133.68 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.766 -0.652 . . . . 54.32 109.602 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 17' ' ' ILE . 4.5 mt -87.4 119.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 105.292 -2.114 . . . . 62.13 105.292 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.4 p -106.43 160.48 15.36 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.277 -0.969 . . . . 75.13 111.5 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.89 39.84 85.1 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.902 -0.59 . . . . 70.11 112.46 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -103.83 123.57 57.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 N-CA-C 110.26 -0.274 . . . . 55.51 110.26 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.5 t -73.85 162.42 29.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.582 -0.895 . . . . 55.15 108.582 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.48 -39.3 79.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.015 0.436 . . . . 75.23 109.889 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.52 -32.47 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 40.01 109.84 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.667 ' HB3' HD22 ' A' ' 27' ' ' LEU . 52.8 mt-10 -76.98 -40.23 47.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.27 -0.877 . . . . 63.41 111.508 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.1 tt -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.036 -1.098 . . . . 72.52 108.036 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.591 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.0 t-20 -53.83 -31.55 49.75 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.922 -1.49 . . . . 74.43 110.933 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -31.69 67.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 120.622 -0.431 . . . . 72.25 109.974 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CD1' HD13 ' A' ' 26' ' ' ILE . 90.2 m-85 -72.35 -40.36 67.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.598 -0.89 . . . . 55.42 108.598 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.88 -29.42 70.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.571 -1.195 . . . . 70.14 111.98 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 76' ' ' ASN . 95.5 t -52.63 -22.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 124.036 0.934 . . . . 73.14 112.295 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.96 -29.88 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 N-CA-C 109.661 -0.496 . . . . 71.54 109.661 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 55.53 96.74 0.02 OUTLIER 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.663 1.585 . . . . 73.35 113.836 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.14 107.77 3.46 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 108.704 -1.759 . . . . 43.52 108.704 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.98 -35.42 76.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.323 0.562 . . . . 64.11 112.316 -175.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 109' ' ' TRP . 15.1 m-20 -101.59 17.96 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.055 0.455 . . . . 73.41 110.453 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -115.19 141.98 47.29 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.89 -0.411 . . . . 74.02 109.89 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -131.67 143.84 50.58 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.759 -0.83 . . . . 64.34 108.759 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 106' ' ' THR . 55.4 mtm180 -82.92 113.1 20.29 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.591 -0.444 . . . . 44.15 112.169 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.5 m -116.34 153.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.399 -0.819 . . . . 71.34 110.322 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.2 m -90.46 123.44 34.17 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.853 -0.795 . . . . 72.21 108.853 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.34 171.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.548 -1.278 . . . . 62.3 107.548 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -125.23 123.56 39.8 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.948 -1.501 . . . . 72.44 106.948 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 38' ' ' LEU . 13.7 m -126.81 163.07 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 121.504 0.669 . . . . 73.3 109.976 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 101' ' ' LYS . 53.7 t -107.69 118.42 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.73 -0.668 . . . . 53.5 109.904 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.43 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 40.9 ttm180 -66.04 98.83 0.46 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.965 -1.494 . . . . 64.11 106.965 175.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.551 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -60.48 -36.27 77.89 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 125.03 1.332 . . . . 73.01 110.283 -170.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.7 -41.85 70.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.573 -0.74 . . . . 73.23 112.212 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.14 -1.55 12.97 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.415 0.626 . . . . 73.52 110.952 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 t 64.42 23.12 12.9 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.993 0.917 . . . . 72.31 111.451 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.3 pt-20 -96.59 161.39 13.92 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.88 -0.415 . . . . 73.31 109.88 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.499 ' HG2' HG22 ' A' ' 94' ' ' VAL . 48.0 mtpt -105.03 130.84 53.14 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.718 -0.475 . . . . 74.14 109.718 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.42 130.92 54.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.722 0.772 . . . . 65.13 111.277 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -87.52 120.29 28.67 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.022 -1.473 . . . . 71.13 107.022 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.517 HG12 ' HB2' ' A' ' 10' ' ' ASN . 27.2 m -133.83 172.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.755 0.312 . . . . 60.2 111.17 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.4 152.57 23.43 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.774 -0.454 . . . . 64.53 109.774 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.0 t -151.91 174.64 13.36 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.658 -0.867 . . . . 61.05 108.658 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.1 118.42 36.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.204 -1.036 . . . . 61.53 108.204 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.42 153.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.836 -0.801 . . . . 71.23 108.836 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.603 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 63.7 t-105 -81.9 121.4 26.43 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.395 -1.335 . . . . 72.32 107.395 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.76 -20.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.402 0.89 . . . . 72.43 113.402 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.577 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 28.5 t-20 -80.57 11.35 3.81 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-O 121.702 0.763 . . . . 73.35 109.962 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -50.7 -25.67 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.918 1.287 . . . . 74.03 114.064 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.19 -6.78 57.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.081 0.467 . . . . 75.22 111.669 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.633 ' OD1' ' HB2' ' A' ' 116' ' ' ARG . 12.6 t70 -102.23 128.38 28.55 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 106.062 -1.829 . . . . 70.43 106.062 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.31 46.06 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.229 2.62 . . . . 70.22 111.978 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.633 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 14.2 ttm180 -95.29 115.39 27.37 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.246 -0.888 . . . . 73.33 111.872 -172.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 125.069 1.348 . . . . 74.23 114.546 175.685 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.223 -0.306 0 N-CA-C 109.162 -0.681 . . . . 71.42 109.162 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.42 ' HA ' HG12 ' A' ' 129' ' ' VAL . 75.3 t90 -56.09 -41.95 75.98 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.781 -0.645 . . . . 73.25 110.976 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -60.27 -41.26 92.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.725 -0.67 . . . . 74.3 111.224 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -82.95 -41.63 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.638 -0.425 . . . . 72.35 111.916 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 126' ' ' TRP . 13.0 p -68.82 -40.11 80.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 112.767 0.654 . . . . 74.34 112.767 -174.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -65.17 -35.25 80.49 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 118.882 -1.127 . . . . 74.4 110.645 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -64.3 -55.1 23.63 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.434 0.459 . . . . 62.43 111.03 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -23.42 64.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.168 0.433 . . . . 65.44 112.168 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.618 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.4 tpmt? -67.24 -45.3 77.13 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.78 -0.822 . . . . 73.33 108.78 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -67.47 -33.18 74.6 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.836 -0.345 . . . . 73.02 111.276 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 98.1 t -53.68 -53.19 27.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.11 -0.7 . . . . 73.02 109.11 173.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.95 -42.42 89.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.671 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.7 m -54.96 -50.51 68.74 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.775 0.672 . . . . 71.34 110.463 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -68.35 -29.85 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.162 0.43 . . . . 72.34 112.162 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -68.23 -44.73 75.08 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.463 0.649 . . . . 61.51 109.729 177.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -71.23 -42.09 69.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 75.44 110.378 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.2 mmt -62.53 -31.45 72.22 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-N 116.344 -0.389 . . . . 74.31 110.844 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.46 -50.05 74.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.58 0.752 . . . . 73.43 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.44 -34.37 75.85 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.165 -0.614 . . . . 72.4 111.631 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -75.18 -27.18 59.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.183 0.516 . . . . 73.3 112.035 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -72.88 -37.3 67.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.483 0.713 . . . . 75.32 109.318 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 146' ' ' LYS . 11.3 tmtt? -78.95 -33.0 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.315 -0.624 . . . . 74.22 109.315 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -137.9 95.05 11.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 120.927 0.394 . . . . 73.23 110.628 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.03 -16.61 9.83 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.615 2.21 . . . . 75.05 111.175 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.22 -23.26 61.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.369 -0.832 . . . . 75.04 111.292 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.609 0 C-N-CA 120.454 -0.879 . . . . 65.52 112.506 -179.723 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 106.571 -1.64 . . . . 74.32 106.571 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.638 ' HD1' ' HG ' ' A' ' 75' ' ' LEU . 8.4 m170 -104.23 156.0 18.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.049 -0.523 . . . . 74.13 110.581 -172.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.578 ' HB2' HG12 ' A' ' 104' ' ' VAL . 25.2 m-80 -134.93 133.42 39.55 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.466 -1.679 . . . . 71.43 106.466 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.408 ' HB ' HD12 ' A' ' 67' ' ' ILE . 47.6 t -114.79 121.02 66.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.563 -0.455 . . . . 72.2 111.213 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.535 ' HB2' HG21 ' A' ' 104' ' ' VAL . 59.3 t80 -89.75 98.83 11.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.302 -0.629 . . . . 75.34 109.302 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.48 129.98 31.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.832 -0.803 . . . . 63.23 108.832 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.562 ' CD1' ' HA2' ' A' ' 64' ' ' GLY . 48.2 t80 -105.89 86.17 2.34 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.544 -0.863 . . . . 65.42 110.127 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.76 147.18 4.48 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.652 -1.158 . . . . 75.44 112.367 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t 70.67 -69.34 0.18 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.489 1.515 . . . . 73.41 113.718 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.586 HG21 HD13 ' A' ' 67' ' ' ILE . 28.3 mt -75.96 3.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.027 0.918 . . . . 73.43 110.407 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -67.99 -23.04 64.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.568 -0.742 . . . . 74.45 109.159 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.63 119.94 74.52 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 108.565 -0.902 . . . . 71.21 108.565 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -48.55 -35.96 30.41 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.67 2.913 . . . . 53.14 112.54 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -60.37 -40.29 90.27 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.455 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 25' ' ' VAL . 70.9 t -70.46 -39.71 76.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.356 0.598 . . . . 74.3 110.056 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -66.43 -35.32 80.01 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.378 -0.601 . . . . 72.14 109.378 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -74.28 -10.14 59.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 72.34 112.038 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 21' ' ' ALA . 21.1 m -100.04 -31.68 3.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.346 -0.942 . . . . 72.33 110.513 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.553 HD13 ' CD2' ' A' ' 78' ' ' PHE . 9.9 tt -79.08 -42.96 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.153 0.501 . . . . 75.11 111.582 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 31' ' ' ALA . 95.8 mt -94.97 -21.38 18.65 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.156 -0.34 . . . . 74.24 110.319 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 28.2 t70 67.59 15.98 9.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 123.598 1.666 . . . . 52.31 107.723 -170.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -133.31 131.56 40.3 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.457 -2.053 . . . . 74.33 105.457 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -76.74 111.43 12.24 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.996 -1.082 . . . . 70.4 109.196 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -96.87 143.09 28.09 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.647 -0.706 . . . . 72.35 109.264 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.78 129.06 45.86 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.852 -0.796 . . . . 74.21 108.852 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 12.7 p -93.34 141.83 28.0 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 119.487 -0.885 . . . . 74.04 108.878 175.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.72 140.02 34.62 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.703 -0.851 . . . . 71.34 108.703 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.73 128.94 28.64 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.778 2.319 . . . . 64.13 111.969 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.24 154.45 37.95 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.902 -0.59 . . . . 35.13 109.518 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.85 131.92 71.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 C-N-CA 120.752 -0.379 . . . . 74.13 110.384 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.454 HD11 ' HB ' ' A' ' 91' ' ' VAL . 20.9 tp -94.32 129.98 40.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.022 -0.535 . . . . 75.03 110.531 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -94.59 129.97 41.22 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.446 -0.343 . . . . 63.54 111.232 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 58' ' ' ASP . . . 105.4 -1.43 40.01 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 119.52 -1.324 . . . . 74.1 113.771 173.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.499 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 56.9 m-85 -126.59 160.76 29.73 Favored 'General case' 0 N--CA 1.414 -2.252 0 O-C-N 122.313 -0.522 . . . . 64.23 112.074 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -134.17 130.97 38.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.387 -1.338 . . . . 74.03 107.387 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.83 124.98 34.7 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.06 0.457 . . . . 74.1 111.208 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HE2' ' O ' ' A' ' 55' ' ' VAL . 93.6 m-85 -106.67 145.17 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.897 -1.149 . . . . 62.01 107.897 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 4.3 mmmp? -109.92 125.02 52.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 112.355 0.502 . . . . 73.43 112.355 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.407 HD23 ' HB2' ' A' ' 52' ' ' PRO . 1.4 mm? -131.83 141.67 49.49 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.189 -1.041 . . . . 71.34 108.189 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -90.65 -30.04 17.38 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.818 -0.808 . . . . 52.34 108.818 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -31.76 76.98 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.806 -1.088 . . . . 71.43 112.222 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.43 ' HB2' ' HG3' ' A' ' 52' ' ' PRO . 6.4 mp -90.98 158.45 41.76 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 108.407 -0.96 . . . . 63.5 108.407 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.94 -76.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.849 2.366 . . . . 71.01 114.216 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.62 76.26 69.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.964 -1.124 . . . . 75.24 107.964 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HG3' ' HB2' ' A' ' 49' ' ' LEU 0.257 51.9 Cg_endo -115.52 162.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 123.432 2.754 . . . . 72.31 116.19 -171.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 m -158.01 158.21 34.43 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.205 3.402 . . . . 71.54 107.152 -19.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 108' ' ' VAL . 33.2 pt -124.09 128.33 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.638 -0.825 . . . . 72.33 111.888 174.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 24.2 m -154.58 145.75 13.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 124.342 1.057 . . . . 63.44 108.458 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 p 168.14 -57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.194 0.934 . . . . 72.04 110.671 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 m 69.8 13.6 8.06 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.363 1.078 . . . . 74.34 108.337 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.663 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 26.6 t70 -83.28 -178.05 6.95 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 113.938 -1.483 . . . . 71.24 109.715 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.0 m -80.42 -6.88 58.77 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.684 0.278 . . . . 70.44 110.889 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.42 156.17 31.1 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.887 -0.597 . . . . 74.03 111.971 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -129.03 152.91 48.12 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.895 -0.409 . . . . 71.3 109.895 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 122.53 67.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.295 -1.002 . . . . 72.33 108.295 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -97.77 115.64 28.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.426 -0.583 . . . . 73.14 109.426 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.562 ' HA2' ' CD1' ' A' ' 14' ' ' TYR . . . -146.44 -147.4 4.57 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.953 -0.641 . . . . 75.24 111.993 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 47.9 mtpt -139.68 146.21 39.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.213 -1.032 . . . . 71.31 108.213 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 33' ' ' THR . 35.2 m -104.72 135.14 43.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.165 -0.471 . . . . 64.54 110.883 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.586 HD13 HG21 ' A' ' 17' ' ' ILE . 6.4 mt -86.27 111.8 21.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.762 -2.31 . . . . 64.42 104.762 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -99.44 161.64 13.5 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.495 -0.482 . . . . 71.21 111.694 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.41 35.32 37.6 Favored Glycine 0 C--O 1.245 0.789 0 CA-C-N 115.752 -0.658 . . . . 64.2 112.927 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t -97.37 124.82 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.02 -0.734 . . . . 63.44 109.02 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.0 m -77.95 157.92 29.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.553 -0.906 . . . . 74.41 108.553 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HA ' ' CE1' ' A' ' 9' ' ' HIS . 7.3 p-10 -56.45 -42.74 78.64 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.211 0.529 . . . . 72.41 112.191 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.47 70.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.017 -0.992 . . . . 71.33 110.801 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.58 -30.02 62.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.516 -0.766 . . . . 60.3 110.793 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.638 ' HG ' ' HD1' ' A' ' 9' ' ' HIS . 3.0 tm? -58.21 -35.08 71.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.278 -0.873 . . . . 72.04 109.369 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.575 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -59.46 -27.53 66.17 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.357 -0.838 . . . . 63.12 111.919 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.485 ' OD1' HG13 ' A' ' 26' ' ' ILE . 1.9 t-20 -68.08 -31.61 71.35 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.219 -0.659 . . . . 74.25 109.219 -176.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 26' ' ' ILE . 80.1 m-85 -74.46 -32.28 62.54 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 121.68 0.752 . . . . 72.21 109.007 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.83 -31.26 63.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.159 -0.928 . . . . 63.23 110.241 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 76' ' ' ASN . 98.1 t -66.65 -22.67 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 115.64 -0.709 . . . . 70.34 110.848 175.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.8 mm -58.96 143.22 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.915 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.41 113.71 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.742 1.617 . . . . 72.23 113.266 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.77 85.35 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.561 -0.828 . . . . 42.3 113.266 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -82.55 -33.17 28.22 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.632 -0.334 . . . . 65.14 111.576 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.537 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.5 m-20 -97.75 2.43 49.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.609 0.966 . . . . 74.45 113.609 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.431 ' HD2' ' HB3' ' A' ' 107' ' ' TYR 0.326 1.6 p90 -122.18 142.31 50.55 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.14 -1.024 . . . . 75.12 111.114 171.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 15.5 pt-20 -125.03 159.45 31.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.159 -170.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.403 ' CD ' HD11 ' A' ' 75' ' ' LEU . 30.3 ttp-105 -88.85 128.62 35.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.805 -0.443 . . . . 63.44 109.805 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.35 159.78 40.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 122.634 0.374 . . . . 75.43 110.504 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.7 m -93.67 129.43 39.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.986 -0.746 . . . . 71.31 108.986 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.454 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.8 m -136.48 157.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.918 -1.141 . . . . 72.54 107.918 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.51 ' HG3' ' HD3' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -105.18 135.65 46.15 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.276 -0.97 . . . . 54.01 108.762 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 38' ' ' LEU . 21.8 m -127.36 161.94 33.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.704 -0.85 . . . . 65.34 108.704 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 101' ' ' LYS . 71.6 t -102.44 120.1 51.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 109.005 -0.739 . . . . 63.2 109.005 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -71.91 93.12 1.31 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.476 -1.676 . . . . 72.32 106.476 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -47.84 -49.54 28.91 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 127.262 2.225 . . . . 72.13 115.049 -167.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.88 -23.12 58.34 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.166 -0.614 . . . . 65.22 111.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -97.83 -10.89 23.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.3 -0.409 . . . . 62.34 110.864 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 m 59.26 19.49 7.61 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.464 1.106 . . . . 73.45 112.336 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -105.19 160.78 14.81 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.938 -0.393 . . . . 75.3 109.938 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.3 mtmt -100.31 143.21 30.76 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.618 -0.882 . . . . 73.21 108.618 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.75 162.23 15.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.301 -0.629 . . . . 51.33 109.301 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HD3' ' HG3' ' A' ' 92' ' ' GLU . 3.6 tppp? -110.69 123.83 50.78 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.101 -1.074 . . . . 74.44 108.101 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 10' ' ' ASN . 21.2 m -130.97 174.37 13.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.837 0.351 . . . . 73.42 110.564 -174.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -112.11 146.91 37.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.077 -0.712 . . . . 74.33 109.077 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.4 t -149.26 174.03 12.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.085 -1.08 . . . . 75.42 108.085 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.431 ' HB3' ' HD2' ' A' ' 86' ' ' TYR . 90.1 m-85 -113.43 119.55 38.0 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.61 0.719 . . . . 64.53 110.542 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 54' ' ' ILE . 14.0 p -114.0 143.79 22.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.975 -1.011 . . . . 70.31 109.747 -175.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.686 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 61.0 t-105 -70.01 127.86 34.31 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.57 -0.9 . . . . 75.41 108.57 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 85' ' ' ASP . 31.6 m -72.02 -19.82 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.519 0.676 . . . . 72.14 112.559 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.686 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -86.83 15.64 5.62 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 125.216 1.406 . . . . 71.31 109.29 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 0.8 OUTLIER -48.27 -22.96 0.76 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.23 1.812 . . . . 72.43 113.85 -176.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -101.71 68.51 1.16 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.551 -0.859 . . . . 73.32 110.984 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -128.56 144.38 51.93 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 114.798 -1.092 . . . . 74.14 108.331 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.35 -33.2 84.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 53.44 113.642 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.559 ' O ' ' HD2' ' A' ' 116' ' ' ARG 0.265 0.0 OUTLIER -133.26 114.22 13.53 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.112 1.153 . . . . 64.13 114.112 -178.463 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.436 ' HE2' ' HA ' ' A' ' 117' ' ' MET . 1.7 mmt . . . . . 0 CA--C 1.495 -1.146 0 CA-C-N 115.83 -0.623 . . . . 71.21 110.342 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 108.571 -0.9 . . . . 74.11 108.571 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -86.96 -23.84 24.94 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.467 -0.788 . . . . 74.31 109.546 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -59.49 -45.7 90.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 62.24 110.391 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.6 m -64.18 -19.75 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 116.362 -0.381 . . . . 73.13 111.956 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.3 -22.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.13 0.491 . . . . 63.21 110.552 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.474 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 5.2 p-80 -115.79 -33.12 5.25 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.695 -0.802 . . . . 74.33 112.952 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -59.4 -55.73 31.0 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.811 0.671 . . . . 55.22 112.811 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.49 -34.07 77.37 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.694 -0.402 . . . . 74.43 111.855 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.482 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 1.1 tmtp? -61.55 -50.31 73.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.107 -0.701 . . . . 73.14 109.107 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 84.3 m-85 -69.37 -31.99 70.74 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.052 0.39 . . . . 51.43 112.052 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 131' ' ' ALA . 97.7 t -60.01 -38.66 77.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.061 -0.348 . . . . 62.41 110.061 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 12.8 mm-40 -57.39 -48.13 79.87 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.698 -0.482 . . . . 71.54 109.698 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' A' ' 141' ' ' MET . 34.8 m -57.51 -46.67 83.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.335 -0.848 . . . . 75.4 110.412 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.402 ' O ' HD23 ' A' ' 142' ' ' LEU . 74.1 m-85 -61.47 -48.51 80.79 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.809 -0.356 . . . . 71.5 111.569 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -54.61 -47.51 73.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.703 0.287 . . . . 64.12 110.822 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 75.4 mmtt -66.9 -42.96 84.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.684 -0.689 . . . . 45.35 111.909 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 137' ' ' THR . 60.5 mtm -66.52 -42.95 86.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.718 -0.393 . . . . 73.45 111.248 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.557 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 4.6 mm? -59.22 -49.96 75.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.246 0.832 . . . . 62.43 113.246 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.29 0.567 . . . . 75.22 111.698 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -75.91 -36.57 59.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.171 -0.922 . . . . 72.03 110.836 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -83.42 -35.57 24.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.299 0.851 . . . . 75.41 113.299 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -79.62 -7.24 58.41 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.863 -0.735 . . . . 73.43 112.308 -177.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -143.29 86.41 9.05 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-O 121.027 0.441 . . . . 75.01 111.398 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.4 -22.75 28.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.864 2.376 . . . . 74.33 110.496 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -76.84 -12.65 60.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.529 -0.76 . . . . 72.23 109.985 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.529 0 CA-C-N 115.387 -0.824 . . . . 71.43 111.181 178.104 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 108.722 -0.844 . . . . 61.24 108.722 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -91.6 148.52 22.22 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.455 -0.793 . . . . 75.32 109.508 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 83.1 m-20 -129.06 122.72 30.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.949 -1.13 . . . . 65.32 107.949 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 29.3 t -117.72 120.36 64.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.554 -0.459 . . . . 75.34 111.422 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -83.78 110.83 18.65 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.465 -1.309 . . . . 70.13 107.465 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG11 HD11 ' A' ' 17' ' ' ILE . 7.9 p -136.17 158.07 38.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.244 -0.582 . . . . 70.03 110.066 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.88 22.02 6.83 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-O 121.074 0.464 . . . . 72.22 110.988 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.501 ' HA3' ' CZ ' ' A' ' 51' ' ' TYR . . . -136.29 -133.7 3.23 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 118.128 -1.987 . . . . 61.02 117.072 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.6 m -40.46 -47.68 2.65 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.821 2.156 . . . . 71.22 116.821 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 67' ' ' ILE . 2.4 pp -84.71 1.48 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 114.583 1.327 . . . . 74.42 114.583 -171.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD11 HG13 ' A' ' 13' ' ' VAL . 9.8 mp -68.54 -11.2 59.59 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.511 0.56 . . . . 64.11 112.511 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.9 119.05 75.45 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 107.121 -1.437 . . . . 52.41 107.121 170.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -47.52 -37.29 25.96 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.751 2.967 . . . . 74.34 114.036 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.98 -35.03 79.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.407 -0.361 . . . . 62.35 111.293 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 17' ' ' ILE . 45.3 t -76.92 -40.59 31.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.252 -0.431 . . . . 71.05 110.219 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -58.84 -33.81 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.676 . . . . 71.4 109.602 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.61 -11.33 59.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.452 -0.794 . . . . 75.11 112.46 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.5 m -102.12 -26.86 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.869 -0.732 . . . . 74.34 110.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 78' ' ' PHE . 9.5 tt -77.05 -36.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.344 0.592 . . . . 75.02 110.607 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 31' ' ' ALA . 90.1 mt -95.93 -14.7 22.89 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.045 -0.525 . . . . 71.53 110.242 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 68.44 -1.22 1.96 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.461 1.124 . . . . 74.04 109.927 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 94.8 mtt180 -133.53 176.85 8.17 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.466 -1.679 . . . . 64.11 106.466 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -77.01 144.09 38.92 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.078 0.466 . . . . 74.23 111.251 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.65 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -116.27 134.97 54.31 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 109.046 -0.724 . . . . 72.34 109.046 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -99.42 109.71 22.27 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.903 -1.519 . . . . 74.24 109.174 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 3.0 p -105.93 142.12 36.18 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 120.272 -0.571 . . . . 75.44 109.933 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.15 137.64 31.43 Favored Pre-proline 0 C--N 1.284 -2.27 0 N-CA-C 108.766 -0.827 . . . . 73.42 108.766 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 96' ' ' MET . 6.4 Cg_endo -57.47 117.72 4.47 Favored 'Trans proline' 0 CA--C 1.504 -0.99 0 C-N-CA 122.254 1.969 . . . . 73.21 109.719 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.86 155.2 50.68 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.972 -0.751 . . . . 63.53 108.972 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.593 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.6 p -125.86 127.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.745 0.783 . . . . 71.24 111.695 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.488 HD11 ' HB ' ' A' ' 91' ' ' VAL . 20.8 tp -87.59 96.29 10.36 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.017 -0.992 . . . . 74.21 112.398 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -72.56 126.35 29.65 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.36 -0.836 . . . . 62.33 110.263 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.84 -7.84 17.05 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 119.635 -1.269 . . . . 70.53 113.14 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 33.8 m-85 -126.7 145.11 50.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 112.642 0.608 . . . . 74.32 112.642 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 22.3 t-160 -105.34 127.09 52.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.363 -0.835 . . . . 64.31 108.765 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' HG22 ' A' ' 54' ' ' ILE . 2.4 ptm180 -87.93 137.59 32.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.162 -0.681 . . . . 71.33 109.162 175.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.4 ' HD2' ' O ' ' A' ' 117' ' ' MET . 22.2 m-85 -98.81 177.93 5.12 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 115.85 -0.614 . . . . 74.45 109.918 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -117.03 -28.59 6.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 114.005 1.113 . . . . 55.11 114.005 -177.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 52' ' ' PRO . 4.1 mm? 57.88 -169.92 0.11 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.503 0.502 . . . . 71.21 111.576 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 23.29 5.19 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.731 -0.788 . . . . 63.45 112.886 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.64 7.18 0.08 OUTLIER Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.284 -0.96 . . . . 70.13 113.112 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.77 161.11 36.92 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 117.163 0.482 . . . . 71.43 110.413 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.41 96.18 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.114 2.543 . . . . 72.23 114.598 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.605 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.6 p90 44.2 35.11 0.2 Allowed Pre-proline 0 N--CA 1.515 2.815 0 N-CA-C 116.52 2.045 . . . . 71.11 116.52 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.893 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 72.6 Cg_endo -108.5 166.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.274 2.65 . . . . 74.13 113.516 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.893 ' SG ' ' HB2' ' A' ' 52' ' ' PRO . 33.5 m -134.29 -179.25 5.46 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 103.94 -2.615 . . . . 61.1 103.94 -4.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 43' ' ' ARG . 40.2 pt -123.99 121.03 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 119.609 1.095 . . . . 75.4 112.179 174.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -154.12 133.04 3.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.743 -0.662 . . . . 73.35 111.454 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t 64.72 -175.99 0.17 Allowed 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.504 1.122 . . . . 75.52 113.426 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.595 ' HB3' ' HB2' ' A' ' 42' ' ' HIS . 20.6 t 78.67 112.52 0.07 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.59 1.956 . . . . 72.24 112.932 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.17 -27.16 32.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.432 0.635 . . . . 75.34 109.944 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.5 m -82.97 -9.2 59.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.771 -0.649 . . . . 65.02 110.421 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.26 153.65 21.48 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.742 -0.663 . . . . 61.34 112.354 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.593 ' HE2' HG21 ' A' ' 37' ' ' VAL . 21.0 ptmt -154.17 145.7 23.18 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.293 -1.003 . . . . 55.31 108.293 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 54' ' ' ILE . 62.1 t -114.27 123.76 70.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 112.044 0.387 . . . . 64.45 112.044 -173.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -88.1 120.6 29.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.536 -0.302 . . . . 74.24 110.242 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.34 -147.23 4.57 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.7 143.58 39.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.465 0.633 . . . . 74.15 110.121 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.68 133.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 109.336 -0.616 . . . . 75.31 109.336 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 4.6 mt -89.47 117.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 106.445 -1.687 . . . . 74.34 106.445 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -104.1 160.42 14.86 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.022 -1.071 . . . . 62.12 109.225 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.57 30.0 41.79 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.224 -0.988 . . . . 53.24 113.656 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.55 124.29 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.29 0.545 . . . . 75.03 110.013 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.563 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.9 m -75.48 158.29 32.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.791 -0.818 . . . . 70.34 108.791 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.17 -39.79 79.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.071 0.397 . . . . 74.02 112.071 -175.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.84 64.73 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.09 0.471 . . . . 51.2 110.732 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.563 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 50.7 mm-40 -73.64 -30.94 63.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.568 -0.742 . . . . 74.21 110.34 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.78 -37.05 73.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.178 0.991 . . . . 75.1 111.32 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 39.1 m-80 -57.37 -27.58 62.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.309 0.644 . . . . 74.02 111.657 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -69.08 -31.7 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.241 -0.652 . . . . 62.41 109.241 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD1' HD13 ' A' ' 26' ' ' ILE . 95.8 m-85 -70.97 -29.25 65.19 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 120.415 -0.514 . . . . 74.22 109.764 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 3.1 m-20 -60.96 -41.19 95.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.586 0.708 . . . . 74.25 109.439 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 76' ' ' ASN . 43.0 t -65.24 -34.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.012 -0.995 . . . . 74.35 110.394 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -62.01 -50.75 78.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.233 -0.44 . . . . 64.11 111.152 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.06 141.83 12.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 120.933 0.397 . . . . 73.05 110.665 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.68 28.71 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.277 -0.874 . . . . 75.01 111.191 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -76.42 -43.06 41.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 120.187 -0.605 . . . . 51.41 110.551 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 110' ' ' VAL . 8.1 m-20 -125.93 13.15 7.89 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.091 0.948 . . . . 61.25 108.534 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 50.5 m-85 -115.9 149.44 38.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.334 -1.358 . . . . 72.3 107.334 -177.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 16.4 pt-20 -130.76 155.88 45.91 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.586 0.232 . . . . 74.1 110.531 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 106' ' ' THR . 45.5 ttm180 -91.1 126.66 36.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.865 0.364 . . . . 71.24 111.511 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.16 159.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.444 -0.947 . . . . 71.4 108.444 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 m -96.17 123.01 39.63 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.223 -0.658 . . . . 52.2 109.223 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 38' ' ' LEU . 26.8 m -125.96 157.76 35.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 123.826 0.85 . . . . 71.11 109.727 -175.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 29.3 tt0 -105.24 125.18 50.69 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.207 -0.597 . . . . 61.4 109.52 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 38' ' ' LEU . 15.1 m -126.13 168.41 19.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.964 -0.754 . . . . 63.33 108.964 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 96' ' ' MET . 68.6 t -104.25 128.12 57.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.341 -0.985 . . . . 73.51 108.341 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -68.53 -15.44 63.54 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.951 0.782 . . . . 73.43 110.215 -174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.566 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER 70.61 -54.86 0.64 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.131 1.773 . . . . 73.12 113.882 172.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -48.63 -45.65 38.7 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 70.43 111.432 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.87 9.95 16.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 123.345 0.658 . . . . 64.24 110.508 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.7 m 62.83 10.06 4.05 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.81 1.041 . . . . 74.54 113.81 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 161.11 21.85 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.569 -0.452 . . . . 44.0 110.361 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HG2' HG22 ' A' ' 94' ' ' VAL . 88.2 mttt -101.91 134.05 45.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.654 -0.869 . . . . 74.11 108.654 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.01 139.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.727 -0.842 . . . . 71.32 108.727 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 28.3 ttpt -107.48 116.65 32.33 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.865 0.84 . . . . 74.25 110.597 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.21 177.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.0 -1.454 . . . . 73.31 110.696 -168.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.32 144.09 28.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.804 -0.443 . . . . 71.22 109.804 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 10.5 t -144.72 175.22 10.33 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.233 -0.654 . . . . 73.34 109.233 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 78.3 m-85 -110.43 119.48 39.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.273 0.358 . . . . 74.14 110.272 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 54' ' ' ILE . 34.8 m -109.84 -173.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.918 -0.771 . . . . 60.44 108.918 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.497 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 61.1 t-105 -99.13 122.71 42.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.018 -0.734 . . . . 74.41 109.018 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' A' ' 87' ' ' GLU . 26.8 m -65.61 -35.89 76.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 CA-C-O 121.363 0.601 . . . . 74.44 111.401 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 114' ' ' ASP . 5.0 t30 -88.18 15.75 7.12 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.979 1.312 . . . . 71.22 109.506 -173.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.7 ptpp? -47.43 -14.87 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 126.859 2.064 . . . . 72.35 115.048 -171.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -90.4 6.8 41.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.828 0.347 . . . . 72.23 111.825 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' HB3' ' ND2' ' A' ' 111' ' ' ASN . 3.1 p30 -85.65 160.07 54.04 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.911 -1.144 . . . . 75.1 107.911 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.18 99.47 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.053 1.836 . . . . 63.21 110.827 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.692 ' HD3' ' H ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.65 -0.704 . . . . 74.03 111.366 -176.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.4 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 49.2 ttm . . . . . 0 C--N 1.304 -1.378 0 CA-C-N 114.486 -1.234 . . . . 74.42 111.707 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 128' ' ' VAL . 8.5 tp10 . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 107.128 -1.434 . . . . 64.03 107.128 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -57.74 -28.67 64.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.902 -1.045 . . . . 74.45 111.364 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -57.74 -49.08 77.77 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.234 0.457 . . . . 73.31 112.234 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 125' ' ' GLU . 18.8 m -72.24 -27.68 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.329 -0.548 . . . . 73.52 110.232 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 125' ' ' GLU . 88.6 t -68.44 -28.29 39.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.246 -0.888 . . . . 54.31 110.954 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -99.4 -28.58 13.21 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.869 -1.132 . . . . 73.23 110.843 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.54 82.45 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.786 -0.643 . . . . 71.42 112.3 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.47 -24.0 66.35 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 113.132 0.79 . . . . 62.42 113.132 -177.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 6.4 tmtt? -76.22 -55.78 5.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 109.604 -0.517 . . . . 64.12 109.604 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -63.86 -32.11 73.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.836 0.68 . . . . 60.05 112.836 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.61 -37.3 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 119.813 -0.755 . . . . 74.43 110.228 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 7.3 mm-40 -62.87 -39.72 95.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.849 -0.426 . . . . 71.32 109.849 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.505 -0.77 . . . . 73.53 110.7 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -67.72 -36.67 81.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.685 -0.487 . . . . 63.32 109.685 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 98.4 mtt180 -64.53 -51.59 62.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.973 -0.558 . . . . 73.4 110.929 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 31.1 mmmt -63.54 -34.54 78.01 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 112.672 0.619 . . . . 73.04 112.672 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.1 ptm -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.521 -0.872 . . . . 73.2 109.717 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 tp -77.36 -50.12 13.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 74.35 111.248 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HG3' ' HA ' ' A' ' 140' ' ' LYS 0.25 0.0 OUTLIER -68.47 -24.61 64.72 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.266 0.469 . . . . 62.54 112.266 -178.287 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -75.41 -43.81 47.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.81 -0.632 . . . . 74.34 110.817 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -69.05 -35.1 76.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.522 0.677 . . . . 74.33 110.01 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 41.1 ttmt -92.52 8.18 39.94 Favored 'General case' 0 CA--C 1.565 1.525 0 CA-C-N 115.498 -0.774 . . . . 72.14 110.554 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 28.0 t-20 -46.71 118.52 5.06 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 123.804 0.842 . . . . 73.51 112.909 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 19.9 Cg_exo -63.18 -24.26 72.75 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.492 2.795 . . . . 74.1 113.577 -176.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.35 -13.77 59.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.462 0.649 . . . . 70.31 110.176 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.905 0 CA-C-N 115.793 -0.639 . . . . 52.12 113.58 176.386 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.1 p . . . . . 0 N--CA 1.409 -2.487 0 N-CA-C 106.864 -1.532 . . . . 61.54 106.864 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.421 ' HD2' ' OE1' ' A' ' 105' ' ' GLU . 78.8 m80 -90.7 143.46 26.71 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.107 0.479 . . . . 71.32 111.739 -175.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.7 m-20 -128.31 122.36 31.43 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.454 -1.313 . . . . 74.24 107.454 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.23 121.28 67.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 121.053 -0.259 . . . . 71.33 110.56 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.4 ' HB2' HG21 ' A' ' 104' ' ' VAL . 64.3 t80 -81.44 112.15 18.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 107.97 -1.122 . . . . 74.1 107.97 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 17' ' ' ILE . 24.1 m -113.49 140.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.531 0.681 . . . . 75.24 112.458 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -131.87 121.79 24.63 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.557 -1.275 . . . . 75.53 107.557 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.3 -58.91 4.17 Favored Glycine 0 C--N 1.302 -1.315 0 C-N-CA 120.895 -0.669 . . . . 72.44 111.441 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.1 m -78.25 145.82 35.23 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.97 -0.381 . . . . 73.13 109.97 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.486 HG21 ' CD1' ' A' ' 67' ' ' ILE . 9.3 mm 70.23 -104.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.8 1.24 . . . . 71.32 108.586 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.259 77.4 mt 49.1 -36.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.651 2.38 . . . . 64.33 117.092 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.19 132.15 29.9 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 109.393 -0.595 . . . . 72.22 109.393 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.4 -40.3 28.71 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.9 3.067 . . . . 61.43 113.543 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -60.16 -47.94 83.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.982 0.42 . . . . 71.42 110.967 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.67 -39.73 85.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.406 0.622 . . . . 23.22 110.402 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 31' ' ' ALA . . . -66.88 -34.94 78.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.81 -0.632 . . . . 64.42 110.947 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -75.62 -26.46 57.81 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.654 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 21' ' ' ALA . 20.9 m -85.34 -23.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.432 -0.507 . . . . 74.24 111.595 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.451 HD13 ' CD1' ' A' ' 78' ' ' PHE . 10.5 tt -82.46 -40.97 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.138 -0.625 . . . . 74.24 111.067 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 31' ' ' ALA . 82.8 mt -83.68 -18.17 38.94 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.293 -0.412 . . . . 74.42 111.27 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 64.18 25.91 13.74 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 106.739 -1.578 . . . . 62.12 106.739 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.4 ttt180 -162.83 166.59 23.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.678 -1.601 . . . . 73.53 106.68 -174.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -75.39 136.44 40.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 118.098 0.408 . . . . 74.11 110.426 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -101.73 141.32 34.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 115.964 -0.562 . . . . 54.12 112.015 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -100.11 110.23 22.51 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.733 -0.667 . . . . 64.24 109.516 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.7 p -115.98 143.42 45.48 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.255 -0.43 . . . . 75.0 110.824 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.41 139.96 35.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.01 -0.737 . . . . 45.43 109.01 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.53 134.12 58.98 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.403 2.069 . . . . 64.23 112.028 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.514 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.88 157.03 42.78 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.377 -0.828 . . . . 64.21 110.246 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.12 127.89 72.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.537 0.684 . . . . 70.15 111.41 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HA ' HG12 ' A' ' 93' ' ' VAL . 28.4 tp -91.39 95.93 10.25 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.405 -0.816 . . . . 71.43 111.809 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 9.9 p-80 -71.94 127.31 32.17 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.318 -0.855 . . . . 74.54 109.148 170.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.95 -17.48 7.63 Favored Glycine 0 C--N 1.292 -1.9 0 C-N-CA 119.69 -1.243 . . . . 51.23 112.651 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -124.93 160.26 29.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.091 0.774 . . . . 72.23 113.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.02 132.85 42.33 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.744 -1.116 . . . . 60.44 109.672 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HB3' HG22 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -92.48 151.48 20.17 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.623 0.971 . . . . 74.43 113.623 -177.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.15 169.86 14.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.846 -1.07 . . . . 73.44 109.539 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 71.5 mmtt -138.46 86.83 2.18 Favored 'General case' 0 CA--C 1.485 -1.524 0 O-C-N 124.055 0.847 . . . . 73.03 111.447 173.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' HG ' ' HD2' ' A' ' 52' ' ' PRO 0.35 0.3 OUTLIER -89.84 97.9 11.46 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.179 -1.008 . . . . 71.51 111.301 174.331 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -66.16 -23.22 66.43 Favored 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.52 1.528 . . . . 75.04 110.792 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.83 -12.91 63.01 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 115.435 -0.802 . . . . 52.14 111.782 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.2 mt -126.26 170.13 10.31 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 125.438 1.495 . . . . 70.14 107.432 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.89 50.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.519 2.978 0 C-N-CA 124.138 3.226 . . . . 73.44 114.981 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.547 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.487 7.8 p90 48.47 63.69 9.91 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 118.94 2.941 . . . . 72.13 118.94 178.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 3.2 Cg_endo -95.98 169.12 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.578 4.185 . . . . 53.21 109.261 172.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 6.0 p -157.41 -167.3 2.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.508 2.723 . . . . 53.0 108.499 -3.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' A' ' 43' ' ' ARG . 47.9 pt -123.74 131.07 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 107.13 -1.433 . . . . 74.13 107.13 162.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.48 HG21 ' SD ' ' A' ' 117' ' ' MET . 31.1 m -145.21 166.77 10.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 116.478 -0.328 . . . . 74.44 111.227 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t 63.6 138.7 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.797 1.639 . . . . 73.02 113.922 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -80.79 75.47 7.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.333 1.063 . . . . 64.13 110.711 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.65 168.25 16.49 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.254 -1.339 . . . . 75.4 110.044 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.8 m -91.69 4.8 51.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.151 0.501 . . . . 73.2 110.942 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.13 -167.84 43.74 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.334 -0.706 . . . . 73.2 111.334 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 39' ' ' HIS . 8.8 ptpp? -153.77 151.57 29.73 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.37 -0.532 . . . . 73.24 112.193 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.4 128.66 71.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 C-N-CA 124.095 0.958 . . . . 73.2 109.109 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -100.97 132.53 46.34 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.526 -0.87 . . . . 65.34 110.594 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.92 -138.08 2.44 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.93 -0.868 . . . . 52.34 110.93 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -142.68 145.23 33.2 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.12 0.568 . . . . 71.21 110.708 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.28 129.79 56.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.673 -0.491 . . . . 73.4 109.673 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.486 ' CD1' HG21 ' A' ' 17' ' ' ILE . 18.1 mt -89.46 110.91 22.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 106.834 -1.543 . . . . 63.21 106.834 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.2 p -99.25 161.84 13.39 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 116.054 -0.521 . . . . 64.04 111.464 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.57 74.25 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.329 -0.462 . . . . 73.04 113.189 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.29 128.93 38.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.652 -0.87 . . . . 72.43 108.652 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -85.3 160.95 19.71 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.823 -0.806 . . . . 64.3 108.823 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -52.36 -37.89 57.34 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.475 0.71 . . . . 72.42 111.846 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.83 63.13 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.924 -0.58 . . . . 34.32 111.464 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.57 -32.07 72.58 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.929 -0.309 . . . . 72.34 111.149 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.11 -33.85 69.56 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.742 -0.663 . . . . 74.02 110.469 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 80' ' ' VAL . 22.1 t-20 -63.58 -28.65 70.08 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.61 -0.723 . . . . 63.13 110.692 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.405 ' ND2' HG13 ' A' ' 26' ' ' ILE . 4.9 t30 -74.91 -31.88 61.66 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.817 -0.808 . . . . 63.22 108.817 -175.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CD1' HD13 ' A' ' 26' ' ' ILE . 96.4 m-85 -64.8 -36.5 84.53 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 115.461 -0.79 . . . . 74.35 110.476 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.21 -31.55 71.15 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.541 0.686 . . . . 73.32 110.116 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 76' ' ' ASN . 55.6 t -75.64 -44.34 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 115.64 -0.709 . . . . 62.41 112.344 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 ' HA ' ' A' ' 78' ' ' PHE . 11.3 tt -72.13 117.72 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.306 0.574 . . . . 63.14 112.24 -175.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.19 3.09 0.49 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.714 1.206 . . . . 75.4 113.978 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.37 53.56 1.54 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 111.358 -0.697 . . . . 53.33 111.358 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -82.37 -40.71 20.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.838 0.351 . . . . 62.43 110.825 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.615 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 5.6 t70 -119.88 28.87 7.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.667 1.222 . . . . 54.14 107.806 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.446 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 70.6 m-85 -113.76 161.16 17.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.48 -1.236 . . . . 75.25 109.707 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -130.48 141.91 50.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.936 -1.135 . . . . 75.45 107.936 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -81.88 121.47 26.5 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.191 -0.458 . . . . 74.51 110.996 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.33 159.64 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.71 -0.677 . . . . 75.54 110.205 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.1 m -97.8 124.56 42.24 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.945 -0.761 . . . . 70.04 108.945 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.13 169.95 13.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.582 -0.896 . . . . 72.5 108.582 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -124.79 120.93 33.13 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.651 -0.87 . . . . 75.32 108.651 -173.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 38' ' ' LEU . 21.0 m -126.0 168.78 18.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-O 121.383 0.611 . . . . 72.31 110.886 -170.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.539 HG22 ' HG2' ' A' ' 101' ' ' LYS . 71.3 t -110.52 118.81 58.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.481 -0.782 . . . . 64.25 109.464 175.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -74.33 95.1 2.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 109.246 -0.65 . . . . 74.42 109.246 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.514 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -48.1 -33.64 8.51 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 126.57 1.948 . . . . 75.04 110.596 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.76 -38.71 70.2 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.458 -0.792 . . . . 64.1 112.013 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -115.61 -10.62 11.83 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.341 0.591 . . . . 72.04 109.748 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.6 t 67.71 22.5 8.93 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.07 0.948 . . . . 62.43 110.074 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -97.17 160.38 14.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.922 -0.581 . . . . 75.22 109.458 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HG2' HG22 ' A' ' 94' ' ' VAL . 5.9 mtpm? -101.85 135.78 42.82 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.613 -0.884 . . . . 52.42 108.613 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.86 145.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.064 0.459 . . . . 73.21 110.345 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -91.94 124.15 35.84 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.238 -1.023 . . . . 74.32 108.238 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 12' ' ' PHE . 32.6 m -136.69 175.59 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.815 0.446 . . . . 73.41 110.691 -175.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.421 ' OE1' ' HD2' ' A' ' 9' ' ' HIS . 45.3 mt-10 -106.8 153.5 22.37 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.972 -0.455 . . . . 74.13 111.057 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 t -154.87 177.9 10.76 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 110.273 -0.269 . . . . 70.43 110.273 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -104.76 119.8 39.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.08 0.952 . . . . 62.51 108.673 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.75 151.88 20.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.553 -0.459 . . . . 73.51 109.913 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.615 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 35.6 t-105 -79.36 127.05 31.61 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.084 -0.709 . . . . 75.31 109.084 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.7 m -72.64 -28.3 27.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.115 0.483 . . . . 63.22 112.236 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 62.5 t30 -79.3 13.21 1.99 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.678 0.791 . . . . 70.24 111.282 -176.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -51.65 -14.86 0.38 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.014 1.857 . . . . 52.32 116.014 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.412 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 9.4 m-20 -72.87 9.96 1.01 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.124 0.488 . . . . 65.13 112.135 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.41 131.82 49.15 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 108.064 -1.087 . . . . 70.41 108.064 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 -15.98 28.48 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.317 2.678 . . . . 74.23 116.457 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -130.6 113.97 14.87 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 117.673 -1.611 . . . . 72.32 114.259 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 55' ' ' VAL . 66.2 mtt . . . . . 0 C--N 1.306 -1.283 0 CA-C-N 114.745 -1.116 . . . . 63.53 109.064 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.7 mt-10 . . . . . 0 C--O 1.217 -0.619 0 N-CA-C 111.791 0.293 . . . . 73.15 111.791 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -60.95 -24.46 66.08 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.909 0.385 . . . . 74.3 111.301 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -58.43 -43.19 88.63 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.281 -0.637 . . . . 74.13 109.281 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 125' ' ' GLU . 17.9 m -84.37 -31.68 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 119.993 -0.683 . . . . 65.2 110.946 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 125' ' ' GLU . 52.2 t -68.18 -39.31 81.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 116.794 -0.185 . . . . 73.12 111.066 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.405 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 1.4 p-80 -67.47 -32.34 73.12 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.413 -0.915 . . . . 73.24 110.254 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.73 83.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 54.43 110.024 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.5 -25.77 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.259 -0.882 . . . . 71.04 112.249 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.532 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -76.68 -57.37 3.89 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.231 -1.396 . . . . 64.5 107.231 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 92.0 m-85 -61.79 -33.5 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.503 1.297 . . . . 63.31 114.503 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.461 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.8 p -58.1 -41.94 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.33 -0.548 . . . . 63.45 110.66 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 24.0 mm-40 -66.12 -39.35 89.83 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.172 -0.467 . . . . 54.31 110.494 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.7 m -59.32 -49.6 77.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 72.42 110.475 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -57.77 -41.61 82.38 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 121.134 -0.226 . . . . 64.33 111.247 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 82.5 mtp180 -63.27 -47.92 80.32 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.572 0.545 . . . . 71.33 111.193 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 73.1 mmtt -65.35 -42.97 92.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.747 0.308 . . . . 74.4 110.881 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.6 mmt -61.79 -35.82 79.3 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.052 -0.722 . . . . 65.25 109.052 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.77 -39.09 90.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.537 -0.912 . . . . 74.03 108.537 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -64.06 -47.84 78.6 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.555 -0.293 . . . . 74.04 110.798 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -69.95 -28.66 65.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.611 0.967 . . . . 70.13 113.611 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -82.0 -47.76 12.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.972 0.36 . . . . 51.22 111.972 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.0 -26.94 30.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.227 0.455 . . . . 73.41 112.227 -175.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -136.03 78.16 47.78 Favored Pre-proline 0 C--N 1.313 -1.007 0 C-N-CA 120.605 -0.438 . . . . 71.22 111.885 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.71 -29.71 35.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.99 1.793 . . . . 73.3 109.875 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -87.56 0.11 56.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.308 -0.86 . . . . 74.43 109.763 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.968 0 N-CA-C 109.984 -1.246 . . . . 64.23 109.984 176.936 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 N--CA 1.433 -1.29 0 CA-C-O 121.772 0.796 . . . . 53.25 112.253 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -107.97 156.35 19.32 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.75 -1.113 . . . . 73.32 111.034 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.3 m-20 -125.14 122.91 38.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.144 -1.428 . . . . 75.11 107.144 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 19.5 t -119.78 124.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 120.753 -0.379 . . . . 72.25 110.976 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.509 ' HB2' HG21 ' A' ' 104' ' ' VAL . 73.4 t80 -84.02 113.91 21.34 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.825 -0.806 . . . . 74.32 108.825 175.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -125.17 160.54 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.518 0.675 . . . . 73.33 111.973 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -145.71 -55.67 0.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.815 -1.55 . . . . 71.51 106.815 175.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.5 63.27 0.6 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.513 -1.035 . . . . 75.2 110.513 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 m -153.97 -79.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.192 . . . . 71.4 111.033 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 67' ' ' ILE . 33.2 pt -145.78 86.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 122.173 0.987 . . . . 51.44 111.312 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 65' ' ' LYS . 77.7 mt -99.63 -5.19 29.39 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.474 -0.766 . . . . 63.24 109.223 175.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.78 130.81 24.6 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.258 -0.883 . . . . 65.23 111.046 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.62 -42.56 18.77 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.174 3.249 . . . . 71.14 114.417 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.38 83.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.744 0.276 . . . . 44.55 111.744 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.7 p -77.26 -30.87 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.288 0.566 . . . . 65.34 111.044 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.397 0.618 . . . . 71.14 109.377 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -74.85 -5.69 44.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.644 -0.707 . . . . 62.22 112.197 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.1 m -105.98 -15.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.805 -0.758 . . . . 72.3 111.223 177.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.587 HG21 HD13 ' A' ' 17' ' ' ILE . 10.0 tt -92.72 -42.47 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 121.468 0.651 . . . . 74.44 110.333 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 95.3 mt -87.08 -27.24 23.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.882 -0.599 . . . . 75.34 110.002 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 73.17 3.3 4.61 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.479 1.133 . . . . 75.04 108.122 -170.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.9 mmt180 -126.07 154.81 42.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.195 -2.15 . . . . 72.32 105.195 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -96.96 110.41 22.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.677 -1.209 . . . . 71.22 108.75 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 156.29 17.67 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.882 -0.599 . . . . 74.54 110.532 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.66 125.54 41.2 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.516 0.674 . . . . 54.21 112.816 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 p -100.44 143.94 30.03 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.582 -1.19 . . . . 72.42 109.532 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.7 141.66 38.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.304 -0.999 . . . . 74.4 108.304 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.483 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 2.1 Cg_endo -65.44 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.001 1.801 . . . . 75.44 111.637 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -150.17 156.36 41.46 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.691 -0.686 . . . . 75.42 110.444 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -122.44 127.84 75.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-O 121.399 0.619 . . . . 73.03 111.378 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 93' ' ' VAL . 23.7 tp -90.49 97.86 11.43 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.206 -0.906 . . . . 72.34 109.429 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.532 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 6.3 p80 -70.63 132.3 45.23 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.014 -0.994 . . . . 71.43 110.018 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.61 38.57 Favored Glycine 0 C--O 1.215 -1.044 0 C-N-CA 118.844 -1.646 . . . . 74.22 113.993 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -101.99 143.35 31.95 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 113.768 1.025 . . . . 72.01 113.768 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.579 ' HB2' ' CB ' ' A' ' 58' ' ' ASP . 2.9 t-160 -104.63 122.55 45.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.386 -1.279 . . . . 53.25 108.379 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -89.53 115.86 27.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.189 -1.041 . . . . 71.41 108.189 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.401 ' HD2' ' O ' ' A' ' 117' ' ' MET . 26.3 m-85 -81.3 141.86 33.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.6 -0.518 . . . . 62.14 109.6 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -97.54 124.54 41.82 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.37 0.605 . . . . 75.34 111.291 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.77 133.1 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.835 -0.62 . . . . 62.33 110.079 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.89 -41.08 7.38 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 108.08 -1.082 . . . . 54.0 108.08 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.56 -21.15 77.62 Favored Glycine 0 N--CA 1.425 -2.096 0 CA-C-N 114.234 -1.348 . . . . 53.04 112.156 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 6.1 mp -107.67 151.34 41.04 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 108.83 -0.804 . . . . 74.41 108.83 177.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.52 -61.76 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.832 2.355 . . . . 74.43 115.62 -172.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.685 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 4.1 p90 -132.62 16.33 0.05 OUTLIER Pre-proline 0 CA--C 1.585 2.299 0 N-CA-C 117.208 2.299 . . . . 75.24 117.208 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -89.24 164.29 5.62 Favored 'Trans proline' 0 C--N 1.369 1.609 0 CA-C-N 122.129 1.796 . . . . 74.13 112.005 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 20.6 p -155.0 167.44 30.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.484 1.914 . . . . 74.03 108.034 -6.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 131.37 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.775 -0.77 . . . . 51.21 109.537 170.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 112' ' ' LYS . 8.1 p -157.52 170.51 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 108.572 -0.899 . . . . 73.01 108.572 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 55' ' ' VAL . 25.6 m 77.67 145.45 0.09 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.47 1.106 . . . . 53.52 112.83 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.1 t -88.73 76.23 8.07 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.225 -1.398 . . . . 75.24 107.225 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.579 ' CB ' ' HB2' ' A' ' 42' ' ' HIS . 17.9 t70 -84.22 175.24 9.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.26 -1.791 . . . . 74.44 109.325 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 m -83.75 -16.58 44.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.498 . . . . 73.4 109.706 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.62 170.24 53.94 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 115.391 -0.822 . . . . 45.34 113.602 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 42.3 mtmt -137.82 146.75 43.89 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.399 -1.334 . . . . 71.44 107.399 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.86 123.42 61.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.528 -0.545 . . . . 73.35 109.528 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -95.93 124.86 40.12 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.517 -0.549 . . . . 64.43 109.517 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.99 -141.89 3.26 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.101 -0.8 . . . . 34.22 111.101 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 48.9 mtmt -140.17 147.43 40.12 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 120.874 0.368 . . . . 75.42 111.622 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.1 m -104.87 133.71 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 115.454 -0.794 . . . . 75.45 109.551 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.749 HD13 HD11 ' A' ' 17' ' ' ILE . 18.3 mt -88.37 130.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 106.023 -1.843 . . . . 64.41 106.023 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.3 p -115.01 161.32 18.49 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.732 -0.787 . . . . 62.25 111.415 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 33.66 67.67 Favored Glycine 0 N--CA 1.439 -1.114 0 O-C-N 123.543 0.527 . . . . 75.11 113.211 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -90.39 122.37 41.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.964 0.382 . . . . 63.13 110.633 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.451 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 36.8 m -76.62 158.7 30.88 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.458 -0.571 . . . . 75.1 109.458 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.79 -42.93 65.49 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.461 0.541 . . . . 72.42 112.461 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.2 -40.71 77.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.29 0.567 . . . . 73.5 110.141 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 4.4 mm-40 -68.37 -37.26 80.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.709 -1.132 . . . . 64.33 109.099 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.95 -33.5 74.4 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.404 1.082 . . . . 70.02 110.155 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -62.86 -27.14 69.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.158 -0.928 . . . . 70.34 113.16 179.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -32.89 71.4 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.191 -1.04 . . . . 64.31 108.191 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -70.98 -28.59 64.56 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.29 0.566 . . . . 75.03 109.532 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.548 ' HA ' HH12 ' A' ' 88' ' ' ARG . 28.6 t70 -70.94 -36.13 72.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.614 -0.721 . . . . 60.41 109.848 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 76' ' ' ASN . 72.4 t -66.6 -22.51 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.229 -0.896 . . . . 75.31 111.511 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.4 103.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.337 0.589 . . . . 75.32 110.488 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.389 0.1 OUTLIER 64.39 -58.39 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.937 2.495 . . . . 73.42 112.631 -174.001 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.51 1.66 16.98 Favored Glycine 0 C--O 1.234 0.132 0 C-N-CA 123.191 0.424 . . . . 75.03 113.638 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -83.92 -44.17 14.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.649 0.24 . . . . 75.54 111.649 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.522 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 2.1 t70 -136.94 16.12 3.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 118.626 -1.23 . . . . 73.3 111.532 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.65 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 30.6 m-85 -112.56 151.88 29.51 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.224 -0.591 . . . . 63.42 110.723 175.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -131.56 159.65 37.57 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.172 -0.922 . . . . 73.14 109.292 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.548 HH12 ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -90.11 113.74 25.53 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.332 -0.395 . . . . 74.44 109.954 -178.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.62 159.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.662 0.267 . . . . 63.1 110.859 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.3 m -102.57 129.78 49.24 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.066 -0.716 . . . . 73.25 109.066 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.07 168.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.345 -1.354 . . . . 64.01 107.345 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -120.35 131.97 55.08 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.473 -1.291 . . . . 50.34 108.662 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.419 HG12 ' HB2' ' A' ' 38' ' ' LEU . 18.6 m -125.99 168.13 19.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.243 0.544 . . . . 44.41 109.617 -175.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 101' ' ' LYS . 69.3 t -109.78 120.1 60.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 115.658 -0.701 . . . . 64.14 109.962 177.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 77.3 ttt180 -67.41 97.23 0.55 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.799 -1.556 . . . . 75.42 106.799 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.454 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 25.5 ttt -48.74 -45.82 40.14 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 127.088 2.155 . . . . 53.54 113.664 -169.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.4 -34.15 75.51 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.586 0.587 . . . . 74.13 112.586 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -103.48 -9.29 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.306 0.574 . . . . 65.43 111.272 -175.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m 64.8 25.58 12.92 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.793 0.837 . . . . 63.33 111.653 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -102.58 161.69 13.52 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.561 -0.903 . . . . 72.54 108.561 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.555 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.3 mtmt -104.6 135.85 45.24 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.953 -0.758 . . . . 63.21 108.953 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.52 135.86 48.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-O 121.139 0.495 . . . . 63.1 109.855 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -87.16 126.41 34.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.143 -1.428 . . . . 71.21 107.143 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 12' ' ' PHE . 32.9 m -137.58 169.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.977 0.417 . . . . 73.11 111.123 -174.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.4 149.39 24.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.384 -0.371 . . . . 64.23 110.138 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 t -153.01 176.86 11.42 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.776 -0.453 . . . . 71.23 109.776 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.461 ' HD2' ' CE1' ' A' ' 86' ' ' TYR . 15.1 p90 -107.35 120.01 40.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 125.08 1.352 . . . . 75.13 110.407 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.77 171.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 O-C-N 122.096 -0.377 . . . . 50.3 110.077 175.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.522 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 23.7 t-105 -97.7 121.2 39.34 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.483 -0.562 . . . . 74.23 109.483 -168.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.427 ' HA ' ' HZ2' ' A' ' 112' ' ' LYS . 33.5 m -73.12 -23.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 112.425 0.528 . . . . 74.54 112.425 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -76.42 11.81 1.45 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.352 0.596 . . . . 71.22 109.959 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.581 ' HB3' HG21 ' A' ' 55' ' ' VAL . 10.5 ptpp? -59.31 -20.07 51.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.298 1.039 . . . . 72.22 112.686 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.33 -24.67 50.78 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.253 0.549 . . . . 43.32 110.481 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.1 145.9 41.65 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.188 -1.782 . . . . 62.43 106.188 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -31.28 125.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 124.192 3.262 . . . . 75.11 112.687 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.82 114.33 13.16 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.477 0.656 . . . . 72.24 109.973 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.401 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 28.0 ttt . . . . . 0 N--CA 1.437 -1.125 0 N-CA-C 114.47 1.285 . . . . 73.35 114.47 -171.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 129' ' ' VAL . 16.5 tp10 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 108.738 -0.838 . . . . 73.43 108.738 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -55.3 -49.73 71.38 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-N 115.436 -0.802 . . . . 74.41 110.852 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -64.7 -40.07 94.74 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.752 -0.658 . . . . 73.13 112.225 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 m -70.78 -32.41 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.918 -0.713 . . . . 74.43 111.734 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.573 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 88.3 t -67.93 -45.23 84.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 109.009 -0.737 . . . . 74.41 109.009 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -70.52 -39.55 74.02 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.184 -0.606 . . . . 74.24 111.67 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.21 -54.7 42.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.662 0.245 . . . . 62.33 111.662 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 42.5 mt-10 -62.01 -38.16 87.59 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.078 0.466 . . . . 74.24 111.83 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -69.59 -43.68 72.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.555 -0.748 . . . . 64.41 111.965 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -72.24 -40.53 67.65 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.266 0.839 . . . . 72.24 113.266 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.09 -34.2 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 118.952 -0.546 . . . . 64.35 112.421 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 45.7 mt-10 -55.91 -51.82 66.28 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.204 -1.035 . . . . 74.04 108.204 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.3 m -58.63 -50.43 73.86 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.084 -1.416 . . . . 52.55 110.76 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -59.97 -50.48 73.57 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 112.166 0.432 . . . . 75.14 112.166 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -63.25 -53.41 53.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.669 0.618 . . . . 71.31 112.669 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -66.23 -31.73 72.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 112.096 0.406 . . . . 64.41 112.096 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.5 mmt -76.17 -35.56 59.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 119.998 -0.681 . . . . 71.1 109.651 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.8 tp -63.94 -36.67 84.73 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 122.741 0.417 . . . . 63.43 110.599 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.253 -0.43 . . . . 75.23 111.358 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -76.24 -35.38 59.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.815 -0.63 . . . . 72.35 111.017 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.98 -39.6 61.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 75.03 112.135 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -99.62 9.36 43.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.32 0.581 . . . . 74.11 109.942 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 38.3 t30 -38.89 117.36 1.04 Allowed Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.592 1.557 . . . . 54.35 112.734 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 36.9 Cg_exo -59.53 -19.59 52.94 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 123.907 3.071 . . . . 71.12 113.245 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -74.98 -7.09 52.63 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.206 -0.452 . . . . 54.22 111.551 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.565 0 C-N-CA 121.066 -0.588 . . . . 64.45 113.474 175.504 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.422 -1.847 0 CA-C-O 121.804 0.811 . . . . 71.25 112.296 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -130.3 157.67 41.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.692 -1.14 . . . . 75.52 109.891 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.578 ' HB2' HG12 ' A' ' 104' ' ' VAL . 32.7 m-80 -121.87 127.82 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.765 -0.828 . . . . 75.14 108.765 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.42 120.95 64.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 110.126 -0.324 . . . . 72.13 110.126 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.61 118.83 24.09 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 122.59 0.356 . . . . 72.21 110.275 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.35 160.61 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.314 -0.625 . . . . 73.4 109.314 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -131.15 17.21 5.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.846 0.831 . . . . 74.54 109.998 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.38 159.38 30.07 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 119.897 -1.144 . . . . 73.3 112.603 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.417 ' HB3' HG11 ' A' ' 22' ' ' VAL . 18.3 m 67.11 -74.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.218 1.407 . . . . 73.51 113.946 175.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.585 HG21 HD13 ' A' ' 67' ' ' ILE . 26.1 mt -70.25 -5.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.641 0.777 . . . . 73.31 111.757 -171.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -65.87 -30.12 70.68 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.163 -0.681 . . . . 75.13 109.163 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.07 132.21 25.05 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 115.155 -0.93 . . . . 75.42 110.446 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.54 -44.53 4.44 Favored 'Trans proline' 0 C--N 1.359 1.103 1 C-N-CA 125.362 4.041 . . . . 71.45 115.375 -175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -56.68 -42.52 79.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.888 0.699 . . . . 31.13 112.888 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.506 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -76.18 -35.85 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.279 0.561 . . . . 75.34 110.292 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -66.74 -32.85 74.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.451 0.643 . . . . 73.44 109.728 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -73.63 -20.82 60.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.607 -0.724 . . . . 65.14 111.837 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.6 m -87.71 -23.89 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.381 -0.928 . . . . 74.35 111.195 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.434 ' C ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -87.01 -46.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 116.508 -0.314 . . . . 62.13 110.904 178.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.587 HD12 ' HB2' ' A' ' 31' ' ' ALA . 82.1 mt -93.86 -14.6 25.91 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.793 -0.363 . . . . 74.23 111.958 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.0 t70 73.56 6.86 5.07 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.494 1.14 . . . . 72.41 109.191 -175.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.2 mtp180 -144.22 163.81 32.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.22 1.408 . . . . 62.14 107.727 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.6 p -76.69 122.64 24.98 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.21 -0.293 . . . . 74.33 110.21 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.587 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -87.44 156.91 19.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 120.642 0.258 . . . . 54.34 111.052 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -99.93 109.86 22.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.176 -0.609 . . . . 74.1 110.843 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -99.92 142.09 31.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.171 -1.048 . . . . 71.31 108.171 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.76 147.54 57.36 Favored Pre-proline 0 C--N 1.289 -2.047 0 N-CA-C 108.751 -0.833 . . . . 74.21 108.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -59.51 135.73 66.65 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.573 2.182 . . . . 64.42 112.219 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.81 156.46 41.31 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.137 -0.69 . . . . 60.1 109.137 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.509 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.2 p -123.75 126.53 72.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 118.704 -1.198 . . . . 74.41 111.676 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 93' ' ' VAL . 25.1 tp -92.17 90.88 7.51 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.729 0.776 . . . . 74.23 110.864 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.9 p80 -73.08 124.91 26.48 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 114.556 -1.202 . . . . 72.13 109.395 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.45 -16.8 8.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.369 -0.919 . . . . 63.04 112.699 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 62' ' ' VAL . 38.4 m-85 -122.27 155.04 36.74 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 110.108 -0.33 . . . . 63.51 110.108 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.443 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 5.4 t60 -129.27 135.95 49.44 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 37.2 ttp180 -88.16 127.18 35.43 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.128 -1.434 . . . . 74.32 107.128 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -100.65 123.05 44.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 106.188 -1.782 . . . . 74.31 106.188 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -76.3 94.03 3.52 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-O 122.014 0.911 . . . . 74.43 109.591 -173.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 10.5 mp -81.07 98.76 8.14 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.057 -1.429 . . . . 75.2 112.709 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.551 ' O ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.76 84.36 7.37 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 123.139 1.447 . . . . 72.14 109.276 172.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.91 -53.84 0.13 Allowed Glycine 0 N--CA 1.405 -3.427 0 CA-C-N 113.679 -1.601 . . . . 74.23 110.016 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -93.45 166.99 14.87 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.563 -0.532 . . . . 72.32 109.563 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.91 135.08 1.54 Allowed 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 122.599 2.199 . . . . 64.23 112.73 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.617 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 38.9 p90 44.97 47.26 3.59 Favored Pre-proline 0 N--CA 1.513 2.676 0 N-CA-C 115.383 1.623 . . . . 71.23 115.383 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 51' ' ' TYR 0.265 37.7 Cg_endo -114.93 157.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.231 3.287 . . . . 74.33 114.68 -175.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 91.9 m -153.76 166.55 32.5 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 131.684 3.994 . . . . 65.14 104.3 -13.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.419 HG22 ' HA ' ' A' ' 43' ' ' ARG . 49.1 pt -123.19 145.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 119.978 1.263 . . . . 63.13 112.102 175.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -144.82 150.07 16.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 106.763 -1.569 . . . . 64.32 106.763 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 p -94.44 94.34 8.18 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 121.452 0.644 . . . . 64.34 110.283 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -134.82 -57.43 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.823 -1.547 . . . . 64.44 106.823 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -82.23 139.1 34.44 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.839 -1.073 . . . . 64.54 108.622 174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -78.77 15.09 1.13 Allowed 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.57 0.952 . . . . 62.2 113.57 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.24 -172.06 5.44 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 121.514 0.508 . . . . 64.33 113.461 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HE2' HG21 ' A' ' 37' ' ' VAL . 19.8 ptmt -139.42 140.06 37.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.472 -0.566 . . . . 74.13 109.472 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 41' ' ' TYR . 93.6 t -108.82 124.07 65.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 123.189 0.596 . . . . 73.04 109.575 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.417 HD21 ' CB ' ' A' ' 132' ' ' GLU . 3.4 p-10 -90.27 144.62 25.68 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.475 -1.306 . . . . 74.44 107.475 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.63 -150.38 6.62 Favored Glycine 0 C--N 1.279 -2.619 0 N-CA-C 110.012 -1.235 . . . . 74.24 110.012 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -135.36 145.35 47.29 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.633 -0.827 . . . . 73.35 109.939 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.4 m -103.69 134.56 44.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.517 -0.765 . . . . 65.22 109.435 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.585 HD13 HG21 ' A' ' 17' ' ' ILE . 11.0 mt -86.5 110.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 104.486 -2.413 . . . . 73.33 104.486 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.453 HG22 ' OD1' ' A' ' 10' ' ' ASN . 75.0 p -98.05 162.07 13.41 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.915 -0.584 . . . . 73.14 111.149 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 34.4 70.47 Favored Glycine 0 N--CA 1.436 -1.304 0 O-C-N 123.604 0.565 . . . . 54.55 112.866 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.43 121.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 120.55 -0.46 . . . . 54.22 109.936 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.702 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 42.7 m -81.64 158.61 24.25 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.642 -0.873 . . . . 70.42 108.642 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.6 -40.13 62.37 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.798 1.036 . . . . 73.14 113.798 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.64 -32.88 64.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.632 0.73 . . . . 73.11 110.656 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.702 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 3.8 mp0 -73.43 -31.41 63.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.031 -0.986 . . . . 73.24 110.251 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.91 -36.48 83.5 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.607 -1.257 . . . . 73.31 107.607 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.67 -28.11 53.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.416 -1.266 . . . . 74.34 111.913 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.43 ' ND2' HG12 ' A' ' 26' ' ' ILE . 64.2 t30 -75.29 -30.5 60.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.558 -0.857 . . . . 64.14 109.855 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 17' ' ' ILE . 64.7 m-85 -65.72 -34.28 77.82 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.446 0.641 . . . . 64.32 109.822 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.77 -38.43 90.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.838 -1.073 . . . . 64.35 110.526 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.5 -43.6 48.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.532 -0.758 . . . . 75.1 111.307 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -68.0 -64.06 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.829 1.048 . . . . 54.2 113.829 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.16 69.47 1.02 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.633 0.73 . . . . 73.4 110.931 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.36 15.44 2.29 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.055 -0.975 . . . . 64.2 111.776 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -82.59 -42.53 18.15 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.87 0.322 . . . . 73.04 111.87 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.01 14.0 6.27 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.602 -1.259 . . . . 44.42 107.602 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -128.28 157.02 42.09 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.172 -1.418 . . . . 74.41 107.172 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HB3' HG23 ' A' ' 110' ' ' VAL . 11.7 pt-20 -129.35 146.68 51.18 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.229 -0.656 . . . . 54.43 109.229 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -83.75 117.09 23.02 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.502 -0.555 . . . . 71.23 109.502 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.07 159.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-O 120.84 0.352 . . . . 55.32 110.982 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.6 m -91.09 129.91 37.04 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 108.314 -0.995 . . . . 63.24 108.314 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.57 168.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.543 -1.28 . . . . 63.03 107.543 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -121.3 128.62 52.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.687 -1.205 . . . . 74.11 109.783 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 38' ' ' LEU . 17.0 m -127.19 168.37 20.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.831 -0.622 . . . . 61.23 109.66 -176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 101' ' ' LYS . 75.0 t -103.44 112.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.214 -1.032 . . . . 44.35 108.214 172.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -80.51 99.66 8.16 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.738 -1.208 . . . . 73.54 107.738 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.503 ' SD ' ' HG3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.06 -18.08 59.52 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.959 1.304 . . . . 54.51 110.085 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -46.78 -37.33 8.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.602 0.761 . . . . 72.41 111.101 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -137.39 10.13 2.96 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 108.277 -1.009 . . . . 74.13 108.277 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t 60.01 26.41 15.71 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.966 0.889 . . . . 65.41 110.079 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -93.16 160.7 14.73 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.397 -0.82 . . . . 73.21 109.425 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 7.1 mptt -104.31 128.79 52.16 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 106.935 -1.506 . . . . 74.03 106.935 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.74 142.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.389 0.614 . . . . 52.13 111.803 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -89.38 125.81 35.29 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.287 -1.746 . . . . 73.33 106.287 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 10' ' ' ASN . 18.5 m -133.2 174.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 120.587 0.232 . . . . 65.53 110.985 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -100.63 153.29 19.53 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.101 -1.074 . . . . 65.23 108.101 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -155.62 174.72 14.88 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.029 -0.73 . . . . 71.03 109.029 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -106.95 119.19 38.7 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.974 -1.121 . . . . 72.34 107.974 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.4 HG12 HG13 ' A' ' 54' ' ' ILE . 35.7 m -113.36 163.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 109.531 -0.544 . . . . 73.52 109.531 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -70.1 121.92 18.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.792 -0.818 . . . . 52.21 108.792 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.0 p -68.1 -20.58 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.231 0.538 . . . . 70.42 111.438 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 114' ' ' ASP . 8.2 t30 -89.13 12.13 16.63 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.648 -0.705 . . . . 71.4 110.422 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -51.81 -19.73 1.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.997 1.851 . . . . 74.44 115.997 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.33 -20.89 36.45 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.881 0.848 . . . . 65.31 109.854 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.506 ' HB3' ' ND2' ' A' ' 111' ' ' ASN . 14.5 t70 -91.66 139.09 24.87 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 107.844 -1.169 . . . . 74.04 107.844 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 8.8 Cg_exo -71.85 78.56 1.73 Allowed 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 121.972 1.781 . . . . 75.21 111.984 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -134.53 114.57 12.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 116.084 -0.507 . . . . 52.53 110.171 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.468 0.471 0 O-C-N 124.405 1.066 . . . . 64.21 112.86 -178.899 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 129' ' ' VAL . 10.4 tp10 . . . . . 0 N--CA 1.432 -1.337 0 N-CA-C 109.073 -0.714 . . . . 62.22 109.073 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -71.44 -30.58 66.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.042 -1.463 . . . . 75.2 110.711 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -57.46 -46.17 83.93 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.847 -0.615 . . . . 75.2 109.547 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.31 -38.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.494 -0.482 . . . . 75.13 110.987 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 125' ' ' GLU . 92.2 t -67.63 -32.39 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 111.928 0.344 . . . . 71.24 111.928 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -83.06 -37.99 23.13 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 117.82 -1.552 . . . . 72.0 111.079 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.68 76.87 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.632 0.253 . . . . 42.33 111.363 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 22.8 mm-40 -64.35 -37.86 88.99 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 116.156 -0.474 . . . . 62.15 110.639 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -56.03 -42.53 76.65 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 116.245 -0.434 . . . . 53.43 111.133 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -76.45 -44.1 37.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 112.756 0.65 . . . . 73.53 112.756 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 132' ' ' GLU . 14.4 p -59.89 -37.28 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.024 -0.67 . . . . 74.42 111.226 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.594 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 91.9 mt-10 -58.34 -43.68 88.41 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.993 -0.743 . . . . 73.24 108.993 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.9 m -60.84 -50.19 74.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.19 -0.914 . . . . 70.51 110.535 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -63.86 -34.68 78.48 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 111.879 0.326 . . . . 73.24 111.879 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 76.4 mtp180 -63.84 -52.6 59.35 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.67 0.271 . . . . 72.12 110.352 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.503 ' HG3' ' SD ' ' A' ' 96' ' ' MET . 31.3 mmmt -60.95 -44.56 97.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.915 0.709 . . . . 74.45 112.915 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.9 mmt -63.08 -41.34 99.39 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.77 -0.372 . . . . 75.12 110.445 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.27 -46.31 84.25 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.286 -0.415 . . . . 71.14 110.72 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.39 -34.38 77.83 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.173 -0.611 . . . . 73.52 112.013 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -68.86 -29.49 67.8 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.437 0.532 . . . . 73.25 112.437 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.94 -47.03 13.22 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.02 0.438 . . . . 74.05 111.181 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -79.75 -31.89 41.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 73.23 111.73 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -117.79 117.15 35.96 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.939 0.399 . . . . 64.12 111.889 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 -28.72 63.1 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.599 2.199 . . . . 61.24 110.522 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -73.15 -5.21 37.69 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.008 -0.996 . . . . 75.44 112.261 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.495 0 N-CA-C 110.405 -1.078 . . . . 33.34 110.405 176.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.326 0.584 . . . . 71.14 109.96 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.508 ' CG ' HD12 ' A' ' 75' ' ' LEU . 69.6 m80 -93.38 156.59 16.69 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.815 -0.629 . . . . 72.44 111.694 -173.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.496 ' HB2' HG12 ' A' ' 104' ' ' VAL . 91.4 m-20 -129.0 133.53 47.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.533 -1.284 . . . . 65.03 107.533 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.5 121.54 63.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.762 -0.375 . . . . 74.2 110.416 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.495 ' HB2' HG21 ' A' ' 104' ' ' VAL . 59.9 t80 -81.9 111.5 18.16 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.053 -1.091 . . . . 75.51 108.053 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 17' ' ' ILE . 95.8 t -120.19 142.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-O 121.488 0.661 . . . . 73.22 110.831 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -99.47 115.44 29.31 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.166 -1.05 . . . . 74.31 108.166 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.19 -68.09 2.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 116.096 1.199 . . . . 45.11 116.096 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.3 t -40.12 -81.26 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.669 2.1 . . . . 73.41 116.669 -167.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.588 ' HB ' HD11 ' A' ' 67' ' ' ILE . 3.1 mp -93.92 27.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 122.074 0.94 . . . . 63.51 109.552 -173.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 65' ' ' LYS . 18.9 mt -74.52 -15.89 60.85 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.406 -0.809 . . . . 73.44 111.654 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.26 134.1 19.87 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 114.872 -1.058 . . . . 71.13 109.975 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.69 -31.6 41.75 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.753 2.968 . . . . 74.2 114.011 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.29 80.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.982 0.42 . . . . 72.13 111.332 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.596 ' O ' HG22 ' A' ' 25' ' ' VAL . 47.8 t -77.36 -34.32 20.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.151 -0.685 . . . . 63.44 109.151 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.31 75.66 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.87 -0.789 . . . . 71.02 108.87 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -71.08 -12.11 61.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.519 -0.764 . . . . 50.35 111.602 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 22' ' ' VAL . 10.6 m -97.94 -35.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 119.665 -0.814 . . . . 74.13 110.513 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.555 HG12 ' ND2' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -80.47 -48.44 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 120.782 0.325 . . . . 73.13 110.909 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 81.0 mt -90.12 -18.01 26.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.365 -0.606 . . . . 51.11 109.365 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 33.3 t70 70.64 8.76 6.69 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.896 1.332 . . . . 70.2 109.283 -175.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -142.0 143.7 33.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 113.757 -1.565 . . . . 73.53 107.721 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -76.45 117.05 17.72 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.545 0.212 . . . . 55.14 111.512 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.423 ' HB2' ' CD1' ' A' ' 27' ' ' LEU . . . -105.72 158.8 16.47 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 116.074 -0.512 . . . . 72.45 110.018 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.94 131.81 46.64 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.694 -0.685 . . . . 72.21 111.965 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.3 p -103.46 143.81 32.22 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.312 -0.858 . . . . 71.42 110.272 174.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.4 144.94 51.07 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.394 -0.595 . . . . 71.34 109.394 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -68.24 133.77 29.5 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.035 1.823 . . . . 53.11 112.875 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.08 156.61 41.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.156 -0.929 . . . . 65.32 109.397 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.14 129.99 74.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.459 0.647 . . . . 73.13 110.86 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.4 ' HA ' HG12 ' A' ' 93' ' ' VAL . 20.9 tp -88.29 117.3 27.1 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.416 -0.811 . . . . 71.12 109.75 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -94.08 128.84 40.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.059 -0.519 . . . . 52.23 110.507 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 56' ' ' SER . . . 111.67 -4.54 27.72 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.029 -1.081 . . . . 51.02 112.561 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.494 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 63.8 m-85 -124.82 147.42 48.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.242 0.46 . . . . 74.31 112.242 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -117.83 130.06 56.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.56 -1.274 . . . . 72.4 107.56 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.467 ' HA ' HG22 ' A' ' 54' ' ' ILE . 19.4 ptt180 -87.85 140.42 29.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.794 0.438 . . . . 72.22 110.804 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -112.22 150.64 30.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.774 -0.37 . . . . 70.22 111.235 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.46 100.66 13.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.66 0.743 . . . . 72.52 111.91 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.67 72.97 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 122.025 0.917 . . . . 53.32 109.915 172.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -83.14 8.78 12.11 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 113.968 1.099 . . . . 72.03 113.968 -175.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.41 -19.19 74.57 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.971 -2.052 . . . . 64.44 107.971 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 3.4 mm? -98.11 168.53 9.81 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 105.498 -2.038 . . . . 71.32 105.498 172.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 99.8 Cg_exo -42.47 -65.79 0.18 Allowed 'Trans proline' 0 C--N 1.365 1.431 0 C-N-CA 122.271 1.981 . . . . 61.44 113.891 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.605 ' H ' ' HD2' ' A' ' 52' ' ' PRO . 33.7 m-85 -164.62 -36.44 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 125.366 1.466 . . . . 74.42 113.959 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' ' H ' ' A' ' 51' ' ' TYR . 63.3 Cg_exo -48.96 166.69 0.15 Allowed 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.33 2.02 . . . . 65.14 112.504 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.6 p -135.69 -171.7 2.91 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.445 1.098 . . . . 72.43 112.61 10.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 17.6 pt -131.02 150.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 114.076 -1.42 . . . . 61.42 110.109 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 151.71 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.448 -1.686 . . . . 65.11 106.448 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 33.0 t -71.34 145.5 49.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.384 0.611 . . . . 73.54 112.073 -174.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -155.05 163.52 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.462 -1.31 . . . . 74.42 107.462 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.04 -56.6 4.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.274 0.559 . . . . 75.41 110.887 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 m -91.96 12.18 22.63 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.823 -0.626 . . . . 71.33 111.954 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.52 131.49 10.81 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 120.468 -0.872 . . . . 54.55 111.666 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -136.87 140.15 42.16 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.394 -0.965 . . . . 63.23 108.394 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 41' ' ' TYR . 57.3 t -114.36 122.84 69.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.837 -0.431 . . . . 72.42 109.837 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.7 126.51 37.82 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.528 -0.545 . . . . 62.12 109.528 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.93 -148.56 5.18 Favored Glycine 0 N--CA 1.42 -2.404 0 C-N-CA 120.23 -0.986 . . . . 72.33 111.747 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.679 ' HB2' HD22 ' A' ' 18' ' ' LEU . 44.3 mtmt -139.23 145.77 39.65 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.923 0.489 . . . . 74.32 110.53 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.44 134.3 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.415 -0.811 . . . . 64.33 109.827 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.588 HD11 ' HB ' ' A' ' 17' ' ' ILE . 15.3 mt -86.94 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 105.193 -2.151 . . . . 70.2 105.193 178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 161.61 13.48 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.718 -0.393 . . . . 75.14 112.03 -173.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.55 37.2 77.79 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.799 -0.637 . . . . 20.24 112.901 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.43 121.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.653 -0.419 . . . . 74.5 109.97 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.401 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 46.7 m -73.99 158.8 33.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.052 -0.722 . . . . 65.21 109.052 177.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -52.92 -44.08 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.186 0.439 . . . . 73.5 112.186 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.47 78.49 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.539 0.685 . . . . 62.33 110.143 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.9 mm-40 -76.26 -38.69 55.88 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.775 -1.102 . . . . 63.23 110.217 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.508 HD12 ' CG ' ' A' ' 9' ' ' HIS . 3.6 tt -61.57 -37.51 84.13 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.695 -1.224 . . . . 71.1 107.695 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.618 ' O ' HG23 ' A' ' 80' ' ' VAL . 28.5 t-20 -54.71 -28.8 50.54 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 114.272 -1.331 . . . . 73.04 112.239 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.555 ' ND2' HG12 ' A' ' 26' ' ' ILE . 6.3 t30 -73.74 -30.88 63.07 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 118.957 -1.097 . . . . 70.51 109.633 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.592 ' O ' HG22 ' A' ' 81' ' ' ILE . 68.0 m-85 -73.23 -31.12 63.94 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 107.912 -1.144 . . . . 72.43 107.912 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.34 -37.56 63.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.424 -0.807 . . . . 65.42 110.274 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 76' ' ' ASN . 58.3 t -76.41 -27.38 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 N-CA-C 113.475 0.917 . . . . 63.2 113.475 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 78' ' ' PHE . 13.7 tt -59.25 165.15 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 O-C-N 122.053 -0.404 . . . . 72.42 110.339 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -53.97 95.51 0.01 OUTLIER 'General case' 0 C--O 1.242 0.691 0 N-CA-C 114.296 1.221 . . . . 75.4 114.296 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.66 60.21 0.64 Allowed Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 107.848 -2.101 . . . . 63.22 107.848 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -57.95 -41.28 82.49 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.739 0.816 . . . . 65.04 112.43 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.518 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 8.2 t70 -128.44 24.25 5.86 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.932 -1.507 . . . . 74.11 106.932 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.491 ' CE2' ' HB2' ' A' ' 52' ' ' PRO . 73.8 m-85 -119.2 150.71 39.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.453 -1.249 . . . . 70.21 108.695 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.85 144.44 51.31 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.781 -0.451 . . . . 71.54 109.781 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -93.17 114.93 27.56 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.906 -0.775 . . . . 75.04 108.906 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -128.69 161.05 38.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.663 0.785 . . . . 65.25 111.755 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.2 m -90.82 130.72 36.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.136 -1.061 . . . . 53.12 108.136 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.69 159.82 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.407 0.683 . . . . 72.41 109.158 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.68 123.87 46.38 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.3 -0.56 . . . . 61.34 110.545 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 38' ' ' LEU . 23.6 m -125.61 160.72 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 109.469 -0.567 . . . . 70.12 109.469 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 68.8 t -104.36 113.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.03 -0.986 . . . . 71.24 109.12 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -73.38 103.57 4.09 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 108.663 -0.866 . . . . 52.43 108.663 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -29.86 48.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.809 1.644 . . . . 71.12 110.437 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.29 -40.07 64.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.509 0.724 . . . . 73.33 111.729 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -123.95 -3.08 8.16 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.321 0.581 . . . . 72.43 111.025 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.94 26.19 14.11 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.014 0.926 . . . . 61.44 110.013 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 12.9 pt-20 -95.5 160.6 14.44 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.652 -0.704 . . . . 63.51 109.399 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -108.64 130.19 55.33 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.938 -1.134 . . . . 75.43 107.938 -178.473 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.77 144.27 21.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 109.702 -0.481 . . . . 54.34 109.702 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -87.62 127.09 35.28 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.683 0.754 . . . . 72.4 112.652 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.496 HG12 ' HB2' ' A' ' 10' ' ' ASN . 23.1 m -128.33 175.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 113.668 -1.605 . . . . 74.32 109.037 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.457 ' HG3' HD11 ' A' ' 75' ' ' LEU . 10.7 mm-40 -99.4 153.36 19.05 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.064 -0.717 . . . . 74.43 109.064 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 t -159.12 175.25 13.7 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.436 -0.579 . . . . 64.54 109.436 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -107.56 119.34 39.14 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.963 -0.754 . . . . 71.52 108.963 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG12 HG13 ' A' ' 54' ' ' ILE . 31.9 m -114.17 178.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 120.71 -0.396 . . . . 73.25 110.154 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.535 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 44.9 t-105 -101.54 124.84 47.86 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 -173.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.6 m -72.66 -26.71 24.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-O 121.28 0.562 . . . . 71.54 111.3 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.535 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 28.4 t-20 -80.01 12.51 2.73 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.732 0.813 . . . . 54.41 110.078 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.8 ptpp? -51.81 -24.67 6.36 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.362 1.065 . . . . 74.43 112.764 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -90.39 -3.15 57.9 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.143 0.497 . . . . 73.33 112.017 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.41 153.45 39.07 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.485 -0.325 . . . . 64.35 110.275 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.78 110.67 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.632 2.221 . . . . 73.41 111.248 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -133.55 166.77 21.79 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.922 -1.51 . . . . 73.24 106.922 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.342 -0.984 . . . . 60.22 108.342 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 121.113 0.482 . . . . 71.22 110.22 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -66.53 -37.44 85.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.053 -0.521 . . . . 75.2 109.712 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -56.45 -48.37 77.19 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 123.045 0.538 . . . . 75.25 110.311 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.5 m -69.37 -30.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.471 -0.491 . . . . 62.44 112.285 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -75.28 -44.47 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.421 -0.585 . . . . 74.11 109.421 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.47 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 26.3 t-80 -61.37 -40.79 95.6 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.07 -1.085 . . . . 74.31 108.07 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.89 97.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.703 -0.681 . . . . 42.43 111.652 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.436 ' HA ' HG12 ' A' ' 135' ' ' VAL . 36.3 mm-40 -67.81 -26.7 66.21 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 112.095 0.406 . . . . 73.22 112.095 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 8.8 tmtt? -70.71 -55.99 7.41 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.582 -0.896 . . . . 73.52 108.582 176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 94.1 m-85 -66.29 -32.04 73.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.006 1.113 . . . . 74.32 114.006 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.9 p -62.37 -38.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.017 -0.673 . . . . 71.32 110.648 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -72.16 -32.41 66.83 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 119.593 -0.843 . . . . 71.3 111.277 179.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 80.1 m -61.92 -46.24 90.19 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.841 -0.618 . . . . 73.44 110.287 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -61.41 -34.7 75.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 121.073 -0.251 . . . . 65.1 111.123 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 99.3 mtt180 -70.13 -49.23 52.81 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.106 -0.497 . . . . 74.04 110.681 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 33.4 mmtp -58.51 -43.13 88.98 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.719 -0.474 . . . . 75.03 109.719 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.9 mtm -67.59 -31.17 71.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.693 -0.685 . . . . 63.35 111.295 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.56 -40.47 73.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.68 -0.489 . . . . 72.31 109.68 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 9.5 mm-40 -63.0 -34.16 76.96 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.982 0.896 . . . . 64.51 109.363 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -71.87 -44.36 63.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.509 -1.223 . . . . 75.22 108.956 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.49 -37.78 83.35 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 51.22 111.242 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -78.74 -11.71 59.99 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.06 0.763 . . . . 62.33 113.06 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -115.91 131.7 23.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 C-N-CA 120.101 -0.64 . . . . 73.11 112.168 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.61 -14.99 45.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.391 2.728 . . . . 73.23 111.324 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -75.39 -20.63 58.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.265 -0.88 . . . . 64.43 110.121 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.652 0 N-CA-C 108.942 -1.663 . . . . 73.35 108.942 176.156 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.18 -0.674 . . . . 70.41 109.18 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.6 m -78.35 100.95 6.98 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.972 -0.751 . . . . 64.23 108.972 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -151.92 133.27 14.53 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.805 -0.442 . . . . 73.14 109.805 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.3 p -77.17 142.89 39.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.612 0.244 . . . . 73.03 110.451 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -100.6 170.21 6.92 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 116.563 -0.29 . . . . 61.22 110.743 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.85 -177.22 0.31 Allowed 'Trans proline' 0 C--O 1.258 1.486 0 C-N-CA 122.699 2.266 . . . . 72.33 111.682 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 68.34 77.96 0.23 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.933 0.873 . . . . 74.23 109.659 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.1 m -80.72 144.25 32.34 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.736 -1.12 . . . . 73.15 109.915 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -107.81 150.53 26.89 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.673 -0.694 . . . . 71.54 111.925 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -124.52 124.65 42.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.075 -1.454 . . . . 74.14 107.075 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 7.6 p -130.61 123.5 55.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 120.539 -0.464 . . . . 53.4 111.991 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -77.81 120.09 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.974 -0.75 . . . . 72.33 108.974 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.97 148.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.136 0.493 . . . . 64.44 110.217 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.33 106.58 9.61 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.85 -0.796 . . . . 71.43 108.85 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 -69.04 1.44 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 114.285 0.474 . . . . 74.34 114.285 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -44.75 -72.31 0.06 Allowed 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.198 1.555 . . . . 64.3 115.198 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.526 ' HB ' HD11 ' A' ' 67' ' ' ILE . 4.2 mp -105.67 66.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 109.167 -0.679 . . . . 61.34 109.167 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.8 mt -114.6 16.35 17.58 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.472 -1.307 . . . . 61.12 107.472 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.36 146.75 43.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.423 -1.262 . . . . 73.4 110.956 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.38 -42.83 51.74 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.806 3.004 . . . . 70.24 114.165 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.48 -47.65 78.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 120.627 0.251 . . . . 73.22 111.233 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 26' ' ' ILE . 93.9 t -65.09 -45.16 95.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 CA-C-N 115.861 -0.608 . . . . 73.14 111.64 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB1' ' H ' ' A' ' 31' ' ' ALA . . . -60.38 -37.3 80.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.118 0.485 . . . . 35.13 110.629 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.92 -33.49 68.31 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.768 -0.651 . . . . 63.31 111.522 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 22' ' ' VAL . 17.9 m -82.47 -28.58 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.969 -0.692 . . . . 73.42 111.254 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.5 tt -72.3 -47.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 119.736 -0.786 . . . . 72.41 111.829 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 74' ' ' GLU . 77.7 mt -95.62 -55.56 2.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.834 -1.146 . . . . 60.04 112.072 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.1 t70 150.39 -33.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.534 -1.654 . . . . 73.41 106.534 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -134.78 159.86 40.0 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.786 -1.552 . . . . 73.12 108.028 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.0 m -76.01 119.04 19.41 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.205 0.526 . . . . 71.33 110.144 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' H ' ' HB1' ' A' ' 23' ' ' ALA . . . -87.2 152.98 21.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.723 -0.843 . . . . 72.4 108.723 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -95.75 120.74 36.54 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.302 0.572 . . . . 54.34 112.322 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.3 p -93.46 145.24 24.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 115.144 -0.934 . . . . 63.34 109.114 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.2 t -124.08 134.71 25.63 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 106.82 -1.548 . . . . 73.3 106.82 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 33.1 Cg_endo -65.4 126.5 16.35 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.137 1.892 . . . . 74.44 111.73 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.54 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.97 155.26 39.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.516 -0.765 . . . . 63.2 110.558 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.425 HG21 ' HD3' ' A' ' 61' ' ' LYS . 7.1 p -121.75 129.08 75.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.55 0.691 . . . . 70.35 111.385 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.456 ' HB2' HG12 ' A' ' 93' ' ' VAL . 27.2 tp -91.58 95.36 9.89 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.332 -0.849 . . . . 64.43 111.804 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 17.6 p-80 -73.55 131.96 42.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.123 -0.695 . . . . 75.12 109.123 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.11 -10.56 20.39 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 119.213 -1.47 . . . . 65.32 113.064 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.01 158.71 34.62 Favored 'General case' 0 CA--C 1.473 -1.993 0 N-CA-C 110.242 -0.281 . . . . 65.04 110.242 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.456 ' NE2' ' HB2' ' A' ' 120' ' ' GLU . 3.6 t60 -126.19 131.5 51.98 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.767 -1.197 . . . . 73.12 107.767 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.428 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -91.36 137.23 32.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.568 0.699 . . . . 73.43 112.665 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 118' ' ' TYR . 62.0 m-85 -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.33 -1.359 . . . . 73.23 107.33 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -88.12 -45.21 10.33 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.862 0.319 . . . . 73.3 111.862 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.507 HD23 HD22 ' A' ' 49' ' ' LEU 0.261 7.5 mp 57.23 77.34 0.27 Allowed 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 114.912 1.449 . . . . 70.14 114.912 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -78.58 105.25 9.74 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.79 -1.096 . . . . 51.54 110.626 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.88 -31.57 3.04 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 110.882 -0.887 . . . . 33.14 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD22 HD23 ' A' ' 46' ' ' LEU . 4.2 mp -96.86 156.16 36.8 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 108.025 -1.102 . . . . 71.24 108.025 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.27 87.87 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 123.133 2.555 . . . . 62.43 113.955 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.601 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.595 34.6 p90 33.42 54.83 1.34 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 119.556 3.169 . . . . 75.31 119.556 -176.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 5.7 Cg_endo -103.63 169.49 0.21 Allowed 'Trans proline' 0 CA--C 1.555 1.542 1 C-N-CA 125.637 4.225 . . . . 73.14 110.298 174.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p -155.97 -178.43 7.3 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.245 2.218 . . . . 64.23 107.122 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.464 HG13 HG12 ' A' ' 108' ' ' VAL . 44.4 pt -126.64 124.24 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.625 -1.25 . . . . 65.22 107.625 164.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 m -146.71 172.71 3.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.856 -1.164 . . . . 71.14 107.856 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.6 m 71.04 129.94 0.03 OUTLIER 'General case' 0 C--O 1.24 0.577 0 O-C-N 124.909 1.38 . . . . 73.34 111.495 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -80.31 75.05 7.14 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.04 -1.467 . . . . 74.41 107.04 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.61 161.9 20.98 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 113.066 -1.879 . . . . 73.41 109.708 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.9 m -82.79 -4.29 57.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.667 0.27 . . . . 71.25 111.332 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.68 -171.17 47.4 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 121.505 -0.379 . . . . 70.31 112.433 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HD3' HG21 ' A' ' 37' ' ' VAL . 9.4 ptpp? -144.69 154.78 43.13 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 120.82 0.343 . . . . 75.3 110.609 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG13 ' HG2' ' A' ' 43' ' ' ARG . 65.7 t -116.92 122.16 69.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.775 -0.648 . . . . 71.12 109.3 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -96.04 123.41 39.63 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.374 -0.531 . . . . 75.04 109.672 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.91 -143.8 3.76 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.894 -1.282 . . . . 71.12 109.894 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 48.6 mtpt -140.76 150.68 43.69 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.762 0.781 . . . . 53.14 109.632 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.5 m -104.45 133.99 47.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 115.629 -0.714 . . . . 62.24 109.773 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.526 HD11 ' HB ' ' A' ' 17' ' ' ILE . 45.4 mt -87.23 111.54 21.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.8 -1.926 . . . . 72.2 105.8 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -103.91 162.03 13.47 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.296 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.67 72.03 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 116.147 -0.479 . . . . 73.42 111.966 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -94.97 122.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 109.939 -0.393 . . . . 72.01 109.939 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.0 t -73.74 163.22 28.26 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.325 -0.991 . . . . 74.15 108.325 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.9 -26.0 68.58 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.973 0.416 . . . . 64.13 110.575 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 -43.91 32.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.42 -0.585 . . . . 75.11 109.42 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.631 ' HB3' HD22 ' A' ' 27' ' ' LEU . 53.9 mt-10 -63.73 -43.2 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 71.45 110.599 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.15 -36.62 77.97 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.723 0.809 . . . . 73.31 110.077 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' HG23 ' A' ' 80' ' ' VAL . 58.4 t30 -60.92 -28.71 69.13 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.348 -0.842 . . . . 52.15 111.18 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.511 ' ND2' HG13 ' A' ' 26' ' ' ILE . 3.1 t30 -70.74 -30.17 66.61 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 119.791 -0.763 . . . . 64.24 109.484 -173.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.554 ' CE2' HD21 ' A' ' 27' ' ' LEU . 92.6 m-85 -70.53 -32.59 70.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 64.01 109.484 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.13 -39.99 62.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.186 -0.915 . . . . 63.34 109.67 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 76' ' ' ASN . 65.5 t -74.62 -44.15 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.118 -0.946 . . . . 72.35 112.031 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.35 120.76 51.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.412 -0.358 . . . . 70.14 111.527 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 75.87 -26.78 0.19 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.934 1.294 . . . . 74.42 113.7 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 51.16 3.89 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.289 -0.724 . . . . 60.31 111.289 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.65 -43.11 49.29 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.073 0.549 . . . . 62.23 112.285 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.628 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 4.2 t70 -118.03 25.87 10.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 122.88 1.324 . . . . 72.51 107.552 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 89.5 m-85 -114.75 151.36 33.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.072 -1.422 . . . . 74.33 109.68 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.74 149.23 49.72 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.522 -0.547 . . . . 75.02 109.522 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -85.8 125.4 33.23 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.922 0.712 . . . . 63.35 112.922 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.25 155.79 41.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.965 -1.016 . . . . 70.32 109.218 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.5 m -96.98 124.14 40.87 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.384 -0.599 . . . . 71.3 109.384 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.3 m -128.96 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 107.904 -1.147 . . . . 60.33 107.904 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -112.52 131.63 55.5 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.747 -1.181 . . . . 74.55 108.26 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 38' ' ' LEU . 24.1 m -125.67 163.68 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 73.41 109.458 -174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 101' ' ' LYS . 70.4 t -102.48 117.27 47.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.839 -0.619 . . . . 54.24 109.338 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -66.72 94.58 0.31 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.863 -1.162 . . . . 74.41 107.863 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.54 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -54.34 -35.57 62.86 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 125.496 1.518 . . . . 74.31 109.567 -177.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -52.6 -30.89 33.54 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.763 -1.108 . . . . 63.45 112.592 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -136.08 4.61 2.99 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.617 0.722 . . . . 53.22 110.968 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m 59.88 25.58 14.72 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.119 0.968 . . . . 74.44 112.742 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.83 160.61 14.33 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.656 -0.868 . . . . 72.41 108.656 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 94' ' ' VAL . 39.8 mtmt -102.35 129.69 48.88 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.49 -0.559 . . . . 74.44 109.49 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.74 144.38 37.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.092 0.472 . . . . 53.31 110.431 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -93.94 126.35 39.09 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.524 -0.917 . . . . 75.23 108.524 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.081 0.467 . . . . 64.01 111.28 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 46.7 mt-10 -100.53 153.36 19.44 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.636 -1.246 . . . . 73.51 107.636 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -151.01 173.63 14.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 86' ' ' TYR . 92.5 m-85 -113.55 118.68 35.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 121.122 0.487 . . . . 72.24 110.29 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG12 HG13 ' A' ' 54' ' ' ILE . 27.4 m -109.79 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.472 -0.936 . . . . 74.02 108.472 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.628 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 46.4 t-105 -93.33 129.17 39.53 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.223 -1.028 . . . . 64.33 108.223 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 85' ' ' ASP . 34.8 m -71.47 -20.07 20.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 N-CA-C 112.51 0.559 . . . . 71.41 112.51 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.556 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 25.4 t-20 -80.48 11.8 3.46 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.744 0.783 . . . . 75.13 109.942 176.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 19.6 ptpt -51.29 -15.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.747 2.019 . . . . 70.15 114.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.46 -52.07 18.24 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.957 0.903 . . . . 65.11 111.218 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -108.05 127.54 27.42 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 109.432 -0.581 . . . . 75.25 109.432 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.87 103.61 0.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 62.02 111.056 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -100.9 133.09 45.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.503 -0.771 . . . . 73.44 109.653 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 58.9 44.43 16.63 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.987 0.805 . . . . 72.13 110.078 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.413 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 47.5 p90 -57.63 -21.33 38.98 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.358 0.873 . . . . 64.44 113.358 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.21 129.36 9.34 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.313 -1.115 . . . . 73.14 110.313 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 67.6 tt0 -85.68 132.5 34.14 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.784 -0.821 . . . . 74.13 108.784 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -76.06 -172.97 2.18 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.818 -1.083 . . . . 74.45 111.298 -172.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -80.4 119.65 23.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.565 0.698 . . . . 74.41 110.184 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.482 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 50.2 m-85 -66.25 -34.98 79.24 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.479 -1.237 . . . . 73.54 108.93 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.77 -32.02 72.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.065 -0.971 . . . . 70.31 110.796 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 129' ' ' VAL . 36.9 tt0 -71.21 -40.59 71.05 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.4 -0.963 . . . . 75.2 108.4 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -61.99 -44.17 97.3 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.424 -0.51 . . . . 70.45 109.871 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 83.1 mtp180 -56.27 -48.93 75.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.662 -0.699 . . . . 74.35 111.177 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.57 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 32.0 m -70.43 -40.59 77.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.154 -0.618 . . . . 40.22 112.37 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 125' ' ' GLU . 95.2 t -68.16 -44.81 84.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.548 -0.461 . . . . 63.4 111.767 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.514 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.6 p80 -67.39 -33.77 75.9 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 118.401 -1.319 . . . . 61.51 109.737 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -64.54 -47.27 79.43 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.977 -0.556 . . . . 73.15 110.863 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 48.1 mt-10 -60.28 -41.52 93.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 120.954 0.406 . . . . 73.41 110.389 -176.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.25 -48.05 81.67 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.179 -0.919 . . . . 72.31 111.897 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.514 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 56.4 m-85 -67.94 -45.43 74.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.581 -0.448 . . . . 74.23 111.572 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 131' ' ' ALA . 94.5 t -57.37 -48.26 83.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 116.391 -0.368 . . . . 70.43 111.68 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -58.55 -48.88 79.43 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 120.439 -0.504 . . . . 63.0 109.928 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -45.2 81.27 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.527 -0.76 . . . . 75.53 112.343 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.52 -43.05 73.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.872 -0.731 . . . . 63.12 112.067 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 98.9 mtt180 -61.49 -46.74 88.76 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.992 0.425 . . . . 62.22 111.207 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.95 -32.05 66.93 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.909 -0.587 . . . . 62.4 112.316 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -72.86 -32.07 65.18 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.41 -0.959 . . . . 75.24 108.41 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.6 tp -68.56 -37.17 79.69 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.464 -0.789 . . . . 73.24 110.166 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 8.6 mm-40 -61.59 -46.44 89.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.1 0.476 . . . . 74.41 110.283 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -65.39 -43.73 89.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.871 -0.604 . . . . 74.14 110.8 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.6 -22.21 65.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.698 0.761 . . . . 74.23 111.09 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 146' ' ' LYS . 0.7 OUTLIER -78.45 -26.66 46.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.447 -0.797 . . . . 72.22 109.193 177.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.01 82.14 0.22 Allowed Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.349 0.66 . . . . 73.0 109.72 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.25 -37.26 2.68 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.216 1.944 . . . . 61.33 112.031 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -96.47 3.44 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.562 -0.744 . . . . 73.34 110.572 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 67.96 34.15 81.23 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 109.636 -1.386 . . . . 75.32 109.636 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -81.57 121.79 26.76 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.756 -0.722 . . . . 51.11 109.41 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.2 m -102.79 164.58 11.55 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.908 -0.405 . . . . 74.54 109.908 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 26.3 mmt -56.85 -43.44 81.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.272 0.841 . . . . 71.4 113.272 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -79.98 -25.01 40.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.46 0.648 . . . . 74.34 110.827 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.25 -45.8 45.58 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.899 -0.778 . . . . 60.51 108.899 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.97 -27.7 69.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.836 . . . . 31.33 112.412 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.7 p -92.79 128.66 44.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.422 -0.511 . . . . 70.34 110.708 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -77.25 78.07 1.48 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.062 -0.815 . . . . 64.43 111.062 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.0 t -76.66 152.35 35.83 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.655 -0.498 . . . . 75.34 109.655 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.62 141.61 46.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.543 -0.54 . . . . 61.33 109.543 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.0 mt -100.15 -16.71 17.71 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.128 0.489 . . . . 72.43 109.726 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 70.0 m 61.61 78.38 0.29 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.914 -1.039 . . . . 72.01 111.005 -174.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.4 t -77.32 131.91 38.34 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 114.093 -1.412 . . . . 64.54 109.232 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.45 108.82 2.86 Favored Glycine 0 N--CA 1.422 -2.282 0 N-CA-C 110.636 -0.986 . . . . 60.5 110.636 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--N 1.292 -1.898 0 CA-C-O 118.344 -0.836 . . . . 63.53 109.177 -179.561 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 109.031 -0.729 . . . . 72.22 109.031 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.1 m -79.69 -31.18 41.25 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.683 -0.407 . . . . 71.14 111.096 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.2 t -163.07 178.87 7.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.953 -1.129 . . . . 74.02 107.953 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -83.88 143.64 29.75 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.854 -1.165 . . . . 75.24 107.854 174.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 12.1 t70 -64.65 125.05 87.95 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.538 -0.541 . . . . 75.51 109.538 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.1 -12.99 31.03 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.119 2.546 . . . . 72.42 114.197 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -140.34 38.98 1.9 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.257 -1.016 . . . . 73.31 108.257 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 42.3 p -52.23 124.09 12.29 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.161 -1.381 . . . . 63.21 110.351 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.95 156.2 19.04 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 114.647 -1.16 . . . . 73.33 111.059 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.557 ' HB2' HG12 ' A' ' 104' ' ' VAL . 3.3 m-20 -125.31 131.92 52.96 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.96 -1.496 . . . . 50.24 106.96 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 13' ' ' VAL . 49.1 t -119.5 120.33 63.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 120.336 -0.546 . . . . 51.35 110.694 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' HB2' HG21 ' A' ' 104' ' ' VAL . 43.4 t80 -91.5 96.73 10.65 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 104.861 -2.274 . . . . 71.12 104.861 173.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 11' ' ' VAL . 10.3 p -119.1 121.93 67.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 118.329 -1.348 . . . . 71.05 111.576 -173.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -92.35 66.86 4.77 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 106.025 -1.843 . . . . 64.45 106.025 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.38 -169.82 13.9 Favored Glycine 0 N--CA 1.42 -2.392 0 CA-C-N 113.537 -1.665 . . . . 70.43 109.381 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -88.0 85.11 6.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-O 121.606 0.717 . . . . 65.23 112.749 -174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 67' ' ' ILE . 8.0 mm -144.43 -84.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 104.846 -2.279 . . . . 74.14 104.846 169.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' H ' ' HB ' ' A' ' 17' ' ' ILE . 80.6 mt 50.89 -42.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 128.086 2.554 . . . . 73.31 117.368 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.89 140.29 22.55 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 109.199 -0.667 . . . . 72.41 109.199 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -48.57 -28.65 12.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.586 3.524 . . . . 62.45 114.861 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.48 97.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.929 0.395 . . . . 73.54 111.08 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 25' ' ' VAL . 35.9 t -77.07 -30.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.882 -0.784 . . . . 65.05 108.882 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.64 -28.96 70.27 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.934 -0.765 . . . . 71.33 108.934 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.09 -8.7 57.59 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.434 -0.803 . . . . 21.42 111.767 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 22' ' ' VAL . 14.4 m -99.25 -23.07 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 119.619 -0.833 . . . . 71.52 110.773 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.559 HG21 HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -85.85 -47.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 116.251 -0.431 . . . . 62.32 110.588 176.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 31' ' ' ALA . 97.7 mt -89.66 -21.3 22.83 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 116.57 -0.286 . . . . 73.51 110.796 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 37.2 t70 68.72 10.7 8.04 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.289 1.519 . . . . 70.22 108.882 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -136.11 141.83 44.22 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 104.928 -2.249 . . . . 75.22 104.928 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -77.74 136.83 38.21 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.485 -0.886 . . . . 60.1 109.887 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -121.0 154.86 35.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.689 -0.485 . . . . 42.32 109.689 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -89.89 117.98 29.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.473 -0.566 . . . . 62.02 109.473 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.6 m -104.96 142.67 34.36 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.459 -2.052 . . . . 75.25 105.459 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.56 149.84 70.44 Favored Pre-proline 0 C--N 1.296 -1.75 0 O-C-N 122.088 -0.383 . . . . 74.02 110.133 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.53 133.47 37.24 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.605 2.203 . . . . 71.5 111.522 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.79 156.51 41.94 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.942 -0.572 . . . . 73.22 109.868 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.0 p -122.59 128.04 75.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-O 121.496 0.665 . . . . 73.23 111.045 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.47 ' HA ' HG12 ' A' ' 93' ' ' VAL . 22.4 tp -87.91 111.07 21.04 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.196 -0.911 . . . . 75.2 110.103 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 13.9 p80 -87.06 122.21 30.57 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.473 -0.785 . . . . 64.14 110.187 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.45 7.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.374 -1.393 . . . . 71.31 112.866 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.444 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 57.0 m-85 -117.78 161.11 20.24 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 109.288 -0.634 . . . . 73.12 109.288 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -133.41 131.98 40.62 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.25 -1.389 . . . . 72.0 107.25 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.711 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 1.2 tmt_? -88.56 120.56 30.06 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 109.292 -0.633 . . . . 71.31 109.292 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 39.0 m-85 -95.99 159.82 14.77 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.987 -1.486 . . . . 74.43 106.987 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' C ' ' HD3' ' A' ' 45' ' ' LYS . 7.7 tmtm? -82.78 -41.76 18.76 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 112.156 0.428 . . . . 70.53 112.156 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 49' ' ' LEU . 7.9 mp 62.75 158.27 0.07 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.529 1.307 . . . . 71.1 114.529 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.41 -51.25 1.28 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.799 -0.815 . . . . 75.5 108.799 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.29 74.63 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.661 -1.154 . . . . 71.4 111.678 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HB2' HD23 ' A' ' 46' ' ' LEU . 3.0 mm? -107.63 167.34 9.5 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.409 -0.96 . . . . 62.42 108.409 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 41.5 Cg_exo -62.68 -157.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.52 0 C-N-CA 123.01 2.473 . . . . 51.32 112.905 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' N ' ' HD2' ' A' ' 52' ' ' PRO 0.349 12.8 p90 -57.49 -31.34 9.92 Favored Pre-proline 0 CA--C 1.568 1.665 0 N-CA-C 116.557 2.058 . . . . 72.13 116.557 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 51' ' ' TYR . 3.3 Cg_exo -39.74 168.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.59 3.317 0 C-N-CA 123.631 2.887 . . . . 71.52 112.746 163.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 p -139.29 -175.87 4.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.199 -1.563 . . . . 72.4 110.963 11.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 45.1 pt -123.77 141.32 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.116 -1.068 . . . . 70.1 108.116 172.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.407 HG22 ' HE2' ' A' ' 44' ' ' TYR . 30.8 m -148.18 158.77 7.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.951 -0.759 . . . . 45.21 108.951 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 m -80.5 88.91 5.62 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.739 0.78 . . . . 62.42 109.839 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.5 t -144.1 -66.02 0.35 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.574 -1.639 . . . . 74.22 106.574 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.63 125.68 30.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.387 -1.709 . . . . 73.13 106.387 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -84.41 15.46 3.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.846 0.684 . . . . 64.13 112.846 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.84 -147.73 0.45 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 114.617 0.607 . . . . 53.44 114.617 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 27.0 mtmm -139.82 154.09 47.25 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 120.167 -0.613 . . . . 75.32 111.184 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 54' ' ' ILE . 45.2 t -114.55 123.23 70.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.474 -0.785 . . . . 61.24 109.861 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -94.13 123.9 37.8 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.855 -0.424 . . . . 63.03 109.855 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.32 -149.03 5.19 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.16 -0.776 . . . . 63.22 111.16 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -138.3 156.55 47.55 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.904 -0.776 . . . . 73.32 108.904 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . 29.8 m -125.8 129.62 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 120.782 0.325 . . . . 74.24 111.053 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.603 HD13 HG21 ' A' ' 17' ' ' ILE . 6.2 mt -90.15 116.77 32.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.163 -1.421 . . . . 61.42 107.163 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.2 p -100.89 161.15 13.79 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.936 -0.306 . . . . 75.01 110.717 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.13 33.39 23.58 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.135 -0.555 . . . . 73.05 112.805 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.59 122.32 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 O-C-N 122.473 -0.428 . . . . 64.1 110.642 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.483 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 65.8 m -79.23 158.64 27.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.794 -0.762 . . . . 65.12 109.951 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -52.17 -34.93 47.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.171 0.804 . . . . 53.13 113.171 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -37.64 37.56 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.306 0.574 . . . . 73.24 110.654 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 13.3 mm-40 -68.16 -30.53 69.67 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.229 -0.896 . . . . 74.15 109.43 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 ' HG3' ' A' ' 105' ' ' GLU . 4.2 tt -59.37 -35.09 73.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.397 -1.274 . . . . 74.23 109.538 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 80' ' ' VAL . 3.4 t-20 -60.37 -28.16 67.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 72.34 110.96 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -31.63 70.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.439 -0.949 . . . . 72.24 108.439 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.411 ' CZ ' HD12 ' A' ' 26' ' ' ILE . 73.3 m-85 -67.78 -35.3 78.42 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 116.421 -0.354 . . . . 73.24 110.38 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -69.59 -35.94 75.77 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.726 0.774 . . . . 74.44 109.478 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 76' ' ' ASN . 80.5 t -72.64 -24.59 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 CA-C-N 115.154 -0.93 . . . . 74.34 112.792 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.467 ' HB ' ' OH ' ' A' ' 107' ' ' TYR . 47.9 mm -44.4 -74.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 113.15 0.796 . . . . 73.11 113.15 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -141.77 19.55 2.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.249 0.547 . . . . 75.14 110.847 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.46 62.89 4.0 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.927 -0.654 . . . . 71.44 113.183 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.38 -42.88 18.08 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.908 -0.404 . . . . 73.13 109.908 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.8 m-20 -114.49 17.19 17.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.251 1.024 . . . . 75.35 109.718 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.98 156.58 26.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.497 -1.298 . . . . 64.34 107.497 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HB3' HG12 ' A' ' 110' ' ' VAL . 14.3 pt-20 -126.17 142.29 51.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.829 -0.804 . . . . 74.11 108.829 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 tmm_? -88.09 118.07 27.41 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.579 -0.737 . . . . 73.34 109.824 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 m -126.27 160.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.359 0.664 . . . . 65.2 111.834 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.3 m -89.18 129.61 35.74 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 123.628 0.58 . . . . 63.54 109.552 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.87 172.16 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.362 -1.347 . . . . 65.34 107.362 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -123.6 129.85 51.78 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.319 -0.952 . . . . 74.34 109.167 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 38' ' ' LEU . 16.2 m -127.03 168.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.073 0.464 . . . . 73.32 110.72 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.534 HG22 ' HG2' ' A' ' 101' ' ' LYS . 68.0 t -114.07 122.43 68.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.819 -0.628 . . . . 74.44 110.931 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.48 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 75.0 ttt180 -70.98 102.12 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.926 -1.138 . . . . 74.55 107.926 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.37 -60.0 2.38 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 126.818 2.047 . . . . 72.34 111.511 -171.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.1 -32.64 62.16 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.804 1.039 . . . . 71.54 113.804 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -110.47 -8.78 14.63 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.292 0.849 . . . . 62.22 113.292 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.41 25.69 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.966 0.907 . . . . 74.41 110.384 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -98.83 160.19 14.43 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.864 -0.791 . . . . 72.43 108.864 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.534 ' HG2' HG22 ' A' ' 94' ' ' VAL . 88.2 mttt -105.05 137.31 42.99 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.582 -0.525 . . . . 74.14 109.582 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.13 140.62 43.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.714 -0.476 . . . . 55.25 109.714 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -90.8 127.74 36.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.241 -1.392 . . . . 71.12 107.241 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.557 HG12 ' HB2' ' A' ' 10' ' ' ASN . 28.2 m -133.98 171.95 17.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.024 0.44 . . . . 75.01 112.121 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.558 ' HG3' HD11 ' A' ' 75' ' ' LEU . 31.2 mm-40 -104.24 153.97 20.35 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.255 -1.387 . . . . 74.04 107.255 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -156.0 177.79 11.01 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.247 0.476 . . . . 74.15 110.166 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' A' ' 81' ' ' ILE . 3.9 m-85 -103.55 119.78 39.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 122.914 0.485 . . . . 74.45 109.85 177.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -119.55 159.99 20.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.873 -1.528 . . . . 73.32 106.873 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.715 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 54.0 t-105 -83.96 134.27 34.66 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.669 -0.863 . . . . 75.33 108.669 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 85' ' ' ASP . 29.5 m -72.21 -20.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 118.981 0.809 . . . . 54.44 112.419 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.715 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 26.0 t-20 -92.0 15.5 13.11 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 125.323 1.449 . . . . 54.54 108.992 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 45.5 pttt -47.75 -15.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 127.242 2.217 . . . . 71.44 116.356 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.41 -20.39 60.07 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 119.112 -1.035 . . . . 61.42 111.442 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -97.46 124.48 48.64 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 107.544 -1.28 . . . . 74.05 107.544 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.25 102.24 1.5 Allowed 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 121.403 1.402 . . . . 73.44 111.011 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.79 112.02 17.78 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.895 -1.15 . . . . 72.22 107.895 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 23.7 mmt 67.81 148.05 0.05 Allowed 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.639 1.212 . . . . 73.42 110.97 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -116.68 -20.88 9.35 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.962 -0.695 . . . . 75.31 111.199 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -134.26 164.38 24.54 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.748 -0.941 . . . . 64.54 110.748 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.711 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -144.75 149.91 36.35 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 115.128 1.529 . . . . 64.44 115.128 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -158.73 86.97 0.86 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.646 -1.615 . . . . 74.23 109.836 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.49 ' CB ' HH12 ' A' ' 43' ' ' ARG . 9.8 t70 -100.25 124.09 45.28 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.621 -0.718 . . . . 73.23 109.805 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -68.45 -42.98 78.03 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.687 0.995 . . . . 74.12 113.687 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 128' ' ' VAL 0.268 0.0 OUTLIER -74.3 -39.19 63.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 119.686 -0.805 . . . . 75.23 111.949 -175.156 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.76 -37.76 71.51 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.589 -0.732 . . . . 63.04 110.352 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -51.6 -57.18 9.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.29 -0.868 . . . . 73.44 111.406 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.3 -34.18 65.59 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.044 -0.662 . . . . 73.34 111.81 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 124' ' ' GLU . 70.8 t -62.75 -47.63 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.535 0.568 . . . . 74.11 112.535 -177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.16 -33.9 63.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.549 0.69 . . . . 72.21 109.905 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.47 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 55.6 t-80 -69.88 -45.71 67.06 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.961 -1.018 . . . . 65.44 109.844 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -61.26 -52.97 62.5 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.98 -0.554 . . . . 52.11 111.022 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.03 -45.67 71.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 123.414 0.446 . . . . 72.11 111.51 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -61.51 -53.96 49.5 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.018 -0.992 . . . . 73.11 111.886 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.47 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 96.7 m-85 -74.95 -31.5 61.51 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 113.79 1.033 . . . . 71.44 113.79 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 131' ' ' ALA . 79.4 t -63.8 -45.94 95.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 121.139 -0.225 . . . . 54.13 111.295 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 12.5 pt-20 -67.77 -36.71 80.97 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.401 -0.919 . . . . 71.11 110.937 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.7 m -60.82 -47.21 87.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.937 -0.574 . . . . 73.13 109.46 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.554 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 87.1 t80 -59.16 -48.05 83.06 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.831 -0.622 . . . . 74.12 110.028 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 97.4 mtt180 -61.58 -42.89 99.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.181 -0.463 . . . . 74.1 112.148 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.4 mmtp -65.17 -42.37 93.73 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 121.019 -0.272 . . . . 75.25 110.537 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.7 mmt -63.83 -31.86 73.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.199 -0.455 . . . . 71.02 111.728 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 90.6 mt -67.71 -45.53 74.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.858 -0.423 . . . . 70.03 109.858 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.1 mt-10 -60.79 -47.07 88.01 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 109.579 -0.526 . . . . 73.24 109.579 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -59.97 -38.98 84.11 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.216 1.007 . . . . 72.34 111.494 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.5 -45.61 13.41 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.056 -0.52 . . . . 72.05 112.262 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.71 -26.33 25.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.224 0.453 . . . . 63.21 112.224 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -123.25 124.17 26.46 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-O 120.731 0.301 . . . . 63.04 111.149 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.38 -19.41 67.17 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.656 2.237 . . . . 62.23 111.664 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -93.8 3.81 54.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.079 -0.51 . . . . 63.45 110.613 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.75 -32.98 74.78 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 108.912 -1.675 . . . . 74.22 108.912 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -94.92 145.37 24.96 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 105.774 -1.935 . . . . 53.24 105.774 170.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.6 m -74.25 155.65 38.05 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.271 -0.972 . . . . 62.3 110.337 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.443 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.3 mpt? -61.32 -39.84 92.02 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.822 0.849 . . . . 70.03 111.975 -172.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 161' ' ' LEU . 38.8 tt0 -67.66 -41.97 82.94 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 122.003 0.906 . . . . 71.14 110.497 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.83 -29.85 62.36 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.597 -1.183 . . . . 71.2 108.414 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.61 -27.28 69.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.786 -0.643 . . . . 65.23 110.219 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 153' ' ' MET . 48.3 t -84.32 -56.31 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.756 -0.831 . . . . 75.11 108.756 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 82.48 -44.72 3.25 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 121.156 -0.545 . . . . 63.12 112.869 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.8 m -71.73 -27.86 63.29 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.022 0.529 . . . . 74.2 111.032 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.9 mt -123.19 113.15 18.56 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.427 -0.583 . . . . 75.32 109.427 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 154' ' ' GLU . 6.9 tt -134.42 138.27 44.68 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.066 -1.087 . . . . 73.31 108.066 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.7 t -74.34 97.41 3.02 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.594 0.712 . . . . 72.23 110.163 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.8 t -171.27 124.64 0.61 Allowed 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 106.38 -1.711 . . . . 51.33 106.38 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -104.73 7.88 46.09 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.396 -0.906 . . . . 65.41 113.488 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.317 -0.841 0 CA-C-O 118.359 -0.829 . . . . 62.04 109.789 177.547 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.1 p . . . . . 0 C--O 1.241 0.65 0 N-CA-C 109.612 -0.514 . . . . 63.53 109.612 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 m -84.65 114.26 21.88 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.399 -1.334 . . . . 61.53 107.399 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -132.32 137.17 47.33 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 116.476 -0.329 . . . . 71.22 110.233 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.6 m 61.2 89.38 0.08 Allowed 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.987 0.915 . . . . 73.23 112.665 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.531 ' H ' ' HB3' ' A' ' 71' ' ' SER . 12.4 m-20 -78.9 137.47 57.67 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 115.836 -0.62 . . . . 74.35 109.784 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.39 160.8 33.7 Favored 'Trans proline' 0 C--O 1.252 1.201 0 C-N-CA 122.206 1.937 . . . . 72.03 109.886 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 62.58 84.65 0.14 Allowed 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.861 0.839 . . . . 74.02 109.736 -172.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.7 p -64.23 149.07 48.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.673 -1.149 . . . . 74.45 111.619 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.407 ' CB ' HD12 ' A' ' 75' ' ' LEU . 80.6 m80 -108.9 156.26 19.89 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.655 -0.702 . . . . 65.34 110.411 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.552 ' HB2' HG12 ' A' ' 104' ' ' VAL . 84.1 m-20 -132.16 126.41 33.56 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.164 -1.421 . . . . 73.4 107.164 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.78 120.62 65.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 121.18 -0.208 . . . . 35.24 110.85 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -84.67 112.76 20.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.476 -0.935 . . . . 72.23 108.476 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.2 t -113.55 142.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.76 -0.83 . . . . 53.42 108.76 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -81.24 -53.98 5.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.708 -0.223 . . . . 70.32 111.426 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.95 79.64 0.13 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 118.531 -1.795 . . . . 75.31 114.974 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 p -162.6 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.38 0.61 . . . . 74.34 110.902 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -91.16 70.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 CA-C-O 123.69 1.709 . . . . 71.42 107.605 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 65' ' ' LYS . 80.7 mt -114.12 -11.7 12.64 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-N 113.372 -1.74 . . . . 65.42 106.96 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -85.68 125.97 67.58 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 113.469 -1.696 . . . . 73.33 110.168 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.12 -38.24 80.57 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.805 2.336 . . . . 75.0 111.669 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.84 -44.97 91.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.918 0.39 . . . . 34.23 111.07 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.533 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -70.16 -34.42 58.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 121.258 0.551 . . . . 51.34 109.795 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -62.32 -35.71 79.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.223 0.535 . . . . 71.44 109.557 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.84 -13.07 61.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.581 -0.736 . . . . 63.25 111.94 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 22' ' ' VAL . 12.0 m -98.58 -26.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 119.602 -0.839 . . . . 73.32 110.45 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.555 HG21 HG13 ' A' ' 17' ' ' ILE . 6.0 tt -84.41 -41.63 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.015 0.436 . . . . 65.44 112.095 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 86.1 mt -99.62 -21.16 15.99 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.299 -0.409 . . . . 63.22 111.173 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.4 t70 75.84 -5.0 2.26 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.624 1.202 . . . . 64.02 108.925 -171.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 27' ' ' LEU . 84.9 mtt180 -105.94 138.11 42.69 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 113.754 -1.566 . . . . 65.31 107.665 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -79.62 111.15 15.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 106.403 -1.703 . . . . 71.4 106.403 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -89.52 157.06 18.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.388 0.613 . . . . 73.04 111.726 -174.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.63 114.61 27.77 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.959 -1.019 . . . . 74.23 111.323 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 1.7 p -102.62 143.07 32.77 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.519 -0.764 . . . . 52.51 109.775 174.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 m -136.16 143.26 43.13 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 109.155 -0.683 . . . . 62.23 109.155 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.2 132.79 54.05 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.272 1.981 . . . . 64.15 110.671 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.12 36.51 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 109.014 -0.735 . . . . 62.21 109.014 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.23 127.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-O 121.743 0.782 . . . . 72.43 111.988 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 93' ' ' VAL . 22.3 tp -90.24 102.36 15.08 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.723 -1.126 . . . . 63.34 109.943 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 61' ' ' LYS . 9.9 p-80 -76.28 125.26 28.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.302 -0.863 . . . . 72.13 109.771 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 117.42 -21.04 10.93 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 118.869 -1.634 . . . . 74.22 114.207 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -106.65 157.31 17.8 Favored 'General case' 0 CA--C 1.48 -1.724 0 CA-C-N 117.888 0.844 . . . . 73.15 111.482 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -124.92 124.26 41.67 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.403 -0.962 . . . . 53.41 108.403 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -90.86 147.19 23.34 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.763 0.316 . . . . 71.11 110.976 177.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.54 -169.99 1.96 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.527 0.566 . . . . 72.43 112.527 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -109.27 -36.83 5.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.592 -0.276 . . . . 75.25 110.878 178.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 3.8 mm? 64.06 -178.02 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.045 0.538 . . . . 62.51 111.991 -174.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 28.04 6.58 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 113.035 0.754 . . . . 71.52 113.035 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.44 15.0 0.17 Allowed Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.731 -1.223 . . . . 71.31 113.339 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.418 ' C ' ' HG3' ' A' ' 52' ' ' PRO . 3.6 mm? -95.49 160.17 31.08 Favored Pre-proline 0 C--N 1.311 -1.075 0 O-C-N 122.291 -0.534 . . . . 74.14 110.834 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -90.35 119.56 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.01 2.474 . . . . 74.14 112.504 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.497 ' HA ' ' CG ' ' A' ' 125' ' ' GLU 0.341 21.6 p90 39.78 60.66 6.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 113.835 1.05 . . . . 73.44 113.835 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 89.3 Cg_endo -115.52 144.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.153 3.235 . . . . 74.25 116.764 -170.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 82.2 m -153.46 -178.84 7.26 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 130.123 3.369 . . . . 54.21 101.916 -13.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.535 HG13 HG12 ' A' ' 108' ' ' VAL . 43.0 pt -123.35 122.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.988 -1.085 . . . . 74.3 110.94 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.33 177.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.704 -1.134 . . . . 75.05 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.8 p 50.96 102.43 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.619 1.568 . . . . 71.54 112.261 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 23.2 t -73.82 83.89 1.66 Allowed 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.799 -0.76 . . . . 73.22 111.617 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.0 -167.3 1.61 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.137 -0.938 . . . . 44.52 109.808 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.3 m -89.45 5.57 44.72 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.567 -0.901 . . . . 61.01 108.567 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.43 165.31 53.81 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.202 -0.908 . . . . 64.23 111.563 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 39' ' ' HIS . 27.9 mtmm -138.06 146.73 43.33 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.329 -0.619 . . . . 72.54 109.329 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 54' ' ' ILE . 40.3 t -110.08 122.89 65.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.183 -0.673 . . . . 73.23 109.183 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.38 125.43 46.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.288 -1.004 . . . . 61.43 108.288 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.46 -141.24 3.17 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.501 -1.04 . . . . 52.31 110.501 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.502 ' HB2' HD22 ' A' ' 18' ' ' LEU . 38.9 mtmt -136.82 138.79 41.2 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 113.291 0.849 . . . . 74.51 113.291 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 93' ' ' VAL . 31.5 m -104.7 133.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 114.689 -1.141 . . . . 53.34 110.054 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.566 HD13 HD12 ' A' ' 17' ' ' ILE . 14.5 mt -88.42 111.64 22.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 105.638 -1.986 . . . . 64.4 105.638 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -97.49 161.53 13.73 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.236 -0.586 . . . . 62.41 111.536 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 34.05 60.12 Favored Glycine 0 CA--C 1.522 0.52 0 O-C-N 123.285 0.366 . . . . 54.35 113.635 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.62 131.98 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 110.25 -0.278 . . . . 70.23 110.25 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 5' ' ' ASP . 24.2 m -78.37 158.96 28.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.124 -0.631 . . . . 75.45 109.775 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.493 ' H ' ' HB2' ' A' ' 5' ' ' ASP . 19.0 t70 -55.81 -45.44 78.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.612 -0.722 . . . . 70.12 111.342 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.51 -36.09 76.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.735 -0.666 . . . . 51.5 111.232 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 54.1 mt-10 -73.72 -35.7 65.13 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.722 -0.672 . . . . 75.21 111.09 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.5 tt -60.21 -35.41 75.37 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.706 -0.85 . . . . 65.05 108.706 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -55.5 -27.75 50.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.784 -1.098 . . . . 73.44 112.141 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.507 ' O ' HG22 ' A' ' 81' ' ' ILE . 5.4 t30 -74.33 -31.86 62.61 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 119.391 -0.924 . . . . 74.23 109.503 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.479 ' CD1' HD13 ' A' ' 26' ' ' ILE . 73.6 m-85 -71.81 -42.03 67.53 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.229 -1.397 . . . . 74.12 107.229 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.424 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 9.4 t70 -55.96 -52.63 63.47 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.261 -1.336 . . . . 72.22 110.291 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.02 -33.14 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 113.294 0.85 . . . . 61.23 113.294 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 77' ' ' ASN . 17.0 tt -101.21 -34.24 3.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 C-N-CA 118.464 -1.294 . . . . 73.14 113.996 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -79.26 -19.0 51.69 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.929 -0.708 . . . . 74.52 110.841 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.81 60.37 3.89 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.992 -0.623 . . . . 70.32 112.427 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -81.81 -44.59 16.73 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.853 -0.795 . . . . 74.44 108.853 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -141.05 21.55 2.27 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.873 -1.528 . . . . 71.44 106.873 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -122.7 153.74 39.01 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.731 -1.577 . . . . 75.43 107.401 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HB3' HG23 ' A' ' 110' ' ' VAL . 9.9 pt-20 -126.33 153.8 44.37 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 120.195 -0.602 . . . . 74.4 111.086 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' HD3' ' OD2' ' A' ' 79' ' ' ASP . 58.3 ttt180 -82.84 121.29 26.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.773 -1.103 . . . . 73.43 111.427 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.73 159.11 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.583 -0.735 . . . . 70.33 109.607 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.57 131.2 39.06 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.564 -0.902 . . . . 70.1 108.564 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.414 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.4 m -137.79 165.48 26.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.431 -1.322 . . . . 73.53 107.431 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -117.92 128.74 55.11 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.56 -1.256 . . . . 71.35 109.097 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 66' ' ' VAL . 18.3 m -125.98 168.71 18.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.879 -0.415 . . . . 65.22 109.879 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' A' ' 101' ' ' LYS . 73.5 t -109.96 118.01 55.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 115.957 -0.565 . . . . 72.0 110.786 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -73.04 105.22 4.41 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.137 -1.06 . . . . 72.31 108.137 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.87 62.31 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 124.423 1.089 . . . . 75.44 110.032 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.98 -33.92 71.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.493 -0.776 . . . . 74.23 112.334 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -128.73 0.65 5.45 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 120.627 -0.429 . . . . 71.13 111.66 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 62.28 26.78 16.04 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.471 0.708 . . . . 24.33 110.615 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.9 160.52 14.54 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.557 -0.747 . . . . 72.24 109.727 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.535 ' HG2' HG22 ' A' ' 94' ' ' VAL . 38.7 mtmt -102.4 135.69 43.55 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.536 -0.913 . . . . 45.53 108.536 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.1 m -133.87 139.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.249 0.547 . . . . 71.14 109.892 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.62 122.06 30.84 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.648 -1.612 . . . . 61.25 106.648 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 10' ' ' ASN . 17.8 m -131.52 175.13 11.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.083 0.468 . . . . 75.31 111.137 -171.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.82 146.99 27.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.771 -1.196 . . . . 73.21 107.771 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.0 t -149.5 174.32 12.62 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.279 -1.008 . . . . 60.03 108.279 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 92.6 m-85 -118.75 118.72 32.35 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.276 0.56 . . . . 73.01 109.739 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG12 HG13 ' A' ' 54' ' ' ILE . 33.7 m -108.98 175.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.184 -1.043 . . . . 63.4 108.184 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 23.0 t-105 -74.69 132.49 41.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.929 -1.508 . . . . 74.41 106.929 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.8 p -69.62 -20.78 24.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.918 0.866 . . . . 75.14 110.61 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.54 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 7.9 t30 -88.92 15.12 8.98 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.719 1.208 . . . . 72.22 109.17 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 61.3 pttt -48.94 -15.66 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.069 1.748 . . . . 75.13 115.123 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -72.84 -22.95 60.71 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.012 -0.675 . . . . 65.41 110.404 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -113.84 122.94 33.81 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.486 -0.561 . . . . 63.21 109.486 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.63 115.36 4.05 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.679 2.252 . . . . 74.54 109.591 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.697 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 30.7 ttm180 -129.61 124.26 33.3 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.741 -0.837 . . . . 72.5 108.741 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.697 ' SD ' ' HG2' ' A' ' 116' ' ' ARG . 1.3 mpt? 74.07 129.47 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.353 1.061 . . . . 74.04 112.263 -174.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -108.23 -11.33 15.25 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.671 -0.695 . . . . 72.23 110.132 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 45' ' ' LYS . . . -79.56 137.11 18.43 Favored Glycine 0 N--CA 1.431 -1.665 0 CA-C-N 115.277 -0.874 . . . . 73.03 112.539 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.53 -179.86 4.35 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.869 -0.789 . . . . 52.42 108.869 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 79.82 109.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.173 0.921 . . . . 74.13 112.381 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.603 ' O ' ' HB2' ' A' ' 126' ' ' TRP . 7.5 t70 -127.27 143.02 51.32 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.83 -1.915 . . . . 74.34 105.83 173.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.512 ' O ' ' HB3' ' A' ' 126' ' ' TRP . 53.8 p90 -67.54 -47.69 69.14 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.548 1.314 . . . . 71.32 114.548 -174.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.89 -33.78 59.96 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.803 -0.759 . . . . 64.44 112.328 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -77.13 -2.33 33.75 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.515 0.674 . . . . 75.55 111.599 174.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.603 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 28.0 t90 -81.37 -35.64 30.57 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.185 -0.916 . . . . 74.13 110.1 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -51.85 -48.92 63.78 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.88 0.738 . . . . 71.51 111.49 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.7 -34.47 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.356 -0.838 . . . . 71.41 112.835 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.46 -44.3 17.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.224 -0.658 . . . . 43.12 109.224 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -55.49 -37.67 68.13 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.033 0.933 . . . . 74.34 111.73 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.74 72.05 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.855 -0.338 . . . . 53.15 111.256 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.555 ' HA ' HG12 ' A' ' 135' ' ' VAL . 7.4 mm-40 -72.3 -35.03 68.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.597 0.713 . . . . 63.34 111.028 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -68.32 -22.08 64.72 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.466 -0.788 . . . . 73.21 112.276 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 163' ' ' SER . 5.2 m-85 -98.15 -31.85 11.9 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.051 -0.659 . . . . 75.25 112.015 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 132' ' ' GLU . 11.4 p -66.07 -33.81 66.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 C-N-CA 120.04 -0.664 . . . . 61.23 109.64 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 11.4 pt-20 -60.15 -38.79 84.2 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.432 -0.349 . . . . 65.32 110.22 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 162' ' ' SER . 74.0 m -56.38 -46.4 80.09 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 123.538 0.524 . . . . 72.54 111.038 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.483 ' HA ' ' HG2' ' A' ' 141' ' ' MET . 95.6 m-85 -67.43 -32.2 72.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.231 -0.441 . . . . 70.21 111.265 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.647 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 53.5 mtp180 -70.38 -38.88 74.79 Favored 'General case' 0 C--O 1.184 -2.391 0 C-N-CA 119.474 -0.89 . . . . 70.02 111.087 171.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 75.2 mmtt -56.24 -47.23 78.9 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.807 -0.442 . . . . 71.04 109.807 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.671 ' HA ' ' CE3' ' A' ' 144' ' ' TRP . 27.0 ptm -66.22 -30.75 71.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.074 -0.512 . . . . 75.01 110.511 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -44.71 74.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.551 -1.277 . . . . 74.35 107.551 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 7.2 mm-40 -60.93 -29.64 69.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.912 0.885 . . . . 74.35 110.747 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.671 ' CE3' ' HA ' ' A' ' 141' ' ' MET . 26.1 m0 -75.3 -44.19 46.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.627 -0.508 . . . . 74.5 109.627 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.29 -47.85 72.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.384 -0.825 . . . . 63.41 112.248 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.11 -19.41 24.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.281 0.562 . . . . 74.35 110.351 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 143' ' ' GLU 0.345 7.9 p30 46.19 72.41 1.25 Allowed Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 116.96 2.208 . . . . 74.25 116.96 176.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.22 -27.11 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.14 1.893 . . . . 74.34 112.092 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.23 -25.53 22.83 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.108 0.48 . . . . 62.2 110.711 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 90.39 12.81 60.84 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.52 -1.032 . . . . 72.32 110.52 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.63 144.94 24.83 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 109.68 -0.489 . . . . 73.14 109.68 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.1 m -105.72 171.32 7.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.435 -0.58 . . . . 42.12 109.435 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -65.41 -36.16 83.12 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.619 0.97 . . . . 61.04 113.619 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.68 -19.03 58.18 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.28 0.562 . . . . 72.32 110.753 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.9 -40.75 91.8 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.129 -1.063 . . . . 75.23 108.129 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.83 61.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.353 -0.84 . . . . 71.44 111.812 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 87.2 t -57.27 108.79 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.464 0.65 . . . . 73.32 110.743 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.25 -103.8 0.24 Allowed Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 109.277 -1.529 . . . . 72.32 109.277 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 56.6 p -89.52 75.75 7.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.39 0.614 . . . . 53.32 110.144 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 37.3 tp 179.29 150.83 0.32 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 104.977 -2.231 . . . . 70.25 104.977 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.475 ' HG ' ' H ' ' A' ' 163' ' ' SER . 48.7 tp -136.64 151.11 48.95 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.96 -0.756 . . . . 53.5 108.96 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.447 ' O ' HG21 ' A' ' 137' ' ' THR . 19.8 m -57.28 -37.33 72.23 Favored 'General case' 0 C--O 1.222 -0.385 0 O-C-N 123.6 0.563 . . . . 64.43 109.759 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.475 ' H ' ' HG ' ' A' ' 161' ' ' LEU . 60.5 p 64.83 144.37 0.03 OUTLIER 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.425 1.49 . . . . 73.4 114.873 175.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.41 -155.16 25.97 Favored Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 108.223 -1.951 . . . . 74.33 108.223 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--N 1.282 -2.328 0 N-CA-C 109.106 -0.701 . . . . 53.41 109.106 176.33 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 109.498 -0.556 . . . . 52.43 109.498 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.9 m -132.96 92.91 3.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.552 -1.277 . . . . 71.4 107.552 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.1 m -111.1 95.89 5.81 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.717 0.77 . . . . 64.33 111.534 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 m -134.83 156.38 49.0 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.636 -1.246 . . . . 72.02 107.636 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 7.2 p-10 -71.56 137.55 83.35 Favored Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 107.422 -1.325 . . . . 72.01 107.422 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 5' ' ' ASP . 3.8 Cg_exo -72.15 82.42 1.32 Allowed 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 121.782 1.654 . . . . 55.11 112.313 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.11 93.01 8.06 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 104.896 -2.261 . . . . 71.34 104.896 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.4 p -71.2 128.38 35.73 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 115.038 -0.983 . . . . 65.02 111.111 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -87.56 153.07 21.69 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.555 -0.748 . . . . 70.11 110.23 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 84.5 m-20 -133.64 131.34 39.45 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.065 -1.828 . . . . 53.43 106.065 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 28.4 t -116.3 119.37 61.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 120.326 -0.55 . . . . 62.45 110.788 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.418 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.1 t80 -89.21 109.26 20.16 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.961 -1.496 . . . . 61.14 106.961 173.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.539 HG11 HD11 ' A' ' 17' ' ' ILE . 12.4 p -136.29 154.98 33.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 119.741 -0.784 . . . . 54.12 109.994 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.439 ' HA ' HD11 ' A' ' 18' ' ' LEU . 51.0 t80 -125.11 93.27 3.83 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.094 -0.706 . . . . 64.11 109.094 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.88 -176.46 16.16 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.76 -1.109 . . . . 72.34 111.217 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m 67.5 -73.59 0.08 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 115.137 1.532 . . . . 42.33 115.137 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.539 HD11 HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -119.06 14.71 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.046 0.758 . . . . 70.35 113.046 -172.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 13' ' ' VAL . 74.7 mt -74.89 -6.72 50.71 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.195 0.522 . . . . 74.52 111.033 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 115.11 60.47 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 107.436 -1.32 . . . . 62.03 107.436 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -42.24 -44.09 7.72 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.326 3.35 . . . . 71.04 114.659 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.69 -43.12 94.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.169 0.509 . . . . 72.35 111.494 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 25' ' ' VAL . 46.6 t -71.58 -38.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.965 -0.561 . . . . 74.33 110.248 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.73 74.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.465 0.65 . . . . 64.03 110.05 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -74.84 -16.48 60.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.648 -0.705 . . . . 75.34 111.903 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.3 m -93.54 -33.51 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.493 -0.883 . . . . 65.04 111.233 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' ' 78' ' ' PHE . 9.2 tt -72.46 -47.04 53.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 CA-C-O 120.587 0.232 . . . . 74.11 111.119 177.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 31' ' ' ALA . 90.7 mt -85.71 -11.98 52.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 121.221 -0.191 . . . . 71.3 110.877 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.53 8.91 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.287 1.042 . . . . 74.33 110.296 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 97.5 mtt180 -145.12 178.66 7.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.162 -0.926 . . . . 75.24 109.321 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.6 p -76.66 111.2 11.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.523 0.678 . . . . 72.04 110.922 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.55 -0.75 . . . . 55.31 110.321 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -100.17 109.69 21.96 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.571 -0.529 . . . . 73.31 109.571 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 2.8 p -114.09 142.58 46.03 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 109.096 -0.705 . . . . 74.15 109.096 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -142.22 141.45 21.36 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 107.896 -1.15 . . . . 64.13 107.896 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 3.2 Cg_endo -59.76 135.78 66.05 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 121.47 1.447 . . . . 73.32 110.456 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -148.88 157.87 43.75 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.691 -0.686 . . . . 41.23 110.461 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.574 HG11 ' HD3' ' A' ' 61' ' ' LYS . 22.0 t -115.63 124.21 71.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 115.353 -0.839 . . . . 62.44 111.443 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.491 HD11 ' HB ' ' A' ' 91' ' ' VAL . 22.6 tp -97.6 86.67 3.88 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.211 0.529 . . . . 75.13 111.015 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 25.0 p-80 -62.34 132.47 52.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.027 -0.988 . . . . 74.44 109.46 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.38 -23.93 11.9 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.349 -0.929 . . . . 71.41 112.425 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.464 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 48.2 m-85 -109.81 160.46 16.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 112.481 0.548 . . . . 74.2 112.481 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -131.61 126.84 35.77 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.26 -1.385 . . . . 73.32 107.26 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 24.7 ptt180 -89.68 136.71 32.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.102 -1.039 . . . . 72.4 111.376 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.39 -177.56 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.946 -1.025 . . . . 75.12 109.58 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HD2' ' A' ' 45' ' ' LYS 0.252 0.0 OUTLIER -138.43 91.83 2.58 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.73 1.252 . . . . 75.1 112.199 178.497 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mm? -92.54 125.73 37.31 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.415 -0.812 . . . . 61.24 109.937 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -9.01 23.39 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.574 -0.739 . . . . 75.44 110.508 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.72 -14.82 39.07 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.409 -0.814 . . . . 71.35 111.191 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.441 HD12 ' HG ' ' A' ' 46' ' ' LEU . 94.8 mt -118.46 163.57 24.75 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 109.448 -0.575 . . . . 73.01 109.448 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -79.25 99.65 1.26 Allowed 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 123.074 2.516 . . . . 64.01 114.708 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.615 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.5 p90 43.91 37.86 0.32 Allowed Pre-proline 0 CA--C 1.594 2.668 0 N-CA-C 116.614 2.079 . . . . 75.04 116.614 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 9.3 Cg_endo -97.77 167.18 0.8 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 123.384 2.723 . . . . 74.02 111.775 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.475 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 16.3 p -155.97 -169.52 3.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.582 2.353 . . . . 71.23 107.302 -4.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 36.5 pt -125.88 123.35 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 109.99 -0.374 . . . . 74.33 109.99 167.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' SER . 59.1 t -146.21 118.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.841 -0.8 . . . . 61.55 108.841 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 26.8 t 174.57 164.43 0.23 Allowed 'General case' 0 C--O 1.241 0.658 0 O-C-N 123.533 0.52 . . . . 71.32 110.23 175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -137.19 7.85 2.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.227 -1.397 . . . . 74.3 107.227 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.94 -166.94 1.47 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.198 -1.365 . . . . 73.34 109.774 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.8 m -93.86 14.69 18.67 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.838 0.455 . . . . 43.11 111.657 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.79 168.26 54.78 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 109.557 -1.417 . . . . 64.43 109.557 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.574 ' HD3' HG11 ' A' ' 37' ' ' VAL . 7.8 ptpp? -146.21 152.1 38.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.894 0.847 . . . . 72.14 111.117 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.402 HG21 ' CG2' ' A' ' 54' ' ' ILE . 54.0 t -115.51 133.41 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.402 -0.592 . . . . 55.12 109.402 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -99.9 137.64 38.08 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.3 -1.0 . . . . 62.13 108.3 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -166.1 -147.61 5.25 Favored Glycine 0 C--N 1.301 -1.373 0 N-CA-C 110.471 -1.052 . . . . 64.24 110.471 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' HB2' HD22 ' A' ' 18' ' ' LEU . 44.8 mtmt -133.8 143.02 48.13 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.065 0.432 . . . . 60.11 111.844 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.1 m -108.68 133.18 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.157 -0.928 . . . . 60.23 110.946 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 23.7 mt -90.31 114.99 28.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.142 -1.799 . . . . 71.3 106.142 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.2 p -103.92 161.36 14.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.026 -0.67 . . . . 74.3 111.89 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.89 22.46 68.94 Favored Glycine 0 CA--C 1.506 -0.528 0 CA-C-N 115.728 -0.669 . . . . 53.43 113.082 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.02 121.83 37.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.893 -0.41 . . . . 72.04 109.893 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 18.0 m -73.18 158.62 34.9 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.378 -0.971 . . . . 64.24 108.378 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.39 -40.31 71.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.154 0.502 . . . . 71.43 111.64 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.64 78.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.927 -0.579 . . . . 74.44 110.838 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 48.0 mm-40 -72.31 -34.39 68.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.184 0.516 . . . . 70.54 110.212 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.63 -36.64 76.76 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.368 -0.833 . . . . 74.2 108.859 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.682 ' O ' HG23 ' A' ' 80' ' ' VAL . 28.2 t-20 -58.92 -29.41 67.07 Favored 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 114.628 -1.169 . . . . 70.1 111.467 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -68.3 -35.25 77.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.822 -0.807 . . . . 51.12 108.822 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 26' ' ' ILE . 94.2 m-85 -74.16 -37.27 64.06 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.536 -0.756 . . . . 65.34 108.964 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.99 -34.19 77.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.201 -1.363 . . . . 73.03 110.995 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 76' ' ' ASN . 60.8 t -75.26 -42.96 43.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.71 -0.677 . . . . 71.13 111.709 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.8 tt -74.85 -61.14 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 114.675 1.361 . . . . 64.21 114.675 -170.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -115.65 171.57 7.66 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.99 -0.444 . . . . 54.35 109.845 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 55.67 2.26 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.648 -0.787 . . . . 70.41 112.83 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.27 -42.31 46.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.759 0.281 . . . . 72.52 111.759 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.602 ' HB3' ' CH2' ' A' ' 109' ' ' TRP . 1.9 t70 -108.16 26.43 10.42 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.325 -1.361 . . . . 73.01 107.325 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 51.6 m-85 -114.1 155.51 25.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.608 -1.178 . . . . 74.14 109.692 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.54 ' HB3' HG12 ' A' ' 110' ' ' VAL . 15.7 pt-20 -126.66 158.6 35.94 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.3 0.375 . . . . 73.4 110.321 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -88.86 113.73 24.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.82 -0.627 . . . . 63.55 110.426 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.47 150.33 34.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 109.974 -0.38 . . . . 72.3 109.974 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.9 m -94.86 123.1 38.13 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.026 -0.731 . . . . 72.11 109.026 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' A' ' 38' ' ' LEU . 33.7 m -127.38 158.76 38.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.11 -1.07 . . . . 72.14 108.11 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -113.52 132.23 55.77 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.907 -1.117 . . . . 72.05 108.615 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.515 HG21 HG11 ' A' ' 66' ' ' VAL . 20.1 m -126.41 168.27 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 121.304 0.573 . . . . 74.35 110.331 -176.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 101' ' ' LYS . 67.5 t -110.04 117.13 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 115.325 -0.852 . . . . 61.44 110.299 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 38.3 ttm180 -65.43 98.58 0.36 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.546 -0.909 . . . . 74.3 108.546 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.473 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 1.2 tmt? -53.84 -34.76 60.28 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 126.259 1.824 . . . . 74.12 110.908 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.02 -41.31 87.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.587 -0.733 . . . . 72.43 112.232 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -118.84 -3.95 10.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 120.315 -0.554 . . . . 75.32 112.355 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.8 m 67.44 24.98 8.66 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.73 0.812 . . . . 35.42 111.495 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.5 pt-20 -104.61 159.71 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.246 -0.65 . . . . 70.21 109.246 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.0 mtmt -102.48 135.08 44.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.699 -0.852 . . . . 62.03 108.699 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.62 138.47 44.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.03 0.443 . . . . 75.44 110.237 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.89 126.22 34.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.971 -1.122 . . . . 75.01 107.971 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 10' ' ' ASN . 16.3 m -133.23 174.68 12.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 120.733 0.301 . . . . 74.15 110.256 -173.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.97 150.27 28.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.558 -1.275 . . . . 72.02 107.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 t -145.94 175.18 10.63 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.421 -0.585 . . . . 61.24 109.421 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.68 118.35 36.43 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.052 -1.092 . . . . 62.11 108.052 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 54' ' ' ILE . 12.7 p -112.35 148.65 15.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.288 -1.375 . . . . 62.33 107.288 176.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.602 ' CH2' ' HB3' ' A' ' 85' ' ' ASP . 41.6 t-105 -73.08 125.93 28.82 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.693 -1.225 . . . . 72.22 107.693 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 87' ' ' GLU . 24.8 m -62.6 -22.46 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.947 0.721 . . . . 62.13 112.947 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.539 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 63.1 t30 -81.39 12.7 3.43 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.765 0.793 . . . . 73.32 110.09 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 -14.83 0.16 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.005 1.854 . . . . 64.43 116.005 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.07 -17.5 52.53 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.408 -0.517 . . . . 74.44 112.075 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.63 126.89 67.57 Favored Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 119.37 -0.932 . . . . 74.33 110.355 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.0 -6.11 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.719 2.946 . . . . 54.44 115.373 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -125.69 113.78 17.79 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.581 0.705 . . . . 54.04 110.846 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 39.3 ttm -153.14 27.81 0.52 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.19 0.995 . . . . 71.5 108.735 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -72.72 -19.09 61.46 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 114.73 -1.123 . . . . 75.35 111.243 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.81 -139.07 23.9 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.5 -0.773 . . . . 52.33 112.811 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -113.23 -178.13 3.3 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 122.652 0.381 . . . . 64.45 111.447 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 76.0 m95 85.83 -159.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.416 1.886 . . . . 71.32 108.786 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.03 137.46 39.36 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.855 -0.338 . . . . 75.51 111.307 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -68.33 -40.48 81.59 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.954 -0.566 . . . . 74.22 111.98 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.7 tt0 -73.03 -35.81 66.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 120.948 0.404 . . . . 74.22 110.094 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 129' ' ' VAL . 33.1 tt0 -56.35 -43.56 79.22 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.499 -0.926 . . . . 64.35 108.499 173.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -60.23 -42.72 95.83 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.825 -0.625 . . . . 72.4 110.481 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.591 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 99.8 mtt180 -56.87 -48.58 77.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.272 -0.64 . . . . 64.42 109.272 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.624 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 79.2 t -59.21 -47.08 91.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.93 -1.032 . . . . 74.11 111.023 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 125' ' ' GLU . 98.6 t -67.35 -44.36 87.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.709 -0.223 . . . . 61.21 111.537 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.591 ' CE1' ' HA ' ' A' ' 127' ' ' ARG 0.253 3.7 p-80 -72.16 -30.41 64.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 118.612 -1.235 . . . . 74.51 111.827 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.33 77.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.979 -0.378 . . . . 43.45 109.979 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 42.6 mt-10 -63.31 -37.98 89.36 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-N 115.728 -0.669 . . . . 71.15 109.969 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 8.9 mmpt? -62.26 -38.26 88.6 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.069 -0.969 . . . . 74.43 110.479 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 86.8 m-85 -73.09 -52.16 15.32 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.842 -0.617 . . . . 64.25 111.098 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.1 p -59.89 -39.02 78.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 112.134 0.42 . . . . 72.53 112.134 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 48.6 mt-10 -59.07 -43.5 91.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 117.678 0.217 . . . . 60.21 111.048 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 86.6 m -58.36 -48.53 80.29 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.986 -0.552 . . . . 63.4 110.045 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.48 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 83.3 m-85 -61.73 -43.93 97.9 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.374 -0.376 . . . . 73.31 111.543 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 81.9 mtp180 -59.8 -44.83 93.79 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 123.047 0.217 . . . . 74.01 111.051 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 67.9 mttm -61.57 -47.34 85.95 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.314 0.384 . . . . 73.15 110.535 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.1 -34.99 78.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.12 110.964 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 91.3 mt -69.19 -38.88 78.88 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 116.291 -0.413 . . . . 73.41 110.628 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 32.3 mm-40 -59.35 -36.36 75.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.714 0.292 . . . . 74.41 110.362 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -68.22 -40.68 82.02 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.218 0.821 . . . . 64.54 113.218 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -74.32 -25.83 59.79 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.586 0.707 . . . . 51.23 110.606 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -78.91 -30.58 44.9 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.719 1.207 . . . . 74.43 112.161 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.36 99.82 45.39 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 120.249 -0.581 . . . . 53.04 112.457 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.28 -35.62 72.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.506 2.138 . . . . 74.55 110.103 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.27 -8.72 58.38 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.893 -1.049 . . . . 75.22 111.156 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.22 72.4 Favored Glycine 0 CA--C 1.507 -0.41 0 N-CA-C 111.252 -0.739 . . . . 73.01 111.252 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -94.04 149.3 21.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.438 -1.69 . . . . 72.04 106.438 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.495 ' H ' ' HB2' ' A' ' 155' ' ' GLU . 89.4 p -81.64 178.32 8.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.81 -0.811 . . . . 74.12 108.81 175.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -60.41 -30.83 69.86 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.193 0.521 . . . . 73.53 110.658 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -91.94 -23.69 19.5 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 116.015 -0.539 . . . . 70.34 110.814 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.495 ' HB2' ' H ' ' A' ' 152' ' ' SER . 23.5 mm-40 -74.82 -42.27 58.34 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.983 0.421 . . . . 64.01 111.397 174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.35 -34.83 48.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.077 -0.51 . . . . 65.44 109.933 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.9 t 58.16 114.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.785 1.234 . . . . 74.23 111.972 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.14 32.15 6.89 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 120.38 -0.914 . . . . 32.22 111.973 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.4 m -84.38 137.58 33.33 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.261 -1.014 . . . . 70.15 108.261 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.3 tp -96.7 130.11 43.99 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.601 -0.518 . . . . 73.01 109.601 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.7 tp -158.98 157.52 31.45 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.672 -1.232 . . . . 71.15 107.672 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 m -76.77 84.12 3.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.377 0.608 . . . . 71.33 110.34 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 54.7 m -157.18 90.57 1.13 Allowed 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 124.499 1.12 . . . . 72.31 108.273 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 174.8 73.08 0.05 OUTLIER Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 110.431 -1.068 . . . . 64.31 110.431 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 108.855 -0.795 . . . . 72.5 108.855 179.505 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 120.589 0.233 . . . . 63.42 110.791 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.9 p -84.44 105.79 15.54 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 121.234 0.54 . . . . 74.31 110.774 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 m -68.62 -26.44 65.35 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.254 -0.885 . . . . 75.42 112.532 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 m -127.29 83.87 2.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.29 0.567 . . . . 74.24 110.757 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 11.6 t70 -93.79 -61.74 0.18 Allowed Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.873 -0.603 . . . . 43.42 112.574 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 5' ' ' ASP . 5.7 Cg_exo -80.98 -43.56 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.215 1.277 . . . . 72.23 112.679 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -142.01 -173.9 3.94 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 123.565 0.746 . . . . 74.0 109.218 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m -127.77 151.89 48.44 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.686 -1.598 . . . . 74.2 106.686 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -87.88 155.56 19.81 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.553 0.692 . . . . 71.35 112.186 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.467 ' HB2' HG12 ' A' ' 104' ' ' VAL . 42.4 m-80 -135.82 123.74 22.71 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.901 -1.518 . . . . 75.3 106.901 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.554 HG12 HG23 ' A' ' 13' ' ' VAL . 51.3 t -120.31 122.95 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 120.959 -0.297 . . . . 61.35 110.71 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -90.95 99.15 12.23 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.122 -0.695 . . . . 72.54 109.122 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.554 HG23 HG12 ' A' ' 11' ' ' VAL . 72.9 t -139.15 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.228 -0.286 . . . . 71.41 110.228 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.12 -73.89 0.23 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.932 -1.136 . . . . 74.12 107.932 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' HA2' ' CG ' ' A' ' 51' ' ' TYR . . . 45.38 -123.83 6.25 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 123.739 0.649 . . . . 63.14 113.344 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -139.07 9.36 2.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.743 -0.836 . . . . 74.13 108.743 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.523 HG21 HD13 ' A' ' 67' ' ' ILE . 40.9 mt -74.94 -8.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.972 -1.013 . . . . 65.34 110.31 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 65' ' ' LYS . 54.1 mt -59.27 -24.39 63.2 Favored 'General case' 0 C--O 1.247 0.944 0 CA-C-N 115.241 -0.89 . . . . 74.0 110.826 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.76 124.86 48.85 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.1 -0.955 . . . . 75.3 108.953 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.29 -35.43 11.41 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.603 3.535 . . . . 72.43 114.491 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -42.74 82.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.923 0.392 . . . . 72.3 111.224 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.6 -35.43 56.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.322 -0.399 . . . . 73.2 110.597 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.11 70.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.235 0.54 . . . . 60.43 109.844 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.61 71.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.663 -0.699 . . . . 73.34 110.854 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 m -71.02 -29.19 35.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.143 -0.623 . . . . 72.13 111.604 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.619 HG13 ' ND2' ' A' ' 77' ' ' ASN . 4.7 tt -79.46 -46.96 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 112.532 0.568 . . . . 64.32 112.532 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 74' ' ' GLU . 36.8 mt -91.1 -14.55 31.02 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.188 -0.605 . . . . 60.5 112.227 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 t70 69.49 14.63 8.35 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 123.433 1.587 . . . . 63.23 108.35 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -147.36 135.43 21.4 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.643 -1.984 . . . . 60.13 105.643 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.0 m -76.95 111.12 12.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.5 -0.48 . . . . 65.31 110.295 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -93.74 143.73 26.06 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.607 -0.886 . . . . 31.44 108.607 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.4 126.04 42.4 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.122 -0.49 . . . . 64.13 110.303 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 14.7 p -93.71 144.05 25.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.969 -0.382 . . . . 44.43 109.969 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.22 139.41 35.59 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 108.829 -0.804 . . . . 73.24 108.829 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.92 129.53 35.46 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.754 2.303 . . . . 60.33 111.807 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.57 157.41 43.24 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.594 -0.73 . . . . 74.35 110.097 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.551 HG22 ' CG ' ' A' ' 61' ' ' LYS . 11.5 p -126.28 132.74 70.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-O 121.158 0.504 . . . . 72.11 110.429 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.453 ' HA ' HG12 ' A' ' 93' ' ' VAL . 22.3 tp -91.68 112.33 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.71 -0.677 . . . . 73.3 111.745 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -88.68 112.21 22.86 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.473 -0.785 . . . . 61.15 109.494 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.09 -40.42 1.4 Allowed Glycine 0 C--N 1.305 -1.149 0 C-N-CA 120.653 -0.784 . . . . 64.55 112.695 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.466 ' O ' HG23 ' A' ' 62' ' ' VAL . 41.7 m-85 -108.96 166.41 10.85 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 122.782 -0.246 . . . . 72.05 111.346 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -137.08 134.58 36.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.008 -1.108 . . . . 60.22 108.008 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 25.7 ptt180 -88.87 125.84 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.339 0.59 . . . . 73.03 111.1 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CE2' ' HA ' ' A' ' 118' ' ' TYR . 91.6 m-85 -98.23 145.92 26.14 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.097 -0.956 . . . . 74.24 110.691 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -91.39 100.13 12.97 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-O 121.729 0.776 . . . . 75.31 110.942 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -119.96 121.55 39.23 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.591 -1.186 . . . . 71.41 111.032 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -85.87 -5.63 59.21 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 113.233 0.827 . . . . 64.42 113.233 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.15 -25.66 65.86 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.398 -0.906 . . . . 71.0 111.751 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 46' ' ' LEU . 3.6 mm? -119.56 156.46 53.44 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-O 120.772 0.32 . . . . 64.24 111.607 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.73 146.86 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.87 2.38 . . . . 72.11 111.063 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.612 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 37.3 p90 44.47 41.91 0.82 Allowed Pre-proline 0 N--CA 1.506 2.33 0 N-CA-C 115.39 1.626 . . . . 73.0 115.39 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 78.4 Cg_endo -110.54 156.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.242 2.628 . . . . 74.34 114.806 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 89.0 m -153.76 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 131.368 3.867 . . . . 72.43 103.33 -15.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 25.5 pt -121.82 136.84 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-N 119.553 1.069 . . . . 63.45 110.914 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.45 HG13 ' HA ' ' A' ' 112' ' ' LYS . 43.1 t -127.0 -80.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 115.026 -0.988 . . . . 72.33 112.589 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.4 p -177.17 156.21 1.23 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.809 -0.441 . . . . 75.25 109.809 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.1 m -165.08 173.63 11.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.138 0.975 . . . . 60.02 109.639 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.1 -65.68 0.58 Allowed 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 123.859 0.724 . . . . 72.34 110.01 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 p -105.98 -36.34 7.0 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 119.74 -0.784 . . . . 74.41 109.535 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.93 117.79 0.0 OUTLIER Glycine 0 C--N 1.361 1.971 0 C-N-CA 125.474 1.511 . . . . 74.32 116.817 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.551 ' CG ' HG22 ' A' ' 37' ' ' VAL . 21.9 ttpp -141.63 139.4 33.04 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.793 -1.563 . . . . 63.11 112.621 173.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 41' ' ' TYR . 54.4 t -123.86 123.72 67.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 C-N-CA 123.715 0.806 . . . . 71.35 111.252 -173.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -96.11 128.62 43.17 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.475 -0.49 . . . . 54.24 110.301 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.97 -142.58 3.44 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.85 -1.3 . . . . 21.12 109.85 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 50.3 mtpt -140.44 146.72 38.65 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.779 -1.193 . . . . 72.43 107.779 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.484 HG11 HG21 ' A' ' 93' ' ' VAL . 26.8 m -104.49 135.44 42.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.043 0.449 . . . . 75.24 110.305 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.523 HD13 HG21 ' A' ' 17' ' ' ILE . 11.6 mt -85.72 110.61 19.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 104.479 -2.415 . . . . 74.51 104.479 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.6 p -101.23 161.94 13.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 111.766 0.284 . . . . 71.23 111.766 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.16 73.62 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.91 -0.586 . . . . 73.12 112.693 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.71 124.23 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 109.046 -0.724 . . . . 75.04 109.046 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 30.9 m -73.71 157.45 36.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.19 -0.67 . . . . 74.12 109.19 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.01 -46.08 68.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.771 0.428 . . . . 73.45 111.003 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -68.72 -36.96 79.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.299 0.571 . . . . 63.13 110.826 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.602 ' HB3' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -68.56 -34.57 76.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.414 -0.812 . . . . 74.22 111.685 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.457 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.6 tt -61.55 -37.9 85.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.302 -1.37 . . . . 65.55 107.302 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.554 ' O ' HG23 ' A' ' 80' ' ' VAL . 13.9 m120 -54.75 -26.73 36.07 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.851 1.056 . . . . 73.04 113.851 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.619 ' ND2' HG13 ' A' ' 26' ' ' ILE . 2.7 t30 -67.32 -34.41 77.3 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.76 -1.176 . . . . 72.21 108.595 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.599 ' CE2' HD21 ' A' ' 27' ' ' LEU . 86.5 m-85 -69.24 -34.2 74.45 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.913 -1.143 . . . . 73.1 107.913 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.99 -31.32 70.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.469 -1.242 . . . . 73.23 110.226 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 76' ' ' ASN . 90.7 t -72.8 -36.6 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.715 -0.675 . . . . 61.22 109.58 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 77' ' ' ASN . 48.2 mm -59.71 -40.95 83.76 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 N-CA-C 106.804 -1.554 . . . . 72.24 106.804 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 73.06 -81.76 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.775 -1.557 . . . . 64.24 114.861 167.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.71 104.2 1.01 Allowed Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 108.636 -1.786 . . . . 74.43 108.636 -172.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.34 -40.52 96.64 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.189 0.519 . . . . 60.43 111.722 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 110' ' ' VAL . 10.9 m-20 -97.73 8.53 44.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.746 -0.661 . . . . 73.14 109.807 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 96.9 m-85 -115.94 154.78 29.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.958 -0.564 . . . . 62.03 110.021 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -136.05 141.93 44.34 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.406 -0.59 . . . . 65.03 109.406 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 0.4 OUTLIER -88.52 109.56 20.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.415 0.626 . . . . 75.22 111.317 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.65 160.7 24.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.749 -1.114 . . . . 53.4 110.966 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -91.12 131.37 36.73 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.696 -0.853 . . . . 55.41 108.696 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.8 m -133.93 172.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.496 -1.298 . . . . 52.44 107.496 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -125.37 127.59 46.83 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.873 -1.131 . . . . 72.43 109.523 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.484 HG21 HG11 ' A' ' 66' ' ' VAL . 18.2 m -126.72 168.24 20.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.316 0.579 . . . . 72.44 110.314 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 101' ' ' LYS . 54.7 t -113.5 121.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.757 -0.831 . . . . 73.42 108.757 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.36 103.93 2.13 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 106.8 -1.555 . . . . 72.53 106.8 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.603 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 9.8 tmm? -61.62 -32.89 73.05 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.91 -1.144 . . . . 71.12 107.91 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.68 -44.96 81.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.936 -1.029 . . . . 73.24 112.336 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -111.42 -2.69 15.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.105 0.478 . . . . 71.1 110.956 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t 63.5 24.28 14.0 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.942 1.297 . . . . 70.04 110.993 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -105.12 160.53 14.99 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.985 -0.376 . . . . 65.45 109.985 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.593 ' HG2' HG22 ' A' ' 94' ' ' VAL . 55.4 mtpt -101.02 132.39 46.46 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.006 -0.739 . . . . 72.33 109.006 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.55 137.82 43.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.302 0.572 . . . . 73.13 110.838 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -87.77 119.34 28.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.835 -1.543 . . . . 74.05 106.835 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 10' ' ' ASN . 21.0 m -127.31 175.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 120.949 0.404 . . . . 73.13 111.066 -172.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.99 150.32 34.03 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.863 -0.421 . . . . 74.14 109.863 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 13.4 t -151.84 174.46 13.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.367 -0.605 . . . . 74.51 109.367 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 88' ' ' ARG . 52.1 m-85 -114.39 118.12 32.96 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.466 -0.939 . . . . 71.24 108.466 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 30.6 m -109.87 172.5 2.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.946 -0.57 . . . . 72.14 110.373 -177.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.53 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 31.5 t-105 -86.39 121.71 29.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.101 -0.703 . . . . 71.21 109.101 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.4 m -72.06 -19.7 19.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-O 121.391 0.615 . . . . 71.41 112.291 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.469 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.6 t-20 -88.68 14.81 9.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.369 1.081 . . . . 62.3 109.333 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 40.1 ttmt -49.78 -24.92 2.63 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 127.459 2.303 . . . . 73.44 114.589 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -80.93 -21.67 40.29 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.776 1.028 . . . . 63.14 113.776 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -103.46 137.0 19.13 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 107.06 -1.459 . . . . 74.45 107.06 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.67 120.98 8.98 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.856 2.37 . . . . 74.15 114.468 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -124.6 113.52 18.15 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 109.047 -0.723 . . . . 74.51 109.047 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 51.88 28.43 5.08 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.326 1.016 . . . . 72.45 112.37 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.409 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 51.7 t80 -77.8 -48.29 16.88 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.746 -0.661 . . . . 70.01 110.244 -177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -104.26 13.42 51.76 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 120.064 -1.065 . . . . 61.13 112.293 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -143.54 130.75 20.79 Favored 'General case' 0 N--CA 1.427 -1.601 0 C-N-CA 120.473 -0.491 . . . . 75.02 110.554 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.0 t90 174.97 159.0 0.18 Allowed 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 126.274 1.829 . . . . 73.44 106.765 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.62 113.27 20.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.623 0.249 . . . . 55.13 110.437 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 126' ' ' TRP . 97.4 m-85 -68.46 -26.11 65.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.71 0.767 . . . . 73.21 109.614 175.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.9 -38.68 91.79 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.272 -0.877 . . . . 65.24 109.521 173.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.55 -34.7 67.7 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.882 -0.784 . . . . 52.31 108.882 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.506 ' HB3' ' O ' ' A' ' 123' ' ' PHE . 1.8 t90 -50.35 -46.86 56.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.61 0.764 . . . . 65.21 109.022 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 90.4 mtt180 -63.16 -49.22 75.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.825 -0.625 . . . . 74.31 111.874 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -38.77 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.328 0.492 . . . . 74.31 112.328 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.02 -43.93 81.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.972 -0.381 . . . . 64.2 109.972 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.542 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 56.4 t-80 -57.13 -38.55 73.63 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.909 -0.404 . . . . 74.21 109.909 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.78 -46.89 70.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.57 -0.287 . . . . 55.35 111.406 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 44.8 mt-10 -68.08 -40.03 82.79 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 111.943 0.349 . . . . 73.43 111.943 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.68 -31.9 73.17 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.152 0.797 . . . . 72.24 113.152 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.542 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 57.9 m-85 -83.91 -44.27 14.43 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.589 -0.844 . . . . 73.14 111.315 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 132' ' ' GLU . 14.7 p -63.92 -36.75 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 120.54 -0.464 . . . . 74.12 111.226 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -62.21 -36.35 81.68 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 120.18 -0.608 . . . . 75.41 110.425 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.8 m -63.39 -46.06 88.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.507 -0.315 . . . . 70.45 110.282 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -63.13 -37.13 85.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.778 0.323 . . . . 60.45 111.26 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.05 -44.54 68.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.45 -0.341 . . . . 75.25 111.316 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 32.3 mmmt -62.26 -44.05 97.44 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.715 0.293 . . . . 72.25 111.402 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.57 -31.88 72.26 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.368 -0.533 . . . . 73.4 110.715 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 tp -66.16 -50.56 63.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.391 -0.368 . . . . 55.23 110.384 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' ' HA2' ' A' ' 150' ' ' GLY . 10.4 pt-20 -62.16 -44.17 97.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 121.055 -0.258 . . . . 70.11 111.263 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.407 ' CZ2' ' HE3' ' A' ' 140' ' ' LYS . 23.5 m0 -65.61 -40.68 92.9 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 112.258 0.466 . . . . 73.24 112.258 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.3 -36.75 53.81 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.102 0.477 . . . . 73.51 111.98 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -79.82 -21.29 44.41 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.353 0.501 . . . . 72.11 112.353 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.69 142.55 45.92 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 119.815 -0.754 . . . . 63.24 109.598 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.66 -37.29 94.97 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.866 2.377 . . . . 72.13 112.253 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.74 -9.41 54.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.449 0.642 . . . . 63.33 109.475 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 143' ' ' GLU . . . 75.45 -100.14 1.27 Allowed Glycine 0 N--CA 1.41 -3.079 0 N-CA-C 108.934 -1.666 . . . . 22.04 108.934 -173.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 156' ' ' ALA . 31.5 ttpt -99.42 130.7 45.71 Favored 'General case' 0 C--N 1.268 -2.953 0 N-CA-C 108.957 -0.757 . . . . 72.02 108.957 174.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.6 m -67.63 161.37 25.92 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 123.278 0.361 . . . . 61.14 111.71 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.5 ' O ' HG23 ' A' ' 157' ' ' VAL . 27.2 ptt? -57.28 -44.55 84.09 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.6 1.333 . . . . 73.42 114.6 -171.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -81.26 -34.31 32.16 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 108.828 -0.804 . . . . 74.15 108.828 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.45 -37.19 86.65 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.429 -1.259 . . . . 74.4 110.091 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.415 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . . . -70.26 -25.82 63.54 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.547 -0.751 . . . . 73.45 110.783 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 153' ' ' MET . 60.8 t -81.41 103.9 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 108.106 -1.072 . . . . 72.24 108.106 176.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 128.81 61.75 0.11 Allowed Glycine 0 N--CA 1.415 -2.711 0 N-CA-C 109.689 -1.364 . . . . 54.43 109.689 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.4 m -86.28 -26.31 25.03 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.408 -0.96 . . . . 74.24 108.408 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 mp 65.88 119.55 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 125.11 1.364 . . . . 73.21 113.387 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 163' ' ' SER . 39.6 tp -81.89 -41.4 21.0 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.242 -1.762 . . . . 74.24 106.242 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t 58.57 23.55 10.98 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 125.324 1.45 . . . . 65.21 110.371 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.417 ' HB2' ' HG ' ' A' ' 161' ' ' LEU . 19.9 m -124.54 85.82 2.47 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.447 -0.797 . . . . 74.31 110.387 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.71 12.49 6.21 Favored Glycine 0 CA--C 1.506 -0.496 0 N-CA-C 111.18 -0.768 . . . . 52.25 111.18 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 . . . . . 0 C--O 1.254 1.299 0 N-CA-C 108.519 -0.919 . . . . 53.55 108.519 -179.569 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.883 -0.414 . . . . 62.21 109.883 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 t -88.25 97.16 10.86 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.021 -0.733 . . . . 72.54 109.021 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 m 64.89 95.94 0.05 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.208 -0.905 . . . . 75.52 110.221 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.6 m -65.59 105.91 1.33 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 116.26 -0.427 . . . . 72.03 110.32 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.9 t70 69.25 103.07 0.03 OUTLIER Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.865 1.266 . . . . 72.15 109.502 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.48 37.43 0.68 Allowed 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 123.441 2.761 . . . . 62.01 112.242 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 63.57 90.82 0.08 Allowed 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 124.353 1.061 . . . . 71.42 110.683 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.506 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 58.8 m -110.62 171.46 7.45 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 121.516 0.675 . . . . 74.12 111.141 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -130.42 157.4 42.7 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.029 -0.987 . . . . 73.33 109.298 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.9 m-20 -127.44 124.6 38.83 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 31.11 107.933 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 59.6 t -120.9 120.72 63.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 121.027 -0.269 . . . . 71.32 111.685 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' HB2' HG21 ' A' ' 104' ' ' VAL . 46.0 t80 -84.38 111.36 19.37 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.949 -1.5 . . . . 75.25 106.949 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 17' ' ' ILE . 8.6 p -123.25 137.63 55.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.732 -0.787 . . . . 63.23 111.105 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -100.04 97.85 8.66 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.943 -1.132 . . . . 74.42 107.943 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.454 ' H ' HD12 ' A' ' 18' ' ' LEU . . . 81.8 -142.0 22.24 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.012 -0.835 . . . . 50.14 111.012 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.9 t 65.49 -79.03 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.261 1.024 . . . . 74.45 113.416 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.581 HG22 HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -117.95 12.98 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 75.3 111.763 -175.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.469 HD13 ' HE3' ' A' ' 65' ' ' LYS . 80.3 mt -68.18 -18.65 64.66 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 73.4 109.416 174.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.78 116.86 63.02 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 107.648 -1.242 . . . . 63.2 107.648 172.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.69 -39.72 18.35 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.302 3.334 . . . . 65.22 114.634 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.17 94.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.991 0.424 . . . . 74.33 111.688 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 17' ' ' ILE . 22.3 t -72.46 -36.56 54.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.714 -0.676 . . . . 73.11 109.606 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 17' ' ' ILE . . . -62.53 -37.11 84.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.405 0.622 . . . . 31.42 109.88 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.92 -19.05 62.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.556 -0.747 . . . . 74.45 112.059 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.3 m -91.17 -30.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 119.511 -0.876 . . . . 74.12 110.975 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.553 HG12 ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -78.63 -47.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-O 120.696 0.284 . . . . 63.22 110.356 178.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.434 ' HG ' HG23 ' A' ' 26' ' ' ILE . 95.5 mt -92.96 -10.41 36.48 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 112.106 0.41 . . . . 74.11 112.106 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 19.5 t70 76.61 -14.05 0.86 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.513 1.149 . . . . 73.51 110.279 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 27' ' ' LEU . 27.8 ptt180 -133.73 168.03 19.46 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.405 -1.27 . . . . 75.13 108.153 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.2 m -76.25 135.22 39.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.611 -0.885 . . . . 72.52 108.611 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.414 ' HB1' HG23 ' A' ' 67' ' ' ILE . . . -75.1 135.58 41.17 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 116.43 -0.35 . . . . 61.22 110.979 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.06 109.07 19.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.122 -1.436 . . . . 72.44 107.122 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.1 p -117.9 143.89 45.93 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 115.723 -0.672 . . . . 62.3 110.718 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.9 146.17 60.2 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 107.771 -1.196 . . . . 73.41 107.771 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -71.18 137.05 30.6 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 121.359 1.372 . . . . 62.31 111.302 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.32 156.05 41.48 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.315 -0.857 . . . . 74.01 108.921 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.444 HG21 ' HD3' ' A' ' 61' ' ' LYS . 14.7 p -120.19 126.39 75.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.897 -0.721 . . . . 71.33 111.005 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.467 HD11 ' HB ' ' A' ' 91' ' ' VAL . 25.3 tp -92.43 89.2 6.68 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.35 -0.841 . . . . 53.55 111.204 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.45 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 27.6 p80 -66.09 131.37 46.04 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.973 -1.012 . . . . 75.44 108.824 171.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 119.32 -13.54 11.08 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 118.969 -1.586 . . . . 64.31 112.842 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 47.5 m-85 -127.33 157.76 39.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 112.686 0.624 . . . . 70.52 112.686 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -116.54 138.5 51.36 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.549 -1.278 . . . . 64.41 107.549 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.599 ' HA ' HG22 ' A' ' 54' ' ' ILE . 19.1 ptp180 -86.55 127.21 34.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.297 -0.631 . . . . 73.33 109.297 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.446 ' HD2' ' O ' ' A' ' 117' ' ' MET . 88.1 m-85 -108.82 112.27 24.44 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.03 -0.532 . . . . 71.31 111.689 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -86.4 116.8 24.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.38 -0.827 . . . . 73.31 111.533 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.5 147.84 50.43 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.391 -1.277 . . . . 72.14 109.399 174.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -115.84 -12.44 11.44 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.268 0.556 . . . . 71.2 110.162 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 -26.2 71.63 Favored Glycine 0 N--CA 1.41 -3.088 0 C-N-CA 120.086 -1.054 . . . . 62.04 110.903 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HB2' HD23 ' A' ' 46' ' ' LEU . 2.1 mm? -115.9 166.57 12.01 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 105.475 -2.046 . . . . 64.04 105.475 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 37.1 Cg_endo -66.6 -155.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.227 0 C-N-CA 122.326 2.018 . . . . 74.01 114.297 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CD1' ' HD3' ' A' ' 52' ' ' PRO . 18.9 p90 -48.35 -26.42 0.71 Allowed Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 119.452 3.13 . . . . 61.25 119.452 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HB3' ' HB3' ' A' ' 53' ' ' CYS . 84.3 Cg_exo -49.32 165.69 0.22 Allowed 'Trans proline' 0 CA--C 1.584 2.989 0 CA-C-N 122.141 1.8 . . . . 54.22 111.999 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 52' ' ' PRO . 22.0 p -152.3 -178.99 7.15 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.508 1.523 . . . . 75.42 110.717 5.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 43' ' ' ARG . 43.1 pt -135.31 132.44 52.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.36 -0.978 . . . . 74.43 108.36 170.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 112' ' ' LYS . 30.4 m -154.2 -175.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.777 -0.823 . . . . 43.42 108.777 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m 82.05 -177.61 0.05 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.923 1.289 . . . . 63.33 114.443 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -71.9 -178.97 2.51 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.732 0.813 . . . . 65.45 112.746 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.473 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 3.5 p30 -82.13 28.92 0.42 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 124.689 1.196 . . . . 44.33 113.038 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 m -76.78 -8.28 57.0 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.129 0.418 . . . . 74.04 112.129 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.98 -172.81 19.74 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.149 -1.024 . . . . 61.02 112.076 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 18.6 ptpt -143.46 147.45 34.58 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.607 -0.516 . . . . 63.51 109.607 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -111.36 123.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.392 -0.596 . . . . 63.24 109.392 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -98.75 124.25 43.49 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.006 -0.739 . . . . 73.43 109.006 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.98 -139.03 2.67 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.761 -0.733 . . . . 75.33 111.921 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.469 ' HE3' HD13 ' A' ' 18' ' ' LEU . 39.2 mtmt -137.39 140.73 41.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.06 0.457 . . . . 40.24 112.082 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.7 m -107.21 133.93 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.149 -0.932 . . . . 74.35 109.653 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 48.7 mt -87.93 123.72 40.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.507 -1.664 . . . . 65.23 106.507 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.6 p -103.8 161.21 14.13 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.2 -0.6 . . . . 73.33 110.514 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 8' ' ' SER . . . 69.06 28.5 72.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.039 -0.6 . . . . 74.11 113.382 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.74 121.49 36.44 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 117.223 0.512 . . . . 54.05 109.651 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.9 m -77.37 164.22 25.7 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.997 -0.742 . . . . 54.31 108.997 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.83 -32.18 72.49 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.153 0.433 . . . . 72.24 111.289 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.36 64.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.389 0.614 . . . . 72.01 110.331 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.08 -44.22 39.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 75.14 110.326 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.66 -37.56 87.81 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.775 -1.194 . . . . 54.55 107.775 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.555 ' O ' HG23 ' A' ' 80' ' ' VAL . 27.5 t-20 -54.69 -31.49 58.0 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.471 -1.241 . . . . 73.22 111.547 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.553 ' OD1' HG12 ' A' ' 26' ' ' ILE . 20.8 t-20 -75.1 -31.18 61.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.065 -0.654 . . . . 74.2 109.588 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -65.99 -35.56 80.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.39 0.614 . . . . 74.3 109.567 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.76 -33.71 72.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.307 -0.861 . . . . 61.23 110.283 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 76' ' ' ASN . 71.0 t -74.83 -25.44 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.498 -0.774 . . . . 75.45 111.784 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.7 mt -53.4 139.28 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 109.701 -0.481 . . . . 71.23 109.701 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.75 109.75 0.55 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.735 0.778 . . . . 72.51 112.174 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.26 55.83 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.003 0 N-CA-C 109.001 -1.64 . . . . 62.31 109.001 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -64.05 -19.28 65.1 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.302 0.572 . . . . 72.43 110.702 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.529 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 17.9 m-20 -91.0 10.16 27.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.419 . . . . 73.22 111.022 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.27 160.28 26.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 119.917 -0.713 . . . . 74.03 109.455 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -131.22 142.9 50.23 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 109.397 -0.594 . . . . 71.14 109.397 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -83.48 120.18 25.59 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.965 -0.754 . . . . 72.41 108.965 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.33 160.15 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 116.104 -0.498 . . . . 73.32 111.43 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -95.43 126.7 40.9 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 115.69 -0.686 . . . . 72.25 109.474 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' HB ' HD11 ' A' ' 38' ' ' LEU . 28.8 m -129.66 168.31 23.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.042 -1.096 . . . . 75.24 108.042 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -123.22 128.53 50.14 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.812 -1.155 . . . . 73.32 108.521 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' LEU . 19.8 m -126.18 169.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.176 0.512 . . . . 71.34 110.465 -173.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 96' ' ' MET . 76.7 t -103.81 128.63 56.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.74 -0.664 . . . . 72.45 110.183 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -64.93 3.97 0.49 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 126.77 2.028 . . . . 72.04 113.119 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.618 ' H ' HG12 ' A' ' 94' ' ' VAL . 12.5 tmm? 58.56 -72.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.704 2.002 . . . . 71.0 113.277 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.03 -29.34 67.2 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.301 1.041 . . . . 63.13 113.296 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -110.64 -5.18 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.372 -0.531 . . . . 63.41 110.68 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.2 m 62.82 4.94 1.59 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.801 0.841 . . . . 73.43 112.863 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.95 160.84 27.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.827 -0.805 . . . . 74.32 108.827 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 6.8 mptt -106.76 146.45 30.84 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.446 -0.946 . . . . 62.23 108.446 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.33 139.51 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.145 0.498 . . . . 61.12 110.336 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -87.4 129.77 34.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.148 -1.056 . . . . 62.41 108.148 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 12' ' ' PHE . 33.3 m -139.45 173.16 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 122.325 0.25 . . . . 63.14 110.981 -174.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -100.87 153.78 19.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.027 -1.101 . . . . 74.44 108.027 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -152.69 176.89 11.27 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-N 118.341 0.519 . . . . 64.41 110.881 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.31 117.88 35.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.734 0.813 . . . . 73.32 108.84 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.23 156.95 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 109.187 -0.671 . . . . 72.11 109.187 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 42.8 t-105 -98.86 120.12 38.77 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.645 0.378 . . . . 72.11 110.519 -171.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 85' ' ' ASP . 8.3 m -73.1 -23.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.312 0.486 . . . . 74.53 112.312 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.42 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 64.5 t30 -80.31 12.82 2.7 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.018 0.913 . . . . 73.35 110.99 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.444 ' HB3' HG11 ' A' ' 55' ' ' VAL . 20.9 ptmt -63.85 -15.33 58.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.566 1.321 . . . . 74.42 114.566 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.41 -42.95 92.0 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.29 0.478 . . . . 63.25 112.29 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -85.59 138.19 35.95 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 107.747 -1.205 . . . . 74.52 107.747 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -40.7 116.85 0.43 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 124.288 3.326 . . . . 71.4 114.537 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.596 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 1.1 mmp_? -106.3 165.09 11.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 65.52 109.219 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.497 ' HG3' ' H ' ' A' ' 119' ' ' GLY . 12.7 tpt -58.81 130.73 48.33 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.29 -0.633 . . . . 74.51 109.29 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -59.53 -23.46 62.85 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.436 0.636 . . . . 75.03 111.742 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.497 ' H ' ' HG3' ' A' ' 117' ' ' MET . . . 85.36 107.15 0.68 Allowed Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 115.366 -0.834 . . . . 64.05 112.348 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -98.89 132.63 44.08 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.102 -0.703 . . . . 72.5 109.102 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -144.56 155.31 43.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.07 -2.196 . . . . 74.33 105.07 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -81.21 121.32 26.0 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.473 -0.891 . . . . 63.41 113.072 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -68.45 -26.97 65.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.643 -1.162 . . . . 75.24 111.226 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 41.7 tt0 -74.65 -20.07 60.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.531 0.681 . . . . 72.23 109.522 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.519 ' O ' HG22 ' A' ' 128' ' ' VAL . 9.1 tp10 -76.26 -40.93 50.64 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.581 -1.266 . . . . 72.11 107.581 173.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -56.73 -36.98 70.35 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.375 -0.829 . . . . 75.41 110.914 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 124' ' ' GLU 0.269 4.0 ppt_? -63.16 -33.63 75.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.43 0.9 . . . . 75.24 113.43 -178.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 125' ' ' GLU . 29.9 m -77.38 -25.22 14.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 119.287 -0.965 . . . . 74.44 110.246 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.86 -44.78 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.493 -0.558 . . . . 65.21 109.493 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 127' ' ' ARG . 2.4 p-80 -75.21 -28.95 60.17 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 119.124 -1.03 . . . . 53.34 111.038 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.65 36.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.144 -0.48 . . . . 45.22 111.161 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 128' ' ' VAL . 10.0 mm-40 -61.67 -26.16 67.85 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.202 0.525 . . . . 71.54 110.835 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.54 ' HE3' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.05 -59.64 2.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.935 -1.135 . . . . 74.44 107.935 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -69.46 -31.58 69.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 114.354 1.242 . . . . 61.42 114.354 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.7 p -58.35 -38.48 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.25 0.477 . . . . 71.42 110.2 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.11 -46.0 82.83 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.691 -0.485 . . . . 63.54 109.691 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.0 m -57.12 -46.37 82.69 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.609 -0.723 . . . . 74.5 110.821 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 40.8 m-85 -60.26 -49.0 79.34 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 121.235 -0.186 . . . . 72.43 110.65 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 99.1 mtt180 -57.68 -44.84 86.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.042 0.213 . . . . 71.34 110.863 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -60.98 -52.54 64.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.347 -0.388 . . . . 61.43 110.688 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -31.58 72.51 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.657 0.614 . . . . 63.35 112.657 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 94.3 mt -72.48 -42.77 64.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.246 0.462 . . . . 65.0 112.246 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.6 -35.16 75.05 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 119.492 -0.883 . . . . 73.12 110.369 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.699 ' O ' ' HA3' ' A' ' 150' ' ' GLY . 1.3 m-90 -63.86 -28.98 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.337 0.589 . . . . 74.45 111.042 171.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -78.37 -44.46 24.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.135 0.493 . . . . 53.43 110.857 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.37 -31.52 42.94 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.912 0.708 . . . . 75.22 112.912 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 4.1 m-20 -95.26 143.87 26.85 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 111.806 0.298 . . . . 55.03 111.806 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 24.6 Cg_exo -64.82 -16.37 55.02 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.482 2.788 . . . . 75.31 112.009 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.24 -13.32 60.43 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.768 0.794 . . . . 74.31 108.98 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 144' ' ' TRP . . . -69.74 111.75 4.03 Favored Glycine 0 N--CA 1.399 -3.829 0 CA-C-N 114.658 -1.155 . . . . 53.31 112.455 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.38 140.12 57.19 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.605 -0.798 . . . . 74.2 109.646 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.2 m -67.41 157.4 34.22 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.537 -0.756 . . . . 64.54 111.406 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.43 -43.46 98.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.93 -0.577 . . . . 61.25 112.465 -176.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -72.76 -25.14 61.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.241 0.543 . . . . 71.15 110.969 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -75.7 -33.81 60.36 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.707 -0.679 . . . . 71.54 110.933 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.61 -30.36 62.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.841 . . . . 61.44 111.121 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.4 m -91.01 145.39 7.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.934 0.397 . . . . 65.43 110.719 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.01 -4.6 20.83 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.86 -0.896 . . . . 62.54 110.86 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.8 t -113.94 108.1 16.58 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.891 -0.781 . . . . 73.25 108.891 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.81 150.45 23.47 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.683 -1.228 . . . . 74.3 107.683 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.0 tp -87.5 119.4 27.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.752 -0.462 . . . . 54.23 109.752 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.0 p -73.66 97.88 2.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.665 0.745 . . . . 71.11 109.739 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.8 m -146.16 131.69 18.75 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.278 -0.874 . . . . 61.14 108.996 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 110.5 -84.96 0.38 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 108.281 -1.928 . . . . 73.32 108.281 -173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.246 0.87 0 C-N-CA 123.535 0.734 . . . . 73.11 109.28 175.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.0 p . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 109.684 -0.487 . . . . 70.53 109.684 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.5 t -83.18 132.86 35.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 121.193 0.52 . . . . 73.51 109.961 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -140.93 113.25 7.98 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.491 -0.559 . . . . 73.5 109.491 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.8 t -147.77 147.42 29.84 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.396 -0.594 . . . . 74.15 109.396 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -87.78 150.14 47.48 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.401 -0.592 . . . . 45.52 109.401 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.99 -36.65 97.93 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.232 1.955 . . . . 65.41 109.607 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -72.88 92.46 1.61 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.066 -1.457 . . . . 74.12 107.066 173.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 p -136.65 159.62 41.26 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-O 121.689 0.757 . . . . 74.52 112.616 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -109.25 147.43 32.61 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.859 -1.064 . . . . 72.13 109.705 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.5 m-20 -132.4 122.5 25.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.269 -1.382 . . . . 52.41 107.269 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.58 125.09 73.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.937 -0.305 . . . . 65.02 111.061 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -80.86 112.83 18.61 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.206 -1.035 . . . . 75.43 108.206 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.15 151.81 24.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.256 -0.646 . . . . 74.34 109.256 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -131.3 -22.83 2.46 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 120.519 -0.472 . . . . 73.14 111.126 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' HA3' ' CD2' ' A' ' 51' ' ' TYR . . . -114.05 108.82 2.1 Favored Glycine 0 C--O 1.248 1.005 0 C-N-CA 120.303 -0.951 . . . . 65.31 112.428 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 22.6 t 69.56 -177.25 0.21 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.921 1.288 . . . . 60.41 110.489 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.602 HD12 ' CE1' ' A' ' 78' ' ' PHE . 12.4 pt 47.12 18.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 126.761 2.024 . . . . 74.12 114.476 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 16' ' ' SER . 85.1 mt -93.04 -1.37 56.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.438 0.637 . . . . 63.03 110.942 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -103.53 132.34 21.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.009 -0.996 . . . . 74.42 108.879 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -42.85 -45.22 8.97 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 124.247 3.298 . . . . 74.54 113.756 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.32 -37.6 85.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 72.4 111.474 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 17' ' ' ILE . 44.9 t -75.72 -39.47 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.202 0.525 . . . . 72.4 109.981 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -66.96 -25.84 66.53 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.966 -0.753 . . . . 71.24 108.966 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.74 -31.49 57.15 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.677 -0.692 . . . . 65.54 111.588 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 22' ' ' VAL . 28.1 m -76.48 -30.41 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 119.584 -0.847 . . . . 72.2 111.619 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.457 HG23 ' HG ' ' A' ' 27' ' ' LEU . 3.3 tt -74.36 -42.29 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 63.34 111.925 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.77 HD21 ' CE2' ' A' ' 78' ' ' PHE . 75.2 mt -93.76 -22.25 18.81 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.706 0.632 . . . . 63.31 112.706 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 71.64 17.49 5.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.937 0.875 . . . . 72.42 109.92 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 ttm-85 -141.27 147.57 38.44 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.728 -1.953 . . . . 73.45 105.728 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.5 m -76.24 111.01 11.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.923 -0.769 . . . . 65.25 108.923 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -95.38 145.68 24.95 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.105 -0.498 . . . . 63.22 109.91 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.48 118.51 36.83 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.577 -0.738 . . . . 73.01 112.419 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 5.1 p -95.27 143.04 26.98 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.73 -0.668 . . . . 60.14 109.626 173.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.2 137.49 26.84 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 108.92 -0.77 . . . . 74.52 108.92 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 127.22 22.64 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.749 2.3 . . . . 72.34 112.083 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.58 37.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.516 -0.765 . . . . 35.55 109.022 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.505 HG21 ' CE ' ' A' ' 61' ' ' LYS . 11.4 p -118.14 130.05 73.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.722 0.772 . . . . 71.4 112.042 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.449 HD11 ' HB ' ' A' ' 91' ' ' VAL . 21.6 tp -87.95 106.77 18.34 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 122.123 0.963 . . . . 62.45 109.586 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.476 ' CD2' HG23 ' A' ' 94' ' ' VAL . 14.3 p80 -92.22 127.9 37.87 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.264 -1.335 . . . . 72.51 109.807 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.65 -5.93 29.59 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.023 -1.084 . . . . 51.54 112.044 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -117.86 144.86 45.04 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.709 0.29 . . . . 63.31 110.669 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -115.5 135.12 54.42 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.172 -0.677 . . . . 62.4 109.172 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.575 ' NH2' ' HA ' ' A' ' 125' ' ' GLU . 55.6 mtm180 -87.33 114.89 24.35 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 108.565 -0.902 . . . . 64.15 108.565 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -82.39 137.28 34.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.117 -0.697 . . . . 75.43 109.117 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' HB3' ' H ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -95.25 110.41 22.4 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.887 -1.153 . . . . 73.25 107.887 -177.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 49' ' ' LEU 0.308 0.0 OUTLIER -124.75 160.98 27.4 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.764 -1.107 . . . . 72.21 112.394 179.488 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -99.02 -22.84 15.52 Favored 'General case' 0 N--CA 1.398 -3.039 0 CA-C-N 113.406 -1.725 . . . . 71.03 110.999 -169.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.09 -25.51 61.76 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.895 -0.669 . . . . 53.34 113.06 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 46' ' ' LEU . 2.1 mm? -122.7 146.89 49.19 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 109.397 -0.594 . . . . 71.22 109.397 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.49 -34.88 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.336 2.024 . . . . 64.14 111.724 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.676 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 37.9 p90 -123.38 177.63 1.62 Allowed Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 116.735 -1.602 . . . . 73.25 106.772 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.676 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.34 0.0 OUTLIER 34.5 169.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.608 0 C-N-CA 123.625 2.883 . . . . 73.34 119.172 -163.145 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 14.7 p -122.73 172.88 8.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 120.218 -1.551 . . . . 74.42 113.588 10.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.526 HG21 HG21 ' A' ' 62' ' ' VAL . 41.1 pt -130.71 149.92 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.831 -1.077 . . . . 61.4 109.911 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.449 HG11 ' HG3' ' A' ' 112' ' ' LYS . 12.7 m -148.12 164.27 5.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.355 -1.72 . . . . 75.33 106.355 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -80.04 123.27 27.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 114.064 1.135 . . . . 62.21 114.064 -170.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 p -147.67 120.08 8.46 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.486 -1.672 . . . . 73.13 106.486 172.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.23 -11.56 22.24 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 117.433 2.383 . . . . 63.44 117.433 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.5 m -98.08 1.1 47.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.489 -0.885 . . . . 75.15 111.382 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.5 159.09 15.59 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.182 -1.009 . . . . 51.21 114.044 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' CE ' HG21 ' A' ' 37' ' ' VAL . 48.9 mtpt -140.39 147.27 39.51 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 123.879 0.872 . . . . 64.15 109.827 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.526 HG21 HG21 ' A' ' 54' ' ' ILE . 48.0 t -123.74 122.05 63.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.534 -1.284 . . . . 75.53 107.534 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -111.35 115.99 30.21 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.582 -0.447 . . . . 62.54 111.287 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.9 -131.4 1.73 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.742 -0.543 . . . . 64.34 111.742 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB2' HD22 ' A' ' 18' ' ' LEU . 94.1 mttt -141.12 154.4 45.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.423 -0.584 . . . . 72.03 109.423 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.7 m -109.6 133.58 54.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.626 -0.509 . . . . 74.41 109.626 173.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.424 HD11 HG13 ' A' ' 17' ' ' ILE . 47.4 mt -88.02 112.43 23.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.536 -1.654 . . . . 72.33 106.536 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.7 p -106.68 160.66 15.29 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.119 0.414 . . . . 74.24 112.119 -174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.74 24.98 59.27 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.713 -0.676 . . . . 43.25 113.84 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 127.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 O-C-N 122.642 -0.328 . . . . 64.1 110.337 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 m -78.85 160.45 27.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.213 -1.032 . . . . 72.34 108.213 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.39 -37.36 75.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.297 0.499 . . . . 72.24 111.768 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.15 -37.08 78.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.434 0.635 . . . . 61.31 110.854 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.695 ' HB3' HD22 ' A' ' 27' ' ' LEU . 37.8 mt-10 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.731 -0.668 . . . . 62.41 109.232 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 75' ' ' LEU . 3.2 tm? -59.76 -31.68 69.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.769 0.828 . . . . 73.31 109.808 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -56.95 -28.6 62.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 71.12 112.126 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.45 ' ND2' HG13 ' A' ' 26' ' ' ILE . 2.9 t30 -76.0 -31.77 59.09 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 119.043 -1.063 . . . . 75.41 109.436 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.77 ' CE2' HD21 ' A' ' 27' ' ' LEU . 41.2 m-85 -70.33 -28.96 65.57 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.638 0.732 . . . . 75.0 109.21 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.541 ' HA ' ' OH ' ' A' ' 107' ' ' TYR . 18.5 t70 -67.11 -43.21 83.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.827 -1.079 . . . . 74.43 111.693 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.04 -30.48 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 N-CA-C 112.708 0.633 . . . . 74.22 112.708 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.2 tt -82.48 111.16 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 112.905 0.705 . . . . 64.54 112.905 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 58.33 35.07 24.59 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.138 0.975 . . . . 74.33 110.486 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.55 25.49 9.65 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.647 -0.787 . . . . 53.05 111.485 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.61 -36.03 24.2 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.878 0.371 . . . . 73.3 111.669 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 12.8 m-20 -117.62 19.24 13.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.88 0.848 . . . . 71.02 109.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -130.62 161.36 31.74 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.791 -1.095 . . . . 72.34 108.666 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -130.06 147.18 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.781 -0.822 . . . . 75.14 108.781 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 40.0 ttp-105 -92.86 108.51 20.05 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.24 0.543 . . . . 63.43 111.36 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.4 m -111.18 159.38 11.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.749 -0.66 . . . . 75.32 110.416 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -91.33 133.43 35.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.575 -0.898 . . . . 55.3 108.575 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 38' ' ' LEU . 30.2 m -133.75 168.81 23.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.803 -1.184 . . . . 73.11 107.803 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.457 ' HB2' ' HE3' ' A' ' 103' ' ' LYS . 42.8 tt0 -114.2 129.93 56.62 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.515 -0.874 . . . . 74.22 110.192 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 38' ' ' LEU . 20.6 m -126.12 163.02 28.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.166 -0.679 . . . . 72.3 109.166 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 101' ' ' LYS . 77.8 t -102.05 113.86 39.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 109.352 -0.61 . . . . 73.55 109.352 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -69.45 90.21 0.53 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.19 -2.522 . . . . 74.14 104.19 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -55.65 -45.81 77.58 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 125.079 1.351 . . . . 72.4 113.99 -162.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.74 -27.38 68.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.076 0.465 . . . . 70.2 111.304 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -101.47 -9.48 21.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.068 -0.515 . . . . 72.33 110.51 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.5 t 64.42 15.87 9.82 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.634 1.174 . . . . 53.1 112.106 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -96.07 161.26 14.05 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 122.647 0.379 . . . . 74.35 110.421 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -108.89 128.49 54.97 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.946 -0.761 . . . . 64.21 108.946 -175.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.5 148.51 28.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.988 0.423 . . . . 62.01 111.9 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 92' ' ' GLU . 27.3 mmtp -90.84 118.12 29.99 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.556 0.742 . . . . 64.32 111.077 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.44 170.56 17.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.244 -0.889 . . . . 73.04 108.877 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.78 150.16 23.08 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.979 -0.378 . . . . 74.3 109.979 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.1 t -156.0 173.85 16.19 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.618 -0.882 . . . . 60.11 108.618 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 79' ' ' ASP . 95.4 m-85 -110.11 122.82 48.5 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.296 0.569 . . . . 53.12 111.691 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.15 159.72 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 115.318 -0.856 . . . . 65.2 110.04 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 53' ' ' CYS . 26.1 t-105 -79.38 112.67 16.85 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.912 0.863 . . . . 74.41 111.963 -173.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 85' ' ' ASP . 43.1 t -72.33 -32.09 41.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.08 -1.418 . . . . 64.54 112.35 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.478 ' HB2' ' CZ2' ' A' ' 109' ' ' TRP . 86.1 m-20 -88.43 14.34 9.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 123.013 0.525 . . . . 55.2 112.074 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.531 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 0.4 OUTLIER -49.84 -36.81 28.13 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.512 1.525 . . . . 65.34 111.766 -177.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.362 15.7 m-20 -73.98 71.46 1.57 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 115.934 1.827 . . . . 71.03 115.934 -171.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -129.0 141.82 43.05 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 104.413 -2.44 . . . . 75.3 104.413 170.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.36 -25.55 57.66 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.216 2.611 . . . . 63.13 114.616 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -116.81 113.05 21.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.251 -0.98 . . . . 63.03 111.624 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HA ' ' A' ' 112' ' ' LYS . 68.8 mtp -161.08 100.28 1.23 Allowed 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 124.184 0.994 . . . . 74.01 111.131 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -149.18 -46.38 0.14 Allowed 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.769 -1.567 . . . . 73.24 106.769 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.47 -127.04 8.16 Favored Glycine 0 N--CA 1.407 -3.236 0 CA-C-N 114.101 -1.409 . . . . 73.12 111.767 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.439 ' H ' ' HB3' ' A' ' 45' ' ' LYS . 38.5 tt0 -145.89 141.18 27.57 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.7 -0.852 . . . . 52.24 108.7 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -82.58 100.9 10.42 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 118.306 -1.358 . . . . 55.15 109.298 167.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -81.65 148.64 28.93 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.695 -1.224 . . . . 75.25 107.695 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.41 -38.01 65.73 Favored 'General case' 0 N--CA 1.435 -1.203 0 O-C-N 123.54 0.525 . . . . 74.12 111.356 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.55 -37.82 65.45 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 120.586 -0.446 . . . . 61.21 110.438 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.575 ' HA ' ' NH2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -61.18 -30.88 70.68 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.31 -0.405 . . . . 75.12 111.651 176.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -86.04 -36.91 19.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.11 0.481 . . . . 71.41 109.799 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -51.59 -47.07 63.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.608 1.163 . . . . 75.11 111.878 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 34.2 m -62.5 -33.15 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.376 0.51 . . . . 74.34 112.376 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.32 -37.14 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.7 0.762 . . . . 63.42 109.527 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.456 ' CE1' ' HE1' ' A' ' 134' ' ' PHE . 17.5 t-80 -66.83 -35.63 80.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.576 -0.738 . . . . 72.44 109.571 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -65.47 -34.78 79.07 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 123.457 0.473 . . . . 71.11 110.643 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 128' ' ' VAL . 43.4 mt-10 -59.4 -39.06 82.2 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.801 0.334 . . . . 73.13 110.577 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.613 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.1 tpmt? -57.56 -45.87 84.62 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.545 -0.752 . . . . 73.25 109.076 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.456 ' HE1' ' CE1' ' A' ' 130' ' ' HIS . 78.9 m-85 -62.6 -45.34 93.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.444 -0.798 . . . . 62.11 110.932 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.561 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 80.2 t -54.67 -49.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 O-C-N 123.55 0.531 . . . . 74.34 110.291 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.02 -41.3 91.88 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 123.197 0.311 . . . . 64.05 110.458 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.1 m -58.57 -47.31 84.69 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.856 -0.611 . . . . 61.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.403 ' O ' HD13 ' A' ' 142' ' ' LEU . 37.8 m-85 -63.62 -44.22 94.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.114 -0.494 . . . . 75.04 110.564 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 31.4 mtm180 -56.5 -49.92 73.31 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.882 -0.327 . . . . 72.13 110.147 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.13 -44.33 96.87 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.46 0.475 . . . . 64.52 111.684 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.86 -34.7 78.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.861 0.362 . . . . 55.12 110.997 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.565 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 10.8 mp -72.63 -31.82 65.43 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 120.622 -0.431 . . . . 72.33 111.403 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 46.5 mt-10 -59.79 -34.23 72.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.876 -0.416 . . . . 72.45 109.876 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -72.74 -44.77 61.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.199 -0.455 . . . . 73.13 111.817 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -73.81 -36.1 64.96 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.169 0.803 . . . . 74.33 113.169 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 142' ' ' LEU . 23.0 pttp -84.87 -6.38 59.34 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.937 -0.477 . . . . 72.11 111.458 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -74.67 144.7 80.78 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.492 -0.929 . . . . 73.54 108.492 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -43.0 -31.94 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.238 3.292 . . . . 71.24 115.018 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -71.85 -20.55 61.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.038 0.447 . . . . 75.12 110.871 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 57.67 42.22 94.15 Favored Glycine 0 CA--C 1.5 -0.868 0 CA-C-N 115.448 -0.796 . . . . 61.05 114.844 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.49 121.26 26.05 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.749 -0.781 . . . . 74.45 109.535 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.3 m -94.51 172.93 7.88 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.865 -0.607 . . . . 71.55 109.63 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -66.53 -35.91 81.4 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 111.919 0.34 . . . . 61.55 111.919 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.82 -28.51 68.42 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.819 0.818 . . . . 74.05 109.859 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -75.81 -45.49 35.72 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.838 -1.073 . . . . 73.44 110.748 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.03 65.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.27 -0.877 . . . . 65.43 112.074 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.72 -56.22 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 112.912 0.708 . . . . 70.15 112.912 -176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 160.9 154.04 7.23 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.85 -0.9 . . . . 53.23 110.85 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.9 p -69.03 116.0 8.97 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.862 0.331 . . . . 64.1 110.305 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.0 tt -72.56 -53.16 12.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.079 -0.712 . . . . 72.31 109.079 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.37 -31.69 26.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.42 -0.354 . . . . 72.44 110.897 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 t 73.4 -69.81 0.18 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.301 1.04 . . . . 71.01 109.33 -176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.1 m 53.14 88.45 0.03 OUTLIER 'General case' 0 C--O 1.238 0.45 0 N-CA-C 114.795 1.406 . . . . 74.12 114.795 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.23 -78.05 1.1 Allowed Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 109.64 -1.384 . . . . 72.31 109.64 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 C--N 1.311 -1.097 0 N-CA-C 108.254 -1.017 . . . . 65.42 108.254 176.622 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.438 -1.062 0 N-CA-C 109.168 -0.678 . . . . 42.42 109.168 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 t -74.31 136.9 42.59 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.783 -0.821 . . . . 61.33 108.783 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.0 p -153.16 160.19 42.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.594 -0.521 . . . . 64.13 109.594 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.0 m -94.73 -22.96 17.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.357 -0.608 . . . . 73.24 109.357 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 57.82 98.26 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 124.61 1.164 . . . . 55.21 113.9 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.17 -26.97 35.76 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.849 1.699 . . . . 64.44 109.918 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 58.05 70.57 0.64 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 124.343 1.027 . . . . 73.35 108.858 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.3 m 61.79 -173.73 0.14 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.162 -0.927 . . . . 44.32 109.267 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.431 ' C ' HD22 ' A' ' 10' ' ' ASN . 78.7 m80 -125.16 143.13 51.09 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 109.375 -0.602 . . . . 64.54 109.375 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -128.95 123.85 33.57 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.307 -1.738 . . . . 70.31 106.307 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 13' ' ' VAL . 20.7 t -111.82 120.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 119.777 -0.769 . . . . 72.23 109.393 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.0 t80 -81.97 113.89 20.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.755 -0.831 . . . . 74.11 108.755 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 11' ' ' VAL . 27.2 m -135.16 159.25 41.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.345 0.593 . . . . 72.22 110.151 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -148.62 109.73 4.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 106.021 -1.844 . . . . 71.41 106.021 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 163.6 -92.21 0.11 Allowed Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.74 -0.944 . . . . 71.12 110.74 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.518 ' O ' HG11 ' A' ' 22' ' ' VAL . 49.5 m -149.6 78.95 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.19 1.182 . . . . 74.13 114.19 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.641 HG21 HD13 ' A' ' 67' ' ' ILE . 63.8 mt -155.57 8.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 104.713 -2.329 . . . . 75.33 104.713 168.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 6.9 mp -92.07 -17.21 25.34 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.372 -1.285 . . . . 52.0 109.676 -173.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.71 129.54 37.91 Favored Pre-proline 0 N--CA 1.403 -2.783 0 CA-C-N 114.676 -1.147 . . . . 45.41 108.635 172.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.71 -36.82 10.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.09 3.193 . . . . 73.12 113.034 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -55.46 -45.94 76.86 Favored 'General case' 0 C--O 1.224 -0.237 0 O-C-N 123.522 0.514 . . . . 73.42 112.008 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 16' ' ' SER . 92.3 t -77.3 -44.37 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.508 0.194 . . . . 51.04 111.446 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.48 -30.98 71.66 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.37 -0.532 . . . . 74.33 110.702 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.12 -40.62 74.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.062 -0.517 . . . . 74.35 111.268 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 21' ' ' ALA . 16.9 m -71.15 -31.16 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.294 -0.562 . . . . 74.23 111.687 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.547 HD13 ' CD1' ' A' ' 78' ' ' PHE . 6.1 tt -77.95 -38.57 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.275 0.56 . . . . 70.41 112.135 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 31' ' ' ALA . 95.6 mt -100.28 -10.75 20.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 113.93 1.085 . . . . 62.15 113.93 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 68.12 19.16 9.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.995 0.902 . . . . 71.04 109.432 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -162.28 142.68 10.05 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.338 -2.097 . . . . 73.3 105.338 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.2 m -77.06 119.24 20.5 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 120.948 0.404 . . . . 62.5 110.335 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -90.88 152.8 20.6 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 109.661 -0.496 . . . . 72.41 109.661 176.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.32 125.18 41.74 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.988 -0.551 . . . . 72.02 110.404 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 5.5 p -100.16 142.61 31.4 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 115.675 -0.693 . . . . 53.44 109.508 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.19 134.61 25.59 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.384 -1.339 . . . . 61.01 107.384 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.586 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.5 Cg_endo -61.8 130.38 31.04 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 121.932 1.755 . . . . 62.03 111.369 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.83 156.17 41.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.774 -1.103 . . . . 74.41 109.753 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.438 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.3 p -121.66 127.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.651 0.738 . . . . 64.32 111.546 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.422 HD22 HG21 ' A' ' 91' ' ' VAL . 23.3 tp -91.87 95.34 9.78 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.215 -0.902 . . . . 44.12 110.9 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 23.7 p80 -70.67 123.14 21.18 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.76 -1.109 . . . . 54.02 110.096 173.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 120.52 -13.59 10.1 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.878 -1.153 . . . . 73.22 113.8 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.404 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 60.1 m-85 -123.62 166.06 16.12 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.326 0.861 . . . . 73.53 113.326 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -134.39 128.24 33.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.448 -1.686 . . . . 72.32 106.448 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -87.46 135.19 33.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.889 0.852 . . . . 62.21 112.722 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -107.53 106.98 17.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.305 -1.739 . . . . 71.44 106.305 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.652 ' HG3' ' OE2' ' A' ' 120' ' ' GLU . 24.1 tptp -47.79 -51.94 20.62 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.593 2.072 . . . . 74.31 116.593 -173.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.405 HD21 ' HG2' ' A' ' 117' ' ' MET . 8.6 mp 53.43 95.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.746 1.387 . . . . 71.1 114.746 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 47' ' ' LYS 0.306 0.0 OUTLIER -82.67 -11.73 58.14 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.888 1.07 . . . . 72.22 113.888 174.524 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.99 -43.4 10.94 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.849 -0.691 . . . . 54.42 111.929 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.2 152.36 39.37 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.038 -0.727 . . . . 74.45 109.038 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.6 112.0 3.37 Favored 'Trans proline' 0 CA--C 1.552 1.379 0 C-N-CA 122.867 2.378 . . . . 70.03 114.382 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.554 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.513 35.2 p90 35.79 59.91 2.93 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 119.044 2.979 . . . . 71.13 119.044 -178.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 10.4 Cg_endo -106.02 172.25 0.12 Allowed 'Trans proline' 0 CA--C 1.547 1.136 1 C-N-CA 126.504 4.803 . . . . 72.33 110.132 175.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 109' ' ' TRP . 43.3 t -158.13 175.24 14.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.577 3.151 . . . . 70.23 103.751 -11.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.413 HG13 HG12 ' A' ' 108' ' ' VAL . 25.8 pt -135.65 138.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 119.407 1.003 . . . . 44.2 111.307 174.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 56' ' ' SER . 5.5 m -154.37 -160.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.984 1.313 . . . . 71.12 108.88 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.43 ' H ' ' HB ' ' A' ' 55' ' ' VAL . 47.5 m 83.73 -39.87 0.08 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.226 1.41 . . . . 75.35 113.305 176.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 50.0 m 56.65 31.0 18.44 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.969 0.89 . . . . 73.11 109.402 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.09 175.77 7.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.194 -1.366 . . . . 74.1 110.159 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -79.74 -0.58 34.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.783 0.325 . . . . 72.43 111.073 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.94 -172.16 21.75 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 116.168 -0.469 . . . . 74.12 112.43 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.438 ' HE2' HG21 ' A' ' 37' ' ' VAL . 17.7 ptmt -154.44 143.01 20.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.308 -0.525 . . . . 54.4 109.785 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.7 t -105.11 123.38 59.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.685 -0.857 . . . . 62.35 108.685 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -102.96 115.82 31.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.018 -0.673 . . . . 63.03 109.241 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -150.65 -136.75 2.58 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 111.708 -0.557 . . . . 53.3 111.708 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 35' ' ' PRO . 52.4 mtmt -139.28 147.22 41.37 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.551 0.691 . . . . 75.12 112.775 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' THR . 27.8 m -104.4 133.11 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.838 -1.074 . . . . 63.35 108.887 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.641 HD13 HG21 ' A' ' 17' ' ' ILE . 5.8 mt -87.49 111.0 21.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 104.953 -2.24 . . . . 72.42 104.953 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -97.72 167.26 11.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.633 -0.427 . . . . 75.12 111.888 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.7 39.38 93.68 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.645 -0.707 . . . . 73.0 113.274 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.1 t -103.97 122.04 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.125 -1.065 . . . . 62.42 108.125 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 m -78.6 158.57 28.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.064 -1.088 . . . . 63.11 108.064 176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.89 -35.56 69.09 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.44 0.563 . . . . 64.54 110.949 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HA ' HD22 ' A' ' 76' ' ' ASN . . . -63.98 -44.81 91.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 73.35 110.714 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 27' ' ' LEU . 47.9 mt-10 -69.03 -32.67 72.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.678 0.791 . . . . 74.31 110.536 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.482 HD22 HH11 ' A' ' 88' ' ' ARG . 1.3 tt -64.16 -28.29 69.66 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.466 -0.938 . . . . 72.34 108.466 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' A' ' 73' ' ' ALA . 58.9 m-80 -56.54 -27.76 58.41 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 112.729 0.64 . . . . 75.04 112.729 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.426 ' HA ' HG12 ' A' ' 80' ' ' VAL . 45.0 t-20 -72.56 -37.45 68.23 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 119.559 -0.856 . . . . 60.25 109.292 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.547 ' CD1' HD13 ' A' ' 26' ' ' ILE . 90.8 m-85 -70.43 -30.19 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.628 -0.879 . . . . 64.32 108.628 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 76' ' ' ASN . 19.8 t70 -73.77 -41.07 62.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 65.04 112.446 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 77' ' ' ASN . 9.4 p -67.09 -21.61 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.023 0.44 . . . . 71.42 110.255 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 77' ' ' ASN . 69.9 mt -57.27 116.37 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.526 -1.287 . . . . 74.11 107.526 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -71.36 119.44 15.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.197 1.184 . . . . 70.53 114.197 -171.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.646 ' HA3' ' CE1' ' A' ' 86' ' ' TYR . . . -150.7 86.43 0.15 Allowed Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 107.709 -2.156 . . . . 75.33 107.709 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -65.58 -38.35 89.25 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.838 0.855 . . . . 63.53 111.307 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB2' ' CH2' ' A' ' 109' ' ' TRP . 10.2 m-20 -91.4 8.62 35.36 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.108 -0.951 . . . . 75.4 112.103 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.646 ' CE1' ' HA3' ' A' ' 83' ' ' GLY 0.266 0.3 OUTLIER -125.04 157.95 34.95 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 119.443 -0.903 . . . . 73.52 112.237 172.488 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 11.8 pt-20 -127.61 158.37 37.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 120.501 0.191 . . . . 72.14 110.614 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.482 HH11 HD22 ' A' ' 75' ' ' LEU . 61.9 ttp180 -93.77 110.96 22.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.047 0.451 . . . . 75.12 110.679 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.9 159.49 28.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.257 -0.429 . . . . 64.25 111.145 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.51 HG22 ' HG2' ' A' ' 103' ' ' LYS . 99.2 m -99.08 124.16 43.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.916 -0.584 . . . . 54.34 109.596 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.422 HG21 HD22 ' A' ' 38' ' ' LEU . 29.6 m -125.37 155.65 34.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.872 1.269 . . . . 73.44 108.165 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 31.0 tt0 -105.1 127.44 52.89 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.784 -0.767 . . . . 75.34 110.395 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 38' ' ' LEU . 19.0 m -126.43 167.9 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 115.424 -0.807 . . . . 74.22 108.993 -175.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 101' ' ' LYS . 62.2 t -107.1 123.06 62.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 173.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -73.66 84.14 1.59 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.768 -1.197 . . . . 73.22 107.768 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.613 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 25.3 ttt -39.59 -51.75 2.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 128.02 2.528 . . . . 75.33 114.035 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.42 -36.39 78.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.071 0.397 . . . . 72.14 112.071 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.75 -9.43 23.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.98 0.419 . . . . 72.54 110.922 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.86 20.76 12.36 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.035 1.334 . . . . 73.01 111.853 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -105.13 161.16 14.49 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 120.878 0.371 . . . . 72.23 110.369 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HG2' HG22 ' A' ' 94' ' ' VAL . 89.4 mttt -100.09 131.28 46.14 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.232 -0.655 . . . . 65.31 109.232 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.82 140.99 37.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 109.89 -0.411 . . . . 71.31 109.89 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 31.2 ttpt -104.07 117.96 35.52 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 119.449 -0.9 . . . . 74.55 110.224 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' A' ' 12' ' ' PHE . 19.8 m -123.82 176.26 5.52 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 CA-C-N 115.076 -0.965 . . . . 74.25 112.181 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -99.46 150.62 21.99 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 122.782 0.433 . . . . 72.21 110.026 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.4 t -159.43 175.01 13.83 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.689 -0.856 . . . . 65.24 108.689 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 97.6 m-85 -114.38 119.13 35.89 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.086 0.47 . . . . 73.01 111.837 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.413 HG12 HG13 ' A' ' 54' ' ' ILE . 27.1 m -109.49 142.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.713 -0.676 . . . . 61.1 109.908 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 85' ' ' ASP . 25.1 t-105 -72.16 113.88 9.67 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.515 0.726 . . . . 74.23 110.119 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 m -72.38 -23.23 21.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 122.047 0.927 . . . . 65.32 110.055 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.469 ' OD1' ' HG3' ' A' ' 116' ' ' ARG . 28.6 t-20 -83.08 5.24 23.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.409 -1.269 . . . . 54.21 112.173 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -59.62 -15.06 16.22 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.437 1.273 . . . . 70.15 114.437 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -59.38 -28.57 67.0 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.992 1.108 . . . . 70.02 113.992 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . 24.5 m-20 -106.06 167.09 10.13 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.196 -1.409 . . . . 65.0 107.196 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.14 98.03 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 N-CA-C 108.371 -1.434 . . . . 74.4 108.371 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.469 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 40.4 mmt180 -133.15 128.62 36.47 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.707 -0.679 . . . . 65.33 110.236 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.405 ' HG2' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER 71.82 130.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.537 1.148 . . . . 70.33 114.044 171.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -104.58 -44.22 4.95 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.408 -0.96 . . . . 73.15 108.408 175.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.07 176.37 27.05 Favored Glycine 0 C--O 1.244 0.748 0 CA-C-N 115.848 -0.615 . . . . 54.0 113.354 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.652 ' OE2' ' HG3' ' A' ' 45' ' ' LYS . 1.5 mp0 -94.26 131.04 40.27 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 119.596 -0.841 . . . . 75.51 109.223 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.45 ' H ' ' H ' ' A' ' 122' ' ' ASP . 37.6 p-90 -165.38 5.12 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 124.519 1.128 . . . . 64.43 109.3 174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 124' ' ' GLU . 17.9 t70 -82.4 142.09 32.25 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 106.792 -1.559 . . . . 70.31 106.792 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -63.57 -38.32 90.67 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 111.795 0.294 . . . . 75.12 111.795 -174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.465 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 38.9 tt0 -66.19 -45.85 79.38 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.781 -0.451 . . . . 74.52 109.781 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.438 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 42.7 mt-10 -66.5 -35.64 80.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.185 -0.461 . . . . 74.01 111.159 176.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -67.72 -34.09 76.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 73.12 110.643 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -58.31 -39.15 78.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.538 -0.912 . . . . 72.15 108.538 174.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 98.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.556 -1.202 . . . . 35.22 110.385 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 125' ' ' GLU . 97.6 t -67.61 -45.19 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.782 -0.451 . . . . 70.22 109.782 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.458 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 23.7 t60 -60.84 -34.26 74.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.771 -0.649 . . . . 74.41 109.701 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.36 -52.46 39.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.025 -0.534 . . . . 71.43 110.622 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.507 ' HA ' HG12 ' A' ' 135' ' ' VAL . 42.5 mt-10 -63.69 -40.96 98.1 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.487 0.492 . . . . 63.03 112.14 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.596 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -60.22 -47.62 85.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.987 -0.551 . . . . 74.14 111.499 -177.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.458 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 78.9 m-85 -76.99 -34.57 57.51 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.929 0.714 . . . . 71.24 112.929 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.55 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 12.5 p -67.34 -40.95 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.628 -0.829 . . . . 60.32 111.168 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.4 pt-20 -64.76 -34.56 78.63 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 120.11 -0.636 . . . . 73.5 110.747 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.2 m -66.13 -38.34 87.91 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.96 -0.564 . . . . 71.43 109.541 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.472 ' HA ' ' HG3' ' A' ' 141' ' ' MET . 87.6 t80 -66.64 -44.71 81.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.606 -0.724 . . . . 61.14 109.674 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.6 mtp180 -55.06 -46.85 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 61.33 109.956 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 13.8 mmmm -61.97 -44.17 97.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.606 -0.725 . . . . 64.44 111.816 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.472 ' HG3' ' HA ' ' A' ' 138' ' ' PHE . 3.0 ppp? -70.28 -33.05 71.11 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 120.631 -0.427 . . . . 72.12 109.97 -176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.96 -42.07 97.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.785 -0.643 . . . . 55.11 109.279 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 148' ' ' PRO . 13.7 mm-40 -61.19 -39.14 89.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.036 -0.529 . . . . 74.53 110.551 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.442 ' NE1' ' HB1' ' A' ' 156' ' ' ALA . 43.7 t90 -75.32 -29.99 60.19 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.572 -0.451 . . . . 72.01 111.009 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.63 -31.89 36.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.241 0.544 . . . . 74.05 110.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.74 -32.42 46.7 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.945 -0.57 . . . . 72.43 110.89 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.614 ' HB3' ' O ' ' A' ' 151' ' ' LYS . 40.9 m-80 54.8 67.96 2.93 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 123.506 0.723 . . . . 63.1 111.908 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 143' ' ' GLU . 91.3 Cg_endo -105.82 -15.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.981 2.454 . . . . 53.34 115.047 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -94.01 13.59 22.42 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.992 0.738 . . . . 74.31 112.992 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.35 -20.38 16.15 Favored Glycine 0 CA--C 1.496 -1.123 0 C-N-CA 120.149 -1.024 . . . . 64.04 112.018 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.614 ' O ' ' HB3' ' A' ' 147' ' ' ASN . 97.3 mttt -78.26 143.77 36.76 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.753 -0.462 . . . . 72.41 109.753 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.3 m -117.87 156.65 28.04 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 106.874 -1.528 . . . . 74.42 106.874 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 157' ' ' VAL . 26.1 ptt? -56.67 -43.37 80.35 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.582 0.956 . . . . 71.21 113.582 -173.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -66.58 -35.88 81.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.11 0.957 . . . . 74.02 109.976 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -76.36 -39.07 54.82 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.658 -1.156 . . . . 74.41 110.924 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.442 ' HB1' ' NE1' ' A' ' 144' ' ' TRP . . . -74.18 -25.07 59.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.456 -1.247 . . . . 53.33 112.794 -175.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 153' ' ' MET . 28.7 m -73.63 137.48 23.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 C-N-CA 119.488 -0.885 . . . . 73.31 111.216 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.55 98.67 0.21 Allowed Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 115.798 -0.637 . . . . 71.34 112.318 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.2 m -114.65 172.81 6.81 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 120.837 0.351 . . . . 74.31 110.055 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.461 ' HG ' HD12 ' A' ' 161' ' ' LEU . 43.6 tp -122.95 142.53 50.72 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.776 -1.564 . . . . 74.33 106.776 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.461 HD12 ' HG ' ' A' ' 160' ' ' LEU . 8.1 mp 77.18 108.7 0.08 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.168 0.918 . . . . 72.23 110.919 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 42.8 t -73.98 -18.75 60.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.419 -0.81 . . . . 73.42 110.436 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.6 p 53.18 79.68 0.12 Allowed 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.611 1.165 . . . . 74.4 113.654 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -113.68 -84.48 1.29 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.551 -1.02 . . . . 62.55 110.551 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 107.438 -1.319 . . . . 64.23 107.438 178.092 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.445 -0.725 0 N-CA-C 109.883 -0.414 . . . . 75.42 109.883 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.6 m -96.22 108.9 21.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.562 -0.533 . . . . 75.32 109.562 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 t -143.08 -44.46 0.3 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.437 -0.949 . . . . 34.42 108.437 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 t -106.34 157.51 17.55 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.653 -1.61 . . . . 61.31 106.653 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -112.46 143.39 28.82 Favored Pre-proline 0 C--N 1.31 -1.111 0 C-N-CA 120.379 -0.528 . . . . 72.14 111.191 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -73.97 -33.94 5.64 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.181 1.92 . . . . 70.11 108.715 168.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -164.68 121.88 1.61 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 106.682 -1.599 . . . . 72.54 106.682 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.5 p -85.3 142.67 29.19 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.683 0.754 . . . . 74.22 112.278 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -106.91 155.7 19.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.518 -1.29 . . . . 72.25 107.518 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.421 ' HB2' HG12 ' A' ' 104' ' ' VAL . 91.3 m-20 -136.24 133.51 37.1 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.947 -1.501 . . . . 72.44 106.947 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 t -118.96 120.82 65.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 120.693 -0.403 . . . . 71.24 110.551 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 66' ' ' VAL . 62.2 t80 -85.34 113.49 21.69 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.536 -0.913 . . . . 72.03 108.536 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 m -121.65 160.23 23.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.91 -0.586 . . . . 52.52 110.792 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -132.55 118.45 19.24 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.402 -0.817 . . . . 74.31 109.186 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.501 ' H ' HD11 ' A' ' 18' ' ' LEU . . . 102.08 -71.2 0.34 Allowed Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.889 -0.596 . . . . 70.13 113.168 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -92.17 155.6 17.9 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 111.556 0.206 . . . . 71.55 111.556 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.596 HG21 HD13 ' A' ' 67' ' ' ILE . 25.1 mt 72.73 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 125.003 1.321 . . . . 64.32 111.166 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.501 HD11 ' H ' ' A' ' 15' ' ' GLY . 56.4 mt -66.09 -28.19 68.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.137 0.494 . . . . 44.4 110.11 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.22 129.24 44.23 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 115.24 -0.891 . . . . 71.33 108.965 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.65 -33.52 31.81 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.804 3.003 . . . . 72.3 112.993 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.4 80.81 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 120.85 0.357 . . . . 72.52 111.173 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 25' ' ' VAL . 60.6 t -73.73 -36.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.483 0.659 . . . . 64.52 109.647 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -67.45 -31.5 71.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.913 -0.773 . . . . 72.12 108.913 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -76.34 -3.88 39.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.133 -0.94 . . . . 74.25 111.903 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 22' ' ' VAL . 19.6 m -105.75 -34.4 3.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.528 -0.869 . . . . 72.24 110.476 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.547 HD13 ' CD1' ' A' ' 78' ' ' PHE . 5.1 tt -70.03 -41.03 79.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 121.023 0.439 . . . . 71.25 111.067 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 31' ' ' ALA . 81.7 mt -100.37 -17.65 17.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.614 -0.434 . . . . 70.42 110.7 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 34.2 t70 73.08 -2.77 2.62 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.9 1.334 . . . . 65.02 110.017 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.2 ttm105 -121.2 144.85 48.37 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.608 -1.997 . . . . 74.54 105.608 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.1 m -77.8 111.14 13.31 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.107 -0.637 . . . . 74.13 111.416 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . . . -93.51 143.75 26.0 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.011 -1.107 . . . . 65.1 108.011 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -98.05 125.42 43.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.867 0.692 . . . . 63.25 112.867 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.6 p -94.47 145.13 25.0 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.189 -0.914 . . . . 75.02 109.612 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.2 137.38 29.65 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 108.26 -1.015 . . . . 63.32 108.26 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 127.51 23.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.965 1.777 . . . . 71.53 111.363 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.78 154.96 39.3 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 116.21 -0.45 . . . . 55.43 110.3 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.24 127.48 75.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.389 0.614 . . . . 74.03 111.157 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.47 HD11 ' HB ' ' A' ' 91' ' ' VAL . 19.2 tp -88.04 119.69 28.66 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.66 -0.7 . . . . 64.1 109.768 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -88.56 134.75 33.78 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.469 -0.787 . . . . 70.41 110.918 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.03 -2.02 59.63 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 119.516 -1.326 . . . . 72.42 113.441 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 64.3 m-85 -121.51 151.99 39.68 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 117.212 0.506 . . . . 72.31 110.752 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 12.4 t-160 -122.86 138.26 54.71 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.994 -0.548 . . . . 74.43 109.993 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.512 HH21 ' HB2' ' A' ' 125' ' ' GLU . 32.0 ptt180 -86.03 109.75 19.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.165 0.983 . . . . 64.22 108.985 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 118' ' ' TYR . 3.1 m-85 -74.62 154.72 38.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.701 -1.136 . . . . 73.42 112.781 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -87.69 -7.61 57.19 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.606 1.335 . . . . 74.33 114.606 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.2 pt? -72.29 73.63 0.97 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.601 0.963 . . . . 73.44 113.601 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 52' ' ' PRO . 54.6 pttt -72.83 1.19 9.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.816 1.414 . . . . 74.41 114.816 -175.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.66 -20.25 79.79 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 109.358 -1.497 . . . . 54.21 109.358 172.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.9 157.57 51.47 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 109.285 -0.635 . . . . 73.33 109.285 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.28 106.27 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.672 2.248 . . . . 73.12 114.368 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 45.84 69.54 2.54 Favored Pre-proline 0 N--CA 1.496 1.827 0 C-N-CA 124.469 1.108 . . . . 75.51 111.342 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 68.8 Cg_endo -110.88 153.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 124.108 3.205 . . . . 71.32 117.235 -167.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.484 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 72.9 m -155.15 163.03 40.78 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 130.012 3.325 . . . . 74.22 102.295 -17.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 43.7 pt -123.59 138.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 117.806 -1.557 . . . . 72.2 112.619 170.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' CE1' ' A' ' 44' ' ' TYR . 71.9 t -135.84 153.26 32.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 106.014 -1.847 . . . . 71.21 106.014 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.5 t -65.84 136.17 55.81 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 122.148 0.975 . . . . 72.4 112.295 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.6 t -156.42 104.53 2.21 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 103.717 -2.697 . . . . 73.51 103.717 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.77 -37.51 73.8 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 114.111 1.152 . . . . 71.13 114.111 -169.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -86.63 -0.06 55.46 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.306 -0.557 . . . . 71.14 111.985 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.79 146.76 16.18 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.761 -0.733 . . . . 71.21 111.549 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -140.44 152.74 45.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.139 -0.689 . . . . 72.25 109.139 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 41' ' ' TYR . 46.4 t -114.96 122.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.623 -0.51 . . . . 42.32 109.623 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -96.96 121.23 38.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.238 -0.652 . . . . 45.41 109.238 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.39 -143.44 3.7 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.003 -0.839 . . . . 54.13 111.003 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.468 ' HB2' HD22 ' A' ' 18' ' ' LEU . 55.5 mtpt -140.53 142.88 35.17 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.74 -0.837 . . . . 65.4 108.74 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.544 HG11 HG21 ' A' ' 93' ' ' VAL . 30.7 m -104.37 134.05 46.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 120.915 0.388 . . . . 63.01 110.722 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 17' ' ' ILE . 11.4 mt -86.44 110.27 19.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 104.67 -2.345 . . . . 74.45 104.67 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -101.58 162.72 12.7 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.27 0.47 . . . . 73.12 112.27 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.36 47.45 70.81 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.646 -0.706 . . . . 50.33 112.123 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.4 122.77 59.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.024 -0.732 . . . . 71.3 109.024 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 m -77.82 158.71 29.39 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.316 -0.954 . . . . 41.54 108.857 175.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -54.57 -35.94 63.84 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 112.172 0.434 . . . . 73.43 112.172 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.22 79.72 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.482 0.658 . . . . 70.31 110.587 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HB3' HD22 ' A' ' 27' ' ' LEU . 6.3 mm-40 -77.25 -37.23 53.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.331 -0.849 . . . . 62.43 109.921 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -33.47 71.04 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.986 -1.006 . . . . 72.4 109.697 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.06 -34.71 66.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.671 -1.149 . . . . 53.34 111.494 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.461 ' ND2' HG13 ' A' ' 26' ' ' ILE . 53.1 t30 -76.13 -29.77 57.93 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.113 -1.035 . . . . 64.42 109.856 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.695 ' O ' HG22 ' A' ' 81' ' ' ILE . 97.1 m-85 -66.06 -28.59 68.95 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.6 -0.727 . . . . 73.32 110.906 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.22 -31.63 71.26 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.591 -0.892 . . . . 73.34 108.591 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.21 -22.69 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 114.887 -1.051 . . . . 75.31 111.847 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 78' ' ' PHE . 11.7 tt -74.05 2.31 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 CA-C-O 121.842 0.829 . . . . 64.14 110.239 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.371 31.1 mm-40 88.63 126.95 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 117.539 2.422 . . . . 64.1 117.539 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.74 53.72 0.34 Allowed Glycine 0 N--CA 1.425 -2.097 0 N-CA-C 106.883 -2.487 . . . . 64.44 106.883 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.59 -42.56 99.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.021 0.928 . . . . 64.13 113.011 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 110' ' ' VAL . 7.3 m-20 -100.12 16.3 24.57 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.756 0.789 . . . . 61.34 109.701 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.17 159.2 26.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.428 -0.806 . . . . 72.43 109.032 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 110' ' ' VAL . 12.5 pt-20 -127.88 157.91 39.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.417 -0.216 . . . . 63.23 110.417 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -85.15 113.05 21.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.18 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.31 159.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.447 -0.342 . . . . 63.23 110.485 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.411 HG22 ' HD2' ' A' ' 103' ' ' LYS . 12.7 m -106.41 122.47 46.34 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 108.902 -0.777 . . . . 73.34 108.902 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.47 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.3 m -128.01 161.9 35.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.946 -1.131 . . . . 74.04 107.946 -175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.516 ' HG3' ' CE ' ' A' ' 103' ' ' LYS . 1.2 mp0 -108.76 138.87 44.39 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.069 -1.452 . . . . 70.34 108.352 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 66' ' ' VAL . 26.2 m -126.51 161.1 33.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 108.983 -0.747 . . . . 44.13 108.983 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.576 HG22 ' HG3' ' A' ' 101' ' ' LYS . 75.5 t -104.79 116.85 49.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.693 -0.685 . . . . 74.54 110.083 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 15.5 ttm180 -68.13 110.79 4.14 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.948 -1.871 . . . . 61.2 105.948 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.32 -54.1 49.45 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 114.848 1.425 . . . . 73.41 114.848 -164.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.53 -12.8 61.21 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.235 1.198 . . . . 71.01 114.235 -172.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.1 -6.19 9.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.185 0.517 . . . . 72.53 110.705 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.2 m 61.46 25.93 15.78 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.148 0.579 . . . . 74.53 111.288 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 12.9 pt-20 -93.91 158.71 15.51 Favored 'General case' 0 C--O 1.214 -0.786 0 N-CA-C 109.429 -0.582 . . . . 74.24 109.429 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.1 mptt -109.99 132.63 53.98 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.084 -0.71 . . . . 63.44 109.084 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.87 146.57 25.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.74 -0.467 . . . . 74.24 109.74 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.516 ' CE ' ' HG3' ' A' ' 92' ' ' GLU . 14.1 tppt? -91.6 132.77 36.08 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.622 -0.881 . . . . 74.44 108.622 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 10' ' ' ASN . 23.0 m -139.56 173.33 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.733 0.301 . . . . 74.41 110.847 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.79 148.78 24.88 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.598 -0.89 . . . . 74.22 108.598 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 t -153.39 175.18 13.42 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 109.16 -0.682 . . . . 71.53 109.16 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -107.19 118.61 37.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.67 -1.233 . . . . 70.04 107.67 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.32 162.6 10.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.196 -1.039 . . . . 73.01 108.196 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.559 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 33.6 t-105 -77.8 127.59 32.65 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.724 -0.843 . . . . 74.34 108.724 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 85' ' ' ASP . 26.9 m -69.81 -23.57 25.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 O-C-N 121.757 -0.589 . . . . 74.14 111.579 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.559 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -91.75 14.35 15.59 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.717 -0.674 . . . . 53.21 109.703 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.5 ptpp? -49.68 -18.81 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.352 1.461 . . . . 73.33 113.822 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.35 -39.53 76.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.921 -0.4 . . . . 73.31 109.921 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -114.2 124.07 31.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 N-CA-C 109.69 -0.485 . . . . 74.12 109.69 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -74.83 116.51 4.62 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.167 1.911 . . . . 53.23 109.565 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -86.98 113.66 22.94 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.31 -0.996 . . . . 65.13 108.31 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 69.89 -47.49 0.61 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.465 1.106 . . . . 72.42 113.0 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.643 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 69.1 t80 76.45 -61.72 0.44 Allowed 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 125.642 1.577 . . . . 72.31 107.908 -172.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 37.27 102.75 0.01 OUTLIER Glycine 0 C--N 1.339 0.702 0 O-C-N 125.761 1.913 . . . . 61.53 117.189 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -86.55 132.43 33.91 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 106.333 -1.728 . . . . 73.14 106.333 174.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -121.89 -29.76 4.23 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 113.362 0.875 . . . . 75.33 113.362 -170.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.505 ' OD2' ' HB3' ' A' ' 124' ' ' GLU . 30.5 t70 -97.68 130.32 44.68 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.897 -0.721 . . . . 73.15 110.742 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -68.83 -30.52 69.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.407 -0.36 . . . . 75.25 111.916 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.505 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 39.8 tt0 -70.56 -39.59 73.84 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.738 -1.208 . . . . 72.01 107.738 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.512 ' HB2' HH21 ' A' ' 43' ' ' ARG . 39.9 tt0 -58.13 -51.04 71.37 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.689 -1.141 . . . . 61.4 109.672 173.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -52.52 -46.63 66.79 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.802 -0.814 . . . . 74.22 108.802 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -60.5 -48.88 79.84 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.104 -0.953 . . . . 61.42 111.702 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 125' ' ' GLU . 24.7 m -73.91 -31.6 31.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 N-CA-C 112.682 0.623 . . . . 72.32 112.682 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 125' ' ' GLU . 84.4 t -67.48 -40.28 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.023 -0.732 . . . . 71.53 109.023 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.545 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 46.0 t60 -65.86 -42.88 89.88 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 115.644 -0.707 . . . . 72.32 109.189 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -62.59 -52.69 62.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.615 -0.266 . . . . 73.43 111.367 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 13.6 mm-40 -62.46 -31.69 72.45 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.378 -0.374 . . . . 73.32 111.407 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 3.4 tmtm? -59.64 -40.5 87.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.698 0.761 . . . . 75.52 109.645 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.545 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 82.7 m-85 -82.31 -36.13 27.28 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.593 -0.692 . . . . 53.52 110.857 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 131' ' ' ALA . 99.3 t -62.49 -44.8 99.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.445 -0.343 . . . . 72.53 111.254 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 11.2 pt-20 -60.27 -37.46 80.52 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 110.18 -0.304 . . . . 72.34 110.18 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -64.42 -44.43 91.24 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.734 -0.469 . . . . 73.4 109.734 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.08 -46.21 90.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.68 -0.489 . . . . 64.34 109.68 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.636 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 98.2 mtt180 -63.84 -49.26 73.51 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.566 -0.743 . . . . 74.41 112.681 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -60.4 -47.03 87.86 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.905 0.128 . . . . 74.44 110.82 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtm -63.38 -32.73 74.24 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.948 0.404 . . . . 63.21 110.053 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 139' ' ' ARG . 65.0 tp -62.62 -47.15 85.02 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.717 -0.674 . . . . 61.13 109.195 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 36.0 mt-10 -60.88 -46.99 88.44 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.427 0.454 . . . . 71.45 110.279 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -66.3 -36.9 84.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.768 0.655 . . . . 65.53 112.768 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.04 -28.23 29.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.047 0.451 . . . . 70.12 111.427 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 12.3 tmtt? -79.64 -32.28 41.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.447 -0.342 . . . . 74.22 110.194 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.4 HD21 ' HB3' ' A' ' 149' ' ' ASN . 30.8 t30 -69.88 118.75 66.24 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.258 -0.428 . . . . 71.43 111.06 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.13 -14.72 45.64 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.796 2.997 . . . . 72.22 113.188 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.4 ' HB3' HD21 ' A' ' 147' ' ' ASN . 27.7 t-20 -70.77 -25.16 62.77 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.997 0.427 . . . . 75.41 111.301 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.73 32.06 38.28 Favored Glycine 0 C--O 1.218 -0.883 0 N-CA-C 115.578 0.991 . . . . 51.33 115.578 172.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -79.66 127.64 32.42 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 118.138 0.969 . . . . 62.52 110.12 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.4 m -88.04 178.31 6.69 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.323 -0.399 . . . . 52.53 110.675 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.457 ' O ' HG12 ' A' ' 157' ' ' VAL . 26.9 ttt -64.24 -43.63 94.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.808 0.337 . . . . 72.53 110.664 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.68 -24.21 67.52 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.941 -0.572 . . . . 73.12 111.486 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -75.84 -44.51 40.57 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.46 0.647 . . . . 53.31 110.042 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.35 -25.08 62.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.267 -0.879 . . . . 73.1 112.996 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 153' ' ' MET . 14.7 p -128.09 141.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 120.43 -0.508 . . . . 63.33 110.062 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.23 93.91 1.0 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.713 -0.756 . . . . 64.52 111.221 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.3 t -94.15 146.07 24.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.889 -0.782 . . . . 72.44 108.889 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.74 108.78 15.56 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.934 -0.395 . . . . 73.41 109.934 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.4 tt -172.65 -46.91 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.328 -0.99 . . . . 63.45 108.328 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.7 t 68.45 78.93 0.22 Allowed 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.061 -0.972 . . . . 71.04 109.809 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.8 t -93.02 132.11 37.4 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.859 -1.064 . . . . 72.31 110.834 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.94 -134.36 2.02 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 109.365 -1.494 . . . . 75.1 109.365 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--N 1.295 -1.774 0 N-CA-C 108.793 -0.817 . . . . 71.54 108.793 177.904 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 109.316 -0.624 . . . . 71.42 109.316 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.2 p -127.88 147.94 50.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.292 -1.003 . . . . 73.45 108.292 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.0 t -84.75 82.64 8.34 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.844 -1.169 . . . . 72.14 107.844 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -178.68 -164.89 0.08 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.192 -2.521 . . . . 70.55 104.192 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 51.9 m-20 -84.37 120.76 74.81 Favored Pre-proline 0 C--N 1.313 -1.01 0 C-N-CA 119.523 -0.871 . . . . 70.42 110.819 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 5' ' ' ASP . 8.2 Cg_exo -74.91 -41.08 0.74 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.435 2.09 . . . . 51.0 112.652 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.22 -16.01 39.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.179 0.514 . . . . 52.52 110.774 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.4 m -121.03 173.67 7.12 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 121.49 0.662 . . . . 72.43 111.082 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -106.34 156.15 18.8 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 124.63 1.172 . . . . 75.2 109.25 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.539 HD22 HG22 ' A' ' 68' ' ' THR . 14.1 m120 -134.62 122.77 22.77 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.713 -1.958 . . . . 64.32 105.713 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.05 122.61 68.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.86 -0.736 . . . . 72.4 111.565 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' HB2' HG21 ' A' ' 104' ' ' VAL . 52.0 t80 -83.84 108.36 16.81 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.419 -1.326 . . . . 61.34 107.419 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.5 147.76 26.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.886 -0.725 . . . . 75.44 110.716 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' HA ' HD11 ' A' ' 18' ' ' LEU . 50.0 t80 -127.34 96.76 4.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.465 -2.05 . . . . 74.43 105.465 170.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.0 -145.84 11.05 Favored Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.069 -1.539 . . . . 63.11 114.453 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 m -43.8 -61.51 1.4 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 127.396 2.278 . . . . 74.44 116.926 -170.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.508 HG13 ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -89.06 17.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 114.16 1.17 . . . . 75.04 114.16 -167.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 65' ' ' LYS . 54.7 mt -73.38 -17.27 61.3 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 120.12 -0.632 . . . . 65.23 111.13 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.97 125.96 80.8 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.501 -0.772 . . . . 62.35 109.4 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -46.62 -38.08 21.42 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 124.258 3.305 . . . . 74.24 114.785 -174.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -60.15 -64.46 0.94 Allowed 'General case' 0 C--O 1.217 -0.649 0 O-C-N 123.126 0.266 . . . . 71.24 110.379 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 41.9 t -55.88 -32.68 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 124.13 0.972 . . . . 73.13 111.19 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -65.42 -33.55 76.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.027 0.442 . . . . 54.45 111.394 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -80.94 -30.78 35.19 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 122.126 0.965 . . . . 75.03 108.648 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 22' ' ' VAL . 26.9 t -65.58 -33.85 66.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 125.26 1.424 . . . . 65.12 111.377 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.684 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tt -87.33 -42.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.733 0.642 . . . . 62.32 112.733 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 31' ' ' ALA . 87.8 mt -85.18 -30.15 24.16 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 112.188 0.44 . . . . 74.32 112.188 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 t70 81.78 1.75 1.47 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.245 1.418 . . . . 74.24 109.19 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 52.1 mtt180 -126.08 163.63 22.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.115 -1.439 . . . . 73.42 107.115 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -76.63 115.02 16.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.003 -0.74 . . . . 72.0 109.003 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -80.27 136.02 36.35 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.62 -0.718 . . . . 70.22 111.911 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.72 110.2 22.61 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.809 -0.757 . . . . 60.22 109.496 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.507 ' CG2' HG12 ' A' ' 67' ' ' ILE . 4.2 p -110.16 143.81 39.72 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.663 -0.699 . . . . 64.14 110.21 174.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -133.48 140.57 37.37 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 107.361 -1.348 . . . . 64.4 107.361 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 96' ' ' MET . 19.2 Cg_endo -60.62 137.18 71.82 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.68 1.586 . . . . 74.11 109.512 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.36 42.72 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.261 -0.644 . . . . 72.13 109.261 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.89 125.69 70.11 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 121.861 0.838 . . . . 73.35 111.543 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD11 ' HB ' ' A' ' 91' ' ' VAL . 22.8 tp -89.71 113.39 24.89 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 114.731 -1.122 . . . . 61.03 109.743 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -85.32 136.22 33.57 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.712 -0.847 . . . . 71.44 108.712 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . 106.6 -23.38 28.33 Favored Glycine 0 C--O 1.203 -1.785 0 C-N-CA 118.965 -1.588 . . . . 63.24 112.666 174.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 62' ' ' VAL . 16.8 m-85 -101.59 143.37 31.65 Favored 'General case' 0 CA--C 1.456 -2.669 0 C-N-CA 119.718 -0.793 . . . . 63.13 110.928 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 3.7 t60 -112.31 135.08 53.43 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 115.285 -0.871 . . . . 75.21 109.26 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -87.2 112.22 21.77 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.7 -0.682 . . . . 71.01 109.792 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -105.76 126.58 52.33 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.757 -1.572 . . . . 70.41 106.757 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.543 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -85.12 -11.82 54.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.697 0.761 . . . . 73.15 109.612 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.636 HD12 ' SD ' ' A' ' 117' ' ' MET 0.282 2.6 mm? 72.79 -99.4 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 125.108 1.363 . . . . 73.42 112.723 -177.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt 171.49 -37.52 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.191 0.996 . . . . 71.21 110.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.51 4.26 3.67 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.069 -1.062 . . . . 64.23 112.718 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 6.3 mp -91.36 134.01 30.43 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 119.038 -1.065 . . . . 71.35 111.797 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.793 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 73.6 Cg_endo -74.69 103.36 1.7 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.462 2.775 . . . . 72.53 114.466 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.455 38.5 p90 71.23 1.49 0.0 OUTLIER Pre-proline 0 CA--C 1.608 3.196 0 N-CA-C 121.025 3.713 . . . . 72.2 121.025 176.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.793 ' HD3' ' C ' ' A' ' 50' ' ' PRO . 1.7 Cg_endo -88.41 169.45 5.93 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.862 2.375 . . . . 72.52 108.502 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 15.2 p -156.42 -176.32 5.91 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 127.568 2.347 . . . . 74.01 108.535 -3.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.556 HG21 HG21 ' A' ' 62' ' ' VAL . 46.0 pt -134.9 130.59 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 62.23 108.113 167.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.19 -175.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.133 -1.432 . . . . 61.24 107.133 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.2 m 69.83 -173.09 0.18 Allowed 'General case' 0 C--O 1.242 0.66 0 O-C-N 124.323 1.014 . . . . 71.2 111.431 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 56.8 m -148.69 34.28 0.77 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.466 -0.568 . . . . 74.41 109.466 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -75.15 -166.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.73 -0.668 . . . . 74.04 111.905 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 m -75.49 -9.75 58.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.86 0.689 . . . . 75.53 112.86 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.85 160.0 45.47 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.018 -0.611 . . . . 64.5 112.846 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -136.67 159.33 42.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.544 -0.91 . . . . 62.43 108.544 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.556 HG21 HG21 ' A' ' 54' ' ' ILE . 49.1 t -126.25 128.02 71.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 110.088 -0.338 . . . . 74.42 110.088 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.79 122.06 42.2 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.746 -0.464 . . . . 65.15 109.746 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.51 -146.84 4.41 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 111.349 -0.7 . . . . 55.11 111.349 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.551 ' HB2' HD22 ' A' ' 18' ' ' LEU . 61.6 mtpt -138.96 139.96 38.11 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.79 -0.819 . . . . 72.43 108.79 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -104.23 132.24 51.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 119.782 -0.767 . . . . 73.01 109.954 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.507 HG12 ' CG2' ' A' ' 33' ' ' THR . 36.0 mt -90.15 117.48 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.302 -1.37 . . . . 64.02 107.302 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.539 HG22 HD22 ' A' ' 10' ' ' ASN . 81.2 p -103.04 162.07 13.25 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.155 0.428 . . . . 52.41 112.155 -174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.04 33.6 74.73 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.619 -0.719 . . . . 53.14 113.671 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.57 122.28 39.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 122.506 -0.408 . . . . 54.35 110.198 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -75.04 159.11 32.12 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.579 -0.896 . . . . 74.45 108.579 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.21 -42.35 81.13 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.363 0.602 . . . . 71.21 112.075 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.58 72.01 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.339 -0.846 . . . . 52.44 110.857 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -76.26 -32.99 59.15 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.586 -0.734 . . . . 74.41 109.172 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.59 -40.68 95.67 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.97 -1.014 . . . . 75.45 109.847 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.619 ' O ' HG23 ' A' ' 80' ' ' VAL . 27.2 t-20 -55.88 -30.49 61.61 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.801 -1.091 . . . . 64.14 111.644 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.684 ' ND2' HG13 ' A' ' 26' ' ' ILE . 64.6 t30 -69.5 -31.47 69.75 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 120.768 -0.373 . . . . 72.44 110.671 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.579 ' CD1' HD13 ' A' ' 26' ' ' ILE . 81.2 m-85 -72.06 -42.13 66.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.516 -0.92 . . . . 75.45 108.516 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.18 -35.2 78.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.114 -1.403 . . . . 71.44 110.291 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 76' ' ' ASN . 60.9 t -74.98 -23.84 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 112.859 0.688 . . . . 72.22 112.859 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 77' ' ' ASN . 46.2 mm -75.76 -84.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 119.308 -0.957 . . . . 75.44 112.42 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.07 10.88 32.0 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 121.657 -0.652 . . . . 72.01 112.548 178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.55 32.01 2.65 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.52 -0.848 . . . . 63.31 112.847 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -83.16 -39.99 20.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.961 0.41 . . . . 74.44 111.361 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.17 14.97 20.66 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.148 0.975 . . . . 62.12 108.635 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -123.81 156.85 35.36 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.423 -1.325 . . . . 63.55 107.423 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.431 ' HB3' HG23 ' A' ' 110' ' ' VAL . 14.0 pt-20 -126.71 155.2 43.06 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.737 -0.838 . . . . 74.12 108.737 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 106' ' ' THR . 49.0 mtm105 -94.84 107.69 19.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.481 0.548 . . . . 73.11 112.481 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.35 158.15 11.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.75 -0.659 . . . . 63.24 109.3 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.441 HG22 ' HD2' ' A' ' 103' ' ' LYS . 15.1 m -94.98 126.11 40.1 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.104 -0.702 . . . . 72.32 109.104 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.444 ' HB ' HD11 ' A' ' 38' ' ' LEU . 34.4 m -132.11 158.31 43.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.802 -1.184 . . . . 74.13 107.802 -177.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -113.96 129.74 56.58 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.454 -1.298 . . . . 72.14 108.605 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 38' ' ' LEU . 16.4 m -126.24 166.1 23.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.444 -0.576 . . . . 61.04 109.444 -174.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 96' ' ' MET . 73.0 t -99.76 124.79 53.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.598 -0.889 . . . . 74.33 108.598 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -68.24 5.12 1.04 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 125.558 1.543 . . . . 73.21 112.462 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.608 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.9 OUTLIER 51.5 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 127.004 2.122 . . . . 64.14 115.166 174.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.8 -43.09 80.57 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.779 0.832 . . . . 54.25 110.751 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.01 -8.84 24.76 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.448 -1.315 . . . . 64.12 107.448 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.7 m 62.63 12.36 5.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.742 1.217 . . . . 75.42 113.888 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.81 161.95 15.05 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.4 -0.592 . . . . 61.31 109.4 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 94' ' ' VAL . 89.3 mttt -96.89 129.68 44.3 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.701 -0.852 . . . . 63.43 108.701 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.14 130.04 69.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 121.256 0.55 . . . . 74.01 110.93 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HD2' HG22 ' A' ' 90' ' ' THR . 5.6 tppp? -86.95 119.75 27.49 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.076 -1.083 . . . . 73.13 108.076 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 10' ' ' ASN . 30.9 m -135.47 174.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.122 -0.49 . . . . 61.21 110.589 -173.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.14 153.7 19.36 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.442 -0.948 . . . . 53.01 108.442 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 14.7 t -146.58 173.43 12.33 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.634 -0.876 . . . . 61.34 108.634 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -107.91 118.19 36.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.174 0.511 . . . . 74.55 110.02 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 54' ' ' ILE . 27.3 m -110.23 168.74 4.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.417 -0.957 . . . . 43.14 108.417 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 53' ' ' CYS . 32.1 t-105 -83.14 119.62 24.75 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.997 -0.742 . . . . 75.11 108.997 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 87' ' ' GLU . 2.2 p -68.65 -20.44 25.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.396 -0.82 . . . . 51.31 111.48 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 18.1 m120 -84.95 13.52 5.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.173 1.389 . . . . 41.42 111.425 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -51.49 -27.66 11.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.541 1.136 . . . . 61.43 113.04 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -78.09 -15.46 58.86 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 120.865 0.364 . . . . 64.21 111.373 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.51 138.57 26.75 Favored Pre-proline 0 C--N 1.304 -1.405 0 N-CA-C 107.089 -1.449 . . . . 64.52 107.089 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -40.15 108.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.683 2.922 . . . . 75.43 112.664 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -95.47 162.47 13.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.039 -0.528 . . . . 75.21 110.471 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.636 ' SD ' HD12 ' A' ' 46' ' ' LEU . 1.3 mpt? -73.58 95.91 2.36 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 105.692 -1.966 . . . . 73.4 105.692 171.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -92.67 -32.19 14.83 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 116.043 -0.526 . . . . 75.23 110.76 -171.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.543 ' HA3' ' CD1' ' A' ' 126' ' ' TRP . . . -148.49 43.27 0.81 Allowed Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 119.345 -1.407 . . . . 63.1 113.336 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.9 165.75 15.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.622 -0.831 . . . . 72.33 109.926 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 78.3 m95 74.8 -39.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.752 1.221 . . . . 74.41 112.769 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -125.35 112.49 16.4 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.284 -0.636 . . . . 71.45 109.284 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -69.74 -40.82 75.96 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.527 -0.76 . . . . 74.23 113.037 -176.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -32.95 65.31 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.373 -0.531 . . . . 74.42 110.963 -173.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.58 -39.82 88.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.091 -0.707 . . . . 65.41 109.091 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.543 ' CD1' ' HA3' ' A' ' 119' ' ' GLY . 29.0 t90 -62.59 -48.28 80.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.665 -0.698 . . . . 74.54 110.108 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -59.06 -47.91 83.52 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 116.005 -0.543 . . . . 71.22 111.991 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.8 m -69.29 -40.44 80.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.461 -0.495 . . . . 70.1 112.29 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.04 -28.33 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 120.588 -0.445 . . . . 74.23 110.535 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.471 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 14.2 t60 -55.66 -47.05 77.34 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.905 -0.776 . . . . 73.12 108.905 174.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.91 98.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.66 -0.7 . . . . 74.11 110.919 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -67.37 -40.83 85.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.116 -0.493 . . . . 52.21 111.407 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.617 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -67.07 -53.5 30.38 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 108.383 -0.969 . . . . 65.31 108.383 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 77.2 m-85 -63.17 -31.44 72.59 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.904 1.446 . . . . 73.02 114.904 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.27 -34.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 119.117 -1.033 . . . . 52.52 109.508 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.414 ' OE2' ' HG2' ' A' ' 140' ' ' LYS . 1.6 tm-20 -69.34 -34.67 74.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.227 1.011 . . . . 73.23 109.028 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.3 m -57.62 -44.02 85.21 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.332 -0.618 . . . . 61.54 109.332 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.462 ' O ' ' HG3' ' A' ' 141' ' ' MET . 79.4 t80 -66.19 -36.31 82.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.764 -0.653 . . . . 70.43 109.266 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.566 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 81.2 mtp180 -60.94 -52.52 64.67 Favored 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.155 -0.475 . . . . 53.4 109.795 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.546 ' HE3' ' OE1' ' A' ' 155' ' ' GLU . 46.3 mmtm -56.03 -39.23 71.65 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.224 0.824 . . . . 73.32 113.224 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 3.3 ppp? -67.47 -31.79 72.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.968 -0.693 . . . . 71.43 110.001 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.2 tp -76.54 -41.71 45.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.527 -0.76 . . . . 75.14 109.622 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 12.4 mm-40 -59.54 -46.84 87.7 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.605 -0.517 . . . . 73.41 109.605 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -64.92 -36.63 85.0 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.285 -0.871 . . . . 74.33 112.027 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -82.17 -38.64 24.36 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.989 0.424 . . . . 75.42 111.438 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -79.48 -31.61 42.39 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.65 0.262 . . . . 65.55 110.508 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -124.7 82.85 59.41 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-O 120.863 0.363 . . . . 54.44 110.213 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.401 ' O ' ' HE3' ' A' ' 151' ' ' LYS . 13.9 Cg_exo -72.76 -24.18 18.44 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.81 2.34 . . . . 74.33 112.563 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -96.84 -15.97 21.0 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.372 0.606 . . . . 75.43 109.957 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.36 -3.69 78.18 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.407 -0.815 . . . . 74.35 113.384 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.603 ' O ' ' HD2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -75.27 132.03 40.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.219 0.533 . . . . 75.22 111.91 178.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.45 ' HB2' ' HG2' ' A' ' 155' ' ' GLU . 50.6 m -101.11 177.94 4.8 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.147 -0.478 . . . . 72.5 111.991 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 66.9 mtt -56.56 -36.61 69.51 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.718 1.007 . . . . 45.54 113.718 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -99.63 -18.9 17.09 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.12 -1.067 . . . . 74.13 108.12 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.546 ' OE1' ' HE3' ' A' ' 140' ' ' LYS . 23.1 mm-40 -73.85 -52.32 13.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.275 0.559 . . . . 71.22 109.667 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.84 -25.53 37.66 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.322 -0.854 . . . . 70.42 109.807 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.7 t 65.54 92.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 113.973 -1.467 . . . . 74.1 111.368 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -128.27 -94.33 0.8 Allowed Glycine 0 C--N 1.297 -1.632 0 CA-C-N 114.627 -1.17 . . . . 74.43 110.413 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.6 p -76.66 96.88 4.28 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.213 -0.662 . . . . 60.43 109.213 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.4 tp -155.46 158.8 39.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.124 -1.806 . . . . 74.44 106.124 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.04 90.75 7.5 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.277 -0.569 . . . . 63.15 112.012 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.8 p -77.79 124.1 27.54 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.033 -1.099 . . . . 51.41 108.033 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 46.7 p -148.98 167.85 24.68 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.089 0.471 . . . . 62.34 111.694 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -149.81 -173.15 19.96 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 109.755 -1.338 . . . . 64.33 109.755 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 C--N 1.294 -1.811 0 N-CA-C 109.854 -0.424 . . . . 73.32 109.854 179.137 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 109.544 -0.539 . . . . 74.32 109.544 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p 44.87 -90.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.343 1.238 . . . . 52.31 114.343 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 p -138.43 117.61 12.66 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 115.897 -0.592 . . . . 74.31 109.537 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.5 p -77.16 101.3 6.1 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.397 -0.964 . . . . 72.35 108.397 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -57.72 108.79 1.39 Allowed Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 123.716 0.635 . . . . 73.12 109.662 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -89.21 -3.94 5.97 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.607 2.204 . . . . 64.42 112.251 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -162.9 -173.93 3.69 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 106.466 -1.679 . . . . 74.21 106.466 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m 68.45 179.78 0.23 Allowed 'General case' 0 C--N 1.31 -1.11 0 O-C-N 124.6 1.188 . . . . 73.12 111.939 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.505 ' CG ' HD12 ' A' ' 75' ' ' LEU . 75.5 m80 -126.89 155.42 43.03 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 115.222 -0.899 . . . . 73.54 110.171 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 90.1 m-20 -127.5 129.5 47.51 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.789 -1.56 . . . . 71.14 106.789 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.69 128.06 59.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.436 0.532 . . . . 74.53 112.436 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -82.01 108.24 15.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.044 -1.465 . . . . 75.25 107.044 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.5 t -113.29 123.16 68.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.422 0.63 . . . . 72.14 110.635 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -96.69 107.21 19.62 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.383 -1.34 . . . . 64.01 107.383 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' A' ' 18' ' ' LEU . . . 75.59 -138.02 22.55 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.782 -0.927 . . . . 50.2 110.782 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.8 m 60.43 -80.77 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.159 1.17 . . . . 74.04 114.159 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 67' ' ' ILE . 32.6 pt -120.03 18.13 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 112.391 0.515 . . . . 74.44 112.391 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 64.1 mt -60.33 -21.91 62.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.429 0.633 . . . . 45.41 109.834 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.88 118.31 71.61 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.347 -1.353 . . . . 63.15 107.347 170.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -48.37 -36.46 30.39 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.961 3.107 . . . . 75.31 113.836 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.93 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 35.03 111.849 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.591 ' O ' HG22 ' A' ' 25' ' ' VAL . 13.0 t -77.86 -32.61 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.515 0.674 . . . . 64.02 109.797 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.18 -33.34 74.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.62 0.724 . . . . 62.13 109.118 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -75.46 -16.13 60.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.252 -0.886 . . . . 72.53 111.65 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 22' ' ' VAL . 13.1 m -89.01 -30.03 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 118.89 -1.124 . . . . 71.13 110.44 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.524 HG21 HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -81.57 -48.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 121.023 -0.271 . . . . 73.25 110.919 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.78 -16.59 25.19 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 120.808 0.337 . . . . 62.12 111.299 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 72.01 6.59 5.63 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.904 1.335 . . . . 61.13 109.999 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -141.97 169.28 17.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.32 -1.363 . . . . 61.4 107.32 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -76.43 128.46 34.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.891 -0.781 . . . . 74.35 108.891 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.25 137.81 41.46 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.711 0.291 . . . . 61.13 110.325 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -98.33 109.91 22.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.943 -1.132 . . . . 54.34 107.943 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.0 p -115.14 146.18 41.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.513 -0.767 . . . . 63.3 111.466 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.71 145.73 50.55 Favored Pre-proline 0 C--N 1.286 -2.162 0 N-CA-C 106.724 -1.584 . . . . 75.52 106.724 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.91 140.84 51.66 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.12 1.213 . . . . 74.14 110.243 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.68 156.44 41.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.051 -0.522 . . . . 53.41 109.808 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 7.3 p -122.93 123.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 121.628 0.728 . . . . 73.41 111.452 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.44 ' HA ' HG12 ' A' ' 93' ' ' VAL . 23.1 tp -87.64 93.23 9.37 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.316 -0.856 . . . . 73.42 110.219 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.428 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 26.3 p80 -68.64 134.85 50.51 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.485 -1.234 . . . . 72.01 107.771 174.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 115.74 -29.85 6.96 Favored Glycine 0 C--N 1.29 -2.015 0 C-N-CA 118.618 -1.753 . . . . 71.01 112.35 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.543 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 58.9 m-85 -109.56 166.55 10.81 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 112.014 0.376 . . . . 71.12 112.014 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.522 ' NE2' ' HB2' ' A' ' 56' ' ' SER . 0.1 OUTLIER -155.14 139.29 16.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.756 -0.656 . . . . 71.21 111.707 -177.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.806 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 67.0 ttt180 -87.48 138.99 31.0 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.441 1.088 . . . . 74.54 112.792 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.628 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 6.8 m-85 -104.69 158.77 16.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.677 -1.147 . . . . 74.52 109.575 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.56 ' H ' ' HD3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.78 -44.92 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.795 1.035 . . . . 72.44 113.795 -174.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.57 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 3.1 mm? 60.63 -179.34 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.991 0.517 . . . . 51.12 111.678 -175.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.07 -71.45 0.68 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.088 0.47 . . . . 44.43 109.86 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.57 20.12 50.08 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.325 -0.941 . . . . 72.33 114.209 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 52' ' ' PRO . 2.8 mm? -101.9 151.03 37.9 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.749 -0.834 . . . . 74.42 108.749 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.4 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 123.015 2.476 . . . . 61.11 114.823 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -134.09 73.39 70.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 122.004 0.907 . . . . 73.22 112.507 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.679 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 20.7 Cg_endo -108.45 167.48 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.995 3.797 . . . . 52.44 112.501 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.806 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 20.2 p -156.18 162.4 40.2 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 127.882 2.473 . . . . 71.21 106.145 -8.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 41.7 pt -123.33 121.46 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.354 0 CA-C-N 119.57 1.077 . . . . 74.03 110.265 170.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.581 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 33.7 m -149.59 -173.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.312 -0.858 . . . . 73.44 110.423 -173.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.522 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 37.7 m 69.44 -161.18 0.17 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 124.626 1.204 . . . . 73.24 111.553 174.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -105.65 -172.66 2.13 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 120.911 0.386 . . . . 60.33 111.252 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 8.8 m-20 -68.02 36.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.413 1.885 . . . . 70.44 115.764 -169.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -79.53 -11.48 59.89 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.188 -0.945 . . . . 71.21 112.536 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.13 -169.99 15.68 Favored Glycine 0 CA--C 1.488 -1.63 0 C-N-CA 119.928 -1.13 . . . . 40.12 112.569 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 33.0 mtmt -145.32 152.61 40.18 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.708 -1.219 . . . . 72.24 107.708 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.49 HG21 HG21 ' A' ' 54' ' ' ILE . 48.7 t -122.2 123.18 68.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 110.177 -0.305 . . . . 75.23 110.177 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 3.8 p-10 -95.41 129.37 42.59 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.373 -0.931 . . . . 64.31 109.967 177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.1 -142.32 3.48 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 111.019 -0.833 . . . . 70.22 111.019 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -138.79 136.85 36.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.008 0.523 . . . . 70.31 111.524 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.45 133.67 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.697 -0.683 . . . . 70.41 109.842 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.677 ' CD1' HD11 ' A' ' 17' ' ' ILE . 32.6 mt -88.62 131.06 37.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.443 -1.688 . . . . 64.44 106.443 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -110.73 160.97 16.23 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.927 -0.709 . . . . 70.24 110.477 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.34 36.77 63.17 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.077 -0.582 . . . . 65.4 112.797 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -95.65 122.79 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.427 -0.455 . . . . 73.03 109.863 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.486 ' OG ' ' HG2' ' A' ' 74' ' ' GLU . 80.3 p -76.91 173.18 12.04 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 121.494 -0.754 . . . . 70.23 109.497 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.44 -29.56 70.25 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.87 0.367 . . . . 72.15 110.298 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.42 -41.27 40.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 71.25 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.486 ' HG2' ' OG ' ' A' ' 71' ' ' SER . 9.5 mm-40 -69.34 -36.49 76.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 75.53 110.194 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.505 HD12 ' CG ' ' A' ' 9' ' ' HIS . 2.3 tt -63.34 -37.86 88.91 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.28 -1.007 . . . . 64.22 108.28 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 80' ' ' VAL . 51.8 t30 -54.83 -31.19 59.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.636 -1.166 . . . . 72.4 111.567 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.511 ' OD1' HG12 ' A' ' 26' ' ' ILE . 23.3 t-20 -75.21 -32.42 61.17 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.519 -0.873 . . . . 73.32 109.826 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HE1' HD13 ' A' ' 17' ' ' ILE . 57.7 m-85 -64.52 -36.17 83.32 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.068 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.57 -33.03 73.37 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.632 -0.713 . . . . 73.04 110.253 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 76' ' ' ASN . 99.6 t -69.16 -37.64 76.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.846 -0.615 . . . . 74.23 110.435 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 77' ' ' ASN . 66.6 mt -57.79 -68.49 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 116.135 -0.484 . . . . 63.14 111.095 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' CE2' ' A' ' 107' ' ' TYR . 21.0 mm-40 -110.54 103.4 12.0 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.482 0.658 . . . . 74.24 112.591 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 86' ' ' TYR . . . -150.64 11.79 0.85 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 115.045 -0.979 . . . . 72.33 111.695 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -75.17 -44.12 48.47 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.725 -0.472 . . . . 63.4 109.725 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 3.9 t70 -136.97 14.17 3.09 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.665 1.222 . . . . 63.21 107.786 175.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 21.1 m-85 -113.82 145.46 41.4 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.396 -1.275 . . . . 75.52 109.462 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.72 151.89 47.55 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.612 -0.884 . . . . 75.33 108.612 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 -91.14 125.37 35.9 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.718 0.294 . . . . 74.32 111.038 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.66 159.6 34.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 116.013 -0.54 . . . . 72.31 110.559 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 m -93.28 129.8 39.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.638 -1.245 . . . . 73.44 107.638 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.411 ' HB ' HD11 ' A' ' 38' ' ' LEU . 30.6 m -128.65 169.13 20.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 108.628 -0.878 . . . . 63.41 108.628 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -118.72 124.55 47.59 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.28 -1.378 . . . . 74.11 107.28 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 38' ' ' LEU . 17.4 m -127.33 168.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.37 0.605 . . . . 71.3 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 101' ' ' LYS . 69.5 t -102.41 117.58 47.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.739 -0.664 . . . . 73.34 109.474 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -74.69 88.26 2.21 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.5 -1.667 . . . . 62.31 106.5 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -50.26 -35.91 29.02 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 126.168 1.787 . . . . 71.12 112.701 -170.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.86 -31.4 39.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.908 0.755 . . . . 74.11 111.811 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -127.83 -1.29 5.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 120.282 -0.567 . . . . 61.02 110.746 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.5 t 69.13 16.71 8.56 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.802 0.841 . . . . 74.42 111.517 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.3 160.01 15.72 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 109.341 -0.614 . . . . 61.25 109.341 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.666 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.4 mptt -101.63 134.02 45.41 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 108.787 -0.82 . . . . 73.54 108.787 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.91 140.99 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.279 0.561 . . . . 64.34 111.047 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -87.84 125.52 34.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.628 -1.249 . . . . 63.23 107.628 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.29 176.09 8.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 C-N-CA 122.608 0.363 . . . . 70.53 111.171 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -99.59 153.55 18.97 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.355 -0.98 . . . . 73.05 108.355 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -159.56 177.07 11.29 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 117.951 0.341 . . . . 70.21 110.164 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 82' ' ' GLU . 81.6 m-85 -105.57 121.36 43.8 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.268 -1.012 . . . . 54.33 108.268 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.68 165.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 109.053 -0.721 . . . . 74.32 109.053 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.663 ' CD1' ' HB2' ' A' ' 111' ' ' ASN . 61.8 t-105 -97.4 129.65 44.61 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 107.682 -1.229 . . . . 73.33 107.682 -169.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.0 -20.21 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.569 . . . . 74.2 112.298 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.663 ' HB2' ' CD1' ' A' ' 109' ' ' TRP . 26.5 m-80 -77.77 15.6 0.82 Allowed 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 124.1 0.96 . . . . 72.23 110.837 171.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 19.3 ptpt -49.28 -21.0 0.73 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.711 1.204 . . . . 74.45 113.484 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.485 ' O ' HD21 ' A' ' 160' ' ' LEU . 4.7 t70 -124.02 94.28 4.17 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 104.005 -2.591 . . . . 71.12 104.005 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 111' ' ' ASN . 5.4 p-10 -120.5 158.83 50.36 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 113.888 -1.505 . . . . 73.05 111.767 -172.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -106.65 12.05 0.16 Allowed 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.806 2.337 . . . . 75.33 111.881 170.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -134.26 133.15 40.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.359 0.874 . . . . 71.01 113.359 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.57 ' SD ' ' HA ' ' A' ' 46' ' ' LEU . 57.6 mtt 60.96 28.62 18.4 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.738 0.815 . . . . 74.03 111.306 174.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -70.74 27.95 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 115.267 1.581 . . . . 74.31 115.267 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 126' ' ' TRP . . . -138.65 137.79 8.97 Favored Glycine 0 C--N 1.279 -2.617 0 C-N-CA 121.113 -0.565 . . . . 61.33 112.816 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.79 -178.86 6.15 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.152 0.581 . . . . 72.35 110.68 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -67.57 -34.58 77.33 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.231 0.456 . . . . 75.21 112.231 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.71 112.03 19.19 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.419 0.628 . . . . 64.55 111.349 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -68.2 -32.05 72.0 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.997 -1.002 . . . . 64.13 111.576 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.99 -40.82 98.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.414 0.626 . . . . 74.23 109.956 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.1 tt0 -78.12 -41.76 34.03 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.944 -1.026 . . . . 75.44 109.734 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.437 ' CE2' ' HA3' ' A' ' 119' ' ' GLY . 9.6 t90 -55.91 -28.5 57.06 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.231 0.538 . . . . 73.33 110.012 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -58.0 -47.47 82.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.1 -0.5 . . . . 55.31 110.835 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 125' ' ' GLU . 20.0 m -81.86 -22.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.337 0.589 . . . . 71.22 110.133 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 125' ' ' GLU . 99.3 t -68.05 -34.4 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.697 -0.683 . . . . 63.24 109.835 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -55.54 -34.51 64.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.123 -0.489 . . . . 73.53 111.837 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.94 -55.11 9.08 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 121.02 -0.272 . . . . 73.32 111.178 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.565 ' HA ' HG12 ' A' ' 135' ' ' VAL . 9.5 pt-20 -66.84 -37.9 85.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 113.133 0.79 . . . . 55.32 113.133 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.569 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -59.29 -47.12 86.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.424 -0.353 . . . . 73.11 111.147 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -81.72 -37.58 27.08 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 112.573 0.583 . . . . 62.45 112.573 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 132' ' ' GLU . 15.0 p -62.75 -41.64 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 119.625 -0.83 . . . . 52.22 111.226 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 29.4 mm-40 -58.81 -44.14 90.75 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 123.018 0.199 . . . . 74.52 110.919 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.9 m -54.1 -48.64 70.49 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 123.661 0.6 . . . . 73.51 110.761 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.33 -36.87 85.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.747 0.308 . . . . 74.54 111.288 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 83.7 mtp180 -66.68 -43.6 84.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.228 0.537 . . . . 73.2 110.494 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.1 -40.6 71.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.932 -0.576 . . . . 71.13 111.725 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.4 mtm -66.82 -31.41 72.01 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.602 -0.439 . . . . 70.23 110.819 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.05 -43.94 97.75 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.654 -0.869 . . . . 62.4 108.654 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 149' ' ' ASN . 12.6 mm-40 -62.41 -30.21 71.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.639 . . . . 70.41 111.004 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.65 ' CG ' ' HB1' ' A' ' 156' ' ' ALA . 46.5 m0 -75.39 -38.92 59.68 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.839 -0.619 . . . . 74.2 112.477 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -77.75 -43.31 31.26 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.796 0.331 . . . . 72.14 111.677 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.521 ' C ' ' HD3' ' A' ' 148' ' ' PRO . 88.0 tttt -79.23 -17.03 55.58 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.292 -0.413 . . . . 74.14 111.438 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.583 ' N ' ' HD3' ' A' ' 148' ' ' PRO . 3.5 t-20 75.7 16.59 0.0 OUTLIER Pre-proline 0 CA--C 1.609 3.224 0 N-CA-C 115.394 1.627 . . . . 73.24 115.394 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 147' ' ' ASN . 6.9 Cg_exo -73.85 -16.57 23.29 Favored 'Trans proline' 0 C--N 1.4 3.247 0 CA-C-N 122.795 2.034 . . . . 55.13 110.958 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 143' ' ' GLU . 26.6 t-20 -73.81 -22.71 59.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.528 -0.76 . . . . 74.13 110.212 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.89 -47.46 1.04 Allowed Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.774 -0.727 . . . . 61.32 112.051 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -70.34 135.0 48.46 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 109.618 -0.512 . . . . 73.21 109.618 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 21.7 m -69.29 167.14 17.0 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.092 -0.707 . . . . 75.12 109.092 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.544 ' O ' HG23 ' A' ' 157' ' ' VAL . 27.9 ttt -54.1 -43.85 70.76 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.295 1.22 . . . . 34.4 114.295 -172.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 154' ' ' GLU . 0.1 OUTLIER -77.06 -30.67 55.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.125 -0.63 . . . . 63.1 110.915 -177.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.84 -32.99 70.2 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.094 0.949 . . . . 71.21 108.99 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.65 ' HB1' ' CG ' ' A' ' 144' ' ' TRP . . . -77.96 -24.72 48.04 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.987 -1.461 . . . . 70.32 112.375 -177.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 153' ' ' MET . 99.2 t -53.23 109.48 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.409 0.624 . . . . 74.12 112.108 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -117.61 -170.83 15.29 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.957 -1.657 . . . . 31.43 108.957 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.3 m -86.71 88.99 7.79 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 118.046 0.923 . . . . 72.35 111.479 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 113' ' ' ASP . 67.1 mt -154.21 -58.55 0.12 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.568 0.747 . . . . 71.44 111.465 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.1 tp -74.42 -8.1 55.16 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.047 -0.524 . . . . 64.15 111.38 -176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 56.6 m 68.09 78.05 0.24 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.25 1.02 . . . . 44.13 110.86 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 30.2 t -171.86 -175.06 1.44 Allowed 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.404 -1.702 . . . . 65.23 106.404 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -177.12 -47.56 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.719 0 N-CA-C 110.706 -0.958 . . . . 53.02 110.706 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 C--N 1.301 -1.524 0 CA-C-N 115.226 -0.487 . . . . 71.22 109.74 178.182 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.239 0.54 0 N-CA-C 109.187 -0.672 . . . . 73.22 109.187 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.3 m -137.46 96.67 3.3 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.346 -1.724 . . . . 63.31 106.346 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.5 m -134.21 151.87 51.54 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.23 -0.441 . . . . 63.22 111.56 -174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.8 t 67.94 14.39 9.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.296 1.038 . . . . 55.33 110.003 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 54.8 84.24 0.21 Allowed Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 124.922 1.289 . . . . 75.21 112.763 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.84 118.89 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.11 1.873 . . . . 64.41 108.325 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -137.57 127.56 25.79 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 120.996 0.427 . . . . 71.14 111.234 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.5 m -66.26 119.68 11.94 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.502 -1.295 . . . . 44.3 107.502 173.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -87.54 156.1 19.68 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.445 -0.798 . . . . 71.2 112.976 -173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -133.63 125.03 27.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.624 -1.625 . . . . 71.41 107.241 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 49.7 t -119.25 120.51 63.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.68 -0.408 . . . . 75.41 110.548 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.73 121.25 23.78 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.283 -1.747 . . . . 70.41 106.283 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HB ' HD11 ' A' ' 67' ' ' ILE . 13.0 p -113.2 138.81 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 C-N-CA 118.858 -1.137 . . . . 73.14 112.206 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.4 -36.68 68.72 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.969 -1.468 . . . . 74.03 110.471 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 13' ' ' VAL . . . 179.45 -175.13 46.81 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.794 -0.922 . . . . 61.15 110.794 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m 69.88 -65.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.304 1.041 . . . . 62.14 113.561 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.628 HG21 HD13 ' A' ' 67' ' ' ILE . 45.9 mt -68.81 -8.75 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.677 0.751 . . . . 72.43 110.223 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.06 -29.12 69.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.852 -0.796 . . . . 61.44 108.852 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.36 114.22 58.62 Favored Pre-proline 0 N--CA 1.418 -2.033 0 N-CA-C 107.86 -1.163 . . . . 74.4 107.86 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.47 -28.39 8.64 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 124.808 3.672 . . . . 74.33 115.739 -174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -71.07 -29.78 65.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 63.51 110.955 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 25' ' ' VAL . 63.0 t -76.72 -36.08 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.4 -0.593 . . . . 62.53 109.4 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.62 76.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.819 -0.808 . . . . 63.12 108.819 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -72.13 -17.72 61.95 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.256 -0.884 . . . . 74.21 111.894 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 22' ' ' VAL . 21.4 m -91.54 -25.4 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 119.191 -1.004 . . . . 74.42 110.831 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.507 HD13 ' CD1' ' A' ' 78' ' ' PHE . 11.2 tt -87.03 -45.3 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 120.054 -0.658 . . . . 64.41 112.123 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 31' ' ' ALA . 89.7 mt -89.08 -18.4 27.33 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.996 -0.44 . . . . 64.41 110.434 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 32.0 t70 71.28 10.8 6.74 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.929 1.347 . . . . 71.13 108.526 -171.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -143.45 145.15 32.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.673 -1.603 . . . . 73.13 106.673 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.7 m -80.23 116.98 20.62 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 120.682 0.277 . . . . 63.25 110.291 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 27' ' ' LEU . . . -95.65 156.46 16.31 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.646 -0.501 . . . . 61.14 109.646 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.26 125.43 44.88 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.977 -0.556 . . . . 73.44 110.317 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -94.45 143.29 26.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.887 -0.783 . . . . 63.2 108.887 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.96 138.7 33.68 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 109.129 -0.693 . . . . 74.24 109.129 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.82 129.81 37.01 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 123.322 2.681 . . . . 65.31 113.063 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -150.52 157.08 42.6 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.467 -0.788 . . . . 70.3 110.218 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.1 126.77 72.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.518 0.675 . . . . 62.54 111.71 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.461 HD11 ' HB ' ' A' ' 91' ' ' VAL . 21.7 tp -89.69 95.35 10.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.339 -0.846 . . . . 74.53 112.188 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 7.0 p-80 -70.33 128.54 36.56 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.058 -0.974 . . . . 73.52 111.568 174.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.28 -19.72 11.61 Favored Glycine 0 N--CA 1.436 -1.363 0 C-N-CA 120.291 -0.957 . . . . 74.42 112.34 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.491 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 61.5 m-85 -114.79 158.76 21.45 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 113.015 0.746 . . . . 74.23 113.015 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.423 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 3.3 t-160 -128.02 124.4 37.06 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.53 -1.285 . . . . 74.44 107.53 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.423 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 10.6 ptm180 -91.88 144.39 25.53 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.838 -0.43 . . . . 72.13 109.838 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -109.78 176.54 5.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.949 0.404 . . . . 74.32 111.126 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -91.76 100.28 13.01 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.285 0.564 . . . . 74.41 109.702 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.418 HD12 HD13 ' A' ' 49' ' ' LEU . 4.0 mm? -94.68 118.61 32.0 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.631 0.729 . . . . 73.15 110.544 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -93.7 -43.96 8.39 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.775 -1.102 . . . . 74.35 108.713 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.14 -25.99 32.38 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.719 -1.128 . . . . 63.22 113.149 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.418 HD13 HD12 ' A' ' 46' ' ' LEU . 7.2 mp -92.27 132.71 31.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.415 -0.462 . . . . 65.43 110.868 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 57.4 Cg_endo -85.12 -20.8 3.3 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.466 2.777 . . . . 73.54 112.859 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.652 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 51.9 p90 -139.49 175.85 2.97 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 104.668 -2.345 . . . . 74.02 104.668 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.329 0.0 OUTLIER 31.43 169.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.595 3.55 0 C-N-CA 124.002 3.135 . . . . 71.41 119.795 -162.701 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 24.6 p -131.52 160.85 34.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.563 -1.336 . . . . 71.21 113.069 9.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 22.1 pt -122.92 137.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.92 -1.491 . . . . 73.33 107.863 174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.36 151.78 34.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 106.141 -1.8 . . . . 53.21 106.141 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m -65.6 140.95 58.57 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.242 1.201 . . . . 65.44 114.242 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m -155.99 102.86 2.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.222 -2.14 . . . . 65.13 105.222 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.23 -31.83 65.91 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.258 0.836 . . . . 65.31 113.258 -172.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -87.52 -0.81 57.36 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.682 0.253 . . . . 72.3 111.682 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.86 168.11 12.96 Favored Glycine 0 C--O 1.238 0.372 0 C-N-CA 120.371 -0.919 . . . . 63.31 113.134 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 39' ' ' HIS . 18.5 ptpt -150.05 154.68 38.55 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 110.049 -0.352 . . . . 73.42 110.049 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.0 123.4 69.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.801 -0.444 . . . . 74.11 109.801 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -96.63 128.49 43.62 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.791 -0.763 . . . . 74.35 109.512 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.07 -141.03 3.07 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 109.887 -1.285 . . . . 54.33 109.887 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 49.6 mtpt -141.1 150.71 43.23 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.873 -0.788 . . . . 63.31 108.873 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . 28.7 m -104.11 134.16 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.123 -0.49 . . . . 64.33 110.094 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.628 HD13 HG21 ' A' ' 17' ' ' ILE . 8.8 mt -87.19 115.78 28.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.744 -2.317 . . . . 65.31 104.744 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -109.63 160.49 16.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.838 -0.745 . . . . 75.33 112.421 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.37 41.47 11.57 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 115.806 -0.634 . . . . 43.53 112.702 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.6 t -106.68 122.16 60.28 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 108.862 -0.792 . . . . 74.21 108.862 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.2 t -79.3 174.23 11.78 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.019 -1.072 . . . . 64.35 109.409 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.45 -25.62 67.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.065 -0.346 . . . . 75.24 110.065 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.72 -53.34 18.93 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.852 -0.613 . . . . 71.34 110.371 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.19 -30.62 69.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.353 0.501 . . . . 73.53 112.353 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 75' ' ' LEU . 3.4 tm? -57.27 -31.69 65.86 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.335 0.588 . . . . 74.42 110.659 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.564 ' O ' HG23 ' A' ' 80' ' ' VAL . 15.0 m120 -60.07 -28.28 67.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.364 -0.835 . . . . 72.14 112.078 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.17 -38.02 69.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.591 -0.892 . . . . 51.43 108.591 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CD1' HD13 ' A' ' 26' ' ' ILE . 97.3 m-85 -67.9 -32.7 73.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.616 -0.72 . . . . 74.12 109.338 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 29.0 t70 -67.93 -30.8 70.21 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.191 -0.913 . . . . 63.2 110.538 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 76' ' ' ASN . 58.2 t -72.83 -22.32 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-O 121.259 0.552 . . . . 73.41 110.864 177.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.4 mm -70.19 -24.42 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.32 0.581 . . . . 75.13 110.803 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HG2' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -94.85 -171.72 2.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.767 -0.827 . . . . 74.41 108.767 176.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.49 -64.25 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 118.358 -1.877 . . . . 71.1 114.642 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -57.33 -46.25 83.45 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 117.521 0.66 . . . . 64.35 111.99 -173.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.484 ' O ' HG22 ' A' ' 110' ' ' VAL . 17.4 m-20 -154.8 12.38 0.38 Allowed 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.499 0.666 . . . . 70.43 109.222 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -116.06 147.6 41.1 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.641 -1.614 . . . . 75.11 106.641 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.471 ' OE2' ' HA ' ' A' ' 110' ' ' VAL . 11.4 pt-20 -133.5 138.72 46.26 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.432 -0.507 . . . . 73.13 111.7 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HB2' ' HG2' ' A' ' 82' ' ' GLU . 2.2 tmm_? -88.65 114.01 24.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.771 -0.649 . . . . 75.13 109.502 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.07 160.28 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.492 -0.776 . . . . 64.44 111.54 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 m -90.09 130.01 36.31 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.229 -0.656 . . . . 60.23 109.229 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.6 m -133.16 172.28 16.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 124.703 1.201 . . . . 75.3 108.043 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -121.07 127.78 51.99 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.875 -1.13 . . . . 60.31 110.032 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 38' ' ' LEU . 18.5 m -126.9 166.59 23.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.452 0.644 . . . . 61.24 110.519 -175.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 101' ' ' LYS . 73.0 t -105.56 113.58 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 107.807 -1.182 . . . . 72.33 107.807 172.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -78.51 89.55 4.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 108.539 -0.911 . . . . 72.52 108.539 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.446 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -48.28 -36.83 14.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.285 2.234 . . . . 64.45 112.012 -174.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -45.15 -48.26 12.28 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.239 0.962 . . . . 74.34 111.908 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -108.38 -3.83 17.93 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.308 -0.245 . . . . 73.35 111.219 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 m 66.13 28.65 10.17 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.898 0.879 . . . . 73.14 110.836 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -102.8 161.26 13.88 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.326 -0.852 . . . . 72.13 109.76 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.602 ' HG2' HG22 ' A' ' 94' ' ' VAL . 48.0 mtmt -98.0 133.85 41.91 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.063 -1.088 . . . . 71.34 108.063 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.22 139.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.439 0.638 . . . . 72.44 110.564 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.23 126.57 35.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.725 -1.213 . . . . 64.31 107.725 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.3 m -137.27 175.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.508 0.323 . . . . 72.44 110.419 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 44.4 mt-10 -105.2 153.28 21.76 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.979 -0.378 . . . . 75.24 109.979 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -156.01 176.79 12.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.694 0.283 . . . . 73.24 110.326 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -105.98 119.36 39.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 73.43 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 54' ' ' ILE . 27.6 m -119.3 -178.66 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 109.165 -0.68 . . . . 72.3 109.165 175.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.521 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 64.8 t-105 -100.62 137.09 39.48 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.586 -1.264 . . . . 63.05 107.586 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 85' ' ' ASP . 30.6 m -66.8 -20.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 113.636 0.976 . . . . 74.1 113.636 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -90.51 13.96 14.38 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.099 0.952 . . . . 74.12 109.027 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 60.3 pttt -49.62 -17.39 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.712 2.005 . . . . 64.21 115.17 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.08 -22.38 65.84 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.212 0.529 . . . . 74.23 110.439 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -118.0 140.69 28.18 Favored Pre-proline 0 CA--C 1.513 -0.458 0 N-CA-C 109.628 -0.508 . . . . 72.25 109.628 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.86 104.86 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.112 1.875 . . . . 74.31 110.346 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 116' ' ' ARG . 2.8 mmp_? -99.06 142.7 30.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.512 -0.313 . . . . 74.24 110.876 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 tpt 68.15 17.5 9.4 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.698 1.199 . . . . 70.31 109.307 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -83.58 81.25 8.82 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.777 -1.194 . . . . 75.42 107.777 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.21 -33.53 0.02 OUTLIER Glycine 0 C--N 1.278 -2.684 0 CA-C-N 113.48 -1.691 . . . . 61.43 110.013 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -93.37 140.01 30.04 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.402 -1.333 . . . . 51.24 107.402 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -76.69 154.27 34.35 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.798 -0.361 . . . . 74.11 111.098 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.86 148.71 27.57 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.943 -0.571 . . . . 74.24 112.322 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -55.47 -41.22 72.66 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.206 1.002 . . . . 73.45 111.347 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -73.06 -43.47 61.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.484 -0.561 . . . . 74.11 109.484 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 129' ' ' VAL . 46.9 mt-10 -65.81 -8.69 22.98 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.634 -0.712 . . . . 74.42 112.389 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.526 ' HA ' HG12 ' A' ' 129' ' ' VAL . 72.6 t-105 -59.86 -22.7 62.65 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-O 120.775 0.321 . . . . 73.33 110.254 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.61 -45.82 91.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.116 0.484 . . . . 51.34 110.38 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.41 -43.41 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 113.084 0.772 . . . . 61.43 113.084 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 126' ' ' TRP . 7.7 p -75.38 -18.89 15.94 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.22 0 N-CA-C 111.946 0.351 . . . . 72.24 111.946 -174.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 126' ' ' TRP . 9.4 t60 -48.45 -45.53 36.69 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 122.49 0.316 . . . . 74.14 110.6 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.26 -44.5 75.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.451 -0.34 . . . . 65.42 110.666 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.44 -44.14 97.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 74.4 110.821 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER -61.58 -55.51 30.05 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.556 -0.747 . . . . 72.52 110.74 -177.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.418 ' O ' ' HD1' ' A' ' 138' ' ' PHE . 81.1 m-85 -65.46 -32.66 74.39 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.808 1.41 . . . . 74.01 114.808 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.543 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 9.1 p -63.59 -42.19 95.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 118.913 -1.115 . . . . 62.41 109.331 176.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.07 -37.6 69.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.18 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 141' ' ' MET . 97.1 m -49.62 -51.41 37.76 Favored 'General case' 0 C--O 1.214 -0.816 0 O-C-N 123.518 0.511 . . . . 73.32 110.407 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.67 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 90.5 m-85 -70.54 -39.34 74.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.434 0.531 . . . . 74.54 112.434 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -63.44 -48.86 76.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.039 -0.264 . . . . 64.03 110.775 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.24 -35.66 80.99 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.876 -0.416 . . . . 72.34 109.876 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 137' ' ' THR . 46.9 tpp -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.956 -0.566 . . . . 70.22 109.57 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 80.4 mt -66.49 -41.65 88.63 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.987 -0.375 . . . . 71.31 109.987 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 34.3 mt-10 -65.98 -34.91 79.19 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.529 0.681 . . . . 72.52 110.024 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.413 ' CZ2' ' HB3' ' A' ' 153' ' ' MET . 32.5 t90 -75.42 -33.56 60.94 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.52 -0.764 . . . . 73.4 110.315 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -47.12 16.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.729 -0.669 . . . . 75.11 112.365 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.73 -32.25 41.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.456 -0.498 . . . . 74.14 109.724 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' GLU . 52.3 t30 58.4 84.23 0.21 Allowed Pre-proline 0 C--N 1.315 -0.917 0 C-N-CA 125.221 1.408 . . . . 72.14 114.434 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -93.43 -16.25 0.78 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.288 1.992 . . . . 75.25 112.245 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.67 -20.0 22.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.954 0.353 . . . . 73.44 111.954 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.96 31.37 9.28 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.154 -1.022 . . . . 14.22 111.967 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.43 144.97 25.64 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.556 -0.535 . . . . 44.52 109.556 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.8 m -86.12 155.6 20.71 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 106.154 -1.795 . . . . 71.12 106.154 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.413 ' HB3' ' CZ2' ' A' ' 144' ' ' TRP . 1.3 mpt? -67.82 -45.18 75.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.511 0.56 . . . . 73.42 112.511 -173.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.79 -26.07 61.39 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.066 0.46 . . . . 75.31 110.833 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -70.79 -48.11 55.93 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.327 0.584 . . . . 64.01 109.97 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.67 69.91 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.474 -0.785 . . . . 54.02 112.232 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 160' ' ' LEU . 34.3 m -94.94 -32.26 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 119.905 -0.718 . . . . 71.52 112.635 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 104.74 -108.22 3.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.747 -0.739 . . . . 53.42 111.376 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.7 p -115.06 20.41 15.03 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.927 0.87 . . . . 71.32 110.136 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 45.7 tp -92.92 -19.19 21.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.066 -0.97 . . . . 75.13 111.378 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.5 mp 66.84 -66.96 0.17 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.46 1.104 . . . . 54.31 111.627 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.9 t -172.73 -49.72 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.21 -2.145 . . . . 61.41 105.21 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.3 t 55.23 85.59 0.06 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.329 -1.305 . . . . 72.34 112.154 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.4 46.46 0.02 OUTLIER Glycine 0 C--N 1.305 -1.154 0 N-CA-C 110.252 -1.139 . . . . 61.13 110.252 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 108.416 -0.957 . . . . 51.32 108.416 -178.26 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 C--O 1.241 0.624 0 N-CA-C 109.324 -0.621 . . . . 60.31 109.324 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.2 m -79.92 123.51 27.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.585 -1.265 . . . . 61.22 107.585 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -68.39 110.62 4.21 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.352 0.596 . . . . 74.12 111.724 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 p -85.46 124.87 32.54 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.781 -0.822 . . . . 65.5 108.781 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -133.48 103.48 12.4 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 109.559 -0.534 . . . . 71.53 109.559 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.56 -74.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.04 1.826 . . . . 60.33 111.193 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -121.2 -77.63 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.302 -1.74 . . . . 70.54 106.302 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 m 49.08 -169.82 0.02 OUTLIER 'General case' 0 C--O 1.248 0.977 0 O-C-N 124.873 1.358 . . . . 64.41 114.271 171.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.44 ' C ' HD22 ' A' ' 10' ' ' ASN . 76.5 m80 -107.89 142.35 38.1 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.781 -1.1 . . . . 73.22 109.097 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.44 HD22 ' C ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -124.36 130.95 53.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.876 -1.157 . . . . 75.21 107.876 178.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 27.7 t -124.59 120.32 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 110.172 -0.307 . . . . 74.14 110.172 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.617 ' HB3' HG22 ' A' ' 106' ' ' THR . 41.5 t80 -83.02 117.71 23.01 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.449 -0.945 . . . . 72.42 108.449 174.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 17' ' ' ILE . 7.5 p -136.76 150.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.669 -0.696 . . . . 54.21 109.709 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -127.36 -10.08 5.77 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.522 -0.547 . . . . 65.21 109.522 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.07 -128.4 1.08 Allowed Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 115.348 0.899 . . . . 74.21 115.348 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -62.83 -42.65 99.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.706 1.373 . . . . 60.44 114.706 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.582 HG21 HD13 ' A' ' 67' ' ' ILE . 30.4 mt -60.59 -21.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.427 0.899 . . . . 72.41 113.427 -171.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' CD1' HG13 ' A' ' 13' ' ' VAL . 7.2 mp -66.14 -20.58 66.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.961 0.41 . . . . 61.4 111.117 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.19 116.16 65.73 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 108.509 -0.923 . . . . 74.21 108.509 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -40.11 -38.78 2.23 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 125.096 3.864 . . . . 62.21 115.456 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -57.82 -47.27 83.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.924 0.392 . . . . 73.52 111.065 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.6 t -67.03 -43.56 88.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.723 -0.671 . . . . 50.0 110.48 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB1' ' CB ' ' A' ' 31' ' ' ALA . . . -62.59 -37.12 84.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.805 -0.634 . . . . 71.33 109.988 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -72.67 -29.57 63.52 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.81 -0.632 . . . . 64.52 111.867 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 21' ' ' ALA . 23.0 m -81.45 -25.06 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.554 -0.859 . . . . 62.41 111.424 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.463 ' C ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -82.93 -47.92 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 120.274 -0.571 . . . . 72.21 111.04 178.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 92.2 mt -92.96 -12.69 30.15 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.206 0.447 . . . . 71.23 112.206 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 t70 76.36 -6.57 1.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.37 1.081 . . . . 73.42 109.381 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.7 ptt180 -133.99 163.76 28.82 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 125.646 1.578 . . . . 72.4 106.747 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.8 m -76.72 127.81 33.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.237 -0.653 . . . . 42.03 109.237 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' CB ' ' HB1' ' A' ' 23' ' ' ALA . . . -75.72 144.93 41.26 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 120.887 0.375 . . . . 65.12 111.489 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.77 108.89 20.9 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.817 -0.809 . . . . 53.23 108.817 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.1 p -111.71 143.7 42.19 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 115.144 -0.934 . . . . 53.54 109.934 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.29 138.89 33.83 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 108.503 -0.925 . . . . 74.1 108.503 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.71 134.76 62.77 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.636 2.224 . . . . 75.23 111.653 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.31 156.21 41.11 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.597 -0.729 . . . . 13.11 109.738 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.42 126.58 75.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.593 0.711 . . . . 75.25 111.58 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 93' ' ' VAL . 22.6 tp -93.67 96.19 9.66 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.918 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.464 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 19.7 p80 -71.62 131.78 43.68 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.569 -0.901 . . . . 53.31 108.569 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 116.56 -22.87 10.66 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 117.854 -2.117 . . . . 73.21 113.151 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 156.17 24.47 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 120.939 0.399 . . . . 72.23 111.224 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -127.24 140.51 52.17 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.619 -0.719 . . . . 44.31 109.125 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -85.72 137.21 32.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.601 0.76 . . . . 65.44 109.809 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.512 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 91.4 m-85 -124.33 145.78 49.22 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.858 -1.534 . . . . 72.43 106.858 174.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 25.1 pttm -90.43 -46.6 8.25 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.018 0.747 . . . . 64.45 113.018 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.537 ' HG ' HD22 ' A' ' 49' ' ' LEU . 2.7 mm? 60.77 179.99 0.1 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.98 0.912 . . . . 73.0 111.947 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.9 -43.22 0.81 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.372 0.606 . . . . 52.23 109.859 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.27 -13.44 76.73 Favored Glycine 0 N--CA 1.422 -2.234 0 CA-C-N 115.368 -0.833 . . . . 74.1 113.213 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.537 HD22 ' HG ' ' A' ' 46' ' ' LEU . 7.1 mp -89.73 163.29 33.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 O-C-N 122.69 -0.3 . . . . 71.25 110.604 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.18 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.881 2.387 . . . . 75.34 114.096 -173.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.86 75.87 75.03 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 122.61 1.195 . . . . 75.33 109.266 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CB ' ' SG ' ' A' ' 53' ' ' CYS 0.301 43.9 Cg_endo -113.2 165.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 125.071 3.847 . . . . 74.13 114.743 -171.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 69.6 m -156.06 175.87 13.4 Favored 'General case' 0 N--CA 1.505 2.288 1 C-N-CA 132.137 4.175 . . . . 73.03 104.82 -18.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 pt -123.94 143.31 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 120.199 -0.6 . . . . 64.04 110.505 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -131.56 146.22 33.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 m -59.49 113.43 2.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.562 0.745 . . . . 75.22 111.34 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -157.54 98.01 1.64 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.751 -1.203 . . . . 45.22 107.751 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 11.4 m-20 -62.4 -16.87 57.32 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.606 1.336 . . . . 75.24 114.606 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -75.35 -17.77 60.16 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.224 0.535 . . . . 71.45 109.953 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.51 164.1 12.11 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.808 -0.633 . . . . 62.42 112.451 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 28.6 mtmm -143.77 152.09 40.81 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.027 -1.471 . . . . 71.2 107.027 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.2 123.1 71.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.328 -0.619 . . . . 75.44 109.328 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.23 126.67 46.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.369 -0.604 . . . . 61.11 109.369 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.9 -138.42 2.55 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 110.485 -1.046 . . . . 44.44 110.485 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 97.4 mttt -138.49 147.43 43.19 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 117.502 0.651 . . . . 64.43 110.785 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 31.2 m -105.41 133.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.829 -0.623 . . . . 63.33 109.833 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.582 HD13 HG21 ' A' ' 17' ' ' ILE . 6.4 mt -87.14 110.63 20.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 104.189 -2.523 . . . . 64.32 104.189 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 p -104.42 167.21 9.89 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 116.424 -0.353 . . . . 74.13 111.025 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.07 38.29 95.86 Favored Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.603 0.564 . . . . 72.43 112.935 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.96 122.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.61 -0.885 . . . . 72.34 108.61 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.45 ' HB3' ' HG2' ' A' ' 74' ' ' GLU . 32.2 t -72.69 163.34 28.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.151 -0.685 . . . . 64.34 109.151 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.87 -38.42 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.206 -0.294 . . . . 71.15 110.206 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.4 71.84 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.936 0.874 . . . . 64.43 110.221 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.1 mm-40 -76.46 -38.24 55.71 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.811 -1.086 . . . . 65.03 110.022 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.526 HD21 HH12 ' A' ' 88' ' ' ARG . 3.1 tm? -65.21 -38.37 90.25 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.571 -0.74 . . . . 72.52 109.709 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 80' ' ' VAL . 94.9 m-20 -57.53 -27.58 62.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.026 -0.988 . . . . 64.43 112.725 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -75.38 -30.87 60.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.011 -1.076 . . . . 72.5 109.741 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -67.1 -30.34 70.34 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.698 -0.853 . . . . 74.11 108.698 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.84 -31.63 68.4 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.02 -0.991 . . . . 75.31 110.087 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 76' ' ' ASN . 94.7 t -65.65 -35.25 74.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.649 -0.705 . . . . 75.45 109.626 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -58.62 -54.87 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.162 -0.681 . . . . 73.42 109.162 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 66.86 166.15 0.22 Allowed 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 123.672 0.789 . . . . 72.23 112.642 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.83 20.3 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.654 -0.979 . . . . 32.21 110.654 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.89 -43.51 71.63 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.6 0.593 . . . . 72.13 112.6 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.688 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 15.5 t70 -143.73 34.18 1.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.498 -1.667 . . . . 63.22 106.498 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 55.7 m-85 -115.42 150.38 36.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.013 -1.449 . . . . 75.34 108.468 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.68 158.33 44.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.599 -0.519 . . . . 72.21 109.599 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 106' ' ' THR . 37.4 mtt180 -84.22 124.65 31.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 112.776 0.658 . . . . 75.43 112.776 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.7 150.05 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 CA-C-N 115.298 -0.864 . . . . 65.24 108.722 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.1 m -94.42 122.78 37.34 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.449 -0.945 . . . . 72.24 108.449 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.421 HG21 HD22 ' A' ' 38' ' ' LEU . 20.1 m -123.81 163.12 23.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 106.56 -1.645 . . . . 70.21 106.56 -176.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -115.23 132.05 56.73 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 117.872 -1.531 . . . . 55.15 109.42 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' LEU . 18.7 m -126.35 169.5 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 109.133 -0.691 . . . . 73.44 109.133 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.537 HG22 ' HG3' ' A' ' 101' ' ' LYS . 58.8 t -106.1 117.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 109.209 -0.663 . . . . 62.42 109.209 173.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -72.45 90.04 1.29 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.194 -1.41 . . . . 64.13 107.194 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.62 -36.83 57.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.145 1.378 . . . . 54.13 111.714 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -51.41 -27.75 10.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.484 0.714 . . . . 73.25 112.713 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -134.11 9.44 3.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 63.01 109.679 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m 56.76 17.55 3.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.106 0.962 . . . . 61.0 113.489 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -92.58 160.78 14.87 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.618 -0.512 . . . . 61.42 109.618 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.537 ' HG3' HG22 ' A' ' 94' ' ' VAL . 8.3 mptt -100.52 132.68 45.78 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 108.129 -1.063 . . . . 73.43 108.129 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.09 138.48 30.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.249 0.547 . . . . 72.51 110.874 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.39 122.55 32.71 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.417 -0.957 . . . . 63.34 108.417 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.503 HG21 ' HB2' ' A' ' 12' ' ' PHE . 23.3 m -131.22 169.39 21.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.628 0.251 . . . . 73.34 111.22 -172.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.94 148.55 26.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.926 -0.398 . . . . 74.02 109.926 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 66.0 p -141.15 173.72 11.21 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 123.197 0.311 . . . . 62.11 111.623 -176.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.4 118.19 36.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.759 -1.571 . . . . 74.21 106.759 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' TYR . 13.2 p -113.43 159.89 13.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.702 -0.851 . . . . 73.04 108.702 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.688 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 52.1 t-105 -83.14 118.49 23.61 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.844 -1.539 . . . . 71.01 106.844 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.9 m -62.73 -19.64 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.641 0.608 . . . . 63.4 112.641 -174.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.525 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 7.9 t30 -85.79 12.14 9.69 Favored 'General case' 0 C--O 1.199 -1.578 0 C-N-CA 123.996 0.918 . . . . 70.03 109.853 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.48 -15.12 0.22 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.798 2.148 . . . . 72.51 116.798 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.24 -14.4 55.57 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.521 -0.472 . . . . 73.03 110.759 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -115.36 124.58 29.91 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 123.727 0.811 . . . . 73.31 109.148 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -90.15 128.5 1.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.588 2.192 . . . . 61.11 113.255 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -131.07 118.01 19.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.887 -0.597 . . . . 70.25 110.176 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.562 ' HG2' ' H ' ' A' ' 119' ' ' GLY . 51.6 ttm 70.36 152.17 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 124.238 0.961 . . . . 75.03 111.515 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -77.37 -33.79 55.19 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.868 -0.79 . . . . 71.51 108.868 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.562 ' H ' ' HG2' ' A' ' 117' ' ' MET . . . 66.65 56.27 13.9 Favored Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 114.277 -1.329 . . . . 64.21 115.536 173.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -87.61 131.59 34.37 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.015 -0.674 . . . . 61.2 109.273 177.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -167.2 -32.81 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.788 -0.642 . . . . 72.11 110.959 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.45 142.81 33.93 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.697 -0.853 . . . . 73.15 108.697 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.637 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 62.9 t80 -58.99 -37.37 76.71 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.673 0.619 . . . . 63.22 112.673 -173.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.23 -33.39 74.32 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.686 0.755 . . . . 70.5 109.419 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.496 ' O ' HG22 ' A' ' 128' ' ' VAL . 11.3 tp10 -76.18 -42.85 45.08 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.138 -0.937 . . . . 71.24 109.223 177.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -58.23 -33.44 69.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 72.52 111.52 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 63.5 mtp180 -57.51 -36.08 71.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.043 -0.526 . . . . 74.03 112.227 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 125' ' ' GLU . 15.9 m -84.24 -29.96 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 119.96 -0.696 . . . . 74.32 110.534 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.54 -42.36 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.731 -0.668 . . . . 74.42 109.462 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.5 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 20.8 t60 -54.51 -38.37 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.675 -0.693 . . . . 64.34 110.733 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.51 50.83 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.55 -0.295 . . . . 74.21 111.159 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 40.8 mt-10 -69.47 -30.93 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.482 -0.487 . . . . 65.44 112.117 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -68.39 -50.67 51.33 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.06 -0.718 . . . . 70.35 109.06 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.5 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 69.3 m-85 -67.39 -31.21 71.27 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.473 1.286 . . . . 71.43 114.473 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.94 -42.03 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 119.052 -1.059 . . . . 75.42 111.477 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 9.7 pt-20 -70.06 -42.57 72.66 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.882 -0.327 . . . . 73.14 110.859 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 141' ' ' MET . 98.5 m -60.92 -42.01 97.3 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.417 -0.356 . . . . 75.32 110.753 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -57.6 -50.11 74.2 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.032 -0.358 . . . . 70.41 110.032 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 88.2 mtt180 -60.59 -46.54 89.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.556 . . . . 74.13 111.028 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.69 -33.03 74.93 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.592 0.59 . . . . 74.43 112.592 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 137' ' ' THR . 91.7 mtp -65.03 -36.27 83.83 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.88 -0.328 . . . . 71.33 110.578 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.4 -35.8 73.68 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 111.716 0.265 . . . . 72.15 111.716 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 23.9 mm-40 -62.86 -45.05 94.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 63.02 109.539 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -71.27 -29.36 64.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.249 -0.887 . . . . 73.2 110.783 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -71.99 -34.43 68.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.305 0.574 . . . . 65.51 109.769 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.97 -32.2 45.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.868 -0.605 . . . . 75.43 110.644 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -149.5 112.64 3.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 116.362 -0.381 . . . . 74.22 110.143 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.4 -23.55 76.99 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.805 2.336 . . . . 73.13 111.789 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -93.51 9.12 37.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.844 -0.616 . . . . 75.33 110.238 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.68 -30.17 72.79 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.84 -0.618 . . . . 53.12 112.649 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.01 121.8 34.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.704 -0.398 . . . . 55.03 111.111 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.5 m -90.64 157.94 17.2 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.013 -1.477 . . . . 55.53 107.013 173.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -66.71 -43.33 84.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 118.132 0.424 . . . . 72.43 111.054 -175.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 157' ' ' VAL . 63.4 mm-40 -68.67 -32.7 72.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.587 0.708 . . . . 75.32 110.917 176.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.59 -37.46 56.43 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 114.207 1.188 . . . . 70.11 114.207 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -76.94 -46.18 25.1 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.586 -0.445 . . . . 53.43 110.474 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 154' ' ' GLU . 58.1 t 24.57 79.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 125.094 1.496 . . . . 61.33 112.897 -169.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -96.53 -105.85 2.26 Favored Glycine 0 C--N 1.286 -2.244 0 N-CA-C 110.007 -1.237 . . . . 60.3 110.007 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 25.5 m -82.92 94.02 7.63 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 109.329 -0.619 . . . . 74.54 109.329 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 46.1 tp -100.18 111.49 23.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.34 -1.356 . . . . 73.15 107.34 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.4 -40.02 9.71 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 115.452 -0.795 . . . . 75.51 111.338 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.2 m 65.05 83.04 0.17 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.694 -1.225 . . . . 73.42 107.694 -169.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.5 t -65.32 112.28 3.41 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.173 -1.376 . . . . 72.21 111.487 -173.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -124.16 49.51 0.9 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 108.68 -1.768 . . . . 65.05 108.68 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 CA--C 1.49 -1.334 0 CA-C-N 114.694 -0.753 . . . . 75.31 109.582 -177.689 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 p . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 109.595 -0.521 . . . . 72.4 109.595 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.6 p 58.53 -172.41 0.1 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.991 0.917 . . . . 73.44 111.48 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 m -80.66 104.54 11.25 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.87 -0.789 . . . . 71.0 108.87 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.4 p -73.73 -34.36 64.75 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.096 -0.502 . . . . 72.45 110.768 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.41 126.05 91.79 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.681 -0.859 . . . . 74.52 108.681 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.91 122.16 10.88 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.585 2.857 . . . . 64.32 113.659 -174.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -89.31 91.72 8.86 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.652 -0.704 . . . . 64.22 109.28 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.0 p -73.34 124.28 25.43 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.638 0.732 . . . . 71.32 110.498 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -89.5 153.31 20.9 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.844 -1.071 . . . . 65.13 111.402 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 36.7 m-80 -135.0 122.34 21.71 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.002 -1.851 . . . . 74.24 106.002 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 38.9 t -115.62 122.58 69.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 121.107 -0.237 . . . . 63.12 111.045 -173.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.49 ' HB2' HG21 ' A' ' 104' ' ' VAL . 48.7 t80 -87.48 108.22 18.92 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.857 -1.164 . . . . 71.43 107.857 175.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.83 149.18 33.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 120.974 0.416 . . . . 50.4 110.072 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.82 105.07 10.37 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.928 -1.138 . . . . 63.42 107.928 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.456 ' H ' ' CD1' ' A' ' 18' ' ' LEU . . . 87.44 -163.17 33.86 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.337 -0.705 . . . . 52.51 111.337 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t 70.0 -62.02 0.44 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.538 1.135 . . . . 75.03 113.785 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 67' ' ' ILE . 2.7 pp -129.84 9.17 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.157 0.799 . . . . 74.33 113.157 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 65' ' ' LYS . 48.0 mt -64.42 -13.98 54.22 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.291 0.848 . . . . 74.45 113.291 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.56 124.51 83.77 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.112 -1.07 . . . . 70.51 108.112 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.79 -41.64 31.39 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.71 2.94 . . . . 73.21 114.047 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.475 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -65.61 -32.71 74.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 52.23 110.806 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.2 -43.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.06 -0.518 . . . . 74.33 110.14 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.68 70.73 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.395 0.616 . . . . 53.41 109.555 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.96 75.14 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.51 -0.768 . . . . 62.51 111.652 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 21' ' ' ALA . 18.1 m -72.69 -31.46 37.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 120.277 -0.569 . . . . 73.3 112.075 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.589 HD13 ' CD1' ' A' ' 78' ' ' PHE . 7.8 tt -73.57 -36.77 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.925 0.393 . . . . 63.31 111.799 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 74' ' ' GLU . 92.0 mt -100.25 -10.75 21.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 113.767 1.025 . . . . 72.35 113.767 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.3 18.25 10.24 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.972 1.368 . . . . 72.03 108.665 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -160.45 140.74 11.5 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 105.539 -2.023 . . . . 75.5 105.539 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -76.53 118.51 19.27 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.551 -0.86 . . . . 73.23 108.808 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -93.04 147.98 22.39 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 116.188 -0.46 . . . . 63.44 109.877 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -88.67 114.16 25.0 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.299 -0.864 . . . . 75.2 111.181 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.431 ' HB ' ' HE3' ' A' ' 65' ' ' LYS . 4.2 p -100.79 143.43 30.95 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.533 -0.758 . . . . 71.25 109.527 174.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.52 140.03 37.43 Favored Pre-proline 0 C--N 1.277 -2.552 0 N-CA-C 109.219 -0.66 . . . . 51.22 109.219 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 39.7 Cg_endo -67.29 132.14 26.81 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.869 1.713 . . . . 75.51 110.671 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.551 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -145.58 156.1 43.47 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.23 -0.895 . . . . 72.11 109.029 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 11.3 p -120.47 128.24 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 CA-C-O 121.681 0.753 . . . . 74.41 110.979 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.463 ' HA ' HG12 ' A' ' 93' ' ' VAL . 23.1 tp -87.43 108.91 19.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.096 -0.957 . . . . 75.41 109.631 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -83.78 125.48 31.97 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.912 -1.04 . . . . 74.1 109.053 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 117.34 -13.74 13.65 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 118.277 -1.916 . . . . 52.33 113.611 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.516 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 39.1 m-85 -124.96 159.61 30.82 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 110.034 -0.358 . . . . 74.31 110.034 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 11.3 t-80 -130.16 137.26 50.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 120.014 -0.674 . . . . 75.34 109.679 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 44' ' ' TYR . 3.2 tmm_? -88.9 129.51 35.59 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.157 -1.053 . . . . 64.1 108.157 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.45 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 46.9 m-85 -95.5 152.88 18.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.642 -0.708 . . . . 71.23 110.979 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 6.1 tmtm? -84.91 -30.27 24.5 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.766 -0.827 . . . . 75.25 108.766 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.39 -166.26 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.438 0.695 . . . . 73.05 111.03 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.83 -42.93 2.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.335 -0.987 . . . . 73.32 108.335 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.81 -8.67 53.99 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.485 -0.864 . . . . 74.31 113.755 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.83 126.32 29.32 Favored Pre-proline 0 C--N 1.321 -0.648 0 O-C-N 122.521 -0.399 . . . . 55.41 110.475 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -83.49 -44.93 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.94 2.427 . . . . 75.32 112.267 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.677 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.9 p90 -113.67 172.11 3.83 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 105.59 -2.004 . . . . 65.33 105.59 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 51' ' ' TYR 0.308 0.0 OUTLIER 30.36 168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.593 3.466 0 C-N-CA 124.376 3.384 . . . . 63.44 118.713 -161.236 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 52' ' ' PRO . 10.5 p -122.58 -175.29 3.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 119.623 -1.923 . . . . 71.11 112.513 8.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 30.1 pt -123.64 132.34 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.822 -1.081 . . . . 74.22 108.788 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 27.4 m -150.46 116.48 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.191 0 O-C-N 123.203 0.314 . . . . 73.22 111.521 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.6 t 55.91 -158.59 0.23 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.182 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.9 m 71.88 80.2 0.15 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.541 1.536 . . . . 70.23 111.23 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.584 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 p-10 -73.49 -10.26 59.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.613 0.72 . . . . 61.54 110.094 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.9 t -83.85 -6.16 59.36 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.0 -1.0 . . . . 73.34 109.097 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.69 164.74 13.36 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.864 -0.684 . . . . 62.53 112.246 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -142.15 147.17 36.22 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.029 -1.471 . . . . 72.4 107.029 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 41' ' ' TYR . 58.1 t -121.04 122.95 68.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 110.104 -0.332 . . . . 72.23 110.104 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -92.4 118.11 30.6 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.454 -0.943 . . . . 73.13 108.454 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -145.21 -152.96 5.74 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.048 -1.221 . . . . 72.4 110.048 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 18' ' ' LEU . 30.3 mtpp -137.4 138.82 40.25 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.315 -0.624 . . . . 73.34 109.315 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.3 m -103.95 133.68 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.766 -0.652 . . . . 54.32 109.602 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 17' ' ' ILE . 4.5 mt -87.4 119.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 105.292 -2.114 . . . . 62.13 105.292 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.4 p -106.43 160.48 15.36 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.277 -0.969 . . . . 75.13 111.5 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.89 39.84 85.1 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.902 -0.59 . . . . 70.11 112.46 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 t -103.83 123.57 57.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 N-CA-C 110.26 -0.274 . . . . 55.51 110.26 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.5 t -73.85 162.42 29.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.582 -0.895 . . . . 55.15 108.582 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.48 -39.3 79.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.015 0.436 . . . . 75.23 109.889 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.52 -32.47 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 40.01 109.84 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.667 ' HB3' HD22 ' A' ' 27' ' ' LEU . 52.8 mt-10 -76.98 -40.23 47.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.27 -0.877 . . . . 63.41 111.508 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.1 tt -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.036 -1.098 . . . . 72.52 108.036 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.591 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.0 t-20 -53.83 -31.55 49.75 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.922 -1.49 . . . . 74.43 110.933 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -31.69 67.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 120.622 -0.431 . . . . 72.25 109.974 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CD1' HD13 ' A' ' 26' ' ' ILE . 90.2 m-85 -72.35 -40.36 67.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.598 -0.89 . . . . 55.42 108.598 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.88 -29.42 70.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.571 -1.195 . . . . 70.14 111.98 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 76' ' ' ASN . 95.5 t -52.63 -22.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 124.036 0.934 . . . . 73.14 112.295 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.96 -29.88 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 N-CA-C 109.661 -0.496 . . . . 71.54 109.661 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 55.53 96.74 0.02 OUTLIER 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.663 1.585 . . . . 73.35 113.836 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.14 107.77 3.46 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 108.704 -1.759 . . . . 43.52 108.704 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.98 -35.42 76.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.323 0.562 . . . . 64.11 112.316 -175.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 109' ' ' TRP . 15.1 m-20 -101.59 17.96 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.055 0.455 . . . . 73.41 110.453 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -115.19 141.98 47.29 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.89 -0.411 . . . . 74.02 109.89 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -131.67 143.84 50.58 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.759 -0.83 . . . . 64.34 108.759 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 106' ' ' THR . 55.4 mtm180 -82.92 113.1 20.29 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.591 -0.444 . . . . 44.15 112.169 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.5 m -116.34 153.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.399 -0.819 . . . . 71.34 110.322 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.2 m -90.46 123.44 34.17 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.853 -0.795 . . . . 72.21 108.853 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.34 171.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.548 -1.278 . . . . 62.3 107.548 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -125.23 123.56 39.8 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.948 -1.501 . . . . 72.44 106.948 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 38' ' ' LEU . 13.7 m -126.81 163.07 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 121.504 0.669 . . . . 73.3 109.976 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 101' ' ' LYS . 53.7 t -107.69 118.42 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.73 -0.668 . . . . 53.5 109.904 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.43 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 40.9 ttm180 -66.04 98.83 0.46 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.965 -1.494 . . . . 64.11 106.965 175.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.551 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -60.48 -36.27 77.89 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 125.03 1.332 . . . . 73.01 110.283 -170.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.7 -41.85 70.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.573 -0.74 . . . . 73.23 112.212 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.14 -1.55 12.97 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.415 0.626 . . . . 73.52 110.952 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 t 64.42 23.12 12.9 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.993 0.917 . . . . 72.31 111.451 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.3 pt-20 -96.59 161.39 13.92 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.88 -0.415 . . . . 73.31 109.88 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.499 ' HG2' HG22 ' A' ' 94' ' ' VAL . 48.0 mtpt -105.03 130.84 53.14 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.718 -0.475 . . . . 74.14 109.718 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.42 130.92 54.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.722 0.772 . . . . 65.13 111.277 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -87.52 120.29 28.67 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.022 -1.473 . . . . 71.13 107.022 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.517 HG12 ' HB2' ' A' ' 10' ' ' ASN . 27.2 m -133.83 172.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.755 0.312 . . . . 60.2 111.17 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.4 152.57 23.43 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.774 -0.454 . . . . 64.53 109.774 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 15.0 t -151.91 174.64 13.36 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.658 -0.867 . . . . 61.05 108.658 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.1 118.42 36.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.204 -1.036 . . . . 61.53 108.204 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.42 153.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.836 -0.801 . . . . 71.23 108.836 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.603 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 63.7 t-105 -81.9 121.4 26.43 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.395 -1.335 . . . . 72.32 107.395 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.76 -20.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.402 0.89 . . . . 72.43 113.402 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.577 ' HB3' ' CD1' ' A' ' 109' ' ' TRP . 28.5 t-20 -80.57 11.35 3.81 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-O 121.702 0.763 . . . . 73.35 109.962 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -50.7 -25.67 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.918 1.287 . . . . 74.03 114.064 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.19 -6.78 57.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.081 0.467 . . . . 75.22 111.669 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.633 ' OD1' ' HB2' ' A' ' 116' ' ' ARG . 12.6 t70 -102.23 128.38 28.55 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 106.062 -1.829 . . . . 70.43 106.062 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.31 46.06 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.229 2.62 . . . . 70.22 111.978 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.633 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 14.2 ttm180 -95.29 115.39 27.37 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.246 -0.888 . . . . 73.33 111.872 -172.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.9 mtt 75.54 142.81 0.07 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.069 1.348 . . . . 74.23 114.546 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -149.1 -42.23 0.15 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.293 -1.321 . . . . 52.0 109.039 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.16 -155.83 52.42 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.141 -0.936 . . . . 65.11 114.447 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.85 151.7 48.33 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.883 -0.784 . . . . 64.45 108.883 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -156.91 -62.7 0.1 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.933 0.873 . . . . 75.13 108.846 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.463 ' HB3' ' CB ' ' A' ' 125' ' ' GLU . 13.3 t70 -121.76 144.2 48.93 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.194 -1.41 . . . . 42.34 107.194 174.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.591 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 81.5 m-85 -66.3 -46.16 77.89 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.274 0.472 . . . . 73.24 112.274 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.432 ' OE1' ' HD3' ' A' ' 127' ' ' ARG . 8.1 tp10 -68.27 -41.24 81.36 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.927 -0.768 . . . . 72.21 108.927 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.463 ' CB ' ' HB3' ' A' ' 122' ' ' ASP . 7.4 tp10 -56.85 -46.75 81.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.888 -1.051 . . . . 71.42 109.162 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.42 ' HA ' HG12 ' A' ' 129' ' ' VAL . 75.3 t90 -56.09 -41.95 75.98 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.781 -0.645 . . . . 73.25 110.976 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 123' ' ' PHE . 72.4 mtp180 -60.27 -41.26 92.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.725 -0.67 . . . . 74.3 111.224 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -82.95 -41.63 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.638 -0.425 . . . . 72.35 111.916 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 126' ' ' TRP . 13.0 p -68.82 -40.11 80.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 112.767 0.654 . . . . 74.34 112.767 -174.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -65.17 -35.25 80.49 Favored 'General case' 0 C--O 1.21 -1.024 0 C-N-CA 118.882 -1.127 . . . . 74.4 110.645 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -64.3 -55.1 23.63 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.434 0.459 . . . . 62.43 111.03 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -23.42 64.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.168 0.433 . . . . 65.44 112.168 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.618 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 1.4 tpmt? -67.24 -45.3 77.13 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.78 -0.822 . . . . 73.33 108.78 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -67.47 -33.18 74.6 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.836 -0.345 . . . . 73.02 111.276 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 98.1 t -53.68 -53.19 27.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.11 -0.7 . . . . 73.02 109.11 173.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.95 -42.42 89.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.671 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.7 m -54.96 -50.51 68.74 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.775 0.672 . . . . 71.34 110.463 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -68.35 -29.85 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.162 0.43 . . . . 72.34 112.162 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 74.5 mtp180 -68.23 -44.73 75.08 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.463 0.649 . . . . 61.51 109.729 177.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -71.23 -42.09 69.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 75.44 110.378 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.2 mmt -62.53 -31.45 72.22 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-N 116.344 -0.389 . . . . 74.31 110.844 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.46 -50.05 74.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.58 0.752 . . . . 73.43 110.869 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.44 -34.37 75.85 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.165 -0.614 . . . . 72.4 111.631 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -75.18 -27.18 59.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.183 0.516 . . . . 73.3 112.035 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -72.88 -37.3 67.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.483 0.713 . . . . 75.32 109.318 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 146' ' ' LYS . 11.3 tmtt? -78.95 -33.0 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.315 -0.624 . . . . 74.22 109.315 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -137.9 95.05 11.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 120.927 0.394 . . . . 73.23 110.628 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.03 -16.61 9.83 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.615 2.21 . . . . 75.05 111.175 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.22 -23.26 61.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.369 -0.832 . . . . 75.04 111.292 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.43 7.05 71.7 Favored Glycine 0 C--O 1.242 0.609 0 C-N-CA 120.454 -0.879 . . . . 65.52 112.506 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.402 ' HD3' HD23 ' A' ' 161' ' ' LEU . 82.7 tttt -93.79 136.84 33.66 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.429 -1.323 . . . . 70.14 107.429 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.455 ' HB2' ' OE1' ' A' ' 155' ' ' GLU . 49.7 m -79.07 164.64 24.15 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 112.491 0.552 . . . . 53.44 112.491 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 66.4 mtt -59.86 -44.2 94.27 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.192 0.812 . . . . 74.3 113.192 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.407 ' HA ' HG22 ' A' ' 157' ' ' VAL . 40.6 tt0 -71.06 -28.66 64.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.439 0.638 . . . . 54.31 110.713 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 159' ' ' SER . 1.1 mp0 -75.44 -32.9 60.83 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.51 -0.768 . . . . 71.01 110.734 175.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.99 -27.9 63.06 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.837 -0.62 . . . . 70.04 111.316 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 154' ' ' GLU . 27.4 m -88.22 133.36 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 120.047 -0.661 . . . . 51.34 109.525 175.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 89.87 -55.53 3.72 Favored Glycine 0 C--N 1.305 -1.147 0 N-CA-C 109.544 -1.422 . . . . 75.42 109.544 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 155' ' ' GLU . 48.4 t -103.31 96.11 6.54 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 107.618 -1.253 . . . . 64.31 107.618 174.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.7 166.39 3.31 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.014 -0.539 . . . . 64.12 111.88 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.402 HD23 ' HD3' ' A' ' 151' ' ' LYS . 93.0 mt -79.75 70.76 6.33 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.24 -0.652 . . . . 54.21 109.24 176.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.4 m -75.57 97.45 3.75 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 115.088 -0.96 . . . . 55.5 109.743 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.3 t -127.12 176.72 7.16 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.812 -1.085 . . . . 71.53 108.2 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.02 103.72 0.24 Allowed Glycine 0 N--CA 1.424 -2.108 0 C-N-CA 120.25 -0.976 . . . . 72.2 112.494 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 C--N 1.306 -1.326 0 N-CA-C 109.061 -0.718 . . . . 38.01 109.061 175.219 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.434 -0.58 . . . . 73.53 109.434 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.6 m -117.81 128.65 55.06 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.723 -0.843 . . . . 71.4 108.723 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 p -58.2 113.67 2.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.143 0.497 . . . . 44.45 111.996 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.1 t -101.43 -29.08 12.22 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.799 -0.637 . . . . 73.11 109.763 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.56 151.91 41.58 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.545 -0.909 . . . . 64.24 108.545 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.37 -6.03 17.77 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.703 2.269 . . . . 65.22 113.511 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.522 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 8.2 mm-40 -96.46 -6.89 36.23 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 119.657 -0.817 . . . . 63.3 111.835 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m -96.71 108.34 20.96 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.571 -1.64 . . . . 74.32 106.571 169.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.638 ' HD1' ' HG ' ' A' ' 75' ' ' LEU . 8.4 m170 -104.23 156.0 18.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.049 -0.523 . . . . 74.13 110.581 -172.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.578 ' HB2' HG12 ' A' ' 104' ' ' VAL . 25.2 m-80 -134.93 133.42 39.55 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.466 -1.679 . . . . 71.43 106.466 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.408 ' HB ' HD12 ' A' ' 67' ' ' ILE . 47.6 t -114.79 121.02 66.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.563 -0.455 . . . . 72.2 111.213 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.535 ' HB2' HG21 ' A' ' 104' ' ' VAL . 59.3 t80 -89.75 98.83 11.99 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.302 -0.629 . . . . 75.34 109.302 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.48 129.98 31.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.832 -0.803 . . . . 63.23 108.832 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.562 ' CD1' ' HA2' ' A' ' 64' ' ' GLY . 48.2 t80 -105.89 86.17 2.34 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.544 -0.863 . . . . 65.42 110.127 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.76 147.18 4.48 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.652 -1.158 . . . . 75.44 112.367 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t 70.67 -69.34 0.18 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.489 1.515 . . . . 73.41 113.718 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.586 HG21 HD13 ' A' ' 67' ' ' ILE . 28.3 mt -75.96 3.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.027 0.918 . . . . 73.43 110.407 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -67.99 -23.04 64.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.568 -0.742 . . . . 74.45 109.159 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.63 119.94 74.52 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 108.565 -0.902 . . . . 71.21 108.565 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -48.55 -35.96 30.41 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.67 2.913 . . . . 53.14 112.54 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -60.37 -40.29 90.27 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.455 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 25' ' ' VAL . 70.9 t -70.46 -39.71 76.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.356 0.598 . . . . 74.3 110.056 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -66.43 -35.32 80.01 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.378 -0.601 . . . . 72.14 109.378 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -74.28 -10.14 59.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 72.34 112.038 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 21' ' ' ALA . 21.1 m -100.04 -31.68 3.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 119.346 -0.942 . . . . 72.33 110.513 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.553 HD13 ' CD2' ' A' ' 78' ' ' PHE . 9.9 tt -79.08 -42.96 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.153 0.501 . . . . 75.11 111.582 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 31' ' ' ALA . 95.8 mt -94.97 -21.38 18.65 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.156 -0.34 . . . . 74.24 110.319 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 28.2 t70 67.59 15.98 9.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 123.598 1.666 . . . . 52.31 107.723 -170.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -133.31 131.56 40.3 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.457 -2.053 . . . . 74.33 105.457 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -76.74 111.43 12.24 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.996 -1.082 . . . . 70.4 109.196 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -96.87 143.09 28.09 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.647 -0.706 . . . . 72.35 109.264 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.78 129.06 45.86 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.852 -0.796 . . . . 74.21 108.852 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 12.7 p -93.34 141.83 28.0 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 119.487 -0.885 . . . . 74.04 108.878 175.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.72 140.02 34.62 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.703 -0.851 . . . . 71.34 108.703 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.73 128.94 28.64 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.778 2.319 . . . . 64.13 111.969 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.24 154.45 37.95 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.902 -0.59 . . . . 35.13 109.518 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.85 131.92 71.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 C-N-CA 120.752 -0.379 . . . . 74.13 110.384 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.454 HD11 ' HB ' ' A' ' 91' ' ' VAL . 20.9 tp -94.32 129.98 40.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.022 -0.535 . . . . 75.03 110.531 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -94.59 129.97 41.22 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.446 -0.343 . . . . 63.54 111.232 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 58' ' ' ASP . . . 105.4 -1.43 40.01 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 119.52 -1.324 . . . . 74.1 113.771 173.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.499 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 56.9 m-85 -126.59 160.76 29.73 Favored 'General case' 0 N--CA 1.414 -2.252 0 O-C-N 122.313 -0.522 . . . . 64.23 112.074 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -134.17 130.97 38.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.387 -1.338 . . . . 74.03 107.387 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.83 124.98 34.7 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.06 0.457 . . . . 74.1 111.208 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HE2' ' O ' ' A' ' 55' ' ' VAL . 93.6 m-85 -106.67 145.17 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.897 -1.149 . . . . 62.01 107.897 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 4.3 mmmp? -109.92 125.02 52.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 112.355 0.502 . . . . 73.43 112.355 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.407 HD23 ' HB2' ' A' ' 52' ' ' PRO . 1.4 mm? -131.83 141.67 49.49 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.189 -1.041 . . . . 71.34 108.189 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -90.65 -30.04 17.38 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.818 -0.808 . . . . 52.34 108.818 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -31.76 76.98 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.806 -1.088 . . . . 71.43 112.222 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.43 ' HB2' ' HG3' ' A' ' 52' ' ' PRO . 6.4 mp -90.98 158.45 41.76 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 108.407 -0.96 . . . . 63.5 108.407 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.94 -76.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.849 2.366 . . . . 71.01 114.216 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.62 76.26 69.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.964 -1.124 . . . . 75.24 107.964 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HG3' ' HB2' ' A' ' 49' ' ' LEU 0.257 51.9 Cg_endo -115.52 162.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 123.432 2.754 . . . . 72.31 116.19 -171.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 m -158.01 158.21 34.43 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.205 3.402 . . . . 71.54 107.152 -19.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 108' ' ' VAL . 33.2 pt -124.09 128.33 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.638 -0.825 . . . . 72.33 111.888 174.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 109' ' ' TRP . 24.2 m -154.58 145.75 13.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 124.342 1.057 . . . . 63.44 108.458 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 p 168.14 -57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.194 0.934 . . . . 72.04 110.671 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 m 69.8 13.6 8.06 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 122.363 1.078 . . . . 74.34 108.337 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.663 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 26.6 t70 -83.28 -178.05 6.95 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 113.938 -1.483 . . . . 71.24 109.715 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.0 m -80.42 -6.88 58.77 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.684 0.278 . . . . 70.44 110.889 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.42 156.17 31.1 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.887 -0.597 . . . . 74.03 111.971 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -129.03 152.91 48.12 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.895 -0.409 . . . . 71.3 109.895 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 122.53 67.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.295 -1.002 . . . . 72.33 108.295 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -97.77 115.64 28.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.426 -0.583 . . . . 73.14 109.426 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.562 ' HA2' ' CD1' ' A' ' 14' ' ' TYR . . . -146.44 -147.4 4.57 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.953 -0.641 . . . . 75.24 111.993 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 47.9 mtpt -139.68 146.21 39.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.213 -1.032 . . . . 71.31 108.213 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 33' ' ' THR . 35.2 m -104.72 135.14 43.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.165 -0.471 . . . . 64.54 110.883 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.586 HD13 HG21 ' A' ' 17' ' ' ILE . 6.4 mt -86.27 111.8 21.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.762 -2.31 . . . . 64.42 104.762 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.3 p -99.44 161.64 13.5 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.495 -0.482 . . . . 71.21 111.694 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.41 35.32 37.6 Favored Glycine 0 C--O 1.245 0.789 0 CA-C-N 115.752 -0.658 . . . . 64.2 112.927 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.5 t -97.37 124.82 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.02 -0.734 . . . . 63.44 109.02 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.0 m -77.95 157.92 29.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.553 -0.906 . . . . 74.41 108.553 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HA ' ' CE1' ' A' ' 9' ' ' HIS . 7.3 p-10 -56.45 -42.74 78.64 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.211 0.529 . . . . 72.41 112.191 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.76 -38.47 70.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.017 -0.992 . . . . 71.33 110.801 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.58 -30.02 62.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.516 -0.766 . . . . 60.3 110.793 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.638 ' HG ' ' HD1' ' A' ' 9' ' ' HIS . 3.0 tm? -58.21 -35.08 71.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.278 -0.873 . . . . 72.04 109.369 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.575 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -59.46 -27.53 66.17 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.357 -0.838 . . . . 63.12 111.919 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.485 ' OD1' HG13 ' A' ' 26' ' ' ILE . 1.9 t-20 -68.08 -31.61 71.35 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.219 -0.659 . . . . 74.25 109.219 -176.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 26' ' ' ILE . 80.1 m-85 -74.46 -32.28 62.54 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 121.68 0.752 . . . . 72.21 109.007 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.83 -31.26 63.12 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.159 -0.928 . . . . 63.23 110.241 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 76' ' ' ASN . 98.1 t -66.65 -22.67 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 115.64 -0.709 . . . . 70.34 110.848 175.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.8 mm -58.96 143.22 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.915 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.41 113.71 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.742 1.617 . . . . 72.23 113.266 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.77 85.35 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.561 -0.828 . . . . 42.3 113.266 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -82.55 -33.17 28.22 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.632 -0.334 . . . . 65.14 111.576 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.537 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.5 m-20 -97.75 2.43 49.53 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.609 0.966 . . . . 74.45 113.609 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.431 ' HD2' ' HB3' ' A' ' 107' ' ' TYR 0.326 1.6 p90 -122.18 142.31 50.55 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.14 -1.024 . . . . 75.12 111.114 171.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 15.5 pt-20 -125.03 159.45 31.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.159 -170.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.403 ' CD ' HD11 ' A' ' 75' ' ' LEU . 30.3 ttp-105 -88.85 128.62 35.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.805 -0.443 . . . . 63.44 109.805 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.35 159.78 40.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 122.634 0.374 . . . . 75.43 110.504 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.7 m -93.67 129.43 39.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.986 -0.746 . . . . 71.31 108.986 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.454 ' HB ' HD11 ' A' ' 38' ' ' LEU . 35.8 m -136.48 157.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.918 -1.141 . . . . 72.54 107.918 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.51 ' HG3' ' HD3' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -105.18 135.65 46.15 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.276 -0.97 . . . . 54.01 108.762 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 38' ' ' LEU . 21.8 m -127.36 161.94 33.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.704 -0.85 . . . . 65.34 108.704 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 101' ' ' LYS . 71.6 t -102.44 120.1 51.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 109.005 -0.739 . . . . 63.2 109.005 176.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -71.91 93.12 1.31 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.476 -1.676 . . . . 72.32 106.476 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -47.84 -49.54 28.91 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 127.262 2.225 . . . . 72.13 115.049 -167.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.88 -23.12 58.34 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.166 -0.614 . . . . 65.22 111.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -97.83 -10.89 23.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.3 -0.409 . . . . 62.34 110.864 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 m 59.26 19.49 7.61 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.464 1.106 . . . . 73.45 112.336 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -105.19 160.78 14.81 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.938 -0.393 . . . . 75.3 109.938 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.3 mtmt -100.31 143.21 30.76 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.618 -0.882 . . . . 73.21 108.618 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.75 162.23 15.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.301 -0.629 . . . . 51.33 109.301 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HD3' ' HG3' ' A' ' 92' ' ' GLU . 3.6 tppp? -110.69 123.83 50.78 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.101 -1.074 . . . . 74.44 108.101 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 10' ' ' ASN . 21.2 m -130.97 174.37 13.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 120.837 0.351 . . . . 73.42 110.564 -174.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -112.11 146.91 37.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.077 -0.712 . . . . 74.33 109.077 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.4 t -149.26 174.03 12.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.085 -1.08 . . . . 75.42 108.085 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.431 ' HB3' ' HD2' ' A' ' 86' ' ' TYR . 90.1 m-85 -113.43 119.55 38.0 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.61 0.719 . . . . 64.53 110.542 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 54' ' ' ILE . 14.0 p -114.0 143.79 22.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.975 -1.011 . . . . 70.31 109.747 -175.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.686 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 61.0 t-105 -70.01 127.86 34.31 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.57 -0.9 . . . . 75.41 108.57 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 85' ' ' ASP . 31.6 m -72.02 -19.82 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.519 0.676 . . . . 72.14 112.559 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.686 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 2.9 t-20 -86.83 15.64 5.62 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 125.216 1.406 . . . . 71.31 109.29 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 109' ' ' TRP . 0.8 OUTLIER -48.27 -22.96 0.76 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.23 1.812 . . . . 72.43 113.85 -176.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -101.71 68.51 1.16 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.551 -0.859 . . . . 73.32 110.984 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -128.56 144.38 51.93 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 114.798 -1.092 . . . . 74.14 108.331 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.35 -33.2 84.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 53.44 113.642 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.559 ' O ' ' HD2' ' A' ' 116' ' ' ARG 0.265 0.0 OUTLIER -133.26 114.22 13.53 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 114.112 1.153 . . . . 64.13 114.112 -178.463 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.436 ' HE2' ' HA ' ' A' ' 117' ' ' MET . 1.7 mmt -118.83 -12.58 9.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 115.83 -0.623 . . . . 71.21 110.342 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -86.12 91.24 8.37 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.841 -0.744 . . . . 74.31 109.772 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.41 153.25 2.89 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 114.2 -1.363 . . . . 64.12 111.312 170.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -86.02 131.69 34.22 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.367 0.603 . . . . 53.2 112.19 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -142.64 -154.01 0.5 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.085 -1.45 . . . . 75.33 107.085 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.665 ' OD1' ' HG2' ' A' ' 124' ' ' GLU . 12.1 t70 -127.71 148.66 50.41 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.448 -1.315 . . . . 75.14 107.448 177.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -58.75 -38.16 77.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.934 0.334 . . . . 65.21 111.622 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.665 ' HG2' ' OD1' ' A' ' 122' ' ' ASP . 12.7 pt-20 -73.66 -26.17 60.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.486 0.66 . . . . 72.22 110.109 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -72.67 -34.19 67.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.053 -0.976 . . . . 74.11 108.571 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -86.96 -23.84 24.94 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.467 -0.788 . . . . 74.31 109.546 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -59.49 -45.7 90.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 62.24 110.391 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.6 m -64.18 -19.75 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 116.362 -0.381 . . . . 73.13 111.956 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.3 -22.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.13 0.491 . . . . 63.21 110.552 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.474 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 5.2 p-80 -115.79 -33.12 5.25 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.695 -0.802 . . . . 74.33 112.952 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 135' ' ' VAL . . . -59.4 -55.73 31.0 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.811 0.671 . . . . 55.22 112.811 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.49 -34.07 77.37 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 120.694 -0.402 . . . . 74.43 111.855 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.482 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 1.1 tmtp? -61.55 -50.31 73.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.107 -0.701 . . . . 73.14 109.107 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 84.3 m-85 -69.37 -31.99 70.74 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.052 0.39 . . . . 51.43 112.052 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 131' ' ' ALA . 97.7 t -60.01 -38.66 77.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.061 -0.348 . . . . 62.41 110.061 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 12.8 mm-40 -57.39 -48.13 79.87 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.698 -0.482 . . . . 71.54 109.698 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' A' ' 141' ' ' MET . 34.8 m -57.51 -46.67 83.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.335 -0.848 . . . . 75.4 110.412 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.402 ' O ' HD23 ' A' ' 142' ' ' LEU . 74.1 m-85 -61.47 -48.51 80.79 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.809 -0.356 . . . . 71.5 111.569 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -54.61 -47.51 73.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.703 0.287 . . . . 64.12 110.822 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 75.4 mmtt -66.9 -42.96 84.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.684 -0.689 . . . . 45.35 111.909 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 137' ' ' THR . 60.5 mtm -66.52 -42.95 86.5 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.718 -0.393 . . . . 73.45 111.248 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.557 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 4.6 mm? -59.22 -49.96 75.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.246 0.832 . . . . 62.43 113.246 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.29 0.567 . . . . 75.22 111.698 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.52 ' NE1' ' HE2' ' A' ' 151' ' ' LYS . 27.6 t90 -75.91 -36.57 59.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.171 -0.922 . . . . 72.03 110.836 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -83.42 -35.57 24.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.299 0.851 . . . . 75.41 113.299 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -79.62 -7.24 58.41 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.863 -0.735 . . . . 73.43 112.308 -177.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -143.29 86.41 9.05 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-O 121.027 0.441 . . . . 75.01 111.398 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.4 -22.75 28.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.864 2.376 . . . . 74.33 110.496 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -76.84 -12.65 60.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.529 -0.76 . . . . 72.23 109.985 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -95.83 3.43 65.07 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 115.387 -0.824 . . . . 71.43 111.181 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.52 ' HE2' ' NE1' ' A' ' 144' ' ' TRP . 40.6 ttmt -82.96 137.17 34.28 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.447 -1.316 . . . . 74.5 107.447 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.5 m -62.96 156.51 24.28 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 123.587 0.555 . . . . 72.25 111.428 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 157' ' ' VAL . 65.5 mtt -66.0 -44.2 85.47 Favored 'General case' 0 C--O 1.209 -1.037 0 N-CA-C 113.465 0.913 . . . . 74.24 113.465 -171.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.06 -33.52 63.72 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.575 0.703 . . . . 75.23 111.044 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.14 -39.18 63.46 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.443 -0.799 . . . . 73.24 111.11 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.95 -25.88 60.19 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 116.125 -0.489 . . . . 63.12 112.092 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 153' ' ' MET 0.267 35.0 m -81.21 76.42 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 113.846 1.054 . . . . 62.31 113.846 -178.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -91.76 -23.38 28.3 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 108.635 -1.786 . . . . 55.42 108.635 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.6 p -153.1 89.01 1.34 Allowed 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 113.769 -1.215 . . . . 75.14 108.608 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 63.6 tp -90.11 -57.38 2.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.083 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.1 mp 63.11 173.81 0.15 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.84 0.856 . . . . 71.44 110.626 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.0 m -100.67 82.19 2.4 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.972 -1.492 . . . . 65.35 106.972 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.0 m -107.95 168.5 9.24 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.549 -0.751 . . . . 61.21 110.65 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 83.77 -63.1 4.5 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 109.906 -1.278 . . . . 21.11 109.906 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 . . . . . 0 C--N 1.303 -1.43 0 N-CA-C 107.861 -1.163 . . . . 63.55 107.861 176.567 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 C--O 1.239 0.544 0 N-CA-C 109.46 -0.57 . . . . 63.44 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 p -64.1 120.56 12.3 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.508 -0.923 . . . . 72.11 108.508 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -114.85 148.99 37.8 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 113.927 1.084 . . . . 72.13 113.927 -171.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 t -131.33 103.82 6.67 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 104.547 -2.39 . . . . 74.42 104.547 176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -85.11 119.78 72.82 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 121.08 -0.248 . . . . 64.41 111.25 -172.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.65 -53.07 6.19 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.546 2.83 . . . . 70.41 113.746 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -99.79 69.38 1.58 Allowed 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.336 0.589 . . . . 62.32 112.159 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m -163.49 168.94 19.52 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 124.633 1.173 . . . . 61.24 108.722 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -91.6 148.52 22.22 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.455 -0.793 . . . . 75.32 109.508 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 83.1 m-20 -129.06 122.72 30.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.949 -1.13 . . . . 65.32 107.949 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 29.3 t -117.72 120.36 64.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.554 -0.459 . . . . 75.34 111.422 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -83.78 110.83 18.65 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.465 -1.309 . . . . 70.13 107.465 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG11 HD11 ' A' ' 17' ' ' ILE . 7.9 p -136.17 158.07 38.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.244 -0.582 . . . . 70.03 110.066 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -126.88 22.02 6.83 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-O 121.074 0.464 . . . . 72.22 110.988 -170.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.501 ' HA3' ' CZ ' ' A' ' 51' ' ' TYR . . . -136.29 -133.7 3.23 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 118.128 -1.987 . . . . 61.02 117.072 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.6 m -40.46 -47.68 2.65 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.821 2.156 . . . . 71.22 116.821 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 67' ' ' ILE . 2.4 pp -84.71 1.48 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 114.583 1.327 . . . . 74.42 114.583 -171.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD11 HG13 ' A' ' 13' ' ' VAL . 9.8 mp -68.54 -11.2 59.59 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.511 0.56 . . . . 64.11 112.511 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.9 119.05 75.45 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 107.121 -1.437 . . . . 52.41 107.121 170.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -47.52 -37.29 25.96 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.751 2.967 . . . . 74.34 114.036 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.98 -35.03 79.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.407 -0.361 . . . . 62.35 111.293 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 17' ' ' ILE . 45.3 t -76.92 -40.59 31.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.252 -0.431 . . . . 71.05 110.219 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -58.84 -33.81 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.676 . . . . 71.4 109.602 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -76.61 -11.33 59.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.452 -0.794 . . . . 75.11 112.46 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 22' ' ' VAL . 16.5 m -102.12 -26.86 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.869 -0.732 . . . . 74.34 110.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 78' ' ' PHE . 9.5 tt -77.05 -36.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.344 0.592 . . . . 75.02 110.607 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 31' ' ' ALA . 90.1 mt -95.93 -14.7 22.89 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.045 -0.525 . . . . 71.53 110.242 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 68.44 -1.22 1.96 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.461 1.124 . . . . 74.04 109.927 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 94.8 mtt180 -133.53 176.85 8.17 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.466 -1.679 . . . . 64.11 106.466 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -77.01 144.09 38.92 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.078 0.466 . . . . 74.23 111.251 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.65 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -116.27 134.97 54.31 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 109.046 -0.724 . . . . 72.34 109.046 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -99.42 109.71 22.27 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.903 -1.519 . . . . 74.24 109.174 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 3.0 p -105.93 142.12 36.18 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 120.272 -0.571 . . . . 75.44 109.933 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.15 137.64 31.43 Favored Pre-proline 0 C--N 1.284 -2.27 0 N-CA-C 108.766 -0.827 . . . . 73.42 108.766 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 96' ' ' MET . 6.4 Cg_endo -57.47 117.72 4.47 Favored 'Trans proline' 0 CA--C 1.504 -0.99 0 C-N-CA 122.254 1.969 . . . . 73.21 109.719 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.86 155.2 50.68 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.972 -0.751 . . . . 63.53 108.972 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.593 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.6 p -125.86 127.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.745 0.783 . . . . 71.24 111.695 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.488 HD11 ' HB ' ' A' ' 91' ' ' VAL . 20.8 tp -87.59 96.29 10.36 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.017 -0.992 . . . . 74.21 112.398 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -72.56 126.35 29.65 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.36 -0.836 . . . . 62.33 110.263 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.84 -7.84 17.05 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 119.635 -1.269 . . . . 70.53 113.14 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 33.8 m-85 -126.7 145.11 50.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 112.642 0.608 . . . . 74.32 112.642 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 22.3 t-160 -105.34 127.09 52.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.363 -0.835 . . . . 64.31 108.765 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' HG22 ' A' ' 54' ' ' ILE . 2.4 ptm180 -87.93 137.59 32.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.162 -0.681 . . . . 71.33 109.162 175.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.4 ' HD2' ' O ' ' A' ' 117' ' ' MET . 22.2 m-85 -98.81 177.93 5.12 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 115.85 -0.614 . . . . 74.45 109.918 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -117.03 -28.59 6.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 114.005 1.113 . . . . 55.11 114.005 -177.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 52' ' ' PRO . 4.1 mm? 57.88 -169.92 0.11 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.503 0.502 . . . . 71.21 111.576 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 23.29 5.19 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.731 -0.788 . . . . 63.45 112.886 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.64 7.18 0.08 OUTLIER Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.284 -0.96 . . . . 70.13 113.112 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.77 161.11 36.92 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 117.163 0.482 . . . . 71.43 110.413 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.41 96.18 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.114 2.543 . . . . 72.23 114.598 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.605 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 53.6 p90 44.2 35.11 0.2 Allowed Pre-proline 0 N--CA 1.515 2.815 0 N-CA-C 116.52 2.045 . . . . 71.11 116.52 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.893 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 72.6 Cg_endo -108.5 166.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 123.274 2.65 . . . . 74.13 113.516 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.893 ' SG ' ' HB2' ' A' ' 52' ' ' PRO . 33.5 m -134.29 -179.25 5.46 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 103.94 -2.615 . . . . 61.1 103.94 -4.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 43' ' ' ARG . 40.2 pt -123.99 121.03 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 119.609 1.095 . . . . 75.4 112.179 174.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -154.12 133.04 3.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.743 -0.662 . . . . 73.35 111.454 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t 64.72 -175.99 0.17 Allowed 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.504 1.122 . . . . 75.52 113.426 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.595 ' HB3' ' HB2' ' A' ' 42' ' ' HIS . 20.6 t 78.67 112.52 0.07 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.59 1.956 . . . . 72.24 112.932 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.17 -27.16 32.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.432 0.635 . . . . 75.34 109.944 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.5 m -82.97 -9.2 59.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.771 -0.649 . . . . 65.02 110.421 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.26 153.65 21.48 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.742 -0.663 . . . . 61.34 112.354 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.593 ' HE2' HG21 ' A' ' 37' ' ' VAL . 21.0 ptmt -154.17 145.7 23.18 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.293 -1.003 . . . . 55.31 108.293 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 54' ' ' ILE . 62.1 t -114.27 123.76 70.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 112.044 0.387 . . . . 64.45 112.044 -173.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -88.1 120.6 29.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.536 -0.302 . . . . 74.24 110.242 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.34 -147.23 4.57 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.7 143.58 39.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.465 0.633 . . . . 74.15 110.121 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.68 133.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 109.336 -0.616 . . . . 75.31 109.336 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 4.6 mt -89.47 117.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 106.445 -1.687 . . . . 74.34 106.445 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -104.1 160.42 14.86 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.022 -1.071 . . . . 62.12 109.225 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.57 30.0 41.79 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.224 -0.988 . . . . 53.24 113.656 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.55 124.29 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.29 0.545 . . . . 75.03 110.013 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.563 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.9 m -75.48 158.29 32.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.791 -0.818 . . . . 70.34 108.791 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.17 -39.79 79.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.071 0.397 . . . . 74.02 112.071 -175.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -32.84 64.73 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.09 0.471 . . . . 51.2 110.732 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.563 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 50.7 mm-40 -73.64 -30.94 63.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.568 -0.742 . . . . 74.21 110.34 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.78 -37.05 73.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.178 0.991 . . . . 75.1 111.32 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 39.1 m-80 -57.37 -27.58 62.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.309 0.644 . . . . 74.02 111.657 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -69.08 -31.7 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.241 -0.652 . . . . 62.41 109.241 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD1' HD13 ' A' ' 26' ' ' ILE . 95.8 m-85 -70.97 -29.25 65.19 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 120.415 -0.514 . . . . 74.22 109.764 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 3.1 m-20 -60.96 -41.19 95.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.586 0.708 . . . . 74.25 109.439 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 76' ' ' ASN . 43.0 t -65.24 -34.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.012 -0.995 . . . . 74.35 110.394 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 mm -62.01 -50.75 78.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.233 -0.44 . . . . 64.11 111.152 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.06 141.83 12.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 120.933 0.397 . . . . 73.05 110.665 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.68 28.71 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.277 -0.874 . . . . 75.01 111.191 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -76.42 -43.06 41.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 120.187 -0.605 . . . . 51.41 110.551 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 110' ' ' VAL . 8.1 m-20 -125.93 13.15 7.89 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.091 0.948 . . . . 61.25 108.534 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 50.5 m-85 -115.9 149.44 38.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.334 -1.358 . . . . 72.3 107.334 -177.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 16.4 pt-20 -130.76 155.88 45.91 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.586 0.232 . . . . 74.1 110.531 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 106' ' ' THR . 45.5 ttm180 -91.1 126.66 36.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.865 0.364 . . . . 71.24 111.511 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.16 159.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.444 -0.947 . . . . 71.4 108.444 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 m -96.17 123.01 39.63 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.223 -0.658 . . . . 52.2 109.223 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 38' ' ' LEU . 26.8 m -125.96 157.76 35.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 123.826 0.85 . . . . 71.11 109.727 -175.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 29.3 tt0 -105.24 125.18 50.69 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.207 -0.597 . . . . 61.4 109.52 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 38' ' ' LEU . 15.1 m -126.13 168.41 19.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.964 -0.754 . . . . 63.33 108.964 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 96' ' ' MET . 68.6 t -104.25 128.12 57.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.341 -0.985 . . . . 73.51 108.341 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -68.53 -15.44 63.54 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.951 0.782 . . . . 73.43 110.215 -174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.566 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER 70.61 -54.86 0.64 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.131 1.773 . . . . 73.12 113.882 172.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -48.63 -45.65 38.7 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 70.43 111.432 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.87 9.95 16.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 123.345 0.658 . . . . 64.24 110.508 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.7 m 62.83 10.06 4.05 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.81 1.041 . . . . 74.54 113.81 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 161.11 21.85 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.569 -0.452 . . . . 44.0 110.361 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HG2' HG22 ' A' ' 94' ' ' VAL . 88.2 mttt -101.91 134.05 45.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.654 -0.869 . . . . 74.11 108.654 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.01 139.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.727 -0.842 . . . . 71.32 108.727 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 28.3 ttpt -107.48 116.65 32.33 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.865 0.84 . . . . 74.25 110.597 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.21 177.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.0 -1.454 . . . . 73.31 110.696 -168.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.32 144.09 28.83 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.804 -0.443 . . . . 71.22 109.804 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 10.5 t -144.72 175.22 10.33 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.233 -0.654 . . . . 73.34 109.233 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 78.3 m-85 -110.43 119.48 39.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.273 0.358 . . . . 74.14 110.272 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 54' ' ' ILE . 34.8 m -109.84 -173.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.918 -0.771 . . . . 60.44 108.918 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.497 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 61.1 t-105 -99.13 122.71 42.7 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.018 -0.734 . . . . 74.41 109.018 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' A' ' 87' ' ' GLU . 26.8 m -65.61 -35.89 76.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 CA-C-O 121.363 0.601 . . . . 74.44 111.401 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 114' ' ' ASP . 5.0 t30 -88.18 15.75 7.12 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.979 1.312 . . . . 71.22 109.506 -173.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.7 ptpp? -47.43 -14.87 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 126.859 2.064 . . . . 72.35 115.048 -171.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -90.4 6.8 41.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.828 0.347 . . . . 72.23 111.825 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' HB3' ' ND2' ' A' ' 111' ' ' ASN . 3.1 p30 -85.65 160.07 54.04 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.911 -1.144 . . . . 75.1 107.911 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.18 99.47 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.053 1.836 . . . . 63.21 110.827 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.692 ' HD3' ' H ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.65 -0.704 . . . . 74.03 111.366 -176.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.4 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 49.2 ttm -72.93 98.48 2.49 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.486 -1.234 . . . . 74.42 111.707 -174.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -101.65 -48.22 4.38 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 119.918 -0.713 . . . . 71.51 109.814 175.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.43 -112.95 2.64 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.535 -1.426 . . . . 71.31 109.535 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -121.46 137.93 54.51 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 106.035 -1.839 . . . . 61.21 106.035 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -100.34 172.82 6.91 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.326 -1.731 . . . . 70.2 106.326 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.09 111.74 18.5 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.136 -1.026 . . . . 71.45 110.987 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -68.22 -33.04 73.68 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.758 -1.11 . . . . 61.53 110.142 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.24 -28.85 64.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.682 -0.69 . . . . 70.1 110.381 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 128' ' ' VAL . 8.5 tp10 -76.02 -37.45 58.39 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.128 -1.434 . . . . 64.03 107.128 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -57.74 -28.67 64.11 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.902 -1.045 . . . . 74.45 111.364 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -57.74 -49.08 77.77 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.234 0.457 . . . . 73.31 112.234 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 125' ' ' GLU . 18.8 m -72.24 -27.68 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.329 -0.548 . . . . 73.52 110.232 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 125' ' ' GLU . 88.6 t -68.44 -28.29 39.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.246 -0.888 . . . . 54.31 110.954 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -99.4 -28.58 13.21 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.869 -1.132 . . . . 73.23 110.843 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.54 82.45 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.786 -0.643 . . . . 71.42 112.3 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.47 -24.0 66.35 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 113.132 0.79 . . . . 62.42 113.132 -177.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 6.4 tmtt? -76.22 -55.78 5.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 109.604 -0.517 . . . . 64.12 109.604 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -63.86 -32.11 73.51 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.836 0.68 . . . . 60.05 112.836 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.61 -37.3 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 119.813 -0.755 . . . . 74.43 110.228 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 7.3 mm-40 -62.87 -39.72 95.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.849 -0.426 . . . . 71.32 109.849 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.505 -0.77 . . . . 73.53 110.7 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -67.72 -36.67 81.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.685 -0.487 . . . . 63.32 109.685 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 98.4 mtt180 -64.53 -51.59 62.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.973 -0.558 . . . . 73.4 110.929 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 31.1 mmmt -63.54 -34.54 78.01 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 112.672 0.619 . . . . 73.04 112.672 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.1 ptm -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.521 -0.872 . . . . 73.2 109.717 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 tp -77.36 -50.12 13.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 74.35 111.248 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HG3' ' HA ' ' A' ' 140' ' ' LYS 0.25 0.0 OUTLIER -68.47 -24.61 64.72 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.266 0.469 . . . . 62.54 112.266 -178.287 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -75.41 -43.81 47.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.81 -0.632 . . . . 74.34 110.817 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -69.05 -35.1 76.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.522 0.677 . . . . 74.33 110.01 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 41.1 ttmt -92.52 8.18 39.94 Favored 'General case' 0 CA--C 1.565 1.525 0 CA-C-N 115.498 -0.774 . . . . 72.14 110.554 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 28.0 t-20 -46.71 118.52 5.06 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 123.804 0.842 . . . . 73.51 112.909 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 19.9 Cg_exo -63.18 -24.26 72.75 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.492 2.795 . . . . 74.1 113.577 -176.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.35 -13.77 59.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.462 0.649 . . . . 70.31 110.176 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.04 24.38 55.17 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.793 -0.639 . . . . 52.12 113.58 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.07 122.33 29.94 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.818 0.673 . . . . 73.34 112.818 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 77.5 p -115.53 168.48 9.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.652 -1.24 . . . . 71.54 107.652 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 19.1 ptp -73.34 -25.7 60.73 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.968 -0.693 . . . . 74.12 109.93 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.33 -37.8 68.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.314 -0.857 . . . . 73.24 109.137 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.45 ' HA ' ' OG ' ' A' ' 159' ' ' SER . 34.3 tt0 -75.07 -31.59 61.27 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.247 -0.888 . . . . 63.2 109.816 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.99 -34.98 78.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.199 -0.91 . . . . 43.32 110.195 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.03 -172.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.336 -0.616 . . . . 75.32 109.336 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -67.75 102.88 0.88 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.914 -0.875 . . . . 63.42 110.914 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 155' ' ' GLU . 16.2 m -75.05 155.37 37.3 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.181 0.592 . . . . 73.32 110.113 -178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.0 tp -88.13 128.65 35.43 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.592 -0.522 . . . . 71.2 109.592 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.19 126.51 42.43 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.423 -0.954 . . . . 74.41 108.423 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 p -66.07 93.26 0.19 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.826 0.822 . . . . 71.32 110.945 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.7 p -160.37 115.56 2.28 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.244 -0.889 . . . . 74.41 110.34 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.69 -38.47 5.23 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.432 -0.89 . . . . 42.4 111.602 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.306 -1.305 0 N-CA-C 108.567 -0.901 . . . . 73.0 108.567 -179.624 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.441 -0.898 0 N-CA-C 108.532 -0.914 . . . . 74.23 108.532 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.1 p -84.34 96.07 8.93 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.539 0.685 . . . . 73.14 110.692 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 p -102.15 92.5 4.78 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 115.882 -0.599 . . . . 51.33 110.662 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.0 m -84.05 -31.26 25.48 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.701 -1.222 . . . . 63.24 107.701 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.9 t70 68.13 129.2 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.288 1.435 . . . . 44.31 112.739 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.86 17.5 0.82 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.09 2.527 . . . . 73.34 114.821 -176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -56.58 -36.21 69.08 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.878 0.847 . . . . 51.34 109.509 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.1 p -135.38 130.49 35.0 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 106.864 -1.532 . . . . 61.54 106.864 173.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.421 ' HD2' ' OE1' ' A' ' 105' ' ' GLU . 78.8 m80 -90.7 143.46 26.71 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.107 0.479 . . . . 71.32 111.739 -175.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 81.7 m-20 -128.31 122.36 31.43 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.454 -1.313 . . . . 74.24 107.454 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.23 121.28 67.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 121.053 -0.259 . . . . 71.33 110.56 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.4 ' HB2' HG21 ' A' ' 104' ' ' VAL . 64.3 t80 -81.44 112.15 18.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 107.97 -1.122 . . . . 74.1 107.97 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 17' ' ' ILE . 24.1 m -113.49 140.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.531 0.681 . . . . 75.24 112.458 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -131.87 121.79 24.63 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.557 -1.275 . . . . 75.53 107.557 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.3 -58.91 4.17 Favored Glycine 0 C--N 1.302 -1.315 0 C-N-CA 120.895 -0.669 . . . . 72.44 111.441 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.1 m -78.25 145.82 35.23 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.97 -0.381 . . . . 73.13 109.97 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.486 HG21 ' CD1' ' A' ' 67' ' ' ILE . 9.3 mm 70.23 -104.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.8 1.24 . . . . 71.32 108.586 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.259 77.4 mt 49.1 -36.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.651 2.38 . . . . 64.33 117.092 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.19 132.15 29.9 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 109.393 -0.595 . . . . 72.22 109.393 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.4 -40.3 28.71 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.9 3.067 . . . . 61.43 113.543 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -60.16 -47.94 83.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.982 0.42 . . . . 71.42 110.967 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.67 -39.73 85.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.406 0.622 . . . . 23.22 110.402 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 31' ' ' ALA . . . -66.88 -34.94 78.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.81 -0.632 . . . . 64.42 110.947 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -75.62 -26.46 57.81 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.654 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 21' ' ' ALA . 20.9 m -85.34 -23.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.432 -0.507 . . . . 74.24 111.595 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.451 HD13 ' CD1' ' A' ' 78' ' ' PHE . 10.5 tt -82.46 -40.97 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.138 -0.625 . . . . 74.24 111.067 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 31' ' ' ALA . 82.8 mt -83.68 -18.17 38.94 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.293 -0.412 . . . . 74.42 111.27 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 64.18 25.91 13.74 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 106.739 -1.578 . . . . 62.12 106.739 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.4 ttt180 -162.83 166.59 23.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.678 -1.601 . . . . 73.53 106.68 -174.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -75.39 136.44 40.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 118.098 0.408 . . . . 74.11 110.426 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -101.73 141.32 34.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 115.964 -0.562 . . . . 54.12 112.015 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -100.11 110.23 22.51 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.733 -0.667 . . . . 64.24 109.516 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.7 p -115.98 143.42 45.48 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.255 -0.43 . . . . 75.0 110.824 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.41 139.96 35.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.01 -0.737 . . . . 45.43 109.01 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.53 134.12 58.98 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.403 2.069 . . . . 64.23 112.028 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.514 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -149.88 157.03 42.78 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.377 -0.828 . . . . 64.21 110.246 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.12 127.89 72.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.537 0.684 . . . . 70.15 111.41 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HA ' HG12 ' A' ' 93' ' ' VAL . 28.4 tp -91.39 95.93 10.25 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.405 -0.816 . . . . 71.43 111.809 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 9.9 p-80 -71.94 127.31 32.17 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.318 -0.855 . . . . 74.54 109.148 170.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.95 -17.48 7.63 Favored Glycine 0 C--N 1.292 -1.9 0 C-N-CA 119.69 -1.243 . . . . 51.23 112.651 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -124.93 160.26 29.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.091 0.774 . . . . 72.23 113.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.02 132.85 42.33 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.744 -1.116 . . . . 60.44 109.672 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HB3' HG22 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -92.48 151.48 20.17 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.623 0.971 . . . . 74.43 113.623 -177.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.476 ' HA ' ' CH2' ' A' ' 121' ' ' TRP . 94.2 m-85 -130.15 169.86 14.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.846 -1.07 . . . . 73.44 109.539 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 71.5 mmtt -138.46 86.83 2.18 Favored 'General case' 0 CA--C 1.485 -1.524 0 O-C-N 124.055 0.847 . . . . 73.03 111.447 173.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.524 ' HB3' ' HG3' ' A' ' 120' ' ' GLU 0.35 0.3 OUTLIER -89.84 97.9 11.46 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.179 -1.008 . . . . 71.51 111.301 174.331 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -66.16 -23.22 66.43 Favored 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.52 1.528 . . . . 75.04 110.792 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.83 -12.91 63.01 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 115.435 -0.802 . . . . 52.14 111.782 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.2 mt -126.26 170.13 10.31 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 125.438 1.495 . . . . 70.14 107.432 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.89 50.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.519 2.978 0 C-N-CA 124.138 3.226 . . . . 73.44 114.981 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.547 ' N ' ' HD3' ' A' ' 52' ' ' PRO 0.487 7.8 p90 48.47 63.69 9.91 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 118.94 2.941 . . . . 72.13 118.94 178.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 3.2 Cg_endo -95.98 169.12 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.578 4.185 . . . . 53.21 109.261 172.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 109' ' ' TRP . 6.0 p -157.41 -167.3 2.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.508 2.723 . . . . 53.0 108.499 -3.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' A' ' 43' ' ' ARG . 47.9 pt -123.74 131.07 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 107.13 -1.433 . . . . 74.13 107.13 162.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.48 HG21 ' SD ' ' A' ' 117' ' ' MET . 31.1 m -145.21 166.77 10.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 116.478 -0.328 . . . . 74.44 111.227 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t 63.6 138.7 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.797 1.639 . . . . 73.02 113.922 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -80.79 75.47 7.72 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.333 1.063 . . . . 64.13 110.711 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.65 168.25 16.49 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.254 -1.339 . . . . 75.4 110.044 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.8 m -91.69 4.8 51.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.151 0.501 . . . . 73.2 110.942 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.13 -167.84 43.74 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.334 -0.706 . . . . 73.2 111.334 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 39' ' ' HIS . 8.8 ptpp? -153.77 151.57 29.73 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.37 -0.532 . . . . 73.24 112.193 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.4 128.66 71.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 C-N-CA 124.095 0.958 . . . . 73.2 109.109 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -100.97 132.53 46.34 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.526 -0.87 . . . . 65.34 110.594 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.92 -138.08 2.44 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.93 -0.868 . . . . 52.34 110.93 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -142.68 145.23 33.2 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.12 0.568 . . . . 71.21 110.708 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' THR . 30.7 m -104.28 129.79 56.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.673 -0.491 . . . . 73.4 109.673 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.486 ' CD1' HG21 ' A' ' 17' ' ' ILE . 18.1 mt -89.46 110.91 22.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 106.834 -1.543 . . . . 63.21 106.834 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.2 p -99.25 161.84 13.39 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 116.054 -0.521 . . . . 64.04 111.464 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.57 74.25 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.329 -0.462 . . . . 73.04 113.189 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.29 128.93 38.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.652 -0.87 . . . . 72.43 108.652 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -85.3 160.95 19.71 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.823 -0.806 . . . . 64.3 108.823 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -52.36 -37.89 57.34 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.475 0.71 . . . . 72.42 111.846 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.83 63.13 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.924 -0.58 . . . . 34.32 111.464 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.57 -32.07 72.58 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.929 -0.309 . . . . 72.34 111.149 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.11 -33.85 69.56 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.742 -0.663 . . . . 74.02 110.469 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 80' ' ' VAL . 22.1 t-20 -63.58 -28.65 70.08 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.61 -0.723 . . . . 63.13 110.692 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.405 ' ND2' HG13 ' A' ' 26' ' ' ILE . 4.9 t30 -74.91 -31.88 61.66 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.817 -0.808 . . . . 63.22 108.817 -175.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CD1' HD13 ' A' ' 26' ' ' ILE . 96.4 m-85 -64.8 -36.5 84.53 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 115.461 -0.79 . . . . 74.35 110.476 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.21 -31.55 71.15 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.541 0.686 . . . . 73.32 110.116 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 76' ' ' ASN . 55.6 t -75.64 -44.34 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 115.64 -0.709 . . . . 62.41 112.344 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 ' HA ' ' A' ' 78' ' ' PHE . 11.3 tt -72.13 117.72 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.306 0.574 . . . . 63.14 112.24 -175.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.19 3.09 0.49 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.714 1.206 . . . . 75.4 113.978 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.37 53.56 1.54 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 111.358 -0.697 . . . . 53.33 111.358 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -82.37 -40.71 20.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.838 0.351 . . . . 62.43 110.825 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.615 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 5.6 t70 -119.88 28.87 7.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.667 1.222 . . . . 54.14 107.806 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.446 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 70.6 m-85 -113.76 161.16 17.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.48 -1.236 . . . . 75.25 109.707 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -130.48 141.91 50.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.936 -1.135 . . . . 75.45 107.936 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -81.88 121.47 26.5 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.191 -0.458 . . . . 74.51 110.996 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.33 159.64 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.71 -0.677 . . . . 75.54 110.205 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.1 m -97.8 124.56 42.24 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.945 -0.761 . . . . 70.04 108.945 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.13 169.95 13.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.582 -0.896 . . . . 72.5 108.582 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -124.79 120.93 33.13 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.651 -0.87 . . . . 75.32 108.651 -173.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 38' ' ' LEU . 21.0 m -126.0 168.78 18.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-O 121.383 0.611 . . . . 72.31 110.886 -170.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.539 HG22 ' HG2' ' A' ' 101' ' ' LYS . 71.3 t -110.52 118.81 58.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.481 -0.782 . . . . 64.25 109.464 175.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -74.33 95.1 2.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 109.246 -0.65 . . . . 74.42 109.246 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.514 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -48.1 -33.64 8.51 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 126.57 1.948 . . . . 75.04 110.596 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.76 -38.71 70.2 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.458 -0.792 . . . . 64.1 112.013 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -115.61 -10.62 11.83 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.341 0.591 . . . . 72.04 109.748 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.6 t 67.71 22.5 8.93 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.07 0.948 . . . . 62.43 110.074 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -97.17 160.38 14.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.922 -0.581 . . . . 75.22 109.458 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HG2' HG22 ' A' ' 94' ' ' VAL . 5.9 mtpm? -101.85 135.78 42.82 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.613 -0.884 . . . . 52.42 108.613 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.86 145.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.064 0.459 . . . . 73.21 110.345 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -91.94 124.15 35.84 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.238 -1.023 . . . . 74.32 108.238 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 12' ' ' PHE . 32.6 m -136.69 175.59 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.815 0.446 . . . . 73.41 110.691 -175.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.421 ' OE1' ' HD2' ' A' ' 9' ' ' HIS . 45.3 mt-10 -106.8 153.5 22.37 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.972 -0.455 . . . . 74.13 111.057 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 t -154.87 177.9 10.76 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 110.273 -0.269 . . . . 70.43 110.273 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -104.76 119.8 39.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.08 0.952 . . . . 62.51 108.673 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.75 151.88 20.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.553 -0.459 . . . . 73.51 109.913 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.615 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 35.6 t-105 -79.36 127.05 31.61 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.084 -0.709 . . . . 75.31 109.084 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 85' ' ' ASP . 33.7 m -72.64 -28.3 27.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.115 0.483 . . . . 63.22 112.236 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 62.5 t30 -79.3 13.21 1.99 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.678 0.791 . . . . 70.24 111.282 -176.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -51.65 -14.86 0.38 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 116.014 1.857 . . . . 52.32 116.014 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 9.4 m-20 -72.87 9.96 1.01 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.124 0.488 . . . . 65.13 112.135 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.41 131.82 49.15 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 108.064 -1.087 . . . . 70.41 108.064 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 -15.98 28.48 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.317 2.678 . . . . 74.23 116.457 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -130.6 113.97 14.87 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 117.673 -1.611 . . . . 72.32 114.259 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 55' ' ' VAL . 66.2 mtt -140.64 111.54 7.02 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.745 -1.116 . . . . 63.53 109.064 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.5 p90 176.01 -28.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.598 1.159 . . . . 75.44 109.668 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.99 36.04 3.73 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.976 -0.556 . . . . 75.51 111.719 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 46' ' ' LEU . 1.2 mp0 -87.73 -179.69 6.33 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 123.809 0.844 . . . . 54.45 110.987 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.476 ' CH2' ' HA ' ' A' ' 44' ' ' TYR . 31.2 m-90 74.33 166.72 0.29 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.493 1.117 . . . . 75.54 111.201 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.86 147.63 28.2 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.629 -1.249 . . . . 73.11 107.629 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -57.97 -40.54 80.87 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.727 0.299 . . . . 62.2 111.193 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -74.5 -42.88 58.18 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.44 -0.578 . . . . 61.34 109.44 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.7 mt-10 -66.94 -41.34 87.16 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.954 -0.566 . . . . 73.15 111.791 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -60.95 -24.46 66.08 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.909 0.385 . . . . 74.3 111.301 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -58.43 -43.19 88.63 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.281 -0.637 . . . . 74.13 109.281 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 125' ' ' GLU . 17.9 m -84.37 -31.68 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 119.993 -0.683 . . . . 65.2 110.946 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 125' ' ' GLU . 52.2 t -68.18 -39.31 81.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 116.794 -0.185 . . . . 73.12 111.066 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.405 ' O ' ' HD2' ' A' ' 134' ' ' PHE . 1.4 p-80 -67.47 -32.34 73.12 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.413 -0.915 . . . . 73.24 110.254 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.73 83.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 54.43 110.024 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.5 -25.77 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.259 -0.882 . . . . 71.04 112.249 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.532 ' O ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -76.68 -57.37 3.89 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.231 -1.396 . . . . 64.5 107.231 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 130' ' ' HIS . 92.0 m-85 -61.79 -33.5 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.503 1.297 . . . . 63.31 114.503 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.461 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 7.8 p -58.1 -41.94 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.33 -0.548 . . . . 63.45 110.66 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 24.0 mm-40 -66.12 -39.35 89.83 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.172 -0.467 . . . . 54.31 110.494 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.7 m -59.32 -49.6 77.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 72.42 110.475 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -57.77 -41.61 82.38 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 121.134 -0.226 . . . . 64.33 111.247 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 82.5 mtp180 -63.27 -47.92 80.32 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.572 0.545 . . . . 71.33 111.193 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 73.1 mmtt -65.35 -42.97 92.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.747 0.308 . . . . 74.4 110.881 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.6 mmt -61.79 -35.82 79.3 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.052 -0.722 . . . . 65.25 109.052 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.77 -39.09 90.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.537 -0.912 . . . . 74.03 108.537 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -64.06 -47.84 78.6 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.555 -0.293 . . . . 74.04 110.798 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -69.95 -28.66 65.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.611 0.967 . . . . 70.13 113.611 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -82.0 -47.76 12.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.972 0.36 . . . . 51.22 111.972 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.0 -26.94 30.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.227 0.455 . . . . 73.41 112.227 -175.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -136.03 78.16 47.78 Favored Pre-proline 0 C--N 1.313 -1.007 0 C-N-CA 120.605 -0.438 . . . . 71.22 111.885 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.71 -29.71 35.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.99 1.793 . . . . 73.3 109.875 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -87.56 0.11 56.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.308 -0.86 . . . . 74.43 109.763 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -80.33 -23.89 60.06 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.984 -1.246 . . . . 64.23 109.984 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -80.07 151.08 30.08 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.981 -1.488 . . . . 74.02 106.981 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 45.4 m -62.44 156.74 21.88 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 112.169 0.433 . . . . 75.33 112.169 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 67.2 mtt -61.78 -45.09 95.38 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 114.949 1.463 . . . . 72.21 114.949 -169.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -65.18 -36.21 83.5 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.595 0.712 . . . . 74.23 109.97 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -73.45 -36.69 65.92 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.701 -1.136 . . . . 72.14 109.764 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.86 45.05 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.67 -0.696 . . . . 50.42 112.499 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.69 -12.95 9.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 113.11 0.781 . . . . 64.02 113.11 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -139.74 -138.69 3.66 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 119.857 -1.163 . . . . 23.35 111.876 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.0 m 72.77 163.75 0.28 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.718 1.207 . . . . 73.24 111.948 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.54 116.44 28.96 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.489 0.661 . . . . 72.33 109.439 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -174.32 139.1 0.58 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.036 -1.438 . . . . 74.22 108.357 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.1 m -81.71 79.48 8.26 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.679 0.752 . . . . 63.5 109.476 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.7 m -153.65 119.46 5.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.904 -1.044 . . . . 71.5 108.203 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 147.48 -60.7 0.46 Allowed Glycine 0 CA--C 1.492 -1.358 0 N-CA-C 110.062 -1.215 . . . . 60.04 110.062 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 109.434 -0.58 . . . . 63.12 109.434 176.839 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 109.345 -0.613 . . . . 73.42 109.345 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 4' ' ' SER . 37.2 m 76.77 146.32 0.09 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.998 0.919 . . . . 73.21 110.397 -177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 m -57.07 -29.84 63.8 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.448 0.699 . . . . 72.32 111.15 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 2' ' ' THR . 20.4 m -108.52 102.62 11.68 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.668 -0.696 . . . . 54.51 111.579 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 7' ' ' GLN . 15.7 t70 -81.92 150.49 65.53 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 106.913 -1.514 . . . . 70.3 106.913 172.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -57.49 35.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 124.839 3.693 . . . . 71.01 116.082 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -152.13 54.9 0.82 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 102.51 -3.144 . . . . 73.43 102.51 175.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 m -75.12 135.65 41.14 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.368 -1.287 . . . . 53.25 112.253 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -107.97 156.35 19.32 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.75 -1.113 . . . . 73.32 111.034 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.3 m-20 -125.14 122.91 38.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.144 -1.428 . . . . 75.11 107.144 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 19.5 t -119.78 124.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 120.753 -0.379 . . . . 72.25 110.976 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.509 ' HB2' HG21 ' A' ' 104' ' ' VAL . 73.4 t80 -84.02 113.91 21.34 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.825 -0.806 . . . . 74.32 108.825 175.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -125.17 160.54 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.518 0.675 . . . . 73.33 111.973 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -145.71 -55.67 0.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.815 -1.55 . . . . 71.51 106.815 175.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.5 63.27 0.6 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.513 -1.035 . . . . 75.2 110.513 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 m -153.97 -79.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.192 . . . . 71.4 111.033 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 67' ' ' ILE . 33.2 pt -145.78 86.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 122.173 0.987 . . . . 51.44 111.312 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 65' ' ' LYS . 77.7 mt -99.63 -5.19 29.39 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.474 -0.766 . . . . 63.24 109.223 175.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.78 130.81 24.6 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.258 -0.883 . . . . 65.23 111.046 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.62 -42.56 18.77 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.174 3.249 . . . . 71.14 114.417 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.38 83.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.744 0.276 . . . . 44.55 111.744 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.7 p -77.26 -30.87 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.288 0.566 . . . . 65.34 111.044 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.397 0.618 . . . . 71.14 109.377 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -74.85 -5.69 44.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.644 -0.707 . . . . 62.22 112.197 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.1 m -105.98 -15.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 119.805 -0.758 . . . . 72.3 111.223 177.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.587 HG21 HD13 ' A' ' 17' ' ' ILE . 10.0 tt -92.72 -42.47 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 121.468 0.651 . . . . 74.44 110.333 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 95.3 mt -87.08 -27.24 23.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.882 -0.599 . . . . 75.34 110.002 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 23.0 t70 73.17 3.3 4.61 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.479 1.133 . . . . 75.04 108.122 -170.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.9 mmt180 -126.07 154.81 42.52 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.195 -2.15 . . . . 72.32 105.195 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -96.96 110.41 22.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.677 -1.209 . . . . 71.22 108.75 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 156.29 17.67 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.882 -0.599 . . . . 74.54 110.532 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.66 125.54 41.2 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.516 0.674 . . . . 54.21 112.816 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 p -100.44 143.94 30.03 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.582 -1.19 . . . . 72.42 109.532 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.7 141.66 38.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.304 -0.999 . . . . 74.4 108.304 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.483 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 2.1 Cg_endo -65.44 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.001 1.801 . . . . 75.44 111.637 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HA ' ' H ' ' A' ' 96' ' ' MET . . . -150.17 156.36 41.46 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.691 -0.686 . . . . 75.42 110.444 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -122.44 127.84 75.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-O 121.399 0.619 . . . . 73.03 111.378 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 93' ' ' VAL . 23.7 tp -90.49 97.86 11.43 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.206 -0.906 . . . . 72.34 109.429 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.532 ' HA ' ' HG2' ' A' ' 61' ' ' LYS . 6.3 p80 -70.63 132.3 45.23 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.014 -0.994 . . . . 71.43 110.018 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.61 38.57 Favored Glycine 0 C--O 1.215 -1.044 0 C-N-CA 118.844 -1.646 . . . . 74.22 113.993 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -101.99 143.35 31.95 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 113.768 1.025 . . . . 72.01 113.768 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.579 ' HB2' ' CB ' ' A' ' 58' ' ' ASP . 2.9 t-160 -104.63 122.55 45.87 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.386 -1.279 . . . . 53.25 108.379 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -89.53 115.86 27.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.189 -1.041 . . . . 71.41 108.189 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.401 ' HD2' ' O ' ' A' ' 117' ' ' MET . 26.3 m-85 -81.3 141.86 33.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.6 -0.518 . . . . 62.14 109.6 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -97.54 124.54 41.82 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.37 0.605 . . . . 75.34 111.291 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.77 133.1 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.835 -0.62 . . . . 62.33 110.079 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.89 -41.08 7.38 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 108.08 -1.082 . . . . 54.0 108.08 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.56 -21.15 77.62 Favored Glycine 0 N--CA 1.425 -2.096 0 CA-C-N 114.234 -1.348 . . . . 53.04 112.156 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 6.1 mp -107.67 151.34 41.04 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 108.83 -0.804 . . . . 74.41 108.83 177.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.52 -61.76 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.832 2.355 . . . . 74.43 115.62 -172.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.685 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 4.1 p90 -132.62 16.33 0.05 OUTLIER Pre-proline 0 CA--C 1.585 2.299 0 N-CA-C 117.208 2.299 . . . . 75.24 117.208 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD3' ' N ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -89.24 164.29 5.62 Favored 'Trans proline' 0 C--N 1.369 1.609 0 CA-C-N 122.129 1.796 . . . . 74.13 112.005 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 52' ' ' PRO . 20.6 p -155.0 167.44 30.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.484 1.914 . . . . 74.03 108.034 -6.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 131.37 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.775 -0.77 . . . . 51.21 109.537 170.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 112' ' ' LYS . 8.1 p -157.52 170.51 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 108.572 -0.899 . . . . 73.01 108.572 175.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 55' ' ' VAL . 25.6 m 77.67 145.45 0.09 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.47 1.106 . . . . 53.52 112.83 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.1 t -88.73 76.23 8.07 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.225 -1.398 . . . . 75.24 107.225 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.579 ' CB ' ' HB2' ' A' ' 42' ' ' HIS . 17.9 t70 -84.22 175.24 9.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.26 -1.791 . . . . 74.44 109.325 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 m -83.75 -16.58 44.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.498 . . . . 73.4 109.706 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.62 170.24 53.94 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 115.391 -0.822 . . . . 45.34 113.602 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 39' ' ' HIS . 42.3 mtmt -137.82 146.75 43.89 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.399 -1.334 . . . . 71.44 107.399 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.86 123.42 61.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.528 -0.545 . . . . 73.35 109.528 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -95.93 124.86 40.12 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.517 -0.549 . . . . 64.43 109.517 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.99 -141.89 3.26 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.101 -0.8 . . . . 34.22 111.101 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 48.9 mtmt -140.17 147.43 40.12 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 120.874 0.368 . . . . 75.42 111.622 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 35.1 m -104.87 133.71 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 115.454 -0.794 . . . . 75.45 109.551 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.749 HD13 HD11 ' A' ' 17' ' ' ILE . 18.3 mt -88.37 130.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 106.023 -1.843 . . . . 64.41 106.023 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.3 p -115.01 161.32 18.49 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.732 -0.787 . . . . 62.25 111.415 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 33.66 67.67 Favored Glycine 0 N--CA 1.439 -1.114 0 O-C-N 123.543 0.527 . . . . 75.11 113.211 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -90.39 122.37 41.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.964 0.382 . . . . 63.13 110.633 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.451 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 36.8 m -76.62 158.7 30.88 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.458 -0.571 . . . . 75.1 109.458 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.79 -42.93 65.49 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 112.461 0.541 . . . . 72.42 112.461 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.2 -40.71 77.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.29 0.567 . . . . 73.5 110.141 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 71' ' ' SER . 4.4 mm-40 -68.37 -37.26 80.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.709 -1.132 . . . . 64.33 109.099 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.95 -33.5 74.4 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.404 1.082 . . . . 70.02 110.155 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -62.86 -27.14 69.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.158 -0.928 . . . . 70.34 113.16 179.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -32.89 71.4 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.191 -1.04 . . . . 64.31 108.191 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -70.98 -28.59 64.56 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.29 0.566 . . . . 75.03 109.532 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.548 ' HA ' HH12 ' A' ' 88' ' ' ARG . 28.6 t70 -70.94 -36.13 72.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.614 -0.721 . . . . 60.41 109.848 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 76' ' ' ASN . 72.4 t -66.6 -22.51 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.229 -0.896 . . . . 75.31 111.511 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.4 103.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.337 0.589 . . . . 75.32 110.488 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.389 0.1 OUTLIER 64.39 -58.39 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.937 2.495 . . . . 73.42 112.631 -174.001 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.51 1.66 16.98 Favored Glycine 0 C--O 1.234 0.132 0 C-N-CA 123.191 0.424 . . . . 75.03 113.638 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -83.92 -44.17 14.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.649 0.24 . . . . 75.54 111.649 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.522 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 2.1 t70 -136.94 16.12 3.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 118.626 -1.23 . . . . 73.3 111.532 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.65 ' OH ' ' HA ' ' A' ' 52' ' ' PRO . 30.6 m-85 -112.56 151.88 29.51 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.224 -0.591 . . . . 63.42 110.723 175.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -131.56 159.65 37.57 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.172 -0.922 . . . . 73.14 109.292 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.548 HH12 ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -90.11 113.74 25.53 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.332 -0.395 . . . . 74.44 109.954 -178.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.62 159.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.662 0.267 . . . . 63.1 110.859 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.3 m -102.57 129.78 49.24 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.066 -0.716 . . . . 73.25 109.066 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.07 168.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.345 -1.354 . . . . 64.01 107.345 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -120.35 131.97 55.08 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.473 -1.291 . . . . 50.34 108.662 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.419 HG12 ' HB2' ' A' ' 38' ' ' LEU . 18.6 m -125.99 168.13 19.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.243 0.544 . . . . 44.41 109.617 -175.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 101' ' ' LYS . 69.3 t -109.78 120.1 60.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 115.658 -0.701 . . . . 64.14 109.962 177.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 77.3 ttt180 -67.41 97.23 0.55 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.799 -1.556 . . . . 75.42 106.799 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.454 ' H ' ' HA ' ' A' ' 36' ' ' ALA . 25.5 ttt -48.74 -45.82 40.14 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 127.088 2.155 . . . . 53.54 113.664 -169.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.4 -34.15 75.51 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.586 0.587 . . . . 74.13 112.586 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -103.48 -9.29 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.306 0.574 . . . . 65.43 111.272 -175.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m 64.8 25.58 12.92 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.793 0.837 . . . . 63.33 111.653 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 95' ' ' ARG . 13.9 pt-20 -102.58 161.69 13.52 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.561 -0.903 . . . . 72.54 108.561 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.555 ' HG2' HG22 ' A' ' 94' ' ' VAL . 44.3 mtmt -104.6 135.85 45.24 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.953 -0.758 . . . . 63.21 108.953 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.52 135.86 48.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-O 121.139 0.495 . . . . 63.1 109.855 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -87.16 126.41 34.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.143 -1.428 . . . . 71.21 107.143 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 12' ' ' PHE . 32.9 m -137.58 169.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.977 0.417 . . . . 73.11 111.123 -174.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.4 149.39 24.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.384 -0.371 . . . . 64.23 110.138 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 t -153.01 176.86 11.42 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.776 -0.453 . . . . 71.23 109.776 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.461 ' HD2' ' CE1' ' A' ' 86' ' ' TYR . 15.1 p90 -107.35 120.01 40.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 125.08 1.352 . . . . 75.13 110.407 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.77 171.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 O-C-N 122.096 -0.377 . . . . 50.3 110.077 175.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.522 ' CZ3' ' HB3' ' A' ' 85' ' ' ASP . 23.7 t-105 -97.7 121.2 39.34 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.483 -0.562 . . . . 74.23 109.483 -168.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.427 ' HA ' ' HZ2' ' A' ' 112' ' ' LYS . 33.5 m -73.12 -23.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 112.425 0.528 . . . . 74.54 112.425 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -76.42 11.81 1.45 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.352 0.596 . . . . 71.22 109.959 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.581 ' HB3' HG21 ' A' ' 55' ' ' VAL . 10.5 ptpp? -59.31 -20.07 51.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.298 1.039 . . . . 72.22 112.686 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.33 -24.67 50.78 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.253 0.549 . . . . 43.32 110.481 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.1 145.9 41.65 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.188 -1.782 . . . . 62.43 106.188 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -31.28 125.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 124.192 3.262 . . . . 75.11 112.687 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.82 114.33 13.16 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.477 0.656 . . . . 72.24 109.973 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.401 ' O ' ' HD2' ' A' ' 44' ' ' TYR . 28.0 ttt -84.92 93.42 8.54 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 114.47 1.285 . . . . 73.35 114.47 -171.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -113.96 -16.77 12.12 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.186 -1.783 . . . . 73.54 106.186 167.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.53 -103.59 0.33 Allowed Glycine 0 CA--C 1.481 -2.031 0 CA-C-N 113.578 -1.647 . . . . 62.22 111.638 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -144.28 132.35 21.64 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.527 -0.916 . . . . 74.02 108.527 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.408 ' HE3' ' HA ' ' A' ' 121' ' ' TRP . 0.0 OUTLIER -132.1 167.84 19.02 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 104.645 -2.354 . . . . 74.53 104.645 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.592 ' HB3' ' HG2' ' A' ' 124' ' ' GLU . 9.0 m-20 -80.72 133.53 35.69 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 119.329 -0.948 . . . . 64.52 111.866 -174.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.402 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 90.1 t80 -61.3 -29.45 69.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.764 -1.107 . . . . 74.35 110.524 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.592 ' HG2' ' HB3' ' A' ' 122' ' ' ASP . 10.8 pt-20 -61.3 -38.22 86.03 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 120.997 0.427 . . . . 74.51 110.09 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 129' ' ' VAL . 16.5 tp10 -77.71 -44.28 28.37 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.738 -0.838 . . . . 73.43 108.738 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -55.3 -49.73 71.38 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-N 115.436 -0.802 . . . . 74.41 110.852 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 123' ' ' PHE . 16.7 ptm180 -64.7 -40.07 94.74 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.752 -0.658 . . . . 73.13 112.225 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 m -70.78 -32.41 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.918 -0.713 . . . . 74.43 111.734 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.573 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 88.3 t -67.93 -45.23 84.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 109.009 -0.737 . . . . 74.41 109.009 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -70.52 -39.55 74.02 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.184 -0.606 . . . . 74.24 111.67 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.21 -54.7 42.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.662 0.245 . . . . 62.33 111.662 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 42.5 mt-10 -62.01 -38.16 87.59 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.078 0.466 . . . . 74.24 111.83 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -69.59 -43.68 72.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.555 -0.748 . . . . 64.41 111.965 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -72.24 -40.53 67.65 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.266 0.839 . . . . 72.24 113.266 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.09 -34.2 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 118.952 -0.546 . . . . 64.35 112.421 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 45.7 mt-10 -55.91 -51.82 66.28 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.204 -1.035 . . . . 74.04 108.204 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.3 m -58.63 -50.43 73.86 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.084 -1.416 . . . . 52.55 110.76 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -59.97 -50.48 73.57 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 112.166 0.432 . . . . 75.14 112.166 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -63.25 -53.41 53.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.669 0.618 . . . . 71.31 112.669 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -66.23 -31.73 72.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 112.096 0.406 . . . . 64.41 112.096 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.5 mmt -76.17 -35.56 59.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 119.998 -0.681 . . . . 71.1 109.651 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.8 tp -63.94 -36.67 84.73 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 122.741 0.417 . . . . 63.43 110.599 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.253 -0.43 . . . . 75.23 111.358 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -76.24 -35.38 59.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.815 -0.63 . . . . 72.35 111.017 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.98 -39.6 61.17 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 75.03 112.135 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -99.62 9.36 43.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.32 0.581 . . . . 74.11 109.942 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 38.3 t30 -38.89 117.36 1.04 Allowed Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.592 1.557 . . . . 54.35 112.734 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 147' ' ' ASN . 36.9 Cg_exo -59.53 -19.59 52.94 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 123.907 3.071 . . . . 71.12 113.245 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -74.98 -7.09 52.63 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.206 -0.452 . . . . 54.22 111.551 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.53 -7.63 79.7 Favored Glycine 0 CA--C 1.505 -0.565 0 C-N-CA 121.066 -0.588 . . . . 64.45 113.474 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.61 ' HG2' ' OE2' ' A' ' 155' ' ' GLU . 66.0 mttm -77.73 122.48 25.43 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.877 0.37 . . . . 42.05 111.744 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.8 m -97.44 172.61 7.65 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.252 -0.885 . . . . 45.31 109.388 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 20.6 ptp -56.78 -43.33 80.75 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.372 0.879 . . . . 74.1 113.372 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.86 -10.21 59.37 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.04 0.385 . . . . 70.21 112.04 -176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.61 ' OE2' ' HG2' ' A' ' 151' ' ' LYS . 39.4 tt0 -73.93 -33.07 63.8 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.984 -0.747 . . . . 74.42 108.984 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.12 -25.5 58.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.231 -0.895 . . . . 43.1 109.841 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.45 154.34 4.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.447 -0.946 . . . . 73.21 108.447 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.75 79.08 0.72 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.235 -0.746 . . . . 40.54 111.235 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.3 p -100.56 144.73 29.19 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 123.251 0.621 . . . . 64.04 110.923 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.5 tp -104.76 124.81 50.05 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.592 -0.892 . . . . 74.11 108.592 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.8 165.3 20.37 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.575 -0.898 . . . . 75.11 108.575 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -83.77 -66.27 0.91 Allowed 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.356 -1.35 . . . . 75.15 107.356 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.3 p 51.49 21.53 1.27 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.27 1.428 . . . . 63.43 114.678 175.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.34 -123.74 2.48 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.565 -1.014 . . . . 70.24 110.565 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.305 -1.326 0 N-CA-C 108.76 -0.83 . . . . 51.45 108.76 176.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 C--O 1.236 0.391 0 N-CA-C 108.555 -0.905 . . . . 62.14 108.555 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.2 p -115.7 -31.02 5.96 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.317 0.858 . . . . 71.23 113.317 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 29.9 m -83.39 115.16 21.91 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.354 0.501 . . . . 74.44 112.354 -174.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.5 m 64.04 12.01 6.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.782 0.833 . . . . 70.11 113.098 177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.62 154.45 94.78 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 116.642 -0.253 . . . . 70.12 111.093 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.56 1.75 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.429 2.753 . . . . 45.42 114.35 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -77.94 88.13 4.12 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 108.087 -1.079 . . . . 70.04 108.087 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 p -88.13 145.27 26.02 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.804 0.811 . . . . 71.25 112.296 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -130.3 157.67 41.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.692 -1.14 . . . . 75.52 109.891 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.578 ' HB2' HG12 ' A' ' 104' ' ' VAL . 32.7 m-80 -121.87 127.82 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.765 -0.828 . . . . 75.14 108.765 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.42 120.95 64.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 110.126 -0.324 . . . . 72.13 110.126 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.61 118.83 24.09 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 122.59 0.356 . . . . 72.21 110.275 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.35 160.61 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.314 -0.625 . . . . 73.4 109.314 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -131.15 17.21 5.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.846 0.831 . . . . 74.54 109.998 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.38 159.38 30.07 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 119.897 -1.144 . . . . 73.3 112.603 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.417 ' HB3' HG11 ' A' ' 22' ' ' VAL . 18.3 m 67.11 -74.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.218 1.407 . . . . 73.51 113.946 175.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.585 HG21 HD13 ' A' ' 67' ' ' ILE . 26.1 mt -70.25 -5.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.641 0.777 . . . . 73.31 111.757 -171.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.8 mt -65.87 -30.12 70.68 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.163 -0.681 . . . . 75.13 109.163 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.07 132.21 25.05 Favored Pre-proline 0 N--CA 1.425 -1.712 0 CA-C-N 115.155 -0.93 . . . . 75.42 110.446 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.54 -44.53 4.44 Favored 'Trans proline' 0 C--N 1.359 1.103 1 C-N-CA 125.362 4.041 . . . . 71.45 115.375 -175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -56.68 -42.52 79.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.888 0.699 . . . . 31.13 112.888 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.506 ' O ' HG22 ' A' ' 25' ' ' VAL . 59.4 t -76.18 -35.85 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.279 0.561 . . . . 75.34 110.292 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 31' ' ' ALA . . . -66.74 -32.85 74.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.451 0.643 . . . . 73.44 109.728 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 29' ' ' ARG . . . -73.63 -20.82 60.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.607 -0.724 . . . . 65.14 111.837 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 22' ' ' VAL . 18.6 m -87.71 -23.89 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.381 -0.928 . . . . 74.35 111.195 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.434 ' C ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -87.01 -46.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 116.508 -0.314 . . . . 62.13 110.904 178.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.587 HD12 ' HB2' ' A' ' 31' ' ' ALA . 82.1 mt -93.86 -14.6 25.91 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.793 -0.363 . . . . 74.23 111.958 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.0 t70 73.56 6.86 5.07 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.494 1.14 . . . . 72.41 109.191 -175.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 72.2 mtp180 -144.22 163.81 32.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.22 1.408 . . . . 62.14 107.727 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.6 p -76.69 122.64 24.98 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.21 -0.293 . . . . 74.33 110.21 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.587 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -87.44 156.91 19.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 120.642 0.258 . . . . 54.34 111.052 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -99.93 109.86 22.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.176 -0.609 . . . . 74.1 110.843 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -99.92 142.09 31.86 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.171 -1.048 . . . . 71.31 108.171 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.76 147.54 57.36 Favored Pre-proline 0 C--N 1.289 -2.047 0 N-CA-C 108.751 -0.833 . . . . 74.21 108.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -59.51 135.73 66.65 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.573 2.182 . . . . 64.42 112.219 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.81 156.46 41.31 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.137 -0.69 . . . . 60.1 109.137 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.509 HG21 ' HE2' ' A' ' 61' ' ' LYS . 12.2 p -123.75 126.53 72.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 118.704 -1.198 . . . . 74.41 111.676 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 93' ' ' VAL . 25.1 tp -92.17 90.88 7.51 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.729 0.776 . . . . 74.23 110.864 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.9 p80 -73.08 124.91 26.48 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 114.556 -1.202 . . . . 72.13 109.395 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.45 -16.8 8.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.369 -0.919 . . . . 63.04 112.699 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 62' ' ' VAL . 38.4 m-85 -122.27 155.04 36.74 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 110.108 -0.33 . . . . 63.51 110.108 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.443 ' HD2' ' O ' ' A' ' 43' ' ' ARG . 5.4 t60 -129.27 135.95 49.44 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 42' ' ' HIS . 37.2 ttp180 -88.16 127.18 35.43 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.128 -1.434 . . . . 74.32 107.128 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -100.65 123.05 44.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 106.188 -1.782 . . . . 74.31 106.188 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -76.3 94.03 3.52 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-O 122.014 0.911 . . . . 74.43 109.591 -173.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 52' ' ' PRO . 10.5 mp -81.07 98.76 8.14 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.057 -1.429 . . . . 75.2 112.709 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.551 ' O ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.76 84.36 7.37 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 123.139 1.447 . . . . 72.14 109.276 172.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.91 -53.84 0.13 Allowed Glycine 0 N--CA 1.405 -3.427 0 CA-C-N 113.679 -1.601 . . . . 74.23 110.016 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -93.45 166.99 14.87 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.563 -0.532 . . . . 72.32 109.563 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.91 135.08 1.54 Allowed 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 122.599 2.199 . . . . 64.23 112.73 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.617 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 38.9 p90 44.97 47.26 3.59 Favored Pre-proline 0 N--CA 1.513 2.676 0 N-CA-C 115.383 1.623 . . . . 71.23 115.383 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 51' ' ' TYR 0.265 37.7 Cg_endo -114.93 157.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.231 3.287 . . . . 74.33 114.68 -175.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 52' ' ' PRO . 91.9 m -153.76 166.55 32.5 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 131.684 3.994 . . . . 65.14 104.3 -13.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.419 HG22 ' HA ' ' A' ' 43' ' ' ARG . 49.1 pt -123.19 145.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 119.978 1.263 . . . . 63.13 112.102 175.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -144.82 150.07 16.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 106.763 -1.569 . . . . 64.32 106.763 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 p -94.44 94.34 8.18 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 121.452 0.644 . . . . 64.34 110.283 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -134.82 -57.43 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.823 -1.547 . . . . 64.44 106.823 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -82.23 139.1 34.44 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.839 -1.073 . . . . 64.54 108.622 174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.9 m -78.77 15.09 1.13 Allowed 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.57 0.952 . . . . 62.2 113.57 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.24 -172.06 5.44 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 121.514 0.508 . . . . 64.33 113.461 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HE2' HG21 ' A' ' 37' ' ' VAL . 19.8 ptmt -139.42 140.06 37.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.472 -0.566 . . . . 74.13 109.472 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 41' ' ' TYR . 93.6 t -108.82 124.07 65.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 123.189 0.596 . . . . 73.04 109.575 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.417 HD21 ' CB ' ' A' ' 132' ' ' GLU . 3.4 p-10 -90.27 144.62 25.68 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.475 -1.306 . . . . 74.44 107.475 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.63 -150.38 6.62 Favored Glycine 0 C--N 1.279 -2.619 0 N-CA-C 110.012 -1.235 . . . . 74.24 110.012 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -135.36 145.35 47.29 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.633 -0.827 . . . . 73.35 109.939 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 33' ' ' THR . 31.4 m -103.69 134.56 44.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.517 -0.765 . . . . 65.22 109.435 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.585 HD13 HG21 ' A' ' 17' ' ' ILE . 11.0 mt -86.5 110.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 104.486 -2.413 . . . . 73.33 104.486 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.453 HG22 ' OD1' ' A' ' 10' ' ' ASN . 75.0 p -98.05 162.07 13.41 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.915 -0.584 . . . . 73.14 111.149 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 34.4 70.47 Favored Glycine 0 N--CA 1.436 -1.304 0 O-C-N 123.604 0.565 . . . . 54.55 112.866 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.43 121.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 120.55 -0.46 . . . . 54.22 109.936 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.702 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 42.7 m -81.64 158.61 24.25 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.642 -0.873 . . . . 70.42 108.642 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.6 -40.13 62.37 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.798 1.036 . . . . 73.14 113.798 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 3' ' ' SER . . . -73.64 -32.88 64.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.632 0.73 . . . . 73.11 110.656 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.702 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 3.8 mp0 -73.43 -31.41 63.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.031 -0.986 . . . . 73.24 110.251 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.91 -36.48 83.5 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.607 -1.257 . . . . 73.31 107.607 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.67 -28.11 53.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.416 -1.266 . . . . 74.34 111.913 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.43 ' ND2' HG12 ' A' ' 26' ' ' ILE . 64.2 t30 -75.29 -30.5 60.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.558 -0.857 . . . . 64.14 109.855 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 17' ' ' ILE . 64.7 m-85 -65.72 -34.28 77.82 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.446 0.641 . . . . 64.32 109.822 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.77 -38.43 90.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.838 -1.073 . . . . 64.35 110.526 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.5 -43.6 48.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.532 -0.758 . . . . 75.1 111.307 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -68.0 -64.06 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.829 1.048 . . . . 54.2 113.829 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.16 69.47 1.02 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.633 0.73 . . . . 73.4 110.931 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.36 15.44 2.29 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.055 -0.975 . . . . 64.2 111.776 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -82.59 -42.53 18.15 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.87 0.322 . . . . 73.04 111.87 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -129.01 14.0 6.27 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.602 -1.259 . . . . 44.42 107.602 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -128.28 157.02 42.09 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.172 -1.418 . . . . 74.41 107.172 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HB3' HG23 ' A' ' 110' ' ' VAL . 11.7 pt-20 -129.35 146.68 51.18 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.229 -0.656 . . . . 54.43 109.229 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -83.75 117.09 23.02 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.502 -0.555 . . . . 71.23 109.502 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.07 159.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-O 120.84 0.352 . . . . 55.32 110.982 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.6 m -91.09 129.91 37.04 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 108.314 -0.995 . . . . 63.24 108.314 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.57 168.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.543 -1.28 . . . . 63.03 107.543 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -121.3 128.62 52.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.687 -1.205 . . . . 74.11 109.783 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 38' ' ' LEU . 17.0 m -127.19 168.37 20.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.831 -0.622 . . . . 61.23 109.66 -176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 101' ' ' LYS . 75.0 t -103.44 112.82 38.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.214 -1.032 . . . . 44.35 108.214 172.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -80.51 99.66 8.16 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.738 -1.208 . . . . 73.54 107.738 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.503 ' SD ' ' HG3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.06 -18.08 59.52 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.959 1.304 . . . . 54.51 110.085 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -46.78 -37.33 8.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.602 0.761 . . . . 72.41 111.101 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -137.39 10.13 2.96 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 108.277 -1.009 . . . . 74.13 108.277 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t 60.01 26.41 15.71 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.966 0.889 . . . . 65.41 110.079 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -93.16 160.7 14.73 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.397 -0.82 . . . . 73.21 109.425 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 7.1 mptt -104.31 128.79 52.16 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 106.935 -1.506 . . . . 74.03 106.935 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.74 142.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.389 0.614 . . . . 52.13 111.803 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -89.38 125.81 35.29 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.287 -1.746 . . . . 73.33 106.287 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 10' ' ' ASN . 18.5 m -133.2 174.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 120.587 0.232 . . . . 65.53 110.985 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -100.63 153.29 19.53 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.101 -1.074 . . . . 65.23 108.101 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -155.62 174.72 14.88 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.029 -0.73 . . . . 71.03 109.029 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -106.95 119.19 38.7 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.974 -1.121 . . . . 72.34 107.974 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.4 HG12 HG13 ' A' ' 54' ' ' ILE . 35.7 m -113.36 163.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 109.531 -0.544 . . . . 73.52 109.531 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -70.1 121.92 18.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.792 -0.818 . . . . 52.21 108.792 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 87' ' ' GLU . 3.0 p -68.1 -20.58 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.231 0.538 . . . . 70.42 111.438 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 114' ' ' ASP . 8.2 t30 -89.13 12.13 16.63 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.648 -0.705 . . . . 71.4 110.422 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -51.81 -19.73 1.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.997 1.851 . . . . 74.44 115.997 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.33 -20.89 36.45 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.881 0.848 . . . . 65.31 109.854 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.506 ' HB3' ' ND2' ' A' ' 111' ' ' ASN . 14.5 t70 -91.66 139.09 24.87 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 107.844 -1.169 . . . . 74.04 107.844 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 8.8 Cg_exo -71.85 78.56 1.73 Allowed 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 121.972 1.781 . . . . 75.21 111.984 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -134.53 114.57 12.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 116.084 -0.507 . . . . 52.53 110.171 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 57.02 79.21 0.19 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.405 1.066 . . . . 64.21 112.86 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -142.31 4.6 1.6 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.807 -0.633 . . . . 74.05 110.648 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -105.08 -176.02 24.46 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.847 -0.692 . . . . 53.13 111.843 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -109.14 146.13 34.61 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.988 -0.745 . . . . 71.4 108.988 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -163.74 -5.08 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 O-C-N 123.409 0.443 . . . . 74.34 111.903 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 124' ' ' GLU . 34.6 t70 -127.83 114.65 17.5 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.407 1.262 . . . . 63.01 114.407 -170.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -68.22 -27.32 66.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.157 -0.929 . . . . 74.11 110.321 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.499 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 39.6 tt0 -70.31 -41.12 73.73 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 124.159 0.984 . . . . 73.24 109.761 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 129' ' ' VAL . 10.4 tp10 -56.12 -51.42 67.99 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.943 -1.026 . . . . 62.22 109.073 176.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -71.44 -30.58 66.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.042 -1.463 . . . . 75.2 110.711 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -57.46 -46.17 83.93 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.847 -0.615 . . . . 75.2 109.547 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.31 -38.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 120.494 -0.482 . . . . 75.13 110.987 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 125' ' ' GLU . 92.2 t -67.63 -32.39 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 111.928 0.344 . . . . 71.24 111.928 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -83.06 -37.99 23.13 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 117.82 -1.552 . . . . 72.0 111.079 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.68 76.87 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.632 0.253 . . . . 42.33 111.363 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 22.8 mm-40 -64.35 -37.86 88.99 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 116.156 -0.474 . . . . 62.15 110.639 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -56.03 -42.53 76.65 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 116.245 -0.434 . . . . 53.43 111.133 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -76.45 -44.1 37.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 112.756 0.65 . . . . 73.53 112.756 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 132' ' ' GLU . 14.4 p -59.89 -37.28 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.024 -0.67 . . . . 74.42 111.226 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.594 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 91.9 mt-10 -58.34 -43.68 88.41 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.993 -0.743 . . . . 73.24 108.993 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.9 m -60.84 -50.19 74.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.19 -0.914 . . . . 70.51 110.535 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -63.86 -34.68 78.48 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 111.879 0.326 . . . . 73.24 111.879 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 76.4 mtp180 -63.84 -52.6 59.35 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.67 0.271 . . . . 72.12 110.352 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.503 ' HG3' ' SD ' ' A' ' 96' ' ' MET . 31.3 mmmt -60.95 -44.56 97.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.915 0.709 . . . . 74.45 112.915 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.9 mmt -63.08 -41.34 99.39 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.77 -0.372 . . . . 75.12 110.445 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.27 -46.31 84.25 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.286 -0.415 . . . . 71.14 110.72 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.39 -34.38 77.83 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.173 -0.611 . . . . 73.52 112.013 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -68.86 -29.49 67.8 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.437 0.532 . . . . 73.25 112.437 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.94 -47.03 13.22 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.02 0.438 . . . . 74.05 111.181 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -79.75 -31.89 41.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 73.23 111.73 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -117.79 117.15 35.96 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.939 0.399 . . . . 64.12 111.889 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 -28.72 63.1 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.599 2.199 . . . . 61.24 110.522 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -73.15 -5.21 37.69 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.008 -0.996 . . . . 75.44 112.261 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -70.45 -29.33 70.06 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.405 -1.078 . . . . 33.34 110.405 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.597 ' HE2' ' OE1' ' A' ' 155' ' ' GLU . 2.2 tpmt? -97.09 146.51 24.96 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.048 -1.834 . . . . 74.33 106.048 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.4 m -80.19 155.9 27.18 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.333 -1.347 . . . . 72.4 108.178 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 66.2 mtt -72.09 -44.37 63.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.421 0.526 . . . . 74.53 112.421 -175.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -71.17 -22.01 62.1 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.051 0.929 . . . . 71.04 109.628 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.597 ' OE1' ' HE2' ' A' ' 151' ' ' LYS . 43.5 tt0 -75.76 -40.37 55.44 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.685 -1.143 . . . . 73.04 111.181 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.405 ' HB2' ' HG2' ' A' ' 151' ' ' LYS . . . -68.98 -35.68 77.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.972 -0.558 . . . . 65.12 110.77 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -133.54 116.1 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 115.868 -0.605 . . . . 73.14 111.038 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.79 -34.36 31.23 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.764 -0.731 . . . . 62.4 112.664 -177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.4 p -146.78 128.74 15.46 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.571 0.7 . . . . 72.13 112.556 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.2 mt -128.93 160.39 32.83 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.293 -1.373 . . . . 71.15 107.293 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.24 140.28 32.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.782 0.66 . . . . 73.13 112.782 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 p -90.87 -35.74 14.6 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.531 0.681 . . . . 70.24 109.213 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 43.6 p 53.45 70.47 0.59 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.819 1.247 . . . . 65.21 114.291 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -113.89 -11.73 12.23 Favored Glycine 0 C--O 1.246 0.887 0 N-CA-C 109.635 -1.386 . . . . 51.52 109.635 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 N--CA 1.436 -1.155 0 C-N-CA 124.342 1.057 . . . . 62.55 108.317 178.859 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.283 -0.636 . . . . 63.23 109.283 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 83.8 m -136.87 109.98 7.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.514 -0.55 . . . . 71.22 109.514 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -111.09 140.14 45.89 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 116.57 -0.286 . . . . 73.21 110.654 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -87.1 88.74 7.77 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.395 -0.965 . . . . 72.43 108.395 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.484 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 5.7 m-20 -72.42 121.62 85.29 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.558 -0.747 . . . . 73.42 111.525 -178.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 5' ' ' ASP . 5.8 Cg_exo -77.9 12.56 1.94 Allowed 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 123.154 2.569 . . . . 72.53 113.16 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -76.71 108.2 9.56 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.65 -1.241 . . . . 75.12 107.65 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.2 p -56.66 123.51 15.15 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.326 0.584 . . . . 71.14 109.96 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.508 ' CG ' HD12 ' A' ' 75' ' ' LEU . 69.6 m80 -93.38 156.59 16.69 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.815 -0.629 . . . . 72.44 111.694 -173.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.496 ' HB2' HG12 ' A' ' 104' ' ' VAL . 91.4 m-20 -129.0 133.53 47.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.533 -1.284 . . . . 65.03 107.533 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.5 121.54 63.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.762 -0.375 . . . . 74.2 110.416 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.495 ' HB2' HG21 ' A' ' 104' ' ' VAL . 59.9 t80 -81.9 111.5 18.16 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.053 -1.091 . . . . 75.51 108.053 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 17' ' ' ILE . 95.8 t -120.19 142.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-O 121.488 0.661 . . . . 73.22 110.831 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -99.47 115.44 29.31 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.166 -1.05 . . . . 74.31 108.166 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.19 -68.09 2.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 116.096 1.199 . . . . 45.11 116.096 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.3 t -40.12 -81.26 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.669 2.1 . . . . 73.41 116.669 -167.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.588 ' HB ' HD11 ' A' ' 67' ' ' ILE . 3.1 mp -93.92 27.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 122.074 0.94 . . . . 63.51 109.552 -173.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 65' ' ' LYS . 18.9 mt -74.52 -15.89 60.85 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.406 -0.809 . . . . 73.44 111.654 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.26 134.1 19.87 Favored Pre-proline 0 N--CA 1.435 -1.217 0 CA-C-N 114.872 -1.058 . . . . 71.13 109.975 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.69 -31.6 41.75 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.753 2.968 . . . . 74.2 114.011 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.29 80.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.982 0.42 . . . . 72.13 111.332 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.596 ' O ' HG22 ' A' ' 25' ' ' VAL . 47.8 t -77.36 -34.32 20.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.151 -0.685 . . . . 63.44 109.151 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.31 75.66 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.87 -0.789 . . . . 71.02 108.87 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -71.08 -12.11 61.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.519 -0.764 . . . . 50.35 111.602 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 22' ' ' VAL . 10.6 m -97.94 -35.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 119.665 -0.814 . . . . 74.13 110.513 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.555 HG12 ' ND2' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -80.47 -48.44 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 120.782 0.325 . . . . 73.13 110.909 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 81.0 mt -90.12 -18.01 26.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.365 -0.606 . . . . 51.11 109.365 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 33.3 t70 70.64 8.76 6.69 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.896 1.332 . . . . 70.2 109.283 -175.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -142.0 143.7 33.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 113.757 -1.565 . . . . 73.53 107.721 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -76.45 117.05 17.72 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.545 0.212 . . . . 55.14 111.512 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.423 ' HB2' ' CD1' ' A' ' 27' ' ' LEU . . . -105.72 158.8 16.47 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 116.074 -0.512 . . . . 72.45 110.018 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.94 131.81 46.64 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.694 -0.685 . . . . 72.21 111.965 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 65' ' ' LYS . 3.3 p -103.46 143.81 32.22 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.312 -0.858 . . . . 71.42 110.272 174.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.4 144.94 51.07 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.394 -0.595 . . . . 71.34 109.394 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -68.24 133.77 29.5 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.035 1.823 . . . . 53.11 112.875 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.08 156.61 41.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.156 -0.929 . . . . 65.32 109.397 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.14 129.99 74.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.459 0.647 . . . . 73.13 110.86 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.4 ' HA ' HG12 ' A' ' 93' ' ' VAL . 20.9 tp -88.29 117.3 27.1 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.416 -0.811 . . . . 71.12 109.75 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -94.08 128.84 40.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.059 -0.519 . . . . 52.23 110.507 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 56' ' ' SER . . . 111.67 -4.54 27.72 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.029 -1.081 . . . . 51.02 112.561 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.494 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 63.8 m-85 -124.82 147.42 48.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.242 0.46 . . . . 74.31 112.242 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -117.83 130.06 56.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.56 -1.274 . . . . 72.4 107.56 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.467 ' HA ' HG22 ' A' ' 54' ' ' ILE . 19.4 ptt180 -87.85 140.42 29.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.794 0.438 . . . . 72.22 110.804 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.648 ' CE1' ' HA ' ' A' ' 118' ' ' TYR . 87.5 m-85 -112.22 150.64 30.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.774 -0.37 . . . . 70.22 111.235 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.46 100.66 13.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.66 0.743 . . . . 72.52 111.91 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.67 72.97 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 122.025 0.917 . . . . 53.32 109.915 172.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -83.14 8.78 12.11 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 113.968 1.099 . . . . 72.03 113.968 -175.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.41 -19.19 74.57 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.971 -2.052 . . . . 64.44 107.971 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 3.4 mm? -98.11 168.53 9.81 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 105.498 -2.038 . . . . 71.32 105.498 172.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 49' ' ' LEU . 99.8 Cg_exo -42.47 -65.79 0.18 Allowed 'Trans proline' 0 C--N 1.365 1.431 0 C-N-CA 122.271 1.981 . . . . 61.44 113.891 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.605 ' H ' ' HD2' ' A' ' 52' ' ' PRO . 33.7 m-85 -164.62 -36.44 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 125.366 1.466 . . . . 74.42 113.959 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' ' H ' ' A' ' 51' ' ' TYR . 63.3 Cg_exo -48.96 166.69 0.15 Allowed 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.33 2.02 . . . . 65.14 112.504 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.6 p -135.69 -171.7 2.91 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.445 1.098 . . . . 72.43 112.61 10.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 41' ' ' TYR . 17.6 pt -131.02 150.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 114.076 -1.42 . . . . 61.42 110.109 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 151.71 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.448 -1.686 . . . . 65.11 106.448 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 40' ' ' GLY . 33.0 t -71.34 145.5 49.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.384 0.611 . . . . 73.54 112.073 -174.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -155.05 163.52 40.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.462 -1.31 . . . . 74.42 107.462 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.04 -56.6 4.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.274 0.559 . . . . 75.41 110.887 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 m -91.96 12.18 22.63 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.823 -0.626 . . . . 71.33 111.954 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.52 131.49 10.81 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 120.468 -0.872 . . . . 54.55 111.666 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -136.87 140.15 42.16 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.394 -0.965 . . . . 63.23 108.394 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 41' ' ' TYR . 57.3 t -114.36 122.84 69.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.837 -0.431 . . . . 72.42 109.837 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.7 126.51 37.82 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.528 -0.545 . . . . 62.12 109.528 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.93 -148.56 5.18 Favored Glycine 0 N--CA 1.42 -2.404 0 C-N-CA 120.23 -0.986 . . . . 72.33 111.747 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.679 ' HB2' HD22 ' A' ' 18' ' ' LEU . 44.3 mtmt -139.23 145.77 39.65 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 122.923 0.489 . . . . 74.32 110.53 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.44 134.3 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.415 -0.811 . . . . 64.33 109.827 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.588 HD11 ' HB ' ' A' ' 17' ' ' ILE . 15.3 mt -86.94 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 105.193 -2.151 . . . . 70.2 105.193 178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 161.61 13.48 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.718 -0.393 . . . . 75.14 112.03 -173.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.55 37.2 77.79 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.799 -0.637 . . . . 20.24 112.901 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.43 121.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.653 -0.419 . . . . 74.5 109.97 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.401 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 46.7 m -73.99 158.8 33.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.052 -0.722 . . . . 65.21 109.052 177.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -52.92 -44.08 66.74 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.186 0.439 . . . . 73.5 112.186 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.47 78.49 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.539 0.685 . . . . 62.33 110.143 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 6.9 mm-40 -76.26 -38.69 55.88 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.775 -1.102 . . . . 63.23 110.217 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.508 HD12 ' CG ' ' A' ' 9' ' ' HIS . 3.6 tt -61.57 -37.51 84.13 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.695 -1.224 . . . . 71.1 107.695 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.618 ' O ' HG23 ' A' ' 80' ' ' VAL . 28.5 t-20 -54.71 -28.8 50.54 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 114.272 -1.331 . . . . 73.04 112.239 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.555 ' ND2' HG12 ' A' ' 26' ' ' ILE . 6.3 t30 -73.74 -30.88 63.07 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 118.957 -1.097 . . . . 70.51 109.633 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.592 ' O ' HG22 ' A' ' 81' ' ' ILE . 68.0 m-85 -73.23 -31.12 63.94 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 107.912 -1.144 . . . . 72.43 107.912 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.34 -37.56 63.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.424 -0.807 . . . . 65.42 110.274 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 76' ' ' ASN . 58.3 t -76.41 -27.38 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 N-CA-C 113.475 0.917 . . . . 63.2 113.475 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 78' ' ' PHE . 13.7 tt -59.25 165.15 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 O-C-N 122.053 -0.404 . . . . 72.42 110.339 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -53.97 95.51 0.01 OUTLIER 'General case' 0 C--O 1.242 0.691 0 N-CA-C 114.296 1.221 . . . . 75.4 114.296 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.66 60.21 0.64 Allowed Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 107.848 -2.101 . . . . 63.22 107.848 173.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -57.95 -41.28 82.49 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.739 0.816 . . . . 65.04 112.43 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.518 ' HB3' ' CZ3' ' A' ' 109' ' ' TRP . 8.2 t70 -128.44 24.25 5.86 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.932 -1.507 . . . . 74.11 106.932 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.491 ' CE2' ' HB2' ' A' ' 52' ' ' PRO . 73.8 m-85 -119.2 150.71 39.62 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.453 -1.249 . . . . 70.21 108.695 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.85 144.44 51.31 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.781 -0.451 . . . . 71.54 109.781 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -93.17 114.93 27.56 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.906 -0.775 . . . . 75.04 108.906 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -128.69 161.05 38.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.663 0.785 . . . . 65.25 111.755 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.2 m -90.82 130.72 36.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.136 -1.061 . . . . 53.12 108.136 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.69 159.82 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.407 0.683 . . . . 72.41 109.158 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.68 123.87 46.38 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.3 -0.56 . . . . 61.34 110.545 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 38' ' ' LEU . 23.6 m -125.61 160.72 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 109.469 -0.567 . . . . 70.12 109.469 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 68.8 t -104.36 113.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.03 -0.986 . . . . 71.24 109.12 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -73.38 103.57 4.09 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 108.663 -0.866 . . . . 52.43 108.663 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -29.86 48.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.809 1.644 . . . . 71.12 110.437 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.29 -40.07 64.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.509 0.724 . . . . 73.33 111.729 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -123.95 -3.08 8.16 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.321 0.581 . . . . 72.43 111.025 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t 63.94 26.19 14.11 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.014 0.926 . . . . 61.44 110.013 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 12.9 pt-20 -95.5 160.6 14.44 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.652 -0.704 . . . . 63.51 109.399 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -108.64 130.19 55.33 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.938 -1.134 . . . . 75.43 107.938 -178.473 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.77 144.27 21.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 109.702 -0.481 . . . . 54.34 109.702 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -87.62 127.09 35.28 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.683 0.754 . . . . 72.4 112.652 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.496 HG12 ' HB2' ' A' ' 10' ' ' ASN . 23.1 m -128.33 175.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 113.668 -1.605 . . . . 74.32 109.037 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.457 ' HG3' HD11 ' A' ' 75' ' ' LEU . 10.7 mm-40 -99.4 153.36 19.05 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.064 -0.717 . . . . 74.43 109.064 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 t -159.12 175.25 13.7 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.436 -0.579 . . . . 64.54 109.436 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -107.56 119.34 39.14 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.963 -0.754 . . . . 71.52 108.963 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG12 HG13 ' A' ' 54' ' ' ILE . 31.9 m -114.17 178.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 120.71 -0.396 . . . . 73.25 110.154 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.535 ' NE1' ' HB3' ' A' ' 111' ' ' ASN . 44.9 t-105 -101.54 124.84 47.86 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 -173.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 85' ' ' ASP . 27.6 m -72.66 -26.71 24.2 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-O 121.28 0.562 . . . . 71.54 111.3 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.535 ' HB3' ' NE1' ' A' ' 109' ' ' TRP . 28.4 t-20 -80.01 12.51 2.73 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.732 0.813 . . . . 54.41 110.078 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 109' ' ' TRP . 10.8 ptpp? -51.81 -24.67 6.36 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.362 1.065 . . . . 74.43 112.764 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -90.39 -3.15 57.9 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.143 0.497 . . . . 73.33 112.017 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.41 153.45 39.07 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.485 -0.325 . . . . 64.35 110.275 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.78 110.67 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.632 2.221 . . . . 73.41 111.248 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -133.55 166.77 21.79 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.922 -1.51 . . . . 73.24 106.922 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.24 122.57 5.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.342 -0.984 . . . . 60.22 108.342 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.648 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 54.6 p90 -130.78 5.62 4.64 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 120.904 0.383 . . . . 71.2 111.414 -176.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.21 -155.3 10.8 Favored Glycine 0 C--N 1.299 -1.486 0 N-CA-C 115.537 0.975 . . . . 63.22 115.537 -173.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -93.16 176.32 6.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.376 -0.912 . . . . 74.44 111.478 -177.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -96.61 -57.49 2.29 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.32 1.057 . . . . 72.31 109.26 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 125' ' ' GLU . 33.6 m-20 -124.48 118.73 27.29 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 113.428 -1.715 . . . . 62.04 108.508 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -65.44 -27.47 68.54 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 112.096 0.406 . . . . 62.44 112.096 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -68.51 -49.65 58.06 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.441 -0.577 . . . . 71.23 109.441 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 122' ' ' ASP . 41.4 tt0 -62.83 -44.83 95.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.202 -0.908 . . . . 71.22 110.22 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -66.53 -37.44 85.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.053 -0.521 . . . . 75.2 109.712 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -56.45 -48.37 77.19 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 123.045 0.538 . . . . 75.25 110.311 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.5 m -69.37 -30.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.471 -0.491 . . . . 62.44 112.285 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -75.28 -44.47 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.421 -0.585 . . . . 74.11 109.421 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.47 ' O ' ' HD1' ' A' ' 134' ' ' PHE . 26.3 t-80 -61.37 -40.79 95.6 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.07 -1.085 . . . . 74.31 108.07 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.89 97.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.703 -0.681 . . . . 42.43 111.652 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.436 ' HA ' HG12 ' A' ' 135' ' ' VAL . 36.3 mm-40 -67.81 -26.7 66.21 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 112.095 0.406 . . . . 73.22 112.095 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 8.8 tmtt? -70.71 -55.99 7.41 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.582 -0.896 . . . . 73.52 108.582 176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' ' 130' ' ' HIS . 94.1 m-85 -66.29 -32.04 73.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.006 1.113 . . . . 74.32 114.006 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 11.9 p -62.37 -38.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.017 -0.673 . . . . 71.32 110.648 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -72.16 -32.41 66.83 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 119.593 -0.843 . . . . 71.3 111.277 179.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 80.1 m -61.92 -46.24 90.19 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.841 -0.618 . . . . 73.44 110.287 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -61.41 -34.7 75.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 121.073 -0.251 . . . . 65.1 111.123 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 99.3 mtt180 -70.13 -49.23 52.81 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.106 -0.497 . . . . 74.04 110.681 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 33.4 mmtp -58.51 -43.13 88.98 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.719 -0.474 . . . . 75.03 109.719 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.9 mtm -67.59 -31.17 71.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.693 -0.685 . . . . 63.35 111.295 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.56 -40.47 73.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.68 -0.489 . . . . 72.31 109.68 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 9.5 mm-40 -63.0 -34.16 76.96 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.982 0.896 . . . . 64.51 109.363 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.502 ' HD1' ' HG2' ' A' ' 151' ' ' LYS . 3.3 t-105 -71.87 -44.36 63.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.509 -1.223 . . . . 75.22 108.956 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.49 -37.78 83.35 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 51.22 111.242 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -78.74 -11.71 59.99 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.06 0.763 . . . . 62.33 113.06 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -115.91 131.7 23.59 Favored Pre-proline 0 C--N 1.302 -1.481 0 C-N-CA 120.101 -0.64 . . . . 73.11 112.168 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 151' ' ' LYS . 30.4 Cg_endo -63.61 -14.99 45.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.391 2.728 . . . . 73.23 111.324 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -75.39 -20.63 58.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.265 -0.88 . . . . 64.43 110.121 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -98.76 -63.46 0.85 Allowed Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 108.942 -1.663 . . . . 73.35 108.942 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 73.1 mmtt -97.61 124.0 41.72 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.502 -0.555 . . . . 71.32 109.502 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.4 m -66.75 157.11 33.63 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 109.755 -0.461 . . . . 73.54 109.755 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -60.47 -42.27 95.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.884 0.698 . . . . 72.43 112.884 -174.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.39 -19.69 59.4 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 120.402 -0.519 . . . . 54.43 111.127 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -74.77 -47.6 30.13 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.437 0.637 . . . . 64.2 109.601 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.83 79.49 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.799 -1.091 . . . . 72.52 112.568 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 153' ' ' MET . 14.7 p -115.35 -20.24 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 119.382 -0.927 . . . . 51.25 112.65 -174.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 94.56 141.77 11.82 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.8 -1.32 . . . . 72.12 109.8 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.1 m -62.56 112.42 2.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.518 0.675 . . . . 74.51 111.43 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.16 165.18 27.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.006 -0.997 . . . . 45.34 108.891 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.6 mt -99.36 143.78 29.22 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.582 -1.636 . . . . 72.45 106.582 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -64.45 -56.16 16.07 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.5 m 56.77 -165.62 0.14 Allowed 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.829 0.705 . . . . 75.31 111.528 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.17 -37.67 3.69 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 110.321 -1.112 . . . . 52.24 110.321 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 108.106 -1.072 . . . . 74.25 108.106 176.867 . . . . . . . . 0 0 . 1 stop_ save_